
export const drugData = [
  {
    "cid": "D001",
    "marketInformation": {
      "brandName": "Xalkori",
      "indication": "ALK- or ROS1-positive nonâ€‘small cell lung cancer (NSCLC), as well as certain forms of ALK-positive anaplastic large cell lymphoma (ALCL) and inflammatory myofibroblastic tumors (IMT)",
      "approvedFor": "Pfizer Inc.",
      "approvedCountries": " US,EU.",
      "approvedDate": "2011",
      "genericName": "Generic not available yet",
      "genericApprovedDate": "N/A",
      "potentialGenericAvailability": "Nov, 2029 (based on patent expiration, this can change based on legal challenges and licensing agreements.)",
      "specialStatus": "Orphan Drug Designation available for pediatric ALCL treatment until Jan 14, 2028",
      "patentExclusivityInfo": "",
      "References": ""
    },
    "drugSubstance": {
      "physicalAndChemicalProperties": {
        "chemicalName": "Crizotinib",
        "chemicalStructure": "See media/image1.png",
        "potencyClassification": "",
        "elementalFormula": "C21H22Cl2FN5O",
        "bcsClass": "Class IV (low solubility and low permeability)",
        "molecularWeight": "450.3 g/mol",
        "averageIsotopicMass": "449.11854397 g/mol",
        "structureName": "(R)-3-[1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-5-[1-(piperidin-4-yl)-1H-pyrazol-4-yl]pyridin-2-amine",
        "solubility": "Insoluble in water. Solubility decreases as pH increases, dropping from >10 mg/mL at pH 1.6 to <0.1 mg/mL at pH 8.2.",
        "pka": "Has two pKa values: 9.4 (piperidinium cation) and 5.6 (pyridinium cation).",
        "logp": "The partition coefficient (octanol/water) at pH 7.4 is 1.65.",
        "References": ""
      },
      "processDevelopment": {
        "availableDmfVendors": [
          "LGM Pharma",
          "Chongqing Huapont Pharmaceutical",
          "Navinta",
          "Wuxi further pharmaceutical CO"
        ],
        "vendorReference": "http://pharmacompass.com/manufacturers-suppliers-exporters/crizotinib",
        "potencyClassification": "",
        "manufacturingSites": [
          {
            "vendor": "LGM Pharma",
            "location": "USA"
          },
          {
            "vendor": "Chongqing Huapont Pharmaceutical",
            "location": "China"
          },
          {
            "vendor": "Navinta",
            "location": "USA"
          }
        ],
        "manufacturingRoute": "See Appendix 1",
        "polymorphStudies": "Only one crystalline form has been found, thermodynamically stable form A",
        "regulatoryStartingMaterials": "",
        "rsmAndIntermediateSpecifications": "",
        "drugSubstanceSpecifications": "Appendix 2: DS Specification",
        "forcedDegradationStudies": "Stress studies were performed at high temperatures, and no significant degradation was observed after 14 days stored at 100Â°C. Minor degradation was observed when crizotinib was exposed to strongly acidic, strongly basic, intense light and oxidative conditions.",
        "impurityQualification": "",
        "genotoxicImpuritiesAssessment": "",
        "nitrosaminesAssessment": "",
        "fateOfImpurities": "",
        "cppsAndCqaStudies": "",
        "otherInformation": "",
        "References": ""
      },
      "analyticalDevelopment": {
        "rsmMethods": "",
        "ipcTestMethods": "",
        "finalApiMethods": "",
        "residualSolventRiskAssessment": "",
        "rsmSynthesis": "",
        "stabilityOfDrugSubstance": "",
        "drugSubstanceSites": "Manufacturing, Analytical Testing and Release are performed at: Pfizer Ireland Pharmaceuticals Little Island County Cork Ireland",
        "dsImpurities": "",
        "dsImpurityMethods": "",
        "References": ""
      }
    },
    "drugProduct": {
      "information": {
        "dosageForms": "Capsules, Oral pellets(encapsulated)",
        "strengths": [
          {
            "strength": "200 mg",
            "description": "hard gelatin capsule, size 1, white opaque body and pink opaque cap, with 'Pfizer' on the cap and 'CRZ 200' on the body.",
            "type": "capsule"
          },
          {
            "strength": "250 mg",
            "description": "hard gelatin capsule, size 0, pink opaque cap and body, with 'Pfizer' on the cap and 'CRZ 250' on the body.",
            "type": "capsule"
          },
          {
            "strength": "20 mg",
            "description": "Oral Pellets: hard gelatin capsule, size 4, white opaque body and light blue opaque cap, printed with black ink 'Pfizer' on the cap and 'CRZ 20' on the body.",
            "type": "oral_pellets"
          },
          {
            "strength": "50 mg",
            "description": "Oral Pellets: hard gelatin capsule, size 3, light gray opaque body and gray opaque cap, printed with black ink 'Pfizer' on the cap and 'CRZ 50' on the body.",
            "type": "oral_pellets"
          },
          {
            "strength": "150 mg",
            "description": "Oral Pellets: hard gelatin capsule, size 0, light blue opaque body and cap, printed with black ink 'Pfizer' on the cap and 'CRZ 150' on the body.",
            "type": "oral_pellets"
          }
        ],
        "targetPopulation": "Adults",
        "maximumDailyDose": "1000 mg, 2*250 mg capsules taken twice daily",
        "storageAndShippingConditions": "USP CRT",
        "developmentProgramDesignation": "Xalkori (crizotinib) received multiple developmental program designations from the FDA for different indications, including Breakthrough Therapy, Orphan Drug, Fast Track, Priority Review, and Accelerated Approval. Appendix 3",
        "dpFormulation": "",
        "unmetClinicalNeed": "",
        "manufacturingProcess": "",
        "excipientsgGrade": "",
        "impurities": "",
        "specification": "",
        "testMethods": "",
        "residualSolventsRiskAssessment": "",
        "nitrosamineRiskAssessment": "",
        "stabilityStudies": "",
        "dissolutionStudies": "",
        "baBeStudies": "",
        "foodStudyReports": "",
        "currentLabel": "",
        "dpEmbossingDebossingInfo": "",
        "currentExpirationDating": {
          "oralPellets": "24 months from the date of manufacture",
          "capsules": "15 months from the date of manufacture when first approved by the FDA in 2011. The specific expiration for a particular bottle can be found printed on the outer package."
        },
        "foodInteractions": [
          "Avoid grapefruit products. Grapefruit inhibits CYP3A4 metabolism, which may increase the serum levels of crizotinib.",
          "Take with or without food. High-fat food decreases drug absorption, but not to a clinically significant extent."
        ],
        "drugDrugInteractions": [
          "Avoid St. John's Wort. This herb induces CYP3A4 metabolism, which may reduce serum levels of crizotinib."
        ],
        "packagingAndStorageConditions": {
          "200mg": {
            "description": "Hard gelatin capsule with pink opaque cap and white opaque body, printed with black ink 'Pfizer' on the cap, 'CRZ 200' on the body",
            "packaging": "Bottles of 60 capsules: NDC 0069-8141-20",
            "type": "capsules",
            "storageTemperature": "Store at room temperature 20Â° to 25Â°C (68Â° to 77Â°F); excursions permitted between 15Â° to 30Â°C (59Â° to 86Â°F) [see USP Controlled Room Temperature]."
          },
          "250mg": {
            "description": "Hard gelatin capsule with pink opaque cap and body, printed with black ink 'Pfizer' on the cap, 'CRZ 250' on the body",
            "packaging": "Bottles of 60 capsules: NDC 0069-8140-20",
            "type": "capsules",
            "storageTemperature": "Store at room temperature 20Â° to 25Â°C (68Â° to 77Â°F); excursions permitted between 15Â° to 30Â°C (59Â° to 86Â°F) [see USP Controlled Room Temperature]."
          },
          "20mg": {
            "description": "Hard gelatin capsule, size 4, light blue opaque cap and white opaque body, printed with black ink 'Pfizer' on the cap, 'CRZ 20' on the body",
            "packaging": "Bottles of 60 capsules: NDC 0069-0251-60",
            "type": "oral_pellets",
            "storageTemperature": "Store at room temperature 20Â° to 25Â°C (68Â° to 77Â°F); excursions permitted between 15Â° to 30Â°C (59Â° to 86Â°F) [see USP Controlled Room Temperature]."
          },
          "50mg": {
            "description": "Hard gelatin capsule, size 3, gray opaque cap and light gray opaque body, printed with black ink 'Pfizer' on the cap, 'CRZ 50' on the body",
            "packaging": "Bottles of 60 capsules: NDC 0069-0507-60",
            "type": "oral_pellets",
            "storageTemperature": "Store at room temperature 20Â° to 25Â°C (68Â° to 77Â°F); excursions permitted between 15Â° to 30Â°C (59Â° to 86Â°F) [see USP Controlled Room Temperature]."
          },
          "150mg": {
            "description": "Hard gelatin capsule, size 0, light blue opaque cap and body, printed with black ink 'Pfizer' on the cap, 'CRZ 150' on the body",
            "packaging": "Bottles of 60 capsules: NDC 0069-1500-60",
            "type": "oral_pellets",
            "storageTemperature": "Store at room temperature 20Â° to 25Â°C (68Â° to 77Â°F); excursions permitted between 15Â° to 30Â°C (59Â° to 86Â°F) [see USP Controlled Room Temperature]."
          },

        },
        "labeling": "Appendix 4: Labeling Information",
        "developmentProgramDesignationDetails": "Appendix 5: Development program designation",
        "References": ""
      }
    },

    "appendices": {
      "appendix1": {

        "name": "API Synthetic Route",
        "reference": "https://pubs.acs.org/doi/10.1021/acs.oprd.0c00302",
        "description": "Crizotinib API is manufactured through a stepwise synthetic organic chemistry process that constructs the pyrazole and pyridine rings separately, joins them via ether linkage to the dichloro-fluoroaryl group, and resolves the final product to the R-enantiomer. Manufacturing emphasizes chiral control, impurity management, and recrystallization for purity.",
        "modularSynthesis": {
          "overview": "The synthesis is modular, built from heteroaryl intermediates:",
          "steps": [
            {
              "name": "Pyrazole Core Formation",
              "details": [
                "Constructed from hydrazine derivatives + diketone or equivalent starting materials.",
                "Functionalization introduces the piperidin-4-yl substituent."
              ]
            },
            {
              "name": "Pyridine Intermediate",
              "details": [
                "Prepared via nucleophilic substitution and amination chemistry.",
                "Introduces the amine group at the 2-position."
              ]
            },
            {
              "name": "Ether Coupling",
              "details": [
                "Key step: O-alkylation (ether formation) between the pyridine ring and the dichloro-fluorophenyl moiety.",
                "Typically achieved under basic conditions with appropriate leaving groups."
              ]
            },
            {
              "name": "Chiral Resolution / Enantioselective Step",
              "details": [
                "The API used in Xalkori is the R-enantiomer.",
                "Resolution achieved either by:",
                "Chiral chromatography, or",
                "Diastereomeric salt formation and recrystallization, depending on scale."
              ]
            },
            {
              "name": "Final Purification & Salt Form",
              "details": [
                "API is isolated as crizotinib free base (not a salt form).",
                "Purified by recrystallization, meeting ICH impurity thresholds."
              ]
            },
            {
              "name": "Crizotinib (PF-02341066) | Route overview",
              "details": ["3-position ether on pyridine via Mitsunobu from the benzylic alcohol",
                "5-position arylâ€“aryl bond via Suzukiâ€“Miyaura to install the pyrazol-4-yl-piperidin-4-yl fragment",
                "Nitro â†’ amine reduction on the pyridine core (gives the 2-amine)"],
            }
          ]
        },
        "processDocumentation": "Pfizer's published process-development paper plus process patents that describe scalable conditions.",
        "synthesisSteps": [
          {
            "step": "A",
            "title": "Chiral benzylic alcohol",
            "description": "Prepare (S)-1-(2,6-dichloro-3-fluorophenyl)ethanol (enantiopure). In Pfizer's enabling route the downstream Mitsunobu inverts this center, delivering the (R) configuration in the API.",
            "links": [
              "https://www.researchgate.net/publication/278699491_Fit-for-Purpose_Development_of_the_Enabling_Route_to_Crizotinib_PF-02341066?utm_source=chatgpt.com"
            ]
          },
          {
            "step": "B",
            "title": "Mitsunobu etherification (installs the 3-ethoxy)",
            "description": "substrates: 5-bromo-3-hydroxy-2-nitropyridine + (S)-benzylic alcohol,conditions: Typical conditions (scaleable): PPhâ‚ƒ / DIAD, toluene, 0--25 Â°C â†’ then EtOH crystallization to purge TPPO; delivers 5-bromo-3-[1-(2,6-dichloro-3-fluorophenyl)ethoxy]-2-nitropyridine in ~80--90% yield with retained ee after inversion.yield: ~80--90% yield with retained ee after inversion,",
            "links": [
              "https://www.researchgate.net/publication/278699491_Fit-for-Purpose_Development_of_the_Enabling_Route_to_Crizotinib_PF-02341066?utm_source=chatgpt.com",
              "https://pmc.ncbi.nlm.nih.gov/articles/PMC8173612/?utm_source=chatgpt.com",
              "https://pubs.acs.org/doi/10.1021/acsomega.1c01996?utm_source=chatgpt.com",
              "https://patents.google.com/patent/US9604966B2/en?utm_source=chatgpt.com"
            ]
          },
          {
            "step": "C",
            "title": "Chemoselective nitro â†’ amine reduction (builds the 2-amine)",
            "description": "method: Hydrogenation (Hâ‚‚, sponge-Ni or Raney-Ni, MeOH, ambient--40 Â°C) converts the nitro to give (R)-5-bromo-3-[1-(2,6-dichloro-3-fluorophenyl)ethoxy]pyridin-2-amine.,product: (R)-5-bromo-3-[1-(2,6-dichloro-3-fluorophenyl)ethoxy]pyridin-2-amine (CAS 877399-00-3)",
            "links": [
              "https://www.lookchem.com/casno877399-52-5.html?utm_source=chatgpt.com",
              "https://www.ruifuchemical.com/cas-877399-00-3-product/?utm_source=chatgpt.com"
            ]
          },
          {
            "step": "D",
            "title": "Pyrazolyl-piperidine boron partner",
            "description": "Prepare 1-(1-Boc-4-piperidinyl)-1H-pyrazol-4-yl boronic acid/ester. This is the coupling partner for the 5-bromo pyridinamine.",
            "links": [
              "https://www.ruifuchemical.com/cas-877399-00-3-product/?utm_source=chatgpt.com",
              "https://patents.google.com/patent/US9604966B2/en?utm_source=chatgpt.com"
            ]
          },
          {
            "step": "E",
            "title": "Suzuki--Miyaura at C-5 of pyridine",
            "description": "substrates: (R)-5-bromo pyridin-2-amine (from Step C) + Boc-protected pyrazolyl-piperidinyl boronic acid,conditions: Representative conditions: Pd(PPhâ‚ƒ)â‚„, Naâ‚‚COâ‚ƒ (aq), DMF/Hâ‚‚O, âˆ¼60 Â°C, giving the Boc-protected crizotinib precursor in high yield, chromatography-free.",
            "links": [
              "https://patents.google.com/patent/US9604966B2/en?utm_source=chatgpt.com",
              "https://commonorganicchemistry.com/Rxn_Pages/Suzuki/Suzuki.htm?utm_source=chatgpt.com"
            ]
          },
          {
            "step": "F",
            "title": "Global deprotection / finish",
            "description": "method: Acidolysis of Boc (e.g., HCl/EtOH or HCl/dioxane) â†’ neutralization/recrystallization to the free base crizotinib.",
            "links": [
              "https://patents.google.com/patent/US9604966B2/en?utm_source=chatgpt.com",
              "https://www.ema.europa.eu/en/documents/assessment-report/xalkori-epar-public-assessment-report_en.pdf?utm_source=chatgpt.com"
            ]
          }, {
            "step": "G",
            "title": "Why this is the industrial route",
            "description": "Chiral center control: single inversion at Mitsunobu gives the desired (R) configuration with no racemization; ee is preserved through downstream steps.Robust scale-ups: chromatography-free EtOH crystallizations purge TPPO; sponge-Ni Hâ‚‚ reduction and Suzuki run cleanly at moderate T.  Proven at >100 kg scale in Pfizerâ€™s process-development report.",
            "links": [
              "https://www.researchgate.net/publication/278699491_Fit-for-Purpose_Development_of_the_Enabling_Route_to_Crizotinib_PF-02341066?utm_source=chatgpt.com",
              "https://pmc.ncbi.nlm.nih.gov/articles/PMC8173612/?utm_source=chatgpt.com",
              "https://pubs.acs.org/doi/10.1021/op200131n?utm_source=chatgpt.com"
            ]
          }
        ],

        "currentManufacturers": "Pfizer sites across the globe"
      },
      "appendix2": {
        "name": "DS Specification",
        "specifications": {
          "description": "A white pale-yellow powder. Non-hygroscopic",
          "assay": "",
          "relatedSubstances": "",
          "chiral": "",
          "polymorph": "Amorphous form is used",
          "idByHplc": "",
          "idByFtir": "",
          "particleSizeDistribution": "",
          "residueOnIgnition": "",
          "heavyMetals": "",
          "palladium": "Limit set as per EMA/CHMP/SWP/4666/2000 Option 2a"
        }
      },
      "appendix3": {
        "name": "Formulation Composition",
        "note": "All excipients used in the formulation are compendial and conventional for solid oral dosage forms.",
        "inactiveIngredients": {
          "SILICON DIOXIDE (UNII: ETJ7Z6XBU4)": "",
          "MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)": "",
          "ANHYDROUS DIBASIC CALCIUM PHOSPHATE (UNII: L11K75P92J)": "",
          "MAGNESIUM STEARATE (UNII: 70097M6I30)": "",
          "GELATIN, UNSPECIFIED (UNII: 2G86QN327L)": "",
          "TITANIUM DIOXIDE (UNII: 15FIX9V2JP)": "",
          "FERRIC OXIDE RED (UNII: 1K09F3G675)": "",
          "SHELLAC (UNII: 46N107B71O)": "",
          "PROPYLENE GLYCOL (UNII: 6DC9Q167V3)": "",
          "AMMONIA (UNII: 5138Q19F1X)": "",
          "POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)": "",
          "FERROSOFERRIC OXIDE (UNII: XM0M87F357)": "",
          "SODIUM STARCH GLYCOLATE TYPE A (UNII: H8AV0SQX4D)": ""
        }
      },
      "appendix4": {

        "name": "Labeling Information",
        "labels": [
          { "label": "250 mg Capsule Bottle", "image": "image2" },
          { "label": "200 mg Capsule Bottle", "image": "image3" },
          { "label": "20 mg Oral Pellets", "image": "image4" },
          { "label": "50 mg Oral Pellets", "image": "image5" },
          { "label": "150 mg Oral Pellets", "image": "image6" }
        ]
      },
      "appendix5": {
        "name": "Development Program Designation",
        "description": "Xalkori (crizotinib) received multiple developmental program designations from the FDA for different indications, including Breakthrough Therapy, Orphan Drug, Fast Track, Priority Review, and Accelerated Approval.",
        "designations": {
          "Breakthrough Therapy": [
            "ROS1-positive non-small cell lung cancer (NSCLC): In April 2015, the FDA granted Breakthrough Therapy status for Xalkori in treating patients with ROS1-positive NSCLC.",
            "MET exon 14 alterations: In May 2018, Xalkori received Breakthrough Therapy designation for treating patients with metastatic NSCLC who have MET exon 14 alterations.",
            "ALK-positive anaplastic large cell lymphoma (ALCL): At the same time in May 2018, it also received this designation for treating relapsed or refractory ALK-positive ALCL."
          ],
          "Orphan Drug": [
            "Anaplastic lymphoma kinase (ALK)-positive NSCLC: This designation was given in September 2010 to encourage the development of the drug for this rare form of lung cancer.",
            "ALK-positive anaplastic large cell lymphoma (ALCL): In September 2012, Xalkori was designated as an Orphan Drug for ALCL.",
            "ALK-positive inflammatory myofibroblastic tumor (IMT): The FDA also granted this designation for treating ALK-positive IMT."
          ],
          "Fast Track": [
            "ALK-positive advanced NSCLC: This designation was given in December 2010 to expedite the review of Xalkori for patients with ALK-positive NSCLC."
          ],
          "Accelerated Approval and Priority Review": [
            "ALK-positive NSCLC: The FDA granted accelerated approval for Xalkori for ALK-positive NSCLC in August 2011, reflecting the drug's potential for a serious condition.",
            "ROS1-positive NSCLC: In March 2016, the FDA approved Xalkori for ROS1-positive NSCLC and granted the application Priority Review status."
          ]
        }
      }
    },


    "references": [
      {
        "title": "Pfizer OPRD process paper (six-step enabling route; Mitsunobu â†” Suzuki â†” Hâ‚‚/Ni): de Koning et al. 2011.",
        "url": "https://pubs.acs.org/doi/10.1021/op200131n"
      },
      {
        "title": "Process patent with explicit conditions (Mitsunobu in THF/toluene; Suzuki in DMF/Naâ‚‚COâ‚ƒ; Boc deprotection HCl/EtOH): US 9,604,966.",
        "url": "https://patents.google.com/patent/US9604966B2/en"
      },
      {
        "title": "J. Med. Chem. chemistry note (Mitsunobu of 5-bromo-3-hydroxy-2-nitropyridine alcoholates to intermediates): design paper.",
        "url": "https://pubs.acs.org/doi/10.1021/jm401805h"
      },
      {
        "title": "Commercial intermediates listing (confirms structures/CAS used on route): Ruifu Chemical.",
        "url": "https://www.ruifuchemical.com/cas-877399-00-3-product/"
      },
      {
        "title": "EMA EPAR (API as free base in product): Xalkori (crizotinib).",
        "url": "https://www.ema.europa.eu/en/documents/assessment-report/xalkori-epar-public-assessment-report_en.pdf"
      }
    ]
  },
  {
    "cid": "D002",
    "marketInformation": {
      "brandName": "Exblifep (cefepime and enmetazobactam)",
      "indication": "complicated urinary tract infections (cUTI) including pyelonephritis, caused by susceptible strains of Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Proteus mirabilis, and Enterobacter cloacae complex.",
      "approvedFor": "Allecra Therapeutics",
      "approvedCountries": "United States, European Union, United Kingdom, Switzerland, Norway, Gulf Cooperation Council (GCC) Countries: Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the United Arab Emirates, South Africa",
      "approvedDate": "22 Feb 2024",
      "genericName": "Cefepime and enmetazobactam",
      "genericApprovedDate": "N/A",
      "potentialGenericAvailability": "Not available",
      "specialStatus": "Exblifep (cefepime and enmetazobactam) has been granted several special statuses by the U.S. Food and Drug Administration (FDA) to incentivize the development of new anti-infective drugs. These statuses, which were granted to Exblifep's manufacturer, Allecra Therapeutics, include: Qualified Infectious Disease Product (QIDP) status: This designation is given to antibacterial or antifungal drugs that treat serious or life-threatening infections. QIDP is intended to combat the growing threat of antimicrobial resistance. Fast Track designation: This process is designed to expedite the review of drugs that treat serious conditions and fill an unmet medical need. These designations provided Allecra with significant incentives: Priority Review: QIDP status makes the drug eligible for a faster-than-normal review process by the FDA. Market Exclusivity Extension: Under the Generating Antibiotic Incentives Now (GAIN) Act, which created the QIDP designation, Exblifep was awarded an additional five years of market exclusivity.",
      "patentExclusivityInfo": "Exblifep has patent exclusivity information that includes an estimated generic launch date in November 2034, a 5-year market exclusivity extension through the GAIN Act, and several US patents filed in 2024 that have not yet expired. Its patent challenges can begin in 2033.",
    },
    "drugSubstance": {
      "physicalAndChemicalProperties": {
        "chemicalName": {
          "Cefepime": "",
          "Enmetazobactam": ""
        },
        "chemicalStructure": {
          "Cefepime": "structure image",
          "Enmetazobactam": "structure image"
        },
        "potencyClassification": "",
        "elementalFormula": {
          "Cefepime": "C19H24N6O5S2",
          "Enmetazobactam": "C11H14N4O5S"
        },
        "bcsClass": {
          "Cefepime": "BCS Class III",
          "Enmetazobactam": "Not available"
        },
        "molecularWeight": {
          "Cefepime": "480.6 g/mol",
          "Enmetazobactam": "314.32 g/mol"
        },
        "averageIsotopicMass": {
          "Cefepime": "480.12496023 Da (monoisotopic mass)",
          "Enmetazobactam": "314.06849073 Da"
        },
        "structureName":   { "Cefepime": "1-[[(6R,7R)-7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-1-methyl-pyrrolidinium, monochloride, monohydrate.",
          "Enmetazobactam": "(2S,3S,5R)-3-methyl-3-[(3-methyltriazol-3-ium-1-yl)methyl]-4,4,7-trioxo-4Î»6-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate."}
        ,
        "solubility": {
          "Cefepime": {
            "cefepimeHydrochloride": {
              "description": "The form of cefepime used for injectable medication is a hydrochloride salt, which is formulated for high solubility in water.",
              "water": "It is highly and easily soluble in water. The hydrochloride salt is added to the formulation specifically to enhance its aqueous solubility.",
              "aqueousSolutions": "Cefepime hydrochloride is readily soluble in various aqueous solutions, including IV solutions and phosphate-buffered saline (PBS). A solubility of approximately 10 mg/ml in PBS (pH 7.2) has been reported.",
              "methanol": "Cefepime dihydrochloride hydrate is reported as soluble in methanol.",
              "ethanol": "It is only slightly soluble in ethanol."
            },
            "pureCefepime": {
              "description": "The base compound, which is a zwitterion (containing both positive and negative charges), is less soluble in water than its hydrochloride salt.",
              "water": "Pure cefepime is considered only slightly soluble or sparingly soluble in water. PubChem reports a solubility of 0.0173 mg/ml in water.",
              "dmso": "It is soluble in organic solvents like dimethyl sulfoxide (DMSO). For example, cefepime hydrochloride hydrate has a solubility of about 0.2 mg/ml in DMSO"
            }
          },
          "Enmetazobactam": {
            "dmso": "Enmetazobactam is known to be soluble in DMSO, a common solvent in scientific research.",
            "ethanol": "soluble in Ethanol",
            "water": "It is sparingly soluble in pure water, meaning its solubility is less than 1 mg/mL.",
            "formulationWithSBECD": "Formulations combining enmetazobactam with sulfobutylether-Î²-cyclodextrin (SBE-Î²-CD) in saline can achieve higher concentrations, such as â‰¥ 2.08 mg/mL.",
            "solventCombinations": "When preparing the drug for use in animal studies, protocols combine DMSO stock solution with 20% SBE-Î²-CD in Saline to create a higher concentration solution.",
            "concentrationAndTemperature": "Solubility can increase with higher concentration or elevated temperatures, as seen with its solubility in water at 40Â°C compared to 25Â°C."
          }
        },
        "pka": {
          "Cefepime": {
            "strongestAcidic": "2.82 (predicted) Chemaxon",
            "strongestBasic": "3.62 (predicted)"
          },
          "Enmetazobactam": {
            "strongestAcidic": "2.09 (predicted) (Chemaxon)",
            "strongestBasic": "2.83 (predicted)"
          }
        },
        "logp": {
          "Cefepime": {
            "alogps": "-0.37 (predicted)",
            "chemaxon": "-4.2 (predicted)"
          },
          "Enmetazobactam": {
            "chemaxon": "-4.6 (predicted)"
          }
        },
      },
      "processDevelopment": {
        "availableDmfVendors": {
          "Cefepime": ["Orchid Pharma"],
          "Enmetazobactam": ["Orchid Pharma", "Cipla"]
        },
        "vendorReference": "https://www.pharmacompass.com/manufacturers-suppliers-exporters/cefepime",
        "potencyClassification": {
          "CefepimeHydrochloride": "One material safety data sheet (MSDS) sets a specific OEL for cefepime hydrochloride at 500 g/m3. Other SDS documents note that official agencies like OSHA or ACGIH have not established an OEL for cefepime, so the OEL would be based on the manufacturer's internal guidance.",
          "Enmetazobactam": "No information found"
        },
        "manufacturingSites": {
          "Cefepime": [
            { "vendor": "Orchid pharma", "location": "" },
            { "vendor": "Kopran R.L", "location": "" },
            { "vendor": "Sterile India", "location": "" },
            { "vendor": "Nectar life sciences", "location": "" },
            { "vendor": "Actiza Pharmacutical", "location": "" },
            { "vendor": "SETV Global", "location": "" },
            { "vendor": "NCPC Hebei Huamin pharmaceutical Co, Ltd", "location": "" },
            { "vendor": "Qilu pharmaceutical", "location": "" },
            { "vendor": "Sinoway industrial Co; Ltd", "location": "" },
            { "vendor": "Hangzhou Viwa", "location": "" },
            { "vendor": "Guangzhou Pi&Pi Biotech", "location": "" },
            { "vendor": "Shenzhen SalubrisACS Dobfar", "location": "" },
            { "vendor": "Sandoz", "location": "" },
            { "vendor": "Corden pharma", "location": "" },
            { "vendor": "Berr chem", "location": "" },
            { "vendor": "API Corp", "location": "" },
            { "vendor": "Antibioticos do Brasila", "location": "" }
          ],
          "Enmetazobactam": [
            { "vendor": "Orchid Pharma", "location": "" }
          ]
        }
        ,
        "manufacturingRoute": {
          "route1": {
            "name": "Route using 7-ACA and N-methylpyrrolidine",
            "description": "This pathway involves three main steps, as outlined in a Google Patent filing.",
            "synthesisDetails": "Synthesis details based on patent CN107201391B. A representative synthetic route found in patent literature, which is likely similar to an industrial process like Orchid's, is as follows:",
            "steps": [
              {
                "step": "Step 1",
                "description": "Starts with a cephalosporin derivative like GCLE. The C-7 amino group is protected by a phenylacetyl group. The C-3 acetoxymethyl group is converted to a chloromethyl group using trifluoroacetic acid."
              },
              {
                "step": "Step 2",
                "description": "The C-3 chloromethyl group undergoes nucleophilic substitution with N-methylpyrrolidine to form 7-phenylacetamido-3-[(1-methylpyrrolidinio)methyl]-3-cephem-4-carboxylic acid (3-NMP-DGCLE)."
              },
              {
                "step": "Step 3",
                "description": "The C-7 amino group is deprotected (cleaved) using an enzyme like immobilized penicillin acylase, yielding the key intermediate 7-amino-3-[(1-methylpyrrolidinio)methyl]-3-cephem-4-carboxylic acid (7-ACP)."
              },
              {
                "step": "Step 4",
                "description": "The C-7 amino group of 7-ACP is acylated with the AE-active ester to produce cefepime. The final product is then converted into dihydrochloride salt."
              }
            ],
            "note": "Specific process variations, including solvents, catalysts, and conditions, are often proprietary to manufacturers like Orchid Pharma, optimized for cost, yield, and purity.",
          },
          "route2": {
            "name": "Route using GCLE (7-phenylacetamido-3-chloromethyl-3-cephem-4-carboxylic acid)",
            "description": "An alternative pathway described in patent literature uses GCLE as an early-stage intermediate.",
            "steps": [
              {
                "step": "1",
                "description": "Starting material: GCLE."
              },
              {
                "step": "2",
                "description": "Intermediates: 3-NMP-DGCLE: GCLE reacts with N-methylpyrrolidine to form 7-phenylacetamido-3-[(1-methyltetrahydropyrrole)methyl]-3-cephem-4-carboxylic acid. 7-ACP: Enzymatic deacylation of 3-NMP-DGCLE is performed to remove the phenylacetamido group and form 7-amino-3-[(1-methyltetrahydropyrrole)methyl]-3-ceph-4-carboxylic acid hydrochloride (7-ACP)."
              },
              {
                "step": "3",
                "description": "Final step: The 7-ACP is reacted with an AE-active ester in an acylation step to produce cefepime."
              }
            ]
          }
        },
        "polymorphStudies": "",
        "regulatoryStartingMaterials": {
          "startingMaterials": [
            {
              "name": "7-aminocephalosporanic acid (7-ACA)",
              "description": "This is the core cephalosporin building block."
            },
            {
              "name": "ð‘-Methylpyrrolidine",
              "description": "Used to add the characteristic side chain at the C-3 position of the cephalosporin nucleus."
            },
            {
              "name": "(Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetic acid active ester (AE-active ester)",
              "description": "This provides the C-7 side chain."
            }
          ],
          "keyIntermediates": [
            {
              "name": "3-Chloromethyl derivative",
              "description": "The acetoxymethyl group of 7-ACA is first converted to a 3-chloromethyl group. This is often achieved using reagents like iodotrimethylsilane (TMSI) or other halogenating agents."
            },
            {
              "name": "7-phenylacetamido-3-(chloromethyl)-3-cephem-4-carboxylic acid (GCLE or DGCLE)",
              "description": "A precursor where the C-7 amino group is protected with a phenylacetyl group and the C-3 position has a chloromethyl group."
            },
            {
              "name": "7-amino-3-[(1-methyl-1-pyrrolidine)methyl]-3-cephem-4-carboxylic acid (7-ACP)",
              "description": "This is a crucial late-stage intermediate. It is formed by reacting the 3-chloromethyl derivative with ð‘-methylpyrrolidine, followed by deacylation of the C-7 amino group using an enzyme like penicillin acylase."
            }
          ]
        },
        "rsmAndIntermediateSpecifications": "",
        "drugSubstanceSpecifications": "Appendix 2: DS Specification",
        "forcedDegradationStudies": "",
        "impurityQualification": "",
        "genotoxicImpuritiesAssessment": "",
        "nitrosaminesAssessment": "",
        "fateOfImpurities": "",
        "cppsAndCqaStudies": "",
        "otherInformation": "",

      },
      "analyticalDevelopment": {
        "rsmMethods": "",
        "ipcTestMethods": "",
        "finalApiMethods": "",
        "residualSolventRiskAssessment": "",
        "rsmSynthesis": "",
        "stabilityOfDrugSubstance": "",
        "drugSubstanceSites": "",
        "dsImpurities": "",
        "dsImpurityMethods": "",
      }
    },
    "drugProduct": {
      "information": {
        "dosageForms": "Intravenous use â€” supplied as a sterile powder for reconstitution in single-dose vials containing 2 g cefepime + 0.5 g enmetazobactam (2.5 g/vial). EMEA wording: powder for concentrate for solution for infusion; strength 2 g/0.5 g per vial",
        "strengths": [
          {
            "strength": "2.5 grams per vial",
            "composition": "2 grams cefepime and 0.5 grams enmetazobactam",
            "description": "powder for reconstitution in single-dose vials",
            "type": "powder for reconstitution"
          },
          {
            "strength": "1.25 grams",
            "composition": "1 gram cefepime and 0.25 grams enmetazobactam",
            "description": "Reduced dose for patients with renal impairment",
            "type": "powder for reconstitution"
          },
          {
            "strength": "0.625 grams",
            "composition": "0.5 grams cefepime and 0.125 grams enmetazobactam",
            "description": "Maintenance dose for severe renal impairment or hemodialysis",
            "type": "powder for reconstitution"
          }
        ],
        "dosingTable": {
          "description": "The recommended dosage of EXBLIFEP in patients 18 years of age and older with varying degrees of renal function is described in Table 1. For patients with changing renal function, monitor serum creatinine concentrations and eGFR at least daily and adjust the dosage of EXBLIFEP accordingly.",
          "notes": [
            "a As calculated using the Modification of Diet in Renal Disease (MDRD) formula",
            "b The total duration of treatment is for 7 to 14 days.",
            "c In patients requiring intermittent hemodialysis, complete the hemodialysis session before the start of EXBLIFEP dosing. Whenever possible, administer cefepime and enmetazobactam at the same time each day."
          ],
          "regimenByRenalFunction": [
            {
              "eGFR_mL_per_min": "Greater than or equal to 130",
              "dose": "EXBLIFEP 2.5 grams (2 grams cefepime and 0.5 grams enmetazobactam)",
              "dosingInterval": "Every 8 hours",
              "infusionTime": "4 hours"
            },
            {
              "eGFR_mL_per_min": "90 to 129",
              "dose": "EXBLIFEP 2.5 grams (2 grams cefepime and 0.5 grams enmetazobactam)",
              "dosingInterval": "Every 8 hours",
              "infusionTime": "2 hours"
            },
            {
              "eGFR_mL_per_min": "60 to 89",
              "dose": "EXBLIFEP 2.5 grams (2 grams cefepime and 0.5 grams enmetazobactam)",
              "dosingInterval": "Every 8 hours",
              "infusionTime": "2 hours"
            },
            {
              "eGFR_mL_per_min": "30 to 59",
              "dose": "EXBLIFEP 1.25 grams (1 gram cefepime and 0.25 grams enmetazobactam)",
              "dosingInterval": "Every 8 hours",
              "infusionTime": "2 hours"
            },
            {
              "eGFR_mL_per_min": "15 to 29",
              "dose": "EXBLIFEP 1.25 grams (1gram cefepime and 0.25 grams enmetazobactam)",
              "dosingInterval": "Every 12 hours",
              "infusionTime": "2 hours"
            },
            {
              "eGFR_mL_per_min": "less than 15 or receiving intermittent hemodialysis",
              "dose": "Loading dose of EXBLIFEP 1.25 grams (1 gram cefepime and 0.25 grams enmetazobactam) on the first day of treatment, followed by EXBLIFEP 0.625 grams (0.5 grams cefepime and 0.125 grams enmetazobactam)",
              "dosingInterval": "Every 24 hours",
              "infusionTime": "2 hours"
            }
          ]
        },
        "targetPopulation": "Adults (â‰¥18 years). Pediatric use has not been established",
        "maximumDailyDose": "7.5 g/day total delivered as 2g of cefepime and 0.5g of enmetazobactam every 8 hours 7 days up to 14 days",
        "storageAndShippingConditions": "Store EXBLIFEP vials refrigerated at 2Â°C to 8Â°C (36Â°F to 46Â°F); excursions are permitted to 15Â°C to 25Â°C (59Â°F to 77Â°F) [see USP, Controlled Room Temperature (CRT)]. Keep the vials in the outer carton to protect from light.",
        "developmentProgramDesignation": "",
        "dpFormulation": "",
        "unmetClinicalNeed": "",
        "manufacturingProcess": "",
        "excipientsgGrade": "",
        "impurities": "",
        "specification": "",
        "testMethods": "",
        "residualSolventsRiskAssessment": "",
        "nitrosamineRiskAssessment": "",
        "stabilityStudies": "",
        "dissolutionStudies": "",
        "baBeStudies": "",
        "foodStudyReports": "",
        "currentLabel": "",
        "dpEmbossingDebossingInfo": "",
        "currentExpirationDating": "",
        "foodInteractions": "",
        "drugDrugInteractions": "",
        "packagingAndStorageConditions": {
          "description": "clear glass vials sealed with a rubber stopper (not made with natural rubber latex) and an aluminum overseal. Each vial is supplied in cartons of 10 vials (NDC 83289-101-02)",
          "packaging": "cartons of 10 vials",
          "ndc": "NDC 83289-101-02",
          "type": "vials",
          "storageTemperature": "Store EXBLIFEP vials refrigerated at 2Â°C to 8Â°C (36Â°F to 46Â°F); excursions are permitted to 15Â°C to 25Â°C (59Â°F to 77Â°F) [see USP, Controlled Room Temperature (CRT)]. Keep the vials in the outer carton to protect from light."
        },
        "labeling": "",
        "developmentProgramDesignationDetails": "Appendix 6: Development program designation",
        "References": ""
      }
    },
    "appendices": {
      "appendix1": {
        "name": "API Synthetic route",
        "reference": "",
        "description": "See manufacturing route in processDevelopment section",
        "modularSynthesis": {},
        "processDocumentation": "",
        "synthesisSteps": [],
        "currentManufacturers": ""
      },
      "appendix2": {
        "name": "DS Specification",
        "specifications": {
          "description": "",
          "assay": "",
          "relatedSubstances": "",
          "chiral": "",
          "polymorph": "",
          "idByHplc": "",
          "idByFtir": "",
          "particleSizeDistribution": "",
          "residueOnIgnition": "",
          "heavyMetals": "",
          "palladium": ""
        }
      },
      "appendix3": {
        "name": "Formulation Composition",
        "description": "All excipients used in the formulation are compendial and are conventional for solid oral dosage forms.",
        "inactiveIngredients": {
          "SHELLAC (UNII: 46N107B71O)": "",
          "PROPYLENE GLYCOL (UNII: 6DC9Q167V3)": "",
          "AMMONIA (UNII: 5138Q19F1X)": "",
          "POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)": "",
          "FERROSOFERRIC OXIDE (UNII: XM0M87F357)": "",
          "SODIUM STARCH GLYCOLATE TYPE A (UNII: H8AV0SQX4D)": ""
        }
      },
      "appendix4": {
        "name": "Preparation of Exblifep",
        "description": "EXBLIFEP is supplied as a dry powder in a single-dose vial that must be reconstituted and further diluted prior to intravenous infusion as outlined below. EXBLIFEP does not contain preservatives. Aseptic technique must be used for reconstitution and dilution.",
        "preparationSteps": [
          "Reconstitute the powder in the EXBLIFEP vial, with 10 mL of 0.9% Sodium Chloride Injection, or 5% Dextrose Injection, or 2.5% Dextrose and 0.45% Sodium Chloride Injection, from a 250 mL infusion bag.",
          "Mix gently to dissolve. The reconstituted EXBLIFEP solution will have a resultant concentration of 0.2 grams/mL (cefepime 0.16 grams/mL and enmetazobactam 0.04 grams/mL). The final volume is approximately 13 mL. The reconstituted solution is not for direct injection.",

          "The reconstituted solution must immediately be diluted further in the 250 mL infusion bag used in Step 1. The same injection solution should be used for both reconstitution and dilution (e.g., if reconstitution in Step 1 is performed with 5% dextrose, the dilution in Step 3 should be performed with a 250 mL infusion bag of 5% dextrose). To dilute the reconstituted solution, withdraw the full or partial reconstituted vial contents and add it back into the infusion bag in accordance with Table 2 below."
          ,
          "Store the prepared diluted solution refrigerated at 2Â°C to 8Â°C (36Â°F to 46Â°F) for up to 4 hours prior to administration. The intravenous infusion administration of the diluted solution must be completed within 6 hours of dilution."
          ,
          "Visually inspect the diluted EXBLIFEP solution. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. The color of the EXBLIFEP infusion solution for administration is clear to yellowish. Discard unused portion after use."

        ],
        "preparationTable": {
          "title": "Table 2: Preparation of EXBLIFEP Doses",
          "doses": [
            {
              "dose": "2.5 grams (2 grams cefepime and 0.5 grams enmetazobactam)",
              "numberOfVials": "1 vial",
              "volumeToWithdraw": "Entire contents (approximately 13 mL)",
              "infusionBagVolume": "250 mL"
            },
            {
              "dose": "1.25 grams (1 gram cefepime and 0.25 grams enmetazobactam)",
              "numberOfVials": "1 vial",
              "volumeToWithdraw": "Partial contents (6.5 mL)",
              "infusionBagVolume": "250 mL"
            },
            {
              "dose": "0.625 grams (0.5 grams cefepime and 0.125 grams enmetazobactam)",
              "numberOfVials": "1 vial",
              "volumeToWithdraw": "Partial contents (3.3 mL)",
              "infusionBagVolume": "250 mL"
            }
          ]
        },
        "labels": []
      },
      "appendix5": {
        "name": "Labeling Information",
        "description": "",
        "labels": []
      },
      "appendix6": {
        "name": "Development program designation",
        "description": "",
        "designations": {}
      }
    },
    "references": [
      {
        "title": "Process patent using 7-ACA and N-methylpyrrolidine: CN107201391B.",
        "url": "https://patents.google.com/patent/CN107201391B/en"
      },
      {
        "title": "Alternative process patent using GCLE and N-methylpyrrolidine: CN102408440A.",
        "url": "https://patents.google.com/patent/CN102408440A/en"
      }, {
        "title": "DS Specification",
        "url": "https://www.ema.europa.eu/en/documents/assessment-report/xalkori-epar-public-assessment-report_en.pdf"
      }

    ]
  }
]


export const sampleRawData:any=[
  {
    "approvalDate": "01/02/2024",
    "drugName": "LOTRIMIN ULTRANDA   #021307",
    "submission": "SUPPL-22",
    "activeIngredients": "BUTENAFINE HYDROCHLORIDE",
    "company": "BAYER HEALTHCARE LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/02/2024",
    "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #040248",
    "submission": "SUPPL-9",
    "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
    "company": "CHARTWELL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/02/2024",
    "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #040248",
    "submission": "SUPPL-10",
    "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
    "company": "CHARTWELL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/02/2024",
    "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #207834",
    "submission": "SUPPL-2",
    "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
    "company": "CHARTWELL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/02/2024",
    "drugName": "EMTRICITABINE AND TENOFOVIR ALAFENAMIDEANDA  #211148",
    "submission": "ORIG-1",
    "activeIngredients": "EMTRICITABINE, TENOFOVIR ALAFENAMIDE",
    "company": "MYLAN LABS LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "01/02/2024",
    "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #211690",
    "submission": "SUPPL-1",
    "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
    "company": "SANALUZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/02/2024",
    "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #211690",
    "submission": "SUPPL-2",
    "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
    "company": "SANALUZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/02/2024",
    "drugName": "ROPIVACAINE HYDROCHLORIDEANDA  #212808",
    "submission": "SUPPL-6",
    "activeIngredients": "ROPIVACAINE HYDROCHLORIDE",
    "company": "CAPLIN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/02/2024",
    "drugName": "POMALIDOMIDEANDA  #213234",
    "submission": "ORIG-1",
    "activeIngredients": "POMALIDOMIDE",
    "company": "DR REDDYS LABS LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "01/02/2024",
    "drugName": "VORICONAZOLEANDA  #216805",
    "submission": "ORIG-1",
    "activeIngredients": "VORICONAZOLE",
    "company": "ZHEJIANG POLY PHARM",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/02/2024",
    "drugName": "SITAGLIPTINANDA  #216919",
    "submission": "ORIG-1",
    "activeIngredients": "SITAGLIPTIN PHOSPHATE",
    "company": "MANKIND PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "01/03/2024",
    "drugName": "NICORETTENDA   #018612",
    "submission": "SUPPL-84",
    "activeIngredients": "NICOTINE POLACRILEX",
    "company": "HALEON US HOLDINGS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2024",
    "drugName": "NICORETTE (MINT)NDA   #018612",
    "submission": "SUPPL-84",
    "activeIngredients": "NICOTINE POLACRILEX",
    "company": "HALEON US HOLDINGS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2024",
    "drugName": "NICORETTENDA   #020066",
    "submission": "SUPPL-66",
    "activeIngredients": "NICOTINE POLACRILEX",
    "company": "HALEON US HOLDINGS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2024",
    "drugName": "NICORETTE (MINT)NDA   #020066",
    "submission": "SUPPL-66",
    "activeIngredients": "NICOTINE POLACRILEX",
    "company": "HALEON US HOLDINGS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2024",
    "drugName": "METHADONE HYDROCHLORIDEANDA  #040517",
    "submission": "SUPPL-36",
    "activeIngredients": "METHADONE HYDROCHLORIDE",
    "company": "SPECGX LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2024",
    "drugName": "METHADONE HYDROCHLORIDEANDA  #040517",
    "submission": "SUPPL-37",
    "activeIngredients": "METHADONE HYDROCHLORIDE",
    "company": "SPECGX LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2024",
    "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #040778",
    "submission": "SUPPL-27",
    "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
    "company": "AMNEAL PHARMS NY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2024",
    "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #040778",
    "submission": "SUPPL-29",
    "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
    "company": "AMNEAL PHARMS NY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2024",
    "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #040778",
    "submission": "SUPPL-30",
    "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
    "company": "AMNEAL PHARMS NY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2024",
    "drugName": "AMOXICILLINANDA  #061926",
    "submission": "SUPPL-132",
    "activeIngredients": "AMOXICILLIN",
    "company": "TEVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2024",
    "drugName": "AMOXICILLINANDA  #061931",
    "submission": "SUPPL-56",
    "activeIngredients": "AMOXICILLIN",
    "company": "TEVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2024",
    "drugName": "AMOXICILLIN PEDIATRICANDA  #061931",
    "submission": "SUPPL-56",
    "activeIngredients": "AMOXICILLIN",
    "company": "TEVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2024",
    "drugName": "AMOXICILLINANDA  #064013",
    "submission": "SUPPL-61",
    "activeIngredients": "AMOXICILLIN",
    "company": "TEVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2024",
    "drugName": "AMOXICILLINANDA  #065056",
    "submission": "SUPPL-21",
    "activeIngredients": "AMOXICILLIN",
    "company": "TEVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2024",
    "drugName": "AMOXICILLINANDA  #065119",
    "submission": "SUPPL-31",
    "activeIngredients": "AMOXICILLIN",
    "company": "TEVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2024",
    "drugName": "NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDEANDA  #075735",
    "submission": "SUPPL-21",
    "activeIngredients": "NALOXONE HYDROCHLORIDE; PENTAZOCINE HYDROCHLORIDE",
    "company": "LUPIN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2024",
    "drugName": "MEPERIDINE HYDROCHLORIDE PRESERVATIVE FREEANDA  #081002",
    "submission": "SUPPL-11",
    "activeIngredients": "MEPERIDINE HYDROCHLORIDE",
    "company": "WEST-WARD PHARMS INT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2024",
    "drugName": "MEPERIDINE HYDROCHLORIDE PRESERVATIVE FREEANDA  #081002",
    "submission": "SUPPL-12",
    "activeIngredients": "MEPERIDINE HYDROCHLORIDE",
    "company": "WEST-WARD PHARMS INT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2024",
    "drugName": "METHADONE HYDROCHLORIDEANDA  #090707",
    "submission": "SUPPL-28",
    "activeIngredients": "METHADONE HYDROCHLORIDE",
    "company": "VISTAPHARM LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2024",
    "drugName": "MYCOPHENOLATE MOFETILANDA  #091249",
    "submission": "SUPPL-25",
    "activeIngredients": "MYCOPHENOLATE MOFETIL",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2024",
    "drugName": "MYCOPHENOLATE MOFETILANDA  #091249",
    "submission": "SUPPL-26",
    "activeIngredients": "MYCOPHENOLATE MOFETIL",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2024",
    "drugName": "MYCOPHENOLATE MOFETILANDA  #091249",
    "submission": "SUPPL-27",
    "activeIngredients": "MYCOPHENOLATE MOFETIL",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2024",
    "drugName": "MYCOPHENOLATE MOFETILANDA  #091249",
    "submission": "SUPPL-28",
    "activeIngredients": "MYCOPHENOLATE MOFETIL",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2024",
    "drugName": "MARLISSAANDA  #091452",
    "submission": "SUPPL-10",
    "activeIngredients": "ETHINYL ESTRADIOL; LEVONORGESTREL",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2024",
    "drugName": "MYCOPHENOLATE MOFETILANDA  #200197",
    "submission": "SUPPL-22",
    "activeIngredients": "MYCOPHENOLATE MOFETIL",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2024",
    "drugName": "MYCOPHENOLATE MOFETILANDA  #200197",
    "submission": "SUPPL-23",
    "activeIngredients": "MYCOPHENOLATE MOFETIL",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2024",
    "drugName": "MYCOPHENOLATE MOFETILANDA  #200197",
    "submission": "SUPPL-24",
    "activeIngredients": "MYCOPHENOLATE MOFETIL",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2024",
    "drugName": "MYCOPHENOLATE MOFETILANDA  #200197",
    "submission": "SUPPL-25",
    "activeIngredients": "MYCOPHENOLATE MOFETIL",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2024",
    "drugName": "VENLAFAXINE HYDROCHLORIDEANDA  #200834",
    "submission": "SUPPL-29",
    "activeIngredients": "VENLAFAXINE HYDROCHLORIDE",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2024",
    "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #201013",
    "submission": "SUPPL-15",
    "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
    "company": "AUROLIFE PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2024",
    "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #201013",
    "submission": "SUPPL-16",
    "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
    "company": "AUROLIFE PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2024",
    "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #201972",
    "submission": "SUPPL-16",
    "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
    "company": "AUROLIFE PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2024",
    "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #201972",
    "submission": "SUPPL-17",
    "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
    "company": "AUROLIFE PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2024",
    "drugName": "METFORMIN HYDROCHLORIDEANDA  #202917",
    "submission": "SUPPL-1",
    "activeIngredients": "METFORMIN HYDROCHLORIDE",
    "company": "SUN PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2024",
    "drugName": "METFORMIN HYDROCHLORIDEANDA  #202917",
    "submission": "SUPPL-6",
    "activeIngredients": "METFORMIN HYDROCHLORIDE",
    "company": "SUN PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2024",
    "drugName": "ONDANSETRON HYDROCHLORIDEANDA  #204906",
    "submission": "SUPPL-1",
    "activeIngredients": "ONDANSETRON HYDROCHLORIDE",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2024",
    "drugName": "PIPERACILLIN AND TAZOBACTAMANDA  #204959",
    "submission": "SUPPL-7",
    "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
    "company": "SHANDONG",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2024",
    "drugName": "PIPERACILLIN AND TAZOBACTAMANDA  #204959",
    "submission": "SUPPL-8",
    "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
    "company": "SHANDONG",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2024",
    "drugName": "HYDROCODONE BITARTRATE AND ASPIRINANDA  #205479",
    "submission": "SUPPL-1",
    "activeIngredients": "ASPIRIN; HYDROCODONE BITARTRATE",
    "company": "LGM PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2024",
    "drugName": "HYDROCODONE BITARTRATE AND ASPIRINANDA  #205479",
    "submission": "SUPPL-2",
    "activeIngredients": "ASPIRIN; HYDROCODONE BITARTRATE",
    "company": "LGM PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2024",
    "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #206718",
    "submission": "SUPPL-13",
    "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
    "company": "SPECGX LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2024",
    "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #206718",
    "submission": "SUPPL-15",
    "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
    "company": "SPECGX LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2024",
    "drugName": "METHADONE HYDROCHLORIDEANDA  #207537",
    "submission": "SUPPL-8",
    "activeIngredients": "METHADONE HYDROCHLORIDE",
    "company": "SPECGX LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2024",
    "drugName": "METHADONE HYDROCHLORIDEANDA  #207537",
    "submission": "SUPPL-9",
    "activeIngredients": "METHADONE HYDROCHLORIDE",
    "company": "SPECGX LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2024",
    "drugName": "VILAZODONE HYDROCHLORIDEANDA  #208200",
    "submission": "SUPPL-3",
    "activeIngredients": "VILAZODONE HYDROCHLORIDE",
    "company": "INVAGEN PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2024",
    "drugName": "VILAZODONE HYDROCHLORIDEANDA  #208202",
    "submission": "SUPPL-8",
    "activeIngredients": "VILAZODONE HYDROCHLORIDE",
    "company": "ALEMBIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2024",
    "drugName": "VILAZODONE HYDROCHLORIDEANDA  #208228",
    "submission": "SUPPL-1",
    "activeIngredients": "VILAZODONE HYDROCHLORIDE",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2024",
    "drugName": "DAPAGLIFLOZIN AND SAXAGLIPTIN MONOHYDRATEANDA  #211532",
    "submission": "ORIG-1",
    "activeIngredients": "DAPAGLIFLOZIN, SAXAGLIPTIN MONOHYDRATE",
    "company": "LUPIN LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "01/03/2024",
    "drugName": "FLUOXETINE HYDROCHLORIDEANDA  #211632",
    "submission": "SUPPL-4",
    "activeIngredients": "FLUOXETINE HYDROCHLORIDE",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2024",
    "drugName": "FLUOXETINE HYDROCHLORIDEANDA  #211632",
    "submission": "SUPPL-5",
    "activeIngredients": "FLUOXETINE HYDROCHLORIDE",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2024",
    "drugName": "NELARABINEANDA  #212605",
    "submission": "ORIG-1",
    "activeIngredients": "NELARABINE",
    "company": "GLAND",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2024",
    "drugName": "SILDENAFIL CITRATEANDA  #212883",
    "submission": "SUPPL-11",
    "activeIngredients": "SILDENAFIL CITRATE",
    "company": "AJANTA PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2024",
    "drugName": "VENLAFAXINE HYDROCHLORIDEANDA  #213927",
    "submission": "SUPPL-3",
    "activeIngredients": "VENLAFAXINE HYDROCHLORIDE",
    "company": "ADAPTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2024",
    "drugName": "PRAZOSIN HYDROCHLORIDEANDA  #214083",
    "submission": "ORIG-1",
    "activeIngredients": "PRAZOSIN HYDROCHLORIDE",
    "company": "LANNETT CO INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2024",
    "drugName": "SKYRIZIBLA   #761105",
    "submission": "SUPPL-32",
    "activeIngredients": "RISANKIZUMAB-RZAA",
    "company": "ABBVIE INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2024",
    "drugName": "SKYRIZIBLA   #761262",
    "submission": "SUPPL-5",
    "activeIngredients": "RISANKIZUMAB-RZAA",
    "company": "ABBVIE INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/04/2024",
    "drugName": "TOPIRAMATEANDA  #076314",
    "submission": "SUPPL-15",
    "activeIngredients": "TOPIRAMATE",
    "company": "NATCO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/04/2024",
    "drugName": "TOPIRAMATEANDA  #076314",
    "submission": "SUPPL-17",
    "activeIngredients": "TOPIRAMATE",
    "company": "NATCO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/04/2024",
    "drugName": "TOPIRAMATEANDA  #076314",
    "submission": "SUPPL-18",
    "activeIngredients": "TOPIRAMATE",
    "company": "NATCO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/04/2024",
    "drugName": "TOPIRAMATEANDA  #078462",
    "submission": "SUPPL-33",
    "activeIngredients": "TOPIRAMATE",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/04/2024",
    "drugName": "TROKENDI XRNDA   #201635",
    "submission": "SUPPL-32",
    "activeIngredients": "TOPIRAMATE",
    "company": "SUPERNUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/04/2024",
    "drugName": "ESZOPICLONEANDA  #205504",
    "submission": "ORIG-1",
    "activeIngredients": "ESZOPICLONE",
    "company": "HETERO LABS LTD V",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/04/2024",
    "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #206484",
    "submission": "SUPPL-6",
    "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
    "company": "UPSHER SMITH LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/04/2024",
    "drugName": "PAROXETINE HYDROCHLORIDEANDA  #209748",
    "submission": "ORIG-1",
    "activeIngredients": "PAROXETINE HYDROCHLORIDE",
    "company": "PRINSTON INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/04/2024",
    "drugName": "FEXOFENADINE HYDROCHLORIDE ALLERGYANDA  #211075",
    "submission": "SUPPL-8",
    "activeIngredients": "FEXOFENADINE HYDROCHLORIDE",
    "company": "GRANULES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/05/2024",
    "drugName": "SANDOSTATIN LARNDA   #021008",
    "submission": "SUPPL-47",
    "activeIngredients": "OCTREOTIDE ACETATE",
    "company": "NOVARTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/05/2024",
    "drugName": "PIPERACILLIN AND TAZOBACTAMANDA  #065362",
    "submission": "SUPPL-37",
    "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/05/2024",
    "drugName": "METRONIDAZOLEANDA  #070039",
    "submission": "SUPPL-16",
    "activeIngredients": "METRONIDAZOLE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/05/2024",
    "drugName": "METRONIDAZOLEANDA  #070040",
    "submission": "SUPPL-16",
    "activeIngredients": "METRONIDAZOLE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/05/2024",
    "drugName": "METRONIDAZOLEANDA  #070772",
    "submission": "SUPPL-47",
    "activeIngredients": "METRONIDAZOLE",
    "company": "INNOGENIX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/05/2024",
    "drugName": "TRAMADOL HYDROCHLORIDEANDA  #076003",
    "submission": "SUPPL-56",
    "activeIngredients": "TRAMADOL HYDROCHLORIDE",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/05/2024",
    "drugName": "DEXAMETHASONE INTENSOLANDA  #088252",
    "submission": "SUPPL-35",
    "activeIngredients": "DEXAMETHASONE",
    "company": "HIKMA",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/05/2024",
    "drugName": "TNKASEBLA   #103909",
    "submission": "SUPPL-5195",
    "activeIngredients": "TENECTEPLASE",
    "company": "GENENTECH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/05/2024",
    "drugName": "NORETHINDRONE ACETATE AND ETHINYL ESTRADIOLANDA  #202741",
    "submission": "SUPPL-6",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "XIROMED",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/05/2024",
    "drugName": "NORETHINDRONE ACETATE AND ETHINYL ESTRADIOLANDA  #202741",
    "submission": "SUPPL-8",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "XIROMED",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/05/2024",
    "drugName": "NILOTINIB HYDROCHLORIDEANDA  #203640",
    "submission": "ORIG-1",
    "activeIngredients": "NILOTINIB HYDROCHLORIDE",
    "company": "APOTEX",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/05/2024",
    "drugName": "PIPERACILLIN AND TAZOBACTAMANDA  #203720",
    "submission": "SUPPL-8",
    "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
    "company": "FRESENIUS KABI",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/05/2024",
    "drugName": "PIPERACILLIN AND TAZOBACTAMANDA  #203720",
    "submission": "SUPPL-9",
    "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
    "company": "FRESENIUS KABI",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/05/2024",
    "drugName": "OXALIPLATINANDA  #203869",
    "submission": "SUPPL-10",
    "activeIngredients": "OXALIPLATIN",
    "company": "HENGRUI PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/05/2024",
    "drugName": "IMATINIB MESYLATEANDA  #204644",
    "submission": "SUPPL-2",
    "activeIngredients": "IMATINIB MESYLATE",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/05/2024",
    "drugName": "IMATINIB MESYLATEANDA  #204644",
    "submission": "SUPPL-3",
    "activeIngredients": "IMATINIB MESYLATE",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/05/2024",
    "drugName": "IMATINIB MESYLATEANDA  #204644",
    "submission": "SUPPL-5",
    "activeIngredients": "IMATINIB MESYLATE",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/05/2024",
    "drugName": "IMATINIB MESYLATEANDA  #204644",
    "submission": "SUPPL-8",
    "activeIngredients": "IMATINIB MESYLATE",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/05/2024",
    "drugName": "IMATINIB MESYLATEANDA  #204644",
    "submission": "SUPPL-11",
    "activeIngredients": "IMATINIB MESYLATE",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/05/2024",
    "drugName": "IMATINIB MESYLATEANDA  #204644",
    "submission": "SUPPL-15",
    "activeIngredients": "IMATINIB MESYLATE",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/05/2024",
    "drugName": "ROSUVASTATIN CALCIUMANDA  #206434",
    "submission": "SUPPL-7",
    "activeIngredients": "ROSUVASTATIN CALCIUM",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/05/2024",
    "drugName": "ROSUVASTATIN CALCIUMANDA  #206434",
    "submission": "SUPPL-8",
    "activeIngredients": "ROSUVASTATIN CALCIUM",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/05/2024",
    "drugName": "ROSUVASTATIN CALCIUMANDA  #206434",
    "submission": "SUPPL-10",
    "activeIngredients": "ROSUVASTATIN CALCIUM",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/05/2024",
    "drugName": "POTASSIUM CHLORIDEANDA  #211648",
    "submission": "SUPPL-7",
    "activeIngredients": "POTASSIUM CHLORIDE",
    "company": "SCIEGEN PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/05/2024",
    "drugName": "POTASSIUM CHLORIDEANDA  #211648",
    "submission": "SUPPL-8",
    "activeIngredients": "POTASSIUM CHLORIDE",
    "company": "SCIEGEN PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/05/2024",
    "drugName": "LISDEXAMFETAMINE DIMESYLATEANDA  #214134",
    "submission": "SUPPL-1",
    "activeIngredients": "LISDEXAMFETAMINE DIMESYLATE",
    "company": "SUN PHARM INDS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/05/2024",
    "drugName": "LISDEXAMFETAMINE DIMESYLATEANDA  #214484",
    "submission": "SUPPL-1",
    "activeIngredients": "LISDEXAMFETAMINE DIMESYLATE",
    "company": "SUN PHARM INDS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/05/2024",
    "drugName": "LISDEXAMFETAMINE DIMESYLATEANDA  #214547",
    "submission": "SUPPL-2",
    "activeIngredients": "LISDEXAMFETAMINE DIMESYLATE",
    "company": "NORWICH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/05/2024",
    "drugName": "NETARSUDIL MESYLATEANDA  #216855",
    "submission": "ORIG-1",
    "activeIngredients": "NETARSUDIL",
    "company": "GLAND PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "01/05/2024",
    "drugName": "ATORVASTATIN CALCIUMANDA  #217081",
    "submission": "ORIG-1",
    "activeIngredients": "ATORVASTATIN CALCIUM",
    "company": "MANKIND PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/05/2024",
    "drugName": "ZELSUVMINDA   #217424",
    "submission": "ORIG-1",
    "activeIngredients": "BERDAZIMER SODIUM",
    "company": "LNHC",
    "submissionClassification": "Type 1 - New Molecular Entity",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/05/2024",
    "drugName": "METFORMIN HYDROCHLORIDEANDA  #217631",
    "submission": "SUPPL-1",
    "activeIngredients": "METFORMIN HYDROCHLORIDE",
    "company": "LAURUS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/05/2024",
    "drugName": "MYCOPHENOLATE MOFETILANDA  #217828",
    "submission": "ORIG-1",
    "activeIngredients": "MYCOPHENOLATE MOFETIL",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/05/2024",
    "drugName": "OFLOXACINANDA  #217903",
    "submission": "ORIG-1",
    "activeIngredients": "OFLOXACIN",
    "company": "CAPLIN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/05/2024",
    "drugName": "IDACIOBLA   #761255",
    "submission": "ORIG-2",
    "activeIngredients": "ADALIMUMAB-AACF",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/08/2024",
    "drugName": "ISOFLURANEANDA  #074416",
    "submission": "SUPPL-8",
    "activeIngredients": "ISOFLURANE",
    "company": "PIRAMAL CRITICAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/08/2024",
    "drugName": "ISOFLURANEANDA  #074416",
    "submission": "SUPPL-10",
    "activeIngredients": "ISOFLURANE",
    "company": "PIRAMAL CRITICAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/08/2024",
    "drugName": "ISOFLURANEANDA  #074416",
    "submission": "SUPPL-11",
    "activeIngredients": "ISOFLURANE",
    "company": "PIRAMAL CRITICAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/08/2024",
    "drugName": "ISOFLURANEANDA  #074416",
    "submission": "SUPPL-12",
    "activeIngredients": "ISOFLURANE",
    "company": "PIRAMAL CRITICAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/08/2024",
    "drugName": "CITALOPRAM HYDROBROMIDEANDA  #077289",
    "submission": "SUPPL-20",
    "activeIngredients": "CITALOPRAM HYDROBROMIDE",
    "company": "AMNEAL PHARMS NY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/08/2024",
    "drugName": "CITALOPRAM HYDROBROMIDEANDA  #077289",
    "submission": "SUPPL-24",
    "activeIngredients": "CITALOPRAM HYDROBROMIDE",
    "company": "AMNEAL PHARMS NY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/08/2024",
    "drugName": "CITALOPRAM HYDROBROMIDEANDA  #077289",
    "submission": "SUPPL-29",
    "activeIngredients": "CITALOPRAM HYDROBROMIDE",
    "company": "AMNEAL PHARMS NY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/08/2024",
    "drugName": "CITALOPRAM HYDROBROMIDEANDA  #077289",
    "submission": "SUPPL-31",
    "activeIngredients": "CITALOPRAM HYDROBROMIDE",
    "company": "AMNEAL PHARMS NY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/08/2024",
    "drugName": "CITALOPRAM HYDROBROMIDEANDA  #077289",
    "submission": "SUPPL-32",
    "activeIngredients": "CITALOPRAM HYDROBROMIDE",
    "company": "AMNEAL PHARMS NY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/08/2024",
    "drugName": "CITALOPRAM HYDROBROMIDEANDA  #077289",
    "submission": "SUPPL-33",
    "activeIngredients": "CITALOPRAM HYDROBROMIDE",
    "company": "AMNEAL PHARMS NY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/08/2024",
    "drugName": "NEVIRAPINEANDA  #078644",
    "submission": "SUPPL-6",
    "activeIngredients": "NEVIRAPINE",
    "company": "PRINSTON INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/08/2024",
    "drugName": "RISEDRONATE SODIUMANDA  #090886",
    "submission": "SUPPL-11",
    "activeIngredients": "RISEDRONATE SODIUM",
    "company": "SUN PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/08/2024",
    "drugName": "TRIAMTERENE AND HYDROCHLOROTHIAZIDEANDA  #201407",
    "submission": "SUPPL-12",
    "activeIngredients": "HYDROCHLOROTHIAZIDE; TRIAMTERENE",
    "company": "LANNETT CO INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/08/2024",
    "drugName": "ESTRADIOLANDA  #201675",
    "submission": "SUPPL-9",
    "activeIngredients": "ESTRADIOL",
    "company": "MYLAN TECHNOLOGIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/08/2024",
    "drugName": "HYDROCORTISONE BUTYRATEANDA  #202145",
    "submission": "SUPPL-4",
    "activeIngredients": "HYDROCORTISONE BUTYRATE",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/08/2024",
    "drugName": "METHOXSALENANDA  #202687",
    "submission": "SUPPL-3",
    "activeIngredients": "METHOXSALEN",
    "company": "ONESOURCE SPECIALTY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/08/2024",
    "drugName": "PROVAYBLUENDA   #204630",
    "submission": "SUPPL-21",
    "activeIngredients": "METHYLENE BLUE",
    "company": "PROVEPHARM SAS",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/08/2024",
    "drugName": "HYDROXYCHLOROQUINE SULFATEANDA  #210959",
    "submission": "SUPPL-14",
    "activeIngredients": "HYDROXYCHLOROQUINE SULFATE",
    "company": "LAURUS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/08/2024",
    "drugName": "GENTAMICIN SULFATEANDA  #215236",
    "submission": "ORIG-1",
    "activeIngredients": "GENTAMICIN SULFATE",
    "company": "EUGIA PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/08/2024",
    "drugName": "GENTAMICIN SULFATEANDA  #215237",
    "submission": "ORIG-1",
    "activeIngredients": "GENTAMICIN SULFATE",
    "company": "EUGIA PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/08/2024",
    "drugName": "ENALAPRIL MALEATEANDA  #216458",
    "submission": "ORIG-1",
    "activeIngredients": "ENALAPRIL MALEATE",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/08/2024",
    "drugName": "ACYCLOVIR SODIUMANDA  #218111",
    "submission": "ORIG-1",
    "activeIngredients": "ACYCLOVIR SODIUM",
    "company": "SLATE RUN PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/08/2024",
    "drugName": "ATROPINE SULFATEANDA  #218148",
    "submission": "ORIG-1",
    "activeIngredients": "ATROPINE SULFATE",
    "company": "MANKIND PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/09/2024",
    "drugName": "LYSODRENNDA   #016885",
    "submission": "SUPPL-32",
    "activeIngredients": "MITOTANE",
    "company": "ESTEVE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/09/2024",
    "drugName": "TOPIRAMATEANDA  #076575",
    "submission": "SUPPL-8",
    "activeIngredients": "TOPIRAMATE",
    "company": "TEVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/09/2024",
    "drugName": "TOPIRAMATEANDA  #076575",
    "submission": "SUPPL-9",
    "activeIngredients": "TOPIRAMATE",
    "company": "TEVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/09/2024",
    "drugName": "TOPIRAMATEANDA  #076575",
    "submission": "SUPPL-10",
    "activeIngredients": "TOPIRAMATE",
    "company": "TEVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/09/2024",
    "drugName": "TOPIRAMATEANDA  #076575",
    "submission": "SUPPL-12",
    "activeIngredients": "TOPIRAMATE",
    "company": "TEVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/09/2024",
    "drugName": "TOPIRAMATEANDA  #076575",
    "submission": "SUPPL-13",
    "activeIngredients": "TOPIRAMATE",
    "company": "TEVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/09/2024",
    "drugName": "TOPIRAMATEANDA  #076575",
    "submission": "SUPPL-14",
    "activeIngredients": "TOPIRAMATE",
    "company": "TEVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/09/2024",
    "drugName": "TOPIRAMATEANDA  #076575",
    "submission": "SUPPL-15",
    "activeIngredients": "TOPIRAMATE",
    "company": "TEVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/09/2024",
    "drugName": "TOPIRAMATEANDA  #076575",
    "submission": "SUPPL-16",
    "activeIngredients": "TOPIRAMATE",
    "company": "TEVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/09/2024",
    "drugName": "TOPIRAMATEANDA  #076575",
    "submission": "SUPPL-18",
    "activeIngredients": "TOPIRAMATE",
    "company": "TEVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/09/2024",
    "drugName": "TOPIRAMATEANDA  #076575",
    "submission": "SUPPL-20",
    "activeIngredients": "TOPIRAMATE",
    "company": "TEVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/09/2024",
    "drugName": "TOPIRAMATEANDA  #076575",
    "submission": "SUPPL-21",
    "activeIngredients": "TOPIRAMATE",
    "company": "TEVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/09/2024",
    "drugName": "TOPIRAMATEANDA  #076575",
    "submission": "SUPPL-22",
    "activeIngredients": "TOPIRAMATE",
    "company": "TEVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/09/2024",
    "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #202142",
    "submission": "SUPPL-8",
    "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
    "company": "MIKART",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/09/2024",
    "drugName": "LEVONORGESTREL AND ETHINYL ESTRADIOLANDA  #203164",
    "submission": "SUPPL-4",
    "activeIngredients": "ETHINYL ESTRADIOL; LEVONORGESTREL",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/09/2024",
    "drugName": "LEVONORGESTREL AND ETHINYL ESTRADIOLANDA  #203164",
    "submission": "SUPPL-6",
    "activeIngredients": "ETHINYL ESTRADIOL; LEVONORGESTREL",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/09/2024",
    "drugName": "METRONIDAZOLEANDA  #203974",
    "submission": "SUPPL-12",
    "activeIngredients": "METRONIDAZOLE",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/09/2024",
    "drugName": "FLUOXETINE HYDROCHLORIDEANDA  #204597",
    "submission": "SUPPL-13",
    "activeIngredients": "FLUOXETINE HYDROCHLORIDE",
    "company": "SCIEGEN PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/09/2024",
    "drugName": "FLUOXETINE HYDROCHLORIDEANDA  #204597",
    "submission": "SUPPL-21",
    "activeIngredients": "FLUOXETINE HYDROCHLORIDE",
    "company": "SCIEGEN PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/09/2024",
    "drugName": "FESOTERODINE FUMARATEANDA  #204792",
    "submission": "ORIG-1",
    "activeIngredients": "FESOTERODINE FUMARATE",
    "company": "HETERO LABS LTD V",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/09/2024",
    "drugName": "METRONIDAZOLEANDA  #208162",
    "submission": "SUPPL-9",
    "activeIngredients": "METRONIDAZOLE",
    "company": "NOVITIUM PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/09/2024",
    "drugName": "METRONIDAZOLEANDA  #208162",
    "submission": "SUPPL-10",
    "activeIngredients": "METRONIDAZOLE",
    "company": "NOVITIUM PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/09/2024",
    "drugName": "MACITENTANANDA  #211195",
    "submission": "ORIG-1",
    "activeIngredients": "MACITENTAN",
    "company": "APOTEX",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/09/2024",
    "drugName": "FLUOXETINE HYDROCHLORIDEANDA  #211282",
    "submission": "SUPPL-4",
    "activeIngredients": "FLUOXETINE HYDROCHLORIDE",
    "company": "SCIEGEN PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/09/2024",
    "drugName": "FLUOXETINE HYDROCHLORIDEANDA  #211282",
    "submission": "SUPPL-8",
    "activeIngredients": "FLUOXETINE HYDROCHLORIDE",
    "company": "SCIEGEN PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/09/2024",
    "drugName": "CARBAMAZEPINEANDA  #213311",
    "submission": "SUPPL-3",
    "activeIngredients": "CARBAMAZEPINE",
    "company": "CSPC OUYI",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/09/2024",
    "drugName": "NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATEANDA  #213418",
    "submission": "SUPPL-4",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/09/2024",
    "drugName": "CARBAMAZEPINEANDA  #214277",
    "submission": "SUPPL-7",
    "activeIngredients": "CARBAMAZEPINE",
    "company": "NOVITIUM PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/09/2024",
    "drugName": "FLUOROMETHOLONEANDA  #216348",
    "submission": "ORIG-1",
    "activeIngredients": "FLUOROMETHOLONE",
    "company": "AMNEAL",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/10/2024",
    "drugName": "METAXALONENDA   #022503",
    "submission": "SUPPL-3",
    "activeIngredients": "METAXALONE",
    "company": "PRIMUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/10/2024",
    "drugName": "BUTORPHANOL TARTRATE PRESERVATIVE FREEANDA  #075045",
    "submission": "SUPPL-16",
    "activeIngredients": "BUTORPHANOL TARTRATE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/10/2024",
    "drugName": "BUTORPHANOL TARTRATE PRESERVATIVE FREEANDA  #075045",
    "submission": "SUPPL-17",
    "activeIngredients": "BUTORPHANOL TARTRATE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/10/2024",
    "drugName": "BUTORPHANOL TARTRATEANDA  #075046",
    "submission": "SUPPL-14",
    "activeIngredients": "BUTORPHANOL TARTRATE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/10/2024",
    "drugName": "BUTORPHANOL TARTRATEANDA  #075046",
    "submission": "SUPPL-15",
    "activeIngredients": "BUTORPHANOL TARTRATE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/10/2024",
    "drugName": "TRAMADOL HYDROCHLORIDEANDA  #075964",
    "submission": "SUPPL-43",
    "activeIngredients": "TRAMADOL HYDROCHLORIDE",
    "company": "SUN PHARM INDS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/10/2024",
    "drugName": "PERINDOPRIL ERBUMINEANDA  #079070",
    "submission": "SUPPL-7",
    "activeIngredients": "PERINDOPRIL ERBUMINE",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/10/2024",
    "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #203863",
    "submission": "SUPPL-6",
    "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
    "company": "EPIC PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/10/2024",
    "drugName": "LINEZOLIDANDA  #207001",
    "submission": "SUPPL-2",
    "activeIngredients": "LINEZOLID",
    "company": "HQ SPCLT PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/10/2024",
    "drugName": "LINEZOLIDANDA  #207001",
    "submission": "SUPPL-4",
    "activeIngredients": "LINEZOLID",
    "company": "HQ SPCLT PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/10/2024",
    "drugName": "LINEZOLIDANDA  #207001",
    "submission": "SUPPL-5",
    "activeIngredients": "LINEZOLID",
    "company": "HQ SPCLT PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/10/2024",
    "drugName": "LINEZOLIDANDA  #207001",
    "submission": "SUPPL-6",
    "activeIngredients": "LINEZOLID",
    "company": "HQ SPCLT PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/10/2024",
    "drugName": "LINEZOLIDANDA  #207001",
    "submission": "SUPPL-8",
    "activeIngredients": "LINEZOLID",
    "company": "HQ SPCLT PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/10/2024",
    "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #211729",
    "submission": "SUPPL-2",
    "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
    "company": "GRANULES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/10/2024",
    "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #211729",
    "submission": "SUPPL-5",
    "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
    "company": "GRANULES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/10/2024",
    "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #211729",
    "submission": "SUPPL-6",
    "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
    "company": "GRANULES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/10/2024",
    "drugName": "DOXAZOSIN MESYLATEANDA  #212329",
    "submission": "ORIG-1",
    "activeIngredients": "DOXAZOSIN MESYLATE",
    "company": "UNICHEM",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/10/2024",
    "drugName": "ESOMEPRAZOLE MAGNESIUMANDA  #213486",
    "submission": "SUPPL-3",
    "activeIngredients": "ESOMEPRAZOLE MAGNESIUM",
    "company": "GRAVITI PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/10/2024",
    "drugName": "ESOMEPRAZOLE MAGNESIUMANDA  #213486",
    "submission": "SUPPL-4",
    "activeIngredients": "ESOMEPRAZOLE MAGNESIUM",
    "company": "GRAVITI PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/10/2024",
    "drugName": "ESOMEPRAZOLE MAGNESIUMANDA  #213486",
    "submission": "SUPPL-8",
    "activeIngredients": "ESOMEPRAZOLE MAGNESIUM",
    "company": "GRAVITI PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/10/2024",
    "drugName": "AMPHETAMINE SULFATEANDA  #213720",
    "submission": "SUPPL-3",
    "activeIngredients": "AMPHETAMINE SULFATE",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/10/2024",
    "drugName": "RIBOCICLIBANDA  #215677",
    "submission": "ORIG-1",
    "activeIngredients": "RIBOCICLIB",
    "company": "ALEMBIC PHARMS LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "01/10/2024",
    "drugName": "BACLOFENANDA  #217788",
    "submission": "ORIG-1",
    "activeIngredients": "BACLOFEN",
    "company": "RISING",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/11/2024",
    "drugName": "METRONIDAZOLEANDA  #079065",
    "submission": "SUPPL-16",
    "activeIngredients": "METRONIDAZOLE",
    "company": "ALEMBIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/11/2024",
    "drugName": "METRONIDAZOLEANDA  #079065",
    "submission": "SUPPL-17",
    "activeIngredients": "METRONIDAZOLE",
    "company": "ALEMBIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/11/2024",
    "drugName": "LEVOFLOXACINANDA  #202590",
    "submission": "SUPPL-11",
    "activeIngredients": "LEVOFLOXACIN",
    "company": "AVET LIFESCIENCES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/11/2024",
    "drugName": "METHYLPHENIDATE HYDROCHLORIDEANDA  #205327",
    "submission": "SUPPL-16",
    "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "company": "OSMOTICA PHARM US",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/11/2024",
    "drugName": "METHYLPHENIDATE HYDROCHLORIDEANDA  #205327",
    "submission": "SUPPL-20",
    "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "company": "OSMOTICA PHARM US",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/11/2024",
    "drugName": "BELRAPZONDA   #205580",
    "submission": "SUPPL-13",
    "activeIngredients": "BENDAMUSTINE HYDROCHLORIDE",
    "company": "EAGLE PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/11/2024",
    "drugName": "CAPECITABINEANDA  #207456",
    "submission": "SUPPL-3",
    "activeIngredients": "CAPECITABINE",
    "company": "SHILPA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/11/2024",
    "drugName": "CAPECITABINEANDA  #207456",
    "submission": "SUPPL-5",
    "activeIngredients": "CAPECITABINE",
    "company": "SHILPA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/11/2024",
    "drugName": "OMEPRAZOLE AND SODIUM BICARBONATEANDA  #207476",
    "submission": "SUPPL-8",
    "activeIngredients": "OMEPRAZOLE; SODIUM BICARBONATE",
    "company": "SCIEGEN PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/11/2024",
    "drugName": "OMEPRAZOLE AND SODIUM BICARBONATEANDA  #207476",
    "submission": "SUPPL-12",
    "activeIngredients": "OMEPRAZOLE; SODIUM BICARBONATE",
    "company": "SCIEGEN PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/11/2024",
    "drugName": "BENDEKANDA   #208194",
    "submission": "SUPPL-26",
    "activeIngredients": "BENDAMUSTINE HYDROCHLORIDE",
    "company": "EAGLE PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/11/2024",
    "drugName": "VILAZODONE HYDROCHLORIDEANDA  #208209",
    "submission": "SUPPL-2",
    "activeIngredients": "VILAZODONE HYDROCHLORIDE",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/11/2024",
    "drugName": "OXALIPLATINANDA  #217348",
    "submission": "ORIG-1",
    "activeIngredients": "OXALIPLATIN",
    "company": "MEITHEAL",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/12/2024",
    "drugName": "VITRASEBLA   #021640",
    "submission": "SUPPL-28",
    "activeIngredients": "HYALURONIDASE",
    "company": "BAUSCH AND LOMB",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/12/2024",
    "drugName": "HYLENEX RECOMBINANTBLA   #021859",
    "submission": "SUPPL-31",
    "activeIngredients": "HYALURONIDASE RECOMBINANT HUMAN",
    "company": "HALOZYME THERAP",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/12/2024",
    "drugName": "FENTANYL CITRATE PRESERVATIVE FREEANDA  #074917",
    "submission": "SUPPL-2",
    "activeIngredients": "FENTANYL CITRATE",
    "company": "DR REDDYS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/12/2024",
    "drugName": "FENTANYL CITRATE PRESERVATIVE FREEANDA  #074917",
    "submission": "SUPPL-3",
    "activeIngredients": "FENTANYL CITRATE",
    "company": "DR REDDYS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/12/2024",
    "drugName": "DIPYRIDAMOLEANDA  #086944",
    "submission": "SUPPL-41",
    "activeIngredients": "DIPYRIDAMOLE",
    "company": "ANI PHARMS",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/12/2024",
    "drugName": "METHADONE HYDROCHLORIDEANDA  #090065",
    "submission": "SUPPL-14",
    "activeIngredients": "METHADONE HYDROCHLORIDE",
    "company": "EPIC PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/12/2024",
    "drugName": "MESALAMINEANDA  #091640",
    "submission": "SUPPL-22",
    "activeIngredients": "MESALAMINE",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/12/2024",
    "drugName": "KEYTRUDABLA   #125514",
    "submission": "SUPPL-147",
    "activeIngredients": "PEMBROLIZUMAB",
    "company": "MERCK SHARP DOHME",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/12/2024",
    "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #203863",
    "submission": "SUPPL-7",
    "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
    "company": "EPIC PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/12/2024",
    "drugName": "PROPRANOLOL HYDROCHLORIDEANDA  #204349",
    "submission": "ORIG-1",
    "activeIngredients": "PROPRANOLOL HYDROCHLORIDE",
    "company": "LUPIN LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/12/2024",
    "drugName": "SOTYLIZENDA   #205108",
    "submission": "SUPPL-3",
    "activeIngredients": "SOTALOL HYDROCHLORIDE",
    "company": "AZURITY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/12/2024",
    "drugName": "DOCETAXELANDA  #210072",
    "submission": "SUPPL-8",
    "activeIngredients": "DOCETAXEL",
    "company": "MYLAN LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/12/2024",
    "drugName": "DOCETAXELANDA  #210072",
    "submission": "SUPPL-10",
    "activeIngredients": "DOCETAXEL",
    "company": "MYLAN LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/12/2024",
    "drugName": "CEFTRIAXONEANDA  #210197",
    "submission": "ORIG-1",
    "activeIngredients": "CEFTRIAXONE SODIUM",
    "company": "DEVA HOLDING AS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/12/2024",
    "drugName": "DOCETAXELANDA  #210848",
    "submission": "SUPPL-5",
    "activeIngredients": "DOCETAXEL",
    "company": "MYLAN LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/12/2024",
    "drugName": "DOCETAXELANDA  #210848",
    "submission": "SUPPL-7",
    "activeIngredients": "DOCETAXEL",
    "company": "MYLAN LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/12/2024",
    "drugName": "TEGSEDINDA   #211172",
    "submission": "SUPPL-14",
    "activeIngredients": "INOTERSEN SODIUM",
    "company": "AKCEA THERAPS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/12/2024",
    "drugName": "LEVETIRACETAMANDA  #217878",
    "submission": "SUPPL-2",
    "activeIngredients": "LEVETIRACETAM",
    "company": "GRANULES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/12/2024",
    "drugName": "INDOMETHACINANDA  #217883",
    "submission": "ORIG-1",
    "activeIngredients": "INDOMETHACIN",
    "company": "NOVITIUM PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/12/2024",
    "drugName": "DUPIXENTBLA   #761055",
    "submission": "SUPPL-55",
    "activeIngredients": "DUPILUMAB",
    "company": "REGENERON PHARMACEUTICALS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/16/2024",
    "drugName": "XYREMNDA   #021196",
    "submission": "SUPPL-43",
    "activeIngredients": "SODIUM OXYBATE",
    "company": "JAZZ PHARMS",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/16/2024",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #075913",
    "submission": "SUPPL-37",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "IMPAX LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/16/2024",
    "drugName": "OLANZAPINE AND FLUOXETINE HYDROCHLORIDEANDA  #077742",
    "submission": "SUPPL-21",
    "activeIngredients": "FLUOXETINE HYDROCHLORIDE; OLANZAPINE",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/16/2024",
    "drugName": "SIMVASTATINANDA  #078034",
    "submission": "SUPPL-19",
    "activeIngredients": "SIMVASTATIN",
    "company": "BIOCON PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/16/2024",
    "drugName": "BUTORPHANOL TARTRATEANDA  #078247",
    "submission": "SUPPL-6",
    "activeIngredients": "BUTORPHANOL TARTRATE",
    "company": "HIKMA FARMACEUTICA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/16/2024",
    "drugName": "BUTORPHANOL TARTRATEANDA  #078247",
    "submission": "SUPPL-7",
    "activeIngredients": "BUTORPHANOL TARTRATE",
    "company": "HIKMA FARMACEUTICA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/16/2024",
    "drugName": "BUTORPHANOL TARTRATEANDA  #078400",
    "submission": "SUPPL-6",
    "activeIngredients": "BUTORPHANOL TARTRATE",
    "company": "HIKMA FARMACEUTICA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/16/2024",
    "drugName": "BUTORPHANOL TARTRATEANDA  #078400",
    "submission": "SUPPL-7",
    "activeIngredients": "BUTORPHANOL TARTRATE",
    "company": "HIKMA FARMACEUTICA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/16/2024",
    "drugName": "PAROXETINE HYDROCHLORIDEANDA  #078406",
    "submission": "SUPPL-35",
    "activeIngredients": "PAROXETINE HYDROCHLORIDE",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/16/2024",
    "drugName": "EDARBINDA   #200796",
    "submission": "SUPPL-13",
    "activeIngredients": "AZILSARTAN KAMEDOXOMIL",
    "company": "AZURITY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/16/2024",
    "drugName": "DOXEPIN HYDROCHLORIDEANDA  #201951",
    "submission": "SUPPL-10",
    "activeIngredients": "DOXEPIN HYDROCHLORIDE",
    "company": "ACTAVIS ELIZABETH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/16/2024",
    "drugName": "FIDAXOMICINANDA  #208443",
    "submission": "ORIG-1",
    "activeIngredients": "FIDAXOMICIN",
    "company": "ACTAVIS LABS FL",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/16/2024",
    "drugName": "AMPHETAMINE SULFATEANDA  #211639",
    "submission": "SUPPL-3",
    "activeIngredients": "AMPHETAMINE SULFATE",
    "company": "AUROLIFE PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/16/2024",
    "drugName": "XYWAVNDA   #212690",
    "submission": "SUPPL-12",
    "activeIngredients": "CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE",
    "company": "JAZZ",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/16/2024",
    "drugName": "PIMAVANSERINANDA  #214493",
    "submission": "ORIG-1",
    "activeIngredients": "PIMAVANSERIN TARTRATE",
    "company": "ZYDUS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/16/2024",
    "drugName": "PIMAVANSERINANDA  #214502",
    "submission": "ORIG-1",
    "activeIngredients": "PIMAVANSERIN TARTRATE",
    "company": "ZYDUS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/16/2024",
    "drugName": "PIMAVANSERINANDA  #214925",
    "submission": "ORIG-1",
    "activeIngredients": "PIMAVANSERIN TARTRATE",
    "company": "MSN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/16/2024",
    "drugName": "ZILBRYSQNDA   #216834",
    "submission": "SUPPL-4",
    "activeIngredients": "ZILUCOPLAN SODIUM",
    "company": "UCB INC",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/16/2024",
    "drugName": "FAMOTIDINEANDA  #217605",
    "submission": "ORIG-1",
    "activeIngredients": "FAMOTIDINE",
    "company": "UNICHEM",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/17/2024",
    "drugName": "BUMEXNDA   #018225",
    "submission": "SUPPL-29",
    "activeIngredients": "BUMETANIDE",
    "company": "VALIDUS PHARMS",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/17/2024",
    "drugName": "LISDEXAMFETAMINE DIMESYLATEANDA  #202827",
    "submission": "SUPPL-1",
    "activeIngredients": "LISDEXAMFETAMINE DIMESYLATE",
    "company": "HIKMA",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/17/2024",
    "drugName": "FEBUXOSTATANDA  #205406",
    "submission": "ORIG-1",
    "activeIngredients": "FEBUXOSTAT",
    "company": "LUPIN LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/17/2024",
    "drugName": "ASCORNDA   #209112",
    "submission": "SUPPL-9",
    "activeIngredients": "ASCORBIC ACID",
    "company": "MCGUFF",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/17/2024",
    "drugName": "SUCRALFATEANDA  #213549",
    "submission": "ORIG-1",
    "activeIngredients": "SUCRALFATE",
    "company": "PD PARTNERS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/17/2024",
    "drugName": "CLORAZEPATE DIPOTASSIUMANDA  #215566",
    "submission": "SUPPL-1",
    "activeIngredients": "CLORAZEPATE DIPOTASSIUM",
    "company": "COREPHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/17/2024",
    "drugName": "ISOSORBIDE DINITRATE AND HYDRALAZINE HYDROCHLORIDEANDA  #215988",
    "submission": "ORIG-1",
    "activeIngredients": "HYDRALAZINE HYDROCHLORIDE; ISOSORBIDE DINITRATE",
    "company": "MLV",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/17/2024",
    "drugName": "TOFACITINIBANDA  #217298",
    "submission": "ORIG-1",
    "activeIngredients": "TOFACITINIB",
    "company": "MSN LABORATORIES PRIVATE LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "01/17/2024",
    "drugName": "GABAPENTINANDA  #217682",
    "submission": "ORIG-1",
    "activeIngredients": "GABAPENTIN",
    "company": "ANNORA PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/17/2024",
    "drugName": "SUCCINYLCHOLINE CHLORIDEANDA  #218467",
    "submission": "ORIG-1",
    "activeIngredients": "SUCCINYLCHOLINE CHLORIDE",
    "company": "DR REDDYS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/18/2024",
    "drugName": "SERTRALINE HYDROCHLORIDEANDA  #078626",
    "submission": "SUPPL-18",
    "activeIngredients": "SERTRALINE HYDROCHLORIDE",
    "company": "QUAGEN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/18/2024",
    "drugName": "TOPIRAMATEANDA  #207382",
    "submission": "SUPPL-5",
    "activeIngredients": "TOPIRAMATE",
    "company": "ZYDUS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/18/2024",
    "drugName": "TOPIRAMATEANDA  #207382",
    "submission": "SUPPL-6",
    "activeIngredients": "TOPIRAMATE",
    "company": "ZYDUS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/18/2024",
    "drugName": "HARLIKUNDA   #209449",
    "submission": "SUPPL-17",
    "activeIngredients": "NITISINONE",
    "company": "CYCLE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/18/2024",
    "drugName": "NITYRNDA   #209449",
    "submission": "SUPPL-17",
    "activeIngredients": "NITISINONE",
    "company": "CYCLE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/18/2024",
    "drugName": "ACETAMINOPHENANDA  #211544",
    "submission": "SUPPL-16",
    "activeIngredients": "ACETAMINOPHEN",
    "company": "GRANULES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/18/2024",
    "drugName": "DOLUTEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDENDA   #212427",
    "submission": "ORIG-1",
    "activeIngredients": "DOLUTEGRAVIR;EMTRICITABINE;TENOFOVIR ALAFENAMIDE",
    "company": "HETERO LABS LTD III",
    "submissionClassification": "Type 4 - New Combination",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "01/18/2024",
    "drugName": "PIQRAYNDA   #212526",
    "submission": "SUPPL-9",
    "activeIngredients": "ALPELISIB",
    "company": "NOVARTIS",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/18/2024",
    "drugName": "BUTALBITAL, ACETAMINOPHEN AND CAFFEINEANDA  #214287",
    "submission": "ORIG-1",
    "activeIngredients": "ACETAMINOPHEN; BUTALBITAL; CAFFEINE",
    "company": "QUAGEN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/18/2024",
    "drugName": "BUTALBITAL AND ACETAMINOPHENANDA  #214291",
    "submission": "ORIG-1",
    "activeIngredients": "ACETAMINOPHEN; BUTALBITAL",
    "company": "QUAGEN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/18/2024",
    "drugName": "BISOPROLOL FUMARATEANDA  #217617",
    "submission": "ORIG-1",
    "activeIngredients": "BISOPROLOL FUMARATE",
    "company": "HARMAN FINOCHEM",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/19/2024",
    "drugName": "FIRAZYRNDA   #022150",
    "submission": "SUPPL-16",
    "activeIngredients": "ICATIBANT ACETATE",
    "company": "TAKEDA PHARMS USA",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/19/2024",
    "drugName": "CARBAGLUNDA   #022562",
    "submission": "SUPPL-14",
    "activeIngredients": "CARGLUMIC ACID",
    "company": "RECORDATI RARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/19/2024",
    "drugName": "FENTANYL CITRATE PRESERVATIVE FREEANDA  #072786",
    "submission": "SUPPL-40",
    "activeIngredients": "FENTANYL CITRATE",
    "company": "HOSPIRA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/19/2024",
    "drugName": "SUFENTANIL CITRATEANDA  #074413",
    "submission": "SUPPL-23",
    "activeIngredients": "SUFENTANIL CITRATE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/19/2024",
    "drugName": "TERAZOSIN HYDROCHLORIDEANDA  #075667",
    "submission": "SUPPL-2",
    "activeIngredients": "TERAZOSIN HYDROCHLORIDE",
    "company": "BIONPHARMA",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/19/2024",
    "drugName": "OXYMORPHONE HYDROCHLORIDEANDA  #090964",
    "submission": "SUPPL-10",
    "activeIngredients": "OXYMORPHONE HYDROCHLORIDE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/19/2024",
    "drugName": "ORENCIABLA   #125118",
    "submission": "SUPPL-249",
    "activeIngredients": "ABATACEPT",
    "company": "BRISTOL MYERS SQUIBB",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/19/2024",
    "drugName": "PROLIABLA   #125320",
    "submission": "SUPPL-216",
    "activeIngredients": "DENOSUMAB",
    "company": "AMGEN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/19/2024",
    "drugName": "XGEVABLA   #125320",
    "submission": "SUPPL-216",
    "activeIngredients": "DENOSUMAB",
    "company": "AMGEN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/19/2024",
    "drugName": "ARZERRABLA   #125326",
    "submission": "SUPPL-80",
    "activeIngredients": "OFATUMUMAB",
    "company": "NOVARTIS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/19/2024",
    "drugName": "KESIMPTABLA   #125326",
    "submission": "SUPPL-80",
    "activeIngredients": "OFATUMUMAB",
    "company": "NOVARTIS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/19/2024",
    "drugName": "ZARXIOBLA   #125553",
    "submission": "SUPPL-36",
    "activeIngredients": "FILGRASTIM-SNDZ",
    "company": "SANDOZ INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/19/2024",
    "drugName": "INVOKAMETNDA   #204353",
    "submission": "SUPPL-43",
    "activeIngredients": "CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE",
    "company": "JANSSEN PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/19/2024",
    "drugName": "DEXLANSOPRAZOLEANDA  #205205",
    "submission": "ORIG-1",
    "activeIngredients": "DEXLANSOPRAZOLE",
    "company": "MYLAN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/19/2024",
    "drugName": "AURYXIANDA   #205874",
    "submission": "SUPPL-29",
    "activeIngredients": "FERRIC CITRATE",
    "company": "KERYX BIOPHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/19/2024",
    "drugName": "INVOKAMET XRNDA   #205879",
    "submission": "SUPPL-20",
    "activeIngredients": "CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE",
    "company": "JANSSEN PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/19/2024",
    "drugName": "RAYALDEENDA   #208010",
    "submission": "SUPPL-13",
    "activeIngredients": "CALCIFEDIOL",
    "company": "EIRGEN",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/19/2024",
    "drugName": "BALVERSANDA   #212018",
    "submission": "SUPPL-7",
    "activeIngredients": "ERDAFITINIB",
    "company": "JANSSEN BIOTECH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/19/2024",
    "drugName": "BALVERSANDA   #212018",
    "submission": "SUPPL-8",
    "activeIngredients": "ERDAFITINIB",
    "company": "JANSSEN BIOTECH",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/19/2024",
    "drugName": "BALVERSANDA   #212018",
    "submission": "SUPPL-9",
    "activeIngredients": "ERDAFITINIB",
    "company": "JANSSEN BIOTECH",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/19/2024",
    "drugName": "PAROXETINE HYDROCHLORIDEANDA  #215003",
    "submission": "SUPPL-7",
    "activeIngredients": "PAROXETINE HYDROCHLORIDE",
    "company": "NOVITIUM PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/19/2024",
    "drugName": "OCREVUSBLA   #761053",
    "submission": "SUPPL-34",
    "activeIngredients": "OCRELIZUMAB",
    "company": "GENENTECH INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2024",
    "drugName": "FENTANYL CITRATE PRESERVATIVE FREEANDA  #072786",
    "submission": "SUPPL-42",
    "activeIngredients": "FENTANYL CITRATE",
    "company": "HOSPIRA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2024",
    "drugName": "SUFENTANIL CITRATEANDA  #074413",
    "submission": "SUPPL-24",
    "activeIngredients": "SUFENTANIL CITRATE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2024",
    "drugName": "SUFENTANIL CITRATEANDA  #074413",
    "submission": "SUPPL-25",
    "activeIngredients": "SUFENTANIL CITRATE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2024",
    "drugName": "HEPZATONDA   #201848",
    "submission": "SUPPL-4",
    "activeIngredients": "MELPHALAN HYDROCHLORIDE",
    "company": "DELCATH SYSTEMS INC",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2024",
    "drugName": "VALSARTANANDA  #209261",
    "submission": "SUPPL-5",
    "activeIngredients": "VALSARTAN",
    "company": "UNICHEM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2024",
    "drugName": "VALSARTANANDA  #209261",
    "submission": "SUPPL-6",
    "activeIngredients": "VALSARTAN",
    "company": "UNICHEM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2024",
    "drugName": "CHLORZOXAZONEANDA  #210961",
    "submission": "ORIG-1",
    "activeIngredients": "CHLORZOXAZONE",
    "company": "ANDA REPOSITORY",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2024",
    "drugName": "ATORVASTATIN CALCIUMANDA  #214513",
    "submission": "ORIG-1",
    "activeIngredients": "ATORVASTATIN CALCIUM",
    "company": "LAURUS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2024",
    "drugName": "SODIUM ACETATEANDA  #214805",
    "submission": "SUPPL-5",
    "activeIngredients": "SODIUM ACETATE",
    "company": "MILLA PHARMS",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2024",
    "drugName": "FLUPHENAZINE HYDROCHLORIDEANDA  #217094",
    "submission": "ORIG-1",
    "activeIngredients": "FLUPHENAZINE HYDROCHLORIDE",
    "company": "TORRENT",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2024",
    "drugName": "FLUVOXAMINE MALEATEANDA  #217917",
    "submission": "ORIG-1",
    "activeIngredients": "FLUVOXAMINE MALEATE",
    "company": "BIONPHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/23/2024",
    "drugName": "ELIGARD KITNDA   #021343",
    "submission": "SUPPL-51",
    "activeIngredients": "LEUPROLIDE ACETATE",
    "company": "TOLMAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/23/2024",
    "drugName": "ELIGARD KITNDA   #021379",
    "submission": "SUPPL-53",
    "activeIngredients": "LEUPROLIDE ACETATE",
    "company": "TOLMAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/23/2024",
    "drugName": "ELIGARD KITNDA   #021488",
    "submission": "SUPPL-48",
    "activeIngredients": "LEUPROLIDE ACETATE",
    "company": "TOLMAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/23/2024",
    "drugName": "ELIGARD KITNDA   #021731",
    "submission": "SUPPL-51",
    "activeIngredients": "LEUPROLIDE ACETATE",
    "company": "TOLMAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/23/2024",
    "drugName": "VARENICLINE TARTRATEANDA  #201785",
    "submission": "SUPPL-5",
    "activeIngredients": "VARENICLINE TARTRATE",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/23/2024",
    "drugName": "FLUCONAZOLEANDA  #208963",
    "submission": "SUPPL-13",
    "activeIngredients": "FLUCONAZOLE",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/23/2024",
    "drugName": "FLUCONAZOLEANDA  #208963",
    "submission": "SUPPL-15",
    "activeIngredients": "FLUCONAZOLE",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/23/2024",
    "drugName": "ZYNRELEF KITNDA   #211988",
    "submission": "SUPPL-13",
    "activeIngredients": "BUPIVACAINE; MELOXICAM",
    "company": "HERON THERAPS INC",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/23/2024",
    "drugName": "PRIMIDONEANDA  #218366",
    "submission": "ORIG-1",
    "activeIngredients": "PRIMIDONE",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2024",
    "drugName": "HYDROXYCHLOROQUINE SULFATEANDA  #040766",
    "submission": "SUPPL-24",
    "activeIngredients": "HYDROXYCHLOROQUINE SULFATE",
    "company": "IPCA LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2024",
    "drugName": "HYDROXYCHLOROQUINE SULFATEANDA  #040766",
    "submission": "SUPPL-27",
    "activeIngredients": "HYDROXYCHLOROQUINE SULFATE",
    "company": "IPCA LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2024",
    "drugName": "LEVETIRACETAMANDA  #078154",
    "submission": "SUPPL-28",
    "activeIngredients": "LEVETIRACETAM",
    "company": "LUPIN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2024",
    "drugName": "LEVETIRACETAMANDA  #078154",
    "submission": "SUPPL-29",
    "activeIngredients": "LEVETIRACETAM",
    "company": "LUPIN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2024",
    "drugName": "LEVETIRACETAMANDA  #078154",
    "submission": "SUPPL-30",
    "activeIngredients": "LEVETIRACETAM",
    "company": "LUPIN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2024",
    "drugName": "LEVETIRACETAMANDA  #078154",
    "submission": "SUPPL-34",
    "activeIngredients": "LEVETIRACETAM",
    "company": "LUPIN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2024",
    "drugName": "LEVETIRACETAMANDA  #078154",
    "submission": "SUPPL-37",
    "activeIngredients": "LEVETIRACETAM",
    "company": "LUPIN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2024",
    "drugName": "LEVETIRACETAMANDA  #078154",
    "submission": "SUPPL-39",
    "activeIngredients": "LEVETIRACETAM",
    "company": "LUPIN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2024",
    "drugName": "LEVETIRACETAMANDA  #078154",
    "submission": "SUPPL-43",
    "activeIngredients": "LEVETIRACETAM",
    "company": "LUPIN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2024",
    "drugName": "LEVETIRACETAMANDA  #078858",
    "submission": "SUPPL-33",
    "activeIngredients": "LEVETIRACETAM",
    "company": "TORRENT PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2024",
    "drugName": "LEVETIRACETAMANDA  #078858",
    "submission": "SUPPL-36",
    "activeIngredients": "LEVETIRACETAM",
    "company": "TORRENT PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2024",
    "drugName": "LEVETIRACETAMANDA  #078993",
    "submission": "SUPPL-14",
    "activeIngredients": "LEVETIRACETAM",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2024",
    "drugName": "LEVETIRACETAMANDA  #078993",
    "submission": "SUPPL-15",
    "activeIngredients": "LEVETIRACETAM",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2024",
    "drugName": "LEVETIRACETAMANDA  #078993",
    "submission": "SUPPL-17",
    "activeIngredients": "LEVETIRACETAM",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2024",
    "drugName": "LEVETIRACETAMANDA  #078993",
    "submission": "SUPPL-19",
    "activeIngredients": "LEVETIRACETAM",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2024",
    "drugName": "LEVETIRACETAMANDA  #078993",
    "submission": "SUPPL-20",
    "activeIngredients": "LEVETIRACETAM",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2024",
    "drugName": "LEVETIRACETAMANDA  #078993",
    "submission": "SUPPL-24",
    "activeIngredients": "LEVETIRACETAM",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2024",
    "drugName": "LEVETIRACETAMANDA  #078993",
    "submission": "SUPPL-28",
    "activeIngredients": "LEVETIRACETAM",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2024",
    "drugName": "LEVETIRACETAMANDA  #078993",
    "submission": "SUPPL-33",
    "activeIngredients": "LEVETIRACETAM",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2024",
    "drugName": "LEVETIRACETAMANDA  #079042",
    "submission": "SUPPL-4",
    "activeIngredients": "LEVETIRACETAM",
    "company": "INGENUS PHARMS LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2024",
    "drugName": "LEVETIRACETAMANDA  #090025",
    "submission": "SUPPL-28",
    "activeIngredients": "LEVETIRACETAM",
    "company": "LUPIN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2024",
    "drugName": "LEVETIRACETAMANDA  #090025",
    "submission": "SUPPL-29",
    "activeIngredients": "LEVETIRACETAM",
    "company": "LUPIN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2024",
    "drugName": "LEVETIRACETAMANDA  #090025",
    "submission": "SUPPL-30",
    "activeIngredients": "LEVETIRACETAM",
    "company": "LUPIN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2024",
    "drugName": "LEVETIRACETAMANDA  #090025",
    "submission": "SUPPL-34",
    "activeIngredients": "LEVETIRACETAM",
    "company": "LUPIN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2024",
    "drugName": "LEVETIRACETAMANDA  #090025",
    "submission": "SUPPL-39",
    "activeIngredients": "LEVETIRACETAM",
    "company": "LUPIN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2024",
    "drugName": "LEVETIRACETAMANDA  #090025",
    "submission": "SUPPL-41",
    "activeIngredients": "LEVETIRACETAM",
    "company": "LUPIN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2024",
    "drugName": "LEVETIRACETAMANDA  #090025",
    "submission": "SUPPL-44",
    "activeIngredients": "LEVETIRACETAM",
    "company": "LUPIN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2024",
    "drugName": "LEVETIRACETAMANDA  #090515",
    "submission": "SUPPL-5",
    "activeIngredients": "LEVETIRACETAM",
    "company": "HETERO LABS LTD III",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2024",
    "drugName": "LEVETIRACETAMANDA  #090515",
    "submission": "SUPPL-7",
    "activeIngredients": "LEVETIRACETAM",
    "company": "HETERO LABS LTD III",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2024",
    "drugName": "LEVETIRACETAMANDA  #090515",
    "submission": "SUPPL-9",
    "activeIngredients": "LEVETIRACETAM",
    "company": "HETERO LABS LTD III",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2024",
    "drugName": "LEVETIRACETAMANDA  #090515",
    "submission": "SUPPL-13",
    "activeIngredients": "LEVETIRACETAM",
    "company": "HETERO LABS LTD III",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2024",
    "drugName": "LEVETIRACETAMANDA  #090515",
    "submission": "SUPPL-14",
    "activeIngredients": "LEVETIRACETAM",
    "company": "HETERO LABS LTD III",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2024",
    "drugName": "LEVETIRACETAMANDA  #090515",
    "submission": "SUPPL-17",
    "activeIngredients": "LEVETIRACETAM",
    "company": "HETERO LABS LTD III",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2024",
    "drugName": "GABAPENTINANDA  #203934",
    "submission": "ORIG-1",
    "activeIngredients": "GABAPENTIN",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2024",
    "drugName": "LEVETIRACETAMANDA  #205130",
    "submission": "SUPPL-4",
    "activeIngredients": "LEVETIRACETAM",
    "company": "SCIEGEN PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2024",
    "drugName": "TRAMADOL HYDROCHLORIDEANDA  #206706",
    "submission": "SUPPL-1",
    "activeIngredients": "TRAMADOL HYDROCHLORIDE",
    "company": "MERRO PHARM USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2024",
    "drugName": "TRAMADOL HYDROCHLORIDEANDA  #206706",
    "submission": "SUPPL-2",
    "activeIngredients": "TRAMADOL HYDROCHLORIDE",
    "company": "MERRO PHARM USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2024",
    "drugName": "LACOSAMIDEANDA  #209224",
    "submission": "ORIG-1",
    "activeIngredients": "LACOSAMIDE",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2024",
    "drugName": "PREGABALINANDA  #209883",
    "submission": "ORIG-1",
    "activeIngredients": "PREGABALIN",
    "company": "STRIDES PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2024",
    "drugName": "RYBELSUSNDA   #213051",
    "submission": "SUPPL-18",
    "activeIngredients": "SEMAGLUTIDE",
    "company": "NOVO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2024",
    "drugName": "KOSELUGONDA   #213756",
    "submission": "SUPPL-4",
    "activeIngredients": "SELUMETINIB SULFATE",
    "company": "ASTRAZENECA",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2024",
    "drugName": "PREGABALINANDA  #216197",
    "submission": "SUPPL-1",
    "activeIngredients": "PREGABALIN",
    "company": "ADAPTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2024",
    "drugName": "PREGABALINANDA  #216197",
    "submission": "SUPPL-2",
    "activeIngredients": "PREGABALIN",
    "company": "ADAPTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2024",
    "drugName": "APREMILASTANDA  #217258",
    "submission": "ORIG-1",
    "activeIngredients": "APREMILAST",
    "company": "APOTEX",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "01/25/2024",
    "drugName": "VOTRIENTNDA   #022465",
    "submission": "SUPPL-36",
    "activeIngredients": "PAZOPANIB HYDROCHLORIDE",
    "company": "NOVARTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/25/2024",
    "drugName": "ACETAZOLAMIDE SODIUMANDA  #040089",
    "submission": "SUPPL-19",
    "activeIngredients": "ACETAZOLAMIDE SODIUM",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/25/2024",
    "drugName": "MEDROXYPROGESTERONE ACETATEANDA  #077334",
    "submission": "SUPPL-5",
    "activeIngredients": "MEDROXYPROGESTERONE ACETATE",
    "company": "AMPHASTAR PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/25/2024",
    "drugName": "KEYTRUDABLA   #125514",
    "submission": "SUPPL-124",
    "activeIngredients": "PEMBROLIZUMAB",
    "company": "MERCK SHARP DOHME",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/25/2024",
    "drugName": "LEVETIRACETAMANDA  #201464",
    "submission": "SUPPL-11",
    "activeIngredients": "LEVETIRACETAM",
    "company": "PHARMADAX INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/25/2024",
    "drugName": "OLMESARTAN MEDOXOMILANDA  #206227",
    "submission": "ORIG-1",
    "activeIngredients": "OLMESARTAN MEDOXOMIL",
    "company": "CHARTWELL RX",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/25/2024",
    "drugName": "BENDAMUSTINE HYDROCHLORIDENDA   #211530",
    "submission": "SUPPL-1",
    "activeIngredients": "BENDAMUSTINE HYDROCHLORIDE",
    "company": "HOSPIRA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/25/2024",
    "drugName": "ATORVASTATIN CALCIUMANDA  #211886",
    "submission": "ORIG-1",
    "activeIngredients": "ATORVASTATIN CALCIUM",
    "company": "SHANDONG XINHUA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/25/2024",
    "drugName": "TACROLIMUSANDA  #215012",
    "submission": "ORIG-1",
    "activeIngredients": "TACROLIMUS",
    "company": "CHENGDU",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/25/2024",
    "drugName": "CARBOPROST TROMETHAMINEANDA  #215901",
    "submission": "ORIG-1",
    "activeIngredients": "CARBOPROST TROMETHAMINE",
    "company": "ANI PHARMS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/25/2024",
    "drugName": "SKYCLARYSNDA   #216718",
    "submission": "SUPPL-2",
    "activeIngredients": "OMAVELOXOLONE",
    "company": "BIOGEN US",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/25/2024",
    "drugName": "DUPIXENTBLA   #761055",
    "submission": "SUPPL-57",
    "activeIngredients": "DUPILUMAB",
    "company": "REGENERON PHARMACEUTICALS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/25/2024",
    "drugName": "IMJUDOBLA   #761289",
    "submission": "SUPPL-4",
    "activeIngredients": "TREMELIMUMAB-ACTL",
    "company": "ASTRAZENECA AB",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/26/2024",
    "drugName": "OMNISCANNDA   #020123",
    "submission": "SUPPL-50",
    "activeIngredients": "GADODIAMIDE",
    "company": "GE HEALTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/26/2024",
    "drugName": "PROHANCENDA   #020131",
    "submission": "SUPPL-40",
    "activeIngredients": "GADOTERIDOL",
    "company": "BRACCO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/26/2024",
    "drugName": "MULTIHANCENDA   #021357",
    "submission": "SUPPL-25",
    "activeIngredients": "GADOBENATE DIMEGLUMINE",
    "company": "BRACCO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/26/2024",
    "drugName": "MULTIHANCE MULTIPACKNDA   #021358",
    "submission": "SUPPL-23",
    "activeIngredients": "GADOBENATE DIMEGLUMINE",
    "company": "BRACCO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/26/2024",
    "drugName": "PROHANCE MULTIPACKNDA   #021489",
    "submission": "SUPPL-21",
    "activeIngredients": "GADOTERIDOL",
    "company": "BRACCO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/26/2024",
    "drugName": "OMNISCANNDA   #022066",
    "submission": "SUPPL-13",
    "activeIngredients": "GADODIAMIDE",
    "company": "GE HEALTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/26/2024",
    "drugName": "SUFENTANIL CITRATEANDA  #074534",
    "submission": "SUPPL-19",
    "activeIngredients": "SUFENTANIL CITRATE",
    "company": "HOSPIRA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/26/2024",
    "drugName": "ALFENTANILANDA  #075221",
    "submission": "SUPPL-20",
    "activeIngredients": "ALFENTANIL HYDROCHLORIDE",
    "company": "HOSPIRA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/26/2024",
    "drugName": "OPDIVOBLA   #125554",
    "submission": "SUPPL-122",
    "activeIngredients": "NIVOLUMAB",
    "company": "BRISTOL MYERS SQUIBB",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/26/2024",
    "drugName": "GADAVISTNDA   #201277",
    "submission": "SUPPL-23",
    "activeIngredients": "GADOBUTROL",
    "company": "BAYER HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/26/2024",
    "drugName": "DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATEANDA  #202424",
    "submission": "SUPPL-9",
    "activeIngredients": "AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE",
    "company": "AUROLIFE PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/26/2024",
    "drugName": "NORETHINDRONE ACETATE AND ETHINYL ESTRADIOLANDA  #203038",
    "submission": "SUPPL-6",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/26/2024",
    "drugName": "DOTAREMNDA   #204781",
    "submission": "SUPPL-15",
    "activeIngredients": "GADOTERATE MEGLUMINE",
    "company": "GUERBET",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/26/2024",
    "drugName": "AVYCAZNDA   #206494",
    "submission": "SUPPL-12",
    "activeIngredients": "AVIBACTAM SODIUM; CEFTAZIDIME",
    "company": "ABBVIE",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/26/2024",
    "drugName": "NORETHINDRONE ACETATE AND ETHINYL ESTRADIOLANDA  #207260",
    "submission": "SUPPL-1",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "XIROMED",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/26/2024",
    "drugName": "NORETHINDRONE ACETATE AND ETHINYL ESTRADIOLANDA  #207260",
    "submission": "SUPPL-3",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "XIROMED",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/26/2024",
    "drugName": "DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATEANDA  #210293",
    "submission": "SUPPL-2",
    "activeIngredients": "AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/26/2024",
    "drugName": "ROZLYTREKNDA   #212725",
    "submission": "SUPPL-11",
    "activeIngredients": "ENTRECTINIB",
    "company": "GENENTECH INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/26/2024",
    "drugName": "XCOPRINDA   #212839",
    "submission": "SUPPL-8",
    "activeIngredients": "CENOBAMATE",
    "company": "SK LIFE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/26/2024",
    "drugName": "ACETAZOLAMIDEANDA  #213706",
    "submission": "ORIG-1",
    "activeIngredients": "ACETAZOLAMIDE",
    "company": "TORRENT",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/26/2024",
    "drugName": "ELUCIREMNDA   #216986",
    "submission": "SUPPL-2",
    "activeIngredients": "GADOPICLENOL",
    "company": "GUERBET",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/27/2024",
    "drugName": "PERINDOPRIL ERBUMINEANDA  #090072",
    "submission": "SUPPL-10",
    "activeIngredients": "PERINDOPRIL ERBUMINE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/27/2024",
    "drugName": "PACLITAXELANDA  #090130",
    "submission": "SUPPL-4",
    "activeIngredients": "PACLITAXEL",
    "company": "ACTAVIS TOTOWA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/29/2024",
    "drugName": "ALLOPURINOLANDA  #071450",
    "submission": "SUPPL-44",
    "activeIngredients": "ALLOPURINOL",
    "company": "SUN PHARM INDUSTRIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/29/2024",
    "drugName": "CARBAMAZEPINEANDA  #075714",
    "submission": "SUPPL-18",
    "activeIngredients": "CARBAMAZEPINE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/29/2024",
    "drugName": "CARBAMAZEPINEANDA  #075948",
    "submission": "SUPPL-21",
    "activeIngredients": "CARBAMAZEPINE",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/29/2024",
    "drugName": "NORETHINDRONE ACETATE AND ETHINYL ESTRADIOLANDA  #076221",
    "submission": "SUPPL-14",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "BARR LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/29/2024",
    "drugName": "CARBAMAZEPINEANDA  #076697",
    "submission": "SUPPL-17",
    "activeIngredients": "CARBAMAZEPINE",
    "company": "ANI PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/29/2024",
    "drugName": "ALLOPURINOLANDA  #090637",
    "submission": "SUPPL-6",
    "activeIngredients": "ALLOPURINOL",
    "company": "IPCA LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/29/2024",
    "drugName": "TOBRAMYCINANDA  #091589",
    "submission": "SUPPL-12",
    "activeIngredients": "TOBRAMYCIN",
    "company": "TEVA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/29/2024",
    "drugName": "CARBAMAZEPINEANDA  #205571",
    "submission": "SUPPL-4",
    "activeIngredients": "CARBAMAZEPINE",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/29/2024",
    "drugName": "MOXIFLOXACIN HYDROCHLORIDEANDA  #206242",
    "submission": "SUPPL-3",
    "activeIngredients": "MOXIFLOXACIN HYDROCHLORIDE",
    "company": "EUGIA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/29/2024",
    "drugName": "NORETHINDRONE ACETATE AND ETHINYL ESTRADIOLANDA  #207259",
    "submission": "SUPPL-1",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "XIROMED",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/29/2024",
    "drugName": "NORETHINDRONE ACETATE AND ETHINYL ESTRADIOLANDA  #207259",
    "submission": "SUPPL-3",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "XIROMED",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/29/2024",
    "drugName": "ITRACONAZOLEANDA  #209460",
    "submission": "SUPPL-5",
    "activeIngredients": "ITRACONAZOLE",
    "company": "TORRENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/29/2024",
    "drugName": "ESTRADIOLANDA  #209767",
    "submission": "SUPPL-11",
    "activeIngredients": "ESTRADIOL",
    "company": "ENCUBE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/29/2024",
    "drugName": "CARBAMAZEPINEANDA  #211623",
    "submission": "SUPPL-4",
    "activeIngredients": "CARBAMAZEPINE",
    "company": "UNIQUE PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/29/2024",
    "drugName": "ALLOPURINOLANDA  #211820",
    "submission": "SUPPL-11",
    "activeIngredients": "ALLOPURINOL",
    "company": "UNICHEM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/29/2024",
    "drugName": "LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINERANDA  #216164",
    "submission": "ORIG-1",
    "activeIngredients": "LEVOFLOXACIN",
    "company": "KNACK",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/29/2024",
    "drugName": "ISOTRETINOINANDA  #218194",
    "submission": "ORIG-1",
    "activeIngredients": "ISOTRETINOIN",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/30/2024",
    "drugName": "EOVISTNDA   #022090",
    "submission": "SUPPL-24",
    "activeIngredients": "GADOXETATE DISODIUM",
    "company": "BAYER HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/30/2024",
    "drugName": "FLUOROURACILANDA  #090368",
    "submission": "SUPPL-12",
    "activeIngredients": "FLUOROURACIL",
    "company": "TARO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/30/2024",
    "drugName": "EZETIMIBEANDA  #203931",
    "submission": "SUPPL-3",
    "activeIngredients": "EZETIMIBE",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/30/2024",
    "drugName": "PLERIXAFORANDA  #205182",
    "submission": "SUPPL-1",
    "activeIngredients": "PLERIXAFOR",
    "company": "DR REDDYS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/30/2024",
    "drugName": "PLERIXAFORANDA  #208980",
    "submission": "SUPPL-1",
    "activeIngredients": "PLERIXAFOR",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/30/2024",
    "drugName": "LYBALVINDA   #213378",
    "submission": "SUPPL-7",
    "activeIngredients": "OLANZAPINE; SAMIDORPHAN L-MALATE",
    "company": "ALKERMES INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/30/2024",
    "drugName": "VENLAFAXINE HYDROCHLORIDEANDA  #214654",
    "submission": "SUPPL-1",
    "activeIngredients": "VENLAFAXINE HYDROCHLORIDE",
    "company": "YICHANG HUMANWELL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/30/2024",
    "drugName": "VENLAFAXINE HYDROCHLORIDEANDA  #214654",
    "submission": "SUPPL-3",
    "activeIngredients": "VENLAFAXINE HYDROCHLORIDE",
    "company": "YICHANG HUMANWELL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/30/2024",
    "drugName": "VENLAFAXINE HYDROCHLORIDEANDA  #214654",
    "submission": "SUPPL-6",
    "activeIngredients": "VENLAFAXINE HYDROCHLORIDE",
    "company": "YICHANG HUMANWELL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/30/2024",
    "drugName": "VENLAFAXINE HYDROCHLORIDEANDA  #214654",
    "submission": "SUPPL-8",
    "activeIngredients": "VENLAFAXINE HYDROCHLORIDE",
    "company": "YICHANG HUMANWELL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/30/2024",
    "drugName": "VENLAFAXINE HYDROCHLORIDEANDA  #214654",
    "submission": "SUPPL-14",
    "activeIngredients": "VENLAFAXINE HYDROCHLORIDE",
    "company": "YICHANG HUMANWELL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/30/2024",
    "drugName": "ISOSORBIDE DINITRATE AND HYDRALAZINE HYDROCHLORIDEANDA  #215988",
    "submission": "SUPPL-1",
    "activeIngredients": "HYDRALAZINE HYDROCHLORIDE; ISOSORBIDE DINITRATE",
    "company": "MLV",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/30/2024",
    "drugName": "LISDEXAMFETAMINE DIMESYLATEANDA  #216944",
    "submission": "SUPPL-1",
    "activeIngredients": "LISDEXAMFETAMINE DIMESYLATE",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/30/2024",
    "drugName": "VENXXIVAANDA  #216990",
    "submission": "ORIG-1",
    "activeIngredients": "TIOPRONIN",
    "company": "TORRENT",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/31/2024",
    "drugName": "SIMVASTATINANDA  #077691",
    "submission": "SUPPL-48",
    "activeIngredients": "SIMVASTATIN",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/31/2024",
    "drugName": "SIMVASTATINANDA  #078103",
    "submission": "SUPPL-54",
    "activeIngredients": "SIMVASTATIN",
    "company": "LUPIN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/31/2024",
    "drugName": "ONDANSETRONANDA  #090469",
    "submission": "SUPPL-18",
    "activeIngredients": "ONDANSETRON",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/31/2024",
    "drugName": "ONDANSETRONANDA  #090469",
    "submission": "SUPPL-19",
    "activeIngredients": "ONDANSETRON",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/31/2024",
    "drugName": "HYDROCHLOROTHIAZIDEANDA  #090510",
    "submission": "SUPPL-22",
    "activeIngredients": "HYDROCHLOROTHIAZIDE",
    "company": "UNICHEM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/31/2024",
    "drugName": "DULOXETINE HYDROCHLORIDEANDA  #202045",
    "submission": "SUPPL-17",
    "activeIngredients": "DULOXETINE HYDROCHLORIDE",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/31/2024",
    "drugName": "DRONEDARONE HYDROCHLORIDEANDA  #205904",
    "submission": "ORIG-1",
    "activeIngredients": "DRONEDARONE HYDROCHLORIDE",
    "company": "LUPIN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/31/2024",
    "drugName": "TAGRISSONDA   #208065",
    "submission": "SUPPL-29",
    "activeIngredients": "OSIMERTINIB MESYLATE",
    "company": "ASTRAZENECA",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/31/2024",
    "drugName": "ZYPITAMAGNDA   #208379",
    "submission": "SUPPL-5",
    "activeIngredients": "PITAVASTATIN MAGNESIUM",
    "company": "MEDICURE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/31/2024",
    "drugName": "VARDENAFIL HYDROCHLORIDEANDA  #209057",
    "submission": "SUPPL-5",
    "activeIngredients": "VARDENAFIL HYDROCHLORIDE",
    "company": "CROSSMEDIKA SA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/31/2024",
    "drugName": "FENOFIBRATE (MICRONIZED)ANDA  #211407",
    "submission": "ORIG-1",
    "activeIngredients": "FENOFIBRATE",
    "company": "CHARTWELL",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/31/2024",
    "drugName": "MESALAMINEANDA  #213377",
    "submission": "SUPPL-4",
    "activeIngredients": "MESALAMINE",
    "company": "ANNORA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/31/2024",
    "drugName": "HALOPERIDOLANDA  #218371",
    "submission": "ORIG-1",
    "activeIngredients": "HALOPERIDOL LACTATE",
    "company": "RUBICON RESEARCH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/31/2024",
    "drugName": "HEMLIBRABLA   #761083",
    "submission": "SUPPL-18",
    "activeIngredients": "EMICIZUMAB",
    "company": "GENENTECH INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  }
,
  {
    "approvalDate": "02/01/2024",
    "drugName": "FURADANTINNDA   #009175",
    "submission": "SUPPL-50",
    "activeIngredients": "NITROFURANTOIN",
    "company": "CASPER PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/01/2024",
    "drugName": "EXTENDED PHENYTOIN SODIUMANDA  #040298",
    "submission": "SUPPL-36",
    "activeIngredients": "PHENYTOIN SODIUM",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/01/2024",
    "drugName": "EXTENDED PHENYTOIN SODIUMANDA  #040298",
    "submission": "SUPPL-38",
    "activeIngredients": "PHENYTOIN SODIUM",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/01/2024",
    "drugName": "EXTENDED PHENYTOIN SODIUMANDA  #040298",
    "submission": "SUPPL-41",
    "activeIngredients": "PHENYTOIN SODIUM",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/01/2024",
    "drugName": "EXTENDED PHENYTOIN SODIUMANDA  #040298",
    "submission": "SUPPL-44",
    "activeIngredients": "PHENYTOIN SODIUM",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/01/2024",
    "drugName": "EXTENDED PHENYTOIN SODIUMANDA  #040298",
    "submission": "SUPPL-47",
    "activeIngredients": "PHENYTOIN SODIUM",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/01/2024",
    "drugName": "PHENYTEKANDA  #040298",
    "submission": "SUPPL-36",
    "activeIngredients": "PHENYTOIN SODIUM",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/01/2024",
    "drugName": "PHENYTEKANDA  #040298",
    "submission": "SUPPL-38",
    "activeIngredients": "PHENYTOIN SODIUM",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/01/2024",
    "drugName": "PHENYTEKANDA  #040298",
    "submission": "SUPPL-41",
    "activeIngredients": "PHENYTOIN SODIUM",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/01/2024",
    "drugName": "PHENYTEKANDA  #040298",
    "submission": "SUPPL-44",
    "activeIngredients": "PHENYTOIN SODIUM",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/01/2024",
    "drugName": "PHENYTEKANDA  #040298",
    "submission": "SUPPL-47",
    "activeIngredients": "PHENYTOIN SODIUM",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/01/2024",
    "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #040746",
    "submission": "SUPPL-31",
    "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
    "company": "AMNEAL PHARMS NY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/01/2024",
    "drugName": "GEMFIBROZILANDA  #074270",
    "submission": "SUPPL-18",
    "activeIngredients": "GEMFIBROZIL",
    "company": "CHARTWELL MOLECULES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/01/2024",
    "drugName": "TRAMADOL HYDROCHLORIDEANDA  #075968",
    "submission": "SUPPL-13",
    "activeIngredients": "TRAMADOL HYDROCHLORIDE",
    "company": "GRAVITI PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/01/2024",
    "drugName": "SERTRALINE HYDROCHLORIDEANDA  #077206",
    "submission": "SUPPL-41",
    "activeIngredients": "SERTRALINE HYDROCHLORIDE",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/01/2024",
    "drugName": "HYDROCHLOROTHIAZIDEANDA  #079237",
    "submission": "SUPPL-14",
    "activeIngredients": "HYDROCHLOROTHIAZIDE",
    "company": "IPCA LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/01/2024",
    "drugName": "TRI-ESTARYLLAANDA  #090793",
    "submission": "SUPPL-11",
    "activeIngredients": "ETHINYL ESTRADIOL; NORGESTIMATE",
    "company": "XIROMED",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/01/2024",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #206556",
    "submission": "SUPPL-16",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "INVAGEN PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/01/2024",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #206556",
    "submission": "SUPPL-18",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "INVAGEN PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/01/2024",
    "drugName": "CEFAZOLIN IN DEXTROSENDA   #207131",
    "submission": "SUPPL-9",
    "activeIngredients": "CEFAZOLIN SODIUM",
    "company": "BAXTER HLTHCARE CORP",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/01/2024",
    "drugName": "AUROVELA 1.5/30ANDA  #207581",
    "submission": "SUPPL-1",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/01/2024",
    "drugName": "AUROVELA 1.5/30ANDA  #207581",
    "submission": "SUPPL-7",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/01/2024",
    "drugName": "AUROVELA 1.5/30ANDA  #207581",
    "submission": "SUPPL-9",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/01/2024",
    "drugName": "TOFACITINIBANDA  #209813",
    "submission": "ORIG-1",
    "activeIngredients": "TOFACITINIB",
    "company": "TEVA PHARMS USA INC",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "02/01/2024",
    "drugName": "HYDROXYCHLOROQUINE SULFATEANDA  #210959",
    "submission": "SUPPL-15",
    "activeIngredients": "HYDROXYCHLOROQUINE SULFATE",
    "company": "LAURUS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/01/2024",
    "drugName": "VENLAFAXINE HYDROCHLORIDEANDA  #211323",
    "submission": "SUPPL-4",
    "activeIngredients": "VENLAFAXINE HYDROCHLORIDE",
    "company": "CADILA PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/01/2024",
    "drugName": "BUTALBITAL AND ACETAMINOPHENANDA  #214305",
    "submission": "ORIG-1",
    "activeIngredients": "ACETAMINOPHEN; BUTALBITAL",
    "company": "QUAGEN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/01/2024",
    "drugName": "AZMIRONDA   #216318",
    "submission": "SUPPL-2",
    "activeIngredients": "TESTOSTERONE CYPIONATE",
    "company": "AZURITY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/01/2024",
    "drugName": "METHSCOPOLAMINE BROMIDEANDA  #216786",
    "submission": "ORIG-1",
    "activeIngredients": "METHSCOPOLAMINE BROMIDE",
    "company": "NE RX PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/02/2024",
    "drugName": "CLOZAPINEANDA  #075713",
    "submission": "SUPPL-49",
    "activeIngredients": "CLOZAPINE",
    "company": "SUN PHARM INDS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/02/2024",
    "drugName": "CLOZAPINEANDA  #075713",
    "submission": "SUPPL-51",
    "activeIngredients": "CLOZAPINE",
    "company": "SUN PHARM INDS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/02/2024",
    "drugName": "CLOZAPINEANDA  #075713",
    "submission": "SUPPL-56",
    "activeIngredients": "CLOZAPINE",
    "company": "SUN PHARM INDS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/02/2024",
    "drugName": "CLOZAPINEANDA  #075713",
    "submission": "SUPPL-57",
    "activeIngredients": "CLOZAPINE",
    "company": "SUN PHARM INDS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/02/2024",
    "drugName": "SERTRALINE HYDROCHLORIDEANDA  #078861",
    "submission": "SUPPL-26",
    "activeIngredients": "SERTRALINE HYDROCHLORIDE",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/02/2024",
    "drugName": "ROSUVASTATIN CALCIUMANDA  #079172",
    "submission": "SUPPL-18",
    "activeIngredients": "ROSUVASTATIN CALCIUM",
    "company": "GLENMARK SPECLT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/02/2024",
    "drugName": "CHLOROQUINE PHOSPHATEANDA  #080880",
    "submission": "SUPPL-69",
    "activeIngredients": "CHLOROQUINE PHOSPHATE",
    "company": "IMPAX LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/02/2024",
    "drugName": "BROMFENAC SODIUMANDA  #211239",
    "submission": "ORIG-1",
    "activeIngredients": "BROMFENAC SODIUM",
    "company": "LUPIN LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/02/2024",
    "drugName": "TYRVAYANDA   #213978",
    "submission": "SUPPL-5",
    "activeIngredients": "VARENICLINE TARTRATE",
    "company": "OYSTER POINT PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/02/2024",
    "drugName": "EZETIMIBEANDA  #215693",
    "submission": "SUPPL-2",
    "activeIngredients": "EZETIMIBE",
    "company": "ORIENT PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/02/2024",
    "drugName": "BICTEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDEANDA  #217037",
    "submission": "ORIG-1",
    "activeIngredients": "BICTEGRAVIR;EMTRICITABINE;TENOFOVIR ALAFENAMIDE",
    "company": "LAURUS LABS LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "02/02/2024",
    "drugName": "LISDEXAMFETAMINE DIMESYLATEANDA  #218306",
    "submission": "ORIG-1",
    "activeIngredients": "LISDEXAMFETAMINE DIMESYLATE",
    "company": "MSN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2024",
    "drugName": "SPORANOXNDA   #020083",
    "submission": "SUPPL-68",
    "activeIngredients": "ITRACONAZOLE",
    "company": "JANSSEN PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2024",
    "drugName": "SPORANOXNDA   #020657",
    "submission": "SUPPL-40",
    "activeIngredients": "ITRACONAZOLE",
    "company": "JANSSEN PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2024",
    "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #040746",
    "submission": "SUPPL-34",
    "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
    "company": "AMNEAL PHARMS NY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2024",
    "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #040746",
    "submission": "SUPPL-35",
    "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
    "company": "AMNEAL PHARMS NY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2024",
    "drugName": "SERTRALINE HYDROCHLORIDEANDA  #076671",
    "submission": "SUPPL-14",
    "activeIngredients": "SERTRALINE HYDROCHLORIDE",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2024",
    "drugName": "SERTRALINE HYDROCHLORIDEANDA  #076671",
    "submission": "SUPPL-15",
    "activeIngredients": "SERTRALINE HYDROCHLORIDE",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2024",
    "drugName": "DROSPIRENONE AND ETHINYL ESTRADIOLANDA  #077527",
    "submission": "SUPPL-4",
    "activeIngredients": "DROSPIRENONE; ETHINYL ESTRADIOL",
    "company": "BARR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2024",
    "drugName": "ESCITALOPRAM OXALATEANDA  #078604",
    "submission": "SUPPL-21",
    "activeIngredients": "ESCITALOPRAM OXALATE",
    "company": "INVAGEN PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2024",
    "drugName": "ESCITALOPRAM OXALATEANDA  #078604",
    "submission": "SUPPL-22",
    "activeIngredients": "ESCITALOPRAM OXALATE",
    "company": "INVAGEN PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2024",
    "drugName": "ESCITALOPRAM OXALATEANDA  #078604",
    "submission": "SUPPL-23",
    "activeIngredients": "ESCITALOPRAM OXALATE",
    "company": "INVAGEN PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2024",
    "drugName": "DROSPIRENONE AND ETHINYL ESTRADIOLANDA  #090081",
    "submission": "SUPPL-21",
    "activeIngredients": "DROSPIRENONE; ETHINYL ESTRADIOL",
    "company": "DR REDDYS LABS SA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2024",
    "drugName": "IMIPENEM AND CILASTATINANDA  #090577",
    "submission": "SUPPL-16",
    "activeIngredients": "CILASTATIN SODIUM; IMIPENEM",
    "company": "ACS DOBFAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2024",
    "drugName": "CLINDAMYCIN PHOSPHATEANDA  #090785",
    "submission": "SUPPL-18",
    "activeIngredients": "CLINDAMYCIN PHOSPHATE",
    "company": "PADAGIS ISRAEL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2024",
    "drugName": "ACETYLCYSTEINEANDA  #091684",
    "submission": "SUPPL-3",
    "activeIngredients": "ACETYLCYSTEINE",
    "company": "SAGENT PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2024",
    "drugName": "OMEPRAZOLE AND SODIUM BICARBONATEANDA  #201361",
    "submission": "SUPPL-4",
    "activeIngredients": "OMEPRAZOLE; SODIUM BICARBONATE",
    "company": "PERRIGO R AND D",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2024",
    "drugName": "OMEPRAZOLE AND SODIUM BICARBONATEANDA  #201361",
    "submission": "SUPPL-6",
    "activeIngredients": "OMEPRAZOLE; SODIUM BICARBONATE",
    "company": "PERRIGO R AND D",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2024",
    "drugName": "OMEPRAZOLE AND SODIUM BICARBONATEANDA  #201361",
    "submission": "SUPPL-15",
    "activeIngredients": "OMEPRAZOLE; SODIUM BICARBONATE",
    "company": "PERRIGO R AND D",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2024",
    "drugName": "OMEPRAZOLE AND SODIUM BICARBONATEANDA  #201361",
    "submission": "SUPPL-17",
    "activeIngredients": "OMEPRAZOLE; SODIUM BICARBONATE",
    "company": "PERRIGO R AND D",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2024",
    "drugName": "ESCITALOPRAM OXALATEANDA  #202754",
    "submission": "SUPPL-20",
    "activeIngredients": "ESCITALOPRAM OXALATE",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2024",
    "drugName": "ESCITALOPRAM OXALATEANDA  #202754",
    "submission": "SUPPL-23",
    "activeIngredients": "ESCITALOPRAM OXALATE",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2024",
    "drugName": "ALLOPURINOLANDA  #204467",
    "submission": "SUPPL-5",
    "activeIngredients": "ALLOPURINOL",
    "company": "REGCON HOLDINGS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2024",
    "drugName": "ALLOPURINOLANDA  #204467",
    "submission": "SUPPL-12",
    "activeIngredients": "ALLOPURINOL",
    "company": "REGCON HOLDINGS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2024",
    "drugName": "PROVAYBLUENDA   #204630",
    "submission": "SUPPL-23",
    "activeIngredients": "METHYLENE BLUE",
    "company": "PROVEPHARM SAS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2024",
    "drugName": "EVEROLIMUSANDA  #205432",
    "submission": "SUPPL-7",
    "activeIngredients": "EVEROLIMUS",
    "company": "BRECKENRIDGE",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2024",
    "drugName": "ESOMEPRAZOLE MAGNESIUMANDA  #206296",
    "submission": "SUPPL-2",
    "activeIngredients": "ESOMEPRAZOLE MAGNESIUM",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2024",
    "drugName": "ESOMEPRAZOLE MAGNESIUMANDA  #206296",
    "submission": "SUPPL-4",
    "activeIngredients": "ESOMEPRAZOLE MAGNESIUM",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2024",
    "drugName": "ESOMEPRAZOLE MAGNESIUMANDA  #206296",
    "submission": "SUPPL-5",
    "activeIngredients": "ESOMEPRAZOLE MAGNESIUM",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2024",
    "drugName": "ESOMEPRAZOLE MAGNESIUMANDA  #206296",
    "submission": "SUPPL-7",
    "activeIngredients": "ESOMEPRAZOLE MAGNESIUM",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2024",
    "drugName": "DEFEROXAMINE MESYLATEANDA  #207384",
    "submission": "SUPPL-2",
    "activeIngredients": "DEFEROXAMINE MESYLATE",
    "company": "GLAND",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2024",
    "drugName": "NADOLOLANDA  #207761",
    "submission": "SUPPL-5",
    "activeIngredients": "NADOLOL",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2024",
    "drugName": "ATORVASTATIN CALCIUMANDA  #208478",
    "submission": "SUPPL-4",
    "activeIngredients": "ATORVASTATIN CALCIUM",
    "company": "PERRIGO R AND D",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2024",
    "drugName": "NEBIVOLOL HYDROCHLORIDEANDA  #208717",
    "submission": "SUPPL-3",
    "activeIngredients": "NEBIVOLOL HYDROCHLORIDE",
    "company": "CADILA PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2024",
    "drugName": "BACLOFENANDA  #209102",
    "submission": "SUPPL-15",
    "activeIngredients": "BACLOFEN",
    "company": "RUBICON RESEARCH",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2024",
    "drugName": "ALLOPURINOLANDA  #210117",
    "submission": "SUPPL-5",
    "activeIngredients": "ALLOPURINOL",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2024",
    "drugName": "PALIPERIDONE PALMITATEANDA  #210397",
    "submission": "ORIG-1",
    "activeIngredients": "PALIPERIDONE PALMITATE",
    "company": "PHARMASCIENCE INC",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "02/05/2024",
    "drugName": "VARDENAFIL HYDROCHLORIDEANDA  #210738",
    "submission": "SUPPL-1",
    "activeIngredients": "VARDENAFIL HYDROCHLORIDE",
    "company": "STEVENS J",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2024",
    "drugName": "TAUVIDNDA   #212123",
    "submission": "SUPPL-31",
    "activeIngredients": "FLORTAUCIPIR F-18",
    "company": "AVID RADIOPHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2024",
    "drugName": "BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDEANDA  #215666",
    "submission": "SUPPL-3",
    "activeIngredients": "BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE",
    "company": "CADILA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2024",
    "drugName": "PLERIXAFORANDA  #215698",
    "submission": "SUPPL-2",
    "activeIngredients": "PLERIXAFOR",
    "company": "MEITHEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2024",
    "drugName": "MESALAMINEANDA  #216334",
    "submission": "ORIG-1",
    "activeIngredients": "MESALAMINE",
    "company": "ANNORA PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2024",
    "drugName": "VASOPRESSIN IN SODIUM CHLORIDE 0.9%NDA   #217569",
    "submission": "SUPPL-1",
    "activeIngredients": "VASOPRESSIN",
    "company": "BAXTER HLTHCARE CORP",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/06/2024",
    "drugName": "TASIGNANDA   #022068",
    "submission": "SUPPL-39",
    "activeIngredients": "NILOTINIB HYDROCHLORIDE",
    "company": "NOVARTIS",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/06/2024",
    "drugName": "QSYMIANDA   #022580",
    "submission": "SUPPL-24",
    "activeIngredients": "PHENTERMINE HYDROCHLORIDE; TOPIRAMATE",
    "company": "VIVUS LLC",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/06/2024",
    "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #040746",
    "submission": "SUPPL-36",
    "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
    "company": "AMNEAL PHARMS NY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/06/2024",
    "drugName": "FABRAZYMEBLA   #103979",
    "submission": "SUPPL-5312",
    "activeIngredients": "AGALSIDASE BETA",
    "company": "GENZYME",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/06/2024",
    "drugName": "EFAVIRENZANDA  #204766",
    "submission": "SUPPL-1",
    "activeIngredients": "EFAVIRENZ",
    "company": "CIPLA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/06/2024",
    "drugName": "EFAVIRENZANDA  #204766",
    "submission": "SUPPL-4",
    "activeIngredients": "EFAVIRENZ",
    "company": "CIPLA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/06/2024",
    "drugName": "EFAVIRENZANDA  #204869",
    "submission": "SUPPL-2",
    "activeIngredients": "EFAVIRENZ",
    "company": "NORVIUM BIOSCIENCE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/06/2024",
    "drugName": "EFAVIRENZANDA  #204869",
    "submission": "SUPPL-7",
    "activeIngredients": "EFAVIRENZ",
    "company": "NORVIUM BIOSCIENCE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/06/2024",
    "drugName": "TALZENNANDA   #211651",
    "submission": "SUPPL-12",
    "activeIngredients": "TALAZOPARIB TOSYLATE",
    "company": "PFIZER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/06/2024",
    "drugName": "MEMANTINE HYDROCHLORIDEANDA  #213985",
    "submission": "SUPPL-1",
    "activeIngredients": "MEMANTINE HYDROCHLORIDE",
    "company": "VITRUVIAS",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/06/2024",
    "drugName": "POTASSIUM CITRATEANDA  #213986",
    "submission": "ORIG-1",
    "activeIngredients": "POTASSIUM CITRATE",
    "company": "TORRENT",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/06/2024",
    "drugName": "LIOTHYRONINE SODIUMANDA  #218070",
    "submission": "ORIG-1",
    "activeIngredients": "LIOTHYRONINE SODIUM",
    "company": "BIOCON PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/07/2024",
    "drugName": "HEPARIN SODIUM 10,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINERNDA   #019339",
    "submission": "SUPPL-68",
    "activeIngredients": "HEPARIN SODIUM",
    "company": "HOSPIRA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/07/2024",
    "drugName": "HEPARIN SODIUM 12,500 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINERNDA   #019339",
    "submission": "SUPPL-68",
    "activeIngredients": "HEPARIN SODIUM",
    "company": "HOSPIRA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/07/2024",
    "drugName": "HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINERNDA   #019339",
    "submission": "SUPPL-68",
    "activeIngredients": "HEPARIN SODIUM",
    "company": "HOSPIRA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/07/2024",
    "drugName": "FOLLISTIM AQBLA   #021211",
    "submission": "SUPPL-37",
    "activeIngredients": "FOLLITROPIN ALFA/BETA",
    "company": "ORGANON USA LLC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/07/2024",
    "drugName": "MAVENCLADNDA   #022561",
    "submission": "SUPPL-9",
    "activeIngredients": "CLADRIBINE",
    "company": "EMD SERONO INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/07/2024",
    "drugName": "MYCOPHENOLATE MOFETILANDA  #065410",
    "submission": "SUPPL-20",
    "activeIngredients": "MYCOPHENOLATE MOFETIL",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/07/2024",
    "drugName": "MYCOPHENOLATE MOFETILANDA  #065410",
    "submission": "SUPPL-21",
    "activeIngredients": "MYCOPHENOLATE MOFETIL",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/07/2024",
    "drugName": "MYCOPHENOLATE MOFETILANDA  #065410",
    "submission": "SUPPL-22",
    "activeIngredients": "MYCOPHENOLATE MOFETIL",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/07/2024",
    "drugName": "MYCOPHENOLATE MOFETILANDA  #065413",
    "submission": "SUPPL-21",
    "activeIngredients": "MYCOPHENOLATE MOFETIL",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/07/2024",
    "drugName": "MYCOPHENOLATE MOFETILANDA  #065413",
    "submission": "SUPPL-22",
    "activeIngredients": "MYCOPHENOLATE MOFETIL",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/07/2024",
    "drugName": "MYCOPHENOLATE MOFETILANDA  #065413",
    "submission": "SUPPL-23",
    "activeIngredients": "MYCOPHENOLATE MOFETIL",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/07/2024",
    "drugName": "TACROLIMUSANDA  #065461",
    "submission": "SUPPL-38",
    "activeIngredients": "TACROLIMUS",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/07/2024",
    "drugName": "LOPINAVIR AND RITONAVIRANDA  #079074",
    "submission": "ORIG-1",
    "activeIngredients": "LOPINAVIR; RITONAVIR",
    "company": "MYLAN LABS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/07/2024",
    "drugName": "VALACYCLOVIR HYDROCHLORIDEANDA  #090500",
    "submission": "SUPPL-4",
    "activeIngredients": "VALACYCLOVIR HYDROCHLORIDE",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/07/2024",
    "drugName": "TESTOSTERONEANDA  #091073",
    "submission": "SUPPL-3",
    "activeIngredients": "TESTOSTERONE",
    "company": "ACTAVIS LABS UT INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/07/2024",
    "drugName": "TESTOSTERONEANDA  #091073",
    "submission": "SUPPL-6",
    "activeIngredients": "TESTOSTERONE",
    "company": "ACTAVIS LABS UT INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/07/2024",
    "drugName": "METHAMPHETAMINE HYDROCHLORIDEANDA  #091189",
    "submission": "SUPPL-7",
    "activeIngredients": "METHAMPHETAMINE HYDROCHLORIDE",
    "company": "DR REDDYS LABS SA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/07/2024",
    "drugName": "PRAMIPEXOLE DIHYDROCHLORIDEANDA  #202702",
    "submission": "SUPPL-1",
    "activeIngredients": "PRAMIPEXOLE DIHYDROCHLORIDE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/07/2024",
    "drugName": "PRAMIPEXOLE DIHYDROCHLORIDEANDA  #202702",
    "submission": "SUPPL-2",
    "activeIngredients": "PRAMIPEXOLE DIHYDROCHLORIDE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/07/2024",
    "drugName": "PRAMIPEXOLE DIHYDROCHLORIDEANDA  #202702",
    "submission": "SUPPL-3",
    "activeIngredients": "PRAMIPEXOLE DIHYDROCHLORIDE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/07/2024",
    "drugName": "PRAMIPEXOLE DIHYDROCHLORIDEANDA  #202702",
    "submission": "SUPPL-5",
    "activeIngredients": "PRAMIPEXOLE DIHYDROCHLORIDE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/07/2024",
    "drugName": "COBICISTATANDA  #209986",
    "submission": "ORIG-1",
    "activeIngredients": "COBICISTAT",
    "company": "MYLAN LABS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/07/2024",
    "drugName": "APREMILASTANDA  #211734",
    "submission": "ORIG-1",
    "activeIngredients": "APREMILAST",
    "company": "MANKIND PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/07/2024",
    "drugName": "DEXAMETHASONEANDA  #216282",
    "submission": "ORIG-1",
    "activeIngredients": "DEXAMETHASONE",
    "company": "ZYDUS LIFESCIENCES",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/07/2024",
    "drugName": "DEXAMETHASONEANDA  #216283",
    "submission": "ORIG-1",
    "activeIngredients": "DEXAMETHASONE",
    "company": "ZYDUS LIFESCIENCES",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/08/2024",
    "drugName": "TRACLEERNDA   #021290",
    "submission": "SUPPL-44",
    "activeIngredients": "BOSENTAN",
    "company": "ACTELION",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/08/2024",
    "drugName": "VYTORINNDA   #021687",
    "submission": "SUPPL-61",
    "activeIngredients": "EZETIMIBE; SIMVASTATIN",
    "company": "ORGANON",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/08/2024",
    "drugName": "VYTORINNDA   #021687",
    "submission": "SUPPL-64",
    "activeIngredients": "EZETIMIBE; SIMVASTATIN",
    "company": "ORGANON",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/08/2024",
    "drugName": "VYTORINNDA   #021687",
    "submission": "SUPPL-65",
    "activeIngredients": "EZETIMIBE; SIMVASTATIN",
    "company": "ORGANON",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/08/2024",
    "drugName": "TASIGNANDA   #022068",
    "submission": "SUPPL-41",
    "activeIngredients": "NILOTINIB HYDROCHLORIDE",
    "company": "NOVARTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/08/2024",
    "drugName": "ACETAMINOPHEN AND CODEINE PHOSPHATEANDA  #040119",
    "submission": "SUPPL-20",
    "activeIngredients": "ACETAMINOPHEN; CODEINE PHOSPHATE",
    "company": "PAI HOLDINGS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/08/2024",
    "drugName": "ACETAMINOPHEN AND CODEINE PHOSPHATEANDA  #040119",
    "submission": "SUPPL-21",
    "activeIngredients": "ACETAMINOPHEN; CODEINE PHOSPHATE",
    "company": "PAI HOLDINGS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/08/2024",
    "drugName": "CAMPATHBLA   #103948",
    "submission": "SUPPL-5192",
    "activeIngredients": "ALEMTUZUMAB",
    "company": "GENZYME",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/08/2024",
    "drugName": "LEMTRADABLA   #103948",
    "submission": "SUPPL-5192",
    "activeIngredients": "ALEMTUZUMAB",
    "company": "GENZYME",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/08/2024",
    "drugName": "SOLIRISBLA   #125166",
    "submission": "SUPPL-446",
    "activeIngredients": "ECULIZUMAB",
    "company": "ALEXION PHARM",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/08/2024",
    "drugName": "BLINCYTOBLA   #125557",
    "submission": "SUPPL-29",
    "activeIngredients": "BLINATUMOMAB",
    "company": "AMGEN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/08/2024",
    "drugName": "DULOXETINE HYDROCHLORIDEANDA  #202949",
    "submission": "SUPPL-2",
    "activeIngredients": "DULOXETINE HYDROCHLORIDE",
    "company": "ALEMBIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/08/2024",
    "drugName": "DULOXETINE HYDROCHLORIDEANDA  #202949",
    "submission": "SUPPL-3",
    "activeIngredients": "DULOXETINE HYDROCHLORIDE",
    "company": "ALEMBIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/08/2024",
    "drugName": "DULOXETINE HYDROCHLORIDEANDA  #202949",
    "submission": "SUPPL-4",
    "activeIngredients": "DULOXETINE HYDROCHLORIDE",
    "company": "ALEMBIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/08/2024",
    "drugName": "DULOXETINE HYDROCHLORIDEANDA  #202949",
    "submission": "SUPPL-8",
    "activeIngredients": "DULOXETINE HYDROCHLORIDE",
    "company": "ALEMBIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/08/2024",
    "drugName": "DULOXETINE HYDROCHLORIDEANDA  #202949",
    "submission": "SUPPL-9",
    "activeIngredients": "DULOXETINE HYDROCHLORIDE",
    "company": "ALEMBIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/08/2024",
    "drugName": "DULOXETINE HYDROCHLORIDEANDA  #202949",
    "submission": "SUPPL-11",
    "activeIngredients": "DULOXETINE HYDROCHLORIDE",
    "company": "ALEMBIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/08/2024",
    "drugName": "DULOXETINE HYDROCHLORIDEANDA  #202949",
    "submission": "SUPPL-16",
    "activeIngredients": "DULOXETINE HYDROCHLORIDE",
    "company": "ALEMBIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/08/2024",
    "drugName": "DULOXETINE HYDROCHLORIDEANDA  #202949",
    "submission": "SUPPL-19",
    "activeIngredients": "DULOXETINE HYDROCHLORIDE",
    "company": "ALEMBIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/08/2024",
    "drugName": "DULOXETINE HYDROCHLORIDEANDA  #202949",
    "submission": "SUPPL-23",
    "activeIngredients": "DULOXETINE HYDROCHLORIDE",
    "company": "ALEMBIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/08/2024",
    "drugName": "LOKELMANDA   #207078",
    "submission": "SUPPL-10",
    "activeIngredients": "SODIUM ZIRCONIUM CYCLOSILICATE",
    "company": "ASTRAZENECA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/08/2024",
    "drugName": "FENOFIBRIC ACIDANDA  #207796",
    "submission": "ORIG-1",
    "activeIngredients": "CHOLINE FENOFIBRATE",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/08/2024",
    "drugName": "IMATINIB MESYLATEANDA  #207818",
    "submission": "SUPPL-1",
    "activeIngredients": "IMATINIB MESYLATE",
    "company": "NATCO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/08/2024",
    "drugName": "IMATINIB MESYLATEANDA  #207818",
    "submission": "SUPPL-3",
    "activeIngredients": "IMATINIB MESYLATE",
    "company": "NATCO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/08/2024",
    "drugName": "TRACLEERNDA   #209279",
    "submission": "SUPPL-10",
    "activeIngredients": "BOSENTAN",
    "company": "ACTELION",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/08/2024",
    "drugName": "DIMETHYL FUMARATEANDA  #210305",
    "submission": "SUPPL-1",
    "activeIngredients": "DIMETHYL FUMARATE",
    "company": "CIPLA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/08/2024",
    "drugName": "DIMETHYL FUMARATEANDA  #210305",
    "submission": "SUPPL-2",
    "activeIngredients": "DIMETHYL FUMARATE",
    "company": "CIPLA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/08/2024",
    "drugName": "DIMETHYL FUMARATEANDA  #210305",
    "submission": "SUPPL-4",
    "activeIngredients": "DIMETHYL FUMARATE",
    "company": "CIPLA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/08/2024",
    "drugName": "DIMETHYL FUMARATEANDA  #210305",
    "submission": "SUPPL-5",
    "activeIngredients": "DIMETHYL FUMARATE",
    "company": "CIPLA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/08/2024",
    "drugName": "DIMETHYL FUMARATEANDA  #210305",
    "submission": "SUPPL-7",
    "activeIngredients": "DIMETHYL FUMARATE",
    "company": "CIPLA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/08/2024",
    "drugName": "DIMETHYL FUMARATEANDA  #210305",
    "submission": "SUPPL-8",
    "activeIngredients": "DIMETHYL FUMARATE",
    "company": "CIPLA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/08/2024",
    "drugName": "DIMETHYL FUMARATEANDA  #210309",
    "submission": "SUPPL-1",
    "activeIngredients": "DIMETHYL FUMARATE",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/08/2024",
    "drugName": "DIMETHYL FUMARATEANDA  #210309",
    "submission": "SUPPL-2",
    "activeIngredients": "DIMETHYL FUMARATE",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/08/2024",
    "drugName": "DIMETHYL FUMARATEANDA  #210309",
    "submission": "SUPPL-3",
    "activeIngredients": "DIMETHYL FUMARATE",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/08/2024",
    "drugName": "DIMETHYL FUMARATEANDA  #210309",
    "submission": "SUPPL-4",
    "activeIngredients": "DIMETHYL FUMARATE",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/08/2024",
    "drugName": "DIMETHYL FUMARATEANDA  #210309",
    "submission": "SUPPL-5",
    "activeIngredients": "DIMETHYL FUMARATE",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/08/2024",
    "drugName": "DIMETHYL FUMARATEANDA  #210382",
    "submission": "SUPPL-6",
    "activeIngredients": "DIMETHYL FUMARATE",
    "company": "TWI PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/08/2024",
    "drugName": "DIMETHYL FUMARATEANDA  #210382",
    "submission": "SUPPL-8",
    "activeIngredients": "DIMETHYL FUMARATE",
    "company": "TWI PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/08/2024",
    "drugName": "DIMETHYL FUMARATEANDA  #210382",
    "submission": "SUPPL-11",
    "activeIngredients": "DIMETHYL FUMARATE",
    "company": "TWI PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/08/2024",
    "drugName": "DIMETHYL FUMARATEANDA  #210382",
    "submission": "SUPPL-12",
    "activeIngredients": "DIMETHYL FUMARATE",
    "company": "TWI PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/08/2024",
    "drugName": "VIVIMUSTANDA   #212209",
    "submission": "SUPPL-4",
    "activeIngredients": "BENDAMUSTINE HYDROCHLORIDE",
    "company": "AZURITY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/08/2024",
    "drugName": "ESTRADIOLANDA  #212313",
    "submission": "SUPPL-1",
    "activeIngredients": "ESTRADIOL",
    "company": "PRASCO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/08/2024",
    "drugName": "REGADENOSONANDA  #213236",
    "submission": "SUPPL-4",
    "activeIngredients": "REGADENOSON",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/08/2024",
    "drugName": "DEXMETHYLPHENIDATE HYDROCHLORIDEANDA  #213813",
    "submission": "SUPPL-13",
    "activeIngredients": "DEXMETHYLPHENIDATE HYDROCHLORIDE",
    "company": "GRANULES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/08/2024",
    "drugName": "BUTALBITAL, ACETAMINOPHEN AND CAFFEINEANDA  #214288",
    "submission": "ORIG-1",
    "activeIngredients": "ACETAMINOPHEN; BUTALBITAL; CAFFEINE",
    "company": "QUAGEN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/08/2024",
    "drugName": "EMPAVELINDA   #215014",
    "submission": "SUPPL-6",
    "activeIngredients": "PEGCETACOPLAN",
    "company": "APELLIS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/08/2024",
    "drugName": "ESOMEPRAZOLE SODIUMANDA  #215732",
    "submission": "SUPPL-2",
    "activeIngredients": "ESOMEPRAZOLE SODIUM",
    "company": "SLATE RUN PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/08/2024",
    "drugName": "ORMALVIANDA  #215924",
    "submission": "SUPPL-1",
    "activeIngredients": "DICHLORPHENAMIDE",
    "company": "TORRENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/08/2024",
    "drugName": "ULTOMIRISBLA   #761108",
    "submission": "SUPPL-35",
    "activeIngredients": "RAVULIZUMAB-CWVZ",
    "company": "ALEXION PHARM",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/08/2024",
    "drugName": "ENJAYMOBLA   #761164",
    "submission": "SUPPL-4",
    "activeIngredients": "SUTIMLIMAB-JOME",
    "company": "RECORDATI RARE DISEASES, INC.",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/09/2024",
    "drugName": "CIPROFLOXACIN HYDROCHLORIDEANDA  #077859",
    "submission": "SUPPL-44",
    "activeIngredients": "CIPROFLOXACIN HYDROCHLORIDE",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/09/2024",
    "drugName": "PULMOZYMEBLA   #103532",
    "submission": "SUPPL-5194",
    "activeIngredients": "DORNASE ALFA",
    "company": "GENENTECH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/09/2024",
    "drugName": "BENLYSTABLA   #125370",
    "submission": "SUPPL-82",
    "activeIngredients": "BELIMUMAB",
    "company": "HUMAN GENOME SCIENCES INC.",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/09/2024",
    "drugName": "EOHILIANDA   #213976",
    "submission": "ORIG-1",
    "activeIngredients": "BUDESONIDE",
    "company": "TAKEDA PHARMS USA",
    "submissionClassification": "Type 3 - New Dosage Form",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/09/2024",
    "drugName": "HYDROMORPHONE HYDROCHLORIDEANDA  #216899",
    "submission": "ORIG-1",
    "activeIngredients": "HYDROMORPHONE HYDROCHLORIDE",
    "company": "HIKMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/09/2024",
    "drugName": "VASOPRESSINANDA  #216963",
    "submission": "ORIG-1",
    "activeIngredients": "VASOPRESSIN",
    "company": "GLAND",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/09/2024",
    "drugName": "VASOPRESSIN IN DEXTROSE 5%ANDA  #216963",
    "submission": "ORIG-1",
    "activeIngredients": "VASOPRESSIN",
    "company": "GLAND",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/09/2024",
    "drugName": "DEFLAZACORTANDA  #217123",
    "submission": "ORIG-1",
    "activeIngredients": "DEFLAZACORT",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/09/2024",
    "drugName": "STERILE WATER FOR INJECTIONANDA  #217341",
    "submission": "SUPPL-1",
    "activeIngredients": "STERILE WATER FOR INJECTION",
    "company": "AM REGENT",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/09/2024",
    "drugName": "BENLYSTABLA   #761043",
    "submission": "SUPPL-28",
    "activeIngredients": "BELIMUMAB",
    "company": "GLAXOSMITHKLINE LLC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/12/2024",
    "drugName": "DIFLUCANNDA   #019949",
    "submission": "SUPPL-72",
    "activeIngredients": "FLUCONAZOLE",
    "company": "PFIZER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/12/2024",
    "drugName": "DIFLUCAN IN DEXTROSE 5% IN PLASTIC CONTAINERNDA   #019950",
    "submission": "SUPPL-71",
    "activeIngredients": "FLUCONAZOLE",
    "company": "PFIZER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/12/2024",
    "drugName": "DIFLUCAN IN SODIUM CHLORIDE 0.9%NDA   #019950",
    "submission": "SUPPL-71",
    "activeIngredients": "FLUCONAZOLE",
    "company": "PFIZER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/12/2024",
    "drugName": "DIFLUCAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERNDA   #019950",
    "submission": "SUPPL-71",
    "activeIngredients": "FLUCONAZOLE",
    "company": "PFIZER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/12/2024",
    "drugName": "DIFLUCANNDA   #020090",
    "submission": "SUPPL-53",
    "activeIngredients": "FLUCONAZOLE",
    "company": "PFIZER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/12/2024",
    "drugName": "BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATEANDA  #075231",
    "submission": "SUPPL-7",
    "activeIngredients": "ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE",
    "company": "LGM PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/12/2024",
    "drugName": "BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATEANDA  #075231",
    "submission": "SUPPL-9",
    "activeIngredients": "ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE",
    "company": "LGM PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/12/2024",
    "drugName": "BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATEANDA  #075231",
    "submission": "SUPPL-10",
    "activeIngredients": "ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE",
    "company": "LGM PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/12/2024",
    "drugName": "BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATEANDA  #075231",
    "submission": "SUPPL-11",
    "activeIngredients": "ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE",
    "company": "LGM PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/12/2024",
    "drugName": "ATOMOXETINE HYDROCHLORIDEANDA  #079019",
    "submission": "SUPPL-2",
    "activeIngredients": "ATOMOXETINE HYDROCHLORIDE",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/12/2024",
    "drugName": "ATOMOXETINE HYDROCHLORIDEANDA  #079019",
    "submission": "SUPPL-5",
    "activeIngredients": "ATOMOXETINE HYDROCHLORIDE",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/12/2024",
    "drugName": "LORAZEPAMANDA  #091383",
    "submission": "SUPPL-5",
    "activeIngredients": "LORAZEPAM",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/12/2024",
    "drugName": "LORAZEPAMANDA  #091383",
    "submission": "SUPPL-9",
    "activeIngredients": "LORAZEPAM",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/12/2024",
    "drugName": "FLUVOXAMINE MALEATEANDA  #091482",
    "submission": "SUPPL-12",
    "activeIngredients": "FLUVOXAMINE MALEATE",
    "company": "ACTAVIS ELIZABETH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/12/2024",
    "drugName": "LINEZOLIDANDA  #205154",
    "submission": "SUPPL-13",
    "activeIngredients": "LINEZOLID",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/12/2024",
    "drugName": "FLUOXETINE HYDROCHLORIDEANDA  #206993",
    "submission": "SUPPL-3",
    "activeIngredients": "FLUOXETINE HYDROCHLORIDE",
    "company": "CADILA PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/12/2024",
    "drugName": "FLUOXETINE HYDROCHLORIDEANDA  #206993",
    "submission": "SUPPL-4",
    "activeIngredients": "FLUOXETINE HYDROCHLORIDE",
    "company": "CADILA PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/12/2024",
    "drugName": "LEVETIRACETAM IN SODIUM CHLORIDEANDA  #211356",
    "submission": "ORIG-1",
    "activeIngredients": "LEVETIRACETAM",
    "company": "HIKMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/12/2024",
    "drugName": "MIRABEGRONANDA  #215948",
    "submission": "ORIG-1",
    "activeIngredients": "MIRABEGRON",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/12/2024",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #216766",
    "submission": "SUPPL-1",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "YICHANG HUMANWELL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/13/2024",
    "drugName": "BIMATOPROSTANDA  #090449",
    "submission": "SUPPL-7",
    "activeIngredients": "BIMATOPROST",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/13/2024",
    "drugName": "SUMATRIPTAN AND NAPROXEN SODIUMANDA  #090872",
    "submission": "SUPPL-2",
    "activeIngredients": "NAPROXEN SODIUM; SUMATRIPTAN SUCCINATE",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/13/2024",
    "drugName": "ELETRIPTAN HYDROBROMIDEANDA  #202040",
    "submission": "SUPPL-6",
    "activeIngredients": "ELETRIPTAN HYDROBROMIDE",
    "company": "TEVA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/13/2024",
    "drugName": "ONIVYDENDA   #207793",
    "submission": "SUPPL-16",
    "activeIngredients": "IRINOTECAN HYDROCHLORIDE",
    "company": "IPSEN",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/13/2024",
    "drugName": "RUKOBIANDA   #212950",
    "submission": "SUPPL-4",
    "activeIngredients": "FOSTEMSAVIR TROMETHAMINE",
    "company": "VIIV HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/13/2024",
    "drugName": "LEGUBETINDA   #215040",
    "submission": "ORIG-1",
    "activeIngredients": "ACETYLCYSTEINE LYSINE",
    "company": "GALEPHAR",
    "submissionClassification": "Type 2 - New Active Ingredient and Type 3 - New Dosage Form",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/13/2024",
    "drugName": "OSPEMIFENEANDA  #215574",
    "submission": "ORIG-1",
    "activeIngredients": "OSPEMIFENE",
    "company": "HETERO LABS LTD V",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/13/2024",
    "drugName": "ATORVASTATIN CALCIUMANDA  #217118",
    "submission": "ORIG-1",
    "activeIngredients": "ATORVASTATIN CALCIUM",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/13/2024",
    "drugName": "IBUPROFENANDA  #217236",
    "submission": "ORIG-1",
    "activeIngredients": "IBUPROFEN",
    "company": "PATHEON SOFTGELS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/13/2024",
    "drugName": "LACOSAMIDEANDA  #217311",
    "submission": "ORIG-1",
    "activeIngredients": "LACOSAMIDE",
    "company": "HAINAN POLY",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/13/2024",
    "drugName": "AURLUMYNNDA   #217933",
    "submission": "ORIG-1",
    "activeIngredients": "ILOPROST",
    "company": "BTG INTL",
    "submissionClassification": "Type 3 - New Dosage Form",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/14/2024",
    "drugName": "LANSOPRAZOLEANDA  #090763",
    "submission": "SUPPL-10",
    "activeIngredients": "LANSOPRAZOLE",
    "company": "MYLAN PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/14/2024",
    "drugName": "LANSOPRAZOLEANDA  #090763",
    "submission": "SUPPL-12",
    "activeIngredients": "LANSOPRAZOLE",
    "company": "MYLAN PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/14/2024",
    "drugName": "LANSOPRAZOLEANDA  #090763",
    "submission": "SUPPL-16",
    "activeIngredients": "LANSOPRAZOLE",
    "company": "MYLAN PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/14/2024",
    "drugName": "LANSOPRAZOLEANDA  #090763",
    "submission": "SUPPL-17",
    "activeIngredients": "LANSOPRAZOLE",
    "company": "MYLAN PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/14/2024",
    "drugName": "VORICONAZOLEANDA  #206799",
    "submission": "SUPPL-3",
    "activeIngredients": "VORICONAZOLE",
    "company": "NOVEL LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/14/2024",
    "drugName": "VORICONAZOLEANDA  #206799",
    "submission": "SUPPL-4",
    "activeIngredients": "VORICONAZOLE",
    "company": "NOVEL LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/14/2024",
    "drugName": "VORICONAZOLEANDA  #206799",
    "submission": "SUPPL-7",
    "activeIngredients": "VORICONAZOLE",
    "company": "NOVEL LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/14/2024",
    "drugName": "VORICONAZOLEANDA  #206799",
    "submission": "SUPPL-8",
    "activeIngredients": "VORICONAZOLE",
    "company": "NOVEL LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/14/2024",
    "drugName": "VORICONAZOLEANDA  #206799",
    "submission": "SUPPL-9",
    "activeIngredients": "VORICONAZOLE",
    "company": "NOVEL LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/14/2024",
    "drugName": "COLESEVELAM HYDROCHLORIDEANDA  #207765",
    "submission": "SUPPL-2",
    "activeIngredients": "COLESEVELAM HYDROCHLORIDE",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/14/2024",
    "drugName": "COLESEVELAM HYDROCHLORIDEANDA  #207765",
    "submission": "SUPPL-4",
    "activeIngredients": "COLESEVELAM HYDROCHLORIDE",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/14/2024",
    "drugName": "COLESEVELAM HYDROCHLORIDEANDA  #207765",
    "submission": "SUPPL-5",
    "activeIngredients": "COLESEVELAM HYDROCHLORIDE",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/14/2024",
    "drugName": "LISDEXAMFETAMINE DIMESYLATEANDA  #215802",
    "submission": "SUPPL-1",
    "activeIngredients": "LISDEXAMFETAMINE DIMESYLATE",
    "company": "LANNETT CO INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/14/2024",
    "drugName": "PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDENDA   #217512",
    "submission": "ORIG-1",
    "activeIngredients": "PANTOPRAZOLE SODIUM",
    "company": "BAXTER HLTHCARE CORP",
    "submissionClassification": "Type 3 - New Dosage Form",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/14/2024",
    "drugName": "OXCARBAZEPINEANDA  #217782",
    "submission": "ORIG-1",
    "activeIngredients": "OXCARBAZEPINE",
    "company": "KANCHAN HLTHCARE",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "PREMARINNDA   #004782",
    "submission": "SUPPL-181",
    "activeIngredients": "ESTROGENS, CONJUGATED",
    "company": "WYETH PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "DELESTROGENNDA   #009402",
    "submission": "SUPPL-63",
    "activeIngredients": "ESTRADIOL VALERATE",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "PREMARINNDA   #010402",
    "submission": "SUPPL-73",
    "activeIngredients": "ESTROGENS, CONJUGATED",
    "company": "WYETH PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "PROVERANDA   #011839",
    "submission": "SUPPL-83",
    "activeIngredients": "MEDROXYPROGESTERONE ACETATE",
    "company": "PFIZER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "PROMETRIUMNDA   #019781",
    "submission": "SUPPL-25",
    "activeIngredients": "PROGESTERONE",
    "company": "ACERTIS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "PREMARINNDA   #020216",
    "submission": "SUPPL-91",
    "activeIngredients": "ESTROGENS, CONJUGATED",
    "company": "WYETH PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "VIVELLENDA   #020323",
    "submission": "SUPPL-38",
    "activeIngredients": "ESTRADIOL",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "CLIMARANDA   #020375",
    "submission": "SUPPL-49",
    "activeIngredients": "ESTRADIOL",
    "company": "BAYER HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "CLIMARANDA   #020375",
    "submission": "SUPPL-50",
    "activeIngredients": "ESTRADIOL",
    "company": "BAYER HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "MENOSTARNDA   #020375",
    "submission": "SUPPL-49",
    "activeIngredients": "ESTRADIOL",
    "company": "BAYER HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "MENOSTARNDA   #020375",
    "submission": "SUPPL-50",
    "activeIngredients": "ESTRADIOL",
    "company": "BAYER HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "ESTRINGNDA   #020472",
    "submission": "SUPPL-20",
    "activeIngredients": "ESTRADIOL",
    "company": "PFIZER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "PREMPHASE 14/14NDA   #020527",
    "submission": "SUPPL-68",
    "activeIngredients": "ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE",
    "company": "WYETH PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "PREMPRONDA   #020527",
    "submission": "SUPPL-68",
    "activeIngredients": "ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE",
    "company": "WYETH PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "ESTRADIOLNDA   #020538",
    "submission": "SUPPL-43",
    "activeIngredients": "ESTRADIOL",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "VIVELLE-DOTNDA   #020538",
    "submission": "SUPPL-43",
    "activeIngredients": "ESTRADIOL",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "ALORANDA   #020655",
    "submission": "SUPPL-23",
    "activeIngredients": "ESTRADIOL",
    "company": "ABBVIE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "COMBIPATCHNDA   #020870",
    "submission": "SUPPL-33",
    "activeIngredients": "ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "NOVEN PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "ACTIVELLANDA   #020907",
    "submission": "SUPPL-30",
    "activeIngredients": "ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "AMNEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "VAGIFEMNDA   #020908",
    "submission": "SUPPL-30",
    "activeIngredients": "ESTRADIOL",
    "company": "NOVO NORDISK INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "CENESTINNDA   #020992",
    "submission": "SUPPL-41",
    "activeIngredients": "ESTROGENS, CONJUGATED SYNTHETIC A",
    "company": "ASPEN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "PREFESTNDA   #021040",
    "submission": "SUPPL-15",
    "activeIngredients": "ESTRADIOL; NORGESTIMATE",
    "company": "TEVA WOMENS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "ESTROGELNDA   #021166",
    "submission": "SUPPL-19",
    "activeIngredients": "ESTRADIOL",
    "company": "ASCEND THERAPS US",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "CLIMARA PRONDA   #021258",
    "submission": "SUPPL-15",
    "activeIngredients": "ESTRADIOL; LEVONORGESTREL",
    "company": "BAYER HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "ANGELIQNDA   #021355",
    "submission": "SUPPL-12",
    "activeIngredients": "DROSPIRENONE; ESTRADIOL",
    "company": "BAYER HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "FEMRINGNDA   #021367",
    "submission": "SUPPL-21",
    "activeIngredients": "ESTRADIOL ACETATE",
    "company": "MILLICENT PR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "ESTRASORBNDA   #021371",
    "submission": "SUPPL-10",
    "activeIngredients": "ESTRADIOL HEMIHYDRATE",
    "company": "EXELTIS USA INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "ENJUVIANDA   #021443",
    "submission": "SUPPL-13",
    "activeIngredients": "ESTROGENS, CONJUGATED SYNTHETIC B",
    "company": "ASPEN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "ELESTRINNDA   #021813",
    "submission": "SUPPL-14",
    "activeIngredients": "ESTRADIOL",
    "company": "VIATRIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "EVAMISTNDA   #022014",
    "submission": "SUPPL-15",
    "activeIngredients": "ESTRADIOL",
    "company": "PADAGIS US",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "DIVIGELNDA   #022038",
    "submission": "SUPPL-12",
    "activeIngredients": "ESTRADIOL",
    "company": "VERTICAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "ESTRADIOLANDA  #040197",
    "submission": "SUPPL-33",
    "activeIngredients": "ESTRADIOL",
    "company": "BARR LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "ESTRADIOLANDA  #040326",
    "submission": "SUPPL-16",
    "activeIngredients": "ESTRADIOL",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "ESTROPIPATEANDA  #040359",
    "submission": "SUPPL-6",
    "activeIngredients": "ESTROPIPATE",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "RIFAMPINANDA  #065421",
    "submission": "SUPPL-18",
    "activeIngredients": "RIFAMPIN",
    "company": "MYLAN LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "RIFAMPINANDA  #065421",
    "submission": "SUPPL-19",
    "activeIngredients": "RIFAMPIN",
    "company": "MYLAN LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "RIFAMPINANDA  #065421",
    "submission": "SUPPL-21",
    "activeIngredients": "RIFAMPIN",
    "company": "MYLAN LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "RIFAMPINANDA  #065421",
    "submission": "SUPPL-23",
    "activeIngredients": "RIFAMPIN",
    "company": "MYLAN LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "RIFAMPINANDA  #065421",
    "submission": "SUPPL-26",
    "activeIngredients": "RIFAMPIN",
    "company": "MYLAN LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "NORETHINDRONE ACETATE AND ETHINYL ESTRADIOLANDA  #076221",
    "submission": "SUPPL-15",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "BARR LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "ESTRADIOL AND NORGESTIMATEANDA  #076812",
    "submission": "SUPPL-21",
    "activeIngredients": "ESTRADIOL; NORGESTIMATE",
    "company": "BARR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "OGEN .625ANDA  #083220",
    "submission": "SUPPL-45",
    "activeIngredients": "ESTROPIPATE",
    "company": "PFIZER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "OGEN 1.25ANDA  #083220",
    "submission": "SUPPL-45",
    "activeIngredients": "ESTROPIPATE",
    "company": "PFIZER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "OGEN 2.5ANDA  #083220",
    "submission": "SUPPL-45",
    "activeIngredients": "ESTROPIPATE",
    "company": "PFIZER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "OGEN 5ANDA  #083220",
    "submission": "SUPPL-45",
    "activeIngredients": "ESTROPIPATE",
    "company": "PFIZER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "MENESTANDA  #084948",
    "submission": "SUPPL-24",
    "activeIngredients": "ESTROGENS, ESTERIFIED",
    "company": "MONARCH PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "MENESTANDA  #084949",
    "submission": "SUPPL-24",
    "activeIngredients": "ESTROGENS, ESTERIFIED",
    "company": "MONARCH PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "MENESTANDA  #084950",
    "submission": "SUPPL-21",
    "activeIngredients": "ESTROGENS, ESTERIFIED",
    "company": "MONARCH PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "MENESTANDA  #084951",
    "submission": "SUPPL-25",
    "activeIngredients": "ESTROGENS, ESTERIFIED",
    "company": "MONARCH PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "ESTRACEANDA  #086069",
    "submission": "SUPPL-27",
    "activeIngredients": "ESTRADIOL",
    "company": "ALLERGAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "GLATIRAMER ACETATEANDA  #091646",
    "submission": "SUPPL-19",
    "activeIngredients": "GLATIRAMER ACETATE",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "GLATIRAMER ACETATEANDA  #091646",
    "submission": "SUPPL-20",
    "activeIngredients": "GLATIRAMER ACETATE",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "LUCENTISBLA   #125156",
    "submission": "SUPPL-128",
    "activeIngredients": "RANIBIZUMAB",
    "company": "GENENTECH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #202304",
    "submission": "SUPPL-16",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "PRINSTON INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "OSPHENANDA   #203505",
    "submission": "SUPPL-22",
    "activeIngredients": "OSPEMIFENE",
    "company": "DUCHESNAY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "MINIVELLENDA   #203752",
    "submission": "SUPPL-22",
    "activeIngredients": "ESTRADIOL",
    "company": "NOVEN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "DIHYDROERGOTAMINE MESYLATEANDA  #206621",
    "submission": "SUPPL-2",
    "activeIngredients": "DIHYDROERGOTAMINE MESYLATE",
    "company": "HIKMA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "GLATIRAMER ACETATEANDA  #206936",
    "submission": "SUPPL-19",
    "activeIngredients": "GLATIRAMER ACETATE",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "GLATIRAMER ACETATEANDA  #206936",
    "submission": "SUPPL-20",
    "activeIngredients": "GLATIRAMER ACETATE",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "MONTELUKAST SODIUMANDA  #207463",
    "submission": "SUPPL-5",
    "activeIngredients": "MONTELUKAST SODIUM",
    "company": "CIPLA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "MONTELUKAST SODIUMANDA  #207464",
    "submission": "SUPPL-4",
    "activeIngredients": "MONTELUKAST SODIUM",
    "company": "CHARTWELL MOLECULAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "GANCICLOVIR SODIUMANDA  #207645",
    "submission": "SUPPL-2",
    "activeIngredients": "GANCICLOVIR SODIUM",
    "company": "PHARMASCIENCE INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "IMVEXXYNDA   #208564",
    "submission": "SUPPL-6",
    "activeIngredients": "ESTRADIOL",
    "company": "MAYNE PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "ESTRADIOLANDA  #208788",
    "submission": "SUPPL-3",
    "activeIngredients": "ESTRADIOL",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "BIJUVANDA   #210132",
    "submission": "SUPPL-11",
    "activeIngredients": "ESTRADIOL; PROGESTERONE",
    "company": "MAYNE PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "ESTRADIOLANDA  #210488",
    "submission": "SUPPL-3",
    "activeIngredients": "ESTRADIOL",
    "company": "TEVA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "TEPMETKONDA   #214096",
    "submission": "SUPPL-3",
    "activeIngredients": "TEPOTINIB HYDROCHLORIDE",
    "company": "EMD SERONO INC",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "MINZOYAANDA  #217087",
    "submission": "ORIG-1",
    "activeIngredients": "ETHINYL ESTRADIOL; LEVONORGESTREL",
    "company": "LUPIN LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "ISOSORBIDE MONONITRATEANDA  #218255",
    "submission": "ORIG-1",
    "activeIngredients": "ISOSORBIDE MONONITRATE",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2024",
    "drugName": "ENHERTUBLA   #761139",
    "submission": "SUPPL-26",
    "activeIngredients": "FAM-TRASTUZUMAB DERUXTECAN-NXKI",
    "company": "DAIICHI SANKYO",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/16/2024",
    "drugName": "ESTRADIOLANDA  #040114",
    "submission": "SUPPL-28",
    "activeIngredients": "ESTRADIOL",
    "company": "RUBICON RESEARCH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/16/2024",
    "drugName": "ESTRADIOLANDA  #040275",
    "submission": "SUPPL-13",
    "activeIngredients": "ESTRADIOL",
    "company": "EPIC PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/16/2024",
    "drugName": "ALLOPURINOLANDA  #075798",
    "submission": "SUPPL-23",
    "activeIngredients": "ALLOPURINOL",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/16/2024",
    "drugName": "MYORISANANDA  #076485",
    "submission": "SUPPL-34",
    "activeIngredients": "ISOTRETINOIN",
    "company": "UPSHER SMITH LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/16/2024",
    "drugName": "MYORISANANDA  #076485",
    "submission": "SUPPL-39",
    "activeIngredients": "ISOTRETINOIN",
    "company": "UPSHER SMITH LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/16/2024",
    "drugName": "FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERANDA  #076766",
    "submission": "SUPPL-16",
    "activeIngredients": "FLUCONAZOLE",
    "company": "BAXTER HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/16/2024",
    "drugName": "BALSALAZIDE DISODIUMANDA  #077806",
    "submission": "SUPPL-9",
    "activeIngredients": "BALSALAZIDE DISODIUM",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/16/2024",
    "drugName": "BALSALAZIDE DISODIUMANDA  #077883",
    "submission": "SUPPL-13",
    "activeIngredients": "BALSALAZIDE DISODIUM",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/16/2024",
    "drugName": "EZETIMIBEANDA  #078560",
    "submission": "SUPPL-8",
    "activeIngredients": "EZETIMIBE",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/16/2024",
    "drugName": "ESTROPIPATEANDA  #081213",
    "submission": "SUPPL-30",
    "activeIngredients": "ESTROPIPATE",
    "company": "WATSON LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/16/2024",
    "drugName": "ESTROPIPATEANDA  #081214",
    "submission": "SUPPL-30",
    "activeIngredients": "ESTROPIPATE",
    "company": "WATSON LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/16/2024",
    "drugName": "ESTROPIPATEANDA  #081215",
    "submission": "SUPPL-30",
    "activeIngredients": "ESTROPIPATE",
    "company": "WATSON LABS TEVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/16/2024",
    "drugName": "ESTRADIOL CYPIONATEANDA  #085620",
    "submission": "SUPPL-20",
    "activeIngredients": "ESTRADIOL CYPIONATE",
    "company": "DR REDDYS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/16/2024",
    "drugName": "ORTHO-ESTANDA  #089567",
    "submission": "SUPPL-21",
    "activeIngredients": "ESTROPIPATE",
    "company": "SUN PHARM INDS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/16/2024",
    "drugName": "ORTHO-ESTANDA  #089582",
    "submission": "SUPPL-20",
    "activeIngredients": "ESTROPIPATE",
    "company": "SUN PHARM INDS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/16/2024",
    "drugName": "XOLAIRBLA   #103976",
    "submission": "SUPPL-5245",
    "activeIngredients": "OMALIZUMAB",
    "company": "GENENTECH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/16/2024",
    "drugName": "NORETHINDRONE ACETATE AND ETHINYL ESTRADIOLANDA  #203038",
    "submission": "SUPPL-8",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/16/2024",
    "drugName": "LERIBANEANDA  #203435",
    "submission": "SUPPL-7",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "NOVAST LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/16/2024",
    "drugName": "FYAVOLVANDA  #204213",
    "submission": "SUPPL-8",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/16/2024",
    "drugName": "RITONAVIRANDA  #205024",
    "submission": "ORIG-1",
    "activeIngredients": "RITONAVIR",
    "company": "QUAGEN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/16/2024",
    "drugName": "IRBESARTANANDA  #206194",
    "submission": "SUPPL-4",
    "activeIngredients": "IRBESARTAN",
    "company": "HISUN PHARM HANGZHOU",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/16/2024",
    "drugName": "IRBESARTANANDA  #206194",
    "submission": "SUPPL-6",
    "activeIngredients": "IRBESARTAN",
    "company": "HISUN PHARM HANGZHOU",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/16/2024",
    "drugName": "IRBESARTANANDA  #206194",
    "submission": "SUPPL-7",
    "activeIngredients": "IRBESARTAN",
    "company": "HISUN PHARM HANGZHOU",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/16/2024",
    "drugName": "NORETHINDRONE ACETATE AND ETHINYL ESTRADIOLANDA  #207259",
    "submission": "SUPPL-4",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "XIROMED",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/16/2024",
    "drugName": "NORETHINDRONE ACETATE AND ETHINYL ESTRADIOLANDA  #207260",
    "submission": "SUPPL-4",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "XIROMED",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/16/2024",
    "drugName": "TAGRISSONDA   #208065",
    "submission": "SUPPL-30",
    "activeIngredients": "OSIMERTINIB MESYLATE",
    "company": "ASTRAZENECA",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/16/2024",
    "drugName": "TOBRAMYCINANDA  #209554",
    "submission": "SUPPL-1",
    "activeIngredients": "TOBRAMYCIN",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/16/2024",
    "drugName": "ESTRADIOLANDA  #209767",
    "submission": "SUPPL-13",
    "activeIngredients": "ESTRADIOL",
    "company": "ENCUBE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/16/2024",
    "drugName": "APIXABANANDA  #210091",
    "submission": "ORIG-1",
    "activeIngredients": "APIXABAN",
    "company": "APOTEX",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/16/2024",
    "drugName": "ESTRADIOLANDA  #210194",
    "submission": "SUPPL-11",
    "activeIngredients": "ESTRADIOL",
    "company": "PADAGIS ISRAEL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/16/2024",
    "drugName": "DIMETHYL FUMARATEANDA  #210226",
    "submission": "SUPPL-1",
    "activeIngredients": "DIMETHYL FUMARATE",
    "company": "LUPIN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/16/2024",
    "drugName": "DIMETHYL FUMARATEANDA  #210226",
    "submission": "SUPPL-2",
    "activeIngredients": "DIMETHYL FUMARATE",
    "company": "LUPIN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/16/2024",
    "drugName": "DIMETHYL FUMARATEANDA  #210226",
    "submission": "SUPPL-3",
    "activeIngredients": "DIMETHYL FUMARATE",
    "company": "LUPIN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/16/2024",
    "drugName": "DIMETHYL FUMARATEANDA  #210226",
    "submission": "SUPPL-4",
    "activeIngredients": "DIMETHYL FUMARATE",
    "company": "LUPIN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/16/2024",
    "drugName": "URSODIOLANDA  #211301",
    "submission": "SUPPL-7",
    "activeIngredients": "URSODIOL",
    "company": "AMNEAL PHARMS CO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/16/2024",
    "drugName": "ESTRADIOLANDA  #212313",
    "submission": "SUPPL-2",
    "activeIngredients": "ESTRADIOL",
    "company": "PRASCO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/16/2024",
    "drugName": "NITROGLYCERINANDA  #216103",
    "submission": "ORIG-1",
    "activeIngredients": "NITROGLYCERIN",
    "company": "COSETTE",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/16/2024",
    "drugName": "BRIMONIDINE TARTRATEANDA  #216361",
    "submission": "ORIG-1",
    "activeIngredients": "BRIMONIDINE TARTRATE",
    "company": "DR REDDYS LABS SA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/16/2024",
    "drugName": "ICOSAPENT ETHYLANDA  #216811",
    "submission": "ORIG-2",
    "activeIngredients": "ICOSAPENT ETHYL",
    "company": "ASCENT PHARMS INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/16/2024",
    "drugName": "BALSALAZIDE DISODIUMANDA  #217592",
    "submission": "SUPPL-1",
    "activeIngredients": "BALSALAZIDE DISODIUM",
    "company": "ZYDUS LIFESCIENCES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/16/2024",
    "drugName": "CARBAMAZEPINEANDA  #218221",
    "submission": "ORIG-1",
    "activeIngredients": "CARBAMAZEPINE",
    "company": "BIONPHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/16/2024",
    "drugName": "SEHIPPYNDA   #218328",
    "submission": "ORIG-1",
    "activeIngredients": "VORTIOXETINE",
    "company": "SEASONS BIOTECHNOLOGY (TAIZHOU) CO LTD",
    "submissionClassification": "Type 2 - New Active Ingredient and Type 3 - New Dosage Form",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "02/16/2024",
    "drugName": "NIVESTYMBLA   #761080",
    "submission": "SUPPL-14",
    "activeIngredients": "FILGRASTIM-AAFI",
    "company": "HOSPIRA INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/17/2024",
    "drugName": "CARBON DIOXIDE, USPNDA   #219303",
    "submission": "ORIG-1",
    "activeIngredients": "CARBON DIOXIDE",
    "company": "HAUN SPECIALTY GASES INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/20/2024",
    "drugName": "AZELEXNDA   #020428",
    "submission": "SUPPL-27",
    "activeIngredients": "AZELAIC ACID",
    "company": "ALMIRALL",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/20/2024",
    "drugName": "SYNTHROIDNDA   #021402",
    "submission": "SUPPL-38",
    "activeIngredients": "LEVOTHYROXINE SODIUM",
    "company": "ABBVIE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/20/2024",
    "drugName": "DOXYLAMINE SUCCINATEANDA  #040167",
    "submission": "SUPPL-51",
    "activeIngredients": "DOXYLAMINE SUCCINATE",
    "company": "PERRIGO",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/20/2024",
    "drugName": "LACTULOSEANDA  #076645",
    "submission": "SUPPL-7",
    "activeIngredients": "LACTULOSE",
    "company": "BAJAJ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/20/2024",
    "drugName": "DORZOLAMIDE HYDROCHLORIDEANDA  #202053",
    "submission": "SUPPL-5",
    "activeIngredients": "DORZOLAMIDE HYDROCHLORIDE",
    "company": "REGCON HOLDINGS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/20/2024",
    "drugName": "DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATEANDA  #202054",
    "submission": "SUPPL-7",
    "activeIngredients": "DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE",
    "company": "REGCON HOLDINGS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/20/2024",
    "drugName": "AMLODIPINE BESYLATE AND VALSARTANANDA  #202829",
    "submission": "SUPPL-2",
    "activeIngredients": "AMLODIPINE BESYLATE; VALSARTAN",
    "company": "NOVEL LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/20/2024",
    "drugName": "AMLODIPINE BESYLATE AND VALSARTANANDA  #202829",
    "submission": "SUPPL-3",
    "activeIngredients": "AMLODIPINE BESYLATE; VALSARTAN",
    "company": "NOVEL LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/20/2024",
    "drugName": "SOLIFENACIN SUCCINATEANDA  #204374",
    "submission": "ORIG-1",
    "activeIngredients": "SOLIFENACIN SUCCINATE",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/20/2024",
    "drugName": "DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATEANDA  #205295",
    "submission": "SUPPL-8",
    "activeIngredients": "DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE",
    "company": "FDC LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/20/2024",
    "drugName": "GUANFACINE HYDROCHLORIDEANDA  #205430",
    "submission": "SUPPL-5",
    "activeIngredients": "GUANFACINE HYDROCHLORIDE",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/20/2024",
    "drugName": "GABAPENTINANDA  #207099",
    "submission": "SUPPL-7",
    "activeIngredients": "GABAPENTIN",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/20/2024",
    "drugName": "TOBRAMYCINANDA  #207444",
    "submission": "SUPPL-1",
    "activeIngredients": "TOBRAMYCIN",
    "company": "SOMERSET THERAPS LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/20/2024",
    "drugName": "TOBRAMYCINANDA  #207444",
    "submission": "SUPPL-3",
    "activeIngredients": "TOBRAMYCIN",
    "company": "SOMERSET THERAPS LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/20/2024",
    "drugName": "TOBRAMYCINANDA  #207444",
    "submission": "SUPPL-4",
    "activeIngredients": "TOBRAMYCIN",
    "company": "SOMERSET THERAPS LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/20/2024",
    "drugName": "TERIFLUNOMIDEANDA  #209613",
    "submission": "SUPPL-7",
    "activeIngredients": "TERIFLUNOMIDE",
    "company": "AMNEAL PHARMS CO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/20/2024",
    "drugName": "TERIFLUNOMIDEANDA  #209700",
    "submission": "SUPPL-3",
    "activeIngredients": "TERIFLUNOMIDE",
    "company": "TEVA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/20/2024",
    "drugName": "NITROGLYCERINANDA  #209779",
    "submission": "SUPPL-3",
    "activeIngredients": "NITROGLYCERIN",
    "company": "RUBICON RESEARCH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/20/2024",
    "drugName": "ZILXINDA   #213690",
    "submission": "SUPPL-9",
    "activeIngredients": "MINOCYCLINE HYDROCHLORIDE",
    "company": "JOURNEY",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/20/2024",
    "drugName": "SUGAMMADEXANDA  #214126",
    "submission": "ORIG-1",
    "activeIngredients": "SUGAMMADEX",
    "company": "TEVA PHARMS USA INC",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "02/20/2024",
    "drugName": "VENLAFAXINE HYDROCHLORIDEANDA  #214691",
    "submission": "SUPPL-3",
    "activeIngredients": "VENLAFAXINE HYDROCHLORIDE",
    "company": "AJANTA PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/20/2024",
    "drugName": "MYCOPHENOLATE MOFETILANDA  #217937",
    "submission": "ORIG-1",
    "activeIngredients": "MYCOPHENOLATE MOFETIL",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/20/2024",
    "drugName": "LIDOCAINE HYDROCHLORIDE VISCOUSANDA  #218138",
    "submission": "ORIG-1",
    "activeIngredients": "LIDOCAINE HYDROCHLORIDE",
    "company": "PAI HOLDINGS PHARM",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/20/2024",
    "drugName": "TECVAYLIBLA   #761291",
    "submission": "SUPPL-3",
    "activeIngredients": "TECLISTAMAB-CQYV",
    "company": "JANSSEN BIOTECH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/20/2024",
    "drugName": "TALVEYBLA   #761342",
    "submission": "SUPPL-4",
    "activeIngredients": "TALQUETAMAB-TGVS",
    "company": "JANSSEN BIOTECH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2024",
    "drugName": "ZETIANDA   #021445",
    "submission": "SUPPL-43",
    "activeIngredients": "EZETIMIBE",
    "company": "ORGANON",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2024",
    "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #040777",
    "submission": "SUPPL-25",
    "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2024",
    "drugName": "DEPO-ESTRADIOLANDA  #085470",
    "submission": "SUPPL-27",
    "activeIngredients": "ESTRADIOL CYPIONATE",
    "company": "PFIZER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2024",
    "drugName": "GATTEX KITNDA   #203441",
    "submission": "SUPPL-21",
    "activeIngredients": "TEDUGLUTIDE",
    "company": "TAKEDA PHARMS USA",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/22/2024",
    "drugName": "INTRALIPID 30%NDA   #019942",
    "submission": "SUPPL-22",
    "activeIngredients": "SOYBEAN OIL",
    "company": "FRESENIUS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/22/2024",
    "drugName": "CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATEANDA  #040860",
    "submission": "SUPPL-9",
    "activeIngredients": "ASPIRIN; CARISOPRODOL; CODEINE PHOSPHATE",
    "company": "INGENUS PHARMS NJ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/22/2024",
    "drugName": "CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATEANDA  #040860",
    "submission": "SUPPL-10",
    "activeIngredients": "ASPIRIN; CARISOPRODOL; CODEINE PHOSPHATE",
    "company": "INGENUS PHARMS NJ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/22/2024",
    "drugName": "TOPIRAMATEANDA  #077627",
    "submission": "SUPPL-24",
    "activeIngredients": "TOPIRAMATE",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/22/2024",
    "drugName": "DROSPIRENONE AND ETHINYL ESTRADIOLANDA  #204296",
    "submission": "SUPPL-5",
    "activeIngredients": "DROSPIRENONE; ETHINYL ESTRADIOL",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/22/2024",
    "drugName": "DROSPIRENONE AND ETHINYL ESTRADIOLANDA  #204296",
    "submission": "SUPPL-7",
    "activeIngredients": "DROSPIRENONE; ETHINYL ESTRADIOL",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/22/2024",
    "drugName": "EXBLIFEPNDA   #216165",
    "submission": "ORIG-1",
    "activeIngredients": "CEFEPIME HYDROCHLORIDE; ENMETAZOBACTAM",
    "company": "ALLECRA THERAPS",
    "submissionClassification": "Type 1 - New Molecular Entity and Type 4 - New Combination",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/22/2024",
    "drugName": "IMBRUVICANDA   #217003",
    "submission": "SUPPL-2",
    "activeIngredients": "IBRUTINIB",
    "company": "PHARMACYCLICS LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/22/2024",
    "drugName": "LENALIDOMIDEANDA  #217265",
    "submission": "ORIG-1",
    "activeIngredients": "LENALIDOMIDE",
    "company": "QILU",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/22/2024",
    "drugName": "OXCARBAZEPINEANDA  #217659",
    "submission": "ORIG-1",
    "activeIngredients": "OXCARBAZEPINE",
    "company": "AJANTA PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/22/2024",
    "drugName": "ZYMFENTRABLA   #761358",
    "submission": "SUPPL-1",
    "activeIngredients": "INFLIXIMAB-DYYB",
    "company": "CELLTRION",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/23/2024",
    "drugName": "PAXIL CRNDA   #020936",
    "submission": "SUPPL-65",
    "activeIngredients": "PAROXETINE HYDROCHLORIDE",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/23/2024",
    "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #040777",
    "submission": "SUPPL-27",
    "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/23/2024",
    "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #040777",
    "submission": "SUPPL-28",
    "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/23/2024",
    "drugName": "NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATEANDA  #078267",
    "submission": "SUPPL-16",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/23/2024",
    "drugName": "ENTYVIOBLA   #125476",
    "submission": "SUPPL-54",
    "activeIngredients": "VEDOLIZUMAB",
    "company": "TAKEDA PHARMS USA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/23/2024",
    "drugName": "ESOMEPRAZOLE SODIUMANDA  #204657",
    "submission": "SUPPL-2",
    "activeIngredients": "ESOMEPRAZOLE SODIUM",
    "company": "EUGIA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/23/2024",
    "drugName": "ESOMEPRAZOLE SODIUMANDA  #204657",
    "submission": "SUPPL-3",
    "activeIngredients": "ESOMEPRAZOLE SODIUM",
    "company": "EUGIA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/23/2024",
    "drugName": "ESOMEPRAZOLE SODIUMANDA  #204657",
    "submission": "SUPPL-4",
    "activeIngredients": "ESOMEPRAZOLE SODIUM",
    "company": "EUGIA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/23/2024",
    "drugName": "ESOMEPRAZOLE SODIUMANDA  #204657",
    "submission": "SUPPL-5",
    "activeIngredients": "ESOMEPRAZOLE SODIUM",
    "company": "EUGIA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/23/2024",
    "drugName": "ESOMEPRAZOLE SODIUMANDA  #204657",
    "submission": "SUPPL-6",
    "activeIngredients": "ESOMEPRAZOLE SODIUM",
    "company": "EUGIA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/23/2024",
    "drugName": "ESOMEPRAZOLE SODIUMANDA  #204657",
    "submission": "SUPPL-7",
    "activeIngredients": "ESOMEPRAZOLE SODIUM",
    "company": "EUGIA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/23/2024",
    "drugName": "ESOMEPRAZOLE SODIUMANDA  #204657",
    "submission": "SUPPL-8",
    "activeIngredients": "ESOMEPRAZOLE SODIUM",
    "company": "EUGIA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/23/2024",
    "drugName": "IRBESARTANANDA  #204740",
    "submission": "SUPPL-3",
    "activeIngredients": "IRBESARTAN",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/23/2024",
    "drugName": "IRBESARTANANDA  #204740",
    "submission": "SUPPL-4",
    "activeIngredients": "IRBESARTAN",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/23/2024",
    "drugName": "IRBESARTANANDA  #204740",
    "submission": "SUPPL-5",
    "activeIngredients": "IRBESARTAN",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/23/2024",
    "drugName": "CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDEANDA  #205397",
    "submission": "SUPPL-5",
    "activeIngredients": "BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE",
    "company": "PADAGIS ISRAEL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/23/2024",
    "drugName": "TOPOTECAN HYDROCHLORIDEANDA  #206962",
    "submission": "SUPPL-1",
    "activeIngredients": "TOPOTECAN HYDROCHLORIDE",
    "company": "NOVAST LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/23/2024",
    "drugName": "LANSOPRAZOLEANDA  #207394",
    "submission": "SUPPL-6",
    "activeIngredients": "LANSOPRAZOLE",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/23/2024",
    "drugName": "LANSOPRAZOLEANDA  #207394",
    "submission": "SUPPL-8",
    "activeIngredients": "LANSOPRAZOLE",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/23/2024",
    "drugName": "LANSOPRAZOLEANDA  #207394",
    "submission": "SUPPL-10",
    "activeIngredients": "LANSOPRAZOLE",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/23/2024",
    "drugName": "LURASIDONE HYDROCHLORIDEANDA  #208028",
    "submission": "SUPPL-2",
    "activeIngredients": "LURASIDONE HYDROCHLORIDE",
    "company": "INVAGEN PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/23/2024",
    "drugName": "DOCETAXELANDA  #208859",
    "submission": "SUPPL-7",
    "activeIngredients": "DOCETAXEL",
    "company": "MYLAN LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/23/2024",
    "drugName": "DOCETAXELANDA  #208859",
    "submission": "SUPPL-9",
    "activeIngredients": "DOCETAXEL",
    "company": "MYLAN LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/23/2024",
    "drugName": "IBUPROFENANDA  #208865",
    "submission": "SUPPL-10",
    "activeIngredients": "IBUPROFEN",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/23/2024",
    "drugName": "EVEROLIMUSANDA  #210130",
    "submission": "SUPPL-7",
    "activeIngredients": "EVEROLIMUS",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/23/2024",
    "drugName": "BIKTARVYNDA   #210251",
    "submission": "SUPPL-18",
    "activeIngredients": "BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE",
    "company": "GILEAD SCIENCES INC",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/23/2024",
    "drugName": "GUANFACINE HYDROCHLORIDEANDA  #218326",
    "submission": "ORIG-1",
    "activeIngredients": "GUANFACINE HYDROCHLORIDE",
    "company": "XIROMED",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/23/2024",
    "drugName": "ENTYVIOBLA   #761133",
    "submission": "SUPPL-3",
    "activeIngredients": "VEDOLIZUMAB",
    "company": "TAKEDA PHARMS USA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/23/2024",
    "drugName": "SIMLANDIBLA   #761299",
    "submission": "ORIG-1",
    "activeIngredients": "ADALIMUMAB-RYVK",
    "company": "ALVOTECH USA INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/23/2024",
    "drugName": "BEYFORTUSBLA   #761328",
    "submission": "SUPPL-7",
    "activeIngredients": "NIRSEVIMAB-ALIP",
    "company": "ASTRAZENECA AB",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/26/2024",
    "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #203864",
    "submission": "SUPPL-8",
    "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
    "company": "EPIC PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/26/2024",
    "drugName": "WELIREGNDA   #215383",
    "submission": "SUPPL-7",
    "activeIngredients": "BELZUTIFAN",
    "company": "MERCK SHARP DOHME",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/26/2024",
    "drugName": "BENDAMUSTINE HYDROCHLORIDENDA   #216078",
    "submission": "SUPPL-2",
    "activeIngredients": "BENDAMUSTINE HYDROCHLORIDE",
    "company": "BAXTER HLTHCARE CORP",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/26/2024",
    "drugName": "GABAPENTINANDA  #216252",
    "submission": "ORIG-1",
    "activeIngredients": "GABAPENTIN",
    "company": "HUMANWELL",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/26/2024",
    "drugName": "BRIVARACETAMANDA  #218048",
    "submission": "ORIG-1",
    "activeIngredients": "BRIVARACETAM",
    "company": "ANNORA PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "02/26/2024",
    "drugName": "GABAPENTINANDA  #218075",
    "submission": "ORIG-1",
    "activeIngredients": "GABAPENTIN",
    "company": "ANNORA PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/27/2024",
    "drugName": "EGRIFTABLA   #022505",
    "submission": "SUPPL-18",
    "activeIngredients": "TESAMORELIN ACETATE",
    "company": "THERATECHNOLOGIES",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/27/2024",
    "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #040482",
    "submission": "SUPPL-24",
    "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
    "company": "CHARTWELL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/27/2024",
    "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #040834",
    "submission": "SUPPL-22",
    "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
    "company": "PHARM ASSOC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/27/2024",
    "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #040838",
    "submission": "SUPPL-22",
    "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
    "company": "PHARM ASSOC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/27/2024",
    "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #040881",
    "submission": "SUPPL-17",
    "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
    "company": "MIKART",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/27/2024",
    "drugName": "DEXMETHYLPHENIDATE HYDROCHLORIDEANDA  #201231",
    "submission": "SUPPL-17",
    "activeIngredients": "DEXMETHYLPHENIDATE HYDROCHLORIDE",
    "company": "SUN PHARM INDUSTRIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/27/2024",
    "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #201295",
    "submission": "SUPPL-3",
    "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
    "company": "TRIS PHARMA INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/27/2024",
    "drugName": "TAFINLARNDA   #202806",
    "submission": "SUPPL-29",
    "activeIngredients": "DABRAFENIB MESYLATE",
    "company": "NOVARTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/27/2024",
    "drugName": "MEKINISTNDA   #204114",
    "submission": "SUPPL-31",
    "activeIngredients": "TRAMETINIB DIMETHYL SULFOXIDE",
    "company": "NOVARTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/27/2024",
    "drugName": "PIROXICAMANDA  #209256",
    "submission": "SUPPL-5",
    "activeIngredients": "PIROXICAM",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/27/2024",
    "drugName": "PIROXICAMANDA  #209256",
    "submission": "SUPPL-6",
    "activeIngredients": "PIROXICAM",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/27/2024",
    "drugName": "LEVETIRACETAM IN SODIUM CHLORIDEANDA  #209705",
    "submission": "ORIG-1",
    "activeIngredients": "LEVETIRACETAM",
    "company": "B BRAUN MEDICAL",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/27/2024",
    "drugName": "NEBIVOLOL HYDROCHLORIDEANDA  #209741",
    "submission": "ORIG-1",
    "activeIngredients": "NEBIVOLOL HYDROCHLORIDE",
    "company": "APOTEX",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/27/2024",
    "drugName": "FINZALAANDA  #210087",
    "submission": "SUPPL-9",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "TEVA PHARMS USA INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/27/2024",
    "drugName": "METHYLPHENIDATE HYDROCHLORIDEANDA  #210139",
    "submission": "SUPPL-3",
    "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "company": "HIBROW HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/27/2024",
    "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #211023",
    "submission": "SUPPL-4",
    "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
    "company": "WES PHARMA INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/27/2024",
    "drugName": "ESLICARBAZEPINE ACETATEANDA  #211227",
    "submission": "ORIG-1",
    "activeIngredients": "ESLICARBAZEPINE ACETATE",
    "company": "TORRENT",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/27/2024",
    "drugName": "VIVIMUSTANDA   #212209",
    "submission": "SUPPL-5",
    "activeIngredients": "BENDAMUSTINE HYDROCHLORIDE",
    "company": "AZURITY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/27/2024",
    "drugName": "CLOBAZAMANDA  #213404",
    "submission": "SUPPL-1",
    "activeIngredients": "CLOBAZAM",
    "company": "MSN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/27/2024",
    "drugName": "DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATEANDA  #214403",
    "submission": "SUPPL-4",
    "activeIngredients": "AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE",
    "company": "LANNETT CO INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/27/2024",
    "drugName": "MESALAMINEANDA  #214477",
    "submission": "SUPPL-2",
    "activeIngredients": "MESALAMINE",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/27/2024",
    "drugName": "DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATEANDA  #215771",
    "submission": "SUPPL-5",
    "activeIngredients": "AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE",
    "company": "GRANULES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/27/2024",
    "drugName": "SODIUM BICARBONATEANDA  #216042",
    "submission": "ORIG-1",
    "activeIngredients": "SODIUM BICARBONATE",
    "company": "LONG GROVE PHARMS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/27/2024",
    "drugName": "DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATEANDA  #217027",
    "submission": "SUPPL-3",
    "activeIngredients": "AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE",
    "company": "GRANULES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/27/2024",
    "drugName": "MEKINISTNDA   #217513",
    "submission": "SUPPL-2",
    "activeIngredients": "TRAMETINIB",
    "company": "NOVARTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/27/2024",
    "drugName": "MEKINISTNDA   #217513",
    "submission": "SUPPL-2",
    "activeIngredients": "TRAMETINIB DIMETHYL SULFOXIDE",
    "company": "NOVARTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/27/2024",
    "drugName": "TAFINLARNDA   #217514",
    "submission": "SUPPL-2",
    "activeIngredients": "DABRAFENIB MESYLATE",
    "company": "NOVARTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/27/2024",
    "drugName": "LINAGLIPTINANDA  #218552",
    "submission": "ORIG-1",
    "activeIngredients": "LINAGLIPTIN",
    "company": "APOTEX",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "02/27/2024",
    "drugName": "MYCOPHENOLATE SODIUMANDA  #218603",
    "submission": "ORIG-1",
    "activeIngredients": "MYCOPHENOLATE SODIUM",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/28/2024",
    "drugName": "CREONBLA   #020725",
    "submission": "SUPPL-31",
    "activeIngredients": "PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)",
    "company": "ABBVIE",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/28/2024",
    "drugName": "ZORTRESSNDA   #021560",
    "submission": "SUPPL-32",
    "activeIngredients": "EVEROLIMUS",
    "company": "NOVARTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/28/2024",
    "drugName": "TOVIAZNDA   #022030",
    "submission": "SUPPL-22",
    "activeIngredients": "FESOTERODINE FUMARATE",
    "company": "PFIZER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/28/2024",
    "drugName": "TOVIAZNDA   #022030",
    "submission": "SUPPL-23",
    "activeIngredients": "FESOTERODINE FUMARATE",
    "company": "PFIZER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/28/2024",
    "drugName": "PERTZYEBLA   #022175",
    "submission": "SUPPL-10",
    "activeIngredients": "PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)",
    "company": "DIGESTIVE CARE INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/28/2024",
    "drugName": "ZENPEPBLA   #022210",
    "submission": "SUPPL-26",
    "activeIngredients": "PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)",
    "company": "EURAND PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/28/2024",
    "drugName": "PANCREAZEBLA   #022523",
    "submission": "SUPPL-19",
    "activeIngredients": "PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)",
    "company": "VIVUS INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/28/2024",
    "drugName": "VIOKACEBLA   #022542",
    "submission": "SUPPL-9",
    "activeIngredients": "PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)",
    "company": "VIOKACE",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/28/2024",
    "drugName": "METHYLPHENIDATE HYDROCHLORIDEANDA  #090710",
    "submission": "SUPPL-25",
    "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "company": "SUN PHARM INDS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/28/2024",
    "drugName": "METHYLPHENIDATE HYDROCHLORIDEANDA  #090710",
    "submission": "SUPPL-28",
    "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "company": "SUN PHARM INDS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/28/2024",
    "drugName": "AUVI-QNDA   #201739",
    "submission": "SUPPL-28",
    "activeIngredients": "EPINEPHRINE",
    "company": "KALEO INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/28/2024",
    "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #203864",
    "submission": "SUPPL-9",
    "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
    "company": "EPIC PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/28/2024",
    "drugName": "LINEZOLIDANDA  #204696",
    "submission": "SUPPL-8",
    "activeIngredients": "LINEZOLID",
    "company": "SAGENT PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/28/2024",
    "drugName": "LINEZOLIDANDA  #204696",
    "submission": "SUPPL-10",
    "activeIngredients": "LINEZOLID",
    "company": "SAGENT PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/28/2024",
    "drugName": "LINEZOLIDANDA  #204696",
    "submission": "SUPPL-11",
    "activeIngredients": "LINEZOLID",
    "company": "SAGENT PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/28/2024",
    "drugName": "FINGOLIMOD HYDROCHLORIDEANDA  #207983",
    "submission": "ORIG-1",
    "activeIngredients": "FINGOLIMOD HYDROCHLORIDE",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/28/2024",
    "drugName": "LUMIFYNDA   #208144",
    "submission": "SUPPL-17",
    "activeIngredients": "BRIMONIDINE TARTRATE",
    "company": "BAUSCH AND LOMB INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/28/2024",
    "drugName": "DAPAGLIFLOZINANDA  #211582",
    "submission": "ORIG-1",
    "activeIngredients": "DAPAGLIFLOZIN",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "02/28/2024",
    "drugName": "TESTOSTERONE ENANTHATEANDA  #212659",
    "submission": "ORIG-1",
    "activeIngredients": "TESTOSTERONE ENANTHATE",
    "company": "EUGIA PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/28/2024",
    "drugName": "VEKLURYNDA   #214787",
    "submission": "SUPPL-26",
    "activeIngredients": "REMDESIVIR",
    "company": "GILEAD SCIENCES INC",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/28/2024",
    "drugName": "DOCETAXELANDA  #216677",
    "submission": "ORIG-1",
    "activeIngredients": "DOCETAXEL",
    "company": "HERITAGE",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/28/2024",
    "drugName": "ZIEXTENZOBLA   #761045",
    "submission": "SUPPL-14",
    "activeIngredients": "PEGFILGRASTIM-BMEZ",
    "company": "SANDOZ INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/29/2024",
    "drugName": "ACTHAR GELNDA   #008372",
    "submission": "SUPPL-74",
    "activeIngredients": "CORTICOTROPIN",
    "company": "MALLINCKRODT IRELAND",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/29/2024",
    "drugName": "ACTHAR GEL (AUTOINJECTOR)NDA   #008372",
    "submission": "SUPPL-74",
    "activeIngredients": "CORTICOTROPIN",
    "company": "MALLINCKRODT IRELAND",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/29/2024",
    "drugName": "TASIGNANDA   #022068",
    "submission": "SUPPL-40",
    "activeIngredients": "NILOTINIB HYDROCHLORIDE",
    "company": "NOVARTIS",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/29/2024",
    "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #040171",
    "submission": "SUPPL-38",
    "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
    "company": "WATSON LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/29/2024",
    "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #040171",
    "submission": "SUPPL-39",
    "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
    "company": "WATSON LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/29/2024",
    "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #040535",
    "submission": "SUPPL-38",
    "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
    "company": "WATSON LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/29/2024",
    "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #040535",
    "submission": "SUPPL-39",
    "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
    "company": "WATSON LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/29/2024",
    "drugName": "LORAZEPAMANDA  #071193",
    "submission": "SUPPL-27",
    "activeIngredients": "LORAZEPAM",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/29/2024",
    "drugName": "LORAZEPAMANDA  #071194",
    "submission": "SUPPL-29",
    "activeIngredients": "LORAZEPAM",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/29/2024",
    "drugName": "LORAZEPAMANDA  #071195",
    "submission": "SUPPL-28",
    "activeIngredients": "LORAZEPAM",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/29/2024",
    "drugName": "TENOFOVIR DISOPROXIL FUMARATEANDA  #079071",
    "submission": "ORIG-1",
    "activeIngredients": "TENOFOVIR DISOPROXIL FUMARATE",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/29/2024",
    "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #090535",
    "submission": "SUPPL-17",
    "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
    "company": "SUN PHARM INDS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/29/2024",
    "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #090535",
    "submission": "SUPPL-18",
    "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
    "company": "SUN PHARM INDS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/29/2024",
    "drugName": "VARENICLINE TARTRATEANDA  #202019",
    "submission": "ORIG-1",
    "activeIngredients": "VARENICLINE TARTRATE",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/29/2024",
    "drugName": "PEMETREXED DISODIUMANDA  #203774",
    "submission": "SUPPL-1",
    "activeIngredients": "PEMETREXED DISODIUM",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/29/2024",
    "drugName": "PEMETREXED DISODIUMANDA  #203774",
    "submission": "SUPPL-2",
    "activeIngredients": "PEMETREXED DISODIUM",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/29/2024",
    "drugName": "PEMETREXED DISODIUMANDA  #203774",
    "submission": "SUPPL-3",
    "activeIngredients": "PEMETREXED DISODIUM",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/29/2024",
    "drugName": "MILNACIPRAN HYDROCHLORIDEANDA  #205081",
    "submission": "SUPPL-1",
    "activeIngredients": "MILNACIPRAN HYDROCHLORIDE",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/29/2024",
    "drugName": "MILNACIPRAN HYDROCHLORIDEANDA  #205081",
    "submission": "SUPPL-4",
    "activeIngredients": "MILNACIPRAN HYDROCHLORIDE",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/29/2024",
    "drugName": "MILNACIPRAN HYDROCHLORIDEANDA  #205081",
    "submission": "SUPPL-5",
    "activeIngredients": "MILNACIPRAN HYDROCHLORIDE",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/29/2024",
    "drugName": "MILNACIPRAN HYDROCHLORIDEANDA  #205081",
    "submission": "SUPPL-6",
    "activeIngredients": "MILNACIPRAN HYDROCHLORIDE",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/29/2024",
    "drugName": "TRAZODONE HYDROCHLORIDEANDA  #205253",
    "submission": "SUPPL-21",
    "activeIngredients": "TRAZODONE HYDROCHLORIDE",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "02/29/2024",
    "drugName": "PEMETREXED DISODIUMANDA  #209085",
    "submission": "SUPPL-1",
    "activeIngredients": "PEMETREXED DISODIUM",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/29/2024",
    "drugName": "PEMETREXED DISODIUMANDA  #209085",
    "submission": "SUPPL-2",
    "activeIngredients": "PEMETREXED DISODIUM",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/29/2024",
    "drugName": "PEMETREXED DISODIUMANDA  #209085",
    "submission": "SUPPL-3",
    "activeIngredients": "PEMETREXED DISODIUM",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/29/2024",
    "drugName": "PEMETREXED DISODIUMANDA  #209851",
    "submission": "SUPPL-1",
    "activeIngredients": "PEMETREXED DISODIUM",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/29/2024",
    "drugName": "PEMETREXED DISODIUMANDA  #209851",
    "submission": "SUPPL-2",
    "activeIngredients": "PEMETREXED DISODIUM",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/29/2024",
    "drugName": "PEMETREXED DISODIUMANDA  #209851",
    "submission": "SUPPL-3",
    "activeIngredients": "PEMETREXED DISODIUM",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/29/2024",
    "drugName": "DIMETHYL FUMARATEANDA  #210499",
    "submission": "SUPPL-1",
    "activeIngredients": "DIMETHYL FUMARATE",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/29/2024",
    "drugName": "DIMETHYL FUMARATEANDA  #210499",
    "submission": "SUPPL-2",
    "activeIngredients": "DIMETHYL FUMARATE",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/29/2024",
    "drugName": "DIMETHYL FUMARATEANDA  #210499",
    "submission": "SUPPL-3",
    "activeIngredients": "DIMETHYL FUMARATE",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/29/2024",
    "drugName": "MICAFUNGIN SODIUMANDA  #211713",
    "submission": "SUPPL-2",
    "activeIngredients": "MICAFUNGIN SODIUM",
    "company": "XELLIA PHARMS APS",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/29/2024",
    "drugName": "EVRYSDINDA   #213535",
    "submission": "SUPPL-12",
    "activeIngredients": "RISDIPLAM",
    "company": "GENENTECH INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/29/2024",
    "drugName": "CLOTRIMAZOLEANDA  #215641",
    "submission": "ORIG-1",
    "activeIngredients": "CLOTRIMAZOLE",
    "company": "THINQ PHARM-CRO PVT",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/29/2024",
    "drugName": "BRIVARACETAMANDA  #218249",
    "submission": "ORIG-1",
    "activeIngredients": "BRIVARACETAM",
    "company": "HAINAN POLY PHARM",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "02/29/2024",
    "drugName": "NALOXONE HYDROCHLORIDEANDA  #218404",
    "submission": "ORIG-1",
    "activeIngredients": "NALOXONE HYDROCHLORIDE",
    "company": "MANKIND PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/29/2024",
    "drugName": "LETYBOBLA   #761225",
    "submission": "ORIG-1",
    "activeIngredients": "LETIBOTULINUMTOXINA-WLBG",
    "company": "HUGEL INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  }
,
  {
    "approvalDate": "03/01/2024",
    "drugName": "CORTIFOAMNDA   #017351",
    "submission": "SUPPL-41",
    "activeIngredients": "HYDROCORTISONE ACETATE",
    "company": "VIATRIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/01/2024",
    "drugName": "TRANSDERM SCOPNDA   #017874",
    "submission": "SUPPL-51",
    "activeIngredients": "SCOPOLAMINE",
    "company": "BAXTER HLTHCARE CORP",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/01/2024",
    "drugName": "DEFINITYNDA   #021064",
    "submission": "SUPPL-33",
    "activeIngredients": "PERFLUTREN",
    "company": "LANTHEUS MEDCL",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/01/2024",
    "drugName": "DEFINITY RTNDA   #021064",
    "submission": "SUPPL-33",
    "activeIngredients": "PERFLUTREN",
    "company": "LANTHEUS MEDCL",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/01/2024",
    "drugName": "GLEEVECNDA   #021588",
    "submission": "SUPPL-63",
    "activeIngredients": "IMATINIB MESYLATE",
    "company": "NOVARTIS",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/01/2024",
    "drugName": "LORAZEPAMANDA  #072926",
    "submission": "SUPPL-47",
    "activeIngredients": "LORAZEPAM",
    "company": "WATSON LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/01/2024",
    "drugName": "LORAZEPAMANDA  #072926",
    "submission": "SUPPL-48",
    "activeIngredients": "LORAZEPAM",
    "company": "WATSON LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/01/2024",
    "drugName": "LORAZEPAMANDA  #072927",
    "submission": "SUPPL-45",
    "activeIngredients": "LORAZEPAM",
    "company": "WATSON LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/01/2024",
    "drugName": "LORAZEPAMANDA  #072927",
    "submission": "SUPPL-46",
    "activeIngredients": "LORAZEPAM",
    "company": "WATSON LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/01/2024",
    "drugName": "LORAZEPAMANDA  #072928",
    "submission": "SUPPL-46",
    "activeIngredients": "LORAZEPAM",
    "company": "WATSON LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/01/2024",
    "drugName": "LORAZEPAMANDA  #072928",
    "submission": "SUPPL-47",
    "activeIngredients": "LORAZEPAM",
    "company": "WATSON LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/01/2024",
    "drugName": "DICLOFENAC SODIUMANDA  #076201",
    "submission": "SUPPL-29",
    "activeIngredients": "DICLOFENAC SODIUM",
    "company": "DEXCEL LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/01/2024",
    "drugName": "BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDEANDA  #079106",
    "submission": "SUPPL-36",
    "activeIngredients": "BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE",
    "company": "UNICHEM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/01/2024",
    "drugName": "NADOLOLANDA  #201893",
    "submission": "SUPPL-7",
    "activeIngredients": "NADOLOL",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/01/2024",
    "drugName": "NADOLOLANDA  #203455",
    "submission": "SUPPL-9",
    "activeIngredients": "NADOLOL",
    "company": "INVAGEN PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/01/2024",
    "drugName": "PARICALCITOLANDA  #204910",
    "submission": "SUPPL-2",
    "activeIngredients": "PARICALCITOL",
    "company": "CAPLIN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/01/2024",
    "drugName": "PARICALCITOLANDA  #204910",
    "submission": "SUPPL-3",
    "activeIngredients": "PARICALCITOL",
    "company": "CAPLIN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/01/2024",
    "drugName": "MESALAMINEANDA  #207271",
    "submission": "SUPPL-4",
    "activeIngredients": "MESALAMINE",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/01/2024",
    "drugName": "MESALAMINEANDA  #207271",
    "submission": "SUPPL-7",
    "activeIngredients": "MESALAMINE",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/01/2024",
    "drugName": "DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDEANDA  #207769",
    "submission": "SUPPL-3",
    "activeIngredients": "DUTASTERIDE; TAMSULOSIN HYDROCHLORIDE",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/01/2024",
    "drugName": "NINLARONDA   #208462",
    "submission": "SUPPL-16",
    "activeIngredients": "IXAZOMIB CITRATE",
    "company": "TAKEDA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/01/2024",
    "drugName": "ALCAFTADINEANDA  #209706",
    "submission": "ORIG-1",
    "activeIngredients": "ALCAFTADINE",
    "company": "GLAND",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/01/2024",
    "drugName": "ATENOLOL AND CHLORTHALIDONEANDA  #210028",
    "submission": "SUPPL-7",
    "activeIngredients": "ATENOLOL; CHLORTHALIDONE",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/01/2024",
    "drugName": "XOFLUZANDA   #210854",
    "submission": "SUPPL-20",
    "activeIngredients": "BALOXAVIR MARBOXIL",
    "company": "GENENTECH INC",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/01/2024",
    "drugName": "OFLOXACINANDA  #211524",
    "submission": "ORIG-1",
    "activeIngredients": "OFLOXACIN",
    "company": "AMNEAL",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/01/2024",
    "drugName": "XOFLUZANDA   #214410",
    "submission": "SUPPL-6",
    "activeIngredients": "BALOXAVIR MARBOXIL",
    "company": "GENENTECH INC",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/01/2024",
    "drugName": "FOSCARNET SODIUMANDA  #216602",
    "submission": "ORIG-1",
    "activeIngredients": "FOSCARNET SODIUM",
    "company": "AMNEAL",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/01/2024",
    "drugName": "DOCOSANOLANDA  #217090",
    "submission": "ORIG-1",
    "activeIngredients": "DOCOSANOL",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/01/2024",
    "drugName": "TRANEXAMIC ACIDANDA  #217155",
    "submission": "SUPPL-1",
    "activeIngredients": "TRANEXAMIC ACID",
    "company": "AMNEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/01/2024",
    "drugName": "OXCARBAZEPINEANDA  #218278",
    "submission": "ORIG-1",
    "activeIngredients": "OXCARBAZEPINE",
    "company": "BIOCON PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/01/2024",
    "drugName": "RYBREVANTBLA   #761210",
    "submission": "SUPPL-3",
    "activeIngredients": "AMIVANTAMAB-VMJW",
    "company": "JANSSEN BIOTECH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/04/2024",
    "drugName": "DUAVEENDA   #022247",
    "submission": "SUPPL-10",
    "activeIngredients": "BAZEDOXIFENE ACETATE; ESTROGENS, CONJUGATED",
    "company": "WYETH PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/04/2024",
    "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #040545",
    "submission": "SUPPL-27",
    "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
    "company": "SPECGX LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/04/2024",
    "drugName": "CLARAVISANDA  #076135",
    "submission": "SUPPL-56",
    "activeIngredients": "ISOTRETINOIN",
    "company": "TEVA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/04/2024",
    "drugName": "CLARAVISANDA  #076356",
    "submission": "SUPPL-51",
    "activeIngredients": "ISOTRETINOIN",
    "company": "TEVA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/04/2024",
    "drugName": "OXYCETANDA  #087463",
    "submission": "SUPPL-56",
    "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
    "company": "SPECGX LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/04/2024",
    "drugName": "CAMPATHBLA   #103948",
    "submission": "SUPPL-5191",
    "activeIngredients": "ALEMTUZUMAB",
    "company": "GENZYME",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/04/2024",
    "drugName": "LEMTRADABLA   #103948",
    "submission": "SUPPL-5191",
    "activeIngredients": "ALEMTUZUMAB",
    "company": "GENZYME",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/04/2024",
    "drugName": "BRIMONIDINE TARTRATEANDA  #203172",
    "submission": "ORIG-1",
    "activeIngredients": "BRIMONIDINE TARTRATE",
    "company": "SANDOZ",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/04/2024",
    "drugName": "EPINEPHRINENDA   #205029",
    "submission": "SUPPL-12",
    "activeIngredients": "EPINEPHRINE",
    "company": "BPI LABS",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/04/2024",
    "drugName": "ACETYLCYSTEINEANDA  #208166",
    "submission": "SUPPL-1",
    "activeIngredients": "ACETYLCYSTEINE",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/04/2024",
    "drugName": "ACETYLCYSTEINEANDA  #208166",
    "submission": "SUPPL-4",
    "activeIngredients": "ACETYLCYSTEINE",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/04/2024",
    "drugName": "EPIDIOLEXNDA   #210365",
    "submission": "SUPPL-21",
    "activeIngredients": "CANNABIDIOL",
    "company": "JAZZ PHARMS RES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/04/2024",
    "drugName": "GABAPENTINANDA  #211313",
    "submission": "ORIG-1",
    "activeIngredients": "GABAPENTIN",
    "company": "STRIDES PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/04/2024",
    "drugName": "ATENOLOL AND CHLORTHALIDONEANDA  #213302",
    "submission": "SUPPL-11",
    "activeIngredients": "ATENOLOL; CHLORTHALIDONE",
    "company": "UNICHEM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/04/2024",
    "drugName": "TADALAFILANDA  #216279",
    "submission": "ORIG-1",
    "activeIngredients": "TADALAFIL",
    "company": "SHANDONG",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/04/2024",
    "drugName": "BYQLOVINDA   #218158",
    "submission": "ORIG-1",
    "activeIngredients": "CLOBETASOL PROPIONATE",
    "company": "HARROW EYE",
    "submissionClassification": "Type 5 - New Formulation or New Manufacturer",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/04/2024",
    "drugName": "SKYRIZIBLA   #761105",
    "submission": "SUPPL-27",
    "activeIngredients": "RISANKIZUMAB-RZAA",
    "company": "ABBVIE INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/04/2024",
    "drugName": "SKYRIZIBLA   #761262",
    "submission": "SUPPL-8",
    "activeIngredients": "RISANKIZUMAB-RZAA",
    "company": "ABBVIE INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/05/2024",
    "drugName": "RISPERIDONEANDA  #077493",
    "submission": "SUPPL-10",
    "activeIngredients": "RISPERIDONE",
    "company": "PRINSTON INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/05/2024",
    "drugName": "RISPERIDONEANDA  #077543",
    "submission": "SUPPL-5",
    "activeIngredients": "RISPERIDONE",
    "company": "CHARTWELL MOLECULAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/05/2024",
    "drugName": "RISPERIDONEANDA  #077543",
    "submission": "SUPPL-6",
    "activeIngredients": "RISPERIDONE",
    "company": "CHARTWELL MOLECULAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/05/2024",
    "drugName": "FLUOXETINE HYDROCHLORIDEANDA  #078619",
    "submission": "SUPPL-13",
    "activeIngredients": "FLUOXETINE HYDROCHLORIDE",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/05/2024",
    "drugName": "FLUOXETINE HYDROCHLORIDEANDA  #078619",
    "submission": "SUPPL-14",
    "activeIngredients": "FLUOXETINE HYDROCHLORIDE",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/05/2024",
    "drugName": "FLUOXETINE HYDROCHLORIDEANDA  #078619",
    "submission": "SUPPL-15",
    "activeIngredients": "FLUOXETINE HYDROCHLORIDE",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/05/2024",
    "drugName": "FLUOXETINE HYDROCHLORIDEANDA  #078619",
    "submission": "SUPPL-17",
    "activeIngredients": "FLUOXETINE HYDROCHLORIDE",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/05/2024",
    "drugName": "FLUOXETINE HYDROCHLORIDEANDA  #078619",
    "submission": "SUPPL-24",
    "activeIngredients": "FLUOXETINE HYDROCHLORIDE",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/05/2024",
    "drugName": "FLUOXETINE HYDROCHLORIDEANDA  #078619",
    "submission": "SUPPL-27",
    "activeIngredients": "FLUOXETINE HYDROCHLORIDE",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/05/2024",
    "drugName": "FLUOXETINE HYDROCHLORIDEANDA  #078619",
    "submission": "SUPPL-28",
    "activeIngredients": "FLUOXETINE HYDROCHLORIDE",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/05/2024",
    "drugName": "PROLIABLA   #125320",
    "submission": "SUPPL-213",
    "activeIngredients": "DENOSUMAB",
    "company": "AMGEN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/05/2024",
    "drugName": "PROLIABLA   #125320",
    "submission": "SUPPL-217",
    "activeIngredients": "DENOSUMAB",
    "company": "AMGEN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/05/2024",
    "drugName": "XGEVABLA   #125320",
    "submission": "SUPPL-213",
    "activeIngredients": "DENOSUMAB",
    "company": "AMGEN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/05/2024",
    "drugName": "XGEVABLA   #125320",
    "submission": "SUPPL-217",
    "activeIngredients": "DENOSUMAB",
    "company": "AMGEN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/05/2024",
    "drugName": "PRAMIPEXOLE DIHYDROCHLORIDEANDA  #202633",
    "submission": "SUPPL-14",
    "activeIngredients": "PRAMIPEXOLE DIHYDROCHLORIDE",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/05/2024",
    "drugName": "ACETAMINOPHEN AND CODEINE PHOSPHATEANDA  #202800",
    "submission": "SUPPL-14",
    "activeIngredients": "ACETAMINOPHEN; CODEINE PHOSPHATE",
    "company": "AUROLIFE PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/05/2024",
    "drugName": "ACETAMINOPHEN AND CODEINE PHOSPHATEANDA  #202800",
    "submission": "SUPPL-15",
    "activeIngredients": "ACETAMINOPHEN; CODEINE PHOSPHATE",
    "company": "AUROLIFE PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/05/2024",
    "drugName": "ACETAMINOPHEN AND CODEINE PHOSPHATEANDA  #202800",
    "submission": "SUPPL-16",
    "activeIngredients": "ACETAMINOPHEN; CODEINE PHOSPHATE",
    "company": "AUROLIFE PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/05/2024",
    "drugName": "PANTOPRAZOLE SODIUMANDA  #205675",
    "submission": "SUPPL-23",
    "activeIngredients": "PANTOPRAZOLE SODIUM",
    "company": "EUGIA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/05/2024",
    "drugName": "SORAFENIB TOSYLATEANDA  #207012",
    "submission": "SUPPL-3",
    "activeIngredients": "SORAFENIB TOSYLATE",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/05/2024",
    "drugName": "OXCARBAZEPINEANDA  #207717",
    "submission": "ORIG-1",
    "activeIngredients": "OXCARBAZEPINE",
    "company": "RUBICON RESEARCH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/05/2024",
    "drugName": "CINVANTINDA   #209296",
    "submission": "SUPPL-15",
    "activeIngredients": "APREPITANT",
    "company": "HERON THERAPS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/05/2024",
    "drugName": "CAPECITABINEANDA  #210203",
    "submission": "ORIG-1",
    "activeIngredients": "CAPECITABINE",
    "company": "HETERO LABS LTD V",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/05/2024",
    "drugName": "DEFERASIROXANDA  #211383",
    "submission": "SUPPL-6",
    "activeIngredients": "DEFERASIROX",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/05/2024",
    "drugName": "AMPHETAMINE SULFATEANDA  #213898",
    "submission": "SUPPL-2",
    "activeIngredients": "AMPHETAMINE SULFATE",
    "company": "DR REDDYS LABS SA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/05/2024",
    "drugName": "APONVIENDA   #216457",
    "submission": "SUPPL-3",
    "activeIngredients": "APREPITANT",
    "company": "HERON THERAPS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/05/2024",
    "drugName": "GILTERITINIBANDA  #217683",
    "submission": "ORIG-1",
    "activeIngredients": "GILTERITINIB",
    "company": "SANDOZ INC",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "03/05/2024",
    "drugName": "TYENNEBLA   #761275",
    "submission": "ORIG-1",
    "activeIngredients": "TOCILIZUMAB-AAZG",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/05/2024",
    "drugName": "JUBBONTIBLA   #761362",
    "submission": "ORIG-1",
    "activeIngredients": "DENOSUMAB-BBDZ",
    "company": "SANDOZ INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/05/2024",
    "drugName": "WYOSTBLA   #761362",
    "submission": "ORIG-1",
    "activeIngredients": "DENOSUMAB-BBDZ",
    "company": "SANDOZ INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/06/2024",
    "drugName": "VANCOMYCIN HYDROCHLORIDEANDA  #065490",
    "submission": "SUPPL-14",
    "activeIngredients": "VANCOMYCIN HYDROCHLORIDE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/06/2024",
    "drugName": "VANCOMYCIN HYDROCHLORIDEANDA  #065490",
    "submission": "SUPPL-15",
    "activeIngredients": "VANCOMYCIN HYDROCHLORIDE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/06/2024",
    "drugName": "VANCOMYCIN HYDROCHLORIDEANDA  #065490",
    "submission": "SUPPL-16",
    "activeIngredients": "VANCOMYCIN HYDROCHLORIDE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/06/2024",
    "drugName": "METOCLOPRAMIDE HYDROCHLORIDEANDA  #073135",
    "submission": "SUPPL-25",
    "activeIngredients": "METOCLOPRAMIDE HYDROCHLORIDE",
    "company": "TEVA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/06/2024",
    "drugName": "METOCLOPRAMIDE HYDROCHLORIDEANDA  #073135",
    "submission": "SUPPL-28",
    "activeIngredients": "METOCLOPRAMIDE HYDROCHLORIDE",
    "company": "TEVA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/06/2024",
    "drugName": "DOBUTAMINE HYDROCHLORIDEANDA  #074277",
    "submission": "SUPPL-21",
    "activeIngredients": "DOBUTAMINE HYDROCHLORIDE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/06/2024",
    "drugName": "OPDIVOBLA   #125554",
    "submission": "SUPPL-125",
    "activeIngredients": "NIVOLUMAB",
    "company": "BRISTOL MYERS SQUIBB",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/06/2024",
    "drugName": "OPDIVOBLA   #125554",
    "submission": "SUPPL-128",
    "activeIngredients": "NIVOLUMAB",
    "company": "BRISTOL MYERS SQUIBB",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/06/2024",
    "drugName": "ACETAMINOPHEN AND CODEINE PHOSPHATEANDA  #202800",
    "submission": "SUPPL-17",
    "activeIngredients": "ACETAMINOPHEN; CODEINE PHOSPHATE",
    "company": "AUROLIFE PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/06/2024",
    "drugName": "CLOZAPINEANDA  #202873",
    "submission": "SUPPL-3",
    "activeIngredients": "CLOZAPINE",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/06/2024",
    "drugName": "CLOZAPINEANDA  #202873",
    "submission": "SUPPL-7",
    "activeIngredients": "CLOZAPINE",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/06/2024",
    "drugName": "CLOZAPINEANDA  #202873",
    "submission": "SUPPL-13",
    "activeIngredients": "CLOZAPINE",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/06/2024",
    "drugName": "CLOZAPINEANDA  #202873",
    "submission": "SUPPL-14",
    "activeIngredients": "CLOZAPINE",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/06/2024",
    "drugName": "CLOZAPINEANDA  #202873",
    "submission": "SUPPL-15",
    "activeIngredients": "CLOZAPINE",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/06/2024",
    "drugName": "BEXAROTENEANDA  #203174",
    "submission": "SUPPL-3",
    "activeIngredients": "BEXAROTENE",
    "company": "BIONPHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/06/2024",
    "drugName": "LETROZOLEANDA  #203796",
    "submission": "SUPPL-1",
    "activeIngredients": "LETROZOLE",
    "company": "HIKMA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/06/2024",
    "drugName": "PEMETREXED DISODIUMANDA  #207352",
    "submission": "SUPPL-1",
    "activeIngredients": "PEMETREXED DISODIUM",
    "company": "NANG KUANG PHARM CO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/06/2024",
    "drugName": "PEMETREXED DISODIUMANDA  #207352",
    "submission": "SUPPL-5",
    "activeIngredients": "PEMETREXED DISODIUM",
    "company": "NANG KUANG PHARM CO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/06/2024",
    "drugName": "AZELAIC ACIDANDA  #208011",
    "submission": "SUPPL-3",
    "activeIngredients": "AZELAIC ACID",
    "company": "ACTAVIS LABS UT INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/06/2024",
    "drugName": "AZELAIC ACIDANDA  #208011",
    "submission": "SUPPL-4",
    "activeIngredients": "AZELAIC ACID",
    "company": "ACTAVIS LABS UT INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/06/2024",
    "drugName": "BYDUREON BCISENDA   #209210",
    "submission": "SUPPL-23",
    "activeIngredients": "EXENATIDE SYNTHETIC",
    "company": "ASTRAZENECA AB",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/06/2024",
    "drugName": "IVERMECTINANDA  #210019",
    "submission": "SUPPL-3",
    "activeIngredients": "IVERMECTIN",
    "company": "TEVA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/06/2024",
    "drugName": "IVERMECTINANDA  #210225",
    "submission": "SUPPL-4",
    "activeIngredients": "IVERMECTIN",
    "company": "PADAGIS ISRAEL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/06/2024",
    "drugName": "EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDEANDA  #217049",
    "submission": "ORIG-1",
    "activeIngredients": "EMPAGLIFLOZIN;LINAGLIPTIN;METFORMIN HYDROCHLORIDE",
    "company": "ZYDUS PHARMS USA INC",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "03/06/2024",
    "drugName": "VARENICLINE TARTRATEANDA  #217283",
    "submission": "ORIG-1",
    "activeIngredients": "VARENICLINE TARTRATE",
    "company": "NE RX PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/06/2024",
    "drugName": "HYDROXYUREAANDA  #218021",
    "submission": "ORIG-1",
    "activeIngredients": "HYDROXYUREA",
    "company": "QILU",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/06/2024",
    "drugName": "BESPONSABLA   #761040",
    "submission": "SUPPL-3",
    "activeIngredients": "INOTUZUMAB OZOGAMICIN",
    "company": "WYETH PHARMS INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/06/2024",
    "drugName": "BAVENCIOBLA   #761049",
    "submission": "SUPPL-16",
    "activeIngredients": "AVELUMAB",
    "company": "EMD SERONO INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/06/2024",
    "drugName": "LIBTAYOBLA   #761097",
    "submission": "SUPPL-25",
    "activeIngredients": "CEMIPLIMAB-RWLC",
    "company": "REGENERON PHARMACEUTICALS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/06/2024",
    "drugName": "JEMPERLIBLA   #761174",
    "submission": "SUPPL-10",
    "activeIngredients": "DOSTARLIMAB-GXLY",
    "company": "GLAXOSMITHKLINE",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/06/2024",
    "drugName": "OPDUALAGBLA   #761234",
    "submission": "SUPPL-6",
    "activeIngredients": "NIVOLUMAB;RELATLIMAB-RMBW",
    "company": "BRISTOL MYERS SQUIBB",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/07/2024",
    "drugName": "CAPRELSANDA   #022405",
    "submission": "SUPPL-22",
    "activeIngredients": "VANDETANIB",
    "company": "GENZYME CORP",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/07/2024",
    "drugName": "ROXICETANDA  #087003",
    "submission": "SUPPL-47",
    "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/07/2024",
    "drugName": "BRUKINSANDA   #213217",
    "submission": "SUPPL-11",
    "activeIngredients": "ZANUBRUTINIB",
    "company": "BEONE MEDICINES USA",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/07/2024",
    "drugName": "TALZENNANDA   #217439",
    "submission": "ORIG-1",
    "activeIngredients": "TALAZOPARIB TOSYLATE",
    "company": "PFIZER",
    "submissionClassification": "Type 5 - New Formulation or New Manufacturer",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/08/2024",
    "drugName": "ESCITALOPRAM OXALATEANDA  #079121",
    "submission": "SUPPL-13",
    "activeIngredients": "ESCITALOPRAM OXALATE",
    "company": "TARO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/08/2024",
    "drugName": "METHADONE HYDROCHLORIDEANDA  #090635",
    "submission": "SUPPL-31",
    "activeIngredients": "METHADONE HYDROCHLORIDE",
    "company": "THEPHARMANETWORK LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/08/2024",
    "drugName": "METHADONE HYDROCHLORIDEANDA  #090635",
    "submission": "SUPPL-32",
    "activeIngredients": "METHADONE HYDROCHLORIDE",
    "company": "THEPHARMANETWORK LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/08/2024",
    "drugName": "PRALUENTBLA   #125559",
    "submission": "SUPPL-39",
    "activeIngredients": "ALIROCUMAB",
    "company": "REGENERON PHARMACEUTICALS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/08/2024",
    "drugName": "DEXTROAMPHETAMINE SULFATEANDA  #202893",
    "submission": "SUPPL-5",
    "activeIngredients": "DEXTROAMPHETAMINE SULFATE",
    "company": "AUROLIFE PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/08/2024",
    "drugName": "DEXTROAMPHETAMINE SULFATEANDA  #203548",
    "submission": "SUPPL-9",
    "activeIngredients": "DEXTROAMPHETAMINE SULFATE",
    "company": "AVANTHI INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/08/2024",
    "drugName": "CEFAZOLIN SODIUMNDA   #211413",
    "submission": "SUPPL-1",
    "activeIngredients": "CEFAZOLIN SODIUM",
    "company": "HQ SPCLT PHARMA",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/08/2024",
    "drugName": "CARBAMAZEPINEANDA  #213159",
    "submission": "ORIG-1",
    "activeIngredients": "CARBAMAZEPINE",
    "company": "APOTEX",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/08/2024",
    "drugName": "ALLOPURINOLANDA  #214443",
    "submission": "SUPPL-2",
    "activeIngredients": "ALLOPURINOL",
    "company": "HARMAN FINOCHEM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/08/2024",
    "drugName": "WEGOVYNDA   #215256",
    "submission": "SUPPL-11",
    "activeIngredients": "SEMAGLUTIDE",
    "company": "NOVO",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/08/2024",
    "drugName": "CISATRACURIUM BESYLATEANDA  #216538",
    "submission": "ORIG-1",
    "activeIngredients": "CISATRACURIUM BESYLATE",
    "company": "HAINAN POLY",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/08/2024",
    "drugName": "METOCLOPRAMIDEANDA  #216931",
    "submission": "ORIG-1",
    "activeIngredients": "METOCLOPRAMIDE",
    "company": "TEVA PHARMS INC",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "03/09/2024",
    "drugName": "INDOMETHACINANDA  #090403",
    "submission": "SUPPL-7",
    "activeIngredients": "INDOMETHACIN",
    "company": "ZYDUS LIFESCIENCES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/09/2024",
    "drugName": "EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATEANDA  #091215",
    "submission": "SUPPL-2",
    "activeIngredients": "EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE",
    "company": "TEVA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/09/2024",
    "drugName": "SUCCINYLCHOLINE CHLORIDEANDA  #211346",
    "submission": "SUPPL-3",
    "activeIngredients": "SUCCINYLCHOLINE CHLORIDE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/09/2024",
    "drugName": "ROPIVACAINE HYDROCHLORIDEANDA  #214074",
    "submission": "SUPPL-1",
    "activeIngredients": "ROPIVACAINE HYDROCHLORIDE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/11/2024",
    "drugName": "OPILLNDA   #017031",
    "submission": "SUPPL-42",
    "activeIngredients": "NORGESTREL",
    "company": "LABORATOIRE HRA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/11/2024",
    "drugName": "OPILLNDA   #017031",
    "submission": "SUPPL-43",
    "activeIngredients": "NORGESTREL",
    "company": "LABORATOIRE HRA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/11/2024",
    "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #040894",
    "submission": "SUPPL-24",
    "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
    "company": "GENUS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/11/2024",
    "drugName": "OXYCODONE HYDROCHLORIDE AND IBUPROFENANDA  #078316",
    "submission": "SUPPL-17",
    "activeIngredients": "IBUPROFEN; OXYCODONE HYDROCHLORIDE",
    "company": "BARR LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/11/2024",
    "drugName": "OXYCODONE HYDROCHLORIDE AND IBUPROFENANDA  #078316",
    "submission": "SUPPL-18",
    "activeIngredients": "IBUPROFEN; OXYCODONE HYDROCHLORIDE",
    "company": "BARR LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/11/2024",
    "drugName": "KEYTRUDABLA   #125514",
    "submission": "SUPPL-160",
    "activeIngredients": "PEMBROLIZUMAB",
    "company": "MERCK SHARP DOHME",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/11/2024",
    "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #200343",
    "submission": "SUPPL-23",
    "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
    "company": "GENUS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/11/2024",
    "drugName": "AFINITOR DISPERZNDA   #203985",
    "submission": "SUPPL-27",
    "activeIngredients": "EVEROLIMUS",
    "company": "NOVARTIS PHARM",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/11/2024",
    "drugName": "DEXTROAMPHETAMINE SULFATEANDA  #205673",
    "submission": "SUPPL-2",
    "activeIngredients": "DEXTROAMPHETAMINE SULFATE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/11/2024",
    "drugName": "DEXTROAMPHETAMINE SULFATEANDA  #205673",
    "submission": "SUPPL-3",
    "activeIngredients": "DEXTROAMPHETAMINE SULFATE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/11/2024",
    "drugName": "AMELUZNDA   #208081",
    "submission": "SUPPL-26",
    "activeIngredients": "AMINOLEVULINIC ACID HYDROCHLORIDE",
    "company": "BIOFRONTERA",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/11/2024",
    "drugName": "QUETIAPINE FUMARATEANDA  #208781",
    "submission": "SUPPL-3",
    "activeIngredients": "QUETIAPINE FUMARATE",
    "company": "PRINSTON INC",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/11/2024",
    "drugName": "PHENYLEPHRINE HYDROCHLORIDEANDA  #209968",
    "submission": "SUPPL-1",
    "activeIngredients": "PHENYLEPHRINE HYDROCHLORIDE",
    "company": "AVET LIFESCIENCES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/11/2024",
    "drugName": "SELEXIPAGANDA  #216607",
    "submission": "ORIG-1",
    "activeIngredients": "SELEXIPAG",
    "company": "CIPLA LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "03/12/2024",
    "drugName": "ALLOPURINOLANDA  #018659",
    "submission": "SUPPL-33",
    "activeIngredients": "ALLOPURINOL",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2024",
    "drugName": "KEPPRANDA   #021035",
    "submission": "SUPPL-115",
    "activeIngredients": "LEVETIRACETAM",
    "company": "UCB INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2024",
    "drugName": "KEPPRANDA   #021505",
    "submission": "SUPPL-53",
    "activeIngredients": "LEVETIRACETAM",
    "company": "UCB INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2024",
    "drugName": "KEPPRANDA   #021872",
    "submission": "SUPPL-35",
    "activeIngredients": "LEVETIRACETAM",
    "company": "UCB INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2024",
    "drugName": "KEPPRA XRNDA   #022285",
    "submission": "SUPPL-36",
    "activeIngredients": "LEVETIRACETAM",
    "company": "UCB INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2024",
    "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #040105",
    "submission": "SUPPL-38",
    "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2024",
    "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #040203",
    "submission": "SUPPL-15",
    "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
    "company": "ACTAVIS ELIZABETH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2024",
    "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #040203",
    "submission": "SUPPL-16",
    "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
    "company": "ACTAVIS ELIZABETH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2024",
    "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #040608",
    "submission": "SUPPL-21",
    "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
    "company": "MIKART",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2024",
    "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #040800",
    "submission": "SUPPL-12",
    "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
    "company": "ACTAVIS ELIZABETH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2024",
    "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #040800",
    "submission": "SUPPL-13",
    "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
    "company": "ACTAVIS ELIZABETH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2024",
    "drugName": "METOPROLOL TARTRATEANDA  #078459",
    "submission": "SUPPL-15",
    "activeIngredients": "METOPROLOL TARTRATE",
    "company": "IPCA LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2024",
    "drugName": "METOPROLOL TARTRATEANDA  #078459",
    "submission": "SUPPL-16",
    "activeIngredients": "METOPROLOL TARTRATE",
    "company": "IPCA LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2024",
    "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #201447",
    "submission": "SUPPL-21",
    "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
    "company": "ACTAVIS ELIZABETH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2024",
    "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #201447",
    "submission": "SUPPL-22",
    "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
    "company": "ACTAVIS ELIZABETH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2024",
    "drugName": "OLANZAPINEANDA  #202050",
    "submission": "SUPPL-10",
    "activeIngredients": "OLANZAPINE",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2024",
    "drugName": "OLANZAPINEANDA  #202050",
    "submission": "SUPPL-11",
    "activeIngredients": "OLANZAPINE",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2024",
    "drugName": "OLANZAPINEANDA  #202050",
    "submission": "SUPPL-12",
    "activeIngredients": "OLANZAPINE",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2024",
    "drugName": "OLANZAPINEANDA  #202050",
    "submission": "SUPPL-13",
    "activeIngredients": "OLANZAPINE",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2024",
    "drugName": "OLANZAPINEANDA  #202050",
    "submission": "SUPPL-15",
    "activeIngredients": "OLANZAPINE",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2024",
    "drugName": "OLANZAPINEANDA  #202050",
    "submission": "SUPPL-16",
    "activeIngredients": "OLANZAPINE",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2024",
    "drugName": "OLANZAPINEANDA  #202050",
    "submission": "SUPPL-19",
    "activeIngredients": "OLANZAPINE",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2024",
    "drugName": "OLANZAPINEANDA  #202050",
    "submission": "SUPPL-21",
    "activeIngredients": "OLANZAPINE",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2024",
    "drugName": "ONFINDA   #202067",
    "submission": "SUPPL-8",
    "activeIngredients": "CLOBAZAM",
    "company": "LUNDBECK PHARMS LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2024",
    "drugName": "LEVETIRACETAM IN SODIUM CHLORIDENDA   #202543",
    "submission": "SUPPL-24",
    "activeIngredients": "LEVETIRACETAM",
    "company": "HQ SPCLT PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2024",
    "drugName": "ONFINDA   #203993",
    "submission": "SUPPL-10",
    "activeIngredients": "CLOBAZAM",
    "company": "LUNDBECK PHARMS LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2024",
    "drugName": "TECFIDERANDA   #204063",
    "submission": "SUPPL-31",
    "activeIngredients": "DIMETHYL FUMARATE",
    "company": "BIOGEN INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2024",
    "drugName": "ADZENYS XR-ODTNDA   #204326",
    "submission": "SUPPL-14",
    "activeIngredients": "AMPHETAMINE",
    "company": "NEOS THERAPS",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2024",
    "drugName": "ELEPSIA XRNDA   #204417",
    "submission": "SUPPL-9",
    "activeIngredients": "LEVETIRACETAM",
    "company": "TRIPOINT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2024",
    "drugName": "COTEMPLA XR-ODTNDA   #205489",
    "submission": "SUPPL-16",
    "activeIngredients": "METHYLPHENIDATE",
    "company": "NEOS THERAPS INC",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2024",
    "drugName": "HYDROMORPHONE HYDROCHLORIDEANDA  #205629",
    "submission": "SUPPL-19",
    "activeIngredients": "HYDROMORPHONE HYDROCHLORIDE",
    "company": "OSMOTICA PHARM US",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2024",
    "drugName": "ROSUVASTATIN CALCIUMANDA  #207616",
    "submission": "SUPPL-11",
    "activeIngredients": "ROSUVASTATIN CALCIUM",
    "company": "HETERO LABS LTD V",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2024",
    "drugName": "ROSUVASTATIN CALCIUMANDA  #207616",
    "submission": "SUPPL-17",
    "activeIngredients": "ROSUVASTATIN CALCIUM",
    "company": "HETERO LABS LTD V",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2024",
    "drugName": "SPRITAMNDA   #207958",
    "submission": "SUPPL-25",
    "activeIngredients": "LEVETIRACETAM",
    "company": "APRECIA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2024",
    "drugName": "SYMPAZANNDA   #210833",
    "submission": "SUPPL-6",
    "activeIngredients": "CLOBAZAM",
    "company": "ASSERTIO SPECLTY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2024",
    "drugName": "BUTALBITAL, ACETAMINOPHEN AND CAFFEINEANDA  #216376",
    "submission": "ORIG-1",
    "activeIngredients": "ACETAMINOPHEN; BUTALBITAL; CAFFEINE",
    "company": "QUAGEN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2024",
    "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #040778",
    "submission": "SUPPL-31",
    "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
    "company": "AMNEAL PHARMS NY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2024",
    "drugName": "PANTOPRAZOLE SODIUMANDA  #090797",
    "submission": "SUPPL-12",
    "activeIngredients": "PANTOPRAZOLE SODIUM",
    "company": "ACTAVIS TOTOWA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2024",
    "drugName": "PANTOPRAZOLE SODIUMANDA  #090797",
    "submission": "SUPPL-13",
    "activeIngredients": "PANTOPRAZOLE SODIUM",
    "company": "ACTAVIS TOTOWA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2024",
    "drugName": "PANTOPRAZOLE SODIUMANDA  #090797",
    "submission": "SUPPL-14",
    "activeIngredients": "PANTOPRAZOLE SODIUM",
    "company": "ACTAVIS TOTOWA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2024",
    "drugName": "PANTOPRAZOLE SODIUMANDA  #090797",
    "submission": "SUPPL-15",
    "activeIngredients": "PANTOPRAZOLE SODIUM",
    "company": "ACTAVIS TOTOWA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2024",
    "drugName": "ONCASPARBLA   #103411",
    "submission": "SUPPL-5207",
    "activeIngredients": "PEGASPARGASE",
    "company": "SIGMA TAU",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2024",
    "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #202677",
    "submission": "SUPPL-18",
    "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
    "company": "ALVOGEN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2024",
    "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #207333",
    "submission": "SUPPL-12",
    "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
    "company": "LANNETT CO INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2024",
    "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #207510",
    "submission": "SUPPL-11",
    "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
    "company": "WES PHARMA INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2024",
    "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #207510",
    "submission": "SUPPL-12",
    "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
    "company": "WES PHARMA INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2024",
    "drugName": "METFORMIN HYDROCHLORIDEANDA  #211163",
    "submission": "ORIG-1",
    "activeIngredients": "METFORMIN HYDROCHLORIDE",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2024",
    "drugName": "CAMCEVI KITNDA   #211488",
    "submission": "SUPPL-4",
    "activeIngredients": "LEUPROLIDE MESYLATE",
    "company": "ACCORD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2024",
    "drugName": "LIVMARLINDA   #214662",
    "submission": "SUPPL-5",
    "activeIngredients": "MARALIXIBAT CHLORIDE",
    "company": "MIRUM",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2024",
    "drugName": "LIVMARLINDA   #214662",
    "submission": "SUPPL-8",
    "activeIngredients": "MARALIXIBAT CHLORIDE",
    "company": "MIRUM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2024",
    "drugName": "CHLORPROMAZINE HYDROCHLORIDEANDA  #217275",
    "submission": "ORIG-1",
    "activeIngredients": "CHLORPROMAZINE HYDROCHLORIDE",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2024",
    "drugName": "EDARAVONEANDA  #218349",
    "submission": "ORIG-1",
    "activeIngredients": "EDARAVONE",
    "company": "ZYDUS PHARMS USA INC",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "03/13/2024",
    "drugName": "TEVIMBRABLA   #761232",
    "submission": "ORIG-1",
    "activeIngredients": "TISLELIZUMAB-JSGR",
    "company": "BEIGENE",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/14/2024",
    "drugName": "NIZORAL ANTI-DANDRUFFNDA   #020310",
    "submission": "SUPPL-32",
    "activeIngredients": "KETOCONAZOLE",
    "company": "KRAMER",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/14/2024",
    "drugName": "ALTOPREVNDA   #021316",
    "submission": "SUPPL-37",
    "activeIngredients": "LOVASTATIN",
    "company": "COVIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/14/2024",
    "drugName": "LIVALONDA   #022363",
    "submission": "SUPPL-22",
    "activeIngredients": "PITAVASTATIN CALCIUM",
    "company": "KOWA CO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/14/2024",
    "drugName": "TEMAZEPAMANDA  #071456",
    "submission": "SUPPL-15",
    "activeIngredients": "TEMAZEPAM",
    "company": "NOVEL LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/14/2024",
    "drugName": "ROXICETANDA  #089351",
    "submission": "SUPPL-36",
    "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/14/2024",
    "drugName": "ENTYVIOBLA   #125476",
    "submission": "SUPPL-58",
    "activeIngredients": "VEDOLIZUMAB",
    "company": "TAKEDA PHARMS USA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/14/2024",
    "drugName": "TREPROSTINILANDA  #203649",
    "submission": "SUPPL-10",
    "activeIngredients": "TREPROSTINIL",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/14/2024",
    "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #204407",
    "submission": "SUPPL-9",
    "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
    "company": "NOVEL LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/14/2024",
    "drugName": "CABAZITAXELNDA   #207970",
    "submission": "ORIG-1",
    "activeIngredients": "CABAZITAXEL",
    "company": "ACTAVIS",
    "submissionClassification": "Type 5 - New Formulation or New Manufacturer",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/14/2024",
    "drugName": "TICAGRELORANDA  #208390",
    "submission": "SUPPL-1",
    "activeIngredients": "TICAGRELOR",
    "company": "WATSON LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/14/2024",
    "drugName": "TICAGRELORANDA  #208390",
    "submission": "SUPPL-2",
    "activeIngredients": "TICAGRELOR",
    "company": "WATSON LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/14/2024",
    "drugName": "CLOBETASOL PROPIONATEANDA  #208563",
    "submission": "ORIG-1",
    "activeIngredients": "CLOBETASOL PROPIONATE",
    "company": "TARO",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/14/2024",
    "drugName": "TABRECTANDA   #213591",
    "submission": "SUPPL-11",
    "activeIngredients": "CAPMATINIB HYDROCHLORIDE",
    "company": "NOVARTIS PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/14/2024",
    "drugName": "REZDIFFRANDA   #217785",
    "submission": "ORIG-1",
    "activeIngredients": "RESMETIROM",
    "company": "MADRIGAL",
    "submissionClassification": "Type 1 - New Molecular Entity",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/14/2024",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #217794",
    "submission": "ORIG-1",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "LUPIN LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/14/2024",
    "drugName": "PHENYLEPHRINE HYDROCHLORIDEANDA  #218412",
    "submission": "ORIG-1",
    "activeIngredients": "PHENYLEPHRINE HYDROCHLORIDE",
    "company": "HAINAN POLY",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/14/2024",
    "drugName": "FAMOTIDINEANDA  #218461",
    "submission": "ORIG-1",
    "activeIngredients": "FAMOTIDINE",
    "company": "GRAVITI PHARMS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/14/2024",
    "drugName": "SUNITINIB MALATEANDA  #218615",
    "submission": "ORIG-1",
    "activeIngredients": "SUNITINIB MALATE",
    "company": "EUGIA PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/14/2024",
    "drugName": "ENTYVIOBLA   #761133",
    "submission": "SUPPL-4",
    "activeIngredients": "VEDOLIZUMAB",
    "company": "TAKEDA PHARMS USA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/15/2024",
    "drugName": "DELSYMNDA   #018658",
    "submission": "SUPPL-34",
    "activeIngredients": "DEXTROMETHORPHAN POLISTIREX",
    "company": "RB HLTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/15/2024",
    "drugName": "INCRELEXBLA   #021839",
    "submission": "SUPPL-31",
    "activeIngredients": "MECASERMIN RECOMBINANT",
    "company": "IPSEN INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/15/2024",
    "drugName": "VANCOMYCIN HYDROCHLORIDEANDA  #065478",
    "submission": "SUPPL-2",
    "activeIngredients": "VANCOMYCIN HYDROCHLORIDE",
    "company": "ABON PHARMS LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/15/2024",
    "drugName": "VANCOMYCIN HYDROCHLORIDEANDA  #065478",
    "submission": "SUPPL-3",
    "activeIngredients": "VANCOMYCIN HYDROCHLORIDE",
    "company": "ABON PHARMS LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/15/2024",
    "drugName": "NICOTINE POLACRILEXANDA  #076775",
    "submission": "SUPPL-31",
    "activeIngredients": "NICOTINE POLACRILEX",
    "company": "L PERRIGO CO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/15/2024",
    "drugName": "NICOTINE POLACRILEXANDA  #076776",
    "submission": "SUPPL-20",
    "activeIngredients": "NICOTINE POLACRILEX",
    "company": "L PERRIGO CO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/15/2024",
    "drugName": "NICOTINE POLACRILEXANDA  #076777",
    "submission": "SUPPL-30",
    "activeIngredients": "NICOTINE POLACRILEX",
    "company": "L PERRIGO CO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/15/2024",
    "drugName": "NICOTINE POLACRILEXANDA  #076777",
    "submission": "SUPPL-35",
    "activeIngredients": "NICOTINE POLACRILEX",
    "company": "L PERRIGO CO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/15/2024",
    "drugName": "NICOTINE POLACRILEXANDA  #076779",
    "submission": "SUPPL-31",
    "activeIngredients": "NICOTINE POLACRILEX",
    "company": "L PERRIGO CO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/15/2024",
    "drugName": "NICOTINE POLACRILEXANDA  #076779",
    "submission": "SUPPL-36",
    "activeIngredients": "NICOTINE POLACRILEX",
    "company": "L PERRIGO CO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/15/2024",
    "drugName": "NICOTINE POLACRILEXANDA  #076789",
    "submission": "SUPPL-31",
    "activeIngredients": "NICOTINE POLACRILEX",
    "company": "L PERRIGO CO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/15/2024",
    "drugName": "NICOTINE POLACRILEXANDA  #078325",
    "submission": "SUPPL-19",
    "activeIngredients": "NICOTINE POLACRILEX",
    "company": "PERRIGO R AND D",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/15/2024",
    "drugName": "NICOTINE POLACRILEXANDA  #078326",
    "submission": "SUPPL-20",
    "activeIngredients": "NICOTINE POLACRILEX",
    "company": "PERRIGO R AND D",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/15/2024",
    "drugName": "ALPRAZOLAMANDA  #078387",
    "submission": "SUPPL-5",
    "activeIngredients": "ALPRAZOLAM",
    "company": "AMNEAL PHARMS NY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/15/2024",
    "drugName": "ALPRAZOLAMANDA  #078387",
    "submission": "SUPPL-6",
    "activeIngredients": "ALPRAZOLAM",
    "company": "AMNEAL PHARMS NY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/15/2024",
    "drugName": "ALPRAZOLAMANDA  #078387",
    "submission": "SUPPL-9",
    "activeIngredients": "ALPRAZOLAM",
    "company": "AMNEAL PHARMS NY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/15/2024",
    "drugName": "ALPRAZOLAMANDA  #078387",
    "submission": "SUPPL-10",
    "activeIngredients": "ALPRAZOLAM",
    "company": "AMNEAL PHARMS NY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/15/2024",
    "drugName": "NICOTINE POLACRILEXANDA  #078546",
    "submission": "SUPPL-16",
    "activeIngredients": "NICOTINE POLACRILEX",
    "company": "PERRIGO R AND D",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/15/2024",
    "drugName": "NICOTINE POLACRILEXANDA  #078546",
    "submission": "SUPPL-20",
    "activeIngredients": "NICOTINE POLACRILEX",
    "company": "PERRIGO R AND D",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/15/2024",
    "drugName": "NICOTINE POLACRILEXANDA  #078547",
    "submission": "SUPPL-20",
    "activeIngredients": "NICOTINE POLACRILEX",
    "company": "PERRIGO R AND D",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/15/2024",
    "drugName": "NICOTINE POLACRILEXANDA  #078968",
    "submission": "SUPPL-10",
    "activeIngredients": "NICOTINE POLACRILEX",
    "company": "PERRIGO R AND D",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/15/2024",
    "drugName": "NICOTINE POLACRILEXANDA  #078968",
    "submission": "SUPPL-13",
    "activeIngredients": "NICOTINE POLACRILEX",
    "company": "PERRIGO R AND D",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/15/2024",
    "drugName": "NICOTINE POLACRILEXANDA  #091349",
    "submission": "SUPPL-15",
    "activeIngredients": "NICOTINE POLACRILEX",
    "company": "PERRIGO R AND D",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/15/2024",
    "drugName": "NICOTINE POLACRILEXANDA  #091354",
    "submission": "SUPPL-14",
    "activeIngredients": "NICOTINE POLACRILEX",
    "company": "PERRIGO R AND D",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/15/2024",
    "drugName": "EDURANTNDA   #202022",
    "submission": "SUPPL-20",
    "activeIngredients": "RILPIVIRINE HYDROCHLORIDE",
    "company": "JANSSEN PRODS",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/15/2024",
    "drugName": "EDURANTNDA   #202022",
    "submission": "SUPPL-22",
    "activeIngredients": "RILPIVIRINE HYDROCHLORIDE",
    "company": "JANSSEN PRODS",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/15/2024",
    "drugName": "DASATINIBANDA  #202103",
    "submission": "SUPPL-7",
    "activeIngredients": "DASATINIB",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/15/2024",
    "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #202142",
    "submission": "SUPPL-9",
    "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
    "company": "MIKART",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/15/2024",
    "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #204407",
    "submission": "SUPPL-10",
    "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
    "company": "NOVEL LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/15/2024",
    "drugName": "ETODOLACANDA  #208834",
    "submission": "SUPPL-7",
    "activeIngredients": "ETODOLAC",
    "company": "AMNEAL PHARMS CO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/15/2024",
    "drugName": "XHANCENDA   #209022",
    "submission": "SUPPL-19",
    "activeIngredients": "FLUTICASONE PROPIONATE",
    "company": "OPTINOSE US INC",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/15/2024",
    "drugName": "SAPROPTERIN DIHYDROCHLORIDEANDA  #209452",
    "submission": "SUPPL-6",
    "activeIngredients": "SAPROPTERIN DIHYDROCHLORIDE",
    "company": "DR REDDYS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/15/2024",
    "drugName": "CHLORPROMAZINE HYDROCHLORIDEANDA  #213368",
    "submission": "SUPPL-1",
    "activeIngredients": "CHLORPROMAZINE HYDROCHLORIDE",
    "company": "ZYDUS LIFESCIENCES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/15/2024",
    "drugName": "ARIPIPRAZOLEANDA  #215595",
    "submission": "SUPPL-1",
    "activeIngredients": "ARIPIPRAZOLE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/15/2024",
    "drugName": "SAPROPTERIN DIHYDROCHLORIDEANDA  #215798",
    "submission": "SUPPL-2",
    "activeIngredients": "SAPROPTERIN DIHYDROCHLORIDE",
    "company": "DR REDDYS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/15/2024",
    "drugName": "SODIUM ACETATEANDA  #216920",
    "submission": "ORIG-1",
    "activeIngredients": "SODIUM ACETATE",
    "company": "HIKMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/15/2024",
    "drugName": "FAMOTIDINEANDA  #217655",
    "submission": "SUPPL-1",
    "activeIngredients": "FAMOTIDINE",
    "company": "APPCO",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/15/2024",
    "drugName": "FINASTERIDE AND TADALAFILANDA  #218232",
    "submission": "ORIG-1",
    "activeIngredients": "FINASTERIDE; TADALAFIL",
    "company": "ZYDUS LIFESCIENCES",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/15/2024",
    "drugName": "EDURANT PEDNDA   #219016",
    "submission": "ORIG-1",
    "activeIngredients": "RILPIVIRINE HYDROCHLORIDE",
    "company": "JANSSEN PRODS",
    "submissionClassification": "Type 3 - New Dosage Form",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/15/2024",
    "drugName": "ADUHELMBLA   #761178",
    "submission": "SUPPL-12",
    "activeIngredients": "ADUCANUMAB-AVWA",
    "company": "BIOGEN INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/18/2024",
    "drugName": "DEPAKOTENDA   #018723",
    "submission": "SUPPL-68",
    "activeIngredients": "DIVALPROEX SODIUM",
    "company": "ABBVIE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/18/2024",
    "drugName": "DEPAKOTENDA   #019680",
    "submission": "SUPPL-55",
    "activeIngredients": "DIVALPROEX SODIUM",
    "company": "ABBVIE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/18/2024",
    "drugName": "SPORANOXNDA   #020657",
    "submission": "SUPPL-42",
    "activeIngredients": "ITRACONAZOLE",
    "company": "JANSSEN PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/18/2024",
    "drugName": "DEPAKOTE ERNDA   #021168",
    "submission": "SUPPL-46",
    "activeIngredients": "DIVALPROEX SODIUM",
    "company": "ABBVIE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/18/2024",
    "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #040658",
    "submission": "SUPPL-19",
    "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
    "company": "CHARTWELL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/18/2024",
    "drugName": "STELARABLA   #125261",
    "submission": "SUPPL-163",
    "activeIngredients": "USTEKINUMAB",
    "company": "CENTOCOR ORTHO BIOTECH INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/18/2024",
    "drugName": "METHADONE HYDROCHLORIDEANDA  #203502",
    "submission": "SUPPL-9",
    "activeIngredients": "METHADONE HYDROCHLORIDE",
    "company": "AUROLIFE PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/18/2024",
    "drugName": "METHADONE HYDROCHLORIDEANDA  #203502",
    "submission": "SUPPL-10",
    "activeIngredients": "METHADONE HYDROCHLORIDE",
    "company": "AUROLIFE PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/18/2024",
    "drugName": "ARIPIPRAZOLEANDA  #205589",
    "submission": "ORIG-1",
    "activeIngredients": "ARIPIPRAZOLE",
    "company": "LUPIN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/18/2024",
    "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #206245",
    "submission": "SUPPL-14",
    "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
    "company": "NOVEL LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/18/2024",
    "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #206245",
    "submission": "SUPPL-15",
    "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
    "company": "NOVEL LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/18/2024",
    "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #207709",
    "submission": "SUPPL-4",
    "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
    "company": "AUROLIFE PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/18/2024",
    "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #207709",
    "submission": "SUPPL-5",
    "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
    "company": "AUROLIFE PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/18/2024",
    "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #207709",
    "submission": "SUPPL-6",
    "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
    "company": "AUROLIFE PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/18/2024",
    "drugName": "OXCARBAZEPINEANDA  #213183",
    "submission": "ORIG-1",
    "activeIngredients": "OXCARBAZEPINE",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/18/2024",
    "drugName": "MOMETASONE FUROATEANDA  #215878",
    "submission": "ORIG-1",
    "activeIngredients": "MOMETASONE FUROATE",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/18/2024",
    "drugName": "IBUPROFEN AND FAMOTIDINEANDA  #215925",
    "submission": "ORIG-1",
    "activeIngredients": "FAMOTIDINE; IBUPROFEN",
    "company": "TORRENT",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/18/2024",
    "drugName": "METRONIDAZOLEANDA  #216795",
    "submission": "ORIG-1",
    "activeIngredients": "METRONIDAZOLE",
    "company": "ENCUBE",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/18/2024",
    "drugName": "LITHIUM CITRATEANDA  #217183",
    "submission": "ORIG-1",
    "activeIngredients": "LITHIUM CITRATE",
    "company": "SCIEGEN PHARMS INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/18/2024",
    "drugName": "STELARABLA   #761044",
    "submission": "SUPPL-13",
    "activeIngredients": "USTEKINUMAB",
    "company": "JANSSEN BIOTECH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/18/2024",
    "drugName": "SPEVIGOBLA   #761244",
    "submission": "SUPPL-3",
    "activeIngredients": "SPESOLIMAB-SBZO",
    "company": "BOEHRINGER INGELHEIM PHARMACEUTICALS INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/19/2024",
    "drugName": "VALIUMNDA   #013263",
    "submission": "SUPPL-101",
    "activeIngredients": "DIAZEPAM",
    "company": "WAYLIS THERAP",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/19/2024",
    "drugName": "PRAMIPEXOLE DIHYDROCHLORIDEANDA  #077854",
    "submission": "SUPPL-4",
    "activeIngredients": "PRAMIPEXOLE DIHYDROCHLORIDE",
    "company": "NATCO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/19/2024",
    "drugName": "PRAMIPEXOLE DIHYDROCHLORIDEANDA  #077854",
    "submission": "SUPPL-6",
    "activeIngredients": "PRAMIPEXOLE DIHYDROCHLORIDE",
    "company": "NATCO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/19/2024",
    "drugName": "PRAMIPEXOLE DIHYDROCHLORIDEANDA  #077854",
    "submission": "SUPPL-7",
    "activeIngredients": "PRAMIPEXOLE DIHYDROCHLORIDE",
    "company": "NATCO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/19/2024",
    "drugName": "PRAMIPEXOLE DIHYDROCHLORIDEANDA  #077854",
    "submission": "SUPPL-8",
    "activeIngredients": "PRAMIPEXOLE DIHYDROCHLORIDE",
    "company": "NATCO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/19/2024",
    "drugName": "PRAMIPEXOLE DIHYDROCHLORIDEANDA  #077854",
    "submission": "SUPPL-9",
    "activeIngredients": "PRAMIPEXOLE DIHYDROCHLORIDE",
    "company": "NATCO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/19/2024",
    "drugName": "PRAMIPEXOLE DIHYDROCHLORIDEANDA  #077854",
    "submission": "SUPPL-11",
    "activeIngredients": "PRAMIPEXOLE DIHYDROCHLORIDE",
    "company": "NATCO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/19/2024",
    "drugName": "BICALUTAMIDEANDA  #078917",
    "submission": "SUPPL-13",
    "activeIngredients": "BICALUTAMIDE",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/19/2024",
    "drugName": "GLATOPAANDA  #090218",
    "submission": "SUPPL-28",
    "activeIngredients": "GLATIRAMER ACETATE",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/19/2024",
    "drugName": "PRAMIPEXOLE DIHYDROCHLORIDEANDA  #090764",
    "submission": "SUPPL-9",
    "activeIngredients": "PRAMIPEXOLE DIHYDROCHLORIDE",
    "company": "NATCO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/19/2024",
    "drugName": "PRAMIPEXOLE DIHYDROCHLORIDEANDA  #090764",
    "submission": "SUPPL-10",
    "activeIngredients": "PRAMIPEXOLE DIHYDROCHLORIDE",
    "company": "NATCO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/19/2024",
    "drugName": "PRAMIPEXOLE DIHYDROCHLORIDEANDA  #090764",
    "submission": "SUPPL-11",
    "activeIngredients": "PRAMIPEXOLE DIHYDROCHLORIDE",
    "company": "NATCO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/19/2024",
    "drugName": "PRAMIPEXOLE DIHYDROCHLORIDEANDA  #090764",
    "submission": "SUPPL-13",
    "activeIngredients": "PRAMIPEXOLE DIHYDROCHLORIDE",
    "company": "NATCO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/19/2024",
    "drugName": "ICLUSIGNDA   #203469",
    "submission": "SUPPL-37",
    "activeIngredients": "PONATINIB HYDROCHLORIDE",
    "company": "TAKEDA PHARMS USA",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/19/2024",
    "drugName": "METHADONE HYDROCHLORIDEANDA  #203502",
    "submission": "SUPPL-11",
    "activeIngredients": "METHADONE HYDROCHLORIDE",
    "company": "AUROLIFE PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/19/2024",
    "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #204407",
    "submission": "SUPPL-12",
    "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
    "company": "NOVEL LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/19/2024",
    "drugName": "SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATEANDA  #206431",
    "submission": "ORIG-1",
    "activeIngredients": "MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE",
    "company": "TARO",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/19/2024",
    "drugName": "ESMOLOL HYDROCHLORIDEANDA  #206608",
    "submission": "SUPPL-12",
    "activeIngredients": "ESMOLOL HYDROCHLORIDE",
    "company": "MYLAN LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/19/2024",
    "drugName": "GLATOPAANDA  #206921",
    "submission": "SUPPL-29",
    "activeIngredients": "GLATIRAMER ACETATE",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/19/2024",
    "drugName": "TRIAMTERENE AND HYDROCHLOROTHIAZIDEANDA  #208358",
    "submission": "SUPPL-1",
    "activeIngredients": "HYDROCHLOROTHIAZIDE; TRIAMTERENE",
    "company": "CADILA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/19/2024",
    "drugName": "DOCETAXELANDA  #210327",
    "submission": "SUPPL-4",
    "activeIngredients": "DOCETAXEL",
    "company": "SHILPA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/19/2024",
    "drugName": "VENLAFAXINE HYDROCHLORIDEANDA  #212277",
    "submission": "SUPPL-2",
    "activeIngredients": "VENLAFAXINE HYDROCHLORIDE",
    "company": "ANNORA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/19/2024",
    "drugName": "VENLAFAXINE HYDROCHLORIDEANDA  #212277",
    "submission": "SUPPL-3",
    "activeIngredients": "VENLAFAXINE HYDROCHLORIDE",
    "company": "ANNORA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/19/2024",
    "drugName": "VENLAFAXINE HYDROCHLORIDEANDA  #212277",
    "submission": "SUPPL-5",
    "activeIngredients": "VENLAFAXINE HYDROCHLORIDE",
    "company": "ANNORA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/19/2024",
    "drugName": "VARENICLINE TARTRATEANDA  #213019",
    "submission": "ORIG-1",
    "activeIngredients": "VARENICLINE TARTRATE",
    "company": "AJANTA PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/19/2024",
    "drugName": "DEFERASIROXANDA  #216229",
    "submission": "SUPPL-2",
    "activeIngredients": "DEFERASIROX",
    "company": "ANNORA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/19/2024",
    "drugName": "MESALAMINEANDA  #216967",
    "submission": "SUPPL-1",
    "activeIngredients": "MESALAMINE",
    "company": "ALEMBIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/19/2024",
    "drugName": "TRYVIONDA   #217686",
    "submission": "ORIG-1",
    "activeIngredients": "APROCITENTAN",
    "company": "IDORSIA",
    "submissionClassification": "Type 1 - New Molecular Entity",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/19/2024",
    "drugName": "AMIKACIN SULFATEANDA  #218146",
    "submission": "ORIG-1",
    "activeIngredients": "AMIKACIN SULFATE",
    "company": "QILU",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/20/2024",
    "drugName": "SUBOXONENDA   #022410",
    "submission": "SUPPL-50",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE",
    "company": "INDIVIOR",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/20/2024",
    "drugName": "BUPRENORPHINE HYDROCHLORIDEANDA  #078633",
    "submission": "SUPPL-30",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE",
    "company": "HIKMA",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/20/2024",
    "drugName": "BUPRENORPHINE HYDROCHLORIDEANDA  #090279",
    "submission": "SUPPL-21",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE",
    "company": "RUBICON RESEARCH",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/20/2024",
    "drugName": "BUPRENORPHINE HYDROCHLORIDEANDA  #090360",
    "submission": "SUPPL-25",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE",
    "company": "BARR",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/20/2024",
    "drugName": "GEMIFLOXACIN MESYLATEANDA  #090466",
    "submission": "SUPPL-3",
    "activeIngredients": "GEMIFLOXACIN MESYLATE",
    "company": "ORBION PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/20/2024",
    "drugName": "ESCITALOPRAM OXALATEANDA  #090477",
    "submission": "SUPPL-13",
    "activeIngredients": "ESCITALOPRAM OXALATE",
    "company": "CHARTWELL MOLECULAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/20/2024",
    "drugName": "BUPRENORPHINE HYDROCHLORIDEANDA  #090622",
    "submission": "SUPPL-40",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE",
    "company": "ETHYPHARM",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/20/2024",
    "drugName": "BUPRENORPHINE HYDROCHLORIDEANDA  #090819",
    "submission": "SUPPL-29",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE",
    "company": "ACTAVIS ELIZABETH",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/20/2024",
    "drugName": "BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #091149",
    "submission": "SUPPL-22",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE",
    "company": "TEVA PHARMS USA",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/20/2024",
    "drugName": "BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #091422",
    "submission": "SUPPL-51",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE",
    "company": "ACTAVIS ELIZABETH",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/20/2024",
    "drugName": "BUPRENORPHINE HYDROCHLORIDEANDA  #201066",
    "submission": "SUPPL-21",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/20/2024",
    "drugName": "BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE ANDA  #201633",
    "submission": "SUPPL-29",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE",
    "company": "SUN PHARM",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/20/2024",
    "drugName": "BUPRENORPHINE HYDROCHLORIDEANDA  #201760",
    "submission": "SUPPL-32",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE",
    "company": "SUN PHARM",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/20/2024",
    "drugName": "BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE ANDA  #203136",
    "submission": "SUPPL-43",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/20/2024",
    "drugName": "BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #203326",
    "submission": "SUPPL-29",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE",
    "company": "HIKMA",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/20/2024",
    "drugName": "ZUBSOLVNDA   #204242",
    "submission": "SUPPL-26",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE",
    "company": "OREXO US INC",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/20/2024",
    "drugName": "BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #204431",
    "submission": "SUPPL-31",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE",
    "company": "ETHYPHARM USA CORP",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/20/2024",
    "drugName": "BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #205022",
    "submission": "SUPPL-17",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE",
    "company": "LANNETT CO INC",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/20/2024",
    "drugName": "BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #205299",
    "submission": "SUPPL-15",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE",
    "company": "DR REDDYS LABS SA",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/20/2024",
    "drugName": "BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #205601",
    "submission": "SUPPL-15",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE",
    "company": "RHODES PHARMS",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/20/2024",
    "drugName": "BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #205806",
    "submission": "SUPPL-14",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE",
    "company": "DR REDDYS LABS SA",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/20/2024",
    "drugName": "BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #205954",
    "submission": "SUPPL-26",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE",
    "company": "ALVOGEN",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/20/2024",
    "drugName": "IRINOTECAN HYDROCHLORIDEANDA  #206935",
    "submission": "SUPPL-8",
    "activeIngredients": "IRINOTECAN HYDROCHLORIDE",
    "company": "NOVAST LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/20/2024",
    "drugName": "BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #207000",
    "submission": "SUPPL-29",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE",
    "company": "SPECGX LLC",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/20/2024",
    "drugName": "BUPRENORPHINE HYDROCHLORIDEANDA  #207276",
    "submission": "SUPPL-15",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE",
    "company": "RHODES PHARMS",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/20/2024",
    "drugName": "BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #207607",
    "submission": "SUPPL-17",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE",
    "company": "MYLAN TECHNOLOGIES",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/20/2024",
    "drugName": "CASSIPANDA   #208042",
    "submission": "SUPPL-10",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE",
    "company": "TEVA PHARMS USA",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/20/2024",
    "drugName": "EZALLOR SPRINKLENDA   #208647",
    "submission": "SUPPL-13",
    "activeIngredients": "ROSUVASTATIN CALCIUM",
    "company": "SUN PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/20/2024",
    "drugName": "BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #209069",
    "submission": "SUPPL-10",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE",
    "company": "WES PHARMA INC",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/20/2024",
    "drugName": "BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #211785",
    "submission": "SUPPL-7",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE",
    "company": "MYLAN TECHNOLOGIES",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/20/2024",
    "drugName": "BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #212756",
    "submission": "SUPPL-4",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE",
    "company": "DIFGEN PHARMS",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/20/2024",
    "drugName": "DEFERASIROXANDA  #214180",
    "submission": "SUPPL-5",
    "activeIngredients": "DEFERASIROX",
    "company": "TEVA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/20/2024",
    "drugName": "BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #214930",
    "submission": "SUPPL-8",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/20/2024",
    "drugName": "GANIRELIX ACETATEANDA  #214996",
    "submission": "SUPPL-2",
    "activeIngredients": "GANIRELIX ACETATE",
    "company": "MEITHEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/20/2024",
    "drugName": "GANIRELIX ACETATEANDA  #215658",
    "submission": "SUPPL-1",
    "activeIngredients": "GANIRELIX ACETATE",
    "company": "GLAND",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/20/2024",
    "drugName": "DIPHENHYDRAMINE HYDROCHLORIDEANDA  #218448",
    "submission": "ORIG-1",
    "activeIngredients": "DIPHENHYDRAMINE HYDROCHLORIDE",
    "company": "GLAND",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/20/2024",
    "drugName": "DANYELZABLA   #761171",
    "submission": "SUPPL-8",
    "activeIngredients": "NAXITAMAB-GQGK",
    "company": "Y-MABS THERAPEUTICS INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2024",
    "drugName": "LUPRON DEPOTNDA   #019732",
    "submission": "SUPPL-49",
    "activeIngredients": "LEUPROLIDE ACETATE",
    "company": "ABBVIE ENDOCRINE INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2024",
    "drugName": "LUPRON DEPOTNDA   #020517",
    "submission": "SUPPL-46",
    "activeIngredients": "LEUPROLIDE ACETATE",
    "company": "ABBVIE ENDOCRINE INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2024",
    "drugName": "PLAN BNDA   #021045",
    "submission": "SUPPL-18",
    "activeIngredients": "LEVONORGESTREL",
    "company": "FDN CONSUMER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2024",
    "drugName": "FLUOROURACILANDA  #040278",
    "submission": "SUPPL-27",
    "activeIngredients": "FLUOROURACIL",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2024",
    "drugName": "FLUOROURACILANDA  #040279",
    "submission": "SUPPL-30",
    "activeIngredients": "FLUOROURACIL",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2024",
    "drugName": "FLUOROURACILANDA  #040333",
    "submission": "SUPPL-33",
    "activeIngredients": "FLUOROURACIL",
    "company": "TEVA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2024",
    "drugName": "FLUOROURACILANDA  #040334",
    "submission": "SUPPL-33",
    "activeIngredients": "FLUOROURACIL",
    "company": "TEVA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2024",
    "drugName": "FLUOROURACILANDA  #040743",
    "submission": "SUPPL-16",
    "activeIngredients": "FLUOROURACIL",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2024",
    "drugName": "HYDROXYCHLOROQUINE SULFATEANDA  #040760",
    "submission": "SUPPL-10",
    "activeIngredients": "HYDROXYCHLOROQUINE SULFATE",
    "company": "HIKMA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2024",
    "drugName": "HYDROXYCHLOROQUINE SULFATEANDA  #040760",
    "submission": "SUPPL-11",
    "activeIngredients": "HYDROXYCHLOROQUINE SULFATE",
    "company": "HIKMA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2024",
    "drugName": "FLUOROURACILANDA  #040798",
    "submission": "SUPPL-17",
    "activeIngredients": "FLUOROURACIL",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2024",
    "drugName": "AMIKACIN SULFATEANDA  #063315",
    "submission": "SUPPL-23",
    "activeIngredients": "AMIKACIN SULFATE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2024",
    "drugName": "NYSTATINANDA  #064142",
    "submission": "SUPPL-22",
    "activeIngredients": "NYSTATIN",
    "company": "VISTAPHARM LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2024",
    "drugName": "ESCITALOPRAM OXALATEANDA  #090477",
    "submission": "SUPPL-14",
    "activeIngredients": "ESCITALOPRAM OXALATE",
    "company": "CHARTWELL MOLECULAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2024",
    "drugName": "HYDROCHLOROTHIAZIDEANDA  #200645",
    "submission": "SUPPL-6",
    "activeIngredients": "HYDROCHLOROTHIAZIDE",
    "company": "ALEMBIC PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2024",
    "drugName": "NEVIRAPINEANDA  #202523",
    "submission": "SUPPL-2",
    "activeIngredients": "NEVIRAPINE",
    "company": "MYLAN PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2024",
    "drugName": "NEVIRAPINEANDA  #202523",
    "submission": "SUPPL-5",
    "activeIngredients": "NEVIRAPINE",
    "company": "MYLAN PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2024",
    "drugName": "NEVIRAPINEANDA  #202523",
    "submission": "SUPPL-6",
    "activeIngredients": "NEVIRAPINE",
    "company": "MYLAN PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2024",
    "drugName": "NEVIRAPINEANDA  #202523",
    "submission": "SUPPL-9",
    "activeIngredients": "NEVIRAPINE",
    "company": "MYLAN PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2024",
    "drugName": "FLUOROURACILANDA  #202668",
    "submission": "SUPPL-9",
    "activeIngredients": "FLUOROURACIL",
    "company": "EUGIA PHARMA SPECLTS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2024",
    "drugName": "FLUOROURACILANDA  #202669",
    "submission": "SUPPL-9",
    "activeIngredients": "FLUOROURACIL",
    "company": "EUGIA PHARMA SPECLTS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2024",
    "drugName": "FLUOROURACILANDA  #203608",
    "submission": "SUPPL-3",
    "activeIngredients": "FLUOROURACIL",
    "company": "SAGENT PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2024",
    "drugName": "FLUOROURACILANDA  #203609",
    "submission": "SUPPL-14",
    "activeIngredients": "FLUOROURACIL",
    "company": "SAGENT PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2024",
    "drugName": "PALIPERIDONEANDA  #204707",
    "submission": "SUPPL-9",
    "activeIngredients": "PALIPERIDONE",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2024",
    "drugName": "PALIPERIDONEANDA  #204707",
    "submission": "SUPPL-16",
    "activeIngredients": "PALIPERIDONE",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2024",
    "drugName": "DICLOFENAC SODIUM AND MISOPROSTOLANDA  #205143",
    "submission": "SUPPL-2",
    "activeIngredients": "DICLOFENAC SODIUM; MISOPROSTOL",
    "company": "YUNG SHIN PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2024",
    "drugName": "DICLOFENAC SODIUM AND MISOPROSTOLANDA  #205143",
    "submission": "SUPPL-4",
    "activeIngredients": "DICLOFENAC SODIUM; MISOPROSTOL",
    "company": "YUNG SHIN PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2024",
    "drugName": "DICLOFENAC SODIUM AND MISOPROSTOLANDA  #205143",
    "submission": "SUPPL-6",
    "activeIngredients": "DICLOFENAC SODIUM; MISOPROSTOL",
    "company": "YUNG SHIN PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2024",
    "drugName": "DICLOFENAC SODIUM AND MISOPROSTOLANDA  #205143",
    "submission": "SUPPL-7",
    "activeIngredients": "DICLOFENAC SODIUM; MISOPROSTOL",
    "company": "YUNG SHIN PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2024",
    "drugName": "DEXMEDETOMIDINE HYDROCHLORIDENDA   #206628",
    "submission": "SUPPL-5",
    "activeIngredients": "DEXMEDETOMIDINE HYDROCHLORIDE",
    "company": "HQ SPCLT PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2024",
    "drugName": "ACETAZOLAMIDEANDA  #207659",
    "submission": "SUPPL-6",
    "activeIngredients": "ACETAZOLAMIDE",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2024",
    "drugName": "FLUOROURACILANDA  #209219",
    "submission": "SUPPL-2",
    "activeIngredients": "FLUOROURACIL",
    "company": "NOVAST LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2024",
    "drugName": "FLUOROURACILANDA  #209271",
    "submission": "SUPPL-2",
    "activeIngredients": "FLUOROURACIL",
    "company": "NOVAST LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2024",
    "drugName": "FULVESTRANTANDA  #210044",
    "submission": "SUPPL-1",
    "activeIngredients": "FULVESTRANT",
    "company": "AMNEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2024",
    "drugName": "FULVESTRANTANDA  #210044",
    "submission": "SUPPL-2",
    "activeIngredients": "FULVESTRANT",
    "company": "AMNEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2024",
    "drugName": "FULVESTRANTANDA  #210044",
    "submission": "SUPPL-5",
    "activeIngredients": "FULVESTRANT",
    "company": "AMNEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2024",
    "drugName": "FULVESTRANTANDA  #210044",
    "submission": "SUPPL-11",
    "activeIngredients": "FULVESTRANT",
    "company": "AMNEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2024",
    "drugName": "FULVESTRANTANDA  #210044",
    "submission": "SUPPL-13",
    "activeIngredients": "FULVESTRANT",
    "company": "AMNEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2024",
    "drugName": "FULVESTRANTANDA  #210044",
    "submission": "SUPPL-18",
    "activeIngredients": "FULVESTRANT",
    "company": "AMNEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2024",
    "drugName": "FLUOROURACILANDA  #210123",
    "submission": "SUPPL-8",
    "activeIngredients": "FLUOROURACIL",
    "company": "GLAND",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2024",
    "drugName": "FLUOROURACILANDA  #210124",
    "submission": "SUPPL-9",
    "activeIngredients": "FLUOROURACIL",
    "company": "GLAND",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2024",
    "drugName": "DESMOPRESSIN ACETATEANDA  #213095",
    "submission": "ORIG-1",
    "activeIngredients": "DESMOPRESSIN ACETATE",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2024",
    "drugName": "TENOFOVIR ALAFENAMIDE FUMARATEANDA  #213867",
    "submission": "ORIG-1",
    "activeIngredients": "TENOFOVIR ALAFENAMIDE FUMARATE",
    "company": "APOTEX",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2024",
    "drugName": "ZOKINVYNDA   #213969",
    "submission": "SUPPL-2",
    "activeIngredients": "LONAFARNIB",
    "company": "SENTYNL THERAPS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2024",
    "drugName": "ZOKINVYNDA   #213969",
    "submission": "SUPPL-3",
    "activeIngredients": "LONAFARNIB",
    "company": "SENTYNL THERAPS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2024",
    "drugName": "SUCRALFATEANDA  #216726",
    "submission": "ORIG-1",
    "activeIngredients": "SUCRALFATE",
    "company": "ABON PHARMS LLC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2024",
    "drugName": "FLUOROURACILANDA  #217295",
    "submission": "SUPPL-2",
    "activeIngredients": "FLUOROURACIL",
    "company": "ALEMBIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2024",
    "drugName": "FLUOROURACILANDA  #217676",
    "submission": "SUPPL-2",
    "activeIngredients": "FLUOROURACIL",
    "company": "ALEMBIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2024",
    "drugName": "DUVYZATNDA   #217865",
    "submission": "ORIG-1",
    "activeIngredients": "GIVINOSTAT HYDROCHLORIDE",
    "company": "ITALFARMACO SPA",
    "submissionClassification": "Type 1 - New Molecular Entity",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/22/2024",
    "drugName": "BRILINTANDA   #022433",
    "submission": "SUPPL-35",
    "activeIngredients": "TICAGRELOR",
    "company": "ASTRAZENECA",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/22/2024",
    "drugName": "MEPERIDINE HYDROCHLORIDEANDA  #040331",
    "submission": "SUPPL-20",
    "activeIngredients": "MEPERIDINE HYDROCHLORIDE",
    "company": "EPIC PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/22/2024",
    "drugName": "CEFTRIAXONE IN PLASTIC CONTAINERANDA  #065224",
    "submission": "SUPPL-14",
    "activeIngredients": "CEFTRIAXONE SODIUM",
    "company": "BAXTER HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/22/2024",
    "drugName": "TRAMADOL HYDROCHLORIDEANDA  #075977",
    "submission": "SUPPL-29",
    "activeIngredients": "TRAMADOL HYDROCHLORIDE",
    "company": "TEVA",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/22/2024",
    "drugName": "SOLIRISBLA   #125166",
    "submission": "SUPPL-443",
    "activeIngredients": "ECULIZUMAB",
    "company": "ALEXION PHARM",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/22/2024",
    "drugName": "LUMIZYMEBLA   #125291",
    "submission": "SUPPL-160",
    "activeIngredients": "ALGLUCOSIDASE ALFA",
    "company": "GENZYME",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/22/2024",
    "drugName": "IBUPROFEN AND FAMOTIDINEANDA  #203658",
    "submission": "ORIG-1",
    "activeIngredients": "FAMOTIDINE; IBUPROFEN",
    "company": "PH HEALTH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/22/2024",
    "drugName": "DEFERASIROXANDA  #211395",
    "submission": "ORIG-1",
    "activeIngredients": "DEFERASIROX",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/22/2024",
    "drugName": "NEXLETOLNDA   #211616",
    "submission": "SUPPL-12",
    "activeIngredients": "BEMPEDOIC ACID",
    "company": "ESPERION THERAPS INC",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/22/2024",
    "drugName": "NEXLETOLNDA   #211616",
    "submission": "SUPPL-13",
    "activeIngredients": "BEMPEDOIC ACID",
    "company": "ESPERION THERAPS INC",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/22/2024",
    "drugName": "NEXLIZETNDA   #211617",
    "submission": "SUPPL-16",
    "activeIngredients": "BEMPEDOIC ACID; EZETIMIBE",
    "company": "ESPERION THERAPS INC",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/22/2024",
    "drugName": "NEXLIZETNDA   #211617",
    "submission": "SUPPL-17",
    "activeIngredients": "BEMPEDOIC ACID; EZETIMIBE",
    "company": "ESPERION THERAPS INC",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/22/2024",
    "drugName": "VUMERITYNDA   #211855",
    "submission": "SUPPL-15",
    "activeIngredients": "DIROXIMEL FUMARATE",
    "company": "BIOGEN INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/22/2024",
    "drugName": "EFAVIRENZ, EMTRICITABINE AND TENOFOVIR ALAFENAMIDENDA   #213509",
    "submission": "ORIG-1",
    "activeIngredients": "EFAVIRENZ, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE",
    "company": "MYLAN",
    "submissionClassification": "Type 4 - New Combination",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "03/22/2024",
    "drugName": "GAVRETONDA   #213721",
    "submission": "SUPPL-15",
    "activeIngredients": "PRALSETINIB",
    "company": "RIGEL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/22/2024",
    "drugName": "LIVTENCITYNDA   #215596",
    "submission": "SUPPL-5",
    "activeIngredients": "MARIBAVIR",
    "company": "TAKEDA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/22/2024",
    "drugName": "CIPROFLOXACIN AND DEXAMETHASONEANDA  #216501",
    "submission": "ORIG-1",
    "activeIngredients": "CIPROFLOXACIN; DEXAMETHASONE",
    "company": "AMNEAL",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/22/2024",
    "drugName": "LETERMOVIRANDA  #216799",
    "submission": "ORIG-1",
    "activeIngredients": "LETERMOVIR",
    "company": "ZYDUS PHARMS USA INC",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "03/22/2024",
    "drugName": "OPSYNVINDA   #218490",
    "submission": "ORIG-1",
    "activeIngredients": "MACITENTAN; TADALAFIL",
    "company": "ACTELION",
    "submissionClassification": "Type 4 - New Combination",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/22/2024",
    "drugName": "ULTOMIRISBLA   #761108",
    "submission": "SUPPL-26",
    "activeIngredients": "RAVULIZUMAB-CWVZ",
    "company": "ALEXION PHARM",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/22/2024",
    "drugName": "ULTOMIRISBLA   #761108",
    "submission": "SUPPL-31",
    "activeIngredients": "RAVULIZUMAB-CWVZ",
    "company": "ALEXION PHARM",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/22/2024",
    "drugName": "ELAHEREBLA   #761310",
    "submission": "SUPPL-5",
    "activeIngredients": "MIRVETUXIMAB SORAVTANSINE-GYNX",
    "company": "IMMUNOGEN INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/25/2024",
    "drugName": "FOSFOMYCIN TROMETHAMINEANDA  #216600",
    "submission": "ORIG-1",
    "activeIngredients": "FOSFOMYCIN TROMETHAMINE",
    "company": "AMNEAL",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/25/2024",
    "drugName": "LACOSAMIDEANDA  #217718",
    "submission": "ORIG-1",
    "activeIngredients": "LACOSAMIDE",
    "company": "DR REDDYS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/26/2024",
    "drugName": "PRAMIPEXOLE DIHYDROCHLORIDEANDA  #077724",
    "submission": "SUPPL-10",
    "activeIngredients": "PRAMIPEXOLE DIHYDROCHLORIDE",
    "company": "HERITAGE PHARMA AVET",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/26/2024",
    "drugName": "PRAMIPEXOLE DIHYDROCHLORIDEANDA  #077724",
    "submission": "SUPPL-11",
    "activeIngredients": "PRAMIPEXOLE DIHYDROCHLORIDE",
    "company": "HERITAGE PHARMA AVET",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/26/2024",
    "drugName": "PRAMIPEXOLE DIHYDROCHLORIDEANDA  #077724",
    "submission": "SUPPL-12",
    "activeIngredients": "PRAMIPEXOLE DIHYDROCHLORIDE",
    "company": "HERITAGE PHARMA AVET",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/26/2024",
    "drugName": "PRAMIPEXOLE DIHYDROCHLORIDEANDA  #077724",
    "submission": "SUPPL-13",
    "activeIngredients": "PRAMIPEXOLE DIHYDROCHLORIDE",
    "company": "HERITAGE PHARMA AVET",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/26/2024",
    "drugName": "ATAZANAVIR SULFATEANDA  #209717",
    "submission": "SUPPL-3",
    "activeIngredients": "ATAZANAVIR SULFATE",
    "company": "AMNEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/26/2024",
    "drugName": "COLCHICINEANDA  #215762",
    "submission": "ORIG-1",
    "activeIngredients": "COLCHICINE",
    "company": "ANNORA PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "03/26/2024",
    "drugName": "KETOROLAC TROMETHAMINEANDA  #218204",
    "submission": "ORIG-1",
    "activeIngredients": "KETOROLAC TROMETHAMINE",
    "company": "CAPLIN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/26/2024",
    "drugName": "FABHALTANDA   #218276",
    "submission": "SUPPL-2",
    "activeIngredients": "IPTACOPAN HYDROCHLORIDE",
    "company": "NOVARTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/26/2024",
    "drugName": "ACETAMINOPHEN AND IBUPROFENANDA  #218359",
    "submission": "ORIG-1",
    "activeIngredients": "ACETAMINOPHEN; IBUPROFEN",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/26/2024",
    "drugName": "WINREVAIRBLA   #761363",
    "submission": "ORIG-1",
    "activeIngredients": "SOTATERCEPT-CSRK",
    "company": "MERCK SHARP DOHME",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/27/2024",
    "drugName": "OXYCODONE HYDROCHLORIDE AND IBUPROFENANDA  #078769",
    "submission": "SUPPL-34",
    "activeIngredients": "IBUPROFEN; OXYCODONE HYDROCHLORIDE",
    "company": "ACTAVIS ELIZABETH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/27/2024",
    "drugName": "OXYCODONE HYDROCHLORIDE AND IBUPROFENANDA  #078769",
    "submission": "SUPPL-35",
    "activeIngredients": "IBUPROFEN; OXYCODONE HYDROCHLORIDE",
    "company": "ACTAVIS ELIZABETH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/27/2024",
    "drugName": "BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDEANDA  #078794",
    "submission": "SUPPL-5",
    "activeIngredients": "BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/27/2024",
    "drugName": "NICOTINE POLACRILEXANDA  #078967",
    "submission": "SUPPL-11",
    "activeIngredients": "NICOTINE POLACRILEX",
    "company": "PERRIGO R AND D",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/27/2024",
    "drugName": "NICOTINE POLACRILEXANDA  #078967",
    "submission": "SUPPL-14",
    "activeIngredients": "NICOTINE POLACRILEX",
    "company": "PERRIGO R AND D",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/27/2024",
    "drugName": "PRAMIPEXOLE DIHYDROCHLORIDEANDA  #090241",
    "submission": "SUPPL-5",
    "activeIngredients": "PRAMIPEXOLE DIHYDROCHLORIDE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/27/2024",
    "drugName": "LACOSAMIDEANDA  #204839",
    "submission": "ORIG-1",
    "activeIngredients": "LACOSAMIDE",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/27/2024",
    "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #207834",
    "submission": "SUPPL-3",
    "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
    "company": "CHARTWELL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/27/2024",
    "drugName": "VEMLIDYNDA   #208464",
    "submission": "SUPPL-16",
    "activeIngredients": "TENOFOVIR ALAFENAMIDE FUMARATE",
    "company": "GILEAD SCIENCES INC",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/27/2024",
    "drugName": "VEMLIDYNDA   #208464",
    "submission": "SUPPL-17",
    "activeIngredients": "TENOFOVIR ALAFENAMIDE FUMARATE",
    "company": "GILEAD SCIENCES INC",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/27/2024",
    "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #210644",
    "submission": "SUPPL-14",
    "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
    "company": "ABHAI LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/27/2024",
    "drugName": "ESLICARBAZEPINE ACETATEANDA  #211246",
    "submission": "ORIG-1",
    "activeIngredients": "ESLICARBAZEPINE ACETATE",
    "company": "LUPIN LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/27/2024",
    "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #211499",
    "submission": "SUPPL-9",
    "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
    "company": "ABHAI LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/27/2024",
    "drugName": "CISATRACURIUM BESYLATEANDA  #212432",
    "submission": "SUPPL-5",
    "activeIngredients": "CISATRACURIUM BESYLATE",
    "company": "PIRAMAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/27/2024",
    "drugName": "VAFSEONDA   #215192",
    "submission": "ORIG-1",
    "activeIngredients": "VADADUSTAT",
    "company": "AKEBIA",
    "submissionClassification": "Type 1 - New Molecular Entity",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/27/2024",
    "drugName": "ZOLEDRONIC ACIDANDA  #216534",
    "submission": "ORIG-1",
    "activeIngredients": "ZOLEDRONIC ACID",
    "company": "SHANDONG NEW TIME PHARMACEUTICAL CO LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "03/27/2024",
    "drugName": "ACETAMINOPHEN AND IBUPROFENANDA  #216592",
    "submission": "SUPPL-2",
    "activeIngredients": "ACETAMINOPHEN; IBUPROFEN",
    "company": "GRANULES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/27/2024",
    "drugName": "DEXAMETHASONE SODIUM PHOSPHATEANDA  #217797",
    "submission": "ORIG-1",
    "activeIngredients": "DEXAMETHASONE SODIUM PHOSPHATE",
    "company": "MICRO LABS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/27/2024",
    "drugName": "BUPIVACAINE HYDROCHLORIDEANDA  #217821",
    "submission": "ORIG-1",
    "activeIngredients": "BUPIVACAINE HYDROCHLORIDE",
    "company": "ASPIRO",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/28/2024",
    "drugName": "ZYRTEC ALLERGYNDA   #019835",
    "submission": "SUPPL-47",
    "activeIngredients": "CETIRIZINE HYDROCHLORIDE",
    "company": "KENVUE BRANDS",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/28/2024",
    "drugName": "ZYRTEC HIVESNDA   #019835",
    "submission": "SUPPL-47",
    "activeIngredients": "CETIRIZINE HYDROCHLORIDE",
    "company": "KENVUE BRANDS",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/28/2024",
    "drugName": "VYTORINNDA   #021687",
    "submission": "SUPPL-66",
    "activeIngredients": "EZETIMIBE; SIMVASTATIN",
    "company": "ORGANON",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/28/2024",
    "drugName": "HYDROCORTISONEANDA  #040761",
    "submission": "SUPPL-10",
    "activeIngredients": "HYDROCORTISONE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/28/2024",
    "drugName": "HYDROCORTISONEANDA  #040761",
    "submission": "SUPPL-15",
    "activeIngredients": "HYDROCORTISONE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/28/2024",
    "drugName": "ACYCLOVIR SODIUMANDA  #074930",
    "submission": "SUPPL-12",
    "activeIngredients": "ACYCLOVIR SODIUM",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/28/2024",
    "drugName": "ALFENTANILANDA  #075221",
    "submission": "SUPPL-22",
    "activeIngredients": "ALFENTANIL HYDROCHLORIDE",
    "company": "HOSPIRA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/28/2024",
    "drugName": "SERTRALINE HYDROCHLORIDEANDA  #076465",
    "submission": "SUPPL-20",
    "activeIngredients": "SERTRALINE HYDROCHLORIDE",
    "company": "HERITAGE PHARMA AVET",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/28/2024",
    "drugName": "SERTRALINE HYDROCHLORIDEANDA  #076465",
    "submission": "SUPPL-23",
    "activeIngredients": "SERTRALINE HYDROCHLORIDE",
    "company": "HERITAGE PHARMA AVET",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/28/2024",
    "drugName": "ATENOLOLANDA  #076900",
    "submission": "SUPPL-31",
    "activeIngredients": "ATENOLOL",
    "company": "ZYDUS PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/28/2024",
    "drugName": "SERTRALINE HYDROCHLORIDEANDA  #077397",
    "submission": "SUPPL-36",
    "activeIngredients": "SERTRALINE HYDROCHLORIDE",
    "company": "INVAGEN PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/28/2024",
    "drugName": "ATENOLOLANDA  #077877",
    "submission": "SUPPL-18",
    "activeIngredients": "ATENOLOL",
    "company": "IPCA LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/28/2024",
    "drugName": "ABACAVIR SULFATEANDA  #077950",
    "submission": "SUPPL-11",
    "activeIngredients": "ABACAVIR SULFATE",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/28/2024",
    "drugName": "ABACAVIR SULFATEANDA  #078119",
    "submission": "SUPPL-29",
    "activeIngredients": "ABACAVIR SULFATE",
    "company": "CIPLA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/28/2024",
    "drugName": "CITALOPRAM HYDROBROMIDEANDA  #078216",
    "submission": "SUPPL-37",
    "activeIngredients": "CITALOPRAM HYDROBROMIDE",
    "company": "TORRENT PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/28/2024",
    "drugName": "NORETHINDRONEANDA  #200961",
    "submission": "SUPPL-5",
    "activeIngredients": "NORETHINDRONE",
    "company": "NOVAST LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/28/2024",
    "drugName": "METHYLPHENIDATE HYDROCHLORIDEANDA  #204115",
    "submission": "SUPPL-8",
    "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "company": "NOVEL LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/28/2024",
    "drugName": "QUDEXY XRNDA   #205122",
    "submission": "SUPPL-16",
    "activeIngredients": "TOPIRAMATE",
    "company": "UPSHER SMITH LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/28/2024",
    "drugName": "DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATEANDA  #205401",
    "submission": "SUPPL-8",
    "activeIngredients": "AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE",
    "company": "ANI PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/28/2024",
    "drugName": "AUROVELA FE 1/20ANDA  #207505",
    "submission": "SUPPL-1",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/28/2024",
    "drugName": "AUROVELA FE 1/20ANDA  #207505",
    "submission": "SUPPL-8",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/28/2024",
    "drugName": "AUROVELA FE 1/20ANDA  #207505",
    "submission": "SUPPL-10",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/28/2024",
    "drugName": "AUROVELA 1/20ANDA  #207506",
    "submission": "SUPPL-1",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/28/2024",
    "drugName": "AUROVELA 1/20ANDA  #207506",
    "submission": "SUPPL-6",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/28/2024",
    "drugName": "AUROVELA 1/20ANDA  #207506",
    "submission": "SUPPL-8",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/28/2024",
    "drugName": "IMATINIB MESYLATEANDA  #207586",
    "submission": "SUPPL-3",
    "activeIngredients": "IMATINIB MESYLATE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/28/2024",
    "drugName": "IMATINIB MESYLATEANDA  #207586",
    "submission": "SUPPL-4",
    "activeIngredients": "IMATINIB MESYLATE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/28/2024",
    "drugName": "IMATINIB MESYLATEANDA  #207586",
    "submission": "SUPPL-5",
    "activeIngredients": "IMATINIB MESYLATE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/28/2024",
    "drugName": "PIPERACILLIN AND TAZOBACTAMANDA  #208675",
    "submission": "SUPPL-3",
    "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
    "company": "SAGENT PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/28/2024",
    "drugName": "PIPERACILLIN AND TAZOBACTAMANDA  #208675",
    "submission": "SUPPL-4",
    "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
    "company": "SAGENT PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/28/2024",
    "drugName": "MESALAMINEANDA  #208953",
    "submission": "SUPPL-7",
    "activeIngredients": "MESALAMINE",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/28/2024",
    "drugName": "ATENOLOLANDA  #213136",
    "submission": "SUPPL-12",
    "activeIngredients": "ATENOLOL",
    "company": "UNICHEM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/28/2024",
    "drugName": "DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATEANDA  #215997",
    "submission": "SUPPL-2",
    "activeIngredients": "AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE",
    "company": "SUN PHARM INDS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/28/2024",
    "drugName": "MIGALASTATANDA  #217793",
    "submission": "ORIG-1",
    "activeIngredients": "MIGALASTAT HYDROCHLORIDE",
    "company": "LUPIN LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "03/28/2024",
    "drugName": "ZEPBOUNDNDA   #217806",
    "submission": "SUPPL-3",
    "activeIngredients": "TIRZEPATIDE",
    "company": "ELI LILLY AND CO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/28/2024",
    "drugName": "ZEPBOUND (AUTOINJECTOR)NDA   #217806",
    "submission": "SUPPL-3",
    "activeIngredients": "TIRZEPATIDE",
    "company": "ELI LILLY AND CO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/29/2024",
    "drugName": "CYCLOPHOSPHAMIDEANDA  #040745",
    "submission": "SUPPL-4",
    "activeIngredients": "CYCLOPHOSPHAMIDE",
    "company": "BAXTER HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/29/2024",
    "drugName": "AMPICILLIN SODIUMANDA  #062719",
    "submission": "SUPPL-12",
    "activeIngredients": "AMPICILLIN SODIUM",
    "company": "ISTITUTO BIO ITA SPA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/29/2024",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #075310",
    "submission": "SUPPL-24",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "HERITAGE PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/29/2024",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #075310",
    "submission": "SUPPL-25",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "HERITAGE PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/29/2024",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #075310",
    "submission": "SUPPL-26",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "HERITAGE PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/29/2024",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #075310",
    "submission": "SUPPL-27",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "HERITAGE PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/29/2024",
    "drugName": "METFORMIN HYDROCHLORIDEANDA  #077095",
    "submission": "SUPPL-32",
    "activeIngredients": "METFORMIN HYDROCHLORIDE",
    "company": "AUROBINDO",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/29/2024",
    "drugName": "ATENOLOLANDA  #078512",
    "submission": "SUPPL-18",
    "activeIngredients": "ATENOLOL",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/29/2024",
    "drugName": "TAFINLARNDA   #202806",
    "submission": "SUPPL-30",
    "activeIngredients": "DABRAFENIB MESYLATE",
    "company": "NOVARTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/29/2024",
    "drugName": "MEKINISTNDA   #204114",
    "submission": "SUPPL-32",
    "activeIngredients": "TRAMETINIB DIMETHYL SULFOXIDE",
    "company": "NOVARTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/29/2024",
    "drugName": "EZETIMIBEANDA  #204331",
    "submission": "SUPPL-7",
    "activeIngredients": "EZETIMIBE",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/29/2024",
    "drugName": "DICLOFENAC SODIUM AND MISOPROSTOLANDA  #204355",
    "submission": "SUPPL-1",
    "activeIngredients": "DICLOFENAC SODIUM; MISOPROSTOL",
    "company": "MICRO LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/29/2024",
    "drugName": "DICLOFENAC SODIUM AND MISOPROSTOLANDA  #204355",
    "submission": "SUPPL-2",
    "activeIngredients": "DICLOFENAC SODIUM; MISOPROSTOL",
    "company": "MICRO LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/29/2024",
    "drugName": "DICLOFENAC SODIUM AND MISOPROSTOLANDA  #204355",
    "submission": "SUPPL-3",
    "activeIngredients": "DICLOFENAC SODIUM; MISOPROSTOL",
    "company": "MICRO LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/29/2024",
    "drugName": "TRAVOPROSTANDA  #205050",
    "submission": "SUPPL-3",
    "activeIngredients": "TRAVOPROST",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/29/2024",
    "drugName": "TRAVOPROSTANDA  #205050",
    "submission": "SUPPL-4",
    "activeIngredients": "TRAVOPROST",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/29/2024",
    "drugName": "KETOROLAC TROMETHAMINEANDA  #205191",
    "submission": "SUPPL-2",
    "activeIngredients": "KETOROLAC TROMETHAMINE",
    "company": "EUGIA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/29/2024",
    "drugName": "AZACITIDINEANDA  #207475",
    "submission": "SUPPL-7",
    "activeIngredients": "AZACITIDINE",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/29/2024",
    "drugName": "AZACITIDINEANDA  #207475",
    "submission": "SUPPL-9",
    "activeIngredients": "AZACITIDINE",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/29/2024",
    "drugName": "AZACITIDINEANDA  #207475",
    "submission": "SUPPL-10",
    "activeIngredients": "AZACITIDINE",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/29/2024",
    "drugName": "RISVANNDA   #214835",
    "submission": "ORIG-1",
    "activeIngredients": "RISPERIDONE",
    "company": "LABS FARMS ROVI SA",
    "submissionClassification": "Type 3 - New Dosage Form",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/29/2024",
    "drugName": "MEKINISTNDA   #217513",
    "submission": "SUPPL-3",
    "activeIngredients": "TRAMETINIB",
    "company": "NOVARTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/29/2024",
    "drugName": "MEKINISTNDA   #217513",
    "submission": "SUPPL-3",
    "activeIngredients": "TRAMETINIB DIMETHYL SULFOXIDE",
    "company": "NOVARTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/29/2024",
    "drugName": "TAFINLARNDA   #217514",
    "submission": "SUPPL-3",
    "activeIngredients": "DABRAFENIB MESYLATE",
    "company": "NOVARTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/29/2024",
    "drugName": "VOYDEYANDA   #218037",
    "submission": "ORIG-1",
    "activeIngredients": "DANICOPAN",
    "company": "ALEXION PHARMS INC",
    "submissionClassification": "Type 1 - New Molecular Entity",
    "submissionStatus": "Approval"
  }
,
  {
    "approvalDate": "04/01/2024",
    "drugName": "METHYLPHENIDATE HYDROCHLORIDEANDA  #078458",
    "submission": "SUPPL-20",
    "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "company": "DR REDDYS LABS SA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/01/2024",
    "drugName": "METHYLPHENIDATE HYDROCHLORIDEANDA  #200886",
    "submission": "SUPPL-6",
    "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "company": "DR REDDYS LABS SA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/01/2024",
    "drugName": "IBUTILIDE FUMARATEANDA  #204146",
    "submission": "ORIG-1",
    "activeIngredients": "IBUTILIDE FUMARATE",
    "company": "AVET LIFESCIENCES",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/01/2024",
    "drugName": "METHYLPHENIDATE HYDROCHLORIDEANDA  #204659",
    "submission": "SUPPL-1",
    "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/01/2024",
    "drugName": "DEXTROAMPHETAMINE SULFATEANDA  #205077",
    "submission": "SUPPL-1",
    "activeIngredients": "DEXTROAMPHETAMINE SULFATE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/01/2024",
    "drugName": "DEXTROAMPHETAMINE SULFATEANDA  #205077",
    "submission": "SUPPL-2",
    "activeIngredients": "DEXTROAMPHETAMINE SULFATE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/01/2024",
    "drugName": "DEXMETHYLPHENIDATE HYDROCHLORIDEANDA  #206734",
    "submission": "SUPPL-5",
    "activeIngredients": "DEXMETHYLPHENIDATE HYDROCHLORIDE",
    "company": "SUN PHARM INDS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/01/2024",
    "drugName": "METHYLPHENIDATE HYDROCHLORIDEANDA  #207884",
    "submission": "SUPPL-5",
    "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "company": "NOVEL LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/01/2024",
    "drugName": "METHYLPHENIDATE HYDROCHLORIDEANDA  #208737",
    "submission": "SUPPL-2",
    "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "company": "CEDIPROF INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/01/2024",
    "drugName": "DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATEANDA  #211715",
    "submission": "SUPPL-2",
    "activeIngredients": "AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE",
    "company": "SUN PHARM INDUSTRIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/01/2024",
    "drugName": "DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATEANDA  #211715",
    "submission": "SUPPL-5",
    "activeIngredients": "AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE",
    "company": "SUN PHARM INDUSTRIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/01/2024",
    "drugName": "DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATEANDA  #211715",
    "submission": "SUPPL-11",
    "activeIngredients": "AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE",
    "company": "SUN PHARM INDUSTRIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/01/2024",
    "drugName": "DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATEANDA  #212037",
    "submission": "SUPPL-7",
    "activeIngredients": "AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE",
    "company": "ELITE LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/01/2024",
    "drugName": "TRANEXAMIC ACIDANDA  #212676",
    "submission": "SUPPL-2",
    "activeIngredients": "TRANEXAMIC ACID",
    "company": "MILLA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/01/2024",
    "drugName": "MESALAMINEANDA  #214585",
    "submission": "SUPPL-4",
    "activeIngredients": "MESALAMINE",
    "company": "SUN PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/02/2024",
    "drugName": "DANTRIUMNDA   #018264",
    "submission": "SUPPL-42",
    "activeIngredients": "DANTROLENE SODIUM",
    "company": "ENDO OPERATIONS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/02/2024",
    "drugName": "BIO-TROPINBLA   #019774",
    "submission": "SUPPL-63",
    "activeIngredients": "SOMATROPIN",
    "company": "FERRING",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/02/2024",
    "drugName": "ZOMACTONBLA   #019774",
    "submission": "SUPPL-63",
    "activeIngredients": "SOMATROPIN",
    "company": "FERRING",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/02/2024",
    "drugName": "LIPITORNDA   #020702",
    "submission": "SUPPL-81",
    "activeIngredients": "ATORVASTATIN CALCIUM",
    "company": "UPJOHN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/02/2024",
    "drugName": "FANAPTNDA   #022192",
    "submission": "SUPPL-23",
    "activeIngredients": "ILOPERIDONE",
    "company": "VANDA PHARMS INC",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/02/2024",
    "drugName": "CANDESARTAN CILEXETILANDA  #091390",
    "submission": "SUPPL-1",
    "activeIngredients": "CANDESARTAN CILEXETIL",
    "company": "ZYDUS LIFESCIENCES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/02/2024",
    "drugName": "NORETHINDRONE ACETATE AND ETHINYL ESTRADIOLANDA  #202771",
    "submission": "SUPPL-7",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "XIROMED",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/02/2024",
    "drugName": "NORETHINDRONE ACETATE AND ETHINYL ESTRADIOLANDA  #202771",
    "submission": "SUPPL-9",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "XIROMED",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/02/2024",
    "drugName": "RIFAMPINANDA  #204101",
    "submission": "SUPPL-11",
    "activeIngredients": "RIFAMPIN",
    "company": "AVET LIFESCIENCES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/02/2024",
    "drugName": "RIFAMPINANDA  #204101",
    "submission": "SUPPL-12",
    "activeIngredients": "RIFAMPIN",
    "company": "AVET LIFESCIENCES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/02/2024",
    "drugName": "RYANODEXNDA   #205579",
    "submission": "SUPPL-11",
    "activeIngredients": "DANTROLENE SODIUM",
    "company": "EAGLE PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/02/2024",
    "drugName": "ATOVAQUONEANDA  #210692",
    "submission": "SUPPL-3",
    "activeIngredients": "ATOVAQUONE",
    "company": "HETERO LABS LTD III",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/02/2024",
    "drugName": "VORTIOXETINE HYDROBROMIDEANDA  #211146",
    "submission": "ORIG-1",
    "activeIngredients": "VORTIOXETINE HYDROBROMIDE",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "04/02/2024",
    "drugName": "FINTEPLANDA   #212102",
    "submission": "SUPPL-14",
    "activeIngredients": "FENFLURAMINE HYDROCHLORIDE",
    "company": "UCB INC",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/02/2024",
    "drugName": "CLINDAMYCIN PHOSPHATEANDA  #212466",
    "submission": "ORIG-1",
    "activeIngredients": "CLINDAMYCIN PHOSPHATE",
    "company": "ALEMBIC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/02/2024",
    "drugName": "NALOXONE HYDROCHLORIDEANDA  #213573",
    "submission": "ORIG-1",
    "activeIngredients": "NALOXONE HYDROCHLORIDE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/02/2024",
    "drugName": "ARFORMOTEROL TARTRATEANDA  #214901",
    "submission": "ORIG-1",
    "activeIngredients": "ARFORMOTEROL TARTRATE",
    "company": "AIPING PHARM INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/02/2024",
    "drugName": "FUROSEMIDEANDA  #215856",
    "submission": "ORIG-1",
    "activeIngredients": "FUROSEMIDE",
    "company": "SABA ILAC SANAYIVE",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/02/2024",
    "drugName": "BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDEANDA  #215995",
    "submission": "SUPPL-4",
    "activeIngredients": "BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/02/2024",
    "drugName": "LACOSAMIDEANDA  #218014",
    "submission": "ORIG-1",
    "activeIngredients": "LACOSAMIDE",
    "company": "KANCHAN HLTHCARE",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/03/2024",
    "drugName": "ALLOPURINOLNDA   #018832",
    "submission": "SUPPL-56",
    "activeIngredients": "ALLOPURINOL",
    "company": "WATSON LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/03/2024",
    "drugName": "ALLOPURINOLNDA   #018832",
    "submission": "SUPPL-58",
    "activeIngredients": "ALLOPURINOL",
    "company": "WATSON LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/03/2024",
    "drugName": "ALLOPURINOLNDA   #018832",
    "submission": "SUPPL-61",
    "activeIngredients": "ALLOPURINOL",
    "company": "WATSON LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/03/2024",
    "drugName": "ALLOPURINOLNDA   #018877",
    "submission": "SUPPL-63",
    "activeIngredients": "ALLOPURINOL",
    "company": "WATSON LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/03/2024",
    "drugName": "ALLOPURINOLNDA   #018877",
    "submission": "SUPPL-65",
    "activeIngredients": "ALLOPURINOL",
    "company": "WATSON LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/03/2024",
    "drugName": "ALLOPURINOLNDA   #018877",
    "submission": "SUPPL-68",
    "activeIngredients": "ALLOPURINOL",
    "company": "WATSON LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/03/2024",
    "drugName": "APTIVUSNDA   #021814",
    "submission": "SUPPL-30",
    "activeIngredients": "TIPRANAVIR",
    "company": "BOEHRINGER INGELHEIM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/03/2024",
    "drugName": "PERCOCETANDA  #040330",
    "submission": "SUPPL-61",
    "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
    "company": "ENDO OPERATIONS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/03/2024",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #079094",
    "submission": "SUPPL-30",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "ACTAVIS LABS FL INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/03/2024",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #079094",
    "submission": "SUPPL-33",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "ACTAVIS LABS FL INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/03/2024",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #079094",
    "submission": "SUPPL-35",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "ACTAVIS LABS FL INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/03/2024",
    "drugName": "PERCOCETANDA  #085106",
    "submission": "SUPPL-32",
    "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
    "company": "ENDO OPERATIONS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/03/2024",
    "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #090734",
    "submission": "SUPPL-30",
    "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/03/2024",
    "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #201278",
    "submission": "SUPPL-20",
    "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
    "company": "RHODES PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/03/2024",
    "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #201972",
    "submission": "SUPPL-18",
    "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
    "company": "AUROLIFE PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/03/2024",
    "drugName": "MYTESINDA   #202292",
    "submission": "SUPPL-9",
    "activeIngredients": "CROFELEMER",
    "company": "NAPO PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/03/2024",
    "drugName": "PIPERACILLIN AND TAZOBACTAMANDA  #203557",
    "submission": "SUPPL-27",
    "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/03/2024",
    "drugName": "PIPERACILLIN AND TAZOBACTAMANDA  #203557",
    "submission": "SUPPL-28",
    "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/03/2024",
    "drugName": "LENVIMANDA   #206947",
    "submission": "SUPPL-30",
    "activeIngredients": "LENVATINIB MESYLATE",
    "company": "EISAI INC",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/03/2024",
    "drugName": "CARBOPROST TROMETHAMINEANDA  #218013",
    "submission": "ORIG-1",
    "activeIngredients": "CARBOPROST TROMETHAMINE",
    "company": "MICRO LABS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/03/2024",
    "drugName": "ZEVTERANDA   #218275",
    "submission": "ORIG-1",
    "activeIngredients": "CEFTOBIPROLE MEDOCARIL SODIUM",
    "company": "ISTX",
    "submissionClassification": "Type 1 - New Molecular Entity",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/03/2024",
    "drugName": "VORICONAZOLEANDA  #218533",
    "submission": "ORIG-1",
    "activeIngredients": "VORICONAZOLE",
    "company": "ASPIRO",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/03/2024",
    "drugName": "ILUMYABLA   #761067",
    "submission": "SUPPL-18",
    "activeIngredients": "TILDRAKIZUMAB-ASMN",
    "company": "SUN PHARMA GLOBAL",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/04/2024",
    "drugName": "CAMPTOSARNDA   #020571",
    "submission": "SUPPL-56",
    "activeIngredients": "IRINOTECAN HYDROCHLORIDE",
    "company": "PFIZER INC",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/04/2024",
    "drugName": "DOXYLAMINE SUCCINATEANDA  #040167",
    "submission": "SUPPL-52",
    "activeIngredients": "DOXYLAMINE SUCCINATE",
    "company": "PERRIGO",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/04/2024",
    "drugName": "AMOXICILLINANDA  #065271",
    "submission": "SUPPL-15",
    "activeIngredients": "AMOXICILLIN",
    "company": "AUROBINDO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/04/2024",
    "drugName": "AMOXICILLINANDA  #065271",
    "submission": "SUPPL-16",
    "activeIngredients": "AMOXICILLIN",
    "company": "AUROBINDO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/04/2024",
    "drugName": "AMOXICILLINANDA  #065271",
    "submission": "SUPPL-19",
    "activeIngredients": "AMOXICILLIN",
    "company": "AUROBINDO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/04/2024",
    "drugName": "AMOXICILLINANDA  #065271",
    "submission": "SUPPL-23",
    "activeIngredients": "AMOXICILLIN",
    "company": "AUROBINDO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/04/2024",
    "drugName": "BUTORPHANOL TARTRATE PRESERVATIVE FREEANDA  #074626",
    "submission": "SUPPL-38",
    "activeIngredients": "BUTORPHANOL TARTRATE",
    "company": "HOSPIRA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/04/2024",
    "drugName": "VALPROATE SODIUMANDA  #076539",
    "submission": "SUPPL-11",
    "activeIngredients": "VALPROATE SODIUM",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/04/2024",
    "drugName": "VALPROATE SODIUMANDA  #076539",
    "submission": "SUPPL-12",
    "activeIngredients": "VALPROATE SODIUM",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/04/2024",
    "drugName": "PACLITAXELANDA  #077574",
    "submission": "SUPPL-15",
    "activeIngredients": "PACLITAXEL",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/04/2024",
    "drugName": "PACLITAXELANDA  #077574",
    "submission": "SUPPL-17",
    "activeIngredients": "PACLITAXEL",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/04/2024",
    "drugName": "PACLITAXELANDA  #077574",
    "submission": "SUPPL-20",
    "activeIngredients": "PACLITAXEL",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/04/2024",
    "drugName": "ROPINIROLE HYDROCHLORIDEANDA  #077852",
    "submission": "SUPPL-12",
    "activeIngredients": "ROPINIROLE HYDROCHLORIDE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/04/2024",
    "drugName": "ROPINIROLE HYDROCHLORIDEANDA  #077852",
    "submission": "SUPPL-13",
    "activeIngredients": "ROPINIROLE HYDROCHLORIDE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/04/2024",
    "drugName": "HYDROCHLOROTHIAZIDEANDA  #077885",
    "submission": "SUPPL-4",
    "activeIngredients": "HYDROCHLOROTHIAZIDE",
    "company": "HIKMA INTL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/04/2024",
    "drugName": "HYDROCHLOROTHIAZIDEANDA  #078164",
    "submission": "SUPPL-11",
    "activeIngredients": "HYDROCHLOROTHIAZIDE",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/04/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #204755",
    "submission": "SUPPL-5",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "MICRO LABS LTD INDIA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/04/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #204755",
    "submission": "SUPPL-6",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "MICRO LABS LTD INDIA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/04/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #204755",
    "submission": "SUPPL-9",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "MICRO LABS LTD INDIA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/04/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #205707",
    "submission": "SUPPL-5",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "MICRO LABS LTD INDIA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/04/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #205707",
    "submission": "SUPPL-6",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "MICRO LABS LTD INDIA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/04/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #205707",
    "submission": "SUPPL-9",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "MICRO LABS LTD INDIA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/04/2024",
    "drugName": "PITAVASTATIN CALCIUMANDA  #205932",
    "submission": "SUPPL-1",
    "activeIngredients": "PITAVASTATIN CALCIUM",
    "company": "ORIENT PHARMA CO LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/04/2024",
    "drugName": "IMIPENEM AND CILASTATINANDA  #207594",
    "submission": "SUPPL-2",
    "activeIngredients": "CILASTATIN SODIUM; IMIPENEM",
    "company": "HQ SPCLT PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/04/2024",
    "drugName": "CABAZITAXELANDA  #207736",
    "submission": "SUPPL-2",
    "activeIngredients": "CABAZITAXEL",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/04/2024",
    "drugName": "XIIDRANDA   #208073",
    "submission": "SUPPL-12",
    "activeIngredients": "LIFITEGRAST",
    "company": "BAUSCH AND LOMB INC",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/04/2024",
    "drugName": "TRAMADOL HYDROCHLORIDEANDA  #208708",
    "submission": "SUPPL-16",
    "activeIngredients": "TRAMADOL HYDROCHLORIDE",
    "company": "RUBICON RESEARCH",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/04/2024",
    "drugName": "TERIFLUNOMIDEANDA  #209697",
    "submission": "ORIG-1",
    "activeIngredients": "TERIFLUNOMIDE",
    "company": "TORRENT",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/04/2024",
    "drugName": "SIROLIMUSANDA  #211406",
    "submission": "SUPPL-1",
    "activeIngredients": "SIROLIMUS",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/04/2024",
    "drugName": "SIROLIMUSANDA  #211406",
    "submission": "SUPPL-4",
    "activeIngredients": "SIROLIMUS",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/04/2024",
    "drugName": "MESALAMINEANDA  #214242",
    "submission": "SUPPL-3",
    "activeIngredients": "MESALAMINE",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/04/2024",
    "drugName": "XROMINDA   #216593",
    "submission": "ORIG-1",
    "activeIngredients": "HYDROXYUREA",
    "company": "NOVA LABS LTD",
    "submissionClassification": "Type 3 - New Dosage Form",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/04/2024",
    "drugName": "OGSIVEONDA   #217677",
    "submission": "SUPPL-1",
    "activeIngredients": "NIROGACESTAT HYDROBROMIDE",
    "company": "SPRINGWORKS",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/04/2024",
    "drugName": "COSENTYXBLA   #761349",
    "submission": "SUPPL-1",
    "activeIngredients": "SECUKINUMAB",
    "company": "NOVARTIS PHARMS CORP",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/05/2024",
    "drugName": "AMOXICILLINANDA  #065291",
    "submission": "SUPPL-32",
    "activeIngredients": "AMOXICILLIN",
    "company": "HIKMA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/05/2024",
    "drugName": "PIPERACILLIN AND TAZOBACTAMANDA  #065523",
    "submission": "SUPPL-26",
    "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
    "company": "ISTITUTO BIO ITA SPA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/05/2024",
    "drugName": "CLOZAPINEANDA  #076809",
    "submission": "SUPPL-42",
    "activeIngredients": "CLOZAPINE",
    "company": "IVAX SUB TEVA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/05/2024",
    "drugName": "CLOZAPINEANDA  #076809",
    "submission": "SUPPL-46",
    "activeIngredients": "CLOZAPINE",
    "company": "IVAX SUB TEVA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/05/2024",
    "drugName": "CLOZAPINEANDA  #076809",
    "submission": "SUPPL-51",
    "activeIngredients": "CLOZAPINE",
    "company": "IVAX SUB TEVA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/05/2024",
    "drugName": "LEVETIRACETAMANDA  #078869",
    "submission": "SUPPL-3",
    "activeIngredients": "LEVETIRACETAM",
    "company": "VIWIT PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/05/2024",
    "drugName": "LEVETIRACETAMANDA  #078869",
    "submission": "SUPPL-4",
    "activeIngredients": "LEVETIRACETAM",
    "company": "VIWIT PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/05/2024",
    "drugName": "LEVETIRACETAMANDA  #078869",
    "submission": "SUPPL-5",
    "activeIngredients": "LEVETIRACETAM",
    "company": "VIWIT PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/05/2024",
    "drugName": "LEVETIRACETAMANDA  #078869",
    "submission": "SUPPL-6",
    "activeIngredients": "LEVETIRACETAM",
    "company": "VIWIT PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/05/2024",
    "drugName": "LARIN 1.5/30ANDA  #202996",
    "submission": "SUPPL-2",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "NOVAST LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/05/2024",
    "drugName": "LARIN 1.5/30ANDA  #202996",
    "submission": "SUPPL-9",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "NOVAST LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/05/2024",
    "drugName": "LARIN 1.5/30ANDA  #202996",
    "submission": "SUPPL-10",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "NOVAST LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/05/2024",
    "drugName": "PIPERACILLIN AND TAZOBACTAMANDA  #203719",
    "submission": "SUPPL-9",
    "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
    "company": "FRESENIUS KABI",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/05/2024",
    "drugName": "PIPERACILLIN AND TAZOBACTAMANDA  #203719",
    "submission": "SUPPL-10",
    "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
    "company": "FRESENIUS KABI",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/05/2024",
    "drugName": "ETHINYL ESTRADIOL; ETONOGESTRELANDA  #204305",
    "submission": "SUPPL-7",
    "activeIngredients": "ETHINYL ESTRADIOL; ETONOGESTREL",
    "company": "TEVA PHARMS USA INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/05/2024",
    "drugName": "LINEZOLIDANDA  #205517",
    "submission": "SUPPL-7",
    "activeIngredients": "LINEZOLID",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/05/2024",
    "drugName": "LINEZOLIDANDA  #205517",
    "submission": "SUPPL-9",
    "activeIngredients": "LINEZOLID",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/05/2024",
    "drugName": "LINEZOLIDANDA  #205517",
    "submission": "SUPPL-13",
    "activeIngredients": "LINEZOLID",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/05/2024",
    "drugName": "LACOSAMIDEANDA  #206355",
    "submission": "SUPPL-1",
    "activeIngredients": "LACOSAMIDE",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/05/2024",
    "drugName": "LACOSAMIDEANDA  #206355",
    "submission": "SUPPL-2",
    "activeIngredients": "LACOSAMIDE",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/05/2024",
    "drugName": "LACOSAMIDEANDA  #206355",
    "submission": "SUPPL-3",
    "activeIngredients": "LACOSAMIDE",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/05/2024",
    "drugName": "MITOMYCINANDA  #211269",
    "submission": "ORIG-1",
    "activeIngredients": "MITOMYCIN",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/05/2024",
    "drugName": "DOVATONDA   #211994",
    "submission": "SUPPL-18",
    "activeIngredients": "DOLUTEGRAVIR SODIUM; LAMIVUDINE",
    "company": "VIIV HLTHCARE",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/05/2024",
    "drugName": "DOVATONDA   #211994",
    "submission": "SUPPL-19",
    "activeIngredients": "DOLUTEGRAVIR SODIUM; LAMIVUDINE",
    "company": "VIIV HLTHCARE",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/05/2024",
    "drugName": "FLUOXETINE HYDROCHLORIDEANDA  #212684",
    "submission": "ORIG-1",
    "activeIngredients": "FLUOXETINE HYDROCHLORIDE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/05/2024",
    "drugName": "XCOPRINDA   #212839",
    "submission": "SUPPL-9",
    "activeIngredients": "CENOBAMATE",
    "company": "SK LIFE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/05/2024",
    "drugName": "XCOPRINDA   #212839",
    "submission": "SUPPL-10",
    "activeIngredients": "CENOBAMATE",
    "company": "SK LIFE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/05/2024",
    "drugName": "DAPTOMYCINANDA  #213425",
    "submission": "SUPPL-3",
    "activeIngredients": "DAPTOMYCIN",
    "company": "BE PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/05/2024",
    "drugName": "VALBENAZINE TOSYLATEANDA  #216064",
    "submission": "ORIG-1",
    "activeIngredients": "VALBENAZINE TOSYLATE",
    "company": "LUPIN LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/05/2024",
    "drugName": "VALBENAZINE TOSYLATEANDA  #216064",
    "submission": "ORIG-2",
    "activeIngredients": "VALBENAZINE TOSYLATE",
    "company": "LUPIN LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "04/05/2024",
    "drugName": "PANTOPRAZOLE SODIUMANDA  #216247",
    "submission": "SUPPL-1",
    "activeIngredients": "PANTOPRAZOLE SODIUM",
    "company": "DEXCEL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/05/2024",
    "drugName": "PANTOPRAZOLE SODIUMANDA  #216247",
    "submission": "SUPPL-2",
    "activeIngredients": "PANTOPRAZOLE SODIUM",
    "company": "DEXCEL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/05/2024",
    "drugName": "LACOSAMIDEANDA  #216806",
    "submission": "ORIG-1",
    "activeIngredients": "LACOSAMIDE",
    "company": "HIKMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/05/2024",
    "drugName": "TAFLUPROSTANDA  #218002",
    "submission": "ORIG-1",
    "activeIngredients": "TAFLUPROST",
    "company": "INGENUS PHARMS LLC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/05/2024",
    "drugName": "ERIBULIN MESYLATEANDA  #218047",
    "submission": "ORIG-1",
    "activeIngredients": "ERIBULIN MESYLATE",
    "company": "GLAND",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/05/2024",
    "drugName": "FASENRABLA   #761070",
    "submission": "SUPPL-20",
    "activeIngredients": "BENRALIZUMAB",
    "company": "ASTRAZENECA AB",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/05/2024",
    "drugName": "HYRIMOZBLA   #761071",
    "submission": "SUPPL-19",
    "activeIngredients": "ADALIMUMAB-ADAZ",
    "company": "SANDOZ INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/05/2024",
    "drugName": "LIBTAYOBLA   #761097",
    "submission": "SUPPL-23",
    "activeIngredients": "CEMIPLIMAB-RWLC",
    "company": "REGENERON PHARMACEUTICALS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/05/2024",
    "drugName": "ENHERTUBLA   #761139",
    "submission": "SUPPL-28",
    "activeIngredients": "FAM-TRASTUZUMAB DERUXTECAN-NXKI",
    "company": "DAIICHI SANKYO",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/08/2024",
    "drugName": "ENVARSUS XRNDA   #206406",
    "submission": "SUPPL-9",
    "activeIngredients": "TACROLIMUS",
    "company": "VELOXIS PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/08/2024",
    "drugName": "ATROPINE SULFATEANDA  #212461",
    "submission": "SUPPL-1",
    "activeIngredients": "ATROPINE SULFATE",
    "company": "INTL MEDICATION SYS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/08/2024",
    "drugName": "IBUPROFENANDA  #213506",
    "submission": "ORIG-1",
    "activeIngredients": "IBUPROFEN",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/08/2024",
    "drugName": "DOXYCYCLINEANDA  #216631",
    "submission": "ORIG-1",
    "activeIngredients": "DOXYCYCLINE",
    "company": "LUPIN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/08/2024",
    "drugName": "DEXTROSE 5%ANDA  #217263",
    "submission": "ORIG-1",
    "activeIngredients": "DEXTROSE",
    "company": "AM REGENT",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/08/2024",
    "drugName": "GABAPENTINANDA  #217965",
    "submission": "ORIG-1",
    "activeIngredients": "GABAPENTIN",
    "company": "LAURUS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/08/2024",
    "drugName": "DOXYCYCLINEANDA  #218034",
    "submission": "ORIG-1",
    "activeIngredients": "DOXYCYCLINE",
    "company": "DR REDDYS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/09/2024",
    "drugName": "AMOXICILLINANDA  #065334",
    "submission": "SUPPL-11",
    "activeIngredients": "AMOXICILLIN",
    "company": "AUROBINDO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/09/2024",
    "drugName": "AMOXICILLINANDA  #065334",
    "submission": "SUPPL-12",
    "activeIngredients": "AMOXICILLIN",
    "company": "AUROBINDO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/09/2024",
    "drugName": "AMOXICILLINANDA  #065334",
    "submission": "SUPPL-14",
    "activeIngredients": "AMOXICILLIN",
    "company": "AUROBINDO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/09/2024",
    "drugName": "AMOXICILLINANDA  #065334",
    "submission": "SUPPL-20",
    "activeIngredients": "AMOXICILLIN",
    "company": "AUROBINDO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/09/2024",
    "drugName": "PIPERACILLIN AND TAZOBACTAMANDA  #065458",
    "submission": "SUPPL-15",
    "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
    "company": "ONESOURCE SPECIALTY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/09/2024",
    "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #090733",
    "submission": "SUPPL-24",
    "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/09/2024",
    "drugName": "CEFPROZILANDA  #090857",
    "submission": "ORIG-1",
    "activeIngredients": "CEFPROZIL",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/09/2024",
    "drugName": "PROLIABLA   #125320",
    "submission": "SUPPL-218",
    "activeIngredients": "DENOSUMAB",
    "company": "AMGEN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/09/2024",
    "drugName": "XGEVABLA   #125320",
    "submission": "SUPPL-218",
    "activeIngredients": "DENOSUMAB",
    "company": "AMGEN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/09/2024",
    "drugName": "OLOPATADINE HYDROCHLORIDEANDA  #206306",
    "submission": "SUPPL-11",
    "activeIngredients": "OLOPATADINE HYDROCHLORIDE",
    "company": "SOMERSET THERAPS LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/09/2024",
    "drugName": "PIPERACILLIN AND TAZOBACTAMANDA  #206996",
    "submission": "SUPPL-8",
    "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
    "company": "WOCKHARDT BIO AG",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/09/2024",
    "drugName": "TOFACITINIBANDA  #209923",
    "submission": "ORIG-1",
    "activeIngredients": "TOFACITINIB",
    "company": "PRINSTON PHARMA INC",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "04/09/2024",
    "drugName": "HYDROXYUREAANDA  #213438",
    "submission": "SUPPL-1",
    "activeIngredients": "HYDROXYUREA",
    "company": "LEADING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/09/2024",
    "drugName": "HYDROXYUREAANDA  #213438",
    "submission": "SUPPL-3",
    "activeIngredients": "HYDROXYUREA",
    "company": "LEADING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/09/2024",
    "drugName": "EVEROLIMUSANDA  #214182",
    "submission": "SUPPL-10",
    "activeIngredients": "EVEROLIMUS",
    "company": "BIOCON PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/09/2024",
    "drugName": "VENLAFAXINE HYDROCHLORIDEANDA  #214609",
    "submission": "SUPPL-2",
    "activeIngredients": "VENLAFAXINE HYDROCHLORIDE",
    "company": "APPCO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/09/2024",
    "drugName": "IOPAMIDOLANDA  #217134",
    "submission": "SUPPL-1",
    "activeIngredients": "IOPAMIDOL",
    "company": "HAINAN POLY",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/09/2024",
    "drugName": "RASAGILINE MESYLATEANDA  #218163",
    "submission": "ORIG-1",
    "activeIngredients": "RASAGILINE MESYLATE",
    "company": "RISING",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/10/2024",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #202775",
    "submission": "SUPPL-6",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "JUBILANT GENERICS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/10/2024",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #202775",
    "submission": "SUPPL-14",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "JUBILANT GENERICS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/10/2024",
    "drugName": "SEVELAMER CARBONATEANDA  #206100",
    "submission": "SUPPL-3",
    "activeIngredients": "SEVELAMER CARBONATE",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/10/2024",
    "drugName": "PIPERACILLIN AND TAZOBACTAMANDA  #207146",
    "submission": "SUPPL-8",
    "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
    "company": "WOCKHARDT BIO AG",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/10/2024",
    "drugName": "PIPERACILLIN AND TAZOBACTAMANDA  #208674",
    "submission": "SUPPL-3",
    "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
    "company": "SAGENT PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/10/2024",
    "drugName": "PIPERACILLIN AND TAZOBACTAMANDA  #208674",
    "submission": "SUPPL-4",
    "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
    "company": "SAGENT PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/10/2024",
    "drugName": "SPINRAZANDA   #209531",
    "submission": "SUPPL-13",
    "activeIngredients": "NUSINERSEN SODIUM",
    "company": "BIOGEN IDEC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/10/2024",
    "drugName": "SPINRAZANDA   #209531",
    "submission": "SUPPL-14",
    "activeIngredients": "NUSINERSEN SODIUM",
    "company": "BIOGEN IDEC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/10/2024",
    "drugName": "RETEVMONDA   #213246",
    "submission": "SUPPL-10",
    "activeIngredients": "SELPERCATINIB",
    "company": "ELI LILLY AND CO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/10/2024",
    "drugName": "REZUROCKNDA   #214783",
    "submission": "SUPPL-5",
    "activeIngredients": "BELUMOSUDIL MESYLATE",
    "company": "KADMON PHARMS LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/10/2024",
    "drugName": "TOPIRAMATEANDA  #215918",
    "submission": "ORIG-1",
    "activeIngredients": "TOPIRAMATE",
    "company": "TORRENT PHARMS LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "04/10/2024",
    "drugName": "METHYLPHENIDATE HYDROCHLORIDEANDA  #217229",
    "submission": "SUPPL-1",
    "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "company": "SUN PHARM INDS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/10/2024",
    "drugName": "RETEVMONDA   #218160",
    "submission": "ORIG-1",
    "activeIngredients": "SELPERCATINIB",
    "company": "ELI LILLY AND CO",
    "submissionClassification": "Type 3 - New Dosage Form",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/10/2024",
    "drugName": "NICARDIPINE HYDROCHLORIDEANDA  #218202",
    "submission": "ORIG-1",
    "activeIngredients": "NICARDIPINE HYDROCHLORIDE",
    "company": "AMNEAL",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/10/2024",
    "drugName": "BETAMETHASONE DIPROPIONATEANDA  #218289",
    "submission": "ORIG-1",
    "activeIngredients": "BETAMETHASONE DIPROPIONATE",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/11/2024",
    "drugName": "ZOSYN IN PLASTIC CONTAINERNDA   #050750",
    "submission": "SUPPL-50",
    "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
    "company": "BAXTER HLTHCARE CORP",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/11/2024",
    "drugName": "AMOXICILLINANDA  #065256",
    "submission": "SUPPL-13",
    "activeIngredients": "AMOXICILLIN",
    "company": "AUROBINDO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/11/2024",
    "drugName": "AMOXICILLINANDA  #065256",
    "submission": "SUPPL-14",
    "activeIngredients": "AMOXICILLIN",
    "company": "AUROBINDO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/11/2024",
    "drugName": "AMOXICILLINANDA  #065256",
    "submission": "SUPPL-17",
    "activeIngredients": "AMOXICILLIN",
    "company": "AUROBINDO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/11/2024",
    "drugName": "AMOXICILLINANDA  #065256",
    "submission": "SUPPL-21",
    "activeIngredients": "AMOXICILLIN",
    "company": "AUROBINDO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/11/2024",
    "drugName": "DIAZEPAMANDA  #070325",
    "submission": "SUPPL-24",
    "activeIngredients": "DIAZEPAM",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/11/2024",
    "drugName": "DIAZEPAMANDA  #070325",
    "submission": "SUPPL-25",
    "activeIngredients": "DIAZEPAM",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/11/2024",
    "drugName": "DIAZEPAMANDA  #070325",
    "submission": "SUPPL-27",
    "activeIngredients": "DIAZEPAM",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/11/2024",
    "drugName": "DIAZEPAMANDA  #070325",
    "submission": "SUPPL-30",
    "activeIngredients": "DIAZEPAM",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/11/2024",
    "drugName": "INDOMETHACINANDA  #070673",
    "submission": "SUPPL-23",
    "activeIngredients": "INDOMETHACIN",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/11/2024",
    "drugName": "INDOMETHACINANDA  #070674",
    "submission": "SUPPL-23",
    "activeIngredients": "INDOMETHACIN",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/11/2024",
    "drugName": "LISINOPRILANDA  #076063",
    "submission": "SUPPL-67",
    "activeIngredients": "LISINOPRIL",
    "company": "HIKMA INTL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/11/2024",
    "drugName": "LISINOPRILANDA  #076071",
    "submission": "SUPPL-34",
    "activeIngredients": "LISINOPRIL",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/11/2024",
    "drugName": "VALSARTAN AND HYDROCHLOROTHIAZIDEANDA  #078020",
    "submission": "SUPPL-15",
    "activeIngredients": "HYDROCHLOROTHIAZIDE; VALSARTAN",
    "company": "MYLAN PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/11/2024",
    "drugName": "LAMOTRIGINEANDA  #079099",
    "submission": "SUPPL-15",
    "activeIngredients": "LAMOTRIGINE",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/11/2024",
    "drugName": "LAMOTRIGINEANDA  #079099",
    "submission": "SUPPL-16",
    "activeIngredients": "LAMOTRIGINE",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/11/2024",
    "drugName": "ALPRAZOLAMANDA  #090248",
    "submission": "SUPPL-6",
    "activeIngredients": "ALPRAZOLAM",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/11/2024",
    "drugName": "ALPRAZOLAMANDA  #090248",
    "submission": "SUPPL-7",
    "activeIngredients": "ALPRAZOLAM",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/11/2024",
    "drugName": "ALPRAZOLAMANDA  #090248",
    "submission": "SUPPL-8",
    "activeIngredients": "ALPRAZOLAM",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/11/2024",
    "drugName": "ALPRAZOLAMANDA  #090871",
    "submission": "SUPPL-8",
    "activeIngredients": "ALPRAZOLAM",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/11/2024",
    "drugName": "ALPRAZOLAMANDA  #090871",
    "submission": "SUPPL-10",
    "activeIngredients": "ALPRAZOLAM",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/11/2024",
    "drugName": "ALPRAZOLAMANDA  #090871",
    "submission": "SUPPL-11",
    "activeIngredients": "ALPRAZOLAM",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/11/2024",
    "drugName": "ALPRAZOLAMANDA  #090871",
    "submission": "SUPPL-12",
    "activeIngredients": "ALPRAZOLAM",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/11/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #201091",
    "submission": "SUPPL-2",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/11/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #201091",
    "submission": "SUPPL-4",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/11/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #201091",
    "submission": "SUPPL-10",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/11/2024",
    "drugName": "OPSUMITNDA   #204410",
    "submission": "SUPPL-27",
    "activeIngredients": "MACITENTAN",
    "company": "ACTELION",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/11/2024",
    "drugName": "PLERIXAFORANDA  #205197",
    "submission": "SUPPL-2",
    "activeIngredients": "PLERIXAFOR",
    "company": "TEVA PHARMS USA INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/11/2024",
    "drugName": "ADAPALENE AND BENZOYL PEROXIDEANDA  #209148",
    "submission": "SUPPL-7",
    "activeIngredients": "ADAPALENE; BENZOYL PEROXIDE",
    "company": "TARO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/11/2024",
    "drugName": "MACITENTANANDA  #211195",
    "submission": "SUPPL-1",
    "activeIngredients": "MACITENTAN",
    "company": "APOTEX",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/11/2024",
    "drugName": "MACITENTANANDA  #211198",
    "submission": "SUPPL-2",
    "activeIngredients": "MACITENTAN",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/11/2024",
    "drugName": "MACITENTANANDA  #211224",
    "submission": "SUPPL-2",
    "activeIngredients": "MACITENTAN",
    "company": "ZYDUS LIFESCIENCES",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/11/2024",
    "drugName": "IBUPROFEN AND DIPHENHYDRAMINE CITRATEANDA  #211404",
    "submission": "ORIG-1",
    "activeIngredients": "DIPHENHYDRAMINE CITRATE; IBUPROFEN",
    "company": "PLD ACQUISITIONS LLC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/11/2024",
    "drugName": "METHYLPHENIDATE HYDROCHLORIDEANDA  #213473",
    "submission": "SUPPL-2",
    "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "company": "GRANULES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/11/2024",
    "drugName": "PLERIXAFORANDA  #215334",
    "submission": "SUPPL-2",
    "activeIngredients": "PLERIXAFOR",
    "company": "AMNEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/11/2024",
    "drugName": "CALCITONIN-SALMONANDA  #215715",
    "submission": "ORIG-1",
    "activeIngredients": "CALCITONIN SALMON",
    "company": "DR REDDYS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/11/2024",
    "drugName": "DOCETAXELNDA   #215813",
    "submission": "SUPPL-1",
    "activeIngredients": "DOCETAXEL",
    "company": "AVYXA HOLDINGS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/11/2024",
    "drugName": "DOCETAXELNDA   #215813",
    "submission": "SUPPL-2",
    "activeIngredients": "DOCETAXEL",
    "company": "AVYXA HOLDINGS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/11/2024",
    "drugName": "DOCIVYXNDA   #215813",
    "submission": "SUPPL-1",
    "activeIngredients": "DOCETAXEL",
    "company": "AVYXA HOLDINGS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/11/2024",
    "drugName": "DOCIVYXNDA   #215813",
    "submission": "SUPPL-2",
    "activeIngredients": "DOCETAXEL",
    "company": "AVYXA HOLDINGS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/11/2024",
    "drugName": "VIVJOANDA   #215888",
    "submission": "SUPPL-2",
    "activeIngredients": "OTESECONAZOLE",
    "company": "MYCOVIA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/11/2024",
    "drugName": "HALOPERIDOLANDA  #216918",
    "submission": "ORIG-1",
    "activeIngredients": "HALOPERIDOL",
    "company": "MANKIND PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/11/2024",
    "drugName": "EMPAGLIFLOZINANDA  #217600",
    "submission": "ORIG-1",
    "activeIngredients": "EMPAGLIFLOZIN",
    "company": "PRINSTON PHARMA INC",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "04/11/2024",
    "drugName": "CABLIVIBLA   #761112",
    "submission": "SUPPL-11",
    "activeIngredients": "CAPLACIZUMAB-YHDP",
    "company": "ABLYNX NV",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/12/2024",
    "drugName": "TRELSTARNDA   #020715",
    "submission": "SUPPL-49",
    "activeIngredients": "TRIPTORELIN PAMOATE",
    "company": "VERITY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/12/2024",
    "drugName": "TRELSTARNDA   #021288",
    "submission": "SUPPL-44",
    "activeIngredients": "TRIPTORELIN PAMOATE",
    "company": "VERITY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/12/2024",
    "drugName": "TRELSTARNDA   #022437",
    "submission": "SUPPL-24",
    "activeIngredients": "TRIPTORELIN PAMOATE",
    "company": "VERITY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/12/2024",
    "drugName": "MEPERIDINE HYDROCHLORIDEANDA  #040331",
    "submission": "SUPPL-21",
    "activeIngredients": "MEPERIDINE HYDROCHLORIDE",
    "company": "EPIC PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/12/2024",
    "drugName": "MEPERIDINE HYDROCHLORIDEANDA  #040331",
    "submission": "SUPPL-22",
    "activeIngredients": "MEPERIDINE HYDROCHLORIDE",
    "company": "EPIC PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/12/2024",
    "drugName": "PHENYTOINANDA  #040342",
    "submission": "SUPPL-23",
    "activeIngredients": "PHENYTOIN",
    "company": "VISTAPHARM LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/12/2024",
    "drugName": "PIPERACILLIN AND TAZOBACTAMANDA  #065523",
    "submission": "SUPPL-27",
    "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
    "company": "ISTITUTO BIO ITA SPA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/12/2024",
    "drugName": "PIPERACILLIN AND TAZOBACTAMANDA  #065523",
    "submission": "SUPPL-28",
    "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
    "company": "ISTITUTO BIO ITA SPA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/12/2024",
    "drugName": "RIFABUTINANDA  #090033",
    "submission": "SUPPL-4",
    "activeIngredients": "RIFABUTIN",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/12/2024",
    "drugName": "RIFABUTINANDA  #090033",
    "submission": "SUPPL-5",
    "activeIngredients": "RIFABUTIN",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/12/2024",
    "drugName": "RIFABUTINANDA  #090033",
    "submission": "SUPPL-6",
    "activeIngredients": "RIFABUTIN",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/12/2024",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #090134",
    "submission": "SUPPL-23",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "ACTAVIS ELIZABETH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/12/2024",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #090134",
    "submission": "SUPPL-26",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "ACTAVIS ELIZABETH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/12/2024",
    "drugName": "ARZERRABLA   #125326",
    "submission": "SUPPL-79",
    "activeIngredients": "OFATUMUMAB",
    "company": "NOVARTIS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/12/2024",
    "drugName": "KESIMPTABLA   #125326",
    "submission": "SUPPL-79",
    "activeIngredients": "OFATUMUMAB",
    "company": "NOVARTIS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/12/2024",
    "drugName": "RIZATRIPTAN BENZOATEANDA  #203252",
    "submission": "SUPPL-7",
    "activeIngredients": "RIZATRIPTAN BENZOATE",
    "company": "JUBILANT GENERICS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/12/2024",
    "drugName": "AMOXICILLINANDA  #204030",
    "submission": "SUPPL-10",
    "activeIngredients": "AMOXICILLIN",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/12/2024",
    "drugName": "ENTRESTONDA   #207620",
    "submission": "SUPPL-25",
    "activeIngredients": "SACUBITRIL; VALSARTAN",
    "company": "NOVARTIS PHARMS CORP",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/12/2024",
    "drugName": "MESALAMINEANDA  #210509",
    "submission": "SUPPL-8",
    "activeIngredients": "MESALAMINE",
    "company": "AMNEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/12/2024",
    "drugName": "NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)ANDA  #211013",
    "submission": "SUPPL-2",
    "activeIngredients": "NITROFURANTOIN; NITROFURANTOIN, MACROCRYSTALLINE",
    "company": "INVENTIA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/12/2024",
    "drugName": "PIRFENIDONEANDA  #212077",
    "submission": "SUPPL-2",
    "activeIngredients": "PIRFENIDONE",
    "company": "SCIEGEN PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/12/2024",
    "drugName": "PIRFENIDONEANDA  #212078",
    "submission": "SUPPL-3",
    "activeIngredients": "PIRFENIDONE",
    "company": "SCIEGEN PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/12/2024",
    "drugName": "BIORPHENNDA   #212909",
    "submission": "SUPPL-2",
    "activeIngredients": "PHENYLEPHRINE HYDROCHLORIDE",
    "company": "DR REDDYS LABS SA",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/12/2024",
    "drugName": "MESALAMINEANDA  #216941",
    "submission": "SUPPL-1",
    "activeIngredients": "MESALAMINE",
    "company": "ENCUBE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/12/2024",
    "drugName": "OFLOXACINANDA  #217904",
    "submission": "ORIG-1",
    "activeIngredients": "OFLOXACIN",
    "company": "CAPLIN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/12/2024",
    "drugName": "ENTRESTO SPRINKLENDA   #218591",
    "submission": "ORIG-1",
    "activeIngredients": "SACUBITRIL; VALSARTAN",
    "company": "NOVARTIS",
    "submissionClassification": "Type 3 - New Dosage Form",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/12/2024",
    "drugName": "DUPIXENTBLA   #761055",
    "submission": "SUPPL-59",
    "activeIngredients": "DUPILUMAB",
    "company": "REGENERON PHARMACEUTICALS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/15/2024",
    "drugName": "HYDROXYCHLOROQUINE SULFATEANDA  #040081",
    "submission": "SUPPL-35",
    "activeIngredients": "HYDROXYCHLOROQUINE SULFATE",
    "company": "TEVA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/15/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #065317",
    "submission": "SUPPL-3",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "APOTEX INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/15/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #065333",
    "submission": "SUPPL-3",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "APOTEX INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/15/2024",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #076834",
    "submission": "SUPPL-15",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/15/2024",
    "drugName": "METFORMIN HYDROCHLORIDEANDA  #079118",
    "submission": "SUPPL-16",
    "activeIngredients": "METFORMIN HYDROCHLORIDE",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/15/2024",
    "drugName": "ESCITALOPRAM OXALATEANDA  #202227",
    "submission": "SUPPL-19",
    "activeIngredients": "ESCITALOPRAM OXALATE",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/15/2024",
    "drugName": "URSODIOLANDA  #202540",
    "submission": "SUPPL-8",
    "activeIngredients": "URSODIOL",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/15/2024",
    "drugName": "CLINDAMYCIN PALMITATE HYDROCHLORIDEANDA  #206958",
    "submission": "SUPPL-1",
    "activeIngredients": "CLINDAMYCIN PALMITATE HYDROCHLORIDE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/15/2024",
    "drugName": "CLINDAMYCIN PALMITATE HYDROCHLORIDEANDA  #206958",
    "submission": "SUPPL-2",
    "activeIngredients": "CLINDAMYCIN PALMITATE HYDROCHLORIDE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/15/2024",
    "drugName": "CLINDAMYCIN PALMITATE HYDROCHLORIDEANDA  #206958",
    "submission": "SUPPL-3",
    "activeIngredients": "CLINDAMYCIN PALMITATE HYDROCHLORIDE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/15/2024",
    "drugName": "ASPIRIN AND DIPYRIDAMOLEANDA  #206964",
    "submission": "SUPPL-8",
    "activeIngredients": "ASPIRIN; DIPYRIDAMOLE",
    "company": "ANI PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/15/2024",
    "drugName": "ASPIRIN AND DIPYRIDAMOLEANDA  #206964",
    "submission": "SUPPL-10",
    "activeIngredients": "ASPIRIN; DIPYRIDAMOLE",
    "company": "ANI PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/15/2024",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #207403",
    "submission": "SUPPL-2",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "MICRO LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/15/2024",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #207403",
    "submission": "SUPPL-3",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "MICRO LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/15/2024",
    "drugName": "FINGOLIMOD HYDROCHLORIDEANDA  #208000",
    "submission": "SUPPL-1",
    "activeIngredients": "FINGOLIMOD HYDROCHLORIDE",
    "company": "DR REDDYS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/15/2024",
    "drugName": "FINGOLIMOD HYDROCHLORIDEANDA  #208000",
    "submission": "SUPPL-2",
    "activeIngredients": "FINGOLIMOD HYDROCHLORIDE",
    "company": "DR REDDYS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/15/2024",
    "drugName": "FINGOLIMOD HYDROCHLORIDEANDA  #208005",
    "submission": "SUPPL-4",
    "activeIngredients": "FINGOLIMOD HYDROCHLORIDE",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/15/2024",
    "drugName": "FINGOLIMOD HYDROCHLORIDEANDA  #208005",
    "submission": "SUPPL-5",
    "activeIngredients": "FINGOLIMOD HYDROCHLORIDE",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/15/2024",
    "drugName": "EZETIMIBEANDA  #208332",
    "submission": "SUPPL-6",
    "activeIngredients": "EZETIMIBE",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/15/2024",
    "drugName": "CAPECITABINEANDA  #209365",
    "submission": "SUPPL-5",
    "activeIngredients": "CAPECITABINE",
    "company": "MSN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/15/2024",
    "drugName": "CAPECITABINEANDA  #209365",
    "submission": "SUPPL-7",
    "activeIngredients": "CAPECITABINE",
    "company": "MSN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/15/2024",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #209560",
    "submission": "ORIG-1",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/15/2024",
    "drugName": "FINGOLIMOD HYDROCHLORIDEANDA  #210252",
    "submission": "SUPPL-1",
    "activeIngredients": "FINGOLIMOD HYDROCHLORIDE",
    "company": "BIONPHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/15/2024",
    "drugName": "EXTENDED PHENYTOIN SODIUMANDA  #211633",
    "submission": "SUPPL-3",
    "activeIngredients": "PHENYTOIN SODIUM",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/15/2024",
    "drugName": "EXTENDED PHENYTOIN SODIUMANDA  #211633",
    "submission": "SUPPL-5",
    "activeIngredients": "PHENYTOIN SODIUM",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/15/2024",
    "drugName": "LAMOTRIGINEANDA  #213271",
    "submission": "SUPPL-2",
    "activeIngredients": "LAMOTRIGINE",
    "company": "AJANTA PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/15/2024",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #214356",
    "submission": "ORIG-1",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "TORRENT",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/15/2024",
    "drugName": "PANTOPRAZOLE SODIUMANDA  #214680",
    "submission": "SUPPL-1",
    "activeIngredients": "PANTOPRAZOLE SODIUM",
    "company": "KNACK",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/15/2024",
    "drugName": "BENDAMUSTINE HYDROCHLORIDENDA   #215033",
    "submission": "SUPPL-3",
    "activeIngredients": "BENDAMUSTINE HYDROCHLORIDE",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/15/2024",
    "drugName": "RYLAZEBLA   #761179",
    "submission": "SUPPL-7",
    "activeIngredients": "ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)-RYWN",
    "company": "JAZZ PHARMS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/16/2024",
    "drugName": "CITALOPRAM HYDROBROMIDEANDA  #077534",
    "submission": "SUPPL-24",
    "activeIngredients": "CITALOPRAM HYDROBROMIDE",
    "company": "INVAGEN PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/16/2024",
    "drugName": "MEPERIDINE HYDROCHLORIDEANDA  #088639",
    "submission": "SUPPL-48",
    "activeIngredients": "MEPERIDINE HYDROCHLORIDE",
    "company": "BARR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/16/2024",
    "drugName": "MEPERIDINE HYDROCHLORIDEANDA  #088640",
    "submission": "SUPPL-50",
    "activeIngredients": "MEPERIDINE HYDROCHLORIDE",
    "company": "BARR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/16/2024",
    "drugName": "CARVEDILOL PHOSPHATEANDA  #090132",
    "submission": "SUPPL-2",
    "activeIngredients": "CARVEDILOL PHOSPHATE",
    "company": "SUN PHARM INDUSTRIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/16/2024",
    "drugName": "CARVEDILOL PHOSPHATEANDA  #090132",
    "submission": "SUPPL-5",
    "activeIngredients": "CARVEDILOL PHOSPHATE",
    "company": "SUN PHARM INDUSTRIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/16/2024",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #090941",
    "submission": "SUPPL-13",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/16/2024",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #090941",
    "submission": "SUPPL-15",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/16/2024",
    "drugName": "PANTOPRAZOLE SODIUMANDA  #202052",
    "submission": "SUPPL-10",
    "activeIngredients": "PANTOPRAZOLE SODIUM",
    "company": "ORBION PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/16/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #205187",
    "submission": "SUPPL-3",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "MICRO LABS LTD INDIA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/16/2024",
    "drugName": "FINGOLIMOD HYDROCHLORIDEANDA  #207979",
    "submission": "SUPPL-6",
    "activeIngredients": "FINGOLIMOD HYDROCHLORIDE",
    "company": "BIOCON LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/16/2024",
    "drugName": "TRANEXAMIC ACIDANDA  #216877",
    "submission": "ORIG-1",
    "activeIngredients": "TRANEXAMIC ACID",
    "company": "NEXUS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/16/2024",
    "drugName": "CETRORELIX ACETATEANDA  #217776",
    "submission": "ORIG-1",
    "activeIngredients": "CETRORELIX ACETATE",
    "company": "QILU",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/16/2024",
    "drugName": "TRANEXAMIC ACIDANDA  #218599",
    "submission": "ORIG-1",
    "activeIngredients": "TRANEXAMIC ACID",
    "company": "GLAND",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/16/2024",
    "drugName": "SELARSDIBLA   #761343",
    "submission": "ORIG-1",
    "activeIngredients": "USTEKINUMAB-AEKN",
    "company": "ALVOTECH USA INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/17/2024",
    "drugName": "NICARDIPINE HYDROCHLORIDE IN 0.83% SODIUM CHLORIDEANDA  #203978",
    "submission": "ORIG-1",
    "activeIngredients": "NICARDIPINE HYDROCHLORIDE",
    "company": "INFORLIFE",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/17/2024",
    "drugName": "NICARDIPINE HYDROCHLORIDE IN 0.86% SODIUM CHLORIDEANDA  #203978",
    "submission": "ORIG-1",
    "activeIngredients": "NICARDIPINE HYDROCHLORIDE",
    "company": "INFORLIFE",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/17/2024",
    "drugName": "PRASUGRELANDA  #205897",
    "submission": "SUPPL-2",
    "activeIngredients": "PRASUGREL HYDROCHLORIDE",
    "company": "PANACEA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/17/2024",
    "drugName": "LUMISIGHTNDA   #214511",
    "submission": "ORIG-1",
    "activeIngredients": "PEGULICIANINE ACETATE",
    "company": "LUMICELL",
    "submissionClassification": "Type 1 - New Molecular Entity",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/17/2024",
    "drugName": "LYTGOBINDA   #214801",
    "submission": "SUPPL-2",
    "activeIngredients": "FUTIBATINIB",
    "company": "TAIHO ONCOLOGY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/17/2024",
    "drugName": "LEUCOVORIN CALCIUMANDA  #216590",
    "submission": "SUPPL-5",
    "activeIngredients": "LEUCOVORIN CALCIUM",
    "company": "MEITHEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/17/2024",
    "drugName": "METOLAZONEANDA  #218606",
    "submission": "ORIG-1",
    "activeIngredients": "METOLAZONE",
    "company": "IXORA LIFESCIENCE",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/18/2024",
    "drugName": "ENTYVIOBLA   #125476",
    "submission": "SUPPL-60",
    "activeIngredients": "VEDOLIZUMAB",
    "company": "TAKEDA PHARMS USA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/18/2024",
    "drugName": "ENTYVIOBLA   #125476",
    "submission": "SUPPL-61",
    "activeIngredients": "VEDOLIZUMAB",
    "company": "TAKEDA PHARMS USA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/18/2024",
    "drugName": "OXYCODONE HYDROCHLORIDE AND ACETAMINOPHENANDA  #203573",
    "submission": "SUPPL-14",
    "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/18/2024",
    "drugName": "METHAMPHETAMINE HYDROCHLORIDEANDA  #203846",
    "submission": "SUPPL-1",
    "activeIngredients": "METHAMPHETAMINE HYDROCHLORIDE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/18/2024",
    "drugName": "METHAMPHETAMINE HYDROCHLORIDEANDA  #203846",
    "submission": "SUPPL-2",
    "activeIngredients": "METHAMPHETAMINE HYDROCHLORIDE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/18/2024",
    "drugName": "METHAMPHETAMINE HYDROCHLORIDEANDA  #203846",
    "submission": "SUPPL-3",
    "activeIngredients": "METHAMPHETAMINE HYDROCHLORIDE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/18/2024",
    "drugName": "METHAMPHETAMINE HYDROCHLORIDEANDA  #203846",
    "submission": "SUPPL-4",
    "activeIngredients": "METHAMPHETAMINE HYDROCHLORIDE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/18/2024",
    "drugName": "METHAMPHETAMINE HYDROCHLORIDEANDA  #203846",
    "submission": "SUPPL-6",
    "activeIngredients": "METHAMPHETAMINE HYDROCHLORIDE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/18/2024",
    "drugName": "TIVICAYNDA   #204790",
    "submission": "SUPPL-31",
    "activeIngredients": "DOLUTEGRAVIR SODIUM",
    "company": "VIIV HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/18/2024",
    "drugName": "TRIUMEQNDA   #205551",
    "submission": "SUPPL-32",
    "activeIngredients": "ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE",
    "company": "VIIV HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/18/2024",
    "drugName": "ALECENSANDA   #208434",
    "submission": "SUPPL-15",
    "activeIngredients": "ALECTINIB HYDROCHLORIDE",
    "company": "HOFFMANN-LA ROCHE",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/18/2024",
    "drugName": "JULUCANDA   #210192",
    "submission": "SUPPL-14",
    "activeIngredients": "DOLUTEGRAVIR SODIUM; RILPIVIRINE HYDROCHLORIDE",
    "company": "VIIV HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/18/2024",
    "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #211708",
    "submission": "SUPPL-7",
    "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
    "company": "GRANULES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/18/2024",
    "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #211708",
    "submission": "SUPPL-9",
    "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
    "company": "GRANULES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/18/2024",
    "drugName": "DOVATONDA   #211994",
    "submission": "SUPPL-21",
    "activeIngredients": "DOLUTEGRAVIR SODIUM; LAMIVUDINE",
    "company": "VIIV HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/18/2024",
    "drugName": "TIVICAY PDNDA   #213983",
    "submission": "SUPPL-4",
    "activeIngredients": "DOLUTEGRAVIR SODIUM",
    "company": "VIIV HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/18/2024",
    "drugName": "TRIUMEQ PDNDA   #215413",
    "submission": "SUPPL-3",
    "activeIngredients": "ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE",
    "company": "VIIV HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/18/2024",
    "drugName": "FLEQSUVYNDA   #215602",
    "submission": "SUPPL-3",
    "activeIngredients": "BACLOFEN",
    "company": "AZURITY",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/18/2024",
    "drugName": "ELTROMBOPAG OLAMINEANDA  #216620",
    "submission": "ORIG-1",
    "activeIngredients": "ELTROMBOPAG OLAMINE",
    "company": "ANNORA PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/18/2024",
    "drugName": "ENTYVIOBLA   #761133",
    "submission": "SUPPL-5",
    "activeIngredients": "VEDOLIZUMAB",
    "company": "TAKEDA PHARMS USA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/18/2024",
    "drugName": "ENTYVIOBLA   #761133",
    "submission": "SUPPL-6",
    "activeIngredients": "VEDOLIZUMAB",
    "company": "TAKEDA PHARMS USA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/18/2024",
    "drugName": "ENTYVIOBLA   #761359",
    "submission": "ORIG-1",
    "activeIngredients": "VEDOLIZUMAB",
    "company": "TAKEDA PHARMS USA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/19/2024",
    "drugName": "PERCODANNDA   #007337",
    "submission": "SUPPL-55",
    "activeIngredients": "ASPIRIN; OXYCODONE HYDROCHLORIDE",
    "company": "ENDO OPERATIONS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/19/2024",
    "drugName": "PERCODANNDA   #007337",
    "submission": "SUPPL-55",
    "activeIngredients": "ASPIRIN; OXYCODONE HYDROCHLORIDE; OXYCODONE TEREPHTHALATE",
    "company": "ENDO OPERATIONS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/19/2024",
    "drugName": "PERCODAN-DEMINDA   #007337",
    "submission": "SUPPL-55",
    "activeIngredients": "ASPIRIN; OXYCODONE HYDROCHLORIDE; OXYCODONE TEREPHTHALATE",
    "company": "ENDO OPERATIONS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/19/2024",
    "drugName": "CELEXANDA   #020822",
    "submission": "SUPPL-55",
    "activeIngredients": "CITALOPRAM HYDROBROMIDE",
    "company": "ABBVIE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/19/2024",
    "drugName": "ROXICODONENDA   #021011",
    "submission": "SUPPL-14",
    "activeIngredients": "OXYCODONE HYDROCHLORIDE",
    "company": "SPECGX LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/19/2024",
    "drugName": "LOTRIMIN ULTRANDA   #021307",
    "submission": "SUPPL-23",
    "activeIngredients": "BUTENAFINE HYDROCHLORIDE",
    "company": "BAYER HEALTHCARE LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/19/2024",
    "drugName": "LEXAPRONDA   #021323",
    "submission": "SUPPL-58",
    "activeIngredients": "ESCITALOPRAM OXALATE",
    "company": "ABBVIE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/19/2024",
    "drugName": "LEXAPRONDA   #021365",
    "submission": "SUPPL-41",
    "activeIngredients": "ESCITALOPRAM OXALATE",
    "company": "ABBVIE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/19/2024",
    "drugName": "VIIBRYDNDA   #022567",
    "submission": "SUPPL-25",
    "activeIngredients": "VILAZODONE HYDROCHLORIDE",
    "company": "ABBVIE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/19/2024",
    "drugName": "OXYCODONE HYDROCHLORIDENDA   #200534",
    "submission": "SUPPL-14",
    "activeIngredients": "OXYCODONE HYDROCHLORIDE",
    "company": "GENUS LIFESCIENCES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/19/2024",
    "drugName": "OXYCODONE HYDROCHLORIDENDA   #200535",
    "submission": "SUPPL-23",
    "activeIngredients": "OXYCODONE HYDROCHLORIDE",
    "company": "GENUS LIFESCIENCES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/19/2024",
    "drugName": "OXYCODONE HYDROCHLORIDENDA   #201194",
    "submission": "SUPPL-19",
    "activeIngredients": "OXYCODONE HYDROCHLORIDE",
    "company": "VISTAPHARM LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/19/2024",
    "drugName": "OXAYDONDA   #202080",
    "submission": "SUPPL-14",
    "activeIngredients": "OXYCODONE HYDROCHLORIDE",
    "company": "ZYLA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/19/2024",
    "drugName": "FETZIMANDA   #204168",
    "submission": "SUPPL-12",
    "activeIngredients": "LEVOMILNACIPRAN HYDROCHLORIDE",
    "company": "ABBVIE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/19/2024",
    "drugName": "ROXYBONDNDA   #209777",
    "submission": "SUPPL-9",
    "activeIngredients": "OXYCODONE HYDROCHLORIDE",
    "company": "PROTEGA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/19/2024",
    "drugName": "SUBLOCADENDA   #209819",
    "submission": "SUPPL-29",
    "activeIngredients": "BUPRENORPHINE",
    "company": "INDIVIOR",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/19/2024",
    "drugName": "REZENOPYNDA   #215487",
    "submission": "ORIG-1",
    "activeIngredients": "NALOXONE HYDROCHLORIDE",
    "company": "SCIENTURE",
    "submissionClassification": "Type 5 - New Formulation or New Manufacturer",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/19/2024",
    "drugName": "LUMIFY PRESERVATIVE FREENDA   #218424",
    "submission": "ORIG-1",
    "activeIngredients": "BRIMONIDINE TARTRATE",
    "company": "BAUSCH AND LOMB INC",
    "submissionClassification": "Type 5 - New Formulation or New Manufacturer",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/19/2024",
    "drugName": "HALOPERIDOLANDA  #218789",
    "submission": "ORIG-1",
    "activeIngredients": "HALOPERIDOL",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/22/2024",
    "drugName": "EXTRANEALNDA   #021321",
    "submission": "SUPPL-38",
    "activeIngredients": "ICODEXTRIN",
    "company": "VANTIVE US HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/22/2024",
    "drugName": "ESTRADIOLANDA  #216160",
    "submission": "ORIG-1",
    "activeIngredients": "ESTRADIOL",
    "company": "SOLARIS PHARMA CORP",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/22/2024",
    "drugName": "ENZALUTAMIDEANDA  #218187",
    "submission": "ORIG-1",
    "activeIngredients": "ENZALUTAMIDE",
    "company": "TEVA PHARMS INC",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "04/22/2024",
    "drugName": "MINOXIDIL (FOR MEN)ANDA  #218616",
    "submission": "ORIG-1",
    "activeIngredients": "MINOXIDIL",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/22/2024",
    "drugName": "MINOXIDIL (FOR WOMEN)ANDA  #218616",
    "submission": "ORIG-1",
    "activeIngredients": "MINOXIDIL",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/22/2024",
    "drugName": "TECENTRIQBLA   #761034",
    "submission": "SUPPL-53",
    "activeIngredients": "ATEZOLIZUMAB",
    "company": "GENENTECH INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/22/2024",
    "drugName": "IMFINZIBLA   #761069",
    "submission": "SUPPL-48",
    "activeIngredients": "DURVALUMAB",
    "company": "ASTRAZENECA UK LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/22/2024",
    "drugName": "LOQTORZIBLA   #761240",
    "submission": "SUPPL-1",
    "activeIngredients": "TORIPALIMAB-TPZI",
    "company": "COHERUS BIOSCIENCES INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/22/2024",
    "drugName": "ZYNYZBLA   #761334",
    "submission": "SUPPL-2",
    "activeIngredients": "RETIFANLIMAB-DLWR",
    "company": "INCYTE CORP",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/22/2024",
    "drugName": "ANKTIVABLA   #761336",
    "submission": "ORIG-1",
    "activeIngredients": "nogapendekin alfa inbakicept-pmln",
    "company": "ALTOR BIOSCIENCE, LLC, AN INDIRECT WHOLLY-OWNED SU",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/23/2024",
    "drugName": "CAMBIANDA   #022165",
    "submission": "SUPPL-6",
    "activeIngredients": "DICLOFENAC POTASSIUM",
    "company": "ASIO HOLDINGS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/23/2024",
    "drugName": "AMOXICILLINANDA  #062927",
    "submission": "SUPPL-26",
    "activeIngredients": "AMOXICILLIN",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/23/2024",
    "drugName": "AMOXICILLINANDA  #062927",
    "submission": "SUPPL-27",
    "activeIngredients": "AMOXICILLIN",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/23/2024",
    "drugName": "AMOXICILLINANDA  #062927",
    "submission": "SUPPL-28",
    "activeIngredients": "AMOXICILLIN",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/23/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #065191",
    "submission": "SUPPL-32",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "HIKMA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/23/2024",
    "drugName": "LEVETIRACETAMANDA  #091261",
    "submission": "SUPPL-15",
    "activeIngredients": "LEVETIRACETAM",
    "company": "APOTEX INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/23/2024",
    "drugName": "RABEPRAZOLE SODIUMANDA  #202376",
    "submission": "SUPPL-20",
    "activeIngredients": "RABEPRAZOLE SODIUM",
    "company": "TORRENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/23/2024",
    "drugName": "LEVETIRACETAMANDA  #202958",
    "submission": "SUPPL-7",
    "activeIngredients": "LEVETIRACETAM",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/23/2024",
    "drugName": "GLEOLANNDA   #208630",
    "submission": "SUPPL-7",
    "activeIngredients": "AMINOLEVULINIC ACID HYDROCHLORIDE",
    "company": "NXDC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/23/2024",
    "drugName": "LUTATHERANDA   #208700",
    "submission": "SUPPL-31",
    "activeIngredients": "LUTETIUM LU 177 DOTATATE",
    "company": "AAA USA INC",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/23/2024",
    "drugName": "ATORVALIQNDA   #213260",
    "submission": "SUPPL-2",
    "activeIngredients": "ATORVASTATIN CALCIUM",
    "company": "CMP DEV LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/23/2024",
    "drugName": "VERAPAMIL HYDROCHLORIDEANDA  #216471",
    "submission": "ORIG-1",
    "activeIngredients": "VERAPAMIL HYDROCHLORIDE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/23/2024",
    "drugName": "PANTOPRAZOLE SODIUMANDA  #217416",
    "submission": "SUPPL-2",
    "activeIngredients": "PANTOPRAZOLE SODIUM",
    "company": "AJANTA PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/23/2024",
    "drugName": "MOMETASONE FUROATEANDA  #217438",
    "submission": "ORIG-1",
    "activeIngredients": "MOMETASONE FUROATE",
    "company": "APOTEX",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/23/2024",
    "drugName": "OJEMDANDA   #217700",
    "submission": "ORIG-1",
    "activeIngredients": "TOVORAFENIB",
    "company": "DAY ONE BIOPHARMS",
    "submissionClassification": "Type 1 - New Molecular Entity",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/23/2024",
    "drugName": "NALOXONE HYDROCHLORIDEANDA  #217992",
    "submission": "ORIG-1",
    "activeIngredients": "NALOXONE HYDROCHLORIDE",
    "company": "AMNEAL",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/23/2024",
    "drugName": "OJEMDANDA   #218033",
    "submission": "ORIG-1",
    "activeIngredients": "TOVORAFENIB",
    "company": "DAY ONE BIOPHARMS",
    "submissionClassification": "Type 3 - New Dosage Form",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/23/2024",
    "drugName": "PAZOPANIB HYDROCHLORIDEANDA  #218231",
    "submission": "ORIG-1",
    "activeIngredients": "PAZOPANIB HYDROCHLORIDE",
    "company": "NOVUGEN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/24/2024",
    "drugName": "AMPICILLIN TRIHYDRATEANDA  #061502",
    "submission": "SUPPL-138",
    "activeIngredients": "AMPICILLIN/AMPICILLIN TRIHYDRATE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/24/2024",
    "drugName": "AMPICILLIN TRIHYDRATEANDA  #061502",
    "submission": "SUPPL-139",
    "activeIngredients": "AMPICILLIN/AMPICILLIN TRIHYDRATE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/24/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #065089",
    "submission": "SUPPL-21",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "TEVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/24/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #065089",
    "submission": "SUPPL-26",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "TEVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/24/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #065096",
    "submission": "SUPPL-33",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "TEVA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/24/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #065096",
    "submission": "SUPPL-36",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "TEVA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/24/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #065101",
    "submission": "SUPPL-32",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "TEVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/24/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #065101",
    "submission": "SUPPL-35",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "TEVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/24/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #065205",
    "submission": "SUPPL-19",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "TEVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/24/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #065205",
    "submission": "SUPPL-26",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "TEVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/24/2024",
    "drugName": "PIPERACILLIN AND TAZOBACTAMANDA  #065363",
    "submission": "SUPPL-39",
    "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/24/2024",
    "drugName": "PIPERACILLIN AND TAZOBACTAMANDA  #065363",
    "submission": "SUPPL-40",
    "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/24/2024",
    "drugName": "AMPICILLIN SODIUMANDA  #065499",
    "submission": "SUPPL-11",
    "activeIngredients": "AMPICILLIN SODIUM",
    "company": "EUGIA PHARMA SPECLTS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/24/2024",
    "drugName": "NORTRIPTYLINE HYDROCHLORIDEANDA  #074132",
    "submission": "SUPPL-31",
    "activeIngredients": "NORTRIPTYLINE HYDROCHLORIDE",
    "company": "TEVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/24/2024",
    "drugName": "NORETHINDRONE ACETATE AND ETHINYL ESTRADIOLANDA  #202770",
    "submission": "SUPPL-7",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "XIROMED",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/24/2024",
    "drugName": "NORETHINDRONE ACETATE AND ETHINYL ESTRADIOLANDA  #202770",
    "submission": "SUPPL-9",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "XIROMED",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/24/2024",
    "drugName": "CLINOLIPID 20%NDA   #204508",
    "submission": "SUPPL-22",
    "activeIngredients": "OLIVE OIL; SOYBEAN OIL",
    "company": "BAXTER HLTHCARE CORP",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/24/2024",
    "drugName": "BIKTARVYNDA   #210251",
    "submission": "SUPPL-19",
    "activeIngredients": "BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE",
    "company": "GILEAD SCIENCES INC",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/24/2024",
    "drugName": "CETRORELIX ACETATEANDA  #214540",
    "submission": "ORIG-1",
    "activeIngredients": "CETRORELIX ACETATE",
    "company": "LIVZON GRP",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/24/2024",
    "drugName": "LACOSAMIDEANDA  #214695",
    "submission": "SUPPL-2",
    "activeIngredients": "LACOSAMIDE",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/24/2024",
    "drugName": "LACOSAMIDEANDA  #214695",
    "submission": "SUPPL-4",
    "activeIngredients": "LACOSAMIDE",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/24/2024",
    "drugName": "LACOSAMIDEANDA  #214695",
    "submission": "SUPPL-6",
    "activeIngredients": "LACOSAMIDE",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/24/2024",
    "drugName": "LACOSAMIDEANDA  #214695",
    "submission": "SUPPL-7",
    "activeIngredients": "LACOSAMIDE",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/24/2024",
    "drugName": "VIJOICENDA   #215039",
    "submission": "SUPPL-2",
    "activeIngredients": "ALPELISIB",
    "company": "NOVARTIS",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/24/2024",
    "drugName": "LOTEPREDNOL ETABONATEANDA  #215719",
    "submission": "ORIG-1",
    "activeIngredients": "LOTEPREDNOL ETABONATE",
    "company": "LUPIN LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/24/2024",
    "drugName": "PIVYANDA   #216483",
    "submission": "ORIG-1",
    "activeIngredients": "PIVMECILLINAM HYDROCHLORIDE",
    "company": "UTILITY THERAP",
    "submissionClassification": "Type 2 - New Active Ingredient",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/24/2024",
    "drugName": "VIJOICENDA   #218466",
    "submission": "ORIG-1",
    "activeIngredients": "ALPELISIB",
    "company": "NOVARTIS",
    "submissionClassification": "Type 3 - New Dosage Form",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/24/2024",
    "drugName": "FENOFIBRATEANDA  #218548",
    "submission": "ORIG-1",
    "activeIngredients": "FENOFIBRATE",
    "company": "YICHANG HUMANWELL",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2024",
    "drugName": "TRANDATENDA   #018716",
    "submission": "SUPPL-36",
    "activeIngredients": "LABETALOL HYDROCHLORIDE",
    "company": "ALVOGEN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2024",
    "drugName": "ZINC CHLORIDE IN PLASTIC CONTAINERNDA   #018959",
    "submission": "SUPPL-32",
    "activeIngredients": "ZINC CHLORIDE",
    "company": "HOSPIRA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2024",
    "drugName": "GALZINNDA   #020458",
    "submission": "SUPPL-9",
    "activeIngredients": "ZINC ACETATE",
    "company": "ETON",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2024",
    "drugName": "DIGOXINNDA   #021648",
    "submission": "SUPPL-15",
    "activeIngredients": "DIGOXIN",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2024",
    "drugName": "AMRIXNDA   #021777",
    "submission": "SUPPL-19",
    "activeIngredients": "CYCLOBENZAPRINE HYDROCHLORIDE",
    "company": "TEVA PHARMS INTL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2024",
    "drugName": "AMOXICILLINANDA  #062881",
    "submission": "SUPPL-26",
    "activeIngredients": "AMOXICILLIN",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2024",
    "drugName": "AMOXICILLINANDA  #062881",
    "submission": "SUPPL-27",
    "activeIngredients": "AMOXICILLIN",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2024",
    "drugName": "AMOXICILLINANDA  #062881",
    "submission": "SUPPL-28",
    "activeIngredients": "AMOXICILLIN",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2024",
    "drugName": "AMOXICILLINANDA  #062884",
    "submission": "SUPPL-23",
    "activeIngredients": "AMOXICILLIN",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2024",
    "drugName": "AMOXICILLINANDA  #062884",
    "submission": "SUPPL-24",
    "activeIngredients": "AMOXICILLIN",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2024",
    "drugName": "AMOXICILLINANDA  #062884",
    "submission": "SUPPL-25",
    "activeIngredients": "AMOXICILLIN",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2024",
    "drugName": "AMOXICILLINANDA  #064076",
    "submission": "SUPPL-37",
    "activeIngredients": "AMOXICILLIN",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2024",
    "drugName": "AMOXICILLINANDA  #064139",
    "submission": "SUPPL-13",
    "activeIngredients": "AMOXICILLIN",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2024",
    "drugName": "AMOXICILLINANDA  #064139",
    "submission": "SUPPL-14",
    "activeIngredients": "AMOXICILLIN",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2024",
    "drugName": "AMOXICILLINANDA  #064139",
    "submission": "SUPPL-15",
    "activeIngredients": "AMOXICILLIN",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2024",
    "drugName": "AMOXICILLINANDA  #065228",
    "submission": "SUPPL-17",
    "activeIngredients": "AMOXICILLIN",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2024",
    "drugName": "AMOXICILLINANDA  #065228",
    "submission": "SUPPL-19",
    "activeIngredients": "AMOXICILLIN",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2024",
    "drugName": "AMOXICILLINANDA  #065255",
    "submission": "SUPPL-25",
    "activeIngredients": "AMOXICILLIN",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2024",
    "drugName": "AMOXICILLINANDA  #065325",
    "submission": "SUPPL-32",
    "activeIngredients": "AMOXICILLIN",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2024",
    "drugName": "AMOXICILLINANDA  #065344",
    "submission": "SUPPL-5",
    "activeIngredients": "AMOXICILLIN",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2024",
    "drugName": "AMOXICILLINANDA  #065344",
    "submission": "SUPPL-6",
    "activeIngredients": "AMOXICILLIN",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2024",
    "drugName": "AMOXICILLINANDA  #065344",
    "submission": "SUPPL-7",
    "activeIngredients": "AMOXICILLIN",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2024",
    "drugName": "AMOXICILLINANDA  #065378",
    "submission": "SUPPL-18",
    "activeIngredients": "AMOXICILLIN",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2024",
    "drugName": "AMOXICILLINANDA  #065387",
    "submission": "SUPPL-18",
    "activeIngredients": "AMOXICILLIN",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2024",
    "drugName": "VIORELEANDA  #091346",
    "submission": "SUPPL-16",
    "activeIngredients": "DESOGESTREL; ETHINYL ESTRADIOL",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #201090",
    "submission": "SUPPL-5",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #201090",
    "submission": "SUPPL-11",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2024",
    "drugName": "BRINZOLAMIDEANDA  #204884",
    "submission": "SUPPL-7",
    "activeIngredients": "BRINZOLAMIDE",
    "company": "BAUSCH AND LOMB",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2024",
    "drugName": "OTEZLANDA   #205437",
    "submission": "SUPPL-13",
    "activeIngredients": "APREMILAST",
    "company": "AMGEN INC",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2024",
    "drugName": "SEVELAMER CARBONATEANDA  #207291",
    "submission": "ORIG-1",
    "activeIngredients": "SEVELAMER CARBONATE",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2024",
    "drugName": "SAFINAMIDE MESYLATEANDA  #215739",
    "submission": "ORIG-1",
    "activeIngredients": "SAFINAMIDE MESYLATE",
    "company": "PRINSTON INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2024",
    "drugName": "DEFLAZACORTANDA  #217813",
    "submission": "ORIG-1",
    "activeIngredients": "DEFLAZACORT",
    "company": "TRIS PHARMA INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2024",
    "drugName": "CETRORELIX ACETATEANDA  #218150",
    "submission": "ORIG-1",
    "activeIngredients": "CETRORELIX ACETATE",
    "company": "GLAND",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2024",
    "drugName": "DIAZEPAMANDA  #218450",
    "submission": "ORIG-1",
    "activeIngredients": "DIAZEPAM",
    "company": "ALEMBIC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2024",
    "drugName": "TRETINOINANDA  #218561",
    "submission": "ORIG-1",
    "activeIngredients": "TRETINOIN",
    "company": "ZYDUS LIFESCIENCES",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2024",
    "drugName": "HERCESSIBLA   #761346",
    "submission": "ORIG-1",
    "activeIngredients": "TRASTUZUMAB-STRF",
    "company": "ACCORD BIOPHARMA INC.",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/26/2024",
    "drugName": "CLINDAMYCIN PHOSPHATEANDA  #064050",
    "submission": "SUPPL-24",
    "activeIngredients": "CLINDAMYCIN PHOSPHATE",
    "company": "PADAGIS US",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/26/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #065162",
    "submission": "SUPPL-29",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "TEVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/26/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #065162",
    "submission": "SUPPL-32",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "TEVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/26/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #065162",
    "submission": "SUPPL-36",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "TEVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/26/2024",
    "drugName": "RINVOQNDA   #211675",
    "submission": "SUPPL-21",
    "activeIngredients": "UPADACITINIB",
    "company": "ABBVIE",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/26/2024",
    "drugName": "RINVOQNDA   #211675",
    "submission": "SUPPL-22",
    "activeIngredients": "UPADACITINIB",
    "company": "ABBVIE",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/26/2024",
    "drugName": "ZILBRYSQNDA   #216834",
    "submission": "SUPPL-1",
    "activeIngredients": "ZILUCOPLAN SODIUM",
    "company": "UCB INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/26/2024",
    "drugName": "BINIMETINIBANDA  #217678",
    "submission": "ORIG-1",
    "activeIngredients": "BINIMETINIB",
    "company": "ALEMBIC PHARMS LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "04/26/2024",
    "drugName": "ACETAMINOPHEN AND IBUPROFENANDA  #218311",
    "submission": "ORIG-1",
    "activeIngredients": "ACETAMINOPHEN; IBUPROFEN",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/26/2024",
    "drugName": "RINVOQ LQNDA   #218347",
    "submission": "ORIG-1",
    "activeIngredients": "UPADACITINIB",
    "company": "ABBVIE",
    "submissionClassification": "Type 3 - New Dosage Form",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/26/2024",
    "drugName": "XOLREMDINDA   #218709",
    "submission": "ORIG-1",
    "activeIngredients": "MAVORIXAFOR",
    "company": "X4 PHARMS",
    "submissionClassification": "Type 1 - New Molecular Entity",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/27/2024",
    "drugName": "PIPERACILLIN AND TAZOBACTAMANDA  #065363",
    "submission": "SUPPL-36",
    "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/29/2024",
    "drugName": "LANOXINNDA   #020405",
    "submission": "SUPPL-17",
    "activeIngredients": "DIGOXIN",
    "company": "ADVANZ PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/29/2024",
    "drugName": "TRUVADANDA   #021752",
    "submission": "SUPPL-64",
    "activeIngredients": "EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE",
    "company": "GILEAD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/29/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #065063",
    "submission": "SUPPL-48",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/29/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #065064",
    "submission": "SUPPL-47",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/29/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #065065",
    "submission": "SUPPL-34",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/29/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #065066",
    "submission": "SUPPL-45",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/29/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #065189",
    "submission": "SUPPL-28",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/29/2024",
    "drugName": "TAGRISSONDA   #208065",
    "submission": "SUPPL-31",
    "activeIngredients": "OSIMERTINIB MESYLATE",
    "company": "ASTRAZENECA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/29/2024",
    "drugName": "COLCHICINEANDA  #210757",
    "submission": "ORIG-1",
    "activeIngredients": "COLCHICINE",
    "company": "GRANULES",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/29/2024",
    "drugName": "EZETIMIBEANDA  #211159",
    "submission": "ORIG-1",
    "activeIngredients": "EZETIMIBE",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/29/2024",
    "drugName": "GIVLAARINDA   #212194",
    "submission": "SUPPL-7",
    "activeIngredients": "GIVOSIRAN SODIUM",
    "company": "ALNYLAM PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/29/2024",
    "drugName": "LUPKYNISNDA   #213716",
    "submission": "SUPPL-4",
    "activeIngredients": "VOCLOSPORIN",
    "company": "AURINIA",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/29/2024",
    "drugName": "DARUNAVIR; COBICISTATANDA  #215036",
    "submission": "ORIG-1",
    "activeIngredients": "DARUNAVIR;COBICISTAT",
    "company": "MYLAN PHARMS INC",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "04/29/2024",
    "drugName": "COLCHICINEANDA  #215463",
    "submission": "ORIG-1",
    "activeIngredients": "COLCHICINE",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/29/2024",
    "drugName": "MIDOSTAURINANDA  #216076",
    "submission": "ORIG-1",
    "activeIngredients": "MIDOSTAURIN",
    "company": "TEVA PHARMS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/29/2024",
    "drugName": "COLCHICINEANDA  #217620",
    "submission": "ORIG-1",
    "activeIngredients": "COLCHICINE",
    "company": "ANNORA PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/29/2024",
    "drugName": "ATROPINE SULFATEANDA  #217791",
    "submission": "ORIG-1",
    "activeIngredients": "ATROPINE SULFATE",
    "company": "SOMERSET",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/29/2024",
    "drugName": "TRETINOINANDA  #217804",
    "submission": "ORIG-1",
    "activeIngredients": "TRETINOIN",
    "company": "ALEMBIC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/29/2024",
    "drugName": "LIDOCAINE HYDROCHLORIDEANDA  #218411",
    "submission": "ORIG-1",
    "activeIngredients": "LIDOCAINE HYDROCHLORIDE",
    "company": "THE J MOLNER",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/29/2024",
    "drugName": "BESREMIBLA   #761166",
    "submission": "SUPPL-7",
    "activeIngredients": "ROPEGINTERFERON ALFA-2B-NJFT",
    "company": "PHARMAESSENTIA CORP",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/29/2024",
    "drugName": "TIVDAKBLA   #761208",
    "submission": "SUPPL-7",
    "activeIngredients": "TISOTUMAB VEDOTIN-TFTV",
    "company": "SEAGEN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/29/2024",
    "drugName": "OMVOHBLA   #761279",
    "submission": "SUPPL-1",
    "activeIngredients": "MIRIKIZUMAB-MRKZ",
    "company": "ELI LILLY AND CO",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2024",
    "drugName": "NICORETTENDA   #022360",
    "submission": "SUPPL-17",
    "activeIngredients": "NICOTINE POLACRILEX",
    "company": "HALEON US HOLDINGS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2024",
    "drugName": "MEPERIDINE HYDROCHLORIDEANDA  #040186",
    "submission": "SUPPL-13",
    "activeIngredients": "MEPERIDINE HYDROCHLORIDE",
    "company": "WATSON LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2024",
    "drugName": "URSODIOLANDA  #075517",
    "submission": "SUPPL-18",
    "activeIngredients": "URSODIOL",
    "company": "EPIC PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2024",
    "drugName": "NICOTINE POLACRILEXANDA  #076778",
    "submission": "SUPPL-19",
    "activeIngredients": "NICOTINE POLACRILEX",
    "company": "L PERRIGO CO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2024",
    "drugName": "SOTALOL HYDROCHLORIDEANDA  #077616",
    "submission": "SUPPL-5",
    "activeIngredients": "SOTALOL HYDROCHLORIDE",
    "company": "AUROBINDO PHARMA USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2024",
    "drugName": "SOTALOL HYDROCHLORIDEANDA  #077616",
    "submission": "SUPPL-8",
    "activeIngredients": "SOTALOL HYDROCHLORIDE",
    "company": "AUROBINDO PHARMA USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2024",
    "drugName": "MEPERIDINE HYDROCHLORIDEANDA  #080448",
    "submission": "SUPPL-23",
    "activeIngredients": "MEPERIDINE HYDROCHLORIDE",
    "company": "SUN PHARM INDUSTRIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #090227",
    "submission": "SUPPL-18",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2024",
    "drugName": "EPOGEN/PROCRITBLA   #103234",
    "submission": "SUPPL-5378",
    "activeIngredients": "EPOETIN ALFA",
    "company": "AMGEN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2024",
    "drugName": "ARANESPBLA   #103951",
    "submission": "SUPPL-5383",
    "activeIngredients": "DARBEPOETIN ALFA",
    "company": "AMGEN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2024",
    "drugName": "MIRCERABLA   #125164",
    "submission": "SUPPL-89",
    "activeIngredients": "METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA",
    "company": "HOFFMAN-LA ROCHE",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2024",
    "drugName": "VALSARTAN AND HYDROCHLOROTHIAZIDEANDA  #201662",
    "submission": "SUPPL-26",
    "activeIngredients": "HYDROCHLOROTHIAZIDE; VALSARTAN",
    "company": "ALEMBIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2024",
    "drugName": "LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDEANDA  #201845",
    "submission": "SUPPL-20",
    "activeIngredients": "HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM",
    "company": "JUBILANT CADISTA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2024",
    "drugName": "HYDROCHLOROTHIAZIDEANDA  #202556",
    "submission": "SUPPL-8",
    "activeIngredients": "HYDROCHLOROTHIAZIDE",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2024",
    "drugName": "NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATEANDA  #202742",
    "submission": "SUPPL-10",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "XIROMED",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2024",
    "drugName": "NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATEANDA  #202742",
    "submission": "SUPPL-12",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "XIROMED",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2024",
    "drugName": "VALSARTAN AND HYDROCHLOROTHIAZIDEANDA  #203000",
    "submission": "SUPPL-1",
    "activeIngredients": "HYDROCHLOROTHIAZIDE; VALSARTAN",
    "company": "ZYDUS LIFESCIENCES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2024",
    "drugName": "VALSARTAN AND HYDROCHLOROTHIAZIDEANDA  #203000",
    "submission": "SUPPL-2",
    "activeIngredients": "HYDROCHLOROTHIAZIDE; VALSARTAN",
    "company": "ZYDUS LIFESCIENCES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2024",
    "drugName": "HYDROCHLOROTHIAZIDEANDA  #203561",
    "submission": "SUPPL-3",
    "activeIngredients": "HYDROCHLOROTHIAZIDE",
    "company": "SCIEGEN PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2024",
    "drugName": "HYDROCHLOROTHIAZIDEANDA  #203561",
    "submission": "SUPPL-5",
    "activeIngredients": "HYDROCHLOROTHIAZIDE",
    "company": "SCIEGEN PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2024",
    "drugName": "LINEZOLIDANDA  #204536",
    "submission": "SUPPL-7",
    "activeIngredients": "LINEZOLID",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2024",
    "drugName": "LINEZOLIDANDA  #204536",
    "submission": "SUPPL-8",
    "activeIngredients": "LINEZOLID",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2024",
    "drugName": "LINEZOLIDANDA  #204536",
    "submission": "SUPPL-9",
    "activeIngredients": "LINEZOLID",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2024",
    "drugName": "PITAVASTATIN CALCIUMANDA  #205977",
    "submission": "ORIG-1",
    "activeIngredients": "PITAVASTATIN CALCIUM",
    "company": "HETERO LABS LTD V",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2024",
    "drugName": "EVEROLIMUSANDA  #206133",
    "submission": "SUPPL-6",
    "activeIngredients": "EVEROLIMUS",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2024",
    "drugName": "SEVELAMER CARBONATEANDA  #207179",
    "submission": "SUPPL-11",
    "activeIngredients": "SEVELAMER CARBONATE",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2024",
    "drugName": "ESOMEPRAZOLE MAGNESIUMANDA  #207198",
    "submission": "ORIG-1",
    "activeIngredients": "ESOMEPRAZOLE MAGNESIUM",
    "company": "DR REDDYS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2024",
    "drugName": "EZETIMIBEANDA  #207311",
    "submission": "SUPPL-12",
    "activeIngredients": "EZETIMIBE",
    "company": "OHM LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2024",
    "drugName": "HYDROCORTISONE BUTYRATEANDA  #209556",
    "submission": "SUPPL-4",
    "activeIngredients": "HYDROCORTISONE BUTYRATE",
    "company": "THE J MOLNER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2024",
    "drugName": "DIMETHYL FUMARATEANDA  #210531",
    "submission": "SUPPL-3",
    "activeIngredients": "DIMETHYL FUMARATE",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2024",
    "drugName": "DIMETHYL FUMARATEANDA  #210531",
    "submission": "SUPPL-6",
    "activeIngredients": "DIMETHYL FUMARATE",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2024",
    "drugName": "DIMETHYL FUMARATEANDA  #210531",
    "submission": "SUPPL-10",
    "activeIngredients": "DIMETHYL FUMARATE",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2024",
    "drugName": "DIMETHYL FUMARATEANDA  #210531",
    "submission": "SUPPL-12",
    "activeIngredients": "DIMETHYL FUMARATE",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2024",
    "drugName": "DIMETHYL FUMARATEANDA  #210531",
    "submission": "SUPPL-13",
    "activeIngredients": "DIMETHYL FUMARATE",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2024",
    "drugName": "DOFETILIDEANDA  #212750",
    "submission": "SUPPL-2",
    "activeIngredients": "DOFETILIDE",
    "company": "GRANULES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2024",
    "drugName": "ELTROMBOPAGANDA  #212884",
    "submission": "ORIG-1",
    "activeIngredients": "ELTROMBOPAG",
    "company": "AMNEAL EU LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "04/30/2024",
    "drugName": "MYFEMBREENDA   #214846",
    "submission": "SUPPL-7",
    "activeIngredients": "ESTRADIOL; NORETHINDRONE ACETATE; RELUGOLIX",
    "company": "SUMITOMO PHARMA AM",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2024",
    "drugName": "CAMZYOSNDA   #214998",
    "submission": "SUPPL-9",
    "activeIngredients": "MAVACAMTEN",
    "company": "BRISTOL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2024",
    "drugName": "CUPRIC CHLORIDEANDA  #216113",
    "submission": "ORIG-1",
    "activeIngredients": "CUPRIC CHLORIDE",
    "company": "SOMERSET",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2024",
    "drugName": "CUPRIC CHLORIDEANDA  #217626",
    "submission": "ORIG-1",
    "activeIngredients": "CUPRIC CHLORIDE",
    "company": "RK PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2024",
    "drugName": "INGREZZA SPRINKLENDA   #218390",
    "submission": "ORIG-1",
    "activeIngredients": "VALBENAZINE TOSYLATE",
    "company": "NEUROCRINE",
    "submissionClassification": "Type 3 - New Dosage Form",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2024",
    "drugName": "CYLTEZOBLA   #761058",
    "submission": "SUPPL-26",
    "activeIngredients": "ADALIMUMAB-ADBM",
    "company": "BOEHRINGER INGELHEIM",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2024",
    "drugName": "ABRILADABLA   #761118",
    "submission": "SUPPL-12",
    "activeIngredients": "ADALIMUMAB-AFZB",
    "company": "PFIZER INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  }
,
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMOXILNDA   #050542",
    "submission": "SUPPL-32",
    "activeIngredients": "AMOXICILLIN",
    "company": "US ANTIBIOTICS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AUGMENTIN '250'NDA   #050564",
    "submission": "SUPPL-60",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "US ANTIBIOTICS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AUGMENTIN '500'NDA   #050564",
    "submission": "SUPPL-60",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "US ANTIBIOTICS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AUGMENTIN '125'NDA   #050575",
    "submission": "SUPPL-51",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "US ANTIBIOTICS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AUGMENTIN '250'NDA   #050575",
    "submission": "SUPPL-51",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "US ANTIBIOTICS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AUGMENTIN '125'NDA   #050597",
    "submission": "SUPPL-52",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "US ANTIBIOTICS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AUGMENTIN '250'NDA   #050597",
    "submission": "SUPPL-52",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "US ANTIBIOTICS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "UNASYNNDA   #050608",
    "submission": "SUPPL-53",
    "activeIngredients": "AMPICILLIN SODIUM; SULBACTAM SODIUM",
    "company": "PFIZER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "ZOSYNNDA   #050684",
    "submission": "SUPPL-104",
    "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
    "company": "WYETH PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AUGMENTIN '875'NDA   #050720",
    "submission": "SUPPL-37",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "US ANTIBIOTICS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AUGMENTIN '200'NDA   #050725",
    "submission": "SUPPL-36",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "US ANTIBIOTICS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AUGMENTIN '400'NDA   #050725",
    "submission": "SUPPL-36",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "US ANTIBIOTICS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AUGMENTIN '200'NDA   #050726",
    "submission": "SUPPL-27",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "US ANTIBIOTICS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AUGMENTIN '400'NDA   #050726",
    "submission": "SUPPL-27",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "US ANTIBIOTICS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "ZOSYN IN PLASTIC CONTAINERNDA   #050750",
    "submission": "SUPPL-51",
    "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
    "company": "BAXTER HLTHCARE CORP",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMOXILNDA   #050754",
    "submission": "SUPPL-22",
    "activeIngredients": "AMOXICILLIN",
    "company": "US ANTIBIOTICS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AUGMENTIN ES-600NDA   #050755",
    "submission": "SUPPL-29",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "US ANTIBIOTICS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMOXILNDA   #050760",
    "submission": "SUPPL-23",
    "activeIngredients": "AMOXICILLIN",
    "company": "US ANTIBIOTICS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMOXILNDA   #050761",
    "submission": "SUPPL-19",
    "activeIngredients": "AMOXICILLIN",
    "company": "US ANTIBIOTICS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AUGMENTIN XRNDA   #050785",
    "submission": "SUPPL-18",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "US ANTIBIOTICS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "MOXATAGNDA   #050813",
    "submission": "SUPPL-10",
    "activeIngredients": "AMOXICILLIN",
    "company": "PRAGMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "OMECLAMOX-PAKNDA   #050824",
    "submission": "SUPPL-13",
    "activeIngredients": "AMOXICILLIN; CLARITHROMYCIN; OMEPRAZOLE",
    "company": "CUMBERLAND",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMPICILLIN SODIUMANDA  #061395",
    "submission": "SUPPL-52",
    "activeIngredients": "AMPICILLIN SODIUM",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMPICILLIN TRIHYDRATEANDA  #061502",
    "submission": "SUPPL-140",
    "activeIngredients": "AMPICILLIN/AMPICILLIN TRIHYDRATE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "PROBAMPACINANDA  #061741",
    "submission": "SUPPL-1",
    "activeIngredients": "AMPICILLIN/AMPICILLIN TRIHYDRATE; PROBENECID",
    "company": "COSETTE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMOXICILLINANDA  #061926",
    "submission": "SUPPL-136",
    "activeIngredients": "AMOXICILLIN",
    "company": "TEVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMOXICILLINANDA  #061931",
    "submission": "SUPPL-60",
    "activeIngredients": "AMOXICILLIN",
    "company": "TEVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMOXICILLIN PEDIATRICANDA  #061931",
    "submission": "SUPPL-60",
    "activeIngredients": "AMOXICILLIN",
    "company": "TEVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMOXICILLINANDA  #062058",
    "submission": "SUPPL-15",
    "activeIngredients": "AMOXICILLIN",
    "company": "CHARTWELL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMOXICILLINANDA  #062059",
    "submission": "SUPPL-6",
    "activeIngredients": "AMOXICILLIN",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMOXILANDA  #062216",
    "submission": "SUPPL-44",
    "activeIngredients": "AMOXICILLIN",
    "company": "US ANTIBIOTICS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMOXILANDA  #062226",
    "submission": "SUPPL-40",
    "activeIngredients": "AMOXICILLIN",
    "company": "US ANTIBIOTICS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "LAROTIDANDA  #062226",
    "submission": "SUPPL-40",
    "activeIngredients": "AMOXICILLIN",
    "company": "US ANTIBIOTICS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMPICILLIN SODIUMANDA  #062692",
    "submission": "SUPPL-2",
    "activeIngredients": "AMPICILLIN SODIUM",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMPICILLIN SODIUMANDA  #062719",
    "submission": "SUPPL-16",
    "activeIngredients": "AMPICILLIN SODIUM",
    "company": "ISTITUTO BIO ITA SPA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMPICILLIN SODIUMANDA  #062738",
    "submission": "SUPPL-33",
    "activeIngredients": "AMPICILLIN SODIUM",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMPICILLIN SODIUMANDA  #062772",
    "submission": "SUPPL-17",
    "activeIngredients": "AMPICILLIN SODIUM",
    "company": "HQ SPECLT PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMPICILLIN SODIUMANDA  #062797",
    "submission": "SUPPL-13",
    "activeIngredients": "AMPICILLIN SODIUM",
    "company": "ISTITUTO BIO ITA SPA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMOXICILLINANDA  #062881",
    "submission": "SUPPL-29",
    "activeIngredients": "AMOXICILLIN",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMPICILLIN TRIHYDRATEANDA  #062882",
    "submission": "SUPPL-17",
    "activeIngredients": "AMPICILLIN/AMPICILLIN TRIHYDRATE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMPICILLIN TRIHYDRATEANDA  #062883",
    "submission": "SUPPL-15",
    "activeIngredients": "AMPICILLIN/AMPICILLIN TRIHYDRATE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMOXICILLINANDA  #062884",
    "submission": "SUPPL-26",
    "activeIngredients": "AMOXICILLIN",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMOXICILLINANDA  #062927",
    "submission": "SUPPL-29",
    "activeIngredients": "AMOXICILLIN",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMPICILLIN TRIHYDRATEANDA  #062982",
    "submission": "SUPPL-16",
    "activeIngredients": "AMPICILLIN/AMPICILLIN TRIHYDRATE",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMPICILLIN SODIUMANDA  #063142",
    "submission": "SUPPL-18",
    "activeIngredients": "AMPICILLIN SODIUM",
    "company": "HQ SPECLT PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMOXICILLINANDA  #064013",
    "submission": "SUPPL-64",
    "activeIngredients": "AMOXICILLIN",
    "company": "TEVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMOXICILLINANDA  #064076",
    "submission": "SUPPL-38",
    "activeIngredients": "AMOXICILLIN",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMPICILLIN TRIHYDRATEANDA  #064082",
    "submission": "SUPPL-22",
    "activeIngredients": "AMPICILLIN/AMPICILLIN TRIHYDRATE",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMOXICILLINANDA  #064139",
    "submission": "SUPPL-16",
    "activeIngredients": "AMOXICILLIN",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMOXICILLINANDA  #065056",
    "submission": "SUPPL-26",
    "activeIngredients": "AMOXICILLIN",
    "company": "TEVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #065063",
    "submission": "SUPPL-51",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #065064",
    "submission": "SUPPL-50",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #065065",
    "submission": "SUPPL-35",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #065066",
    "submission": "SUPPL-50",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #065089",
    "submission": "SUPPL-30",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "TEVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #065093",
    "submission": "SUPPL-33",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "SANDOZ INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #065096",
    "submission": "SUPPL-39",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "TEVA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #065098",
    "submission": "SUPPL-25",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "SANDOZ INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #065101",
    "submission": "SUPPL-38",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "TEVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "PIPERACILLINANDA  #065114",
    "submission": "SUPPL-18",
    "activeIngredients": "PIPERACILLIN SODIUM",
    "company": "ISTITUTO BIO ITA SPA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #065117",
    "submission": "SUPPL-34",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "SANDOZ INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMOXICILLINANDA  #065119",
    "submission": "SUPPL-33",
    "activeIngredients": "AMOXICILLIN",
    "company": "TEVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "PIPERACILLINANDA  #065157",
    "submission": "SUPPL-15",
    "activeIngredients": "PIPERACILLIN SODIUM",
    "company": "ISTITUTO BIO ITA SPA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #065162",
    "submission": "SUPPL-40",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "TEVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #065189",
    "submission": "SUPPL-30",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #065191",
    "submission": "SUPPL-35",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "HIKMA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #065205",
    "submission": "SUPPL-30",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "TEVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMOXICILLINANDA  #065228",
    "submission": "SUPPL-20",
    "activeIngredients": "AMOXICILLIN",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMOXICILLINANDA  #065255",
    "submission": "SUPPL-28",
    "activeIngredients": "AMOXICILLIN",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMOXICILLINANDA  #065256",
    "submission": "SUPPL-25",
    "activeIngredients": "AMOXICILLIN",
    "company": "AUROBINDO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMOXICILLINANDA  #065271",
    "submission": "SUPPL-25",
    "activeIngredients": "AMOXICILLIN",
    "company": "AUROBINDO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMOXICILLINANDA  #065291",
    "submission": "SUPPL-33",
    "activeIngredients": "AMOXICILLIN",
    "company": "HIKMA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #065317",
    "submission": "SUPPL-4",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "APOTEX INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMOXICILLINANDA  #065322",
    "submission": "SUPPL-39",
    "activeIngredients": "AMOXICILLIN",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMOXICILLINANDA  #065325",
    "submission": "SUPPL-35",
    "activeIngredients": "AMOXICILLIN",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #065333",
    "submission": "SUPPL-4",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "APOTEX INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMOXICILLINANDA  #065334",
    "submission": "SUPPL-25",
    "activeIngredients": "AMOXICILLIN",
    "company": "AUROBINDO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMOXICILLINANDA  #065344",
    "submission": "SUPPL-8",
    "activeIngredients": "AMOXICILLIN",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "PIPERACILLIN AND TAZOBACTAMANDA  #065362",
    "submission": "SUPPL-44",
    "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "PIPERACILLIN AND TAZOBACTAMANDA  #065363",
    "submission": "SUPPL-47",
    "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #065373",
    "submission": "SUPPL-23",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "HIKMA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #065373",
    "submission": "SUPPL-27",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "HIKMA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #065373",
    "submission": "SUPPL-30",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "HIKMA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMOXICILLINANDA  #065378",
    "submission": "SUPPL-19",
    "activeIngredients": "AMOXICILLIN",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMOXICILLINANDA  #065387",
    "submission": "SUPPL-19",
    "activeIngredients": "AMOXICILLIN",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "PIPERACILLIN AND TAZOBACTAMANDA  #065458",
    "submission": "SUPPL-16",
    "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
    "company": "ONESOURCE SPECIALTY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMPICILLIN SODIUMANDA  #065493",
    "submission": "SUPPL-11",
    "activeIngredients": "AMPICILLIN SODIUM",
    "company": "EUGIA PHARMA SPECLTS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "PIPERACILLIN AND TAZOBACTAMANDA  #065498",
    "submission": "SUPPL-26",
    "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
    "company": "EUGIA PHARMA SPECLTS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMPICILLIN SODIUMANDA  #065499",
    "submission": "SUPPL-13",
    "activeIngredients": "AMPICILLIN SODIUM",
    "company": "EUGIA PHARMA SPECLTS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "PIPERACILLIN AND TAZOBACTAMANDA  #065523",
    "submission": "SUPPL-30",
    "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
    "company": "ISTITUTO BIO ITA SPA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #090227",
    "submission": "SUPPL-19",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMPICILLIN SODIUMANDA  #090354",
    "submission": "SUPPL-7",
    "activeIngredients": "AMPICILLIN SODIUM",
    "company": "ANTIBIOTICE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "PIPERACILLIN AND TAZOBACTAMANDA  #090498",
    "submission": "SUPPL-24",
    "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
    "company": "ISTITUTO BIO ITA SPA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMPICILLIN SODIUMANDA  #090581",
    "submission": "SUPPL-5",
    "activeIngredients": "AMPICILLIN SODIUM",
    "company": "SAGENT PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMPICILLIN SODIUMANDA  #090583",
    "submission": "SUPPL-5",
    "activeIngredients": "AMPICILLIN SODIUM",
    "company": "SAGENT PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMPICILLIN SODIUMANDA  #090884",
    "submission": "SUPPL-3",
    "activeIngredients": "AMPICILLIN SODIUM",
    "company": "ACS DOBFAR SPA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMPICILLIN SODIUMANDA  #090889",
    "submission": "SUPPL-3",
    "activeIngredients": "AMPICILLIN SODIUM",
    "company": "ACS DOBFAR SPA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN (COPACKAGED)ANDA  #200218",
    "submission": "SUPPL-12",
    "activeIngredients": "AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE",
    "company": "ANI PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMPICILLIN SODIUMANDA  #201025",
    "submission": "SUPPL-10",
    "activeIngredients": "AMPICILLIN SODIUM",
    "company": "ONESOURCE SPECIALTY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #201090",
    "submission": "SUPPL-14",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #201091",
    "submission": "SUPPL-13",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMPICILLIN SODIUMANDA  #201404",
    "submission": "SUPPL-8",
    "activeIngredients": "AMPICILLIN SODIUM",
    "company": "ISTITUTO BIO ITA SPA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMPICILLIN SODIUMANDA  #202198",
    "submission": "SUPPL-7",
    "activeIngredients": "AMPICILLIN SODIUM",
    "company": "ONESOURCE SPECIALTY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "PIPERACILLIN AND TAZOBACTAMANDA  #203557",
    "submission": "SUPPL-35",
    "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "PIPERACILLIN AND TAZOBACTAMANDA  #203719",
    "submission": "SUPPL-12",
    "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
    "company": "FRESENIUS KABI",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "PIPERACILLIN AND TAZOBACTAMANDA  #203720",
    "submission": "SUPPL-11",
    "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
    "company": "FRESENIUS KABI",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "DEXMEDETOMIDINE HYDROCHLORIDEANDA  #203972",
    "submission": "SUPPL-14",
    "activeIngredients": "DEXMEDETOMIDINE HYDROCHLORIDE",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "DEXMEDETOMIDINE HYDROCHLORIDEANDA  #203972",
    "submission": "SUPPL-15",
    "activeIngredients": "DEXMEDETOMIDINE HYDROCHLORIDE",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMOXICILLINANDA  #204030",
    "submission": "SUPPL-13",
    "activeIngredients": "AMOXICILLIN",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "OXYMORPHONE HYDROCHLORIDEANDA  #204459",
    "submission": "SUPPL-7",
    "activeIngredients": "OXYMORPHONE HYDROCHLORIDE",
    "company": "AUROLIFE PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "OXYMORPHONE HYDROCHLORIDEANDA  #204459",
    "submission": "SUPPL-8",
    "activeIngredients": "OXYMORPHONE HYDROCHLORIDE",
    "company": "AUROLIFE PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "OXYMORPHONE HYDROCHLORIDEANDA  #204459",
    "submission": "SUPPL-9",
    "activeIngredients": "OXYMORPHONE HYDROCHLORIDE",
    "company": "AUROLIFE PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "OXYMORPHONE HYDROCHLORIDEANDA  #204459",
    "submission": "SUPPL-10",
    "activeIngredients": "OXYMORPHONE HYDROCHLORIDE",
    "company": "AUROLIFE PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "ETODOLACANDA  #204729",
    "submission": "ORIG-1",
    "activeIngredients": "ETODOLAC",
    "company": "IPCA LABS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #204755",
    "submission": "SUPPL-12",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "MICRO LABS LTD INDIA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "PIPERACILLIN AND TAZOBACTAMANDA  #204959",
    "submission": "SUPPL-13",
    "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
    "company": "SHANDONG",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #205187",
    "submission": "SUPPL-4",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "MICRO LABS LTD INDIA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #205707",
    "submission": "SUPPL-12",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "MICRO LABS LTD INDIA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "PIPERACILLIN AND TAZOBACTAMANDA  #206996",
    "submission": "SUPPL-9",
    "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
    "company": "WOCKHARDT BIO AG",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "PIPERACILLIN AND TAZOBACTAMANDA  #207146",
    "submission": "SUPPL-9",
    "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
    "company": "WOCKHARDT BIO AG",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMOXICILLINANDA  #207471",
    "submission": "SUPPL-2",
    "activeIngredients": "AMOXICILLIN",
    "company": "MICRO LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "PIPERACILLIN AND TAZOBACTAMANDA  #207847",
    "submission": "SUPPL-15",
    "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
    "company": "MILLA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "PIPERACILLIN AND TAZOBACTAMANDA  #207848",
    "submission": "SUPPL-15",
    "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
    "company": "MILLA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "DEXMEDETOMIDINE HYDROCHLORIDEANDA  #208266",
    "submission": "SUPPL-9",
    "activeIngredients": "DEXMEDETOMIDINE HYDROCHLORIDE",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "PIPERACILLIN AND TAZOBACTAMANDA  #208674",
    "submission": "SUPPL-5",
    "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
    "company": "SAGENT PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "PIPERACILLIN AND TAZOBACTAMANDA  #208675",
    "submission": "SUPPL-5",
    "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
    "company": "SAGENT PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "MYCOPHENOLATE MOFETILANDA  #212634",
    "submission": "SUPPL-1",
    "activeIngredients": "MYCOPHENOLATE MOFETIL",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "TALICIANDA   #213004",
    "submission": "SUPPL-14",
    "activeIngredients": "AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN",
    "company": "REDHILL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "VOQUEZNA TRIPLE PAKNDA   #215152",
    "submission": "SUPPL-7",
    "activeIngredients": "AMOXICILLIN; CLARITHROMYCIN; VONOPRAZAN FUMARATE",
    "company": "PHATHOM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "VOQUEZNA DUAL PAKNDA   #215153",
    "submission": "SUPPL-7",
    "activeIngredients": "AMOXICILLIN; VONOPRAZAN FUMARATE",
    "company": "PHATHOM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "MYHIBBINNDA   #216482",
    "submission": "ORIG-1",
    "activeIngredients": "MYCOPHENOLATE MOFETIL",
    "company": "AZURITY",
    "submissionClassification": "Type 5 - New Formulation or New Manufacturer",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "AMPICILLIN TRIHYDRATEANDA  #216554",
    "submission": "SUPPL-1",
    "activeIngredients": "AMPICILLIN/AMPICILLIN TRIHYDRATE",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "PIPERACILLIN AND TAZOBACTAMANDA  #217243",
    "submission": "SUPPL-4",
    "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
    "company": "SHANDONG",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "PIPERACILLIN AND TAZOBACTAMANDA  #217409",
    "submission": "SUPPL-1",
    "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
    "company": "EUGIA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "PIPERACILLIN AND TAZOBACTAMANDA  #217409",
    "submission": "SUPPL-1",
    "activeIngredients": "PIPERACILLIN,TAZOBACTAM",
    "company": "EUGIA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2024",
    "drugName": "OSELTAMIVIR PHOSPHATEANDA  #218565",
    "submission": "ORIG-1",
    "activeIngredients": "OSELTAMIVIR PHOSPHATE",
    "company": "LAURUS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/02/2024",
    "drugName": "LANSOPRAZOLEANDA  #201921",
    "submission": "SUPPL-8",
    "activeIngredients": "LANSOPRAZOLE",
    "company": "NATCO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/02/2024",
    "drugName": "ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINERNDA   #205703",
    "submission": "SUPPL-3",
    "activeIngredients": "ESMOLOL HYDROCHLORIDE",
    "company": "HQ SPCLT PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/02/2024",
    "drugName": "ESMOLOL HYDROCHLORIDE IN PLASTIC CONTAINERNDA   #205703",
    "submission": "SUPPL-3",
    "activeIngredients": "ESMOLOL HYDROCHLORIDE",
    "company": "HQ SPCLT PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/02/2024",
    "drugName": "FLUOXETINE HYDROCHLORIDEANDA  #213265",
    "submission": "SUPPL-3",
    "activeIngredients": "FLUOXETINE HYDROCHLORIDE",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/02/2024",
    "drugName": "FLUOXETINE HYDROCHLORIDEANDA  #213265",
    "submission": "SUPPL-4",
    "activeIngredients": "FLUOXETINE HYDROCHLORIDE",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/02/2024",
    "drugName": "MIDAZOLAM HYDROCHLORIDE (AUTOINJECTOR)NDA   #216359",
    "submission": "SUPPL-2",
    "activeIngredients": "MIDAZOLAM HYDROCHLORIDE",
    "company": "RAFA LABS LTD",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/02/2024",
    "drugName": "OCTREOTIDE ACETATEANDA  #217860",
    "submission": "ORIG-1",
    "activeIngredients": "OCTREOTIDE ACETATE",
    "company": "SHUANGCHENG",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/02/2024",
    "drugName": "PREDNISOLONEANDA  #218083",
    "submission": "ORIG-1",
    "activeIngredients": "PREDNISOLONE",
    "company": "ZHEJIANG XIANJU",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/03/2024",
    "drugName": "KIONEXANDA  #040028",
    "submission": "SUPPL-19",
    "activeIngredients": "SODIUM POLYSTYRENE SULFONATE",
    "company": "ANI PHARMS",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/03/2024",
    "drugName": "LANSOPRAZOLEANDA  #202396",
    "submission": "SUPPL-3",
    "activeIngredients": "LANSOPRAZOLE",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/03/2024",
    "drugName": "LANSOPRAZOLEANDA  #202396",
    "submission": "SUPPL-4",
    "activeIngredients": "LANSOPRAZOLE",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/03/2024",
    "drugName": "LANSOPRAZOLEANDA  #202396",
    "submission": "SUPPL-6",
    "activeIngredients": "LANSOPRAZOLE",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/03/2024",
    "drugName": "PLERIXAFORANDA  #206644",
    "submission": "ORIG-1",
    "activeIngredients": "PLERIXAFOR",
    "company": "GLAND",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/03/2024",
    "drugName": "TRAVOPROSTANDA  #207040",
    "submission": "ORIG-1",
    "activeIngredients": "TRAVOPROST",
    "company": "LUPIN LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/03/2024",
    "drugName": "CANAGLIFLOZIN; METFORMIN HYDROCHLORIDEANDA  #210380",
    "submission": "ORIG-1",
    "activeIngredients": "CANAGLIFLOZIN;METFORMIN HYDROCHLORIDE",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "05/03/2024",
    "drugName": "BORTEZOMIBANDA  #212204",
    "submission": "ORIG-1",
    "activeIngredients": "BORTEZOMIB",
    "company": "HETERO LABS LTD VI",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/03/2024",
    "drugName": "DEFERASIROXANDA  #213146",
    "submission": "ORIG-1",
    "activeIngredients": "DEFERASIROX",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/03/2024",
    "drugName": "ALBUTEROL SULFATEANDA  #215571",
    "submission": "ORIG-1",
    "activeIngredients": "ALBUTEROL SULFATE",
    "company": "LEXENPHARM",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/03/2024",
    "drugName": "ETICOVOBLA   #761066",
    "submission": "SUPPL-1",
    "activeIngredients": "ETANERCEPT-YKRO",
    "company": "SAMSUNG BIOEPIS CO LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/03/2024",
    "drugName": "ETICOVOBLA   #761066",
    "submission": "SUPPL-3",
    "activeIngredients": "ETANERCEPT-YKRO",
    "company": "SAMSUNG BIOEPIS CO LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/06/2024",
    "drugName": "NADOLOLANDA  #074501",
    "submission": "SUPPL-13",
    "activeIngredients": "NADOLOL",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/06/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #091568",
    "submission": "SUPPL-11",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/06/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #091568",
    "submission": "SUPPL-14",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/06/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #091568",
    "submission": "SUPPL-18",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/06/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #091568",
    "submission": "SUPPL-24",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/06/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #091569",
    "submission": "SUPPL-13",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/06/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #091569",
    "submission": "SUPPL-17",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/06/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #091569",
    "submission": "SUPPL-22",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/06/2024",
    "drugName": "METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDEANDA  #202870",
    "submission": "SUPPL-22",
    "activeIngredients": "HYDROCHLOROTHIAZIDE; METOPROLOL TARTRATE",
    "company": "ALEMBIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/06/2024",
    "drugName": "KAITLIB FEANDA  #203448",
    "submission": "SUPPL-3",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/06/2024",
    "drugName": "KAITLIB FEANDA  #203448",
    "submission": "SUPPL-5",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE",
    "company": "LUPIN LTD",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/06/2024",
    "drugName": "ROPINIROLE HYDROCHLORIDEANDA  #204022",
    "submission": "SUPPL-3",
    "activeIngredients": "ROPINIROLE HYDROCHLORIDE",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/06/2024",
    "drugName": "LEVOCETIRIZINE DIHYDROCHLORIDEANDA  #204626",
    "submission": "ORIG-1",
    "activeIngredients": "LEVOCETIRIZINE DIHYDROCHLORIDE",
    "company": "IPCA LABS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/06/2024",
    "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #207709",
    "submission": "SUPPL-7",
    "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
    "company": "AUROLIFE PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/06/2024",
    "drugName": "EZETIMIBEANDA  #210673",
    "submission": "SUPPL-8",
    "activeIngredients": "EZETIMIBE",
    "company": "SCIEGEN PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/06/2024",
    "drugName": "CLOBAZAMANDA  #211711",
    "submission": "SUPPL-6",
    "activeIngredients": "CLOBAZAM",
    "company": "MICRO LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/06/2024",
    "drugName": "CERIANNANDA   #212155",
    "submission": "SUPPL-21",
    "activeIngredients": "FLUOROESTRADIOL F-18",
    "company": "GE HEALTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/06/2024",
    "drugName": "PERPHENAZINEANDA  #212545",
    "submission": "ORIG-1",
    "activeIngredients": "PERPHENAZINE",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/06/2024",
    "drugName": "SCOPOLAMINEANDA  #215329",
    "submission": "ORIG-1",
    "activeIngredients": "SCOPOLAMINE",
    "company": "RHODES PHARMS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/06/2024",
    "drugName": "EDARAVONEANDA  #215508",
    "submission": "ORIG-1",
    "activeIngredients": "EDARAVONE",
    "company": "HIKMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/06/2024",
    "drugName": "EDARAVONEANDA  #215917",
    "submission": "ORIG-1",
    "activeIngredients": "EDARAVONE",
    "company": "DR REDDYS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/06/2024",
    "drugName": "EDARAVONEANDA  #216199",
    "submission": "ORIG-1",
    "activeIngredients": "EDARAVONE",
    "company": "GLAND",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/06/2024",
    "drugName": "EDARAVONEANDA  #218354",
    "submission": "ORIG-1",
    "activeIngredients": "EDARAVONE",
    "company": "LONG GROVE PHARMS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/07/2024",
    "drugName": "WELLBUTRINNDA   #018644",
    "submission": "SUPPL-61",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "GLAXOSMITHKLINE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/07/2024",
    "drugName": "WELLBUTRIN SRNDA   #020358",
    "submission": "SUPPL-68",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "GLAXOSMITHKLINE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/07/2024",
    "drugName": "WELLBUTRIN XLNDA   #021515",
    "submission": "SUPPL-46",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "BAUSCH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/07/2024",
    "drugName": "APLENZINNDA   #022108",
    "submission": "SUPPL-23",
    "activeIngredients": "BUPROPION HYDROBROMIDE",
    "company": "BAUSCH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/07/2024",
    "drugName": "FORFIVO XLNDA   #022497",
    "submission": "SUPPL-15",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "TWI PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/07/2024",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #075310",
    "submission": "SUPPL-28",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "HERITAGE PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/07/2024",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #075491",
    "submission": "SUPPL-40",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "AUROBINDO PHARMA USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/07/2024",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #075584",
    "submission": "SUPPL-60",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "APNAR PHARMA LP",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/07/2024",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #075914",
    "submission": "SUPPL-32",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "IMPAX LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/07/2024",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #076143",
    "submission": "SUPPL-33",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/07/2024",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #076834",
    "submission": "SUPPL-16",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/07/2024",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #077475",
    "submission": "SUPPL-21",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/07/2024",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #079094",
    "submission": "SUPPL-36",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "ACTAVIS LABS FL INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/07/2024",
    "drugName": "CORTISONE ACETATEANDA  #080776",
    "submission": "SUPPL-44",
    "activeIngredients": "CORTISONE ACETATE",
    "company": "HIKMA INTL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/07/2024",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #090941",
    "submission": "SUPPL-16",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/07/2024",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #091520",
    "submission": "SUPPL-9",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/07/2024",
    "drugName": "CONTRAVENDA   #200063",
    "submission": "SUPPL-22",
    "activeIngredients": "BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE",
    "company": "NALPROPION",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/07/2024",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #202775",
    "submission": "SUPPL-15",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "JUBILANT GENERICS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/07/2024",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #203013",
    "submission": "SUPPL-15",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "ALEMBIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/07/2024",
    "drugName": "REXULTINDA   #205422",
    "submission": "SUPPL-11",
    "activeIngredients": "BREXPIPRAZOLE",
    "company": "OTSUKA",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/07/2024",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #206122",
    "submission": "SUPPL-16",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "SCIEGEN PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/07/2024",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #206975",
    "submission": "SUPPL-30",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "HERITAGE PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/07/2024",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #207389",
    "submission": "SUPPL-8",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "INVAGEN PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/07/2024",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #207403",
    "submission": "SUPPL-4",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "MICRO LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/07/2024",
    "drugName": "METHYLPREDNISOLONE SODIUM SUCCINATEANDA  #207549",
    "submission": "SUPPL-12",
    "activeIngredients": "METHYLPREDNISOLONE SODIUM SUCCINATE",
    "company": "AMNEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/07/2024",
    "drugName": "METHYLPREDNISOLONE SODIUM SUCCINATEANDA  #207549",
    "submission": "SUPPL-16",
    "activeIngredients": "METHYLPREDNISOLONE SODIUM SUCCINATE",
    "company": "AMNEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/07/2024",
    "drugName": "METHYLPREDNISOLONE SODIUM SUCCINATEANDA  #207549",
    "submission": "SUPPL-17",
    "activeIngredients": "METHYLPREDNISOLONE SODIUM SUCCINATE",
    "company": "AMNEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/07/2024",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #208606",
    "submission": "SUPPL-3",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "CADILA PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/07/2024",
    "drugName": "METHYLPREDNISOLONE ACETATEANDA  #210043",
    "submission": "SUPPL-32",
    "activeIngredients": "METHYLPREDNISOLONE ACETATE",
    "company": "AMNEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/07/2024",
    "drugName": "METHYLPREDNISOLONE ACETATEANDA  #210043",
    "submission": "SUPPL-33",
    "activeIngredients": "METHYLPREDNISOLONE ACETATE",
    "company": "AMNEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/07/2024",
    "drugName": "AUVELITYNDA   #215430",
    "submission": "SUPPL-8",
    "activeIngredients": "BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE",
    "company": "AXSOME",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/07/2024",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #216766",
    "submission": "SUPPL-2",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "YICHANG HUMANWELL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/07/2024",
    "drugName": "DICYCLOMINE HYDROCHLORIDEANDA  #217566",
    "submission": "ORIG-1",
    "activeIngredients": "DICYCLOMINE HYDROCHLORIDE",
    "company": "ANNORA PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/08/2024",
    "drugName": "EXELONNDA   #022083",
    "submission": "SUPPL-28",
    "activeIngredients": "RIVASTIGMINE",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/08/2024",
    "drugName": "MONODOXNDA   #050641",
    "submission": "SUPPL-33",
    "activeIngredients": "DOXYCYCLINE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/08/2024",
    "drugName": "DOCETAXELANDA  #208137",
    "submission": "SUPPL-6",
    "activeIngredients": "DOCETAXEL",
    "company": "MYLAN LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/08/2024",
    "drugName": "LINAGLIPTINANDA  #213602",
    "submission": "ORIG-1",
    "activeIngredients": "LINAGLIPTIN",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "05/08/2024",
    "drugName": "VASOPRESSINANDA  #213988",
    "submission": "ORIG-1",
    "activeIngredients": "VASOPRESSIN",
    "company": "DR REDDYS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/08/2024",
    "drugName": "DAPSONEANDA  #214019",
    "submission": "ORIG-1",
    "activeIngredients": "DAPSONE",
    "company": "ZYDUS LIFESCIENCES",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/08/2024",
    "drugName": "AZELASTINE HYDROCHLORIDEANDA  #216801",
    "submission": "ORIG-1",
    "activeIngredients": "AZELASTINE HYDROCHLORIDE",
    "company": "PADAGIS ISRAEL",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/09/2024",
    "drugName": "DOXORUBICIN HYDROCHLORIDENDA   #050629",
    "submission": "SUPPL-33",
    "activeIngredients": "DOXORUBICIN HYDROCHLORIDE",
    "company": "PFIZER",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/09/2024",
    "drugName": "ANAGRELIDE HYDROCHLORIDEANDA  #076683",
    "submission": "SUPPL-11",
    "activeIngredients": "ANAGRELIDE HYDROCHLORIDE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/09/2024",
    "drugName": "VALSARTAN AND HYDROCHLOROTHIAZIDEANDA  #078946",
    "submission": "SUPPL-10",
    "activeIngredients": "HYDROCHLOROTHIAZIDE; VALSARTAN",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/09/2024",
    "drugName": "BETASERONBLA   #103471",
    "submission": "SUPPL-5203",
    "activeIngredients": "INTERFERON BETA-1B",
    "company": "BAYER HEALTHCARE PHARMS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/09/2024",
    "drugName": "DOXAZOSIN MESYLATEANDA  #205210",
    "submission": "SUPPL-7",
    "activeIngredients": "DOXAZOSIN MESYLATE",
    "company": "HERITAGE PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/09/2024",
    "drugName": "IMBRUVICANDA   #205552",
    "submission": "SUPPL-42",
    "activeIngredients": "IBRUTINIB",
    "company": "PHARMACYCLICS LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/09/2024",
    "drugName": "NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)ANDA  #207372",
    "submission": "SUPPL-16",
    "activeIngredients": "NITROFURANTOIN; NITROFURANTOIN, MACROCRYSTALLINE",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/09/2024",
    "drugName": "IMBRUVICANDA   #210563",
    "submission": "SUPPL-18",
    "activeIngredients": "IBRUTINIB",
    "company": "PHARMACYCLICS LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/09/2024",
    "drugName": "SEVELAMER CARBONATEANDA  #211915",
    "submission": "ORIG-1",
    "activeIngredients": "SEVELAMER CARBONATE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/09/2024",
    "drugName": "EPTIFIBATIDEANDA  #213599",
    "submission": "ORIG-1",
    "activeIngredients": "EPTIFIBATIDE",
    "company": "MEITHEAL",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/09/2024",
    "drugName": "POTASSIUM CHLORIDEANDA  #216269",
    "submission": "ORIG-1",
    "activeIngredients": "POTASSIUM CHLORIDE",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/09/2024",
    "drugName": "DEXAMETHASONEANDA  #216284",
    "submission": "ORIG-1",
    "activeIngredients": "DEXAMETHASONE",
    "company": "ZYDUS LIFESCIENCES",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/09/2024",
    "drugName": "IMBRUVICANDA   #217003",
    "submission": "SUPPL-3",
    "activeIngredients": "IBRUTINIB",
    "company": "PHARMACYCLICS LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/09/2024",
    "drugName": "OMEPRAZOLE AND SODIUM BICARBONATEANDA  #217784",
    "submission": "ORIG-1",
    "activeIngredients": "OMEPRAZOLE; SODIUM BICARBONATE",
    "company": "DR REDDYS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/09/2024",
    "drugName": "PROCHLORPERAZINE MALEATEANDA  #218515",
    "submission": "ORIG-1",
    "activeIngredients": "PROCHLORPERAZINE MALEATE",
    "company": "AJANTA PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/10/2024",
    "drugName": "MAVENCLADNDA   #022561",
    "submission": "SUPPL-11",
    "activeIngredients": "CLADRIBINE",
    "company": "EMD SERONO INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/10/2024",
    "drugName": "PREDNISONEANDA  #040538",
    "submission": "SUPPL-6",
    "activeIngredients": "PREDNISONE",
    "company": "HIKMA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/10/2024",
    "drugName": "MELOXICAMANDA  #077927",
    "submission": "SUPPL-44",
    "activeIngredients": "MELOXICAM",
    "company": "UNICHEM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/10/2024",
    "drugName": "DEXAMETHASONEANDA  #085456",
    "submission": "SUPPL-22",
    "activeIngredients": "DEXAMETHASONE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/10/2024",
    "drugName": "EFAVIRENZANDA  #091579",
    "submission": "ORIG-1",
    "activeIngredients": "EFAVIRENZ",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/10/2024",
    "drugName": "DECITABINEANDA  #215355",
    "submission": "ORIG-1",
    "activeIngredients": "DECITABINE",
    "company": "HETERO LABS LTD VI",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/10/2024",
    "drugName": "MIDOSTAURINANDA  #216015",
    "submission": "ORIG-1",
    "activeIngredients": "MIDOSTAURIN",
    "company": "LUPIN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/10/2024",
    "drugName": "CALCIUM GLUCONATEANDA  #216611",
    "submission": "ORIG-1",
    "activeIngredients": "CALCIUM GLUCONATE",
    "company": "AMNEAL",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/10/2024",
    "drugName": "FLUTICASONE PROPIONATEANDA  #217088",
    "submission": "ORIG-1",
    "activeIngredients": "FLUTICASONE PROPIONATE",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/10/2024",
    "drugName": "PHENYLEPHRINE HYDROCHLORIDEANDA  #218110",
    "submission": "ORIG-1",
    "activeIngredients": "PHENYLEPHRINE HYDROCHLORIDE",
    "company": "ASPIRO",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/10/2024",
    "drugName": "OSELTAMIVIR PHOSPHATEANDA  #218131",
    "submission": "ORIG-1",
    "activeIngredients": "OSELTAMIVIR PHOSPHATE",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/10/2024",
    "drugName": "CISPLATINANDA  #218868",
    "submission": "ORIG-1",
    "activeIngredients": "CISPLATIN",
    "company": "QILU",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/13/2024",
    "drugName": "NAPROSYNNDA   #017581",
    "submission": "SUPPL-116",
    "activeIngredients": "NAPROXEN",
    "company": "ATNAHS PHARMA US",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/13/2024",
    "drugName": "ANAPROXNDA   #018164",
    "submission": "SUPPL-66",
    "activeIngredients": "NAPROXEN SODIUM",
    "company": "ATNAHS PHARMA US",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/13/2024",
    "drugName": "ANAPROX DSNDA   #018164",
    "submission": "SUPPL-66",
    "activeIngredients": "NAPROXEN SODIUM",
    "company": "ATNAHS PHARMA US",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/13/2024",
    "drugName": "EC-NAPROSYNNDA   #020067",
    "submission": "SUPPL-25",
    "activeIngredients": "NAPROXEN",
    "company": "ATNAHS PHARMA US",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/13/2024",
    "drugName": "GONAL-F RFF REDI-JECTBLA   #021684",
    "submission": "SUPPL-50",
    "activeIngredients": "FOLLITROPIN ALFA/BETA",
    "company": "EMD SERONO",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/13/2024",
    "drugName": "GONAL-F RFF REDI-JECTBLA   #021684",
    "submission": "SUPPL-51",
    "activeIngredients": "FOLLITROPIN ALFA/BETA",
    "company": "EMD SERONO",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/13/2024",
    "drugName": "MEPERIDINE HYDROCHLORIDEANDA  #040446",
    "submission": "SUPPL-15",
    "activeIngredients": "MEPERIDINE HYDROCHLORIDE",
    "company": "SUN PHARM INDS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/13/2024",
    "drugName": "DOXYCYCLINEANDA  #065471",
    "submission": "SUPPL-2",
    "activeIngredients": "DOXYCYCLINE",
    "company": "SUN PHARM INDUSTRIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/13/2024",
    "drugName": "METHYLPHENIDATE HYDROCHLORIDEANDA  #091601",
    "submission": "SUPPL-14",
    "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "company": "TRIS PHARMA INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/13/2024",
    "drugName": "MYCOPHENOLATE MOFETIL HYDROCHLORIDEANDA  #203575",
    "submission": "SUPPL-8",
    "activeIngredients": "MYCOPHENOLATE MOFETIL HYDROCHLORIDE",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/13/2024",
    "drugName": "ESOMEPRAZOLE MAGNESIUMANDA  #205606",
    "submission": "SUPPL-4",
    "activeIngredients": "ESOMEPRAZOLE MAGNESIUM",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/13/2024",
    "drugName": "ESOMEPRAZOLE MAGNESIUMANDA  #205606",
    "submission": "SUPPL-6",
    "activeIngredients": "ESOMEPRAZOLE MAGNESIUM",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/13/2024",
    "drugName": "ESOMEPRAZOLE MAGNESIUMANDA  #205606",
    "submission": "SUPPL-8",
    "activeIngredients": "ESOMEPRAZOLE MAGNESIUM",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/13/2024",
    "drugName": "ESOMEPRAZOLE MAGNESIUMANDA  #205606",
    "submission": "SUPPL-14",
    "activeIngredients": "ESOMEPRAZOLE MAGNESIUM",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/13/2024",
    "drugName": "ESOMEPRAZOLE MAGNESIUMANDA  #205606",
    "submission": "SUPPL-17",
    "activeIngredients": "ESOMEPRAZOLE MAGNESIUM",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/13/2024",
    "drugName": "ESOMEPRAZOLE MAGNESIUMANDA  #205606",
    "submission": "SUPPL-19",
    "activeIngredients": "ESOMEPRAZOLE MAGNESIUM",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/13/2024",
    "drugName": "ESOMEPRAZOLE MAGNESIUMANDA  #205606",
    "submission": "SUPPL-21",
    "activeIngredients": "ESOMEPRAZOLE MAGNESIUM",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/13/2024",
    "drugName": "DICLOFENAC SODIUMANDA  #210893",
    "submission": "SUPPL-2",
    "activeIngredients": "DICLOFENAC SODIUM",
    "company": "PADAGIS ISRAEL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/13/2024",
    "drugName": "DICLOFENAC SODIUMANDA  #210893",
    "submission": "SUPPL-5",
    "activeIngredients": "DICLOFENAC SODIUM",
    "company": "PADAGIS ISRAEL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/13/2024",
    "drugName": "TIZANIDINE HYDROCHLORIDEANDA  #213365",
    "submission": "ORIG-1",
    "activeIngredients": "TIZANIDINE HYDROCHLORIDE",
    "company": "ANDA REPOSITORY",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/13/2024",
    "drugName": "NOREPINEPHRINE BITARTRATEANDA  #218758",
    "submission": "ORIG-1",
    "activeIngredients": "NOREPINEPHRINE BITARTRATE",
    "company": "RISING",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/14/2024",
    "drugName": "TRIGLIDENDA   #021350",
    "submission": "SUPPL-24",
    "activeIngredients": "FENOFIBRATE",
    "company": "SKYEPHARMA AG",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/14/2024",
    "drugName": "LANSOPRAZOLEANDA  #202194",
    "submission": "SUPPL-12",
    "activeIngredients": "LANSOPRAZOLE",
    "company": "DR REDDYS LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/14/2024",
    "drugName": "LANSOPRAZOLEANDA  #202194",
    "submission": "SUPPL-13",
    "activeIngredients": "LANSOPRAZOLE",
    "company": "DR REDDYS LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/14/2024",
    "drugName": "XELJANZNDA   #203214",
    "submission": "SUPPL-34",
    "activeIngredients": "TOFACITINIB CITRATE",
    "company": "PF PRISM CV",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/14/2024",
    "drugName": "DIFLUPREDNATEANDA  #207284",
    "submission": "ORIG-1",
    "activeIngredients": "DIFLUPREDNATE",
    "company": "EPIC PHARMA LLC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/14/2024",
    "drugName": "FINGOLIMOD HYDROCHLORIDEANDA  #207939",
    "submission": "SUPPL-10",
    "activeIngredients": "FINGOLIMOD HYDROCHLORIDE",
    "company": "HEC PHARM CO LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/14/2024",
    "drugName": "FINGOLIMOD HYDROCHLORIDEANDA  #207939",
    "submission": "SUPPL-12",
    "activeIngredients": "FINGOLIMOD HYDROCHLORIDE",
    "company": "HEC PHARM CO LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/14/2024",
    "drugName": "XELJANZ XRNDA   #208246",
    "submission": "SUPPL-21",
    "activeIngredients": "TOFACITINIB CITRATE",
    "company": "PFIZER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/14/2024",
    "drugName": "XELJANZNDA   #213082",
    "submission": "SUPPL-6",
    "activeIngredients": "TOFACITINIB CITRATE",
    "company": "PFIZER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/14/2024",
    "drugName": "NIMODIPINEANDA  #216256",
    "submission": "ORIG-1",
    "activeIngredients": "NIMODIPINE",
    "company": "AMNEAL PHARMS LLC",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "05/14/2024",
    "drugName": "LIKMEZNDA   #216755",
    "submission": "SUPPL-1",
    "activeIngredients": "METRONIDAZOLE",
    "company": "SAPTALIS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/14/2024",
    "drugName": "AURLUMYNNDA   #217933",
    "submission": "SUPPL-1",
    "activeIngredients": "ILOPROST",
    "company": "BTG INTL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/14/2024",
    "drugName": "LORATADINE AND PSEUDOEPHEDRINE SULFATEANDA  #218017",
    "submission": "ORIG-1",
    "activeIngredients": "LORATADINE; PSEUDOEPHEDRINE SULFATE",
    "company": "BIONPHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/14/2024",
    "drugName": "ACETAZOLAMIDEANDA  #218023",
    "submission": "ORIG-1",
    "activeIngredients": "ACETAZOLAMIDE",
    "company": "EPIC PHARMA LLC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/15/2024",
    "drugName": "SOTALOL HYDROCHLORIDEANDA  #075429",
    "submission": "SUPPL-30",
    "activeIngredients": "SOTALOL HYDROCHLORIDE",
    "company": "TEVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/15/2024",
    "drugName": "KETOROLAC TROMETHAMINEANDA  #078721",
    "submission": "SUPPL-4",
    "activeIngredients": "KETOROLAC TROMETHAMINE",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/15/2024",
    "drugName": "TEMOZOLOMIDEANDA  #201528",
    "submission": "SUPPL-8",
    "activeIngredients": "TEMOZOLOMIDE",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/15/2024",
    "drugName": "VOLNEAANDA  #202689",
    "submission": "SUPPL-6",
    "activeIngredients": "DESOGESTREL; ETHINYL ESTRADIOL",
    "company": "XIROMED",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/15/2024",
    "drugName": "TEMOZOLOMIDEANDA  #203490",
    "submission": "SUPPL-12",
    "activeIngredients": "TEMOZOLOMIDE",
    "company": "ANI PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/15/2024",
    "drugName": "METHYLPHENIDATE HYDROCHLORIDEANDA  #207515",
    "submission": "SUPPL-12",
    "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/15/2024",
    "drugName": "METHYLPHENIDATE HYDROCHLORIDEANDA  #207515",
    "submission": "SUPPL-17",
    "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/15/2024",
    "drugName": "CLOBAZAMANDA  #209853",
    "submission": "SUPPL-3",
    "activeIngredients": "CLOBAZAM",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/15/2024",
    "drugName": "CLOBAZAMANDA  #210545",
    "submission": "SUPPL-5",
    "activeIngredients": "CLOBAZAM",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/15/2024",
    "drugName": "NADOLOLANDA  #210955",
    "submission": "SUPPL-5",
    "activeIngredients": "NADOLOL",
    "company": "REGCON HOLDINGS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/15/2024",
    "drugName": "ACETAZOLAMIDEANDA  #214282",
    "submission": "SUPPL-18",
    "activeIngredients": "ACETAZOLAMIDE",
    "company": "MANKIND PHARMA",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/15/2024",
    "drugName": "CLOBAZAMANDA  #214404",
    "submission": "SUPPL-2",
    "activeIngredients": "CLOBAZAM",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/15/2024",
    "drugName": "LACOSAMIDEANDA  #215154",
    "submission": "ORIG-1",
    "activeIngredients": "LACOSAMIDE",
    "company": "CHARTWELL RX",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/16/2024",
    "drugName": "IRINOTECAN HYDROCHLORIDEANDA  #078589",
    "submission": "SUPPL-13",
    "activeIngredients": "IRINOTECAN HYDROCHLORIDE",
    "company": "ACTAVIS TOTOWA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/16/2024",
    "drugName": "PREDNISONEANDA  #080352",
    "submission": "SUPPL-69",
    "activeIngredients": "PREDNISONE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/16/2024",
    "drugName": "PREDNISONEANDA  #088703",
    "submission": "SUPPL-31",
    "activeIngredients": "PREDNISONE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/16/2024",
    "drugName": "BENLYSTABLA   #125370",
    "submission": "SUPPL-81",
    "activeIngredients": "BELIMUMAB",
    "company": "HUMAN GENOME SCIENCES INC.",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/16/2024",
    "drugName": "TEMOZOLOMIDEANDA  #204159",
    "submission": "SUPPL-3",
    "activeIngredients": "TEMOZOLOMIDE",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/16/2024",
    "drugName": "MITIGARENDA   #204820",
    "submission": "SUPPL-6",
    "activeIngredients": "COLCHICINE",
    "company": "HIKMA INTL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/16/2024",
    "drugName": "AZACITIDINEANDA  #212580",
    "submission": "ORIG-1",
    "activeIngredients": "AZACITIDINE",
    "company": "MSN LABS PVT LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/16/2024",
    "drugName": "EOHILIANDA   #213976",
    "submission": "SUPPL-1",
    "activeIngredients": "BUDESONIDE",
    "company": "TAKEDA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/16/2024",
    "drugName": "BRIMONIDINE TARTRATE AND TIMOLOL MALEATEANDA  #214987",
    "submission": "ORIG-1",
    "activeIngredients": "BRIMONIDINE TARTRATE; TIMOLOL MALEATE",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/16/2024",
    "drugName": "CYCLOSPORINEANDA  #216046",
    "submission": "SUPPL-7",
    "activeIngredients": "CYCLOSPORINE",
    "company": "ONESOURCE SPECIALTY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/16/2024",
    "drugName": "METHOTREXATE SODIUMANDA  #216453",
    "submission": "ORIG-1",
    "activeIngredients": "METHOTREXATE SODIUM",
    "company": "ELITE LABS INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/16/2024",
    "drugName": "BENLYSTABLA   #761043",
    "submission": "SUPPL-27",
    "activeIngredients": "BELIMUMAB",
    "company": "GLAXOSMITHKLINE LLC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/16/2024",
    "drugName": "REBLOZYLBLA   #761136",
    "submission": "SUPPL-10",
    "activeIngredients": "LUSPATERCEPT-AAMT",
    "company": "CELGENE CORP",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/16/2024",
    "drugName": "IMDELLTRABLA   #761344",
    "submission": "ORIG-1",
    "activeIngredients": "TARLATAMAB-DLLE",
    "company": "AMGEN INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/17/2024",
    "drugName": "MUSENDA   #020700",
    "submission": "SUPPL-32",
    "activeIngredients": "ALPROSTADIL",
    "company": "VIATRIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/17/2024",
    "drugName": "CADUETNDA   #021540",
    "submission": "SUPPL-49",
    "activeIngredients": "AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM",
    "company": "PHARMACIA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/17/2024",
    "drugName": "GEMFIBROZILANDA  #074270",
    "submission": "SUPPL-19",
    "activeIngredients": "GEMFIBROZIL",
    "company": "CHARTWELL MOLECULES",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/17/2024",
    "drugName": "ANASTROZOLEANDA  #078058",
    "submission": "SUPPL-14",
    "activeIngredients": "ANASTROZOLE",
    "company": "TEVA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/17/2024",
    "drugName": "AMLODIPINE BESYLATE AND VALSARTANANDA  #202713",
    "submission": "SUPPL-2",
    "activeIngredients": "AMLODIPINE BESYLATE; VALSARTAN",
    "company": "ALEMBIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/17/2024",
    "drugName": "AMLODIPINE BESYLATE AND VALSARTANANDA  #202713",
    "submission": "SUPPL-12",
    "activeIngredients": "AMLODIPINE BESYLATE; VALSARTAN",
    "company": "ALEMBIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/17/2024",
    "drugName": "AMLODIPINE BESYLATE AND VALSARTANANDA  #202713",
    "submission": "SUPPL-20",
    "activeIngredients": "AMLODIPINE BESYLATE; VALSARTAN",
    "company": "ALEMBIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/17/2024",
    "drugName": "SYNDROSNDA   #205525",
    "submission": "SUPPL-13",
    "activeIngredients": "DRONABINOL",
    "company": "BENUVIA OPERATIONS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/17/2024",
    "drugName": "DEFERASIROXANDA  #206585",
    "submission": "ORIG-1",
    "activeIngredients": "DEFERASIROX",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/17/2024",
    "drugName": "PREGABALINANDA  #208113",
    "submission": "ORIG-1",
    "activeIngredients": "PREGABALIN",
    "company": "REGCON HOLDINGS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/17/2024",
    "drugName": "MONTELUKAST SODIUMANDA  #209011",
    "submission": "SUPPL-1",
    "activeIngredients": "MONTELUKAST SODIUM",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/17/2024",
    "drugName": "MONTELUKAST SODIUMANDA  #209011",
    "submission": "SUPPL-3",
    "activeIngredients": "MONTELUKAST SODIUM",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/17/2024",
    "drugName": "MONTELUKAST SODIUMANDA  #209012",
    "submission": "SUPPL-1",
    "activeIngredients": "MONTELUKAST SODIUM",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/17/2024",
    "drugName": "MONTELUKAST SODIUMANDA  #209012",
    "submission": "SUPPL-3",
    "activeIngredients": "MONTELUKAST SODIUM",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/17/2024",
    "drugName": "FROVATRIPTAN SUCCINATEANDA  #211292",
    "submission": "SUPPL-4",
    "activeIngredients": "FROVATRIPTAN SUCCINATE",
    "company": "AMNEAL PHARMS CO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/17/2024",
    "drugName": "MEMANTINE HYDROCHLORIDEANDA  #212947",
    "submission": "SUPPL-1",
    "activeIngredients": "MEMANTINE HYDROCHLORIDE",
    "company": "YILING",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/17/2024",
    "drugName": "EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATEANDA  #214053",
    "submission": "ORIG-1",
    "activeIngredients": "EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE",
    "company": "APOTEX",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/17/2024",
    "drugName": "EPRONTIANDA   #214679",
    "submission": "SUPPL-7",
    "activeIngredients": "TOPIRAMATE",
    "company": "AZURITY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/17/2024",
    "drugName": "ARFORMOTEROL TARTRATEANDA  #216303",
    "submission": "ORIG-1",
    "activeIngredients": "ARFORMOTEROL TARTRATE",
    "company": "NEOCUBES PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/20/2024",
    "drugName": "MONTELUKAST SODIUMANDA  #078723",
    "submission": "SUPPL-16",
    "activeIngredients": "MONTELUKAST SODIUM",
    "company": "TEVA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/20/2024",
    "drugName": "CAMPATHBLA   #103948",
    "submission": "SUPPL-5193",
    "activeIngredients": "ALEMTUZUMAB",
    "company": "GENZYME",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/20/2024",
    "drugName": "LEMTRADABLA   #103948",
    "submission": "SUPPL-5193",
    "activeIngredients": "ALEMTUZUMAB",
    "company": "GENZYME",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/20/2024",
    "drugName": "QUETIAPINE FUMARATEANDA  #205983",
    "submission": "ORIG-1",
    "activeIngredients": "QUETIAPINE FUMARATE",
    "company": "IPCA LABS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/20/2024",
    "drugName": "VORICONAZOLEANDA  #206799",
    "submission": "SUPPL-14",
    "activeIngredients": "VORICONAZOLE",
    "company": "NOVEL LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/20/2024",
    "drugName": "HYDROXYCHLOROQUINE SULFATEANDA  #210577",
    "submission": "SUPPL-15",
    "activeIngredients": "HYDROXYCHLOROQUINE SULFATE",
    "company": "AMNEAL PHARMS CO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/20/2024",
    "drugName": "HYDROXYCHLOROQUINE SULFATEANDA  #210577",
    "submission": "SUPPL-16",
    "activeIngredients": "HYDROXYCHLOROQUINE SULFATE",
    "company": "AMNEAL PHARMS CO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/20/2024",
    "drugName": "TRAZODONE HYDROCHLORIDEANDA  #211116",
    "submission": "ORIG-1",
    "activeIngredients": "TRAZODONE HYDROCHLORIDE",
    "company": "CROSSMEDIKA SA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/20/2024",
    "drugName": "PALIPERIDONE PALMITATEANDA  #212290",
    "submission": "ORIG-1",
    "activeIngredients": "PALIPERIDONE PALMITATE",
    "company": "MYLAN PHARMS INC",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "05/20/2024",
    "drugName": "PALIPERIDONE PALMITATEANDA  #216228",
    "submission": "ORIG-1",
    "activeIngredients": "PALIPERIDONE PALMITATE",
    "company": "MYLAN PHARMS INC",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "05/20/2024",
    "drugName": "PAZOPANIB HYDROCHLORIDEANDA  #217713",
    "submission": "SUPPL-1",
    "activeIngredients": "PAZOPANIB HYDROCHLORIDE",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/20/2024",
    "drugName": "YESAFILIBLA   #761274",
    "submission": "ORIG-1",
    "activeIngredients": "AFLIBERCEPT-JBVF",
    "company": "BIOCON BIOLOGICS INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/20/2024",
    "drugName": "OPUVIZBLA   #761350",
    "submission": "ORIG-1",
    "activeIngredients": "AFLIBERCEPT-YSZY",
    "company": "SAMSUNG BIOEPIS CO LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/21/2024",
    "drugName": "ELIGARD KITNDA   #021343",
    "submission": "SUPPL-52",
    "activeIngredients": "LEUPROLIDE ACETATE",
    "company": "TOLMAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/21/2024",
    "drugName": "ELIGARD KITNDA   #021379",
    "submission": "SUPPL-55",
    "activeIngredients": "LEUPROLIDE ACETATE",
    "company": "TOLMAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/21/2024",
    "drugName": "ELIGARD KITNDA   #021488",
    "submission": "SUPPL-50",
    "activeIngredients": "LEUPROLIDE ACETATE",
    "company": "TOLMAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/21/2024",
    "drugName": "ELIGARD KITNDA   #021731",
    "submission": "SUPPL-52",
    "activeIngredients": "LEUPROLIDE ACETATE",
    "company": "TOLMAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/21/2024",
    "drugName": "CYCLOSPORINEANDA  #209811",
    "submission": "ORIG-1",
    "activeIngredients": "CYCLOSPORINE",
    "company": "DEVA HOLDING AS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/21/2024",
    "drugName": "ALBUTEROL SULFATEANDA  #212447",
    "submission": "ORIG-1",
    "activeIngredients": "ALBUTEROL SULFATE",
    "company": "ARMSTRONG PHARMS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/21/2024",
    "drugName": "SUCRALFATEANDA  #216474",
    "submission": "ORIG-1",
    "activeIngredients": "SUCRALFATE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/21/2024",
    "drugName": "LANREOTIDE ACETATEANDA  #217193",
    "submission": "ORIG-1",
    "activeIngredients": "LANREOTIDE ACETATE",
    "company": "INVAGEN PHARMS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/21/2024",
    "drugName": "THEOPHYLLINEANDA  #218063",
    "submission": "ORIG-1",
    "activeIngredients": "THEOPHYLLINE",
    "company": "ZYDUS LIFESCIENCES",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/21/2024",
    "drugName": "CIMERLIBLA   #761165",
    "submission": "SUPPL-5",
    "activeIngredients": "RANIBIZUMAB-EQRN",
    "company": "SANDOZ INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/22/2024",
    "drugName": "CLARITINNDA   #020641",
    "submission": "SUPPL-48",
    "activeIngredients": "LORATADINE",
    "company": "BAYER HEALTHCARE LLC",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/22/2024",
    "drugName": "CLARITIN HIVES RELIEFNDA   #020641",
    "submission": "SUPPL-48",
    "activeIngredients": "LORATADINE",
    "company": "BAYER HEALTHCARE LLC",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/22/2024",
    "drugName": "XYREMNDA   #021196",
    "submission": "SUPPL-44",
    "activeIngredients": "SODIUM OXYBATE",
    "company": "JAZZ PHARMS",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/22/2024",
    "drugName": "SAVELLANDA   #022256",
    "submission": "SUPPL-29",
    "activeIngredients": "MILNACIPRAN HYDROCHLORIDE",
    "company": "ABBVIE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/22/2024",
    "drugName": "HEPZATONDA   #201848",
    "submission": "SUPPL-3",
    "activeIngredients": "MELPHALAN HYDROCHLORIDE",
    "company": "DELCATH SYSTEMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/22/2024",
    "drugName": "IRBESARTANANDA  #211056",
    "submission": "ORIG-1",
    "activeIngredients": "IRBESARTAN",
    "company": "IPCA LABS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/22/2024",
    "drugName": "XYWAVNDA   #212690",
    "submission": "SUPPL-15",
    "activeIngredients": "CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE",
    "company": "JAZZ",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/22/2024",
    "drugName": "DABIGATRAN ETEXILATE MESYLATEANDA  #213879",
    "submission": "ORIG-1",
    "activeIngredients": "DABIGATRAN ETEXILATE MESYLATE",
    "company": "MSN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/22/2024",
    "drugName": "CEFEPIME HYDROCHLORIDEANDA  #214402",
    "submission": "ORIG-1",
    "activeIngredients": "CEFEPIME HYDROCHLORIDE",
    "company": "HIKMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/23/2024",
    "drugName": "NICOTROLNDA   #020385",
    "submission": "SUPPL-12",
    "activeIngredients": "NICOTINE",
    "company": "PFIZER INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/23/2024",
    "drugName": "NICOTROLNDA   #020714",
    "submission": "SUPPL-19",
    "activeIngredients": "NICOTINE",
    "company": "PFIZER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/23/2024",
    "drugName": "SUMATRIPTAN SUCCINATEANDA  #202758",
    "submission": "SUPPL-8",
    "activeIngredients": "SUMATRIPTAN SUCCINATE",
    "company": "EUGIA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/23/2024",
    "drugName": "NEVIRAPINEANDA  #203080",
    "submission": "SUPPL-4",
    "activeIngredients": "NEVIRAPINE",
    "company": "MICRO LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/23/2024",
    "drugName": "VALGANCICLOVIR HYDROCHLORIDEANDA  #203511",
    "submission": "SUPPL-6",
    "activeIngredients": "VALGANCICLOVIR HYDROCHLORIDE",
    "company": "DR REDDYS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/23/2024",
    "drugName": "VALGANCICLOVIR HYDROCHLORIDEANDA  #203511",
    "submission": "SUPPL-8",
    "activeIngredients": "VALGANCICLOVIR HYDROCHLORIDE",
    "company": "DR REDDYS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/23/2024",
    "drugName": "RISEDRONATE SODIUMANDA  #203533",
    "submission": "SUPPL-2",
    "activeIngredients": "RISEDRONATE SODIUM",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/23/2024",
    "drugName": "RISEDRONATE SODIUMANDA  #203533",
    "submission": "SUPPL-13",
    "activeIngredients": "RISEDRONATE SODIUM",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/23/2024",
    "drugName": "RISEDRONATE SODIUMANDA  #203533",
    "submission": "SUPPL-24",
    "activeIngredients": "RISEDRONATE SODIUM",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/23/2024",
    "drugName": "LICARTNDA   #206976",
    "submission": "SUPPL-15",
    "activeIngredients": "DICLOFENAC EPOLAMINE",
    "company": "IBSA INST BIO",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/23/2024",
    "drugName": "MESALAMINEANDA  #208954",
    "submission": "SUPPL-4",
    "activeIngredients": "MESALAMINE",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/23/2024",
    "drugName": "MELPHALAN HYDROCHLORIDEANDA  #215024",
    "submission": "ORIG-1",
    "activeIngredients": "MELPHALAN HYDROCHLORIDE",
    "company": "HETERO LABS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/23/2024",
    "drugName": "PHENYLEPHRINE HYDROCHLORIDEANDA  #215183",
    "submission": "ORIG-1",
    "activeIngredients": "PHENYLEPHRINE HYDROCHLORIDE",
    "company": "CAPLIN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/23/2024",
    "drugName": "TIMOLOL MALEATEANDA  #216343",
    "submission": "ORIG-1",
    "activeIngredients": "TIMOLOL MALEATE",
    "company": "AMNEAL",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/23/2024",
    "drugName": "RIVAROXABANANDA  #218768",
    "submission": "ORIG-1",
    "activeIngredients": "RIVAROXABAN",
    "company": "INVAGEN PHARMA INC",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "05/24/2024",
    "drugName": "FLAREXNDA   #019079",
    "submission": "SUPPL-38",
    "activeIngredients": "FLUOROMETHOLONE ACETATE",
    "company": "HARROW EYE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/24/2024",
    "drugName": "ACUVAILNDA   #022427",
    "submission": "SUPPL-7",
    "activeIngredients": "KETOROLAC TROMETHAMINE",
    "company": "ABBVIE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/24/2024",
    "drugName": "ARESTINNDA   #050781",
    "submission": "SUPPL-25",
    "activeIngredients": "MINOCYCLINE HYDROCHLORIDE",
    "company": "ORAPHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/24/2024",
    "drugName": "CHLORHEXIDINE GLUCONATEANDA  #075561",
    "submission": "SUPPL-16",
    "activeIngredients": "CHLORHEXIDINE GLUCONATE",
    "company": "BAJAJ",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/24/2024",
    "drugName": "LACOSAMIDEANDA  #208466",
    "submission": "ORIG-1",
    "activeIngredients": "LACOSAMIDE",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/24/2024",
    "drugName": "CLOBAZAMANDA  #208785",
    "submission": "SUPPL-3",
    "activeIngredients": "CLOBAZAM",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/24/2024",
    "drugName": "CLOBAZAMANDA  #208819",
    "submission": "SUPPL-7",
    "activeIngredients": "CLOBAZAM",
    "company": "BIONPHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/24/2024",
    "drugName": "CLOBAZAMANDA  #208825",
    "submission": "SUPPL-4",
    "activeIngredients": "CLOBAZAM",
    "company": "BIONPHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/24/2024",
    "drugName": "ERLOTINIB HYDROCHLORIDEANDA  #209267",
    "submission": "ORIG-1",
    "activeIngredients": "ERLOTINIB HYDROCHLORIDE",
    "company": "HETERO LABS LTD V",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/24/2024",
    "drugName": "CANAGLIFLOZINANDA  #210514",
    "submission": "ORIG-1",
    "activeIngredients": "CANAGLIFLOZIN",
    "company": "PRINSTON PHARMA INC",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "05/24/2024",
    "drugName": "PREGABALINANDA  #211889",
    "submission": "SUPPL-1",
    "activeIngredients": "PREGABALIN",
    "company": "SUN PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/24/2024",
    "drugName": "BRIVARACETAMANDA  #214831",
    "submission": "ORIG-1",
    "activeIngredients": "BRIVARACETAM",
    "company": "ANNORA PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "05/24/2024",
    "drugName": "ONYDA XRNDA   #217645",
    "submission": "ORIG-1",
    "activeIngredients": "CLONIDINE HYDROCHLORIDE",
    "company": "TRIS PHARMA INC",
    "submissionClassification": "Type 3 - New Dosage Form",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/24/2024",
    "drugName": "FABHALTANDA   #218276",
    "submission": "SUPPL-3",
    "activeIngredients": "IPTACOPAN HYDROCHLORIDE",
    "company": "NOVARTIS",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/28/2024",
    "drugName": "TIMOLOL MALEATENDA   #020963",
    "submission": "SUPPL-15",
    "activeIngredients": "TIMOLOL MALEATE",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/28/2024",
    "drugName": "PREDNISONEANDA  #040256",
    "submission": "SUPPL-9",
    "activeIngredients": "PREDNISONE",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/28/2024",
    "drugName": "PREDNISONEANDA  #040256",
    "submission": "SUPPL-17",
    "activeIngredients": "PREDNISONE",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/28/2024",
    "drugName": "PREDNISONEANDA  #040392",
    "submission": "SUPPL-6",
    "activeIngredients": "PREDNISONE",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/28/2024",
    "drugName": "PREDNISONEANDA  #040581",
    "submission": "SUPPL-6",
    "activeIngredients": "PREDNISONE",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/28/2024",
    "drugName": "PREDNISONEANDA  #040581",
    "submission": "SUPPL-13",
    "activeIngredients": "PREDNISONE",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/28/2024",
    "drugName": "PREDNISONEANDA  #040584",
    "submission": "SUPPL-5",
    "activeIngredients": "PREDNISONE",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/28/2024",
    "drugName": "PREDNISONEANDA  #040584",
    "submission": "SUPPL-12",
    "activeIngredients": "PREDNISONE",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/28/2024",
    "drugName": "PREDNISOLONE SODIUM PHOSPHATEANDA  #075183",
    "submission": "SUPPL-2",
    "activeIngredients": "PREDNISOLONE SODIUM PHOSPHATE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/28/2024",
    "drugName": "TRAMADOL HYDROCHLORIDEANDA  #075968",
    "submission": "SUPPL-12",
    "activeIngredients": "TRAMADOL HYDROCHLORIDE",
    "company": "GRAVITI PHARMS",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/28/2024",
    "drugName": "PREDNISONEANDA  #080356",
    "submission": "SUPPL-110",
    "activeIngredients": "PREDNISONE",
    "company": "WATSON LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/28/2024",
    "drugName": "PREDNISONEANDA  #085161",
    "submission": "SUPPL-91",
    "activeIngredients": "PREDNISONE",
    "company": "WATSON LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/28/2024",
    "drugName": "PREDNISONEANDA  #085162",
    "submission": "SUPPL-79",
    "activeIngredients": "PREDNISONE",
    "company": "WATSON LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/28/2024",
    "drugName": "ARIPIPRAZOLEANDA  #202101",
    "submission": "SUPPL-5",
    "activeIngredients": "ARIPIPRAZOLE",
    "company": "ALEMBIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/28/2024",
    "drugName": "ARIPIPRAZOLEANDA  #202101",
    "submission": "SUPPL-12",
    "activeIngredients": "ARIPIPRAZOLE",
    "company": "ALEMBIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/28/2024",
    "drugName": "ARIPIPRAZOLEANDA  #202101",
    "submission": "SUPPL-13",
    "activeIngredients": "ARIPIPRAZOLE",
    "company": "ALEMBIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/28/2024",
    "drugName": "ARIPIPRAZOLEANDA  #202101",
    "submission": "SUPPL-20",
    "activeIngredients": "ARIPIPRAZOLE",
    "company": "ALEMBIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/28/2024",
    "drugName": "ACETAMINOPHENNDA   #206968",
    "submission": "SUPPL-3",
    "activeIngredients": "ACETAMINOPHEN",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/28/2024",
    "drugName": "DEXMEDETOMIDINE HYDROCHLORIDEANDA  #208129",
    "submission": "SUPPL-5",
    "activeIngredients": "DEXMEDETOMIDINE HYDROCHLORIDE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/28/2024",
    "drugName": "SACUBITRIL AND VALSARTANANDA  #213605",
    "submission": "ORIG-1",
    "activeIngredients": "SACUBITRIL; VALSARTAN",
    "company": "CRYSTAL",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/28/2024",
    "drugName": "SACUBITRIL AND VALSARTANANDA  #213676",
    "submission": "ORIG-1",
    "activeIngredients": "SACUBITRIL; VALSARTAN",
    "company": "LAURUS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/28/2024",
    "drugName": "SACUBITRIL AND VALSARTANANDA  #213682",
    "submission": "ORIG-1",
    "activeIngredients": "SACUBITRIL; VALSARTAN",
    "company": "ALEMBIC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/28/2024",
    "drugName": "VEVYENDA   #217469",
    "submission": "SUPPL-3",
    "activeIngredients": "CYCLOSPORINE",
    "company": "HARROW EYE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/28/2024",
    "drugName": "FAMOTIDINEANDA  #218003",
    "submission": "ORIG-1",
    "activeIngredients": "FAMOTIDINE",
    "company": "CONTRACT PHARMACAL",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/28/2024",
    "drugName": "TECVAYLIBLA   #761291",
    "submission": "SUPPL-8",
    "activeIngredients": "TECLISTAMAB-CQYV",
    "company": "JANSSEN BIOTECH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/28/2024",
    "drugName": "BKEMVBLA   #761333",
    "submission": "ORIG-1",
    "activeIngredients": "ECULIZUMAB-AEEB",
    "company": "AMGEN INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/29/2024",
    "drugName": "OXYTROLNDA   #021351",
    "submission": "SUPPL-20",
    "activeIngredients": "OXYBUTYNIN",
    "company": "ALLERGAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/29/2024",
    "drugName": "PREDNISONEANDA  #040890",
    "submission": "SUPPL-6",
    "activeIngredients": "PREDNISONE",
    "company": "HIKMA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/29/2024",
    "drugName": "AMOXAPINEANDA  #072879",
    "submission": "SUPPL-15",
    "activeIngredients": "AMOXAPINE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/29/2024",
    "drugName": "MICONAZOLE NITRATE COMBINATION PACKANDA  #075329",
    "submission": "SUPPL-44",
    "activeIngredients": "MICONAZOLE NITRATE",
    "company": "L PERRIGO CO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/29/2024",
    "drugName": "MICONAZOLE NITRATE COMBINATION PACKANDA  #075329",
    "submission": "SUPPL-50",
    "activeIngredients": "MICONAZOLE NITRATE",
    "company": "L PERRIGO CO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/29/2024",
    "drugName": "LISINOPRIL AND HYDROCHLOROTHIAZIDEANDA  #076113",
    "submission": "SUPPL-39",
    "activeIngredients": "HYDROCHLOROTHIAZIDE; LISINOPRIL",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/29/2024",
    "drugName": "MELOXICAMANDA  #077918",
    "submission": "SUPPL-8",
    "activeIngredients": "MELOXICAM",
    "company": "YUNG SHIN PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/29/2024",
    "drugName": "PREDNISONEANDA  #088465",
    "submission": "SUPPL-8",
    "activeIngredients": "PREDNISONE",
    "company": "HIKMA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/29/2024",
    "drugName": "ORENCIABLA   #125118",
    "submission": "SUPPL-255",
    "activeIngredients": "ABATACEPT",
    "company": "BRISTOL MYERS SQUIBB",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/29/2024",
    "drugName": "OLANZAPINEANDA  #201588",
    "submission": "SUPPL-3",
    "activeIngredients": "OLANZAPINE",
    "company": "SANDOZ INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/29/2024",
    "drugName": "OLANZAPINEANDA  #201588",
    "submission": "SUPPL-6",
    "activeIngredients": "OLANZAPINE",
    "company": "SANDOZ INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/29/2024",
    "drugName": "OLANZAPINEANDA  #201588",
    "submission": "SUPPL-9",
    "activeIngredients": "OLANZAPINE",
    "company": "SANDOZ INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/29/2024",
    "drugName": "OLANZAPINEANDA  #201588",
    "submission": "SUPPL-10",
    "activeIngredients": "OLANZAPINE",
    "company": "SANDOZ INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/29/2024",
    "drugName": "OLANZAPINEANDA  #201588",
    "submission": "SUPPL-11",
    "activeIngredients": "OLANZAPINE",
    "company": "SANDOZ INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/29/2024",
    "drugName": "GABAPENTINANDA  #202024",
    "submission": "SUPPL-3",
    "activeIngredients": "GABAPENTIN",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/29/2024",
    "drugName": "GABAPENTINANDA  #202024",
    "submission": "SUPPL-4",
    "activeIngredients": "GABAPENTIN",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/29/2024",
    "drugName": "GABAPENTINANDA  #202024",
    "submission": "SUPPL-5",
    "activeIngredients": "GABAPENTIN",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/29/2024",
    "drugName": "GABAPENTINANDA  #202024",
    "submission": "SUPPL-7",
    "activeIngredients": "GABAPENTIN",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/29/2024",
    "drugName": "GABAPENTINANDA  #202024",
    "submission": "SUPPL-10",
    "activeIngredients": "GABAPENTIN",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/29/2024",
    "drugName": "GABAPENTINANDA  #202024",
    "submission": "SUPPL-11",
    "activeIngredients": "GABAPENTIN",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/29/2024",
    "drugName": "PRASUGRELANDA  #205927",
    "submission": "SUPPL-5",
    "activeIngredients": "PRASUGREL HYDROCHLORIDE",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/29/2024",
    "drugName": "PRASUGRELANDA  #205987",
    "submission": "SUPPL-6",
    "activeIngredients": "PRASUGREL HYDROCHLORIDE",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/29/2024",
    "drugName": "PITAVASTATIN CALCIUMANDA  #206070",
    "submission": "SUPPL-1",
    "activeIngredients": "PITAVASTATIN CALCIUM",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/29/2024",
    "drugName": "FINGOLIMOD HYDROCHLORIDEANDA  #207933",
    "submission": "SUPPL-1",
    "activeIngredients": "FINGOLIMOD HYDROCHLORIDE",
    "company": "HETERO LABS LTD V",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/29/2024",
    "drugName": "FINGOLIMOD HYDROCHLORIDEANDA  #207933",
    "submission": "SUPPL-2",
    "activeIngredients": "FINGOLIMOD HYDROCHLORIDE",
    "company": "HETERO LABS LTD V",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/29/2024",
    "drugName": "VILAZODONE HYDROCHLORIDEANDA  #208202",
    "submission": "SUPPL-10",
    "activeIngredients": "VILAZODONE HYDROCHLORIDE",
    "company": "ALEMBIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/29/2024",
    "drugName": "COLCHICINEANDA  #209470",
    "submission": "SUPPL-2",
    "activeIngredients": "COLCHICINE",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/29/2024",
    "drugName": "GABAPENTINANDA  #209855",
    "submission": "ORIG-1",
    "activeIngredients": "GABAPENTIN",
    "company": "IPCA LABS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/29/2024",
    "drugName": "MACITENTANANDA  #211198",
    "submission": "SUPPL-1",
    "activeIngredients": "MACITENTAN",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/29/2024",
    "drugName": "RETEVMONDA   #213246",
    "submission": "SUPPL-12",
    "activeIngredients": "SELPERCATINIB",
    "company": "ELI LILLY AND CO",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/29/2024",
    "drugName": "AUSTEDO XRNDA   #216354",
    "submission": "SUPPL-6",
    "activeIngredients": "DEUTETRABENAZINE",
    "company": "TEVA",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/29/2024",
    "drugName": "AZELASTINE HYDROCHLORIDE ALLERGYANDA  #216421",
    "submission": "ORIG-1",
    "activeIngredients": "AZELASTINE HYDROCHLORIDE",
    "company": "APOTEX",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/29/2024",
    "drugName": "AZELASTINE HYDROCHLORIDE CHILDREN'S ALLERGYANDA  #216421",
    "submission": "ORIG-1",
    "activeIngredients": "AZELASTINE HYDROCHLORIDE",
    "company": "APOTEX",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/29/2024",
    "drugName": "MICAFUNGIN SODIUMANDA  #216438",
    "submission": "ORIG-1",
    "activeIngredients": "MICAFUNGIN SODIUM",
    "company": "BIOCON PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/29/2024",
    "drugName": "MYCOPHENOLATE SODIUMANDA  #216637",
    "submission": "ORIG-1",
    "activeIngredients": "MYCOPHENOLATE SODIUM",
    "company": "FOSUN WANBANG",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/29/2024",
    "drugName": "HALCINONIDEANDA  #217671",
    "submission": "ORIG-1",
    "activeIngredients": "HALCINONIDE",
    "company": "ENCUBE",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/29/2024",
    "drugName": "LEVETIRACETAMANDA  #217878",
    "submission": "SUPPL-3",
    "activeIngredients": "LEVETIRACETAM",
    "company": "GRANULES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/30/2024",
    "drugName": "LISINOPRILANDA  #075752",
    "submission": "SUPPL-41",
    "activeIngredients": "LISINOPRIL",
    "company": "HERITAGE PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/30/2024",
    "drugName": "POTASSIUM CITRATEANDA  #077440",
    "submission": "SUPPL-5",
    "activeIngredients": "POTASSIUM CITRATE",
    "company": "RISING",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/30/2024",
    "drugName": "PRAVASTATIN SODIUMANDA  #079187",
    "submission": "SUPPL-5",
    "activeIngredients": "PRAVASTATIN SODIUM",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/30/2024",
    "drugName": "PRAVASTATIN SODIUMANDA  #079187",
    "submission": "SUPPL-6",
    "activeIngredients": "PRAVASTATIN SODIUM",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/30/2024",
    "drugName": "ALCAINEANDA  #080027",
    "submission": "SUPPL-51",
    "activeIngredients": "PROPARACAINE HYDROCHLORIDE",
    "company": "ALCON LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/30/2024",
    "drugName": "SIMVASTATINANDA  #090868",
    "submission": "SUPPL-7",
    "activeIngredients": "SIMVASTATIN",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/30/2024",
    "drugName": "EZETIMIBE AND SIMVASTATINANDA  #201890",
    "submission": "SUPPL-11",
    "activeIngredients": "EZETIMIBE; SIMVASTATIN",
    "company": "ANI PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/30/2024",
    "drugName": "EZETIMIBE AND SIMVASTATINANDA  #201890",
    "submission": "SUPPL-12",
    "activeIngredients": "EZETIMIBE; SIMVASTATIN",
    "company": "ANI PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/30/2024",
    "drugName": "ESCITALOPRAM OXALATEANDA  #202221",
    "submission": "SUPPL-10",
    "activeIngredients": "ESCITALOPRAM OXALATE",
    "company": "HETERO LABS LTD III",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/30/2024",
    "drugName": "ESCITALOPRAM OXALATEANDA  #202221",
    "submission": "SUPPL-11",
    "activeIngredients": "ESCITALOPRAM OXALATE",
    "company": "HETERO LABS LTD III",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/30/2024",
    "drugName": "ESCITALOPRAM OXALATEANDA  #202221",
    "submission": "SUPPL-12",
    "activeIngredients": "ESCITALOPRAM OXALATE",
    "company": "HETERO LABS LTD III",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/30/2024",
    "drugName": "ESCITALOPRAM OXALATEANDA  #202221",
    "submission": "SUPPL-14",
    "activeIngredients": "ESCITALOPRAM OXALATE",
    "company": "HETERO LABS LTD III",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/30/2024",
    "drugName": "ESCITALOPRAM OXALATEANDA  #202221",
    "submission": "SUPPL-15",
    "activeIngredients": "ESCITALOPRAM OXALATE",
    "company": "HETERO LABS LTD III",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/30/2024",
    "drugName": "INDOMETHACIN SODIUMANDA  #204118",
    "submission": "SUPPL-3",
    "activeIngredients": "INDOMETHACIN SODIUM",
    "company": "HOSPIRA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/30/2024",
    "drugName": "BOSENTANANDA  #207760",
    "submission": "SUPPL-9",
    "activeIngredients": "BOSENTAN",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/30/2024",
    "drugName": "FINGOLIMOD HYDROCHLORIDEANDA  #207991",
    "submission": "SUPPL-2",
    "activeIngredients": "FINGOLIMOD HYDROCHLORIDE",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/30/2024",
    "drugName": "FINGOLIMOD HYDROCHLORIDEANDA  #208004",
    "submission": "SUPPL-4",
    "activeIngredients": "FINGOLIMOD HYDROCHLORIDE",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/30/2024",
    "drugName": "CEFTAROLINE FOSAMILANDA  #208075",
    "submission": "SUPPL-1",
    "activeIngredients": "CEFTAROLINE FOSAMIL",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/30/2024",
    "drugName": "CEFTAROLINE FOSAMILANDA  #208075",
    "submission": "SUPPL-2",
    "activeIngredients": "CEFTAROLINE FOSAMIL",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/30/2024",
    "drugName": "FIRDAPSENDA   #208078",
    "submission": "SUPPL-12",
    "activeIngredients": "AMIFAMPRIDINE PHOSPHATE",
    "company": "CATALYST PHARMS",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/30/2024",
    "drugName": "ITRACONAZOLEANDA  #209460",
    "submission": "SUPPL-7",
    "activeIngredients": "ITRACONAZOLE",
    "company": "TORRENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/30/2024",
    "drugName": "CLOBAZAMANDA  #209715",
    "submission": "SUPPL-3",
    "activeIngredients": "CLOBAZAM",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/30/2024",
    "drugName": "BUPRENORPHINEANDA  #211586",
    "submission": "SUPPL-6",
    "activeIngredients": "BUPRENORPHINE",
    "company": "AMNEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/30/2024",
    "drugName": "BUPRENORPHINEANDA  #211586",
    "submission": "SUPPL-10",
    "activeIngredients": "BUPRENORPHINE",
    "company": "AMNEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/30/2024",
    "drugName": "BUPRENORPHINEANDA  #211586",
    "submission": "SUPPL-16",
    "activeIngredients": "BUPRENORPHINE",
    "company": "AMNEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/30/2024",
    "drugName": "PREGABALINANDA  #211685",
    "submission": "SUPPL-1",
    "activeIngredients": "PREGABALIN",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/30/2024",
    "drugName": "THIOTEPAANDA  #213049",
    "submission": "SUPPL-2",
    "activeIngredients": "THIOTEPA",
    "company": "MSN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/30/2024",
    "drugName": "PREGABALINANDA  #213313",
    "submission": "SUPPL-1",
    "activeIngredients": "PREGABALIN",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/30/2024",
    "drugName": "CARGLUMIC ACIDANDA  #213395",
    "submission": "SUPPL-2",
    "activeIngredients": "CARGLUMIC ACID",
    "company": "NAVINTA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/30/2024",
    "drugName": "CARGLUMIC ACIDANDA  #213729",
    "submission": "SUPPL-8",
    "activeIngredients": "CARGLUMIC ACID",
    "company": "NOVITIUM PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/30/2024",
    "drugName": "DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATEANDA  #215565",
    "submission": "SUPPL-3",
    "activeIngredients": "AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE",
    "company": "LANNETT CO INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/30/2024",
    "drugName": "TOPIRAMATEANDA  #215663",
    "submission": "SUPPL-3",
    "activeIngredients": "TOPIRAMATE",
    "company": "AJANTA PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/31/2024",
    "drugName": "ZANAFLEXNDA   #020397",
    "submission": "SUPPL-28",
    "activeIngredients": "TIZANIDINE HYDROCHLORIDE",
    "company": "LEGACY PHARMA USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/31/2024",
    "drugName": "NUVARINGNDA   #021187",
    "submission": "SUPPL-41",
    "activeIngredients": "ETHINYL ESTRADIOL; ETONOGESTREL",
    "company": "ORGANON USA ORGANON",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/31/2024",
    "drugName": "METHADONE HYDROCHLORIDEANDA  #040180",
    "submission": "SUPPL-12",
    "activeIngredients": "METHADONE HYDROCHLORIDE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/31/2024",
    "drugName": "METHADONE HYDROCHLORIDEANDA  #040180",
    "submission": "SUPPL-13",
    "activeIngredients": "METHADONE HYDROCHLORIDE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/31/2024",
    "drugName": "CRYSELLEANDA  #075840",
    "submission": "SUPPL-33",
    "activeIngredients": "ETHINYL ESTRADIOL; NORGESTREL",
    "company": "DURAMED PHARMS BARR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/31/2024",
    "drugName": "ONDANSETRON HYDROCHLORIDEANDA  #076930",
    "submission": "SUPPL-11",
    "activeIngredients": "ONDANSETRON HYDROCHLORIDE",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/31/2024",
    "drugName": "ONDANSETRONANDA  #078050",
    "submission": "SUPPL-17",
    "activeIngredients": "ONDANSETRON",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/31/2024",
    "drugName": "ONDANSETRONANDA  #078050",
    "submission": "SUPPL-18",
    "activeIngredients": "ONDANSETRON",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/31/2024",
    "drugName": "ALLOPURINOLANDA  #078253",
    "submission": "SUPPL-13",
    "activeIngredients": "ALLOPURINOL",
    "company": "NORTHSTAR HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/31/2024",
    "drugName": "LAMOTRIGINEANDA  #078691",
    "submission": "SUPPL-9",
    "activeIngredients": "LAMOTRIGINE",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/31/2024",
    "drugName": "LAMOTRIGINEANDA  #078691",
    "submission": "SUPPL-10",
    "activeIngredients": "LAMOTRIGINE",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/31/2024",
    "drugName": "LAMOTRIGINEANDA  #078691",
    "submission": "SUPPL-11",
    "activeIngredients": "LAMOTRIGINE",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/31/2024",
    "drugName": "VENLAFAXINE HYDROCHLORIDEANDA  #078789",
    "submission": "SUPPL-12",
    "activeIngredients": "VENLAFAXINE HYDROCHLORIDE",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/31/2024",
    "drugName": "PREDNISONEANDA  #083677",
    "submission": "SUPPL-56",
    "activeIngredients": "PREDNISONE",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/31/2024",
    "drugName": "PREDNISONEANDA  #083677",
    "submission": "SUPPL-57",
    "activeIngredients": "PREDNISONE",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/31/2024",
    "drugName": "PREDNISONEANDA  #083677",
    "submission": "SUPPL-58",
    "activeIngredients": "PREDNISONE",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/31/2024",
    "drugName": "METHADONE HYDROCHLORIDE INTENSOLANDA  #089897",
    "submission": "SUPPL-33",
    "activeIngredients": "METHADONE HYDROCHLORIDE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/31/2024",
    "drugName": "METHADONE HYDROCHLORIDE INTENSOLANDA  #089897",
    "submission": "SUPPL-40",
    "activeIngredients": "METHADONE HYDROCHLORIDE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/31/2024",
    "drugName": "METHADONE HYDROCHLORIDE INTENSOLANDA  #089897",
    "submission": "SUPPL-42",
    "activeIngredients": "METHADONE HYDROCHLORIDE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/31/2024",
    "drugName": "METHADONE HYDROCHLORIDE INTENSOLANDA  #089897",
    "submission": "SUPPL-45",
    "activeIngredients": "METHADONE HYDROCHLORIDE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/31/2024",
    "drugName": "METHADONE HYDROCHLORIDE INTENSOLANDA  #089897",
    "submission": "SUPPL-46",
    "activeIngredients": "METHADONE HYDROCHLORIDE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/31/2024",
    "drugName": "DULOXETINE HYDROCHLORIDEANDA  #090776",
    "submission": "SUPPL-22",
    "activeIngredients": "DULOXETINE HYDROCHLORIDE",
    "company": "ACTAVIS ELIZABETH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/31/2024",
    "drugName": "GEMCITABINE HYDROCHLORIDENDA   #200795",
    "submission": "SUPPL-18",
    "activeIngredients": "GEMCITABINE HYDROCHLORIDE",
    "company": "HOSPIRA INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/31/2024",
    "drugName": "MESALAMINEANDA  #202065",
    "submission": "SUPPL-5",
    "activeIngredients": "MESALAMINE",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/31/2024",
    "drugName": "LISINOPRIL AND HYDROCHLOROTHIAZIDEANDA  #204058",
    "submission": "SUPPL-11",
    "activeIngredients": "HYDROCHLOROTHIAZIDE; LISINOPRIL",
    "company": "INVAGEN PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/31/2024",
    "drugName": "DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATEANDA  #206721",
    "submission": "SUPPL-5",
    "activeIngredients": "AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/31/2024",
    "drugName": "NORETHINDRONE ACETATE AND ETHINYL ESTRADIOLANDA  #206969",
    "submission": "SUPPL-1",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/31/2024",
    "drugName": "NORETHINDRONE ACETATE AND ETHINYL ESTRADIOLANDA  #206969",
    "submission": "SUPPL-5",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/31/2024",
    "drugName": "NORETHINDRONE ACETATE AND ETHINYL ESTRADIOLANDA  #206969",
    "submission": "SUPPL-6",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/31/2024",
    "drugName": "CEFAZOLIN IN DEXTROSENDA   #207131",
    "submission": "SUPPL-10",
    "activeIngredients": "CEFAZOLIN SODIUM",
    "company": "BAXTER HLTHCARE CORP",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/31/2024",
    "drugName": "CLOBAZAMANDA  #209796",
    "submission": "SUPPL-3",
    "activeIngredients": "CLOBAZAM",
    "company": "HETERO LABS LTD III",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/31/2024",
    "drugName": "ESTRADIOL AND NORETHINDRONE ACETATEANDA  #210612",
    "submission": "SUPPL-5",
    "activeIngredients": "ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "NOVAST LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/31/2024",
    "drugName": "NADOLOLANDA  #210786",
    "submission": "SUPPL-1",
    "activeIngredients": "NADOLOL",
    "company": "NOVAST LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/31/2024",
    "drugName": "BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDEANDA  #212678",
    "submission": "SUPPL-6",
    "activeIngredients": "BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE",
    "company": "EDENBRIDGE PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/31/2024",
    "drugName": "LETERMOVIRANDA  #216854",
    "submission": "ORIG-1",
    "activeIngredients": "LETERMOVIR",
    "company": "LUPIN LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "05/31/2024",
    "drugName": "SIMLANDIBLA   #761299",
    "submission": "SUPPL-1",
    "activeIngredients": "ADALIMUMAB-RYVK",
    "company": "ALVOTECH USA INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  }
,
  {
    "approvalDate": "06/03/2024",
    "drugName": "ATENOLOL AND CHLORTHALIDONEANDA  #073665",
    "submission": "SUPPL-47",
    "activeIngredients": "ATENOLOL; CHLORTHALIDONE",
    "company": "WATSON LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/03/2024",
    "drugName": "METOPROLOL TARTRATEANDA  #076704",
    "submission": "SUPPL-41",
    "activeIngredients": "METOPROLOL TARTRATE",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/03/2024",
    "drugName": "METOPROLOL TARTRATEANDA  #076704",
    "submission": "SUPPL-45",
    "activeIngredients": "METOPROLOL TARTRATE",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/03/2024",
    "drugName": "CITALOPRAM HYDROBROMIDEANDA  #077046",
    "submission": "SUPPL-24",
    "activeIngredients": "CITALOPRAM HYDROBROMIDE",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/03/2024",
    "drugName": "DIVALPROEX SODIUMANDA  #077615",
    "submission": "SUPPL-22",
    "activeIngredients": "DIVALPROEX SODIUM",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/03/2024",
    "drugName": "DIVALPROEX SODIUMANDA  #078239",
    "submission": "SUPPL-33",
    "activeIngredients": "DIVALPROEX SODIUM",
    "company": "ZYDUS PHARMS USA INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/03/2024",
    "drugName": "EZETIMIBEANDA  #078560",
    "submission": "SUPPL-11",
    "activeIngredients": "EZETIMIBE",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/03/2024",
    "drugName": "DIVALPROEX SODIUMANDA  #202419",
    "submission": "SUPPL-29",
    "activeIngredients": "DIVALPROEX SODIUM",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/03/2024",
    "drugName": "ARMODAFINILANDA  #202768",
    "submission": "SUPPL-6",
    "activeIngredients": "ARMODAFINIL",
    "company": "NATCO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/03/2024",
    "drugName": "METHYLPHENIDATE HYDROCHLORIDEANDA  #206840",
    "submission": "SUPPL-6",
    "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "company": "ALVOGEN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/03/2024",
    "drugName": "METHYLPHENIDATE HYDROCHLORIDEANDA  #206932",
    "submission": "SUPPL-14",
    "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "company": "ABHAI INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/03/2024",
    "drugName": "ATORVASTATIN CALCIUMANDA  #208480",
    "submission": "ORIG-1",
    "activeIngredients": "ATORVASTATIN CALCIUM",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/03/2024",
    "drugName": "TPOXXNDA   #208627",
    "submission": "SUPPL-8",
    "activeIngredients": "TECOVIRIMAT",
    "company": "SIGA TECHNOLOGIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/03/2024",
    "drugName": "AMLODIPINE AND OLMESARTAN MEDOXOMILANDA  #209010",
    "submission": "SUPPL-7",
    "activeIngredients": "AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL",
    "company": "SCIEGEN PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/03/2024",
    "drugName": "EZETIMIBEANDA  #209838",
    "submission": "SUPPL-11",
    "activeIngredients": "EZETIMIBE",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/03/2024",
    "drugName": "METHYLPHENIDATE HYDROCHLORIDEANDA  #210818",
    "submission": "SUPPL-4",
    "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "company": "ALVOGEN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/03/2024",
    "drugName": "RUFINAMIDEANDA  #213410",
    "submission": "SUPPL-2",
    "activeIngredients": "RUFINAMIDE",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/03/2024",
    "drugName": "TAVNEOSNDA   #214487",
    "submission": "SUPPL-4",
    "activeIngredients": "AVACOPAN",
    "company": "CHEMOCENTRYX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/03/2024",
    "drugName": "TPOXXNDA   #214518",
    "submission": "SUPPL-3",
    "activeIngredients": "TECOVIRIMAT",
    "company": "SIGA TECHNOLOGIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/03/2024",
    "drugName": "DIVALPROEX SODIUMANDA  #214643",
    "submission": "SUPPL-4",
    "activeIngredients": "DIVALPROEX SODIUM",
    "company": "UNICHEM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/03/2024",
    "drugName": "METHYLPREDNISOLONE ACETATEANDA  #214870",
    "submission": "SUPPL-6",
    "activeIngredients": "METHYLPREDNISOLONE ACETATE",
    "company": "WILSHIRE PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/03/2024",
    "drugName": "ARFORMOTEROL TARTRATEANDA  #215032",
    "submission": "ORIG-1",
    "activeIngredients": "ARFORMOTEROL TARTRATE",
    "company": "DR REDDYS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/03/2024",
    "drugName": "METHOTREXATE SODIUMANDA  #217552",
    "submission": "ORIG-1",
    "activeIngredients": "METHOTREXATE SODIUM",
    "company": "ALEMBIC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/03/2024",
    "drugName": "TOFACITINIB CITRATEANDA  #218462",
    "submission": "ORIG-1",
    "activeIngredients": "TOFACITINIB CITRATE",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/04/2024",
    "drugName": "CETROTIDENDA   #021197",
    "submission": "SUPPL-30",
    "activeIngredients": "CETRORELIX ACETATE",
    "company": "EMD SERONO INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/04/2024",
    "drugName": "DEXAMETHASONEANDA  #040700",
    "submission": "SUPPL-6",
    "activeIngredients": "DEXAMETHASONE",
    "company": "BAUSCH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/04/2024",
    "drugName": "METFORMIN HYDROCHLORIDEANDA  #075973",
    "submission": "SUPPL-36",
    "activeIngredients": "METFORMIN HYDROCHLORIDE",
    "company": "MYLAN",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/04/2024",
    "drugName": "MIRCERABLA   #125164",
    "submission": "SUPPL-91",
    "activeIngredients": "METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA",
    "company": "HOFFMAN-LA ROCHE",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/04/2024",
    "drugName": "RETACRITBLA   #125545",
    "submission": "SUPPL-32",
    "activeIngredients": "EPOETIN ALFA-EPBX",
    "company": "HOSPIRA INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/04/2024",
    "drugName": "ALENDRONATE SODIUMANDA  #206387",
    "submission": "ORIG-1",
    "activeIngredients": "ALENDRONATE SODIUM",
    "company": "IPCA LABS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/04/2024",
    "drugName": "TERIFLUNOMIDEANDA  #209710",
    "submission": "SUPPL-5",
    "activeIngredients": "TERIFLUNOMIDE",
    "company": "SANDOZ",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/04/2024",
    "drugName": "VYONDYS 53NDA   #211970",
    "submission": "SUPPL-10",
    "activeIngredients": "GOLODIRSEN",
    "company": "SAREPTA THERAPS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/04/2024",
    "drugName": "VYONDYS 53NDA   #211970",
    "submission": "SUPPL-11",
    "activeIngredients": "GOLODIRSEN",
    "company": "SAREPTA THERAPS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/04/2024",
    "drugName": "BRUKINSANDA   #213217",
    "submission": "SUPPL-14",
    "activeIngredients": "ZANUBRUTINIB",
    "company": "BEONE MEDICINES USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/04/2024",
    "drugName": "ESMOLOL HYDROCHLORIDEANDA  #214172",
    "submission": "SUPPL-2",
    "activeIngredients": "ESMOLOL HYDROCHLORIDE",
    "company": "HQ SPCLT PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/04/2024",
    "drugName": "BRIVARACETAMANDA  #214848",
    "submission": "SUPPL-1",
    "activeIngredients": "BRIVARACETAM",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/04/2024",
    "drugName": "JAYPIRCANDA   #216059",
    "submission": "SUPPL-2",
    "activeIngredients": "PIRTOBRUTINIB",
    "company": "LOXO ONCOL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/04/2024",
    "drugName": "LISDEXAMFETAMINE DIMESYLATEANDA  #216266",
    "submission": "SUPPL-1",
    "activeIngredients": "LISDEXAMFETAMINE DIMESYLATE",
    "company": "PRINSTON INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/04/2024",
    "drugName": "DEXAMETHASONEANDA  #217001",
    "submission": "SUPPL-1",
    "activeIngredients": "DEXAMETHASONE",
    "company": "BIONPHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/04/2024",
    "drugName": "CARBIDOPA AND LEVODOPAANDA  #217482",
    "submission": "ORIG-1",
    "activeIngredients": "CARBIDOPA; LEVODOPA",
    "company": "RUBICON RESEARCH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/04/2024",
    "drugName": "LOSARTAN POTASSIUMANDA  #218551",
    "submission": "ORIG-1",
    "activeIngredients": "LOSARTAN POTASSIUM",
    "company": "APOTEX",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/04/2024",
    "drugName": "TERIPARATIDENDA   #218771",
    "submission": "ORIG-1",
    "activeIngredients": "TERIPARATIDE",
    "company": "ALMAJECT",
    "submissionClassification": "Type 5 - New Formulation or New Manufacturer",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/04/2024",
    "drugName": "IDACIOBLA   #761255",
    "submission": "SUPPL-6",
    "activeIngredients": "ADALIMUMAB-AACF",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "CORTEFNDA   #008697",
    "submission": "SUPPL-40",
    "activeIngredients": "HYDROCORTISONE",
    "company": "PHARMACIA AND UPJOHN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "SOLU-CORTEFNDA   #009866",
    "submission": "SUPPL-121",
    "activeIngredients": "HYDROCORTISONE SODIUM SUCCINATE",
    "company": "PHARMACIA AND UPJOHN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "MEDROLNDA   #011153",
    "submission": "SUPPL-83",
    "activeIngredients": "METHYLPREDNISOLONE",
    "company": "PFIZER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "ARISTOCORTNDA   #011685",
    "submission": "SUPPL-27",
    "activeIngredients": "TRIAMCINOLONE DIACETATE",
    "company": "FOSUN PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "DEPO-MEDROLNDA   #011757",
    "submission": "SUPPL-125",
    "activeIngredients": "METHYLPREDNISOLONE ACETATE",
    "company": "PFIZER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "SOLU-MEDROLNDA   #011856",
    "submission": "SUPPL-144",
    "activeIngredients": "METHYLPREDNISOLONE SODIUM SUCCINATE",
    "company": "PHARMACIA AND UPJOHN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "KENALOG-10NDA   #012041",
    "submission": "SUPPL-51",
    "activeIngredients": "TRIAMCINOLONE ACETONIDE",
    "company": "APOTHECON",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "HEXADROLNDA   #012674",
    "submission": "SUPPL-10",
    "activeIngredients": "DEXAMETHASONE",
    "company": "ASPEN GLOBAL INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "HEXADROLNDA   #012675",
    "submission": "SUPPL-15",
    "activeIngredients": "DEXAMETHASONE",
    "company": "ASPEN GLOBAL INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "ARISTOCORTNDA   #012802",
    "submission": "SUPPL-34",
    "activeIngredients": "TRIAMCINOLONE DIACETATE",
    "company": "FOSUN PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "CELESTONE SOLUSPANNDA   #014602",
    "submission": "SUPPL-68",
    "activeIngredients": "BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE",
    "company": "ORGANON",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "HEXADROLNDA   #014694",
    "submission": "SUPPL-31",
    "activeIngredients": "DEXAMETHASONE SODIUM PHOSPHATE",
    "company": "ASPEN GLOBAL INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "KENALOG-40NDA   #014901",
    "submission": "SUPPL-54",
    "activeIngredients": "TRIAMCINOLONE ACETONIDE",
    "company": "APOTHECON",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "KENALOG-80NDA   #014901",
    "submission": "SUPPL-54",
    "activeIngredients": "TRIAMCINOLONE ACETONIDE",
    "company": "APOTHECON",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "ARISTOSPANNDA   #016466",
    "submission": "SUPPL-47",
    "activeIngredients": "TRIAMCINOLONE HEXACETONIDE",
    "company": "ETHYPHARM INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "PEDIAPREDNDA   #019157",
    "submission": "SUPPL-25",
    "activeIngredients": "PREDNISOLONE SODIUM PHOSPHATE",
    "company": "SETON PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "ENTOCORT ECNDA   #021324",
    "submission": "SUPPL-27",
    "activeIngredients": "BUDESONIDE",
    "company": "PADAGIS US",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "ORAPRED ODTNDA   #021959",
    "submission": "SUPPL-14",
    "activeIngredients": "PREDNISOLONE SODIUM PHOSPHATE",
    "company": "ADVANZ PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "FLO-PREDNDA   #022067",
    "submission": "SUPPL-15",
    "activeIngredients": "PREDNISOLONE ACETATE",
    "company": "SUN PHARMA CANADA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "GILENYANDA   #022527",
    "submission": "SUPPL-42",
    "activeIngredients": "FINGOLIMOD HYDROCHLORIDE",
    "company": "NOVARTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "PREDNISONEANDA  #040256",
    "submission": "SUPPL-24",
    "activeIngredients": "PREDNISONE",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "PREDNISOLONEANDA  #040322",
    "submission": "SUPPL-3",
    "activeIngredients": "PREDNISOLONE",
    "company": "TEVA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "PREDNISOLONEANDA  #040323",
    "submission": "SUPPL-10",
    "activeIngredients": "PREDNISOLONE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "PREDNISONEANDA  #040362",
    "submission": "SUPPL-20",
    "activeIngredients": "PREDNISONE",
    "company": "JUBILANT CADISTA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "PREDNISONEANDA  #040392",
    "submission": "SUPPL-19",
    "activeIngredients": "PREDNISONE",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "PREDNISOLONEANDA  #040399",
    "submission": "SUPPL-4",
    "activeIngredients": "PREDNISOLONE",
    "company": "PHARM ASSOC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "PREDNISOLONEANDA  #040401",
    "submission": "SUPPL-15",
    "activeIngredients": "PREDNISOLONE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "DEXAMETHASONE SODIUM PHOSPHATE PRESERVATIVE FREEANDA  #040491",
    "submission": "SUPPL-15",
    "activeIngredients": "DEXAMETHASONE SODIUM PHOSPHATE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "PREDNISONEANDA  #040538",
    "submission": "SUPPL-7",
    "activeIngredients": "PREDNISONE",
    "company": "HIKMA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "PREDNISOLONEANDA  #040570",
    "submission": "SUPPL-3",
    "activeIngredients": "PREDNISOLONE",
    "company": "PHARM ASSOC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "PREDNISOLONEANDA  #040571",
    "submission": "SUPPL-4",
    "activeIngredients": "PREDNISOLONE",
    "company": "PHARM ASSOC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "DEXAMETHASONE SODIUM PHOSPHATEANDA  #040572",
    "submission": "SUPPL-9",
    "activeIngredients": "DEXAMETHASONE SODIUM PHOSPHATE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "PREDNISONEANDA  #040581",
    "submission": "SUPPL-23",
    "activeIngredients": "PREDNISONE",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "PREDNISONEANDA  #040584",
    "submission": "SUPPL-22",
    "activeIngredients": "PREDNISONE",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "PREDNISONEANDA  #040611",
    "submission": "SUPPL-15",
    "activeIngredients": "PREDNISONE",
    "company": "JUBILANT CADISTA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "DEXAMETHASONEANDA  #040700",
    "submission": "SUPPL-7",
    "activeIngredients": "DEXAMETHASONE",
    "company": "BAUSCH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "PREDNISOLONEANDA  #040775",
    "submission": "SUPPL-13",
    "activeIngredients": "PREDNISOLONE",
    "company": "LANNETT CO INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "DEXAMETHASONE SODIUM PHOSPHATEANDA  #040802",
    "submission": "SUPPL-21",
    "activeIngredients": "DEXAMETHASONE SODIUM PHOSPHATE",
    "company": "MYLAN LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "DEXAMETHASONE SODIUM PHOSPHATEANDA  #040803",
    "submission": "SUPPL-29",
    "activeIngredients": "DEXAMETHASONE SODIUM PHOSPHATE",
    "company": "MYLAN LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "PREDNISONEANDA  #040890",
    "submission": "SUPPL-7",
    "activeIngredients": "PREDNISONE",
    "company": "HIKMA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "PREDNISOLONE SODIUM PHOSPHATEANDA  #075183",
    "submission": "SUPPL-7",
    "activeIngredients": "PREDNISOLONE SODIUM PHOSPHATE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "PREDNISOLONE SODIUM PHOSPHATEANDA  #075988",
    "submission": "SUPPL-10",
    "activeIngredients": "PREDNISOLONE SODIUM PHOSPHATE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "PREDNISOLONE SODIUM PHOSPHATEANDA  #076123",
    "submission": "SUPPL-2",
    "activeIngredients": "PREDNISOLONE SODIUM PHOSPHATE",
    "company": "PHARM ASSOC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "PREDNISOLONE SODIUM PHOSPHATEANDA  #076895",
    "submission": "SUPPL-19",
    "activeIngredients": "PREDNISOLONE SODIUM PHOSPHATE",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "PREDNISOLONE SODIUM PHOSPHATEANDA  #076913",
    "submission": "SUPPL-14",
    "activeIngredients": "PREDNISOLONE SODIUM PHOSPHATE",
    "company": "PHARM ASSOC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "PREDNISOLONE SODIUM PHOSPHATEANDA  #078465",
    "submission": "SUPPL-8",
    "activeIngredients": "PREDNISOLONE SODIUM PHOSPHATE",
    "company": "PHARM ASSOC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "PREDNISOLONE SODIUM PHOSPHATEANDA  #078988",
    "submission": "SUPPL-11",
    "activeIngredients": "PREDNISOLONE SODIUM PHOSPHATE",
    "company": "PHARM ASSOC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "PREDNISOLONE SODIUM PHOSPHATEANDA  #079010",
    "submission": "SUPPL-3",
    "activeIngredients": "PREDNISOLONE SODIUM PHOSPHATE",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "PREDNISONEANDA  #080336",
    "submission": "SUPPL-50",
    "activeIngredients": "PREDNISONE",
    "company": "AIPING PHARM INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "PREDNISOLONEANDA  #080339",
    "submission": "SUPPL-50",
    "activeIngredients": "PREDNISOLONE",
    "company": "FOSUN PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "PREDNISONEANDA  #080352",
    "submission": "SUPPL-74",
    "activeIngredients": "PREDNISONE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "PREDNISOLONEANDA  #080354",
    "submission": "SUPPL-72",
    "activeIngredients": "PREDNISOLONE",
    "company": "WATSON LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "PREDNISONEANDA  #080356",
    "submission": "SUPPL-116",
    "activeIngredients": "PREDNISONE",
    "company": "WATSON LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "DEXAMETHASONEANDA  #080399",
    "submission": "SUPPL-80",
    "activeIngredients": "DEXAMETHASONE",
    "company": "PRASCO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "PREDNISOLONEANDA  #080531",
    "submission": "SUPPL-15",
    "activeIngredients": "PREDNISOLONE",
    "company": "CHARTWELL MOLECULAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "CORTISONE ACETATEANDA  #080694",
    "submission": "SUPPL-8",
    "activeIngredients": "CORTISONE ACETATE",
    "company": "CHARTWELL MOLECULAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "CORTISONE ACETATEANDA  #080776",
    "submission": "SUPPL-53",
    "activeIngredients": "CORTISONE ACETATE",
    "company": "HIKMA INTL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "PREDNISONEANDA  #083677",
    "submission": "SUPPL-69",
    "activeIngredients": "PREDNISONE",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "DEXAMETHASONEANDA  #084013",
    "submission": "SUPPL-30",
    "activeIngredients": "DEXAMETHASONE",
    "company": "SUN PHARM INDUSTRIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "DEXAMETHASONEANDA  #084081",
    "submission": "SUPPL-49",
    "activeIngredients": "DEXAMETHASONE",
    "company": "SUN PHARM INDUSTRIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "DEXAMETHASONEANDA  #084084",
    "submission": "SUPPL-27",
    "activeIngredients": "DEXAMETHASONE",
    "company": "SUN PHARM INDUSTRIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "DEXAMETHASONEANDA  #084086",
    "submission": "SUPPL-29",
    "activeIngredients": "DEXAMETHASONE",
    "company": "SUN PHARM INDUSTRIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "DEXAMETHASONE SODIUM PHOSPHATEANDA  #084282",
    "submission": "SUPPL-59",
    "activeIngredients": "DEXAMETHASONE SODIUM PHOSPHATE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "DEXAMETHASONEANDA  #084612",
    "submission": "SUPPL-33",
    "activeIngredients": "DEXAMETHASONE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "DEXAMETHASONEANDA  #084754",
    "submission": "SUPPL-61",
    "activeIngredients": "DEXAMETHASONE",
    "company": "KANCHAN HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "DEXAMETHASONEANDA  #084763",
    "submission": "SUPPL-28",
    "activeIngredients": "DEXAMETHASONE",
    "company": "SUN PHARM INDUSTRIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "DEXAMETHASONEANDA  #084764",
    "submission": "SUPPL-34",
    "activeIngredients": "DEXAMETHASONE",
    "company": "SUN PHARM INDUSTRIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "DEXAMETHASONEANDA  #084765",
    "submission": "SUPPL-30",
    "activeIngredients": "DEXAMETHASONE",
    "company": "SUN PHARM INDUSTRIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "DEXAMETHASONEANDA  #084766",
    "submission": "SUPPL-32",
    "activeIngredients": "DEXAMETHASONE",
    "company": "SUN PHARM INDUSTRIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "DEXAMETHASONE SODIUM PHOSPHATEANDA  #084916",
    "submission": "SUPPL-75",
    "activeIngredients": "DEXAMETHASONE SODIUM PHOSPHATE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "PREDNISONEANDA  #085161",
    "submission": "SUPPL-97",
    "activeIngredients": "PREDNISONE",
    "company": "WATSON LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "PREDNISONEANDA  #085162",
    "submission": "SUPPL-85",
    "activeIngredients": "PREDNISONE",
    "company": "WATSON LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "DEXAMETHASONEANDA  #085456",
    "submission": "SUPPL-23",
    "activeIngredients": "DEXAMETHASONE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "PREDNISONEANDA  #086596",
    "submission": "SUPPL-24",
    "activeIngredients": "PREDNISONE",
    "company": "SUN PHARM INDUSTRIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "DEXAMETHASONE SODIUM PHOSPHATEANDA  #087668",
    "submission": "SUPPL-26",
    "activeIngredients": "DEXAMETHASONE SODIUM PHOSPHATE",
    "company": "WATSON LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "DEXAMETHASONE SODIUM PHOSPHATEANDA  #087702",
    "submission": "SUPPL-50",
    "activeIngredients": "DEXAMETHASONE SODIUM PHOSPHATE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "DEXAMETHASONEANDA  #088248",
    "submission": "SUPPL-27",
    "activeIngredients": "DEXAMETHASONE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "DEXAMETHASONE INTENSOLANDA  #088252",
    "submission": "SUPPL-36",
    "activeIngredients": "DEXAMETHASONE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "DEXAMETHASONEANDA  #088254",
    "submission": "SUPPL-21",
    "activeIngredients": "DEXAMETHASONE",
    "company": "PHARMOBEDIENT CNSLTG",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "DEXAMETHASONEANDA  #088316",
    "submission": "SUPPL-26",
    "activeIngredients": "DEXAMETHASONE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "PREDNISONEANDA  #088465",
    "submission": "SUPPL-9",
    "activeIngredients": "PREDNISONE",
    "company": "HIKMA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "DEXAMETHASONEANDA  #088481",
    "submission": "SUPPL-32",
    "activeIngredients": "DEXAMETHASONE",
    "company": "ALVOGEN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "PREDNISONEANDA  #088703",
    "submission": "SUPPL-32",
    "activeIngredients": "PREDNISONE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "PREDNISONE INTENSOLANDA  #088810",
    "submission": "SUPPL-30",
    "activeIngredients": "PREDNISONE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "PRELONEANDA  #089081",
    "submission": "SUPPL-40",
    "activeIngredients": "PREDNISOLONE",
    "company": "TEVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "DEXAMETHASONE SODIUM PHOSPHATEANDA  #089169",
    "submission": "SUPPL-21",
    "activeIngredients": "DEXAMETHASONE SODIUM PHOSPHATE",
    "company": "DR REDDYS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "PREDNISONEANDA  #089247",
    "submission": "SUPPL-39",
    "activeIngredients": "PREDNISONE",
    "company": "SUN PHARM INDUSTRIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "DEXAMETHASONEANDA  #090891",
    "submission": "SUPPL-3",
    "activeIngredients": "DEXAMETHASONE",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "DEXAMETHASONEANDA  #091188",
    "submission": "SUPPL-7",
    "activeIngredients": "DEXAMETHASONE",
    "company": "CHARTWELL MOLECULAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "PREDNISOLONE SODIUM PHOSPHATEANDA  #091396",
    "submission": "SUPPL-5",
    "activeIngredients": "PREDNISOLONE SODIUM PHOSPHATE",
    "company": "MISSION PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "RAYOSNDA   #202020",
    "submission": "SUPPL-13",
    "activeIngredients": "PREDNISONE",
    "company": "HORIZON",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "DEXAMETHASONE SODIUM PHOSPHATEANDA  #203129",
    "submission": "SUPPL-9",
    "activeIngredients": "DEXAMETHASONE SODIUM PHOSPHATE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "PREDNISOLONE SODIUM PHOSPHATEANDA  #203559",
    "submission": "SUPPL-6",
    "activeIngredients": "PREDNISOLONE SODIUM PHOSPHATE",
    "company": "EDENBRIDGE PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "UCERISNDA   #203634",
    "submission": "SUPPL-12",
    "activeIngredients": "BUDESONIDE",
    "company": "SALIX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "PREDNISOLONE SODIUM PHOSPHATEANDA  #204962",
    "submission": "SUPPL-2",
    "activeIngredients": "PREDNISOLONE SODIUM PHOSPHATE",
    "company": "PHARM ASSOC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "PREGABALINANDA  #205321",
    "submission": "SUPPL-1",
    "activeIngredients": "PREGABALIN",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "DEXAMETHASONE SODIUM PHOSPHATEANDA  #206781",
    "submission": "SUPPL-8",
    "activeIngredients": "DEXAMETHASONE SODIUM PHOSPHATE",
    "company": "EUGIA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "DEXAMETHASONE SODIUM PHOSPHATE PRESERVATIVE FREEANDA  #207442",
    "submission": "SUPPL-16",
    "activeIngredients": "DEXAMETHASONE SODIUM PHOSPHATE",
    "company": "SOMERSET THERAPS LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "DEXAMETHASONE SODIUM PHOSPHATEANDA  #207521",
    "submission": "SUPPL-3",
    "activeIngredients": "DEXAMETHASONE SODIUM PHOSPHATE",
    "company": "SOMERSET",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "PREDNISONEANDA  #208412",
    "submission": "SUPPL-7",
    "activeIngredients": "PREDNISONE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "GALAFOLDNDA   #208623",
    "submission": "SUPPL-8",
    "activeIngredients": "MIGALASTAT HYDROCHLORIDE",
    "company": "AMICUS THERAP US",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "EMFLAZANDA   #208684",
    "submission": "SUPPL-6",
    "activeIngredients": "DEFLAZACORT",
    "company": "PTC THERAP",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "EMFLAZANDA   #208685",
    "submission": "SUPPL-7",
    "activeIngredients": "DEFLAZACORT",
    "company": "PTC THERAP",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "DEXAMETHASONE SODIUM PHOSPHATEANDA  #208689",
    "submission": "SUPPL-7",
    "activeIngredients": "DEXAMETHASONE SODIUM PHOSPHATE",
    "company": "AMNEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "DEXAMETHASONE SODIUM PHOSPHATE PRESERVATIVE FREEANDA  #208690",
    "submission": "SUPPL-9",
    "activeIngredients": "DEXAMETHASONE SODIUM PHOSPHATE",
    "company": "AMNEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "DEXAMETHASONE SODIUM PHOSPHATEANDA  #209192",
    "submission": "SUPPL-4",
    "activeIngredients": "DEXAMETHASONE SODIUM PHOSPHATE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "MAYZENTNDA   #209884",
    "submission": "SUPPL-19",
    "activeIngredients": "SIPONIMOD",
    "company": "NOVARTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "ZEPOSIANDA   #209899",
    "submission": "SUPPL-13",
    "activeIngredients": "OZANIMOD HYDROCHLORIDE",
    "company": "BRISTOL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "ZEPOSIANDA   #209899",
    "submission": "SUPPL-14",
    "activeIngredients": "OZANIMOD HYDROCHLORIDE",
    "company": "BRISTOL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "CALQUENCENDA   #210259",
    "submission": "SUPPL-10",
    "activeIngredients": "ACALABRUTINIB",
    "company": "ASTRAZENECA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "CANAGLIFLOZIN; METFORMINANDA  #210311",
    "submission": "ORIG-1",
    "activeIngredients": "CANAGLIFLOZIN;METFORMIN HYDROCLORIDE",
    "company": "INDOCO REMEDIES",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "PREDNISONEANDA  #210525",
    "submission": "SUPPL-6",
    "activeIngredients": "PREDNISONE",
    "company": "GENEYORK PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "PREDNISONEANDA  #210785",
    "submission": "SUPPL-5",
    "activeIngredients": "PREDNISONE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "DEXAMETHASONE SODIUM PHOSPHATEANDA  #210966",
    "submission": "SUPPL-5",
    "activeIngredients": "DEXAMETHASONE SODIUM PHOSPHATE",
    "company": "EUGIA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "DEXAMETHASONE SODIUM PHOSPHATEANDA  #210967",
    "submission": "SUPPL-5",
    "activeIngredients": "DEXAMETHASONE SODIUM PHOSPHATE",
    "company": "EUGIA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "DEXAMETHASONE SODIUM PHOSPHATEANDA  #211036",
    "submission": "SUPPL-7",
    "activeIngredients": "DEXAMETHASONE SODIUM PHOSPHATE",
    "company": "SOMERSET THERAPS LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "HEMADYNDA   #211379",
    "submission": "SUPPL-6",
    "activeIngredients": "DEXAMETHASONE",
    "company": "DEXCEL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "DEXAMETHASONE SODIUM PHOSPHATEANDA  #211451",
    "submission": "SUPPL-2",
    "activeIngredients": "DEXAMETHASONE SODIUM PHOSPHATE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "PREDNISONEANDA  #211496",
    "submission": "SUPPL-4",
    "activeIngredients": "PREDNISONE",
    "company": "GENEYORK PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "PREDNISONEANDA  #211575",
    "submission": "SUPPL-16",
    "activeIngredients": "PREDNISONE",
    "company": "NOVITIUM PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "ORTIKOSNDA   #211929",
    "submission": "SUPPL-11",
    "activeIngredients": "BUDESONIDE",
    "company": "SUN PHARM INDS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "PREDNISONEANDA  #213385",
    "submission": "SUPPL-4",
    "activeIngredients": "PREDNISONE",
    "company": "AMNEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "PREDNISONEANDA  #213386",
    "submission": "SUPPL-4",
    "activeIngredients": "PREDNISONE",
    "company": "AMNEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "PONVORYNDA   #213498",
    "submission": "SUPPL-5",
    "activeIngredients": "PONESIMOD",
    "company": "VANDA PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "PONVORYNDA   #213498",
    "submission": "SUPPL-6",
    "activeIngredients": "PONESIMOD",
    "company": "VANDA PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "ALKINDI SPRINKLENDA   #213876",
    "submission": "SUPPL-5",
    "activeIngredients": "HYDROCORTISONE",
    "company": "ETON",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "LAMOTRIGINEANDA  #213949",
    "submission": "SUPPL-1",
    "activeIngredients": "LAMOTRIGINE",
    "company": "YILING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "SUMATRIPTANANDA  #214209",
    "submission": "SUPPL-2",
    "activeIngredients": "SUMATRIPTAN",
    "company": "CIPLA",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "DEXAMETHASONE SODIUM PHOSPHATEANDA  #214890",
    "submission": "SUPPL-1",
    "activeIngredients": "DEXAMETHASONE SODIUM PHOSPHATE",
    "company": "GENEYORK PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "TASCENSO ODTNDA   #214962",
    "submission": "SUPPL-2",
    "activeIngredients": "FINGOLIMOD LAURYL SULFATE",
    "company": "CYCLE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "DEXAMETHASONEANDA  #215106",
    "submission": "SUPPL-2",
    "activeIngredients": "DEXAMETHASONE",
    "company": "AMNEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "AGAMREENDA   #215239",
    "submission": "SUPPL-1",
    "activeIngredients": "VAMOROLONE",
    "company": "CATALYST PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "PREDNISONEANDA  #215246",
    "submission": "SUPPL-8",
    "activeIngredients": "PREDNISONE",
    "company": "NOVITIUM PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "PALBOCICLIBANDA  #215570",
    "submission": "ORIG-1",
    "activeIngredients": "PALBOCICLIB",
    "company": "ZYDUS LIFESCIENCES",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "DEXAMETHASONEANDA  #215604",
    "submission": "SUPPL-6",
    "activeIngredients": "DEXAMETHASONE",
    "company": "NOVITIUM PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "DEXAMETHASONE SODIUM PHOSPHATEANDA  #215654",
    "submission": "SUPPL-3",
    "activeIngredients": "DEXAMETHASONE SODIUM PHOSPHATE",
    "company": "GLAND",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "PREDNISONEANDA  #215671",
    "submission": "SUPPL-1",
    "activeIngredients": "PREDNISONE",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "PREDNISONEANDA  #215672",
    "submission": "SUPPL-1",
    "activeIngredients": "PREDNISONE",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "PREDNISOLONEANDA  #215673",
    "submission": "SUPPL-1",
    "activeIngredients": "PREDNISOLONE",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "TARPEYONDA   #215935",
    "submission": "SUPPL-4",
    "activeIngredients": "BUDESONIDE",
    "company": "CALLIDITAS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "TARPEYONDA   #215935",
    "submission": "SUPPL-5",
    "activeIngredients": "BUDESONIDE",
    "company": "CALLIDITAS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "DEXAMETHASONEANDA  #216295",
    "submission": "SUPPL-1",
    "activeIngredients": "DEXAMETHASONE",
    "company": "AMNEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "CALQUENCENDA   #216387",
    "submission": "SUPPL-4",
    "activeIngredients": "ACALABRUTINIB MALEATE",
    "company": "ASTRAZENECA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "AZELASTINE HYDROCHLORIDEANDA  #216576",
    "submission": "ORIG-1",
    "activeIngredients": "AZELASTINE HYDROCHLORIDE",
    "company": "AMNEAL",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "VELSIPITYNDA   #216956",
    "submission": "SUPPL-1",
    "activeIngredients": "ETRASIMOD ARGININE",
    "company": "PFIZER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "DEXAMETHASONEANDA  #217001",
    "submission": "SUPPL-2",
    "activeIngredients": "DEXAMETHASONE",
    "company": "BIONPHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "DEXAMETHASONEANDA  #217538",
    "submission": "SUPPL-1",
    "activeIngredients": "DEXAMETHASONE",
    "company": "BIONPHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "DEXAMETHASONEANDA  #217695",
    "submission": "SUPPL-1",
    "activeIngredients": "DEXAMETHASONE",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2024",
    "drugName": "DEXAMETHASONEANDA  #217696",
    "submission": "SUPPL-6",
    "activeIngredients": "DEXAMETHASONE",
    "company": "NOVITIUM PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/06/2024",
    "drugName": "METHAMPHETAMINE HYDROCHLORIDEANDA  #091189",
    "submission": "SUPPL-8",
    "activeIngredients": "METHAMPHETAMINE HYDROCHLORIDE",
    "company": "DR REDDYS LABS SA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/06/2024",
    "drugName": "ZOLEDRONIC ACIDANDA  #201783",
    "submission": "SUPPL-24",
    "activeIngredients": "ZOLEDRONIC ACID",
    "company": "AVET LIFESCIENCES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/06/2024",
    "drugName": "MYCOPHENOLATE MOFETILANDA  #204076",
    "submission": "SUPPL-5",
    "activeIngredients": "MYCOPHENOLATE MOFETIL",
    "company": "ZHEJIANG HISUN PHARM",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/06/2024",
    "drugName": "MYCOPHENOLATE MOFETILANDA  #204076",
    "submission": "SUPPL-6",
    "activeIngredients": "MYCOPHENOLATE MOFETIL",
    "company": "ZHEJIANG HISUN PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/06/2024",
    "drugName": "MYCOPHENOLATE MOFETILANDA  #204077",
    "submission": "SUPPL-5",
    "activeIngredients": "MYCOPHENOLATE MOFETIL",
    "company": "ZHEJIANG HISUN PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/06/2024",
    "drugName": "MYCOPHENOLATE MOFETILANDA  #204077",
    "submission": "SUPPL-6",
    "activeIngredients": "MYCOPHENOLATE MOFETIL",
    "company": "ZHEJIANG HISUN PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/06/2024",
    "drugName": "PEG-3350, POTASSIUM CHLORIDE, SODIUM BICARBONATE, SODIUM CHLORIDEANDA  #204559",
    "submission": "SUPPL-16",
    "activeIngredients": "POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/06/2024",
    "drugName": "PEG-3350, POTASSIUM CHLORIDE, SODIUM BICARBONATE, SODIUM CHLORIDEANDA  #204559",
    "submission": "SUPPL-19",
    "activeIngredients": "POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/06/2024",
    "drugName": "LEQVIONDA   #214012",
    "submission": "SUPPL-11",
    "activeIngredients": "INCLISIRAN SODIUM",
    "company": "NOVARTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/06/2024",
    "drugName": "VENLAFAXINE HYDROCHLORIDEANDA  #217767",
    "submission": "ORIG-1",
    "activeIngredients": "VENLAFAXINE HYDROCHLORIDE",
    "company": "ALEMBIC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/06/2024",
    "drugName": "RYTELONDA   #217779",
    "submission": "ORIG-1",
    "activeIngredients": "IMETELSTAT SODIUM",
    "company": "GERON",
    "submissionClassification": "Type 1 - New Molecular Entity",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/07/2024",
    "drugName": "MIRAPEX ERNDA   #022421",
    "submission": "SUPPL-23",
    "activeIngredients": "PRAMIPEXOLE DIHYDROCHLORIDE",
    "company": "BOEHRINGER INGELHEIM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/07/2024",
    "drugName": "VANCOMYCIN HYDROCHLORIDE IN PLASTIC CONTAINERNDA   #050671",
    "submission": "SUPPL-32",
    "activeIngredients": "VANCOMYCIN HYDROCHLORIDE",
    "company": "BAXTER HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/07/2024",
    "drugName": "PENICILLIN G PROCAINEANDA  #060101",
    "submission": "SUPPL-40",
    "activeIngredients": "PENICILLIN G PROCAINE",
    "company": "KING PHARMS LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/07/2024",
    "drugName": "PENICILLIN G PROCAINEANDA  #060101",
    "submission": "SUPPL-41",
    "activeIngredients": "PENICILLIN G PROCAINE",
    "company": "KING PHARMS LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/07/2024",
    "drugName": "PENICILLIN G PROCAINEANDA  #060101",
    "submission": "SUPPL-42",
    "activeIngredients": "PENICILLIN G PROCAINE",
    "company": "KING PHARMS LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/07/2024",
    "drugName": "PENICILLIN G PROCAINEANDA  #060101",
    "submission": "SUPPL-43",
    "activeIngredients": "PENICILLIN G PROCAINE",
    "company": "KING PHARMS LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/07/2024",
    "drugName": "LORAZEPAMANDA  #076150",
    "submission": "SUPPL-6",
    "activeIngredients": "LORAZEPAM",
    "company": "INTL MEDICATION SYS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/07/2024",
    "drugName": "CARBOPLATINANDA  #076517",
    "submission": "SUPPL-24",
    "activeIngredients": "CARBOPLATIN",
    "company": "HOSPIRA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/07/2024",
    "drugName": "CARBOPLATINANDA  #077059",
    "submission": "SUPPL-24",
    "activeIngredients": "CARBOPLATIN",
    "company": "HOSPIRA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/07/2024",
    "drugName": "PREDNISONEANDA  #080514",
    "submission": "SUPPL-12",
    "activeIngredients": "PREDNISONE",
    "company": "CHARTWELL MOLECULAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/07/2024",
    "drugName": "PREDNISONEANDA  #080514",
    "submission": "SUPPL-13",
    "activeIngredients": "PREDNISONE",
    "company": "CHARTWELL MOLECULAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/07/2024",
    "drugName": "PREDNISONEANDA  #084275",
    "submission": "SUPPL-11",
    "activeIngredients": "PREDNISONE",
    "company": "CHARTWELL MOLECULAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/07/2024",
    "drugName": "PREDNISONEANDA  #084275",
    "submission": "SUPPL-12",
    "activeIngredients": "PREDNISONE",
    "company": "CHARTWELL MOLECULAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/07/2024",
    "drugName": "KEYTRUDABLA   #125514",
    "submission": "SUPPL-154",
    "activeIngredients": "PEMBROLIZUMAB",
    "company": "MERCK SHARP DOHME",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/07/2024",
    "drugName": "DEXAMETHASONEANDA  #201270",
    "submission": "SUPPL-4",
    "activeIngredients": "DEXAMETHASONE",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/07/2024",
    "drugName": "LENVIMANDA   #206947",
    "submission": "SUPPL-31",
    "activeIngredients": "LENVATINIB MESYLATE",
    "company": "EISAI INC",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/07/2024",
    "drugName": "LEVORPHANOL TARTRATEANDA  #212024",
    "submission": "SUPPL-6",
    "activeIngredients": "LEVORPHANOL TARTRATE",
    "company": "SPECGX LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/07/2024",
    "drugName": "PREDNISONEANDA  #212629",
    "submission": "SUPPL-1",
    "activeIngredients": "PREDNISONE",
    "company": "POINTVIEW HLDINGS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/07/2024",
    "drugName": "KLISYRINDA   #213189",
    "submission": "SUPPL-1",
    "activeIngredients": "TIRBANIBULIN",
    "company": "ALMIRALL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/07/2024",
    "drugName": "KLISYRINDA   #213189",
    "submission": "SUPPL-3",
    "activeIngredients": "TIRBANIBULIN",
    "company": "ALMIRALL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/07/2024",
    "drugName": "KLISYRINDA   #213189",
    "submission": "SUPPL-5",
    "activeIngredients": "TIRBANIBULIN",
    "company": "ALMIRALL",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/07/2024",
    "drugName": "LEVORPHANOL TARTRATEANDA  #213906",
    "submission": "SUPPL-5",
    "activeIngredients": "LEVORPHANOL TARTRATE",
    "company": "SUN PHARM INDS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/07/2024",
    "drugName": "NASONEX 24HR ALLERGYNDA   #215712",
    "submission": "SUPPL-17",
    "activeIngredients": "MOMETASONE FUROATE",
    "company": "PERRIGO PHARMA INTL",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/07/2024",
    "drugName": "MOTPOLY XRNDA   #216185",
    "submission": "SUPPL-1",
    "activeIngredients": "LACOSAMIDE",
    "company": "AUCTA",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/07/2024",
    "drugName": "FLUPHENAZINE HYDROCHLORIDEANDA  #218283",
    "submission": "ORIG-1",
    "activeIngredients": "FLUPHENAZINE HYDROCHLORIDE",
    "company": "RISING",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/07/2024",
    "drugName": "ACETYLCYSTEINEANDA  #218397",
    "submission": "ORIG-1",
    "activeIngredients": "ACETYLCYSTEINE",
    "company": "SOMERSET THERAPS LLC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/10/2024",
    "drugName": "CIMETIDINE HYDROCHLORIDEANDA  #074251",
    "submission": "SUPPL-5",
    "activeIngredients": "CIMETIDINE HYDROCHLORIDE",
    "company": "CHARTWELL MOLECULAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/10/2024",
    "drugName": "KARIVAANDA  #075863",
    "submission": "SUPPL-35",
    "activeIngredients": "DESOGESTREL; ETHINYL ESTRADIOL",
    "company": "BARR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/10/2024",
    "drugName": "KARIVAANDA  #075863",
    "submission": "SUPPL-37",
    "activeIngredients": "DESOGESTREL; ETHINYL ESTRADIOL",
    "company": "BARR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/10/2024",
    "drugName": "DESOGESTREL AND ETHINYL ESTRADIOLANDA  #076916",
    "submission": "SUPPL-14",
    "activeIngredients": "DESOGESTREL; ETHINYL ESTRADIOL",
    "company": "DR REDDYS LABS SA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/10/2024",
    "drugName": "AUBAGIONDA   #202992",
    "submission": "SUPPL-17",
    "activeIngredients": "TERIFLUNOMIDE",
    "company": "SANOFI AVENTIS US",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/10/2024",
    "drugName": "TRETINOINANDA  #208279",
    "submission": "SUPPL-4",
    "activeIngredients": "TRETINOIN",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/10/2024",
    "drugName": "ITRACONAZOLEANDA  #208591",
    "submission": "SUPPL-10",
    "activeIngredients": "ITRACONAZOLE",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/10/2024",
    "drugName": "EPHEDRINE SULFATENDA   #208609",
    "submission": "SUPPL-12",
    "activeIngredients": "EPHEDRINE SULFATE",
    "company": "RENEW PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/10/2024",
    "drugName": "EZETIMIBE AND SIMVASTATINANDA  #208699",
    "submission": "SUPPL-4",
    "activeIngredients": "EZETIMIBE; SIMVASTATIN",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/10/2024",
    "drugName": "EZETIMIBE AND SIMVASTATINANDA  #208699",
    "submission": "SUPPL-5",
    "activeIngredients": "EZETIMIBE; SIMVASTATIN",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/10/2024",
    "drugName": "CLOBAZAMANDA  #209795",
    "submission": "SUPPL-5",
    "activeIngredients": "CLOBAZAM",
    "company": "HETERO LABS LTD III",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/10/2024",
    "drugName": "CLOBAZAMANDA  #209808",
    "submission": "SUPPL-3",
    "activeIngredients": "CLOBAZAM",
    "company": "PIRAMAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/10/2024",
    "drugName": "PAROXETINE HYDROCHLORIDEANDA  #213485",
    "submission": "SUPPL-1",
    "activeIngredients": "PAROXETINE HYDROCHLORIDE",
    "company": "CSPC OUYI",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/10/2024",
    "drugName": "ZINC SULFATEANDA  #218059",
    "submission": "ORIG-1",
    "activeIngredients": "ZINC SULFATE",
    "company": "APOTEX",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/10/2024",
    "drugName": "IQIRVONDA   #218860",
    "submission": "ORIG-1",
    "activeIngredients": "ELAFIBRANOR",
    "company": "IPSEN",
    "submissionClassification": "Type 1 - New Molecular Entity",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/10/2024",
    "drugName": "KEVZARABLA   #761037",
    "submission": "SUPPL-15",
    "activeIngredients": "SARILUMAB",
    "company": "SANOFI SYNTHELABO",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/11/2024",
    "drugName": "LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN (COPACKAGED)ANDA  #206006",
    "submission": "SUPPL-8",
    "activeIngredients": "AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/11/2024",
    "drugName": "PITAVASTATIN CALCIUMANDA  #206015",
    "submission": "SUPPL-8",
    "activeIngredients": "PITAVASTATIN CALCIUM",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/11/2024",
    "drugName": "PITAVASTATIN CALCIUMANDA  #206047",
    "submission": "SUPPL-2",
    "activeIngredients": "PITAVASTATIN CALCIUM",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/11/2024",
    "drugName": "HYDROCORTISONEANDA  #207029",
    "submission": "SUPPL-5",
    "activeIngredients": "HYDROCORTISONE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/11/2024",
    "drugName": "HYDROCORTISONEANDA  #207029",
    "submission": "SUPPL-17",
    "activeIngredients": "HYDROCORTISONE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/11/2024",
    "drugName": "POMALIDOMIDEANDA  #210164",
    "submission": "ORIG-1",
    "activeIngredients": "POMALIDOMIDE",
    "company": "APOTEX",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/11/2024",
    "drugName": "VALGANCICLOVIR HYDROCHLORIDEANDA  #212876",
    "submission": "ORIG-1",
    "activeIngredients": "VALGANCICLOVIR HYDROCHLORIDE",
    "company": "SOMERSET THERAPS LLC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/11/2024",
    "drugName": "NOREPINEPHRINE BITARTRATE IN 5% DEXTROSENDA   #214313",
    "submission": "SUPPL-4",
    "activeIngredients": "NOREPINEPHRINE BITARTRATE",
    "company": "BAXTER HLTHCARE CORP",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/11/2024",
    "drugName": "HYDROCORTISONEANDA  #214649",
    "submission": "SUPPL-1",
    "activeIngredients": "HYDROCORTISONE",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/11/2024",
    "drugName": "ESOMEPRAZOLE MAGNESIUMANDA  #218092",
    "submission": "ORIG-1",
    "activeIngredients": "ESOMEPRAZOLE MAGNESIUM",
    "company": "GLENMARK SPECLT",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/11/2024",
    "drugName": "TRANEXAMIC ACIDANDA  #218320",
    "submission": "ORIG-1",
    "activeIngredients": "TRANEXAMIC ACID",
    "company": "RUBICON RESEARCH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINERNDA   #020201",
    "submission": "SUPPL-45",
    "activeIngredients": "DOBUTAMINE HYDROCHLORIDE",
    "company": "HOSPIRA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "AMOXICILLINANDA  #065322",
    "submission": "SUPPL-35",
    "activeIngredients": "AMOXICILLIN",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "AMOXICILLINANDA  #065322",
    "submission": "SUPPL-38",
    "activeIngredients": "AMOXICILLIN",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "BUPRENORPHINE HYDROCHLORIDEANDA  #074137",
    "submission": "SUPPL-16",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE",
    "company": "HOSPIRA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "BUPRENORPHINE HYDROCHLORIDEANDA  #074137",
    "submission": "SUPPL-28",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE",
    "company": "HOSPIRA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "BUPRENORPHINE HYDROCHLORIDEANDA  #074137",
    "submission": "SUPPL-36",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE",
    "company": "HOSPIRA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "BUPRENORPHINE HYDROCHLORIDEANDA  #074137",
    "submission": "SUPPL-40",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE",
    "company": "HOSPIRA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "CLONAZEPAMANDA  #074869",
    "submission": "SUPPL-37",
    "activeIngredients": "CLONAZEPAM",
    "company": "ACTAVIS ELIZABETH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "CLONAZEPAMANDA  #074869",
    "submission": "SUPPL-38",
    "activeIngredients": "CLONAZEPAM",
    "company": "ACTAVIS ELIZABETH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "CLONAZEPAMANDA  #074869",
    "submission": "SUPPL-42",
    "activeIngredients": "CLONAZEPAM",
    "company": "ACTAVIS ELIZABETH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "CLONAZEPAMANDA  #074869",
    "submission": "SUPPL-43",
    "activeIngredients": "CLONAZEPAM",
    "company": "ACTAVIS ELIZABETH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "FLUOXETINE HYDROCHLORIDEANDA  #075577",
    "submission": "SUPPL-14",
    "activeIngredients": "FLUOXETINE HYDROCHLORIDE",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "FLUOXETINE HYDROCHLORIDEANDA  #075577",
    "submission": "SUPPL-15",
    "activeIngredients": "FLUOXETINE HYDROCHLORIDE",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "OXYBUTYNIN CHLORIDEANDA  #076745",
    "submission": "SUPPL-21",
    "activeIngredients": "OXYBUTYNIN CHLORIDE",
    "company": "IMPAX PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "OXYBUTYNIN CHLORIDEANDA  #076745",
    "submission": "SUPPL-24",
    "activeIngredients": "OXYBUTYNIN CHLORIDE",
    "company": "IMPAX PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "RISPERIDONEANDA  #076908",
    "submission": "SUPPL-1",
    "activeIngredients": "RISPERIDONE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "RISPERIDONEANDA  #076908",
    "submission": "SUPPL-2",
    "activeIngredients": "RISPERIDONE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "RISPERIDONEANDA  #076908",
    "submission": "SUPPL-3",
    "activeIngredients": "RISPERIDONE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "RISPERIDONEANDA  #076908",
    "submission": "SUPPL-4",
    "activeIngredients": "RISPERIDONE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "PAROXETINE HYDROCHLORIDEANDA  #077584",
    "submission": "SUPPL-37",
    "activeIngredients": "PAROXETINE HYDROCHLORIDE",
    "company": "ZYDUS PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "RISPERIDONEANDA  #079088",
    "submission": "SUPPL-17",
    "activeIngredients": "RISPERIDONE",
    "company": "TORRENT PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "RISPERIDONEANDA  #079088",
    "submission": "SUPPL-18",
    "activeIngredients": "RISPERIDONE",
    "company": "TORRENT PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "RISPERIDONEANDA  #079088",
    "submission": "SUPPL-20",
    "activeIngredients": "RISPERIDONE",
    "company": "TORRENT PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "RISPERIDONEANDA  #079088",
    "submission": "SUPPL-21",
    "activeIngredients": "RISPERIDONE",
    "company": "TORRENT PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "RISPERIDONEANDA  #079088",
    "submission": "SUPPL-22",
    "activeIngredients": "RISPERIDONE",
    "company": "TORRENT PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "RISPERIDONEANDA  #079088",
    "submission": "SUPPL-24",
    "activeIngredients": "RISPERIDONE",
    "company": "TORRENT PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "RIFAMPINANDA  #091181",
    "submission": "SUPPL-3",
    "activeIngredients": "RIFAMPIN",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "RIFAMPINANDA  #091181",
    "submission": "SUPPL-7",
    "activeIngredients": "RIFAMPIN",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "RIFAMPINANDA  #091181",
    "submission": "SUPPL-8",
    "activeIngredients": "RIFAMPIN",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "RIFAMPINANDA  #091181",
    "submission": "SUPPL-9",
    "activeIngredients": "RIFAMPIN",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "RIFAMPINANDA  #091181",
    "submission": "SUPPL-10",
    "activeIngredients": "RIFAMPIN",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "RIFAMPINANDA  #091181",
    "submission": "SUPPL-11",
    "activeIngredients": "RIFAMPIN",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "RIFAMPINANDA  #091181",
    "submission": "SUPPL-12",
    "activeIngredients": "RIFAMPIN",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "RISPERIDONEANDA  #201003",
    "submission": "SUPPL-19",
    "activeIngredients": "RISPERIDONE",
    "company": "AJANTA PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "RISPERIDONEANDA  #201003",
    "submission": "SUPPL-28",
    "activeIngredients": "RISPERIDONE",
    "company": "AJANTA PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "RISPERIDONEANDA  #201003",
    "submission": "SUPPL-45",
    "activeIngredients": "RISPERIDONE",
    "company": "AJANTA PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "FARXIGANDA   #202293",
    "submission": "SUPPL-31",
    "activeIngredients": "DAPAGLIFLOZIN",
    "company": "ASTRAZENECA AB",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "POLYMYXIN B SULFATEANDA  #202766",
    "submission": "SUPPL-6",
    "activeIngredients": "POLYMYXIN B SULFATE",
    "company": "XELLIA PHARMS APS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "LANSOPRAZOLEANDA  #203083",
    "submission": "SUPPL-3",
    "activeIngredients": "LANSOPRAZOLE",
    "company": "HETERO LABS LTD III",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "ESOMEPRAZOLE MAGNESIUMANDA  #203636",
    "submission": "SUPPL-8",
    "activeIngredients": "ESOMEPRAZOLE MAGNESIUM",
    "company": "TORRENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "ESOMEPRAZOLE MAGNESIUMANDA  #203636",
    "submission": "SUPPL-11",
    "activeIngredients": "ESOMEPRAZOLE MAGNESIUM",
    "company": "TORRENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "ESOMEPRAZOLE MAGNESIUMANDA  #203636",
    "submission": "SUPPL-15",
    "activeIngredients": "ESOMEPRAZOLE MAGNESIUM",
    "company": "TORRENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "ESOMEPRAZOLE MAGNESIUMANDA  #203636",
    "submission": "SUPPL-16",
    "activeIngredients": "ESOMEPRAZOLE MAGNESIUM",
    "company": "TORRENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "ESOMEPRAZOLE MAGNESIUMANDA  #203636",
    "submission": "SUPPL-18",
    "activeIngredients": "ESOMEPRAZOLE MAGNESIUM",
    "company": "TORRENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "ESOMEPRAZOLE MAGNESIUMANDA  #203636",
    "submission": "SUPPL-20",
    "activeIngredients": "ESOMEPRAZOLE MAGNESIUM",
    "company": "TORRENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "POLYETHYLENE GLYCOL 3350 AND ELECTROLYTESANDA  #204558",
    "submission": "SUPPL-5",
    "activeIngredients": "POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "POLYETHYLENE GLYCOL 3350 AND ELECTROLYTESANDA  #204558",
    "submission": "SUPPL-7",
    "activeIngredients": "POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "POLYETHYLENE GLYCOL 3350 AND ELECTROLYTESANDA  #204558",
    "submission": "SUPPL-10",
    "activeIngredients": "POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "ACYCLOVIRANDA  #205470",
    "submission": "ORIG-1",
    "activeIngredients": "ACYCLOVIR",
    "company": "TARO",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "XIGDUO XRNDA   #205649",
    "submission": "SUPPL-22",
    "activeIngredients": "DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE",
    "company": "ASTRAZENECA AB",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN (COPACKAGED)ANDA  #206006",
    "submission": "SUPPL-9",
    "activeIngredients": "AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #207607",
    "submission": "SUPPL-6",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE",
    "company": "MYLAN TECHNOLOGIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #207607",
    "submission": "SUPPL-7",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE",
    "company": "MYLAN TECHNOLOGIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #207607",
    "submission": "SUPPL-10",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE",
    "company": "MYLAN TECHNOLOGIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #207607",
    "submission": "SUPPL-14",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE",
    "company": "MYLAN TECHNOLOGIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #207607",
    "submission": "SUPPL-18",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE",
    "company": "MYLAN TECHNOLOGIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #207607",
    "submission": "SUPPL-23",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE",
    "company": "MYLAN TECHNOLOGIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #211785",
    "submission": "SUPPL-1",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE",
    "company": "MYLAN TECHNOLOGIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #211785",
    "submission": "SUPPL-4",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE",
    "company": "MYLAN TECHNOLOGIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #211785",
    "submission": "SUPPL-8",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE",
    "company": "MYLAN TECHNOLOGIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #211785",
    "submission": "SUPPL-13",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE",
    "company": "MYLAN TECHNOLOGIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "RETEVMONDA   #213246",
    "submission": "SUPPL-9",
    "activeIngredients": "SELPERCATINIB",
    "company": "ELI LILLY AND CO",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "LEVORPHANOL TARTRATEANDA  #213479",
    "submission": "SUPPL-20",
    "activeIngredients": "LEVORPHANOL TARTRATE",
    "company": "NOVITIUM PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "EPOPROSTENOL SODIUMANDA  #213913",
    "submission": "ORIG-1",
    "activeIngredients": "EPOPROSTENOL SODIUM",
    "company": "MYLAN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "BRIMONIDINE TARTRATEANDA  #216772",
    "submission": "ORIG-1",
    "activeIngredients": "BRIMONIDINE TARTRATE",
    "company": "UPSHER SMITH LABS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "ZORYVENDA   #217242",
    "submission": "SUPPL-2",
    "activeIngredients": "ROFLUMILAST",
    "company": "ARCUTIS",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "POSACONAZOLEANDA  #217553",
    "submission": "SUPPL-1",
    "activeIngredients": "POSACONAZOLE",
    "company": "GLAND",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "GUANFACINE HYDROCHLORIDEANDA  #217638",
    "submission": "ORIG-1",
    "activeIngredients": "GUANFACINE HYDROCHLORIDE",
    "company": "FOSUN WANBANG",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "ELAGOLIXANDA  #217668",
    "submission": "ORIG-1",
    "activeIngredients": "ELAGOLIX",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "RETEVMONDA   #218160",
    "submission": "SUPPL-1",
    "activeIngredients": "SELPERCATINIB",
    "company": "ELI LILLY AND CO",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "AZILSARTAN MEDOXOMIL; CHLORTHALIDONEANDA  #218451",
    "submission": "ORIG-1",
    "activeIngredients": "AZILSARTAN MEDOXOMIL;CHLORTHALIDONE",
    "company": "ZYDUS PHARMS USA INC",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "NAPROXENANDA  #218497",
    "submission": "ORIG-1",
    "activeIngredients": "NAPROXEN",
    "company": "NOVITIUM PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "HYRIMOZBLA   #761071",
    "submission": "SUPPL-21",
    "activeIngredients": "ADALIMUMAB-ADAZ",
    "company": "SANDOZ INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2024",
    "drugName": "ADBRYBLA   #761180",
    "submission": "SUPPL-6",
    "activeIngredients": "TRALOKINUMAB",
    "company": "LEO PHARMA AS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/13/2024",
    "drugName": "POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINERNDA   #019904",
    "submission": "SUPPL-25",
    "activeIngredients": "POTASSIUM CHLORIDE",
    "company": "BAXTER HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/13/2024",
    "drugName": "POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINERNDA   #019904",
    "submission": "SUPPL-25",
    "activeIngredients": "POTASSIUM CHLORIDE",
    "company": "BAXTER HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/13/2024",
    "drugName": "POTASSIUM CHLORIDE 30MEQ IN PLASTIC CONTAINERNDA   #019904",
    "submission": "SUPPL-25",
    "activeIngredients": "POTASSIUM CHLORIDE",
    "company": "BAXTER HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/13/2024",
    "drugName": "POTASSIUM CHLORIDE 40MEQ IN PLASTIC CONTAINERNDA   #019904",
    "submission": "SUPPL-25",
    "activeIngredients": "POTASSIUM CHLORIDE",
    "company": "BAXTER HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/13/2024",
    "drugName": "ZALEPLONANDA  #077238",
    "submission": "SUPPL-8",
    "activeIngredients": "ZALEPLON",
    "company": "NATCO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/13/2024",
    "drugName": "VENLAFAXINE HYDROCHLORIDEANDA  #090174",
    "submission": "SUPPL-32",
    "activeIngredients": "VENLAFAXINE HYDROCHLORIDE",
    "company": "ZYDUS PHARMS USA INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/13/2024",
    "drugName": "DIVALPROEX SODIUMANDA  #090554",
    "submission": "SUPPL-38",
    "activeIngredients": "DIVALPROEX SODIUM",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/13/2024",
    "drugName": "RAPIVABNDA   #206426",
    "submission": "SUPPL-9",
    "activeIngredients": "PERAMIVIR",
    "company": "BIOCRYST",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/13/2024",
    "drugName": "DOXAZOSIN MESYLATEANDA  #209013",
    "submission": "SUPPL-2",
    "activeIngredients": "DOXAZOSIN MESYLATE",
    "company": "APPCO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/13/2024",
    "drugName": "ERTAPENEM SODIUMANDA  #209133",
    "submission": "SUPPL-15",
    "activeIngredients": "ERTAPENEM SODIUM",
    "company": "EUGIA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/13/2024",
    "drugName": "GEMMILYANDA  #213317",
    "submission": "SUPPL-2",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "XIROMED",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/13/2024",
    "drugName": "GEMMILYANDA  #213317",
    "submission": "SUPPL-3",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "XIROMED",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/13/2024",
    "drugName": "LACOSAMIDEANDA  #216670",
    "submission": "SUPPL-1",
    "activeIngredients": "LACOSAMIDE",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/13/2024",
    "drugName": "BIMATOPROSTANDA  #217456",
    "submission": "ORIG-1",
    "activeIngredients": "BIMATOPROST",
    "company": "SABA ILAC SANAYIVE",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "06/13/2024",
    "drugName": "ESTRADIOLANDA  #217610",
    "submission": "SUPPL-5",
    "activeIngredients": "ESTRADIOL",
    "company": "NOVITIUM PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/13/2024",
    "drugName": "AUGTYRONDA   #218213",
    "submission": "SUPPL-1",
    "activeIngredients": "REPOTRECTINIB",
    "company": "BRISTOL",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/13/2024",
    "drugName": "TOPIRAMATEANDA  #218482",
    "submission": "ORIG-1",
    "activeIngredients": "TOPIRAMATE",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/14/2024",
    "drugName": "NUCYNTANDA   #022304",
    "submission": "SUPPL-28",
    "activeIngredients": "TAPENTADOL HYDROCHLORIDE",
    "company": "COLLEGIUM PHARM INC",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/14/2024",
    "drugName": "ORPHENADRINE CITRATEANDA  #040249",
    "submission": "SUPPL-4",
    "activeIngredients": "ORPHENADRINE CITRATE",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/14/2024",
    "drugName": "TAPAZOLEANDA  #040320",
    "submission": "SUPPL-13",
    "activeIngredients": "METHIMAZOLE",
    "company": "KING PHARMS LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/14/2024",
    "drugName": "DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATEANDA  #040439",
    "submission": "SUPPL-34",
    "activeIngredients": "AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/14/2024",
    "drugName": "DIHYDROERGOTAMINE MESYLATEANDA  #040475",
    "submission": "SUPPL-17",
    "activeIngredients": "DIHYDROERGOTAMINE MESYLATE",
    "company": "PADAGIS US",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/14/2024",
    "drugName": "ERGOTAMINE TARTRATE AND CAFFEINEANDA  #040590",
    "submission": "SUPPL-5",
    "activeIngredients": "CAFFEINE; ERGOTAMINE TARTRATE",
    "company": "ANDA REPOSITORY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/14/2024",
    "drugName": "ERGOTAMINE TARTRATE AND CAFFEINEANDA  #040590",
    "submission": "SUPPL-9",
    "activeIngredients": "CAFFEINE; ERGOTAMINE TARTRATE",
    "company": "ANDA REPOSITORY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/14/2024",
    "drugName": "ACETIC ACIDANDA  #040607",
    "submission": "SUPPL-6",
    "activeIngredients": "ACETIC ACID, GLACIAL",
    "company": "SCIEGEN PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/14/2024",
    "drugName": "TRANYLCYPROMINE SULFATEANDA  #040640",
    "submission": "SUPPL-13",
    "activeIngredients": "TRANYLCYPROMINE SULFATE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/14/2024",
    "drugName": "HYDROXYCHLOROQUINE SULFATEANDA  #040657",
    "submission": "SUPPL-16",
    "activeIngredients": "HYDROXYCHLOROQUINE SULFATE",
    "company": "ZYDUS PHARMS USA INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/14/2024",
    "drugName": "HYDROXYCHLOROQUINE SULFATEANDA  #040657",
    "submission": "SUPPL-17",
    "activeIngredients": "HYDROXYCHLOROQUINE SULFATE",
    "company": "ZYDUS PHARMS USA INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/14/2024",
    "drugName": "HYDROXYCHLOROQUINE SULFATEANDA  #040657",
    "submission": "SUPPL-18",
    "activeIngredients": "HYDROXYCHLOROQUINE SULFATE",
    "company": "ZYDUS PHARMS USA INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/14/2024",
    "drugName": "HYDROXYCHLOROQUINE SULFATEANDA  #040657",
    "submission": "SUPPL-20",
    "activeIngredients": "HYDROXYCHLOROQUINE SULFATE",
    "company": "ZYDUS PHARMS USA INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/14/2024",
    "drugName": "PFIZERPENANDA  #060657",
    "submission": "SUPPL-37",
    "activeIngredients": "PENICILLIN G POTASSIUM",
    "company": "PFIZER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/14/2024",
    "drugName": "ENOXAPARIN SODIUM (PRESERVATIVE FREE)ANDA  #077857",
    "submission": "SUPPL-45",
    "activeIngredients": "ENOXAPARIN SODIUM",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/14/2024",
    "drugName": "BLINCYTOBLA   #125557",
    "submission": "SUPPL-28",
    "activeIngredients": "BLINATUMOMAB",
    "company": "AMGEN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/14/2024",
    "drugName": "NUCYNTA ERNDA   #200533",
    "submission": "SUPPL-29",
    "activeIngredients": "TAPENTADOL HYDROCHLORIDE",
    "company": "COLLEGIUM PHARM INC",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/14/2024",
    "drugName": "ZOLEDRONIC ACIDANDA  #202548",
    "submission": "SUPPL-1",
    "activeIngredients": "ZOLEDRONIC ACID",
    "company": "EPIC PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/14/2024",
    "drugName": "ZOLEDRONIC ACIDANDA  #202548",
    "submission": "SUPPL-3",
    "activeIngredients": "ZOLEDRONIC ACID",
    "company": "EPIC PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/14/2024",
    "drugName": "ZOLEDRONIC ACIDANDA  #202548",
    "submission": "SUPPL-5",
    "activeIngredients": "ZOLEDRONIC ACID",
    "company": "EPIC PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/14/2024",
    "drugName": "ZOLEDRONIC ACIDANDA  #202548",
    "submission": "SUPPL-6",
    "activeIngredients": "ZOLEDRONIC ACID",
    "company": "EPIC PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/14/2024",
    "drugName": "NUCYNTANDA   #203794",
    "submission": "SUPPL-13",
    "activeIngredients": "TAPENTADOL HYDROCHLORIDE",
    "company": "COLLEGIUM PHARM INC",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/14/2024",
    "drugName": "ABACAVIR SULFATE AND LAMIVUDINEANDA  #204990",
    "submission": "SUPPL-11",
    "activeIngredients": "ABACAVIR SULFATE; LAMIVUDINE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/14/2024",
    "drugName": "TRANEXAMIC ACIDANDA  #206634",
    "submission": "SUPPL-6",
    "activeIngredients": "TRANEXAMIC ACID",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/14/2024",
    "drugName": "SPRITAMNDA   #207958",
    "submission": "SUPPL-24",
    "activeIngredients": "LEVETIRACETAM",
    "company": "APRECIA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/14/2024",
    "drugName": "AVANAFILANDA  #209266",
    "submission": "ORIG-1",
    "activeIngredients": "AVANAFIL",
    "company": "HETERO LABS LTD V",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/14/2024",
    "drugName": "ATORVASTATIN CALCIUMANDA  #209912",
    "submission": "SUPPL-27",
    "activeIngredients": "ATORVASTATIN CALCIUM",
    "company": "GRAVITI PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/14/2024",
    "drugName": "EFINACONAZOLEANDA  #212066",
    "submission": "SUPPL-1",
    "activeIngredients": "EFINACONAZOLE",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/14/2024",
    "drugName": "EFINACONAZOLEANDA  #212066",
    "submission": "SUPPL-2",
    "activeIngredients": "EFINACONAZOLE",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/14/2024",
    "drugName": "EFINACONAZOLEANDA  #212178",
    "submission": "SUPPL-1",
    "activeIngredients": "EFINACONAZOLE",
    "company": "ZYDUS LIFESCIENCES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/14/2024",
    "drugName": "ICATIBANT ACETATEANDA  #213773",
    "submission": "ORIG-1",
    "activeIngredients": "ICATIBANT ACETATE",
    "company": "ALEMBIC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/14/2024",
    "drugName": "ATORVASTATIN CALCIUMANDA  #214344",
    "submission": "SUPPL-9",
    "activeIngredients": "ATORVASTATIN CALCIUM",
    "company": "HETERO LABS LTD V",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/14/2024",
    "drugName": "DABIGATRAN ETEXILATE MESYLATEANDA  #215233",
    "submission": "ORIG-1",
    "activeIngredients": "DABIGATRAN ETEXILATE MESYLATE",
    "company": "ALEMBIC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/14/2024",
    "drugName": "PEMETREXED DISODIUMANDA  #215460",
    "submission": "ORIG-1",
    "activeIngredients": "PEMETREXED DISODIUM",
    "company": "HETERO LABS LTD VI",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/14/2024",
    "drugName": "OCTREOTIDE ACETATEANDA  #216807",
    "submission": "SUPPL-1",
    "activeIngredients": "OCTREOTIDE ACETATE",
    "company": "GLAND",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/14/2024",
    "drugName": "OCTREOTIDE ACETATEANDA  #216839",
    "submission": "SUPPL-1",
    "activeIngredients": "OCTREOTIDE ACETATE",
    "company": "GLAND",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/14/2024",
    "drugName": "DICLOFENAC POTASSIUMANDA  #218011",
    "submission": "ORIG-1",
    "activeIngredients": "DICLOFENAC POTASSIUM",
    "company": "TARO",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/14/2024",
    "drugName": "IMFINZIBLA   #761069",
    "submission": "SUPPL-45",
    "activeIngredients": "DURVALUMAB",
    "company": "ASTRAZENECA UK LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/14/2024",
    "drugName": "RYSTIGGOBLA   #761286",
    "submission": "SUPPL-1",
    "activeIngredients": "ROZANOLIXIZUMAB-NOLI",
    "company": "UCB INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/17/2024",
    "drugName": "CITALOPRAM HYDROBROMIDEANDA  #077037",
    "submission": "SUPPL-7",
    "activeIngredients": "CITALOPRAM HYDROBROMIDE",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/17/2024",
    "drugName": "CITALOPRAM HYDROBROMIDEANDA  #077037",
    "submission": "SUPPL-8",
    "activeIngredients": "CITALOPRAM HYDROBROMIDE",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/17/2024",
    "drugName": "FLUCONAZOLEANDA  #077731",
    "submission": "SUPPL-33",
    "activeIngredients": "FLUCONAZOLE",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/17/2024",
    "drugName": "KEYTRUDABLA   #125514",
    "submission": "SUPPL-155",
    "activeIngredients": "PEMBROLIZUMAB",
    "company": "MERCK SHARP DOHME",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/17/2024",
    "drugName": "ADAPALENEANDA  #208322",
    "submission": "SUPPL-7",
    "activeIngredients": "ADAPALENE",
    "company": "TARO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/17/2024",
    "drugName": "EZETIMIBEANDA  #209234",
    "submission": "SUPPL-13",
    "activeIngredients": "EZETIMIBE",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/17/2024",
    "drugName": "BRINZOLAMIDEANDA  #209406",
    "submission": "SUPPL-4",
    "activeIngredients": "BRINZOLAMIDE",
    "company": "WATSON LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/17/2024",
    "drugName": "URSODIOLANDA  #210707",
    "submission": "SUPPL-11",
    "activeIngredients": "URSODIOL",
    "company": "ABHAI LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/17/2024",
    "drugName": "BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDEANDA  #215562",
    "submission": "SUPPL-10",
    "activeIngredients": "BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE",
    "company": "NOVITIUM PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/17/2024",
    "drugName": "VIGAFYDENDA   #217684",
    "submission": "ORIG-1",
    "activeIngredients": "VIGABATRIN",
    "company": "PYROS PHARMS",
    "submissionClassification": "Type 3 - New Dosage Form",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/17/2024",
    "drugName": "GADOTERATE MEGLUMINEANDA  #218073",
    "submission": "ORIG-1",
    "activeIngredients": "GADOTERATE MEGLUMINE",
    "company": "HAINAN POLY",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/18/2024",
    "drugName": "METHADONE HYDROCHLORIDEANDA  #040088",
    "submission": "SUPPL-28",
    "activeIngredients": "METHADONE HYDROCHLORIDE",
    "company": "VISTAPHARM LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/18/2024",
    "drugName": "PRAVASTATIN SODIUMANDA  #077013",
    "submission": "SUPPL-5",
    "activeIngredients": "PRAVASTATIN SODIUM",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/18/2024",
    "drugName": "EFAVIRENZANDA  #077673",
    "submission": "SUPPL-21",
    "activeIngredients": "EFAVIRENZ",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/18/2024",
    "drugName": "KETOROLAC TROMETHAMINEANDA  #077942",
    "submission": "SUPPL-6",
    "activeIngredients": "KETOROLAC TROMETHAMINE",
    "company": "WOCKHARDT BIO AG",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/18/2024",
    "drugName": "KETOROLAC TROMETHAMINEANDA  #077942",
    "submission": "SUPPL-7",
    "activeIngredients": "KETOROLAC TROMETHAMINE",
    "company": "WOCKHARDT BIO AG",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/18/2024",
    "drugName": "KETOROLAC TROMETHAMINEANDA  #077943",
    "submission": "SUPPL-4",
    "activeIngredients": "KETOROLAC TROMETHAMINE",
    "company": "WOCKHARDT BIO AG",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/18/2024",
    "drugName": "KETOROLAC TROMETHAMINEANDA  #077943",
    "submission": "SUPPL-5",
    "activeIngredients": "KETOROLAC TROMETHAMINE",
    "company": "WOCKHARDT BIO AG",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/18/2024",
    "drugName": "METRONIDAZOLEANDA  #090222",
    "submission": "SUPPL-4",
    "activeIngredients": "METRONIDAZOLE",
    "company": "ALEMBIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/18/2024",
    "drugName": "HERCEPTINBLA   #103792",
    "submission": "SUPPL-5354",
    "activeIngredients": "TRASTUZUMAB",
    "company": "GENENTECH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/18/2024",
    "drugName": "DESOGESTREL AND ETHINYL ESTRADIOLANDA  #202296",
    "submission": "SUPPL-9",
    "activeIngredients": "DESOGESTREL; ETHINYL ESTRADIOL",
    "company": "XIROMED",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/18/2024",
    "drugName": "DESOGESTREL AND ETHINYL ESTRADIOLANDA  #202296",
    "submission": "SUPPL-10",
    "activeIngredients": "DESOGESTREL; ETHINYL ESTRADIOL",
    "company": "XIROMED",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/18/2024",
    "drugName": "LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN (COPACKAGED)ANDA  #202588",
    "submission": "SUPPL-12",
    "activeIngredients": "AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/18/2024",
    "drugName": "OLANZAPINEANDA  #204866",
    "submission": "SUPPL-1",
    "activeIngredients": "OLANZAPINE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/18/2024",
    "drugName": "OLANZAPINEANDA  #204866",
    "submission": "SUPPL-2",
    "activeIngredients": "OLANZAPINE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/18/2024",
    "drugName": "OLANZAPINEANDA  #204866",
    "submission": "SUPPL-3",
    "activeIngredients": "OLANZAPINE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/18/2024",
    "drugName": "METRONIDAZOLEANDA  #205245",
    "submission": "SUPPL-9",
    "activeIngredients": "METRONIDAZOLE",
    "company": "APPCO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/18/2024",
    "drugName": "METRONIDAZOLEANDA  #205245",
    "submission": "SUPPL-11",
    "activeIngredients": "METRONIDAZOLE",
    "company": "APPCO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/18/2024",
    "drugName": "OFEVNDA   #205832",
    "submission": "SUPPL-27",
    "activeIngredients": "NINTEDANIB ESYLATE",
    "company": "BOEHRINGER INGELHEIM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/18/2024",
    "drugName": "TROSPIUM CHLORIDEANDA  #206472",
    "submission": "ORIG-1",
    "activeIngredients": "TROSPIUM CHLORIDE",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/18/2024",
    "drugName": "METRONIDAZOLEANDA  #206560",
    "submission": "SUPPL-8",
    "activeIngredients": "METRONIDAZOLE",
    "company": "CADILA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/18/2024",
    "drugName": "METRONIDAZOLEANDA  #209794",
    "submission": "SUPPL-2",
    "activeIngredients": "METRONIDAZOLE",
    "company": "CADILA PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/18/2024",
    "drugName": "METRONIDAZOLEANDA  #209794",
    "submission": "SUPPL-4",
    "activeIngredients": "METRONIDAZOLE",
    "company": "CADILA PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/18/2024",
    "drugName": "METRONIDAZOLEANDA  #209794",
    "submission": "SUPPL-5",
    "activeIngredients": "METRONIDAZOLE",
    "company": "CADILA PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/18/2024",
    "drugName": "REMIFENTANIL HYDROCHLORIDEANDA  #210594",
    "submission": "SUPPL-3",
    "activeIngredients": "REMIFENTANIL HYDROCHLORIDE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/18/2024",
    "drugName": "SCEMBLIXNDA   #215358",
    "submission": "SUPPL-5",
    "activeIngredients": "ASCIMINIB HYDROCHLORIDE",
    "company": "NOVARTIS",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/18/2024",
    "drugName": "LIDOCAINEANDA  #217117",
    "submission": "ORIG-1",
    "activeIngredients": "LIDOCAINE",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/18/2024",
    "drugName": "SOFDRANDA   #217347",
    "submission": "ORIG-1",
    "activeIngredients": "SOFPIRONIUM BROMIDE",
    "company": "BOTANIX SB",
    "submissionClassification": "Type 1 - New Molecular Entity",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/18/2024",
    "drugName": "SKYRIZIBLA   #761105",
    "submission": "SUPPL-29",
    "activeIngredients": "RISANKIZUMAB-RZAA",
    "company": "ABBVIE INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/18/2024",
    "drugName": "HERCEPTIN HYLECTABLA   #761106",
    "submission": "SUPPL-10",
    "activeIngredients": "TRASTUZUMAB AND HYALURONIDASE-OYSK",
    "company": "GENENTECH INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/18/2024",
    "drugName": "SKYRIZIBLA   #761262",
    "submission": "SUPPL-7",
    "activeIngredients": "RISANKIZUMAB-RZAA",
    "company": "ABBVIE INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/20/2024",
    "drugName": "LANOXINNDA   #009330",
    "submission": "SUPPL-39",
    "activeIngredients": "DIGOXIN",
    "company": "COVIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/20/2024",
    "drugName": "LANOXIN PEDIATRICNDA   #009330",
    "submission": "SUPPL-39",
    "activeIngredients": "DIGOXIN",
    "company": "COVIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/20/2024",
    "drugName": "DROXIANDA   #016295",
    "submission": "SUPPL-59",
    "activeIngredients": "HYDROXYUREA",
    "company": "WAYLIS THERAP",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/20/2024",
    "drugName": "HYDREANDA   #016295",
    "submission": "SUPPL-59",
    "activeIngredients": "HYDROXYUREA",
    "company": "WAYLIS THERAP",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/20/2024",
    "drugName": "APTIOMNDA   #022416",
    "submission": "SUPPL-21",
    "activeIngredients": "ESLICARBAZEPINE ACETATE",
    "company": "SUMITOMO PHARMA AM",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/20/2024",
    "drugName": "METRONIDAZOLEANDA  #070027",
    "submission": "SUPPL-52",
    "activeIngredients": "METRONIDAZOLE",
    "company": "TEVA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/20/2024",
    "drugName": "METRONIDAZOLEANDA  #070033",
    "submission": "SUPPL-53",
    "activeIngredients": "METRONIDAZOLE",
    "company": "PLIVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/20/2024",
    "drugName": "METRONIDAZOLEANDA  #070035",
    "submission": "SUPPL-62",
    "activeIngredients": "METRONIDAZOLE",
    "company": "WATSON LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/20/2024",
    "drugName": "METRONIDAZOLEANDA  #070044",
    "submission": "SUPPL-61",
    "activeIngredients": "METRONIDAZOLE",
    "company": "WATSON LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/20/2024",
    "drugName": "PIOGLITAZONE HYDROCHLORIDEANDA  #077210",
    "submission": "SUPPL-11",
    "activeIngredients": "PIOGLITAZONE HYDROCHLORIDE",
    "company": "TEVA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/20/2024",
    "drugName": "EFAVIRENZANDA  #078064",
    "submission": "SUPPL-17",
    "activeIngredients": "EFAVIRENZ",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/20/2024",
    "drugName": "GABAPENTINANDA  #078974",
    "submission": "SUPPL-5",
    "activeIngredients": "GABAPENTIN",
    "company": "MISSION PHARMACAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/20/2024",
    "drugName": "GABAPENTINANDA  #078974",
    "submission": "SUPPL-7",
    "activeIngredients": "GABAPENTIN",
    "company": "MISSION PHARMACAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/20/2024",
    "drugName": "GABAPENTINANDA  #078974",
    "submission": "SUPPL-13",
    "activeIngredients": "GABAPENTIN",
    "company": "MISSION PHARMACAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/20/2024",
    "drugName": "NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)ANDA  #211013",
    "submission": "SUPPL-4",
    "activeIngredients": "NITROFURANTOIN; NITROFURANTOIN, MACROCRYSTALLINE",
    "company": "INVENTIA",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/20/2024",
    "drugName": "RIFAXIMINANDA  #214369",
    "submission": "ORIG-1",
    "activeIngredients": "RIFAXIMIN",
    "company": "NORWICH PHARMACEUTICALS INC",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "06/20/2024",
    "drugName": "PROPOFOLANDA  #217013",
    "submission": "ORIG-1",
    "activeIngredients": "PROPOFOL",
    "company": "ASPIRO",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/20/2024",
    "drugName": "PIASKYBLA   #761388",
    "submission": "ORIG-1",
    "activeIngredients": "CROVALIMAB-AKKZ",
    "company": "GENENTECH INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/21/2024",
    "drugName": "SKELAXINNDA   #013217",
    "submission": "SUPPL-62",
    "activeIngredients": "METAXALONE",
    "company": "KING PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/21/2024",
    "drugName": "KETOROLAC TROMETHAMINEANDA  #078145",
    "submission": "SUPPL-7",
    "activeIngredients": "KETOROLAC TROMETHAMINE",
    "company": "LUITPOLD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/21/2024",
    "drugName": "SIRTURONDA   #204384",
    "submission": "SUPPL-19",
    "activeIngredients": "BEDAQUILINE FUMARATE",
    "company": "JANSSEN THERAP",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/21/2024",
    "drugName": "ATAZANAVIR SULFATEANDA  #204806",
    "submission": "SUPPL-8",
    "activeIngredients": "ATAZANAVIR SULFATE",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/21/2024",
    "drugName": "ATAZANAVIR SULFATEANDA  #204806",
    "submission": "SUPPL-12",
    "activeIngredients": "ATAZANAVIR SULFATE",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/21/2024",
    "drugName": "WAKIXNDA   #211150",
    "submission": "SUPPL-5",
    "activeIngredients": "PITOLISANT HYDROCHLORIDE",
    "company": "HARMONY",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/21/2024",
    "drugName": "WAKIXNDA   #211150",
    "submission": "SUPPL-6",
    "activeIngredients": "PITOLISANT HYDROCHLORIDE",
    "company": "HARMONY",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/21/2024",
    "drugName": "ATAZANAVIR SULFATEANDA  #212579",
    "submission": "SUPPL-3",
    "activeIngredients": "ATAZANAVIR SULFATE",
    "company": "LAURUS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/21/2024",
    "drugName": "KRAZATINDA   #216340",
    "submission": "SUPPL-5",
    "activeIngredients": "ADAGRASIB",
    "company": "BRISTOL",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/21/2024",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #217685",
    "submission": "ORIG-1",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "SLATE RUN PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/21/2024",
    "drugName": "SODIUM PHOSPHATESANDA  #218314",
    "submission": "ORIG-1",
    "activeIngredients": "SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE",
    "company": "AM REGENT",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/21/2024",
    "drugName": "OCREVUSBLA   #761053",
    "submission": "SUPPL-35",
    "activeIngredients": "OCRELIZUMAB",
    "company": "GENENTECH INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/21/2024",
    "drugName": "VYVGART HYTRULOBLA   #761304",
    "submission": "SUPPL-5",
    "activeIngredients": "EFGARTIGIMOD ALFA AND HYALURONIDASE-QVFC",
    "company": "ARGENX BV",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/21/2024",
    "drugName": "VYVGART HYTRULOBLA   #761304",
    "submission": "SUPPL-6",
    "activeIngredients": "EFGARTIGIMOD ALFA AND HYALURONIDASE-QVFC",
    "company": "ARGENX BV",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2024",
    "drugName": "SEPTRANDA   #017376",
    "submission": "SUPPL-66",
    "activeIngredients": "SULFAMETHOXAZOLE; TRIMETHOPRIM",
    "company": "MONARCH PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2024",
    "drugName": "SEPTRA DSNDA   #017376",
    "submission": "SUPPL-66",
    "activeIngredients": "SULFAMETHOXAZOLE; TRIMETHOPRIM",
    "company": "MONARCH PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2024",
    "drugName": "BACTRIMNDA   #017377",
    "submission": "SUPPL-84",
    "activeIngredients": "SULFAMETHOXAZOLE; TRIMETHOPRIM",
    "company": "SUN PHARM INDUSTRIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2024",
    "drugName": "BACTRIM DSNDA   #017377",
    "submission": "SUPPL-84",
    "activeIngredients": "SULFAMETHOXAZOLE; TRIMETHOPRIM",
    "company": "SUN PHARM INDUSTRIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2024",
    "drugName": "BACTRIMNDA   #017560",
    "submission": "SUPPL-46",
    "activeIngredients": "SULFAMETHOXAZOLE; TRIMETHOPRIM",
    "company": "SUN PHARM INDUSTRIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2024",
    "drugName": "BACTRIM PEDIATRICNDA   #017560",
    "submission": "SUPPL-46",
    "activeIngredients": "SULFAMETHOXAZOLE; TRIMETHOPRIM",
    "company": "SUN PHARM INDUSTRIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2024",
    "drugName": "SULFAMETHOXAZOLE AND TRIMETHOPRIMNDA   #018598",
    "submission": "SUPPL-55",
    "activeIngredients": "SULFAMETHOXAZOLE; TRIMETHOPRIM",
    "company": "FOSUN PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2024",
    "drugName": "SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTHNDA   #018598",
    "submission": "SUPPL-55",
    "activeIngredients": "SULFAMETHOXAZOLE; TRIMETHOPRIM",
    "company": "FOSUN PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2024",
    "drugName": "SULFATRIMNDA   #018615",
    "submission": "SUPPL-83",
    "activeIngredients": "SULFAMETHOXAZOLE; TRIMETHOPRIM",
    "company": "PHARM ASSOC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2024",
    "drugName": "SULFATRIM PEDIATRICNDA   #018615",
    "submission": "SUPPL-83",
    "activeIngredients": "SULFAMETHOXAZOLE; TRIMETHOPRIM",
    "company": "PHARM ASSOC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #065358",
    "submission": "SUPPL-23",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "SANDOZ INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2024",
    "drugName": "SULFAMETHOXAZOLE AND TRIMETHOPRIMANDA  #070028",
    "submission": "SUPPL-34",
    "activeIngredients": "SULFAMETHOXAZOLE; TRIMETHOPRIM",
    "company": "ANI PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2024",
    "drugName": "SULFAMETHOXAZOLE AND TRIMETHOPRIMANDA  #074650",
    "submission": "SUPPL-22",
    "activeIngredients": "SULFAMETHOXAZOLE; TRIMETHOPRIM",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2024",
    "drugName": "SULFAMETHOXAZOLE AND TRIMETHOPRIMANDA  #077612",
    "submission": "SUPPL-18",
    "activeIngredients": "SULFAMETHOXAZOLE; TRIMETHOPRIM",
    "company": "PRASCO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2024",
    "drugName": "SULFAMETHOXAZOLE AND TRIMETHOPRIMANDA  #077785",
    "submission": "SUPPL-17",
    "activeIngredients": "SULFAMETHOXAZOLE; TRIMETHOPRIM",
    "company": "CHARTWELL MOLECULAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2024",
    "drugName": "DEXAMETHASONEANDA  #088149",
    "submission": "SUPPL-27",
    "activeIngredients": "DEXAMETHASONE",
    "company": "PANGEA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2024",
    "drugName": "NABUMETONEANDA  #091083",
    "submission": "SUPPL-12",
    "activeIngredients": "NABUMETONE",
    "company": "WATSON LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2024",
    "drugName": "SULFAMETHOXAZOLE AND TRIMETHOPRIMANDA  #091348",
    "submission": "SUPPL-18",
    "activeIngredients": "SULFAMETHOXAZOLE; TRIMETHOPRIM",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2024",
    "drugName": "SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATEANDA  #204135",
    "submission": "ORIG-1",
    "activeIngredients": "MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE",
    "company": "BIONPHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2024",
    "drugName": "ICLEVIAANDA  #206850",
    "submission": "SUPPL-1",
    "activeIngredients": "ETHINYL ESTRADIOL; LEVONORGESTREL",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2024",
    "drugName": "ICLEVIAANDA  #206850",
    "submission": "SUPPL-2",
    "activeIngredients": "ETHINYL ESTRADIOL; LEVONORGESTREL",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2024",
    "drugName": "ICLEVIAANDA  #206850",
    "submission": "SUPPL-3",
    "activeIngredients": "ETHINYL ESTRADIOL; LEVONORGESTREL",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2024",
    "drugName": "SULFAMETHOXAZOLE AND TRIMETHOPRIMANDA  #212699",
    "submission": "SUPPL-2",
    "activeIngredients": "SULFAMETHOXAZOLE; TRIMETHOPRIM",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2024",
    "drugName": "SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERANDA  #213688",
    "submission": "ORIG-1",
    "activeIngredients": "SODIUM CHLORIDE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2024",
    "drugName": "AMITRIPTYLINE HYDROCHLORIDEANDA  #213999",
    "submission": "SUPPL-7",
    "activeIngredients": "AMITRIPTYLINE HYDROCHLORIDE",
    "company": "MANKIND PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2024",
    "drugName": "SULFAMETHOXAZOLE AND TRIMETHOPRIMANDA  #214330",
    "submission": "SUPPL-8",
    "activeIngredients": "SULFAMETHOXAZOLE; TRIMETHOPRIM",
    "company": "NOVITIUM PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/25/2024",
    "drugName": "BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDEANDA  #075768",
    "submission": "SUPPL-27",
    "activeIngredients": "BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/25/2024",
    "drugName": "FLUCONAZOLEANDA  #076658",
    "submission": "SUPPL-25",
    "activeIngredients": "FLUCONAZOLE",
    "company": "DR REDDYS LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/25/2024",
    "drugName": "DEXAMETHASONEANDA  #088149",
    "submission": "SUPPL-28",
    "activeIngredients": "DEXAMETHASONE",
    "company": "PANGEA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/25/2024",
    "drugName": "PHENTERMINE HYDROCHLORIDE AND TOPIRAMATEANDA  #204982",
    "submission": "ORIG-1",
    "activeIngredients": "PHENTERMINE HYDROCHLORIDE; TOPIRAMATE",
    "company": "ACTAVIS LABS FL INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/25/2024",
    "drugName": "BUSULFANANDA  #215102",
    "submission": "ORIG-1",
    "activeIngredients": "BUSULFAN",
    "company": "EUGIA PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/25/2024",
    "drugName": "ACYCLOVIR SODIUMANDA  #215404",
    "submission": "ORIG-1",
    "activeIngredients": "ACYCLOVIR SODIUM",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/25/2024",
    "drugName": "TEPYLUTENDA   #216984",
    "submission": "ORIG-1",
    "activeIngredients": "THIOTEPA",
    "company": "SHORLA",
    "submissionClassification": "Type 3 - New Dosage Form",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/25/2024",
    "drugName": "VANFLYTANDA   #216993",
    "submission": "SUPPL-1",
    "activeIngredients": "QUIZARTINIB DIHYDROCHLORIDE",
    "company": "DAIICHI SANKYO INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/25/2024",
    "drugName": "CABERGOLINEANDA  #218618",
    "submission": "ORIG-1",
    "activeIngredients": "CABERGOLINE",
    "company": "AMNEAL",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/26/2024",
    "drugName": "NATAZIANDA   #022252",
    "submission": "SUPPL-9",
    "activeIngredients": "DIENOGEST; ESTRADIOL VALERATE",
    "company": "BAYER HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/26/2024",
    "drugName": "ONDANSETRONANDA  #078602",
    "submission": "SUPPL-7",
    "activeIngredients": "ONDANSETRON",
    "company": "SUN PHARM INDS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/26/2024",
    "drugName": "ONDANSETRONANDA  #078602",
    "submission": "SUPPL-8",
    "activeIngredients": "ONDANSETRON",
    "company": "SUN PHARM INDS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/26/2024",
    "drugName": "ENOXAPARIN SODIUM (PRESERVATIVE FREE)ANDA  #078990",
    "submission": "SUPPL-16",
    "activeIngredients": "ENOXAPARIN SODIUM",
    "company": "GLAND",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/26/2024",
    "drugName": "ENOXAPARIN SODIUM (PRESERVATIVE FREE)ANDA  #078990",
    "submission": "SUPPL-19",
    "activeIngredients": "ENOXAPARIN SODIUM",
    "company": "GLAND",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/26/2024",
    "drugName": "ROSUVASTATIN CALCIUMANDA  #079161",
    "submission": "SUPPL-4",
    "activeIngredients": "ROSUVASTATIN CALCIUM",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/26/2024",
    "drugName": "ROSUVASTATIN CALCIUMANDA  #079161",
    "submission": "SUPPL-6",
    "activeIngredients": "ROSUVASTATIN CALCIUM",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/26/2024",
    "drugName": "ROSUVASTATIN CALCIUMANDA  #079161",
    "submission": "SUPPL-7",
    "activeIngredients": "ROSUVASTATIN CALCIUM",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/26/2024",
    "drugName": "OLANZAPINEANDA  #201741",
    "submission": "SUPPL-2",
    "activeIngredients": "OLANZAPINE",
    "company": "AM REGENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/26/2024",
    "drugName": "OLANZAPINEANDA  #201741",
    "submission": "SUPPL-4",
    "activeIngredients": "OLANZAPINE",
    "company": "AM REGENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/26/2024",
    "drugName": "OLANZAPINEANDA  #201741",
    "submission": "SUPPL-5",
    "activeIngredients": "OLANZAPINE",
    "company": "AM REGENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/26/2024",
    "drugName": "OLANZAPINEANDA  #201741",
    "submission": "SUPPL-7",
    "activeIngredients": "OLANZAPINE",
    "company": "AM REGENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/26/2024",
    "drugName": "RISPERIDONEANDA  #205104",
    "submission": "ORIG-1",
    "activeIngredients": "RISPERIDONE",
    "company": "IPCA LABS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/26/2024",
    "drugName": "ISOTRETINOINANDA  #207792",
    "submission": "SUPPL-22",
    "activeIngredients": "ISOTRETINOIN",
    "company": "AMNEAL PHARMS NY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/26/2024",
    "drugName": "PROPYLTHIOURACILANDA  #208867",
    "submission": "SUPPL-1",
    "activeIngredients": "PROPYLTHIOURACIL",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/26/2024",
    "drugName": "OLOPATADINE HYDROCHLORIDEANDA  #208896",
    "submission": "ORIG-1",
    "activeIngredients": "OLOPATADINE HYDROCHLORIDE",
    "company": "LUPIN PHARMS",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "06/26/2024",
    "drugName": "VANCOMYCIN HYDROCHLORIDENDA   #209481",
    "submission": "SUPPL-24",
    "activeIngredients": "VANCOMYCIN HYDROCHLORIDE",
    "company": "MYLAN LABS LTD",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/26/2024",
    "drugName": "DIMETHYL FUMARATEANDA  #210377",
    "submission": "ORIG-1",
    "activeIngredients": "DIMETHYL FUMARATE",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/26/2024",
    "drugName": "PENICILLAMINEANDA  #213293",
    "submission": "SUPPL-1",
    "activeIngredients": "PENICILLAMINE",
    "company": "INVAGEN PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/26/2024",
    "drugName": "OHTUVAYRENDA   #217389",
    "submission": "ORIG-1",
    "activeIngredients": "ENSIFENTRINE",
    "company": "VERONA PHARMA",
    "submissionClassification": "Type 1 - New Molecular Entity",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/26/2024",
    "drugName": "OJEMDANDA   #217700",
    "submission": "SUPPL-1",
    "activeIngredients": "TOVORAFENIB",
    "company": "DAY ONE BIOPHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/26/2024",
    "drugName": "OJEMDANDA   #218033",
    "submission": "SUPPL-1",
    "activeIngredients": "TOVORAFENIB",
    "company": "DAY ONE BIOPHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/26/2024",
    "drugName": "FORMOTEROL FUMARATEANDA  #218304",
    "submission": "ORIG-1",
    "activeIngredients": "FORMOTEROL FUMARATE",
    "company": "MICRO LABS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/26/2024",
    "drugName": "PALIPERIDONEANDA  #218514",
    "submission": "ORIG-1",
    "activeIngredients": "PALIPERIDONE",
    "company": "AJANTA PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/26/2024",
    "drugName": "ADAKVEOBLA   #761128",
    "submission": "SUPPL-6",
    "activeIngredients": "CRIZANLIZUMAB-TMCA",
    "company": "NOVARTIS PHARMS CORP",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/26/2024",
    "drugName": "SIMLANDIBLA   #761299",
    "submission": "SUPPL-7",
    "activeIngredients": "ADALIMUMAB-RYVK",
    "company": "ALVOTECH USA INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/26/2024",
    "drugName": "EPKINLYBLA   #761324",
    "submission": "SUPPL-3",
    "activeIngredients": "EPCORITAMAB-BYSP",
    "company": "GENMAB US, INC.",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/27/2024",
    "drugName": "ZYVOXNDA   #021130",
    "submission": "SUPPL-46",
    "activeIngredients": "LINEZOLID",
    "company": "PFIZER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/27/2024",
    "drugName": "ZYVOXNDA   #021131",
    "submission": "SUPPL-44",
    "activeIngredients": "LINEZOLID",
    "company": "PFIZER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/27/2024",
    "drugName": "ZYVOXNDA   #021132",
    "submission": "SUPPL-46",
    "activeIngredients": "LINEZOLID",
    "company": "PFIZER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/27/2024",
    "drugName": "VEKLURYNDA   #214787",
    "submission": "SUPPL-27",
    "activeIngredients": "REMDESIVIR",
    "company": "GILEAD SCIENCES INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/27/2024",
    "drugName": "DOXYCYCLINEANDA  #217674",
    "submission": "ORIG-1",
    "activeIngredients": "DOXYCYCLINE",
    "company": "ALEMBIC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/27/2024",
    "drugName": "KIMMTRAKBLA   #761228",
    "submission": "SUPPL-3",
    "activeIngredients": "TEBENTAFUSP-TEBN",
    "company": "IMMUNOCORE LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/28/2024",
    "drugName": "PARAGARD T 380ANDA   #018680",
    "submission": "SUPPL-74",
    "activeIngredients": "COPPER",
    "company": "COOPERSURGICAL",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/28/2024",
    "drugName": "ARAVANDA   #020905",
    "submission": "SUPPL-33",
    "activeIngredients": "LEFLUNOMIDE",
    "company": "SANOFI AVENTIS US",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/28/2024",
    "drugName": "ACTOPLUS METNDA   #021842",
    "submission": "SUPPL-25",
    "activeIngredients": "METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE",
    "company": "TAKEDA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/28/2024",
    "drugName": "ABSORICANDA   #021951",
    "submission": "SUPPL-16",
    "activeIngredients": "ISOTRETINOIN",
    "company": "SUN PHARM INDS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/28/2024",
    "drugName": "OSENINDA   #022426",
    "submission": "SUPPL-16",
    "activeIngredients": "ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE",
    "company": "TAKEDA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/28/2024",
    "drugName": "VIDAZANDA   #050794",
    "submission": "SUPPL-36",
    "activeIngredients": "AZACITIDINE",
    "company": "BRISTOL-MYERS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/28/2024",
    "drugName": "METRONIDAZOLEANDA  #079067",
    "submission": "SUPPL-18",
    "activeIngredients": "METRONIDAZOLE",
    "company": "ALEMBIC PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/28/2024",
    "drugName": "METRONIDAZOLEANDA  #079067",
    "submission": "SUPPL-22",
    "activeIngredients": "METRONIDAZOLE",
    "company": "ALEMBIC PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/28/2024",
    "drugName": "SOLIRISBLA   #125166",
    "submission": "SUPPL-445",
    "activeIngredients": "ECULIZUMAB",
    "company": "ALEXION PHARM",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/28/2024",
    "drugName": "METOPROLOL SUCCINATEANDA  #204106",
    "submission": "SUPPL-5",
    "activeIngredients": "METOPROLOL SUCCINATE",
    "company": "NOVAST LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/28/2024",
    "drugName": "METOPROLOL SUCCINATEANDA  #204106",
    "submission": "SUPPL-8",
    "activeIngredients": "METOPROLOL SUCCINATE",
    "company": "NOVAST LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/28/2024",
    "drugName": "PEG-3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM ASCORBATE AND ASCORBIC ACIDANDA  #207498",
    "submission": "ORIG-1",
    "activeIngredients": "ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE",
    "company": "TARO",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/28/2024",
    "drugName": "DEXMETHYLPHENIDATE HYDROCHLORIDEANDA  #207901",
    "submission": "SUPPL-4",
    "activeIngredients": "DEXMETHYLPHENIDATE HYDROCHLORIDE",
    "company": "TRIS PHARMA INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/28/2024",
    "drugName": "DEXMETHYLPHENIDATE HYDROCHLORIDEANDA  #207901",
    "submission": "SUPPL-6",
    "activeIngredients": "DEXMETHYLPHENIDATE HYDROCHLORIDE",
    "company": "TRIS PHARMA INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/28/2024",
    "drugName": "DEXMETHYLPHENIDATE HYDROCHLORIDEANDA  #207901",
    "submission": "SUPPL-10",
    "activeIngredients": "DEXMETHYLPHENIDATE HYDROCHLORIDE",
    "company": "TRIS PHARMA INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/28/2024",
    "drugName": "RASAGILINE MESYLATEANDA  #208866",
    "submission": "ORIG-1",
    "activeIngredients": "RASAGILINE MESYLATE",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/28/2024",
    "drugName": "NALOXONE HYDROCHLORIDEANDA  #209522",
    "submission": "SUPPL-12",
    "activeIngredients": "NALOXONE HYDROCHLORIDE",
    "company": "TEVA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/28/2024",
    "drugName": "AXTLENDA   #210661",
    "submission": "ORIG-1",
    "activeIngredients": "PEMETREXED DIPOTASSIUM",
    "company": "AVYXA HOLDINGS",
    "submissionClassification": "Type 2 - New Active Ingredient",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/28/2024",
    "drugName": "REMIFENTANIL HYDROCHLORIDEANDA  #215635",
    "submission": "ORIG-1",
    "activeIngredients": "REMIFENTANIL HYDROCHLORIDE",
    "company": "NIVAGEN PHARMS INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/28/2024",
    "drugName": "MIDOSTAURINANDA  #215921",
    "submission": "ORIG-1",
    "activeIngredients": "MIDOSTAURIN",
    "company": "DR REDDYS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/28/2024",
    "drugName": "PALIPERIDONE PALMITATEANDA  #217889",
    "submission": "ORIG-1",
    "activeIngredients": "PALIPERIDONE PALMITATE",
    "company": "QILU",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "06/28/2024",
    "drugName": "ERIBULIN MESYLATEANDA  #218281",
    "submission": "ORIG-1",
    "activeIngredients": "ERIBULIN MESYLATE",
    "company": "JIANGXI KVVIT PHARM",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/28/2024",
    "drugName": "CHEWTADZYNDA   #218527",
    "submission": "ORIG-1",
    "activeIngredients": "TADALAFIL",
    "company": "B BETTER",
    "submissionClassification": "Type 3 - New Dosage Form",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/28/2024",
    "drugName": "HADLIMABLA   #761059",
    "submission": "SUPPL-18",
    "activeIngredients": "ADALIMUMAB-BWWD",
    "company": "SAMSUNG BIOEPIS CO LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/28/2024",
    "drugName": "ULTOMIRISBLA   #761108",
    "submission": "SUPPL-36",
    "activeIngredients": "RAVULIZUMAB-CWVZ",
    "company": "ALEXION PHARM",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/28/2024",
    "drugName": "NYPOZIBLA   #761126",
    "submission": "ORIG-1",
    "activeIngredients": "FILGRASTIM-TXID",
    "company": "TANVEX BIOPHARMA USA INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/28/2024",
    "drugName": "PYZCHIVABLA   #761373",
    "submission": "ORIG-1",
    "activeIngredients": "USTEKINUMAB-TTWE",
    "company": "SAMSUNG BIOEPIS CO LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/28/2024",
    "drugName": "AHZANTIVEBLA   #761378",
    "submission": "ORIG-1",
    "activeIngredients": "AFLIBERCEPT-MRBB",
    "company": "FORMYCON AG",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/28/2024",
    "drugName": "PYZCHIVABLA   #761425",
    "submission": "ORIG-1",
    "activeIngredients": "USTEKINUMAB-TTWE",
    "company": "SAMSUNG BIOEPIS CO LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  }
,
  {
    "approvalDate": "07/01/2024",
    "drugName": "COSYNTROPINNDA   #022028",
    "submission": "SUPPL-7",
    "activeIngredients": "COSYNTROPIN",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/01/2024",
    "drugName": "FLUCONAZOLEANDA  #076351",
    "submission": "SUPPL-17",
    "activeIngredients": "FLUCONAZOLE",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/01/2024",
    "drugName": "DEXAMETHASONEANDA  #088237",
    "submission": "SUPPL-30",
    "activeIngredients": "DEXAMETHASONE",
    "company": "KEY THERAP",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/01/2024",
    "drugName": "VELPHORONDA   #205109",
    "submission": "SUPPL-9",
    "activeIngredients": "FERRIC OXYHYDROXIDE",
    "company": "VIFOR FRESENIUS",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/01/2024",
    "drugName": "NINLARONDA   #208462",
    "submission": "SUPPL-17",
    "activeIngredients": "IXAZOMIB CITRATE",
    "company": "TAKEDA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/01/2024",
    "drugName": "INDIUM IN-111 PENTETREOTIDE KITANDA  #212785",
    "submission": "ORIG-1",
    "activeIngredients": "INDIUM IN-111 PENTETREOTIDE KIT",
    "company": "SUN PHARM INDS INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/01/2024",
    "drugName": "BUPIVACAINE LIPOSOMEANDA  #214348",
    "submission": "ORIG-1",
    "activeIngredients": "BUPIVACAINE",
    "company": "HENGRUI PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/01/2024",
    "drugName": "ATROPINE SULFATEANDA  #215618",
    "submission": "ORIG-1",
    "activeIngredients": "ATROPINE SULFATE",
    "company": "SOMERSET THERAPS LLC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/01/2024",
    "drugName": "AUSTEDO XRNDA   #216354",
    "submission": "SUPPL-7",
    "activeIngredients": "DEUTETRABENAZINE",
    "company": "TEVA",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/01/2024",
    "drugName": "DICYCLOMINE HYDROCHLORIDEANDA  #218018",
    "submission": "ORIG-1",
    "activeIngredients": "DICYCLOMINE HYDROCHLORIDE",
    "company": "ANNORA PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/01/2024",
    "drugName": "DOXEPIN HYDROCHLORIDEANDA  #218564",
    "submission": "ORIG-1",
    "activeIngredients": "DOXEPIN HYDROCHLORIDE",
    "company": "AJANTA PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/02/2024",
    "drugName": "OSELTAMIVIR PHOSPHATEANDA  #217303",
    "submission": "ORIG-1",
    "activeIngredients": "OSELTAMIVIR PHOSPHATE",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/02/2024",
    "drugName": "SILIQBLA   #761032",
    "submission": "SUPPL-16",
    "activeIngredients": "BRODALUMAB",
    "company": "VALEANT LUXEMBOURG",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/02/2024",
    "drugName": "KISUNLABLA   #761248",
    "submission": "ORIG-1",
    "activeIngredients": "DONANEMAB-AZBT",
    "company": "ELI LILLY CO",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/02/2024",
    "drugName": "TECVAYLIBLA   #761291",
    "submission": "SUPPL-7",
    "activeIngredients": "TECLISTAMAB-CQYV",
    "company": "JANSSEN BIOTECH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/02/2024",
    "drugName": "TALVEYBLA   #761342",
    "submission": "SUPPL-5",
    "activeIngredients": "TALQUETAMAB-TGVS",
    "company": "JANSSEN BIOTECH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/03/2024",
    "drugName": "RISPERIDONEANDA  #077769",
    "submission": "SUPPL-5",
    "activeIngredients": "RISPERIDONE",
    "company": "HERITAGE PHARMA AVET",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/03/2024",
    "drugName": "ADENOSINEANDA  #078686",
    "submission": "SUPPL-13",
    "activeIngredients": "ADENOSINE",
    "company": "MYLAN LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/03/2024",
    "drugName": "IBUPROFEN LYSINEANDA  #202402",
    "submission": "SUPPL-5",
    "activeIngredients": "IBUPROFEN LYSINE",
    "company": "XGEN PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/03/2024",
    "drugName": "MYCOPHENOLATE MOFETIL HYDROCHLORIDEANDA  #204043",
    "submission": "SUPPL-6",
    "activeIngredients": "MYCOPHENOLATE MOFETIL HYDROCHLORIDE",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/03/2024",
    "drugName": "MYCOPHENOLATE MOFETIL HYDROCHLORIDEANDA  #204043",
    "submission": "SUPPL-14",
    "activeIngredients": "MYCOPHENOLATE MOFETIL HYDROCHLORIDE",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/03/2024",
    "drugName": "MYCOPHENOLATE MOFETIL HYDROCHLORIDEANDA  #204043",
    "submission": "SUPPL-15",
    "activeIngredients": "MYCOPHENOLATE MOFETIL HYDROCHLORIDE",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/03/2024",
    "drugName": "METHYLPHENIDATE HYDROCHLORIDEANDA  #207414",
    "submission": "SUPPL-1",
    "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "company": "CHARTWELL MOLECULAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/03/2024",
    "drugName": "METHYLPHENIDATE HYDROCHLORIDEANDA  #207414",
    "submission": "SUPPL-2",
    "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "company": "CHARTWELL MOLECULAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/03/2024",
    "drugName": "LINACLOTIDEANDA  #209564",
    "submission": "SUPPL-4",
    "activeIngredients": "LINACLOTIDE",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/03/2024",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #215568",
    "submission": "SUPPL-10",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "GRANULES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/03/2024",
    "drugName": "ATROPINE SULFATEANDA  #215969",
    "submission": "ORIG-1",
    "activeIngredients": "ATROPINE SULFATE",
    "company": "SOMERSET THERAPS LLC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/03/2024",
    "drugName": "TIMOLOL MALEATEANDA  #216653",
    "submission": "ORIG-1",
    "activeIngredients": "TIMOLOL MALEATE",
    "company": "SOMERSET THERAPS LLC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/03/2024",
    "drugName": "LEVETIRACETAM IN SODIUM CHLORIDEANDA  #217059",
    "submission": "SUPPL-1",
    "activeIngredients": "LEVETIRACETAM",
    "company": "BAXTER HLTHCARE CORP",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/03/2024",
    "drugName": "TIMOLOL MALEATEANDA  #217764",
    "submission": "ORIG-1",
    "activeIngredients": "TIMOLOL MALEATE",
    "company": "SOMERSET",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/03/2024",
    "drugName": "IVOSIDENIBANDA  #217768",
    "submission": "ORIG-1",
    "activeIngredients": "IVOSIDENIB",
    "company": "ALEMBIC PHARMS LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "07/03/2024",
    "drugName": "AZILSARTAN MEDOXOMILANDA  #218658",
    "submission": "ORIG-1",
    "activeIngredients": "AZILSARTAN MEDOXOMIL",
    "company": "ZYDUS PHARMS USA INC",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "07/03/2024",
    "drugName": "VABYSMOBLA   #761235",
    "submission": "SUPPL-5",
    "activeIngredients": "FARICIMAB-SVOA",
    "company": "GENENTECH INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/05/2024",
    "drugName": "NIZORAL ANTI-DANDRUFFNDA   #020310",
    "submission": "SUPPL-33",
    "activeIngredients": "KETOCONAZOLE",
    "company": "KRAMER",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/05/2024",
    "drugName": "LANSOPRAZOLEANDA  #090763",
    "submission": "SUPPL-19",
    "activeIngredients": "LANSOPRAZOLE",
    "company": "MYLAN PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/05/2024",
    "drugName": "XeominBLA   #125360",
    "submission": "SUPPL-99",
    "activeIngredients": "incobotulinumtoxinA",
    "company": "MERZ PHARMS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/05/2024",
    "drugName": "CYCLOSPORINEANDA  #211943",
    "submission": "ORIG-1",
    "activeIngredients": "CYCLOSPORINE",
    "company": "SAPTALIS PHARMS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/05/2024",
    "drugName": "LEVETIRACETAMANDA  #211954",
    "submission": "SUPPL-6",
    "activeIngredients": "LEVETIRACETAM",
    "company": "MICRO LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/05/2024",
    "drugName": "ZINC SULFATEANDA  #214597",
    "submission": "ORIG-1",
    "activeIngredients": "ZINC SULFATE",
    "company": "NIVAGEN PHARMS INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/05/2024",
    "drugName": "ARFORMOTEROL TARTRATEANDA  #216128",
    "submission": "SUPPL-4",
    "activeIngredients": "ARFORMOTEROL TARTRATE",
    "company": "MANKIND PHARMA",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/05/2024",
    "drugName": "LATANOPROSTENE BUNODANDA  #218414",
    "submission": "ORIG-1",
    "activeIngredients": "LATANOPROSTENE",
    "company": "DR REDDYS LABS LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "07/05/2024",
    "drugName": "METFORMIN HYDROCHLORIDEANDA  #218673",
    "submission": "ORIG-1",
    "activeIngredients": "METFORMIN HYDROCHLORIDE",
    "company": "HARMAN FINOCHEM",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/05/2024",
    "drugName": "NGENLABLA   #761184",
    "submission": "SUPPL-3",
    "activeIngredients": "SOMATROGON-GHLA",
    "company": "PFIZER IRELAND PHARMACEUTICALS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "FLAGYLNDA   #012623",
    "submission": "SUPPL-72",
    "activeIngredients": "METRONIDAZOLE",
    "company": "PFIZER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "CELESTONE SOLUSPANNDA   #014602",
    "submission": "SUPPL-64",
    "activeIngredients": "BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE",
    "company": "ORGANON",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "METRONIDAZOLENDA   #018620",
    "submission": "SUPPL-24",
    "activeIngredients": "METRONIDAZOLE",
    "company": "FOSUN PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "FLAGYL I.V. RTU IN PLASTIC CONTAINERNDA   #018657",
    "submission": "SUPPL-42",
    "activeIngredients": "METRONIDAZOLE",
    "company": "BAXTER HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "METRONIDAZOLENDA   #018740",
    "submission": "SUPPL-42",
    "activeIngredients": "METRONIDAZOLE",
    "company": "FOSUN PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "METRONIDAZOLENDA   #018845",
    "submission": "SUPPL-17",
    "activeIngredients": "METRONIDAZOLE",
    "company": "CHARTWELL MOLECULES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "METRONIDAZOLE IN PLASTIC CONTAINERNDA   #018890",
    "submission": "SUPPL-57",
    "activeIngredients": "METRONIDAZOLE",
    "company": "HOSPIRA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "METRO I.V. IN PLASTIC CONTAINERNDA   #018900",
    "submission": "SUPPL-43",
    "activeIngredients": "METRONIDAZOLE",
    "company": "B BRAUN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "METRONIDAZOLENDA   #018907",
    "submission": "SUPPL-8",
    "activeIngredients": "METRONIDAZOLE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "METRONIDAZOLENDA   #018930",
    "submission": "SUPPL-16",
    "activeIngredients": "METRONIDAZOLE",
    "company": "CHARTWELL MOLECULES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "FLAGYLNDA   #020334",
    "submission": "SUPPL-15",
    "activeIngredients": "METRONIDAZOLE",
    "company": "PFIZER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "FLAGYL ERNDA   #020868",
    "submission": "SUPPL-17",
    "activeIngredients": "METRONIDAZOLE",
    "company": "PFIZER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "MUCINEX DNDA   #021585",
    "submission": "SUPPL-38",
    "activeIngredients": "GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE",
    "company": "RB HLTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "HELIDACNDA   #050719",
    "submission": "SUPPL-25",
    "activeIngredients": "BISMUTH SUBSALICYLATE; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE",
    "company": "CASPER PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "PYLERANDA   #050786",
    "submission": "SUPPL-26",
    "activeIngredients": "BISMUTH SUBCITRATE POTASSIUM; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE",
    "company": "LABS JUVISE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "METRONIDAZOLEANDA  #070027",
    "submission": "SUPPL-53",
    "activeIngredients": "METRONIDAZOLE",
    "company": "TEVA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "METRONIDAZOLEANDA  #070033",
    "submission": "SUPPL-54",
    "activeIngredients": "METRONIDAZOLE",
    "company": "PLIVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "METRONIDAZOLEANDA  #070035",
    "submission": "SUPPL-63",
    "activeIngredients": "METRONIDAZOLE",
    "company": "WATSON LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "METRONIDAZOLEANDA  #070039",
    "submission": "SUPPL-17",
    "activeIngredients": "METRONIDAZOLE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "METRONIDAZOLEANDA  #070040",
    "submission": "SUPPL-17",
    "activeIngredients": "METRONIDAZOLE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "METRONIDAZOLEANDA  #070044",
    "submission": "SUPPL-62",
    "activeIngredients": "METRONIDAZOLE",
    "company": "WATSON LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "METRONIDAZOLEANDA  #070772",
    "submission": "SUPPL-48",
    "activeIngredients": "METRONIDAZOLE",
    "company": "INNOGENIX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "ISOFLURANEANDA  #074502",
    "submission": "SUPPL-26",
    "activeIngredients": "ISOFLURANE",
    "company": "PIRAMAL PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "ISOFLURANEANDA  #074502",
    "submission": "SUPPL-27",
    "activeIngredients": "ISOFLURANE",
    "company": "PIRAMAL PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "ISOFLURANEANDA  #074502",
    "submission": "SUPPL-28",
    "activeIngredients": "ISOFLURANE",
    "company": "PIRAMAL PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "CAPTOPRILANDA  #074737",
    "submission": "SUPPL-13",
    "activeIngredients": "CAPTOPRIL",
    "company": "COREPHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "VALPROIC ACIDANDA  #075379",
    "submission": "SUPPL-19",
    "activeIngredients": "VALPROIC ACID",
    "company": "PHARM ASSOC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "VALPROIC ACIDANDA  #075379",
    "submission": "SUPPL-23",
    "activeIngredients": "VALPROIC ACID",
    "company": "PHARM ASSOC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "CLOZAPINEANDA  #075417",
    "submission": "SUPPL-44",
    "activeIngredients": "CLOZAPINE",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "CLOZAPINEANDA  #075417",
    "submission": "SUPPL-47",
    "activeIngredients": "CLOZAPINE",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "CLOZAPINEANDA  #075417",
    "submission": "SUPPL-57",
    "activeIngredients": "CLOZAPINE",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "CLOZAPINEANDA  #075417",
    "submission": "SUPPL-59",
    "activeIngredients": "CLOZAPINE",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "ETODOLACANDA  #075419",
    "submission": "SUPPL-15",
    "activeIngredients": "ETODOLAC",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "GABAPENTINANDA  #075428",
    "submission": "SUPPL-4",
    "activeIngredients": "GABAPENTIN",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "GABAPENTINANDA  #075428",
    "submission": "SUPPL-5",
    "activeIngredients": "GABAPENTIN",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "PAROXETINE HYDROCHLORIDEANDA  #075716",
    "submission": "SUPPL-13",
    "activeIngredients": "PAROXETINE HYDROCHLORIDE",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "PAROXETINE HYDROCHLORIDEANDA  #077395",
    "submission": "SUPPL-15",
    "activeIngredients": "PAROXETINE HYDROCHLORIDE",
    "company": "APOTEX INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "LOSARTAN POTASSIUMANDA  #078243",
    "submission": "SUPPL-22",
    "activeIngredients": "LOSARTAN POTASSIUM",
    "company": "ZYDUS PHARMS USA INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "LOSARTAN POTASSIUMANDA  #078243",
    "submission": "SUPPL-24",
    "activeIngredients": "LOSARTAN POTASSIUM",
    "company": "ZYDUS PHARMS USA INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "LOSARTAN POTASSIUMANDA  #078243",
    "submission": "SUPPL-28",
    "activeIngredients": "LOSARTAN POTASSIUM",
    "company": "ZYDUS PHARMS USA INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "LOSARTAN POTASSIUMANDA  #078243",
    "submission": "SUPPL-37",
    "activeIngredients": "LOSARTAN POTASSIUM",
    "company": "ZYDUS PHARMS USA INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "METRONIDAZOLEANDA  #079067",
    "submission": "SUPPL-23",
    "activeIngredients": "METRONIDAZOLE",
    "company": "ALEMBIC PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "METRONIDAZOLEANDA  #090222",
    "submission": "SUPPL-5",
    "activeIngredients": "METRONIDAZOLE",
    "company": "ALEMBIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "PIMTREAANDA  #091247",
    "submission": "SUPPL-10",
    "activeIngredients": "DESOGESTREL; ETHINYL ESTRADIOL",
    "company": "NOVAST LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "MUPIROCINANDA  #201587",
    "submission": "SUPPL-11",
    "activeIngredients": "MUPIROCIN CALCIUM",
    "company": "GLENMARK PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "MUPIROCINANDA  #201587",
    "submission": "SUPPL-13",
    "activeIngredients": "MUPIROCIN CALCIUM",
    "company": "GLENMARK PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREEANDA  #202253",
    "submission": "SUPPL-8",
    "activeIngredients": "ONDANSETRON HYDROCHLORIDE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREEANDA  #202253",
    "submission": "SUPPL-12",
    "activeIngredients": "ONDANSETRON HYDROCHLORIDE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREEANDA  #202253",
    "submission": "SUPPL-13",
    "activeIngredients": "ONDANSETRON HYDROCHLORIDE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "BISMUTH SUBSALICYLATE, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDEANDA  #202584",
    "submission": "SUPPL-3",
    "activeIngredients": "BISMUTH SUBSALICYLATE; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE",
    "company": "AILEX PHARMS LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "METRONIDAZOLEANDA  #203458",
    "submission": "SUPPL-22",
    "activeIngredients": "METRONIDAZOLE",
    "company": "UNICHEM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "METRONIDAZOLEANDA  #203974",
    "submission": "SUPPL-14",
    "activeIngredients": "METRONIDAZOLE",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "METRONIDAZOLEANDA  #205245",
    "submission": "SUPPL-12",
    "activeIngredients": "METRONIDAZOLE",
    "company": "APPCO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "PIROXICAMANDA  #205585",
    "submission": "SUPPL-2",
    "activeIngredients": "PIROXICAM",
    "company": "ZYDUS LIFESCIENCES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "ARSENIC TRIOXIDEANDA  #206228",
    "submission": "SUPPL-4",
    "activeIngredients": "ARSENIC TRIOXIDE",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "METRONIDAZOLEANDA  #206560",
    "submission": "SUPPL-9",
    "activeIngredients": "METRONIDAZOLE",
    "company": "CADILA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "BROMFENAC SODIUMANDA  #207334",
    "submission": "ORIG-1",
    "activeIngredients": "BROMFENAC SODIUM",
    "company": "APOTEX",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "METRONIDAZOLEANDA  #208162",
    "submission": "SUPPL-11",
    "activeIngredients": "METRONIDAZOLE",
    "company": "NOVITIUM PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "METRONIDAZOLEANDA  #208681",
    "submission": "SUPPL-1",
    "activeIngredients": "METRONIDAZOLE",
    "company": "ALEMBIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "METRONIDAZOLEANDA  #209096",
    "submission": "SUPPL-5",
    "activeIngredients": "METRONIDAZOLE",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "METRONIDAZOLEANDA  #209794",
    "submission": "SUPPL-6",
    "activeIngredients": "METRONIDAZOLE",
    "company": "CADILA PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "MYCOPHENOLATE MOFETILANDA  #210181",
    "submission": "SUPPL-18",
    "activeIngredients": "MYCOPHENOLATE MOFETIL",
    "company": "CONCORD BIOTECH LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "MYCOPHENOLATE MOFETILANDA  #212087",
    "submission": "SUPPL-11",
    "activeIngredients": "MYCOPHENOLATE MOFETIL",
    "company": "CONCORD BIOTECH LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "SILDENAFIL CITRATEANDA  #212260",
    "submission": "SUPPL-15",
    "activeIngredients": "SILDENAFIL CITRATE",
    "company": "NOVITIUM PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDEANDA  #212344",
    "submission": "ORIG-1",
    "activeIngredients": "CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE",
    "company": "WINDER LABS LLC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "BROMFENAC SODIUMANDA  #214340",
    "submission": "ORIG-1",
    "activeIngredients": "BROMFENAC SODIUM",
    "company": "ALEMBIC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDEANDA  #215072",
    "submission": "ORIG-1",
    "activeIngredients": "EMPAGLIFLOZIN;LINAGLIPTIN;METFORMIN HYDROCHLORIDE",
    "company": "LUPIN LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "L-GLUTAMINEANDA  #215647",
    "submission": "ORIG-1",
    "activeIngredients": "L-GLUTAMINE",
    "company": "NOVITIUM PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "AZITHROMYCINANDA  #215772",
    "submission": "SUPPL-4",
    "activeIngredients": "AZITHROMYCIN",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "LIKMEZNDA   #216755",
    "submission": "SUPPL-3",
    "activeIngredients": "METRONIDAZOLE",
    "company": "SAPTALIS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "CALCIUM CHLORIDE 10%ANDA  #217524",
    "submission": "ORIG-1",
    "activeIngredients": "CALCIUM CHLORIDE",
    "company": "AMNEAL",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2024",
    "drugName": "GABAPENTINANDA  #217965",
    "submission": "SUPPL-1",
    "activeIngredients": "GABAPENTIN",
    "company": "LAURUS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/09/2024",
    "drugName": "PURINETHOLNDA   #009053",
    "submission": "SUPPL-44",
    "activeIngredients": "MERCAPTOPURINE",
    "company": "STASON PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/09/2024",
    "drugName": "THIOGUANINENDA   #012429",
    "submission": "SUPPL-29",
    "activeIngredients": "THIOGUANINE",
    "company": "WAYLIS THERAP",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/09/2024",
    "drugName": "IMURANNDA   #016324",
    "submission": "SUPPL-40",
    "activeIngredients": "AZATHIOPRINE",
    "company": "LEGACY PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/09/2024",
    "drugName": "IMURANNDA   #017391",
    "submission": "SUPPL-18",
    "activeIngredients": "AZATHIOPRINE SODIUM",
    "company": "CASPER PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/09/2024",
    "drugName": "AZATHIOPRINE SODIUMANDA  #074419",
    "submission": "SUPPL-18",
    "activeIngredients": "AZATHIOPRINE SODIUM",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/09/2024",
    "drugName": "OCTREOTIDE ACETATEANDA  #203765",
    "submission": "SUPPL-6",
    "activeIngredients": "OCTREOTIDE ACETATE",
    "company": "HERITAGE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/09/2024",
    "drugName": "OCTREOTIDE ACETATEANDA  #204669",
    "submission": "SUPPL-6",
    "activeIngredients": "OCTREOTIDE ACETATE",
    "company": "HERITAGE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/09/2024",
    "drugName": "ESMOLOL HYDROCHLORIDEANDA  #205520",
    "submission": "SUPPL-7",
    "activeIngredients": "ESMOLOL HYDROCHLORIDE",
    "company": "EUGIA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/09/2024",
    "drugName": "PURIXANNDA   #205919",
    "submission": "SUPPL-8",
    "activeIngredients": "MERCAPTOPURINE",
    "company": "NOVA LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/09/2024",
    "drugName": "ERLEADANDA   #210951",
    "submission": "SUPPL-17",
    "activeIngredients": "APALUTAMIDE",
    "company": "JANSSEN BIOTECH",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/09/2024",
    "drugName": "SACUBITRIL AND VALSARTANANDA  #213719",
    "submission": "ORIG-1",
    "activeIngredients": "SACUBITRIL; VALSARTAN",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/09/2024",
    "drugName": "ZORYVENDA   #215985",
    "submission": "SUPPL-7",
    "activeIngredients": "ROFLUMILAST",
    "company": "ARCUTIS",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/09/2024",
    "drugName": "ESMOLOL HYDROCHLORIDEANDA  #216244",
    "submission": "SUPPL-2",
    "activeIngredients": "ESMOLOL HYDROCHLORIDE",
    "company": "EUGIA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/09/2024",
    "drugName": "NIMODIPINEANDA  #216937",
    "submission": "ORIG-1",
    "activeIngredients": "NIMODIPINE",
    "company": "ANNORA PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/09/2024",
    "drugName": "SUCCINYLCHOLINE CHLORIDEANDA  #217873",
    "submission": "ORIG-1",
    "activeIngredients": "SUCCINYLCHOLINE CHLORIDE",
    "company": "STERISCIENCE",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/09/2024",
    "drugName": "DIROXIMEL FUMARATEANDA  #218596",
    "submission": "ORIG-1",
    "activeIngredients": "DIROXIMEL FUMARATE",
    "company": "ZYDUS PHARMS USA INC",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "07/10/2024",
    "drugName": "SOLU-CORTEFNDA   #009866",
    "submission": "SUPPL-120",
    "activeIngredients": "HYDROCORTISONE SODIUM SUCCINATE",
    "company": "PHARMACIA AND UPJOHN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2024",
    "drugName": "CEREZYMEBLA   #020367",
    "submission": "SUPPL-121",
    "activeIngredients": "IMIGLUCERASE",
    "company": "GENZYME",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2024",
    "drugName": "LOTRIMIN ULTRANDA   #021307",
    "submission": "SUPPL-24",
    "activeIngredients": "BUTENAFINE HYDROCHLORIDE",
    "company": "BAYER HEALTHCARE LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2024",
    "drugName": "ELELYSOBLA   #022458",
    "submission": "SUPPL-31",
    "activeIngredients": "TALIGLUCERASE ALFA",
    "company": "PFIZER",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2024",
    "drugName": "VPRIVBLA   #022575",
    "submission": "SUPPL-30",
    "activeIngredients": "VELAGLUCERASE ALFA",
    "company": "SHIRE HUMAN GENETIC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2024",
    "drugName": "METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDEANDA  #076792",
    "submission": "SUPPL-37",
    "activeIngredients": "HYDROCHLOROTHIAZIDE; METOPROLOL TARTRATE",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2024",
    "drugName": "DIVALPROEX SODIUMANDA  #090070",
    "submission": "SUPPL-25",
    "activeIngredients": "DIVALPROEX SODIUM",
    "company": "REDDYS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2024",
    "drugName": "DIVALPROEX SODIUMANDA  #090161",
    "submission": "SUPPL-25",
    "activeIngredients": "DIVALPROEX SODIUM",
    "company": "DR REDDYS LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2024",
    "drugName": "FABRAZYMEBLA   #103979",
    "submission": "SUPPL-5313",
    "activeIngredients": "AGALSIDASE BETA",
    "company": "GENZYME",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2024",
    "drugName": "NAGLAZYMEBLA   #125117",
    "submission": "SUPPL-131",
    "activeIngredients": "GALSULFASE",
    "company": "BIOMARIN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2024",
    "drugName": "STRENSIQBLA   #125513",
    "submission": "SUPPL-33",
    "activeIngredients": "ASFOTASE ALFA",
    "company": "ALEXION PHARM",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2024",
    "drugName": "KANUMABLA   #125561",
    "submission": "SUPPL-20",
    "activeIngredients": "SEBELIPASE ALFA",
    "company": "ALEXION PHARM",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2024",
    "drugName": "EZETIMIBE AND SIMVASTATINANDA  #200082",
    "submission": "SUPPL-2",
    "activeIngredients": "EZETIMIBE; SIMVASTATIN",
    "company": "AUROBINDO PHARMA USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2024",
    "drugName": "HEPZATONDA   #201848",
    "submission": "SUPPL-5",
    "activeIngredients": "MELPHALAN HYDROCHLORIDE",
    "company": "DELCATH SYSTEMS INC",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2024",
    "drugName": "ITRACONAZOLEANDA  #205080",
    "submission": "SUPPL-16",
    "activeIngredients": "ITRACONAZOLE",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2024",
    "drugName": "ATORVASTATIN CALCIUMANDA  #206536",
    "submission": "SUPPL-18",
    "activeIngredients": "ATORVASTATIN CALCIUM",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2024",
    "drugName": "EZETIMIBEANDA  #208803",
    "submission": "SUPPL-14",
    "activeIngredients": "EZETIMIBE",
    "company": "AMNEAL PHARMS CO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2024",
    "drugName": "DIVALPROEX SODIUMANDA  #209286",
    "submission": "SUPPL-11",
    "activeIngredients": "DIVALPROEX SODIUM",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2024",
    "drugName": "MULTRYSNDA   #209376",
    "submission": "SUPPL-7",
    "activeIngredients": "CUPRIC SULFATE; MANGANESE SULFATE; SELENIOUS ACID; ZINC SULFATE",
    "company": "AM REGENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2024",
    "drugName": "TRALEMENTNDA   #209376",
    "submission": "SUPPL-7",
    "activeIngredients": "CUPRIC SULFATE; MANGANESE SULFATE; SELENIOUS ACID; ZINC SULFATE",
    "company": "AM REGENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2024",
    "drugName": "EZETIMIBEANDA  #210859",
    "submission": "SUPPL-5",
    "activeIngredients": "EZETIMIBE",
    "company": "HETERO LABS LTD III",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2024",
    "drugName": "CLOBAZAMANDA  #210978",
    "submission": "SUPPL-7",
    "activeIngredients": "CLOBAZAM",
    "company": "TARO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2024",
    "drugName": "ELIGLUSTAT TARTRATEANDA  #212425",
    "submission": "ORIG-1",
    "activeIngredients": "ELIGLUSTAT TARTRATE",
    "company": "APOTEX",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2024",
    "drugName": "GLYCOPYRROLATEANDA  #212696",
    "submission": "ORIG-1",
    "activeIngredients": "GLYCOPYRROLATE",
    "company": "QUAGEN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2024",
    "drugName": "DIVALPROEX SODIUMANDA  #214462",
    "submission": "SUPPL-2",
    "activeIngredients": "DIVALPROEX SODIUM",
    "company": "YICHANG HUMANWELL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2024",
    "drugName": "LOTEPREDNOL ETABONATEANDA  #215203",
    "submission": "ORIG-1",
    "activeIngredients": "LOTEPREDNOL ETABONATE",
    "company": "PADAGIS US",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2024",
    "drugName": "EZETIMIBEANDA  #215693",
    "submission": "SUPPL-3",
    "activeIngredients": "EZETIMIBE",
    "company": "ORIENT PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2024",
    "drugName": "CYANOCOBALAMINANDA  #217839",
    "submission": "ORIG-1",
    "activeIngredients": "CYANOCOBALAMIN",
    "company": "MANKIND PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2024",
    "drugName": "BRINEURABLA   #761052",
    "submission": "SUPPL-16",
    "activeIngredients": "CERLIPONASE ALFA",
    "company": "BIOMARIN PHARM",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2024",
    "drugName": "SANDOSTATINNDA   #019667",
    "submission": "SUPPL-78",
    "activeIngredients": "OCTREOTIDE ACETATE",
    "company": "NOVARTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2024",
    "drugName": "DEPO-PROVERANDA   #020246",
    "submission": "SUPPL-68",
    "activeIngredients": "MEDROXYPROGESTERONE ACETATE",
    "company": "PFIZER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2024",
    "drugName": "SANDOSTATIN LARNDA   #021008",
    "submission": "SUPPL-49",
    "activeIngredients": "OCTREOTIDE ACETATE",
    "company": "NOVARTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2024",
    "drugName": "DEPO-SUBQ PROVERA 104NDA   #021583",
    "submission": "SUPPL-40",
    "activeIngredients": "MEDROXYPROGESTERONE ACETATE",
    "company": "PFIZER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2024",
    "drugName": "CHILDREN'S CLARITINNDA   #021891",
    "submission": "SUPPL-44",
    "activeIngredients": "LORATADINE",
    "company": "BAYER HEALTHCARE LLC",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2024",
    "drugName": "CLARITINNDA   #021891",
    "submission": "SUPPL-44",
    "activeIngredients": "LORATADINE",
    "company": "BAYER HEALTHCARE LLC",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2024",
    "drugName": "SOMATULINE DEPOTNDA   #022074",
    "submission": "SUPPL-32",
    "activeIngredients": "LANREOTIDE ACETATE",
    "company": "IPSEN PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2024",
    "drugName": "HYDROXYCHLOROQUINE SULFATEANDA  #040133",
    "submission": "SUPPL-32",
    "activeIngredients": "HYDROXYCHLOROQUINE SULFATE",
    "company": "WATSON LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2024",
    "drugName": "HYDROXYCHLOROQUINE SULFATEANDA  #040133",
    "submission": "SUPPL-33",
    "activeIngredients": "HYDROXYCHLOROQUINE SULFATE",
    "company": "WATSON LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2024",
    "drugName": "HYDROXYCHLOROQUINE SULFATEANDA  #040133",
    "submission": "SUPPL-34",
    "activeIngredients": "HYDROXYCHLOROQUINE SULFATE",
    "company": "WATSON LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2024",
    "drugName": "DICLOFENAC SODIUMANDA  #074514",
    "submission": "SUPPL-46",
    "activeIngredients": "DICLOFENAC SODIUM",
    "company": "ACTAVIS ELIZABETH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2024",
    "drugName": "FLUOXETINE HYDROCHLORIDEANDA  #075207",
    "submission": "SUPPL-26",
    "activeIngredients": "FLUOXETINE HYDROCHLORIDE",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2024",
    "drugName": "KETOROLAC TROMETHAMINEANDA  #075222",
    "submission": "SUPPL-22",
    "activeIngredients": "KETOROLAC TROMETHAMINE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2024",
    "drugName": "KETOROLAC TROMETHAMINEANDA  #075228",
    "submission": "SUPPL-19",
    "activeIngredients": "KETOROLAC TROMETHAMINE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2024",
    "drugName": "EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATEANDA  #090894",
    "submission": "SUPPL-13",
    "activeIngredients": "EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE",
    "company": "TEVA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2024",
    "drugName": "SIGNIFORNDA   #200677",
    "submission": "SUPPL-12",
    "activeIngredients": "PASIREOTIDE DIASPARTATE",
    "company": "RECORDATI RARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2024",
    "drugName": "TAFINLARNDA   #202806",
    "submission": "SUPPL-31",
    "activeIngredients": "DABRAFENIB MESYLATE",
    "company": "NOVARTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2024",
    "drugName": "SIGNIFOR LAR KITNDA   #203255",
    "submission": "SUPPL-11",
    "activeIngredients": "PASIREOTIDE PAMOATE",
    "company": "RECORDATI RARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2024",
    "drugName": "RISEDRONATE SODIUMANDA  #203822",
    "submission": "SUPPL-1",
    "activeIngredients": "RISEDRONATE SODIUM",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2024",
    "drugName": "IBANDRONATE SODIUMANDA  #203987",
    "submission": "SUPPL-9",
    "activeIngredients": "IBANDRONATE SODIUM",
    "company": "AVET LIFESCIENCES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2024",
    "drugName": "MEKINISTNDA   #204114",
    "submission": "SUPPL-33",
    "activeIngredients": "TRAMETINIB DIMETHYL SULFOXIDE",
    "company": "NOVARTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2024",
    "drugName": "IBANDRONATE SODIUMANDA  #204222",
    "submission": "SUPPL-3",
    "activeIngredients": "IBANDRONATE SODIUM",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2024",
    "drugName": "OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDEANDA  #207037",
    "submission": "ORIG-1",
    "activeIngredients": "HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2024",
    "drugName": "MYCAPSSANDA   #208232",
    "submission": "SUPPL-6",
    "activeIngredients": "OCTREOTIDE ACETATE",
    "company": "CHIESI",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2024",
    "drugName": "PREGABALINANDA  #208677",
    "submission": "SUPPL-17",
    "activeIngredients": "PREGABALIN",
    "company": "SCIEGEN PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2024",
    "drugName": "EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATEANDA  #208740",
    "submission": "SUPPL-1",
    "activeIngredients": "EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2024",
    "drugName": "XYZAL ALLERGY 24HRNDA   #209089",
    "submission": "SUPPL-7",
    "activeIngredients": "LEVOCETIRIZINE DIHYDROCHLORIDE",
    "company": "CHATTEM SANOFI",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2024",
    "drugName": "FLUVASTATIN SODIUMANDA  #209397",
    "submission": "SUPPL-3",
    "activeIngredients": "FLUVASTATIN SODIUM",
    "company": "BEIJING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2024",
    "drugName": "BOSENTANANDA  #209742",
    "submission": "SUPPL-6",
    "activeIngredients": "BOSENTAN",
    "company": "AMNEAL PHARMS CO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2024",
    "drugName": "BOSENTANANDA  #209742",
    "submission": "SUPPL-7",
    "activeIngredients": "BOSENTAN",
    "company": "AMNEAL PHARMS CO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2024",
    "drugName": "NADOLOLANDA  #211763",
    "submission": "SUPPL-2",
    "activeIngredients": "NADOLOL",
    "company": "ALEMBIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2024",
    "drugName": "PROPRANOLOL HYDROCHLORIDEANDA  #212026",
    "submission": "SUPPL-7",
    "activeIngredients": "PROPRANOLOL HYDROCHLORIDE",
    "company": "AMTA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2024",
    "drugName": "AMONDYS 45NDA   #213026",
    "submission": "SUPPL-8",
    "activeIngredients": "CASIMERSEN",
    "company": "SAREPTA THERAPS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2024",
    "drugName": "LANREOTIDE ACETATENDA   #215395",
    "submission": "SUPPL-8",
    "activeIngredients": "LANREOTIDE ACETATE",
    "company": "INVAGEN PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2024",
    "drugName": "TOPIRAMATEANDA  #215561",
    "submission": "ORIG-1",
    "activeIngredients": "TOPIRAMATE",
    "company": "LUPIN LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2024",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #216800",
    "submission": "SUPPL-1",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "ANNORA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2024",
    "drugName": "ERTUGLIFLOZINANDA  #216947",
    "submission": "SUPPL-1",
    "activeIngredients": "ERTUGLIFLOZIN",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2024",
    "drugName": "ATORVASTATIN CALCIUMANDA  #217081",
    "submission": "SUPPL-6",
    "activeIngredients": "ATORVASTATIN CALCIUM",
    "company": "MANKIND PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2024",
    "drugName": "ATORVASTATIN CALCIUMANDA  #217118",
    "submission": "SUPPL-1",
    "activeIngredients": "ATORVASTATIN CALCIUM",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2024",
    "drugName": "DOXYCYCLINEANDA  #217170",
    "submission": "ORIG-1",
    "activeIngredients": "DOXYCYCLINE",
    "company": "APOTEX",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2024",
    "drugName": "MEKINISTNDA   #217513",
    "submission": "SUPPL-4",
    "activeIngredients": "TRAMETINIB",
    "company": "NOVARTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2024",
    "drugName": "MEKINISTNDA   #217513",
    "submission": "SUPPL-4",
    "activeIngredients": "TRAMETINIB DIMETHYL SULFOXIDE",
    "company": "NOVARTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2024",
    "drugName": "TAFINLARNDA   #217514",
    "submission": "SUPPL-4",
    "activeIngredients": "DABRAFENIB MESYLATE",
    "company": "NOVARTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2024",
    "drugName": "SELEXIPAGANDA  #217717",
    "submission": "ORIG-1",
    "activeIngredients": "SELEXIPAG",
    "company": "ALEMBIC PHARMS LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "07/11/2024",
    "drugName": "POTASSIUM PHOSPHATESANDA  #217726",
    "submission": "ORIG-1",
    "activeIngredients": "POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC",
    "company": "SOMERSET THERAPS LLC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2024",
    "drugName": "VASOPRESSIN IN SODIUM CHLORIDE 0.9%NDA   #217766",
    "submission": "ORIG-1",
    "activeIngredients": "VASOPRESSIN",
    "company": "LONG GROVE PHARMS",
    "submissionClassification": "Type 3 - New Dosage Form",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2024",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #217805",
    "submission": "SUPPL-1",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "MICRO LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/12/2024",
    "drugName": "ROBINULNDA   #017558",
    "submission": "SUPPL-63",
    "activeIngredients": "GLYCOPYRROLATE",
    "company": "HIKMA",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/12/2024",
    "drugName": "NEURONTINNDA   #020235",
    "submission": "SUPPL-76",
    "activeIngredients": "GABAPENTIN",
    "company": "VIATRIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/12/2024",
    "drugName": "NEURONTINNDA   #020882",
    "submission": "SUPPL-57",
    "activeIngredients": "GABAPENTIN",
    "company": "VIATRIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/12/2024",
    "drugName": "NEURONTINNDA   #021129",
    "submission": "SUPPL-56",
    "activeIngredients": "GABAPENTIN",
    "company": "VIATRIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/12/2024",
    "drugName": "AZITHROMYCINANDA  #065302",
    "submission": "SUPPL-12",
    "activeIngredients": "AZITHROMYCIN",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/12/2024",
    "drugName": "AZITHROMYCINANDA  #065404",
    "submission": "SUPPL-15",
    "activeIngredients": "AZITHROMYCIN",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/12/2024",
    "drugName": "AZITHROMYCINANDA  #065405",
    "submission": "SUPPL-14",
    "activeIngredients": "AZITHROMYCIN",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/12/2024",
    "drugName": "NICOTINE POLACRILEXANDA  #077007",
    "submission": "SUPPL-51",
    "activeIngredients": "NICOTINE POLACRILEX",
    "company": "PERRIGO R AND D",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/12/2024",
    "drugName": "ROCURONIUM BROMIDEANDA  #204918",
    "submission": "ORIG-1",
    "activeIngredients": "ROCURONIUM BROMIDE",
    "company": "RISING",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/12/2024",
    "drugName": "SEVELAMER CARBONATEANDA  #206234",
    "submission": "ORIG-1",
    "activeIngredients": "SEVELAMER CARBONATE",
    "company": "INVAGEN PHARMS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/12/2024",
    "drugName": "TACROLIMUSANDA  #206651",
    "submission": "SUPPL-7",
    "activeIngredients": "TACROLIMUS",
    "company": "AJENAT PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/12/2024",
    "drugName": "OLOPATADINE HYDROCHLORIDEANDA  #209015",
    "submission": "ORIG-1",
    "activeIngredients": "OLOPATADINE HYDROCHLORIDE",
    "company": "APOTEX",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "07/12/2024",
    "drugName": "ROCURONIUM BROMIDEANDA  #215684",
    "submission": "ORIG-1",
    "activeIngredients": "ROCURONIUM BROMIDE",
    "company": "SHANDONG",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/12/2024",
    "drugName": "ESTRADIOLANDA  #216055",
    "submission": "ORIG-1",
    "activeIngredients": "ESTRADIOL",
    "company": "AMNEAL",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/12/2024",
    "drugName": "ESTRADIOLANDA  #217863",
    "submission": "ORIG-1",
    "activeIngredients": "ESTRADIOL",
    "company": "QUAGEN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/12/2024",
    "drugName": "TRAVOPROSTANDA  #218159",
    "submission": "ORIG-1",
    "activeIngredients": "TRAVOPROST",
    "company": "GLAND",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/13/2024",
    "drugName": "MEDICAL AIR, USPNDA   #219709",
    "submission": "ORIG-1",
    "activeIngredients": "MEDICAL AIR",
    "company": "WSM SUPPLIER LLC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/14/2024",
    "drugName": "RISPERIDONEANDA  #076440",
    "submission": "SUPPL-6",
    "activeIngredients": "RISPERIDONE",
    "company": "ANI PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/14/2024",
    "drugName": "RISPERIDONEANDA  #076440",
    "submission": "SUPPL-7",
    "activeIngredients": "RISPERIDONE",
    "company": "ANI PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/14/2024",
    "drugName": "RISPERIDONEANDA  #076440",
    "submission": "SUPPL-8",
    "activeIngredients": "RISPERIDONE",
    "company": "ANI PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/14/2024",
    "drugName": "RISPERIDONEANDA  #078040",
    "submission": "SUPPL-28",
    "activeIngredients": "RISPERIDONE",
    "company": "ZYDUS PHARMS USA INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/14/2024",
    "drugName": "RISPERIDONEANDA  #078040",
    "submission": "SUPPL-29",
    "activeIngredients": "RISPERIDONE",
    "company": "ZYDUS PHARMS USA INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/15/2024",
    "drugName": "MEPERIDINE HYDROCHLORIDEANDA  #040191",
    "submission": "SUPPL-19",
    "activeIngredients": "MEPERIDINE HYDROCHLORIDE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/15/2024",
    "drugName": "DORYXNDA   #050795",
    "submission": "SUPPL-36",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "MAYNE PHARMA",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/15/2024",
    "drugName": "DORYX MPCNDA   #050795",
    "submission": "SUPPL-36",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "MAYNE PHARMA",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/15/2024",
    "drugName": "FENTANYL CITRATE PRESERVATIVE FREEANDA  #072786",
    "submission": "SUPPL-45",
    "activeIngredients": "FENTANYL CITRATE",
    "company": "HOSPIRA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/15/2024",
    "drugName": "TRIAMTERENE AND HYDROCHLOROTHIAZIDEANDA  #074821",
    "submission": "SUPPL-42",
    "activeIngredients": "HYDROCHLOROTHIAZIDE; TRIAMTERENE",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/15/2024",
    "drugName": "ATORVASTATIN CALCIUMANDA  #077575",
    "submission": "SUPPL-16",
    "activeIngredients": "ATORVASTATIN CALCIUM",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/15/2024",
    "drugName": "DIVALPROEX SODIUMANDA  #078597",
    "submission": "SUPPL-40",
    "activeIngredients": "DIVALPROEX SODIUM",
    "company": "SUN PHARM INDS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/15/2024",
    "drugName": "PAROXETINEANDA  #203854",
    "submission": "SUPPL-3",
    "activeIngredients": "PAROXETINE HYDROCHLORIDE",
    "company": "PRINSTON INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/15/2024",
    "drugName": "PAROXETINEANDA  #203854",
    "submission": "SUPPL-4",
    "activeIngredients": "PAROXETINE HYDROCHLORIDE",
    "company": "PRINSTON INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/15/2024",
    "drugName": "TEMOZOLOMIDEANDA  #204639",
    "submission": "SUPPL-3",
    "activeIngredients": "TEMOZOLOMIDE",
    "company": "CHEMI SPA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/15/2024",
    "drugName": "TEMOZOLOMIDEANDA  #206309",
    "submission": "SUPPL-4",
    "activeIngredients": "TEMOZOLOMIDE",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/15/2024",
    "drugName": "NADOLOLANDA  #208832",
    "submission": "SUPPL-7",
    "activeIngredients": "NADOLOL",
    "company": "AMNEAL PHARMS CO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/15/2024",
    "drugName": "EZETIMIBE AND SIMVASTATINANDA  #209222",
    "submission": "SUPPL-14",
    "activeIngredients": "EZETIMIBE; SIMVASTATIN",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/15/2024",
    "drugName": "CLOBAZAMANDA  #209687",
    "submission": "SUPPL-8",
    "activeIngredients": "CLOBAZAM",
    "company": "UPSHER SMITH LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/15/2024",
    "drugName": "PREGABALINANDA  #209743",
    "submission": "SUPPL-18",
    "activeIngredients": "PREGABALIN",
    "company": "AMNEAL PHARMS CO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/15/2024",
    "drugName": "DICLOFENAC SODIUMANDA  #209903",
    "submission": "SUPPL-10",
    "activeIngredients": "DICLOFENAC SODIUM",
    "company": "CIPLA",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/15/2024",
    "drugName": "SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATEANDA  #209941",
    "submission": "ORIG-1",
    "activeIngredients": "MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE",
    "company": "PAI HOLDINGS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/15/2024",
    "drugName": "CLOBAZAMANDA  #210546",
    "submission": "SUPPL-5",
    "activeIngredients": "CLOBAZAM",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/15/2024",
    "drugName": "CLOBAZAMANDA  #210746",
    "submission": "SUPPL-10",
    "activeIngredients": "CLOBAZAM",
    "company": "VISTAPHARM LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/15/2024",
    "drugName": "DIVALPROEX SODIUMANDA  #213181",
    "submission": "SUPPL-18",
    "activeIngredients": "DIVALPROEX SODIUM",
    "company": "AJANTA PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/15/2024",
    "drugName": "CLOBAZAMANDA  #213404",
    "submission": "SUPPL-2",
    "activeIngredients": "CLOBAZAM",
    "company": "MSN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/15/2024",
    "drugName": "GLIPIZIDEANDA  #214874",
    "submission": "SUPPL-2",
    "activeIngredients": "GLIPIZIDE",
    "company": "RUBICON RESEARCH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/15/2024",
    "drugName": "SODIUM SULFATE; MAGNESIUM SULFATE; POTASSIUM CHLORIDEANDA  #216095",
    "submission": "ORIG-1",
    "activeIngredients": "SODIUM SULFATE;MAGNESIUM SULFATE;POTASSIUM CHLORIDE",
    "company": "LUPIN LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "07/15/2024",
    "drugName": "TAZAROTENEANDA  #217075",
    "submission": "ORIG-1",
    "activeIngredients": "TAZAROTENE",
    "company": "PADAGIS ISRAEL",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/16/2024",
    "drugName": "ALESSENDA   #020683",
    "submission": "SUPPL-14",
    "activeIngredients": "ETHINYL ESTRADIOL; LEVONORGESTREL",
    "company": "CADENCE HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/16/2024",
    "drugName": "EXTENDED PHENYTOIN SODIUMANDA  #040684",
    "submission": "SUPPL-7",
    "activeIngredients": "PHENYTOIN SODIUM",
    "company": "TARO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/16/2024",
    "drugName": "EXTENDED PHENYTOIN SODIUMANDA  #040684",
    "submission": "SUPPL-8",
    "activeIngredients": "PHENYTOIN SODIUM",
    "company": "TARO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/16/2024",
    "drugName": "EXTENDED PHENYTOIN SODIUMANDA  #040684",
    "submission": "SUPPL-9",
    "activeIngredients": "PHENYTOIN SODIUM",
    "company": "TARO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/16/2024",
    "drugName": "EXTENDED PHENYTOIN SODIUMANDA  #040684",
    "submission": "SUPPL-10",
    "activeIngredients": "PHENYTOIN SODIUM",
    "company": "TARO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/16/2024",
    "drugName": "EXTENDED PHENYTOIN SODIUMANDA  #040684",
    "submission": "SUPPL-12",
    "activeIngredients": "PHENYTOIN SODIUM",
    "company": "TARO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/16/2024",
    "drugName": "EXTENDED PHENYTOIN SODIUMANDA  #040684",
    "submission": "SUPPL-13",
    "activeIngredients": "PHENYTOIN SODIUM",
    "company": "TARO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/16/2024",
    "drugName": "EXTENDED PHENYTOIN SODIUMANDA  #040684",
    "submission": "SUPPL-15",
    "activeIngredients": "PHENYTOIN SODIUM",
    "company": "TARO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/16/2024",
    "drugName": "EXTENDED PHENYTOIN SODIUMANDA  #040684",
    "submission": "SUPPL-16",
    "activeIngredients": "PHENYTOIN SODIUM",
    "company": "TARO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/16/2024",
    "drugName": "EXTENDED PHENYTOIN SODIUMANDA  #040684",
    "submission": "SUPPL-20",
    "activeIngredients": "PHENYTOIN SODIUM",
    "company": "TARO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/16/2024",
    "drugName": "EXTENDED PHENYTOIN SODIUMANDA  #040684",
    "submission": "SUPPL-21",
    "activeIngredients": "PHENYTOIN SODIUM",
    "company": "TARO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/16/2024",
    "drugName": "EXTENDED PHENYTOIN SODIUMANDA  #040684",
    "submission": "SUPPL-23",
    "activeIngredients": "PHENYTOIN SODIUM",
    "company": "TARO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/16/2024",
    "drugName": "GABAPENTINANDA  #075539",
    "submission": "SUPPL-4",
    "activeIngredients": "GABAPENTIN",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/16/2024",
    "drugName": "GABAPENTINANDA  #075539",
    "submission": "SUPPL-5",
    "activeIngredients": "GABAPENTIN",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/16/2024",
    "drugName": "GABAPENTINANDA  #075539",
    "submission": "SUPPL-6",
    "activeIngredients": "GABAPENTIN",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/16/2024",
    "drugName": "GABAPENTINANDA  #075539",
    "submission": "SUPPL-7",
    "activeIngredients": "GABAPENTIN",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/16/2024",
    "drugName": "GABAPENTINANDA  #075539",
    "submission": "SUPPL-8",
    "activeIngredients": "GABAPENTIN",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/16/2024",
    "drugName": "LEVOCARNITINEANDA  #075567",
    "submission": "SUPPL-13",
    "activeIngredients": "LEVOCARNITINE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/16/2024",
    "drugName": "LEVOCARNITINEANDA  #075567",
    "submission": "SUPPL-14",
    "activeIngredients": "LEVOCARNITINE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/16/2024",
    "drugName": "TESTOSTERONEANDA  #076744",
    "submission": "SUPPL-18",
    "activeIngredients": "TESTOSTERONE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/16/2024",
    "drugName": "FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERANDA  #076766",
    "submission": "SUPPL-17",
    "activeIngredients": "FLUCONAZOLE",
    "company": "BAXTER HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/16/2024",
    "drugName": "DILTIAZEM HYDROCHLORIDEANDA  #077686",
    "submission": "SUPPL-11",
    "activeIngredients": "DILTIAZEM HYDROCHLORIDE",
    "company": "ACTAVIS LABS FL INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/16/2024",
    "drugName": "FLUCONAZOLEANDA  #079150",
    "submission": "SUPPL-26",
    "activeIngredients": "FLUCONAZOLE",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/16/2024",
    "drugName": "INLYTANDA   #202324",
    "submission": "SUPPL-16",
    "activeIngredients": "AXITINIB",
    "company": "PF PRISM CV",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/16/2024",
    "drugName": "CELECOXIBANDA  #204519",
    "submission": "SUPPL-16",
    "activeIngredients": "CELECOXIB",
    "company": "ALEMBIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/16/2024",
    "drugName": "CELECOXIBANDA  #207872",
    "submission": "SUPPL-5",
    "activeIngredients": "CELECOXIB",
    "company": "TIANJIN TIANYAO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/16/2024",
    "drugName": "DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)ANDA  #215178",
    "submission": "ORIG-1",
    "activeIngredients": "DOXORUBICIN HYDROCHLORIDE",
    "company": "LUPIN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/16/2024",
    "drugName": "FORMOTEROL FUMARATEANDA  #215883",
    "submission": "SUPPL-3",
    "activeIngredients": "FORMOTEROL FUMARATE",
    "company": "MANKIND PHARMA",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/16/2024",
    "drugName": "LEVOTHYROXINE SODIUMANDA  #216414",
    "submission": "ORIG-1",
    "activeIngredients": "LEVOTHYROXINE SODIUM",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/16/2024",
    "drugName": "TOPIRAMATEANDA  #217869",
    "submission": "ORIG-1",
    "activeIngredients": "TOPIRAMATE",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/17/2024",
    "drugName": "MESNAANDA  #075739",
    "submission": "SUPPL-7",
    "activeIngredients": "MESNA",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/17/2024",
    "drugName": "MESNAANDA  #075739",
    "submission": "SUPPL-9",
    "activeIngredients": "MESNA",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/17/2024",
    "drugName": "MESNAANDA  #075739",
    "submission": "SUPPL-10",
    "activeIngredients": "MESNA",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/17/2024",
    "drugName": "POSFREANDA   #203050",
    "submission": "SUPPL-2",
    "activeIngredients": "PALONOSETRON HYDROCHLORIDE",
    "company": "AVYXA HOLDINGS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/17/2024",
    "drugName": "ESOMEPRAZOLE MAGNESIUMANDA  #213859",
    "submission": "SUPPL-7",
    "activeIngredients": "ESOMEPRAZOLE MAGNESIUM",
    "company": "GUANGZHOU NOVAKEN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/17/2024",
    "drugName": "ESOMEPRAZOLE MAGNESIUMANDA  #213859",
    "submission": "SUPPL-10",
    "activeIngredients": "ESOMEPRAZOLE MAGNESIUM",
    "company": "GUANGZHOU NOVAKEN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/17/2024",
    "drugName": "MYFEMBREENDA   #214846",
    "submission": "SUPPL-8",
    "activeIngredients": "ESTRADIOL; NORETHINDRONE ACETATE; RELUGOLIX",
    "company": "SUMITOMO PHARMA AM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/17/2024",
    "drugName": "VOQUEZNANDA   #215151",
    "submission": "SUPPL-6",
    "activeIngredients": "VONOPRAZAN FUMARATE",
    "company": "PHATHOM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/17/2024",
    "drugName": "SUNLENCANDA   #215973",
    "submission": "SUPPL-5",
    "activeIngredients": "LENACAPAVIR SODIUM",
    "company": "GILEAD SCIENCES INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/17/2024",
    "drugName": "SUNLENCANDA   #215974",
    "submission": "SUPPL-7",
    "activeIngredients": "LENACAPAVIR SODIUM",
    "company": "GILEAD SCIENCES INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/17/2024",
    "drugName": "ZINC SULFATEANDA  #216135",
    "submission": "ORIG-1",
    "activeIngredients": "ZINC SULFATE",
    "company": "SOMERSET THERAPS LLC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/17/2024",
    "drugName": "DORAVIRINE; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATEANDA  #217747",
    "submission": "ORIG-1",
    "activeIngredients": "DORAVIRINE;LAMIVUDINE;TENOFOVIR DISOPROXIL FUMARATE",
    "company": "HETERO LABS",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "07/17/2024",
    "drugName": "VOQUEZNANDA   #218710",
    "submission": "ORIG-1",
    "activeIngredients": "VONOPRAZAN FUMARATE",
    "company": "PHATHOM PHARMACEUTICALS INC",
    "submissionClassification": "Type 9 - New Indication Submitted as Distinct NDA, Consolidated with Original NDA after Approval",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/18/2024",
    "drugName": "PROGLYCEMNDA   #017453",
    "submission": "SUPPL-24",
    "activeIngredients": "DIAZOXIDE",
    "company": "TEVA BRANDED PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/18/2024",
    "drugName": "MINOCINNDA   #050445",
    "submission": "SUPPL-31",
    "activeIngredients": "MINOCYCLINE HYDROCHLORIDE",
    "company": "BAUSCH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/18/2024",
    "drugName": "MINOCINNDA   #050649",
    "submission": "SUPPL-28",
    "activeIngredients": "MINOCYCLINE HYDROCHLORIDE",
    "company": "BAUSCH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/18/2024",
    "drugName": "TENOFOVIR DISOPROXIL FUMARATEANDA  #090742",
    "submission": "SUPPL-15",
    "activeIngredients": "TENOFOVIR DISOPROXIL FUMARATE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/18/2024",
    "drugName": "PREGABALINANDA  #209664",
    "submission": "SUPPL-7",
    "activeIngredients": "PREGABALIN",
    "company": "DR REDDYS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/18/2024",
    "drugName": "ICATIBANT ACETATEANDA  #210118",
    "submission": "SUPPL-5",
    "activeIngredients": "ICATIBANT ACETATE",
    "company": "TEVA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/18/2024",
    "drugName": "DOPTELETNDA   #210238",
    "submission": "SUPPL-9",
    "activeIngredients": "AVATROMBOPAG MALEATE",
    "company": "AKARX INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/18/2024",
    "drugName": "PREGABALINANDA  #210432",
    "submission": "SUPPL-10",
    "activeIngredients": "PREGABALIN",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/18/2024",
    "drugName": "MIDAZOLAM IN 0.9% SODIUM CHLORIDENDA   #211844",
    "submission": "SUPPL-5",
    "activeIngredients": "MIDAZOLAM",
    "company": "INFORLIFE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/18/2024",
    "drugName": "DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDEANDA  #213300",
    "submission": "ORIG-1",
    "activeIngredients": "DUTASTERIDE; TAMSULOSIN HYDROCHLORIDE",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/18/2024",
    "drugName": "AZILSARTAN MEDOXOMILANDA  #214489",
    "submission": "SUPPL-3",
    "activeIngredients": "AZILSARTAN KAMEDOXOMIL",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/18/2024",
    "drugName": "ERIBULIN MESYLATEANDA  #214850",
    "submission": "ORIG-1",
    "activeIngredients": "ERIBULIN MESYLATE",
    "company": "LONG GROVE PHARMS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/18/2024",
    "drugName": "DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATEANDA  #215936",
    "submission": "SUPPL-3",
    "activeIngredients": "DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE",
    "company": "MICRO LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/18/2024",
    "drugName": "ZITUVIMET XRNDA   #216778",
    "submission": "ORIG-1",
    "activeIngredients": "METFORMIN HYDROCHLORIDE; SITAGLIPTIN",
    "company": "ZYDUS LIFESCIENCES",
    "submissionClassification": "Type 5 - New Formulation or New Manufacturer",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/18/2024",
    "drugName": "POSACONAZOLEANDA  #217119",
    "submission": "ORIG-1",
    "activeIngredients": "POSACONAZOLE",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/18/2024",
    "drugName": "DIAZEPAMANDA  #218422",
    "submission": "ORIG-1",
    "activeIngredients": "DIAZEPAM",
    "company": "DR REDDYS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/18/2024",
    "drugName": "EPHEDRINE SULFATEANDA  #219050",
    "submission": "ORIG-1",
    "activeIngredients": "EPHEDRINE SULFATE",
    "company": "CAPLIN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/19/2024",
    "drugName": "EPYSQLIBLA   #761340",
    "submission": "ORIG-1",
    "activeIngredients": "ECULIZUMAB-AAGH",
    "company": "SAMSUNG BIOEPIS CO LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/22/2024",
    "drugName": "VIRAMUNENDA   #020933",
    "submission": "SUPPL-48",
    "activeIngredients": "NEVIRAPINE",
    "company": "BOEHRINGER INGELHEIM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/22/2024",
    "drugName": "PREDNISOLONEANDA  #040313",
    "submission": "SUPPL-4",
    "activeIngredients": "PREDNISOLONE",
    "company": "PHARMOBEDIENT CNSLTG",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/22/2024",
    "drugName": "EPITOLANDA  #070541",
    "submission": "SUPPL-72",
    "activeIngredients": "CARBAMAZEPINE",
    "company": "TEVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/22/2024",
    "drugName": "EPITOLANDA  #073524",
    "submission": "SUPPL-54",
    "activeIngredients": "CARBAMAZEPINE",
    "company": "TEVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/22/2024",
    "drugName": "PREDNISOLONE SODIUM PHOSPHATEANDA  #075099",
    "submission": "SUPPL-7",
    "activeIngredients": "PREDNISOLONE SODIUM PHOSPHATE",
    "company": "PHARMOBEDIENT CNSLTG",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/22/2024",
    "drugName": "CLOPIDOGREL BISULFATEANDA  #076999",
    "submission": "SUPPL-16",
    "activeIngredients": "CLOPIDOGREL BISULFATE",
    "company": "TEVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/22/2024",
    "drugName": "CLOPIDOGREL BISULFATEANDA  #076999",
    "submission": "SUPPL-17",
    "activeIngredients": "CLOPIDOGREL BISULFATE",
    "company": "TEVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/22/2024",
    "drugName": "ENBRELBLA   #103795",
    "submission": "SUPPL-5597",
    "activeIngredients": "ETANERCEPT",
    "company": "IMMUNEX",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/22/2024",
    "drugName": "ENBRELBLA   #103795",
    "submission": "SUPPL-5598",
    "activeIngredients": "ETANERCEPT",
    "company": "IMMUNEX",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/22/2024",
    "drugName": "ENBRELBLA   #103795",
    "submission": "SUPPL-5599",
    "activeIngredients": "ETANERCEPT",
    "company": "IMMUNEX",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/22/2024",
    "drugName": "VIRAMUNE XRNDA   #201152",
    "submission": "SUPPL-15",
    "activeIngredients": "NEVIRAPINE",
    "company": "BOEHRINGER INGELHEIM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/22/2024",
    "drugName": "PITAVASTATIN CALCIUMANDA  #205955",
    "submission": "SUPPL-4",
    "activeIngredients": "PITAVASTATIN CALCIUM",
    "company": "SAWAI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/22/2024",
    "drugName": "CYCLOBENZAPRINE HYDROCHLORIDEANDA  #207314",
    "submission": "ORIG-1",
    "activeIngredients": "CYCLOBENZAPRINE HYDROCHLORIDE",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/22/2024",
    "drugName": "METOPROLOL SUCCINATEANDA  #207465",
    "submission": "SUPPL-2",
    "activeIngredients": "METOPROLOL SUCCINATE",
    "company": "CIPLA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/22/2024",
    "drugName": "METOPROLOL SUCCINATEANDA  #207465",
    "submission": "SUPPL-3",
    "activeIngredients": "METOPROLOL SUCCINATE",
    "company": "CIPLA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/22/2024",
    "drugName": "KISQALINDA   #209092",
    "submission": "SUPPL-19",
    "activeIngredients": "RIBOCICLIB SUCCINATE",
    "company": "NOVARTIS",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/22/2024",
    "drugName": "BUSULFANANDA  #210148",
    "submission": "SUPPL-6",
    "activeIngredients": "BUSULFAN",
    "company": "ACCORD HLTHCARE INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/22/2024",
    "drugName": "FEBUXOSTATANDA  #213069",
    "submission": "SUPPL-7",
    "activeIngredients": "FEBUXOSTAT",
    "company": "SUNSHINE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/22/2024",
    "drugName": "MEROPENEMANDA  #216424",
    "submission": "ORIG-1",
    "activeIngredients": "MEROPENEM",
    "company": "QILU",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/22/2024",
    "drugName": "TIOPRONINANDA  #216456",
    "submission": "ORIG-1",
    "activeIngredients": "TIOPRONIN",
    "company": "TEVA PHARMS INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/22/2024",
    "drugName": "OPIPZANDA   #216655",
    "submission": "ORIG-1",
    "activeIngredients": "ARIPIPRAZOLE",
    "company": "XIAMEN LP PHARM CO",
    "submissionClassification": "Type 3 - New Dosage Form",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/22/2024",
    "drugName": "ROCURONIUM BROMIDEANDA  #217092",
    "submission": "ORIG-1",
    "activeIngredients": "ROCURONIUM BROMIDE",
    "company": "STERISCIENCE",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/22/2024",
    "drugName": "IVRANDA   #217110",
    "submission": "SUPPL-2",
    "activeIngredients": "MELPHALAN HYDROCHLORIDE",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/22/2024",
    "drugName": "BARICITINIBANDA  #217542",
    "submission": "ORIG-1",
    "activeIngredients": "BARICITINIB",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/22/2024",
    "drugName": "PROCAINAMIDE HYDROCHLORIDEANDA  #218135",
    "submission": "ORIG-1",
    "activeIngredients": "PROCAINAMIDE HYDROCHLORIDE",
    "company": "GLAND",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/22/2024",
    "drugName": "FEMLYVNDA   #218718",
    "submission": "ORIG-1",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "MILLICENT PR",
    "submissionClassification": "Type 3 - New Dosage Form",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/22/2024",
    "drugName": "VALSARTANANDA  #218991",
    "submission": "ORIG-1",
    "activeIngredients": "VALSARTAN",
    "company": "ZYDUS LIFESCIENCES",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/22/2024",
    "drugName": "TOFIDENCEBLA   #761354",
    "submission": "SUPPL-2",
    "activeIngredients": "TOCILIZUMAB-BAVI",
    "company": "BIOGEN MA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/23/2024",
    "drugName": "PEPCIDNDA   #019527",
    "submission": "SUPPL-32",
    "activeIngredients": "FAMOTIDINE",
    "company": "SALIX PHARMS",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/23/2024",
    "drugName": "OMNISCANNDA   #020123",
    "submission": "SUPPL-51",
    "activeIngredients": "GADODIAMIDE",
    "company": "GE HEALTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/23/2024",
    "drugName": "PROHANCENDA   #020131",
    "submission": "SUPPL-43",
    "activeIngredients": "GADOTERIDOL",
    "company": "BRACCO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/23/2024",
    "drugName": "MULTIHANCENDA   #021357",
    "submission": "SUPPL-27",
    "activeIngredients": "GADOBENATE DIMEGLUMINE",
    "company": "BRACCO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/23/2024",
    "drugName": "MULTIHANCE MULTIPACKNDA   #021358",
    "submission": "SUPPL-25",
    "activeIngredients": "GADOBENATE DIMEGLUMINE",
    "company": "BRACCO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/23/2024",
    "drugName": "RECTIVNDA   #021359",
    "submission": "SUPPL-5",
    "activeIngredients": "NITROGLYCERIN",
    "company": "ABBVIE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/23/2024",
    "drugName": "PROHANCE MULTIPACKNDA   #021489",
    "submission": "SUPPL-24",
    "activeIngredients": "GADOTERIDOL",
    "company": "BRACCO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/23/2024",
    "drugName": "OMNISCANNDA   #022066",
    "submission": "SUPPL-14",
    "activeIngredients": "GADODIAMIDE",
    "company": "GE HEALTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/23/2024",
    "drugName": "EOVISTNDA   #022090",
    "submission": "SUPPL-26",
    "activeIngredients": "GADOXETATE DISODIUM",
    "company": "BAYER HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/23/2024",
    "drugName": "GADAVISTNDA   #201277",
    "submission": "SUPPL-26",
    "activeIngredients": "GADOBUTROL",
    "company": "BAYER HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/23/2024",
    "drugName": "DOTAREMNDA   #204781",
    "submission": "SUPPL-16",
    "activeIngredients": "GADOTERATE MEGLUMINE",
    "company": "GUERBET",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/23/2024",
    "drugName": "DOXEPIN HYDROCHLORIDEANDA  #207482",
    "submission": "SUPPL-11",
    "activeIngredients": "DOXEPIN HYDROCHLORIDE",
    "company": "AMNEAL PHARMS CO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/23/2024",
    "drugName": "SUCRALFATEANDA  #212769",
    "submission": "ORIG-1",
    "activeIngredients": "SUCRALFATE",
    "company": "HIKMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/23/2024",
    "drugName": "TICAGRELORANDA  #212891",
    "submission": "ORIG-1",
    "activeIngredients": "TICAGRELOR",
    "company": "TORRENT PHARMS LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "07/23/2024",
    "drugName": "ELUCIREMNDA   #216986",
    "submission": "SUPPL-5",
    "activeIngredients": "GADOPICLENOL",
    "company": "GUERBET",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/23/2024",
    "drugName": "VARENICLINE TARTRATEANDA  #217115",
    "submission": "ORIG-1",
    "activeIngredients": "VARENICLINE TARTRATE",
    "company": "PIRAMAL",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/23/2024",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #217854",
    "submission": "ORIG-1",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "HERITAGE",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/23/2024",
    "drugName": "FLUPHENAZINE HYDROCHLORIDEANDA  #218173",
    "submission": "ORIG-1",
    "activeIngredients": "FLUPHENAZINE HYDROCHLORIDE",
    "company": "ALEMBIC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/24/2024",
    "drugName": "SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERNDA   #016677",
    "submission": "SUPPL-185",
    "activeIngredients": "SODIUM CHLORIDE",
    "company": "BAXTER HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/24/2024",
    "drugName": "LACTATED RINGER'S IN PLASTIC CONTAINERNDA   #016682",
    "submission": "SUPPL-124",
    "activeIngredients": "CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE",
    "company": "BAXTER HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/24/2024",
    "drugName": "SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINERNDA   #018016",
    "submission": "SUPPL-71",
    "activeIngredients": "SODIUM CHLORIDE",
    "company": "BAXTER HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/24/2024",
    "drugName": "SUCRAIDBLA   #020772",
    "submission": "SUPPL-30",
    "activeIngredients": "SACROSIDASE",
    "company": "QOL MEDCL",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/24/2024",
    "drugName": "FORTEONDA   #021318",
    "submission": "SUPPL-57",
    "activeIngredients": "TERIPARATIDE",
    "company": "LILLY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/24/2024",
    "drugName": "LOVASTATINANDA  #077520",
    "submission": "SUPPL-15",
    "activeIngredients": "LOVASTATIN",
    "company": "SUN PHARM INDUSTRIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/24/2024",
    "drugName": "LIVMARLINDA   #214662",
    "submission": "SUPPL-9",
    "activeIngredients": "MARALIXIBAT CHLORIDE",
    "company": "MIRUM",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/24/2024",
    "drugName": "LIVMARLINDA   #214662",
    "submission": "SUPPL-10",
    "activeIngredients": "MARALIXIBAT CHLORIDE",
    "company": "MIRUM",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/24/2024",
    "drugName": "OSPEMIFENEANDA  #215574",
    "submission": "SUPPL-1",
    "activeIngredients": "OSPEMIFENE",
    "company": "HETERO LABS LTD V",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/24/2024",
    "drugName": "BRINEURABLA   #761052",
    "submission": "SUPPL-14",
    "activeIngredients": "CERLIPONASE ALFA",
    "company": "BIOMARIN PHARM",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/24/2024",
    "drugName": "IMFINZIBLA   #761069",
    "submission": "SUPPL-47",
    "activeIngredients": "DURVALUMAB",
    "company": "ASTRAZENECA UK LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/24/2024",
    "drugName": "VYVGARTBLA   #761195",
    "submission": "SUPPL-6",
    "activeIngredients": "EFGARTIGIMOD ALFA",
    "company": "ARGENX BV",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/24/2024",
    "drugName": "IMJUDOBLA   #761289",
    "submission": "SUPPL-6",
    "activeIngredients": "TREMELIMUMAB-ACTL",
    "company": "ASTRAZENECA AB",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/25/2024",
    "drugName": "ISTALOLNDA   #021516",
    "submission": "SUPPL-14",
    "activeIngredients": "TIMOLOL MALEATE",
    "company": "BAUSCH AND LOMB",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/25/2024",
    "drugName": "AZASITENDA   #050810",
    "submission": "SUPPL-17",
    "activeIngredients": "AZITHROMYCIN",
    "company": "THEA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/25/2024",
    "drugName": "LOPINAVIR AND RITONAVIRANDA  #204739",
    "submission": "ORIG-1",
    "activeIngredients": "LOPINAVIR; RITONAVIR",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/25/2024",
    "drugName": "PHYTONADIONEANDA  #209373",
    "submission": "SUPPL-8",
    "activeIngredients": "PHYTONADIONE",
    "company": "AMNEAL PHARMS CO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/25/2024",
    "drugName": "OPFOLDANDA   #215211",
    "submission": "SUPPL-2",
    "activeIngredients": "MIGLUSTAT",
    "company": "AMICUS THERAP US",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/25/2024",
    "drugName": "DOXEPIN HYDROCHLORIDEANDA  #216041",
    "submission": "ORIG-1",
    "activeIngredients": "DOXEPIN HYDROCHLORIDE",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/25/2024",
    "drugName": "LEQSELVINDA   #217900",
    "submission": "ORIG-1",
    "activeIngredients": "DEURUXOLITINIB PHOSPHATE",
    "company": "SUN PHARM INDS INC",
    "submissionClassification": "Type 1 - New Molecular Entity",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/25/2024",
    "drugName": "APREPITANTNDA   #218754",
    "submission": "ORIG-1",
    "activeIngredients": "APREPITANT",
    "company": "AZURITY",
    "submissionClassification": "Type 5 - New Formulation or New Manufacturer",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "07/25/2024",
    "drugName": "POMBILITIBLA   #761204",
    "submission": "SUPPL-4",
    "activeIngredients": "CIPAGLUCOSIDASE ALFA-ATGA",
    "company": "AMICUS THERAP US",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/26/2024",
    "drugName": "TRIAMCINOLONE ACETONIDEANDA  #040671",
    "submission": "SUPPL-11",
    "activeIngredients": "TRIAMCINOLONE ACETONIDE",
    "company": "MICRO LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/26/2024",
    "drugName": "METHYLDOPAANDA  #070535",
    "submission": "SUPPL-17",
    "activeIngredients": "METHYLDOPA",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/26/2024",
    "drugName": "METHYLDOPAANDA  #070536",
    "submission": "SUPPL-20",
    "activeIngredients": "METHYLDOPA",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/26/2024",
    "drugName": "METHYLDOPAANDA  #070537",
    "submission": "SUPPL-20",
    "activeIngredients": "METHYLDOPA",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/26/2024",
    "drugName": "TEMAZEPAMANDA  #071456",
    "submission": "SUPPL-16",
    "activeIngredients": "TEMAZEPAM",
    "company": "NOVEL LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/26/2024",
    "drugName": "BUSPIRONE HYDROCHLORIDEANDA  #075022",
    "submission": "SUPPL-33",
    "activeIngredients": "BUSPIRONE HYDROCHLORIDE",
    "company": "TEVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/26/2024",
    "drugName": "ACETAZOLAMIDE SODIUMANDA  #202693",
    "submission": "SUPPL-5",
    "activeIngredients": "ACETAZOLAMIDE SODIUM",
    "company": "AVET LIFESCIENCES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/26/2024",
    "drugName": "ACETAZOLAMIDE SODIUMANDA  #202693",
    "submission": "SUPPL-7",
    "activeIngredients": "ACETAZOLAMIDE SODIUM",
    "company": "AVET LIFESCIENCES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/26/2024",
    "drugName": "LISDEXAMFETAMINE DIMESYLATEANDA  #202836",
    "submission": "ORIG-1",
    "activeIngredients": "LISDEXAMFETAMINE DIMESYLATE",
    "company": "SANDOZ",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/26/2024",
    "drugName": "KETOROLAC TROMETHAMINEANDA  #203242",
    "submission": "SUPPL-10",
    "activeIngredients": "KETOROLAC TROMETHAMINE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/26/2024",
    "drugName": "KETOROLAC TROMETHAMINEANDA  #203242",
    "submission": "SUPPL-11",
    "activeIngredients": "KETOROLAC TROMETHAMINE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/26/2024",
    "drugName": "FYREMADELANDA  #204246",
    "submission": "SUPPL-10",
    "activeIngredients": "GANIRELIX ACETATE",
    "company": "SUN PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/26/2024",
    "drugName": "FESOTERODINE FUMARATEANDA  #204973",
    "submission": "SUPPL-1",
    "activeIngredients": "FESOTERODINE FUMARATE",
    "company": "ALEMBIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/26/2024",
    "drugName": "ATORVASTATIN CALCIUMANDA  #205945",
    "submission": "SUPPL-1",
    "activeIngredients": "ATORVASTATIN CALCIUM",
    "company": "MICRO LABS LTD INDIA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/26/2024",
    "drugName": "ATORVASTATIN CALCIUMANDA  #205945",
    "submission": "SUPPL-3",
    "activeIngredients": "ATORVASTATIN CALCIUM",
    "company": "MICRO LABS LTD INDIA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/26/2024",
    "drugName": "ATORVASTATIN CALCIUMANDA  #205945",
    "submission": "SUPPL-4",
    "activeIngredients": "ATORVASTATIN CALCIUM",
    "company": "MICRO LABS LTD INDIA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/26/2024",
    "drugName": "ATORVASTATIN CALCIUMANDA  #205945",
    "submission": "SUPPL-6",
    "activeIngredients": "ATORVASTATIN CALCIUM",
    "company": "MICRO LABS LTD INDIA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/26/2024",
    "drugName": "RANITIDINE HYDROCHLORIDEANDA  #209161",
    "submission": "SUPPL-2",
    "activeIngredients": "RANITIDINE HYDROCHLORIDE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/26/2024",
    "drugName": "RANITIDINE HYDROCHLORIDEANDA  #209161",
    "submission": "SUPPL-3",
    "activeIngredients": "RANITIDINE HYDROCHLORIDE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/26/2024",
    "drugName": "COPIKTRANDA   #211155",
    "submission": "SUPPL-7",
    "activeIngredients": "DUVELISIB",
    "company": "SECURA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/26/2024",
    "drugName": "METOPROLOL SUCCINATEANDA  #214110",
    "submission": "ORIG-1",
    "activeIngredients": "METOPROLOL SUCCINATE",
    "company": "ZHEJIANG JUTAI PHARM",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/26/2024",
    "drugName": "FENOPROFEN CALCIUMANDA  #214475",
    "submission": "SUPPL-1",
    "activeIngredients": "FENOPROFEN CALCIUM",
    "company": "RISING",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/26/2024",
    "drugName": "ERZOFRINDA   #216352",
    "submission": "ORIG-1",
    "activeIngredients": "PALIPERIDONE PALMITATE",
    "company": "LUYE INNOMIND PHARMA",
    "submissionClassification": "Type 5 - New Formulation or New Manufacturer",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/26/2024",
    "drugName": "VENXXIVAANDA  #216990",
    "submission": "SUPPL-1",
    "activeIngredients": "TIOPRONIN",
    "company": "TORRENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/26/2024",
    "drugName": "POTASSIUM PHOSPHATES IN 0.9% SODIUM CHLORIDENDA   #218343",
    "submission": "ORIG-1",
    "activeIngredients": "POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC",
    "company": "AMNEAL",
    "submissionClassification": "Type 5 - New Formulation or New Manufacturer",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/26/2024",
    "drugName": "ZUNVEYLNDA   #218549",
    "submission": "ORIG-1",
    "activeIngredients": "BENZGALANTAMINE GLUCONATE",
    "company": "ALPHA COGNITION",
    "submissionClassification": "Type 2 - New Active Ingredient and Type 3 - New Dosage Form",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/29/2024",
    "drugName": "CLEOCIN HYDROCHLORIDENDA   #050162",
    "submission": "SUPPL-105",
    "activeIngredients": "CLINDAMYCIN HYDROCHLORIDE",
    "company": "PFIZER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/29/2024",
    "drugName": "CITALOPRAM HYDROBROMIDEANDA  #077031",
    "submission": "SUPPL-44",
    "activeIngredients": "CITALOPRAM HYDROBROMIDE",
    "company": "AUROBINDO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/29/2024",
    "drugName": "CITALOPRAM HYDROBROMIDEANDA  #077213",
    "submission": "SUPPL-5",
    "activeIngredients": "CITALOPRAM HYDROBROMIDE",
    "company": "HERITAGE PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/29/2024",
    "drugName": "CLOBAZAMANDA  #209718",
    "submission": "SUPPL-10",
    "activeIngredients": "CLOBAZAM",
    "company": "AMNEAL PHARMS CO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/29/2024",
    "drugName": "BROMFENAC SODIUMANDA  #210962",
    "submission": "ORIG-1",
    "activeIngredients": "BROMFENAC SODIUM",
    "company": "AMNEAL",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/29/2024",
    "drugName": "EMTRICITABINE; TENOFOVIR ALAFENAMIDEANDA  #215071",
    "submission": "ORIG-1",
    "activeIngredients": "EMTRICITABINE;TENOFOVIR ALAFENAMIDE",
    "company": "LUPIN LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "07/29/2024",
    "drugName": "TEZRULYNDA   #218139",
    "submission": "ORIG-1",
    "activeIngredients": "TERAZOSIN HYDROCHLORIDE",
    "company": "NOVITIUM PHARMA",
    "submissionClassification": "Type 3 - New Dosage Form",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/29/2024",
    "drugName": "BEOVUBLA   #761125",
    "submission": "SUPPL-21",
    "activeIngredients": "brolucizumab-dbll",
    "company": "NOVARTIS PHARMS CORP",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/30/2024",
    "drugName": "ROWASANDA   #019618",
    "submission": "SUPPL-33",
    "activeIngredients": "MESALAMINE",
    "company": "MYLAN SPECIALITY LP",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/30/2024",
    "drugName": "SFROWASANDA   #019618",
    "submission": "SUPPL-33",
    "activeIngredients": "MESALAMINE",
    "company": "MYLAN SPECIALITY LP",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/30/2024",
    "drugName": "DIPENTUMNDA   #019715",
    "submission": "SUPPL-35",
    "activeIngredients": "OLSALAZINE SODIUM",
    "company": "MYLAN SPCLT VIATRIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/30/2024",
    "drugName": "PENTASANDA   #020049",
    "submission": "SUPPL-41",
    "activeIngredients": "MESALAMINE",
    "company": "TAKEDA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/30/2024",
    "drugName": "ANTARA (MICRONIZED)NDA   #021695",
    "submission": "SUPPL-28",
    "activeIngredients": "FENOFIBRATE",
    "company": "LUPIN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/30/2024",
    "drugName": "VANCOMYCIN HYDROCHLORIDENDA   #210274",
    "submission": "SUPPL-2",
    "activeIngredients": "VANCOMYCIN HYDROCHLORIDE",
    "company": "ZHEJIANG NOVUS PHARM",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/30/2024",
    "drugName": "INREBICNDA   #212327",
    "submission": "SUPPL-6",
    "activeIngredients": "FEDRATINIB HYDROCHLORIDE",
    "company": "BRISTOL-MYERS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/30/2024",
    "drugName": "ORIAHNN (COPACKAGED)NDA   #213388",
    "submission": "SUPPL-5",
    "activeIngredients": "ELAGOLIX SODIUM,ESTRADIOL,NORETHINDRONE ACETATE; ELAGOLIX SODIUM",
    "company": "ABBVIE",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/30/2024",
    "drugName": "ROPIVACAINE HYDROCHLORIDEANDA  #218713",
    "submission": "ORIG-1",
    "activeIngredients": "ROPIVACAINE HYDROCHLORIDE",
    "company": "KINDOS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/30/2024",
    "drugName": "DARZALEX FASPROBLA   #761145",
    "submission": "SUPPL-25",
    "activeIngredients": "DARATUMUMAB AND HYALURONIDASE-FIHJ",
    "company": "JANSSEN BIOTECH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/31/2024",
    "drugName": "CRESTORNDA   #021366",
    "submission": "SUPPL-46",
    "activeIngredients": "ROSUVASTATIN CALCIUM",
    "company": "ASTRAZENECA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/31/2024",
    "drugName": "SPRYCELNDA   #021986",
    "submission": "SUPPL-28",
    "activeIngredients": "DASATINIB",
    "company": "BRISTOL MYERS SQUIBB",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/31/2024",
    "drugName": "QUTENZANDA   #022395",
    "submission": "SUPPL-24",
    "activeIngredients": "CAPSAICIN",
    "company": "AVERITAS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/31/2024",
    "drugName": "KEYTRUDABLA   #125514",
    "submission": "SUPPL-158",
    "activeIngredients": "PEMBROLIZUMAB",
    "company": "MERCK SHARP DOHME",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/31/2024",
    "drugName": "PREGABALINANDA  #212280",
    "submission": "SUPPL-8",
    "activeIngredients": "PREGABALIN",
    "company": "CIPLA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/31/2024",
    "drugName": "VOQUEZNA TRIPLE PAKNDA   #215152",
    "submission": "SUPPL-3",
    "activeIngredients": "AMOXICILLIN; CLARITHROMYCIN; VONOPRAZAN FUMARATE",
    "company": "PHATHOM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/31/2024",
    "drugName": "VOQUEZNA DUAL PAKNDA   #215153",
    "submission": "SUPPL-3",
    "activeIngredients": "AMOXICILLIN; VONOPRAZAN FUMARATE",
    "company": "PHATHOM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/31/2024",
    "drugName": "PHYRAGONDA   #216099",
    "submission": "SUPPL-4",
    "activeIngredients": "DASATINIB",
    "company": "HANDA THERAP",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/31/2024",
    "drugName": "ZURZUVAENDA   #217369",
    "submission": "SUPPL-1",
    "activeIngredients": "ZURANOLONE",
    "company": "BIOGEN INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/31/2024",
    "drugName": "DARZALEXBLA   #761036",
    "submission": "SUPPL-50",
    "activeIngredients": "DARATUMUMAB",
    "company": "JANSSEN BIOTECH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  }
,
 {
  "approvalDate": "08\/01\/2024",
  "drugName": "INFEDNDA   #017441",
  "submission": "SUPPL-181",
  "activeIngredients": "IRON DEXTRAN",
  "company": "ALLERGAN",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/01\/2024",
  "drugName": "VENOFERNDA   #021135",
  "submission": "SUPPL-38",
  "activeIngredients": "IRON SUCROSE",
  "company": "AM REGENT",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/01\/2024",
  "drugName": "METFORMIN HYDROCHLORIDEANDA  #076269",
  "submission": "SUPPL-18",
  "activeIngredients": "METFORMIN HYDROCHLORIDE",
  "company": "TEVA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/01\/2024",
  "drugName": "METFORMIN HYDROCHLORIDEANDA  #076269",
  "submission": "SUPPL-19",
  "activeIngredients": "METFORMIN HYDROCHLORIDE",
  "company": "TEVA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/01\/2024",
  "drugName": "ETODOLACANDA  #205448",
  "submission": "ORIG-1",
  "activeIngredients": "ETODOLAC",
  "company": "IPCA LABS LTD",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/01\/2024",
  "drugName": "MONOFERRICNDA   #208171",
  "submission": "SUPPL-3",
  "activeIngredients": "FERRIC DERISOMALTOSE",
  "company": "PHARMACOSMOS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/01\/2024",
  "drugName": "DAPTOMYCINANDA  #213396",
  "submission": "ORIG-1",
  "activeIngredients": "DAPTOMYCIN",
  "company": "FRESENIUS KABI USA",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/01\/2024",
  "drugName": "OFLOXACINANDA  #213597",
  "submission": "ORIG-1",
  "activeIngredients": "OFLOXACIN",
  "company": "SOMERSET",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/01\/2024",
  "drugName": "PANTOPRAZOLE SODIUMANDA  #216021",
  "submission": "ORIG-1",
  "activeIngredients": "PANTOPRAZOLE SODIUM",
  "company": "FRESENIUS KABI USA",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/01\/2024",
  "drugName": "NELARABINEANDA  #218554",
  "submission": "ORIG-1",
  "activeIngredients": "NELARABINE",
  "company": "ALEMBIC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/01\/2024",
  "drugName": "JEMPERLIBLA   #761174",
  "submission": "SUPPL-9",
  "activeIngredients": "DOSTARLIMAB-GXLY",
  "company": "GLAXOSMITHKLINE",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/02\/2024",
  "drugName": "SUCRAIDBLA   #020772",
  "submission": "SUPPL-31",
  "activeIngredients": "SACROSIDASE",
  "company": "QOL MEDCL",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/02\/2024",
  "drugName": "BENZTROPINE MESYLATEANDA  #040103",
  "submission": "SUPPL-24",
  "activeIngredients": "BENZTROPINE MESYLATE",
  "company": "AIPING PHARM INC",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/02\/2024",
  "drugName": "TRAMADOL HYDROCHLORIDEANDA  #075968",
  "submission": "SUPPL-14",
  "activeIngredients": "TRAMADOL HYDROCHLORIDE",
  "company": "GRAVITI PHARMS",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/02\/2024",
  "drugName": "AMPICILLIN AND SULBACTAMANDA  #090339",
  "submission": "SUPPL-14",
  "activeIngredients": "AMPICILLIN SODIUM; SULBACTAM SODIUM",
  "company": "EUGIA PHARMA SPECLTS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/02\/2024",
  "drugName": "EZETIMIBEANDA  #200831",
  "submission": "SUPPL-5",
  "activeIngredients": "EZETIMIBE",
  "company": "WATSON LABS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/02\/2024",
  "drugName": "EZETIMIBEANDA  #200831",
  "submission": "SUPPL-6",
  "activeIngredients": "EZETIMIBE",
  "company": "WATSON LABS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/02\/2024",
  "drugName": "PHENDIMETRAZINE TARTRATEANDA  #203600",
  "submission": "SUPPL-2",
  "activeIngredients": "PHENDIMETRAZINE TARTRATE",
  "company": "MPP PHARMA",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/02\/2024",
  "drugName": "ERLEADANDA   #210951",
  "submission": "SUPPL-16",
  "activeIngredients": "APALUTAMIDE",
  "company": "JANSSEN BIOTECH",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/02\/2024",
  "drugName": "ESTRADIOLANDA  #211396",
  "submission": "SUPPL-6",
  "activeIngredients": "ESTRADIOL",
  "company": "AMNEAL",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/02\/2024",
  "drugName": "ESTRADIOLANDA  #216550",
  "submission": "ORIG-1",
  "activeIngredients": "ESTRADIOL",
  "company": "AUROBINDO PHARMA",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/02\/2024",
  "drugName": "PREDNISOLONE ACETATEANDA  #216935",
  "submission": "ORIG-1",
  "activeIngredients": "PREDNISOLONE ACETATE",
  "company": "LUPIN LTD",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/05\/2024",
  "drugName": "MACITENTANANDA  #211107",
  "submission": "ORIG-1",
  "activeIngredients": "MACITENTAN",
  "company": "TORRENT",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/05\/2024",
  "drugName": "TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATEANDA  #211572",
  "submission": "ORIG-1",
  "activeIngredients": "POLYMYXIN B SULFATE; TRIMETHOPRIM SULFATE",
  "company": "SOMERSET THERAPS LLC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/05\/2024",
  "drugName": "REGADENOSONANDA  #215955",
  "submission": "ORIG-1",
  "activeIngredients": "REGADENOSON",
  "company": "GE HEALTHCARE",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/05\/2024",
  "drugName": "ACITRETINANDA  #217774",
  "submission": "ORIG-1",
  "activeIngredients": "ACITRETIN",
  "company": "ALEMBIC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/05\/2024",
  "drugName": "VALSARTANANDA  #218169",
  "submission": "ORIG-1",
  "activeIngredients": "VALSARTAN",
  "company": "SOMERSET THERAPS LLC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/06\/2024",
  "drugName": "MUCINEX DMNDA   #021620",
  "submission": "SUPPL-45",
  "activeIngredients": "DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN",
  "company": "RB HLTH",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/06\/2024",
  "drugName": "CANAGLIFLOZINANDA  #210783",
  "submission": "ORIG-1",
  "activeIngredients": "CANAGLIFLOZIN",
  "company": "MACLEODS PHARMS LTD",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "08\/06\/2024",
  "drugName": "ISOPROTERENOL HYDROCHLORIDEANDA  #211590",
  "submission": "ORIG-1",
  "activeIngredients": "ISOPROTERENOL HYDROCHLORIDE",
  "company": "SOMERSET THERAPS LLC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/06\/2024",
  "drugName": "FOTIVDANDA   #212904",
  "submission": "SUPPL-2",
  "activeIngredients": "TIVOZANIB HYDROCHLORIDE",
  "company": "AVEO PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/06\/2024",
  "drugName": "FAMOTIDINEANDA  #217400",
  "submission": "ORIG-1",
  "activeIngredients": "FAMOTIDINE",
  "company": "MSN",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/06\/2024",
  "drugName": "AZILSARTAN MEDOXOMIL; CHLORTHALIDONEANDA  #218737",
  "submission": "ORIG-1",
  "activeIngredients": "AZILSARTAN MEDOXOMIL;CHLORTHALIDONE",
  "company": "TEVA PHARMS INC",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "08\/06\/2024",
  "drugName": "VORANIGONDA   #218784",
  "submission": "ORIG-1",
  "activeIngredients": "VORASIDENIB",
  "company": "SERVIER",
  "submissionClassification": "Type 1 - New Molecular Entity",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/06\/2024",
  "drugName": "TRAMETINIB DIMETHYL SULFOXIDEANDA  #219002",
  "submission": "ORIG-1",
  "activeIngredients": "TRAMETINIB DIMETHYL SULFOXIDE",
  "company": "HIKMA",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/06\/2024",
  "drugName": "AIMOVIGBLA   #761077",
  "submission": "SUPPL-22",
  "activeIngredients": "ERENUMAB-AOOE",
  "company": "AMGEN INC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/07\/2024",
  "drugName": "VOLTAREN ARTHRITIS PAINNDA   #022122",
  "submission": "SUPPL-26",
  "activeIngredients": "DICLOFENAC SODIUM",
  "company": "HALEON US HOLDINGS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/07\/2024",
  "drugName": "AMOXICILLINANDA  #065256",
  "submission": "SUPPL-28",
  "activeIngredients": "AMOXICILLIN",
  "company": "AUROBINDO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/07\/2024",
  "drugName": "DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATEANDA  #085372",
  "submission": "SUPPL-15",
  "activeIngredients": "ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE",
  "company": "LANNETT",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/07\/2024",
  "drugName": "DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATEANDA  #085372",
  "submission": "SUPPL-16",
  "activeIngredients": "ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE",
  "company": "LANNETT",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/07\/2024",
  "drugName": "DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATEANDA  #085372",
  "submission": "SUPPL-21",
  "activeIngredients": "ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE",
  "company": "LANNETT",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/07\/2024",
  "drugName": "KEYTRUDABLA   #125514",
  "submission": "SUPPL-157",
  "activeIngredients": "PEMBROLIZUMAB",
  "company": "MERCK SHARP DOHME",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/07\/2024",
  "drugName": "TRAVOPROSTANDA  #205050",
  "submission": "SUPPL-12",
  "activeIngredients": "TRAVOPROST",
  "company": "MYLAN",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/07\/2024",
  "drugName": "OLOPATADINE HYDROCHLORIDEANDA  #206046",
  "submission": "SUPPL-3",
  "activeIngredients": "OLOPATADINE HYDROCHLORIDE",
  "company": "BAUSCH AND LOMB INC",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/07\/2024",
  "drugName": "SCEMBLIXNDA   #215358",
  "submission": "SUPPL-7",
  "activeIngredients": "ASCIMINIB HYDROCHLORIDE",
  "company": "NOVARTIS",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/07\/2024",
  "drugName": "VALBENAZINE TOSYLATEANDA  #216137",
  "submission": "ORIG-1",
  "activeIngredients": "VALBENAZINE TOSYLATE",
  "company": "ZYDUS LIFESCIENCES",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/07\/2024",
  "drugName": "CREXONTNDA   #217186",
  "submission": "ORIG-1",
  "activeIngredients": "CARBIDOPA; LEVODOPA",
  "company": "IMPAX",
  "submissionClassification": "Type 3 - New Dosage Form",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/07\/2024",
  "drugName": "TRYVIONDA   #217686",
  "submission": "SUPPL-2",
  "activeIngredients": "APROCITENTAN",
  "company": "IDORSIA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/07\/2024",
  "drugName": "FABHALTANDA   #218276",
  "submission": "SUPPL-1",
  "activeIngredients": "IPTACOPAN HYDROCHLORIDE",
  "company": "NOVARTIS",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/07\/2024",
  "drugName": "TIMOLOL MALEATEANDA  #218460",
  "submission": "ORIG-1",
  "activeIngredients": "TIMOLOL MALEATE",
  "company": "CAPLIN",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/07\/2024",
  "drugName": "ZURNAI (AUTOINJECTOR)NDA   #218590",
  "submission": "ORIG-1",
  "activeIngredients": "NALMEFENE HYDROCHLORIDE",
  "company": "PURDUE PHARMA LP",
  "submissionClassification": "Type 3 - New Dosage Form",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/07\/2024",
  "drugName": "TIZANIDINE HYDROCHLORIDEANDA  #218920",
  "submission": "ORIG-1",
  "activeIngredients": "TIZANIDINE HYDROCHLORIDE",
  "company": "RISING",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/07\/2024",
  "drugName": "SAPHNELOBLA   #761123",
  "submission": "SUPPL-5",
  "activeIngredients": "ANIFROLUMAB-FNIA",
  "company": "ASTRAZENECA AB",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/07\/2024",
  "drugName": "LYMPHIRBLA   #761312",
  "submission": "ORIG-1",
  "activeIngredients": "DENILEUKIN DIFTITOX-CXDL",
  "company": "CITIUS PHARMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/08\/2024",
  "drugName": "LEUPROLIDE ACETATE FOR DEPOT SUSPENSIONNDA   #205054",
  "submission": "SUPPL-6",
  "activeIngredients": "LEUPROLIDE ACETATE",
  "company": "INVAGEN PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/08\/2024",
  "drugName": "DIMETHYL FUMARATEANDA  #210402",
  "submission": "SUPPL-3",
  "activeIngredients": "DIMETHYL FUMARATE",
  "company": "AMNEAL",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/08\/2024",
  "drugName": "DIMETHYL FUMARATEANDA  #210402",
  "submission": "SUPPL-5",
  "activeIngredients": "DIMETHYL FUMARATE",
  "company": "AMNEAL",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/08\/2024",
  "drugName": "DIMETHYL FUMARATEANDA  #210402",
  "submission": "SUPPL-8",
  "activeIngredients": "DIMETHYL FUMARATE",
  "company": "AMNEAL",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/08\/2024",
  "drugName": "DIMETHYL FUMARATEANDA  #210402",
  "submission": "SUPPL-9",
  "activeIngredients": "DIMETHYL FUMARATE",
  "company": "AMNEAL",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/08\/2024",
  "drugName": "DIMETHYL FUMARATEANDA  #210402",
  "submission": "SUPPL-10",
  "activeIngredients": "DIMETHYL FUMARATE",
  "company": "AMNEAL",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/08\/2024",
  "drugName": "DIMETHYL FUMARATEANDA  #210402",
  "submission": "SUPPL-12",
  "activeIngredients": "DIMETHYL FUMARATE",
  "company": "AMNEAL",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/08\/2024",
  "drugName": "FENFLURAMINEANDA  #216108",
  "submission": "ORIG-1",
  "activeIngredients": "FENFLURAMINE",
  "company": "APOTEX INC",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "08\/08\/2024",
  "drugName": "NEBIVOLOL HYDROCHLORIDEANDA  #216568",
  "submission": "SUPPL-3",
  "activeIngredients": "NEBIVOLOL HYDROCHLORIDE",
  "company": "REGCON HOLDINGS",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/08\/2024",
  "drugName": "TRAZODONE HYDROCHLORIDEANDA  #218988",
  "submission": "ORIG-1",
  "activeIngredients": "TRAZODONE HYDROCHLORIDE",
  "company": "GRANULES",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/08\/2024",
  "drugName": "VYVGARTBLA   #761195",
  "submission": "SUPPL-4",
  "activeIngredients": "EFGARTIGIMOD ALFA",
  "company": "ARGENX BV",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/08\/2024",
  "drugName": "VYVGART HYTRULOBLA   #761304",
  "submission": "SUPPL-3",
  "activeIngredients": "EFGARTIGIMOD ALFA AND HYALURONIDASE-QVFC",
  "company": "ARGENX BV",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/09\/2024",
  "drugName": "KENALOG-40NDA   #014901",
  "submission": "SUPPL-55",
  "activeIngredients": "TRIAMCINOLONE ACETONIDE",
  "company": "APOTHECON",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/09\/2024",
  "drugName": "KENALOG-80NDA   #014901",
  "submission": "SUPPL-55",
  "activeIngredients": "TRIAMCINOLONE ACETONIDE",
  "company": "APOTHECON",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/09\/2024",
  "drugName": "DEXTROSE 5% IN PLASTIC CONTAINERNDA   #016673",
  "submission": "SUPPL-173",
  "activeIngredients": "DEXTROSE",
  "company": "BAXTER HLTHCARE",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/09\/2024",
  "drugName": "MYCOPHENOLATE MOFETILANDA  #065416",
  "submission": "SUPPL-23",
  "activeIngredients": "MYCOPHENOLATE MOFETIL",
  "company": "ACCORD HLTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/09\/2024",
  "drugName": "MINOXIDILANDA  #071344",
  "submission": "SUPPL-41",
  "activeIngredients": "MINOXIDIL",
  "company": "WATSON LABS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/09\/2024",
  "drugName": "MINOXIDILANDA  #071345",
  "submission": "SUPPL-42",
  "activeIngredients": "MINOXIDIL",
  "company": "WATSON LABS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/09\/2024",
  "drugName": "LORAZEPAMANDA  #074282",
  "submission": "SUPPL-26",
  "activeIngredients": "LORAZEPAM",
  "company": "HOSPIRA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/09\/2024",
  "drugName": "MYCOPHENOLATE MOFETILANDA  #090253",
  "submission": "SUPPL-23",
  "activeIngredients": "MYCOPHENOLATE MOFETIL",
  "company": "ACCORD HLTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/09\/2024",
  "drugName": "ZARXIOBLA   #125553",
  "submission": "SUPPL-35",
  "activeIngredients": "FILGRASTIM-SNDZ",
  "company": "SANDOZ INC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/09\/2024",
  "drugName": "FUROSCIXNDA   #209988",
  "submission": "SUPPL-1",
  "activeIngredients": "FUROSEMIDE",
  "company": "SCPHARMACEUTICALS",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/09\/2024",
  "drugName": "NEFFYNDA   #214697",
  "submission": "ORIG-1",
  "activeIngredients": "EPINEPHRINE",
  "company": "ARS PHARMS OPERATION",
  "submissionClassification": "Type 3 - New Dosage Form",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/09\/2024",
  "drugName": "PROPARACAINE HYDROCHLORIDEANDA  #215816",
  "submission": "ORIG-1",
  "activeIngredients": "PROPARACAINE HYDROCHLORIDE",
  "company": "SOMERSET THERAPS LLC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/09\/2024",
  "drugName": "YORVIPATHNDA   #216490",
  "submission": "ORIG-1",
  "activeIngredients": "PALOPEGTERIPARATIDE",
  "company": "ASCENDIS PHARMA BONE",
  "submissionClassification": "Type 1 - New Molecular Entity",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/09\/2024",
  "drugName": "BRIMONIDINE TARTRATEANDA  #216906",
  "submission": "ORIG-1",
  "activeIngredients": "BRIMONIDINE TARTRATE",
  "company": "SOMERSET THERAPS LLC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/09\/2024",
  "drugName": "REZVOGLARBLA   #761215",
  "submission": "SUPPL-5",
  "activeIngredients": "INSULIN GLARGINE-AGLR",
  "company": "ELI LILLY CO",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/09\/2024",
  "drugName": "ENZEEVUBLA   #761382",
  "submission": "ORIG-1",
  "activeIngredients": "AFLIBERCEPT-ABZV",
  "company": "SANDOZ INC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/10\/2024",
  "drugName": "CARBON DIOXIDE, USPNDA   #219779",
  "submission": "ORIG-1",
  "activeIngredients": "CARBON DIOXIDE",
  "company": "CENTRAL WELDING SUPPLY",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/12\/2024",
  "drugName": "PROTONIX IVNDA   #020988",
  "submission": "SUPPL-70",
  "activeIngredients": "PANTOPRAZOLE SODIUM",
  "company": "WYETH PHARMS",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/12\/2024",
  "drugName": "VENLAFAXINE HYDROCHLORIDEANDA  #076565",
  "submission": "SUPPL-23",
  "activeIngredients": "VENLAFAXINE HYDROCHLORIDE",
  "company": "TEVA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/12\/2024",
  "drugName": "VENLAFAXINE HYDROCHLORIDEANDA  #203332",
  "submission": "SUPPL-11",
  "activeIngredients": "VENLAFAXINE HYDROCHLORIDE",
  "company": "INVENTIA HLTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/12\/2024",
  "drugName": "VENLAFAXINE HYDROCHLORIDEANDA  #203332",
  "submission": "SUPPL-14",
  "activeIngredients": "VENLAFAXINE HYDROCHLORIDE",
  "company": "INVENTIA HLTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/12\/2024",
  "drugName": "SCENESSENDA   #210797",
  "submission": "SUPPL-7",
  "activeIngredients": "AFAMELANOTIDE",
  "company": "CLIVUNEL INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/12\/2024",
  "drugName": "DABIGATRAN ETEXILATE MESYLATEANDA  #213879",
  "submission": "ORIG-2",
  "activeIngredients": "DABIGATRAN ETEXILATE MESYLATE",
  "company": "MSN",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/12\/2024",
  "drugName": "VENLAFAXINE HYDROCHLORIDEANDA  #214127",
  "submission": "SUPPL-6",
  "activeIngredients": "VENLAFAXINE HYDROCHLORIDE",
  "company": "ALKEM LABS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/12\/2024",
  "drugName": "DABIGATRAN ETEXILATE MESYLATEANDA  #215233",
  "submission": "ORIG-2",
  "activeIngredients": "DABIGATRAN ETEXILATE MESYLATE",
  "company": "ALEMBIC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/12\/2024",
  "drugName": "STERILE WATER FOR IRRIGATIONANDA  #216123",
  "submission": "ORIG-1",
  "activeIngredients": "STERILE WATER FOR IRRIGATION",
  "company": "FRESENIUS KABI USA",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/12\/2024",
  "drugName": "BRIVARACETAMANDA  #218494",
  "submission": "ORIG-1",
  "activeIngredients": "BRIVARACETAM",
  "company": "HAINAN POLY PHARM",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "08\/12\/2024",
  "drugName": "MIDAZOLAM IN 0.9% SODIUM CHLORIDEANDA  #218993",
  "submission": "ORIG-1",
  "activeIngredients": "MIDAZOLAM",
  "company": "GLAND",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/12\/2024",
  "drugName": "SILIQBLA   #761032",
  "submission": "SUPPL-14",
  "activeIngredients": "BRODALUMAB",
  "company": "VALEANT LUXEMBOURG",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/12\/2024",
  "drugName": "NEMLUVIOBLA   #761390",
  "submission": "ORIG-1",
  "activeIngredients": "NEMOLIZUMAB-ILTO",
  "company": "GALDERMA LABS LP",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "MEPERIDINE HYDROCHLORIDEANDA  #040110",
  "submission": "SUPPL-12",
  "activeIngredients": "MEPERIDINE HYDROCHLORIDE",
  "company": "HIKMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "CELLCEPTNDA   #050722",
  "submission": "SUPPL-53",
  "activeIngredients": "MYCOPHENOLATE MOFETIL",
  "company": "ROCHE PALO",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "CELLCEPTNDA   #050723",
  "submission": "SUPPL-53",
  "activeIngredients": "MYCOPHENOLATE MOFETIL",
  "company": "ROCHE PALO",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "CELLCEPTNDA   #050758",
  "submission": "SUPPL-51",
  "activeIngredients": "MYCOPHENOLATE MOFETIL HYDROCHLORIDE",
  "company": "ROCHE PALO",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "CELLCEPTNDA   #050759",
  "submission": "SUPPL-59",
  "activeIngredients": "MYCOPHENOLATE MOFETIL",
  "company": "ROCHE PALO",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "MYFORTICNDA   #050791",
  "submission": "SUPPL-38",
  "activeIngredients": "MYCOPHENOLATE SODIUM",
  "company": "NOVARTIS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "MYCOPHENOLATE MOFETILANDA  #065379",
  "submission": "SUPPL-37",
  "activeIngredients": "MYCOPHENOLATE MOFETIL",
  "company": "SANDOZ",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "MYCOPHENOLATE MOFETILANDA  #065410",
  "submission": "SUPPL-23",
  "activeIngredients": "MYCOPHENOLATE MOFETIL",
  "company": "HIKMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "MYCOPHENOLATE MOFETILANDA  #065413",
  "submission": "SUPPL-24",
  "activeIngredients": "MYCOPHENOLATE MOFETIL",
  "company": "HIKMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "MYCOPHENOLATE MOFETILANDA  #065416",
  "submission": "SUPPL-25",
  "activeIngredients": "MYCOPHENOLATE MOFETIL",
  "company": "ACCORD HLTHCARE",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "MYCOPHENOLATE MOFETILANDA  #065451",
  "submission": "SUPPL-38",
  "activeIngredients": "MYCOPHENOLATE MOFETIL",
  "company": "SANDOZ",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "MYCOPHENOLATE MOFETILANDA  #065457",
  "submission": "SUPPL-18",
  "activeIngredients": "MYCOPHENOLATE MOFETIL",
  "company": "TEVA PHARMS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "MYCOPHENOLATE MOFETILANDA  #065491",
  "submission": "SUPPL-30",
  "activeIngredients": "MYCOPHENOLATE MOFETIL",
  "company": "TEVA PHARMS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "MYCOPHENOLATE MOFETILANDA  #065520",
  "submission": "SUPPL-36",
  "activeIngredients": "MYCOPHENOLATE MOFETIL",
  "company": "MYLAN",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "MYCOPHENOLATE MOFETILANDA  #065521",
  "submission": "SUPPL-34",
  "activeIngredients": "MYCOPHENOLATE MOFETIL",
  "company": "MYLAN",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "NALOXONE HYDROCHLORIDEANDA  #070256",
  "submission": "SUPPL-18",
  "activeIngredients": "NALOXONE HYDROCHLORIDE",
  "company": "HOSPIRA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "NALOXONE HYDROCHLORIDEANDA  #070257",
  "submission": "SUPPL-23",
  "activeIngredients": "NALOXONE HYDROCHLORIDE",
  "company": "HOSPIRA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "CAPTOPRILANDA  #074481",
  "submission": "SUPPL-3",
  "activeIngredients": "CAPTOPRIL",
  "company": "SANDOZ",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "CAPTOPRILANDA  #074481",
  "submission": "SUPPL-4",
  "activeIngredients": "CAPTOPRIL",
  "company": "SANDOZ",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "DILTIAZEM HYDROCHLORIDEANDA  #077686",
  "submission": "SUPPL-19",
  "activeIngredients": "DILTIAZEM HYDROCHLORIDE",
  "company": "ACTAVIS LABS FL INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "DIVALPROEX SODIUMANDA  #078790",
  "submission": "SUPPL-29",
  "activeIngredients": "DIVALPROEX SODIUM",
  "company": "LUPIN",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATEANDA  #085762",
  "submission": "SUPPL-64",
  "activeIngredients": "ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE",
  "company": "PHARMOBEDIENT",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "MEPERIDINE HYDROCHLORIDEANDA  #088744",
  "submission": "SUPPL-33",
  "activeIngredients": "MEPERIDINE HYDROCHLORIDE",
  "company": "HIKMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "MYCOPHENOLATE MOFETILANDA  #090055",
  "submission": "SUPPL-33",
  "activeIngredients": "MYCOPHENOLATE MOFETIL",
  "company": "STRIDES PHARMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "MYCOPHENOLATE MOFETILANDA  #090111",
  "submission": "SUPPL-15",
  "activeIngredients": "MYCOPHENOLATE MOFETIL",
  "company": "STRIDES PHARMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "MYCOPHENOLATE MOFETILANDA  #090253",
  "submission": "SUPPL-25",
  "activeIngredients": "MYCOPHENOLATE MOFETIL",
  "company": "ACCORD HLTHCARE",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "MYCOPHENOLATE MOFETILANDA  #090456",
  "submission": "SUPPL-37",
  "activeIngredients": "MYCOPHENOLATE MOFETIL",
  "company": "STRIDES PHARMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "MYCOPHENOLATE MOFETILANDA  #090606",
  "submission": "SUPPL-15",
  "activeIngredients": "MYCOPHENOLATE MOFETIL",
  "company": "AMNEAL",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "MYCOPHENOLATE MOFETILANDA  #090661",
  "submission": "SUPPL-11",
  "activeIngredients": "MYCOPHENOLATE MOFETIL",
  "company": "JUBILANT CADISTA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "MYCOPHENOLATE MOFETILANDA  #090762",
  "submission": "SUPPL-11",
  "activeIngredients": "MYCOPHENOLATE MOFETIL",
  "company": "JUBILANT CADISTA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "MYCOPHENOLATE SODIUMANDA  #091248",
  "submission": "SUPPL-20",
  "activeIngredients": "MYCOPHENOLATE SODIUM",
  "company": "RK PHARMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "MYCOPHENOLATE MOFETILANDA  #091249",
  "submission": "SUPPL-30",
  "activeIngredients": "MYCOPHENOLATE MOFETIL",
  "company": "ALKEM LABS LTD",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "MYCOPHENOLATE SODIUMANDA  #091558",
  "submission": "SUPPL-22",
  "activeIngredients": "MYCOPHENOLATE SODIUM",
  "company": "APOTEX INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "MYCOPHENOLATE MOFETILANDA  #200197",
  "submission": "SUPPL-27",
  "activeIngredients": "MYCOPHENOLATE MOFETIL",
  "company": "ALKEM LABS LTD",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "MYCOPHENOLATE SODIUMANDA  #202555",
  "submission": "SUPPL-12",
  "activeIngredients": "MYCOPHENOLATE SODIUM",
  "company": "ACCORD HLTHCARE",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "SILDENAFIL CITRATEANDA  #202598",
  "submission": "SUPPL-4",
  "activeIngredients": "SILDENAFIL CITRATE",
  "company": "CHARTWELL RX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "MYCOPHENOLATE SODIUMANDA  #202720",
  "submission": "SUPPL-11",
  "activeIngredients": "MYCOPHENOLATE SODIUM",
  "company": "TEVA PHARMS USA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "MYCOPHENOLATE MOFETILANDA  #203005",
  "submission": "SUPPL-20",
  "activeIngredients": "MYCOPHENOLATE MOFETIL",
  "company": "ALKEM LABS LTD",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "MYCOPHENOLATE MOFETIL HYDROCHLORIDEANDA  #203575",
  "submission": "SUPPL-9",
  "activeIngredients": "MYCOPHENOLATE MOFETIL HYDROCHLORIDE",
  "company": "PH HEALTH",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "MYCOPHENOLATE MOFETIL HYDROCHLORIDEANDA  #203859",
  "submission": "SUPPL-15",
  "activeIngredients": "MYCOPHENOLATE MOFETIL HYDROCHLORIDE",
  "company": "MYLAN LABS LTD",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "MYCOPHENOLATE MOFETIL HYDROCHLORIDEANDA  #204043",
  "submission": "SUPPL-16",
  "activeIngredients": "MYCOPHENOLATE MOFETIL HYDROCHLORIDE",
  "company": "RISING",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "MYCOPHENOLATE MOFETILANDA  #204076",
  "submission": "SUPPL-7",
  "activeIngredients": "MYCOPHENOLATE MOFETIL",
  "company": "ZHEJIANG HISUN PHARM",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "MYCOPHENOLATE MOFETILANDA  #204077",
  "submission": "SUPPL-7",
  "activeIngredients": "MYCOPHENOLATE MOFETIL",
  "company": "ZHEJIANG HISUN PHARM",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "MYCOPHENOLATE MOFETIL HYDROCHLORIDEANDA  #204473",
  "submission": "SUPPL-9",
  "activeIngredients": "MYCOPHENOLATE MOFETIL HYDROCHLORIDE",
  "company": "ZYDUS PHARMS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "DABIGATRAN ETEXILATE MESYLATEANDA  #207961",
  "submission": "ORIG-2",
  "activeIngredients": "DABIGATRAN ETEXILATE MESYLATE",
  "company": "HETERO LABS LTD III",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "MYCOPHENOLATE SODIUMANDA  #208315",
  "submission": "SUPPL-8",
  "activeIngredients": "MYCOPHENOLATE SODIUM",
  "company": "ALKEM LABS LTD",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "MYCOPHENOLATE MOFETILANDA  #210181",
  "submission": "SUPPL-20",
  "activeIngredients": "MYCOPHENOLATE MOFETIL",
  "company": "CONCORD BIOTECH LTD",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "MYCOPHENOLATE MOFETILANDA  #210370",
  "submission": "SUPPL-15",
  "activeIngredients": "MYCOPHENOLATE MOFETIL",
  "company": "VISTAPHARM LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "MYCOPHENOLATE SODIUMANDA  #211173",
  "submission": "SUPPL-16",
  "activeIngredients": "MYCOPHENOLATE SODIUM",
  "company": "CONCORD BIOTECH LTD",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "MYCOPHENOLATE MOFETILANDA  #211272",
  "submission": "SUPPL-3",
  "activeIngredients": "MYCOPHENOLATE MOFETIL",
  "company": "TEVA PHARMS USA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "MYCOPHENOLATE MOFETIL HYDROCHLORIDEANDA  #211374",
  "submission": "SUPPL-8",
  "activeIngredients": "MYCOPHENOLATE MOFETIL HYDROCHLORIDE",
  "company": "AMNEAL",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "TAZVERIKNDA   #211723",
  "submission": "SUPPL-5",
  "activeIngredients": "TAZEMETOSTAT HYDROBROMIDE",
  "company": "EPIZYME INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "ERYTHROMYCINANDA  #211975",
  "submission": "SUPPL-6",
  "activeIngredients": "ERYTHROMYCIN",
  "company": "TORRENT",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "MYCOPHENOLATE MOFETILANDA  #212087",
  "submission": "SUPPL-14",
  "activeIngredients": "MYCOPHENOLATE MOFETIL",
  "company": "CONCORD BIOTECH LTD",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "MYCOPHENOLATE MOFETIL HYDROCHLORIDEANDA  #212130",
  "submission": "SUPPL-10",
  "activeIngredients": "MYCOPHENOLATE MOFETIL HYDROCHLORIDE",
  "company": "MEITHEAL",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDEANDA  #212198",
  "submission": "SUPPL-4",
  "activeIngredients": "EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE",
  "company": "ZYDUS PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "MYCOPHENOLATE MOFETILANDA  #212634",
  "submission": "SUPPL-3",
  "activeIngredients": "MYCOPHENOLATE MOFETIL",
  "company": "STRIDES PHARMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "MYCOPHENOLATE MOFETILANDA  #213955",
  "submission": "SUPPL-1",
  "activeIngredients": "MYCOPHENOLATE MOFETIL",
  "company": "RISING",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "MYCOPHENOLATE SODIUMANDA  #214289",
  "submission": "SUPPL-7",
  "activeIngredients": "MYCOPHENOLATE SODIUM",
  "company": "TWI PHARMS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "MYCOPHENOLATE SODIUMANDA  #214376",
  "submission": "SUPPL-12",
  "activeIngredients": "MYCOPHENOLATE SODIUM",
  "company": "YICHANG HUMANWELL",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "MYCOPHENOLATE MOFETILANDA  #214525",
  "submission": "SUPPL-7",
  "activeIngredients": "MYCOPHENOLATE MOFETIL",
  "company": "LANNETT CO INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "MYCOPHENOLATE SODIUMANDA  #214630",
  "submission": "SUPPL-7",
  "activeIngredients": "MYCOPHENOLATE SODIUM",
  "company": "BIOCON PHARMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "MYCOPHENOLATE MOFETILANDA  #214871",
  "submission": "SUPPL-8",
  "activeIngredients": "MYCOPHENOLATE MOFETIL",
  "company": "AMNEAL",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "MYCOPHENOLATE MOFETIL HYDROCHLORIDEANDA  #216390",
  "submission": "SUPPL-3",
  "activeIngredients": "MYCOPHENOLATE MOFETIL HYDROCHLORIDE",
  "company": "ONESOURCE SPECIALTY",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "MYHIBBINNDA   #216482",
  "submission": "SUPPL-1",
  "activeIngredients": "MYCOPHENOLATE MOFETIL",
  "company": "AZURITY",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "CARBAMAZEPINEANDA  #216594",
  "submission": "SUPPL-3",
  "activeIngredients": "CARBAMAZEPINE",
  "company": "UMEDICA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "CARBAMAZEPINEANDA  #216594",
  "submission": "SUPPL-5",
  "activeIngredients": "CARBAMAZEPINE",
  "company": "UMEDICA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "BRIMONIDINE TARTRATEANDA  #216716",
  "submission": "ORIG-1",
  "activeIngredients": "BRIMONIDINE TARTRATE",
  "company": "LUPIN LTD",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "MYCOPHENOLATE SODIUMANDA  #217031",
  "submission": "SUPPL-1",
  "activeIngredients": "MYCOPHENOLATE SODIUM",
  "company": "BIOCON PHARMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "TADALAFILANDA  #217606",
  "submission": "ORIG-1",
  "activeIngredients": "TADALAFIL",
  "company": "HIBROW HLTHCARE",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "MYCOPHENOLATE MOFETILANDA  #217828",
  "submission": "SUPPL-1",
  "activeIngredients": "MYCOPHENOLATE MOFETIL",
  "company": "AUROBINDO PHARMA LTD",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "MYCOPHENOLATE MOFETILANDA  #217937",
  "submission": "SUPPL-1",
  "activeIngredients": "MYCOPHENOLATE MOFETIL",
  "company": "AUROBINDO PHARMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/13\/2024",
  "drugName": "MYCOPHENOLATE SODIUMANDA  #218603",
  "submission": "SUPPL-1",
  "activeIngredients": "MYCOPHENOLATE SODIUM",
  "company": "AUROBINDO PHARMA LTD",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/14\/2024",
  "drugName": "KENALOG-10NDA   #012041",
  "submission": "SUPPL-52",
  "activeIngredients": "TRIAMCINOLONE ACETONIDE",
  "company": "APOTHECON",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/14\/2024",
  "drugName": "OMNISCANNDA   #020123",
  "submission": "SUPPL-49",
  "activeIngredients": "GADODIAMIDE",
  "company": "GE HEALTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/14\/2024",
  "drugName": "PROHANCENDA   #020131",
  "submission": "SUPPL-42",
  "activeIngredients": "GADOTERIDOL",
  "company": "BRACCO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/14\/2024",
  "drugName": "MULTIHANCENDA   #021357",
  "submission": "SUPPL-26",
  "activeIngredients": "GADOBENATE DIMEGLUMINE",
  "company": "BRACCO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/14\/2024",
  "drugName": "MULTIHANCE MULTIPACKNDA   #021358",
  "submission": "SUPPL-24",
  "activeIngredients": "GADOBENATE DIMEGLUMINE",
  "company": "BRACCO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/14\/2024",
  "drugName": "PROHANCE MULTIPACKNDA   #021489",
  "submission": "SUPPL-23",
  "activeIngredients": "GADOTERIDOL",
  "company": "BRACCO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/14\/2024",
  "drugName": "OMNISCANNDA   #022066",
  "submission": "SUPPL-12",
  "activeIngredients": "GADODIAMIDE",
  "company": "GE HEALTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/14\/2024",
  "drugName": "TASIGNANDA   #022068",
  "submission": "SUPPL-42",
  "activeIngredients": "NILOTINIB HYDROCHLORIDE",
  "company": "NOVARTIS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/14\/2024",
  "drugName": "EOVISTNDA   #022090",
  "submission": "SUPPL-23",
  "activeIngredients": "GADOXETATE DISODIUM",
  "company": "BAYER HLTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/14\/2024",
  "drugName": "ORPHENADRINE CITRATEANDA  #040284",
  "submission": "SUPPL-25",
  "activeIngredients": "ORPHENADRINE CITRATE",
  "company": "LUPIN",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/14\/2024",
  "drugName": "MOMETASONE FUROATEANDA  #078571",
  "submission": "SUPPL-9",
  "activeIngredients": "MOMETASONE FUROATE",
  "company": "GLENMARK PHARMS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/14\/2024",
  "drugName": "MOMETASONE FUROATEANDA  #078571",
  "submission": "SUPPL-10",
  "activeIngredients": "MOMETASONE FUROATE",
  "company": "GLENMARK PHARMS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/14\/2024",
  "drugName": "OXTELLAR XRNDA   #202810",
  "submission": "SUPPL-20",
  "activeIngredients": "OXCARBAZEPINE",
  "company": "SUPERNUS PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/14\/2024",
  "drugName": "DOTAREMNDA   #204781",
  "submission": "SUPPL-14",
  "activeIngredients": "GADOTERATE MEGLUMINE",
  "company": "GUERBET",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/14\/2024",
  "drugName": "URSODIOLANDA  #214717",
  "submission": "ORIG-1",
  "activeIngredients": "URSODIOL",
  "company": "EPIC PHARMA LLC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/14\/2024",
  "drugName": "ELUCIREMNDA   #216986",
  "submission": "SUPPL-3",
  "activeIngredients": "GADOPICLENOL",
  "company": "GUERBET",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/14\/2024",
  "drugName": "BEPOTASTINE BESILATEANDA  #217770",
  "submission": "ORIG-1",
  "activeIngredients": "BEPOTASTINE BESILATE",
  "company": "SOMERSET THERAPS LLC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/14\/2024",
  "drugName": "LIVDELZINDA   #217899",
  "submission": "ORIG-1",
  "activeIngredients": "SELADELPAR LYSINE",
  "company": "GILEAD SCIENCES INC",
  "submissionClassification": "Type 1 - New Molecular Entity",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/14\/2024",
  "drugName": "NIKTIMVOBLA   #761411",
  "submission": "ORIG-1",
  "activeIngredients": "axatilimab-csfr",
  "company": "INCYTE CORP",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/15\/2024",
  "drugName": "CHILDREN'S ZYRTEC ALLERGYNDA   #021621",
  "submission": "SUPPL-17",
  "activeIngredients": "CETIRIZINE HYDROCHLORIDE",
  "company": "KENVUE BRANDS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/15\/2024",
  "drugName": "CHILDREN'S ZYRTEC HIVES RELIEFNDA   #021621",
  "submission": "SUPPL-17",
  "activeIngredients": "CETIRIZINE HYDROCHLORIDE",
  "company": "KENVUE BRANDS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/15\/2024",
  "drugName": "NAPROXEN AND ESOMEPRAZOLE MAGNESIUMANDA  #204920",
  "submission": "SUPPL-2",
  "activeIngredients": "ESOMEPRAZOLE MAGNESIUM; NAPROXEN",
  "company": "PHARMOBEDIENT",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/15\/2024",
  "drugName": "NAPROXEN AND ESOMEPRAZOLE MAGNESIUMANDA  #204920",
  "submission": "SUPPL-5",
  "activeIngredients": "ESOMEPRAZOLE MAGNESIUM; NAPROXEN",
  "company": "PHARMOBEDIENT",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/15\/2024",
  "drugName": "FLUCONAZOLEANDA  #208963",
  "submission": "SUPPL-17",
  "activeIngredients": "FLUCONAZOLE",
  "company": "ZYDUS PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/15\/2024",
  "drugName": "EZETIMIBEANDA  #209234",
  "submission": "SUPPL-14",
  "activeIngredients": "EZETIMIBE",
  "company": "ALKEM LABS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/15\/2024",
  "drugName": "ROPIVACAINE HYDROCHLORIDEANDA  #211907",
  "submission": "ORIG-1",
  "activeIngredients": "ROPIVACAINE HYDROCHLORIDE",
  "company": "HIKMA",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/15\/2024",
  "drugName": "EMERPHEDNDA   #213407",
  "submission": "SUPPL-9",
  "activeIngredients": "EPHEDRINE SULFATE",
  "company": "NEXUS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/15\/2024",
  "drugName": "PROPOFOLANDA  #217525",
  "submission": "ORIG-1",
  "activeIngredients": "PROPOFOL",
  "company": "AMNEAL",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/15\/2024",
  "drugName": "TRANEXAMIC ACIDANDA  #218242",
  "submission": "ORIG-1",
  "activeIngredients": "TRANEXAMIC ACID",
  "company": "FRESENIUS KABI USA",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/15\/2024",
  "drugName": "IMFINZIBLA   #761069",
  "submission": "SUPPL-43",
  "activeIngredients": "DURVALUMAB",
  "company": "ASTRAZENECA UK LTD",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/15\/2024",
  "drugName": "NEXOBRIDBLA   #761192",
  "submission": "SUPPL-10",
  "activeIngredients": "ANACAULASE-BCDB",
  "company": "MEDIWOUND, LTD",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/16\/2024",
  "drugName": "GENOTROPINBLA   #020280",
  "submission": "SUPPL-92",
  "activeIngredients": "SOMATROPIN",
  "company": "PHARMACIA",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/16\/2024",
  "drugName": "GENOTROPIN PRESERVATIVE FREEBLA   #020280",
  "submission": "SUPPL-92",
  "activeIngredients": "SOMATROPIN",
  "company": "PHARMACIA",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/16\/2024",
  "drugName": "NICARDIPINE HYDROCHLORIDENDA   #022276",
  "submission": "SUPPL-25",
  "activeIngredients": "NICARDIPINE HYDROCHLORIDE",
  "company": "HIKMA INTL PHARMS",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/16\/2024",
  "drugName": "NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDENDA   #022276",
  "submission": "SUPPL-25",
  "activeIngredients": "NICARDIPINE HYDROCHLORIDE",
  "company": "HIKMA INTL PHARMS",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/16\/2024",
  "drugName": "TORSEMIDEANDA  #076226",
  "submission": "SUPPL-5",
  "activeIngredients": "TORSEMIDE",
  "company": "STRIDES PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/16\/2024",
  "drugName": "COSENTYXBLA   #125504",
  "submission": "SUPPL-82",
  "activeIngredients": "SECUKINUMAB",
  "company": "NOVARTIS PHARMS CORP",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/16\/2024",
  "drugName": "DIFLUNISALANDA  #202845",
  "submission": "SUPPL-19",
  "activeIngredients": "DIFLUNISAL",
  "company": "HERITAGE PHARMA",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/16\/2024",
  "drugName": "DESVENLAFAXINE SUCCINATEANDA  #204003",
  "submission": "SUPPL-26",
  "activeIngredients": "DESVENLAFAXINE SUCCINATE",
  "company": "ALEMBIC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/16\/2024",
  "drugName": "DESVENLAFAXINE SUCCINATEANDA  #204065",
  "submission": "SUPPL-10",
  "activeIngredients": "DESVENLAFAXINE SUCCINATE",
  "company": "ACTAVIS LABS FL",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/16\/2024",
  "drugName": "DESVENLAFAXINE SUCCINATEANDA  #204065",
  "submission": "SUPPL-13",
  "activeIngredients": "DESVENLAFAXINE SUCCINATE",
  "company": "ACTAVIS LABS FL",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/16\/2024",
  "drugName": "SILODOSINANDA  #204793",
  "submission": "SUPPL-1",
  "activeIngredients": "SILODOSIN",
  "company": "HETERO LABS LTD V",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/16\/2024",
  "drugName": "DABIGATRAN ETEXILATE MESYLATEANDA  #208040",
  "submission": "SUPPL-2",
  "activeIngredients": "DABIGATRAN ETEXILATE MESYLATE",
  "company": "ALKEM LABS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/16\/2024",
  "drugName": "DABIGATRAN ETEXILATE MESYLATEANDA  #208040",
  "submission": "SUPPL-11",
  "activeIngredients": "DABIGATRAN ETEXILATE MESYLATE",
  "company": "ALKEM LABS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/16\/2024",
  "drugName": "TICAGRELORANDA  #208599",
  "submission": "ORIG-1",
  "activeIngredients": "TICAGRELOR",
  "company": "PRINSTON INC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/16\/2024",
  "drugName": "TICAGRELORANDA  #208599",
  "submission": "ORIG-2",
  "activeIngredients": "TICAGRELOR",
  "company": "PRINSTON INC",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "08\/16\/2024",
  "drugName": "METHYLPHENIDATE HYDROCHLORIDEANDA  #208861",
  "submission": "SUPPL-12",
  "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
  "company": "ACTAVIS ELIZABETH",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/16\/2024",
  "drugName": "ANAGRELIDE HYDROCHLORIDEANDA  #209151",
  "submission": "SUPPL-2",
  "activeIngredients": "ANAGRELIDE HYDROCHLORIDE",
  "company": "TORRENT",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/16\/2024",
  "drugName": "ANAGRELIDE HYDROCHLORIDEANDA  #209151",
  "submission": "SUPPL-4",
  "activeIngredients": "ANAGRELIDE HYDROCHLORIDE",
  "company": "TORRENT",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/16\/2024",
  "drugName": "ANAGRELIDE HYDROCHLORIDEANDA  #209151",
  "submission": "SUPPL-5",
  "activeIngredients": "ANAGRELIDE HYDROCHLORIDE",
  "company": "TORRENT",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/16\/2024",
  "drugName": "COLESTIPOL HYDROCHLORIDEANDA  #217667",
  "submission": "ORIG-1",
  "activeIngredients": "COLESTIPOL HYDROCHLORIDE",
  "company": "EDENBRIDGE PHARMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/16\/2024",
  "drugName": "LAPATINIB DITOSYLATEANDA  #217968",
  "submission": "ORIG-1",
  "activeIngredients": "LAPATINIB DITOSYLATE",
  "company": "TEVA PHARMS USA INC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/16\/2024",
  "drugName": "YUFLYMABLA   #761219",
  "submission": "SUPPL-11",
  "activeIngredients": "ADALIMUMAB-AATY",
  "company": "CELLTRION",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/16\/2024",
  "drugName": "COSENTYXBLA   #761349",
  "submission": "SUPPL-6",
  "activeIngredients": "SECUKINUMAB",
  "company": "NOVARTIS PHARMS CORP",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/19\/2024",
  "drugName": "LETAIRISNDA   #022081",
  "submission": "SUPPL-44",
  "activeIngredients": "AMBRISENTAN",
  "company": "GILEAD",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/19\/2024",
  "drugName": "TEMAZEPAMANDA  #071457",
  "submission": "SUPPL-19",
  "activeIngredients": "TEMAZEPAM",
  "company": "NOVEL LABS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/19\/2024",
  "drugName": "IFOSFAMIDEANDA  #076078",
  "submission": "SUPPL-11",
  "activeIngredients": "IFOSFAMIDE",
  "company": "FRESENIUS KABI USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/19\/2024",
  "drugName": "IFOSFAMIDEANDA  #076078",
  "submission": "SUPPL-17",
  "activeIngredients": "IFOSFAMIDE",
  "company": "FRESENIUS KABI USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/19\/2024",
  "drugName": "LITHIUM CARBONATEANDA  #076170",
  "submission": "SUPPL-8",
  "activeIngredients": "LITHIUM CARBONATE",
  "company": "HERITAGE PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/19\/2024",
  "drugName": "ESTRADIOLANDA  #202985",
  "submission": "SUPPL-1",
  "activeIngredients": "ESTRADIOL",
  "company": "ZYDUS PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/19\/2024",
  "drugName": "IVERMECTINANDA  #204154",
  "submission": "SUPPL-10",
  "activeIngredients": "IVERMECTIN",
  "company": "EDENBRIDGE PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/19\/2024",
  "drugName": "ATORVASTATIN CALCIUMANDA  #205945",
  "submission": "SUPPL-7",
  "activeIngredients": "ATORVASTATIN CALCIUM",
  "company": "MICRO LABS LTD INDIA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/19\/2024",
  "drugName": "AMBRISENTANANDA  #208252",
  "submission": "SUPPL-5",
  "activeIngredients": "AMBRISENTAN",
  "company": "WATSON LABS INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/19\/2024",
  "drugName": "AMBRISENTANANDA  #208354",
  "submission": "SUPPL-5",
  "activeIngredients": "AMBRISENTAN",
  "company": "SIGMAPHARM LABS LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/19\/2024",
  "drugName": "AMBRISENTANANDA  #208441",
  "submission": "SUPPL-4",
  "activeIngredients": "AMBRISENTAN",
  "company": "MYLAN",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/19\/2024",
  "drugName": "BOSENTANANDA  #209324",
  "submission": "SUPPL-7",
  "activeIngredients": "BOSENTAN",
  "company": "SUN PHARM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/19\/2024",
  "drugName": "BOSENTANANDA  #209324",
  "submission": "SUPPL-9",
  "activeIngredients": "BOSENTAN",
  "company": "SUN PHARM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/19\/2024",
  "drugName": "AMBRISENTANANDA  #209509",
  "submission": "SUPPL-5",
  "activeIngredients": "AMBRISENTAN",
  "company": "PH HEALTH",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/19\/2024",
  "drugName": "AMBRISENTANANDA  #210058",
  "submission": "SUPPL-8",
  "activeIngredients": "AMBRISENTAN",
  "company": "ZYDUS PHARMS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/19\/2024",
  "drugName": "AMBRISENTANANDA  #210701",
  "submission": "SUPPL-1",
  "activeIngredients": "AMBRISENTAN",
  "company": "APOTEX",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/19\/2024",
  "drugName": "AMBRISENTANANDA  #210715",
  "submission": "SUPPL-9",
  "activeIngredients": "AMBRISENTAN",
  "company": "CIPLA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/19\/2024",
  "drugName": "AMBRISENTANANDA  #210784",
  "submission": "SUPPL-10",
  "activeIngredients": "AMBRISENTAN",
  "company": "SUN PHARM",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/19\/2024",
  "drugName": "LABETALOL HYDROCHLORIDENDA   #213330",
  "submission": "SUPPL-6",
  "activeIngredients": "LABETALOL HYDROCHLORIDE",
  "company": "HIKMA",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/19\/2024",
  "drugName": "LABETALOL HYDROCHLORIDE IN DEXTROSENDA   #213330",
  "submission": "SUPPL-6",
  "activeIngredients": "LABETALOL HYDROCHLORIDE",
  "company": "HIKMA",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/19\/2024",
  "drugName": "LABETALOL HYDROCHLORIDE IN SODIUM CHLORIDENDA   #213330",
  "submission": "SUPPL-6",
  "activeIngredients": "LABETALOL HYDROCHLORIDE",
  "company": "HIKMA",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/19\/2024",
  "drugName": "GLYCOPYRROLATEANDA  #214735",
  "submission": "ORIG-1",
  "activeIngredients": "GLYCOPYRROLATE",
  "company": "GRANULES",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/19\/2024",
  "drugName": "GADOBUTROLANDA  #216081",
  "submission": "SUPPL-4",
  "activeIngredients": "GADOBUTROL",
  "company": "HENGRUI PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/19\/2024",
  "drugName": "FONDAPARINUX SODIUMANDA  #216493",
  "submission": "ORIG-1",
  "activeIngredients": "FONDAPARINUX SODIUM",
  "company": "HANGZHOU ZHONGMEI",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/19\/2024",
  "drugName": "AMBRISENTANANDA  #216531",
  "submission": "SUPPL-1",
  "activeIngredients": "AMBRISENTAN",
  "company": "AUROBINDO PHARMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/19\/2024",
  "drugName": "CUPRIC SULFATEANDA  #218745",
  "submission": "ORIG-1",
  "activeIngredients": "CUPRIC SULFATE",
  "company": "APOTEX CORP",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/19\/2024",
  "drugName": "LAZCLUZENDA   #219008",
  "submission": "ORIG-1",
  "activeIngredients": "LAZERTINIB MESYLATE",
  "company": "JANSSEN BIOTECH",
  "submissionClassification": "Type 1 - New Molecular Entity",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/19\/2024",
  "drugName": "BRIVARACETAMANDA  #219010",
  "submission": "ORIG-1",
  "activeIngredients": "BRIVARACETAM",
  "company": "ZHEJIANG POLY PHARM CO LTD",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "08\/19\/2024",
  "drugName": "RYBREVANTBLA   #761210",
  "submission": "SUPPL-5",
  "activeIngredients": "AMIVANTAMAB-VMJW",
  "company": "JANSSEN BIOTECH",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/20\/2024",
  "drugName": "FAMOTIDINE PRESERVATIVE FREE IN PLASTIC CONTAINERANDA  #075591",
  "submission": "SUPPL-12",
  "activeIngredients": "FAMOTIDINE",
  "company": "BAXTER HLTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/20\/2024",
  "drugName": "ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDEANDA  #075624",
  "submission": "SUPPL-30",
  "activeIngredients": "ENALAPRIL MALEATE; HYDROCHLOROTHIAZIDE",
  "company": "RISING",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/20\/2024",
  "drugName": "TALTZBLA   #125521",
  "submission": "SUPPL-32",
  "activeIngredients": "IXEKIZUMAB",
  "company": "ELI LILLY AND CO",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/20\/2024",
  "drugName": "REPATHABLA   #125522",
  "submission": "SUPPL-43",
  "activeIngredients": "EVOLOCUMAB",
  "company": "AMGEN INC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/20\/2024",
  "drugName": "PRASUGRELANDA  #205913",
  "submission": "SUPPL-13",
  "activeIngredients": "PRASUGREL HYDROCHLORIDE",
  "company": "AMNEAL PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/20\/2024",
  "drugName": "PITAVASTATIN CALCIUMANDA  #205961",
  "submission": "ORIG-1",
  "activeIngredients": "PITAVASTATIN CALCIUM",
  "company": "AMNEAL PHARMS NY",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/20\/2024",
  "drugName": "CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDEANDA  #209610",
  "submission": "ORIG-1",
  "activeIngredients": "BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE",
  "company": "PADAGIS ISRAEL",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/20\/2024",
  "drugName": "THIOTEPAANDA  #217559",
  "submission": "ORIG-1",
  "activeIngredients": "THIOTEPA",
  "company": "REGCON HOLDINGS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/20\/2024",
  "drugName": "LOFEXIDINE HYDROCHLORIDEANDA  #218613",
  "submission": "ORIG-1",
  "activeIngredients": "LOFEXIDINE HYDROCHLORIDE",
  "company": "REGCON HOLDINGS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/20\/2024",
  "drugName": "AMJEVITABLA   #761024",
  "submission": "SUPPL-19",
  "activeIngredients": "ADALIMUMAB-ATTO",
  "company": "AMGEN INC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/21\/2024",
  "drugName": "DEXMETHYLPHENIDATE HYDROCHLORIDEANDA  #078908",
  "submission": "SUPPL-14",
  "activeIngredients": "DEXMETHYLPHENIDATE HYDROCHLORIDE",
  "company": "TEVA PHARMS USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/21\/2024",
  "drugName": "DEXMETHYLPHENIDATE HYDROCHLORIDEANDA  #078908",
  "submission": "SUPPL-18",
  "activeIngredients": "DEXMETHYLPHENIDATE HYDROCHLORIDE",
  "company": "TEVA PHARMS USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/21\/2024",
  "drugName": "DEXMETHYLPHENIDATE HYDROCHLORIDEANDA  #078908",
  "submission": "SUPPL-22",
  "activeIngredients": "DEXMETHYLPHENIDATE HYDROCHLORIDE",
  "company": "TEVA PHARMS USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/21\/2024",
  "drugName": "DEXMETHYLPHENIDATE HYDROCHLORIDEANDA  #202731",
  "submission": "SUPPL-11",
  "activeIngredients": "DEXMETHYLPHENIDATE HYDROCHLORIDE",
  "company": "TEVA PHARMS USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/21\/2024",
  "drugName": "DEXMETHYLPHENIDATE HYDROCHLORIDEANDA  #202731",
  "submission": "SUPPL-15",
  "activeIngredients": "DEXMETHYLPHENIDATE HYDROCHLORIDE",
  "company": "TEVA PHARMS USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/21\/2024",
  "drugName": "DEXMETHYLPHENIDATE HYDROCHLORIDEANDA  #202731",
  "submission": "SUPPL-19",
  "activeIngredients": "DEXMETHYLPHENIDATE HYDROCHLORIDE",
  "company": "TEVA PHARMS USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/21\/2024",
  "drugName": "DEXMETHYLPHENIDATE HYDROCHLORIDEANDA  #203614",
  "submission": "SUPPL-3",
  "activeIngredients": "DEXMETHYLPHENIDATE HYDROCHLORIDE",
  "company": "IMPAX LABS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/21\/2024",
  "drugName": "DEXMETHYLPHENIDATE HYDROCHLORIDEANDA  #203614",
  "submission": "SUPPL-6",
  "activeIngredients": "DEXMETHYLPHENIDATE HYDROCHLORIDE",
  "company": "IMPAX LABS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/21\/2024",
  "drugName": "DEXMETHYLPHENIDATE HYDROCHLORIDEANDA  #203614",
  "submission": "SUPPL-7",
  "activeIngredients": "DEXMETHYLPHENIDATE HYDROCHLORIDE",
  "company": "IMPAX LABS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/21\/2024",
  "drugName": "DEXMETHYLPHENIDATE HYDROCHLORIDEANDA  #203614",
  "submission": "SUPPL-12",
  "activeIngredients": "DEXMETHYLPHENIDATE HYDROCHLORIDE",
  "company": "IMPAX LABS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/21\/2024",
  "drugName": "HYDRALAZINE HYDROCHLORIDEANDA  #211010",
  "submission": "ORIG-1",
  "activeIngredients": "HYDRALAZINE HYDROCHLORIDE",
  "company": "MACLEODS PHARMS LTD",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/21\/2024",
  "drugName": "OLMESARTAN MEDOXOMILANDA  #211049",
  "submission": "SUPPL-3",
  "activeIngredients": "OLMESARTAN MEDOXOMIL",
  "company": "SUNSHINE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/21\/2024",
  "drugName": "DIGOXINANDA  #214982",
  "submission": "SUPPL-1",
  "activeIngredients": "DIGOXIN",
  "company": "AUROBINDO PHARMA LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/21\/2024",
  "drugName": "LURASIDONE HYDROCHLORIDEANDA  #218174",
  "submission": "ORIG-1",
  "activeIngredients": "LURASIDONE HYDROCHLORIDE",
  "company": "ANNORA PHARMA",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/22\/2024",
  "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #040777",
  "submission": "SUPPL-29",
  "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
  "company": "AMNEAL PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/22\/2024",
  "drugName": "AMPICILLIN AND SULBACTAMANDA  #065310",
  "submission": "SUPPL-28",
  "activeIngredients": "AMPICILLIN SODIUM; SULBACTAM SODIUM",
  "company": "SANDOZ",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/22\/2024",
  "drugName": "SUFENTANIL CITRATEANDA  #074534",
  "submission": "SUPPL-20",
  "activeIngredients": "SUFENTANIL CITRATE",
  "company": "HOSPIRA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/22\/2024",
  "drugName": "NAPROXEN SODIUMANDA  #075416",
  "submission": "SUPPL-20",
  "activeIngredients": "NAPROXEN SODIUM",
  "company": "ACTAVIS LABS FL INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/22\/2024",
  "drugName": "BUPROPION HYDROCHLORIDEANDA  #076143",
  "submission": "SUPPL-34",
  "activeIngredients": "BUPROPION HYDROCHLORIDE",
  "company": "APOTEX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/22\/2024",
  "drugName": "HYDROCHLOROTHIAZIDEANDA  #078391",
  "submission": "SUPPL-14",
  "activeIngredients": "HYDROCHLOROTHIAZIDE",
  "company": "JUBILANT CADISTA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/22\/2024",
  "drugName": "BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDEANDA  #078794",
  "submission": "SUPPL-6",
  "activeIngredients": "BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE",
  "company": "APOTEX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/22\/2024",
  "drugName": "AMPICILLIN AND SULBACTAMANDA  #090340",
  "submission": "SUPPL-11",
  "activeIngredients": "AMPICILLIN SODIUM; SULBACTAM SODIUM",
  "company": "EUGIA PHARMA SPECLTS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/22\/2024",
  "drugName": "AMPICILLIN AND SULBACTAMANDA  #090349",
  "submission": "SUPPL-14",
  "activeIngredients": "AMPICILLIN SODIUM; SULBACTAM SODIUM",
  "company": "EUGIA PHARMA SPECLTS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/22\/2024",
  "drugName": "FINASTERIDEANDA  #091643",
  "submission": "SUPPL-7",
  "activeIngredients": "FINASTERIDE",
  "company": "ACCORD HLTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/22\/2024",
  "drugName": "FINASTERIDEANDA  #091643",
  "submission": "SUPPL-8",
  "activeIngredients": "FINASTERIDE",
  "company": "ACCORD HLTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/22\/2024",
  "drugName": "FINASTERIDEANDA  #091643",
  "submission": "SUPPL-11",
  "activeIngredients": "FINASTERIDE",
  "company": "ACCORD HLTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/22\/2024",
  "drugName": "QUININE SULFATEANDA  #091661",
  "submission": "SUPPL-9",
  "activeIngredients": "QUININE SULFATE",
  "company": "TEVA PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/22\/2024",
  "drugName": "LINEZOLIDANDA  #200068",
  "submission": "SUPPL-9",
  "activeIngredients": "LINEZOLID",
  "company": "HIKMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/22\/2024",
  "drugName": "LINEZOLIDANDA  #200068",
  "submission": "SUPPL-10",
  "activeIngredients": "LINEZOLID",
  "company": "HIKMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/22\/2024",
  "drugName": "PENTOSTATINANDA  #203554",
  "submission": "SUPPL-2",
  "activeIngredients": "PENTOSTATIN",
  "company": "RISING",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/22\/2024",
  "drugName": "FENOFIBRATEANDA  #205118",
  "submission": "SUPPL-10",
  "activeIngredients": "FENOFIBRATE",
  "company": "AUROBINDO PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/22\/2024",
  "drugName": "NATEGLINIDEANDA  #205248",
  "submission": "SUPPL-6",
  "activeIngredients": "NATEGLINIDE",
  "company": "ZYDUS PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/22\/2024",
  "drugName": "NEVIRAPINEANDA  #205651",
  "submission": "SUPPL-7",
  "activeIngredients": "NEVIRAPINE",
  "company": "MYLAN",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/22\/2024",
  "drugName": "MESALAMINEANDA  #205654",
  "submission": "SUPPL-1",
  "activeIngredients": "MESALAMINE",
  "company": "ACTAVIS MID ATLANTIC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/22\/2024",
  "drugName": "MESALAMINEANDA  #205654",
  "submission": "SUPPL-3",
  "activeIngredients": "MESALAMINE",
  "company": "ACTAVIS MID ATLANTIC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/22\/2024",
  "drugName": "MESALAMINEANDA  #205654",
  "submission": "SUPPL-4",
  "activeIngredients": "MESALAMINE",
  "company": "ACTAVIS MID ATLANTIC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/22\/2024",
  "drugName": "TADALAFILANDA  #205885",
  "submission": "SUPPL-2",
  "activeIngredients": "TADALAFIL",
  "company": "WATSON LABS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/22\/2024",
  "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #207419",
  "submission": "SUPPL-13",
  "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
  "company": "ASCENT PHARMS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/22\/2024",
  "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #207419",
  "submission": "SUPPL-15",
  "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
  "company": "ASCENT PHARMS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/22\/2024",
  "drugName": "ABIRATERONE ACETATEANDA  #208339",
  "submission": "SUPPL-8",
  "activeIngredients": "ABIRATERONE ACETATE",
  "company": "HIKMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/22\/2024",
  "drugName": "PRAZIQUANTELANDA  #208820",
  "submission": "SUPPL-3",
  "activeIngredients": "PRAZIQUANTEL",
  "company": "PH HEALTH",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/22\/2024",
  "drugName": "TERIFLUNOMIDEANDA  #209702",
  "submission": "SUPPL-3",
  "activeIngredients": "TERIFLUNOMIDE",
  "company": "SOMERSET THERAPS LLC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/22\/2024",
  "drugName": "ISOPROTERENOL HYDROCHLORIDEANDA  #210576",
  "submission": "SUPPL-8",
  "activeIngredients": "ISOPROTERENOL HYDROCHLORIDE",
  "company": "AMNEAL",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/22\/2024",
  "drugName": "MESALAMINEANDA  #213191",
  "submission": "ORIG-1",
  "activeIngredients": "MESALAMINE",
  "company": "TEVA PHARMS INC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/22\/2024",
  "drugName": "SACUBITRIL AND VALSARTANANDA  #213604",
  "submission": "ORIG-1",
  "activeIngredients": "SACUBITRIL; VALSARTAN",
  "company": "TORRENT",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/22\/2024",
  "drugName": "POTASSIUM CHLORIDEANDA  #215725",
  "submission": "SUPPL-5",
  "activeIngredients": "POTASSIUM CHLORIDE",
  "company": "RUBICON RESEARCH",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/22\/2024",
  "drugName": "BETAMETHASONE VALERATEANDA  #215832",
  "submission": "ORIG-1",
  "activeIngredients": "BETAMETHASONE VALERATE",
  "company": "ALEMBIC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/22\/2024",
  "drugName": "RILUZOLEANDA  #216035",
  "submission": "ORIG-1",
  "activeIngredients": "RILUZOLE",
  "company": "ALKEM LABS LTD",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/22\/2024",
  "drugName": "REGADENOSONANDA  #218054",
  "submission": "ORIG-1",
  "activeIngredients": "REGADENOSON",
  "company": "INDIES PHARMA",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/22\/2024",
  "drugName": "MESALAMINEANDA  #218410",
  "submission": "ORIG-1",
  "activeIngredients": "MESALAMINE",
  "company": "NOVAST LABS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/22\/2024",
  "drugName": "BEYFORTUSBLA   #761328",
  "submission": "SUPPL-5",
  "activeIngredients": "NIRSEVIMAB-ALIP",
  "company": "ASTRAZENECA AB",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/23\/2024",
  "drugName": "INFASURF PRESERVATIVE FREEBLA   #020521",
  "submission": "SUPPL-38",
  "activeIngredients": "CALFACTANT",
  "company": "ONY",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/23\/2024",
  "drugName": "METOPROLOL TARTRATEANDA  #074141",
  "submission": "SUPPL-37",
  "activeIngredients": "METOPROLOL TARTRATE",
  "company": "HERITAGE PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/23\/2024",
  "drugName": "NADOLOLANDA  #074172",
  "submission": "SUPPL-19",
  "activeIngredients": "NADOLOL",
  "company": "RISING",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/23\/2024",
  "drugName": "INDAPAMIDEANDA  #074461",
  "submission": "SUPPL-16",
  "activeIngredients": "INDAPAMIDE",
  "company": "RISING",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/23\/2024",
  "drugName": "METOPROLOL TARTRATEANDA  #074644",
  "submission": "SUPPL-55",
  "activeIngredients": "METOPROLOL TARTRATE",
  "company": "SUN PHARM INDS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/23\/2024",
  "drugName": "CARVEDILOLANDA  #076373",
  "submission": "SUPPL-19",
  "activeIngredients": "CARVEDILOL",
  "company": "TEVA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/23\/2024",
  "drugName": "METOPROLOL TARTRATEANDA  #076670",
  "submission": "SUPPL-35",
  "activeIngredients": "METOPROLOL TARTRATE",
  "company": "SUN PHARM INDS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/23\/2024",
  "drugName": "PROPRANOLOL HYDROCHLORIDEANDA  #078022",
  "submission": "SUPPL-8",
  "activeIngredients": "PROPRANOLOL HYDROCHLORIDE",
  "company": "EXTROVIS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/23\/2024",
  "drugName": "INVOKANANDA   #204042",
  "submission": "SUPPL-41",
  "activeIngredients": "CANAGLIFLOZIN",
  "company": "JANSSEN PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/23\/2024",
  "drugName": "INVOKANANDA   #204042",
  "submission": "SUPPL-42",
  "activeIngredients": "CANAGLIFLOZIN",
  "company": "JANSSEN PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/23\/2024",
  "drugName": "INVOKAMETNDA   #204353",
  "submission": "SUPPL-45",
  "activeIngredients": "CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE",
  "company": "JANSSEN PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/23\/2024",
  "drugName": "INVOKAMET XRNDA   #205879",
  "submission": "SUPPL-22",
  "activeIngredients": "CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE",
  "company": "JANSSEN PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/23\/2024",
  "drugName": "PREGABALINANDA  #206752",
  "submission": "SUPPL-3",
  "activeIngredients": "PREGABALIN",
  "company": "ZYDUS PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/23\/2024",
  "drugName": "TEMOZOLOMIDEANDA  #207658",
  "submission": "SUPPL-4",
  "activeIngredients": "TEMOZOLOMIDE",
  "company": "DEVA HOLDING AS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/23\/2024",
  "drugName": "PREGABALINANDA  #207883",
  "submission": "SUPPL-4",
  "activeIngredients": "PREGABALIN",
  "company": "PRINSTON INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/23\/2024",
  "drugName": "TEMOZOLOMIDEANDA  #210030",
  "submission": "ORIG-1",
  "activeIngredients": "TEMOZOLOMIDE",
  "company": "HETERO LABS LTD V",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/23\/2024",
  "drugName": "ACETAMINOPHEN AND IBUPROFENANDA  #218247",
  "submission": "ORIG-1",
  "activeIngredients": "ACETAMINOPHEN; IBUPROFEN",
  "company": "DR REDDYS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/23\/2024",
  "drugName": "PAVBLUBLA   #761298",
  "submission": "ORIG-1",
  "activeIngredients": "AFLIBERCEPT-AYYH",
  "company": "AMGEN INC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/26\/2024",
  "drugName": "VFENDNDA   #021630",
  "submission": "SUPPL-46",
  "activeIngredients": "VORICONAZOLE",
  "company": "PF PRISM CV",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/26\/2024",
  "drugName": "KUVANNDA   #022181",
  "submission": "SUPPL-24",
  "activeIngredients": "SAPROPTERIN DIHYDROCHLORIDE",
  "company": "BIOMARIN PHARM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/26\/2024",
  "drugName": "CEFAZOLIN AND DEXTROSENDA   #050779",
  "submission": "SUPPL-34",
  "activeIngredients": "CEFAZOLIN SODIUM",
  "company": "B BRAUN",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/26\/2024",
  "drugName": "DOXYCYCLINEANDA  #065055",
  "submission": "SUPPL-19",
  "activeIngredients": "DOXYCYCLINE",
  "company": "STRIDES PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/26\/2024",
  "drugName": "DOXYCYCLINEANDA  #065055",
  "submission": "SUPPL-21",
  "activeIngredients": "DOXYCYCLINE",
  "company": "STRIDES PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/26\/2024",
  "drugName": "DOXYCYCLINEANDA  #065055",
  "submission": "SUPPL-22",
  "activeIngredients": "DOXYCYCLINE",
  "company": "STRIDES PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/26\/2024",
  "drugName": "DOXYCYCLINEANDA  #065055",
  "submission": "SUPPL-27",
  "activeIngredients": "DOXYCYCLINE",
  "company": "STRIDES PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/26\/2024",
  "drugName": "DOXYCYCLINEANDA  #065070",
  "submission": "SUPPL-32",
  "activeIngredients": "DOXYCYCLINE",
  "company": "STRIDES PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/26\/2024",
  "drugName": "KETOROLAC TROMETHAMINEANDA  #075784",
  "submission": "SUPPL-24",
  "activeIngredients": "KETOROLAC TROMETHAMINE",
  "company": "FRESENIUS KABI USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/26\/2024",
  "drugName": "KETOROLAC TROMETHAMINEANDA  #075784",
  "submission": "SUPPL-25",
  "activeIngredients": "KETOROLAC TROMETHAMINE",
  "company": "FRESENIUS KABI USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/26\/2024",
  "drugName": "FLUCONAZOLEANDA  #076957",
  "submission": "SUPPL-20",
  "activeIngredients": "FLUCONAZOLE",
  "company": "THINQ PHARM-CRO PVT",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/26\/2024",
  "drugName": "BUPROPION HYDROCHLORIDEANDA  #200216",
  "submission": "SUPPL-5",
  "activeIngredients": "BUPROPION HYDROCHLORIDE",
  "company": "SUN PHARM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/26\/2024",
  "drugName": "ADAPALENEANDA  #201000",
  "submission": "SUPPL-7",
  "activeIngredients": "ADAPALENE",
  "company": "ACTAVIS MID ATLANTIC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/26\/2024",
  "drugName": "DOCETAXELNDA   #203551",
  "submission": "SUPPL-12",
  "activeIngredients": "DOCETAXEL",
  "company": "ACTAVIS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/26\/2024",
  "drugName": "KUVANNDA   #205065",
  "submission": "SUPPL-8",
  "activeIngredients": "SAPROPTERIN DIHYDROCHLORIDE",
  "company": "BIOMARIN PHARM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/26\/2024",
  "drugName": "LEVETIRACETAMANDA  #205130",
  "submission": "SUPPL-5",
  "activeIngredients": "LEVETIRACETAM",
  "company": "SCIEGEN PHARMS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/26\/2024",
  "drugName": "ESTRADIOLANDA  #206241",
  "submission": "SUPPL-4",
  "activeIngredients": "ESTRADIOL",
  "company": "ZYDUS PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/26\/2024",
  "drugName": "VORICONAZOLEANDA  #207371",
  "submission": "SUPPL-5",
  "activeIngredients": "VORICONAZOLE",
  "company": "CHARTWELL RX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/26\/2024",
  "drugName": "VORICONAZOLEANDA  #207371",
  "submission": "SUPPL-6",
  "activeIngredients": "VORICONAZOLE",
  "company": "CHARTWELL RX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/26\/2024",
  "drugName": "VORICONAZOLEANDA  #207371",
  "submission": "SUPPL-8",
  "activeIngredients": "VORICONAZOLE",
  "company": "CHARTWELL RX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/26\/2024",
  "drugName": "METHYLNALTREXONE BROMIDEANDA  #208112",
  "submission": "ORIG-1",
  "activeIngredients": "METHYLNALTREXONE BROMIDE",
  "company": "ACTAVIS LLC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/26\/2024",
  "drugName": "LEVOTHYROXINE SODIUMANDA  #210831",
  "submission": "SUPPL-4",
  "activeIngredients": "LEVOTHYROXINE SODIUM",
  "company": "AMNEAL",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/26\/2024",
  "drugName": "ESTRADIOLANDA  #211293",
  "submission": "SUPPL-11",
  "activeIngredients": "ESTRADIOL",
  "company": "AMNEAL",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/26\/2024",
  "drugName": "BORTEZOMIBNDA   #212782",
  "submission": "ORIG-1",
  "activeIngredients": "BORTEZOMIB",
  "company": "SHILPA",
  "submissionClassification": "Type 5 - New Formulation or New Manufacturer",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/26\/2024",
  "drugName": "ROSZETNDA   #213072",
  "submission": "SUPPL-4",
  "activeIngredients": "EZETIMIBE; ROSUVASTATIN CALCIUM",
  "company": "ALTHERA PHARMS",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/26\/2024",
  "drugName": "BRIMONIDINE TARTRATEANDA  #213215",
  "submission": "ORIG-1",
  "activeIngredients": "BRIMONIDINE TARTRATE",
  "company": "LUPIN LTD",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/26\/2024",
  "drugName": "DAPSONEANDA  #213636",
  "submission": "ORIG-1",
  "activeIngredients": "DAPSONE",
  "company": "TP ANDA HOLDINGS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/26\/2024",
  "drugName": "AMANTADINEANDA  #214897",
  "submission": "ORIG-1",
  "activeIngredients": "AMANTADINE",
  "company": "ZYDUS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/26\/2024",
  "drugName": "AMANTADINEANDA  #214897",
  "submission": "ORIG-2",
  "activeIngredients": "AMANTADINE",
  "company": "ZYDUS",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "08\/26\/2024",
  "drugName": "AMANTADINE HYDROCHLORIDEANDA  #214897",
  "submission": "ORIG-1",
  "activeIngredients": "AMANTADINE HYDROCHLORIDE",
  "company": "ZYDUS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/26\/2024",
  "drugName": "AMANTADINE HYDROCHLORIDEANDA  #214897",
  "submission": "ORIG-2",
  "activeIngredients": "AMANTADINE HYDROCHLORIDE",
  "company": "ZYDUS",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "08\/26\/2024",
  "drugName": "SIMLANDIBLA   #761299",
  "submission": "SUPPL-3",
  "activeIngredients": "ADALIMUMAB-RYVK",
  "company": "ALVOTECH USA INC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/26\/2024",
  "drugName": "SIMLANDIBLA   #761299",
  "submission": "SUPPL-6",
  "activeIngredients": "ADALIMUMAB-RYVK",
  "company": "ALVOTECH USA INC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/27\/2024",
  "drugName": "METHOTREXATE PRESERVATIVE FREEANDA  #040266",
  "submission": "SUPPL-22",
  "activeIngredients": "METHOTREXATE SODIUM",
  "company": "FRESENIUS KABI USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/27\/2024",
  "drugName": "NALBUPHINE HYDROCHLORIDEANDA  #070914",
  "submission": "SUPPL-26",
  "activeIngredients": "NALBUPHINE HYDROCHLORIDE",
  "company": "HOSPIRA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/27\/2024",
  "drugName": "NALBUPHINE HYDROCHLORIDEANDA  #070915",
  "submission": "SUPPL-36",
  "activeIngredients": "NALBUPHINE HYDROCHLORIDE",
  "company": "HOSPIRA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/27\/2024",
  "drugName": "NALBUPHINE HYDROCHLORIDEANDA  #070916",
  "submission": "SUPPL-25",
  "activeIngredients": "NALBUPHINE HYDROCHLORIDE",
  "company": "HOSPIRA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/27\/2024",
  "drugName": "NALBUPHINE HYDROCHLORIDEANDA  #070918",
  "submission": "SUPPL-36",
  "activeIngredients": "NALBUPHINE HYDROCHLORIDE",
  "company": "HOSPIRA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/27\/2024",
  "drugName": "METHADONE HYDROCHLORIDEANDA  #075082",
  "submission": "SUPPL-7",
  "activeIngredients": "METHADONE HYDROCHLORIDE",
  "company": "VISTAPHARM LLC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/27\/2024",
  "drugName": "METHADONE HYDROCHLORIDEANDA  #075082",
  "submission": "SUPPL-9",
  "activeIngredients": "METHADONE HYDROCHLORIDE",
  "company": "VISTAPHARM LLC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/27\/2024",
  "drugName": "METHADONE HYDROCHLORIDEANDA  #075082",
  "submission": "SUPPL-14",
  "activeIngredients": "METHADONE HYDROCHLORIDE",
  "company": "VISTAPHARM LLC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/27\/2024",
  "drugName": "METHADONE HYDROCHLORIDEANDA  #075082",
  "submission": "SUPPL-15",
  "activeIngredients": "METHADONE HYDROCHLORIDE",
  "company": "VISTAPHARM LLC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/27\/2024",
  "drugName": "METHADONE HYDROCHLORIDEANDA  #075082",
  "submission": "SUPPL-17",
  "activeIngredients": "METHADONE HYDROCHLORIDE",
  "company": "VISTAPHARM LLC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/27\/2024",
  "drugName": "RISPERIDONEANDA  #076879",
  "submission": "SUPPL-9",
  "activeIngredients": "RISPERIDONE",
  "company": "DR REDDYS LABS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/27\/2024",
  "drugName": "RISPERIDONEANDA  #076879",
  "submission": "SUPPL-10",
  "activeIngredients": "RISPERIDONE",
  "company": "DR REDDYS LABS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/27\/2024",
  "drugName": "RISPERIDONEANDA  #077860",
  "submission": "SUPPL-5",
  "activeIngredients": "RISPERIDONE",
  "company": "WATSON LABS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/27\/2024",
  "drugName": "RALOXIFENE HYDROCHLORIDEANDA  #078193",
  "submission": "SUPPL-14",
  "activeIngredients": "RALOXIFENE HYDROCHLORIDE",
  "company": "TEVA PHARMS USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/27\/2024",
  "drugName": "OXALIPLATINANDA  #078811",
  "submission": "SUPPL-27",
  "activeIngredients": "OXALIPLATIN",
  "company": "FRESENIUS KABI USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/27\/2024",
  "drugName": "LEVETIRACETAMANDA  #091557",
  "submission": "SUPPL-12",
  "activeIngredients": "LEVETIRACETAM",
  "company": "ACTAVIS ELIZABETH",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/27\/2024",
  "drugName": "LEVETIRACETAMANDA  #091557",
  "submission": "SUPPL-13",
  "activeIngredients": "LEVETIRACETAM",
  "company": "ACTAVIS ELIZABETH",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/27\/2024",
  "drugName": "LEVETIRACETAMANDA  #200475",
  "submission": "SUPPL-12",
  "activeIngredients": "LEVETIRACETAM",
  "company": "AUROBINDO PHARMA USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/27\/2024",
  "drugName": "HYDROXYCHLOROQUINE SULFATEANDA  #201691",
  "submission": "SUPPL-8",
  "activeIngredients": "HYDROXYCHLOROQUINE SULFATE",
  "company": "ALKALOIDA ZRT",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/27\/2024",
  "drugName": "LITHIUM CARBONATEANDA  #202288",
  "submission": "SUPPL-14",
  "activeIngredients": "LITHIUM CARBONATE",
  "company": "PHARMOBEDIENT",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/27\/2024",
  "drugName": "NEBIVOLOL HYDROCHLORIDEANDA  #203828",
  "submission": "SUPPL-10",
  "activeIngredients": "NEBIVOLOL HYDROCHLORIDE",
  "company": "INDCHEMIE HEALTH",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/27\/2024",
  "drugName": "FESOTERODINE FUMARATEANDA  #204975",
  "submission": "SUPPL-1",
  "activeIngredients": "FESOTERODINE FUMARATE",
  "company": "DR REDDYS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/27\/2024",
  "drugName": "FESOTERODINE FUMARATEANDA  #204975",
  "submission": "SUPPL-2",
  "activeIngredients": "FESOTERODINE FUMARATE",
  "company": "DR REDDYS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/27\/2024",
  "drugName": "VELPHORONDA   #205109",
  "submission": "SUPPL-10",
  "activeIngredients": "FERRIC OXYHYDROXIDE",
  "company": "VIFOR FRESENIUS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/27\/2024",
  "drugName": "OXALIPLATINANDA  #205529",
  "submission": "SUPPL-4",
  "activeIngredients": "OXALIPLATIN",
  "company": "EUGIA PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/27\/2024",
  "drugName": "DOXEPIN HYDROCHLORIDEANDA  #210675",
  "submission": "SUPPL-3",
  "activeIngredients": "DOXEPIN HYDROCHLORIDE",
  "company": "EPIC PHARMA LLC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/27\/2024",
  "drugName": "DOXEPIN HYDROCHLORIDEANDA  #210675",
  "submission": "SUPPL-4",
  "activeIngredients": "DOXEPIN HYDROCHLORIDE",
  "company": "EPIC PHARMA LLC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/27\/2024",
  "drugName": "PALBOCICLIBANDA  #213088",
  "submission": "ORIG-1",
  "activeIngredients": "PALBOCICLIB",
  "company": "TEVA PHARMS USA INC",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "08\/27\/2024",
  "drugName": "CYCLOBENZAPRINE HYDROCHLORIDEANDA  #214732",
  "submission": "ORIG-1",
  "activeIngredients": "CYCLOBENZAPRINE HYDROCHLORIDE",
  "company": "NOVAST LABS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/27\/2024",
  "drugName": "CUPRIC SULFATEANDA  #216324",
  "submission": "SUPPL-2",
  "activeIngredients": "CUPRIC SULFATE",
  "company": "AM REGENT",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/27\/2024",
  "drugName": "CISATRACURIUM BESYLATE PRESERVATIVE FREEANDA  #216539",
  "submission": "ORIG-1",
  "activeIngredients": "CISATRACURIUM BESYLATE",
  "company": "HAINAN POLY",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/27\/2024",
  "drugName": "TOLTERODINE TARTRATEANDA  #216917",
  "submission": "ORIG-1",
  "activeIngredients": "TOLTERODINE TARTRATE",
  "company": "UNICHEM",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/27\/2024",
  "drugName": "TRAZODONE HYDROCHLORIDEANDA  #217740",
  "submission": "ORIG-1",
  "activeIngredients": "TRAZODONE HYDROCHLORIDE",
  "company": "GRAVITI PHARMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/28\/2024",
  "drugName": "ACTIQNDA   #020747",
  "submission": "SUPPL-64",
  "activeIngredients": "FENTANYL CITRATE",
  "company": "CEPHALON",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/28\/2024",
  "drugName": "AMPHADASEBLA   #021665",
  "submission": "SUPPL-7",
  "activeIngredients": "HYALURONIDASE",
  "company": "AMPHASTAR PHARM",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/28\/2024",
  "drugName": "FENTORANDA   #021947",
  "submission": "SUPPL-45",
  "activeIngredients": "FENTANYL CITRATE",
  "company": "CEPHALON",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/28\/2024",
  "drugName": "DESMOPRESSIN ACETATEANDA  #074888",
  "submission": "SUPPL-30",
  "activeIngredients": "DESMOPRESSIN ACETATE",
  "company": "MEITHEAL",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/28\/2024",
  "drugName": "CLONAZEPAMANDA  #074940",
  "submission": "SUPPL-7",
  "activeIngredients": "CLONAZEPAM",
  "company": "PHARMOBEDIENT",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/28\/2024",
  "drugName": "LEVOFLOXACINANDA  #076276",
  "submission": "SUPPL-10",
  "activeIngredients": "LEVOFLOXACIN",
  "company": "NATCO PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/28\/2024",
  "drugName": "LEVETIRACETAMANDA  #079063",
  "submission": "SUPPL-15",
  "activeIngredients": "LEVETIRACETAM",
  "company": "AUROBINDO PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/28\/2024",
  "drugName": "LEVETIRACETAMANDA  #079063",
  "submission": "SUPPL-16",
  "activeIngredients": "LEVETIRACETAM",
  "company": "AUROBINDO PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/28\/2024",
  "drugName": "LEVETIRACETAMANDA  #079063",
  "submission": "SUPPL-19",
  "activeIngredients": "LEVETIRACETAM",
  "company": "AUROBINDO PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/28\/2024",
  "drugName": "LEVETIRACETAMANDA  #079063",
  "submission": "SUPPL-22",
  "activeIngredients": "LEVETIRACETAM",
  "company": "AUROBINDO PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/28\/2024",
  "drugName": "LEVETIRACETAMANDA  #079063",
  "submission": "SUPPL-23",
  "activeIngredients": "LEVETIRACETAM",
  "company": "AUROBINDO PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/28\/2024",
  "drugName": "LEVETIRACETAMANDA  #079063",
  "submission": "SUPPL-26",
  "activeIngredients": "LEVETIRACETAM",
  "company": "AUROBINDO PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/28\/2024",
  "drugName": "LEVETIRACETAMANDA  #079063",
  "submission": "SUPPL-30",
  "activeIngredients": "LEVETIRACETAM",
  "company": "AUROBINDO PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/28\/2024",
  "drugName": "LEVETIRACETAMANDA  #079063",
  "submission": "SUPPL-32",
  "activeIngredients": "LEVETIRACETAM",
  "company": "AUROBINDO PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/28\/2024",
  "drugName": "FENTANYL CITRATEANDA  #079075",
  "submission": "SUPPL-18",
  "activeIngredients": "FENTANYL CITRATE",
  "company": "WATSON LABS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/28\/2024",
  "drugName": "CISATRACURIUM BESYLATE PRESERVATIVE FREEANDA  #200154",
  "submission": "SUPPL-13",
  "activeIngredients": "CISATRACURIUM BESYLATE",
  "company": "SANDOZ INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/28\/2024",
  "drugName": "CISATRACURIUM BESYLATEANDA  #200159",
  "submission": "SUPPL-11",
  "activeIngredients": "CISATRACURIUM BESYLATE",
  "company": "SANDOZ INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/28\/2024",
  "drugName": "NYMALIZENDA   #203340",
  "submission": "SUPPL-19",
  "activeIngredients": "NIMODIPINE",
  "company": "AZURITY",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/28\/2024",
  "drugName": "PREGABALINANDA  #203459",
  "submission": "SUPPL-14",
  "activeIngredients": "PREGABALIN",
  "company": "ALEMBIC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/28\/2024",
  "drugName": "DOXORUBICIN HYDROCHLORIDEANDA  #203622",
  "submission": "SUPPL-4",
  "activeIngredients": "DOXORUBICIN HYDROCHLORIDE",
  "company": "ACTAVIS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/28\/2024",
  "drugName": "DOXORUBICIN HYDROCHLORIDEANDA  #203622",
  "submission": "SUPPL-5",
  "activeIngredients": "DOXORUBICIN HYDROCHLORIDE",
  "company": "ACTAVIS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/28\/2024",
  "drugName": "DOXORUBICIN HYDROCHLORIDEANDA  #203622",
  "submission": "SUPPL-9",
  "activeIngredients": "DOXORUBICIN HYDROCHLORIDE",
  "company": "ACTAVIS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/28\/2024",
  "drugName": "PREGABALINANDA  #206912",
  "submission": "SUPPL-7",
  "activeIngredients": "PREGABALIN",
  "company": "HETERO LABS LTD III",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/28\/2024",
  "drugName": "FENTANYL CITRATEANDA  #207338",
  "submission": "SUPPL-10",
  "activeIngredients": "FENTANYL CITRATE",
  "company": "ACTAVIS LABS FL INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/28\/2024",
  "drugName": "FINGOLIMOD HYDROCHLORIDEANDA  #207933",
  "submission": "SUPPL-6",
  "activeIngredients": "FINGOLIMOD HYDROCHLORIDE",
  "company": "HETERO LABS LTD V",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/28\/2024",
  "drugName": "DOXORUBICIN HYDROCHLORIDEANDA  #209825",
  "submission": "SUPPL-8",
  "activeIngredients": "DOXORUBICIN HYDROCHLORIDE",
  "company": "GLAND",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/28\/2024",
  "drugName": "DOXORUBICIN HYDROCHLORIDEANDA  #209825",
  "submission": "SUPPL-9",
  "activeIngredients": "DOXORUBICIN HYDROCHLORIDE",
  "company": "GLAND",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/28\/2024",
  "drugName": "GLOPERBANDA   #210942",
  "submission": "SUPPL-2",
  "activeIngredients": "COLCHICINE",
  "company": "SCILEX PHARMS",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/28\/2024",
  "drugName": "DIHYDROERGOTAMINE MESYLATEANDA  #212046",
  "submission": "SUPPL-1",
  "activeIngredients": "DIHYDROERGOTAMINE MESYLATE",
  "company": "MILLA PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/28\/2024",
  "drugName": "DIHYDROERGOTAMINE MESYLATEANDA  #212046",
  "submission": "SUPPL-2",
  "activeIngredients": "DIHYDROERGOTAMINE MESYLATE",
  "company": "MILLA PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/28\/2024",
  "drugName": "NALOXONE HYDROCHLORIDEANDA  #214785",
  "submission": "SUPPL-4",
  "activeIngredients": "NALOXONE HYDROCHLORIDE",
  "company": "BAXTER HLTHCARE CORP",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/28\/2024",
  "drugName": "SUGAMMADEXANDA  #215575",
  "submission": "ORIG-1",
  "activeIngredients": "SUGAMMADEX",
  "company": "QILU PHARM HAINAN",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "08\/28\/2024",
  "drugName": "GLYCOPYRROLATEANDA  #216368",
  "submission": "ORIG-1",
  "activeIngredients": "GLYCOPYRROLATE",
  "company": "CHARTWELL RX",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/28\/2024",
  "drugName": "DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATEANDA  #218426",
  "submission": "ORIG-1",
  "activeIngredients": "DEXTROMETHORPHAN HYDROBROMIDE; QUINIDINE SULFATE",
  "company": "HETERO LABS LTD III",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/28\/2024",
  "drugName": "ZIRABEVBLA   #761099",
  "submission": "SUPPL-12",
  "activeIngredients": "BEVACIZUMAB-BVZR",
  "company": "PFIZER INC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/29\/2024",
  "drugName": "FOSRENOLNDA   #021468",
  "submission": "SUPPL-25",
  "activeIngredients": "LANTHANUM CARBONATE",
  "company": "TAKEDA PHARMS USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/29\/2024",
  "drugName": "NADOLOL AND BENDROFLUMETHIAZIDEANDA  #077833",
  "submission": "SUPPL-16",
  "activeIngredients": "BENDROFLUMETHIAZIDE; NADOLOL",
  "company": "IMPAX LABS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/29\/2024",
  "drugName": "CIPROFLOXACIN HYDROCHLORIDEANDA  #077859",
  "submission": "SUPPL-25",
  "activeIngredients": "CIPROFLOXACIN HYDROCHLORIDE",
  "company": "AUROBINDO PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/29\/2024",
  "drugName": "CIPROFLOXACIN HYDROCHLORIDEANDA  #077859",
  "submission": "SUPPL-26",
  "activeIngredients": "CIPROFLOXACIN HYDROCHLORIDE",
  "company": "AUROBINDO PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/29\/2024",
  "drugName": "CIPROFLOXACIN HYDROCHLORIDEANDA  #077859",
  "submission": "SUPPL-27",
  "activeIngredients": "CIPROFLOXACIN HYDROCHLORIDE",
  "company": "AUROBINDO PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/29\/2024",
  "drugName": "CIPROFLOXACIN HYDROCHLORIDEANDA  #077859",
  "submission": "SUPPL-29",
  "activeIngredients": "CIPROFLOXACIN HYDROCHLORIDE",
  "company": "AUROBINDO PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/29\/2024",
  "drugName": "CIPROFLOXACIN HYDROCHLORIDEANDA  #077859",
  "submission": "SUPPL-30",
  "activeIngredients": "CIPROFLOXACIN HYDROCHLORIDE",
  "company": "AUROBINDO PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/29\/2024",
  "drugName": "CIPROFLOXACIN HYDROCHLORIDEANDA  #077859",
  "submission": "SUPPL-32",
  "activeIngredients": "CIPROFLOXACIN HYDROCHLORIDE",
  "company": "AUROBINDO PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/29\/2024",
  "drugName": "CIPROFLOXACIN HYDROCHLORIDEANDA  #077859",
  "submission": "SUPPL-35",
  "activeIngredients": "CIPROFLOXACIN HYDROCHLORIDE",
  "company": "AUROBINDO PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/29\/2024",
  "drugName": "CIPROFLOXACIN HYDROCHLORIDEANDA  #077859",
  "submission": "SUPPL-38",
  "activeIngredients": "CIPROFLOXACIN HYDROCHLORIDE",
  "company": "AUROBINDO PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/29\/2024",
  "drugName": "LEVETIRACETAMANDA  #203468",
  "submission": "SUPPL-10",
  "activeIngredients": "LEVETIRACETAM",
  "company": "PRINSTON INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/29\/2024",
  "drugName": "FOSRENOLNDA   #204734",
  "submission": "SUPPL-7",
  "activeIngredients": "LANTHANUM CARBONATE",
  "company": "TAKEDA PHARMS USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/29\/2024",
  "drugName": "TOUJEO MAX SOLOSTARBLA   #206538",
  "submission": "SUPPL-17",
  "activeIngredients": "INSULIN GLARGINE RECOMBINANT",
  "company": "SANOFI US SERVICES",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/29\/2024",
  "drugName": "TOUJEO SOLOSTARBLA   #206538",
  "submission": "SUPPL-17",
  "activeIngredients": "INSULIN GLARGINE RECOMBINANT",
  "company": "SANOFI US SERVICES",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/29\/2024",
  "drugName": "FLUOXETINE HYDROCHLORIDEANDA  #211477",
  "submission": "SUPPL-2",
  "activeIngredients": "FLUOXETINE HYDROCHLORIDE",
  "company": "APPCO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/29\/2024",
  "drugName": "FLUOXETINE HYDROCHLORIDEANDA  #211477",
  "submission": "SUPPL-3",
  "activeIngredients": "FLUOXETINE HYDROCHLORIDE",
  "company": "APPCO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/29\/2024",
  "drugName": "PAROXETINE HYDROCHLORIDEANDA  #212645",
  "submission": "SUPPL-2",
  "activeIngredients": "PAROXETINE HYDROCHLORIDE",
  "company": "CADILA PHARMS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/29\/2024",
  "drugName": "PAROXETINE HYDROCHLORIDEANDA  #212645",
  "submission": "SUPPL-4",
  "activeIngredients": "PAROXETINE HYDROCHLORIDE",
  "company": "CADILA PHARMS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/29\/2024",
  "drugName": "DIVALPROEX SODIUMANDA  #215527",
  "submission": "SUPPL-1",
  "activeIngredients": "DIVALPROEX SODIUM",
  "company": "ANNORA PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/29\/2024",
  "drugName": "DAPTOMYCINANDA  #217215",
  "submission": "ORIG-1",
  "activeIngredients": "DAPTOMYCIN",
  "company": "BIOCON PHARMA",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/29\/2024",
  "drugName": "SCOPOLAMINEANDA  #217893",
  "submission": "ORIG-1",
  "activeIngredients": "SCOPOLAMINE",
  "company": "ZYDUS PHARMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/30\/2024",
  "drugName": "DERMA-SMOOTHE\/FSNDA   #019452",
  "submission": "SUPPL-27",
  "activeIngredients": "FLUOCINOLONE ACETONIDE",
  "company": "HILL DERMAC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/30\/2024",
  "drugName": "DERMOTICNDA   #019452",
  "submission": "SUPPL-27",
  "activeIngredients": "FLUOCINOLONE ACETONIDE",
  "company": "HILL DERMAC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/30\/2024",
  "drugName": "MUCINEXNDA   #021282",
  "submission": "SUPPL-55",
  "activeIngredients": "GUAIFENESIN",
  "company": "RB HLTH",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/30\/2024",
  "drugName": "SEVOFLURANEANDA  #075895",
  "submission": "SUPPL-17",
  "activeIngredients": "SEVOFLURANE",
  "company": "BAXTER HLTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/30\/2024",
  "drugName": "DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATEANDA  #076852",
  "submission": "SUPPL-6",
  "activeIngredients": "AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE",
  "company": "IMPAX LABS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/30\/2024",
  "drugName": "DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATEANDA  #076852",
  "submission": "SUPPL-12",
  "activeIngredients": "AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE",
  "company": "IMPAX LABS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/30\/2024",
  "drugName": "DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATEANDA  #076852",
  "submission": "SUPPL-14",
  "activeIngredients": "AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE",
  "company": "IMPAX LABS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/30\/2024",
  "drugName": "DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATEANDA  #076852",
  "submission": "SUPPL-19",
  "activeIngredients": "AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE",
  "company": "IMPAX LABS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/30\/2024",
  "drugName": "DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATEANDA  #076852",
  "submission": "SUPPL-21",
  "activeIngredients": "AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE",
  "company": "IMPAX LABS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/30\/2024",
  "drugName": "DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATEANDA  #076852",
  "submission": "SUPPL-26",
  "activeIngredients": "AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE",
  "company": "IMPAX LABS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/30\/2024",
  "drugName": "PANTOPRAZOLE SODIUMANDA  #200821",
  "submission": "SUPPL-23",
  "activeIngredients": "PANTOPRAZOLE SODIUM",
  "company": "MACLEODS PHARMS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/30\/2024",
  "drugName": "PANTOPRAZOLE SODIUMANDA  #200821",
  "submission": "SUPPL-26",
  "activeIngredients": "PANTOPRAZOLE SODIUM",
  "company": "MACLEODS PHARMS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/30\/2024",
  "drugName": "PANTOPRAZOLE SODIUMANDA  #200821",
  "submission": "SUPPL-27",
  "activeIngredients": "PANTOPRAZOLE SODIUM",
  "company": "MACLEODS PHARMS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/30\/2024",
  "drugName": "PANTOPRAZOLE SODIUMANDA  #200821",
  "submission": "SUPPL-33",
  "activeIngredients": "PANTOPRAZOLE SODIUM",
  "company": "MACLEODS PHARMS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/30\/2024",
  "drugName": "METHYLPHENIDATE HYDROCHLORIDEANDA  #202608",
  "submission": "SUPPL-9",
  "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
  "company": "SPECGX LLC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/30\/2024",
  "drugName": "METHYLPHENIDATE HYDROCHLORIDEANDA  #202608",
  "submission": "SUPPL-17",
  "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
  "company": "SPECGX LLC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/30\/2024",
  "drugName": "METHYLPHENIDATE HYDROCHLORIDEANDA  #202608",
  "submission": "SUPPL-18",
  "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
  "company": "SPECGX LLC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/30\/2024",
  "drugName": "METHYLPHENIDATEANDA  #206497",
  "submission": "SUPPL-2",
  "activeIngredients": "METHYLPHENIDATE",
  "company": "MYLAN TECH VIATRIS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/30\/2024",
  "drugName": "ZEPOSIANDA   #209899",
  "submission": "SUPPL-11",
  "activeIngredients": "OZANIMOD HYDROCHLORIDE",
  "company": "BRISTOL",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/30\/2024",
  "drugName": "ZEPOSIANDA   #209899",
  "submission": "SUPPL-12",
  "activeIngredients": "OZANIMOD HYDROCHLORIDE",
  "company": "BRISTOL",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/30\/2024",
  "drugName": "PREVYMISNDA   #209939",
  "submission": "SUPPL-13",
  "activeIngredients": "LETERMOVIR",
  "company": "MERCK SHARP DOHME",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/30\/2024",
  "drugName": "PREVYMISNDA   #209939",
  "submission": "SUPPL-16",
  "activeIngredients": "LETERMOVIR",
  "company": "MERCK SHARP DOHME",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/30\/2024",
  "drugName": "PREVYMISNDA   #209940",
  "submission": "SUPPL-12",
  "activeIngredients": "LETERMOVIR",
  "company": "MERCK SHARP DOHME",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/30\/2024",
  "drugName": "PREVYMISNDA   #209940",
  "submission": "SUPPL-16",
  "activeIngredients": "LETERMOVIR",
  "company": "MERCK SHARP DOHME",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/30\/2024",
  "drugName": "ESTRADIOLANDA  #210264",
  "submission": "SUPPL-4",
  "activeIngredients": "ESTRADIOL",
  "company": "GLENMARK PHARMS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/30\/2024",
  "drugName": "ESTRADIOLANDA  #210264",
  "submission": "SUPPL-7",
  "activeIngredients": "ESTRADIOL",
  "company": "GLENMARK PHARMS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/30\/2024",
  "drugName": "ESTRADIOLANDA  #210264",
  "submission": "SUPPL-9",
  "activeIngredients": "ESTRADIOL",
  "company": "GLENMARK PHARMS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/30\/2024",
  "drugName": "ATORVASTATIN CALCIUMANDA  #212103",
  "submission": "SUPPL-1",
  "activeIngredients": "ATORVASTATIN CALCIUM",
  "company": "CADILA PHARMS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/30\/2024",
  "drugName": "POTASSIUM PHOSPHATESNDA   #212832",
  "submission": "SUPPL-2",
  "activeIngredients": "POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC",
  "company": "FRESENIUS KABI USA",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/30\/2024",
  "drugName": "POTASSIUM PHOSPHATES IN 0.9% SODIUM CHLORIDENDA   #212832",
  "submission": "SUPPL-2",
  "activeIngredients": "POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC",
  "company": "FRESENIUS KABI USA",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/30\/2024",
  "drugName": "SACUBITRIL AND VALSARTANANDA  #213680",
  "submission": "ORIG-1",
  "activeIngredients": "SACUBITRIL; VALSARTAN",
  "company": "BIOCON PHARMA",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/30\/2024",
  "drugName": "METHYLPHENIDATE HYDROCHLORIDEANDA  #213936",
  "submission": "SUPPL-4",
  "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
  "company": "ACCORD HLTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/30\/2024",
  "drugName": "ALLOPURINOLANDA  #217748",
  "submission": "SUPPL-4",
  "activeIngredients": "ALLOPURINOL",
  "company": "HETERO LABS LTD V",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/30\/2024",
  "drugName": "PREVYMISNDA   #219104",
  "submission": "ORIG-1",
  "activeIngredients": "LETERMOVIR",
  "company": "MSD",
  "submissionClassification": "Type 3 - New Dosage Form",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "08\/31\/2024",
  "drugName": "VEOZAHNDA   #216578",
  "submission": "SUPPL-3",
  "activeIngredients": "FEZOLINETANT",
  "company": "ASTELLAS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 }
,
 {
  "approvalDate": "09\/03\/2024",
  "drugName": "LINAGLIPTINANDA  #208423",
  "submission": "ORIG-1",
  "activeIngredients": "LINAGLIPTIN",
  "company": "INVAGEN PHARMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/03\/2024",
  "drugName": "KISQALINDA   #209092",
  "submission": "SUPPL-20",
  "activeIngredients": "RIBOCICLIB SUCCINATE",
  "company": "NOVARTIS",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/03\/2024",
  "drugName": "KISQALI FEMARA CO-PACK (COPACKAGED)NDA   #209935",
  "submission": "SUPPL-28",
  "activeIngredients": "LETROZOLE; RIBOCICLIB SUCCINATE",
  "company": "NOVARTIS",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/03\/2024",
  "drugName": "ICATIBANT ACETATEANDA  #210118",
  "submission": "SUPPL-6",
  "activeIngredients": "ICATIBANT ACETATE",
  "company": "TEVA PHARMS USA",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/03\/2024",
  "drugName": "IBUPROFENANDA  #215311",
  "submission": "SUPPL-1",
  "activeIngredients": "IBUPROFEN",
  "company": "STRIDES PHARMA",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/04\/2024",
  "drugName": "TRILEPTALNDA   #021014",
  "submission": "SUPPL-50",
  "activeIngredients": "OXCARBAZEPINE",
  "company": "NOVARTIS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/04\/2024",
  "drugName": "TRILEPTALNDA   #021285",
  "submission": "SUPPL-42",
  "activeIngredients": "OXCARBAZEPINE",
  "company": "NOVARTIS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/04\/2024",
  "drugName": "CASPOFUNGIN ACETATEANDA  #200833",
  "submission": "SUPPL-7",
  "activeIngredients": "CASPOFUNGIN ACETATE",
  "company": "HENGRUI PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/04\/2024",
  "drugName": "DESVENLAFAXINE SUCCINATEANDA  #204083",
  "submission": "SUPPL-6",
  "activeIngredients": "DESVENLAFAXINE SUCCINATE",
  "company": "HIKMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/04\/2024",
  "drugName": "DESVENLAFAXINE SUCCINATEANDA  #204083",
  "submission": "SUPPL-7",
  "activeIngredients": "DESVENLAFAXINE SUCCINATE",
  "company": "HIKMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/04\/2024",
  "drugName": "DESVENLAFAXINE SUCCINATEANDA  #204083",
  "submission": "SUPPL-10",
  "activeIngredients": "DESVENLAFAXINE SUCCINATE",
  "company": "HIKMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/04\/2024",
  "drugName": "EMPAGLIFLOZIN; LINAGLIPTINANDA  #212375",
  "submission": "ORIG-1",
  "activeIngredients": "EMPAGLIFLOZIN;LINAGLIPTIN",
  "company": "MACLEODS PHARMS LTD",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "09\/04\/2024",
  "drugName": "LACOSAMIDEANDA  #213109",
  "submission": "ORIG-1",
  "activeIngredients": "LACOSAMIDE",
  "company": "UNICHEM",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/04\/2024",
  "drugName": "ALBENDAZOLEANDA  #215652",
  "submission": "ORIG-1",
  "activeIngredients": "ALBENDAZOLE",
  "company": "ALEMBIC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/05\/2024",
  "drugName": "CYTOXANNDA   #012142",
  "submission": "SUPPL-116",
  "activeIngredients": "CYCLOPHOSPHAMIDE",
  "company": "BAXTER HLTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/05\/2024",
  "drugName": "CYTOXAN (LYOPHILIZED)NDA   #012142",
  "submission": "SUPPL-116",
  "activeIngredients": "CYCLOPHOSPHAMIDE",
  "company": "BAXTER HLTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/05\/2024",
  "drugName": "LYOPHILIZED CYTOXANNDA   #012142",
  "submission": "SUPPL-116",
  "activeIngredients": "CYCLOPHOSPHAMIDE",
  "company": "BAXTER HLTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/05\/2024",
  "drugName": "HYDROXYCHLOROQUINE SULFATEANDA  #040104",
  "submission": "SUPPL-36",
  "activeIngredients": "HYDROXYCHLOROQUINE SULFATE",
  "company": "SANDOZ",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/05\/2024",
  "drugName": "HYDROXYCHLOROQUINE SULFATEANDA  #040104",
  "submission": "SUPPL-37",
  "activeIngredients": "HYDROXYCHLOROQUINE SULFATE",
  "company": "SANDOZ",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/05\/2024",
  "drugName": "HYDROXYCHLOROQUINE SULFATEANDA  #040104",
  "submission": "SUPPL-38",
  "activeIngredients": "HYDROXYCHLOROQUINE SULFATE",
  "company": "SANDOZ",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/05\/2024",
  "drugName": "TICAGRELORANDA  #208597",
  "submission": "SUPPL-1",
  "activeIngredients": "TICAGRELOR",
  "company": "MYLAN",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/05\/2024",
  "drugName": "TICAGRELORANDA  #208597",
  "submission": "SUPPL-2",
  "activeIngredients": "TICAGRELOR",
  "company": "MYLAN",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/05\/2024",
  "drugName": "ZILRETTANDA   #208845",
  "submission": "SUPPL-19",
  "activeIngredients": "TRIAMCINOLONE ACETONIDE",
  "company": "PACIRA PHARMS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/05\/2024",
  "drugName": "EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATEANDA  #209061",
  "submission": "ORIG-1",
  "activeIngredients": "EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE",
  "company": "MYLAN",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/05\/2024",
  "drugName": "LUCEMYRANDA   #209229",
  "submission": "SUPPL-7",
  "activeIngredients": "LOFEXIDINE HYDROCHLORIDE",
  "company": "BIOCORRX PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/05\/2024",
  "drugName": "ROXYBONDNDA   #209777",
  "submission": "SUPPL-11",
  "activeIngredients": "OXYCODONE HYDROCHLORIDE",
  "company": "PROTEGA PHARMS",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/05\/2024",
  "drugName": "MISOPROSTOLANDA  #210201",
  "submission": "SUPPL-2",
  "activeIngredients": "MISOPROSTOL",
  "company": "ACQ PHARMA",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/05\/2024",
  "drugName": "IVABRADINE HYDROCHLORIDEANDA  #213276",
  "submission": "ORIG-1",
  "activeIngredients": "IVABRADINE HYDROCHLORIDE",
  "company": "BIONPHARMA",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/05\/2024",
  "drugName": "HYDROCORTISONE SODIUM SUCCINATEANDA  #214050",
  "submission": "ORIG-1",
  "activeIngredients": "HYDROCORTISONE SODIUM SUCCINATE",
  "company": "CIPLA",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/05\/2024",
  "drugName": "TENOFOVIR ALAFENAMIDEANDA  #214179",
  "submission": "ORIG-1",
  "activeIngredients": "TENOFOVIR ALAFENAMIDE",
  "company": "HETERO LABS LTD V",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "09\/05\/2024",
  "drugName": "HYDROCORTISONEANDA  #214649",
  "submission": "SUPPL-2",
  "activeIngredients": "HYDROCORTISONE",
  "company": "AUROBINDO PHARMA LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/05\/2024",
  "drugName": "THEOPHYLLINEANDA  #215312",
  "submission": "ORIG-1",
  "activeIngredients": "THEOPHYLLINE",
  "company": "STRIDES PHARMA",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/05\/2024",
  "drugName": "FILSPARINDA   #216403",
  "submission": "SUPPL-3",
  "activeIngredients": "SPARSENTAN",
  "company": "TRAVERE",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/05\/2024",
  "drugName": "NELARABINEANDA  #216510",
  "submission": "ORIG-1",
  "activeIngredients": "NELARABINE",
  "company": "XGEN PHARMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/05\/2024",
  "drugName": "TYENNEBLA   #761275",
  "submission": "SUPPL-1",
  "activeIngredients": "TOCILIZUMAB-AAZG",
  "company": "FRESENIUS KABI USA",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/06\/2024",
  "drugName": "NICORETTENDA   #021330",
  "submission": "SUPPL-26",
  "activeIngredients": "NICOTINE POLACRILEX",
  "company": "HALEON US HOLDINGS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/06\/2024",
  "drugName": "DESIPRAMINE HYDROCHLORIDEANDA  #071588",
  "submission": "SUPPL-34",
  "activeIngredients": "DESIPRAMINE HYDROCHLORIDE",
  "company": "ACTAVIS TOTOWA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/06\/2024",
  "drugName": "DESIPRAMINE HYDROCHLORIDEANDA  #071601",
  "submission": "SUPPL-35",
  "activeIngredients": "DESIPRAMINE HYDROCHLORIDE",
  "company": "ACTAVIS TOTOWA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/06\/2024",
  "drugName": "DESIPRAMINE HYDROCHLORIDEANDA  #071602",
  "submission": "SUPPL-32",
  "activeIngredients": "DESIPRAMINE HYDROCHLORIDE",
  "company": "ACTAVIS TOTOWA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/06\/2024",
  "drugName": "DESIPRAMINE HYDROCHLORIDEANDA  #071766",
  "submission": "SUPPL-33",
  "activeIngredients": "DESIPRAMINE HYDROCHLORIDE",
  "company": "ACTAVIS TOTOWA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/06\/2024",
  "drugName": "DESIPRAMINE HYDROCHLORIDEANDA  #074430",
  "submission": "SUPPL-22",
  "activeIngredients": "DESIPRAMINE HYDROCHLORIDE",
  "company": "ACTAVIS TOTOWA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/06\/2024",
  "drugName": "BEXAROTENEANDA  #208628",
  "submission": "ORIG-1",
  "activeIngredients": "BEXAROTENE",
  "company": "ASCENT PHARMS INC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/06\/2024",
  "drugName": "POTASSIUM CHLORIDEANDA  #212987",
  "submission": "ORIG-1",
  "activeIngredients": "POTASSIUM CHLORIDE",
  "company": "MACLEODS PHARMS LTD",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/06\/2024",
  "drugName": "EPINEPHRINEANDA  #217192",
  "submission": "ORIG-1",
  "activeIngredients": "EPINEPHRINE",
  "company": "AM REGENT",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/06\/2024",
  "drugName": "NICARDIPINE HYDROCHLORIDEANDA  #217548",
  "submission": "ORIG-1",
  "activeIngredients": "NICARDIPINE HYDROCHLORIDE",
  "company": "CHENGDU SHUODE",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/06\/2024",
  "drugName": "HERCESSIBLA   #761346",
  "submission": "SUPPL-1",
  "activeIngredients": "TRASTUZUMAB-STRF",
  "company": "ACCORD BIOPHARMA INC.",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/09\/2024",
  "drugName": "ADVIL PMNDA   #021393",
  "submission": "SUPPL-22",
  "activeIngredients": "DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN",
  "company": "HALEON US HOLDINGS",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/09\/2024",
  "drugName": "VERAPAMIL HYDROCHLORIDEANDA  #070737",
  "submission": "SUPPL-28",
  "activeIngredients": "VERAPAMIL HYDROCHLORIDE",
  "company": "HOSPIRA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/09\/2024",
  "drugName": "LEVOFLOXACINANDA  #076361",
  "submission": "SUPPL-16",
  "activeIngredients": "LEVOFLOXACIN",
  "company": "TEVA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/09\/2024",
  "drugName": "CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINERANDA  #078024",
  "submission": "SUPPL-31",
  "activeIngredients": "CIPROFLOXACIN",
  "company": "BAXTER HLTHCARE CORP",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/09\/2024",
  "drugName": "CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINERANDA  #078024",
  "submission": "SUPPL-35",
  "activeIngredients": "CIPROFLOXACIN",
  "company": "BAXTER HLTHCARE CORP",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/09\/2024",
  "drugName": "RISPERIDONEANDA  #091384",
  "submission": "SUPPL-13",
  "activeIngredients": "RISPERIDONE",
  "company": "AMNEAL PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/09\/2024",
  "drugName": "CHOLINE C-11NDA   #203155",
  "submission": "SUPPL-9",
  "activeIngredients": "CHOLINE C-11",
  "company": "MCPRF",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/09\/2024",
  "drugName": "GABAPENTINANDA  #203643",
  "submission": "ORIG-1",
  "activeIngredients": "GABAPENTIN",
  "company": "ABON PHARMS LLC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/09\/2024",
  "drugName": "DEXMETHYLPHENIDATE HYDROCHLORIDEANDA  #204534",
  "submission": "SUPPL-1",
  "activeIngredients": "DEXMETHYLPHENIDATE HYDROCHLORIDE",
  "company": "NOVEL LABS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/09\/2024",
  "drugName": "DEXMETHYLPHENIDATE HYDROCHLORIDEANDA  #204534",
  "submission": "SUPPL-2",
  "activeIngredients": "DEXMETHYLPHENIDATE HYDROCHLORIDE",
  "company": "NOVEL LABS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/09\/2024",
  "drugName": "DEXMETHYLPHENIDATE HYDROCHLORIDEANDA  #204534",
  "submission": "SUPPL-3",
  "activeIngredients": "DEXMETHYLPHENIDATE HYDROCHLORIDE",
  "company": "NOVEL LABS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/09\/2024",
  "drugName": "GABAPENTINANDA  #207099",
  "submission": "SUPPL-18",
  "activeIngredients": "GABAPENTIN",
  "company": "RISING",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/09\/2024",
  "drugName": "LINAGLIPTINANDA  #217749",
  "submission": "ORIG-1",
  "activeIngredients": "LINAGLIPTIN",
  "company": "HETERO LABS LTD",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "09\/09\/2024",
  "drugName": "CABERGOLINEANDA  #218109",
  "submission": "ORIG-1",
  "activeIngredients": "CABERGOLINE",
  "company": "SOMERSET THERAPS LLC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/10\/2024",
  "drugName": "ESTRASORBNDA   #021371",
  "submission": "SUPPL-9",
  "activeIngredients": "ESTRADIOL HEMIHYDRATE",
  "company": "EXELTIS USA INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/10\/2024",
  "drugName": "LEVOFLOXACINANDA  #077097",
  "submission": "SUPPL-10",
  "activeIngredients": "LEVOFLOXACIN",
  "company": "NATCO PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/10\/2024",
  "drugName": "ESTRADIOLANDA  #204379",
  "submission": "SUPPL-1",
  "activeIngredients": "ESTRADIOL",
  "company": "ZYDUS PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/10\/2024",
  "drugName": "DEXMETHYLPHENIDATE HYDROCHLORIDEANDA  #206931",
  "submission": "SUPPL-10",
  "activeIngredients": "DEXMETHYLPHENIDATE HYDROCHLORIDE",
  "company": "ABHAI INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/10\/2024",
  "drugName": "TOPIRAMATEANDA  #207382",
  "submission": "SUPPL-9",
  "activeIngredients": "TOPIRAMATE",
  "company": "ZYDUS",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/10\/2024",
  "drugName": "LEVOTHYROXINE SODIUMANDA  #207588",
  "submission": "SUPPL-6",
  "activeIngredients": "LEVOTHYROXINE SODIUM",
  "company": "WATSON LABS TEVA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/10\/2024",
  "drugName": "DEXMETHYLPHENIDATE HYDROCHLORIDEANDA  #209211",
  "submission": "SUPPL-3",
  "activeIngredients": "DEXMETHYLPHENIDATE HYDROCHLORIDE",
  "company": "CEDIPROF INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/10\/2024",
  "drugName": "CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDEANDA  #210507",
  "submission": "ORIG-1",
  "activeIngredients": "CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE",
  "company": "UNICHEM",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/10\/2024",
  "drugName": "BRIMONIDINE TARTRATE AND TIMOLOL MALEATEANDA  #216114",
  "submission": "ORIG-1",
  "activeIngredients": "BRIMONIDINE TARTRATE; TIMOLOL MALEATE",
  "company": "SOMERSET",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/10\/2024",
  "drugName": "ELREXFIOBLA   #761345",
  "submission": "SUPPL-2",
  "activeIngredients": "ELRANATAMAB",
  "company": "PFIZER INC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/11\/2024",
  "drugName": "ALEVENDA   #020204",
  "submission": "SUPPL-88",
  "activeIngredients": "NAPROXEN SODIUM",
  "company": "BAYER",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/11\/2024",
  "drugName": "DABIGATRAN ETEXILATE MESYLATEANDA  #208040",
  "submission": "ORIG-2",
  "activeIngredients": "DABIGATRAN ETEXILATE MESYLATE",
  "company": "ALKEM LABS LTD",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/11\/2024",
  "drugName": "VUMERITYNDA   #211855",
  "submission": "SUPPL-17",
  "activeIngredients": "DIROXIMEL FUMARATE",
  "company": "BIOGEN INC",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/11\/2024",
  "drugName": "BUSULFANANDA  #215235",
  "submission": "ORIG-1",
  "activeIngredients": "BUSULFAN",
  "company": "PRINSTON INC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/11\/2024",
  "drugName": "LENALIDOMIDEANDA  #217281",
  "submission": "ORIG-1",
  "activeIngredients": "LENALIDOMIDE",
  "company": "NOVUGEN",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/11\/2024",
  "drugName": "AMIODARONE HYDROCHLORIDEANDA  #218253",
  "submission": "ORIG-1",
  "activeIngredients": "AMIODARONE HYDROCHLORIDE",
  "company": "ZHEJIANG POLY PHARM",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/11\/2024",
  "drugName": "TREMFYABLA   #761061",
  "submission": "SUPPL-21",
  "activeIngredients": "GUSELKUMAB",
  "company": "JANSSEN BIOTECH",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/12\/2024",
  "drugName": "CLOZARILNDA   #019758",
  "submission": "SUPPL-104",
  "activeIngredients": "CLOZAPINE",
  "company": "HERITAGE LIFE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/12\/2024",
  "drugName": "SABRILNDA   #020427",
  "submission": "SUPPL-27",
  "activeIngredients": "VIGABATRIN",
  "company": "LUNDBECK PHARMS LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/12\/2024",
  "drugName": "ZYRTEC-D 12 HOURNDA   #021150",
  "submission": "SUPPL-22",
  "activeIngredients": "CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE",
  "company": "KENVUE BRANDS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/12\/2024",
  "drugName": "SABRILNDA   #022006",
  "submission": "SUPPL-28",
  "activeIngredients": "VIGABATRIN",
  "company": "LUNDBECK PHARMS LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/12\/2024",
  "drugName": "INVEGA SUSTENNANDA   #022264",
  "submission": "SUPPL-37",
  "activeIngredients": "PALIPERIDONE PALMITATE",
  "company": "JANSSEN PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/12\/2024",
  "drugName": "DILTIAZEM HYDROCHLORIDEANDA  #074910",
  "submission": "SUPPL-19",
  "activeIngredients": "DILTIAZEM HYDROCHLORIDE",
  "company": "MYLAN",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/12\/2024",
  "drugName": "DICLOFENAC SODIUMANDA  #075910",
  "submission": "SUPPL-30",
  "activeIngredients": "DICLOFENAC SODIUM",
  "company": "ACTAVIS ELIZABETH",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/12\/2024",
  "drugName": "DICLOFENAC SODIUMANDA  #076152",
  "submission": "SUPPL-15",
  "activeIngredients": "DICLOFENAC SODIUM",
  "company": "AUROBINDO PHARMA USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/12\/2024",
  "drugName": "CIPROFLOXACIN EXTENDED RELEASEANDA  #077809",
  "submission": "SUPPL-9",
  "activeIngredients": "CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE",
  "company": "ANI PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/12\/2024",
  "drugName": "CIPROFLOXACIN EXTENDED RELEASEANDA  #078166",
  "submission": "SUPPL-16",
  "activeIngredients": "CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE",
  "company": "PH HEALTH",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/12\/2024",
  "drugName": "CIPROFLOXACIN EXTENDED RELEASEANDA  #078183",
  "submission": "SUPPL-22",
  "activeIngredients": "CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE",
  "company": "RISING",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/12\/2024",
  "drugName": "CIPROFLOXACIN EXTENDED RELEASEANDA  #078183",
  "submission": "SUPPL-24",
  "activeIngredients": "CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE",
  "company": "RISING",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/12\/2024",
  "drugName": "GEMCITABINE HYDROCHLORIDEANDA  #090242",
  "submission": "SUPPL-4",
  "activeIngredients": "GEMCITABINE HYDROCHLORIDE",
  "company": "FRESENIUS KABI USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/12\/2024",
  "drugName": "ENBRELBLA   #103795",
  "submission": "SUPPL-5600",
  "activeIngredients": "ETANERCEPT",
  "company": "IMMUNEX",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/12\/2024",
  "drugName": "NAGLAZYMEBLA   #125117",
  "submission": "SUPPL-132",
  "activeIngredients": "GALSULFASE",
  "company": "BIOMARIN",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/12\/2024",
  "drugName": "INVEGA HAFYERANDA   #207946",
  "submission": "SUPPL-14",
  "activeIngredients": "PALIPERIDONE PALMITATE",
  "company": "JANSSEN PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/12\/2024",
  "drugName": "INVEGA HAFYERANDA   #207946",
  "submission": "SUPPL-15",
  "activeIngredients": "PALIPERIDONE PALMITATE",
  "company": "JANSSEN PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/12\/2024",
  "drugName": "INVEGA TRINZANDA   #207946",
  "submission": "SUPPL-14",
  "activeIngredients": "PALIPERIDONE PALMITATE",
  "company": "JANSSEN PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/12\/2024",
  "drugName": "INVEGA TRINZANDA   #207946",
  "submission": "SUPPL-15",
  "activeIngredients": "PALIPERIDONE PALMITATE",
  "company": "JANSSEN PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/12\/2024",
  "drugName": "VIGABATRINANDA  #208218",
  "submission": "SUPPL-15",
  "activeIngredients": "VIGABATRIN",
  "company": "PH HEALTH",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/12\/2024",
  "drugName": "VIGABATRINANDA  #209822",
  "submission": "SUPPL-12",
  "activeIngredients": "VIGABATRIN",
  "company": "TEVA PHARMS USA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/12\/2024",
  "drugName": "VIGABATRINANDA  #209824",
  "submission": "SUPPL-13",
  "activeIngredients": "VIGABATRIN",
  "company": "TEVA PHARMS USA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/12\/2024",
  "drugName": "VIGABATRINANDA  #210042",
  "submission": "SUPPL-6",
  "activeIngredients": "VIGABATRIN",
  "company": "AMNEAL PHARMS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/12\/2024",
  "drugName": "VIGABATRINANDA  #210155",
  "submission": "SUPPL-19",
  "activeIngredients": "VIGABATRIN",
  "company": "AMNEAL PHARMS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/12\/2024",
  "drugName": "VIGADRONEANDA  #210196",
  "submission": "SUPPL-20",
  "activeIngredients": "VIGABATRIN",
  "company": "AUCTA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/12\/2024",
  "drugName": "BRAFTOVINDA   #210496",
  "submission": "SUPPL-16",
  "activeIngredients": "ENCORAFENIB",
  "company": "ARRAY BIOPHARMA INC",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/12\/2024",
  "drugName": "MEKTOVINDA   #210498",
  "submission": "SUPPL-10",
  "activeIngredients": "BINIMETINIB",
  "company": "ARRAY BIOPHARMA INC",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/12\/2024",
  "drugName": "VIGABATRINANDA  #211481",
  "submission": "SUPPL-9",
  "activeIngredients": "VIGABATRIN",
  "company": "DR REDDYS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/12\/2024",
  "drugName": "VIGABATRINANDA  #211539",
  "submission": "SUPPL-2",
  "activeIngredients": "VIGABATRIN",
  "company": "DR REDDYS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/12\/2024",
  "drugName": "VIGABATRINANDA  #211592",
  "submission": "SUPPL-9",
  "activeIngredients": "VIGABATRIN",
  "company": "INVAGEN PHARMS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/12\/2024",
  "drugName": "VIGABATRINANDA  #213104",
  "submission": "SUPPL-2",
  "activeIngredients": "VIGABATRIN",
  "company": "HIKMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/12\/2024",
  "drugName": "VIGABATRINANDA  #213375",
  "submission": "SUPPL-5",
  "activeIngredients": "VIGABATRIN",
  "company": "ALKEM LABS LTD",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/12\/2024",
  "drugName": "VIGABATRINANDA  #213390",
  "submission": "SUPPL-3",
  "activeIngredients": "VIGABATRIN",
  "company": "PROPEL PHARMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/12\/2024",
  "drugName": "VIGABATRINANDA  #213469",
  "submission": "SUPPL-5",
  "activeIngredients": "VIGABATRIN",
  "company": "GRANULES",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/12\/2024",
  "drugName": "VIGABATRINANDA  #213519",
  "submission": "SUPPL-4",
  "activeIngredients": "VIGABATRIN",
  "company": "ANNORA PHARMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/12\/2024",
  "drugName": "VIGABATRINANDA  #213899",
  "submission": "SUPPL-4",
  "activeIngredients": "VIGABATRIN",
  "company": "AUROBINDO PHARMA LTD",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/12\/2024",
  "drugName": "METHOTREXATENDA   #214121",
  "submission": "SUPPL-3",
  "activeIngredients": "METHOTREXATE",
  "company": "ACCORD HLTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/12\/2024",
  "drugName": "VIGABATRINANDA  #214425",
  "submission": "SUPPL-4",
  "activeIngredients": "VIGABATRIN",
  "company": "ACCORD HLTHCARE",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/12\/2024",
  "drugName": "VIGABATRINANDA  #214671",
  "submission": "SUPPL-1",
  "activeIngredients": "VIGABATRIN",
  "company": "ZYDUS LIFESCIENCES",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/12\/2024",
  "drugName": "VIGABATRINANDA  #214749",
  "submission": "SUPPL-1",
  "activeIngredients": "VIGABATRIN",
  "company": "UPSHER SMITH LABS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/12\/2024",
  "drugName": "VIGPODERANDA  #214961",
  "submission": "SUPPL-7",
  "activeIngredients": "VIGABATRIN",
  "company": "PYROS PHARMS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/12\/2024",
  "drugName": "VIGABATRINANDA  #214992",
  "submission": "SUPPL-3",
  "activeIngredients": "VIGABATRIN",
  "company": "DEXCEL",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/12\/2024",
  "drugName": "VIGABATRINANDA  #215109",
  "submission": "SUPPL-3",
  "activeIngredients": "VIGABATRIN",
  "company": "DEXCEL",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/12\/2024",
  "drugName": "VIGABATRINANDA  #215363",
  "submission": "SUPPL-2",
  "activeIngredients": "VIGABATRIN",
  "company": "MSN",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/12\/2024",
  "drugName": "VIGABATRINANDA  #215519",
  "submission": "SUPPL-1",
  "activeIngredients": "VIGABATRIN",
  "company": "CARNEGIE",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/12\/2024",
  "drugName": "VIGABATRINANDA  #215601",
  "submission": "SUPPL-3",
  "activeIngredients": "VIGABATRIN",
  "company": "AUROBINDO PHARMA LTD",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/12\/2024",
  "drugName": "VIGABATRINANDA  #215707",
  "submission": "SUPPL-3",
  "activeIngredients": "VIGABATRIN",
  "company": "ZYDUS LIFESCIENCES",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/12\/2024",
  "drugName": "PAXLOVID (COPACKAGED)NDA   #217188",
  "submission": "SUPPL-6",
  "activeIngredients": "NIRMATRELVIR; RITONAVIR",
  "company": "PFIZER",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/12\/2024",
  "drugName": "VIGAFYDENDA   #217684",
  "submission": "SUPPL-1",
  "activeIngredients": "VIGABATRIN",
  "company": "PYROS PHARMS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/12\/2024",
  "drugName": "CYCLOBENZAPRINE HYDROCHLORIDEANDA  #218936",
  "submission": "ORIG-1",
  "activeIngredients": "CYCLOBENZAPRINE HYDROCHLORIDE",
  "company": "RISING",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/12\/2024",
  "drugName": "DUPIXENTBLA   #761055",
  "submission": "SUPPL-66",
  "activeIngredients": "DUPILUMAB",
  "company": "REGENERON PHARMACEUTICALS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/12\/2024",
  "drugName": "TECENTRIQ HYBREZABLA   #761347",
  "submission": "ORIG-1",
  "activeIngredients": "ATEZOLIZUMAB AND HYALURONIDASE-TQJS",
  "company": "GENENTECH INC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/13\/2024",
  "drugName": "QSYMIANDA   #022580",
  "submission": "SUPPL-25",
  "activeIngredients": "PHENTERMINE HYDROCHLORIDE; TOPIRAMATE",
  "company": "VIVUS LLC",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/13\/2024",
  "drugName": "CIMZIABLA   #125160",
  "submission": "SUPPL-275",
  "activeIngredients": "CERTOLIZUMAB PEGOL",
  "company": "UCB INC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/13\/2024",
  "drugName": "ERLOTINIB HYDROCHLORIDEANDA  #203843",
  "submission": "ORIG-1",
  "activeIngredients": "ERLOTINIB HYDROCHLORIDE",
  "company": "CHARTWELL RX",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/13\/2024",
  "drugName": "PROCHLORPERAZINE EDISYLATEANDA  #212257",
  "submission": "ORIG-1",
  "activeIngredients": "PROCHLORPERAZINE EDISYLATE",
  "company": "SOMERSET THERAPS LLC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/13\/2024",
  "drugName": "FLUOXETINE HYDROCHLORIDEANDA  #212683",
  "submission": "ORIG-1",
  "activeIngredients": "FLUOXETINE HYDROCHLORIDE",
  "company": "STRIDES PHARMA",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/13\/2024",
  "drugName": "NELARABINEANDA  #216948",
  "submission": "ORIG-1",
  "activeIngredients": "NELARABINE",
  "company": "MSN",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/13\/2024",
  "drugName": "EBGLYSSBLA   #761306",
  "submission": "ORIG-1",
  "activeIngredients": "LEBRIKIZUMAB-LBKZ",
  "company": "ELI LILLY AND CO",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/13\/2024",
  "drugName": "OCREVUS ZUNOVOBLA   #761371",
  "submission": "ORIG-1",
  "activeIngredients": "OCRELIZUMAB AND HYALURONIDASE-OCSQ",
  "company": "GENENTECH INC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/16\/2024",
  "drugName": "CHEMETNDA   #019998",
  "submission": "SUPPL-23",
  "activeIngredients": "SUCCIMER",
  "company": "RECORDATI RARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/16\/2024",
  "drugName": "SANCUSONDA   #022198",
  "submission": "SUPPL-23",
  "activeIngredients": "GRANISETRON",
  "company": "CUMBERLAND",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/16\/2024",
  "drugName": "ZYCLARANDA   #022483",
  "submission": "SUPPL-11",
  "activeIngredients": "IMIQUIMOD",
  "company": "BAUSCH",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/16\/2024",
  "drugName": "MEDROXYPROGESTERONE ACETATEANDA  #040159",
  "submission": "SUPPL-34",
  "activeIngredients": "MEDROXYPROGESTERONE ACETATE",
  "company": "BARR",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/16\/2024",
  "drugName": "BUPROPION HYDROCHLORIDEANDA  #077285",
  "submission": "SUPPL-42",
  "activeIngredients": "BUPROPION HYDROCHLORIDE",
  "company": "WATSON LABS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/16\/2024",
  "drugName": "BUPROPION HYDROCHLORIDEANDA  #077285",
  "submission": "SUPPL-45",
  "activeIngredients": "BUPROPION HYDROCHLORIDE",
  "company": "WATSON LABS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/16\/2024",
  "drugName": "LEVETIRACETAMANDA  #090992",
  "submission": "SUPPL-11",
  "activeIngredients": "LEVETIRACETAM",
  "company": "AMNEAL PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/16\/2024",
  "drugName": "LANSOPRAZOLEANDA  #200816",
  "submission": "SUPPL-4",
  "activeIngredients": "LANSOPRAZOLE",
  "company": "ZYDUS PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/16\/2024",
  "drugName": "LEVOFLOXACINANDA  #200839",
  "submission": "SUPPL-31",
  "activeIngredients": "LEVOFLOXACIN",
  "company": "MACLEODS PHARMS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/16\/2024",
  "drugName": "LEVOFLOXACINANDA  #200839",
  "submission": "SUPPL-33",
  "activeIngredients": "LEVOFLOXACIN",
  "company": "MACLEODS PHARMS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/16\/2024",
  "drugName": "LISDEXAMFETAMINE DIMESYLATEANDA  #202802",
  "submission": "SUPPL-2",
  "activeIngredients": "LISDEXAMFETAMINE DIMESYLATE",
  "company": "ACTAVIS ELIZABETH",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/16\/2024",
  "drugName": "LISDEXAMFETAMINE DIMESYLATEANDA  #202830",
  "submission": "SUPPL-2",
  "activeIngredients": "LISDEXAMFETAMINE DIMESYLATE",
  "company": "AMNEAL",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/16\/2024",
  "drugName": "EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATEANDA  #206436",
  "submission": "SUPPL-2",
  "activeIngredients": "EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE",
  "company": "PHARMOBEDIENT",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/16\/2024",
  "drugName": "EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATEANDA  #206436",
  "submission": "SUPPL-4",
  "activeIngredients": "EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE",
  "company": "PHARMOBEDIENT",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/16\/2024",
  "drugName": "EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATEANDA  #206436",
  "submission": "SUPPL-7",
  "activeIngredients": "EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE",
  "company": "PHARMOBEDIENT",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/16\/2024",
  "drugName": "EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATEANDA  #206436",
  "submission": "SUPPL-8",
  "activeIngredients": "EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE",
  "company": "PHARMOBEDIENT",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/16\/2024",
  "drugName": "CLOBAZAMANDA  #210039",
  "submission": "SUPPL-9",
  "activeIngredients": "CLOBAZAM",
  "company": "AMNEAL",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/16\/2024",
  "drugName": "TIMOLOL MALEATEANDA  #210640",
  "submission": "ORIG-1",
  "activeIngredients": "TIMOLOL MALEATE",
  "company": "SOMERSET THERAPS LLC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/16\/2024",
  "drugName": "FOSAPREPITANT DIMEGLUMINEANDA  #212143",
  "submission": "SUPPL-2",
  "activeIngredients": "FOSAPREPITANT DIMEGLUMINE",
  "company": "CHIA TAI TIANQING",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/16\/2024",
  "drugName": "LEVOTHYROXINE SODIUMANDA  #212399",
  "submission": "SUPPL-6",
  "activeIngredients": "LEVOTHYROXINE SODIUM",
  "company": "ACCORD HLTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/16\/2024",
  "drugName": "LEVOTHYROXINE SODIUMANDA  #212399",
  "submission": "SUPPL-8",
  "activeIngredients": "LEVOTHYROXINE SODIUM",
  "company": "ACCORD HLTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/16\/2024",
  "drugName": "SACUBITRIL AND VALSARTANANDA  #213764",
  "submission": "ORIG-1",
  "activeIngredients": "SACUBITRIL; VALSARTAN",
  "company": "ALKEM LABS LTD",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/16\/2024",
  "drugName": "SIROLIMUSANDA  #215080",
  "submission": "ORIG-1",
  "activeIngredients": "SIROLIMUS",
  "company": "HETERO LABS LTD V",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/16\/2024",
  "drugName": "LANREOTIDE ACETATENDA   #215395",
  "submission": "SUPPL-7",
  "activeIngredients": "LANREOTIDE ACETATE",
  "company": "INVAGEN PHARMS",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/16\/2024",
  "drugName": "CLOBAZAMANDA  #216008",
  "submission": "SUPPL-2",
  "activeIngredients": "CLOBAZAM",
  "company": "ACCORD HLTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/16\/2024",
  "drugName": "IYUZEHNDA   #216472",
  "submission": "SUPPL-2",
  "activeIngredients": "LATANOPROST",
  "company": "THEA PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/16\/2024",
  "drugName": "KETOCONAZOLEANDA  #218498",
  "submission": "ORIG-1",
  "activeIngredients": "KETOCONAZOLE",
  "company": "NOVITIUM PHARMA",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/17\/2024",
  "drugName": "TRACLEERNDA   #021290",
  "submission": "SUPPL-45",
  "activeIngredients": "BOSENTAN",
  "company": "ACTELION",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/17\/2024",
  "drugName": "LACTULOSEANDA  #075911",
  "submission": "SUPPL-12",
  "activeIngredients": "LACTULOSE",
  "company": "PHARMOBEDIENT",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/17\/2024",
  "drugName": "KEYTRUDABLA   #125514",
  "submission": "SUPPL-161",
  "activeIngredients": "PEMBROLIZUMAB",
  "company": "MERCK SHARP DOHME",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/17\/2024",
  "drugName": "DONEPEZIL HYDROCHLORIDEANDA  #200292",
  "submission": "SUPPL-9",
  "activeIngredients": "DONEPEZIL HYDROCHLORIDE",
  "company": "PRINSTON INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/17\/2024",
  "drugName": "DONEPEZIL HYDROCHLORIDEANDA  #200292",
  "submission": "SUPPL-11",
  "activeIngredients": "DONEPEZIL HYDROCHLORIDE",
  "company": "PRINSTON INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/17\/2024",
  "drugName": "BOSENTANANDA  #205699",
  "submission": "SUPPL-4",
  "activeIngredients": "BOSENTAN",
  "company": "PH HEALTH",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/17\/2024",
  "drugName": "BOSENTANANDA  #206987",
  "submission": "SUPPL-5",
  "activeIngredients": "BOSENTAN",
  "company": "NATCO PHARMA LTD",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/17\/2024",
  "drugName": "BOSENTANANDA  #207110",
  "submission": "SUPPL-8",
  "activeIngredients": "BOSENTAN",
  "company": "WATSON LABS INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/17\/2024",
  "drugName": "BOSENTANANDA  #207760",
  "submission": "SUPPL-10",
  "activeIngredients": "BOSENTAN",
  "company": "ZYDUS PHARMS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/17\/2024",
  "drugName": "KISQALINDA   #209092",
  "submission": "SUPPL-18",
  "activeIngredients": "RIBOCICLIB SUCCINATE",
  "company": "NOVARTIS",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/17\/2024",
  "drugName": "TRACLEERNDA   #209279",
  "submission": "SUPPL-11",
  "activeIngredients": "BOSENTAN",
  "company": "ACTELION",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/17\/2024",
  "drugName": "BOSENTANANDA  #209324",
  "submission": "SUPPL-10",
  "activeIngredients": "BOSENTAN",
  "company": "SUN PHARM",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/17\/2024",
  "drugName": "BOSENTANANDA  #209742",
  "submission": "SUPPL-9",
  "activeIngredients": "BOSENTAN",
  "company": "AMNEAL PHARMS CO",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/17\/2024",
  "drugName": "KISQALI FEMARA CO-PACK (COPACKAGED)NDA   #209935",
  "submission": "SUPPL-27",
  "activeIngredients": "LETROZOLE; RIBOCICLIB SUCCINATE",
  "company": "NOVARTIS",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/17\/2024",
  "drugName": "EVRYSDINDA   #213535",
  "submission": "SUPPL-13",
  "activeIngredients": "RISDIPLAM",
  "company": "GENENTECH INC",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/17\/2024",
  "drugName": "METYROSINEANDA  #215541",
  "submission": "ORIG-1",
  "activeIngredients": "METYROSINE",
  "company": "LEADING",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/17\/2024",
  "drugName": "PRAZOSIN HYDROCHLORIDEANDA  #216727",
  "submission": "ORIG-1",
  "activeIngredients": "PRAZOSIN HYDROCHLORIDE",
  "company": "MSN",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/17\/2024",
  "drugName": "ERTUGLIFLOZINANDA  #217071",
  "submission": "ORIG-1",
  "activeIngredients": "ERTUGLIFLOZIN",
  "company": "HETERO LABS LTD V",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/17\/2024",
  "drugName": "BUMETANIDEANDA  #217153",
  "submission": "ORIG-1",
  "activeIngredients": "BUMETANIDE",
  "company": "LUPIN LTD",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/17\/2024",
  "drugName": "DEXAMETHASONEANDA  #218372",
  "submission": "ORIG-1",
  "activeIngredients": "DEXAMETHASONE",
  "company": "COREPHARMA",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/17\/2024",
  "drugName": "FASENRABLA   #761070",
  "submission": "SUPPL-21",
  "activeIngredients": "BENRALIZUMAB",
  "company": "ASTRAZENECA AB",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/18\/2024",
  "drugName": "AMOXICILLINANDA  #065256",
  "submission": "SUPPL-27",
  "activeIngredients": "AMOXICILLIN",
  "company": "AUROBINDO",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/18\/2024",
  "drugName": "ATENOLOLANDA  #073457",
  "submission": "SUPPL-47",
  "activeIngredients": "ATENOLOL",
  "company": "MYLAN",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/18\/2024",
  "drugName": "CITALOPRAM HYDROBROMIDEANDA  #077033",
  "submission": "SUPPL-11",
  "activeIngredients": "CITALOPRAM HYDROBROMIDE",
  "company": "HERITAGE PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/18\/2024",
  "drugName": "CITALOPRAM HYDROBROMIDEANDA  #077033",
  "submission": "SUPPL-12",
  "activeIngredients": "CITALOPRAM HYDROBROMIDE",
  "company": "HERITAGE PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/18\/2024",
  "drugName": "CITALOPRAM HYDROBROMIDEANDA  #077141",
  "submission": "SUPPL-3",
  "activeIngredients": "CITALOPRAM HYDROBROMIDE",
  "company": "NATCO PHARMA LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/18\/2024",
  "drugName": "CITALOPRAM HYDROBROMIDEANDA  #077534",
  "submission": "SUPPL-25",
  "activeIngredients": "CITALOPRAM HYDROBROMIDE",
  "company": "INVAGEN PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/18\/2024",
  "drugName": "CITALOPRAM HYDROBROMIDEANDA  #078216",
  "submission": "SUPPL-39",
  "activeIngredients": "CITALOPRAM HYDROBROMIDE",
  "company": "TORRENT PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/18\/2024",
  "drugName": "CITALOPRAM HYDROBROMIDEANDA  #078216",
  "submission": "SUPPL-40",
  "activeIngredients": "CITALOPRAM HYDROBROMIDE",
  "company": "TORRENT PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/18\/2024",
  "drugName": "RHOPRESSANDA   #208254",
  "submission": "SUPPL-14",
  "activeIngredients": "NETARSUDIL MESYLATE",
  "company": "ALCON LABS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/18\/2024",
  "drugName": "BUMETANIDEANDA  #212931",
  "submission": "ORIG-1",
  "activeIngredients": "BUMETANIDE",
  "company": "APPCO",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/19\/2024",
  "drugName": "PYLERANDA   #050786",
  "submission": "SUPPL-27",
  "activeIngredients": "BISMUTH SUBCITRATE POTASSIUM; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE",
  "company": "LABS JUVISE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/19\/2024",
  "drugName": "CITALOPRAM HYDROBROMIDEANDA  #077038",
  "submission": "SUPPL-16",
  "activeIngredients": "CITALOPRAM HYDROBROMIDE",
  "company": "DR REDDYS LABS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/19\/2024",
  "drugName": "CITALOPRAM HYDROBROMIDEANDA  #077038",
  "submission": "SUPPL-17",
  "activeIngredients": "CITALOPRAM HYDROBROMIDE",
  "company": "DR REDDYS LABS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/19\/2024",
  "drugName": "CITALOPRAM HYDROBROMIDEANDA  #077038",
  "submission": "SUPPL-18",
  "activeIngredients": "CITALOPRAM HYDROBROMIDE",
  "company": "DR REDDYS LABS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/19\/2024",
  "drugName": "CITALOPRAM HYDROBROMIDEANDA  #077038",
  "submission": "SUPPL-19",
  "activeIngredients": "CITALOPRAM HYDROBROMIDE",
  "company": "DR REDDYS LABS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/19\/2024",
  "drugName": "CITALOPRAM HYDROBROMIDEANDA  #077042",
  "submission": "SUPPL-38",
  "activeIngredients": "CITALOPRAM HYDROBROMIDE",
  "company": "MYLAN",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/19\/2024",
  "drugName": "CITALOPRAM HYDROBROMIDEANDA  #077042",
  "submission": "SUPPL-43",
  "activeIngredients": "CITALOPRAM HYDROBROMIDE",
  "company": "MYLAN",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/19\/2024",
  "drugName": "CITALOPRAM HYDROBROMIDEANDA  #077289",
  "submission": "SUPPL-34",
  "activeIngredients": "CITALOPRAM HYDROBROMIDE",
  "company": "AMNEAL PHARMS NY",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/19\/2024",
  "drugName": "LAMIVUDINE AND ZIDOVUDINEANDA  #079124",
  "submission": "SUPPL-10",
  "activeIngredients": "LAMIVUDINE; ZIDOVUDINE",
  "company": "HETERO LABS LTD III",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/19\/2024",
  "drugName": "LAMIVUDINE AND ZIDOVUDINEANDA  #079124",
  "submission": "SUPPL-14",
  "activeIngredients": "LAMIVUDINE; ZIDOVUDINE",
  "company": "HETERO LABS LTD III",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/19\/2024",
  "drugName": "HYDROCHLOROTHIAZIDEANDA  #083177",
  "submission": "SUPPL-236",
  "activeIngredients": "HYDROCHLOROTHIAZIDE",
  "company": "IVAX SUB TEVA PHARMS",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/19\/2024",
  "drugName": "KINERETBLA   #103950",
  "submission": "SUPPL-5198",
  "activeIngredients": "ANAKINRA",
  "company": "BIOVITRUM AB",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/19\/2024",
  "drugName": "SOLIRISBLA   #125166",
  "submission": "SUPPL-447",
  "activeIngredients": "ECULIZUMAB",
  "company": "ALEXION PHARM",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/19\/2024",
  "drugName": "ACTEMRABLA   #125276",
  "submission": "SUPPL-148",
  "activeIngredients": "TOCILIZUMAB",
  "company": "GENENTECH",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/19\/2024",
  "drugName": "ACTEMRABLA   #125472",
  "submission": "SUPPL-60",
  "activeIngredients": "TOCILIZUMAB",
  "company": "GENENTECH",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/19\/2024",
  "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #201448",
  "submission": "SUPPL-3",
  "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
  "company": "SANKALP LIFECARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/19\/2024",
  "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #201448",
  "submission": "SUPPL-5",
  "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
  "company": "SANKALP LIFECARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/19\/2024",
  "drugName": "LANSOPRAZOLEANDA  #202319",
  "submission": "SUPPL-29",
  "activeIngredients": "LANSOPRAZOLE",
  "company": "PERRIGO R AND D",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/19\/2024",
  "drugName": "LANSOPRAZOLEANDA  #202319",
  "submission": "SUPPL-33",
  "activeIngredients": "LANSOPRAZOLE",
  "company": "PERRIGO R AND D",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/19\/2024",
  "drugName": "LANSOPRAZOLEANDA  #202319",
  "submission": "SUPPL-34",
  "activeIngredients": "LANSOPRAZOLE",
  "company": "PERRIGO R AND D",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/19\/2024",
  "drugName": "GATTEX KITNDA   #203441",
  "submission": "SUPPL-22",
  "activeIngredients": "TEDUGLUTIDE",
  "company": "TAKEDA PHARMS USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/19\/2024",
  "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #203864",
  "submission": "SUPPL-10",
  "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
  "company": "EPIC PHARMA LLC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/19\/2024",
  "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #207574",
  "submission": "SUPPL-12",
  "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
  "company": "SANALUZ",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/19\/2024",
  "drugName": "NALBUPHINE HYDROCHLORIDEANDA  #216049",
  "submission": "ORIG-1",
  "activeIngredients": "NALBUPHINE HYDROCHLORIDE",
  "company": "SOMERSET THERAPS LLC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/19\/2024",
  "drugName": "NALBUPHINE HYDROCHLORIDEANDA  #216050",
  "submission": "ORIG-1",
  "activeIngredients": "NALBUPHINE HYDROCHLORIDE",
  "company": "SOMERSET THERAPS LLC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/19\/2024",
  "drugName": "ENALAPRIL MALEATEANDA  #218531",
  "submission": "ORIG-1",
  "activeIngredients": "ENALAPRIL MALEATE",
  "company": "UNIQUE PHARM",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/19\/2024",
  "drugName": "BUMETANIDEANDA  #219116",
  "submission": "ORIG-1",
  "activeIngredients": "BUMETANIDE",
  "company": "QILU PHARM HAINAN",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/19\/2024",
  "drugName": "ULTOMIRISBLA   #761108",
  "submission": "SUPPL-37",
  "activeIngredients": "RAVULIZUMAB-CWVZ",
  "company": "ALEXION PHARM",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/19\/2024",
  "drugName": "RYBREVANTBLA   #761210",
  "submission": "SUPPL-4",
  "activeIngredients": "AMIVANTAMAB-VMJW",
  "company": "JANSSEN BIOTECH",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "DIAMOXNDA   #008943",
  "submission": "SUPPL-53",
  "activeIngredients": "ACETAZOLAMIDE",
  "company": "TEVA BRANDED PHARM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "DIAMOXNDA   #009388",
  "submission": "SUPPL-39",
  "activeIngredients": "ACETAZOLAMIDE SODIUM",
  "company": "TEVA WOMENS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "DIAMOXNDA   #012945",
  "submission": "SUPPL-48",
  "activeIngredients": "ACETAZOLAMIDE",
  "company": "TEVA BRANDED PHARM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "CIPRONDA   #019537",
  "submission": "SUPPL-95",
  "activeIngredients": "CIPROFLOXACIN HYDROCHLORIDE",
  "company": "BAYER HLTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "CIPRONDA   #019847",
  "submission": "SUPPL-64",
  "activeIngredients": "CIPROFLOXACIN",
  "company": "BAYER HLTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "CIPRONDA   #020780",
  "submission": "SUPPL-50",
  "activeIngredients": "CIPROFLOXACIN",
  "company": "BAYER HLTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "LEVOFLOXACINANDA  #076276",
  "submission": "SUPPL-11",
  "activeIngredients": "LEVOFLOXACIN",
  "company": "NATCO PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "LEVOFLOXACINANDA  #076361",
  "submission": "SUPPL-17",
  "activeIngredients": "LEVOFLOXACIN",
  "company": "TEVA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "LEVOFLOXACINANDA  #076710",
  "submission": "SUPPL-20",
  "activeIngredients": "LEVOFLOXACIN",
  "company": "DR REDDYS LABS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "CIPROFLOXACINANDA  #076717",
  "submission": "SUPPL-8",
  "activeIngredients": "CIPROFLOXACIN",
  "company": "HIKMA FARMACEUTICA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "CIPROFLOXACIN IN DEXTROSE 5%ANDA  #076757",
  "submission": "SUPPL-10",
  "activeIngredients": "CIPROFLOXACIN",
  "company": "HIKMA FARMACEUTICA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "LEVOFLOXACINANDA  #076890",
  "submission": "SUPPL-19",
  "activeIngredients": "LEVOFLOXACIN",
  "company": "CHARTWELL MOLECULAR",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "LEVOFLOXACINANDA  #077097",
  "submission": "SUPPL-11",
  "activeIngredients": "LEVOFLOXACIN",
  "company": "NATCO PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "LEVOFLOXACINANDA  #077438",
  "submission": "SUPPL-22",
  "activeIngredients": "LEVOFLOXACIN",
  "company": "SANDOZ",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "LEVOFLOXACINANDA  #077652",
  "submission": "SUPPL-20",
  "activeIngredients": "LEVOFLOXACIN",
  "company": "ZYDUS LIFESCIENCES",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "CIPROFLOXACIN EXTENDED RELEASEANDA  #077701",
  "submission": "SUPPL-17",
  "activeIngredients": "CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE",
  "company": "DR REDDYS LABS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINERANDA  #077753",
  "submission": "SUPPL-25",
  "activeIngredients": "CIPROFLOXACIN",
  "company": "HOSPIRA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "CIPROFLOXACINANDA  #077782",
  "submission": "SUPPL-21",
  "activeIngredients": "CIPROFLOXACIN",
  "company": "DR REDDYS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "CIPROFLOXACIN EXTENDED RELEASEANDA  #077809",
  "submission": "SUPPL-10",
  "activeIngredients": "CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE",
  "company": "ANI PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINERANDA  #078024",
  "submission": "SUPPL-40",
  "activeIngredients": "CIPROFLOXACIN",
  "company": "BAXTER HLTHCARE CORP",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "CIPROFLOXACIN EXTENDED RELEASEANDA  #078166",
  "submission": "SUPPL-17",
  "activeIngredients": "CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE",
  "company": "PH HEALTH",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "CIPROFLOXACIN EXTENDED RELEASEANDA  #078183",
  "submission": "SUPPL-25",
  "activeIngredients": "CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE",
  "company": "RISING",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "LEVOFLOXACINANDA  #078424",
  "submission": "SUPPL-22",
  "activeIngredients": "LEVOFLOXACIN",
  "company": "LUPIN",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINERANDA  #078431",
  "submission": "SUPPL-11",
  "activeIngredients": "CIPROFLOXACIN",
  "company": "HIKMA FARMACEUTICA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINERANDA  #078579",
  "submission": "SUPPL-9",
  "activeIngredients": "LEVOFLOXACIN",
  "company": "HOSPIRA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "CIPROFLOXACIN EXTENDED RELEASEANDA  #078712",
  "submission": "SUPPL-7",
  "activeIngredients": "CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE",
  "company": "FOSUN PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "GEMIFLOXACIN MESYLATEANDA  #090466",
  "submission": "SUPPL-4",
  "activeIngredients": "GEMIFLOXACIN MESYLATE",
  "company": "ORBION PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "TACROLIMUSANDA  #090596",
  "submission": "SUPPL-28",
  "activeIngredients": "TACROLIMUS",
  "company": "MYLAN",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "LEVOFLOXACINANDA  #090722",
  "submission": "SUPPL-16",
  "activeIngredients": "LEVOFLOXACIN",
  "company": "TORRENT PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "LEVOFLOXACINANDA  #090787",
  "submission": "SUPPL-14",
  "activeIngredients": "LEVOFLOXACIN",
  "company": "APOTEX INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINERANDA  #091375",
  "submission": "SUPPL-23",
  "activeIngredients": "LEVOFLOXACIN",
  "company": "HIKMA FARMACEUTICA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINERANDA  #091397",
  "submission": "SUPPL-24",
  "activeIngredients": "LEVOFLOXACIN",
  "company": "BAXTER HLTHCARE CORP",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "LEVOFLOXACINANDA  #091436",
  "submission": "SUPPL-14",
  "activeIngredients": "LEVOFLOXACIN",
  "company": "BAXTER HLTHCARE CORP",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "LEVOFLOXACINANDA  #091644",
  "submission": "SUPPL-19",
  "activeIngredients": "LEVOFLOXACIN",
  "company": "RISING",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "LEVOFLOXACINANDA  #091678",
  "submission": "SUPPL-12",
  "activeIngredients": "LEVOFLOXACIN",
  "company": "NOVITIUM PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "ACTEMRABLA   #125276",
  "submission": "SUPPL-144",
  "activeIngredients": "TOCILIZUMAB",
  "company": "GENENTECH",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "ACTEMRABLA   #125472",
  "submission": "SUPPL-56",
  "activeIngredients": "TOCILIZUMAB",
  "company": "GENENTECH",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "LEVOFLOXACINANDA  #200250",
  "submission": "SUPPL-7",
  "activeIngredients": "LEVOFLOXACIN",
  "company": "GLENMARK PHARMS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "LEVOFLOXACINANDA  #200560",
  "submission": "SUPPL-14",
  "activeIngredients": "LEVOFLOXACIN",
  "company": "PHARMOBEDIENT",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINERANDA  #200674",
  "submission": "SUPPL-13",
  "activeIngredients": "LEVOFLOXACIN",
  "company": "FRESENIUS KABI USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "LEVOFLOXACINANDA  #200839",
  "submission": "SUPPL-42",
  "activeIngredients": "LEVOFLOXACIN",
  "company": "MACLEODS PHARMS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "LEVOFLOXACINANDA  #201043",
  "submission": "SUPPL-34",
  "activeIngredients": "LEVOFLOXACIN",
  "company": "AUROBINDO PHARMA LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "LEVOFLOXACINANDA  #202200",
  "submission": "SUPPL-11",
  "activeIngredients": "LEVOFLOXACIN",
  "company": "ORBION PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "LEVOFLOXACINANDA  #202328",
  "submission": "SUPPL-14",
  "activeIngredients": "LEVOFLOXACIN",
  "company": "EUGIA PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "LEVOFLOXACINANDA  #202590",
  "submission": "SUPPL-12",
  "activeIngredients": "LEVOFLOXACIN",
  "company": "AVET LIFESCIENCES",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "LEVOFLOXACINANDA  #202801",
  "submission": "SUPPL-16",
  "activeIngredients": "LEVOFLOXACIN",
  "company": "HETERO LABS LTD V",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "LEVOFLOXACINANDA  #203613",
  "submission": "SUPPL-12",
  "activeIngredients": "LEVOFLOXACIN",
  "company": "JUBILANT GENERICS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "LEVOFLOXACINANDA  #204968",
  "submission": "SUPPL-2",
  "activeIngredients": "LEVOFLOXACIN",
  "company": "HEC PHARM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "LEVOFLOXACINANDA  #205222",
  "submission": "SUPPL-11",
  "activeIngredients": "LEVOFLOXACIN",
  "company": "LANNETT CO INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "LEVOFLOXACINANDA  #205540",
  "submission": "SUPPL-1",
  "activeIngredients": "LEVOFLOXACIN",
  "company": "GLAND",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "LEVOFLOXACINANDA  #205968",
  "submission": "SUPPL-5",
  "activeIngredients": "LEVOFLOXACIN",
  "company": "ZYDUS PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "CEVIMELINE HYDROCHLORIDEANDA  #206808",
  "submission": "ORIG-1",
  "activeIngredients": "CEVIMELINE HYDROCHLORIDE",
  "company": "MACLEODS PHARMS LTD",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINERANDA  #206908",
  "submission": "SUPPL-1",
  "activeIngredients": "LEVOFLOXACIN",
  "company": "GLAND",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINERANDA  #206919",
  "submission": "SUPPL-9",
  "activeIngredients": "LEVOFLOXACIN",
  "company": "EUGIA PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "DIHYDROERGOTAMINE MESYLATEANDA  #212334",
  "submission": "ORIG-1",
  "activeIngredients": "DIHYDROERGOTAMINE MESYLATE",
  "company": "CIPLA",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "VOCABRIANDA   #212887",
  "submission": "SUPPL-9",
  "activeIngredients": "CABOTEGRAVIR SODIUM",
  "company": "VIIV HLTHCARE",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "VOCABRIANDA   #212887",
  "submission": "SUPPL-10",
  "activeIngredients": "CABOTEGRAVIR SODIUM",
  "company": "VIIV HLTHCARE",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "CABENUVA KITNDA   #212888",
  "submission": "SUPPL-15",
  "activeIngredients": "CABOTEGRAVIR; RILPIVIRINE",
  "company": "VIIV HLTHCARE",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "CALCITONIN-SALMONANDA  #213766",
  "submission": "ORIG-1",
  "activeIngredients": "CALCITONIN SALMON",
  "company": "CIPLA",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "FEXINIDAZOLENDA   #214429",
  "submission": "SUPPL-3",
  "activeIngredients": "FEXINIDAZOLE",
  "company": "SANOFI",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "FEXINIDAZOLENDA   #214429",
  "submission": "SUPPL-4",
  "activeIngredients": "FEXINIDAZOLE",
  "company": "SANOFI",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "MIPLYFFANDA   #214927",
  "submission": "ORIG-1",
  "activeIngredients": "ARIMOCLOMOL CITRATE",
  "company": "ZEVRA DENMARK",
  "submissionClassification": "Type 1 - New Molecular Entity",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "CLOPIDOGREL BISULFATEANDA  #215388",
  "submission": "ORIG-1",
  "activeIngredients": "CLOPIDOGREL BISULFATE",
  "company": "MSN",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "APRETUDENDA   #215499",
  "submission": "SUPPL-8",
  "activeIngredients": "CABOTEGRAVIR",
  "company": "VIIV HLTHCARE",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINERANDA  #216164",
  "submission": "SUPPL-1",
  "activeIngredients": "LEVOFLOXACIN",
  "company": "KNACK",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "SARCLISABLA   #761113",
  "submission": "SUPPL-14",
  "activeIngredients": "ISATUXIMAB-IRFC",
  "company": "SANOFI AVENTIS US",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "BIMZELXBLA   #761151",
  "submission": "SUPPL-5",
  "activeIngredients": "BIMEKIZUMAB-BKZX",
  "company": "UCB INC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "BIMZELXBLA   #761151",
  "submission": "SUPPL-6",
  "activeIngredients": "BIMEKIZUMAB-BKZX",
  "company": "UCB INC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/20\/2024",
  "drugName": "BIMZELXBLA   #761151",
  "submission": "SUPPL-7",
  "activeIngredients": "BIMEKIZUMAB-BKZX",
  "company": "UCB INC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/23\/2024",
  "drugName": "GANIRELIX ACETATENDA   #021057",
  "submission": "SUPPL-24",
  "activeIngredients": "GANIRELIX ACETATE",
  "company": "ORGANON USA ORGANON",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/23\/2024",
  "drugName": "HYDROXYUREAANDA  #075143",
  "submission": "SUPPL-20",
  "activeIngredients": "HYDROXYUREA",
  "company": "BARR",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/23\/2024",
  "drugName": "HYDROXYUREAANDA  #075143",
  "submission": "SUPPL-21",
  "activeIngredients": "HYDROXYUREA",
  "company": "BARR",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/23\/2024",
  "drugName": "HYDROXYUREAANDA  #075143",
  "submission": "SUPPL-22",
  "activeIngredients": "HYDROXYUREA",
  "company": "BARR",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/23\/2024",
  "drugName": "HYDROXYUREAANDA  #075143",
  "submission": "SUPPL-24",
  "activeIngredients": "HYDROXYUREA",
  "company": "BARR",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/23\/2024",
  "drugName": "HYDROXYUREAANDA  #075143",
  "submission": "SUPPL-27",
  "activeIngredients": "HYDROXYUREA",
  "company": "BARR",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/23\/2024",
  "drugName": "HYDROXYUREAANDA  #075143",
  "submission": "SUPPL-28",
  "activeIngredients": "HYDROXYUREA",
  "company": "BARR",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/23\/2024",
  "drugName": "HYDROXYUREAANDA  #075143",
  "submission": "SUPPL-29",
  "activeIngredients": "HYDROXYUREA",
  "company": "BARR",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/23\/2024",
  "drugName": "CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINERANDA  #078252",
  "submission": "SUPPL-33",
  "activeIngredients": "CIPROFLOXACIN",
  "company": "INFORLIFE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/23\/2024",
  "drugName": "CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINERANDA  #078252",
  "submission": "SUPPL-38",
  "activeIngredients": "CIPROFLOXACIN",
  "company": "INFORLIFE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/23\/2024",
  "drugName": "LINEZOLIDANDA  #078987",
  "submission": "SUPPL-5",
  "activeIngredients": "LINEZOLID",
  "company": "GLENMARK SPECLT",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/23\/2024",
  "drugName": "LINEZOLIDANDA  #078987",
  "submission": "SUPPL-6",
  "activeIngredients": "LINEZOLID",
  "company": "GLENMARK SPECLT",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/23\/2024",
  "drugName": "LINEZOLIDANDA  #078987",
  "submission": "SUPPL-7",
  "activeIngredients": "LINEZOLID",
  "company": "GLENMARK SPECLT",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/23\/2024",
  "drugName": "LINEZOLIDANDA  #078987",
  "submission": "SUPPL-8",
  "activeIngredients": "LINEZOLID",
  "company": "GLENMARK SPECLT",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/23\/2024",
  "drugName": "LINEZOLIDANDA  #078987",
  "submission": "SUPPL-9",
  "activeIngredients": "LINEZOLID",
  "company": "GLENMARK SPECLT",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/23\/2024",
  "drugName": "LINEZOLIDANDA  #078987",
  "submission": "SUPPL-10",
  "activeIngredients": "LINEZOLID",
  "company": "GLENMARK SPECLT",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/23\/2024",
  "drugName": "LEFLUNOMIDEANDA  #091369",
  "submission": "SUPPL-1",
  "activeIngredients": "LEFLUNOMIDE",
  "company": "ALEMBIC PHARMS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/23\/2024",
  "drugName": "LEFLUNOMIDEANDA  #091369",
  "submission": "SUPPL-2",
  "activeIngredients": "LEFLUNOMIDE",
  "company": "ALEMBIC PHARMS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/23\/2024",
  "drugName": "LEFLUNOMIDEANDA  #091369",
  "submission": "SUPPL-4",
  "activeIngredients": "LEFLUNOMIDE",
  "company": "ALEMBIC PHARMS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/23\/2024",
  "drugName": "LEFLUNOMIDEANDA  #091369",
  "submission": "SUPPL-5",
  "activeIngredients": "LEFLUNOMIDE",
  "company": "ALEMBIC PHARMS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/23\/2024",
  "drugName": "LEFLUNOMIDEANDA  #091369",
  "submission": "SUPPL-22",
  "activeIngredients": "LEFLUNOMIDE",
  "company": "ALEMBIC PHARMS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/23\/2024",
  "drugName": "EZETIMIBEANDA  #203931",
  "submission": "SUPPL-5",
  "activeIngredients": "EZETIMIBE",
  "company": "SANDOZ",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/23\/2024",
  "drugName": "AFATINIBANDA  #210770",
  "submission": "ORIG-1",
  "activeIngredients": "AFATINIB",
  "company": "EUGIA PHARMA SPECLTS",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "09\/23\/2024",
  "drugName": "ATENOLOL AND CHLORTHALIDONEANDA  #215560",
  "submission": "SUPPL-10",
  "activeIngredients": "ATENOLOL; CHLORTHALIDONE",
  "company": "NOVITIUM PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/23\/2024",
  "drugName": "TRAVOPROSTANDA  #217228",
  "submission": "ORIG-1",
  "activeIngredients": "TRAVOPROST",
  "company": "SOMERSET THERAPS LLC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/23\/2024",
  "drugName": "FOSTAMATINIBANDA  #217329",
  "submission": "ORIG-1",
  "activeIngredients": "FOSTAMATINIB",
  "company": "ANNORA PHARMA",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "09\/23\/2024",
  "drugName": "TRUQAPNDA   #218197",
  "submission": "SUPPL-1",
  "activeIngredients": "CAPIVASERTIB",
  "company": "ASTRAZENECA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/24\/2024",
  "drugName": "DESOXYNNDA   #005378",
  "submission": "SUPPL-32",
  "activeIngredients": "METHAMPHETAMINE HYDROCHLORIDE",
  "company": "AJENAT PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/24\/2024",
  "drugName": "CARVEDILOLANDA  #078227",
  "submission": "SUPPL-16",
  "activeIngredients": "CARVEDILOL",
  "company": "SANDOZ",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/24\/2024",
  "drugName": "GEMCITABINE HYDROCHLORIDEANDA  #078339",
  "submission": "SUPPL-18",
  "activeIngredients": "GEMCITABINE HYDROCHLORIDE",
  "company": "HOSPIRA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/24\/2024",
  "drugName": "GEMCITABINE HYDROCHLORIDEANDA  #078433",
  "submission": "SUPPL-13",
  "activeIngredients": "GEMCITABINE HYDROCHLORIDE",
  "company": "SUN PHARM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/24\/2024",
  "drugName": "GEMCITABINE HYDROCHLORIDEANDA  #078759",
  "submission": "SUPPL-9",
  "activeIngredients": "GEMCITABINE HYDROCHLORIDE",
  "company": "TEYRO LABS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/24\/2024",
  "drugName": "FLUVASTATIN SODIUMANDA  #079011",
  "submission": "SUPPL-7",
  "activeIngredients": "FLUVASTATIN SODIUM",
  "company": "TEVA PHARMS USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/24\/2024",
  "drugName": "GEMCITABINE HYDROCHLORIDEANDA  #079160",
  "submission": "SUPPL-13",
  "activeIngredients": "GEMCITABINE HYDROCHLORIDE",
  "company": "ACTAVIS TOTOWA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/24\/2024",
  "drugName": "GEMCITABINE HYDROCHLORIDEANDA  #079183",
  "submission": "SUPPL-14",
  "activeIngredients": "GEMCITABINE HYDROCHLORIDE",
  "company": "HOSPIRA INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/24\/2024",
  "drugName": "GEMCITABINE HYDROCHLORIDEANDA  #090242",
  "submission": "SUPPL-8",
  "activeIngredients": "GEMCITABINE HYDROCHLORIDE",
  "company": "FRESENIUS KABI USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/24\/2024",
  "drugName": "GEMCITABINE HYDROCHLORIDEANDA  #090799",
  "submission": "SUPPL-20",
  "activeIngredients": "GEMCITABINE HYDROCHLORIDE",
  "company": "FRESENIUS KABI USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/24\/2024",
  "drugName": "GEMCITABINE HYDROCHLORIDEANDA  #091365",
  "submission": "SUPPL-13",
  "activeIngredients": "GEMCITABINE HYDROCHLORIDE",
  "company": "DR REDDYS LABS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/24\/2024",
  "drugName": "GEMCITABINE HYDROCHLORIDEANDA  #091594",
  "submission": "SUPPL-16",
  "activeIngredients": "GEMCITABINE HYDROCHLORIDE",
  "company": "ACCORD HLTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/24\/2024",
  "drugName": "GEMCITABINE HYDROCHLORIDEANDA  #091594",
  "submission": "SUPPL-17",
  "activeIngredients": "GEMCITABINE HYDROCHLORIDE",
  "company": "ACCORD HLTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/24\/2024",
  "drugName": "GEMCITABINE HYDROCHLORIDEANDA  #200145",
  "submission": "SUPPL-15",
  "activeIngredients": "GEMCITABINE HYDROCHLORIDE",
  "company": "PHARMOBEDIENT",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/24\/2024",
  "drugName": "FELBAMATEANDA  #201680",
  "submission": "SUPPL-14",
  "activeIngredients": "FELBAMATE",
  "company": "AMNEAL PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/24\/2024",
  "drugName": "GEMCITABINE HYDROCHLORIDEANDA  #202485",
  "submission": "SUPPL-18",
  "activeIngredients": "GEMCITABINE HYDROCHLORIDE",
  "company": "JIANGSU HANSOH PHARM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/24\/2024",
  "drugName": "GEMCITABINE HYDROCHLORIDEANDA  #202997",
  "submission": "SUPPL-2",
  "activeIngredients": "GEMCITABINE HYDROCHLORIDE",
  "company": "DR REDDYS LABS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/24\/2024",
  "drugName": "GEMCITABINE HYDROCHLORIDEANDA  #204520",
  "submission": "SUPPL-11",
  "activeIngredients": "GEMCITABINE HYDROCHLORIDE",
  "company": "GLAND",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/24\/2024",
  "drugName": "GEMCITABINE HYDROCHLORIDEANDA  #206617",
  "submission": "SUPPL-3",
  "activeIngredients": "GEMCITABINE HYDROCHLORIDE",
  "company": "HIKMA INTL PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/24\/2024",
  "drugName": "GEMCITABINE HYDROCHLORIDEANDA  #207575",
  "submission": "SUPPL-2",
  "activeIngredients": "GEMCITABINE HYDROCHLORIDE",
  "company": "SHILPA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/24\/2024",
  "drugName": "INFUGEMNDA   #208313",
  "submission": "SUPPL-7",
  "activeIngredients": "GEMCITABINE HYDROCHLORIDE",
  "company": "SUN PHARM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/24\/2024",
  "drugName": "GEMCITABINE HYDROCHLORIDENDA   #209604",
  "submission": "SUPPL-11",
  "activeIngredients": "GEMCITABINE HYDROCHLORIDE",
  "company": "ACCORD HLTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/24\/2024",
  "drugName": "LEVOTHYROXINE SODIUMANDA  #209713",
  "submission": "SUPPL-32",
  "activeIngredients": "LEVOTHYROXINE SODIUM",
  "company": "LUPIN",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/24\/2024",
  "drugName": "CLOBAZAMANDA  #212714",
  "submission": "SUPPL-6",
  "activeIngredients": "CLOBAZAM",
  "company": "ALKEM LABS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/24\/2024",
  "drugName": "CLOBAZAMANDA  #212714",
  "submission": "SUPPL-7",
  "activeIngredients": "CLOBAZAM",
  "company": "ALKEM LABS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/24\/2024",
  "drugName": "NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDEANDA  #215592",
  "submission": "ORIG-1",
  "activeIngredients": "NICARDIPINE HYDROCHLORIDE",
  "company": "CIPLA",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/24\/2024",
  "drugName": "FLUOROURACILANDA  #216494",
  "submission": "ORIG-1",
  "activeIngredients": "FLUOROURACIL",
  "company": "KINDOS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/24\/2024",
  "drugName": "DEXMEDETOMIDINE HYDROCHLORIDEANDA  #218112",
  "submission": "ORIG-1",
  "activeIngredients": "DEXMEDETOMIDINE HYDROCHLORIDE",
  "company": "SOMERSET",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/24\/2024",
  "drugName": "CHLORPROMAZINE HYDROCHLORIDEANDA  #218229",
  "submission": "ORIG-1",
  "activeIngredients": "CHLORPROMAZINE HYDROCHLORIDE",
  "company": "DEVA HLDING",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/24\/2024",
  "drugName": "SUCCINYLCHOLINE CHLORIDEANDA  #218878",
  "submission": "ORIG-1",
  "activeIngredients": "SUCCINYLCHOLINE CHLORIDE",
  "company": "BAXTER HLTHCARE CORP",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/24\/2024",
  "drugName": "AQNEURSANDA   #219132",
  "submission": "ORIG-1",
  "activeIngredients": "LEVACETYLLEUCINE",
  "company": "INTRABIO",
  "submissionClassification": "Type 1 - New Molecular Entity",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/25\/2024",
  "drugName": "ALDARANDA   #020723",
  "submission": "SUPPL-28",
  "activeIngredients": "IMIQUIMOD",
  "company": "BAUSCH",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/25\/2024",
  "drugName": "HYDROCORTISONEANDA  #040646",
  "submission": "SUPPL-7",
  "activeIngredients": "HYDROCORTISONE",
  "company": "IMPAX LABS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/25\/2024",
  "drugName": "HYDROCORTISONEANDA  #040646",
  "submission": "SUPPL-8",
  "activeIngredients": "HYDROCORTISONE",
  "company": "IMPAX LABS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/25\/2024",
  "drugName": "OCTREOTIDE ACETATEANDA  #077450",
  "submission": "SUPPL-18",
  "activeIngredients": "OCTREOTIDE ACETATE",
  "company": "FRESENIUS KABI USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/25\/2024",
  "drugName": "OCTREOTIDE ACETATEANDA  #077450",
  "submission": "SUPPL-21",
  "activeIngredients": "OCTREOTIDE ACETATE",
  "company": "FRESENIUS KABI USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/25\/2024",
  "drugName": "OCTREOTIDE ACETATE (PRESERVATIVE FREE)ANDA  #077457",
  "submission": "SUPPL-21",
  "activeIngredients": "OCTREOTIDE ACETATE",
  "company": "FRESENIUS KABI USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/25\/2024",
  "drugName": "OCTREOTIDE ACETATE (PRESERVATIVE FREE)ANDA  #077457",
  "submission": "SUPPL-24",
  "activeIngredients": "OCTREOTIDE ACETATE",
  "company": "FRESENIUS KABI USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/25\/2024",
  "drugName": "METOPROLOL TARTRATEANDA  #202871",
  "submission": "SUPPL-25",
  "activeIngredients": "METOPROLOL TARTRATE",
  "company": "ALEMBIC PHARMS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/25\/2024",
  "drugName": "GLATIRAMER ACETATEANDA  #203857",
  "submission": "ORIG-1",
  "activeIngredients": "GLATIRAMER ACETATE",
  "company": "SYNTHON PHARMS INC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/25\/2024",
  "drugName": "GLATIRAMER ACETATEANDA  #206873",
  "submission": "ORIG-1",
  "activeIngredients": "GLATIRAMER ACETATE",
  "company": "SYNTHON PHARMS INC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/25\/2024",
  "drugName": "VORICONAZOLEANDA  #207371",
  "submission": "SUPPL-9",
  "activeIngredients": "VORICONAZOLE",
  "company": "CHARTWELL RX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/25\/2024",
  "drugName": "VORICONAZOLEANDA  #207371",
  "submission": "SUPPL-10",
  "activeIngredients": "VORICONAZOLE",
  "company": "CHARTWELL RX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/25\/2024",
  "drugName": "VORICONAZOLEANDA  #207371",
  "submission": "SUPPL-11",
  "activeIngredients": "VORICONAZOLE",
  "company": "CHARTWELL RX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/25\/2024",
  "drugName": "METHYLPREDNISOLONEANDA  #207481",
  "submission": "SUPPL-1",
  "activeIngredients": "METHYLPREDNISOLONE",
  "company": "AMNEAL",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/25\/2024",
  "drugName": "TAGRISSONDA   #208065",
  "submission": "SUPPL-33",
  "activeIngredients": "OSIMERTINIB MESYLATE",
  "company": "ASTRAZENECA",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/25\/2024",
  "drugName": "LISDEXAMFETAMINE DIMESYLATEANDA  #211840",
  "submission": "SUPPL-2",
  "activeIngredients": "LISDEXAMFETAMINE DIMESYLATE",
  "company": "SPECGX LLC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/25\/2024",
  "drugName": "LISDEXAMFETAMINE DIMESYLATEANDA  #217194",
  "submission": "SUPPL-2",
  "activeIngredients": "LISDEXAMFETAMINE DIMESYLATE",
  "company": "ALKEM LABS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/25\/2024",
  "drugName": "WAINUA (AUTOINJECTOR)NDA   #217388",
  "submission": "SUPPL-2",
  "activeIngredients": "EPLONTERSEN SODIUM",
  "company": "ASTRAZENECA AB",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/26\/2024",
  "drugName": "HYDROXYZINE HYDROCHLORIDEANDA  #040391",
  "submission": "SUPPL-11",
  "activeIngredients": "HYDROXYZINE HYDROCHLORIDE",
  "company": "PAI HOLDINGS PHARM",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/26\/2024",
  "drugName": "NALBUPHINE HYDROCHLORIDEANDA  #074471",
  "submission": "SUPPL-8",
  "activeIngredients": "NALBUPHINE HYDROCHLORIDE",
  "company": "DR REDDYS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/26\/2024",
  "drugName": "DICLOFENAC POTASSIUMANDA  #075219",
  "submission": "SUPPL-20",
  "activeIngredients": "DICLOFENAC POTASSIUM",
  "company": "TEVA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/26\/2024",
  "drugName": "LEFLUNOMIDEANDA  #077090",
  "submission": "SUPPL-15",
  "activeIngredients": "LEFLUNOMIDE",
  "company": "APOTEX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/26\/2024",
  "drugName": "DICLOFENAC SODIUMANDA  #077863",
  "submission": "SUPPL-19",
  "activeIngredients": "DICLOFENAC SODIUM",
  "company": "UNIQUE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/26\/2024",
  "drugName": "CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINERANDA  #078252",
  "submission": "SUPPL-40",
  "activeIngredients": "CIPROFLOXACIN",
  "company": "INFORLIFE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/26\/2024",
  "drugName": "DICLOFENAC SODIUMANDA  #090066",
  "submission": "SUPPL-14",
  "activeIngredients": "DICLOFENAC SODIUM",
  "company": "UNIQUE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/26\/2024",
  "drugName": "LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINERANDA  #090343",
  "submission": "SUPPL-32",
  "activeIngredients": "LEVOFLOXACIN",
  "company": "INFORLIFE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/26\/2024",
  "drugName": "GABAPENTINANDA  #200651",
  "submission": "SUPPL-32",
  "activeIngredients": "GABAPENTIN",
  "company": "AUROBINDO PHARMA LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/26\/2024",
  "drugName": "LAMOTRIGINEANDA  #204499",
  "submission": "ORIG-1",
  "activeIngredients": "LAMOTRIGINE",
  "company": "IPCA LABS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/26\/2024",
  "drugName": "GABAPENTINANDA  #209306",
  "submission": "SUPPL-4",
  "activeIngredients": "GABAPENTIN",
  "company": "LUPIN LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/26\/2024",
  "drugName": "ENZALUTAMIDEANDA  #209667",
  "submission": "ORIG-1",
  "activeIngredients": "ENZALUTAMIDE",
  "company": "ZYDUS PHARMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/26\/2024",
  "drugName": "POMALIDOMIDEANDA  #210236",
  "submission": "ORIG-1",
  "activeIngredients": "POMALIDOMIDE",
  "company": "HETERO LABS LTD V",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/26\/2024",
  "drugName": "BAFIERTAMNDA   #210296",
  "submission": "SUPPL-7",
  "activeIngredients": "MONOMETHYL FUMARATE",
  "company": "BANNER LIFE SCIENCES",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/26\/2024",
  "drugName": "LEFLUNOMIDEANDA  #212308",
  "submission": "SUPPL-1",
  "activeIngredients": "LEFLUNOMIDE",
  "company": "ZYDUS LIFESCIENCES",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/26\/2024",
  "drugName": "CLOBAZAMANDA  #212398",
  "submission": "SUPPL-4",
  "activeIngredients": "CLOBAZAM",
  "company": "ACCORD HLTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/26\/2024",
  "drugName": "LEFLUNOMIDEANDA  #213652",
  "submission": "SUPPL-2",
  "activeIngredients": "LEFLUNOMIDE",
  "company": "AUROBINDO PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/26\/2024",
  "drugName": "LUMRYZNDA   #214755",
  "submission": "SUPPL-7",
  "activeIngredients": "SODIUM OXYBATE",
  "company": "AVADEL CNS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/26\/2024",
  "drugName": "AMINOCAPROIC ACIDANDA  #215100",
  "submission": "ORIG-1",
  "activeIngredients": "AMINOCAPROIC ACID",
  "company": "MSN",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/26\/2024",
  "drugName": "COBENFYNDA   #216158",
  "submission": "ORIG-1",
  "activeIngredients": "TROSPIUM CHLORIDE; XANOMELINE TARTRATE",
  "company": "BRISTOL-MYERS",
  "submissionClassification": "Type 1 - New Molecular Entity",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/26\/2024",
  "drugName": "GABAPENTINANDA  #217682",
  "submission": "SUPPL-2",
  "activeIngredients": "GABAPENTIN",
  "company": "ANNORA PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/26\/2024",
  "drugName": "MYCOPHENOLATE MOFETILANDA  #218227",
  "submission": "ORIG-1",
  "activeIngredients": "MYCOPHENOLATE MOFETIL",
  "company": "AUROBINDO PHARMA LTD",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/26\/2024",
  "drugName": "PALIPERIDONEANDA  #218330",
  "submission": "ORIG-1",
  "activeIngredients": "PALIPERIDONE",
  "company": "ALEMBIC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/26\/2024",
  "drugName": "AMANTADINE HYDROCHLORIDEANDA  #218598",
  "submission": "ORIG-1",
  "activeIngredients": "AMANTADINE HYDROCHLORIDE",
  "company": "ZHEJIANG JUTAI PHARM",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/27\/2024",
  "drugName": "DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATEANDA  #040357",
  "submission": "SUPPL-3",
  "activeIngredients": "ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE",
  "company": "STRIDES PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/27\/2024",
  "drugName": "AMPICILLIN AND SULBACTAMANDA  #065240",
  "submission": "SUPPL-27",
  "activeIngredients": "AMPICILLIN SODIUM; SULBACTAM SODIUM",
  "company": "SANDOZ",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/27\/2024",
  "drugName": "AMPICILLIN AND SULBACTAMANDA  #065241",
  "submission": "SUPPL-27",
  "activeIngredients": "AMPICILLIN SODIUM; SULBACTAM SODIUM",
  "company": "SANDOZ",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/27\/2024",
  "drugName": "AMPICILLIN AND SULBACTAMANDA  #065403",
  "submission": "SUPPL-11",
  "activeIngredients": "AMPICILLIN SODIUM; SULBACTAM SODIUM",
  "company": "ACS DOBFAR",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/27\/2024",
  "drugName": "AMPICILLIN AND SULBACTAMANDA  #065403",
  "submission": "SUPPL-13",
  "activeIngredients": "AMPICILLIN SODIUM; SULBACTAM SODIUM",
  "company": "ACS DOBFAR",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/27\/2024",
  "drugName": "AMPICILLIN AND SULBACTAMANDA  #065403",
  "submission": "SUPPL-16",
  "activeIngredients": "AMPICILLIN SODIUM; SULBACTAM SODIUM",
  "company": "ACS DOBFAR",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/27\/2024",
  "drugName": "AMPICILLIN AND SULBACTAMANDA  #065403",
  "submission": "SUPPL-19",
  "activeIngredients": "AMPICILLIN SODIUM; SULBACTAM SODIUM",
  "company": "ACS DOBFAR",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/27\/2024",
  "drugName": "DOXAZOSIN MESYLATEANDA  #075580",
  "submission": "SUPPL-24",
  "activeIngredients": "DOXAZOSIN MESYLATE",
  "company": "APOTEX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/27\/2024",
  "drugName": "DOXAZOSIN MESYLATEANDA  #075580",
  "submission": "SUPPL-25",
  "activeIngredients": "DOXAZOSIN MESYLATE",
  "company": "APOTEX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/27\/2024",
  "drugName": "RILUZOLEANDA  #076173",
  "submission": "SUPPL-8",
  "activeIngredients": "RILUZOLE",
  "company": "IMPAX LABS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/27\/2024",
  "drugName": "RILUZOLEANDA  #076173",
  "submission": "SUPPL-10",
  "activeIngredients": "RILUZOLE",
  "company": "IMPAX LABS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/27\/2024",
  "drugName": "NATEGLINIDEANDA  #077462",
  "submission": "SUPPL-3",
  "activeIngredients": "NATEGLINIDE",
  "company": "WATSON LABS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/27\/2024",
  "drugName": "NATEGLINIDEANDA  #077462",
  "submission": "SUPPL-4",
  "activeIngredients": "NATEGLINIDE",
  "company": "WATSON LABS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/27\/2024",
  "drugName": "ALENDRONATE SODIUMANDA  #090124",
  "submission": "SUPPL-22",
  "activeIngredients": "ALENDRONATE SODIUM",
  "company": "AUROBINDO PHARMA",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/27\/2024",
  "drugName": "CELECOXIBANDA  #200562",
  "submission": "SUPPL-8",
  "activeIngredients": "CELECOXIB",
  "company": "WATSON LABS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/27\/2024",
  "drugName": "PHENYTOINANDA  #200691",
  "submission": "SUPPL-5",
  "activeIngredients": "PHENYTOIN",
  "company": "RISING",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/27\/2024",
  "drugName": "PHENYTOINANDA  #200691",
  "submission": "SUPPL-7",
  "activeIngredients": "PHENYTOIN",
  "company": "RISING",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/27\/2024",
  "drugName": "PHENYTOINANDA  #200691",
  "submission": "SUPPL-8",
  "activeIngredients": "PHENYTOIN",
  "company": "RISING",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/27\/2024",
  "drugName": "PHENYTOINANDA  #200691",
  "submission": "SUPPL-11",
  "activeIngredients": "PHENYTOIN",
  "company": "RISING",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/27\/2024",
  "drugName": "AMPICILLIN AND SULBACTAMANDA  #201406",
  "submission": "SUPPL-1",
  "activeIngredients": "AMPICILLIN SODIUM; SULBACTAM SODIUM",
  "company": "ANTIBIOTICE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/27\/2024",
  "drugName": "AMPICILLIN AND SULBACTAMANDA  #201406",
  "submission": "SUPPL-3",
  "activeIngredients": "AMPICILLIN SODIUM; SULBACTAM SODIUM",
  "company": "ANTIBIOTICE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/27\/2024",
  "drugName": "AMPICILLIN AND SULBACTAMANDA  #201406",
  "submission": "SUPPL-7",
  "activeIngredients": "AMPICILLIN SODIUM; SULBACTAM SODIUM",
  "company": "ANTIBIOTICE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/27\/2024",
  "drugName": "METFORMIN HYDROCHLORIDEANDA  #202917",
  "submission": "SUPPL-14",
  "activeIngredients": "METFORMIN HYDROCHLORIDE",
  "company": "SUN PHARM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/27\/2024",
  "drugName": "XELJANZNDA   #203214",
  "submission": "SUPPL-36",
  "activeIngredients": "TOFACITINIB CITRATE",
  "company": "PF PRISM CV",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/27\/2024",
  "drugName": "MONTELUKAST SODIUMANDA  #203366",
  "submission": "SUPPL-25",
  "activeIngredients": "MONTELUKAST SODIUM",
  "company": "MACLEODS PHARMS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/27\/2024",
  "drugName": "MONTELUKAST SODIUMANDA  #203366",
  "submission": "SUPPL-34",
  "activeIngredients": "MONTELUKAST SODIUM",
  "company": "MACLEODS PHARMS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/27\/2024",
  "drugName": "PITAVASTATIN CALCIUMANDA  #206070",
  "submission": "SUPPL-5",
  "activeIngredients": "PITAVASTATIN CALCIUM",
  "company": "MYLAN",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/27\/2024",
  "drugName": "ROSUVASTATIN CALCIUMANDA  #207453",
  "submission": "SUPPL-5",
  "activeIngredients": "ROSUVASTATIN CALCIUM",
  "company": "CADILA PHARMS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/27\/2024",
  "drugName": "ROSUVASTATIN CALCIUMANDA  #207453",
  "submission": "SUPPL-6",
  "activeIngredients": "ROSUVASTATIN CALCIUM",
  "company": "CADILA PHARMS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/27\/2024",
  "drugName": "XELJANZ XRNDA   #208246",
  "submission": "SUPPL-23",
  "activeIngredients": "TOFACITINIB CITRATE",
  "company": "PFIZER",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/27\/2024",
  "drugName": "PENCICLOVIRANDA  #212368",
  "submission": "ORIG-1",
  "activeIngredients": "PENCICLOVIR",
  "company": "PADAGIS ISRAEL",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/27\/2024",
  "drugName": "XELJANZNDA   #213082",
  "submission": "SUPPL-8",
  "activeIngredients": "TOFACITINIB CITRATE",
  "company": "PFIZER",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/27\/2024",
  "drugName": "BYNFEZIA PENNDA   #213224",
  "submission": "ORIG-1",
  "activeIngredients": "OCTREOTIDE ACETATE",
  "company": "SUN PHARM",
  "submissionClassification": "Type 5 - New Formulation or New Manufacturer",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/27\/2024",
  "drugName": "RETEVMONDA   #213246",
  "submission": "SUPPL-11",
  "activeIngredients": "SELPERCATINIB",
  "company": "ELI LILLY AND CO",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/27\/2024",
  "drugName": "RETEVMONDA   #213246",
  "submission": "SUPPL-13",
  "activeIngredients": "SELPERCATINIB",
  "company": "ELI LILLY AND CO",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/27\/2024",
  "drugName": "FLYRCADONDA   #215168",
  "submission": "ORIG-1",
  "activeIngredients": "FLURPIRIDAZ F-18",
  "company": "GE HLTHCARE",
  "submissionClassification": "Type 1 - New Molecular Entity",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/27\/2024",
  "drugName": "RETEVMONDA   #218160",
  "submission": "SUPPL-2",
  "activeIngredients": "SELPERCATINIB",
  "company": "ELI LILLY AND CO",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/27\/2024",
  "drugName": "RETEVMONDA   #218160",
  "submission": "SUPPL-3",
  "activeIngredients": "SELPERCATINIB",
  "company": "ELI LILLY AND CO",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/27\/2024",
  "drugName": "CEPHALEXINANDA  #218817",
  "submission": "ORIG-1",
  "activeIngredients": "CEPHALEXIN",
  "company": "AUROBINDO PHARMA LTD",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/27\/2024",
  "drugName": "CEPHALEXINANDA  #218947",
  "submission": "ORIG-1",
  "activeIngredients": "CEPHALEXIN",
  "company": "ALKEM LABS LTD",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/27\/2024",
  "drugName": "DUPIXENTBLA   #761055",
  "submission": "SUPPL-64",
  "activeIngredients": "DUPILUMAB",
  "company": "REGENERON PHARMACEUTICALS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/27\/2024",
  "drugName": "OTULFIBLA   #761379",
  "submission": "ORIG-1",
  "activeIngredients": "USTEKINUMAB-AAUZ",
  "company": "FRESENIUS KABI USA",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/30\/2024",
  "drugName": "ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINEANDA  #074654",
  "submission": "SUPPL-20",
  "activeIngredients": "ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE",
  "company": "SANDOZ",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/30\/2024",
  "drugName": "CITALOPRAM HYDROBROMIDEANDA  #077034",
  "submission": "SUPPL-4",
  "activeIngredients": "CITALOPRAM HYDROBROMIDE",
  "company": "HERITAGE PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/30\/2024",
  "drugName": "TOBRAMYCINANDA  #201422",
  "submission": "SUPPL-9",
  "activeIngredients": "TOBRAMYCIN",
  "company": "HIKMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/30\/2024",
  "drugName": "ITRACONAZOLEANDA  #208481",
  "submission": "SUPPL-1",
  "activeIngredients": "ITRACONAZOLE",
  "company": "APOTEX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/30\/2024",
  "drugName": "ITRACONAZOLEANDA  #208481",
  "submission": "SUPPL-2",
  "activeIngredients": "ITRACONAZOLE",
  "company": "APOTEX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/30\/2024",
  "drugName": "DAPSONEANDA  #213847",
  "submission": "SUPPL-1",
  "activeIngredients": "DAPSONE",
  "company": "MYLAN",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/30\/2024",
  "drugName": "DOCETAXELANDA  #214575",
  "submission": "SUPPL-2",
  "activeIngredients": "DOCETAXEL",
  "company": "EUGIA PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/30\/2024",
  "drugName": "LUMAKRASNDA   #214665",
  "submission": "SUPPL-12",
  "activeIngredients": "SOTORASIB",
  "company": "AMGEN INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/30\/2024",
  "drugName": "QUVIVIQNDA   #214985",
  "submission": "SUPPL-10",
  "activeIngredients": "DARIDOREXANT HYDROCHLORIDE",
  "company": "IDORSIA",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/30\/2024",
  "drugName": "QUVIVIQNDA   #214985",
  "submission": "SUPPL-11",
  "activeIngredients": "DARIDOREXANT HYDROCHLORIDE",
  "company": "IDORSIA",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/30\/2024",
  "drugName": "QUVIVIQNDA   #214985",
  "submission": "SUPPL-12",
  "activeIngredients": "DARIDOREXANT HYDROCHLORIDE",
  "company": "IDORSIA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/30\/2024",
  "drugName": "OCTREOTIDE ACETATEANDA  #216807",
  "submission": "SUPPL-2",
  "activeIngredients": "OCTREOTIDE ACETATE",
  "company": "GLAND",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/30\/2024",
  "drugName": "DAYBUENDA   #217026",
  "submission": "SUPPL-1",
  "activeIngredients": "TROFINETIDE",
  "company": "ACADIA PHARMS INC",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/30\/2024",
  "drugName": "DAYBUENDA   #217026",
  "submission": "SUPPL-3",
  "activeIngredients": "TROFINETIDE",
  "company": "ACADIA PHARMS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/30\/2024",
  "drugName": "ENZALUTAMIDEANDA  #217322",
  "submission": "ORIG-1",
  "activeIngredients": "ENZALUTAMIDE",
  "company": "ZYDUS PHARMS USA INC",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "09\/30\/2024",
  "drugName": "ATORVASTATIN CALCIUMANDA  #217634",
  "submission": "SUPPL-1",
  "activeIngredients": "ATORVASTATIN CALCIUM",
  "company": "STRIDES PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "09\/30\/2024",
  "drugName": "PROCHLORPERAZINE MALEATEANDA  #218912",
  "submission": "ORIG-1",
  "activeIngredients": "PROCHLORPERAZINE MALEATE",
  "company": "LEADING",
  "submissionStatus": "Approval"
 }
,
 {
  "approvalDate": "10\/01\/2024",
  "drugName": "FUROSEMIDENDA   #018267",
  "submission": "SUPPL-29",
  "activeIngredients": "FUROSEMIDE",
  "company": "HIKMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/01\/2024",
  "drugName": "FUROSEMIDENDA   #018579",
  "submission": "SUPPL-34",
  "activeIngredients": "FUROSEMIDE",
  "company": "AM REGENT",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/01\/2024",
  "drugName": "FUROSEMIDENDA   #018667",
  "submission": "SUPPL-48",
  "activeIngredients": "FUROSEMIDE",
  "company": "HOSPIRA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/01\/2024",
  "drugName": "FUROSEMIDENDA   #018902",
  "submission": "SUPPL-36",
  "activeIngredients": "FUROSEMIDE",
  "company": "FRESENIUS KABI USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/01\/2024",
  "drugName": "METHYLPHENIDATE HYDROCHLORIDEANDA  #079031",
  "submission": "SUPPL-15",
  "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
  "company": "BARR LABS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/01\/2024",
  "drugName": "HEPZATONDA   #201848",
  "submission": "SUPPL-7",
  "activeIngredients": "MELPHALAN HYDROCHLORIDE",
  "company": "DELCATH SYSTEMS INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/01\/2024",
  "drugName": "MEKINISTNDA   #204114",
  "submission": "SUPPL-27",
  "activeIngredients": "TRAMETINIB DIMETHYL SULFOXIDE",
  "company": "NOVARTIS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/01\/2024",
  "drugName": "FINGOLIMOD HYDROCHLORIDEANDA  #207933",
  "submission": "SUPPL-4",
  "activeIngredients": "FINGOLIMOD HYDROCHLORIDE",
  "company": "HETERO LABS LTD V",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "10\/01\/2024",
  "drugName": "BUPROPION HYDROCHLORIDEANDA  #211200",
  "submission": "SUPPL-3",
  "activeIngredients": "BUPROPION HYDROCHLORIDE",
  "company": "ZHEJIANG JUTAI PHARM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/01\/2024",
  "drugName": "BUPROPION HYDROCHLORIDEANDA  #211200",
  "submission": "SUPPL-6",
  "activeIngredients": "BUPROPION HYDROCHLORIDE",
  "company": "ZHEJIANG JUTAI PHARM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/01\/2024",
  "drugName": "BUPROPION HYDROCHLORIDEANDA  #211200",
  "submission": "SUPPL-8",
  "activeIngredients": "BUPROPION HYDROCHLORIDE",
  "company": "ZHEJIANG JUTAI PHARM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/01\/2024",
  "drugName": "LAMOTRIGINEANDA  #211821",
  "submission": "ORIG-1",
  "activeIngredients": "LAMOTRIGINE",
  "company": "ALEMBIC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/01\/2024",
  "drugName": "DABIGATRAN ETEXILATE MESYLATEANDA  #213879",
  "submission": "SUPPL-2",
  "activeIngredients": "DABIGATRAN ETEXILATE MESYLATE",
  "company": "MSN",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/01\/2024",
  "drugName": "VARENICLINE TARTRATEANDA  #215931",
  "submission": "ORIG-1",
  "activeIngredients": "VARENICLINE TARTRATE",
  "company": "DR REDDYS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/01\/2024",
  "drugName": "ERIBULIN MESYLATEANDA  #217250",
  "submission": "ORIG-1",
  "activeIngredients": "ERIBULIN MESYLATE",
  "company": "BAXTER HLTHCARE CORP",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/01\/2024",
  "drugName": "NEBIVOLOL HYDROCHLORIDEANDA  #217397",
  "submission": "ORIG-1",
  "activeIngredients": "NEBIVOLOL HYDROCHLORIDE",
  "company": "MSN",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/01\/2024",
  "drugName": "MEKINISTNDA   #217513",
  "submission": "SUPPL-7",
  "activeIngredients": "TRAMETINIB",
  "company": "NOVARTIS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/01\/2024",
  "drugName": "MEKINISTNDA   #217513",
  "submission": "SUPPL-7",
  "activeIngredients": "TRAMETINIB DIMETHYL SULFOXIDE",
  "company": "NOVARTIS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/02\/2024",
  "drugName": "PHENYTOIN SODIUMANDA  #040573",
  "submission": "SUPPL-15",
  "activeIngredients": "PHENYTOIN SODIUM",
  "company": "ACELLA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/02\/2024",
  "drugName": "NITROFURANTOINANDA  #077025",
  "submission": "SUPPL-9",
  "activeIngredients": "NITROFURANTOIN, MACROCRYSTALLINE",
  "company": "AUROBINDO PHARMA USA",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/02\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND IBUPROFENANDA  #077454",
  "submission": "SUPPL-9",
  "activeIngredients": "HYDROCODONE BITARTRATE; IBUPROFEN",
  "company": "ANI PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/02\/2024",
  "drugName": "GABAPENTINANDA  #077662",
  "submission": "SUPPL-36",
  "activeIngredients": "GABAPENTIN",
  "company": "GLENMARK PHARMS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/02\/2024",
  "drugName": "SOLIFENACIN SUCCINATEANDA  #205484",
  "submission": "ORIG-1",
  "activeIngredients": "SOLIFENACIN SUCCINATE",
  "company": "JUBILANT GENERICS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/02\/2024",
  "drugName": "ESCITALOPRAM OXALATEANDA  #205619",
  "submission": "SUPPL-7",
  "activeIngredients": "ESCITALOPRAM OXALATE",
  "company": "AMNEAL PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/02\/2024",
  "drugName": "ESCITALOPRAM OXALATEANDA  #205619",
  "submission": "SUPPL-8",
  "activeIngredients": "ESCITALOPRAM OXALATE",
  "company": "AMNEAL PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/02\/2024",
  "drugName": "ALCAFTADINEANDA  #209290",
  "submission": "ORIG-1",
  "activeIngredients": "ALCAFTADINE",
  "company": "ALEMBIC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/02\/2024",
  "drugName": "NILOTINIBANDA  #218544",
  "submission": "ORIG-1",
  "activeIngredients": "NILOTINIB",
  "company": "MSN LABORATORIES PRIVATE LTD",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "10\/03\/2024",
  "drugName": "LOCOID LIPOCREAMNDA   #020769",
  "submission": "SUPPL-15",
  "activeIngredients": "HYDROCORTISONE BUTYRATE",
  "company": "PRECISION DERMAT",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/03\/2024",
  "drugName": "BUTORPHANOL TARTRATEANDA  #075759",
  "submission": "SUPPL-36",
  "activeIngredients": "BUTORPHANOL TARTRATE",
  "company": "RISING",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/03\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND IBUPROFENANDA  #076604",
  "submission": "SUPPL-28",
  "activeIngredients": "HYDROCODONE BITARTRATE; IBUPROFEN",
  "company": "ACTAVIS LABS FL INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/03\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND IBUPROFENANDA  #076642",
  "submission": "SUPPL-44",
  "activeIngredients": "HYDROCODONE BITARTRATE; IBUPROFEN",
  "company": "AMNEAL PHARMS NY",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/03\/2024",
  "drugName": "REPREXAINANDA  #076642",
  "submission": "SUPPL-44",
  "activeIngredients": "HYDROCODONE BITARTRATE; IBUPROFEN",
  "company": "AMNEAL PHARMS NY",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/03\/2024",
  "drugName": "HYDROCODONEANDA  #077723",
  "submission": "SUPPL-34",
  "activeIngredients": "HYDROCODONE BITARTRATE; IBUPROFEN",
  "company": "STRIDES PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/03\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND IBUPROFENANDA  #077723",
  "submission": "SUPPL-34",
  "activeIngredients": "HYDROCODONE BITARTRATE; IBUPROFEN",
  "company": "STRIDES PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/03\/2024",
  "drugName": "GABAPENTINANDA  #078926",
  "submission": "SUPPL-19",
  "activeIngredients": "GABAPENTIN",
  "company": "ZYDUS PHARMS USA INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/03\/2024",
  "drugName": "OPDIVOBLA   #125554",
  "submission": "SUPPL-127",
  "activeIngredients": "NIVOLUMAB",
  "company": "BRISTOL MYERS SQUIBB",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/03\/2024",
  "drugName": "MILNACIPRAN HYDROCHLORIDEANDA  #205147",
  "submission": "ORIG-1",
  "activeIngredients": "MILNACIPRAN HYDROCHLORIDE",
  "company": "HETERO LABS LTD V",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/03\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND ASPIRINANDA  #205479",
  "submission": "SUPPL-3",
  "activeIngredients": "ASPIRIN; HYDROCODONE BITARTRATE",
  "company": "LGM PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/03\/2024",
  "drugName": "SUGAMMADEXANDA  #214236",
  "submission": "ORIG-1",
  "activeIngredients": "SUGAMMADEX",
  "company": "DR REDDYS LABS LTD",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "10\/03\/2024",
  "drugName": "LIFITEGRASTANDA  #215058",
  "submission": "ORIG-1",
  "activeIngredients": "LIFITEGRAST",
  "company": "INGENUS PHARMS LLC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/03\/2024",
  "drugName": "METHOHEXITAL SODIUMANDA  #215488",
  "submission": "ORIG-1",
  "activeIngredients": "METHOHEXITAL SODIUM",
  "company": "ONESOURCE SPECIALTY",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/03\/2024",
  "drugName": "SITAGLIPTINANDA  #216886",
  "submission": "ORIG-1",
  "activeIngredients": "SITAGLIPTIN",
  "company": "PRINSTON PHARMA INC",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "10\/03\/2024",
  "drugName": "ISOPROTERENOL HYDROCHLORIDEANDA  #217648",
  "submission": "ORIG-1",
  "activeIngredients": "ISOPROTERENOL HYDROCHLORIDE",
  "company": "GLAND",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/03\/2024",
  "drugName": "CHLOROTHIAZIDE SODIUMANDA  #218630",
  "submission": "ORIG-1",
  "activeIngredients": "CHLOROTHIAZIDE SODIUM",
  "company": "GLAND",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/03\/2024",
  "drugName": "CETIRIZINE HYDROCHLORIDEANDA  #218895",
  "submission": "ORIG-1",
  "activeIngredients": "CETIRIZINE HYDROCHLORIDE",
  "company": "REGCON HOLDINGS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/04\/2024",
  "drugName": "PYRIDOSTIGMINE BROMIDENDA   #020414",
  "submission": "SUPPL-11",
  "activeIngredients": "PYRIDOSTIGMINE BROMIDE",
  "company": "US ARMY",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/04\/2024",
  "drugName": "VESANOIDNDA   #020438",
  "submission": "SUPPL-9",
  "activeIngredients": "TRETINOIN",
  "company": "CHEPLAPHARM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/04\/2024",
  "drugName": "COSENTYXBLA   #125504",
  "submission": "SUPPL-80",
  "activeIngredients": "SECUKINUMAB",
  "company": "NOVARTIS PHARMS CORP",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/04\/2024",
  "drugName": "AMELUZNDA   #208081",
  "submission": "SUPPL-28",
  "activeIngredients": "AMINOLEVULINIC ACID HYDROCHLORIDE",
  "company": "BIOFRONTERA",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/04\/2024",
  "drugName": "ESOMEPRAZOLE MAGNESIUMANDA  #209647",
  "submission": "SUPPL-8",
  "activeIngredients": "ESOMEPRAZOLE MAGNESIUM",
  "company": "AMNEAL PHARMS NY",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/04\/2024",
  "drugName": "JELMYTONDA   #211728",
  "submission": "SUPPL-10",
  "activeIngredients": "MITOMYCIN",
  "company": "UROGEN PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/04\/2024",
  "drugName": "NAPROXEN AND ESOMEPRAZOLE MAGNESIUMANDA  #213699",
  "submission": "SUPPL-3",
  "activeIngredients": "ESOMEPRAZOLE MAGNESIUM; NAPROXEN",
  "company": "AJANTA PHARMA LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/04\/2024",
  "drugName": "EVEROLIMUSANDA  #214138",
  "submission": "SUPPL-8",
  "activeIngredients": "EVEROLIMUS",
  "company": "ALKEM LABS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/04\/2024",
  "drugName": "EVEROLIMUSANDA  #214138",
  "submission": "SUPPL-9",
  "activeIngredients": "EVEROLIMUS",
  "company": "ALKEM LABS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/04\/2024",
  "drugName": "CHLORPROMAZINE HYDROCHLORIDEANDA  #216911",
  "submission": "ORIG-1",
  "activeIngredients": "CHLORPROMAZINE HYDROCHLORIDE",
  "company": "GLAND",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/04\/2024",
  "drugName": "PYRIDOSTIGMINE BROMIDENDA   #217604",
  "submission": "ORIG-1",
  "activeIngredients": "PYRIDOSTIGMINE BROMIDE",
  "company": "AMNEAL",
  "submissionClassification": "Type 5 - New Formulation or New Manufacturer",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/04\/2024",
  "drugName": "RIVAROXABANANDA  #218427",
  "submission": "ORIG-1",
  "activeIngredients": "RIVAROXABAN",
  "company": "APOTEX",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "10\/04\/2024",
  "drugName": "COSENTYXBLA   #761349",
  "submission": "SUPPL-5",
  "activeIngredients": "SECUKINUMAB",
  "company": "NOVARTIS PHARMS CORP",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/07\/2024",
  "drugName": "CEFTRIAXONE IN PLASTIC CONTAINERANDA  #065224",
  "submission": "SUPPL-15",
  "activeIngredients": "CEFTRIAXONE SODIUM",
  "company": "BAXTER HLTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/07\/2024",
  "drugName": "CITALOPRAM HYDROBROMIDEANDA  #077232",
  "submission": "SUPPL-6",
  "activeIngredients": "CITALOPRAM HYDROBROMIDE",
  "company": "HERITAGE PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/07\/2024",
  "drugName": "CITALOPRAM HYDROBROMIDEANDA  #077654",
  "submission": "SUPPL-5",
  "activeIngredients": "CITALOPRAM HYDROBROMIDE",
  "company": "GLENMARK PHARMS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/07\/2024",
  "drugName": "ESCITALOPRAM OXALATEANDA  #090432",
  "submission": "SUPPL-12",
  "activeIngredients": "ESCITALOPRAM OXALATE",
  "company": "AUROBINDO PHARMA LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/07\/2024",
  "drugName": "ESCITALOPRAM OXALATEANDA  #090432",
  "submission": "SUPPL-15",
  "activeIngredients": "ESCITALOPRAM OXALATE",
  "company": "AUROBINDO PHARMA LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/07\/2024",
  "drugName": "ESCITALOPRAM OXALATEANDA  #090432",
  "submission": "SUPPL-18",
  "activeIngredients": "ESCITALOPRAM OXALATE",
  "company": "AUROBINDO PHARMA LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/07\/2024",
  "drugName": "ESCITALOPRAM OXALATEANDA  #090432",
  "submission": "SUPPL-21",
  "activeIngredients": "ESCITALOPRAM OXALATE",
  "company": "AUROBINDO PHARMA LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/07\/2024",
  "drugName": "ESCITALOPRAM OXALATEANDA  #090432",
  "submission": "SUPPL-24",
  "activeIngredients": "ESCITALOPRAM OXALATE",
  "company": "AUROBINDO PHARMA LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/07\/2024",
  "drugName": "ESCITALOPRAM OXALATEANDA  #090432",
  "submission": "SUPPL-27",
  "activeIngredients": "ESCITALOPRAM OXALATE",
  "company": "AUROBINDO PHARMA LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/07\/2024",
  "drugName": "ESCITALOPRAM OXALATEANDA  #202389",
  "submission": "SUPPL-14",
  "activeIngredients": "ESCITALOPRAM OXALATE",
  "company": "ACCORD HLTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/07\/2024",
  "drugName": "ESCITALOPRAM OXALATEANDA  #202389",
  "submission": "SUPPL-16",
  "activeIngredients": "ESCITALOPRAM OXALATE",
  "company": "ACCORD HLTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/07\/2024",
  "drugName": "METHYLPHENIDATE HYDROCHLORIDEANDA  #203583",
  "submission": "SUPPL-7",
  "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
  "company": "SPECGX LLC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/07\/2024",
  "drugName": "METHYLPHENIDATE HYDROCHLORIDEANDA  #203583",
  "submission": "SUPPL-11",
  "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
  "company": "SPECGX LLC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/07\/2024",
  "drugName": "METHYLPHENIDATE HYDROCHLORIDEANDA  #203583",
  "submission": "SUPPL-12",
  "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
  "company": "SPECGX LLC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/07\/2024",
  "drugName": "METHYLPHENIDATE HYDROCHLORIDEANDA  #203583",
  "submission": "SUPPL-13",
  "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
  "company": "SPECGX LLC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/07\/2024",
  "drugName": "OMEPRAZOLE AND SODIUM BICARBONATEANDA  #205545",
  "submission": "SUPPL-24",
  "activeIngredients": "OMEPRAZOLE; SODIUM BICARBONATE",
  "company": "AJANTA PHARMA LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/07\/2024",
  "drugName": "BUPROPION HYDROCHLORIDEANDA  #207224",
  "submission": "SUPPL-7",
  "activeIngredients": "BUPROPION HYDROCHLORIDE",
  "company": "ANBISON LAB",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/07\/2024",
  "drugName": "EMPAVELINDA   #215014",
  "submission": "SUPPL-8",
  "activeIngredients": "PEGCETACOPLAN",
  "company": "APELLIS PHARMS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/07\/2024",
  "drugName": "GLYCOPYRROLATEANDA  #216297",
  "submission": "ORIG-1",
  "activeIngredients": "GLYCOPYRROLATE",
  "company": "SCIEGEN PHARMS INC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/08\/2024",
  "drugName": "OMNIPAQUE 12NDA   #018956",
  "submission": "SUPPL-119",
  "activeIngredients": "IOHEXOL",
  "company": "GE HEALTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/08\/2024",
  "drugName": "OMNIPAQUE 140NDA   #018956",
  "submission": "SUPPL-119",
  "activeIngredients": "IOHEXOL",
  "company": "GE HEALTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/08\/2024",
  "drugName": "OMNIPAQUE 180NDA   #018956",
  "submission": "SUPPL-119",
  "activeIngredients": "IOHEXOL",
  "company": "GE HEALTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/08\/2024",
  "drugName": "OMNIPAQUE 210NDA   #018956",
  "submission": "SUPPL-119",
  "activeIngredients": "IOHEXOL",
  "company": "GE HEALTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/08\/2024",
  "drugName": "OMNIPAQUE 240NDA   #018956",
  "submission": "SUPPL-119",
  "activeIngredients": "IOHEXOL",
  "company": "GE HEALTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/08\/2024",
  "drugName": "OMNIPAQUE 300NDA   #018956",
  "submission": "SUPPL-119",
  "activeIngredients": "IOHEXOL",
  "company": "GE HEALTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/08\/2024",
  "drugName": "OMNIPAQUE 350NDA   #018956",
  "submission": "SUPPL-119",
  "activeIngredients": "IOHEXOL",
  "company": "GE HEALTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/08\/2024",
  "drugName": "OMNIPAQUE 70NDA   #018956",
  "submission": "SUPPL-119",
  "activeIngredients": "IOHEXOL",
  "company": "GE HEALTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/08\/2024",
  "drugName": "OMNIPAQUE 9NDA   #018956",
  "submission": "SUPPL-119",
  "activeIngredients": "IOHEXOL",
  "company": "GE HEALTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/08\/2024",
  "drugName": "OMNIPAQUE 240NDA   #020608",
  "submission": "SUPPL-47",
  "activeIngredients": "IOHEXOL",
  "company": "GE HEALTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/08\/2024",
  "drugName": "OMNIPAQUE 300NDA   #020608",
  "submission": "SUPPL-47",
  "activeIngredients": "IOHEXOL",
  "company": "GE HEALTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/08\/2024",
  "drugName": "OMNIPAQUE 350NDA   #020608",
  "submission": "SUPPL-47",
  "activeIngredients": "IOHEXOL",
  "company": "GE HEALTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/08\/2024",
  "drugName": "AVEEDNDA   #022219",
  "submission": "SUPPL-20",
  "activeIngredients": "TESTOSTERONE UNDECANOATE",
  "company": "ENDO OPERATIONS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/08\/2024",
  "drugName": "SULINDACANDA  #072711",
  "submission": "SUPPL-17",
  "activeIngredients": "SULINDAC",
  "company": "EPIC PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/08\/2024",
  "drugName": "ESCITALOPRAM OXALATEANDA  #078604",
  "submission": "SUPPL-24",
  "activeIngredients": "ESCITALOPRAM OXALATE",
  "company": "INVAGEN PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/08\/2024",
  "drugName": "CISATRACURIUM BESYLATEANDA  #203079",
  "submission": "SUPPL-1",
  "activeIngredients": "CISATRACURIUM BESYLATE",
  "company": "HIKMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/08\/2024",
  "drugName": "NAPROXEN AND ESOMEPRAZOLE MAGNESIUMANDA  #204470",
  "submission": "SUPPL-3",
  "activeIngredients": "ESOMEPRAZOLE MAGNESIUM; NAPROXEN",
  "company": "ACTAVIS LABS FL INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/08\/2024",
  "drugName": "IBANDRONATE SODIUMANDA  #206887",
  "submission": "SUPPL-25",
  "activeIngredients": "IBANDRONATE SODIUM",
  "company": "MACLEODS PHARMS LTD",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/08\/2024",
  "drugName": "BIKTARVYNDA   #210251",
  "submission": "SUPPL-20",
  "activeIngredients": "BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE",
  "company": "GILEAD SCIENCES INC",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/08\/2024",
  "drugName": "DIMETHYL FUMARATEANDA  #210305",
  "submission": "SUPPL-9",
  "activeIngredients": "DIMETHYL FUMARATE",
  "company": "CIPLA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/08\/2024",
  "drugName": "HYDROXYCHLOROQUINE SULFATEANDA  #210441",
  "submission": "SUPPL-15",
  "activeIngredients": "HYDROXYCHLOROQUINE SULFATE",
  "company": "APPCO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/08\/2024",
  "drugName": "DIMETHYL FUMARATEANDA  #210499",
  "submission": "SUPPL-5",
  "activeIngredients": "DIMETHYL FUMARATE",
  "company": "ACCORD HLTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/08\/2024",
  "drugName": "IBUPROFEN AND FAMOTIDINEANDA  #211278",
  "submission": "SUPPL-1",
  "activeIngredients": "FAMOTIDINE; IBUPROFEN",
  "company": "TEVA PHARMS USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/08\/2024",
  "drugName": "PACLITAXELANDA  #212700",
  "submission": "ORIG-1",
  "activeIngredients": "PACLITAXEL",
  "company": "HENGRUI PHARMA",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/08\/2024",
  "drugName": "GEMTESANDA   #213006",
  "submission": "SUPPL-13",
  "activeIngredients": "VIBEGRON",
  "company": "SUMITOMO PHARMA AM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/08\/2024",
  "drugName": "SUGAMMADEX SODIUMANDA  #214337",
  "submission": "SUPPL-2",
  "activeIngredients": "SUGAMMADEX SODIUM",
  "company": "ASPIRO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/08\/2024",
  "drugName": "PALIPERIDONEANDA  #217445",
  "submission": "ORIG-1",
  "activeIngredients": "PALIPERIDONE",
  "company": "ZYDUS PHARMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/09\/2024",
  "drugName": "PROPRANOLOL HYDROCHLORIDEANDA  #070979",
  "submission": "SUPPL-22",
  "activeIngredients": "PROPRANOLOL HYDROCHLORIDE",
  "company": "HIKMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/09\/2024",
  "drugName": "BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATEANDA  #074951",
  "submission": "SUPPL-8",
  "activeIngredients": "ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE",
  "company": "STEVENS J",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/09\/2024",
  "drugName": "CARVEDILOLANDA  #078786",
  "submission": "SUPPL-2",
  "activeIngredients": "CARVEDILOL",
  "company": "MLV",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/09\/2024",
  "drugName": "LANORINALANDA  #086996",
  "submission": "SUPPL-37",
  "activeIngredients": "ASPIRIN; BUTALBITAL; CAFFEINE",
  "company": "SANDOZ",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/09\/2024",
  "drugName": "LEVETIRACETAMANDA  #091261",
  "submission": "SUPPL-18",
  "activeIngredients": "LEVETIRACETAM",
  "company": "APOTEX INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/09\/2024",
  "drugName": "LEVETIRACETAMANDA  #091261",
  "submission": "SUPPL-19",
  "activeIngredients": "LEVETIRACETAM",
  "company": "APOTEX INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/09\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND IBUPROFENANDA  #091633",
  "submission": "SUPPL-15",
  "activeIngredients": "HYDROCODONE BITARTRATE; IBUPROFEN",
  "company": "SUN PHARM INDS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/09\/2024",
  "drugName": "LAMOTRIGINEANDA  #200694",
  "submission": "SUPPL-4",
  "activeIngredients": "LAMOTRIGINE",
  "company": "ALKEM LABS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/09\/2024",
  "drugName": "LEVETIRACETAMANDA  #202958",
  "submission": "SUPPL-8",
  "activeIngredients": "LEVETIRACETAM",
  "company": "APOTEX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/09\/2024",
  "drugName": "LEVETIRACETAMANDA  #202958",
  "submission": "SUPPL-9",
  "activeIngredients": "LEVETIRACETAM",
  "company": "APOTEX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/09\/2024",
  "drugName": "CISATRACURIUM BESYLATEANDA  #203078",
  "submission": "SUPPL-3",
  "activeIngredients": "CISATRACURIUM BESYLATE",
  "company": "HIKMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/09\/2024",
  "drugName": "XELPROSNDA   #206185",
  "submission": "SUPPL-19",
  "activeIngredients": "LATANOPROST",
  "company": "SUN PHARM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/09\/2024",
  "drugName": "METARAMINOL BITARTRATEANDA  #211304",
  "submission": "SUPPL-1",
  "activeIngredients": "METARAMINOL BITARTRATE",
  "company": "AZURITY",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/09\/2024",
  "drugName": "BALVERSANDA   #212018",
  "submission": "SUPPL-10",
  "activeIngredients": "ERDAFITINIB",
  "company": "JANSSEN BIOTECH",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/09\/2024",
  "drugName": "EVEROLIMUSANDA  #212936",
  "submission": "SUPPL-6",
  "activeIngredients": "EVEROLIMUS",
  "company": "MYLAN",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/09\/2024",
  "drugName": "EVEROLIMUSANDA  #212936",
  "submission": "SUPPL-7",
  "activeIngredients": "EVEROLIMUS",
  "company": "MYLAN",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/09\/2024",
  "drugName": "EVEROLIMUSANDA  #212936",
  "submission": "SUPPL-8",
  "activeIngredients": "EVEROLIMUS",
  "company": "MYLAN",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/09\/2024",
  "drugName": "LACOSAMIDEANDA  #214960",
  "submission": "ORIG-1",
  "activeIngredients": "LACOSAMIDE",
  "company": "SOMERSET THERAPS LLC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/10\/2024",
  "drugName": "CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATEANDA  #040860",
  "submission": "SUPPL-11",
  "activeIngredients": "ASPIRIN; CARISOPRODOL; CODEINE PHOSPHATE",
  "company": "INGENUS PHARMS NJ",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/10\/2024",
  "drugName": "RIFADINNDA   #050420",
  "submission": "SUPPL-92",
  "activeIngredients": "RIFAMPIN",
  "company": "SANOFI AVENTIS US",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/10\/2024",
  "drugName": "RIFADINNDA   #050627",
  "submission": "SUPPL-37",
  "activeIngredients": "RIFAMPIN",
  "company": "SANOFI AVENTIS US",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/10\/2024",
  "drugName": "RIFATERNDA   #050705",
  "submission": "SUPPL-26",
  "activeIngredients": "ISONIAZID; PYRAZINAMIDE; RIFAMPIN",
  "company": "SANOFI AVENTIS US",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/10\/2024",
  "drugName": "METRONIDAZOLEANDA  #070027",
  "submission": "SUPPL-54",
  "activeIngredients": "METRONIDAZOLE",
  "company": "TEVA PHARMS USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/10\/2024",
  "drugName": "METRONIDAZOLEANDA  #070033",
  "submission": "SUPPL-55",
  "activeIngredients": "METRONIDAZOLE",
  "company": "PLIVA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/10\/2024",
  "drugName": "METRONIDAZOLEANDA  #070035",
  "submission": "SUPPL-64",
  "activeIngredients": "METRONIDAZOLE",
  "company": "WATSON LABS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/10\/2024",
  "drugName": "METRONIDAZOLEANDA  #070044",
  "submission": "SUPPL-63",
  "activeIngredients": "METRONIDAZOLE",
  "company": "WATSON LABS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/10\/2024",
  "drugName": "DULOXETINE HYDROCHLORIDEANDA  #090783",
  "submission": "SUPPL-5",
  "activeIngredients": "DULOXETINE HYDROCHLORIDE",
  "company": "TEVA PHARMS USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/10\/2024",
  "drugName": "DULOXETINE HYDROCHLORIDEANDA  #090783",
  "submission": "SUPPL-7",
  "activeIngredients": "DULOXETINE HYDROCHLORIDE",
  "company": "TEVA PHARMS USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/10\/2024",
  "drugName": "DULOXETINE HYDROCHLORIDEANDA  #090783",
  "submission": "SUPPL-8",
  "activeIngredients": "DULOXETINE HYDROCHLORIDE",
  "company": "TEVA PHARMS USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/10\/2024",
  "drugName": "DULOXETINE HYDROCHLORIDEANDA  #090783",
  "submission": "SUPPL-10",
  "activeIngredients": "DULOXETINE HYDROCHLORIDE",
  "company": "TEVA PHARMS USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/10\/2024",
  "drugName": "DULOXETINE HYDROCHLORIDEANDA  #090783",
  "submission": "SUPPL-12",
  "activeIngredients": "DULOXETINE HYDROCHLORIDE",
  "company": "TEVA PHARMS USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/10\/2024",
  "drugName": "DULOXETINE HYDROCHLORIDEANDA  #090783",
  "submission": "SUPPL-14",
  "activeIngredients": "DULOXETINE HYDROCHLORIDE",
  "company": "TEVA PHARMS USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/10\/2024",
  "drugName": "DULOXETINE HYDROCHLORIDEANDA  #090783",
  "submission": "SUPPL-17",
  "activeIngredients": "DULOXETINE HYDROCHLORIDE",
  "company": "TEVA PHARMS USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/10\/2024",
  "drugName": "CAPECITABINEANDA  #090943",
  "submission": "SUPPL-15",
  "activeIngredients": "CAPECITABINE",
  "company": "RISING",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/10\/2024",
  "drugName": "EYLEABLA   #125387",
  "submission": "SUPPL-87",
  "activeIngredients": "AFLIBERCEPT",
  "company": "REGENERON PHARMACEUTICALS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/10\/2024",
  "drugName": "CABAZITAXELNDA   #207949",
  "submission": "SUPPL-2",
  "activeIngredients": "CABAZITAXEL",
  "company": "ACCORD HLTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/10\/2024",
  "drugName": "LINEZOLIDANDA  #210378",
  "submission": "ORIG-1",
  "activeIngredients": "LINEZOLID",
  "company": "MACLEODS PHARMS LTD",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/10\/2024",
  "drugName": "DURYSTANDA   #211911",
  "submission": "SUPPL-2",
  "activeIngredients": "BIMATOPROST",
  "company": "ABBVIE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/10\/2024",
  "drugName": "BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #212756",
  "submission": "SUPPL-1",
  "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE",
  "company": "DIFGEN PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/10\/2024",
  "drugName": "BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #212756",
  "submission": "SUPPL-5",
  "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE",
  "company": "DIFGEN PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/10\/2024",
  "drugName": "BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #212756",
  "submission": "SUPPL-7",
  "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE",
  "company": "DIFGEN PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/10\/2024",
  "drugName": "SOVUNANDA   #214581",
  "submission": "SUPPL-11",
  "activeIngredients": "HYDROXYCHLOROQUINE SULFATE",
  "company": "NOVITIUM PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/10\/2024",
  "drugName": "TIMOLOLANDA  #216654",
  "submission": "ORIG-1",
  "activeIngredients": "TIMOLOL",
  "company": "SOMERSET",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/10\/2024",
  "drugName": "TOPIRAMATEANDA  #218642",
  "submission": "ORIG-1",
  "activeIngredients": "TOPIRAMATE",
  "company": "ANDA REPOSITORY",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/10\/2024",
  "drugName": "ITOVEBINDA   #219249",
  "submission": "ORIG-1",
  "activeIngredients": "INAVOLISIB",
  "company": "GENENTECH INC",
  "submissionClassification": "Type 1 - New Molecular Entity",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/10\/2024",
  "drugName": "EYLEA HDBLA   #761355",
  "submission": "SUPPL-6",
  "activeIngredients": "AFLIBERCEPT",
  "company": "REGENERON PHARMACEUTICALS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/10\/2024",
  "drugName": "IMULDOSABLA   #761364",
  "submission": "ORIG-1",
  "activeIngredients": "USTEKINUMAB-SRLF",
  "company": "ACCORD BIOPHARMA INC.",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/11\/2024",
  "drugName": "PRECEDEXNDA   #021038",
  "submission": "SUPPL-55",
  "activeIngredients": "DEXMEDETOMIDINE HYDROCHLORIDE",
  "company": "HOSPIRA",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/11\/2024",
  "drugName": "ONGLYZANDA   #022350",
  "submission": "SUPPL-26",
  "activeIngredients": "SAXAGLIPTIN HYDROCHLORIDE",
  "company": "ASTRAZENECA AB",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/11\/2024",
  "drugName": "HYDROXYCHLOROQUINE SULFATEANDA  #040274",
  "submission": "SUPPL-24",
  "activeIngredients": "HYDROXYCHLOROQUINE SULFATE",
  "company": "AUROBINDO PHARMA USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/11\/2024",
  "drugName": "INVAGESICANDA  #074817",
  "submission": "SUPPL-5",
  "activeIngredients": "ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE",
  "company": "CHARTWELL RX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/11\/2024",
  "drugName": "INVAGESIC FORTEANDA  #074817",
  "submission": "SUPPL-5",
  "activeIngredients": "ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE",
  "company": "CHARTWELL RX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/11\/2024",
  "drugName": "GABAPENTINANDA  #075477",
  "submission": "SUPPL-8",
  "activeIngredients": "GABAPENTIN",
  "company": "CSPC OUYI",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/11\/2024",
  "drugName": "GABAPENTINANDA  #075477",
  "submission": "SUPPL-9",
  "activeIngredients": "GABAPENTIN",
  "company": "CSPC OUYI",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/11\/2024",
  "drugName": "GABAPENTINANDA  #075477",
  "submission": "SUPPL-10",
  "activeIngredients": "GABAPENTIN",
  "company": "CSPC OUYI",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/11\/2024",
  "drugName": "MEPERIDINE HYDROCHLORIDEANDA  #080445",
  "submission": "SUPPL-52",
  "activeIngredients": "MEPERIDINE HYDROCHLORIDE",
  "company": "WEST-WARD PHARMS INT",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/11\/2024",
  "drugName": "DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATEANDA  #086727",
  "submission": "SUPPL-46",
  "activeIngredients": "ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE",
  "company": "ANI PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/11\/2024",
  "drugName": "DIVALPROEX SODIUMANDA  #090062",
  "submission": "SUPPL-7",
  "activeIngredients": "DIVALPROEX SODIUM",
  "company": "PHARMOBEDIENT",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/11\/2024",
  "drugName": "DIVALPROEX SODIUMANDA  #090062",
  "submission": "SUPPL-8",
  "activeIngredients": "DIVALPROEX SODIUM",
  "company": "PHARMOBEDIENT",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/11\/2024",
  "drugName": "DIVALPROEX SODIUMANDA  #090062",
  "submission": "SUPPL-9",
  "activeIngredients": "DIVALPROEX SODIUM",
  "company": "PHARMOBEDIENT",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/11\/2024",
  "drugName": "DIVALPROEX SODIUMANDA  #090062",
  "submission": "SUPPL-10",
  "activeIngredients": "DIVALPROEX SODIUM",
  "company": "PHARMOBEDIENT",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/11\/2024",
  "drugName": "DIVALPROEX SODIUMANDA  #090062",
  "submission": "SUPPL-11",
  "activeIngredients": "DIVALPROEX SODIUM",
  "company": "PHARMOBEDIENT",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/11\/2024",
  "drugName": "DIVALPROEX SODIUMANDA  #090062",
  "submission": "SUPPL-12",
  "activeIngredients": "DIVALPROEX SODIUM",
  "company": "PHARMOBEDIENT",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/11\/2024",
  "drugName": "DIVALPROEX SODIUMANDA  #090062",
  "submission": "SUPPL-13",
  "activeIngredients": "DIVALPROEX SODIUM",
  "company": "PHARMOBEDIENT",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/11\/2024",
  "drugName": "DIVALPROEX SODIUMANDA  #090062",
  "submission": "SUPPL-15",
  "activeIngredients": "DIVALPROEX SODIUM",
  "company": "PHARMOBEDIENT",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/11\/2024",
  "drugName": "DIVALPROEX SODIUMANDA  #090062",
  "submission": "SUPPL-16",
  "activeIngredients": "DIVALPROEX SODIUM",
  "company": "PHARMOBEDIENT",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/11\/2024",
  "drugName": "DIVALPROEX SODIUMANDA  #090062",
  "submission": "SUPPL-17",
  "activeIngredients": "DIVALPROEX SODIUM",
  "company": "PHARMOBEDIENT",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/11\/2024",
  "drugName": "COLESEVELAM HYDROCHLORIDEANDA  #091600",
  "submission": "SUPPL-8",
  "activeIngredients": "COLESEVELAM HYDROCHLORIDE",
  "company": "IMPAX LABS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/11\/2024",
  "drugName": "COLESEVELAM HYDROCHLORIDEANDA  #091600",
  "submission": "SUPPL-12",
  "activeIngredients": "COLESEVELAM HYDROCHLORIDE",
  "company": "IMPAX LABS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/11\/2024",
  "drugName": "COLESEVELAM HYDROCHLORIDEANDA  #091600",
  "submission": "SUPPL-13",
  "activeIngredients": "COLESEVELAM HYDROCHLORIDE",
  "company": "IMPAX LABS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/11\/2024",
  "drugName": "COLESEVELAM HYDROCHLORIDEANDA  #091600",
  "submission": "SUPPL-17",
  "activeIngredients": "COLESEVELAM HYDROCHLORIDE",
  "company": "IMPAX LABS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/11\/2024",
  "drugName": "XIAFLEXBLA   #125338",
  "submission": "SUPPL-138",
  "activeIngredients": "COLLAGENASE CLOSTRIDIUM HISTOLYTICUM",
  "company": "AUXILIUM PHARMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/11\/2024",
  "drugName": "KOMBIGLYZE XRNDA   #200678",
  "submission": "SUPPL-28",
  "activeIngredients": "METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE",
  "company": "ASTRAZENECA AB",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/11\/2024",
  "drugName": "TRETINOINANDA  #201687",
  "submission": "SUPPL-4",
  "activeIngredients": "TRETINOIN",
  "company": "PH HEALTH",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/11\/2024",
  "drugName": "TRETINOINANDA  #201687",
  "submission": "SUPPL-10",
  "activeIngredients": "TRETINOIN",
  "company": "PH HEALTH",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/11\/2024",
  "drugName": "ESOMEPRAZOLE SODIUMANDA  #202686",
  "submission": "SUPPL-3",
  "activeIngredients": "ESOMEPRAZOLE SODIUM",
  "company": "PHARMOBEDIENT",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/11\/2024",
  "drugName": "ESOMEPRAZOLE SODIUMANDA  #202686",
  "submission": "SUPPL-5",
  "activeIngredients": "ESOMEPRAZOLE SODIUM",
  "company": "PHARMOBEDIENT",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/11\/2024",
  "drugName": "ESOMEPRAZOLE SODIUMANDA  #202686",
  "submission": "SUPPL-7",
  "activeIngredients": "ESOMEPRAZOLE SODIUM",
  "company": "PHARMOBEDIENT",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/11\/2024",
  "drugName": "ESOMEPRAZOLE SODIUMANDA  #202686",
  "submission": "SUPPL-9",
  "activeIngredients": "ESOMEPRAZOLE SODIUM",
  "company": "PHARMOBEDIENT",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/11\/2024",
  "drugName": "ESOMEPRAZOLE SODIUMANDA  #202686",
  "submission": "SUPPL-10",
  "activeIngredients": "ESOMEPRAZOLE SODIUM",
  "company": "PHARMOBEDIENT",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/11\/2024",
  "drugName": "METHYLPREDNISOLONEANDA  #204072",
  "submission": "SUPPL-10",
  "activeIngredients": "METHYLPREDNISOLONE",
  "company": "TIANJIN TIANYAO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/11\/2024",
  "drugName": "METHYLPREDNISOLONEANDA  #204072",
  "submission": "SUPPL-11",
  "activeIngredients": "METHYLPREDNISOLONE",
  "company": "TIANJIN TIANYAO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/11\/2024",
  "drugName": "OFEVNDA   #205832",
  "submission": "SUPPL-28",
  "activeIngredients": "NINTEDANIB ESYLATE",
  "company": "BOEHRINGER INGELHEIM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/11\/2024",
  "drugName": "AMLODIPINE BESYLATE AND VALSARTANANDA  #207292",
  "submission": "ORIG-1",
  "activeIngredients": "AMLODIPINE BESYLATE; VALSARTAN",
  "company": "MACLEODS PHARMS LTD",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/11\/2024",
  "drugName": "METHYLPREDNISOLONEANDA  #209097",
  "submission": "SUPPL-1",
  "activeIngredients": "METHYLPREDNISOLONE",
  "company": "CHARTWELL RX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/11\/2024",
  "drugName": "GABAPENTINANDA  #209855",
  "submission": "SUPPL-1",
  "activeIngredients": "GABAPENTIN",
  "company": "IPCA LABS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/11\/2024",
  "drugName": "DIMETHYL FUMARATEANDA  #210440",
  "submission": "SUPPL-2",
  "activeIngredients": "DIMETHYL FUMARATE",
  "company": "ALKEM LABS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/11\/2024",
  "drugName": "DIMETHYL FUMARATEANDA  #210440",
  "submission": "SUPPL-4",
  "activeIngredients": "DIMETHYL FUMARATE",
  "company": "ALKEM LABS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/11\/2024",
  "drugName": "DIMETHYL FUMARATEANDA  #210440",
  "submission": "SUPPL-5",
  "activeIngredients": "DIMETHYL FUMARATE",
  "company": "ALKEM LABS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/11\/2024",
  "drugName": "DIMETHYL FUMARATEANDA  #210440",
  "submission": "SUPPL-7",
  "activeIngredients": "DIMETHYL FUMARATE",
  "company": "ALKEM LABS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/11\/2024",
  "drugName": "DIMETHYL FUMARATEANDA  #210440",
  "submission": "SUPPL-8",
  "activeIngredients": "DIMETHYL FUMARATE",
  "company": "ALKEM LABS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/11\/2024",
  "drugName": "DIMETHYL FUMARATEANDA  #210440",
  "submission": "SUPPL-10",
  "activeIngredients": "DIMETHYL FUMARATE",
  "company": "ALKEM LABS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/11\/2024",
  "drugName": "EFINACONAZOLEANDA  #211969",
  "submission": "SUPPL-1",
  "activeIngredients": "EFINACONAZOLE",
  "company": "UMEDICA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/11\/2024",
  "drugName": "COLCHICINEANDA  #217620",
  "submission": "SUPPL-1",
  "activeIngredients": "COLCHICINE",
  "company": "ANNORA PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/11\/2024",
  "drugName": "EPHEDRINE SULFATEANDA  #217721",
  "submission": "ORIG-1",
  "activeIngredients": "EPHEDRINE SULFATE",
  "company": "HIKMA",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/11\/2024",
  "drugName": "BAVENCIOBLA   #761049",
  "submission": "SUPPL-19",
  "activeIngredients": "AVELUMAB",
  "company": "EMD SERONO INC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/11\/2024",
  "drugName": "BIMZELXBLA   #761151",
  "submission": "SUPPL-9",
  "activeIngredients": "BIMEKIZUMAB-BKZX",
  "company": "UCB INC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/11\/2024",
  "drugName": "HYMPAVZIBLA   #761369",
  "submission": "ORIG-1",
  "activeIngredients": "MARSTACIMAB-HNCQ",
  "company": "PFIZER INC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/15\/2024",
  "drugName": "FRAGMINNDA   #020287",
  "submission": "SUPPL-80",
  "activeIngredients": "DALTEPARIN SODIUM",
  "company": "PFIZER",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/15\/2024",
  "drugName": "METRONIDAZOLEANDA  #070039",
  "submission": "SUPPL-18",
  "activeIngredients": "METRONIDAZOLE",
  "company": "STRIDES PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/15\/2024",
  "drugName": "METRONIDAZOLEANDA  #070040",
  "submission": "SUPPL-18",
  "activeIngredients": "METRONIDAZOLE",
  "company": "STRIDES PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/15\/2024",
  "drugName": "GABAPENTINANDA  #078787",
  "submission": "SUPPL-41",
  "activeIngredients": "GABAPENTIN",
  "company": "AUROBINDO PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/15\/2024",
  "drugName": "ROSUVASTATIN CALCIUMANDA  #079172",
  "submission": "SUPPL-24",
  "activeIngredients": "ROSUVASTATIN CALCIUM",
  "company": "GLENMARK SPECLT",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/15\/2024",
  "drugName": "GABAPENTINANDA  #208928",
  "submission": "SUPPL-1",
  "activeIngredients": "GABAPENTIN",
  "company": "IPCA LABS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/15\/2024",
  "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #209385",
  "submission": "SUPPL-10",
  "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
  "company": "ELITE LABS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/15\/2024",
  "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #209385",
  "submission": "SUPPL-13",
  "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
  "company": "ELITE LABS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/15\/2024",
  "drugName": "METHYLPREDNISOLONE ACETATEANDA  #210043",
  "submission": "SUPPL-36",
  "activeIngredients": "METHYLPREDNISOLONE ACETATE",
  "company": "AMNEAL",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/15\/2024",
  "drugName": "ATORVASTATIN CALCIUMANDA  #214659",
  "submission": "SUPPL-5",
  "activeIngredients": "ATORVASTATIN CALCIUM",
  "company": "DR REDDYS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/15\/2024",
  "drugName": "ATORVASTATIN CALCIUMANDA  #214659",
  "submission": "SUPPL-9",
  "activeIngredients": "ATORVASTATIN CALCIUM",
  "company": "DR REDDYS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/15\/2024",
  "drugName": "AZACITIDINEANDA  #215765",
  "submission": "ORIG-1",
  "activeIngredients": "AZACITIDINE",
  "company": "HETERO LABS LTD VI",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/15\/2024",
  "drugName": "OFLOXACINANDA  #216328",
  "submission": "ORIG-1",
  "activeIngredients": "OFLOXACIN",
  "company": "SOMERSET THERAPS LLC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/15\/2024",
  "drugName": "ESMOLOL HYDROCHLORIDEANDA  #216603",
  "submission": "SUPPL-1",
  "activeIngredients": "ESMOLOL HYDROCHLORIDE",
  "company": "AMNEAL",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/15\/2024",
  "drugName": "ESMOLOL HYDROCHLORIDEANDA  #216603",
  "submission": "SUPPL-2",
  "activeIngredients": "ESMOLOL HYDROCHLORIDE",
  "company": "AMNEAL",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/15\/2024",
  "drugName": "EPHEDRINE SULFATEANDA  #218113",
  "submission": "ORIG-1",
  "activeIngredients": "EPHEDRINE SULFATE",
  "company": "SOMERSET THERAPS LLC",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "10\/15\/2024",
  "drugName": "TELMISARTANANDA  #218157",
  "submission": "ORIG-1",
  "activeIngredients": "TELMISARTAN",
  "company": "MANKIND PHARMA",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/15\/2024",
  "drugName": "TAFAMIDISANDA  #218365",
  "submission": "ORIG-1",
  "activeIngredients": "TAFAMIDIS",
  "company": "DEXCEL PHARMA",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "10\/15\/2024",
  "drugName": "EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDEANDA  #218483",
  "submission": "ORIG-1",
  "activeIngredients": "EMPAGLIFLOZIN;METFORMIN HYDROCHLORIDE",
  "company": "PRINSTON PHARMA INC",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "10\/15\/2024",
  "drugName": "NITROGLYCERINANDA  #218583",
  "submission": "ORIG-1",
  "activeIngredients": "NITROGLYCERIN",
  "company": "VIWIT PHARM",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/15\/2024",
  "drugName": "METRONIDAZOLEANDA  #218941",
  "submission": "ORIG-1",
  "activeIngredients": "METRONIDAZOLE",
  "company": "AUROBINDO PHARMA LTD",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/16\/2024",
  "drugName": "ROSUVASTATIN CALCIUMANDA  #079170",
  "submission": "SUPPL-24",
  "activeIngredients": "ROSUVASTATIN CALCIUM",
  "company": "AUROBINDO PHARMA LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/16\/2024",
  "drugName": "SACUBITRIL AND VALSARTANANDA  #213728",
  "submission": "ORIG-1",
  "activeIngredients": "SACUBITRIL; VALSARTAN",
  "company": "MACLEODS PHARMS LTD",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/16\/2024",
  "drugName": "SUGAMMADEXANDA  #214306",
  "submission": "ORIG-1",
  "activeIngredients": "SUGAMMADEX",
  "company": "ZENARA PHARMA PRIVATE LTD",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "10\/16\/2024",
  "drugName": "LUMRYZNDA   #214755",
  "submission": "SUPPL-6",
  "activeIngredients": "SODIUM OXYBATE",
  "company": "AVADEL CNS",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/16\/2024",
  "drugName": "ZINC CHLORIDEANDA  #216152",
  "submission": "ORIG-1",
  "activeIngredients": "ZINC CHLORIDE",
  "company": "SOMERSET",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/16\/2024",
  "drugName": "VYALEVNDA   #216962",
  "submission": "ORIG-1",
  "activeIngredients": "FOSCARBIDOPA; FOSLEVODOPA",
  "company": "ABBVIE",
  "submissionClassification": "Type 3 - New Dosage Form and Type 4 - New Combination",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/16\/2024",
  "drugName": "IVERMECTINANDA  #218324",
  "submission": "ORIG-1",
  "activeIngredients": "IVERMECTIN",
  "company": "SENORES PHARMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/16\/2024",
  "drugName": "FAMOTIDINEANDA  #218344",
  "submission": "ORIG-1",
  "activeIngredients": "FAMOTIDINE",
  "company": "EPIC PHARMA LLC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/16\/2024",
  "drugName": "FLUDROCORTISONE ACETATEANDA  #219251",
  "submission": "ORIG-1",
  "activeIngredients": "FLUDROCORTISONE ACETATE",
  "company": "ZYDUS LIFESCIENCES",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/17\/2024",
  "drugName": "CLORAZEPATE DIPOTASSIUMANDA  #075731",
  "submission": "SUPPL-9",
  "activeIngredients": "CLORAZEPATE DIPOTASSIUM",
  "company": "TARO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/17\/2024",
  "drugName": "CLORAZEPATE DIPOTASSIUMANDA  #075731",
  "submission": "SUPPL-12",
  "activeIngredients": "CLORAZEPATE DIPOTASSIUM",
  "company": "TARO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/17\/2024",
  "drugName": "CLORAZEPATE DIPOTASSIUMANDA  #075731",
  "submission": "SUPPL-13",
  "activeIngredients": "CLORAZEPATE DIPOTASSIUM",
  "company": "TARO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/17\/2024",
  "drugName": "OXAPROZINANDA  #075849",
  "submission": "SUPPL-13",
  "activeIngredients": "OXAPROZIN",
  "company": "TEVA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/17\/2024",
  "drugName": "OXAPROZINANDA  #075849",
  "submission": "SUPPL-14",
  "activeIngredients": "OXAPROZIN",
  "company": "TEVA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/17\/2024",
  "drugName": "OXAPROZINANDA  #075849",
  "submission": "SUPPL-15",
  "activeIngredients": "OXAPROZIN",
  "company": "TEVA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/17\/2024",
  "drugName": "PROPAFENONE HYDROCHLORIDEANDA  #075938",
  "submission": "SUPPL-19",
  "activeIngredients": "PROPAFENONE HYDROCHLORIDE",
  "company": "STRIDES PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/17\/2024",
  "drugName": "PROPAFENONE HYDROCHLORIDEANDA  #075938",
  "submission": "SUPPL-23",
  "activeIngredients": "PROPAFENONE HYDROCHLORIDE",
  "company": "STRIDES PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/17\/2024",
  "drugName": "MYCOPHENOLATE MOFETILANDA  #211272",
  "submission": "SUPPL-2",
  "activeIngredients": "MYCOPHENOLATE MOFETIL",
  "company": "TEVA PHARMS USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/17\/2024",
  "drugName": "FENSOLVI KITNDA   #213150",
  "submission": "SUPPL-4",
  "activeIngredients": "LEUPROLIDE ACETATE",
  "company": "TOLMAR",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/17\/2024",
  "drugName": "LEUPROLIDE ACETATEANDA  #217957",
  "submission": "ORIG-1",
  "activeIngredients": "LEUPROLIDE ACETATE",
  "company": "UBI",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/17\/2024",
  "drugName": "BUPROPION HYDROCHLORIDEANDA  #218385",
  "submission": "ORIG-1",
  "activeIngredients": "BUPROPION HYDROCHLORIDE",
  "company": "GRANULES",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/17\/2024",
  "drugName": "FLUVOXAMINE MALEATEANDA  #219055",
  "submission": "ORIG-1",
  "activeIngredients": "FLUVOXAMINE MALEATE",
  "company": "AJANTA PHARMA LTD",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/18\/2024",
  "drugName": "DIFLUNISALANDA  #073673",
  "submission": "SUPPL-34",
  "activeIngredients": "DIFLUNISAL",
  "company": "TEVA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/18\/2024",
  "drugName": "ATAZANAVIR SULFATEANDA  #091673",
  "submission": "SUPPL-1",
  "activeIngredients": "ATAZANAVIR SULFATE",
  "company": "TEVA PHARMS USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/18\/2024",
  "drugName": "ATAZANAVIR SULFATEANDA  #091673",
  "submission": "SUPPL-2",
  "activeIngredients": "ATAZANAVIR SULFATE",
  "company": "TEVA PHARMS USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/18\/2024",
  "drugName": "ATAZANAVIR SULFATEANDA  #091673",
  "submission": "SUPPL-4",
  "activeIngredients": "ATAZANAVIR SULFATE",
  "company": "TEVA PHARMS USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/18\/2024",
  "drugName": "ATAZANAVIR SULFATEANDA  #091673",
  "submission": "SUPPL-6",
  "activeIngredients": "ATAZANAVIR SULFATE",
  "company": "TEVA PHARMS USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/18\/2024",
  "drugName": "ATAZANAVIR SULFATEANDA  #091673",
  "submission": "SUPPL-7",
  "activeIngredients": "ATAZANAVIR SULFATE",
  "company": "TEVA PHARMS USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/18\/2024",
  "drugName": "ATAZANAVIR SULFATEANDA  #091673",
  "submission": "SUPPL-8",
  "activeIngredients": "ATAZANAVIR SULFATE",
  "company": "TEVA PHARMS USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/18\/2024",
  "drugName": "ATAZANAVIR SULFATEANDA  #091673",
  "submission": "SUPPL-13",
  "activeIngredients": "ATAZANAVIR SULFATE",
  "company": "TEVA PHARMS USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/18\/2024",
  "drugName": "BOTOXBLA   #103000",
  "submission": "SUPPL-5316",
  "activeIngredients": "OnabotulinumtoxinA",
  "company": "ALLERGAN",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/18\/2024",
  "drugName": "BOTOXBLA   #103000",
  "submission": "SUPPL-5319",
  "activeIngredients": "OnabotulinumtoxinA",
  "company": "ALLERGAN",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/18\/2024",
  "drugName": "BOTOXBLA   #103000",
  "submission": "SUPPL-5323",
  "activeIngredients": "OnabotulinumtoxinA",
  "company": "ALLERGAN",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/18\/2024",
  "drugName": "BOTOXBLA   #103000",
  "submission": "SUPPL-5326",
  "activeIngredients": "OnabotulinumtoxinA",
  "company": "ALLERGAN",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/18\/2024",
  "drugName": "BOTOXBLA   #103000",
  "submission": "SUPPL-5331",
  "activeIngredients": "OnabotulinumtoxinA",
  "company": "ALLERGAN",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/18\/2024",
  "drugName": "BOTOX COSMETICBLA   #103000",
  "submission": "SUPPL-5316",
  "activeIngredients": "OnabotulinumtoxinA",
  "company": "ALLERGAN",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/18\/2024",
  "drugName": "BOTOX COSMETICBLA   #103000",
  "submission": "SUPPL-5319",
  "activeIngredients": "OnabotulinumtoxinA",
  "company": "ALLERGAN",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/18\/2024",
  "drugName": "BOTOX COSMETICBLA   #103000",
  "submission": "SUPPL-5323",
  "activeIngredients": "OnabotulinumtoxinA",
  "company": "ALLERGAN",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/18\/2024",
  "drugName": "BOTOX COSMETICBLA   #103000",
  "submission": "SUPPL-5326",
  "activeIngredients": "OnabotulinumtoxinA",
  "company": "ALLERGAN",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/18\/2024",
  "drugName": "BOTOX COSMETICBLA   #103000",
  "submission": "SUPPL-5331",
  "activeIngredients": "OnabotulinumtoxinA",
  "company": "ALLERGAN",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/18\/2024",
  "drugName": "LABETALOL HYDROCHLORIDEANDA  #209603",
  "submission": "SUPPL-6",
  "activeIngredients": "LABETALOL HYDROCHLORIDE",
  "company": "APPCO",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/18\/2024",
  "drugName": "METFORMIN HYDROCHLORIDEANDA  #209694",
  "submission": "ORIG-1",
  "activeIngredients": "METFORMIN HYDROCHLORIDE",
  "company": "AUROBINDO PHARMA",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/18\/2024",
  "drugName": "FOSAPREPITANT DIMEGLUMINEANDA  #212309",
  "submission": "SUPPL-9",
  "activeIngredients": "FOSAPREPITANT DIMEGLUMINE",
  "company": "BE PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/18\/2024",
  "drugName": "SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATEANDA  #212903",
  "submission": "ORIG-1",
  "activeIngredients": "MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE",
  "company": "ANNORA PHARMA",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/18\/2024",
  "drugName": "PALBOCICLIBANDA  #213015",
  "submission": "ORIG-1",
  "activeIngredients": "PALBOCICLIB",
  "company": "HETERO LABS LTD V",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "10\/18\/2024",
  "drugName": "ORGOVYXNDA   #214621",
  "submission": "SUPPL-6",
  "activeIngredients": "RELUGOLIX",
  "company": "SUMITOMO PHARMA AM",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/18\/2024",
  "drugName": "XROMINDA   #216593",
  "submission": "SUPPL-1",
  "activeIngredients": "HYDROXYUREA",
  "company": "NOVA LABS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/18\/2024",
  "drugName": "ZEPBOUNDNDA   #217806",
  "submission": "SUPPL-5",
  "activeIngredients": "TIRZEPATIDE",
  "company": "ELI LILLY AND CO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/18\/2024",
  "drugName": "ZEPBOUNDNDA   #217806",
  "submission": "SUPPL-6",
  "activeIngredients": "TIRZEPATIDE",
  "company": "ELI LILLY AND CO",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/18\/2024",
  "drugName": "ZEPBOUNDNDA   #217806",
  "submission": "SUPPL-11",
  "activeIngredients": "TIRZEPATIDE",
  "company": "ELI LILLY AND CO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/18\/2024",
  "drugName": "ZEPBOUNDNDA   #217806",
  "submission": "SUPPL-15",
  "activeIngredients": "TIRZEPATIDE",
  "company": "ELI LILLY AND CO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/18\/2024",
  "drugName": "ZEPBOUNDNDA   #217806",
  "submission": "SUPPL-19",
  "activeIngredients": "TIRZEPATIDE",
  "company": "ELI LILLY AND CO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/18\/2024",
  "drugName": "ZEPBOUND (AUTOINJECTOR)NDA   #217806",
  "submission": "SUPPL-5",
  "activeIngredients": "TIRZEPATIDE",
  "company": "ELI LILLY AND CO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/18\/2024",
  "drugName": "ZEPBOUND (AUTOINJECTOR)NDA   #217806",
  "submission": "SUPPL-6",
  "activeIngredients": "TIRZEPATIDE",
  "company": "ELI LILLY AND CO",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/18\/2024",
  "drugName": "ZEPBOUND (AUTOINJECTOR)NDA   #217806",
  "submission": "SUPPL-11",
  "activeIngredients": "TIRZEPATIDE",
  "company": "ELI LILLY AND CO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/18\/2024",
  "drugName": "ZEPBOUND (AUTOINJECTOR)NDA   #217806",
  "submission": "SUPPL-15",
  "activeIngredients": "TIRZEPATIDE",
  "company": "ELI LILLY AND CO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/18\/2024",
  "drugName": "ZEPBOUND (AUTOINJECTOR)NDA   #217806",
  "submission": "SUPPL-19",
  "activeIngredients": "TIRZEPATIDE",
  "company": "ELI LILLY AND CO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/18\/2024",
  "drugName": "DILTIAZEM HYDROCHLORIDEANDA  #218587",
  "submission": "ORIG-1",
  "activeIngredients": "DILTIAZEM HYDROCHLORIDE",
  "company": "ALEMBIC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/18\/2024",
  "drugName": "SELARSDIBLA   #761343",
  "submission": "SUPPL-1",
  "activeIngredients": "USTEKINUMAB-AEKN",
  "company": "ALVOTECH USA INC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/18\/2024",
  "drugName": "SELARSDIBLA   #761343",
  "submission": "SUPPL-2",
  "activeIngredients": "USTEKINUMAB-AEKN",
  "company": "ALVOTECH USA INC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/18\/2024",
  "drugName": "SELARSDIBLA   #761343",
  "submission": "SUPPL-3",
  "activeIngredients": "USTEKINUMAB-AEKN",
  "company": "ALVOTECH USA INC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/18\/2024",
  "drugName": "VYLOYBLA   #761365",
  "submission": "ORIG-1",
  "activeIngredients": "ZOLBETUXIMAB-CLZB",
  "company": "ASTELLAS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/21\/2024",
  "drugName": "OMEPRAZOLE MAGNESIUMANDA  #206582",
  "submission": "SUPPL-2",
  "activeIngredients": "OMEPRAZOLE MAGNESIUM",
  "company": "P AND L",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/21\/2024",
  "drugName": "BREXPIPRAZOLEANDA  #213587",
  "submission": "ORIG-1",
  "activeIngredients": "BREXPIPRAZOLE",
  "company": "PRINSTON PHARMA INC",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "10\/21\/2024",
  "drugName": "ORLADEYONDA   #214094",
  "submission": "SUPPL-3",
  "activeIngredients": "BEROTRALSTAT HYDROCHLORIDE",
  "company": "BIOCRYST",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/21\/2024",
  "drugName": "GLYCEROL PHENYLBUTYRATEANDA  #218738",
  "submission": "ORIG-1",
  "activeIngredients": "GLYCEROL PHENYLBUTYRATE",
  "company": "TEVA PHARMS INC",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "10\/21\/2024",
  "drugName": "LEVALBUTEROL HYDROCHLORIDEANDA  #218770",
  "submission": "ORIG-1",
  "activeIngredients": "LEVALBUTEROL HYDROCHLORIDE",
  "company": "MANKIND PHARMA",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/22\/2024",
  "drugName": "ZARXIOBLA   #125553",
  "submission": "SUPPL-38",
  "activeIngredients": "FILGRASTIM-SNDZ",
  "company": "SANDOZ INC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/22\/2024",
  "drugName": "MYCOPHENOLATE MOFETILANDA  #207022",
  "submission": "ORIG-1",
  "activeIngredients": "MYCOPHENOLATE MOFETIL",
  "company": "HETERO LABS LTD V",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/22\/2024",
  "drugName": "MYCOPHENOLATE MOFETILANDA  #208119",
  "submission": "ORIG-1",
  "activeIngredients": "MYCOPHENOLATE MOFETIL",
  "company": "HETERO LABS LTD V",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/22\/2024",
  "drugName": "CABAZITAXELANDA  #210685",
  "submission": "ORIG-1",
  "activeIngredients": "CABAZITAXEL",
  "company": "MSN LABORATORIES PRIVATE LTD",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "10\/22\/2024",
  "drugName": "EZETIMIBEANDA  #211550",
  "submission": "SUPPL-2",
  "activeIngredients": "EZETIMIBE",
  "company": "ACCORD HLTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/22\/2024",
  "drugName": "EZETIMIBEANDA  #211550",
  "submission": "SUPPL-4",
  "activeIngredients": "EZETIMIBE",
  "company": "ACCORD HLTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/22\/2024",
  "drugName": "ICATIBANT ACETATEANDA  #213521",
  "submission": "SUPPL-2",
  "activeIngredients": "ICATIBANT ACETATE",
  "company": "EUGIA PHARMA",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/22\/2024",
  "drugName": "CARBAMAZEPINEANDA  #215664",
  "submission": "ORIG-1",
  "activeIngredients": "CARBAMAZEPINE",
  "company": "OSMOTICA PHARM US",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/22\/2024",
  "drugName": "FORMOTEROL FUMARATEANDA  #216426",
  "submission": "ORIG-1",
  "activeIngredients": "FORMOTEROL FUMARATE",
  "company": "LEXENPHARM",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/23\/2024",
  "drugName": "BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATEANDA  #075351",
  "submission": "SUPPL-8",
  "activeIngredients": "ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE",
  "company": "NOVITIUM PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/23\/2024",
  "drugName": "BUPROPION HYDROCHLORIDEANDA  #077715",
  "submission": "SUPPL-50",
  "activeIngredients": "BUPROPION HYDROCHLORIDE",
  "company": "ACTAVIS LABS FL INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/23\/2024",
  "drugName": "TOPIRAMATEANDA  #078235",
  "submission": "SUPPL-35",
  "activeIngredients": "TOPIRAMATE",
  "company": "ZYDUS PHARMS USA INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/23\/2024",
  "drugName": "NEVIRAPINEANDA  #078584",
  "submission": "SUPPL-21",
  "activeIngredients": "NEVIRAPINE",
  "company": "HETERO LABS LTD III",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/23\/2024",
  "drugName": "ALFUZOSIN HYDROCHLORIDEANDA  #079057",
  "submission": "SUPPL-22",
  "activeIngredients": "ALFUZOSIN HYDROCHLORIDE",
  "company": "SUN PHARM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/23\/2024",
  "drugName": "PURIXANNDA   #205919",
  "submission": "SUPPL-7",
  "activeIngredients": "MERCAPTOPURINE",
  "company": "NOVA LABS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/23\/2024",
  "drugName": "ESOMEPRAZOLE MAGNESIUMANDA  #208511",
  "submission": "ORIG-1",
  "activeIngredients": "ESOMEPRAZOLE MAGNESIUM",
  "company": "MACLEODS PHARMS LTD",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/23\/2024",
  "drugName": "JYLAMVONDA   #212479",
  "submission": "SUPPL-2",
  "activeIngredients": "METHOTREXATE",
  "company": "SHORLA",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/23\/2024",
  "drugName": "JYLAMVONDA   #212479",
  "submission": "SUPPL-3",
  "activeIngredients": "METHOTREXATE",
  "company": "SHORLA",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/23\/2024",
  "drugName": "VIGABATRINANDA  #214425",
  "submission": "SUPPL-3",
  "activeIngredients": "VIGABATRIN",
  "company": "ACCORD HLTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/23\/2024",
  "drugName": "DEFERASIROXANDA  #214650",
  "submission": "SUPPL-3",
  "activeIngredients": "DEFERASIROX",
  "company": "MSN",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/23\/2024",
  "drugName": "ESTRADIOLANDA  #217882",
  "submission": "ORIG-1",
  "activeIngredients": "ESTRADIOL",
  "company": "NOVITIUM PHARMA",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/23\/2024",
  "drugName": "BRIVARACETAMANDA  #218573",
  "submission": "ORIG-1",
  "activeIngredients": "BRIVARACETAM",
  "company": "PRINSTON PHARMA INC",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "10\/23\/2024",
  "drugName": "BEIZRAYNDA   #218711",
  "submission": "ORIG-1",
  "activeIngredients": "DOCETAXEL",
  "company": "ZHUHAI",
  "submissionClassification": "Type 5 - New Formulation or New Manufacturer",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/23\/2024",
  "drugName": "BKEMVBLA   #761333",
  "submission": "SUPPL-1",
  "activeIngredients": "ECULIZUMAB-AEEB",
  "company": "AMGEN INC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/24\/2024",
  "drugName": "HEPARIN SODIUMNDA   #000552",
  "submission": "SUPPL-26",
  "activeIngredients": "HEPARIN SODIUM",
  "company": "ASPEN GLOBAL INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/24\/2024",
  "drugName": "LIQUAEMIN LOCK FLUSHNDA   #000552",
  "submission": "SUPPL-26",
  "activeIngredients": "HEPARIN SODIUM",
  "company": "ASPEN GLOBAL INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/24\/2024",
  "drugName": "LIQUAEMIN SODIUMNDA   #000552",
  "submission": "SUPPL-26",
  "activeIngredients": "HEPARIN SODIUM",
  "company": "ASPEN GLOBAL INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/24\/2024",
  "drugName": "LIQUAEMIN SODIUM PRESERVATIVE FREENDA   #000552",
  "submission": "SUPPL-26",
  "activeIngredients": "HEPARIN SODIUM",
  "company": "ASPEN GLOBAL INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/24\/2024",
  "drugName": "HEPARIN LOCK FLUSHNDA   #017007",
  "submission": "SUPPL-40",
  "activeIngredients": "HEPARIN SODIUM",
  "company": "HIKMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/24\/2024",
  "drugName": "HEPARIN SODIUMNDA   #017007",
  "submission": "SUPPL-40",
  "activeIngredients": "HEPARIN SODIUM",
  "company": "HIKMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/24\/2024",
  "drugName": "HEPARIN SODIUMNDA   #017029",
  "submission": "SUPPL-178",
  "activeIngredients": "HEPARIN SODIUM",
  "company": "FRESENIUS KABI USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/24\/2024",
  "drugName": "HEPARIN SODIUM 20,000 UNITS IN DEXTROSE 5%NDA   #017029",
  "submission": "SUPPL-178",
  "activeIngredients": "HEPARIN SODIUM",
  "company": "FRESENIUS KABI USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/24\/2024",
  "drugName": "HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5%NDA   #017029",
  "submission": "SUPPL-178",
  "activeIngredients": "HEPARIN SODIUM",
  "company": "FRESENIUS KABI USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/24\/2024",
  "drugName": "HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.45%NDA   #017029",
  "submission": "SUPPL-178",
  "activeIngredients": "HEPARIN SODIUM",
  "company": "FRESENIUS KABI USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/24\/2024",
  "drugName": "HEPARIN SODIUM IN PLASTIC CONTAINERNDA   #017029",
  "submission": "SUPPL-178",
  "activeIngredients": "HEPARIN SODIUM",
  "company": "FRESENIUS KABI USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/24\/2024",
  "drugName": "HEPARIN SODIUM PRESERVATIVE FREENDA   #017029",
  "submission": "SUPPL-178",
  "activeIngredients": "HEPARIN SODIUM",
  "company": "FRESENIUS KABI USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/24\/2024",
  "drugName": "HEPARIN SODIUMNDA   #017037",
  "submission": "SUPPL-201",
  "activeIngredients": "HEPARIN SODIUM",
  "company": "HIKMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/24\/2024",
  "drugName": "HEPARIN LOCK FLUSHNDA   #017064",
  "submission": "SUPPL-60",
  "activeIngredients": "HEPARIN SODIUM",
  "company": "DR REDDYS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/24\/2024",
  "drugName": "HEPARIN SODIUMNDA   #017064",
  "submission": "SUPPL-60",
  "activeIngredients": "HEPARIN SODIUM",
  "company": "DR REDDYS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/24\/2024",
  "drugName": "HEPARIN SODIUMNDA   #017651",
  "submission": "SUPPL-78",
  "activeIngredients": "HEPARIN SODIUM",
  "company": "FRESENIUS KABI USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/24\/2024",
  "drugName": "HEPARIN SODIUM 1,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERNDA   #018916",
  "submission": "SUPPL-79",
  "activeIngredients": "HEPARIN SODIUM",
  "company": "HOSPIRA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/24\/2024",
  "drugName": "HEPARIN SODIUM 10,000 UNITS IN SODIUM CHLORIDE 0.45%NDA   #018916",
  "submission": "SUPPL-79",
  "activeIngredients": "HEPARIN SODIUM",
  "company": "HOSPIRA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/24\/2024",
  "drugName": "HEPARIN SODIUM 10,000 UNITS IN SODIUM CHLORIDE 0.9%NDA   #018916",
  "submission": "SUPPL-79",
  "activeIngredients": "HEPARIN SODIUM",
  "company": "HOSPIRA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/24\/2024",
  "drugName": "HEPARIN SODIUM 12,500 UNITS IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINERNDA   #018916",
  "submission": "SUPPL-79",
  "activeIngredients": "HEPARIN SODIUM",
  "company": "HOSPIRA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/24\/2024",
  "drugName": "HEPARIN SODIUM 12,500 UNITS IN SODIUM CHLORIDE 0.9%NDA   #018916",
  "submission": "SUPPL-79",
  "activeIngredients": "HEPARIN SODIUM",
  "company": "HOSPIRA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/24\/2024",
  "drugName": "HEPARIN SODIUM 2,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERNDA   #018916",
  "submission": "SUPPL-79",
  "activeIngredients": "HEPARIN SODIUM",
  "company": "HOSPIRA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/24\/2024",
  "drugName": "HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINERNDA   #018916",
  "submission": "SUPPL-79",
  "activeIngredients": "HEPARIN SODIUM",
  "company": "HOSPIRA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/24\/2024",
  "drugName": "HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERNDA   #018916",
  "submission": "SUPPL-79",
  "activeIngredients": "HEPARIN SODIUM",
  "company": "HOSPIRA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/24\/2024",
  "drugName": "HEPARIN SODIUM 5,000 UNITS IN SODIUM CHLORIDE 0.45%NDA   #018916",
  "submission": "SUPPL-79",
  "activeIngredients": "HEPARIN SODIUM",
  "company": "HOSPIRA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/24\/2024",
  "drugName": "HEPARIN SODIUM 5,000 UNITS IN SODIUM CHLORIDE 0.9%NDA   #018916",
  "submission": "SUPPL-79",
  "activeIngredients": "HEPARIN SODIUM",
  "company": "HOSPIRA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/24\/2024",
  "drugName": "FRAGMINNDA   #020287",
  "submission": "SUPPL-81",
  "activeIngredients": "DALTEPARIN SODIUM",
  "company": "PFIZER",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/24\/2024",
  "drugName": "FLONASE SENSIMIST ALLERGY RELIEFNDA   #022051",
  "submission": "SUPPL-23",
  "activeIngredients": "FLUTICASONE FUROATE",
  "company": "HALEON US HOLDINGS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/24\/2024",
  "drugName": "AMANTADINE HYDROCHLORIDEANDA  #075060",
  "submission": "SUPPL-12",
  "activeIngredients": "AMANTADINE HYDROCHLORIDE",
  "company": "PHARMOBEDIENT",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/24\/2024",
  "drugName": "FLUOXETINE HYDROCHLORIDEANDA  #076001",
  "submission": "SUPPL-50",
  "activeIngredients": "FLUOXETINE HYDROCHLORIDE",
  "company": "TEVA PHARMS USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/24\/2024",
  "drugName": "FLUOXETINE HYDROCHLORIDEANDA  #076001",
  "submission": "SUPPL-54",
  "activeIngredients": "FLUOXETINE HYDROCHLORIDE",
  "company": "TEVA PHARMS USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/24\/2024",
  "drugName": "FLUOXETINE HYDROCHLORIDEANDA  #076001",
  "submission": "SUPPL-60",
  "activeIngredients": "FLUOXETINE HYDROCHLORIDE",
  "company": "TEVA PHARMS USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/24\/2024",
  "drugName": "ITRACONAZOLEANDA  #076104",
  "submission": "SUPPL-25",
  "activeIngredients": "ITRACONAZOLE",
  "company": "SANDOZ",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/24\/2024",
  "drugName": "ITRACONAZOLEANDA  #076104",
  "submission": "SUPPL-27",
  "activeIngredients": "ITRACONAZOLE",
  "company": "SANDOZ",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/24\/2024",
  "drugName": "ROSUVASTATIN CALCIUMANDA  #079161",
  "submission": "SUPPL-8",
  "activeIngredients": "ROSUVASTATIN CALCIUM",
  "company": "STRIDES PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/24\/2024",
  "drugName": "ISONIAZIDANDA  #080936",
  "submission": "SUPPL-55",
  "activeIngredients": "ISONIAZID",
  "company": "GENUS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/24\/2024",
  "drugName": "ISONIAZIDANDA  #080936",
  "submission": "SUPPL-56",
  "activeIngredients": "ISONIAZID",
  "company": "GENUS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/24\/2024",
  "drugName": "ISONIAZIDANDA  #080937",
  "submission": "SUPPL-62",
  "activeIngredients": "ISONIAZID",
  "company": "GENUS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/24\/2024",
  "drugName": "ISONIAZIDANDA  #080937",
  "submission": "SUPPL-63",
  "activeIngredients": "ISONIAZID",
  "company": "GENUS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/24\/2024",
  "drugName": "HEPARIN SODIUMNDA   #201370",
  "submission": "SUPPL-21",
  "activeIngredients": "HEPARIN SODIUM",
  "company": "PFIZER",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/24\/2024",
  "drugName": "HEPARIN SODIUM PRESERVATIVE FREENDA   #201370",
  "submission": "SUPPL-21",
  "activeIngredients": "HEPARIN SODIUM",
  "company": "PFIZER",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/24\/2024",
  "drugName": "DUTASTERIDEANDA  #203241",
  "submission": "SUPPL-4",
  "activeIngredients": "DUTASTERIDE",
  "company": "PHARMOBEDIENT",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/24\/2024",
  "drugName": "FLONASE ALLERGY RELIEFNDA   #205434",
  "submission": "SUPPL-16",
  "activeIngredients": "FLUTICASONE PROPIONATE",
  "company": "HALEON US HOLDINGS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/24\/2024",
  "drugName": "ITRACONAZOLEANDA  #206741",
  "submission": "SUPPL-15",
  "activeIngredients": "ITRACONAZOLE",
  "company": "ALEMBIC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/24\/2024",
  "drugName": "ITRACONAZOLEANDA  #206741",
  "submission": "SUPPL-17",
  "activeIngredients": "ITRACONAZOLE",
  "company": "ALEMBIC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/24\/2024",
  "drugName": "POSACONAZOLEANDA  #208773",
  "submission": "SUPPL-1",
  "activeIngredients": "POSACONAZOLE",
  "company": "HIKMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/24\/2024",
  "drugName": "POSACONAZOLEANDA  #208773",
  "submission": "SUPPL-2",
  "activeIngredients": "POSACONAZOLE",
  "company": "HIKMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/24\/2024",
  "drugName": "MESALAMINEANDA  #214242",
  "submission": "SUPPL-8",
  "activeIngredients": "MESALAMINE",
  "company": "ALKEM LABS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/24\/2024",
  "drugName": "SEVELAMER CARBONATEANDA  #215998",
  "submission": "ORIG-1",
  "activeIngredients": "SEVELAMER CARBONATE",
  "company": "SHANDONG XINHUA",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/24\/2024",
  "drugName": "ESTRADIOL VALERATEANDA  #216656",
  "submission": "SUPPL-2",
  "activeIngredients": "ESTRADIOL VALERATE",
  "company": "XIROMED",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/24\/2024",
  "drugName": "BACLOFENANDA  #217788",
  "submission": "SUPPL-1",
  "activeIngredients": "BACLOFEN",
  "company": "RISING",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/24\/2024",
  "drugName": "INMAZEBBLA   #761169",
  "submission": "SUPPL-11",
  "activeIngredients": "ATOLTIVIMAB; ODESIVIMAB; MAFTIVIMAB",
  "company": "REGENERON PHARMACEUTICALS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/24\/2024",
  "drugName": "JUBBONTIBLA   #761362",
  "submission": "SUPPL-1",
  "activeIngredients": "DENOSUMAB-BBDZ",
  "company": "SANDOZ INC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/24\/2024",
  "drugName": "WYOSTBLA   #761362",
  "submission": "SUPPL-1",
  "activeIngredients": "DENOSUMAB-BBDZ",
  "company": "SANDOZ INC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/25\/2024",
  "drugName": "SPORANOXNDA   #020083",
  "submission": "SUPPL-71",
  "activeIngredients": "ITRACONAZOLE",
  "company": "JANSSEN PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/25\/2024",
  "drugName": "SPORANOXNDA   #020657",
  "submission": "SUPPL-44",
  "activeIngredients": "ITRACONAZOLE",
  "company": "JANSSEN PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/25\/2024",
  "drugName": "NOXAFILNDA   #022003",
  "submission": "SUPPL-33",
  "activeIngredients": "POSACONAZOLE",
  "company": "SCHERING",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/25\/2024",
  "drugName": "ROSUVASTATIN CALCIUMANDA  #079145",
  "submission": "SUPPL-11",
  "activeIngredients": "ROSUVASTATIN CALCIUM",
  "company": "APOTEX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/25\/2024",
  "drugName": "METRONIDAZOLEANDA  #090222",
  "submission": "SUPPL-6",
  "activeIngredients": "METRONIDAZOLE",
  "company": "ALEMBIC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/25\/2024",
  "drugName": "ESCITALOPRAM OXALATEANDA  #090939",
  "submission": "SUPPL-25",
  "activeIngredients": "ESCITALOPRAM OXALATE",
  "company": "TORRENT PHARMS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/25\/2024",
  "drugName": "ESCITALOPRAM OXALATEANDA  #090939",
  "submission": "SUPPL-28",
  "activeIngredients": "ESCITALOPRAM OXALATE",
  "company": "TORRENT PHARMS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/25\/2024",
  "drugName": "ESCITALOPRAM OXALATEANDA  #090939",
  "submission": "SUPPL-29",
  "activeIngredients": "ESCITALOPRAM OXALATE",
  "company": "TORRENT PHARMS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/25\/2024",
  "drugName": "ESCITALOPRAM OXALATEANDA  #090939",
  "submission": "SUPPL-30",
  "activeIngredients": "ESCITALOPRAM OXALATE",
  "company": "TORRENT PHARMS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/25\/2024",
  "drugName": "ESCITALOPRAM OXALATEANDA  #090939",
  "submission": "SUPPL-31",
  "activeIngredients": "ESCITALOPRAM OXALATE",
  "company": "TORRENT PHARMS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/25\/2024",
  "drugName": "REVATIONDA   #203109",
  "submission": "SUPPL-19",
  "activeIngredients": "SILDENAFIL CITRATE",
  "company": "VIATRIS",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/25\/2024",
  "drugName": "METRONIDAZOLEANDA  #203458",
  "submission": "SUPPL-25",
  "activeIngredients": "METRONIDAZOLE",
  "company": "UNICHEM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/25\/2024",
  "drugName": "DEXTROAMPHETAMINE SULFATEANDA  #203901",
  "submission": "SUPPL-11",
  "activeIngredients": "DEXTROAMPHETAMINE SULFATE",
  "company": "ACTAVIS ELIZABETH",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/25\/2024",
  "drugName": "DEXTROAMPHETAMINE SULFATEANDA  #203901",
  "submission": "SUPPL-13",
  "activeIngredients": "DEXTROAMPHETAMINE SULFATE",
  "company": "ACTAVIS ELIZABETH",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/25\/2024",
  "drugName": "DEXTROAMPHETAMINE SULFATEANDA  #203901",
  "submission": "SUPPL-16",
  "activeIngredients": "DEXTROAMPHETAMINE SULFATE",
  "company": "ACTAVIS ELIZABETH",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/25\/2024",
  "drugName": "DEXTROAMPHETAMINE SULFATEANDA  #203901",
  "submission": "SUPPL-17",
  "activeIngredients": "DEXTROAMPHETAMINE SULFATE",
  "company": "ACTAVIS ELIZABETH",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/25\/2024",
  "drugName": "DEXTROAMPHETAMINE SULFATEANDA  #203901",
  "submission": "SUPPL-20",
  "activeIngredients": "DEXTROAMPHETAMINE SULFATE",
  "company": "ACTAVIS ELIZABETH",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/25\/2024",
  "drugName": "METRONIDAZOLEANDA  #203974",
  "submission": "SUPPL-15",
  "activeIngredients": "METRONIDAZOLE",
  "company": "AUROBINDO PHARMA LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/25\/2024",
  "drugName": "FOSAPREPITANT DIMEGLUMINEANDA  #205020",
  "submission": "SUPPL-3",
  "activeIngredients": "FOSAPREPITANT DIMEGLUMINE",
  "company": "APOTEX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/25\/2024",
  "drugName": "EPINEPHRINENDA   #205029",
  "submission": "SUPPL-15",
  "activeIngredients": "EPINEPHRINE",
  "company": "BPI LABS",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/25\/2024",
  "drugName": "NOXAFILNDA   #205053",
  "submission": "SUPPL-17",
  "activeIngredients": "POSACONAZOLE",
  "company": "MERCK SHARP DOHME",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/25\/2024",
  "drugName": "METRONIDAZOLEANDA  #205245",
  "submission": "SUPPL-13",
  "activeIngredients": "METRONIDAZOLE",
  "company": "APPCO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/25\/2024",
  "drugName": "ROSUVASTATIN CALCIUMANDA  #205587",
  "submission": "SUPPL-5",
  "activeIngredients": "ROSUVASTATIN CALCIUM",
  "company": "LUPIN",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/25\/2024",
  "drugName": "NOXAFILNDA   #205596",
  "submission": "SUPPL-20",
  "activeIngredients": "POSACONAZOLE",
  "company": "MERCK SHARP DOHME",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/25\/2024",
  "drugName": "TOLSURANDA   #208901",
  "submission": "SUPPL-4",
  "activeIngredients": "ITRACONAZOLE",
  "company": "MAYNE PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/25\/2024",
  "drugName": "BUPIVACAINE HYDROCHLORIDEANDA  #209087",
  "submission": "SUPPL-2",
  "activeIngredients": "BUPIVACAINE HYDROCHLORIDE",
  "company": "B BRAUN MEDICAL",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/25\/2024",
  "drugName": "DOXYCYCLINE HYCLATEANDA  #210527",
  "submission": "SUPPL-1",
  "activeIngredients": "DOXYCYCLINE HYCLATE",
  "company": "ALEMBIC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/25\/2024",
  "drugName": "DOXYCYCLINE HYCLATEANDA  #210527",
  "submission": "SUPPL-6",
  "activeIngredients": "DOXYCYCLINE HYCLATE",
  "company": "ALEMBIC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/25\/2024",
  "drugName": "NEOSTIGMINE METHYLSULFATEANDA  #213244",
  "submission": "SUPPL-2",
  "activeIngredients": "NEOSTIGMINE METHYLSULFATE",
  "company": "EUGIA PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/25\/2024",
  "drugName": "PRAMIPEXOLE DIHYDROCHLORIDEANDA  #213444",
  "submission": "SUPPL-2",
  "activeIngredients": "PRAMIPEXOLE DIHYDROCHLORIDE",
  "company": "NOVAST LABS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/25\/2024",
  "drugName": "ORLYNVAHNDA   #213972",
  "submission": "ORIG-1",
  "activeIngredients": "PROBENECID; SULOPENEM ETZADROXIL",
  "company": "ITERUM THERAP",
  "submissionClassification": "Type 1 - New Molecular Entity and Type 4 - New Combination",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/25\/2024",
  "drugName": "NOXAFIL POWDERMIX KITNDA   #214770",
  "submission": "SUPPL-8",
  "activeIngredients": "POSACONAZOLE",
  "company": "MSD MERCK CO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/25\/2024",
  "drugName": "OCTREOTIDE ACETATEANDA  #216839",
  "submission": "SUPPL-2",
  "activeIngredients": "OCTREOTIDE ACETATE",
  "company": "GLAND",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/25\/2024",
  "drugName": "LISDEXAMFETAMINE DIMESYLATEANDA  #217068",
  "submission": "SUPPL-3",
  "activeIngredients": "LISDEXAMFETAMINE DIMESYLATE",
  "company": "ASCENT PHARMS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/25\/2024",
  "drugName": "NAPROXENANDA  #218497",
  "submission": "SUPPL-1",
  "activeIngredients": "NAPROXEN",
  "company": "NOVITIUM PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/25\/2024",
  "drugName": "SARCLISABLA   #761113",
  "submission": "SUPPL-11",
  "activeIngredients": "ISATUXIMAB-IRFC",
  "company": "SANOFI AVENTIS US",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/25\/2024",
  "drugName": "SARCLISABLA   #761113",
  "submission": "SUPPL-12",
  "activeIngredients": "ISATUXIMAB-IRFC",
  "company": "SANOFI AVENTIS US",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/28\/2024",
  "drugName": "LYSODRENNDA   #016885",
  "submission": "SUPPL-33",
  "activeIngredients": "MITOTANE",
  "company": "ESTEVE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/28\/2024",
  "drugName": "LIMBITROLNDA   #016949",
  "submission": "SUPPL-43",
  "activeIngredients": "AMITRIPTYLINE HYDROCHLORIDE; CHLORDIAZEPOXIDE",
  "company": "CHARTWELL RX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/28\/2024",
  "drugName": "LIMBITROL DSNDA   #016949",
  "submission": "SUPPL-43",
  "activeIngredients": "AMITRIPTYLINE HYDROCHLORIDE; CHLORDIAZEPOXIDE",
  "company": "CHARTWELL RX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/28\/2024",
  "drugName": "HYDRALAZINE HYDROCHLORIDEANDA  #040136",
  "submission": "SUPPL-13",
  "activeIngredients": "HYDRALAZINE HYDROCHLORIDE",
  "company": "AM REGENT",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/28\/2024",
  "drugName": "LIPTRUZETNDA   #200153",
  "submission": "SUPPL-9",
  "activeIngredients": "ATORVASTATIN CALCIUM; EZETIMIBE",
  "company": "ORGANON",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/28\/2024",
  "drugName": "LIPTRUZETNDA   #200153",
  "submission": "SUPPL-13",
  "activeIngredients": "ATORVASTATIN CALCIUM; EZETIMIBE",
  "company": "ORGANON",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/28\/2024",
  "drugName": "LIPTRUZETNDA   #200153",
  "submission": "SUPPL-14",
  "activeIngredients": "ATORVASTATIN CALCIUM; EZETIMIBE",
  "company": "ORGANON",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/28\/2024",
  "drugName": "ABIRATERONE ACETATEANDA  #208339",
  "submission": "SUPPL-12",
  "activeIngredients": "ABIRATERONE ACETATE",
  "company": "HIKMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/28\/2024",
  "drugName": "DOXYCYCLINE HYCLATEANDA  #218053",
  "submission": "ORIG-1",
  "activeIngredients": "DOXYCYCLINE HYCLATE",
  "company": "KINDOS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/28\/2024",
  "drugName": "ZINC SULFATEANDA  #218059",
  "submission": "SUPPL-1",
  "activeIngredients": "ZINC SULFATE",
  "company": "APOTEX",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/28\/2024",
  "drugName": "NITROFURANTOINANDA  #218346",
  "submission": "ORIG-1",
  "activeIngredients": "NITROFURANTOIN",
  "company": "BIOCON PHARMA",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/28\/2024",
  "drugName": "POTASSIUM CHLORIDEANDA  #218979",
  "submission": "ORIG-1",
  "activeIngredients": "POTASSIUM CHLORIDE",
  "company": "TWI PHARMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/29\/2024",
  "drugName": "HALOPERIDOLANDA  #091637",
  "submission": "SUPPL-9",
  "activeIngredients": "HALOPERIDOL LACTATE",
  "company": "SAGENT PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/29\/2024",
  "drugName": "HALOPERIDOLANDA  #200742",
  "submission": "SUPPL-6",
  "activeIngredients": "HALOPERIDOL LACTATE",
  "company": "SAGENT PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/29\/2024",
  "drugName": "MELPHALAN HYDROCHLORIDEANDA  #206523",
  "submission": "ORIG-1",
  "activeIngredients": "MELPHALAN HYDROCHLORIDE",
  "company": "AVET LIFESCIENCES",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/29\/2024",
  "drugName": "TICAGRELORANDA  #208541",
  "submission": "ORIG-1",
  "activeIngredients": "TICAGRELOR",
  "company": "DR REDDYS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/29\/2024",
  "drugName": "SCEMBLIXNDA   #215358",
  "submission": "SUPPL-8",
  "activeIngredients": "ASCIMINIB HYDROCHLORIDE",
  "company": "NOVARTIS",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/29\/2024",
  "drugName": "SCEMBLIXNDA   #215358",
  "submission": "SUPPL-9",
  "activeIngredients": "ASCIMINIB HYDROCHLORIDE",
  "company": "NOVARTIS",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/29\/2024",
  "drugName": "CYCLOPHOSPHAMIDEANDA  #216783",
  "submission": "ORIG-1",
  "activeIngredients": "CYCLOPHOSPHAMIDE",
  "company": "NEXUS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/29\/2024",
  "drugName": "DROSPIRENONEANDA  #216936",
  "submission": "ORIG-1",
  "activeIngredients": "DROSPIRENONE",
  "company": "LUPIN LTD",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "10\/29\/2024",
  "drugName": "THIAMINE HYDROCHLORIDEANDA  #217181",
  "submission": "ORIG-1",
  "activeIngredients": "THIAMINE HYDROCHLORIDE",
  "company": "ONESOURCE SPECIALTY",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/29\/2024",
  "drugName": "DEFLAZACORTANDA  #217813",
  "submission": "SUPPL-1",
  "activeIngredients": "DEFLAZACORT",
  "company": "TRIS PHARMA INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/29\/2024",
  "drugName": "VARENICLINE TARTRATEANDA  #219106",
  "submission": "ORIG-1",
  "activeIngredients": "VARENICLINE TARTRATE",
  "company": "REGCON HOLDINGS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/30\/2024",
  "drugName": "XYLOCAINENDA   #006488",
  "submission": "SUPPL-100",
  "activeIngredients": "LIDOCAINE HYDROCHLORIDE",
  "company": "FRESENIUS KABI USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/30\/2024",
  "drugName": "XYLOCAINE W\/ EPINEPHRINENDA   #006488",
  "submission": "SUPPL-100",
  "activeIngredients": "EPINEPHRINE; LIDOCAINE HYDROCHLORIDE",
  "company": "FRESENIUS KABI USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/30\/2024",
  "drugName": "HYDROMORPHONE HYDROCHLORIDEANDA  #205629",
  "submission": "SUPPL-20",
  "activeIngredients": "HYDROMORPHONE HYDROCHLORIDE",
  "company": "OSMOTICA PHARM US",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/30\/2024",
  "drugName": "DOLUTEGRAVIR; LAMIVUDINEANDA  #216543",
  "submission": "ORIG-1",
  "activeIngredients": "DOLUTEGRAVIR;LAMIVUDINE",
  "company": "HETERO LABS LTD III",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "10\/30\/2024",
  "drugName": "IVACAFTORANDA  #217086",
  "submission": "ORIG-1",
  "activeIngredients": "IVACAFTOR",
  "company": "AUROBINDO PHARMA LTD",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "10\/30\/2024",
  "drugName": "OSELTAMIVIR PHOSPHATEANDA  #217133",
  "submission": "ORIG-1",
  "activeIngredients": "OSELTAMIVIR PHOSPHATE",
  "company": "BEIJING JIALIN",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/30\/2024",
  "drugName": "CABLIVIBLA   #761112",
  "submission": "SUPPL-13",
  "activeIngredients": "CAPLACIZUMAB-YHDP",
  "company": "ABLYNX NV",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/30\/2024",
  "drugName": "BRIUMVIBLA   #761238",
  "submission": "SUPPL-11",
  "activeIngredients": "UBLITUXIMAB-XIIY",
  "company": "TG THERAPEUTICS, INC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/30\/2024",
  "drugName": "LOQTORZIBLA   #761240",
  "submission": "SUPPL-2",
  "activeIngredients": "TORIPALIMAB-TPZI",
  "company": "COHERUS BIOSCIENCES INC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "DEMEROLNDA   #005010",
  "submission": "SUPPL-61",
  "activeIngredients": "MEPERIDINE HYDROCHLORIDE",
  "company": "QUAGEN",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "PERCODANNDA   #007337",
  "submission": "SUPPL-56",
  "activeIngredients": "ASPIRIN; OXYCODONE HYDROCHLORIDE",
  "company": "ENDO OPERATIONS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "PERCODANNDA   #007337",
  "submission": "SUPPL-56",
  "activeIngredients": "ASPIRIN; OXYCODONE HYDROCHLORIDE; OXYCODONE TEREPHTHALATE",
  "company": "ENDO OPERATIONS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "PERCODAN-DEMINDA   #007337",
  "submission": "SUPPL-56",
  "activeIngredients": "ASPIRIN; OXYCODONE HYDROCHLORIDE; OXYCODONE TEREPHTHALATE",
  "company": "ENDO OPERATIONS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "SYNALGOS-DCNDA   #011483",
  "submission": "SUPPL-36",
  "activeIngredients": "ASPIRIN; CAFFEINE; DIHYDROCODEINE BITARTRATE",
  "company": "SUN PHARM INDUSTRIES",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "MS CONTINNDA   #019516",
  "submission": "SUPPL-60",
  "activeIngredients": "MORPHINE SULFATE",
  "company": "PURDUE PHARMA LP",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "DILAUDIDNDA   #019891",
  "submission": "SUPPL-33",
  "activeIngredients": "HYDROMORPHONE HYDROCHLORIDE",
  "company": "RHODES PHARMS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "DILAUDIDNDA   #019892",
  "submission": "SUPPL-42",
  "activeIngredients": "HYDROMORPHONE HYDROCHLORIDE",
  "company": "RHODES PHARMS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "FIORICET W\/ CODEINENDA   #020232",
  "submission": "SUPPL-48",
  "activeIngredients": "ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE",
  "company": "ACTAVIS LABS UT INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "ROXICODONENDA   #021011",
  "submission": "SUPPL-15",
  "activeIngredients": "OXYCODONE HYDROCHLORIDE",
  "company": "SPECGX LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "BUTRANSNDA   #021306",
  "submission": "SUPPL-42",
  "activeIngredients": "BUPRENORPHINE",
  "company": "PURDUE PHARMA LP",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OPANA ERNDA   #021610",
  "submission": "SUPPL-32",
  "activeIngredients": "OXYMORPHONE HYDROCHLORIDE",
  "company": "ENDO OPERATIONS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXALIPLATINNDA   #022160",
  "submission": "SUPPL-16",
  "activeIngredients": "OXALIPLATIN",
  "company": "TEVA PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "MORPHINE SULFATENDA   #022195",
  "submission": "SUPPL-23",
  "activeIngredients": "MORPHINE SULFATE",
  "company": "HIKMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "MORPHINE SULFATENDA   #022207",
  "submission": "SUPPL-13",
  "activeIngredients": "MORPHINE SULFATE",
  "company": "HIKMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCONTINNDA   #022272",
  "submission": "SUPPL-49",
  "activeIngredients": "OXYCODONE HYDROCHLORIDE",
  "company": "PURDUE PHARMA LP",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "NUCYNTANDA   #022304",
  "submission": "SUPPL-27",
  "activeIngredients": "TAPENTADOL HYDROCHLORIDE",
  "company": "COLLEGIUM PHARM INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "CONZIPNDA   #022370",
  "submission": "SUPPL-26",
  "activeIngredients": "TRAMADOL HYDROCHLORIDE",
  "company": "CIPHER PHARMS INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "CODEINE SULFATENDA   #022402",
  "submission": "SUPPL-16",
  "activeIngredients": "CODEINE SULFATE",
  "company": "HIKMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "METHADOSEANDA  #040050",
  "submission": "SUPPL-33",
  "activeIngredients": "METHADONE HYDROCHLORIDE",
  "company": "SPECGX LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #040105",
  "submission": "SUPPL-39",
  "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
  "company": "PH HEALTH",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "MEPERIDINE HYDROCHLORIDEANDA  #040110",
  "submission": "SUPPL-13",
  "activeIngredients": "MEPERIDINE HYDROCHLORIDE",
  "company": "HIKMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "ACETAMINOPHEN AND CODEINE PHOSPHATEANDA  #040119",
  "submission": "SUPPL-22",
  "activeIngredients": "ACETAMINOPHEN; CODEINE PHOSPHATE",
  "company": "PAI HOLDINGS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #040171",
  "submission": "SUPPL-40",
  "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
  "company": "WATSON LABS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "MEPERIDINE HYDROCHLORIDEANDA  #040186",
  "submission": "SUPPL-14",
  "activeIngredients": "MEPERIDINE HYDROCHLORIDE",
  "company": "WATSON LABS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "MEPERIDINE HYDROCHLORIDEANDA  #040191",
  "submission": "SUPPL-20",
  "activeIngredients": "MEPERIDINE HYDROCHLORIDE",
  "company": "STRIDES PHARMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #040203",
  "submission": "SUPPL-17",
  "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
  "company": "ACTAVIS ELIZABETH",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "METHADONE HYDROCHLORIDEANDA  #040241",
  "submission": "SUPPL-28",
  "activeIngredients": "METHADONE HYDROCHLORIDE",
  "company": "VISTAPHARM LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE AND ASPIRINANDA  #040255",
  "submission": "SUPPL-32",
  "activeIngredients": "ASPIRIN; OXYCODONE HYDROCHLORIDE; OXYCODONE TEREPHTHALATE",
  "company": "ANI PHARMS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE AND ASPIRINANDA  #040260",
  "submission": "SUPPL-20",
  "activeIngredients": "ASPIRIN; OXYCODONE HYDROCHLORIDE; OXYCODONE TEREPHTHALATE",
  "company": "SUN PHARM INDUSTRIES",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "PERCOCETANDA  #040330",
  "submission": "SUPPL-62",
  "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
  "company": "ENDO OPERATIONS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "MEPERIDINE HYDROCHLORIDEANDA  #040331",
  "submission": "SUPPL-23",
  "activeIngredients": "MEPERIDINE HYDROCHLORIDE",
  "company": "EPIC PHARMA LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #040355",
  "submission": "SUPPL-45",
  "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
  "company": "STRIDES PHARMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #040400",
  "submission": "SUPPL-41",
  "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
  "company": "SPECGX LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "ANEXSIA 7.5\/325ANDA  #040405",
  "submission": "SUPPL-41",
  "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
  "company": "SPECGX LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "ANEXSIA 5\/325ANDA  #040409",
  "submission": "SUPPL-41",
  "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
  "company": "SPECGX LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "ACETAMINOPHEN AND CODEINE PHOSPHATEANDA  #040419",
  "submission": "SUPPL-38",
  "activeIngredients": "ACETAMINOPHEN; CODEINE PHOSPHATE",
  "company": "SPECGX LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "MEPERIDINE HYDROCHLORIDEANDA  #040446",
  "submission": "SUPPL-16",
  "activeIngredients": "MEPERIDINE HYDROCHLORIDE",
  "company": "SUN PHARM INDS INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "METHADONE HYDROCHLORIDEANDA  #040517",
  "submission": "SUPPL-39",
  "activeIngredients": "METHADONE HYDROCHLORIDE",
  "company": "SPECGX LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #040535",
  "submission": "SUPPL-40",
  "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
  "company": "WATSON LABS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #040545",
  "submission": "SUPPL-28",
  "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
  "company": "SPECGX LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #040608",
  "submission": "SUPPL-22",
  "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
  "company": "MIKART",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #040655",
  "submission": "SUPPL-35",
  "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
  "company": "STRIDES PHARMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #040656",
  "submission": "SUPPL-35",
  "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
  "company": "STRIDES PHARMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #040736",
  "submission": "SUPPL-37",
  "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
  "company": "AMNEAL PHARMS NY",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #040746",
  "submission": "SUPPL-37",
  "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
  "company": "AMNEAL PHARMS NY",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #040777",
  "submission": "SUPPL-30",
  "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
  "company": "AMNEAL PHARMS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #040778",
  "submission": "SUPPL-32",
  "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
  "company": "AMNEAL PHARMS NY",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "ACETAMINOPHEN AND CODEINE PHOSPHATEANDA  #040779",
  "submission": "SUPPL-39",
  "activeIngredients": "ACETAMINOPHEN; CODEINE PHOSPHATE",
  "company": "AMNEAL PHARMS NY",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #040800",
  "submission": "SUPPL-14",
  "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
  "company": "ACTAVIS ELIZABETH",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #040826",
  "submission": "SUPPL-16",
  "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
  "company": "SUN PHARM INDS LTD",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #040834",
  "submission": "SUPPL-23",
  "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
  "company": "PHARM ASSOC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #040838",
  "submission": "SUPPL-23",
  "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
  "company": "PHARM ASSOC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATEANDA  #040860",
  "submission": "SUPPL-12",
  "activeIngredients": "ASPIRIN; CARISOPRODOL; CODEINE PHOSPHATE",
  "company": "INGENUS PHARMS NJ",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #040881",
  "submission": "SUPPL-18",
  "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
  "company": "MIKART",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "MEPERIDINE HYDROCHLORIDEANDA  #040893",
  "submission": "SUPPL-7",
  "activeIngredients": "MEPERIDINE HYDROCHLORIDE",
  "company": "GENUS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #040894",
  "submission": "SUPPL-25",
  "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
  "company": "GENUS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE AND ASPIRINANDA  #040910",
  "submission": "SUPPL-3",
  "activeIngredients": "ASPIRIN; OXYCODONE HYDROCHLORIDE",
  "company": "EPIC PHARMA LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "LEVORPHANOL TARTRATEANDA  #074278",
  "submission": "SUPPL-22",
  "activeIngredients": "LEVORPHANOL TARTRATE",
  "company": "HIKMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROMORPHONE HYDROCHLORIDEANDA  #074597",
  "submission": "SUPPL-21",
  "activeIngredients": "HYDROMORPHONE HYDROCHLORIDE",
  "company": "HIKMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROMORPHONE HYDROCHLORIDEANDA  #074653",
  "submission": "SUPPL-17",
  "activeIngredients": "HYDROMORPHONE HYDROCHLORIDE",
  "company": "HIKMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDEANDA  #074736",
  "submission": "SUPPL-42",
  "activeIngredients": "NALOXONE HYDROCHLORIDE; PENTAZOCINE HYDROCHLORIDE",
  "company": "WATSON LABS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATEANDA  #074951",
  "submission": "SUPPL-9",
  "activeIngredients": "ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE",
  "company": "STEVENS J",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATEANDA  #075231",
  "submission": "SUPPL-12",
  "activeIngredients": "ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE",
  "company": "LGM PHARMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "MORPHINE SULFATEANDA  #075295",
  "submission": "SUPPL-57",
  "activeIngredients": "MORPHINE SULFATE",
  "company": "STRIDES PHARMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "BUTORPHANOL TARTRATEANDA  #075499",
  "submission": "SUPPL-36",
  "activeIngredients": "BUTORPHANOL TARTRATE",
  "company": "APOTEX",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDEANDA  #075523",
  "submission": "SUPPL-9",
  "activeIngredients": "NALOXONE HYDROCHLORIDE; PENTAZOCINE HYDROCHLORIDE",
  "company": "SUN PHARM INDS LTD",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "DOXAZOSIN MESYLATEANDA  #075574",
  "submission": "SUPPL-15",
  "activeIngredients": "DOXAZOSIN MESYLATE",
  "company": "ACTAVIS ELIZABETH",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "DOXAZOSIN MESYLATEANDA  #075574",
  "submission": "SUPPL-16",
  "activeIngredients": "DOXAZOSIN MESYLATE",
  "company": "ACTAVIS ELIZABETH",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDEANDA  #075735",
  "submission": "SUPPL-22",
  "activeIngredients": "NALOXONE HYDROCHLORIDE; PENTAZOCINE HYDROCHLORIDE",
  "company": "LUPIN",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "BUTORPHANOL TARTRATEANDA  #075759",
  "submission": "SUPPL-37",
  "activeIngredients": "BUTORPHANOL TARTRATE",
  "company": "RISING",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "BUTORPHANOL TARTRATEANDA  #075824",
  "submission": "SUPPL-21",
  "activeIngredients": "BUTORPHANOL TARTRATE",
  "company": "HIKMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATEANDA  #075929",
  "submission": "SUPPL-31",
  "activeIngredients": "ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE",
  "company": "PHARMOBEDIENT",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "TRAMADOL HYDROCHLORIDEANDA  #075962",
  "submission": "SUPPL-12",
  "activeIngredients": "TRAMADOL HYDROCHLORIDE",
  "company": "WATSON LABS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "TRAMADOL HYDROCHLORIDEANDA  #075964",
  "submission": "SUPPL-46",
  "activeIngredients": "TRAMADOL HYDROCHLORIDE",
  "company": "SUN PHARM INDS INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "TRAMADOL HYDROCHLORIDEANDA  #075968",
  "submission": "SUPPL-15",
  "activeIngredients": "TRAMADOL HYDROCHLORIDE",
  "company": "GRAVITI PHARMS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "TRAMADOL HYDROCHLORIDEANDA  #075977",
  "submission": "SUPPL-34",
  "activeIngredients": "TRAMADOL HYDROCHLORIDE",
  "company": "TEVA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "TRAMADOL HYDROCHLORIDEANDA  #075981",
  "submission": "SUPPL-28",
  "activeIngredients": "TRAMADOL HYDROCHLORIDE",
  "company": "APOTEX",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "TRAMADOL HYDROCHLORIDEANDA  #075982",
  "submission": "SUPPL-17",
  "activeIngredients": "TRAMADOL HYDROCHLORIDE",
  "company": "PLIVA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "TRAMADOL HYDROCHLORIDEANDA  #075983",
  "submission": "SUPPL-15",
  "activeIngredients": "TRAMADOL HYDROCHLORIDE",
  "company": "SPECGX LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "TRAMADOL HYDROCHLORIDEANDA  #076003",
  "submission": "SUPPL-58",
  "activeIngredients": "TRAMADOL HYDROCHLORIDE",
  "company": "AMNEAL PHARMS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "TRAMADOL HYDROCHLORIDEANDA  #076100",
  "submission": "SUPPL-26",
  "activeIngredients": "TRAMADOL HYDROCHLORIDE",
  "company": "SUN PHARM INDUSTRIES",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "FENTANYL-100ANDA  #076258",
  "submission": "SUPPL-49",
  "activeIngredients": "FENTANYL",
  "company": "MYLAN TECHNOLOGIES",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "FENTANYL-12ANDA  #076258",
  "submission": "SUPPL-49",
  "activeIngredients": "FENTANYL",
  "company": "MYLAN TECHNOLOGIES",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "FENTANYL-25ANDA  #076258",
  "submission": "SUPPL-49",
  "activeIngredients": "FENTANYL",
  "company": "MYLAN TECHNOLOGIES",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "FENTANYL-37ANDA  #076258",
  "submission": "SUPPL-49",
  "activeIngredients": "FENTANYL",
  "company": "MYLAN TECHNOLOGIES",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "FENTANYL-50ANDA  #076258",
  "submission": "SUPPL-49",
  "activeIngredients": "FENTANYL",
  "company": "MYLAN TECHNOLOGIES",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "FENTANYL-62ANDA  #076258",
  "submission": "SUPPL-49",
  "activeIngredients": "FENTANYL",
  "company": "MYLAN TECHNOLOGIES",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "FENTANYL-75ANDA  #076258",
  "submission": "SUPPL-49",
  "activeIngredients": "FENTANYL",
  "company": "MYLAN TECHNOLOGIES",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "FENTANYL-87ANDA  #076258",
  "submission": "SUPPL-49",
  "activeIngredients": "FENTANYL",
  "company": "MYLAN TECHNOLOGIES",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "MORPHINE SULFATEANDA  #076412",
  "submission": "SUPPL-43",
  "activeIngredients": "MORPHINE SULFATE",
  "company": "SPECGX LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "MORPHINE SULFATEANDA  #076438",
  "submission": "SUPPL-41",
  "activeIngredients": "MORPHINE SULFATE",
  "company": "SPECGX LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATEANDA  #076560",
  "submission": "SUPPL-11",
  "activeIngredients": "ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE",
  "company": "LGM PHARMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND IBUPROFENANDA  #076604",
  "submission": "SUPPL-29",
  "activeIngredients": "HYDROCODONE BITARTRATE; IBUPROFEN",
  "company": "ACTAVIS LABS FL INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE HYDROCHLORIDEANDA  #076636",
  "submission": "SUPPL-40",
  "activeIngredients": "OXYCODONE HYDROCHLORIDE",
  "company": "ACTAVIS ELIZABETH",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND IBUPROFENANDA  #076642",
  "submission": "SUPPL-45",
  "activeIngredients": "HYDROCODONE BITARTRATE; IBUPROFEN",
  "company": "AMNEAL PHARMS NY",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "REPREXAINANDA  #076642",
  "submission": "SUPPL-45",
  "activeIngredients": "HYDROCODONE BITARTRATE; IBUPROFEN",
  "company": "AMNEAL PHARMS NY",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROMORPHONE HYDROCHLORIDEANDA  #076723",
  "submission": "SUPPL-12",
  "activeIngredients": "HYDROMORPHONE HYDROCHLORIDE",
  "company": "MPP PHARMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE HYDROCHLORIDEANDA  #076758",
  "submission": "SUPPL-28",
  "activeIngredients": "OXYCODONE HYDROCHLORIDE",
  "company": "SPECGX LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROMORPHONE HYDROCHLORIDEANDA  #076855",
  "submission": "SUPPL-22",
  "activeIngredients": "HYDROMORPHONE HYDROCHLORIDE",
  "company": "SPECGX LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "TRAMADOL HYDROCHLORIDE AND ACETAMINOPHENANDA  #076914",
  "submission": "SUPPL-9",
  "activeIngredients": "ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE",
  "company": "GRAVITI PHARMS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "FENTANYL-100ANDA  #077154",
  "submission": "SUPPL-39",
  "activeIngredients": "FENTANYL",
  "company": "SPECGX LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "FENTANYL-12ANDA  #077154",
  "submission": "SUPPL-39",
  "activeIngredients": "FENTANYL",
  "company": "SPECGX LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "FENTANYL-25ANDA  #077154",
  "submission": "SUPPL-39",
  "activeIngredients": "FENTANYL",
  "company": "SPECGX LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "FENTANYL-37ANDA  #077154",
  "submission": "SUPPL-39",
  "activeIngredients": "FENTANYL",
  "company": "SPECGX LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "FENTANYL-50ANDA  #077154",
  "submission": "SUPPL-39",
  "activeIngredients": "FENTANYL",
  "company": "SPECGX LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "FENTANYL-62ANDA  #077154",
  "submission": "SUPPL-39",
  "activeIngredients": "FENTANYL",
  "company": "SPECGX LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "FENTANYL-75ANDA  #077154",
  "submission": "SUPPL-39",
  "activeIngredients": "FENTANYL",
  "company": "SPECGX LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "TRAMADOL HYDROCHLORIDE AND ACETAMINOPHENANDA  #077184",
  "submission": "SUPPL-23",
  "activeIngredients": "ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE",
  "company": "SUN PHARM INDS INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "FENTANYL-100ANDA  #077449",
  "submission": "SUPPL-41",
  "activeIngredients": "FENTANYL",
  "company": "DIFGEN PHARMS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "FENTANYL-12ANDA  #077449",
  "submission": "SUPPL-41",
  "activeIngredients": "FENTANYL",
  "company": "DIFGEN PHARMS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "FENTANYL-25ANDA  #077449",
  "submission": "SUPPL-41",
  "activeIngredients": "FENTANYL",
  "company": "DIFGEN PHARMS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "FENTANYL-37ANDA  #077449",
  "submission": "SUPPL-41",
  "activeIngredients": "FENTANYL",
  "company": "DIFGEN PHARMS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "FENTANYL-50ANDA  #077449",
  "submission": "SUPPL-41",
  "activeIngredients": "FENTANYL",
  "company": "DIFGEN PHARMS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "FENTANYL-62ANDA  #077449",
  "submission": "SUPPL-41",
  "activeIngredients": "FENTANYL",
  "company": "DIFGEN PHARMS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "FENTANYL-75ANDA  #077449",
  "submission": "SUPPL-41",
  "activeIngredients": "FENTANYL",
  "company": "DIFGEN PHARMS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "FENTANYL-87ANDA  #077449",
  "submission": "SUPPL-41",
  "activeIngredients": "FENTANYL",
  "company": "DIFGEN PHARMS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND IBUPROFENANDA  #077454",
  "submission": "SUPPL-10",
  "activeIngredients": "HYDROCODONE BITARTRATE; IBUPROFEN",
  "company": "ANI PHARMS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE HYDROCHLORIDEANDA  #077712",
  "submission": "SUPPL-34",
  "activeIngredients": "OXYCODONE HYDROCHLORIDE",
  "company": "STRIDES PHARMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROCODONEANDA  #077723",
  "submission": "SUPPL-35",
  "activeIngredients": "HYDROCODONE BITARTRATE; IBUPROFEN",
  "company": "STRIDES PHARMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND IBUPROFENANDA  #077723",
  "submission": "SUPPL-35",
  "activeIngredients": "HYDROCODONE BITARTRATE; IBUPROFEN",
  "company": "STRIDES PHARMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "TRAMADOL HYDROCHLORIDE AND ACETAMINOPHENANDA  #077858",
  "submission": "SUPPL-18",
  "activeIngredients": "ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE",
  "company": "RISING",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE HYDROCHLORIDE AND IBUPROFENANDA  #078316",
  "submission": "SUPPL-19",
  "activeIngredients": "IBUPROFEN; OXYCODONE HYDROCHLORIDE",
  "company": "BARR LABS INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "MORPHINE SULFATEANDA  #078761",
  "submission": "SUPPL-24",
  "activeIngredients": "MORPHINE SULFATE",
  "company": "SUN PHARM INDS LTD",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE HYDROCHLORIDE AND IBUPROFENANDA  #078769",
  "submission": "SUPPL-36",
  "activeIngredients": "IBUPROFEN; OXYCODONE HYDROCHLORIDE",
  "company": "ACTAVIS ELIZABETH",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "TRAMADOL HYDROCHLORIDE AND ACETAMINOPHENANDA  #078778",
  "submission": "SUPPL-13",
  "activeIngredients": "ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE",
  "company": "MPP PHARMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "TRAMADOL HYDROCHLORIDEANDA  #078783",
  "submission": "SUPPL-16",
  "activeIngredients": "TRAMADOL HYDROCHLORIDE",
  "company": "STRIDES PHARMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "MORPHINE SULFATEANDA  #079040",
  "submission": "SUPPL-30",
  "activeIngredients": "MORPHINE SULFATE",
  "company": "ACTAVIS ELIZABETH",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYMORPHONE HYDROCHLORIDEANDA  #079046",
  "submission": "SUPPL-37",
  "activeIngredients": "OXYMORPHONE HYDROCHLORIDE",
  "company": "ACTAVIS ELIZABETH",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYMORPHONE HYDROCHLORIDEANDA  #079087",
  "submission": "SUPPL-48",
  "activeIngredients": "OXYMORPHONE HYDROCHLORIDE",
  "company": "IMPAX LABS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "MEPERIDINE HYDROCHLORIDEANDA  #080448",
  "submission": "SUPPL-24",
  "activeIngredients": "MEPERIDINE HYDROCHLORIDE",
  "company": "SUN PHARM INDUSTRIES",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "ACETAMINOPHEN AND CODEINE PHOSPHATEANDA  #081249",
  "submission": "SUPPL-15",
  "activeIngredients": "ACETAMINOPHEN; CODEINE PHOSPHATE",
  "company": "FOSUN PHARMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "ACETAMINOPHEN AND CODEINE PHOSPHATEANDA  #081250",
  "submission": "SUPPL-15",
  "activeIngredients": "ACETAMINOPHEN; CODEINE PHOSPHATE",
  "company": "FOSUN PHARMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "PERCOCETANDA  #085106",
  "submission": "SUPPL-33",
  "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
  "company": "ENDO OPERATIONS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "ACETAMINOPHEN AND CODEINE PHOSPHATEANDA  #085861",
  "submission": "SUPPL-83",
  "activeIngredients": "ACETAMINOPHEN; CODEINE PHOSPHATE",
  "company": "ACTAVIS MID ATLANTIC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "ACETAMINOPHEN AND CODEINE PHOSPHATEANDA  #085868",
  "submission": "SUPPL-69",
  "activeIngredients": "ACETAMINOPHEN; CODEINE PHOSPHATE",
  "company": "SUN PHARM INDS LTD",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "ROXICETANDA  #087003",
  "submission": "SUPPL-48",
  "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
  "company": "HIKMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "ACETAMINOPHEN AND CODEINE PHOSPHATEANDA  #087006",
  "submission": "SUPPL-42",
  "activeIngredients": "ACETAMINOPHEN; CODEINE PHOSPHATE",
  "company": "PHARMOBEDIENT",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "ACETAMINOPHEN AND CODEINE PHOSPHATEANDA  #087083",
  "submission": "SUPPL-57",
  "activeIngredients": "ACETAMINOPHEN; CODEINE PHOSPHATE",
  "company": "SUN PHARM INDS LTD",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "METHADONE HYDROCHLORIDEANDA  #087393",
  "submission": "SUPPL-53",
  "activeIngredients": "METHADONE HYDROCHLORIDE",
  "company": "HIKMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCETANDA  #087463",
  "submission": "SUPPL-57",
  "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
  "company": "SPECGX LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "ACETAMINOPHEN AND CODEINE PHOSPHATEANDA  #087508",
  "submission": "SUPPL-58",
  "activeIngredients": "ACETAMINOPHEN; CODEINE PHOSPHATE",
  "company": "GENUS LIFESCIENCES",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE AND ASPIRINANDA  #087794",
  "submission": "SUPPL-32",
  "activeIngredients": "ASPIRIN; OXYCODONE HYDROCHLORIDE; OXYCODONE TEREPHTHALATE",
  "company": "SUN PHARM INDUSTRIES",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "METHADONE HYDROCHLORIDEANDA  #087997",
  "submission": "SUPPL-45",
  "activeIngredients": "METHADONE HYDROCHLORIDE",
  "company": "HIKMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "METHADONE HYDROCHLORIDEANDA  #088109",
  "submission": "SUPPL-24",
  "activeIngredients": "METHADONE HYDROCHLORIDE",
  "company": "HIKMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "ACETAMINOPHEN AND CODEINE PHOSPHATEANDA  #088629",
  "submission": "SUPPL-75",
  "activeIngredients": "ACETAMINOPHEN; CODEINE PHOSPHATE",
  "company": "ANI PHARMS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "MEPERIDINE HYDROCHLORIDEANDA  #088639",
  "submission": "SUPPL-49",
  "activeIngredients": "MEPERIDINE HYDROCHLORIDE",
  "company": "BARR",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "MEPERIDINE HYDROCHLORIDEANDA  #088640",
  "submission": "SUPPL-51",
  "activeIngredients": "MEPERIDINE HYDROCHLORIDE",
  "company": "BARR",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "MEPERIDINE HYDROCHLORIDEANDA  #088744",
  "submission": "SUPPL-34",
  "activeIngredients": "MEPERIDINE HYDROCHLORIDE",
  "company": "HIKMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "ROXICETANDA  #089351",
  "submission": "SUPPL-37",
  "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
  "company": "HIKMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "ACETAMINOPHEN AND CODEINE PHOSPHATEANDA  #089805",
  "submission": "SUPPL-41",
  "activeIngredients": "ACETAMINOPHEN; CODEINE PHOSPHATE",
  "company": "STRIDES PHARMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "ACETAMINOPHEN AND CODEINE PHOSPHATEANDA  #089828",
  "submission": "SUPPL-38",
  "activeIngredients": "ACETAMINOPHEN; CODEINE PHOSPHATE",
  "company": "STRIDES PHARMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "METHADONE HYDROCHLORIDE INTENSOLANDA  #089897",
  "submission": "SUPPL-48",
  "activeIngredients": "METHADONE HYDROCHLORIDE",
  "company": "HIKMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "ACETAMINOPHEN AND CODEINE PHOSPHATEANDA  #089990",
  "submission": "SUPPL-36",
  "activeIngredients": "ACETAMINOPHEN; CODEINE PHOSPHATE",
  "company": "STRIDES PHARMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "METHADONE HYDROCHLORIDEANDA  #090065",
  "submission": "SUPPL-15",
  "activeIngredients": "METHADONE HYDROCHLORIDE",
  "company": "EPIC PHARMA LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE AND ASPIRINANDA  #090084",
  "submission": "SUPPL-12",
  "activeIngredients": "ASPIRIN; OXYCODONE HYDROCHLORIDE",
  "company": "ACTAVIS LABS FL INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #090118",
  "submission": "SUPPL-36",
  "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
  "company": "SUN PHARM INDS INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "TRAMADOL HYDROCHLORIDEANDA  #090404",
  "submission": "SUPPL-20",
  "activeIngredients": "TRAMADOL HYDROCHLORIDE",
  "company": "SENORES PHARMS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #090415",
  "submission": "SUPPL-28",
  "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
  "company": "PH HEALTH",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "TRAMADOL HYDROCHLORIDE AND ACETAMINOPHENANDA  #090460",
  "submission": "SUPPL-18",
  "activeIngredients": "ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE",
  "company": "ZYDUS PHARMS USA INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "TRAMADOL HYDROCHLORIDE AND ACETAMINOPHENANDA  #090485",
  "submission": "SUPPL-34",
  "activeIngredients": "ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE",
  "company": "AMNEAL PHARMS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #090535",
  "submission": "SUPPL-19",
  "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
  "company": "SUN PHARM INDS INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "METHADONE HYDROCHLORIDEANDA  #090635",
  "submission": "SUPPL-34",
  "activeIngredients": "METHADONE HYDROCHLORIDE",
  "company": "THEPHARMANETWORK LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE HYDROCHLORIDEANDA  #090659",
  "submission": "SUPPL-27",
  "activeIngredients": "OXYCODONE HYDROCHLORIDE",
  "company": "SUN PHARM INDS INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "METHADONE HYDROCHLORIDEANDA  #090707",
  "submission": "SUPPL-32",
  "activeIngredients": "METHADONE HYDROCHLORIDE",
  "company": "VISTAPHARM LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #090733",
  "submission": "SUPPL-25",
  "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
  "company": "PH HEALTH",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #090734",
  "submission": "SUPPL-31",
  "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
  "company": "PH HEALTH",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE HYDROCHLORIDEANDA  #090895",
  "submission": "SUPPL-12",
  "activeIngredients": "OXYCODONE HYDROCHLORIDE",
  "company": "EPIC PHARMA LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYMORPHONE HYDROCHLORIDEANDA  #090964",
  "submission": "SUPPL-12",
  "activeIngredients": "OXYMORPHONE HYDROCHLORIDE",
  "company": "HIKMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "MORPHINE SULFATEANDA  #091357",
  "submission": "SUPPL-6",
  "activeIngredients": "MORPHINE SULFATE",
  "company": "EPIC PHARMA LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE HYDROCHLORIDEANDA  #091393",
  "submission": "SUPPL-28",
  "activeIngredients": "OXYCODONE HYDROCHLORIDE",
  "company": "AVANTHI INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYMORPHONE HYDROCHLORIDEANDA  #091443",
  "submission": "SUPPL-17",
  "activeIngredients": "OXYMORPHONE HYDROCHLORIDE",
  "company": "TEVA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "TRAMADOL HYDROCHLORIDEANDA  #091498",
  "submission": "SUPPL-15",
  "activeIngredients": "TRAMADOL HYDROCHLORIDE",
  "company": "CSPC OUYI PHARM CO",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATEANDA  #091528",
  "submission": "SUPPL-8",
  "activeIngredients": "HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE",
  "company": "NOVEL LABS INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "TRAMADOL HYDROCHLORIDEANDA  #091607",
  "submission": "SUPPL-33",
  "activeIngredients": "TRAMADOL HYDROCHLORIDE",
  "company": "SUN PHARM",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "TRAMADOL HYDROCHLORIDEANDA  #091609",
  "submission": "SUPPL-14",
  "activeIngredients": "TRAMADOL HYDROCHLORIDE",
  "company": "ACTAVIS ELIZABETH",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND IBUPROFENANDA  #091633",
  "submission": "SUPPL-16",
  "activeIngredients": "HYDROCODONE BITARTRATE; IBUPROFEN",
  "company": "SUN PHARM INDS INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #200343",
  "submission": "SUPPL-24",
  "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
  "company": "GENUS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "MORPHINE SULFATEANDA  #200411",
  "submission": "SUPPL-25",
  "activeIngredients": "MORPHINE SULFATE",
  "company": "IMPAX LABS INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "TRAMADOL HYDROCHLORIDEANDA  #200491",
  "submission": "SUPPL-18",
  "activeIngredients": "TRAMADOL HYDROCHLORIDE",
  "company": "PH HEALTH",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "TRAMADOL HYDROCHLORIDEANDA  #200503",
  "submission": "SUPPL-18",
  "activeIngredients": "TRAMADOL HYDROCHLORIDE",
  "company": "LUPIN LTD",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "NUCYNTA ERNDA   #200533",
  "submission": "SUPPL-28",
  "activeIngredients": "TAPENTADOL HYDROCHLORIDE",
  "company": "COLLEGIUM PHARM INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE HYDROCHLORIDENDA   #200534",
  "submission": "SUPPL-15",
  "activeIngredients": "OXYCODONE HYDROCHLORIDE",
  "company": "GENUS LIFESCIENCES",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE HYDROCHLORIDENDA   #200535",
  "submission": "SUPPL-24",
  "activeIngredients": "OXYCODONE HYDROCHLORIDE",
  "company": "GENUS LIFESCIENCES",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "MORPHINE SULFATEANDA  #200812",
  "submission": "SUPPL-16",
  "activeIngredients": "MORPHINE SULFATE",
  "company": "STRIDES PHARMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYMORPHONE HYDROCHLORIDEANDA  #200822",
  "submission": "SUPPL-20",
  "activeIngredients": "OXYMORPHONE HYDROCHLORIDE",
  "company": "HIKMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "MORPHINE SULFATEANDA  #200824",
  "submission": "SUPPL-21",
  "activeIngredients": "MORPHINE SULFATE",
  "company": "RISING",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "MORPHINE SULFATEANDA  #201011",
  "submission": "SUPPL-2",
  "activeIngredients": "MORPHINE SULFATE",
  "company": "SANKALP LIFECARE",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #201013",
  "submission": "SUPPL-18",
  "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
  "company": "AUROLIFE PHARMA LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYMORPHONE HYDROCHLORIDEANDA  #201187",
  "submission": "SUPPL-13",
  "activeIngredients": "OXYMORPHONE HYDROCHLORIDE",
  "company": "EPIC PHARMA LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE HYDROCHLORIDENDA   #201194",
  "submission": "SUPPL-20",
  "activeIngredients": "OXYCODONE HYDROCHLORIDE",
  "company": "VISTAPHARM LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #201295",
  "submission": "SUPPL-4",
  "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
  "company": "TRIS PHARMA INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "TRAMADOL HYDROCHLORIDEANDA  #201384",
  "submission": "SUPPL-31",
  "activeIngredients": "TRAMADOL HYDROCHLORIDE",
  "company": "SUN PHARM",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #201447",
  "submission": "SUPPL-23",
  "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
  "company": "ACTAVIS ELIZABETH",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #201448",
  "submission": "SUPPL-4",
  "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
  "company": "SANKALP LIFECARE",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "MORPHINE SULFATEANDA  #201574",
  "submission": "SUPPL-9",
  "activeIngredients": "MORPHINE SULFATE",
  "company": "PADAGIS US",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "TRAMADOL HYDROCHLORIDE AND ACETAMINOPHENANDA  #201952",
  "submission": "SUPPL-16",
  "activeIngredients": "ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE",
  "company": "MICRO LABS LTD INDIA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #201972",
  "submission": "SUPPL-19",
  "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
  "company": "AUROLIFE PHARMA LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "TRAMADOL HYDROCHLORIDEANDA  #201973",
  "submission": "SUPPL-11",
  "activeIngredients": "TRAMADOL HYDROCHLORIDE",
  "company": "IPCA LABS LTD",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "TRAMADOL HYDROCHLORIDEANDA  #202075",
  "submission": "SUPPL-6",
  "activeIngredients": "TRAMADOL HYDROCHLORIDE",
  "company": "STRIDES PHARMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "TRAMADOL HYDROCHLORIDE AND ACETAMINOPHENANDA  #202076",
  "submission": "SUPPL-8",
  "activeIngredients": "ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE",
  "company": "ALKEM LABS LTD",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXAYDONDA   #202080",
  "submission": "SUPPL-15",
  "activeIngredients": "OXYCODONE HYDROCHLORIDE",
  "company": "ZYLA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "FENTANYL-100ANDA  #202097",
  "submission": "SUPPL-20",
  "activeIngredients": "FENTANYL",
  "company": "KINDEVA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "FENTANYL-12ANDA  #202097",
  "submission": "SUPPL-20",
  "activeIngredients": "FENTANYL",
  "company": "KINDEVA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "FENTANYL-25ANDA  #202097",
  "submission": "SUPPL-20",
  "activeIngredients": "FENTANYL",
  "company": "KINDEVA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "FENTANYL-50ANDA  #202097",
  "submission": "SUPPL-20",
  "activeIngredients": "FENTANYL",
  "company": "KINDEVA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "FENTANYL-75ANDA  #202097",
  "submission": "SUPPL-20",
  "activeIngredients": "FENTANYL",
  "company": "KINDEVA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "MORPHINE SULFATEANDA  #202104",
  "submission": "SUPPL-25",
  "activeIngredients": "MORPHINE SULFATE",
  "company": "UPSHER SMITH LABS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE HYDROCHLORIDEANDA  #202116",
  "submission": "SUPPL-11",
  "activeIngredients": "OXYCODONE HYDROCHLORIDE",
  "company": "ALVOGEN",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #202142",
  "submission": "SUPPL-10",
  "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
  "company": "MIKART",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROMORPHONE HYDROCHLORIDEANDA  #202144",
  "submission": "SUPPL-21",
  "activeIngredients": "HYDROMORPHONE HYDROCHLORIDE",
  "company": "ACTAVIS LABS FL INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE HYDROCHLORIDEANDA  #202160",
  "submission": "SUPPL-11",
  "activeIngredients": "OXYCODONE HYDROCHLORIDE",
  "company": "AUROLIFE PHARMA LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #202214",
  "submission": "SUPPL-21",
  "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
  "company": "TRIS PHARMA INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "CODEINE SULFATENDA   #202245",
  "submission": "SUPPL-11",
  "activeIngredients": "CODEINE SULFATE",
  "company": "HIKMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "MORPHINE SULFATEANDA  #202348",
  "submission": "SUPPL-16",
  "activeIngredients": "MORPHINE SULFATE",
  "company": "SPECGX LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE HYDROCHLORIDEANDA  #202537",
  "submission": "SUPPL-15",
  "activeIngredients": "OXYCODONE HYDROCHLORIDE",
  "company": "VISTAPHARM LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE HYDROCHLORIDEANDA  #202662",
  "submission": "SUPPL-13",
  "activeIngredients": "OXYCODONE HYDROCHLORIDE",
  "company": "EPIC PHARMA LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #202677",
  "submission": "SUPPL-19",
  "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
  "company": "ALVOGEN",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "MORPHINE SULFATEANDA  #202718",
  "submission": "SUPPL-14",
  "activeIngredients": "MORPHINE SULFATE",
  "company": "TEVA PHARMS USA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE HYDROCHLORIDEANDA  #202773",
  "submission": "SUPPL-9",
  "activeIngredients": "OXYCODONE HYDROCHLORIDE",
  "company": "AVANTHI INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "ACETAMINOPHEN AND CODEINE PHOSPHATEANDA  #202800",
  "submission": "SUPPL-18",
  "activeIngredients": "ACETAMINOPHEN; CODEINE PHOSPHATE",
  "company": "AUROLIFE PHARMA LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #202935",
  "submission": "SUPPL-16",
  "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
  "company": "STRIDES PHARMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "CODEINE SULFATEANDA  #203046",
  "submission": "SUPPL-16",
  "activeIngredients": "CODEINE SULFATE",
  "company": "LANNETT CO INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "MORPHINE SULFATEANDA  #203158",
  "submission": "SUPPL-4",
  "activeIngredients": "MORPHINE SULFATE",
  "company": "ANDA REPOSITORY",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE HYDROCHLORIDEANDA  #203208",
  "submission": "SUPPL-11",
  "activeIngredients": "OXYCODONE HYDROCHLORIDE",
  "company": "HIKMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE HYDROCHLORIDEANDA  #203447",
  "submission": "SUPPL-7",
  "activeIngredients": "OXYCODONE HYDROCHLORIDE",
  "company": "ANI PHARMS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "TRAMADOL HYDROCHLORIDEANDA  #203494",
  "submission": "SUPPL-24",
  "activeIngredients": "TRAMADOL HYDROCHLORIDE",
  "company": "AUROBINDO PHARMA LTD",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "METHADONE HYDROCHLORIDEANDA  #203502",
  "submission": "SUPPL-12",
  "activeIngredients": "METHADONE HYDROCHLORIDE",
  "company": "AUROLIFE PHARMA LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "MORPHINE SULFATEANDA  #203518",
  "submission": "SUPPL-17",
  "activeIngredients": "MORPHINE SULFATE",
  "company": "TRIS PHARMA INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDEANDA  #203535",
  "submission": "SUPPL-5",
  "activeIngredients": "HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE",
  "company": "NOVEL LABS INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE HYDROCHLORIDE AND ACETAMINOPHENANDA  #203573",
  "submission": "SUPPL-15",
  "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
  "company": "PH HEALTH",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYMORPHONE HYDROCHLORIDEANDA  #203601",
  "submission": "SUPPL-17",
  "activeIngredients": "OXYMORPHONE HYDROCHLORIDE",
  "company": "AVANTHI INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "MORPHINE SULFATEANDA  #203602",
  "submission": "SUPPL-10",
  "activeIngredients": "MORPHINE SULFATE",
  "company": "NOVEL LABS INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE HYDROCHLORIDEANDA  #203638",
  "submission": "SUPPL-13",
  "activeIngredients": "OXYCODONE HYDROCHLORIDE",
  "company": "AMNEAL PHARMS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "NUCYNTANDA   #203794",
  "submission": "SUPPL-12",
  "activeIngredients": "TAPENTADOL HYDROCHLORIDE",
  "company": "COLLEGIUM PHARM INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE HYDROCHLORIDEANDA  #203823",
  "submission": "SUPPL-14",
  "activeIngredients": "OXYCODONE HYDROCHLORIDE",
  "company": "LANNETT CO INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "MORPHINE SULFATEANDA  #203849",
  "submission": "SUPPL-25",
  "activeIngredients": "MORPHINE SULFATE",
  "company": "ACTAVIS ELIZABETH",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #203863",
  "submission": "SUPPL-10",
  "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
  "company": "EPIC PHARMA LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE HYDROCHLORIDEANDA  #204021",
  "submission": "SUPPL-10",
  "activeIngredients": "OXYCODONE HYDROCHLORIDE",
  "company": "NOVEL LABS INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE HYDROCHLORIDEANDA  #204037",
  "submission": "SUPPL-14",
  "activeIngredients": "OXYCODONE HYDROCHLORIDE",
  "company": "HIKMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "METHADONE HYDROCHLORIDEANDA  #204166",
  "submission": "SUPPL-6",
  "activeIngredients": "METHADONE HYDROCHLORIDE",
  "company": "VISTAPHARM LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROMORPHONE HYDROCHLORIDEANDA  #204278",
  "submission": "SUPPL-23",
  "activeIngredients": "HYDROMORPHONE HYDROCHLORIDE",
  "company": "PADAGIS US",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #204407",
  "submission": "SUPPL-13",
  "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
  "company": "NOVEL LABS INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYMORPHONE HYDROCHLORIDEANDA  #204459",
  "submission": "SUPPL-11",
  "activeIngredients": "OXYMORPHONE HYDROCHLORIDE",
  "company": "AUROLIFE PHARMA LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND IBUPROFENANDA  #204575",
  "submission": "SUPPL-11",
  "activeIngredients": "HYDROCODONE BITARTRATE; IBUPROFEN",
  "company": "AUROLIFE PHARMA LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE HYDROCHLORIDEANDA  #204603",
  "submission": "SUPPL-12",
  "activeIngredients": "OXYCODONE HYDROCHLORIDE",
  "company": "NOVEL LABS INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATEANDA  #204649",
  "submission": "SUPPL-4",
  "activeIngredients": "ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE",
  "company": "STRIDES PHARMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE HYDROCHLORIDEANDA  #204752",
  "submission": "SUPPL-7",
  "activeIngredients": "OXYCODONE HYDROCHLORIDE",
  "company": "NOVEL LABS INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "BUPRENORPHINEANDA  #204937",
  "submission": "SUPPL-10",
  "activeIngredients": "BUPRENORPHINE",
  "company": "WATSON LABS TEVA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE HYDROCHLORIDEANDA  #204979",
  "submission": "SUPPL-17",
  "activeIngredients": "OXYCODONE HYDROCHLORIDE",
  "company": "ANI PHARMS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #205001",
  "submission": "SUPPL-9",
  "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
  "company": "STRIDES PHARMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE HYDROCHLORIDEANDA  #205177",
  "submission": "SUPPL-15",
  "activeIngredients": "OXYCODONE HYDROCHLORIDE",
  "company": "ANI PHARMS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "TRAMADOL HYDROCHLORIDEANDA  #205257",
  "submission": "SUPPL-13",
  "activeIngredients": "TRAMADOL HYDROCHLORIDE",
  "company": "MYLAN",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND ASPIRINANDA  #205479",
  "submission": "SUPPL-4",
  "activeIngredients": "ASPIRIN; HYDROCODONE BITARTRATE",
  "company": "LGM PHARMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OLMESARTAN MEDOXOMILANDA  #205499",
  "submission": "ORIG-1",
  "activeIngredients": "OLMESARTAN MEDOXOMIL",
  "company": "HETERO LABS LTD V",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "MORPHINE SULFATEANDA  #205509",
  "submission": "SUPPL-6",
  "activeIngredients": "MORPHINE SULFATE",
  "company": "ANI PHARMS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROMORPHONE HYDROCHLORIDEANDA  #205629",
  "submission": "SUPPL-21",
  "activeIngredients": "HYDROMORPHONE HYDROCHLORIDE",
  "company": "OSMOTICA PHARM US",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "MORPHINE SULFATEANDA  #205634",
  "submission": "SUPPL-9",
  "activeIngredients": "MORPHINE SULFATE",
  "company": "SUN PHARM INDUSTRIES",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "TRAMADOL HYDROCHLORIDEANDA  #205702",
  "submission": "SUPPL-29",
  "activeIngredients": "TRAMADOL HYDROCHLORIDE",
  "company": "MACLEODS PHARMS LTD",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROMORPHONE HYDROCHLORIDEANDA  #205814",
  "submission": "SUPPL-6",
  "activeIngredients": "HYDROMORPHONE HYDROCHLORIDE",
  "company": "AUROLIFE PHARMA LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #206142",
  "submission": "SUPPL-11",
  "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
  "company": "NOVEL LABS INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #206245",
  "submission": "SUPPL-17",
  "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
  "company": "NOVEL LABS INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE HYDROCHLORIDEANDA  #206456",
  "submission": "SUPPL-10",
  "activeIngredients": "OXYCODONE HYDROCHLORIDE",
  "company": "PHARMOBEDIENT",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #206470",
  "submission": "SUPPL-13",
  "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
  "company": "ACTAVIS LABS FL INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #206484",
  "submission": "SUPPL-8",
  "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
  "company": "UPSHER SMITH LABS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "MORPHINE SULFATEANDA  #206573",
  "submission": "SUPPL-13",
  "activeIngredients": "MORPHINE SULFATE",
  "company": "PHARM ASSOC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYSINGLA ERNDA   #206627",
  "submission": "SUPPL-16",
  "activeIngredients": "HYDROCODONE BITARTRATE",
  "company": "PURDUE PHARMA LP",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #206718",
  "submission": "SUPPL-17",
  "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
  "company": "SPECGX LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE HYDROCHLORIDEANDA  #206822",
  "submission": "SUPPL-12",
  "activeIngredients": "OXYCODONE HYDROCHLORIDE",
  "company": "PHARM ASSOC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #206869",
  "submission": "SUPPL-14",
  "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
  "company": "AMNEAL PHARMS NY",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "TRAMADOL HYDROCHLORIDE AND ACETAMINOPHENANDA  #206885",
  "submission": "SUPPL-29",
  "activeIngredients": "ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE",
  "company": "MACLEODS PHARMS LTD",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE HYDROCHLORIDEANDA  #206914",
  "submission": "SUPPL-9",
  "activeIngredients": "OXYCODONE HYDROCHLORIDE",
  "company": "PHARM ASSOC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROCODONE BITARTRATEANDA  #206986",
  "submission": "SUPPL-7",
  "activeIngredients": "HYDROCODONE BITARTRATE",
  "company": "ALVOGEN",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE HYDROCHLORIDEANDA  #207119",
  "submission": "SUPPL-6",
  "activeIngredients": "OXYCODONE HYDROCHLORIDE",
  "company": "NUVO PHARM",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #207137",
  "submission": "SUPPL-15",
  "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
  "company": "AMNEAL PHARMS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "TRAMADOL HYDROCHLORIDE AND ACETAMINOPHENANDA  #207152",
  "submission": "SUPPL-17",
  "activeIngredients": "ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE",
  "company": "AUROBINDO PHARMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #207171",
  "submission": "SUPPL-11",
  "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
  "company": "LANNETT CO INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #207172",
  "submission": "SUPPL-11",
  "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
  "company": "LANNETT CO INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #207333",
  "submission": "SUPPL-13",
  "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
  "company": "LANNETT CO INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE HYDROCHLORIDEANDA  #207418",
  "submission": "SUPPL-7",
  "activeIngredients": "OXYCODONE HYDROCHLORIDE",
  "company": "ASCENT PHARMS INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #207419",
  "submission": "SUPPL-14",
  "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
  "company": "ASCENT PHARMS INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "BUPRENORPHINEANDA  #207490",
  "submission": "SUPPL-6",
  "activeIngredients": "BUPRENORPHINE",
  "company": "STRIDES PHARMA INTL",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #207509",
  "submission": "SUPPL-8",
  "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
  "company": "HIBROW HLTHCARE",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #207510",
  "submission": "SUPPL-13",
  "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
  "company": "WES PHARMA INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE HYDROCHLORIDEANDA  #207511",
  "submission": "SUPPL-12",
  "activeIngredients": "OXYCODONE HYDROCHLORIDE",
  "company": "HIBROW HLTHCARE",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "METHADONE HYDROCHLORIDEANDA  #207537",
  "submission": "SUPPL-11",
  "activeIngredients": "METHADONE HYDROCHLORIDE",
  "company": "SPECGX LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #207709",
  "submission": "SUPPL-8",
  "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
  "company": "AUROLIFE PHARMA LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "BELBUCANDA   #207932",
  "submission": "SUPPL-27",
  "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE",
  "company": "BDSI",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "XTAMPZA ERNDA   #208090",
  "submission": "SUPPL-23",
  "activeIngredients": "OXYCODONE",
  "company": "COLLEGIUM PHARM INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROCODONE BITARTRATEANDA  #208269",
  "submission": "SUPPL-2",
  "activeIngredients": "HYDROCODONE BITARTRATE",
  "company": "ALVOGEN",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "METHADONE HYDROCHLORIDEANDA  #208305",
  "submission": "SUPPL-8",
  "activeIngredients": "METHADONE HYDROCHLORIDE",
  "company": "SUN PHARM INDUSTRIES",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #208540",
  "submission": "SUPPL-6",
  "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
  "company": "ALVOGEN",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE HYDROCHLORIDEANDA  #208593",
  "submission": "SUPPL-4",
  "activeIngredients": "OXYCODONE HYDROCHLORIDE",
  "company": "ABHAI LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "APADAZNDA   #208653",
  "submission": "SUPPL-9",
  "activeIngredients": "ACETAMINOPHEN; BENZHYDROCODONE HYDROCHLORIDE",
  "company": "ZEVRA THERAP",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "TRAMADOL HYDROCHLORIDEANDA  #208708",
  "submission": "SUPPL-18",
  "activeIngredients": "TRAMADOL HYDROCHLORIDE",
  "company": "RUBICON RESEARCH",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE HYDROCHLORIDEANDA  #208795",
  "submission": "SUPPL-8",
  "activeIngredients": "OXYCODONE HYDROCHLORIDE",
  "company": "HIKMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "MORPHINE SULFATEANDA  #208809",
  "submission": "SUPPL-8",
  "activeIngredients": "MORPHINE SULFATE",
  "company": "HIKMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE HYDROCHLORIDEANDA  #208817",
  "submission": "SUPPL-8",
  "activeIngredients": "OXYCODONE HYDROCHLORIDE",
  "company": "HIKMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE HYDROCHLORIDEANDA  #209021",
  "submission": "SUPPL-3",
  "activeIngredients": "OXYCODONE HYDROCHLORIDE",
  "company": "ASCENT PHARMS INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #209036",
  "submission": "SUPPL-18",
  "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
  "company": "ABHAI LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #209037",
  "submission": "SUPPL-18",
  "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
  "company": "ABHAI LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "CHOLESTYRAMINE LIGHTANDA  #209109",
  "submission": "ORIG-1",
  "activeIngredients": "CHOLESTYRAMINE",
  "company": "MACLEODS PHARMS LTD",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #209385",
  "submission": "SUPPL-11",
  "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
  "company": "ELITE LABS INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "FENTANYL-100ANDA  #209655",
  "submission": "SUPPL-3",
  "activeIngredients": "FENTANYL",
  "company": "ZYDUS PHARMS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "FENTANYL-12ANDA  #209655",
  "submission": "SUPPL-3",
  "activeIngredients": "FENTANYL",
  "company": "ZYDUS PHARMS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "FENTANYL-25ANDA  #209655",
  "submission": "SUPPL-3",
  "activeIngredients": "FENTANYL",
  "company": "ZYDUS PHARMS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "FENTANYL-37ANDA  #209655",
  "submission": "SUPPL-3",
  "activeIngredients": "FENTANYL",
  "company": "ZYDUS PHARMS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "FENTANYL-50ANDA  #209655",
  "submission": "SUPPL-3",
  "activeIngredients": "FENTANYL",
  "company": "ZYDUS PHARMS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "FENTANYL-62ANDA  #209655",
  "submission": "SUPPL-3",
  "activeIngredients": "FENTANYL",
  "company": "ZYDUS PHARMS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "FENTANYL-75ANDA  #209655",
  "submission": "SUPPL-3",
  "activeIngredients": "FENTANYL",
  "company": "ZYDUS PHARMS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "FENTANYL-87ANDA  #209655",
  "submission": "SUPPL-3",
  "activeIngredients": "FENTANYL",
  "company": "ZYDUS PHARMS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "ROXYBONDNDA   #209777",
  "submission": "SUPPL-10",
  "activeIngredients": "OXYCODONE HYDROCHLORIDE",
  "company": "PROTEGA PHARMS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE HYDROCHLORIDEANDA  #209897",
  "submission": "SUPPL-8",
  "activeIngredients": "OXYCODONE HYDROCHLORIDE",
  "company": "HIBROW HLTHCARE",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #209924",
  "submission": "SUPPL-8",
  "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
  "company": "ELITE LABS INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #209958",
  "submission": "SUPPL-6",
  "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
  "company": "ALVOGEN",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "BUPRENORPHINEANDA  #210162",
  "submission": "SUPPL-2",
  "activeIngredients": "BUPRENORPHINE",
  "company": "MYLAN TECH VIATRIS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYMORPHONE HYDROCHLORIDEANDA  #210175",
  "submission": "SUPPL-7",
  "activeIngredients": "OXYMORPHONE HYDROCHLORIDE",
  "company": "ASCENT PHARMS INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROMORPHONE HYDROCHLORIDEANDA  #210176",
  "submission": "SUPPL-3",
  "activeIngredients": "HYDROMORPHONE HYDROCHLORIDE",
  "company": "ASCENT PHARMS INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #210211",
  "submission": "SUPPL-12",
  "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
  "company": "WES PHARMA INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "BUPRENORPHINEANDA  #210272",
  "submission": "SUPPL-8",
  "activeIngredients": "BUPRENORPHINE",
  "company": "DIFGEN PHARMS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "METHADONE HYDROCHLORIDEANDA  #210484",
  "submission": "SUPPL-10",
  "activeIngredients": "METHADONE HYDROCHLORIDE",
  "company": "ELITE LABS INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROMORPHONE HYDROCHLORIDEANDA  #210506",
  "submission": "SUPPL-3",
  "activeIngredients": "HYDROMORPHONE HYDROCHLORIDE",
  "company": "ASCENT PHARMS INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "MORPHINE SULFATEANDA  #210610",
  "submission": "SUPPL-10",
  "activeIngredients": "MORPHINE SULFATE",
  "company": "UPSHER SMITH LABS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #210644",
  "submission": "SUPPL-15",
  "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
  "company": "ABHAI LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE HYDROCHLORIDEANDA  #210758",
  "submission": "SUPPL-14",
  "activeIngredients": "OXYCODONE HYDROCHLORIDE",
  "company": "SPECGX LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #211023",
  "submission": "SUPPL-5",
  "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
  "company": "WES PHARMA INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "METHADONE HYDROCHLORIDEANDA  #211228",
  "submission": "SUPPL-6",
  "activeIngredients": "METHADONE HYDROCHLORIDE",
  "company": "ASCENT PHARMS INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "LEVORPHANOL TARTRATEANDA  #211484",
  "submission": "SUPPL-11",
  "activeIngredients": "LEVORPHANOL TARTRATE",
  "company": "ACERTIS PHARMS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #211487",
  "submission": "SUPPL-12",
  "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
  "company": "ASCENT PHARMS INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #211499",
  "submission": "SUPPL-10",
  "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
  "company": "ABHAI LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "BUPRENORPHINEANDA  #211586",
  "submission": "SUPPL-14",
  "activeIngredients": "BUPRENORPHINE",
  "company": "AMNEAL",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "ACETAMINOPHEN AND CODEINE PHOSPHATEANDA  #211610",
  "submission": "SUPPL-6",
  "activeIngredients": "ACETAMINOPHEN; CODEINE PHOSPHATE",
  "company": "HIBROW HLTHCARE",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #211708",
  "submission": "SUPPL-8",
  "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
  "company": "GRANULES",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #211729",
  "submission": "SUPPL-8",
  "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
  "company": "GRANULES",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE HYDROCHLORIDEANDA  #211748",
  "submission": "SUPPL-4",
  "activeIngredients": "OXYCODONE HYDROCHLORIDE",
  "company": "ALKEM LABS LTD",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE HYDROCHLORIDEANDA  #211749",
  "submission": "SUPPL-4",
  "activeIngredients": "OXYCODONE HYDROCHLORIDE",
  "company": "ALKEM LABS LTD",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "TRAMADOL HYDROCHLORIDEANDA  #211825",
  "submission": "SUPPL-15",
  "activeIngredients": "TRAMADOL HYDROCHLORIDE",
  "company": "UNICHEM",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "LEVORPHANOL TARTRATEANDA  #212024",
  "submission": "SUPPL-5",
  "activeIngredients": "LEVORPHANOL TARTRATE",
  "company": "SPECGX LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "HYDROMORPHONE HYDROCHLORIDEANDA  #212133",
  "submission": "SUPPL-5",
  "activeIngredients": "HYDROMORPHONE HYDROCHLORIDE",
  "company": "ASCENT PHARMS INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "ACETAMINOPHEN AND CODEINE PHOSPHATEANDA  #212418",
  "submission": "SUPPL-6",
  "activeIngredients": "ACETAMINOPHEN; CODEINE PHOSPHATE",
  "company": "ELITE LABS INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE HYDROCHLORIDEANDA  #212429",
  "submission": "SUPPL-3",
  "activeIngredients": "OXYCODONE HYDROCHLORIDE",
  "company": "AUROLIFE PHARMA LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "MORPHINE SULFATEANDA  #212451",
  "submission": "SUPPL-4",
  "activeIngredients": "MORPHINE SULFATE",
  "company": "ALKEM LABS LTD",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "SEGLENTISNDA   #213426",
  "submission": "SUPPL-4",
  "activeIngredients": "CELECOXIB; TRAMADOL HYDROCHLORIDE",
  "company": "KOWA PHARMS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "LEVORPHANOL TARTRATEANDA  #213479",
  "submission": "SUPPL-17",
  "activeIngredients": "LEVORPHANOL TARTRATE",
  "company": "NOVITIUM PHARMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "OXYCODONE HYDROCHLORIDEANDA  #213761",
  "submission": "SUPPL-1",
  "activeIngredients": "OXYCODONE HYDROCHLORIDE",
  "company": "QUAGEN",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "LEVORPHANOL TARTRATEANDA  #213906",
  "submission": "SUPPL-4",
  "activeIngredients": "LEVORPHANOL TARTRATE",
  "company": "SUN PHARM INDS INC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "QDOLONDA   #214044",
  "submission": "SUPPL-3",
  "activeIngredients": "TRAMADOL HYDROCHLORIDE",
  "company": "ATHENA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATEANDA  #215138",
  "submission": "SUPPL-2",
  "activeIngredients": "ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE",
  "company": "HIKMA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "MORPHINE SULFATEANDA  #215194",
  "submission": "SUPPL-1",
  "activeIngredients": "MORPHINE SULFATE",
  "company": "SPECGX LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "NICARDIPINE HYDROCHLORIDEANDA  #215406",
  "submission": "ORIG-1",
  "activeIngredients": "NICARDIPINE HYDROCHLORIDE",
  "company": "AMNEAL",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "MORPHINE SULFATEANDA  #215584",
  "submission": "SUPPL-1",
  "activeIngredients": "MORPHINE SULFATE",
  "company": "INGENUS PHARMS NJ",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "EDARAVONEANDA  #217565",
  "submission": "ORIG-1",
  "activeIngredients": "EDARAVONE",
  "company": "PHARMOBEDIENT",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "TOPIRAMATEANDA  #217795",
  "submission": "ORIG-1",
  "activeIngredients": "TOPIRAMATE",
  "company": "ALKEM LABS LTD",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "10\/31\/2024",
  "drugName": "ERTAPENEM SODIUMANDA  #218067",
  "submission": "ORIG-1",
  "activeIngredients": "ERTAPENEM SODIUM",
  "company": "QILU ANTIBIOTICS",
  "submissionStatus": "Approval"
 }
,
 {
  "approvalDate": "11\/01\/2024",
  "drugName": "BYETTANDA   #021773",
  "submission": "SUPPL-49",
  "activeIngredients": "EXENATIDE SYNTHETIC",
  "company": "ASTRAZENECA AB",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/01\/2024",
  "drugName": "BYDUREONNDA   #022200",
  "submission": "SUPPL-35",
  "activeIngredients": "EXENATIDE SYNTHETIC",
  "company": "ASTRAZENECA AB",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/01\/2024",
  "drugName": "BYDUREON PENNDA   #022200",
  "submission": "SUPPL-35",
  "activeIngredients": "EXENATIDE SYNTHETIC",
  "company": "ASTRAZENECA AB",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/01\/2024",
  "drugName": "VICTOZANDA   #022341",
  "submission": "SUPPL-43",
  "activeIngredients": "LIRAGLUTIDE",
  "company": "NOVO NORDISK INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/01\/2024",
  "drugName": "ILARISBLA   #125319",
  "submission": "SUPPL-110",
  "activeIngredients": "CANAKINUMAB",
  "company": "NOVARTIS PHARMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/01\/2024",
  "drugName": "TRULICITYBLA   #125469",
  "submission": "SUPPL-61",
  "activeIngredients": "DULAGLUTIDE",
  "company": "ELI LILLY AND CO",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/01\/2024",
  "drugName": "TRULICITYBLA   #125469",
  "submission": "SUPPL-62",
  "activeIngredients": "DULAGLUTIDE",
  "company": "ELI LILLY AND CO",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/01\/2024",
  "drugName": "SAXENDANDA   #206321",
  "submission": "SUPPL-19",
  "activeIngredients": "LIRAGLUTIDE",
  "company": "NOVO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/01\/2024",
  "drugName": "ADLYXINBLA   #208471",
  "submission": "SUPPL-9",
  "activeIngredients": "LIXISENATIDE",
  "company": "SANOFI-AVENTIS US",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/01\/2024",
  "drugName": "XULTOPHY 100\/3.6BLA   #208583",
  "submission": "SUPPL-24",
  "activeIngredients": "INSULIN DEGLUDEC; LIRAGLUTIDE",
  "company": "NOVO",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/01\/2024",
  "drugName": "SOLIQUA 100\/33BLA   #208673",
  "submission": "SUPPL-14",
  "activeIngredients": "INSULIN GLARGINE; LIXISENATIDE",
  "company": "SANOFI-AVENTIS US",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/01\/2024",
  "drugName": "BYDUREON BCISENDA   #209210",
  "submission": "SUPPL-24",
  "activeIngredients": "EXENATIDE SYNTHETIC",
  "company": "ASTRAZENECA AB",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/01\/2024",
  "drugName": "OZEMPICNDA   #209637",
  "submission": "SUPPL-32",
  "activeIngredients": "SEMAGLUTIDE",
  "company": "NOVO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/01\/2024",
  "drugName": "RYBELSUSNDA   #213051",
  "submission": "SUPPL-23",
  "activeIngredients": "SEMAGLUTIDE",
  "company": "NOVO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/01\/2024",
  "drugName": "DICYCLOMINE HYDROCHLORIDEANDA  #214332",
  "submission": "ORIG-1",
  "activeIngredients": "DICYCLOMINE HYDROCHLORIDE",
  "company": "SOMERSET THERAPS LLC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/01\/2024",
  "drugName": "DICYCLOMINE HYDROCHLORIDEANDA  #214333",
  "submission": "ORIG-1",
  "activeIngredients": "DICYCLOMINE HYDROCHLORIDE",
  "company": "SOMERSET THERAPS LLC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/01\/2024",
  "drugName": "WEGOVYNDA   #215256",
  "submission": "SUPPL-21",
  "activeIngredients": "SEMAGLUTIDE",
  "company": "NOVO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/01\/2024",
  "drugName": "MOUNJARONDA   #215866",
  "submission": "SUPPL-10",
  "activeIngredients": "TIRZEPATIDE",
  "company": "ELI LILLY AND CO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/01\/2024",
  "drugName": "MOUNJARONDA   #215866",
  "submission": "SUPPL-15",
  "activeIngredients": "TIRZEPATIDE",
  "company": "ELI LILLY AND CO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/01\/2024",
  "drugName": "MOUNJARONDA   #215866",
  "submission": "SUPPL-22",
  "activeIngredients": "TIRZEPATIDE",
  "company": "ELI LILLY AND CO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/01\/2024",
  "drugName": "MOUNJARO (AUTOINJECTOR)NDA   #215866",
  "submission": "SUPPL-10",
  "activeIngredients": "TIRZEPATIDE",
  "company": "ELI LILLY AND CO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/01\/2024",
  "drugName": "MOUNJARO (AUTOINJECTOR)NDA   #215866",
  "submission": "SUPPL-15",
  "activeIngredients": "TIRZEPATIDE",
  "company": "ELI LILLY AND CO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/01\/2024",
  "drugName": "MOUNJARO (AUTOINJECTOR)NDA   #215866",
  "submission": "SUPPL-22",
  "activeIngredients": "TIRZEPATIDE",
  "company": "ELI LILLY AND CO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/01\/2024",
  "drugName": "SODIUM THIOSULFATEANDA  #218028",
  "submission": "ORIG-1",
  "activeIngredients": "SODIUM THIOSULFATE",
  "company": "CIPLA LTD",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "11\/01\/2024",
  "drugName": "EMROSINDA   #219015",
  "submission": "ORIG-1",
  "activeIngredients": "MINOCYCLINE HYDROCHLORIDE",
  "company": "JOURNEY",
  "submissionClassification": "Type 5 - New Formulation or New Manufacturer",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/02\/2024",
  "drugName": "NALOXONE HYDROCHLORIDEANDA  #216977",
  "submission": "SUPPL-2",
  "activeIngredients": "NALOXONE HYDROCHLORIDE",
  "company": "BPI LABS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/04\/2024",
  "drugName": "CADUETNDA   #021540",
  "submission": "SUPPL-50",
  "activeIngredients": "AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM",
  "company": "PHARMACIA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/04\/2024",
  "drugName": "BRILINTANDA   #022433",
  "submission": "SUPPL-37",
  "activeIngredients": "TICAGRELOR",
  "company": "ASTRAZENECA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/04\/2024",
  "drugName": "AMBISOMENDA   #050740",
  "submission": "SUPPL-37",
  "activeIngredients": "AMPHOTERICIN B",
  "company": "ASTELLAS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/04\/2024",
  "drugName": "SULINDACANDA  #071795",
  "submission": "SUPPL-45",
  "activeIngredients": "SULINDAC",
  "company": "WATSON LABS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/04\/2024",
  "drugName": "SULINDACANDA  #071891",
  "submission": "SUPPL-45",
  "activeIngredients": "SULINDAC",
  "company": "WATSON LABS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/04\/2024",
  "drugName": "ANESTACONANDA  #080429",
  "submission": "SUPPL-19",
  "activeIngredients": "LIDOCAINE HYDROCHLORIDE",
  "company": "BIONPHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/04\/2024",
  "drugName": "ANESTACONANDA  #080429",
  "submission": "SUPPL-21",
  "activeIngredients": "LIDOCAINE HYDROCHLORIDE",
  "company": "BIONPHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/04\/2024",
  "drugName": "DODEXANDA  #083022",
  "submission": "SUPPL-10",
  "activeIngredients": "CYANOCOBALAMIN",
  "company": "ACCORD HLTHCARE",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/04\/2024",
  "drugName": "BUTALBITAL, ASPIRIN AND CAFFEINEANDA  #086162",
  "submission": "SUPPL-54",
  "activeIngredients": "ASPIRIN; BUTALBITAL; CAFFEINE",
  "company": "HIKMA INTL PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/04\/2024",
  "drugName": "LINEZOLIDANDA  #200222",
  "submission": "SUPPL-5",
  "activeIngredients": "LINEZOLID",
  "company": "TEVA PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/04\/2024",
  "drugName": "LINEZOLIDANDA  #200222",
  "submission": "SUPPL-6",
  "activeIngredients": "LINEZOLID",
  "company": "TEVA PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/04\/2024",
  "drugName": "FESOTERODINE FUMARATEANDA  #205002",
  "submission": "SUPPL-1",
  "activeIngredients": "FESOTERODINE FUMARATE",
  "company": "AMNEAL PHARMS NY",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/04\/2024",
  "drugName": "FESOTERODINE FUMARATEANDA  #205007",
  "submission": "SUPPL-8",
  "activeIngredients": "FESOTERODINE FUMARATE",
  "company": "AUROBINDO PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/04\/2024",
  "drugName": "PITAVASTATIN CALCIUMANDA  #205955",
  "submission": "SUPPL-6",
  "activeIngredients": "PITAVASTATIN CALCIUM",
  "company": "SAWAI USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/04\/2024",
  "drugName": "METOPROLOL SUCCINATEANDA  #207206",
  "submission": "SUPPL-7",
  "activeIngredients": "METOPROLOL SUCCINATE",
  "company": "VISUM PHARM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/04\/2024",
  "drugName": "METOPROLOL SUCCINATEANDA  #207206",
  "submission": "SUPPL-8",
  "activeIngredients": "METOPROLOL SUCCINATE",
  "company": "VISUM PHARM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/04\/2024",
  "drugName": "LANSOPRAZOLEANDA  #208671",
  "submission": "ORIG-1",
  "activeIngredients": "LANSOPRAZOLE",
  "company": "MACLEODS PHARMS LTD",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/04\/2024",
  "drugName": "DIMETHYL FUMARATEANDA  #210414",
  "submission": "SUPPL-1",
  "activeIngredients": "DIMETHYL FUMARATE",
  "company": "PRINSTON INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/04\/2024",
  "drugName": "DIMETHYL FUMARATEANDA  #210414",
  "submission": "SUPPL-2",
  "activeIngredients": "DIMETHYL FUMARATE",
  "company": "PRINSTON INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/04\/2024",
  "drugName": "DIMETHYL FUMARATEANDA  #210414",
  "submission": "SUPPL-4",
  "activeIngredients": "DIMETHYL FUMARATE",
  "company": "PRINSTON INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/04\/2024",
  "drugName": "DIMETHYL FUMARATEANDA  #210414",
  "submission": "SUPPL-5",
  "activeIngredients": "DIMETHYL FUMARATE",
  "company": "PRINSTON INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/04\/2024",
  "drugName": "SPRAVATONDA   #211243",
  "submission": "SUPPL-15",
  "activeIngredients": "ESKETAMINE HYDROCHLORIDE",
  "company": "JANSSEN PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/04\/2024",
  "drugName": "VOXZOGONDA   #214938",
  "submission": "SUPPL-4",
  "activeIngredients": "VOSORITIDE",
  "company": "BIOMARIN PHARM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/05\/2024",
  "drugName": "ESTRADIOLANDA  #201675",
  "submission": "SUPPL-16",
  "activeIngredients": "ESTRADIOL",
  "company": "MYLAN TECHNOLOGIES",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/05\/2024",
  "drugName": "RABEPRAZOLE SODIUMANDA  #204179",
  "submission": "SUPPL-8",
  "activeIngredients": "RABEPRAZOLE SODIUM",
  "company": "AMNEAL PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/05\/2024",
  "drugName": "RABEPRAZOLE SODIUMANDA  #204179",
  "submission": "SUPPL-9",
  "activeIngredients": "RABEPRAZOLE SODIUM",
  "company": "AMNEAL PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/05\/2024",
  "drugName": "RABEPRAZOLE SODIUMANDA  #204179",
  "submission": "SUPPL-10",
  "activeIngredients": "RABEPRAZOLE SODIUM",
  "company": "AMNEAL PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/05\/2024",
  "drugName": "RABEPRAZOLE SODIUMANDA  #204179",
  "submission": "SUPPL-12",
  "activeIngredients": "RABEPRAZOLE SODIUM",
  "company": "AMNEAL PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/05\/2024",
  "drugName": "METRONIDAZOLEANDA  #206560",
  "submission": "SUPPL-10",
  "activeIngredients": "METRONIDAZOLE",
  "company": "CADILA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/05\/2024",
  "drugName": "DOPAMINE HYDROCHLORIDEANDA  #207707",
  "submission": "SUPPL-3",
  "activeIngredients": "DOPAMINE HYDROCHLORIDE",
  "company": "HIKMA INTL PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/05\/2024",
  "drugName": "METRONIDAZOLEANDA  #208162",
  "submission": "SUPPL-12",
  "activeIngredients": "METRONIDAZOLE",
  "company": "NOVITIUM PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/05\/2024",
  "drugName": "METRONIDAZOLEANDA  #208681",
  "submission": "SUPPL-2",
  "activeIngredients": "METRONIDAZOLE",
  "company": "ALEMBIC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/05\/2024",
  "drugName": "DEFERASIROXANDA  #209426",
  "submission": "ORIG-1",
  "activeIngredients": "DEFERASIROX",
  "company": "TORRENT",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/05\/2024",
  "drugName": "TACROLIMUSANDA  #213112",
  "submission": "SUPPL-4",
  "activeIngredients": "TACROLIMUS",
  "company": "CONCORD BIOTECH LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/05\/2024",
  "drugName": "TACROLIMUSANDA  #213112",
  "submission": "SUPPL-7",
  "activeIngredients": "TACROLIMUS",
  "company": "CONCORD BIOTECH LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/05\/2024",
  "drugName": "TACROLIMUSANDA  #213112",
  "submission": "SUPPL-9",
  "activeIngredients": "TACROLIMUS",
  "company": "CONCORD BIOTECH LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/05\/2024",
  "drugName": "TACROLIMUSANDA  #213112",
  "submission": "SUPPL-12",
  "activeIngredients": "TACROLIMUS",
  "company": "CONCORD BIOTECH LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/05\/2024",
  "drugName": "PALIPERIDONE PALMITATEANDA  #213124",
  "submission": "ORIG-1",
  "activeIngredients": "PALIPERIDONE PALMITATE",
  "company": "MYLAN LABS LTD",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "11\/05\/2024",
  "drugName": "NALOXONE HYDROCHLORIDEANDA  #213209",
  "submission": "SUPPL-8",
  "activeIngredients": "NALOXONE HYDROCHLORIDE",
  "company": "DR REDDYS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/05\/2024",
  "drugName": "TOPIRAMATEANDA  #215638",
  "submission": "ORIG-1",
  "activeIngredients": "TOPIRAMATE",
  "company": "XIAMEN LP PHARM CO",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/05\/2024",
  "drugName": "ESTRADIOLANDA  #216524",
  "submission": "SUPPL-3",
  "activeIngredients": "ESTRADIOL",
  "company": "PADAGIS ISRAEL",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/05\/2024",
  "drugName": "DEFLAZACORTANDA  #216720",
  "submission": "ORIG-1",
  "activeIngredients": "DEFLAZACORT",
  "company": "UPSHER SMITH LABS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/05\/2024",
  "drugName": "CIPROFLOXACIN HYDROCHLORIDEANDA  #217887",
  "submission": "ORIG-1",
  "activeIngredients": "CIPROFLOXACIN HYDROCHLORIDE",
  "company": "NEW HEIGHTSRX",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/06\/2024",
  "drugName": "NICODERM CQNDA   #020165",
  "submission": "SUPPL-50",
  "activeIngredients": "NICOTINE",
  "company": "CHATTEM SANOFI",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/06\/2024",
  "drugName": "INFUVITE ADULTNDA   #021163",
  "submission": "SUPPL-45",
  "activeIngredients": "ALPHA-TOCOPHEROL ACETATE; ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A PALMITATE; VITAMIN K",
  "company": "SANDOZ CANADA INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/06\/2024",
  "drugName": "INFUVITE PEDIATRICNDA   #021265",
  "submission": "SUPPL-44",
  "activeIngredients": "ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE; RIBOFLAVIN; THIAMINE; TOCOPHEROL ACETATE; VITAMIN A; VITAMIN K",
  "company": "SANDOZ CANADA INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/06\/2024",
  "drugName": "INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE)NDA   #021265",
  "submission": "SUPPL-44",
  "activeIngredients": "ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE; RIBOFLAVIN; THIAMINE; TOCOPHEROL ACETATE; VITAMIN A; VITAMIN K",
  "company": "SANDOZ CANADA INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/06\/2024",
  "drugName": "ROSUVASTATIN CALCIUMANDA  #207296",
  "submission": "ORIG-1",
  "activeIngredients": "ROSUVASTATIN CALCIUM",
  "company": "MACLEODS PHARMS LTD",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/06\/2024",
  "drugName": "METHYLPREDNISOLONE SODIUM SUCCINATEANDA  #207549",
  "submission": "SUPPL-18",
  "activeIngredients": "METHYLPREDNISOLONE SODIUM SUCCINATE",
  "company": "AMNEAL",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/06\/2024",
  "drugName": "DEXMEDETOMIDINE HYDROCHLORIDEANDA  #208532",
  "submission": "SUPPL-5",
  "activeIngredients": "DEXMEDETOMIDINE HYDROCHLORIDE",
  "company": "BAXTER HLTHCARE CORP",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/06\/2024",
  "drugName": "DEXMEDETOMIDINE HYDROCHLORIDEANDA  #208532",
  "submission": "SUPPL-6",
  "activeIngredients": "DEXMEDETOMIDINE HYDROCHLORIDE",
  "company": "BAXTER HLTHCARE CORP",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/06\/2024",
  "drugName": "TERIPARATIDEANDA  #208569",
  "submission": "SUPPL-6",
  "activeIngredients": "TERIPARATIDE",
  "company": "TEVA PHARMS USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/06\/2024",
  "drugName": "METOLAZONEANDA  #217563",
  "submission": "ORIG-1",
  "activeIngredients": "METOLAZONE",
  "company": "MICRO LABS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/06\/2024",
  "drugName": "THIAMINE HYDROCHLORIDEANDA  #218471",
  "submission": "ORIG-1",
  "activeIngredients": "THIAMINE HYDROCHLORIDE",
  "company": "ASPIRO",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/07\/2024",
  "drugName": "ESMOLOL HYDROCHLORIDEANDA  #076474",
  "submission": "SUPPL-12",
  "activeIngredients": "ESMOLOL HYDROCHLORIDE",
  "company": "MYLAN INSTITUTIONAL",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/07\/2024",
  "drugName": "ESMOLOL HYDROCHLORIDEANDA  #076474",
  "submission": "SUPPL-15",
  "activeIngredients": "ESMOLOL HYDROCHLORIDE",
  "company": "MYLAN INSTITUTIONAL",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/07\/2024",
  "drugName": "SERTRALINE HYDROCHLORIDEANDA  #202825",
  "submission": "SUPPL-10",
  "activeIngredients": "SERTRALINE HYDROCHLORIDE",
  "company": "ACCORD HLTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/07\/2024",
  "drugName": "SERTRALINE HYDROCHLORIDEANDA  #202825",
  "submission": "SUPPL-11",
  "activeIngredients": "SERTRALINE HYDROCHLORIDE",
  "company": "ACCORD HLTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/07\/2024",
  "drugName": "SERTRALINE HYDROCHLORIDEANDA  #202825",
  "submission": "SUPPL-12",
  "activeIngredients": "SERTRALINE HYDROCHLORIDE",
  "company": "ACCORD HLTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/07\/2024",
  "drugName": "METAXALONEANDA  #203695",
  "submission": "SUPPL-6",
  "activeIngredients": "METAXALONE",
  "company": "ACTAVIS LABS FL INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/07\/2024",
  "drugName": "MESALAMINEANDA  #203817",
  "submission": "SUPPL-18",
  "activeIngredients": "MESALAMINE",
  "company": "ACTAVIS LABS FL",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/07\/2024",
  "drugName": "MESALAMINEANDA  #204354",
  "submission": "SUPPL-8",
  "activeIngredients": "MESALAMINE",
  "company": "QUAGEN",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/07\/2024",
  "drugName": "BUDESONIDEANDA  #206134",
  "submission": "SUPPL-9",
  "activeIngredients": "BUDESONIDE",
  "company": "ZYDUS PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/07\/2024",
  "drugName": "DESFLURANEANDA  #208234",
  "submission": "SUPPL-8",
  "activeIngredients": "DESFLURANE",
  "company": "SHANGHAI HENGRUI",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/07\/2024",
  "drugName": "RIVAROXABANANDA  #208579",
  "submission": "ORIG-1",
  "activeIngredients": "RIVAROXABAN",
  "company": "APOTEX INC",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "11\/07\/2024",
  "drugName": "DEFERASIROXANDA  #208697",
  "submission": "SUPPL-2",
  "activeIngredients": "DEFERASIROX",
  "company": "ACTAVIS ELIZABETH",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/07\/2024",
  "drugName": "DEFERASIROXANDA  #208697",
  "submission": "SUPPL-4",
  "activeIngredients": "DEFERASIROX",
  "company": "ACTAVIS ELIZABETH",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/07\/2024",
  "drugName": "PIFELTRONDA   #210806",
  "submission": "SUPPL-11",
  "activeIngredients": "DORAVIRINE",
  "company": "MSD MERCK CO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/07\/2024",
  "drugName": "DELSTRIGONDA   #210807",
  "submission": "SUPPL-13",
  "activeIngredients": "DORAVIRINE; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE",
  "company": "MSD MERCK CO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/07\/2024",
  "drugName": "TERIPARATIDEANDA  #211097",
  "submission": "SUPPL-1",
  "activeIngredients": "TERIPARATIDE",
  "company": "APOTEX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/07\/2024",
  "drugName": "EFINACONAZOLEANDA  #211851",
  "submission": "SUPPL-1",
  "activeIngredients": "EFINACONAZOLE",
  "company": "PADAGIS US",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/07\/2024",
  "drugName": "DEFERASIROXANDA  #212995",
  "submission": "SUPPL-2",
  "activeIngredients": "DEFERASIROX",
  "company": "PIRAMAL",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/07\/2024",
  "drugName": "MYCOPHENOLATE MOFETILANDA  #214079",
  "submission": "ORIG-1",
  "activeIngredients": "MYCOPHENOLATE MOFETIL",
  "company": "WUXI",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/07\/2024",
  "drugName": "DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATEANDA  #214777",
  "submission": "ORIG-1",
  "activeIngredients": "AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE",
  "company": "LUPIN",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/07\/2024",
  "drugName": "CIMETIDINEANDA  #218220",
  "submission": "ORIG-1",
  "activeIngredients": "CIMETIDINE",
  "company": "BIONPHARMA",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/07\/2024",
  "drugName": "FEDRATINIBANDA  #218907",
  "submission": "ORIG-1",
  "activeIngredients": "FEDRATINIB",
  "company": "TEVA PHARMS INC",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "11\/07\/2024",
  "drugName": "DANZITENNDA   #219293",
  "submission": "ORIG-1",
  "activeIngredients": "NILOTINIB TARTRATE",
  "company": "AZURITY",
  "submissionClassification": "Type 3 - New Dosage Form",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/08\/2024",
  "drugName": "OMEPRAZOLENDA   #022032",
  "submission": "SUPPL-65",
  "activeIngredients": "OMEPRAZOLE",
  "company": "DEXCEL PHARMA",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/08\/2024",
  "drugName": "LINEZOLID IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERNDA   #206473",
  "submission": "SUPPL-10",
  "activeIngredients": "LINEZOLID",
  "company": "HOSPIRA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/08\/2024",
  "drugName": "OMEPRAZOLE MAGNESIUMANDA  #206877",
  "submission": "SUPPL-3",
  "activeIngredients": "OMEPRAZOLE MAGNESIUM",
  "company": "AUROBINDO PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/08\/2024",
  "drugName": "OMEPRAZOLE MAGNESIUMANDA  #206877",
  "submission": "SUPPL-5",
  "activeIngredients": "OMEPRAZOLE MAGNESIUM",
  "company": "AUROBINDO PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/08\/2024",
  "drugName": "OMEPRAZOLE MAGNESIUMANDA  #206877",
  "submission": "SUPPL-8",
  "activeIngredients": "OMEPRAZOLE MAGNESIUM",
  "company": "AUROBINDO PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/08\/2024",
  "drugName": "OMEPRAZOLE MAGNESIUMANDA  #206877",
  "submission": "SUPPL-12",
  "activeIngredients": "OMEPRAZOLE MAGNESIUM",
  "company": "AUROBINDO PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/08\/2024",
  "drugName": "OLMESARTAN MEDOXOMILANDA  #210682",
  "submission": "ORIG-1",
  "activeIngredients": "OLMESARTAN MEDOXOMIL",
  "company": "CADILA PHARMS LTD",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/08\/2024",
  "drugName": "AYVAKITNDA   #212608",
  "submission": "SUPPL-20",
  "activeIngredients": "AVAPRITINIB",
  "company": "BLUEPRINT MEDICINES",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/08\/2024",
  "drugName": "SUGAMMADEX SODIUMANDA  #214290",
  "submission": "SUPPL-2",
  "activeIngredients": "SUGAMMADEX SODIUM",
  "company": "ZYDUS PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/08\/2024",
  "drugName": "LIVMARLINDA   #214662",
  "submission": "SUPPL-11",
  "activeIngredients": "MARALIXIBAT CHLORIDE",
  "company": "MIRUM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/08\/2024",
  "drugName": "IBUPROFENANDA  #214789",
  "submission": "ORIG-1",
  "activeIngredients": "IBUPROFEN",
  "company": "PAI HOLDINGS PHARM",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/08\/2024",
  "drugName": "IVABRADINE HYDROCHLORIDEANDA  #215238",
  "submission": "ORIG-1",
  "activeIngredients": "IVABRADINE HYDROCHLORIDE",
  "company": "ALEMBIC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/08\/2024",
  "drugName": "PAZOPANIB HYDROCHLORIDEANDA  #215837",
  "submission": "SUPPL-1",
  "activeIngredients": "PAZOPANIB HYDROCHLORIDE",
  "company": "SUN PHARM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/08\/2024",
  "drugName": "CLOMIPHENE CITRATEANDA  #216739",
  "submission": "ORIG-1",
  "activeIngredients": "CLOMIPHENE CITRATE",
  "company": "APPCO",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/08\/2024",
  "drugName": "DILTIAZEM HYDROCHLORIDEANDA  #216968",
  "submission": "ORIG-1",
  "activeIngredients": "DILTIAZEM HYDROCHLORIDE",
  "company": "ALEMBIC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/08\/2024",
  "drugName": "DEFLAZACORTANDA  #217123",
  "submission": "SUPPL-1",
  "activeIngredients": "DEFLAZACORT",
  "company": "AUROBINDO PHARMA LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/09\/2024",
  "drugName": "Carbon Dioxide, USPNDA   #220050",
  "submission": "ORIG-1",
  "activeIngredients": "Carbon Dioxide, USP",
  "company": "DJB GAS SERVICES, INC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/11\/2024",
  "drugName": "RETROVIRNDA   #019951",
  "submission": "SUPPL-38",
  "activeIngredients": "ZIDOVUDINE",
  "company": "VIIV HLTHCARE",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/11\/2024",
  "drugName": "RETROVIRNDA   #019951",
  "submission": "SUPPL-39",
  "activeIngredients": "ZIDOVUDINE",
  "company": "VIIV HLTHCARE",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/12\/2024",
  "drugName": "OMNITROPEBLA   #021426",
  "submission": "SUPPL-43",
  "activeIngredients": "SOMATROPIN",
  "company": "SANDOZ",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/12\/2024",
  "drugName": "OMNITROPEBLA   #021426",
  "submission": "SUPPL-58",
  "activeIngredients": "SOMATROPIN",
  "company": "SANDOZ",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/12\/2024",
  "drugName": "METOPROLOL TARTRATEANDA  #077360",
  "submission": "SUPPL-11",
  "activeIngredients": "METOPROLOL TARTRATE",
  "company": "SANDOZ",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/12\/2024",
  "drugName": "ESOMEPRAZOLE MAGNESIUMANDA  #078936",
  "submission": "SUPPL-19",
  "activeIngredients": "ESOMEPRAZOLE MAGNESIUM",
  "company": "MYLAN",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/12\/2024",
  "drugName": "METOPROLOL TARTRATEANDA  #078950",
  "submission": "SUPPL-9",
  "activeIngredients": "METOPROLOL TARTRATE",
  "company": "BAXTER HLTHCARE CORP",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/12\/2024",
  "drugName": "METOPROLOL TARTRATEANDA  #090386",
  "submission": "SUPPL-4",
  "activeIngredients": "METOPROLOL TARTRATE",
  "company": "AM REGENT",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/12\/2024",
  "drugName": "NITROFURANTOINANDA  #205180",
  "submission": "SUPPL-4",
  "activeIngredients": "NITROFURANTOIN",
  "company": "ACTAVIS MID ATLANTIC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/12\/2024",
  "drugName": "NITROFURANTOINANDA  #205180",
  "submission": "SUPPL-5",
  "activeIngredients": "NITROFURANTOIN",
  "company": "ACTAVIS MID ATLANTIC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/12\/2024",
  "drugName": "PREGABALINANDA  #205924",
  "submission": "ORIG-1",
  "activeIngredients": "PREGABALIN",
  "company": "MACLEODS PHARMS LTD",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/12\/2024",
  "drugName": "VONJONDA   #208712",
  "submission": "SUPPL-3",
  "activeIngredients": "PACRITINIB CITRATE",
  "company": "SOBI",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/12\/2024",
  "drugName": "CHLORTHALIDONEANDA  #209162",
  "submission": "ORIG-1",
  "activeIngredients": "CHLORTHALIDONE",
  "company": "IPCA LABS LTD",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/12\/2024",
  "drugName": "ARIPIPRAZOLEANDA  #210479",
  "submission": "SUPPL-5",
  "activeIngredients": "ARIPIPRAZOLE",
  "company": "AUROBINDO PHARMA LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/12\/2024",
  "drugName": "ARIPIPRAZOLEANDA  #210479",
  "submission": "SUPPL-8",
  "activeIngredients": "ARIPIPRAZOLE",
  "company": "AUROBINDO PHARMA LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/12\/2024",
  "drugName": "ARIPIPRAZOLEANDA  #210479",
  "submission": "SUPPL-9",
  "activeIngredients": "ARIPIPRAZOLE",
  "company": "AUROBINDO PHARMA LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/12\/2024",
  "drugName": "ARIPIPRAZOLEANDA  #210479",
  "submission": "SUPPL-12",
  "activeIngredients": "ARIPIPRAZOLE",
  "company": "AUROBINDO PHARMA LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/12\/2024",
  "drugName": "DIAZEPAMANDA  #211998",
  "submission": "SUPPL-9",
  "activeIngredients": "DIAZEPAM",
  "company": "BELOTECA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/12\/2024",
  "drugName": "BREXPIPRAZOLEANDA  #213512",
  "submission": "SUPPL-1",
  "activeIngredients": "BREXPIPRAZOLE",
  "company": "LUPIN LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/12\/2024",
  "drugName": "CLOMIPHENE CITRATEANDA  #216545",
  "submission": "ORIG-1",
  "activeIngredients": "CLOMIPHENE CITRATE",
  "company": "RUBICON",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/12\/2024",
  "drugName": "CIMETIDINEANDA  #218997",
  "submission": "ORIG-1",
  "activeIngredients": "CIMETIDINE",
  "company": "AUROBINDO PHARMA LTD",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/13\/2024",
  "drugName": "CHILDREN'S ZYRTEC ALLERGYNDA   #022155",
  "submission": "SUPPL-25",
  "activeIngredients": "CETIRIZINE HYDROCHLORIDE",
  "company": "KENVUE BRANDS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/13\/2024",
  "drugName": "CHILDREN'S ZYRTEC HIVESNDA   #022155",
  "submission": "SUPPL-25",
  "activeIngredients": "CETIRIZINE HYDROCHLORIDE",
  "company": "KENVUE BRANDS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/13\/2024",
  "drugName": "LEVETIRACETAMANDA  #090515",
  "submission": "SUPPL-20",
  "activeIngredients": "LEVETIRACETAM",
  "company": "HETERO LABS LTD III",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/13\/2024",
  "drugName": "METOPROLOL TARTRATEANDA  #091045",
  "submission": "SUPPL-4",
  "activeIngredients": "METOPROLOL TARTRATE",
  "company": "FRESENIUS KABI USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/13\/2024",
  "drugName": "LEVETIRACETAMANDA  #201157",
  "submission": "SUPPL-12",
  "activeIngredients": "LEVETIRACETAM",
  "company": "PHARM ASSOC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/13\/2024",
  "drugName": "FESOTERODINE FUMARATEANDA  #204504",
  "submission": "SUPPL-2",
  "activeIngredients": "FESOTERODINE FUMARATE",
  "company": "ANI PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/13\/2024",
  "drugName": "METHYLPREDNISOLONE SODIUM SUCCINATEANDA  #207667",
  "submission": "SUPPL-3",
  "activeIngredients": "METHYLPREDNISOLONE SODIUM SUCCINATE",
  "company": "EUGIA PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/13\/2024",
  "drugName": "METHYLPREDNISOLONE SODIUM SUCCINATEANDA  #207667",
  "submission": "SUPPL-5",
  "activeIngredients": "METHYLPREDNISOLONE SODIUM SUCCINATE",
  "company": "EUGIA PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/13\/2024",
  "drugName": "VERZENIONDA   #208716",
  "submission": "SUPPL-17",
  "activeIngredients": "ABEMACICLIB",
  "company": "ELI LILLY AND CO",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/13\/2024",
  "drugName": "DOLUTEGRAVIRANDA  #210036",
  "submission": "ORIG-1",
  "activeIngredients": "DOLUTEGRAVIR",
  "company": "EMCURE PHARMS LTD",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "11\/13\/2024",
  "drugName": "FENOFIBRATEANDA  #210248",
  "submission": "ORIG-1",
  "activeIngredients": "FENOFIBRATE",
  "company": "MACLEODS PHARMS LTD",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/13\/2024",
  "drugName": "DEFERASIROXANDA  #210555",
  "submission": "SUPPL-2",
  "activeIngredients": "DEFERASIROX",
  "company": "ALKEM LABS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/13\/2024",
  "drugName": "LEVETIRACETAMANDA  #214673",
  "submission": "SUPPL-1",
  "activeIngredients": "LEVETIRACETAM",
  "company": "STRIDES PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/13\/2024",
  "drugName": "LEVETIRACETAMANDA  #214673",
  "submission": "SUPPL-2",
  "activeIngredients": "LEVETIRACETAM",
  "company": "STRIDES PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/13\/2024",
  "drugName": "SUNLENCANDA   #215973",
  "submission": "SUPPL-9",
  "activeIngredients": "LENACAPAVIR SODIUM",
  "company": "GILEAD SCIENCES INC",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/13\/2024",
  "drugName": "SUNLENCANDA   #215974",
  "submission": "SUPPL-9",
  "activeIngredients": "LENACAPAVIR SODIUM",
  "company": "GILEAD SCIENCES INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/13\/2024",
  "drugName": "SUCRALFATEANDA  #217126",
  "submission": "ORIG-1",
  "activeIngredients": "SUCRALFATE",
  "company": "COSETTE",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/13\/2024",
  "drugName": "OGIVRIBLA   #761074",
  "submission": "SUPPL-30",
  "activeIngredients": "TRASTUZUMAB-DKST",
  "company": "MYLAN GMBH",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/13\/2024",
  "drugName": "HERZUMABLA   #761091",
  "submission": "SUPPL-33",
  "activeIngredients": "TRASTUZUMAB-PKRB",
  "company": "CELLTRION INC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/14\/2024",
  "drugName": "METAXALONEANDA  #040445",
  "submission": "SUPPL-13",
  "activeIngredients": "METAXALONE",
  "company": "SANDOZ",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/14\/2024",
  "drugName": "CITALOPRAM HYDROBROMIDEANDA  #077040",
  "submission": "SUPPL-4",
  "activeIngredients": "CITALOPRAM HYDROBROMIDE",
  "company": "CHARTWELL RX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/14\/2024",
  "drugName": "CITALOPRAM HYDROBROMIDEANDA  #077045",
  "submission": "SUPPL-8",
  "activeIngredients": "CITALOPRAM HYDROBROMIDE",
  "company": "EPIC PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/14\/2024",
  "drugName": "CITALOPRAM HYDROBROMIDEANDA  #077045",
  "submission": "SUPPL-14",
  "activeIngredients": "CITALOPRAM HYDROBROMIDE",
  "company": "EPIC PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/14\/2024",
  "drugName": "CITALOPRAM HYDROBROMIDEANDA  #077045",
  "submission": "SUPPL-15",
  "activeIngredients": "CITALOPRAM HYDROBROMIDE",
  "company": "EPIC PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/14\/2024",
  "drugName": "CITALOPRAM HYDROBROMIDEANDA  #077045",
  "submission": "SUPPL-17",
  "activeIngredients": "CITALOPRAM HYDROBROMIDE",
  "company": "EPIC PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/14\/2024",
  "drugName": "LINEZOLIDANDA  #078061",
  "submission": "SUPPL-3",
  "activeIngredients": "LINEZOLID",
  "company": "TEVA PHARMS USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/14\/2024",
  "drugName": "LINEZOLIDANDA  #078061",
  "submission": "SUPPL-4",
  "activeIngredients": "LINEZOLID",
  "company": "TEVA PHARMS USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/14\/2024",
  "drugName": "LINEZOLIDANDA  #078061",
  "submission": "SUPPL-5",
  "activeIngredients": "LINEZOLID",
  "company": "TEVA PHARMS USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/14\/2024",
  "drugName": "LINEZOLIDANDA  #078061",
  "submission": "SUPPL-8",
  "activeIngredients": "LINEZOLID",
  "company": "TEVA PHARMS USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/14\/2024",
  "drugName": "LINEZOLIDANDA  #078061",
  "submission": "SUPPL-9",
  "activeIngredients": "LINEZOLID",
  "company": "TEVA PHARMS USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/14\/2024",
  "drugName": "SULFADIAZINEANDA  #080084",
  "submission": "SUPPL-20",
  "activeIngredients": "SULFADIAZINE",
  "company": "CHARTWELL MOLECULAR",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/14\/2024",
  "drugName": "THIAMINE HYDROCHLORIDEANDA  #080556",
  "submission": "SUPPL-38",
  "activeIngredients": "THIAMINE HYDROCHLORIDE",
  "company": "FRESENIUS KABI USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/14\/2024",
  "drugName": "CARISOPRODOLANDA  #081025",
  "submission": "SUPPL-20",
  "activeIngredients": "CARISOPRODOL",
  "company": "FOSUN WANBANG",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/14\/2024",
  "drugName": "DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATEANDA  #087708",
  "submission": "SUPPL-23",
  "activeIngredients": "ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE",
  "company": "HIKMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/14\/2024",
  "drugName": "EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATEANDA  #091055",
  "submission": "SUPPL-7",
  "activeIngredients": "EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE",
  "company": "STRIDES PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/14\/2024",
  "drugName": "EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATEANDA  #091055",
  "submission": "SUPPL-21",
  "activeIngredients": "EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE",
  "company": "STRIDES PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/14\/2024",
  "drugName": "LEVETIRACETAMANDA  #091399",
  "submission": "SUPPL-29",
  "activeIngredients": "LEVETIRACETAM",
  "company": "LUPIN LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/14\/2024",
  "drugName": "LEVETIRACETAMANDA  #201464",
  "submission": "SUPPL-12",
  "activeIngredients": "LEVETIRACETAM",
  "company": "PHARMADAX INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/14\/2024",
  "drugName": "LEVETIRACETAMANDA  #202167",
  "submission": "SUPPL-10",
  "activeIngredients": "LEVETIRACETAM",
  "company": "ADAPTIS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/14\/2024",
  "drugName": "LEVETIRACETAMANDA  #203059",
  "submission": "SUPPL-29",
  "activeIngredients": "LEVETIRACETAM",
  "company": "SUN PHARM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/14\/2024",
  "drugName": "DUTASTERIDEANDA  #204376",
  "submission": "SUPPL-1",
  "activeIngredients": "DUTASTERIDE",
  "company": "GRAVITI PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/14\/2024",
  "drugName": "LEUPROLIDE ACETATE FOR DEPOT SUSPENSIONNDA   #205054",
  "submission": "SUPPL-7",
  "activeIngredients": "LEUPROLIDE ACETATE",
  "company": "INVAGEN PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/14\/2024",
  "drugName": "CITALOPRAM HYDROBROMIDEANDA  #205407",
  "submission": "SUPPL-1",
  "activeIngredients": "CITALOPRAM HYDROBROMIDE",
  "company": "JUBILANT GENERICS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/14\/2024",
  "drugName": "CITALOPRAM HYDROBROMIDEANDA  #205407",
  "submission": "SUPPL-6",
  "activeIngredients": "CITALOPRAM HYDROBROMIDE",
  "company": "JUBILANT GENERICS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/14\/2024",
  "drugName": "CITALOPRAM HYDROBROMIDEANDA  #205407",
  "submission": "SUPPL-9",
  "activeIngredients": "CITALOPRAM HYDROBROMIDE",
  "company": "JUBILANT GENERICS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/14\/2024",
  "drugName": "NATEGLINIDEANDA  #205544",
  "submission": "SUPPL-7",
  "activeIngredients": "NATEGLINIDE",
  "company": "RISING",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/14\/2024",
  "drugName": "DICLOFENAC SODIUMANDA  #206493",
  "submission": "SUPPL-3",
  "activeIngredients": "DICLOFENAC SODIUM",
  "company": "ACTAVIS MID ATLANTIC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/14\/2024",
  "drugName": "DICLOFENAC SODIUMANDA  #206493",
  "submission": "SUPPL-5",
  "activeIngredients": "DICLOFENAC SODIUM",
  "company": "ACTAVIS MID ATLANTIC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/14\/2024",
  "drugName": "DICLOFENAC SODIUMANDA  #206493",
  "submission": "SUPPL-7",
  "activeIngredients": "DICLOFENAC SODIUM",
  "company": "ACTAVIS MID ATLANTIC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/14\/2024",
  "drugName": "LEVETIRACETAMANDA  #207175",
  "submission": "SUPPL-5",
  "activeIngredients": "LEVETIRACETAM",
  "company": "HISUN PHARM HANGZHOU",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/14\/2024",
  "drugName": "MOXIFLOXACIN HYDROCHLORIDEANDA  #209698",
  "submission": "ORIG-1",
  "activeIngredients": "MOXIFLOXACIN HYDROCHLORIDE",
  "company": "SOMERSET THERAPS LLC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/14\/2024",
  "drugName": "METAXALONEANDA  #213836",
  "submission": "SUPPL-1",
  "activeIngredients": "METAXALONE",
  "company": "NOVAST LABS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/14\/2024",
  "drugName": "LEVETIRACETAMANDA  #214815",
  "submission": "SUPPL-4",
  "activeIngredients": "LEVETIRACETAM",
  "company": "MSN",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/14\/2024",
  "drugName": "LACOSAMIDEANDA  #218464",
  "submission": "ORIG-1",
  "activeIngredients": "LACOSAMIDE",
  "company": "ACELLA",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/14\/2024",
  "drugName": "LEQEMBIBLA   #761269",
  "submission": "SUPPL-8",
  "activeIngredients": "LECANEMAB-IRMB",
  "company": "EISAI INC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/15\/2024",
  "drugName": "ZYRTEC ALLERGYNDA   #022578",
  "submission": "SUPPL-14",
  "activeIngredients": "CETIRIZINE HYDROCHLORIDE",
  "company": "KENVUE BRANDS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/15\/2024",
  "drugName": "CITALOPRAM HYDROBROMIDEANDA  #077036",
  "submission": "SUPPL-7",
  "activeIngredients": "CITALOPRAM HYDROBROMIDE",
  "company": "EPIC PHARMA LLC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/15\/2024",
  "drugName": "CITALOPRAM HYDROBROMIDEANDA  #077036",
  "submission": "SUPPL-8",
  "activeIngredients": "CITALOPRAM HYDROBROMIDE",
  "company": "EPIC PHARMA LLC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/15\/2024",
  "drugName": "CITALOPRAM HYDROBROMIDEANDA  #077039",
  "submission": "SUPPL-9",
  "activeIngredients": "CITALOPRAM HYDROBROMIDE",
  "company": "PHARMOBEDIENT",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/15\/2024",
  "drugName": "CITALOPRAM HYDROBROMIDEANDA  #077278",
  "submission": "SUPPL-3",
  "activeIngredients": "CITALOPRAM HYDROBROMIDE",
  "company": "TARO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/15\/2024",
  "drugName": "STELARABLA   #125261",
  "submission": "SUPPL-166",
  "activeIngredients": "USTEKINUMAB",
  "company": "CENTOCOR ORTHO BIOTECH INC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/15\/2024",
  "drugName": "IBUPROFENANDA  #202413",
  "submission": "SUPPL-20",
  "activeIngredients": "IBUPROFEN",
  "company": "SHANDONG XINHUA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/15\/2024",
  "drugName": "DICLOFENAC SODIUMANDA  #202769",
  "submission": "SUPPL-5",
  "activeIngredients": "DICLOFENAC SODIUM",
  "company": "PAI HOLDINGS PHARM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/15\/2024",
  "drugName": "LACOSAMIDEANDA  #204994",
  "submission": "SUPPL-3",
  "activeIngredients": "LACOSAMIDE",
  "company": "AUROBINDO PHARMA LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/15\/2024",
  "drugName": "LACOSAMIDEANDA  #204994",
  "submission": "SUPPL-4",
  "activeIngredients": "LACOSAMIDE",
  "company": "AUROBINDO PHARMA LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/15\/2024",
  "drugName": "LACOSAMIDEANDA  #204994",
  "submission": "SUPPL-5",
  "activeIngredients": "LACOSAMIDE",
  "company": "AUROBINDO PHARMA LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/15\/2024",
  "drugName": "LACOSAMIDEANDA  #204994",
  "submission": "SUPPL-6",
  "activeIngredients": "LACOSAMIDE",
  "company": "AUROBINDO PHARMA LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/15\/2024",
  "drugName": "LACOSAMIDEANDA  #205031",
  "submission": "SUPPL-2",
  "activeIngredients": "LACOSAMIDE",
  "company": "SUN PHARM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/15\/2024",
  "drugName": "LACOSAMIDEANDA  #205031",
  "submission": "SUPPL-3",
  "activeIngredients": "LACOSAMIDE",
  "company": "SUN PHARM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/15\/2024",
  "drugName": "LACOSAMIDEANDA  #205031",
  "submission": "SUPPL-5",
  "activeIngredients": "LACOSAMIDE",
  "company": "SUN PHARM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/15\/2024",
  "drugName": "LACOSAMIDEANDA  #205031",
  "submission": "SUPPL-10",
  "activeIngredients": "LACOSAMIDE",
  "company": "SUN PHARM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/15\/2024",
  "drugName": "ROSUVASTATIN CALCIUMANDA  #208850",
  "submission": "SUPPL-3",
  "activeIngredients": "ROSUVASTATIN CALCIUM",
  "company": "AMNEAL PHARMS CO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/15\/2024",
  "drugName": "ROSUVASTATIN CALCIUMANDA  #208850",
  "submission": "SUPPL-4",
  "activeIngredients": "ROSUVASTATIN CALCIUM",
  "company": "AMNEAL PHARMS CO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/15\/2024",
  "drugName": "ROSUVASTATIN CALCIUMANDA  #208850",
  "submission": "SUPPL-6",
  "activeIngredients": "ROSUVASTATIN CALCIUM",
  "company": "AMNEAL PHARMS CO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/15\/2024",
  "drugName": "ROSUVASTATIN CALCIUMANDA  #208850",
  "submission": "SUPPL-8",
  "activeIngredients": "ROSUVASTATIN CALCIUM",
  "company": "AMNEAL PHARMS CO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/15\/2024",
  "drugName": "LACOSAMIDEANDA  #209224",
  "submission": "SUPPL-1",
  "activeIngredients": "LACOSAMIDE",
  "company": "AUROBINDO PHARMA LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/15\/2024",
  "drugName": "CYANOCOBALAMINANDA  #214316",
  "submission": "ORIG-1",
  "activeIngredients": "CYANOCOBALAMIN",
  "company": "MEITHEAL",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/15\/2024",
  "drugName": "PEMETREXEDNDA   #215179",
  "submission": "SUPPL-2",
  "activeIngredients": "PEMETREXED DISODIUM",
  "company": "SHILPA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/15\/2024",
  "drugName": "LISDEXAMFETAMINE DIMESYLATEANDA  #218604",
  "submission": "ORIG-1",
  "activeIngredients": "LISDEXAMFETAMINE DIMESYLATE",
  "company": "ELITE LABS INC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/15\/2024",
  "drugName": "REVUFORJNDA   #218944",
  "submission": "ORIG-1",
  "activeIngredients": "REVUMENIB CITRATE",
  "company": "SYNDAX",
  "submissionClassification": "Type 1 - New Molecular Entity",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/15\/2024",
  "drugName": "DICYCLOMINE HYDROCHLORIDEANDA  #218952",
  "submission": "ORIG-1",
  "activeIngredients": "DICYCLOMINE HYDROCHLORIDE",
  "company": "RISING",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/15\/2024",
  "drugName": "IPRATROPIUM BROMIDEANDA  #219221",
  "submission": "ORIG-1",
  "activeIngredients": "IPRATROPIUM BROMIDE",
  "company": "RUBICON RESEARCH",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/15\/2024",
  "drugName": "STELARABLA   #761044",
  "submission": "SUPPL-14",
  "activeIngredients": "USTEKINUMAB",
  "company": "JANSSEN BIOTECH",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/15\/2024",
  "drugName": "EPYSQLIBLA   #761340",
  "submission": "SUPPL-3",
  "activeIngredients": "ECULIZUMAB-AAGH",
  "company": "SAMSUNG BIOEPIS CO LTD",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/18\/2024",
  "drugName": "XYREMNDA   #021196",
  "submission": "SUPPL-46",
  "activeIngredients": "SODIUM OXYBATE",
  "company": "JAZZ PHARMS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/18\/2024",
  "drugName": "CETROTIDENDA   #021197",
  "submission": "SUPPL-32",
  "activeIngredients": "CETRORELIX ACETATE",
  "company": "EMD SERONO INC",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/18\/2024",
  "drugName": "MIDAZOLAM HYDROCHLORIDEANDA  #075873",
  "submission": "SUPPL-14",
  "activeIngredients": "MIDAZOLAM HYDROCHLORIDE",
  "company": "HIKMA",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/18\/2024",
  "drugName": "MELOXICAMANDA  #077935",
  "submission": "SUPPL-4",
  "activeIngredients": "MELOXICAM",
  "company": "TP ANDA HOLDINGS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/18\/2024",
  "drugName": "IBUPROFENANDA  #078558",
  "submission": "SUPPL-36",
  "activeIngredients": "IBUPROFEN",
  "company": "AMNEAL PHARMS NY",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/18\/2024",
  "drugName": "DICLOFENAC SODIUM ANDA  #200936",
  "submission": "SUPPL-5",
  "activeIngredients": "DICLOFENAC SODIUM",
  "company": "AMNEAL",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/18\/2024",
  "drugName": "DICLOFENAC SODIUM ANDA  #200936",
  "submission": "SUPPL-8",
  "activeIngredients": "DICLOFENAC SODIUM",
  "company": "AMNEAL",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/18\/2024",
  "drugName": "DICLOFENAC SODIUM ANDA  #200936",
  "submission": "SUPPL-9",
  "activeIngredients": "DICLOFENAC SODIUM",
  "company": "AMNEAL",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/18\/2024",
  "drugName": "QUETIAPINE FUMARATEANDA  #203359",
  "submission": "SUPPL-20",
  "activeIngredients": "QUETIAPINE FUMARATE",
  "company": "MACLEODS PHARMS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/18\/2024",
  "drugName": "QUETIAPINE FUMARATEANDA  #203359",
  "submission": "SUPPL-26",
  "activeIngredients": "QUETIAPINE FUMARATE",
  "company": "MACLEODS PHARMS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/18\/2024",
  "drugName": "DEFERASIROXANDA  #210519",
  "submission": "SUPPL-2",
  "activeIngredients": "DEFERASIROX",
  "company": "ALKEM LABS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/18\/2024",
  "drugName": "XYWAVNDA   #212690",
  "submission": "SUPPL-16",
  "activeIngredients": "CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE",
  "company": "JAZZ",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/18\/2024",
  "drugName": "DEFERASIROXANDA  #214341",
  "submission": "SUPPL-1",
  "activeIngredients": "DEFERASIROX",
  "company": "ANNORA PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/18\/2024",
  "drugName": "LORAZEPAMANDA  #217598",
  "submission": "ORIG-1",
  "activeIngredients": "LORAZEPAM",
  "company": "FRESENIUS KABI USA",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/18\/2024",
  "drugName": "ARFORMOTEROL TARTRATEANDA  #218156",
  "submission": "ORIG-1",
  "activeIngredients": "ARFORMOTEROL TARTRATE",
  "company": "LEXENPHARM",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/18\/2024",
  "drugName": "CHLORPROMAZINE HYDROCHLORIDEANDA  #218272",
  "submission": "ORIG-1",
  "activeIngredients": "CHLORPROMAZINE HYDROCHLORIDE",
  "company": "ASPIRO",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/18\/2024",
  "drugName": "CHROMIC CHLORIDEANDA  #218538",
  "submission": "ORIG-1",
  "activeIngredients": "CHROMIC CHLORIDE",
  "company": "RK PHARMA",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/19\/2024",
  "drugName": "FLUDARABINE PHOSPHATENDA   #022137",
  "submission": "SUPPL-15",
  "activeIngredients": "FLUDARABINE PHOSPHATE",
  "company": "SANDOZ",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/19\/2024",
  "drugName": "QSYMIANDA   #022580",
  "submission": "SUPPL-26",
  "activeIngredients": "PHENTERMINE HYDROCHLORIDE; TOPIRAMATE",
  "company": "VIVUS LLC",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/19\/2024",
  "drugName": "ZOSYN IN PLASTIC CONTAINERNDA   #050750",
  "submission": "SUPPL-54",
  "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
  "company": "BAXTER HLTHCARE CORP",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/19\/2024",
  "drugName": "INDOMETHACINANDA  #070651",
  "submission": "SUPPL-18",
  "activeIngredients": "INDOMETHACIN",
  "company": "CHARTWELL MOLECULES",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/19\/2024",
  "drugName": "HYDROMORPHONE HYDROCHLORIDEANDA  #077471",
  "submission": "SUPPL-20",
  "activeIngredients": "HYDROMORPHONE HYDROCHLORIDE",
  "company": "CHARTWELL",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/19\/2024",
  "drugName": "MELOXICAMANDA  #077936",
  "submission": "SUPPL-18",
  "activeIngredients": "MELOXICAM",
  "company": "CHARTWELL RX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/19\/2024",
  "drugName": "VALACYCLOVIR HYDROCHLORIDEANDA  #078656",
  "submission": "SUPPL-4",
  "activeIngredients": "VALACYCLOVIR HYDROCHLORIDE",
  "company": "HIKMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/19\/2024",
  "drugName": "BELEODAQNDA   #206256",
  "submission": "SUPPL-6",
  "activeIngredients": "BELINOSTAT",
  "company": "ACROTECH BIOPHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/19\/2024",
  "drugName": "ROSUVASTATIN CALCIUMANDA  #206434",
  "submission": "SUPPL-12",
  "activeIngredients": "ROSUVASTATIN CALCIUM",
  "company": "ACCORD HLTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/19\/2024",
  "drugName": "EXENATIDE SYNTHETICANDA  #206697",
  "submission": "ORIG-1",
  "activeIngredients": "EXENATIDE SYNTHETIC",
  "company": "AMNEAL",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/19\/2024",
  "drugName": "HYDROMORPHONE HYDROCHLORIDEANDA  #207108",
  "submission": "SUPPL-2",
  "activeIngredients": "HYDROMORPHONE HYDROCHLORIDE",
  "company": "CHARTWELL",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/19\/2024",
  "drugName": "IPRATROPIUM BROMIDEANDA  #207903",
  "submission": "SUPPL-7",
  "activeIngredients": "IPRATROPIUM BROMIDE",
  "company": "SUN PHARM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/19\/2024",
  "drugName": "EPTIFIBATIDEANDA  #209864",
  "submission": "SUPPL-2",
  "activeIngredients": "EPTIFIBATIDE",
  "company": "SLATE RUN PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/19\/2024",
  "drugName": "DIGOXINANDA  #215307",
  "submission": "SUPPL-9",
  "activeIngredients": "DIGOXIN",
  "company": "NOVITIUM PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/19\/2024",
  "drugName": "IBUPROFENANDA  #215311",
  "submission": "SUPPL-3",
  "activeIngredients": "IBUPROFEN",
  "company": "STRIDES PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/19\/2024",
  "drugName": "INDOMETHACINANDA  #215899",
  "submission": "ORIG-1",
  "activeIngredients": "INDOMETHACIN",
  "company": "HIKMA",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/19\/2024",
  "drugName": "ERYTHROMYCIN LACTOBIONATEANDA  #216761",
  "submission": "ORIG-1",
  "activeIngredients": "ERYTHROMYCIN LACTOBIONATE",
  "company": "GLAND",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/19\/2024",
  "drugName": "PAXLOVID (COPACKAGED)NDA   #217188",
  "submission": "SUPPL-9",
  "activeIngredients": "NIRMATRELVIR; RITONAVIR",
  "company": "PFIZER",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/19\/2024",
  "drugName": "REVEFENACINANDA  #217868",
  "submission": "ORIG-1",
  "activeIngredients": "REVEFENACIN",
  "company": "ORBICULAR",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "11\/19\/2024",
  "drugName": "SOLRIAMFETOLANDA  #218016",
  "submission": "ORIG-1",
  "activeIngredients": "SOLRIAMFETOL",
  "company": "HIKMA PHARMS",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "11\/19\/2024",
  "drugName": "GUANFACINE HYDROCHLORIDEANDA  #219033",
  "submission": "ORIG-1",
  "activeIngredients": "GUANFACINE HYDROCHLORIDE",
  "company": "UNICHEM",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/19\/2024",
  "drugName": "BIMZELXBLA   #761151",
  "submission": "SUPPL-10",
  "activeIngredients": "BIMEKIZUMAB-BKZX",
  "company": "UCB INC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/20\/2024",
  "drugName": "ADRENACLICKNDA   #020800",
  "submission": "SUPPL-52",
  "activeIngredients": "EPINEPHRINE",
  "company": "IMPAX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/20\/2024",
  "drugName": "TWINJECTNDA   #020800",
  "submission": "SUPPL-52",
  "activeIngredients": "EPINEPHRINE",
  "company": "IMPAX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/20\/2024",
  "drugName": "MYCOBUTINNDA   #050689",
  "submission": "SUPPL-27",
  "activeIngredients": "RIFABUTIN",
  "company": "PFIZER",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/20\/2024",
  "drugName": "KEYTRUDABLA   #125514",
  "submission": "SUPPL-164",
  "activeIngredients": "PEMBROLIZUMAB",
  "company": "MERCK SHARP DOHME",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/20\/2024",
  "drugName": "REPATHABLA   #125522",
  "submission": "SUPPL-44",
  "activeIngredients": "EVOLOCUMAB",
  "company": "AMGEN INC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/20\/2024",
  "drugName": "LENVIMANDA   #206947",
  "submission": "SUPPL-32",
  "activeIngredients": "LENVATINIB MESYLATE",
  "company": "EISAI INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/20\/2024",
  "drugName": "OXYCODONE AND ACETAMINOPHENANDA  #207574",
  "submission": "SUPPL-11",
  "activeIngredients": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
  "company": "SANALUZ",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/20\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #211690",
  "submission": "SUPPL-3",
  "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
  "company": "SANALUZ",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/20\/2024",
  "drugName": "EPINEPHRINEANDA  #213708",
  "submission": "ORIG-1",
  "activeIngredients": "EPINEPHRINE",
  "company": "FRESENIUS KABI USA",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/20\/2024",
  "drugName": "SUGAMMADEXANDA  #213915",
  "submission": "ORIG-1",
  "activeIngredients": "SUGAMMADEX",
  "company": "MYLAN PHARMS INC",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "11\/20\/2024",
  "drugName": "ICOSAPENT ETHYLANDA  #218899",
  "submission": "ORIG-1",
  "activeIngredients": "ICOSAPENT ETHYL",
  "company": "QILU",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/20\/2024",
  "drugName": "ZIIHERABLA   #761416",
  "submission": "ORIG-1",
  "activeIngredients": "ZANIDATAMAB-HRII",
  "company": "JAZZ PHARMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "PERCODANNDA   #007337",
  "submission": "SUPPL-57",
  "activeIngredients": "ASPIRIN; OXYCODONE HYDROCHLORIDE",
  "company": "ENDO OPERATIONS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "PERCODANNDA   #007337",
  "submission": "SUPPL-57",
  "activeIngredients": "ASPIRIN; OXYCODONE HYDROCHLORIDE; OXYCODONE TEREPHTHALATE",
  "company": "ENDO OPERATIONS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "PERCODAN-DEMINDA   #007337",
  "submission": "SUPPL-57",
  "activeIngredients": "ASPIRIN; OXYCODONE HYDROCHLORIDE; OXYCODONE TEREPHTHALATE",
  "company": "ENDO OPERATIONS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "SYNALGOS-DCNDA   #011483",
  "submission": "SUPPL-37",
  "activeIngredients": "ASPIRIN; CAFFEINE; DIHYDROCODEINE BITARTRATE",
  "company": "SUN PHARM INDUSTRIES",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "EQUAGESICNDA   #011702",
  "submission": "SUPPL-41",
  "activeIngredients": "ASPIRIN; MEPROBAMATE",
  "company": "SUN PHARM INDUSTRIES",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "PONSTELNDA   #015034",
  "submission": "SUPPL-46",
  "activeIngredients": "MEFENAMIC ACID",
  "company": "AVION PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "INDOCINNDA   #016059",
  "submission": "SUPPL-102",
  "activeIngredients": "INDOMETHACIN",
  "company": "ZYLA LIFE SCIENCES",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "NAPROSYNNDA   #017581",
  "submission": "SUPPL-117",
  "activeIngredients": "NAPROXEN",
  "company": "ATNAHS PHARMA US",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "NALFONNDA   #017604",
  "submission": "SUPPL-54",
  "activeIngredients": "FENOPROFEN CALCIUM",
  "company": "KEY THERAP",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "INDOCINNDA   #017814",
  "submission": "SUPPL-45",
  "activeIngredients": "INDOMETHACIN",
  "company": "ZYLA LIFE SCIENCES",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "FELDENENDA   #018147",
  "submission": "SUPPL-53",
  "activeIngredients": "PIROXICAM",
  "company": "PFIZER",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "ANAPROXNDA   #018164",
  "submission": "SUPPL-67",
  "activeIngredients": "NAPROXEN SODIUM",
  "company": "ATNAHS PHARMA US",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "ANAPROX DSNDA   #018164",
  "submission": "SUPPL-67",
  "activeIngredients": "NAPROXEN SODIUM",
  "company": "ATNAHS PHARMA US",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "INDOCIN SRNDA   #018185",
  "submission": "SUPPL-59",
  "activeIngredients": "INDOMETHACIN",
  "company": "ZYLA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "INDOCINNDA   #018332",
  "submission": "SUPPL-43",
  "activeIngredients": "INDOMETHACIN",
  "company": "ZYLA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "INDOMETHACINNDA   #018829",
  "submission": "SUPPL-25",
  "activeIngredients": "INDOMETHACIN",
  "company": "CHARTWELL MOLECULES",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "DAYPRONDA   #018841",
  "submission": "SUPPL-36",
  "activeIngredients": "OXAPROZIN",
  "company": "PFIZER",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "INDOMETHACINNDA   #018851",
  "submission": "SUPPL-29",
  "activeIngredients": "INDOMETHACIN",
  "company": "HERITAGE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "INDOMETHACINNDA   #018858",
  "submission": "SUPPL-49",
  "activeIngredients": "INDOMETHACIN",
  "company": "RISING",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "NAPROSYNNDA   #018965",
  "submission": "SUPPL-28",
  "activeIngredients": "NAPROXEN",
  "company": "ATNAHS PHARMA US",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "EC-NAPROSYNNDA   #020067",
  "submission": "SUPPL-26",
  "activeIngredients": "NAPROXEN",
  "company": "ATNAHS PHARMA US",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "NAPRELANNDA   #020353",
  "submission": "SUPPL-41",
  "activeIngredients": "NAPROXEN SODIUM",
  "company": "TWI PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "ARTHROTECNDA   #020607",
  "submission": "SUPPL-43",
  "activeIngredients": "DICLOFENAC SODIUM; MISOPROSTOL",
  "company": "PFIZER",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "DAYPRO ALTANDA   #020776",
  "submission": "SUPPL-13",
  "activeIngredients": "OXAPROZIN POTASSIUM",
  "company": "PFIZER",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "MOBICNDA   #020938",
  "submission": "SUPPL-30",
  "activeIngredients": "MELOXICAM",
  "company": "BOEHRINGER INGELHEIM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "CELEBREXNDA   #020998",
  "submission": "SUPPL-58",
  "activeIngredients": "CELECOXIB",
  "company": "UPJOHN",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "SOLARAZENDA   #021005",
  "submission": "SUPPL-25",
  "activeIngredients": "DICLOFENAC SODIUM",
  "company": "FOUGERA PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "FLECTORNDA   #021234",
  "submission": "SUPPL-24",
  "activeIngredients": "DICLOFENAC EPOLAMINE",
  "company": "IBSA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "MELOXICAMNDA   #021530",
  "submission": "SUPPL-20",
  "activeIngredients": "MELOXICAM",
  "company": "AVONDALE PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "TREXIMETNDA   #021926",
  "submission": "SUPPL-19",
  "activeIngredients": "NAPROXEN SODIUM; SUMATRIPTAN SUCCINATE",
  "company": "CURRAX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "CAMBIANDA   #022165",
  "submission": "SUPPL-16",
  "activeIngredients": "DICLOFENAC POTASSIUM",
  "company": "ASIO HOLDINGS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "ZIPSORNDA   #022202",
  "submission": "SUPPL-16",
  "activeIngredients": "DICLOFENAC POTASSIUM",
  "company": "ASIO HOLDINGS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "CALDOLORNDA   #022348",
  "submission": "SUPPL-27",
  "activeIngredients": "IBUPROFEN",
  "company": "CUMBERLAND PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "NICORETTENDA   #022360",
  "submission": "SUPPL-18",
  "activeIngredients": "NICOTINE POLACRILEX",
  "company": "HALEON US HOLDINGS",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "SPRIXNDA   #022382",
  "submission": "SUPPL-22",
  "activeIngredients": "KETOROLAC TROMETHAMINE",
  "company": "ZYLA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "VIMOVONDA   #022511",
  "submission": "SUPPL-30",
  "activeIngredients": "ESOMEPRAZOLE MAGNESIUM; NAPROXEN",
  "company": "HORIZON",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "DUEXISNDA   #022519",
  "submission": "SUPPL-14",
  "activeIngredients": "FAMOTIDINE; IBUPROFEN",
  "company": "HORIZON",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "CARISOPRODOL AND ASPIRINANDA  #040116",
  "submission": "SUPPL-16",
  "activeIngredients": "ASPIRIN; CARISOPRODOL",
  "company": "CHARTWELL",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "OXYCODONE AND ASPIRINANDA  #040255",
  "submission": "SUPPL-33",
  "activeIngredients": "ASPIRIN; OXYCODONE HYDROCHLORIDE; OXYCODONE TEREPHTHALATE",
  "company": "ANI PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "OXYCODONE AND ASPIRINANDA  #040260",
  "submission": "SUPPL-21",
  "activeIngredients": "ASPIRIN; OXYCODONE HYDROCHLORIDE; OXYCODONE TEREPHTHALATE",
  "company": "SUN PHARM INDUSTRIES",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "CARISOPRODOL AND ASPIRINANDA  #040832",
  "submission": "SUPPL-3",
  "activeIngredients": "ASPIRIN; CARISOPRODOL",
  "company": "NOVAST LABS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATEANDA  #040860",
  "submission": "SUPPL-13",
  "activeIngredients": "ASPIRIN; CARISOPRODOL; CODEINE PHOSPHATE",
  "company": "INGENUS PHARMS NJ",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "OXYCODONE AND ASPIRINANDA  #040910",
  "submission": "SUPPL-4",
  "activeIngredients": "ASPIRIN; OXYCODONE HYDROCHLORIDE",
  "company": "EPIC PHARMA LLC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "IBUPROFENANDA  #070045",
  "submission": "SUPPL-31",
  "activeIngredients": "IBUPROFEN",
  "company": "PHARMOBEDIENT",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "IBUPROFENANDA  #070057",
  "submission": "SUPPL-31",
  "activeIngredients": "IBUPROFEN",
  "company": "PHARMOBEDIENT",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "IBUPROFENANDA  #070079",
  "submission": "SUPPL-39",
  "activeIngredients": "IBUPROFEN",
  "company": "SUN PHARM INDUSTRIES",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "IBUPROFENANDA  #070080",
  "submission": "SUPPL-41",
  "activeIngredients": "IBUPROFEN",
  "company": "SUN PHARM INDUSTRIES",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "IBUPROFENANDA  #070329",
  "submission": "SUPPL-41",
  "activeIngredients": "IBUPROFEN",
  "company": "STRIDES PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "IBUPROFENANDA  #070330",
  "submission": "SUPPL-41",
  "activeIngredients": "IBUPROFEN",
  "company": "STRIDES PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "INDOMETHACINANDA  #070624",
  "submission": "SUPPL-41",
  "activeIngredients": "INDOMETHACIN",
  "company": "RISING",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "INDOMETHACINANDA  #070651",
  "submission": "SUPPL-19",
  "activeIngredients": "INDOMETHACIN",
  "company": "CHARTWELL MOLECULES",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "INDOMETHACINANDA  #070673",
  "submission": "SUPPL-24",
  "activeIngredients": "INDOMETHACIN",
  "company": "SANDOZ",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "INDOMETHACINANDA  #070674",
  "submission": "SUPPL-24",
  "activeIngredients": "INDOMETHACIN",
  "company": "SANDOZ",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "INDOMETHACINANDA  #070719",
  "submission": "SUPPL-31",
  "activeIngredients": "INDOMETHACIN",
  "company": "HERITAGE PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "INDOMETHACINANDA  #070756",
  "submission": "SUPPL-34",
  "activeIngredients": "INDOMETHACIN",
  "company": "HERITAGE PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "INDOMETHACINANDA  #070900",
  "submission": "SUPPL-25",
  "activeIngredients": "INDOMETHACIN",
  "company": "SUN PHARM INDUSTRIES",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "IBUPROFENANDA  #070986",
  "submission": "SUPPL-36",
  "activeIngredients": "IBUPROFEN",
  "company": "STRIDES PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "MECLOFENAMATE SODIUMANDA  #071081",
  "submission": "SUPPL-26",
  "activeIngredients": "MECLOFENAMATE SODIUM",
  "company": "MYLAN",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "INDOMETHACINANDA  #071148",
  "submission": "SUPPL-21",
  "activeIngredients": "INDOMETHACIN",
  "company": "ANI PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "INDOMETHACINANDA  #071149",
  "submission": "SUPPL-21",
  "activeIngredients": "INDOMETHACIN",
  "company": "ANI PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "IBUPROFENANDA  #071230",
  "submission": "SUPPL-18",
  "activeIngredients": "IBUPROFEN",
  "company": "PH HEALTH",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "IBUPROFENANDA  #071231",
  "submission": "SUPPL-20",
  "activeIngredients": "IBUPROFEN",
  "company": "PH HEALTH",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "IBUPROFENANDA  #071232",
  "submission": "SUPPL-20",
  "activeIngredients": "IBUPROFEN",
  "company": "PH HEALTH",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "IBUPROFENANDA  #071268",
  "submission": "SUPPL-17",
  "activeIngredients": "IBUPROFEN",
  "company": "CONTRACT PHARMACAL",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "IBUPROFENANDA  #071334",
  "submission": "SUPPL-44",
  "activeIngredients": "IBUPROFEN",
  "company": "AMNEAL PHARMS NY",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "IBUPROFENANDA  #071335",
  "submission": "SUPPL-45",
  "activeIngredients": "IBUPROFEN",
  "company": "AMNEAL PHARMS NY",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "IBUPROFENANDA  #071448",
  "submission": "SUPPL-20",
  "activeIngredients": "IBUPROFEN",
  "company": "SUN PHARM INDUSTRIES",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "MECLOFENAMATE SODIUMANDA  #071469",
  "submission": "SUPPL-25",
  "activeIngredients": "MECLOFENAMATE SODIUM",
  "company": "ANI PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "SULINDACANDA  #071795",
  "submission": "SUPPL-47",
  "activeIngredients": "SULINDAC",
  "company": "WATSON LABS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "SULINDACANDA  #071891",
  "submission": "SUPPL-47",
  "activeIngredients": "SULINDAC",
  "company": "WATSON LABS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "IBUPROFENANDA  #071935",
  "submission": "SUPPL-36",
  "activeIngredients": "IBUPROFEN",
  "company": "AMNEAL PHARMS NY",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "IBUPROFENANDA  #071999",
  "submission": "SUPPL-23",
  "activeIngredients": "IBUPROFEN",
  "company": "PHARMOBEDIENT",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "IBUPROFENANDA  #072004",
  "submission": "SUPPL-18",
  "activeIngredients": "IBUPROFEN",
  "company": "PH HEALTH",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "SULINDACANDA  #072050",
  "submission": "SUPPL-41",
  "activeIngredients": "SULINDAC",
  "company": "SUN PHARM INDUSTRIES",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "SULINDACANDA  #072051",
  "submission": "SUPPL-46",
  "activeIngredients": "SULINDAC",
  "company": "SUN PHARM INDUSTRIES",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "IBUPROFENANDA  #072169",
  "submission": "SUPPL-14",
  "activeIngredients": "IBUPROFEN",
  "company": "SANDOZ",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "MECLOFENAMATE SODIUMANDA  #072262",
  "submission": "SUPPL-8",
  "activeIngredients": "MECLOFENAMATE SODIUM",
  "company": "CHARTWELL RX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "MECLOFENAMATE SODIUMANDA  #072263",
  "submission": "SUPPL-9",
  "activeIngredients": "MECLOFENAMATE SODIUM",
  "company": "CHARTWELL RX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "FENOPROFEN CALCIUMANDA  #072267",
  "submission": "SUPPL-27",
  "activeIngredients": "FENOPROFEN CALCIUM",
  "company": "KEY THERAP",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "FENOPROFEN CALCIUMANDA  #072274",
  "submission": "SUPPL-26",
  "activeIngredients": "FENOPROFEN CALCIUM",
  "company": "ANI PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "FENOPROFEN CALCIUMANDA  #072429",
  "submission": "SUPPL-9",
  "activeIngredients": "FENOPROFEN CALCIUM",
  "company": "STRIDES PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "SULINDACANDA  #072711",
  "submission": "SUPPL-18",
  "activeIngredients": "SULINDAC",
  "company": "EPIC PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "SULINDACANDA  #072712",
  "submission": "SUPPL-15",
  "activeIngredients": "SULINDAC",
  "company": "CHARTWELL RX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "SULINDACANDA  #072713",
  "submission": "SUPPL-15",
  "activeIngredients": "SULINDAC",
  "company": "CHARTWELL RX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "FENOPROFEN CALCIUMANDA  #072902",
  "submission": "SUPPL-20",
  "activeIngredients": "FENOPROFEN CALCIUM",
  "company": "SUN PHARM INDUSTRIES",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "SULINDACANDA  #072973",
  "submission": "SUPPL-25",
  "activeIngredients": "SULINDAC",
  "company": "ANI PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "SULINDACANDA  #073039",
  "submission": "SUPPL-24",
  "activeIngredients": "SULINDAC",
  "company": "RISING",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "SULINDACANDA  #073262",
  "submission": "SUPPL-23",
  "activeIngredients": "SULINDAC",
  "company": "EPIC PHARMA LLC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "TOLMETIN SODIUMANDA  #073290",
  "submission": "SUPPL-19",
  "activeIngredients": "TOLMETIN SODIUM",
  "company": "ANDA REPOSITORY",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "TOLMETIN SODIUMANDA  #073308",
  "submission": "SUPPL-18",
  "activeIngredients": "TOLMETIN SODIUM",
  "company": "ANI PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "TOLMETIN SODIUMANDA  #073311",
  "submission": "SUPPL-19",
  "activeIngredients": "TOLMETIN SODIUM",
  "company": "SUN PHARM INDUSTRIES",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "INDOMETHACINANDA  #073314",
  "submission": "SUPPL-29",
  "activeIngredients": "INDOMETHACIN",
  "company": "COSETTE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "TOLMETIN SODIUMANDA  #073392",
  "submission": "SUPPL-5",
  "activeIngredients": "TOLMETIN SODIUM",
  "company": "ANI PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "TOLMETIN SODIUMANDA  #073393",
  "submission": "SUPPL-14",
  "activeIngredients": "TOLMETIN SODIUM",
  "company": "RISING",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "TOLMETIN SODIUMANDA  #073462",
  "submission": "SUPPL-7",
  "activeIngredients": "TOLMETIN SODIUM",
  "company": "CHARTWELL RX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "KETOPROFENANDA  #073516",
  "submission": "SUPPL-31",
  "activeIngredients": "KETOPROFEN",
  "company": "TEVA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "KETOPROFENANDA  #073517",
  "submission": "SUPPL-29",
  "activeIngredients": "KETOPROFEN",
  "company": "TEVA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "TOLMETIN SODIUMANDA  #073527",
  "submission": "SUPPL-17",
  "activeIngredients": "TOLMETIN SODIUM",
  "company": "ANI PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "TOLMETIN SODIUMANDA  #073588",
  "submission": "SUPPL-5",
  "activeIngredients": "TOLMETIN SODIUM",
  "company": "CHARTWELL RX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "DIFLUNISALANDA  #073673",
  "submission": "SUPPL-35",
  "activeIngredients": "DIFLUNISAL",
  "company": "TEVA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "TOLMETIN SODIUMANDA  #074002",
  "submission": "SUPPL-4",
  "activeIngredients": "TOLMETIN SODIUM",
  "company": "CHARTWELL RX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "KETOPROFENANDA  #074035",
  "submission": "SUPPL-17",
  "activeIngredients": "KETOPROFEN",
  "company": "RISING",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "FLURBIPROFENANDA  #074358",
  "submission": "SUPPL-14",
  "activeIngredients": "FLURBIPROFEN",
  "company": "NATCO PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "DICLOFENAC SODIUMANDA  #074376",
  "submission": "SUPPL-43",
  "activeIngredients": "DICLOFENAC SODIUM",
  "company": "CHARTWELL RX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "DICLOFENAC SODIUMANDA  #074394",
  "submission": "SUPPL-52",
  "activeIngredients": "DICLOFENAC SODIUM",
  "company": "CHARTWELL RX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "TOLMETIN SODIUMANDA  #074399",
  "submission": "SUPPL-5",
  "activeIngredients": "TOLMETIN SODIUM",
  "company": "COSETTE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "INDOMETHACINANDA  #074464",
  "submission": "SUPPL-25",
  "activeIngredients": "INDOMETHACIN",
  "company": "SANDOZ",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "TOLMETIN SODIUMANDA  #074473",
  "submission": "SUPPL-18",
  "activeIngredients": "TOLMETIN SODIUM",
  "company": "RISING",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "DICLOFENAC SODIUMANDA  #074514",
  "submission": "SUPPL-48",
  "activeIngredients": "DICLOFENAC SODIUM",
  "company": "ACTAVIS ELIZABETH",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "DIFLUNISALANDA  #074604",
  "submission": "SUPPL-6",
  "activeIngredients": "DIFLUNISAL",
  "company": "ANI PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINEANDA  #074654",
  "submission": "SUPPL-21",
  "activeIngredients": "ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE",
  "company": "SANDOZ",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "TOLMETIN SODIUMANDA  #074729",
  "submission": "SUPPL-12",
  "activeIngredients": "TOLMETIN SODIUM",
  "company": "COSETTE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "KETOROLAC TROMETHAMINEANDA  #074754",
  "submission": "SUPPL-27",
  "activeIngredients": "KETOROLAC TROMETHAMINE",
  "company": "TEVA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "KETOROLAC TROMETHAMINEANDA  #074761",
  "submission": "SUPPL-22",
  "activeIngredients": "KETOROLAC TROMETHAMINE",
  "company": "MYLAN",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "KETOROLAC TROMETHAMINEANDA  #074802",
  "submission": "SUPPL-59",
  "activeIngredients": "KETOROLAC TROMETHAMINE",
  "company": "HOSPIRA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "INVAGESICANDA  #074817",
  "submission": "SUPPL-6",
  "activeIngredients": "ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE",
  "company": "CHARTWELL RX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "INVAGESIC FORTEANDA  #074817",
  "submission": "SUPPL-6",
  "activeIngredients": "ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE",
  "company": "CHARTWELL RX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "ETODOLACANDA  #074819",
  "submission": "SUPPL-31",
  "activeIngredients": "ETODOLAC",
  "company": "OXFORD PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "ETODOLACANDA  #074841",
  "submission": "SUPPL-4",
  "activeIngredients": "ETODOLAC",
  "company": "CHARTWELL MOLECULES",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "ETODOLACANDA  #074842",
  "submission": "SUPPL-5",
  "activeIngredients": "ETODOLAC",
  "company": "CHARTWELL MOLECULES",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "ETODOLACANDA  #074903",
  "submission": "SUPPL-34",
  "activeIngredients": "ETODOLAC",
  "company": "PANGEA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "ETODOLACANDA  #074932",
  "submission": "SUPPL-10",
  "activeIngredients": "ETODOLAC",
  "company": "NATCO PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "ETODOLACANDA  #074942",
  "submission": "SUPPL-6",
  "activeIngredients": "ETODOLAC",
  "company": "SANDOZ",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATEANDA  #074951",
  "submission": "SUPPL-10",
  "activeIngredients": "ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE",
  "company": "STEVENS J",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "IBUPROFENANDA  #074978",
  "submission": "SUPPL-53",
  "activeIngredients": "IBUPROFEN",
  "company": "ACTAVIS MID ATLANTIC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "DICLOFENAC SODIUMANDA  #074986",
  "submission": "SUPPL-4",
  "activeIngredients": "DICLOFENAC SODIUM",
  "company": "MICRO LABS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINEANDA  #074988",
  "submission": "SUPPL-2",
  "activeIngredients": "ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE",
  "company": "STEVENS J",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "KETOROLAC TROMETHAMINEANDA  #074993",
  "submission": "SUPPL-52",
  "activeIngredients": "KETOROLAC TROMETHAMINE",
  "company": "HOSPIRA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "ETODOLACANDA  #075009",
  "submission": "SUPPL-22",
  "activeIngredients": "ETODOLAC",
  "company": "TEVA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "FLURBIPROFENANDA  #075058",
  "submission": "SUPPL-15",
  "activeIngredients": "FLURBIPROFEN",
  "company": "SUN PHARM INDS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "ETODOLACANDA  #075074",
  "submission": "SUPPL-33",
  "activeIngredients": "ETODOLAC",
  "company": "TARO PHARM INDS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "ETODOLACANDA  #075078",
  "submission": "SUPPL-24",
  "activeIngredients": "ETODOLAC",
  "company": "TARO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "ETODOLACANDA  #075104",
  "submission": "SUPPL-12",
  "activeIngredients": "ETODOLAC",
  "company": "NATCO PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "ETODOLACANDA  #075126",
  "submission": "SUPPL-20",
  "activeIngredients": "ETODOLAC",
  "company": "ANI PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "ORPHENGESICANDA  #075141",
  "submission": "SUPPL-4",
  "activeIngredients": "ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE",
  "company": "GALT PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "ORPHENGESIC FORTEANDA  #075141",
  "submission": "SUPPL-4",
  "activeIngredients": "ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE",
  "company": "GALT PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "DICLOFENAC SODIUMANDA  #075185",
  "submission": "SUPPL-20",
  "activeIngredients": "DICLOFENAC SODIUM",
  "company": "CARLSBAD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "NABUMETONEANDA  #075189",
  "submission": "SUPPL-32",
  "activeIngredients": "NABUMETONE",
  "company": "IMPAX LABS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "DICLOFENAC POTASSIUMANDA  #075219",
  "submission": "SUPPL-22",
  "activeIngredients": "DICLOFENAC POTASSIUM",
  "company": "TEVA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "KETOROLAC TROMETHAMINEANDA  #075222",
  "submission": "SUPPL-23",
  "activeIngredients": "KETOROLAC TROMETHAMINE",
  "company": "HIKMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "KETOROLAC TROMETHAMINEANDA  #075228",
  "submission": "SUPPL-20",
  "activeIngredients": "KETOROLAC TROMETHAMINE",
  "company": "HIKMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "DICLOFENAC POTASSIUMANDA  #075229",
  "submission": "SUPPL-35",
  "activeIngredients": "DICLOFENAC POTASSIUM",
  "company": "RUBICON RESEARCH",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "KETOPROFENANDA  #075270",
  "submission": "SUPPL-15",
  "activeIngredients": "KETOPROFEN",
  "company": "ACTAVIS LABS FL INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "NABUMETONEANDA  #075280",
  "submission": "SUPPL-27",
  "activeIngredients": "NABUMETONE",
  "company": "CHARTWELL RX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "DICLOFENAC SODIUMANDA  #075281",
  "submission": "SUPPL-14",
  "activeIngredients": "DICLOFENAC SODIUM",
  "company": "AUROBINDO PHARMA USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "KETOROLAC TROMETHAMINEANDA  #075299",
  "submission": "SUPPL-7",
  "activeIngredients": "KETOROLAC TROMETHAMINE",
  "company": "HIKMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATEANDA  #075351",
  "submission": "SUPPL-10",
  "activeIngredients": "ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE",
  "company": "NOVITIUM PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "ETODOLACANDA  #075419",
  "submission": "SUPPL-16",
  "activeIngredients": "ETODOLAC",
  "company": "APOTEX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "DICLOFENAC POTASSIUMANDA  #075463",
  "submission": "SUPPL-22",
  "activeIngredients": "DICLOFENAC POTASSIUM",
  "company": "RK PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "DICLOFENAC POTASSIUMANDA  #075470",
  "submission": "SUPPL-12",
  "activeIngredients": "DICLOFENAC POTASSIUM",
  "company": "SUN PHARM INDUSTRIES",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "DICLOFENAC SODIUMANDA  #075492",
  "submission": "SUPPL-16",
  "activeIngredients": "DICLOFENAC SODIUM",
  "company": "VPNA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "DICLOFENAC POTASSIUMANDA  #075582",
  "submission": "SUPPL-8",
  "activeIngredients": "DICLOFENAC POTASSIUM",
  "company": "CHARTWELL RX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "NABUMETONEANDA  #075590",
  "submission": "SUPPL-15",
  "activeIngredients": "NABUMETONE",
  "company": "EPIC PHARMA LLC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "KETOROLAC TROMETHAMINEANDA  #075626",
  "submission": "SUPPL-16",
  "activeIngredients": "KETOROLAC TROMETHAMINE",
  "company": "APOTEX INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "KETOROLAC TROMETHAMINEANDA  #075631",
  "submission": "SUPPL-23",
  "activeIngredients": "KETOROLAC TROMETHAMINE",
  "company": "BAXTER HLTHCARE CORP",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "ETODOLACANDA  #075665",
  "submission": "SUPPL-15",
  "activeIngredients": "ETODOLAC",
  "company": "TEVA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "KETOPROFENANDA  #075679",
  "submission": "SUPPL-19",
  "activeIngredients": "KETOPROFEN",
  "company": "MYLAN",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "IBUPROFENANDA  #075682",
  "submission": "SUPPL-22",
  "activeIngredients": "IBUPROFEN",
  "company": "DR REDDYS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "ETODOLACANDA  #075696",
  "submission": "SUPPL-17",
  "activeIngredients": "ETODOLAC",
  "company": "ACTAVIS ELIZABETH",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "KETOROLAC TROMETHAMINEANDA  #075772",
  "submission": "SUPPL-12",
  "activeIngredients": "KETOROLAC TROMETHAMINE",
  "company": "HIKMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "KETOROLAC TROMETHAMINEANDA  #075784",
  "submission": "SUPPL-28",
  "activeIngredients": "KETOROLAC TROMETHAMINE",
  "company": "FRESENIUS KABI USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "DICLOFENAC SODIUMANDA  #075910",
  "submission": "SUPPL-31",
  "activeIngredients": "DICLOFENAC SODIUM",
  "company": "ACTAVIS ELIZABETH",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "ETODOLACANDA  #076004",
  "submission": "SUPPL-16",
  "activeIngredients": "ETODOLAC",
  "company": "APOTEX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "NABUMETONEANDA  #076009",
  "submission": "SUPPL-15",
  "activeIngredients": "NABUMETONE",
  "company": "CHARTWELL MOLECULES",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "IBUPROFENANDA  #076112",
  "submission": "SUPPL-18",
  "activeIngredients": "IBUPROFEN",
  "company": "DR REDDYS LABS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "DICLOFENAC SODIUMANDA  #076152",
  "submission": "SUPPL-17",
  "activeIngredients": "DICLOFENAC SODIUM",
  "company": "AUROBINDO PHARMA USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "ETODOLACANDA  #076174",
  "submission": "SUPPL-20",
  "activeIngredients": "ETODOLAC",
  "company": "TARO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "DICLOFENAC SODIUMANDA  #076201",
  "submission": "SUPPL-32",
  "activeIngredients": "DICLOFENAC SODIUM",
  "company": "DEXCEL LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "KETOROLAC TROMETHAMINEANDA  #076209",
  "submission": "SUPPL-8",
  "activeIngredients": "KETOROLAC TROMETHAMINE",
  "company": "AMPHASTAR PHARM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "KETOROLAC TROMETHAMINEANDA  #076271",
  "submission": "SUPPL-15",
  "activeIngredients": "KETOROLAC TROMETHAMINE",
  "company": "SANDOZ",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "CATAFLAMANDA  #076561",
  "submission": "SUPPL-17",
  "activeIngredients": "DICLOFENAC POTASSIUM",
  "company": "AMICI PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND IBUPROFENANDA  #076604",
  "submission": "SUPPL-30",
  "activeIngredients": "HYDROCODONE BITARTRATE; IBUPROFEN",
  "company": "ACTAVIS LABS FL INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND IBUPROFENANDA  #076642",
  "submission": "SUPPL-47",
  "activeIngredients": "HYDROCODONE BITARTRATE; IBUPROFEN",
  "company": "AMNEAL PHARMS NY",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "REPREXAINANDA  #076642",
  "submission": "SUPPL-47",
  "activeIngredients": "HYDROCODONE BITARTRATE; IBUPROFEN",
  "company": "AMNEAL PHARMS NY",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "IBUPROFENANDA  #076925",
  "submission": "SUPPL-52",
  "activeIngredients": "IBUPROFEN",
  "company": "PADAGIS US",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "IBUPROFENANDA  #077114",
  "submission": "SUPPL-15",
  "activeIngredients": "IBUPROFEN",
  "company": "L PERRIGO CO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "KETOROLAC TROMETHAMINEANDA  #077201",
  "submission": "SUPPL-7",
  "activeIngredients": "KETOROLAC TROMETHAMINE",
  "company": "APOTEX INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND IBUPROFENANDA  #077454",
  "submission": "SUPPL-11",
  "activeIngredients": "HYDROCODONE BITARTRATE; IBUPROFEN",
  "company": "ANI PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "HYDROCODONEANDA  #077723",
  "submission": "SUPPL-36",
  "activeIngredients": "HYDROCODONE BITARTRATE; IBUPROFEN",
  "company": "STRIDES PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND IBUPROFENANDA  #077723",
  "submission": "SUPPL-36",
  "activeIngredients": "HYDROCODONE BITARTRATE; IBUPROFEN",
  "company": "STRIDES PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "DICLOFENAC SODIUMANDA  #077863",
  "submission": "SUPPL-22",
  "activeIngredients": "DICLOFENAC SODIUM",
  "company": "UNIQUE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "MELOXICAMANDA  #077882",
  "submission": "SUPPL-10",
  "activeIngredients": "MELOXICAM",
  "company": "COREPHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "MELOXICAMANDA  #077918",
  "submission": "SUPPL-9",
  "activeIngredients": "MELOXICAM",
  "company": "YUNG SHIN PHARM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "MELOXICAMANDA  #077920",
  "submission": "SUPPL-9",
  "activeIngredients": "MELOXICAM",
  "company": "AIPING PHARM INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "MELOXICAMANDA  #077921",
  "submission": "SUPPL-38",
  "activeIngredients": "MELOXICAM",
  "company": "ZYDUS PHARMS USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "MELOXICAMANDA  #077923",
  "submission": "SUPPL-13",
  "activeIngredients": "MELOXICAM",
  "company": "NATCO PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "MELOXICAMANDA  #077927",
  "submission": "SUPPL-48",
  "activeIngredients": "MELOXICAM",
  "company": "UNICHEM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "MELOXICAMANDA  #077928",
  "submission": "SUPPL-9",
  "activeIngredients": "MELOXICAM",
  "company": "NOVITIUM PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "MELOXICAMANDA  #077929",
  "submission": "SUPPL-17",
  "activeIngredients": "MELOXICAM",
  "company": "CIPLA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "MELOXICAMANDA  #077931",
  "submission": "SUPPL-5",
  "activeIngredients": "MELOXICAM",
  "company": "RISING",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "MELOXICAMANDA  #077932",
  "submission": "SUPPL-11",
  "activeIngredients": "MELOXICAM",
  "company": "GLENMARK PHARMS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "MELOXICAMANDA  #077933",
  "submission": "SUPPL-4",
  "activeIngredients": "MELOXICAM",
  "company": "YABAO PHARM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "MELOXICAMANDA  #077935",
  "submission": "SUPPL-5",
  "activeIngredients": "MELOXICAM",
  "company": "TP ANDA HOLDINGS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "MELOXICAMANDA  #077936",
  "submission": "SUPPL-19",
  "activeIngredients": "MELOXICAM",
  "company": "CHARTWELL RX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "KETOROLAC TROMETHAMINEANDA  #077942",
  "submission": "SUPPL-8",
  "activeIngredients": "KETOROLAC TROMETHAMINE",
  "company": "WOCKHARDT BIO AG",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "KETOROLAC TROMETHAMINEANDA  #077943",
  "submission": "SUPPL-6",
  "activeIngredients": "KETOROLAC TROMETHAMINE",
  "company": "WOCKHARDT BIO AG",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "MELOXICAMANDA  #077944",
  "submission": "SUPPL-21",
  "activeIngredients": "MELOXICAM",
  "company": "LUPIN PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "MELOXICAMANDA  #078008",
  "submission": "SUPPL-26",
  "activeIngredients": "MELOXICAM",
  "company": "AUROBINDO PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "MELOXICAMANDA  #078102",
  "submission": "SUPPL-3",
  "activeIngredients": "MELOXICAM",
  "company": "TARO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "KETOROLAC TROMETHAMINEANDA  #078145",
  "submission": "SUPPL-8",
  "activeIngredients": "KETOROLAC TROMETHAMINE",
  "company": "LUITPOLD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "BUTALBITAL, ASPIRIN AND CAFFEINEANDA  #078149",
  "submission": "SUPPL-5",
  "activeIngredients": "ASPIRIN; BUTALBITAL; CAFFEINE",
  "company": "MPP PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "KETOROLAC TROMETHAMINEANDA  #078299",
  "submission": "SUPPL-11",
  "activeIngredients": "KETOROLAC TROMETHAMINE",
  "company": "ONESOURCE SPECIALTY",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "OXYCODONE HYDROCHLORIDE AND IBUPROFENANDA  #078316",
  "submission": "SUPPL-20",
  "activeIngredients": "IBUPROFEN; OXYCODONE HYDROCHLORIDE",
  "company": "BARR LABS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "IBUPROFENANDA  #078329",
  "submission": "SUPPL-24",
  "activeIngredients": "IBUPROFEN",
  "company": "STRIDES PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "NABUMETONEANDA  #078420",
  "submission": "SUPPL-15",
  "activeIngredients": "NABUMETONE",
  "company": "SCIEGEN PHARMS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "IBUPROFENANDA  #078558",
  "submission": "SUPPL-41",
  "activeIngredients": "IBUPROFEN",
  "company": "AMNEAL PHARMS NY",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "NABUMETONEANDA  #078671",
  "submission": "SUPPL-24",
  "activeIngredients": "NABUMETONE",
  "company": "INVAGEN PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "KETOROLAC TROMETHAMINEANDA  #078737",
  "submission": "SUPPL-20",
  "activeIngredients": "KETOROLAC TROMETHAMINE",
  "company": "SUN PHARM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "OXYCODONE HYDROCHLORIDE AND IBUPROFENANDA  #078769",
  "submission": "SUPPL-37",
  "activeIngredients": "IBUPROFEN; OXYCODONE HYDROCHLORIDE",
  "company": "ACTAVIS ELIZABETH",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "NABUMETONEANDA  #079093",
  "submission": "SUPPL-3",
  "activeIngredients": "NABUMETONE",
  "company": "OXFORD PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "INDOMETHACINANDA  #079175",
  "submission": "SUPPL-21",
  "activeIngredients": "INDOMETHACIN",
  "company": "AVANTHI INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "METHOCARBAMOL AND ASPIRINANDA  #081145",
  "submission": "SUPPL-2",
  "activeIngredients": "ASPIRIN; METHOCARBAMOL",
  "company": "STEVENS J",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "BUTALBITAL, ASPIRIN AND CAFFEINEANDA  #086162",
  "submission": "SUPPL-55",
  "activeIngredients": "ASPIRIN; BUTALBITAL; CAFFEINE",
  "company": "HIKMA INTL PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "BUTALBITAL, ASPIRIN AND CAFFEINEANDA  #086398",
  "submission": "SUPPL-51",
  "activeIngredients": "ASPIRIN; BUTALBITAL; CAFFEINE",
  "company": "FOSUN PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "LANORINALANDA  #086996",
  "submission": "SUPPL-45",
  "activeIngredients": "ASPIRIN; BUTALBITAL; CAFFEINE",
  "company": "SANDOZ",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "BUTALBITAL, ASPIRIN AND CAFFEINEANDA  #087048",
  "submission": "SUPPL-17",
  "activeIngredients": "ASPIRIN; BUTALBITAL; CAFFEINE",
  "company": "PURACAP PHARM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "OXYCODONE AND ASPIRINANDA  #087794",
  "submission": "SUPPL-33",
  "activeIngredients": "ASPIRIN; OXYCODONE HYDROCHLORIDE; OXYCODONE TEREPHTHALATE",
  "company": "SUN PHARM INDUSTRIES",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "CARISOPRODOL AND ASPIRINANDA  #089594",
  "submission": "SUPPL-13",
  "activeIngredients": "ASPIRIN; CARISOPRODOL",
  "company": "CHARTWELL RX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "DICLOFENAC SODIUMANDA  #090066",
  "submission": "SUPPL-17",
  "activeIngredients": "DICLOFENAC SODIUM",
  "company": "UNIQUE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "OXYCODONE AND ASPIRINANDA  #090084",
  "submission": "SUPPL-13",
  "activeIngredients": "ASPIRIN; OXYCODONE HYDROCHLORIDE",
  "company": "ACTAVIS LABS FL INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "INDOMETHACINANDA  #090403",
  "submission": "SUPPL-8",
  "activeIngredients": "INDOMETHACIN",
  "company": "ZYDUS LIFESCIENCES",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "NABUMETONEANDA  #090427",
  "submission": "SUPPL-3",
  "activeIngredients": "NABUMETONE",
  "company": "MPP PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "NABUMETONEANDA  #090445",
  "submission": "SUPPL-5",
  "activeIngredients": "NABUMETONE",
  "company": "ANNORA PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "DILTIAZEM HYDROCHLORIDEANDA  #090492",
  "submission": "SUPPL-8",
  "activeIngredients": "DILTIAZEM HYDROCHLORIDE",
  "company": "SUN PHARM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "DILTIAZEM HYDROCHLORIDEANDA  #090492",
  "submission": "SUPPL-19",
  "activeIngredients": "DILTIAZEM HYDROCHLORIDE",
  "company": "SUN PHARM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "NABUMETONEANDA  #090516",
  "submission": "SUPPL-5",
  "activeIngredients": "NABUMETONE",
  "company": "AUROBINDO PHARMA USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "IBUPROFENANDA  #090796",
  "submission": "SUPPL-6",
  "activeIngredients": "IBUPROFEN",
  "company": "MARKSANS PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "KETOROLAC TROMETHAMINEANDA  #091065",
  "submission": "SUPPL-6",
  "activeIngredients": "KETOROLAC TROMETHAMINE",
  "company": "SAGENT PHARMS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "KETOROLAC TROMETHAMINEANDA  #091065",
  "submission": "SUPPL-7",
  "activeIngredients": "KETOROLAC TROMETHAMINE",
  "company": "SAGENT PHARMS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "NABUMETONEANDA  #091083",
  "submission": "SUPPL-17",
  "activeIngredients": "NABUMETONE",
  "company": "WATSON LABS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "ETODOLACANDA  #091134",
  "submission": "SUPPL-10",
  "activeIngredients": "ETODOLAC",
  "company": "ZYDUS PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "EMTRICITABINEANDA  #091168",
  "submission": "SUPPL-10",
  "activeIngredients": "EMTRICITABINE",
  "company": "CIPLA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATEANDA  #091215",
  "submission": "SUPPL-6",
  "activeIngredients": "EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE",
  "company": "TEVA PHARMS USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "INDOMETHACINANDA  #091240",
  "submission": "SUPPL-13",
  "activeIngredients": "INDOMETHACIN",
  "company": "HETERO LABS LTD III",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "INDOMETHACINANDA  #091276",
  "submission": "SUPPL-10",
  "activeIngredients": "INDOMETHACIN",
  "company": "GLENMARK PHARMS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "OXALIPLATINANDA  #091358",
  "submission": "SUPPL-12",
  "activeIngredients": "OXALIPLATIN",
  "company": "MYLAN LABS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "INDOMETHACINANDA  #091401",
  "submission": "SUPPL-6",
  "activeIngredients": "INDOMETHACIN",
  "company": "SUN PHARM INDS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "INDOMETHACINANDA  #091549",
  "submission": "SUPPL-18",
  "activeIngredients": "INDOMETHACIN",
  "company": "AMNEAL PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "IBUPROFENANDA  #091625",
  "submission": "SUPPL-21",
  "activeIngredients": "IBUPROFEN",
  "company": "GRANULES",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND IBUPROFENANDA  #091633",
  "submission": "SUPPL-17",
  "activeIngredients": "HYDROCODONE BITARTRATE; IBUPROFEN",
  "company": "SUN PHARM INDS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "INDOMETHACINANDA  #200529",
  "submission": "SUPPL-5",
  "activeIngredients": "INDOMETHACIN",
  "company": "CHARTWELL RX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "DICLOFENAC SODIUM ANDA  #200936",
  "submission": "SUPPL-10",
  "activeIngredients": "DICLOFENAC SODIUM",
  "company": "AMNEAL",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "KETOROLAC TROMETHAMINEANDA  #201155",
  "submission": "SUPPL-5",
  "activeIngredients": "KETOROLAC TROMETHAMINE",
  "company": "ONESOURCE SPECIALTY",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "INDOMETHACINANDA  #201807",
  "submission": "SUPPL-8",
  "activeIngredients": "INDOMETHACIN",
  "company": "HETERO LABS LTD III",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "DICLOFENAC SODIUMANDA  #202027",
  "submission": "SUPPL-10",
  "activeIngredients": "DICLOFENAC SODIUM",
  "company": "APOTEX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "INDOMETHACINANDA  #202139",
  "submission": "SUPPL-6",
  "activeIngredients": "INDOMETHACIN",
  "company": "MYLAN",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "IBUPROFENANDA  #202413",
  "submission": "SUPPL-21",
  "activeIngredients": "IBUPROFEN",
  "company": "SHANDONG XINHUA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "INDOMETHACINANDA  #202572",
  "submission": "SUPPL-4",
  "activeIngredients": "INDOMETHACIN",
  "company": "WATSON LABS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "INDOMETHACINANDA  #202706",
  "submission": "SUPPL-13",
  "activeIngredients": "INDOMETHACIN",
  "company": "JUBILANT GENERICS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "INDOMETHACINANDA  #202711",
  "submission": "SUPPL-3",
  "activeIngredients": "INDOMETHACIN",
  "company": "ZYDUS PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "DICLOFENAC SODIUMANDA  #202769",
  "submission": "SUPPL-6",
  "activeIngredients": "DICLOFENAC SODIUM",
  "company": "PAI HOLDINGS PHARM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "DIFLUNISALANDA  #202845",
  "submission": "SUPPL-21",
  "activeIngredients": "DIFLUNISAL",
  "company": "HERITAGE PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "DICLOFENAC SODIUMANDA  #202852",
  "submission": "SUPPL-4",
  "activeIngredients": "DICLOFENAC SODIUM",
  "company": "WATSON LABS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "KETOROLAC TROMETHAMINEANDA  #203242",
  "submission": "SUPPL-12",
  "activeIngredients": "KETOROLAC TROMETHAMINE",
  "company": "FRESENIUS KABI USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "INDOMETHACINANDA  #203501",
  "submission": "SUPPL-6",
  "activeIngredients": "INDOMETHACIN",
  "company": "GLENMARK PHARMS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "DIFLUNISALANDA  #203547",
  "submission": "SUPPL-2",
  "activeIngredients": "DIFLUNISAL",
  "company": "ZYDUS PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "IBUPROFEN AND FAMOTIDINEANDA  #203658",
  "submission": "SUPPL-2",
  "activeIngredients": "FAMOTIDINE; IBUPROFEN",
  "company": "PH HEALTH",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "DICLOFENAC SODIUMANDA  #203818",
  "submission": "SUPPL-9",
  "activeIngredients": "DICLOFENAC SODIUM",
  "company": "TARO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "IBUPROFENANDA  #204062",
  "submission": "SUPPL-4",
  "activeIngredients": "IBUPROFEN",
  "company": "SUNSHINE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "DICLOFENAC SODIUMANDA  #204132",
  "submission": "SUPPL-10",
  "activeIngredients": "DICLOFENAC SODIUM",
  "company": "LUPIN LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "BUTALBITAL, ASPIRIN AND CAFFEINEANDA  #204195",
  "submission": "SUPPL-2",
  "activeIngredients": "ASPIRIN; BUTALBITAL; CAFFEINE",
  "company": "STRIDES PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "NAPROXEN AND ESOMEPRAZOLE MAGNESIUMANDA  #204206",
  "submission": "SUPPL-4",
  "activeIngredients": "ESOMEPRAZOLE MAGNESIUM; NAPROXEN",
  "company": "DR REDDYS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "NAPROXEN AND ESOMEPRAZOLE MAGNESIUMANDA  #204206",
  "submission": "SUPPL-5",
  "activeIngredients": "ESOMEPRAZOLE MAGNESIUM; NAPROXEN",
  "company": "DR REDDYS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "NAPROXEN AND ESOMEPRAZOLE MAGNESIUMANDA  #204206",
  "submission": "SUPPL-6",
  "activeIngredients": "ESOMEPRAZOLE MAGNESIUM; NAPROXEN",
  "company": "DR REDDYS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "NAPROXEN AND ESOMEPRAZOLE MAGNESIUMANDA  #204206",
  "submission": "SUPPL-7",
  "activeIngredients": "ESOMEPRAZOLE MAGNESIUM; NAPROXEN",
  "company": "DR REDDYS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "NAPROXEN AND ESOMEPRAZOLE MAGNESIUMANDA  #204206",
  "submission": "SUPPL-9",
  "activeIngredients": "ESOMEPRAZOLE MAGNESIUM; NAPROXEN",
  "company": "DR REDDYS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "KETOROLAC TROMETHAMINEANDA  #204216",
  "submission": "SUPPL-15",
  "activeIngredients": "KETOROLAC TROMETHAMINE",
  "company": "GLAND",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "NAPROXEN AND ESOMEPRAZOLE MAGNESIUMANDA  #204470",
  "submission": "SUPPL-4",
  "activeIngredients": "ESOMEPRAZOLE MAGNESIUM; NAPROXEN",
  "company": "ACTAVIS LABS FL INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND IBUPROFENANDA  #204575",
  "submission": "SUPPL-12",
  "activeIngredients": "HYDROCODONE BITARTRATE; IBUPROFEN",
  "company": "AUROLIFE PHARMA LLC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "ZORVOLEXNDA   #204592",
  "submission": "SUPPL-14",
  "activeIngredients": "DICLOFENAC",
  "company": "ZYLA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "PENNSAIDNDA   #204623",
  "submission": "SUPPL-13",
  "activeIngredients": "DICLOFENAC SODIUM",
  "company": "HORIZON",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "ETODOLACANDA  #204729",
  "submission": "SUPPL-1",
  "activeIngredients": "ETODOLAC",
  "company": "IPCA LABS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "INDOMETHACINANDA  #204853",
  "submission": "SUPPL-3",
  "activeIngredients": "INDOMETHACIN",
  "company": "NOVAST LABS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "NAPROXEN AND ESOMEPRAZOLE MAGNESIUMANDA  #204920",
  "submission": "SUPPL-6",
  "activeIngredients": "ESOMEPRAZOLE MAGNESIUM; NAPROXEN",
  "company": "PHARMOBEDIENT",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "YOSPRALANDA   #205103",
  "submission": "SUPPL-10",
  "activeIngredients": "ASPIRIN; OMEPRAZOLE",
  "company": "GENUS LIFESCIENCES",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "INDOMETHACINANDA  #205215",
  "submission": "SUPPL-8",
  "activeIngredients": "INDOMETHACIN",
  "company": "JUBILANT GENERICS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "ETODOLACANDA  #205448",
  "submission": "SUPPL-1",
  "activeIngredients": "ETODOLAC",
  "company": "IPCA LABS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "IBUPROFENANDA  #205647",
  "submission": "SUPPL-9",
  "activeIngredients": "IBUPROFEN",
  "company": "PAI HOLDINGS PHARM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "DICLOFENAC SODIUMANDA  #205878",
  "submission": "SUPPL-3",
  "activeIngredients": "DICLOFENAC SODIUM",
  "company": "NOVEL LABS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "DICLOFENAC SODIUMANDA  #206116",
  "submission": "SUPPL-11",
  "activeIngredients": "DICLOFENAC SODIUM",
  "company": "AMNEAL PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "DICLOFENAC SODIUMANDA  #206298",
  "submission": "SUPPL-9",
  "activeIngredients": "DICLOFENAC SODIUM",
  "company": "TARO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "DICLOFENAC SODIUMANDA  #206411",
  "submission": "SUPPL-3",
  "activeIngredients": "DICLOFENAC SODIUM",
  "company": "ZYDUS LIFESCIENCES",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "DICLOFENAC SODIUMANDA  #206493",
  "submission": "SUPPL-8",
  "activeIngredients": "DICLOFENAC SODIUM",
  "company": "ACTAVIS MID ATLANTIC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "DICLOFENAC SODIUMANDA  #206655",
  "submission": "SUPPL-1",
  "activeIngredients": "DICLOFENAC SODIUM",
  "company": "EPIC PHARMA LLC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "DICLOFENAC SODIUMANDA  #206715",
  "submission": "SUPPL-3",
  "activeIngredients": "DICLOFENAC SODIUM",
  "company": "RISING",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "LICARTNDA   #206976",
  "submission": "SUPPL-16",
  "activeIngredients": "DICLOFENAC EPOLAMINE",
  "company": "IBSA INST BIO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "VIVLODEXNDA   #207233",
  "submission": "SUPPL-5",
  "activeIngredients": "MELOXICAM",
  "company": "ICEUTICA OPERATIONS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "CHOLESTYRAMINEANDA  #207294",
  "submission": "ORIG-1",
  "activeIngredients": "CHOLESTYRAMINE",
  "company": "MACLEODS PHARMS LTD",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "DICLOFENAC SODIUMANDA  #207714",
  "submission": "SUPPL-3",
  "activeIngredients": "DICLOFENAC SODIUM",
  "company": "APOTEX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "DICLOFENAC SODIUMANDA  #208021",
  "submission": "SUPPL-4",
  "activeIngredients": "DICLOFENAC SODIUM",
  "company": "LUPIN PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "DICLOFENAC SODIUMANDA  #208098",
  "submission": "SUPPL-2",
  "activeIngredients": "DICLOFENAC SODIUM",
  "company": "TARO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "DICLOFENAC SODIUMANDA  #208198",
  "submission": "SUPPL-2",
  "activeIngredients": "DICLOFENAC SODIUM",
  "company": "AMNEAL",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "DICLOFENAC SODIUMANDA  #208301",
  "submission": "SUPPL-6",
  "activeIngredients": "DICLOFENAC SODIUM",
  "company": "GLENMARK PHARMS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "DICLOFENAC SODIUMANDA  #208786",
  "submission": "SUPPL-2",
  "activeIngredients": "DICLOFENAC SODIUM",
  "company": "RISING",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "PROGESTERONEANDA  #208801",
  "submission": "SUPPL-3",
  "activeIngredients": "PROGESTERONE",
  "company": "DR REDDYS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "ETODOLACANDA  #208834",
  "submission": "SUPPL-10",
  "activeIngredients": "ETODOLAC",
  "company": "AMNEAL PHARMS CO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "IBUPROFENANDA  #209178",
  "submission": "SUPPL-13",
  "activeIngredients": "IBUPROFEN",
  "company": "AUROBINDO PHARMA LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "IBUPROFENANDA  #209204",
  "submission": "SUPPL-12",
  "activeIngredients": "IBUPROFEN",
  "company": "SUN PHARMA CANADA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "COMBOGESICNDA   #209471",
  "submission": "SUPPL-1",
  "activeIngredients": "ACETAMINOPHEN; IBUPROFEN",
  "company": "AFT PHARMS US",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "MELOXICAMANDA  #209487",
  "submission": "SUPPL-3",
  "activeIngredients": "MELOXICAM",
  "company": "LUPIN LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "ETODOLACANDA  #209888",
  "submission": "SUPPL-5",
  "activeIngredients": "ETODOLAC",
  "company": "ADAPTIS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "KETOROLAC TROMETHAMINEANDA  #209900",
  "submission": "SUPPL-9",
  "activeIngredients": "KETOROLAC TROMETHAMINE",
  "company": "BAXTER HLTHCARE CORP",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "BUPROPION HYDROCHLORIDEANDA  #210497",
  "submission": "SUPPL-6",
  "activeIngredients": "BUPROPION HYDROCHLORIDE",
  "company": "ACCORD HLTHCARE",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "KETOROLAC TROMETHAMINEANDA  #210616",
  "submission": "SUPPL-2",
  "activeIngredients": "KETOROLAC TROMETHAMINE",
  "company": "CHARTWELL RX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "ETODOLACANDA  #210704",
  "submission": "SUPPL-2",
  "activeIngredients": "ETODOLAC",
  "company": "UNICHEM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "DICLOFENAC SODIUMANDA  #210893",
  "submission": "SUPPL-6",
  "activeIngredients": "DICLOFENAC SODIUM",
  "company": "PADAGIS ISRAEL",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "IBUPROFEN AND FAMOTIDINEANDA  #211278",
  "submission": "SUPPL-4",
  "activeIngredients": "FAMOTIDINE; IBUPROFEN",
  "company": "TEVA PHARMS USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "MELOXICAMANDA  #211398",
  "submission": "SUPPL-10",
  "activeIngredients": "MELOXICAM",
  "company": "NOVITIUM PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "KETOROLAC TROMETHAMINEANDA  #211445",
  "submission": "SUPPL-4",
  "activeIngredients": "KETOROLAC TROMETHAMINE",
  "company": "NEPHRON",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "IBUPROFEN AND FAMOTIDINEANDA  #211890",
  "submission": "SUPPL-6",
  "activeIngredients": "FAMOTIDINE; IBUPROFEN",
  "company": "ALKEM LABS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "ZYNRELEF KITNDA   #211988",
  "submission": "SUPPL-18",
  "activeIngredients": "BUPIVACAINE; MELOXICAM",
  "company": "HERON THERAPS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "ELYXYBNDA   #212157",
  "submission": "SUPPL-3",
  "activeIngredients": "CELECOXIB",
  "company": "SCILEX PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "ETODOLACANDA  #212263",
  "submission": "SUPPL-2",
  "activeIngredients": "ETODOLAC",
  "company": "UNICHEM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "DICLOFENAC SODIUMANDA  #212351",
  "submission": "SUPPL-5",
  "activeIngredients": "DICLOFENAC SODIUM",
  "company": "ALEMBIC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "METOPROLOL TARTRATEANDA  #212402",
  "submission": "SUPPL-2",
  "activeIngredients": "METOPROLOL TARTRATE",
  "company": "ZYDUS PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "DICLOFENAC SODIUMANDA  #212506",
  "submission": "SUPPL-3",
  "activeIngredients": "DICLOFENAC SODIUM",
  "company": "ALEMBIC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "KETOROLAC TROMETHAMINEANDA  #212939",
  "submission": "SUPPL-4",
  "activeIngredients": "KETOROLAC TROMETHAMINE",
  "company": "EUGIA PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "DICLOFENAC SODIUMANDA  #213040",
  "submission": "SUPPL-1",
  "activeIngredients": "DICLOFENAC SODIUM",
  "company": "AUROLIFE PHARMA LLC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "SEGLENTISNDA   #213426",
  "submission": "SUPPL-3",
  "activeIngredients": "CELECOXIB; TRAMADOL HYDROCHLORIDE",
  "company": "KOWA PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "IBUPROFENANDA  #213794",
  "submission": "SUPPL-5",
  "activeIngredients": "IBUPROFEN",
  "company": "AUROBINDO PHARMA LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "KETOROLAC TROMETHAMINEANDA  #214456",
  "submission": "SUPPL-5",
  "activeIngredients": "KETOROLAC TROMETHAMINE",
  "company": "ALEMBIC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "FENOPROFEN CALCIUMANDA  #214475",
  "submission": "SUPPL-2",
  "activeIngredients": "FENOPROFEN CALCIUM",
  "company": "RISING",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "IBUPROFENANDA  #214699",
  "submission": "SUPPL-1",
  "activeIngredients": "IBUPROFEN",
  "company": "ALKEM LABS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "IBUPROFENANDA  #215311",
  "submission": "SUPPL-5",
  "activeIngredients": "IBUPROFEN",
  "company": "STRIDES PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "IBUPROFENANDA  #215318",
  "submission": "SUPPL-4",
  "activeIngredients": "IBUPROFEN",
  "company": "YICHANG HUMANWELL",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "COMBOGESIC IVNDA   #215320",
  "submission": "SUPPL-1",
  "activeIngredients": "ACETAMINOPHEN; IBUPROFEN SODIUM",
  "company": "HIKMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "DICLOFENAC POTASSIUMANDA  #215585",
  "submission": "SUPPL-4",
  "activeIngredients": "DICLOFENAC POTASSIUM",
  "company": "NOVAST LABS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "SUMATRIPTAN SUCCINATEANDA  #215651",
  "submission": "ORIG-1",
  "activeIngredients": "SUMATRIPTAN SUCCINATE",
  "company": "ONESOURCE SPECIALTY",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "KETOROLAC TROMETHAMINEANDA  #215745",
  "submission": "SUPPL-1",
  "activeIngredients": "KETOROLAC TROMETHAMINE",
  "company": "LEADING",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "DICLOFENAC POTASSIUMANDA  #215750",
  "submission": "SUPPL-7",
  "activeIngredients": "DICLOFENAC POTASSIUM",
  "company": "UMEDICA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "DICLOFENAC POTASSIUMANDA  #215787",
  "submission": "SUPPL-3",
  "activeIngredients": "DICLOFENAC POTASSIUM",
  "company": "SENORES PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "KETOROLAC TROMETHAMINEANDA  #215788",
  "submission": "SUPPL-5",
  "activeIngredients": "KETOROLAC TROMETHAMINE",
  "company": "SENORES PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "IBUPROFEN AND FAMOTIDINEANDA  #215925",
  "submission": "SUPPL-1",
  "activeIngredients": "FAMOTIDINE; IBUPROFEN",
  "company": "TORRENT",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "INDOMETHACINANDA  #216184",
  "submission": "SUPPL-3",
  "activeIngredients": "INDOMETHACIN",
  "company": "ZYDUS LIFESCIENCES",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "DICLOFENAC SODIUMANDA  #216275",
  "submission": "SUPPL-2",
  "activeIngredients": "DICLOFENAC SODIUM",
  "company": "NOVAST LABS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "KETOROLAC TROMETHAMINEANDA  #216407",
  "submission": "SUPPL-1",
  "activeIngredients": "KETOROLAC TROMETHAMINE",
  "company": "ATNAHS PHARMA US",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "DICLOFENAC SODIUMANDA  #216548",
  "submission": "SUPPL-4",
  "activeIngredients": "DICLOFENAC SODIUM",
  "company": "RUBICON RESEARCH",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "KETOROLAC TROMETHAMINEANDA  #216651",
  "submission": "SUPPL-3",
  "activeIngredients": "KETOROLAC TROMETHAMINE",
  "company": "HETERO LABS LTD III",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "KETOROLAC TROMETHAMINEANDA  #216759",
  "submission": "SUPPL-4",
  "activeIngredients": "KETOROLAC TROMETHAMINE",
  "company": "BIONPHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "IBUPROFEN AND FAMOTIDINEANDA  #216814",
  "submission": "SUPPL-2",
  "activeIngredients": "FAMOTIDINE; IBUPROFEN",
  "company": "ASCENT PHARMS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "KETOROLAC TROMETHAMINEANDA  #217038",
  "submission": "SUPPL-1",
  "activeIngredients": "KETOROLAC TROMETHAMINE",
  "company": "ZYDUS LIFESCIENCES",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "KETOROLAC TROMETHAMINEANDA  #217166",
  "submission": "SUPPL-1",
  "activeIngredients": "KETOROLAC TROMETHAMINE",
  "company": "ASPIRO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "METHYLENE BLUEANDA  #217561",
  "submission": "ORIG-1",
  "activeIngredients": "METHYLENE BLUE",
  "company": "NEXUS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "MELOXICAMANDA  #217579",
  "submission": "SUPPL-1",
  "activeIngredients": "MELOXICAM",
  "company": "ASCENT PHARMS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "DAPTOMYCINNDA   #217630",
  "submission": "ORIG-1",
  "activeIngredients": "DAPTOMYCIN",
  "company": "MAIA PHARMS INC",
  "submissionClassification": "Type 5 - New Formulation or New Manufacturer",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "OXCARBAZEPINEANDA  #217659",
  "submission": "SUPPL-1",
  "activeIngredients": "OXCARBAZEPINE",
  "company": "AJANTA PHARMA LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "NAPROXEN AND ESOMEPRAZOLE MAGNESIUMANDA  #217738",
  "submission": "SUPPL-1",
  "activeIngredients": "ESOMEPRAZOLE MAGNESIUM; NAPROXEN",
  "company": "SCIEGEN PHARMS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "KETOROLAC TROMETHAMINEANDA  #217789",
  "submission": "SUPPL-5",
  "activeIngredients": "KETOROLAC TROMETHAMINE",
  "company": "CAPLIN",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "COXANTONDA   #217927",
  "submission": "SUPPL-2",
  "activeIngredients": "OXAPROZIN",
  "company": "SOLUBIOMIX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/21\/2024",
  "drugName": "LORATADINEANDA  #219223",
  "submission": "ORIG-1",
  "activeIngredients": "LORATADINE",
  "company": "ADAPTIS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/22\/2024",
  "drugName": "ZANAFLEXNDA   #020397",
  "submission": "SUPPL-29",
  "activeIngredients": "TIZANIDINE HYDROCHLORIDE",
  "company": "LEGACY PHARMA USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/22\/2024",
  "drugName": "ZANAFLEXNDA   #021447",
  "submission": "SUPPL-17",
  "activeIngredients": "TIZANIDINE HYDROCHLORIDE",
  "company": "LEGACY PHARMA USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/22\/2024",
  "drugName": "KETOPROFENANDA  #074014",
  "submission": "SUPPL-13",
  "activeIngredients": "KETOPROFEN",
  "company": "MISEMER",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/22\/2024",
  "drugName": "GALANTAMINE HYDROBROMIDEANDA  #077585",
  "submission": "SUPPL-6",
  "activeIngredients": "GALANTAMINE HYDROBROMIDE",
  "company": "HERITAGE PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/22\/2024",
  "drugName": "REVONTOANDA  #078378",
  "submission": "SUPPL-21",
  "activeIngredients": "DANTROLENE SODIUM",
  "company": "USWM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/22\/2024",
  "drugName": "EFAVIRENZANDA  #078886",
  "submission": "SUPPL-30",
  "activeIngredients": "EFAVIRENZ",
  "company": "HETERO LABS LTD III",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/22\/2024",
  "drugName": "ISONIAZIDANDA  #081118",
  "submission": "SUPPL-3",
  "activeIngredients": "ISONIAZID",
  "company": "CHARTWELL RX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/22\/2024",
  "drugName": "LEVETIRACETAMANDA  #090893",
  "submission": "SUPPL-23",
  "activeIngredients": "LEVETIRACETAM",
  "company": "LUPIN LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/22\/2024",
  "drugName": "LEVETIRACETAMANDA  #091668",
  "submission": "SUPPL-3",
  "activeIngredients": "LEVETIRACETAM",
  "company": "SANDOZ",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/22\/2024",
  "drugName": "ATAZANAVIR SULFATEANDA  #200626",
  "submission": "SUPPL-5",
  "activeIngredients": "ATAZANAVIR SULFATE",
  "company": "CIPLA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/22\/2024",
  "drugName": "DOXERCALCIFEROLANDA  #201518",
  "submission": "SUPPL-1",
  "activeIngredients": "DOXERCALCIFEROL",
  "company": "RISING",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/22\/2024",
  "drugName": "NABUMETONEANDA  #203166",
  "submission": "SUPPL-5",
  "activeIngredients": "NABUMETONE",
  "company": "LGM PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/22\/2024",
  "drugName": "VRAYLARNDA   #204370",
  "submission": "SUPPL-12",
  "activeIngredients": "CARIPRAZINE HYDROCHLORIDE",
  "company": "ABBVIE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/22\/2024",
  "drugName": "OMEPRAZOLE AND SODIUM BICARBONATEANDA  #204923",
  "submission": "SUPPL-1",
  "activeIngredients": "OMEPRAZOLE; SODIUM BICARBONATE",
  "company": "AUROBINDO PHARMA",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/22\/2024",
  "drugName": "ETODOLACANDA  #205448",
  "submission": "SUPPL-2",
  "activeIngredients": "ETODOLAC",
  "company": "IPCA LABS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/22\/2024",
  "drugName": "HYDROCODONE BITARTRATE AND ASPIRINANDA  #205479",
  "submission": "SUPPL-5",
  "activeIngredients": "ASPIRIN; HYDROCODONE BITARTRATE",
  "company": "LGM PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/22\/2024",
  "drugName": "INGREZZANDA   #209241",
  "submission": "SUPPL-28",
  "activeIngredients": "VALBENAZINE TOSYLATE",
  "company": "NEUROCRINE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/22\/2024",
  "drugName": "CINACALCET HYDROCHLORIDEANDA  #210207",
  "submission": "SUPPL-4",
  "activeIngredients": "CINACALCET HYDROCHLORIDE",
  "company": "PIRAMAL",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/22\/2024",
  "drugName": "TEGSEDINDA   #211172",
  "submission": "SUPPL-15",
  "activeIngredients": "INOTERSEN SODIUM",
  "company": "AKCEA THERAPS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/22\/2024",
  "drugName": "PRETOMANIDNDA   #212862",
  "submission": "SUPPL-8",
  "activeIngredients": "PRETOMANID",
  "company": "MYLAN IRELAND LTD",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/22\/2024",
  "drugName": "NAPROXEN AND ESOMEPRAZOLE MAGNESIUMANDA  #213699",
  "submission": "SUPPL-6",
  "activeIngredients": "ESOMEPRAZOLE MAGNESIUM; NAPROXEN",
  "company": "AJANTA PHARMA LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/22\/2024",
  "drugName": "OXCARBAZEPINEANDA  #215796",
  "submission": "ORIG-1",
  "activeIngredients": "OXCARBAZEPINE",
  "company": "RICONPHARMA LLC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/22\/2024",
  "drugName": "ATTRUBYNDA   #216540",
  "submission": "ORIG-1",
  "activeIngredients": "ACORAMIDIS HYDROCHLORIDE",
  "company": "BRIDGEBIO PHARMA",
  "submissionClassification": "Type 1 - New Molecular Entity",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/22\/2024",
  "drugName": "METHYLENE BLUEANDA  #216955",
  "submission": "ORIG-1",
  "activeIngredients": "METHYLENE BLUE",
  "company": "STERISCIENCE",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/22\/2024",
  "drugName": "RAPIBLYKNDA   #217202",
  "submission": "ORIG-1",
  "activeIngredients": "LANDIOLOL HYDROCHLORIDE",
  "company": "AOP HLTH US",
  "submissionClassification": "Type 1 - New Molecular Entity",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/22\/2024",
  "drugName": "MOMETASONE FUROATEANDA  #217498",
  "submission": "ORIG-1",
  "activeIngredients": "MOMETASONE FUROATE",
  "company": "AUROBINDO PHARMA",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/22\/2024",
  "drugName": "DAROLUTAMIDEANDA  #218787",
  "submission": "ORIG-1",
  "activeIngredients": "DAROLUTAMIDE",
  "company": "HETERO LABS LTD III",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "11\/22\/2024",
  "drugName": "IMKELDINDA   #219097",
  "submission": "ORIG-1",
  "activeIngredients": "IMATINIB MESYLATE",
  "company": "SHORLA ONCOLOGY",
  "submissionClassification": "Type 3 - New Dosage Form",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/22\/2024",
  "drugName": "TRODELVYBLA   #761115",
  "submission": "SUPPL-58",
  "activeIngredients": "SACITUZUMAB GOVITECAN-HZIY",
  "company": "IMMUNOMEDICS INC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/22\/2024",
  "drugName": "PHESGOBLA   #761170",
  "submission": "SUPPL-7",
  "activeIngredients": "PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF",
  "company": "GENENTECH INC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/22\/2024",
  "drugName": "LUNSUMIOBLA   #761263",
  "submission": "SUPPL-5",
  "activeIngredients": "MOSUNETUZUMAB-AXGB",
  "company": "GENENTECH INC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/22\/2024",
  "drugName": "TECVAYLIBLA   #761291",
  "submission": "SUPPL-9",
  "activeIngredients": "TECLISTAMAB-CQYV",
  "company": "JANSSEN BIOTECH",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/25\/2024",
  "drugName": "ELLENCENDA   #050778",
  "submission": "SUPPL-29",
  "activeIngredients": "EPIRUBICIN HYDROCHLORIDE",
  "company": "PFIZER INC",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/25\/2024",
  "drugName": "CITALOPRAM HYDROBROMIDEANDA  #077035",
  "submission": "SUPPL-12",
  "activeIngredients": "CITALOPRAM HYDROBROMIDE",
  "company": "FOSUN PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/25\/2024",
  "drugName": "CITALOPRAM HYDROBROMIDEANDA  #077035",
  "submission": "SUPPL-13",
  "activeIngredients": "CITALOPRAM HYDROBROMIDE",
  "company": "FOSUN PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/25\/2024",
  "drugName": "CITALOPRAM HYDROBROMIDEANDA  #077037",
  "submission": "SUPPL-9",
  "activeIngredients": "CITALOPRAM HYDROBROMIDE",
  "company": "PHARMOBEDIENT",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/25\/2024",
  "drugName": "ROSUVASTATIN CALCIUMANDA  #207408",
  "submission": "SUPPL-26",
  "activeIngredients": "ROSUVASTATIN CALCIUM",
  "company": "CHANGZHOU PHARM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/25\/2024",
  "drugName": "APREMILASTANDA  #211788",
  "submission": "ORIG-1",
  "activeIngredients": "APREMILAST",
  "company": "MACLEODS PHARMS LTD",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/25\/2024",
  "drugName": "SUNLENCANDA   #215973",
  "submission": "SUPPL-6",
  "activeIngredients": "LENACAPAVIR SODIUM",
  "company": "GILEAD SCIENCES INC",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/25\/2024",
  "drugName": "SUNLENCANDA   #215974",
  "submission": "SUPPL-8",
  "activeIngredients": "LENACAPAVIR SODIUM",
  "company": "GILEAD SCIENCES INC",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/25\/2024",
  "drugName": "HYDROCORTISONEANDA  #217160",
  "submission": "ORIG-1",
  "activeIngredients": "HYDROCORTISONE",
  "company": "HIBROW HLTHCARE",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/25\/2024",
  "drugName": "SEMGLEEBLA   #761201",
  "submission": "SUPPL-10",
  "activeIngredients": "INSULIN GLARGINE-YFGN",
  "company": "MYLAN PHARMS INC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/26\/2024",
  "drugName": "ZYRTEC ALLERGYNDA   #019835",
  "submission": "SUPPL-50",
  "activeIngredients": "CETIRIZINE HYDROCHLORIDE",
  "company": "KENVUE BRANDS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/26\/2024",
  "drugName": "ZYRTEC HIVESNDA   #019835",
  "submission": "SUPPL-50",
  "activeIngredients": "CETIRIZINE HYDROCHLORIDE",
  "company": "KENVUE BRANDS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/26\/2024",
  "drugName": "PAXILNDA   #020031",
  "submission": "SUPPL-83",
  "activeIngredients": "PAROXETINE HYDROCHLORIDE",
  "company": "APOTEX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/26\/2024",
  "drugName": "PAXILNDA   #020710",
  "submission": "SUPPL-51",
  "activeIngredients": "PAROXETINE HYDROCHLORIDE",
  "company": "APOTEX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/26\/2024",
  "drugName": "ACETADOTENDA   #021539",
  "submission": "SUPPL-19",
  "activeIngredients": "ACETYLCYSTEINE",
  "company": "CUMBERLAND PHARMS",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/26\/2024",
  "drugName": "CHILDREN'S ZYRTEC ALLERGYNDA   #022155",
  "submission": "SUPPL-27",
  "activeIngredients": "CETIRIZINE HYDROCHLORIDE",
  "company": "KENVUE BRANDS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/26\/2024",
  "drugName": "CHILDREN'S ZYRTEC HIVESNDA   #022155",
  "submission": "SUPPL-27",
  "activeIngredients": "CETIRIZINE HYDROCHLORIDE",
  "company": "KENVUE BRANDS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/26\/2024",
  "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #065317",
  "submission": "SUPPL-6",
  "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
  "company": "APOTEX INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/26\/2024",
  "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #065333",
  "submission": "SUPPL-6",
  "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
  "company": "APOTEX INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/26\/2024",
  "drugName": "CITALOPRAM HYDROBROMIDEANDA  #077032",
  "submission": "SUPPL-25",
  "activeIngredients": "CITALOPRAM HYDROBROMIDE",
  "company": "SUN PHARM INDS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/26\/2024",
  "drugName": "CITALOPRAM HYDROBROMIDEANDA  #077032",
  "submission": "SUPPL-26",
  "activeIngredients": "CITALOPRAM HYDROBROMIDE",
  "company": "SUN PHARM INDS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/26\/2024",
  "drugName": "CITALOPRAM HYDROBROMIDEANDA  #077032",
  "submission": "SUPPL-28",
  "activeIngredients": "CITALOPRAM HYDROBROMIDE",
  "company": "SUN PHARM INDS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/26\/2024",
  "drugName": "CITALOPRAM HYDROBROMIDEANDA  #077044",
  "submission": "SUPPL-7",
  "activeIngredients": "CITALOPRAM HYDROBROMIDE",
  "company": "CHARTWELL MOLECULAR",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/26\/2024",
  "drugName": "CITALOPRAM HYDROBROMIDEANDA  #077044",
  "submission": "SUPPL-8",
  "activeIngredients": "CITALOPRAM HYDROBROMIDE",
  "company": "CHARTWELL MOLECULAR",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/26\/2024",
  "drugName": "CITALOPRAM HYDROBROMIDEANDA  #077668",
  "submission": "SUPPL-7",
  "activeIngredients": "CITALOPRAM HYDROBROMIDE",
  "company": "PHARMOBEDIENT",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/26\/2024",
  "drugName": "MELOXICAMANDA  #078039",
  "submission": "SUPPL-4",
  "activeIngredients": "MELOXICAM",
  "company": "CR DOUBLE CRANE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/26\/2024",
  "drugName": "BUPROPION HYDROCHLORIDEANDA  #078866",
  "submission": "SUPPL-30",
  "activeIngredients": "BUPROPION HYDROCHLORIDE",
  "company": "SUN PHARM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/26\/2024",
  "drugName": "BUPROPION HYDROCHLORIDEANDA  #078866",
  "submission": "SUPPL-33",
  "activeIngredients": "BUPROPION HYDROCHLORIDE",
  "company": "SUN PHARM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/26\/2024",
  "drugName": "ROSUVASTATIN CALCIUMANDA  #079167",
  "submission": "SUPPL-6",
  "activeIngredients": "ROSUVASTATIN CALCIUM",
  "company": "WATSON LABS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/26\/2024",
  "drugName": "ROSUVASTATIN CALCIUMANDA  #079167",
  "submission": "SUPPL-7",
  "activeIngredients": "ROSUVASTATIN CALCIUM",
  "company": "WATSON LABS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/26\/2024",
  "drugName": "ROSUVASTATIN CALCIUMANDA  #079167",
  "submission": "SUPPL-8",
  "activeIngredients": "ROSUVASTATIN CALCIUM",
  "company": "WATSON LABS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/26\/2024",
  "drugName": "ROSUVASTATIN CALCIUMANDA  #079167",
  "submission": "SUPPL-9",
  "activeIngredients": "ROSUVASTATIN CALCIUM",
  "company": "WATSON LABS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/26\/2024",
  "drugName": "HYDROCORTISONEANDA  #083365",
  "submission": "SUPPL-47",
  "activeIngredients": "HYDROCORTISONE",
  "company": "HIKMA INTL PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/26\/2024",
  "drugName": "HYDROCORTISONEANDA  #083365",
  "submission": "SUPPL-48",
  "activeIngredients": "HYDROCORTISONE",
  "company": "HIKMA INTL PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/26\/2024",
  "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #091568",
  "submission": "SUPPL-25",
  "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
  "company": "AUROBINDO PHARMA LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/26\/2024",
  "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #091569",
  "submission": "SUPPL-23",
  "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
  "company": "AUROBINDO PHARMA LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/26\/2024",
  "drugName": "OLANZAPINEANDA  #202295",
  "submission": "SUPPL-1",
  "activeIngredients": "OLANZAPINE",
  "company": "ALKEM LABS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/26\/2024",
  "drugName": "LANSOPRAZOLEANDA  #202727",
  "submission": "SUPPL-4",
  "activeIngredients": "LANSOPRAZOLE",
  "company": "GLENMARK PHARMS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/26\/2024",
  "drugName": "LANSOPRAZOLEANDA  #202727",
  "submission": "SUPPL-5",
  "activeIngredients": "LANSOPRAZOLE",
  "company": "GLENMARK PHARMS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/26\/2024",
  "drugName": "ACETAZOLAMIDEANDA  #205301",
  "submission": "SUPPL-5",
  "activeIngredients": "ACETAZOLAMIDE",
  "company": "CADILA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/26\/2024",
  "drugName": "ACETAZOLAMIDEANDA  #207401",
  "submission": "SUPPL-2",
  "activeIngredients": "ACETAZOLAMIDE",
  "company": "MICRO LABS LTD INDIA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/26\/2024",
  "drugName": "AUSTEDONDA   #208082",
  "submission": "SUPPL-16",
  "activeIngredients": "DEUTETRABENAZINE",
  "company": "TEVA BRANDED PHARM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/26\/2024",
  "drugName": "AUSTEDONDA   #208082",
  "submission": "SUPPL-17",
  "activeIngredients": "DEUTETRABENAZINE",
  "company": "TEVA BRANDED PHARM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/26\/2024",
  "drugName": "LUTATHERANDA   #208700",
  "submission": "SUPPL-32",
  "activeIngredients": "LUTETIUM LU 177 DOTATATE",
  "company": "AAA USA INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/26\/2024",
  "drugName": "TOPIRAMATEANDA  #210278",
  "submission": "SUPPL-6",
  "activeIngredients": "TOPIRAMATE",
  "company": "GLENMARK PHARMS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/26\/2024",
  "drugName": "QUETIAPINE FUMARATEANDA  #211144",
  "submission": "ORIG-1",
  "activeIngredients": "QUETIAPINE FUMARATE",
  "company": "RISING",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/26\/2024",
  "drugName": "FLUOXETINE HYDROCHLORIDEANDA  #211721",
  "submission": "SUPPL-2",
  "activeIngredients": "FLUOXETINE HYDROCHLORIDE",
  "company": "DR REDDYS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/26\/2024",
  "drugName": "FLUOXETINE HYDROCHLORIDEANDA  #211721",
  "submission": "SUPPL-4",
  "activeIngredients": "FLUOXETINE HYDROCHLORIDE",
  "company": "DR REDDYS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/26\/2024",
  "drugName": "PIRFENIDONEANDA  #212759",
  "submission": "SUPPL-2",
  "activeIngredients": "PIRFENIDONE",
  "company": "TEVA PHARMS USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/26\/2024",
  "drugName": "LEVETIRACETAMANDA  #215069",
  "submission": "SUPPL-5",
  "activeIngredients": "LEVETIRACETAM",
  "company": "SCIEGEN PHARMS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/26\/2024",
  "drugName": "LEVETIRACETAMANDA  #215069",
  "submission": "SUPPL-6",
  "activeIngredients": "LEVETIRACETAM",
  "company": "SCIEGEN PHARMS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/26\/2024",
  "drugName": "IWILFINNDA   #215500",
  "submission": "SUPPL-1",
  "activeIngredients": "EFLORNITHINE HYDROCHLORIDE",
  "company": "USWM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/26\/2024",
  "drugName": "SORAFENIB TOSYLATEANDA  #216073",
  "submission": "SUPPL-1",
  "activeIngredients": "SORAFENIB TOSYLATE",
  "company": "DR REDDYS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/26\/2024",
  "drugName": "MINOXIDIL (FOR WOMEN)ANDA  #218175",
  "submission": "ORIG-1",
  "activeIngredients": "MINOXIDIL",
  "company": "TARO",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/26\/2024",
  "drugName": "LATANOPROSTANDA  #218257",
  "submission": "ORIG-1",
  "activeIngredients": "LATANOPROST",
  "company": "GLAND",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/26\/2024",
  "drugName": "RALDESYNDA   #218637",
  "submission": "ORIG-1",
  "activeIngredients": "TRAZODONE HYDROCHLORIDE",
  "company": "KAMAT",
  "submissionClassification": "Type 3 - New Dosage Form",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/26\/2024",
  "drugName": "BAVENCIOBLA   #761049",
  "submission": "SUPPL-20",
  "activeIngredients": "AVELUMAB",
  "company": "EMD SERONO INC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/27\/2024",
  "drugName": "FLUCONAZOLEANDA  #076246",
  "submission": "SUPPL-21",
  "activeIngredients": "FLUCONAZOLE",
  "company": "HIKMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/27\/2024",
  "drugName": "MOMETASONE FUROATEANDA  #091161",
  "submission": "SUPPL-1",
  "activeIngredients": "MOMETASONE FUROATE",
  "company": "APOTEX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/27\/2024",
  "drugName": "MOMETASONE FUROATEANDA  #091161",
  "submission": "SUPPL-2",
  "activeIngredients": "MOMETASONE FUROATE",
  "company": "APOTEX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/27\/2024",
  "drugName": "MOMETASONE FUROATEANDA  #091161",
  "submission": "SUPPL-5",
  "activeIngredients": "MOMETASONE FUROATE",
  "company": "APOTEX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/27\/2024",
  "drugName": "MOMETASONE FUROATEANDA  #091161",
  "submission": "SUPPL-6",
  "activeIngredients": "MOMETASONE FUROATE",
  "company": "APOTEX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/27\/2024",
  "drugName": "TIZANIDINE HYDROCHLORIDEANDA  #091283",
  "submission": "SUPPL-16",
  "activeIngredients": "TIZANIDINE HYDROCHLORIDE",
  "company": "UNICHEM LABS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/27\/2024",
  "drugName": "ROSUVASTATIN CALCIUMANDA  #201619",
  "submission": "SUPPL-13",
  "activeIngredients": "ROSUVASTATIN CALCIUM",
  "company": "TORRENT",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/27\/2024",
  "drugName": "COSYNTROPINANDA  #202147",
  "submission": "SUPPL-17",
  "activeIngredients": "COSYNTROPIN",
  "company": "SANDOZ",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/27\/2024",
  "drugName": "COSYNTROPINANDA  #202147",
  "submission": "SUPPL-18",
  "activeIngredients": "COSYNTROPIN",
  "company": "SANDOZ",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/27\/2024",
  "drugName": "CAPREOMYCIN SULFATEANDA  #202634",
  "submission": "SUPPL-3",
  "activeIngredients": "CAPREOMYCIN SULFATE",
  "company": "PHARMOBEDIENT",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/27\/2024",
  "drugName": "PANTOPRAZOLE SODIUMANDA  #205119",
  "submission": "SUPPL-13",
  "activeIngredients": "PANTOPRAZOLE SODIUM",
  "company": "AMNEAL PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/27\/2024",
  "drugName": "PANTOPRAZOLE SODIUMANDA  #205119",
  "submission": "SUPPL-15",
  "activeIngredients": "PANTOPRAZOLE SODIUM",
  "company": "AMNEAL PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/27\/2024",
  "drugName": "PANTOPRAZOLE SODIUMANDA  #205119",
  "submission": "SUPPL-16",
  "activeIngredients": "PANTOPRAZOLE SODIUM",
  "company": "AMNEAL PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/27\/2024",
  "drugName": "PANTOPRAZOLE SODIUMANDA  #205119",
  "submission": "SUPPL-19",
  "activeIngredients": "PANTOPRAZOLE SODIUM",
  "company": "AMNEAL PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/27\/2024",
  "drugName": "SIMVASTATINANDA  #211394",
  "submission": "ORIG-1",
  "activeIngredients": "SIMVASTATIN",
  "company": "YILING",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/27\/2024",
  "drugName": "SITAGLIPTIN; METFORMIN HYDROCHLORIDEANDA  #212546",
  "submission": "ORIG-1",
  "activeIngredients": "SITAGLIPTIN;METFORMIN HYDROCHLORIDE",
  "company": "LUPIN LTD",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "11\/27\/2024",
  "drugName": "WEGOVYNDA   #215256",
  "submission": "SUPPL-15",
  "activeIngredients": "SEMAGLUTIDE",
  "company": "NOVO",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/27\/2024",
  "drugName": "PONATINIB HYDROCHLORIDEANDA  #215893",
  "submission": "SUPPL-3",
  "activeIngredients": "PONATINIB HYDROCHLORIDE",
  "company": "APOTEX",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "11\/27\/2024",
  "drugName": "IOMERVUNDA   #216016",
  "submission": "ORIG-1",
  "activeIngredients": "IOMEPROL",
  "company": "BRACCO",
  "submissionClassification": "Type 1 - New Molecular Entity",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/27\/2024",
  "drugName": "IOMERVUNDA   #216017",
  "submission": "ORIG-1",
  "activeIngredients": "IOMEPROL",
  "company": "BRACCO",
  "submissionClassification": "Type 1 - New Molecular Entity",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/27\/2024",
  "drugName": "POTASSIUM ACETATEANDA  #217515",
  "submission": "ORIG-1",
  "activeIngredients": "POTASSIUM ACETATE",
  "company": "FRESENIUS KABI USA",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/27\/2024",
  "drugName": "CALCIUM CHLORIDE 10%ANDA  #219342",
  "submission": "ORIG-1",
  "activeIngredients": "CALCIUM CHLORIDE",
  "company": "EXTROVIS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/29\/2024",
  "drugName": "DAYTRANANDA   #021514",
  "submission": "SUPPL-39",
  "activeIngredients": "METHYLPHENIDATE",
  "company": "NOVEN PHARMS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/29\/2024",
  "drugName": "METHOTREXATE SODIUMANDA  #040263",
  "submission": "SUPPL-23",
  "activeIngredients": "METHOTREXATE SODIUM",
  "company": "FRESENIUS KABI USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/29\/2024",
  "drugName": "NITROGLYCERINANDA  #212222",
  "submission": "ORIG-1",
  "activeIngredients": "NITROGLYCERIN",
  "company": "TP ANDA HOLDINGS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/29\/2024",
  "drugName": "ATROPINE SULFATEANDA  #215005",
  "submission": "ORIG-1",
  "activeIngredients": "ATROPINE SULFATE",
  "company": "SOMERSET THERAPS LLC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/29\/2024",
  "drugName": "XELSTRYMNDA   #215401",
  "submission": "SUPPL-11",
  "activeIngredients": "DEXTROAMPHETAMINE",
  "company": "NOVEN PHARMS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/29\/2024",
  "drugName": "LEVOTHYROXINE SODIUMANDA  #217495",
  "submission": "ORIG-1",
  "activeIngredients": "LEVOTHYROXINE SODIUM",
  "company": "XIROMED",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "11\/29\/2024",
  "drugName": "YESINTEKBLA   #761406",
  "submission": "ORIG-1",
  "activeIngredients": "USTEKINUMAB-KFCE",
  "company": "BIOCON BIOLOGICS INC",
  "submissionStatus": "Approval"
 }
,
 {
  "approvalDate": "12\/02\/2024",
  "drugName": "IFEXNDA   #019763",
  "submission": "SUPPL-21",
  "activeIngredients": "IFOSFAMIDE",
  "company": "BAXTER HLTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/02\/2024",
  "drugName": "IFEX\/MESNEX KITNDA   #019763",
  "submission": "SUPPL-21",
  "activeIngredients": "IFOSFAMIDE; MESNA",
  "company": "BAXTER HLTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/02\/2024",
  "drugName": "GABAPENTINANDA  #077242",
  "submission": "SUPPL-28",
  "activeIngredients": "GABAPENTIN",
  "company": "SUN PHARM INDS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/02\/2024",
  "drugName": "GABAPENTINANDA  #077242",
  "submission": "SUPPL-30",
  "activeIngredients": "GABAPENTIN",
  "company": "SUN PHARM INDS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/02\/2024",
  "drugName": "GABAPENTINANDA  #077242",
  "submission": "SUPPL-31",
  "activeIngredients": "GABAPENTIN",
  "company": "SUN PHARM INDS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/02\/2024",
  "drugName": "GABAPENTINANDA  #077525",
  "submission": "SUPPL-35",
  "activeIngredients": "GABAPENTIN",
  "company": "SUN PHARM INDS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/02\/2024",
  "drugName": "GABAPENTINANDA  #077525",
  "submission": "SUPPL-39",
  "activeIngredients": "GABAPENTIN",
  "company": "SUN PHARM INDS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/02\/2024",
  "drugName": "EFAVIRENZANDA  #078509",
  "submission": "SUPPL-25",
  "activeIngredients": "EFAVIRENZ",
  "company": "STRIDES PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/02\/2024",
  "drugName": "PROVAYBLUENDA   #204630",
  "submission": "SUPPL-26",
  "activeIngredients": "METHYLENE BLUE",
  "company": "PROVEPHARM SAS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/02\/2024",
  "drugName": "AXTLENDA   #210661",
  "submission": "SUPPL-1",
  "activeIngredients": "PEMETREXED DIPOTASSIUM",
  "company": "AVYXA HOLDINGS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/02\/2024",
  "drugName": "CLOBETASOL PROPIONATEANDA  #214345",
  "submission": "ORIG-1",
  "activeIngredients": "CLOBETASOL PROPIONATE",
  "company": "MACLEODS PHARMS LTD",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/02\/2024",
  "drugName": "TECVAYLIBLA   #761291",
  "submission": "SUPPL-11",
  "activeIngredients": "TECLISTAMAB-CQYV",
  "company": "JANSSEN BIOTECH",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/02\/2024",
  "drugName": "TALVEYBLA   #761342",
  "submission": "SUPPL-12",
  "activeIngredients": "TALQUETAMAB-TGVS",
  "company": "JANSSEN BIOTECH",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/03\/2024",
  "drugName": "VOSOL HCNDA   #012770",
  "submission": "SUPPL-33",
  "activeIngredients": "ACETIC ACID, GLACIAL; HYDROCORTISONE",
  "company": "SAPTALIS PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/03\/2024",
  "drugName": "ZOSYNNDA   #050684",
  "submission": "SUPPL-105",
  "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
  "company": "WYETH PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/03\/2024",
  "drugName": "MERREM IVNDA   #050706",
  "submission": "SUPPL-44",
  "activeIngredients": "MEROPENEM",
  "company": "PFIZER",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/03\/2024",
  "drugName": "ZOSYN IN PLASTIC CONTAINERNDA   #050750",
  "submission": "SUPPL-53",
  "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
  "company": "BAXTER HLTHCARE CORP",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/03\/2024",
  "drugName": "PIPERACILLIN AND TAZOBACTAMANDA  #065362",
  "submission": "SUPPL-45",
  "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
  "company": "SANDOZ",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/03\/2024",
  "drugName": "PIPERACILLIN AND TAZOBACTAMANDA  #065363",
  "submission": "SUPPL-48",
  "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
  "company": "SANDOZ",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/03\/2024",
  "drugName": "PIPERACILLIN AND TAZOBACTAMANDA  #065458",
  "submission": "SUPPL-20",
  "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
  "company": "ONESOURCE SPECIALTY",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/03\/2024",
  "drugName": "PIPERACILLIN AND TAZOBACTAMANDA  #065498",
  "submission": "SUPPL-31",
  "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
  "company": "EUGIA PHARMA SPECLTS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/03\/2024",
  "drugName": "MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINERNDA   #202106",
  "submission": "SUPPL-9",
  "activeIngredients": "MEROPENEM",
  "company": "B BRAUN MEDICAL",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/03\/2024",
  "drugName": "BOSULIFNDA   #203341",
  "submission": "SUPPL-26",
  "activeIngredients": "BOSUTINIB MONOHYDRATE",
  "company": "PF PRISM CV",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/03\/2024",
  "drugName": "PIPERACILLIN AND TAZOBACTAMANDA  #203557",
  "submission": "SUPPL-36",
  "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
  "company": "SANDOZ",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/03\/2024",
  "drugName": "PIPERACILLIN AND TAZOBACTAMANDA  #203719",
  "submission": "SUPPL-14",
  "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
  "company": "FRESENIUS KABI",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/03\/2024",
  "drugName": "PIPERACILLIN AND TAZOBACTAMANDA  #203720",
  "submission": "SUPPL-13",
  "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
  "company": "FRESENIUS KABI",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/03\/2024",
  "drugName": "PIPERACILLIN AND TAZOBACTAMANDA  #204959",
  "submission": "SUPPL-15",
  "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
  "company": "SHANDONG",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/03\/2024",
  "drugName": "METRONIDAZOLE IN PLASTIC CONTAINERANDA  #206191",
  "submission": "SUPPL-16",
  "activeIngredients": "METRONIDAZOLE",
  "company": "INFORLIFE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/03\/2024",
  "drugName": "PIPERACILLIN AND TAZOBACTAMANDA  #206996",
  "submission": "SUPPL-10",
  "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
  "company": "WOCKHARDT BIO AG",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/03\/2024",
  "drugName": "PIPERACILLIN AND TAZOBACTAMANDA  #207146",
  "submission": "SUPPL-10",
  "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
  "company": "WOCKHARDT BIO AG",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/03\/2024",
  "drugName": "LURASIDONE HYDROCHLORIDEANDA  #208002",
  "submission": "SUPPL-3",
  "activeIngredients": "LURASIDONE HYDROCHLORIDE",
  "company": "AMNEAL PHARMS CO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/03\/2024",
  "drugName": "LURASIDONE HYDROCHLORIDEANDA  #208002",
  "submission": "SUPPL-4",
  "activeIngredients": "LURASIDONE HYDROCHLORIDE",
  "company": "AMNEAL PHARMS CO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/03\/2024",
  "drugName": "PIPERACILLIN AND TAZOBACTAMANDA  #208674",
  "submission": "SUPPL-6",
  "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
  "company": "SAGENT PHARMS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/03\/2024",
  "drugName": "PIPERACILLIN AND TAZOBACTAMANDA  #208675",
  "submission": "SUPPL-6",
  "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
  "company": "SAGENT PHARMS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/03\/2024",
  "drugName": "ZILRETTANDA   #208845",
  "submission": "SUPPL-21",
  "activeIngredients": "TRIAMCINOLONE ACETONIDE",
  "company": "PACIRA PHARMS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/03\/2024",
  "drugName": "VABOMERENDA   #209776",
  "submission": "SUPPL-9",
  "activeIngredients": "MEROPENEM; VABORBACTAM",
  "company": "REMPEX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/03\/2024",
  "drugName": "NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDENDA   #214628",
  "submission": "SUPPL-4",
  "activeIngredients": "NOREPINEPHRINE BITARTRATE",
  "company": "LONG GROVE PHARMS",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/03\/2024",
  "drugName": "MEROPENEMNDA   #215212",
  "submission": "SUPPL-2",
  "activeIngredients": "MEROPENEM",
  "company": "HQ SPCLT PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/03\/2024",
  "drugName": "PALIPERIDONE PALMITATEANDA  #215682",
  "submission": "ORIG-1",
  "activeIngredients": "PALIPERIDONE PALMITATE",
  "company": "MYLAN PHARMACEUTICALS INC A VIATRIS CO",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "12\/03\/2024",
  "drugName": "PHYRAGONDA   #216099",
  "submission": "SUPPL-3",
  "activeIngredients": "DASATINIB",
  "company": "HANDA THERAP",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/03\/2024",
  "drugName": "ARIPIPRAZOLEANDA  #216608",
  "submission": "ORIG-1",
  "activeIngredients": "ARIPIPRAZOLE",
  "company": "MYLAN",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/03\/2024",
  "drugName": "PIPERACILLIN AND TAZOBACTAMANDA  #217243",
  "submission": "SUPPL-6",
  "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
  "company": "SHANDONG",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/03\/2024",
  "drugName": "PIPERACILLIN AND TAZOBACTAMANDA  #217409",
  "submission": "SUPPL-5",
  "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
  "company": "EUGIA PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/03\/2024",
  "drugName": "PIPERACILLIN AND TAZOBACTAMANDA  #217409",
  "submission": "SUPPL-5",
  "activeIngredients": "PIPERACILLIN,TAZOBACTAM",
  "company": "EUGIA PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/03\/2024",
  "drugName": "OSELTAMIVIR PHOSPHATEANDA  #217451",
  "submission": "ORIG-1",
  "activeIngredients": "OSELTAMIVIR PHOSPHATE",
  "company": "CEDIPROF INC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/03\/2024",
  "drugName": "COLESTIPOL HYDROCHLORIDEANDA  #217462",
  "submission": "ORIG-1",
  "activeIngredients": "COLESTIPOL HYDROCHLORIDE",
  "company": "RICONPHARMA LLC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/03\/2024",
  "drugName": "BOSULIFNDA   #217729",
  "submission": "SUPPL-1",
  "activeIngredients": "BOSUTINIB MONOHYDRATE",
  "company": "PF PRISM CV",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/03\/2024",
  "drugName": "OLOPATADINE HYDROCHLORIDEANDA  #217856",
  "submission": "ORIG-1",
  "activeIngredients": "OLOPATADINE HYDROCHLORIDE",
  "company": "ALEMBIC PHARMS LTD",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "12\/03\/2024",
  "drugName": "CYCLOPHOSPHAMIDEANDA  #218282",
  "submission": "ORIG-1",
  "activeIngredients": "CYCLOPHOSPHAMIDE",
  "company": "EIRGEN",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/03\/2024",
  "drugName": "ABACAVIR; DOLUTEGRAVIR; LAMIVUDINEANDA  #218383",
  "submission": "ORIG-1",
  "activeIngredients": "ABACAVIR;DOLUTEGRAVIR;LAMIVUDINE",
  "company": "LUPIN LTD",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "12\/03\/2024",
  "drugName": "TOPIRAMATEANDA  #218695",
  "submission": "ORIG-1",
  "activeIngredients": "TOPIRAMATE",
  "company": "AMTA",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/03\/2024",
  "drugName": "TYENNEBLA   #761275",
  "submission": "SUPPL-11",
  "activeIngredients": "TOCILIZUMAB-AAZG",
  "company": "FRESENIUS KABI USA",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/03\/2024",
  "drugName": "TOFIDENCEBLA   #761354",
  "submission": "SUPPL-4",
  "activeIngredients": "TOCILIZUMAB-BAVI",
  "company": "BIOGEN MA",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/04\/2024",
  "drugName": "ATORVASTATIN CALCIUMANDA  #076477",
  "submission": "SUPPL-33",
  "activeIngredients": "ATORVASTATIN CALCIUM",
  "company": "SUN PHARM INDS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/04\/2024",
  "drugName": "ATORVASTATIN CALCIUMANDA  #090548",
  "submission": "SUPPL-31",
  "activeIngredients": "ATORVASTATIN CALCIUM",
  "company": "APOTEX INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/04\/2024",
  "drugName": "FULVESTRANTANDA  #208811",
  "submission": "SUPPL-2",
  "activeIngredients": "FULVESTRANT",
  "company": "EUGIA PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/04\/2024",
  "drugName": "FULVESTRANTANDA  #208811",
  "submission": "SUPPL-3",
  "activeIngredients": "FULVESTRANT",
  "company": "EUGIA PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/04\/2024",
  "drugName": "FULVESTRANTANDA  #208811",
  "submission": "SUPPL-4",
  "activeIngredients": "FULVESTRANT",
  "company": "EUGIA PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/04\/2024",
  "drugName": "FULVESTRANTANDA  #208811",
  "submission": "SUPPL-8",
  "activeIngredients": "FULVESTRANT",
  "company": "EUGIA PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/04\/2024",
  "drugName": "EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATEANDA  #212689",
  "submission": "SUPPL-2",
  "activeIngredients": "EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE",
  "company": "ZYDUS PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/04\/2024",
  "drugName": "EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATEANDA  #212689",
  "submission": "SUPPL-3",
  "activeIngredients": "EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE",
  "company": "ZYDUS PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/04\/2024",
  "drugName": "TADALAFILANDA  #216279",
  "submission": "SUPPL-1",
  "activeIngredients": "TADALAFIL",
  "company": "SHANDONG",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/04\/2024",
  "drugName": "DOXYCYCLINE HYCLATEANDA  #217487",
  "submission": "ORIG-1",
  "activeIngredients": "DOXYCYCLINE HYCLATE",
  "company": "AMNEAL",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/04\/2024",
  "drugName": "PAZOPANIB HYDROCHLORIDEANDA  #219034",
  "submission": "ORIG-1",
  "activeIngredients": "PAZOPANIB HYDROCHLORIDE",
  "company": "EUGIA PHARMA",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/04\/2024",
  "drugName": "IMFINZIBLA   #761069",
  "submission": "SUPPL-49",
  "activeIngredients": "DURVALUMAB",
  "company": "ASTRAZENECA UK LTD",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/04\/2024",
  "drugName": "BIZENGRIBLA   #761352",
  "submission": "ORIG-1",
  "activeIngredients": "ZENOCUTUZUMAB-ZBCO",
  "company": "MERUS N.V.",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/05\/2024",
  "drugName": "IC-GREENNDA   #011525",
  "submission": "SUPPL-39",
  "activeIngredients": "INDOCYANINE GREEN",
  "company": "RENEW PHARMS",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/05\/2024",
  "drugName": "REYATAZNDA   #021567",
  "submission": "SUPPL-49",
  "activeIngredients": "ATAZANAVIR SULFATE",
  "company": "BRISTOL MYERS SQUIBB",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/05\/2024",
  "drugName": "DIVALPROEX SODIUMANDA  #079163",
  "submission": "SUPPL-30",
  "activeIngredients": "DIVALPROEX SODIUM",
  "company": "UNICHEM LABS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/05\/2024",
  "drugName": "DIVALPROEX SODIUMANDA  #079163",
  "submission": "SUPPL-32",
  "activeIngredients": "DIVALPROEX SODIUM",
  "company": "UNICHEM LABS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/05\/2024",
  "drugName": "ATORVASTATIN CALCIUMANDA  #091226",
  "submission": "SUPPL-32",
  "activeIngredients": "ATORVASTATIN CALCIUM",
  "company": "MYLAN PHARMS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/05\/2024",
  "drugName": "REYATAZNDA   #206352",
  "submission": "SUPPL-11",
  "activeIngredients": "ATAZANAVIR SULFATE",
  "company": "BRISTOL MYERS SQUIBB",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/05\/2024",
  "drugName": "ATORVASTATIN CALCIUMANDA  #207687",
  "submission": "SUPPL-16",
  "activeIngredients": "ATORVASTATIN CALCIUM",
  "company": "ACCORD HLTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/05\/2024",
  "drugName": "ABACAVIR || DOLUTEGRAVIR || LAMIVUDINEANDA  #212181",
  "submission": "ORIG-1",
  "activeIngredients": "ABACAVIR || DOLUTEGRAVIR || LAMIVUDINE",
  "company": "EMCURE PHARMS LTD",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "12\/05\/2024",
  "drugName": "CALCITONIN-SALMONANDA  #212675",
  "submission": "ORIG-1",
  "activeIngredients": "CALCITONIN SALMON",
  "company": "FRESENIUS KABI USA",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/06\/2024",
  "drugName": "ISOVUE-128NDA   #018735",
  "submission": "SUPPL-73",
  "activeIngredients": "IOPAMIDOL",
  "company": "BRACCO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/06\/2024",
  "drugName": "ISOVUE-200NDA   #018735",
  "submission": "SUPPL-73",
  "activeIngredients": "IOPAMIDOL",
  "company": "BRACCO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/06\/2024",
  "drugName": "ISOVUE-250NDA   #018735",
  "submission": "SUPPL-73",
  "activeIngredients": "IOPAMIDOL",
  "company": "BRACCO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/06\/2024",
  "drugName": "ISOVUE-300NDA   #018735",
  "submission": "SUPPL-73",
  "activeIngredients": "IOPAMIDOL",
  "company": "BRACCO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/06\/2024",
  "drugName": "ISOVUE-370NDA   #018735",
  "submission": "SUPPL-73",
  "activeIngredients": "IOPAMIDOL",
  "company": "BRACCO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/06\/2024",
  "drugName": "ISOVUE-M 200NDA   #018735",
  "submission": "SUPPL-73",
  "activeIngredients": "IOPAMIDOL",
  "company": "BRACCO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/06\/2024",
  "drugName": "ISOVUE-M 300NDA   #018735",
  "submission": "SUPPL-73",
  "activeIngredients": "IOPAMIDOL",
  "company": "BRACCO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/06\/2024",
  "drugName": "ZOLPIDEM TARTRATEANDA  #202657",
  "submission": "SUPPL-2",
  "activeIngredients": "ZOLPIDEM TARTRATE",
  "company": "PHARMOBEDIENT",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/06\/2024",
  "drugName": "ESTRADIOLANDA  #206685",
  "submission": "SUPPL-4",
  "activeIngredients": "ESTRADIOL",
  "company": "MYLAN TECHNOLOGIES",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/06\/2024",
  "drugName": "ESTRADIOLANDA  #206685",
  "submission": "SUPPL-7",
  "activeIngredients": "ESTRADIOL",
  "company": "MYLAN TECHNOLOGIES",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/06\/2024",
  "drugName": "RIVAROXABANANDA  #208549",
  "submission": "ORIG-1",
  "activeIngredients": "RIVAROXABAN",
  "company": "PRINSTON INC",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "12\/06\/2024",
  "drugName": "LURASIDONE HYDROCHLORIDEANDA  #210388",
  "submission": "ORIG-1",
  "activeIngredients": "LURASIDONE HYDROCHLORIDE",
  "company": "JUBILANT GENERICS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/06\/2024",
  "drugName": "BACLOFENANDA  #214445",
  "submission": "ORIG-1",
  "activeIngredients": "BACLOFEN",
  "company": "RUBICON RESEARCH",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/06\/2024",
  "drugName": "ONYDA XRNDA   #217645",
  "submission": "SUPPL-1",
  "activeIngredients": "CLONIDINE HYDROCHLORIDE",
  "company": "TRIS PHARMA INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/09\/2024",
  "drugName": "FORANENDA   #017624",
  "submission": "SUPPL-43",
  "activeIngredients": "ISOFLURANE",
  "company": "BAXTER HLTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/09\/2024",
  "drugName": "FLUCONAZOLE IN SODIUM CHLORIDE 0.9%ANDA  #076653",
  "submission": "SUPPL-22",
  "activeIngredients": "FLUCONAZOLE",
  "company": "DR REDDYS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/09\/2024",
  "drugName": "FLUCONAZOLE IN SODIUM CHLORIDE 0.9%ANDA  #076653",
  "submission": "SUPPL-23",
  "activeIngredients": "FLUCONAZOLE",
  "company": "DR REDDYS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/09\/2024",
  "drugName": "FLUCONAZOLE IN SODIUM CHLORIDE 0.9%ANDA  #076653",
  "submission": "SUPPL-24",
  "activeIngredients": "FLUCONAZOLE",
  "company": "DR REDDYS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/09\/2024",
  "drugName": "FLUCONAZOLE IN SODIUM CHLORIDE 0.9%ANDA  #076653",
  "submission": "SUPPL-25",
  "activeIngredients": "FLUCONAZOLE",
  "company": "DR REDDYS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/09\/2024",
  "drugName": "FLUOXETINE HYDROCHLORIDEANDA  #076990",
  "submission": "SUPPL-29",
  "activeIngredients": "FLUOXETINE HYDROCHLORIDE",
  "company": "SUN PHARM INDS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/09\/2024",
  "drugName": "FLUOXETINE HYDROCHLORIDEANDA  #076990",
  "submission": "SUPPL-30",
  "activeIngredients": "FLUOXETINE HYDROCHLORIDE",
  "company": "SUN PHARM INDS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/09\/2024",
  "drugName": "LEVONORGESTREL AND ETHINYL ESTRADIOLANDA  #203871",
  "submission": "SUPPL-2",
  "activeIngredients": "ETHINYL ESTRADIOL; LEVONORGESTREL",
  "company": "NAARI PTE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/09\/2024",
  "drugName": "IMATINIB MESYLATEANDA  #204644",
  "submission": "SUPPL-18",
  "activeIngredients": "IMATINIB MESYLATE",
  "company": "MYLAN",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/09\/2024",
  "drugName": "DIHYDROERGOTAMINE MESYLATEANDA  #207264",
  "submission": "SUPPL-2",
  "activeIngredients": "DIHYDROERGOTAMINE MESYLATE",
  "company": "SAGENT PHARMS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/09\/2024",
  "drugName": "ROSUVASTATIN CALCIUMANDA  #208898",
  "submission": "SUPPL-6",
  "activeIngredients": "ROSUVASTATIN CALCIUM",
  "company": "MSN",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/09\/2024",
  "drugName": "ROSUVASTATIN CALCIUMANDA  #208898",
  "submission": "SUPPL-13",
  "activeIngredients": "ROSUVASTATIN CALCIUM",
  "company": "MSN",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/09\/2024",
  "drugName": "ROSUVASTATIN CALCIUMANDA  #208898",
  "submission": "SUPPL-15",
  "activeIngredients": "ROSUVASTATIN CALCIUM",
  "company": "MSN",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/09\/2024",
  "drugName": "ROSUVASTATIN CALCIUMANDA  #208898",
  "submission": "SUPPL-17",
  "activeIngredients": "ROSUVASTATIN CALCIUM",
  "company": "MSN",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/09\/2024",
  "drugName": "TROMETHAMINEANDA  #211558",
  "submission": "ORIG-1",
  "activeIngredients": "TROMETHAMINE",
  "company": "B BRAUN MEDICAL",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/09\/2024",
  "drugName": "RYBELSUSNDA   #213051",
  "submission": "SUPPL-20",
  "activeIngredients": "SEMAGLUTIDE",
  "company": "NOVO",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/09\/2024",
  "drugName": "RYBELSUSNDA   #213051",
  "submission": "SUPPL-21",
  "activeIngredients": "SEMAGLUTIDE",
  "company": "NOVO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/09\/2024",
  "drugName": "IOBENGUANE I-123ANDA  #213637",
  "submission": "ORIG-1",
  "activeIngredients": "IOBENGUANE SULFATE I-123",
  "company": "BWXT MEDCL",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/09\/2024",
  "drugName": "VARENICLINE TARTRATEANDA  #215048",
  "submission": "ORIG-1",
  "activeIngredients": "VARENICLINE TARTRATE",
  "company": "MACLEODS PHARMS LTD",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/09\/2024",
  "drugName": "TRIAMCINOLONE ACETONIDEANDA  #215254",
  "submission": "ORIG-1",
  "activeIngredients": "TRIAMCINOLONE ACETONIDE",
  "company": "HIKMA",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/09\/2024",
  "drugName": "PREGABALINANDA  #215755",
  "submission": "SUPPL-1",
  "activeIngredients": "PREGABALIN",
  "company": "STRIDES PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/09\/2024",
  "drugName": "ERTUGLIFLOZINANDA  #216947",
  "submission": "SUPPL-2",
  "activeIngredients": "ERTUGLIFLOZIN",
  "company": "AUROBINDO PHARMA LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/09\/2024",
  "drugName": "TRYVIONDA   #217686",
  "submission": "SUPPL-3",
  "activeIngredients": "APROCITENTAN",
  "company": "IDORSIA",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/10\/2024",
  "drugName": "HEPARIN SODIUM 1,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERNDA   #018916",
  "submission": "SUPPL-80",
  "activeIngredients": "HEPARIN SODIUM",
  "company": "HOSPIRA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/10\/2024",
  "drugName": "HEPARIN SODIUM 10,000 UNITS IN SODIUM CHLORIDE 0.45%NDA   #018916",
  "submission": "SUPPL-80",
  "activeIngredients": "HEPARIN SODIUM",
  "company": "HOSPIRA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/10\/2024",
  "drugName": "HEPARIN SODIUM 10,000 UNITS IN SODIUM CHLORIDE 0.9%NDA   #018916",
  "submission": "SUPPL-80",
  "activeIngredients": "HEPARIN SODIUM",
  "company": "HOSPIRA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/10\/2024",
  "drugName": "HEPARIN SODIUM 12,500 UNITS IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINERNDA   #018916",
  "submission": "SUPPL-80",
  "activeIngredients": "HEPARIN SODIUM",
  "company": "HOSPIRA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/10\/2024",
  "drugName": "HEPARIN SODIUM 12,500 UNITS IN SODIUM CHLORIDE 0.9%NDA   #018916",
  "submission": "SUPPL-80",
  "activeIngredients": "HEPARIN SODIUM",
  "company": "HOSPIRA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/10\/2024",
  "drugName": "HEPARIN SODIUM 2,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERNDA   #018916",
  "submission": "SUPPL-80",
  "activeIngredients": "HEPARIN SODIUM",
  "company": "HOSPIRA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/10\/2024",
  "drugName": "HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINERNDA   #018916",
  "submission": "SUPPL-80",
  "activeIngredients": "HEPARIN SODIUM",
  "company": "HOSPIRA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/10\/2024",
  "drugName": "HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERNDA   #018916",
  "submission": "SUPPL-80",
  "activeIngredients": "HEPARIN SODIUM",
  "company": "HOSPIRA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/10\/2024",
  "drugName": "HEPARIN SODIUM 5,000 UNITS IN SODIUM CHLORIDE 0.45%NDA   #018916",
  "submission": "SUPPL-80",
  "activeIngredients": "HEPARIN SODIUM",
  "company": "HOSPIRA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/10\/2024",
  "drugName": "HEPARIN SODIUM 5,000 UNITS IN SODIUM CHLORIDE 0.9%NDA   #018916",
  "submission": "SUPPL-80",
  "activeIngredients": "HEPARIN SODIUM",
  "company": "HOSPIRA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/10\/2024",
  "drugName": "GABAPENTINANDA  #078428",
  "submission": "SUPPL-59",
  "activeIngredients": "GABAPENTIN",
  "company": "AMNEAL PHARMS NY",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/10\/2024",
  "drugName": "ACTEMRABLA   #125276",
  "submission": "SUPPL-146",
  "activeIngredients": "TOCILIZUMAB",
  "company": "GENENTECH",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/10\/2024",
  "drugName": "ACTEMRABLA   #125472",
  "submission": "SUPPL-58",
  "activeIngredients": "TOCILIZUMAB",
  "company": "GENENTECH",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/10\/2024",
  "drugName": "ESOMEPRAZOLE MAGNESIUMANDA  #208333",
  "submission": "SUPPL-5",
  "activeIngredients": "ESOMEPRAZOLE MAGNESIUM",
  "company": "ALKEM LABS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/10\/2024",
  "drugName": "ESOMEPRAZOLE MAGNESIUMANDA  #208333",
  "submission": "SUPPL-6",
  "activeIngredients": "ESOMEPRAZOLE MAGNESIUM",
  "company": "ALKEM LABS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/10\/2024",
  "drugName": "ESOMEPRAZOLE MAGNESIUMANDA  #208333",
  "submission": "SUPPL-7",
  "activeIngredients": "ESOMEPRAZOLE MAGNESIUM",
  "company": "ALKEM LABS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/10\/2024",
  "drugName": "ESOMEPRAZOLE MAGNESIUMANDA  #208333",
  "submission": "SUPPL-8",
  "activeIngredients": "ESOMEPRAZOLE MAGNESIUM",
  "company": "ALKEM LABS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/10\/2024",
  "drugName": "ESOMEPRAZOLE MAGNESIUMANDA  #208333",
  "submission": "SUPPL-9",
  "activeIngredients": "ESOMEPRAZOLE MAGNESIUM",
  "company": "ALKEM LABS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/10\/2024",
  "drugName": "NILOTINIB HYDROCHLORIDE DIHYDRATEANDA  #209651",
  "submission": "ORIG-1",
  "activeIngredients": "NILOTINIB HYDROCHLORIDE DIHYDRATE",
  "company": "HETERO LABS LIMITED",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "12\/10\/2024",
  "drugName": "BEXAROTENEANDA  #210352",
  "submission": "ORIG-1",
  "activeIngredients": "BEXAROTENE",
  "company": "CIPLA",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/10\/2024",
  "drugName": "CASPOFUNGIN ACETATEANDA  #211263",
  "submission": "SUPPL-2",
  "activeIngredients": "CASPOFUNGIN ACETATE",
  "company": "AREVA PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/10\/2024",
  "drugName": "EZETIMIBE AND SIMVASTATINANDA  #211663",
  "submission": "ORIG-1",
  "activeIngredients": "EZETIMIBE; SIMVASTATIN",
  "company": "SCIEGEN PHARMS INC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/10\/2024",
  "drugName": "ELIGLUSTAT TARTRATEANDA  #212369",
  "submission": "ORIG-1",
  "activeIngredients": "ELIGLUSTAT TARTRATE",
  "company": "CIPLA",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/10\/2024",
  "drugName": "CHLORPROMAZINE HYDROCHLORIDEANDA  #216724",
  "submission": "ORIG-1",
  "activeIngredients": "CHLORPROMAZINE HYDROCHLORIDE",
  "company": "THINQ PHARM-CRO PVT",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/10\/2024",
  "drugName": "PHYTONADIONEANDA  #217386",
  "submission": "ORIG-1",
  "activeIngredients": "PHYTONADIONE",
  "company": "GLAND",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/10\/2024",
  "drugName": "BINIMETINIBANDA  #217509",
  "submission": "ORIG-1",
  "activeIngredients": "BINIMETINIB",
  "company": "TEVA PHARMACEUTICALS USA, INC.",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "12\/11\/2024",
  "drugName": "ALLOPURINOLANDA  #070269",
  "submission": "SUPPL-19",
  "activeIngredients": "ALLOPURINOL",
  "company": "SANDOZ",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/11\/2024",
  "drugName": "CYTARABINEANDA  #076512",
  "submission": "SUPPL-8",
  "activeIngredients": "CYTARABINE",
  "company": "FRESENIUS KABI USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/11\/2024",
  "drugName": "CYTARABINEANDA  #076512",
  "submission": "SUPPL-9",
  "activeIngredients": "CYTARABINE",
  "company": "FRESENIUS KABI USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/11\/2024",
  "drugName": "LANTHANUM CARBONATEANDA  #090977",
  "submission": "SUPPL-3",
  "activeIngredients": "LANTHANUM CARBONATE",
  "company": "BARR",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/11\/2024",
  "drugName": "LANTHANUM CARBONATEANDA  #090977",
  "submission": "SUPPL-4",
  "activeIngredients": "LANTHANUM CARBONATE",
  "company": "BARR",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/11\/2024",
  "drugName": "LANTHANUM CARBONATEANDA  #090977",
  "submission": "SUPPL-5",
  "activeIngredients": "LANTHANUM CARBONATE",
  "company": "BARR",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/11\/2024",
  "drugName": "KEYTRUDABLA   #125514",
  "submission": "SUPPL-162",
  "activeIngredients": "PEMBROLIZUMAB",
  "company": "MERCK SHARP DOHME",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/11\/2024",
  "drugName": "CYTARABINEANDA  #201784",
  "submission": "SUPPL-4",
  "activeIngredients": "CYTARABINE",
  "company": "RISING",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/11\/2024",
  "drugName": "CYTARABINEANDA  #201784",
  "submission": "SUPPL-7",
  "activeIngredients": "CYTARABINE",
  "company": "RISING",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/11\/2024",
  "drugName": "ARIPIPRAZOLEANDA  #202683",
  "submission": "SUPPL-2",
  "activeIngredients": "ARIPIPRAZOLE",
  "company": "ORBION PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/11\/2024",
  "drugName": "ARIPIPRAZOLEANDA  #202683",
  "submission": "SUPPL-3",
  "activeIngredients": "ARIPIPRAZOLE",
  "company": "ORBION PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/11\/2024",
  "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #204755",
  "submission": "SUPPL-13",
  "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
  "company": "MICRO LABS LTD INDIA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/11\/2024",
  "drugName": "REXULTINDA   #205422",
  "submission": "SUPPL-13",
  "activeIngredients": "BREXPIPRAZOLE",
  "company": "OTSUKA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/11\/2024",
  "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #205707",
  "submission": "SUPPL-13",
  "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
  "company": "MICRO LABS LTD INDIA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/11\/2024",
  "drugName": "METFORMIN HYDROCHLORIDEANDA  #211309",
  "submission": "SUPPL-9",
  "activeIngredients": "METFORMIN HYDROCHLORIDE",
  "company": "SAPTALIS PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/11\/2024",
  "drugName": "APREPITANTANDA  #216976",
  "submission": "ORIG-1",
  "activeIngredients": "APREPITANT",
  "company": "MYLAN PHARMACEUTICALS INC",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "12\/11\/2024",
  "drugName": "SOLRIAMFETOLANDA  #218654",
  "submission": "ORIG-1",
  "activeIngredients": "SOLRIAMFETOL",
  "company": "HETERO LABS LIMITED",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "12\/11\/2024",
  "drugName": "SITAGLIPTIN AND METFORMIN HCLANDA  #218971",
  "submission": "ORIG-1",
  "activeIngredients": "SITAGLIPTIN, METFORMIN HYDROCHLORIDE",
  "company": "MANKIND PHARMA LTD",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "12\/12\/2024",
  "drugName": "BRIDIONNDA   #022225",
  "submission": "SUPPL-14",
  "activeIngredients": "SUGAMMADEX SODIUM",
  "company": "MSD SUB MERCK",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/12\/2024",
  "drugName": "THIOTHIXENEANDA  #070600",
  "submission": "SUPPL-18",
  "activeIngredients": "THIOTHIXENE",
  "company": "CHARTWELL RX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/12\/2024",
  "drugName": "THIOTHIXENEANDA  #070601",
  "submission": "SUPPL-18",
  "activeIngredients": "THIOTHIXENE",
  "company": "CHARTWELL RX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/12\/2024",
  "drugName": "THIOTHIXENEANDA  #070602",
  "submission": "SUPPL-19",
  "activeIngredients": "THIOTHIXENE",
  "company": "CHARTWELL RX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/12\/2024",
  "drugName": "THIOTHIXENEANDA  #070603",
  "submission": "SUPPL-17",
  "activeIngredients": "THIOTHIXENE",
  "company": "CHARTWELL RX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/12\/2024",
  "drugName": "FLUNISOLIDEANDA  #074805",
  "submission": "SUPPL-22",
  "activeIngredients": "FLUNISOLIDE",
  "company": "BAUSCH",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/12\/2024",
  "drugName": "TERAZOSIN HYDROCHLORIDEANDA  #074823",
  "submission": "SUPPL-28",
  "activeIngredients": "TERAZOSIN HYDROCHLORIDE",
  "company": "APNAR PHARMA LP",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/12\/2024",
  "drugName": "SILDENAFIL CITRATEANDA  #077342",
  "submission": "SUPPL-4",
  "activeIngredients": "SILDENAFIL CITRATE",
  "company": "TEVA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/12\/2024",
  "drugName": "SILDENAFIL CITRATEANDA  #077342",
  "submission": "SUPPL-5",
  "activeIngredients": "SILDENAFIL CITRATE",
  "company": "TEVA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/12\/2024",
  "drugName": "SILDENAFIL CITRATEANDA  #077342",
  "submission": "SUPPL-11",
  "activeIngredients": "SILDENAFIL CITRATE",
  "company": "TEVA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/12\/2024",
  "drugName": "NEVIRAPINEANDA  #077702",
  "submission": "SUPPL-24",
  "activeIngredients": "NEVIRAPINE",
  "company": "AUROBINDO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/12\/2024",
  "drugName": "MELOXICAMANDA  #077938",
  "submission": "SUPPL-5",
  "activeIngredients": "MELOXICAM",
  "company": "PURACAP PHARM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/12\/2024",
  "drugName": "SUMATRIPTAN SUCCINATEANDA  #200183",
  "submission": "SUPPL-1",
  "activeIngredients": "SUMATRIPTAN SUCCINATE",
  "company": "HIKMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/12\/2024",
  "drugName": "SUMATRIPTAN SUCCINATEANDA  #200183",
  "submission": "SUPPL-2",
  "activeIngredients": "SUMATRIPTAN SUCCINATE",
  "company": "HIKMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/12\/2024",
  "drugName": "DULOXETINE HYDROCHLORIDEANDA  #203197",
  "submission": "SUPPL-23",
  "activeIngredients": "DULOXETINE HYDROCHLORIDE",
  "company": "ALKEM LABS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/12\/2024",
  "drugName": "OPSUMITNDA   #204410",
  "submission": "SUPPL-30",
  "activeIngredients": "MACITENTAN",
  "company": "ACTELION",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/12\/2024",
  "drugName": "GLUCAGONANDA  #204468",
  "submission": "ORIG-1",
  "activeIngredients": "GLUCAGON",
  "company": "MYLAN LABS LTD",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/12\/2024",
  "drugName": "ACETAZOLAMIDEANDA  #204691",
  "submission": "SUPPL-10",
  "activeIngredients": "ACETAZOLAMIDE",
  "company": "MPP PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/12\/2024",
  "drugName": "FESOTERODINE FUMARATEANDA  #204792",
  "submission": "SUPPL-1",
  "activeIngredients": "FESOTERODINE FUMARATE",
  "company": "HETERO LABS LTD V",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/12\/2024",
  "drugName": "TOPIRAMATEANDA  #208949",
  "submission": "SUPPL-2",
  "activeIngredients": "TOPIRAMATE",
  "company": "ZYDUS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/12\/2024",
  "drugName": "ACETAZOLAMIDEANDA  #210423",
  "submission": "SUPPL-8",
  "activeIngredients": "ACETAZOLAMIDE",
  "company": "ALEMBIC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/12\/2024",
  "drugName": "COLCHICINEANDA  #210757",
  "submission": "SUPPL-1",
  "activeIngredients": "COLCHICINE",
  "company": "GRANULES",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/12\/2024",
  "drugName": "COLCHICINEANDA  #210757",
  "submission": "SUPPL-5",
  "activeIngredients": "COLCHICINE",
  "company": "GRANULES",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/12\/2024",
  "drugName": "DIAZOXIDEANDA  #210799",
  "submission": "SUPPL-16",
  "activeIngredients": "DIAZOXIDE",
  "company": "NOVITIUM PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/12\/2024",
  "drugName": "MACITENTANANDA  #211107",
  "submission": "SUPPL-1",
  "activeIngredients": "MACITENTAN",
  "company": "TORRENT",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/12\/2024",
  "drugName": "MACITENTANANDA  #211195",
  "submission": "SUPPL-2",
  "activeIngredients": "MACITENTAN",
  "company": "APOTEX",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/12\/2024",
  "drugName": "MACITENTANANDA  #211198",
  "submission": "SUPPL-3",
  "activeIngredients": "MACITENTAN",
  "company": "AUROBINDO PHARMA LTD",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/12\/2024",
  "drugName": "MACITENTANANDA  #211224",
  "submission": "SUPPL-3",
  "activeIngredients": "MACITENTAN",
  "company": "ZYDUS LIFESCIENCES",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/12\/2024",
  "drugName": "NURTEC ODTNDA   #212728",
  "submission": "SUPPL-25",
  "activeIngredients": "RIMEGEPANT SULFATE",
  "company": "PFIZER",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/12\/2024",
  "drugName": "CLOZAPINEANDA  #212923",
  "submission": "ORIG-1",
  "activeIngredients": "CLOZAPINE",
  "company": "AUROBINDO PHARMA",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/12\/2024",
  "drugName": "PREGABALINANDA  #215249",
  "submission": "SUPPL-2",
  "activeIngredients": "PREGABALIN",
  "company": "RUBICON RESEARCH",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/12\/2024",
  "drugName": "PREGABALINANDA  #215249",
  "submission": "SUPPL-3",
  "activeIngredients": "PREGABALIN",
  "company": "RUBICON RESEARCH",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/12\/2024",
  "drugName": "VTAMANDA   #215272",
  "submission": "SUPPL-2",
  "activeIngredients": "TAPINAROF",
  "company": "ORGANON LLC",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/12\/2024",
  "drugName": "ONTRALFYNDA   #216190",
  "submission": "ORIG-1",
  "activeIngredients": "TIZANIDINE HYDROCHLORIDE",
  "company": "FIDELITY BIOPHARMA",
  "submissionClassification": "Type 3 - New Dosage Form",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/12\/2024",
  "drugName": "OPSYNVINDA   #218490",
  "submission": "SUPPL-1",
  "activeIngredients": "MACITENTAN; TADALAFIL",
  "company": "ACTELION",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/13\/2024",
  "drugName": "PURIFIED CORTROPHIN GELNDA   #008975",
  "submission": "SUPPL-15",
  "activeIngredients": "CORTICOTROPIN",
  "company": "ANI PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/13\/2024",
  "drugName": "FARESTONNDA   #020497",
  "submission": "SUPPL-18",
  "activeIngredients": "TOREMIFENE CITRATE",
  "company": "KYOWA KIRIN",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/13\/2024",
  "drugName": "ORKAMBINDA   #206038",
  "submission": "SUPPL-18",
  "activeIngredients": "IVACAFTOR; LUMACAFTOR",
  "company": "VERTEX PHARMS INC",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/13\/2024",
  "drugName": "TICAGRELORANDA  #208575",
  "submission": "SUPPL-3",
  "activeIngredients": "TICAGRELOR",
  "company": "HISUN PHARM HANGZHOU",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/13\/2024",
  "drugName": "TICAGRELORANDA  #208575",
  "submission": "SUPPL-4",
  "activeIngredients": "TICAGRELOR",
  "company": "HISUN PHARM HANGZHOU",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/13\/2024",
  "drugName": "TICAGRELORANDA  #208575",
  "submission": "SUPPL-6",
  "activeIngredients": "TICAGRELOR",
  "company": "HISUN PHARM HANGZHOU",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/13\/2024",
  "drugName": "XERAVANDA   #211109",
  "submission": "SUPPL-9",
  "activeIngredients": "ERAVACYCLINE DIHYDROCHLORIDE",
  "company": "TETRAPHASE PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/13\/2024",
  "drugName": "ORKAMBINDA   #211358",
  "submission": "SUPPL-6",
  "activeIngredients": "IVACAFTOR; LUMACAFTOR",
  "company": "VERTEX PHARMS INC",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/13\/2024",
  "drugName": "METFORMIN HYDROCHLORIDEANDA  #213356",
  "submission": "SUPPL-1",
  "activeIngredients": "METFORMIN HYDROCHLORIDE",
  "company": "APOTEX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/13\/2024",
  "drugName": "EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATEANDA  #213926",
  "submission": "ORIG-1",
  "activeIngredients": "EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE",
  "company": "LUPIN LTD",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/13\/2024",
  "drugName": "LOTEPREDNOL ETABONATEANDA  #216345",
  "submission": "ORIG-1",
  "activeIngredients": "LOTEPREDNOL ETABONATE",
  "company": "AMNEAL",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/13\/2024",
  "drugName": "FUROSEMIDEANDA  #217557",
  "submission": "ORIG-1",
  "activeIngredients": "FUROSEMIDE",
  "company": "ASPIRO",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/13\/2024",
  "drugName": "CRENESSITYNDA   #218808",
  "submission": "ORIG-1",
  "activeIngredients": "CRINECERFONT",
  "company": "NEUROCRINE",
  "submissionClassification": "Type 1 - New Molecular Entity",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/13\/2024",
  "drugName": "CRENESSITYNDA   #218820",
  "submission": "ORIG-1",
  "activeIngredients": "CRINECERFONT",
  "company": "NEUROCRINE",
  "submissionClassification": "Type 3 - New Dosage Form",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/13\/2024",
  "drugName": "LACTULOSEANDA  #218858",
  "submission": "ORIG-1",
  "activeIngredients": "LACTULOSE",
  "company": "TARO",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/13\/2024",
  "drugName": "DIFLUPREDNATEANDA  #219441",
  "submission": "ORIG-1",
  "activeIngredients": "DIFLUPREDNATE",
  "company": "CAPLIN",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/13\/2024",
  "drugName": "TYENNEBLA   #761275",
  "submission": "SUPPL-13",
  "activeIngredients": "TOCILIZUMAB-AAZG",
  "company": "FRESENIUS KABI USA",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/13\/2024",
  "drugName": "UNLOXCYTBLA   #761297",
  "submission": "ORIG-1",
  "activeIngredients": "COSIBELIMAB-IPDL",
  "company": "CHECKPOINT THERAPEUTICS INC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/13\/2024",
  "drugName": "NEMLUVIOBLA   #761391",
  "submission": "ORIG-1",
  "activeIngredients": "NEMOLIZUMAB-ILTO",
  "company": "GALDERMA LABS LP",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/16\/2024",
  "drugName": "ARIMIDEXNDA   #020541",
  "submission": "SUPPL-36",
  "activeIngredients": "ANASTROZOLE",
  "company": "ANI PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/16\/2024",
  "drugName": "FEMARANDA   #020726",
  "submission": "SUPPL-43",
  "activeIngredients": "LETROZOLE",
  "company": "NOVARTIS PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/16\/2024",
  "drugName": "AROMASINNDA   #020753",
  "submission": "SUPPL-25",
  "activeIngredients": "EXEMESTANE",
  "company": "PFIZER",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/16\/2024",
  "drugName": "DEPO-SUBQ PROVERA 104NDA   #021583",
  "submission": "SUPPL-43",
  "activeIngredients": "MEDROXYPROGESTERONE ACETATE",
  "company": "PFIZER",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/16\/2024",
  "drugName": "REVATIONDA   #021845",
  "submission": "SUPPL-28",
  "activeIngredients": "SILDENAFIL CITRATE",
  "company": "VIATRIS",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/16\/2024",
  "drugName": "DIAZEPAMANDA  #070311",
  "submission": "SUPPL-25",
  "activeIngredients": "DIAZEPAM",
  "company": "HIKMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/16\/2024",
  "drugName": "GABAPENTINANDA  #075428",
  "submission": "SUPPL-6",
  "activeIngredients": "GABAPENTIN",
  "company": "SANDOZ",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/16\/2024",
  "drugName": "CITALOPRAM HYDROBROMIDEANDA  #077048",
  "submission": "SUPPL-23",
  "activeIngredients": "CITALOPRAM HYDROBROMIDE",
  "company": "COSETTE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/16\/2024",
  "drugName": "CITALOPRAM HYDROBROMIDEANDA  #077048",
  "submission": "SUPPL-26",
  "activeIngredients": "CITALOPRAM HYDROBROMIDE",
  "company": "COSETTE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/16\/2024",
  "drugName": "ONDANSETRONANDA  #077406",
  "submission": "SUPPL-8",
  "activeIngredients": "ONDANSETRON",
  "company": "CHARTWELL MOLECULES",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/16\/2024",
  "drugName": "MELOXICAMANDA  #077938",
  "submission": "SUPPL-6",
  "activeIngredients": "MELOXICAM",
  "company": "PURACAP PHARM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/16\/2024",
  "drugName": "ROSUVASTATIN CALCIUMANDA  #079166",
  "submission": "SUPPL-1",
  "activeIngredients": "ROSUVASTATIN CALCIUM",
  "company": "TEVA PHARMS USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/16\/2024",
  "drugName": "ROSUVASTATIN CALCIUMANDA  #079166",
  "submission": "SUPPL-2",
  "activeIngredients": "ROSUVASTATIN CALCIUM",
  "company": "TEVA PHARMS USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/16\/2024",
  "drugName": "ROSUVASTATIN CALCIUMANDA  #079166",
  "submission": "SUPPL-5",
  "activeIngredients": "ROSUVASTATIN CALCIUM",
  "company": "TEVA PHARMS USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/16\/2024",
  "drugName": "JYNARQUENDA   #204441",
  "submission": "SUPPL-12",
  "activeIngredients": "TOLVAPTAN",
  "company": "OTSUKA",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/16\/2024",
  "drugName": "FERUMOXYTOLANDA  #206604",
  "submission": "SUPPL-3",
  "activeIngredients": "FERUMOXYTOL",
  "company": "SANDOZ",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/16\/2024",
  "drugName": "DEFERASIROXANDA  #211641",
  "submission": "SUPPL-2",
  "activeIngredients": "DEFERASIROX",
  "company": "SUN PHARM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/16\/2024",
  "drugName": "OXCARBAZEPINEANDA  #211747",
  "submission": "SUPPL-1",
  "activeIngredients": "OXCARBAZEPINE",
  "company": "ZYDUS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/16\/2024",
  "drugName": "APREMILASTANDA  #211887",
  "submission": "ORIG-1",
  "activeIngredients": "APREMILAST",
  "company": "MSN",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/16\/2024",
  "drugName": "NITROGLYCERINANDA  #216452",
  "submission": "ORIG-1",
  "activeIngredients": "NITROGLYCERIN",
  "company": "ENCUBE",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/16\/2024",
  "drugName": "VEOZAHNDA   #216578",
  "submission": "SUPPL-4",
  "activeIngredients": "FEZOLINETANT",
  "company": "ASTELLAS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/16\/2024",
  "drugName": "METHADONE HYDROCHLORIDEANDA  #218252",
  "submission": "ORIG-1",
  "activeIngredients": "METHADONE HYDROCHLORIDE",
  "company": "BRECKENRIDGE",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/16\/2024",
  "drugName": "TOFACITINIB CITRATEANDA  #218668",
  "submission": "ORIG-1",
  "activeIngredients": "TOFACITINIB CITRATE",
  "company": "DEXCEL",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/16\/2024",
  "drugName": "TOFACITINIB CITRATEANDA  #218668",
  "submission": "ORIG-2",
  "activeIngredients": "TOFACITINIB CITRATE",
  "company": "DEXCEL",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "12\/16\/2024",
  "drugName": "LISDEXAMFETAMINE DIMESYLATEANDA  #219258",
  "submission": "ORIG-1",
  "activeIngredients": "LISDEXAMFETAMINE DIMESYLATE",
  "company": "GRANULES",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/17\/2024",
  "drugName": "CEFOBIDNDA   #050551",
  "submission": "SUPPL-47",
  "activeIngredients": "CEFOPERAZONE SODIUM",
  "company": "PFIZER",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/17\/2024",
  "drugName": "GABAPENTINANDA  #075694",
  "submission": "SUPPL-56",
  "activeIngredients": "GABAPENTIN",
  "company": "ACTAVIS ELIZABETH",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/17\/2024",
  "drugName": "TIZANIDINE HYDROCHLORIDEANDA  #076533",
  "submission": "SUPPL-13",
  "activeIngredients": "TIZANIDINE HYDROCHLORIDE",
  "company": "APOTEX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/17\/2024",
  "drugName": "LEVETIRACETAMANDA  #079042",
  "submission": "SUPPL-5",
  "activeIngredients": "LEVETIRACETAM",
  "company": "INGENUS PHARMS LLC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/17\/2024",
  "drugName": "DEXMETHYLPHENIDATE HYDROCHLORIDEANDA  #079108",
  "submission": "SUPPL-7",
  "activeIngredients": "DEXMETHYLPHENIDATE HYDROCHLORIDE",
  "company": "IMPAX LABS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/17\/2024",
  "drugName": "DEXMETHYLPHENIDATE HYDROCHLORIDEANDA  #079108",
  "submission": "SUPPL-10",
  "activeIngredients": "DEXMETHYLPHENIDATE HYDROCHLORIDE",
  "company": "IMPAX LABS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/17\/2024",
  "drugName": "DEXMETHYLPHENIDATE HYDROCHLORIDEANDA  #079108",
  "submission": "SUPPL-11",
  "activeIngredients": "DEXMETHYLPHENIDATE HYDROCHLORIDE",
  "company": "IMPAX LABS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/17\/2024",
  "drugName": "DEXMETHYLPHENIDATE HYDROCHLORIDEANDA  #079108",
  "submission": "SUPPL-16",
  "activeIngredients": "DEXMETHYLPHENIDATE HYDROCHLORIDE",
  "company": "IMPAX LABS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/17\/2024",
  "drugName": "DIAZEPAMANDA  #091076",
  "submission": "SUPPL-2",
  "activeIngredients": "DIAZEPAM",
  "company": "NOVEL LABS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/17\/2024",
  "drugName": "CYCLOBENZAPRINE HYDROCHLORIDEANDA  #091281",
  "submission": "SUPPL-16",
  "activeIngredients": "CYCLOBENZAPRINE HYDROCHLORIDE",
  "company": "TWI PHARMS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/17\/2024",
  "drugName": "BLINCYTOBLA   #125557",
  "submission": "SUPPL-30",
  "activeIngredients": "BLINATUMOMAB",
  "company": "AMGEN",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/17\/2024",
  "drugName": "DYMISTANDA   #202236",
  "submission": "SUPPL-21",
  "activeIngredients": "AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE",
  "company": "MYLAN SPECIALITY LP",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/17\/2024",
  "drugName": "METOPROLOL SUCCINATEANDA  #204161",
  "submission": "SUPPL-24",
  "activeIngredients": "METOPROLOL SUCCINATE",
  "company": "ACTAVIS ELIZABETH",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/17\/2024",
  "drugName": "CEFIXIMEANDA  #206358",
  "submission": "ORIG-1",
  "activeIngredients": "CEFIXIME",
  "company": "FDC LTD",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/17\/2024",
  "drugName": "GABAPENTINANDA  #206402",
  "submission": "SUPPL-26",
  "activeIngredients": "GABAPENTIN",
  "company": "ALKEM LABS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/17\/2024",
  "drugName": "FINGOLIMOD HYDROCHLORIDEANDA  #208003",
  "submission": "SUPPL-2",
  "activeIngredients": "FINGOLIMOD HYDROCHLORIDE",
  "company": "PRINSTON INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/17\/2024",
  "drugName": "FINGOLIMOD HYDROCHLORIDEANDA  #208014",
  "submission": "SUPPL-3",
  "activeIngredients": "FINGOLIMOD HYDROCHLORIDE",
  "company": "SUN PHARM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/17\/2024",
  "drugName": "FINGOLIMOD HYDROCHLORIDEANDA  #208014",
  "submission": "SUPPL-4",
  "activeIngredients": "FINGOLIMOD HYDROCHLORIDE",
  "company": "SUN PHARM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/17\/2024",
  "drugName": "FINGOLIMOD HYDROCHLORIDEANDA  #208014",
  "submission": "SUPPL-5",
  "activeIngredients": "FINGOLIMOD HYDROCHLORIDE",
  "company": "SUN PHARM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/17\/2024",
  "drugName": "BUPROPION HYDROCHLORIDEANDA  #208652",
  "submission": "SUPPL-9",
  "activeIngredients": "BUPROPION HYDROCHLORIDE",
  "company": "SINOTHERAPEUTICS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/17\/2024",
  "drugName": "BUPROPION HYDROCHLORIDEANDA  #208652",
  "submission": "SUPPL-11",
  "activeIngredients": "BUPROPION HYDROCHLORIDE",
  "company": "SINOTHERAPEUTICS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/17\/2024",
  "drugName": "BUPROPION HYDROCHLORIDEANDA  #208652",
  "submission": "SUPPL-12",
  "activeIngredients": "BUPROPION HYDROCHLORIDE",
  "company": "SINOTHERAPEUTICS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/17\/2024",
  "drugName": "ATORVASTATIN CALCIUMANDA  #209288",
  "submission": "SUPPL-17",
  "activeIngredients": "ATORVASTATIN CALCIUM",
  "company": "ALKEM LABS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/17\/2024",
  "drugName": "VIGABATRINANDA  #209822",
  "submission": "SUPPL-13",
  "activeIngredients": "VIGABATRIN",
  "company": "TEVA PHARMS USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/17\/2024",
  "drugName": "VIGABATRINANDA  #210042",
  "submission": "SUPPL-2",
  "activeIngredients": "VIGABATRIN",
  "company": "AMNEAL PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/17\/2024",
  "drugName": "APIXABANANDA  #210156",
  "submission": "ORIG-1",
  "activeIngredients": "APIXABAN",
  "company": "TORRENT",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/17\/2024",
  "drugName": "DIMETHYL FUMARATEANDA  #210382",
  "submission": "SUPPL-13",
  "activeIngredients": "DIMETHYL FUMARATE",
  "company": "TWI PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/17\/2024",
  "drugName": "DIMETHYL FUMARATEANDA  #210385",
  "submission": "SUPPL-3",
  "activeIngredients": "DIMETHYL FUMARATE",
  "company": "AUROBINDO PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/17\/2024",
  "drugName": "DIMETHYL FUMARATEANDA  #210385",
  "submission": "SUPPL-5",
  "activeIngredients": "DIMETHYL FUMARATE",
  "company": "AUROBINDO PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/17\/2024",
  "drugName": "DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATEANDA  #210876",
  "submission": "SUPPL-1",
  "activeIngredients": "AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE",
  "company": "TEVA PHARMS USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/17\/2024",
  "drugName": "DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATEANDA  #210876",
  "submission": "SUPPL-2",
  "activeIngredients": "AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE",
  "company": "TEVA PHARMS USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/17\/2024",
  "drugName": "DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATEANDA  #210876",
  "submission": "SUPPL-5",
  "activeIngredients": "AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE",
  "company": "TEVA PHARMS USA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/17\/2024",
  "drugName": "DEFERASIROXANDA  #210945",
  "submission": "SUPPL-7",
  "activeIngredients": "DEFERASIROX",
  "company": "MSN",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/17\/2024",
  "drugName": "METHYLPHENIDATE HYDROCHLORIDEANDA  #211796",
  "submission": "SUPPL-2",
  "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
  "company": "GRANULES",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/17\/2024",
  "drugName": "METHYLPHENIDATE HYDROCHLORIDEANDA  #211796",
  "submission": "SUPPL-6",
  "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
  "company": "GRANULES",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/17\/2024",
  "drugName": "METHYLPHENIDATE HYDROCHLORIDEANDA  #211796",
  "submission": "SUPPL-7",
  "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
  "company": "GRANULES",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/17\/2024",
  "drugName": "METHYLPHENIDATE HYDROCHLORIDEANDA  #211796",
  "submission": "SUPPL-14",
  "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
  "company": "GRANULES",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/17\/2024",
  "drugName": "LEFLUNOMIDEANDA  #211863",
  "submission": "SUPPL-2",
  "activeIngredients": "LEFLUNOMIDE",
  "company": "LUPIN LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/17\/2024",
  "drugName": "METRONIDAZOLE IN PLASTIC CONTAINERANDA  #212435",
  "submission": "SUPPL-5",
  "activeIngredients": "METRONIDAZOLE",
  "company": "GLAND",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/17\/2024",
  "drugName": "METHYLENE BLUEANDA  #216959",
  "submission": "ORIG-1",
  "activeIngredients": "METHYLENE BLUE",
  "company": "HIKMA",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/17\/2024",
  "drugName": "CALCIUM CHLORIDE 10%ANDA  #218133",
  "submission": "ORIG-1",
  "activeIngredients": "CALCIUM CHLORIDE",
  "company": "SOMERSET",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/17\/2024",
  "drugName": "LISDEXAMFETAMINE DIMESYLATEANDA  #218850",
  "submission": "ORIG-1",
  "activeIngredients": "LISDEXAMFETAMINE DIMESYLATE",
  "company": "SPECGX LLC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/17\/2024",
  "drugName": "LIDOCAINE AND PRILOCAINEANDA  #219120",
  "submission": "ORIG-1",
  "activeIngredients": "LIDOCAINE; PRILOCAINE",
  "company": "ZYDUS LIFESCIENCES",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/17\/2024",
  "drugName": "STEQEYMABLA   #761338",
  "submission": "ORIG-1",
  "activeIngredients": "USTEKINUMAB-STBA",
  "company": "CELLTRION, INC.",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/18\/2024",
  "drugName": "OMNIPREDNDA   #017469",
  "submission": "SUPPL-54",
  "activeIngredients": "PREDNISOLONE ACETATE",
  "company": "SANDOZ",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/18\/2024",
  "drugName": "RETROVIRNDA   #019655",
  "submission": "SUPPL-60",
  "activeIngredients": "ZIDOVUDINE",
  "company": "VIIV HLTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/18\/2024",
  "drugName": "RETROVIRNDA   #019910",
  "submission": "SUPPL-48",
  "activeIngredients": "ZIDOVUDINE",
  "company": "VIIV HLTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/18\/2024",
  "drugName": "LEVETIRACETAMANDA  #090187",
  "submission": "SUPPL-9",
  "activeIngredients": "LEVETIRACETAM",
  "company": "APOTEX INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/18\/2024",
  "drugName": "INVOKANANDA   #204042",
  "submission": "SUPPL-43",
  "activeIngredients": "CANAGLIFLOZIN",
  "company": "JANSSEN PHARMS",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/18\/2024",
  "drugName": "INVOKAMETNDA   #204353",
  "submission": "SUPPL-46",
  "activeIngredients": "CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE",
  "company": "JANSSEN PHARMS",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/18\/2024",
  "drugName": "INVOKAMET XRNDA   #205879",
  "submission": "SUPPL-23",
  "activeIngredients": "CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE",
  "company": "JANSSEN PHARMS",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/18\/2024",
  "drugName": "IDHIFANDA   #209606",
  "submission": "SUPPL-8",
  "activeIngredients": "ENASIDENIB MESYLATE",
  "company": "BRISTOL MYERS SQUIBB",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/18\/2024",
  "drugName": "DIMETHYL FUMARATEANDA  #210436",
  "submission": "SUPPL-1",
  "activeIngredients": "DIMETHYL FUMARATE",
  "company": "SOLA PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/18\/2024",
  "drugName": "DIMETHYL FUMARATEANDA  #210436",
  "submission": "SUPPL-2",
  "activeIngredients": "DIMETHYL FUMARATE",
  "company": "SOLA PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/18\/2024",
  "drugName": "PIRFENIDONEANDA  #212748",
  "submission": "ORIG-1",
  "activeIngredients": "PIRFENIDONE",
  "company": "MACLEODS PHARMS LTD",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/18\/2024",
  "drugName": "GEMTESANDA   #213006",
  "submission": "SUPPL-11",
  "activeIngredients": "VIBEGRON",
  "company": "SUMITOMO PHARMA AM",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/18\/2024",
  "drugName": "RETEVMONDA   #213246",
  "submission": "SUPPL-14",
  "activeIngredients": "SELPERCATINIB",
  "company": "ELI LILLY AND CO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/18\/2024",
  "drugName": "LUMRYZNDA   #214755",
  "submission": "SUPPL-11",
  "activeIngredients": "SODIUM OXYBATE",
  "company": "AVADEL CNS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/18\/2024",
  "drugName": "OLOPATADINE HYDROCHLORIDEANDA  #215006",
  "submission": "ORIG-1",
  "activeIngredients": "OLOPATADINE HYDROCHLORIDE",
  "company": "SOMERSET",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/18\/2024",
  "drugName": "CEFAZOLIN SODIUMNDA   #216109",
  "submission": "SUPPL-3",
  "activeIngredients": "CEFAZOLIN SODIUM",
  "company": "HIKMA",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/18\/2024",
  "drugName": "AZMIRONDA   #216318",
  "submission": "SUPPL-3",
  "activeIngredients": "TESTOSTERONE CYPIONATE",
  "company": "AZURITY",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/18\/2024",
  "drugName": "PHENYLEPHRINE HYDROCHLORIDEANDA  #218129",
  "submission": "ORIG-1",
  "activeIngredients": "PHENYLEPHRINE HYDROCHLORIDE",
  "company": "GLAND",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/18\/2024",
  "drugName": "RETEVMONDA   #218160",
  "submission": "SUPPL-4",
  "activeIngredients": "SELPERCATINIB",
  "company": "ELI LILLY AND CO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/18\/2024",
  "drugName": "ENSACOVENDA   #218171",
  "submission": "ORIG-1",
  "activeIngredients": "ENSARTINIB HYDROCHLORIDE",
  "company": "XCOVERY",
  "submissionClassification": "Type 1 - New Molecular Entity",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/18\/2024",
  "drugName": "FONDAPARINUX SODIUMANDA  #218312",
  "submission": "ORIG-1",
  "activeIngredients": "FONDAPARINUX SODIUM",
  "company": "BRIGHTGENE",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/18\/2024",
  "drugName": "IDACIOBLA   #761255",
  "submission": "SUPPL-8",
  "activeIngredients": "ADALIMUMAB-AACF",
  "company": "FRESENIUS KABI USA",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "SPORANOXNDA   #020083",
  "submission": "SUPPL-70",
  "activeIngredients": "ITRACONAZOLE",
  "company": "JANSSEN PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "CEREZYMEBLA   #020367",
  "submission": "SUPPL-122",
  "activeIngredients": "IMIGLUCERASE",
  "company": "GENZYME",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "SPORANOXNDA   #020657",
  "submission": "SUPPL-43",
  "activeIngredients": "ITRACONAZOLE",
  "company": "JANSSEN PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "GABAPENTINANDA  #075360",
  "submission": "SUPPL-34",
  "activeIngredients": "GABAPENTIN",
  "company": "GRANULES",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "GABAPENTINANDA  #075539",
  "submission": "SUPPL-11",
  "activeIngredients": "GABAPENTIN",
  "company": "SANDOZ",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "LEVETIRACETAMANDA  #078526",
  "submission": "SUPPL-11",
  "activeIngredients": "LEVETIRACETAM",
  "company": "ORBION PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "LEVETIRACETAMANDA  #078526",
  "submission": "SUPPL-12",
  "activeIngredients": "LEVETIRACETAM",
  "company": "ORBION PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "LEVETIRACETAMANDA  #078526",
  "submission": "SUPPL-13",
  "activeIngredients": "LEVETIRACETAM",
  "company": "ORBION PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "LEVETIRACETAMANDA  #078526",
  "submission": "SUPPL-14",
  "activeIngredients": "LEVETIRACETAM",
  "company": "ORBION PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "LEVETIRACETAMANDA  #078526",
  "submission": "SUPPL-15",
  "activeIngredients": "LEVETIRACETAM",
  "company": "ORBION PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "LEVETIRACETAMANDA  #078526",
  "submission": "SUPPL-16",
  "activeIngredients": "LEVETIRACETAM",
  "company": "ORBION PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "LEVETIRACETAMANDA  #078526",
  "submission": "SUPPL-17",
  "activeIngredients": "LEVETIRACETAM",
  "company": "ORBION PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "ROSUVASTATIN CALCIUMANDA  #079171",
  "submission": "SUPPL-15",
  "activeIngredients": "ROSUVASTATIN CALCIUM",
  "company": "SANDOZ",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "SPIRONOLACTONE AND HYDROCHLOROTHIAZIDEANDA  #086881",
  "submission": "SUPPL-48",
  "activeIngredients": "HYDROCHLOROTHIAZIDE; SPIRONOLACTONE",
  "company": "CHARTWELL RX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "SPIRONOLACTONE AND HYDROCHLOROTHIAZIDEANDA  #086881",
  "submission": "SUPPL-49",
  "activeIngredients": "HYDROCHLOROTHIAZIDE; SPIRONOLACTONE",
  "company": "CHARTWELL RX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "LEVETIRACETAMANDA  #090484",
  "submission": "SUPPL-7",
  "activeIngredients": "LEVETIRACETAM",
  "company": "ORBION PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "LEVETIRACETAMANDA  #090484",
  "submission": "SUPPL-8",
  "activeIngredients": "LEVETIRACETAM",
  "company": "ORBION PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "LEVETIRACETAMANDA  #090484",
  "submission": "SUPPL-9",
  "activeIngredients": "LEVETIRACETAM",
  "company": "ORBION PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "LEVETIRACETAMANDA  #090484",
  "submission": "SUPPL-10",
  "activeIngredients": "LEVETIRACETAM",
  "company": "ORBION PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "LEVETIRACETAMANDA  #090484",
  "submission": "SUPPL-11",
  "activeIngredients": "LEVETIRACETAM",
  "company": "ORBION PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "LEVETIRACETAMANDA  #090484",
  "submission": "SUPPL-12",
  "activeIngredients": "LEVETIRACETAM",
  "company": "ORBION PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "LEVETIRACETAMANDA  #090484",
  "submission": "SUPPL-13",
  "activeIngredients": "LEVETIRACETAM",
  "company": "ORBION PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "LEVETIRACETAMANDA  #090843",
  "submission": "SUPPL-7",
  "activeIngredients": "LEVETIRACETAM",
  "company": "ACCORD HLTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "LEVETIRACETAMANDA  #090843",
  "submission": "SUPPL-8",
  "activeIngredients": "LEVETIRACETAM",
  "company": "ACCORD HLTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "LEVETIRACETAMANDA  #090843",
  "submission": "SUPPL-10",
  "activeIngredients": "LEVETIRACETAM",
  "company": "ACCORD HLTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "LEVETIRACETAMANDA  #090843",
  "submission": "SUPPL-11",
  "activeIngredients": "LEVETIRACETAM",
  "company": "ACCORD HLTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "LEVETIRACETAMANDA  #090843",
  "submission": "SUPPL-12",
  "activeIngredients": "LEVETIRACETAM",
  "company": "ACCORD HLTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "LEVETIRACETAMANDA  #090843",
  "submission": "SUPPL-14",
  "activeIngredients": "LEVETIRACETAM",
  "company": "ACCORD HLTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "GABAPENTINANDA  #090858",
  "submission": "SUPPL-41",
  "activeIngredients": "GABAPENTIN",
  "company": "ALKEM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "LAMIVUDINEANDA  #200406",
  "submission": "ORIG-1",
  "activeIngredients": "LAMIVUDINE",
  "company": "MICRO LABS LTD",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "CISATRACURIUM BESYLATEANDA  #201836",
  "submission": "SUPPL-2",
  "activeIngredients": "CISATRACURIUM BESYLATE",
  "company": "SAGENT PHARMS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "MYCOPHENOLATE SODIUMANDA  #202555",
  "submission": "SUPPL-3",
  "activeIngredients": "MYCOPHENOLATE SODIUM",
  "company": "ACCORD HLTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "MYCOPHENOLATE SODIUMANDA  #202555",
  "submission": "SUPPL-9",
  "activeIngredients": "MYCOPHENOLATE SODIUM",
  "company": "ACCORD HLTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "MYCOPHENOLATE SODIUMANDA  #202555",
  "submission": "SUPPL-11",
  "activeIngredients": "MYCOPHENOLATE SODIUM",
  "company": "ACCORD HLTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "METHYLPREDNISOLONE SODIUM SUCCINATEANDA  #202691",
  "submission": "SUPPL-6",
  "activeIngredients": "METHYLPREDNISOLONE SODIUM SUCCINATE",
  "company": "HIKMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "RALTEGRAVIR POTASSIUMANDA  #203540",
  "submission": "ORIG-1",
  "activeIngredients": "RALTEGRAVIR POTASSIUM",
  "company": "HETERO LABS LTD III",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "HARVONINDA   #205834",
  "submission": "SUPPL-36",
  "activeIngredients": "LEDIPASVIR; SOFOSBUVIR",
  "company": "GILEAD SCIENCES INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "CELECOXIBANDA  #206827",
  "submission": "SUPPL-13",
  "activeIngredients": "CELECOXIB",
  "company": "AUROBINDO PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "GABAPENTINANDA  #206943",
  "submission": "SUPPL-12",
  "activeIngredients": "GABAPENTIN",
  "company": "STRIDES PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "GABAPENTINANDA  #206943",
  "submission": "SUPPL-21",
  "activeIngredients": "GABAPENTIN",
  "company": "STRIDES PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "GABAPENTINANDA  #206943",
  "submission": "SUPPL-22",
  "activeIngredients": "GABAPENTIN",
  "company": "STRIDES PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "LANSOPRAZOLEANDA  #207167",
  "submission": "SUPPL-2",
  "activeIngredients": "LANSOPRAZOLE",
  "company": "AUROBINDO PHARMA LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "LANSOPRAZOLEANDA  #207394",
  "submission": "SUPPL-11",
  "activeIngredients": "LANSOPRAZOLE",
  "company": "ALKEM LABS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "PREGABALINANDA  #207799",
  "submission": "SUPPL-13",
  "activeIngredients": "PREGABALIN",
  "company": "ALKEM LABS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "DABIGATRAN ETEXILATE MESYLATEANDA  #207922",
  "submission": "ORIG-1",
  "activeIngredients": "DABIGATRAN ETEXILATE MESYLATE",
  "company": "BRECKENRIDGE",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "FINGOLIMOD HYDROCHLORIDEANDA  #207991",
  "submission": "SUPPL-3",
  "activeIngredients": "FINGOLIMOD HYDROCHLORIDE",
  "company": "ACCORD HLTHCARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "AZACITIDINENDA   #208216",
  "submission": "SUPPL-7",
  "activeIngredients": "AZACITIDINE",
  "company": "ACTAVIS LLC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "ENTECAVIRANDA  #208782",
  "submission": "SUPPL-5",
  "activeIngredients": "ENTECAVIR",
  "company": "PRINSTON INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "EZETIMIBE AND SIMVASTATINANDA  #208831",
  "submission": "SUPPL-13",
  "activeIngredients": "EZETIMIBE; SIMVASTATIN",
  "company": "AMNEAL PHARMS CO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "EZETIMIBE AND SIMVASTATINANDA  #208831",
  "submission": "SUPPL-14",
  "activeIngredients": "EZETIMIBE; SIMVASTATIN",
  "company": "AMNEAL PHARMS CO",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "DEXMEDETOMIDINE HYDROCHLORIDEANDA  #209307",
  "submission": "SUPPL-5",
  "activeIngredients": "DEXMEDETOMIDINE HYDROCHLORIDE",
  "company": "GLAND",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "XOFLUZANDA   #210854",
  "submission": "SUPPL-21",
  "activeIngredients": "BALOXAVIR MARBOXIL",
  "company": "GENENTECH INC",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "BUPROPION HYDROCHLORIDEANDA  #211200",
  "submission": "SUPPL-7",
  "activeIngredients": "BUPROPION HYDROCHLORIDE",
  "company": "ZHEJIANG JUTAI PHARM",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "PHYTONADIONEANDA  #212112",
  "submission": "ORIG-1",
  "activeIngredients": "PHYTONADIONE",
  "company": "HIKMA",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "HARVONINDA   #212477",
  "submission": "SUPPL-6",
  "activeIngredients": "LEDIPASVIR; SOFOSBUVIR",
  "company": "GILEAD SCIENCES INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "ABACAVIR SULFATE AND LAMIVUDINEANDA  #212663",
  "submission": "ORIG-1",
  "activeIngredients": "ABACAVIR SULFATE; LAMIVUDINE",
  "company": "MACLEODS PHARMS LTD",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDEANDA  #214065",
  "submission": "SUPPL-6",
  "activeIngredients": "CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE",
  "company": "ALKEM LABS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "IODIXANOLANDA  #214271",
  "submission": "SUPPL-8",
  "activeIngredients": "IODIXANOL",
  "company": "HENGRUI PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "XOFLUZANDA   #214410",
  "submission": "SUPPL-7",
  "activeIngredients": "BALOXAVIR MARBOXIL",
  "company": "GENENTECH INC",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "DEFENCATHNDA   #214520",
  "submission": "SUPPL-3",
  "activeIngredients": "HEPARIN SODIUM; TAUROLIDINE",
  "company": "CORMEDIX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "VEKLURYNDA   #214787",
  "submission": "SUPPL-29",
  "activeIngredients": "REMDESIVIR",
  "company": "GILEAD SCIENCES INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "CARBINOXAMINE MALEATEANDA  #215476",
  "submission": "ORIG-1",
  "activeIngredients": "CARBINOXAMINE MALEATE",
  "company": "LEADING",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "OXCARBAZEPINEANDA  #215939",
  "submission": "SUPPL-6",
  "activeIngredients": "OXCARBAZEPINE",
  "company": "ANNORA PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "TRYNGOLZA (AUTOINJECTOR)NDA   #218614",
  "submission": "ORIG-1",
  "activeIngredients": "OLEZARSEN SODIUM",
  "company": "IONIS PHARMS INC",
  "submissionClassification": "Type 1 - New Molecular Entity",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "CYCLOPHOSPHAMIDEANDA  #218644",
  "submission": "ORIG-1",
  "activeIngredients": "CYCLOPHOSPHAMIDE",
  "company": "EPIC PHARMA LLC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "DIVALPROEX SODIUMANDA  #218793",
  "submission": "ORIG-1",
  "activeIngredients": "DIVALPROEX SODIUM",
  "company": "ALEMBIC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/19\/2024",
  "drugName": "KANJINTIBLA   #761073",
  "submission": "SUPPL-10",
  "activeIngredients": "TRASTUZUMAB-ANNS",
  "company": "AMGEN INC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/20\/2024",
  "drugName": "IMIPRAMINE HYDROCHLORIDEANDA  #040751",
  "submission": "SUPPL-2",
  "activeIngredients": "IMIPRAMINE HYDROCHLORIDE",
  "company": "OXFORD PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/20\/2024",
  "drugName": "AUGMENTIN ES-600NDA   #050755",
  "submission": "SUPPL-31",
  "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
  "company": "US ANTIBIOTICS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/20\/2024",
  "drugName": "AUGMENTIN XRNDA   #050785",
  "submission": "SUPPL-19",
  "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
  "company": "US ANTIBIOTICS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/20\/2024",
  "drugName": "FLUPHENAZINE DECANOATEANDA  #075918",
  "submission": "SUPPL-21",
  "activeIngredients": "FLUPHENAZINE DECANOATE",
  "company": "MYLAN LABS LTD",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/20\/2024",
  "drugName": "TERBINAFINE HYDROCHLORIDEANDA  #077714",
  "submission": "SUPPL-3",
  "activeIngredients": "TERBINAFINE HYDROCHLORIDE",
  "company": "BRECKENRIDGE PHARM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/20\/2024",
  "drugName": "TERBINAFINE HYDROCHLORIDEANDA  #077714",
  "submission": "SUPPL-7",
  "activeIngredients": "TERBINAFINE HYDROCHLORIDE",
  "company": "BRECKENRIDGE PHARM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/20\/2024",
  "drugName": "TERBINAFINE HYDROCHLORIDEANDA  #077714",
  "submission": "SUPPL-9",
  "activeIngredients": "TERBINAFINE HYDROCHLORIDE",
  "company": "BRECKENRIDGE PHARM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/20\/2024",
  "drugName": "LEVETIRACETAMANDA  #079120",
  "submission": "SUPPL-12",
  "activeIngredients": "LEVETIRACETAM",
  "company": "BIONPHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/20\/2024",
  "drugName": "LEVETIRACETAMANDA  #079120",
  "submission": "SUPPL-14",
  "activeIngredients": "LEVETIRACETAM",
  "company": "BIONPHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/20\/2024",
  "drugName": "LEVETIRACETAMANDA  #079120",
  "submission": "SUPPL-15",
  "activeIngredients": "LEVETIRACETAM",
  "company": "BIONPHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/20\/2024",
  "drugName": "LEVETIRACETAMANDA  #079120",
  "submission": "SUPPL-18",
  "activeIngredients": "LEVETIRACETAM",
  "company": "BIONPHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/20\/2024",
  "drugName": "LEVETIRACETAMANDA  #079120",
  "submission": "SUPPL-21",
  "activeIngredients": "LEVETIRACETAM",
  "company": "BIONPHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/20\/2024",
  "drugName": "LEVETIRACETAMANDA  #079120",
  "submission": "SUPPL-22",
  "activeIngredients": "LEVETIRACETAM",
  "company": "BIONPHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/20\/2024",
  "drugName": "SILDENAFIL CITRATEANDA  #201156",
  "submission": "ORIG-1",
  "activeIngredients": "SILDENAFIL CITRATE",
  "company": "JUBILANT GENERICS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/20\/2024",
  "drugName": "IMBRUVICANDA   #205552",
  "submission": "SUPPL-43",
  "activeIngredients": "IBRUTINIB",
  "company": "PHARMACYCLICS LLC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/20\/2024",
  "drugName": "XIGDUO XRNDA   #205649",
  "submission": "SUPPL-23",
  "activeIngredients": "DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE",
  "company": "ASTRAZENECA AB",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/20\/2024",
  "drugName": "METHYLPREDNISOLONEANDA  #206751",
  "submission": "SUPPL-1",
  "activeIngredients": "METHYLPREDNISOLONE",
  "company": "ZYDUS PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/20\/2024",
  "drugName": "METHYLPREDNISOLONEANDA  #206751",
  "submission": "SUPPL-2",
  "activeIngredients": "METHYLPREDNISOLONE",
  "company": "ZYDUS PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/20\/2024",
  "drugName": "METHYLPREDNISOLONEANDA  #206751",
  "submission": "SUPPL-5",
  "activeIngredients": "METHYLPREDNISOLONE",
  "company": "ZYDUS PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/20\/2024",
  "drugName": "METHYLPREDNISOLONEANDA  #206751",
  "submission": "SUPPL-7",
  "activeIngredients": "METHYLPREDNISOLONE",
  "company": "ZYDUS PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/20\/2024",
  "drugName": "IBRANCENDA   #207103",
  "submission": "SUPPL-22",
  "activeIngredients": "PALBOCICLIB",
  "company": "PFIZER",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/20\/2024",
  "drugName": "DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATENDA   #209628",
  "submission": "ORIG-1",
  "activeIngredients": "DOLUTEGRAVIR;LAMIVUDINE;TENOFOVIR DISOPROXIL FUMARATE",
  "company": "CIPLA USA",
  "submissionClassification": "Type 4 - New Combination",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "12\/20\/2024",
  "drugName": "TERIFLUNOMIDEANDA  #209639",
  "submission": "SUPPL-2",
  "activeIngredients": "TERIFLUNOMIDE",
  "company": "BIOCON PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/20\/2024",
  "drugName": "STEGLATRONDA   #209803",
  "submission": "SUPPL-8",
  "activeIngredients": "ERTUGLIFLOZIN",
  "company": "MSD SUB MERCK",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/20\/2024",
  "drugName": "STEGLUJANNDA   #209805",
  "submission": "SUPPL-17",
  "activeIngredients": "ERTUGLIFLOZIN; SITAGLIPTIN PHOSPHATE",
  "company": "MSD SUB MERCK",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/20\/2024",
  "drugName": "SEGLUROMETNDA   #209806",
  "submission": "SUPPL-11",
  "activeIngredients": "ERTUGLIFLOZIN; METFORMIN HYDROCHLORIDE",
  "company": "MSD SUB MERCK",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/20\/2024",
  "drugName": "BRAFTOVINDA   #210496",
  "submission": "SUPPL-17",
  "activeIngredients": "ENCORAFENIB",
  "company": "ARRAY BIOPHARMA INC",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/20\/2024",
  "drugName": "IMBRUVICANDA   #210563",
  "submission": "SUPPL-19",
  "activeIngredients": "IBRUTINIB",
  "company": "PHARMACYCLICS LLC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/20\/2024",
  "drugName": "METHYLPREDNISOLONEANDA  #210985",
  "submission": "SUPPL-3",
  "activeIngredients": "METHYLPREDNISOLONE",
  "company": "NOVAST LABS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/20\/2024",
  "drugName": "METHYLPREDNISOLONEANDA  #210985",
  "submission": "SUPPL-4",
  "activeIngredients": "METHYLPREDNISOLONE",
  "company": "NOVAST LABS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/20\/2024",
  "drugName": "TRIKAFTA (COPACKAGED)NDA   #212273",
  "submission": "SUPPL-12",
  "activeIngredients": "ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR",
  "company": "VERTEX PHARMS INC",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/20\/2024",
  "drugName": "TRIKAFTA (COPACKAGED)NDA   #212273",
  "submission": "SUPPL-13",
  "activeIngredients": "ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR",
  "company": "VERTEX PHARMS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/20\/2024",
  "drugName": "IBRANCENDA   #212436",
  "submission": "SUPPL-10",
  "activeIngredients": "PALBOCICLIB",
  "company": "PFIZER",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/20\/2024",
  "drugName": "IMCIVREENDA   #213793",
  "submission": "SUPPL-7",
  "activeIngredients": "SETMELANOTIDE ACETATE",
  "company": "RHYTHM",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/20\/2024",
  "drugName": "SKYCLARYSNDA   #216718",
  "submission": "SUPPL-8",
  "activeIngredients": "OMAVELOXOLONE",
  "company": "BIOGEN US",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/20\/2024",
  "drugName": "SKYCLARYSNDA   #216718",
  "submission": "SUPPL-9",
  "activeIngredients": "OMAVELOXOLONE",
  "company": "BIOGEN US",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/20\/2024",
  "drugName": "IMBRUVICANDA   #217003",
  "submission": "SUPPL-4",
  "activeIngredients": "IBRUTINIB",
  "company": "PHARMACYCLICS LLC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/20\/2024",
  "drugName": "SYFOVRENDA   #217171",
  "submission": "SUPPL-2",
  "activeIngredients": "PEGCETACOPLAN",
  "company": "APELLIS PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/20\/2024",
  "drugName": "TETRACAINE HYDROCHLORIDEANDA  #217227",
  "submission": "ORIG-1",
  "activeIngredients": "TETRACAINE HYDROCHLORIDE",
  "company": "SOMERSET THERAPS LLC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/20\/2024",
  "drugName": "TRIKAFTA (COPACKAGED)NDA   #217660",
  "submission": "SUPPL-3",
  "activeIngredients": "ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR",
  "company": "VERTEX PHARMS INC",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/20\/2024",
  "drugName": "TRIKAFTA (COPACKAGED)NDA   #217660",
  "submission": "SUPPL-5",
  "activeIngredients": "ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR",
  "company": "VERTEX PHARMS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/20\/2024",
  "drugName": "ZEPBOUNDNDA   #217806",
  "submission": "SUPPL-13",
  "activeIngredients": "TIRZEPATIDE",
  "company": "ELI LILLY AND CO",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/20\/2024",
  "drugName": "ZEPBOUND (AUTOINJECTOR)NDA   #217806",
  "submission": "SUPPL-13",
  "activeIngredients": "TIRZEPATIDE",
  "company": "ELI LILLY AND CO",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/20\/2024",
  "drugName": "ALYFTREKNDA   #218730",
  "submission": "ORIG-1",
  "activeIngredients": "DEUTIVACAFTOR; TEZACAFTOR; VANZACAFTOR CALCIUM",
  "company": "VERTEX PHARMS INC",
  "submissionClassification": "Type 1 - New Molecular Entity",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/20\/2024",
  "drugName": "ICOSAPENT ETHYLANDA  #218994",
  "submission": "ORIG-1",
  "activeIngredients": "ICOSAPENT ETHYL",
  "company": "PHARMOBEDIENT",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/20\/2024",
  "drugName": "LASMIDITANANDA  #219350",
  "submission": "ORIG-1",
  "activeIngredients": "LASMIDITAN",
  "company": "QILU PHARMACEUTICAL CO., LTD.",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "12\/20\/2024",
  "drugName": "XENPOZYMEBLA   #761261",
  "submission": "SUPPL-4",
  "activeIngredients": "OLIPUDASE ALFA-RPCP",
  "company": "GENZYME CORP",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/20\/2024",
  "drugName": "ALHEMOBLA   #761315",
  "submission": "ORIG-1",
  "activeIngredients": "CONCIZUMAB-MTCI",
  "company": "NOVO NORDISK INC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/20\/2024",
  "drugName": "PYZCHIVABLA   #761373",
  "submission": "SUPPL-2",
  "activeIngredients": "USTEKINUMAB-TTWE",
  "company": "SAMSUNG BIOEPIS CO LTD",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/20\/2024",
  "drugName": "PYZCHIVABLA   #761425",
  "submission": "SUPPL-1",
  "activeIngredients": "USTEKINUMAB-TTWE",
  "company": "SAMSUNG BIOEPIS CO LTD",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/20\/2024",
  "drugName": "PYZCHIVABLA   #761425",
  "submission": "SUPPL-2",
  "activeIngredients": "USTEKINUMAB-TTWE",
  "company": "SAMSUNG BIOEPIS CO LTD",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/23\/2024",
  "drugName": "CARDIOGEN-82NDA   #019414",
  "submission": "SUPPL-34",
  "activeIngredients": "RUBIDIUM CHLORIDE RB-82",
  "company": "BRACCO",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/23\/2024",
  "drugName": "ARIXTRANDA   #021345",
  "submission": "SUPPL-52",
  "activeIngredients": "FONDAPARINUX SODIUM",
  "company": "MYLAN IRELAND LTD",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/23\/2024",
  "drugName": "CEFACLORANDA  #065146",
  "submission": "SUPPL-8",
  "activeIngredients": "CEFACLOR",
  "company": "YUNG SHIN PHARM",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/23\/2024",
  "drugName": "CEPHALEXINANDA  #065336",
  "submission": "SUPPL-7",
  "activeIngredients": "CEPHALEXIN",
  "company": "YUNG SHIN PHARM",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/23\/2024",
  "drugName": "CEFACLORANDA  #065412",
  "submission": "SUPPL-7",
  "activeIngredients": "CEFACLOR",
  "company": "YUNG SHIN PHARM",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/23\/2024",
  "drugName": "MELOXICAMANDA  #077918",
  "submission": "SUPPL-10",
  "activeIngredients": "MELOXICAM",
  "company": "YUNG SHIN PHARM",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/23\/2024",
  "drugName": "CLONIDINE HYDROCHLORIDEANDA  #202297",
  "submission": "SUPPL-6",
  "activeIngredients": "CLONIDINE HYDROCHLORIDE",
  "company": "YUNG SHIN PHARM",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/23\/2024",
  "drugName": "SOVALDINDA   #204671",
  "submission": "SUPPL-19",
  "activeIngredients": "SOFOSBUVIR",
  "company": "GILEAD SCIENCES INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/23\/2024",
  "drugName": "FELODIPINEANDA  #204800",
  "submission": "SUPPL-3",
  "activeIngredients": "FELODIPINE",
  "company": "YUNG SHIN PHARM",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/23\/2024",
  "drugName": "DICLOFENAC SODIUM AND MISOPROSTOLANDA  #205143",
  "submission": "SUPPL-8",
  "activeIngredients": "DICLOFENAC SODIUM; MISOPROSTOL",
  "company": "YUNG SHIN PHARM",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/23\/2024",
  "drugName": "AZACITIDINEANDA  #207518",
  "submission": "SUPPL-13",
  "activeIngredients": "AZACITIDINE",
  "company": "SHILPA MEDICARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/23\/2024",
  "drugName": "AZACITIDINEANDA  #207518",
  "submission": "SUPPL-16",
  "activeIngredients": "AZACITIDINE",
  "company": "SHILPA MEDICARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/23\/2024",
  "drugName": "AZACITIDINEANDA  #207518",
  "submission": "SUPPL-18",
  "activeIngredients": "AZACITIDINE",
  "company": "SHILPA MEDICARE",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/23\/2024",
  "drugName": "ONIVYDENDA   #207793",
  "submission": "SUPPL-18",
  "activeIngredients": "IRINOTECAN HYDROCHLORIDE",
  "company": "IPSEN",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/23\/2024",
  "drugName": "ENTECAVIRANDA  #208195",
  "submission": "SUPPL-2",
  "activeIngredients": "ENTECAVIR",
  "company": "YUNG SHIN PHARM",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/23\/2024",
  "drugName": "AZITHROMYCINANDA  #211068",
  "submission": "SUPPL-4",
  "activeIngredients": "AZITHROMYCIN",
  "company": "YUNG SHIN PHARM",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/23\/2024",
  "drugName": "AZITHROMYCINANDA  #211317",
  "submission": "SUPPL-2",
  "activeIngredients": "AZITHROMYCIN",
  "company": "YUNG SHIN PHARM",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/23\/2024",
  "drugName": "AZITHROMYCINANDA  #211318",
  "submission": "SUPPL-2",
  "activeIngredients": "AZITHROMYCIN",
  "company": "PHARMOBEDIENT",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/23\/2024",
  "drugName": "SOVALDINDA   #212480",
  "submission": "SUPPL-4",
  "activeIngredients": "SOFOSBUVIR",
  "company": "GILEAD SCIENCES INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/23\/2024",
  "drugName": "PREGABALINANDA  #212865",
  "submission": "SUPPL-1",
  "activeIngredients": "PREGABALIN",
  "company": "CHARTWELL RX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/23\/2024",
  "drugName": "PREGABALINANDA  #212865",
  "submission": "SUPPL-4",
  "activeIngredients": "PREGABALIN",
  "company": "CHARTWELL RX",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/23\/2024",
  "drugName": "LIRAGLUTIDEANDA  #215503",
  "submission": "ORIG-1",
  "activeIngredients": "LIRAGLUTIDE",
  "company": "HIKMA",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/23\/2024",
  "drugName": "OLOPATADINE HYDROCHLORIDEANDA  #216499",
  "submission": "ORIG-1",
  "activeIngredients": "OLOPATADINE HYDROCHLORIDE",
  "company": "SOMERSET THERAPEUTICS, LLC",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "12\/23\/2024",
  "drugName": "XROMINDA   #216593",
  "submission": "ORIG-2",
  "activeIngredients": "HYDROXYUREA",
  "company": "NOVA LABS LTD",
  "submissionClassification": "Efficacy",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/23\/2024",
  "drugName": "ENTECAVIRANDA  #216857",
  "submission": "ORIG-1",
  "activeIngredients": "ENTECAVIR",
  "company": "CONBA USA",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/23\/2024",
  "drugName": "EDARAVONEANDA  #216902",
  "submission": "ORIG-1",
  "activeIngredients": "EDARAVONE",
  "company": "SANDOZ",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/23\/2024",
  "drugName": "POSACONAZOLEANDA  #219057",
  "submission": "ORIG-1",
  "activeIngredients": "POSACONAZOLE",
  "company": "ASPIRO",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/23\/2024",
  "drugName": "YUFLYMABLA   #761219",
  "submission": "SUPPL-13",
  "activeIngredients": "ADALIMUMAB-AATY",
  "company": "CELLTRION",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/26\/2024",
  "drugName": "CHLORHEXIDINE GLUCONATEANDA  #074522",
  "submission": "SUPPL-19",
  "activeIngredients": "CHLORHEXIDINE GLUCONATE",
  "company": "PHARM ASSOC",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/26\/2024",
  "drugName": "CHOLESTYRAMINEANDA  #074557",
  "submission": "SUPPL-16",
  "activeIngredients": "CHOLESTYRAMINE",
  "company": "EPIC PHARMA LLC",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/26\/2024",
  "drugName": "CHOLESTYRAMINE LIGHTANDA  #074558",
  "submission": "SUPPL-14",
  "activeIngredients": "CHOLESTYRAMINE",
  "company": "EPIC PHARMA LLC",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/26\/2024",
  "drugName": "LISDEXAMFETAMINE DIMESYLATEANDA  #202836",
  "submission": "SUPPL-1",
  "activeIngredients": "LISDEXAMFETAMINE DIMESYLATE",
  "company": "SANDOZ",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/26\/2024",
  "drugName": "LAMOTRIGINEANDA  #207497",
  "submission": "SUPPL-14",
  "activeIngredients": "LAMOTRIGINE",
  "company": "AMNEAL PHARMS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/26\/2024",
  "drugName": "TERIFLUNOMIDEANDA  #209638",
  "submission": "SUPPL-8",
  "activeIngredients": "TERIFLUNOMIDE",
  "company": "AUROBINDO PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/26\/2024",
  "drugName": "TERIFLUNOMIDEANDA  #209638",
  "submission": "SUPPL-9",
  "activeIngredients": "TERIFLUNOMIDE",
  "company": "AUROBINDO PHARMA",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/26\/2024",
  "drugName": "EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDEANDA  #212243",
  "submission": "ORIG-1",
  "activeIngredients": "EMPAGLIFLOZIN;METFORMIN HYDROCHLORIDE",
  "company": "CIPLA LTD",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "12\/26\/2024",
  "drugName": "DROSPIRENONE AND ETHINYL ESTRADIOLANDA  #213034",
  "submission": "SUPPL-2",
  "activeIngredients": "DROSPIRENONE; ETHINYL ESTRADIOL",
  "company": "HETERO LABS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/26\/2024",
  "drugName": "DROSPIRENONE AND ETHINYL ESTRADIOLANDA  #213034",
  "submission": "SUPPL-4",
  "activeIngredients": "DROSPIRENONE; ETHINYL ESTRADIOL",
  "company": "HETERO LABS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/26\/2024",
  "drugName": "DEUTETRABENAZINEANDA  #215971",
  "submission": "ORIG-1",
  "activeIngredients": "DEUTETRABENAZINE",
  "company": "AUROBINDO PHARMA LTD",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/26\/2024",
  "drugName": "PRUCALOPRIDE SUCCINATEANDA  #218492",
  "submission": "ORIG-1",
  "activeIngredients": "PRUCALOPRIDE SUCCINATE",
  "company": "NOVITIUM PHARMA",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/26\/2024",
  "drugName": "CYCLOPHOSPHAMIDEANDA  #218632",
  "submission": "ORIG-1",
  "activeIngredients": "CYCLOPHOSPHAMIDE",
  "company": "HAINAN POLY",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/26\/2024",
  "drugName": "EBANGABLA   #761172",
  "submission": "SUPPL-8",
  "activeIngredients": "ANSUVIMAB-ZYKL",
  "company": "RIDGEBACK BIOTHERAPEUTICS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/26\/2024",
  "drugName": "WEZLANABLA   #761285",
  "submission": "SUPPL-1",
  "activeIngredients": "USTEKINUMAB-AUUB",
  "company": "AMGEN INC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/26\/2024",
  "drugName": "WEZLANABLA   #761331",
  "submission": "SUPPL-1",
  "activeIngredients": "USTEKINUMAB-AUUB",
  "company": "AMGEN INC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/26\/2024",
  "drugName": "TEVIMBRABLA   #761417",
  "submission": "ORIG-1",
  "activeIngredients": "TISLELIZUMAB-JSGR",
  "company": "BEIGENE",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/27\/2024",
  "drugName": "SPIRIVA RESPIMATNDA   #021936",
  "submission": "SUPPL-36",
  "activeIngredients": "TIOTROPIUM BROMIDE",
  "company": "BOEHRINGER INGELHEIM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/27\/2024",
  "drugName": "PROMACTANDA   #022291",
  "submission": "SUPPL-40",
  "activeIngredients": "ELTROMBOPAG OLAMINE",
  "company": "NOVARTIS",
  "submissionClassification": "Manufacturing (CMC)",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/27\/2024",
  "drugName": "STRIVERDI RESPIMATNDA   #203108",
  "submission": "SUPPL-23",
  "activeIngredients": "OLODATEROL HYDROCHLORIDE",
  "company": "BOEHRINGER INGELHEIM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/27\/2024",
  "drugName": "EXONDYS 51NDA   #206488",
  "submission": "SUPPL-35",
  "activeIngredients": "ETEPLIRSEN",
  "company": "SAREPTA THERAPS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/27\/2024",
  "drugName": "BUMETANIDEANDA  #213942",
  "submission": "ORIG-1",
  "activeIngredients": "BUMETANIDE",
  "company": "RUBICON RESEARCH",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/27\/2024",
  "drugName": "GABAPENTINANDA  #217995",
  "submission": "SUPPL-2",
  "activeIngredients": "GABAPENTIN",
  "company": "RISING",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/27\/2024",
  "drugName": "TOFACITINIBANDA  #218437",
  "submission": "ORIG-1",
  "activeIngredients": "TOFACITINIB",
  "company": "ANNORA PHARMA PRIVATE LIMITED",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "12\/27\/2024",
  "drugName": "OPDIVO QVANTIGBLA   #761381",
  "submission": "ORIG-1",
  "activeIngredients": "NIVOLUMAB;HYALURONIDASE-NVHY",
  "company": "BRISTOL-MYERS SQUIBB",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/27\/2024",
  "drugName": "OPDIVO QVANTIGBLA   #761429",
  "submission": "ORIG-1",
  "activeIngredients": "NIVOLUMAB;HYALURONIDASE-NVHY",
  "company": "BRISTOL-MYERS SQUIBB",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/30\/2024",
  "drugName": "ADVILNDA   #018989",
  "submission": "SUPPL-104",
  "activeIngredients": "IBUPROFEN",
  "company": "HALEON US HOLDINGS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/30\/2024",
  "drugName": "SPIRIVANDA   #021395",
  "submission": "SUPPL-78",
  "activeIngredients": "TIOTROPIUM BROMIDE",
  "company": "BOEHRINGER INGELHEIM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/30\/2024",
  "drugName": "ATROVENT HFANDA   #021527",
  "submission": "SUPPL-42",
  "activeIngredients": "IPRATROPIUM BROMIDE",
  "company": "BOEHRINGER INGELHEIM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/30\/2024",
  "drugName": "LUMIZYMEBLA   #125291",
  "submission": "SUPPL-161",
  "activeIngredients": "ALGLUCOSIDASE ALFA",
  "company": "GENZYME",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/30\/2024",
  "drugName": "STIOLTO RESPIMATNDA   #206756",
  "submission": "SUPPL-36",
  "activeIngredients": "OLODATEROL HYDROCHLORIDE; TIOTROPIUM BROMIDE",
  "company": "BOEHRINGER INGELHEIM",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/30\/2024",
  "drugName": "REZUROCKNDA   #214783",
  "submission": "SUPPL-7",
  "activeIngredients": "BELUMOSUDIL MESYLATE",
  "company": "KADMON PHARMS LLC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/30\/2024",
  "drugName": "CYCLOPHOSPHAMIDENDA   #217150",
  "submission": "SUPPL-1",
  "activeIngredients": "CYCLOPHOSPHAMIDE",
  "company": "SANDOZ",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/30\/2024",
  "drugName": "BRIMONIDINE TARTRATE AND TIMOLOL MALEATEANDA  #217288",
  "submission": "ORIG-1",
  "activeIngredients": "BRIMONIDINE TARTRATE; TIMOLOL MALEATE",
  "company": "AMNEAL",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/31\/2024",
  "drugName": "CELECOXIBANDA  #204776",
  "submission": "SUPPL-13",
  "activeIngredients": "CELECOXIB",
  "company": "MICRO LABS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/31\/2024",
  "drugName": "GABAPENTINANDA  #204989",
  "submission": "SUPPL-20",
  "activeIngredients": "GABAPENTIN",
  "company": "SCIEGEN PHARMS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/31\/2024",
  "drugName": "GABAPENTINANDA  #204989",
  "submission": "SUPPL-32",
  "activeIngredients": "GABAPENTIN",
  "company": "SCIEGEN PHARMS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/31\/2024",
  "drugName": "GABAPENTINANDA  #204989",
  "submission": "SUPPL-37",
  "activeIngredients": "GABAPENTIN",
  "company": "SCIEGEN PHARMS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/31\/2024",
  "drugName": "GABAPENTINANDA  #205101",
  "submission": "SUPPL-19",
  "activeIngredients": "GABAPENTIN",
  "company": "SCIEGEN PHARMS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/31\/2024",
  "drugName": "GABAPENTINANDA  #205101",
  "submission": "SUPPL-25",
  "activeIngredients": "GABAPENTIN",
  "company": "SCIEGEN PHARMS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/31\/2024",
  "drugName": "GABAPENTINANDA  #205101",
  "submission": "SUPPL-28",
  "activeIngredients": "GABAPENTIN",
  "company": "SCIEGEN PHARMS INC",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/31\/2024",
  "drugName": "GABAPENTINANDA  #207057",
  "submission": "SUPPL-1",
  "activeIngredients": "GABAPENTIN",
  "company": "CSPC OUYI",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/31\/2024",
  "drugName": "GABAPENTINANDA  #207057",
  "submission": "SUPPL-4",
  "activeIngredients": "GABAPENTIN",
  "company": "CSPC OUYI",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/31\/2024",
  "drugName": "GABAPENTINANDA  #207057",
  "submission": "SUPPL-5",
  "activeIngredients": "GABAPENTIN",
  "company": "CSPC OUYI",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/31\/2024",
  "drugName": "GABAPENTINANDA  #207057",
  "submission": "SUPPL-7",
  "activeIngredients": "GABAPENTIN",
  "company": "CSPC OUYI",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/31\/2024",
  "drugName": "SPRAVATONDA   #211243",
  "submission": "SUPPL-13",
  "activeIngredients": "ESKETAMINE HYDROCHLORIDE",
  "company": "JANSSEN PHARMS",
  "submissionClassification": "REMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/31\/2024",
  "drugName": "TROMETHAMINEANDA  #213116",
  "submission": "ORIG-1",
  "activeIngredients": "TROMETHAMINE",
  "company": "MILLA PHARMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/31\/2024",
  "drugName": "EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATEANDA  #214216",
  "submission": "ORIG-1",
  "activeIngredients": "EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE",
  "company": "MACLEODS PHARMS LTD",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "12\/31\/2024",
  "drugName": "GLYCOPYRROLATEANDA  #214847",
  "submission": "ORIG-1",
  "activeIngredients": "GLYCOPYRROLATE",
  "company": "AUROBINDO PHARMA LTD",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/31\/2024",
  "drugName": "SAFINAMIDE MESYLATEANDA  #215978",
  "submission": "ORIG-1",
  "activeIngredients": "SAFINAMIDE MESYLATE",
  "company": "MSN",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/31\/2024",
  "drugName": "METRONIDAZOLEANDA  #216750",
  "submission": "ORIG-1",
  "activeIngredients": "METRONIDAZOLE",
  "company": "SCIEGEN PHARMS INC",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/31\/2024",
  "drugName": "DIAZEPAMANDA  #217178",
  "submission": "ORIG-1",
  "activeIngredients": "DIAZEPAM",
  "company": "LONG GROVE PHARMS",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/31\/2024",
  "drugName": "GABAPENTINANDA  #217546",
  "submission": "SUPPL-6",
  "activeIngredients": "GABAPENTIN",
  "company": "LAURUS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/31\/2024",
  "drugName": "GABAPENTINANDA  #217965",
  "submission": "SUPPL-3",
  "activeIngredients": "GABAPENTIN",
  "company": "LAURUS",
  "submissionClassification": "Labeling",
  "submissionStatus": "Approval"
 },
 {
  "approvalDate": "12\/31\/2024",
  "drugName": "TOFACITINIBANDA  #218123",
  "submission": "ORIG-1",
  "activeIngredients": "TOFACITINIB",
  "company": "ANNORA PHARMA PRIVATE LIMITED",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "12\/31\/2024",
  "drugName": "ABACAVIR; DOLUTEGRAVIR; LAMIVUDINEANDA  #218723",
  "submission": "ORIG-1",
  "activeIngredients": "ABACAVIR;DOLUTEGRAVIR;LAMIVUDINE",
  "company": "LUPIN LTD",
  "submissionStatus": "Tentative Approval"
 },
 {
  "approvalDate": "12\/31\/2024",
  "drugName": "SUMATRIPTAN SUCCINATEANDA  #219036",
  "submission": "ORIG-1",
  "activeIngredients": "SUMATRIPTAN SUCCINATE",
  "company": "VKT PHARMA",
  "submissionStatus": "Approval"
 }
,
  {
    "approvalDate": "01/02/2025",
    "drugName": "MIRABEGRONANDA  #209434",
    "submission": "ORIG-1",
    "activeIngredients": "MIRABEGRON",
    "company": "APOTEX",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/02/2025",
    "drugName": "ELAGOLIXANDA  #217642",
    "submission": "ORIG-1",
    "activeIngredients": "ELAGOLIX",
    "company": "TEVA PHARMS INC",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "01/02/2025",
    "drugName": "LUBIPROSTONEANDA  #218640",
    "submission": "ORIG-1",
    "activeIngredients": "LUBIPROSTONE",
    "company": "ASCENT PHARMS INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2025",
    "drugName": "AMLODIPINE BESYLATEANDA  #078925",
    "submission": "SUPPL-25",
    "activeIngredients": "AMLODIPINE BESYLATE",
    "company": "ALKEM",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2025",
    "drugName": "BICALUTAMIDEANDA  #079089",
    "submission": "SUPPL-6",
    "activeIngredients": "BICALUTAMIDE",
    "company": "ADAPTIS",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2025",
    "drugName": "INJECTAFERNDA   #203565",
    "submission": "SUPPL-27",
    "activeIngredients": "FERRIC CARBOXYMALTOSE",
    "company": "AM REGENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2025",
    "drugName": "VILAZODONE HYDROCHLORIDEANDA  #208200",
    "submission": "SUPPL-6",
    "activeIngredients": "VILAZODONE HYDROCHLORIDE",
    "company": "INVAGEN PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2025",
    "drugName": "VILAZODONE HYDROCHLORIDEANDA  #208209",
    "submission": "SUPPL-4",
    "activeIngredients": "VILAZODONE HYDROCHLORIDE",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2025",
    "drugName": "ICATIBANT ACETATEANDA  #211021",
    "submission": "SUPPL-12",
    "activeIngredients": "ICATIBANT ACETATE",
    "company": "JIANGSU HANSOH PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2025",
    "drugName": "TURALIONDA   #211810",
    "submission": "SUPPL-13",
    "activeIngredients": "PEXIDARTINIB HYDROCHLORIDE",
    "company": "DAIICHI SANKYO INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2025",
    "drugName": "DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)ANDA  #212299",
    "submission": "SUPPL-7",
    "activeIngredients": "DOXORUBICIN HYDROCHLORIDE",
    "company": "ZYDUS LIFESCIENCES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2025",
    "drugName": "PHYTONADIONEANDA  #214966",
    "submission": "ORIG-1",
    "activeIngredients": "PHYTONADIONE",
    "company": "CIPLA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2025",
    "drugName": "PYRUKYNDNDA   #216196",
    "submission": "SUPPL-4",
    "activeIngredients": "MITAPIVAT SULFATE",
    "company": "AGIOS PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2025",
    "drugName": "CLOFARABINEANDA  #216233",
    "submission": "ORIG-1",
    "activeIngredients": "CLOFARABINE",
    "company": "SCINOPHARM TAIWAN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/03/2025",
    "drugName": "UPADACITINIBANDA  #218866",
    "submission": "ORIG-1",
    "activeIngredients": "UPADACITINIB",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "01/06/2025",
    "drugName": "METRONIDAZOLENDA   #018907",
    "submission": "SUPPL-9",
    "activeIngredients": "METRONIDAZOLE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/06/2025",
    "drugName": "DIMETHYL FUMARATEANDA  #210390",
    "submission": "ORIG-1",
    "activeIngredients": "DIMETHYL FUMARATE",
    "company": "TORRENT",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/06/2025",
    "drugName": "VARENICLINEANDA  #217954",
    "submission": "ORIG-1",
    "activeIngredients": "VARENICLINE",
    "company": "APOTEX INC",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "01/06/2025",
    "drugName": "REVEFENACINANDA  #218089",
    "submission": "ORIG-1",
    "activeIngredients": "REVEFENACIN",
    "company": "MANKIND PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "01/07/2025",
    "drugName": "DEMEROLNDA   #021171",
    "submission": "SUPPL-60",
    "activeIngredients": "MEPERIDINE HYDROCHLORIDE",
    "company": "HOSPIRA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/07/2025",
    "drugName": "GABAPENTINANDA  #075350",
    "submission": "SUPPL-72",
    "activeIngredients": "GABAPENTIN",
    "company": "ACTAVIS ELIZABETH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/07/2025",
    "drugName": "GABAPENTINANDA  #075350",
    "submission": "SUPPL-77",
    "activeIngredients": "GABAPENTIN",
    "company": "ACTAVIS ELIZABETH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/07/2025",
    "drugName": "AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDEANDA  #207299",
    "submission": "ORIG-1",
    "activeIngredients": "AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/07/2025",
    "drugName": "METFORMIN HYDROCHLORIDE AND SITAGLIPTIN PHOSPHATEANDA  #212338",
    "submission": "ORIG-1",
    "activeIngredients": "METFORMIN HYDROCHLORIDE || SITAGLIPTIN",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "01/07/2025",
    "drugName": "DIHYDROERGOTAMINE MESYLATEANDA  #216747",
    "submission": "ORIG-1",
    "activeIngredients": "DIHYDROERGOTAMINE MESYLATE",
    "company": "BAXTER HLTHCARE CORP",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/07/2025",
    "drugName": "ESOMEPRAZOLE MAGNESIUMANDA  #217714",
    "submission": "ORIG-1",
    "activeIngredients": "ESOMEPRAZOLE MAGNESIUM",
    "company": "CIPLA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/07/2025",
    "drugName": "PREDNISONEANDA  #218035",
    "submission": "ORIG-1",
    "activeIngredients": "PREDNISONE",
    "company": "DR REDDYS LABS LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "01/07/2025",
    "drugName": "NABUMETONEANDA  #219118",
    "submission": "ORIG-1",
    "activeIngredients": "NABUMETONE",
    "company": "NOVITIUM PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/08/2025",
    "drugName": "ADVIL LIQUI-GELSNDA   #020402",
    "submission": "SUPPL-58",
    "activeIngredients": "IBUPROFEN",
    "company": "HALEON US HOLDINGS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/08/2025",
    "drugName": "ADVIL MIGRAINE LIQUI-GELSNDA   #020402",
    "submission": "SUPPL-58",
    "activeIngredients": "IBUPROFEN",
    "company": "HALEON US HOLDINGS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/08/2025",
    "drugName": "METHYLINNDA   #021475",
    "submission": "SUPPL-13",
    "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "company": "SPECGX LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/08/2025",
    "drugName": "ISOSORBIDE DINITRATEANDA  #086923",
    "submission": "SUPPL-39",
    "activeIngredients": "ISOSORBIDE DINITRATE",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/08/2025",
    "drugName": "ISOSORBIDE DINITRATEANDA  #086925",
    "submission": "SUPPL-41",
    "activeIngredients": "ISOSORBIDE DINITRATE",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/08/2025",
    "drugName": "ISOSORBIDE DINITRATEANDA  #087537",
    "submission": "SUPPL-24",
    "activeIngredients": "ISOSORBIDE DINITRATE",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/08/2025",
    "drugName": "ISOSORBIDE DINITRATEANDA  #087946",
    "submission": "SUPPL-22",
    "activeIngredients": "ISOSORBIDE DINITRATE",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/08/2025",
    "drugName": "LAMOTRIGINEANDA  #207763",
    "submission": "SUPPL-4",
    "activeIngredients": "LAMOTRIGINE",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/08/2025",
    "drugName": "IMATINIB MESYLATEANDA  #208429",
    "submission": "SUPPL-2",
    "activeIngredients": "IMATINIB MESYLATE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/08/2025",
    "drugName": "ELURYNGANDA  #210830",
    "submission": "SUPPL-20",
    "activeIngredients": "ETHINYL ESTRADIOL; ETONOGESTREL",
    "company": "AMNEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/08/2025",
    "drugName": "HALOETTEANDA  #211328",
    "submission": "SUPPL-1",
    "activeIngredients": "ETHINYL ESTRADIOL; ETONOGESTREL",
    "company": "DR REDDYS LABS SA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/08/2025",
    "drugName": "SACUBITRIL AND VALSARTANANDA  #213808",
    "submission": "ORIG-1",
    "activeIngredients": "SACUBITRIL; VALSARTAN",
    "company": "LUPIN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/08/2025",
    "drugName": "TIPIRACIL HYDROCHLORIDE AND TRIFLURIDINEANDA  #214024",
    "submission": "ORIG-1",
    "activeIngredients": "TIPIRACIL HYDROCHLORIDE; TRIFLURIDINE",
    "company": "MSN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/08/2025",
    "drugName": "ESOMEPRAZOLE SODIUMANDA  #214046",
    "submission": "ORIG-1",
    "activeIngredients": "ESOMEPRAZOLE SODIUM",
    "company": "EPIC PHARMA LLC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/08/2025",
    "drugName": "METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDEANDA  #215789",
    "submission": "ORIG-1",
    "activeIngredients": "HYDROCHLOROTHIAZIDE; METOPROLOL TARTRATE",
    "company": "SENORES PHARMS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/08/2025",
    "drugName": "IVACAFTORANDA  #217431",
    "submission": "ORIG-1",
    "activeIngredients": "IVACAFTOR",
    "company": "LUPIN LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "01/08/2025",
    "drugName": "PERAMPANELANDA  #218178",
    "submission": "ORIG-1",
    "activeIngredients": "PERAMPANEL",
    "company": "MSN LABORATORIES PRIVATE LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "01/08/2025",
    "drugName": "OXCARBAZEPINEANDA  #218442",
    "submission": "ORIG-1",
    "activeIngredients": "OXCARBAZEPINE",
    "company": "BIOCON PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "01/10/2025",
    "drugName": "FLONASE SENSIMIST ALLERGY RELIEFNDA   #022051",
    "submission": "SUPPL-24",
    "activeIngredients": "FLUTICASONE FUROATE",
    "company": "HALEON US HOLDINGS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/10/2025",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #090325",
    "submission": "SUPPL-20",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "AUROBINDO PHARMA USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/10/2025",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #090325",
    "submission": "SUPPL-21",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "AUROBINDO PHARMA USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/10/2025",
    "drugName": "FLONASE ALLERGY RELIEFNDA   #205434",
    "submission": "SUPPL-17",
    "activeIngredients": "FLUTICASONE PROPIONATE",
    "company": "HALEON US HOLDINGS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/10/2025",
    "drugName": "IBSRELANDA   #211801",
    "submission": "SUPPL-12",
    "activeIngredients": "TENAPANOR HYDROCHLORIDE",
    "company": "ARDELYX INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/10/2025",
    "drugName": "CYANOCOBALAMINANDA  #214390",
    "submission": "SUPPL-3",
    "activeIngredients": "CYANOCOBALAMIN",
    "company": "GLAND",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/10/2025",
    "drugName": "VEKLURYNDA   #214787",
    "submission": "SUPPL-30",
    "activeIngredients": "REMDESIVIR",
    "company": "GILEAD SCIENCES INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/10/2025",
    "drugName": "POSLUMANDA   #216023",
    "submission": "SUPPL-4",
    "activeIngredients": "FLOTUFOLASTAT F-18 GALLIUM",
    "company": "BLUE EARTH",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/10/2025",
    "drugName": "ATORVASTATIN CALCIUMANDA  #216436",
    "submission": "SUPPL-4",
    "activeIngredients": "ATORVASTATIN CALCIUM",
    "company": "BIOCON PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/10/2025",
    "drugName": "SIPONIMODANDA  #218228",
    "submission": "ORIG-1",
    "activeIngredients": "SIPONIMOD",
    "company": "CIPLA LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "01/10/2025",
    "drugName": "EVEROLIMUSANDA  #218863",
    "submission": "ORIG-1",
    "activeIngredients": "EVEROLIMUS",
    "company": "AMNEAL",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/13/2025",
    "drugName": "DALVANCENDA   #021883",
    "submission": "SUPPL-12",
    "activeIngredients": "DALBAVANCIN HYDROCHLORIDE",
    "company": "ABBVIE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/13/2025",
    "drugName": "HALOPERIDOLANDA  #075689",
    "submission": "SUPPL-22",
    "activeIngredients": "HALOPERIDOL LACTATE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/13/2025",
    "drugName": "HALOPERIDOLANDA  #075689",
    "submission": "SUPPL-24",
    "activeIngredients": "HALOPERIDOL LACTATE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/13/2025",
    "drugName": "HALOPERIDOLANDA  #076035",
    "submission": "SUPPL-26",
    "activeIngredients": "HALOPERIDOL LACTATE",
    "company": "TEVA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/13/2025",
    "drugName": "GUAIFENESINANDA  #078912",
    "submission": "SUPPL-14",
    "activeIngredients": "GUAIFENESIN",
    "company": "PERRIGO R AND D",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/13/2025",
    "drugName": "GUAIFENESINANDA  #078912",
    "submission": "SUPPL-19",
    "activeIngredients": "GUAIFENESIN",
    "company": "PERRIGO R AND D",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/13/2025",
    "drugName": "ARIPIPRAZOLEANDA  #202102",
    "submission": "SUPPL-25",
    "activeIngredients": "ARIPIPRAZOLE",
    "company": "ALEMBIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/13/2025",
    "drugName": "ARIPIPRAZOLEANDA  #203906",
    "submission": "SUPPL-15",
    "activeIngredients": "ARIPIPRAZOLE",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/13/2025",
    "drugName": "LURASIDONE HYDROCHLORIDEANDA  #208055",
    "submission": "ORIG-2",
    "activeIngredients": "LURASIDONE HYDROCHLORIDE",
    "company": "TORRENT",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/13/2025",
    "drugName": "REGORAFENIBANDA  #209728",
    "submission": "ORIG-1",
    "activeIngredients": "REGORAFENIB",
    "company": "ACTAVIS LABS FL",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/13/2025",
    "drugName": "CARBAMAZEPINEANDA  #212524",
    "submission": "ORIG-1",
    "activeIngredients": "CARBAMAZEPINE",
    "company": "TORRENT",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/13/2025",
    "drugName": "ARIPIPRAZOLEANDA  #212870",
    "submission": "SUPPL-6",
    "activeIngredients": "ARIPIPRAZOLE",
    "company": "VISTAPHARM LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/13/2025",
    "drugName": "SACUBITRIL AND VALSARTANANDA  #213627",
    "submission": "ORIG-1",
    "activeIngredients": "SACUBITRIL; VALSARTAN",
    "company": "DR REDDYS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/13/2025",
    "drugName": "BREXPIPRAZOLEANDA  #213683",
    "submission": "ORIG-1",
    "activeIngredients": "BREXPIPRAZOLE",
    "company": "ALEMBIC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/13/2025",
    "drugName": "TRETINOINANDA  #218246",
    "submission": "ORIG-1",
    "activeIngredients": "TRETINOIN",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/13/2025",
    "drugName": "THEOPHYLLINEANDA  #218401",
    "submission": "ORIG-1",
    "activeIngredients": "THEOPHYLLINE",
    "company": "AJANTA PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/13/2025",
    "drugName": "MESNAANDA  #218871",
    "submission": "ORIG-1",
    "activeIngredients": "MESNA",
    "company": "NOVAST LABS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/14/2025",
    "drugName": "TRIFLUOPERAZINE HYDROCHLORIDEANDA  #040209",
    "submission": "SUPPL-21",
    "activeIngredients": "TRIFLUOPERAZINE HYDROCHLORIDE",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/14/2025",
    "drugName": "METHOTREXATE SODIUM PRESERVATIVE FREEANDA  #040716",
    "submission": "SUPPL-16",
    "activeIngredients": "METHOTREXATE SODIUM",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/14/2025",
    "drugName": "METHOTREXATE SODIUM PRESERVATIVE FREEANDA  #040716",
    "submission": "SUPPL-17",
    "activeIngredients": "METHOTREXATE SODIUM",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/14/2025",
    "drugName": "METHOTREXATE SODIUM PRESERVATIVE FREEANDA  #040767",
    "submission": "SUPPL-12",
    "activeIngredients": "METHOTREXATE SODIUM",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/14/2025",
    "drugName": "METHOTREXATE SODIUM PRESERVATIVE FREEANDA  #040767",
    "submission": "SUPPL-13",
    "activeIngredients": "METHOTREXATE SODIUM",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/14/2025",
    "drugName": "METHOTREXATE SODIUM PRESERVATIVE FREEANDA  #040768",
    "submission": "SUPPL-14",
    "activeIngredients": "METHOTREXATE SODIUM",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/14/2025",
    "drugName": "METHOTREXATE SODIUM PRESERVATIVE FREEANDA  #040768",
    "submission": "SUPPL-15",
    "activeIngredients": "METHOTREXATE SODIUM",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/14/2025",
    "drugName": "RISPERIDONEANDA  #076996",
    "submission": "SUPPL-3",
    "activeIngredients": "RISPERIDONE",
    "company": "ACTAVIS LABS FL INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/14/2025",
    "drugName": "ZOLPIDEM TARTRATEANDA  #077903",
    "submission": "SUPPL-34",
    "activeIngredients": "ZOLPIDEM TARTRATE",
    "company": "TORRENT PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/14/2025",
    "drugName": "ESCITALOPRAM OXALATEANDA  #079062",
    "submission": "SUPPL-25",
    "activeIngredients": "ESCITALOPRAM OXALATE",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/14/2025",
    "drugName": "ESCITALOPRAM OXALATEANDA  #079062",
    "submission": "SUPPL-27",
    "activeIngredients": "ESCITALOPRAM OXALATE",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/14/2025",
    "drugName": "FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERANDA  #079104",
    "submission": "SUPPL-12",
    "activeIngredients": "FLUCONAZOLE",
    "company": "INFORLIFE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/14/2025",
    "drugName": "FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERANDA  #079104",
    "submission": "SUPPL-17",
    "activeIngredients": "FLUCONAZOLE",
    "company": "INFORLIFE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/14/2025",
    "drugName": "FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERANDA  #079104",
    "submission": "SUPPL-19",
    "activeIngredients": "FLUCONAZOLE",
    "company": "INFORLIFE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/14/2025",
    "drugName": "FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERANDA  #079104",
    "submission": "SUPPL-20",
    "activeIngredients": "FLUCONAZOLE",
    "company": "INFORLIFE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/14/2025",
    "drugName": "FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERANDA  #079104",
    "submission": "SUPPL-22",
    "activeIngredients": "FLUCONAZOLE",
    "company": "INFORLIFE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/14/2025",
    "drugName": "FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERANDA  #079104",
    "submission": "SUPPL-24",
    "activeIngredients": "FLUCONAZOLE",
    "company": "INFORLIFE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/14/2025",
    "drugName": "ROSUVASTATIN CALCIUMANDA  #079169",
    "submission": "SUPPL-16",
    "activeIngredients": "ROSUVASTATIN CALCIUM",
    "company": "SUN PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/14/2025",
    "drugName": "ROSUVASTATIN CALCIUMANDA  #079169",
    "submission": "SUPPL-17",
    "activeIngredients": "ROSUVASTATIN CALCIUM",
    "company": "SUN PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/14/2025",
    "drugName": "TRIFLUOPERAZINE HYDROCHLORIDEANDA  #085787",
    "submission": "SUPPL-32",
    "activeIngredients": "TRIFLUOPERAZINE HYDROCHLORIDE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/14/2025",
    "drugName": "ROSUVASTATIN CALCIUMANDA  #206381",
    "submission": "SUPPL-8",
    "activeIngredients": "ROSUVASTATIN CALCIUM",
    "company": "SCIEGEN PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/14/2025",
    "drugName": "ROSUVASTATIN CALCIUMANDA  #206381",
    "submission": "SUPPL-13",
    "activeIngredients": "ROSUVASTATIN CALCIUM",
    "company": "SCIEGEN PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/14/2025",
    "drugName": "ROSUVASTATIN CALCIUMANDA  #206465",
    "submission": "SUPPL-16",
    "activeIngredients": "ROSUVASTATIN CALCIUM",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/14/2025",
    "drugName": "ROSUVASTATIN CALCIUMANDA  #206465",
    "submission": "SUPPL-17",
    "activeIngredients": "ROSUVASTATIN CALCIUM",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/14/2025",
    "drugName": "ROSUVASTATIN CALCIUMANDA  #207626",
    "submission": "SUPPL-3",
    "activeIngredients": "ROSUVASTATIN CALCIUM",
    "company": "UMEDICA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/14/2025",
    "drugName": "ROSUVASTATIN CALCIUMANDA  #207626",
    "submission": "SUPPL-7",
    "activeIngredients": "ROSUVASTATIN CALCIUM",
    "company": "UMEDICA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/14/2025",
    "drugName": "ROSUVASTATIN CALCIUMANDA  #207626",
    "submission": "SUPPL-8",
    "activeIngredients": "ROSUVASTATIN CALCIUM",
    "company": "UMEDICA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/14/2025",
    "drugName": "ROSUVASTATIN CALCIUMANDA  #207626",
    "submission": "SUPPL-10",
    "activeIngredients": "ROSUVASTATIN CALCIUM",
    "company": "UMEDICA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/14/2025",
    "drugName": "ROSUVASTATIN CALCIUMANDA  #207626",
    "submission": "SUPPL-12",
    "activeIngredients": "ROSUVASTATIN CALCIUM",
    "company": "UMEDICA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/14/2025",
    "drugName": "ROSUVASTATIN CALCIUMANDA  #207626",
    "submission": "SUPPL-22",
    "activeIngredients": "ROSUVASTATIN CALCIUM",
    "company": "UMEDICA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/14/2025",
    "drugName": "VILAZODONE HYDROCHLORIDEANDA  #208212",
    "submission": "SUPPL-8",
    "activeIngredients": "VILAZODONE HYDROCHLORIDE",
    "company": "TEVA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/14/2025",
    "drugName": "VILAZODONE HYDROCHLORIDEANDA  #208228",
    "submission": "SUPPL-4",
    "activeIngredients": "VILAZODONE HYDROCHLORIDE",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/14/2025",
    "drugName": "NITROFURANTOINANDA  #208909",
    "submission": "ORIG-1",
    "activeIngredients": "NITROFURANTOIN",
    "company": "APPCO",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/14/2025",
    "drugName": "DIMETHYL FUMARATEANDA  #210226",
    "submission": "SUPPL-5",
    "activeIngredients": "DIMETHYL FUMARATE",
    "company": "LUPIN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/14/2025",
    "drugName": "SUCCINYLCHOLINE CHLORIDEANDA  #215022",
    "submission": "SUPPL-1",
    "activeIngredients": "SUCCINYLCHOLINE CHLORIDE",
    "company": "SAGENT PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/14/2025",
    "drugName": "SUCCINYLCHOLINE CHLORIDEANDA  #215022",
    "submission": "SUPPL-2",
    "activeIngredients": "SUCCINYLCHOLINE CHLORIDE",
    "company": "SAGENT PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/14/2025",
    "drugName": "CARBAMAZEPINEANDA  #216404",
    "submission": "SUPPL-2",
    "activeIngredients": "CARBAMAZEPINE",
    "company": "NOVAST LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/14/2025",
    "drugName": "CARBAMAZEPINEANDA  #217277",
    "submission": "ORIG-1",
    "activeIngredients": "CARBAMAZEPINE",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/14/2025",
    "drugName": "CARBIDOPA AND LEVODOPAANDA  #218939",
    "submission": "ORIG-1",
    "activeIngredients": "CARBIDOPA; LEVODOPA",
    "company": "ASCENT PHARMS INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/14/2025",
    "drugName": "IPRATROPIUM BROMIDEANDA  #219222",
    "submission": "ORIG-1",
    "activeIngredients": "IPRATROPIUM BROMIDE",
    "company": "RUBICON RESEARCH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/15/2025",
    "drugName": "TRIFLUOPERAZINE HYDROCHLORIDEANDA  #085785",
    "submission": "SUPPL-84",
    "activeIngredients": "TRIFLUOPERAZINE HYDROCHLORIDE",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/15/2025",
    "drugName": "TRIFLUOPERAZINE HYDROCHLORIDEANDA  #085786",
    "submission": "SUPPL-92",
    "activeIngredients": "TRIFLUOPERAZINE HYDROCHLORIDE",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/15/2025",
    "drugName": "TRIFLUOPERAZINE HYDROCHLORIDEANDA  #085788",
    "submission": "SUPPL-87",
    "activeIngredients": "TRIFLUOPERAZINE HYDROCHLORIDE",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/15/2025",
    "drugName": "TRIFLUOPERAZINE HYDROCHLORIDEANDA  #085789",
    "submission": "SUPPL-88",
    "activeIngredients": "TRIFLUOPERAZINE HYDROCHLORIDE",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/15/2025",
    "drugName": "TELMISARTANANDA  #203986",
    "submission": "ORIG-1",
    "activeIngredients": "TELMISARTAN",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/15/2025",
    "drugName": "EPTIFIBATIDEANDA  #208554",
    "submission": "SUPPL-4",
    "activeIngredients": "EPTIFIBATIDE",
    "company": "BAXTER HLTHCARE CORP",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/15/2025",
    "drugName": "CELECOXIBANDA  #208701",
    "submission": "SUPPL-3",
    "activeIngredients": "CELECOXIB",
    "company": "CADILA PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/15/2025",
    "drugName": "DESVENLAFAXINE SUCCINATEANDA  #211427",
    "submission": "ORIG-1",
    "activeIngredients": "DESVENLAFAXINE SUCCINATE",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/15/2025",
    "drugName": "DEXMETHYLPHENIDATE HYDROCHLORIDEANDA  #215523",
    "submission": "SUPPL-3",
    "activeIngredients": "DEXMETHYLPHENIDATE HYDROCHLORIDE",
    "company": "ASCENT PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/15/2025",
    "drugName": "MARGENZABLA   #761150",
    "submission": "SUPPL-11",
    "activeIngredients": "MARGETUXIMAB-CMKB",
    "company": "MACROGENICS INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/15/2025",
    "drugName": "OMVOHBLA   #761279",
    "submission": "SUPPL-2",
    "activeIngredients": "MIRIKIZUMAB-MRKZ",
    "company": "ELI LILLY AND CO",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/15/2025",
    "drugName": "OMVOHBLA   #761279",
    "submission": "SUPPL-3",
    "activeIngredients": "MIRIKIZUMAB-MRKZ",
    "company": "ELI LILLY AND CO",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/16/2025",
    "drugName": "HALOPERIDOLANDA  #078347",
    "submission": "SUPPL-16",
    "activeIngredients": "HALOPERIDOL LACTATE",
    "company": "MYLAN LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/16/2025",
    "drugName": "VECTIBIXBLA   #125147",
    "submission": "SUPPL-213",
    "activeIngredients": "PANITUMUMAB",
    "company": "AMGEN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/16/2025",
    "drugName": "LINEZOLIDANDA  #205517",
    "submission": "SUPPL-14",
    "activeIngredients": "LINEZOLID",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/16/2025",
    "drugName": "DILTIAZEM HYDROCHLORIDEANDA  #208783",
    "submission": "SUPPL-3",
    "activeIngredients": "DILTIAZEM HYDROCHLORIDE",
    "company": "NOVAST LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/16/2025",
    "drugName": "IDHIFANDA   #209606",
    "submission": "SUPPL-7",
    "activeIngredients": "ENASIDENIB MESYLATE",
    "company": "BRISTOL MYERS SQUIBB",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/16/2025",
    "drugName": "CALQUENCENDA   #210259",
    "submission": "SUPPL-11",
    "activeIngredients": "ACALABRUTINIB",
    "company": "ASTRAZENECA",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/16/2025",
    "drugName": "ARTESUNATENDA   #213036",
    "submission": "SUPPL-8",
    "activeIngredients": "ARTESUNATE",
    "company": "AMIVAS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/16/2025",
    "drugName": "NALOXONE HYDROCHLORIDEANDA  #213843",
    "submission": "SUPPL-6",
    "activeIngredients": "NALOXONE HYDROCHLORIDE",
    "company": "MYLAN LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/16/2025",
    "drugName": "PEMETREXED DISODIUMNDA   #214408",
    "submission": "SUPPL-5",
    "activeIngredients": "PEMETREXED DISODIUM",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/16/2025",
    "drugName": "LUMAKRASNDA   #214665",
    "submission": "SUPPL-9",
    "activeIngredients": "SOTORASIB",
    "company": "AMGEN INC",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/16/2025",
    "drugName": "CALQUENCENDA   #216387",
    "submission": "SUPPL-5",
    "activeIngredients": "ACALABRUTINIB MALEATE",
    "company": "ASTRAZENECA",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/16/2025",
    "drugName": "EPHEDRINE SULFATEANDA  #218211",
    "submission": "ORIG-1",
    "activeIngredients": "EPHEDRINE SULFATE",
    "company": "GLAND",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/16/2025",
    "drugName": "RIFAXIMINANDA  #218862",
    "submission": "ORIG-1",
    "activeIngredients": "RIFAXIMIN",
    "company": "AMNEAL EU LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "01/16/2025",
    "drugName": "CARBAMAZEPINEANDA  #219072",
    "submission": "ORIG-1",
    "activeIngredients": "CARBAMAZEPINE",
    "company": "YICHANG HUMANWELL",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/16/2025",
    "drugName": "PANTOPRAZOLE SODIUMANDA  #219087",
    "submission": "ORIG-1",
    "activeIngredients": "PANTOPRAZOLE SODIUM",
    "company": "GRAVITI PHARMS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/16/2025",
    "drugName": "BRYNOVINNDA   #219122",
    "submission": "ORIG-1",
    "activeIngredients": "SITAGLIPTIN HYDROCHLORIDE",
    "company": "AZURITY",
    "submissionClassification": "Type 3 - New Dosage Form",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/16/2025",
    "drugName": "LEVETIRACETAM IN SODIUM CHLORIDEANDA  #219562",
    "submission": "ORIG-1",
    "activeIngredients": "LEVETIRACETAM",
    "company": "CAPLIN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/17/2025",
    "drugName": "PEPCID COMPLETENDA   #020958",
    "submission": "SUPPL-42",
    "activeIngredients": "CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE",
    "company": "KENVUE BRANDS",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/17/2025",
    "drugName": "ELELYSOBLA   #022458",
    "submission": "SUPPL-33",
    "activeIngredients": "TALIGLUCERASE ALFA",
    "company": "PFIZER",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/17/2025",
    "drugName": "CEFAZOLIN AND DEXTROSENDA   #050779",
    "submission": "SUPPL-35",
    "activeIngredients": "CEFAZOLIN SODIUM",
    "company": "B BRAUN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/17/2025",
    "drugName": "ELTROMBOPAG OLAMINEANDA  #206788",
    "submission": "ORIG-1",
    "activeIngredients": "ELTROMBOPAG OLAMINE",
    "company": "HETERO LABS LTD V",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/17/2025",
    "drugName": "SPRAVATONDA   #211243",
    "submission": "SUPPL-16",
    "activeIngredients": "ESKETAMINE HYDROCHLORIDE",
    "company": "JANSSEN PHARMS",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/17/2025",
    "drugName": "DOCETAXELNDA   #215813",
    "submission": "SUPPL-3",
    "activeIngredients": "DOCETAXEL",
    "company": "AVYXA HOLDINGS",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/17/2025",
    "drugName": "DOCIVYXNDA   #215813",
    "submission": "SUPPL-3",
    "activeIngredients": "DOCETAXEL",
    "company": "AVYXA HOLDINGS",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/17/2025",
    "drugName": "MYINFLANDA   #216469",
    "submission": "ORIG-1",
    "activeIngredients": "COLCHICINE",
    "company": "COLUMBIA THERAPEUTICS INC",
    "submissionClassification": "Type 5 - New Formulation or New Manufacturer",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "01/17/2025",
    "drugName": "ACETAMINOPHEN AND IBUPROFENANDA  #217241",
    "submission": "ORIG-1",
    "activeIngredients": "ACETAMINOPHEN; IBUPROFEN",
    "company": "STRIDES PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/17/2025",
    "drugName": "DATROWAYBLA   #761394",
    "submission": "ORIG-1",
    "activeIngredients": "DATOPOTAMAB DERUXTECAN-DLNK",
    "company": "DAIICHI SANKYO INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/21/2025",
    "drugName": "ADDYINDA   #022526",
    "submission": "SUPPL-12",
    "activeIngredients": "FLIBANSERIN",
    "company": "SPROUT PHARMS",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/21/2025",
    "drugName": "BUTALBITAL, ASPIRIN AND CAFFEINEANDA  #205230",
    "submission": "SUPPL-1",
    "activeIngredients": "ASPIRIN; BUTALBITAL; CAFFEINE",
    "company": "LGM PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/21/2025",
    "drugName": "GRAFAPEXNDA   #214759",
    "submission": "ORIG-1",
    "activeIngredients": "TREOSULFAN",
    "company": "MEDEXUS",
    "submissionClassification": "Type 1 - New Molecular Entity",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/21/2025",
    "drugName": "DARUNAVIRANDA  #216168",
    "submission": "ORIG-1",
    "activeIngredients": "DARUNAVIR",
    "company": "ANNORA PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/21/2025",
    "drugName": "DARUNAVIRANDA  #216168",
    "submission": "ORIG-2",
    "activeIngredients": "DARUNAVIR",
    "company": "ANNORA PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "01/21/2025",
    "drugName": "ERTUGLIFLOZINANDA  #216842",
    "submission": "ORIG-1",
    "activeIngredients": "ERTUGLIFLOZIN",
    "company": "HIKMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/21/2025",
    "drugName": "AZILSARTAN MEDOXOMIL AND CHLORTHALIDONEANDA  #217490",
    "submission": "ORIG-1",
    "activeIngredients": "AZILSARTAN KAMEDOXOMIL; CHLORTHALIDONE",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/21/2025",
    "drugName": "POTELIGEOBLA   #761051",
    "submission": "SUPPL-18",
    "activeIngredients": "MOGAMULIZUMAB-KPKC",
    "company": "KYOWA KIRIN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/21/2025",
    "drugName": "EPYSQLIBLA   #761340",
    "submission": "SUPPL-2",
    "activeIngredients": "ECULIZUMAB-AAGH",
    "company": "SAMSUNG BIOEPIS CO LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "MOBANNDA   #017111",
    "submission": "SUPPL-69",
    "activeIngredients": "MOLINDONE HYDROCHLORIDE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "LOXITANENDA   #017525",
    "submission": "SUPPL-52",
    "activeIngredients": "LOXAPINE SUCCINATE",
    "company": "TEVA BRANDED PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "LOXITANENDA   #017525",
    "submission": "SUPPL-53",
    "activeIngredients": "LOXAPINE SUCCINATE",
    "company": "TEVA BRANDED PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "LOXITANE CNDA   #017658",
    "submission": "SUPPL-39",
    "activeIngredients": "LOXAPINE HYDROCHLORIDE",
    "company": "TEVA BRANDED PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "LOXITANE CNDA   #017658",
    "submission": "SUPPL-40",
    "activeIngredients": "LOXAPINE HYDROCHLORIDE",
    "company": "TEVA BRANDED PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "HALDOLNDA   #018701",
    "submission": "SUPPL-78",
    "activeIngredients": "HALOPERIDOL DECANOATE",
    "company": "JANSSEN PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "CLOZARILNDA   #019758",
    "submission": "SUPPL-106",
    "activeIngredients": "CLOZAPINE",
    "company": "HERITAGE LIFE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "RISPERDALNDA   #020272",
    "submission": "SUPPL-88",
    "activeIngredients": "RISPERIDONE",
    "company": "JANSSEN PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "RISPERDALNDA   #020588",
    "submission": "SUPPL-74",
    "activeIngredients": "RISPERIDONE",
    "company": "JANSSEN PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "ZYPREXANDA   #020592",
    "submission": "SUPPL-77",
    "activeIngredients": "OLANZAPINE",
    "company": "CHEPLAPHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "COPAXONENDA   #020622",
    "submission": "SUPPL-118",
    "activeIngredients": "GLATIRAMER ACETATE",
    "company": "TEVA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "COPAXONENDA   #020622",
    "submission": "SUPPL-119",
    "activeIngredients": "GLATIRAMER ACETATE",
    "company": "TEVA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "SEROQUELNDA   #020639",
    "submission": "SUPPL-74",
    "activeIngredients": "QUETIAPINE FUMARATE",
    "company": "CHEPLAPHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "GEODONNDA   #020825",
    "submission": "SUPPL-65",
    "activeIngredients": "ZIPRASIDONE HYDROCHLORIDE",
    "company": "VIATRIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "GEODONNDA   #020919",
    "submission": "SUPPL-53",
    "activeIngredients": "ZIPRASIDONE MESYLATE",
    "company": "VIATRIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "ZYPREXA ZYDISNDA   #021086",
    "submission": "SUPPL-50",
    "activeIngredients": "OLANZAPINE",
    "company": "CHEPLAPHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "ZYPREXANDA   #021253",
    "submission": "SUPPL-66",
    "activeIngredients": "OLANZAPINE",
    "company": "CHEPLAPHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "RISPERDAL CONSTANDA   #021346",
    "submission": "SUPPL-65",
    "activeIngredients": "RISPERIDONE",
    "company": "JANSSEN PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "ABILIFYNDA   #021436",
    "submission": "SUPPL-46",
    "activeIngredients": "ARIPIPRAZOLE",
    "company": "OTSUKA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "ABILIFYNDA   #021436",
    "submission": "SUPPL-49",
    "activeIngredients": "ARIPIPRAZOLE",
    "company": "OTSUKA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "ABILIFYNDA   #021436",
    "submission": "SUPPL-50",
    "activeIngredients": "ARIPIPRAZOLE",
    "company": "OTSUKA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "RISPERDALNDA   #021444",
    "submission": "SUPPL-60",
    "activeIngredients": "RISPERIDONE",
    "company": "JANSSEN PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "SYMBYAXNDA   #021520",
    "submission": "SUPPL-56",
    "activeIngredients": "FLUOXETINE HYDROCHLORIDE; OLANZAPINE",
    "company": "LILLY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "SEROQUEL XRNDA   #022047",
    "submission": "SUPPL-48",
    "activeIngredients": "QUETIAPINE FUMARATE",
    "company": "CHEPLAPHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "SAPHRISNDA   #022117",
    "submission": "SUPPL-24",
    "activeIngredients": "ASENAPINE MALEATE",
    "company": "ALLERGAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "ZYPREXA RELPREVVNDA   #022173",
    "submission": "SUPPL-47",
    "activeIngredients": "OLANZAPINE PAMOATE",
    "company": "CHEPLAPHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "FANAPTNDA   #022192",
    "submission": "SUPPL-24",
    "activeIngredients": "ILOPERIDONE",
    "company": "VANDA PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "PROCHLORPERAZINEANDA  #040058",
    "submission": "SUPPL-26",
    "activeIngredients": "PROCHLORPERAZINE",
    "company": "COSETTE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "PROCHLORPERAZINE MALEATEANDA  #040101",
    "submission": "SUPPL-19",
    "activeIngredients": "PROCHLORPERAZINE MALEATE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "PROCHLORPERAZINE MALEATEANDA  #040120",
    "submission": "SUPPL-18",
    "activeIngredients": "PROCHLORPERAZINE MALEATE",
    "company": "TEVA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "THIORIDAZINE HYDROCHLORIDEANDA  #040125",
    "submission": "SUPPL-3",
    "activeIngredients": "THIORIDAZINE HYDROCHLORIDE",
    "company": "EPIC PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "THIORIDAZINE HYDROCHLORIDEANDA  #040126",
    "submission": "SUPPL-3",
    "activeIngredients": "THIORIDAZINE HYDROCHLORIDE",
    "company": "EPIC PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "FLUPHENAZINE HYDROCHLORIDEANDA  #040146",
    "submission": "SUPPL-13",
    "activeIngredients": "FLUPHENAZINE HYDROCHLORIDE",
    "company": "PHARM ASSOC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "PROCHLORPERAZINE MALEATEANDA  #040185",
    "submission": "SUPPL-17",
    "activeIngredients": "PROCHLORPERAZINE MALEATE",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "THIORIDAZINE HYDROCHLORIDEANDA  #040187",
    "submission": "SUPPL-5",
    "activeIngredients": "THIORIDAZINE HYDROCHLORIDE",
    "company": "PHARM ASSOC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "TRIFLUOPERAZINE HYDROCHLORIDEANDA  #040209",
    "submission": "SUPPL-22",
    "activeIngredients": "TRIFLUOPERAZINE HYDROCHLORIDE",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "THIORIDAZINE HYDROCHLORIDEANDA  #040213",
    "submission": "SUPPL-4",
    "activeIngredients": "THIORIDAZINE HYDROCHLORIDE",
    "company": "PHARM ASSOC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "PERPHENAZINEANDA  #040226",
    "submission": "SUPPL-30",
    "activeIngredients": "PERPHENAZINE",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "COMPROANDA  #040246",
    "submission": "SUPPL-18",
    "activeIngredients": "PROCHLORPERAZINE",
    "company": "PADAGIS US",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "PROCOMPANDA  #040268",
    "submission": "SUPPL-33",
    "activeIngredients": "PROCHLORPERAZINE MALEATE",
    "company": "JUBILANT CADISTA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "PROCHLORPERAZINE EDISYLATEANDA  #040540",
    "submission": "SUPPL-20",
    "activeIngredients": "PROCHLORPERAZINE EDISYLATE",
    "company": "SAGENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "HALOPERIDOLANDA  #070278",
    "submission": "SUPPL-43",
    "activeIngredients": "HALOPERIDOL",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDEANDA  #070297",
    "submission": "SUPPL-30",
    "activeIngredients": "AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE",
    "company": "SUN PHARM INDUSTRIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "THIOTHIXENEANDA  #070600",
    "submission": "SUPPL-19",
    "activeIngredients": "THIOTHIXENE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "THIOTHIXENEANDA  #070601",
    "submission": "SUPPL-19",
    "activeIngredients": "THIOTHIXENE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "THIOTHIXENEANDA  #070602",
    "submission": "SUPPL-20",
    "activeIngredients": "THIOTHIXENE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "THIOTHIXENEANDA  #070603",
    "submission": "SUPPL-18",
    "activeIngredients": "THIOTHIXENE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "HALOPERIDOLANDA  #070981",
    "submission": "SUPPL-13",
    "activeIngredients": "HALOPERIDOL",
    "company": "WATSON LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "HALOPERIDOLANDA  #070982",
    "submission": "SUPPL-14",
    "activeIngredients": "HALOPERIDOL",
    "company": "WATSON LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "HALOPERIDOLANDA  #070983",
    "submission": "SUPPL-14",
    "activeIngredients": "HALOPERIDOL",
    "company": "WATSON LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "HALOPERIDOLANDA  #070984",
    "submission": "SUPPL-12",
    "activeIngredients": "HALOPERIDOL",
    "company": "WATSON LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDEANDA  #071062",
    "submission": "SUPPL-26",
    "activeIngredients": "AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE",
    "company": "FOSUN PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDEANDA  #071063",
    "submission": "SUPPL-26",
    "activeIngredients": "AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE",
    "company": "FOSUN PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDEANDA  #071064",
    "submission": "SUPPL-21",
    "activeIngredients": "AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE",
    "company": "FOSUN PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDEANDA  #071077",
    "submission": "SUPPL-31",
    "activeIngredients": "AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE",
    "company": "SUN PHARM INDUSTRIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDEANDA  #071078",
    "submission": "SUPPL-28",
    "activeIngredients": "AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE",
    "company": "SUN PHARM INDUSTRIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDEANDA  #071079",
    "submission": "SUPPL-30",
    "activeIngredients": "AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE",
    "company": "SUN PHARM INDUSTRIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "THIOTHIXENEANDA  #071093",
    "submission": "SUPPL-33",
    "activeIngredients": "THIOTHIXENE",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "HALOPERIDOLANDA  #071130",
    "submission": "SUPPL-13",
    "activeIngredients": "HALOPERIDOL",
    "company": "AIPING PHARM INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "HALOPERIDOLANDA  #071173",
    "submission": "SUPPL-20",
    "activeIngredients": "HALOPERIDOL",
    "company": "INNOGENIX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "HALOPERIDOLANDA  #071209",
    "submission": "SUPPL-37",
    "activeIngredients": "HALOPERIDOL",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "HALOPERIDOLANDA  #071210",
    "submission": "SUPPL-37",
    "activeIngredients": "HALOPERIDOL",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "HALOPERIDOLANDA  #071211",
    "submission": "SUPPL-30",
    "activeIngredients": "HALOPERIDOL",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "HALOPERIDOLANDA  #071235",
    "submission": "SUPPL-19",
    "activeIngredients": "HALOPERIDOL",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "FLUPHENAZINE DECANOATEANDA  #071413",
    "submission": "SUPPL-29",
    "activeIngredients": "FLUPHENAZINE DECANOATE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDEANDA  #071443",
    "submission": "SUPPL-43",
    "activeIngredients": "AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "THIOTHIXENEANDA  #071529",
    "submission": "SUPPL-24",
    "activeIngredients": "THIOTHIXENE",
    "company": "EPIC PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "HALOPERIDOLANDA  #071617",
    "submission": "SUPPL-34",
    "activeIngredients": "HALOPERIDOL LACTATE",
    "company": "TEVA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDEANDA  #071862",
    "submission": "SUPPL-20",
    "activeIngredients": "AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE",
    "company": "FOSUN PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDEANDA  #071863",
    "submission": "SUPPL-20",
    "activeIngredients": "AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "LOXAPINE SUCCINATEANDA  #072062",
    "submission": "SUPPL-39",
    "activeIngredients": "LOXAPINE SUCCINATE",
    "company": "WATSON LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "LOXAPINE SUCCINATEANDA  #072204",
    "submission": "SUPPL-40",
    "activeIngredients": "LOXAPINE SUCCINATE",
    "company": "WATSON LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "LOXAPINE SUCCINATEANDA  #072205",
    "submission": "SUPPL-42",
    "activeIngredients": "LOXAPINE SUCCINATE",
    "company": "WATSON LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "LOXAPINE SUCCINATEANDA  #072206",
    "submission": "SUPPL-39",
    "activeIngredients": "LOXAPINE SUCCINATE",
    "company": "WATSON LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDEANDA  #073007",
    "submission": "SUPPL-28",
    "activeIngredients": "AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDEANDA  #073008",
    "submission": "SUPPL-27",
    "activeIngredients": "AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDEANDA  #073009",
    "submission": "SUPPL-28",
    "activeIngredients": "AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDEANDA  #073010",
    "submission": "SUPPL-28",
    "activeIngredients": "AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "HALOPERIDOLANDA  #073037",
    "submission": "SUPPL-22",
    "activeIngredients": "HALOPERIDOL LACTATE",
    "company": "PHARM ASSOC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "HALOPERIDOLANDA  #073364",
    "submission": "SUPPL-15",
    "activeIngredients": "HALOPERIDOL LACTATE",
    "company": "LANNETT CO INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "FLUPHENAZINE HYDROCHLORIDEANDA  #074725",
    "submission": "SUPPL-13",
    "activeIngredients": "FLUPHENAZINE HYDROCHLORIDE",
    "company": "PHARM ASSOC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "HALOPERIDOLANDA  #075689",
    "submission": "SUPPL-29",
    "activeIngredients": "HALOPERIDOL LACTATE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "HALOPERIDOLANDA  #075858",
    "submission": "SUPPL-28",
    "activeIngredients": "HALOPERIDOL LACTATE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "FLUPHENAZINE DECANOATEANDA  #075918",
    "submission": "SUPPL-27",
    "activeIngredients": "FLUPHENAZINE DECANOATE",
    "company": "MYLAN LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "HALOPERIDOLANDA  #076035",
    "submission": "SUPPL-27",
    "activeIngredients": "HALOPERIDOL LACTATE",
    "company": "TEVA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "HALOPERIDOLANDA  #076464",
    "submission": "SUPPL-4",
    "activeIngredients": "HALOPERIDOL LACTATE",
    "company": "FOSUN PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "LOXAPINE SUCCINATEANDA  #076762",
    "submission": "SUPPL-14",
    "activeIngredients": "LOXAPINE SUCCINATE",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "LOXAPINE SUCCINATEANDA  #076868",
    "submission": "SUPPL-12",
    "activeIngredients": "LOXAPINE SUCCINATE",
    "company": "ELITE LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "RISPERIDONEANDA  #076996",
    "submission": "SUPPL-4",
    "activeIngredients": "RISPERIDONE",
    "company": "ACTAVIS LABS FL INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "RISPERIDONEANDA  #077542",
    "submission": "SUPPL-10",
    "activeIngredients": "RISPERIDONE",
    "company": "SUN PHARM INDS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "HALOPERIDOLANDA  #077580",
    "submission": "SUPPL-19",
    "activeIngredients": "HALOPERIDOL",
    "company": "ZYDUS PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "RISPERIDONEANDA  #078116",
    "submission": "SUPPL-17",
    "activeIngredients": "RISPERIDONE",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "HALOPERIDOLANDA  #078347",
    "submission": "SUPPL-22",
    "activeIngredients": "HALOPERIDOL LACTATE",
    "company": "MYLAN LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "RISPERIDONEANDA  #078474",
    "submission": "SUPPL-10",
    "activeIngredients": "RISPERIDONE",
    "company": "SUN PHARM INDS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "TRIFLUOPERAZINE HYDROCHLORIDEANDA  #085785",
    "submission": "SUPPL-85",
    "activeIngredients": "TRIFLUOPERAZINE HYDROCHLORIDE",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "TRIFLUOPERAZINE HYDROCHLORIDEANDA  #085786",
    "submission": "SUPPL-93",
    "activeIngredients": "TRIFLUOPERAZINE HYDROCHLORIDE",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "TRIFLUOPERAZINE HYDROCHLORIDEANDA  #085787",
    "submission": "SUPPL-33",
    "activeIngredients": "TRIFLUOPERAZINE HYDROCHLORIDE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "TRIFLUOPERAZINE HYDROCHLORIDEANDA  #085788",
    "submission": "SUPPL-88",
    "activeIngredients": "TRIFLUOPERAZINE HYDROCHLORIDE",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "TRIFLUOPERAZINE HYDROCHLORIDEANDA  #085789",
    "submission": "SUPPL-89",
    "activeIngredients": "TRIFLUOPERAZINE HYDROCHLORIDE",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "THIORIDAZINE HYDROCHLORIDEANDA  #088004",
    "submission": "SUPPL-47",
    "activeIngredients": "THIORIDAZINE HYDROCHLORIDE",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "THIORIDAZINE HYDROCHLORIDEANDA  #088131",
    "submission": "SUPPL-48",
    "activeIngredients": "THIORIDAZINE HYDROCHLORIDE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "THIORIDAZINE HYDROCHLORIDEANDA  #088132",
    "submission": "SUPPL-47",
    "activeIngredients": "THIORIDAZINE HYDROCHLORIDE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "THIORIDAZINE HYDROCHLORIDEANDA  #088133",
    "submission": "SUPPL-48",
    "activeIngredients": "THIORIDAZINE HYDROCHLORIDE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "THIORIDAZINE HYDROCHLORIDEANDA  #088134",
    "submission": "SUPPL-48",
    "activeIngredients": "THIORIDAZINE HYDROCHLORIDE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "THIORIDAZINE HYDROCHLORIDEANDA  #088135",
    "submission": "SUPPL-36",
    "activeIngredients": "THIORIDAZINE HYDROCHLORIDE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "THIORIDAZINE HYDROCHLORIDEANDA  #088136",
    "submission": "SUPPL-21",
    "activeIngredients": "THIORIDAZINE HYDROCHLORIDE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "THIORIDAZINE HYDROCHLORIDEANDA  #088137",
    "submission": "SUPPL-22",
    "activeIngredients": "THIORIDAZINE HYDROCHLORIDE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "THIORIDAZINE HYDROCHLORIDEANDA  #088461",
    "submission": "SUPPL-23",
    "activeIngredients": "THIORIDAZINE HYDROCHLORIDE",
    "company": "SUN PHARM INDUSTRIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "THIORIDAZINE HYDROCHLORIDEANDA  #088476",
    "submission": "SUPPL-19",
    "activeIngredients": "THIORIDAZINE HYDROCHLORIDE",
    "company": "HERITAGE PHARMA AVET",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "THIORIDAZINE HYDROCHLORIDEANDA  #088478",
    "submission": "SUPPL-19",
    "activeIngredients": "THIORIDAZINE HYDROCHLORIDE",
    "company": "HERITAGE PHARMA AVET",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "THIORIDAZINE HYDROCHLORIDEANDA  #088479",
    "submission": "SUPPL-18",
    "activeIngredients": "THIORIDAZINE HYDROCHLORIDE",
    "company": "HERITAGE PHARMA AVET",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "THIORIDAZINE HYDROCHLORIDEANDA  #088736",
    "submission": "SUPPL-13",
    "activeIngredients": "THIORIDAZINE HYDROCHLORIDE",
    "company": "HERITAGE PHARMA AVET",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "THIORIDAZINE HYDROCHLORIDEANDA  #088737",
    "submission": "SUPPL-23",
    "activeIngredients": "THIORIDAZINE HYDROCHLORIDE",
    "company": "SUN PHARM INDUSTRIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "THIORIDAZINE HYDROCHLORIDEANDA  #088738",
    "submission": "SUPPL-25",
    "activeIngredients": "THIORIDAZINE HYDROCHLORIDE",
    "company": "SUN PHARM INDUSTRIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "PERPHENAZINEANDA  #089456",
    "submission": "SUPPL-35",
    "activeIngredients": "PERPHENAZINE",
    "company": "ANI PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "FLUPHENAZINE HYDROCHLORIDEANDA  #089556",
    "submission": "SUPPL-27",
    "activeIngredients": "FLUPHENAZINE HYDROCHLORIDE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "FLUPHENAZINE HYDROCHLORIDEANDA  #089586",
    "submission": "SUPPL-25",
    "activeIngredients": "FLUPHENAZINE HYDROCHLORIDE",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "PERPHENAZINEANDA  #089685",
    "submission": "SUPPL-38",
    "activeIngredients": "PERPHENAZINE",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "FLUPHENAZINE HYDROCHLORIDEANDA  #089743",
    "submission": "SUPPL-38",
    "activeIngredients": "FLUPHENAZINE HYDROCHLORIDE",
    "company": "LANNETT CO INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "FLUPHENAZINE HYDROCHLORIDEANDA  #089804",
    "submission": "SUPPL-23",
    "activeIngredients": "FLUPHENAZINE HYDROCHLORIDE",
    "company": "PRASCO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "CLOZAPINEANDA  #090308",
    "submission": "SUPPL-13",
    "activeIngredients": "CLOZAPINE",
    "company": "BARR LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "MOLINDONE HYDROCHLORIDEANDA  #090453",
    "submission": "SUPPL-11",
    "activeIngredients": "MOLINDONE HYDROCHLORIDE",
    "company": "EPIC PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "LOXAPINE SUCCINATEANDA  #090695",
    "submission": "SUPPL-19",
    "activeIngredients": "LOXAPINE SUCCINATE",
    "company": "LANNETT CO INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "HALOPERIDOLANDA  #091637",
    "submission": "SUPPL-11",
    "activeIngredients": "HALOPERIDOL LACTATE",
    "company": "SAGENT PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "LATUDANDA   #200603",
    "submission": "SUPPL-41",
    "activeIngredients": "LURASIDONE HYDROCHLORIDE",
    "company": "SUNOVION PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "HALOPERIDOLANDA  #200742",
    "submission": "SUPPL-7",
    "activeIngredients": "HALOPERIDOL LACTATE",
    "company": "SAGENT PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "HALOPERIDOLANDA  #200854",
    "submission": "SUPPL-1",
    "activeIngredients": "HALOPERIDOL",
    "company": "ACTAVIS GROUP",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "CLOZAPINEANDA  #201824",
    "submission": "SUPPL-26",
    "activeIngredients": "CLOZAPINE",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "ABILIFY MAINTENA KITNDA   #202971",
    "submission": "SUPPL-19",
    "activeIngredients": "ARIPIPRAZOLE",
    "company": "OTSUKA PHARM CO LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "XTANDINDA   #203415",
    "submission": "SUPPL-23",
    "activeIngredients": "ENZALUTAMIDE",
    "company": "ASTELLAS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "VERSACLOZNDA   #203479",
    "submission": "SUPPL-22",
    "activeIngredients": "CLOZAPINE",
    "company": "DOUGLAS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "FLUPHENAZINE DECANOATEANDA  #203732",
    "submission": "SUPPL-13",
    "activeIngredients": "FLUPHENAZINE DECANOATE",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "ARIPIPRAZOLEANDA  #204094",
    "submission": "SUPPL-9",
    "activeIngredients": "ARIPIPRAZOLE",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "ARIPIPRAZOLEANDA  #204094",
    "submission": "SUPPL-13",
    "activeIngredients": "ARIPIPRAZOLE",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "PROCHLORPERAZINE EDISYLATEANDA  #204147",
    "submission": "SUPPL-36",
    "activeIngredients": "PROCHLORPERAZINE EDISYLATE",
    "company": "AVET LIFESCIENCES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "HALOPERIDOLANDA  #204849",
    "submission": "SUPPL-4",
    "activeIngredients": "HALOPERIDOL LACTATE",
    "company": "EPIC PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "PERPHENAZINEANDA  #205056",
    "submission": "SUPPL-4",
    "activeIngredients": "PERPHENAZINE",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "PERPHENAZINEANDA  #205232",
    "submission": "SUPPL-2",
    "activeIngredients": "PERPHENAZINE",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "RIVASTIGMINEANDA  #205622",
    "submission": "SUPPL-11",
    "activeIngredients": "RIVASTIGMINE",
    "company": "MYLAN TECHNOLOGIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "PERPHENAZINEANDA  #205973",
    "submission": "SUPPL-5",
    "activeIngredients": "PERPHENAZINE",
    "company": "WILSHIRE PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "PERPHENAZINEANDA  #206691",
    "submission": "SUPPL-2",
    "activeIngredients": "PERPHENAZINE",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "ABILIFY MYCITE KITNDA   #207202",
    "submission": "SUPPL-8",
    "activeIngredients": "ARIPIPRAZOLE",
    "company": "OTSUKA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "ABILIFY MYCITE KITNDA   #207202",
    "submission": "SUPPL-9",
    "activeIngredients": "ARIPIPRAZOLE",
    "company": "OTSUKA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "RIVASTIGMINEANDA  #207308",
    "submission": "SUPPL-10",
    "activeIngredients": "RIVASTIGMINE",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "NUPLAZIDNDA   #207318",
    "submission": "SUPPL-14",
    "activeIngredients": "PIMAVANSERIN TARTRATE",
    "company": "ACADIA PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "ARISTADANDA   #207533",
    "submission": "SUPPL-31",
    "activeIngredients": "ARIPIPRAZOLE LAUROXIL",
    "company": "ALKERMES INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "PERPHENAZINEANDA  #207582",
    "submission": "SUPPL-4",
    "activeIngredients": "PERPHENAZINE",
    "company": "WATSON LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "FLUPHENAZINE DECANOATEANDA  #207739",
    "submission": "SUPPL-4",
    "activeIngredients": "FLUPHENAZINE DECANOATE",
    "company": "EUGIA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "FINGOLIMOD HYDROCHLORIDEANDA  #207983",
    "submission": "SUPPL-1",
    "activeIngredients": "FINGOLIMOD HYDROCHLORIDE",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "FINGOLIMOD HYDROCHLORIDEANDA  #207985",
    "submission": "SUPPL-3",
    "activeIngredients": "FINGOLIMOD HYDROCHLORIDE",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "FINGOLIMOD HYDROCHLORIDEANDA  #207985",
    "submission": "SUPPL-4",
    "activeIngredients": "FINGOLIMOD HYDROCHLORIDE",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "FINGOLIMOD HYDROCHLORIDEANDA  #207993",
    "submission": "SUPPL-2",
    "activeIngredients": "FINGOLIMOD HYDROCHLORIDE",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "FINGOLIMOD HYDROCHLORIDEANDA  #207993",
    "submission": "SUPPL-3",
    "activeIngredients": "FINGOLIMOD HYDROCHLORIDE",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "FINGOLIMOD HYDROCHLORIDEANDA  #208000",
    "submission": "SUPPL-4",
    "activeIngredients": "FINGOLIMOD HYDROCHLORIDE",
    "company": "DR REDDYS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "SIKLOSNDA   #208843",
    "submission": "SUPPL-5",
    "activeIngredients": "HYDROXYUREA",
    "company": "THERAVIA",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "ARISTADA INITIO KITNDA   #209830",
    "submission": "SUPPL-20",
    "activeIngredients": "ARIPIPRAZOLE LAUROXIL",
    "company": "ALKERMES INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #210081",
    "submission": "SUPPL-19",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "TWI PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "PERPHENAZINEANDA  #210163",
    "submission": "SUPPL-1",
    "activeIngredients": "PERPHENAZINE",
    "company": "APPCO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "DIMETHYL FUMARATEANDA  #210309",
    "submission": "SUPPL-6",
    "activeIngredients": "DIMETHYL FUMARATE",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "HALOPERIDOLANDA  #210356",
    "submission": "SUPPL-3",
    "activeIngredients": "HALOPERIDOL LACTATE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "PROCHLORPERAZINE EDISYLATEANDA  #210710",
    "submission": "SUPPL-5",
    "activeIngredients": "PROCHLORPERAZINE EDISYLATE",
    "company": "MYLAN LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "NUPLAZIDNDA   #210793",
    "submission": "SUPPL-12",
    "activeIngredients": "PIMAVANSERIN TARTRATE",
    "company": "ACADIA PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "HALOPERIDOLANDA  #211061",
    "submission": "SUPPL-10",
    "activeIngredients": "HALOPERIDOL",
    "company": "APPCO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "THIOTHIXENEANDA  #211642",
    "submission": "SUPPL-21",
    "activeIngredients": "THIOTHIXENE",
    "company": "NOVITIUM PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "SECUADONDA   #212268",
    "submission": "SUPPL-7",
    "activeIngredients": "ASENAPINE",
    "company": "HISAMITSU",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "PERPHENAZINEANDA  #212545",
    "submission": "SUPPL-1",
    "activeIngredients": "PERPHENAZINE",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "RYKINDONDA   #212849",
    "submission": "SUPPL-1",
    "activeIngredients": "RISPERIDONE",
    "company": "SHANDONG LUYE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "LYBALVINDA   #213378",
    "submission": "SUPPL-9",
    "activeIngredients": "OLANZAPINE; SAMIDORPHAN L-MALATE",
    "company": "ALKERMES INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "NIMODIPINEANDA  #213409",
    "submission": "ORIG-1",
    "activeIngredients": "NIMODIPINE",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "UZEDYNDA   #213586",
    "submission": "SUPPL-7",
    "activeIngredients": "RISPERIDONE",
    "company": "TEVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "FLUPHENAZINE HYDROCHLORIDEANDA  #213647",
    "submission": "SUPPL-4",
    "activeIngredients": "FLUPHENAZINE HYDROCHLORIDE",
    "company": "AMNEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "XTANDINDA   #213674",
    "submission": "SUPPL-11",
    "activeIngredients": "ENZALUTAMIDE",
    "company": "ASTELLAS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "FLUPHENAZINE HYDROCHLORIDEANDA  #213784",
    "submission": "SUPPL-2",
    "activeIngredients": "FLUPHENAZINE HYDROCHLORIDE",
    "company": "UPSHER SMITH LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "PROCHLORPERAZINE EDISYLATEANDA  #213873",
    "submission": "SUPPL-2",
    "activeIngredients": "PROCHLORPERAZINE EDISYLATE",
    "company": "EUGIA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "PROCHLORPERAZINE EDISYLATEANDA  #214107",
    "submission": "SUPPL-1",
    "activeIngredients": "PROCHLORPERAZINE EDISYLATE",
    "company": "GLAND",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "PROCHLORPERAZINE EDISYLATEANDA  #214192",
    "submission": "SUPPL-4",
    "activeIngredients": "PROCHLORPERAZINE EDISYLATE",
    "company": "AMNEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "PROCHLORPERAZINE EDISYLATEANDA  #214379",
    "submission": "SUPPL-2",
    "activeIngredients": "PROCHLORPERAZINE EDISYLATE",
    "company": "CAPLIN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "FLUPHENAZINE HYDROCHLORIDEANDA  #214534",
    "submission": "SUPPL-2",
    "activeIngredients": "FLUPHENAZINE HYDROCHLORIDE",
    "company": "DR REDDYS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "FLUPHENAZINE HYDROCHLORIDEANDA  #214674",
    "submission": "SUPPL-14",
    "activeIngredients": "FLUPHENAZINE HYDROCHLORIDE",
    "company": "NOVITIUM PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "RISVANNDA   #214835",
    "submission": "SUPPL-1",
    "activeIngredients": "RISPERIDONE",
    "company": "LABS FARMS ROVI SA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "RISVANNDA   #214835",
    "submission": "SUPPL-4",
    "activeIngredients": "RISPERIDONE",
    "company": "LABS FARMS ROVI SA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "FLUPHENAZINE HYDROCHLORIDEANDA  #215141",
    "submission": "SUPPL-3",
    "activeIngredients": "FLUPHENAZINE HYDROCHLORIDE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "THIOTHIXENEANDA  #215456",
    "submission": "SUPPL-1",
    "activeIngredients": "THIOTHIXENE",
    "company": "AMNEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "FLUPHENAZINE DECANOATEANDA  #215509",
    "submission": "SUPPL-1",
    "activeIngredients": "FLUPHENAZINE DECANOATE",
    "company": "GLAND",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "FLUPHENAZINE HYDROCHLORIDEANDA  #215674",
    "submission": "SUPPL-4",
    "activeIngredients": "FLUPHENAZINE HYDROCHLORIDE",
    "company": "TARO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "FLUPHENAZINE HYDROCHLORIDEANDA  #215848",
    "submission": "SUPPL-9",
    "activeIngredients": "FLUPHENAZINE HYDROCHLORIDE",
    "company": "TWI PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "DICLOFENAC POTASSIUMANDA  #215891",
    "submission": "ORIG-1",
    "activeIngredients": "DICLOFENAC POTASSIUM",
    "company": "TORRENT",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "IVERMECTINANDA  #215922",
    "submission": "ORIG-1",
    "activeIngredients": "IVERMECTIN",
    "company": "RUBICON RESEARCH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "PROCHLORPERAZINE MALEATEANDA  #216202",
    "submission": "SUPPL-3",
    "activeIngredients": "PROCHLORPERAZINE MALEATE",
    "company": "NOVITIUM PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "FLUPHENAZINE HYDROCHLORIDEANDA  #216350",
    "submission": "SUPPL-1",
    "activeIngredients": "FLUPHENAZINE HYDROCHLORIDE",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "ERZOFRINDA   #216352",
    "submission": "SUPPL-1",
    "activeIngredients": "PALIPERIDONE PALMITATE",
    "company": "LUYE INNOMIND PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "PROCHLORPERAZINE MALEATEANDA  #216595",
    "submission": "SUPPL-1",
    "activeIngredients": "PROCHLORPERAZINE MALEATE",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "PROCHLORPERAZINE MALEATEANDA  #216598",
    "submission": "SUPPL-1",
    "activeIngredients": "PROCHLORPERAZINE MALEATE",
    "company": "AMNEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "FLUPHENAZINE HYDROCHLORIDEANDA  #216649",
    "submission": "SUPPL-1",
    "activeIngredients": "FLUPHENAZINE HYDROCHLORIDE",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "FLUPHENAZINE HYDROCHLORIDEANDA  #216891",
    "submission": "SUPPL-1",
    "activeIngredients": "FLUPHENAZINE HYDROCHLORIDE",
    "company": "BRECKENRIDGE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "HALOPERIDOLANDA  #216918",
    "submission": "SUPPL-2",
    "activeIngredients": "HALOPERIDOL",
    "company": "MANKIND PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "ABILIFY ASIMTUFIINDA   #217006",
    "submission": "SUPPL-2",
    "activeIngredients": "ARIPIPRAZOLE",
    "company": "OTSUKA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "FLUPHENAZINE HYDROCHLORIDEANDA  #217410",
    "submission": "SUPPL-1",
    "activeIngredients": "FLUPHENAZINE HYDROCHLORIDE",
    "company": "AJANTA PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "PROCHLORPERAZINE MALEATEANDA  #217478",
    "submission": "SUPPL-1",
    "activeIngredients": "PROCHLORPERAZINE MALEATE",
    "company": "BIONPHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "FLUPHENAZINE HYDROCHLORIDEANDA  #218055",
    "submission": "SUPPL-1",
    "activeIngredients": "FLUPHENAZINE HYDROCHLORIDE",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "FLUPHENAZINE HYDROCHLORIDEANDA  #218173",
    "submission": "SUPPL-1",
    "activeIngredients": "FLUPHENAZINE HYDROCHLORIDE",
    "company": "ALEMBIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "FLUPHENAZINE HYDROCHLORIDEANDA  #218283",
    "submission": "SUPPL-1",
    "activeIngredients": "FLUPHENAZINE HYDROCHLORIDE",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "HALOPERIDOLANDA  #218371",
    "submission": "SUPPL-1",
    "activeIngredients": "HALOPERIDOL LACTATE",
    "company": "RUBICON RESEARCH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "PROCHLORPERAZINE MALEATEANDA  #218515",
    "submission": "SUPPL-1",
    "activeIngredients": "PROCHLORPERAZINE MALEATE",
    "company": "AJANTA PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/22/2025",
    "drugName": "HALOPERIDOLANDA  #218789",
    "submission": "SUPPL-1",
    "activeIngredients": "HALOPERIDOL",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/23/2025",
    "drugName": "DEPAKOTENDA   #018723",
    "submission": "SUPPL-69",
    "activeIngredients": "DIVALPROEX SODIUM",
    "company": "ABBVIE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/23/2025",
    "drugName": "DEPAKOTENDA   #019680",
    "submission": "SUPPL-56",
    "activeIngredients": "DIVALPROEX SODIUM",
    "company": "ABBVIE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/23/2025",
    "drugName": "DEPAKOTE ERNDA   #021168",
    "submission": "SUPPL-48",
    "activeIngredients": "DIVALPROEX SODIUM",
    "company": "ABBVIE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/23/2025",
    "drugName": "INVEGANDA   #021999",
    "submission": "SUPPL-40",
    "activeIngredients": "PALIPERIDONE",
    "company": "JANSSEN PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/23/2025",
    "drugName": "INVEGANDA   #021999",
    "submission": "SUPPL-41",
    "activeIngredients": "PALIPERIDONE",
    "company": "JANSSEN PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/23/2025",
    "drugName": "INVEGA SUSTENNANDA   #022264",
    "submission": "SUPPL-38",
    "activeIngredients": "PALIPERIDONE PALMITATE",
    "company": "JANSSEN PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/23/2025",
    "drugName": "RISPERIDONEANDA  #077328",
    "submission": "SUPPL-11",
    "activeIngredients": "RISPERIDONE",
    "company": "ANDA REPOSITORY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/23/2025",
    "drugName": "RISPERIDONEANDA  #077328",
    "submission": "SUPPL-12",
    "activeIngredients": "RISPERIDONE",
    "company": "ANDA REPOSITORY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/23/2025",
    "drugName": "OXYCODONE HYDROCHLORIDEANDA  #202116",
    "submission": "SUPPL-4",
    "activeIngredients": "OXYCODONE HYDROCHLORIDE",
    "company": "ALVOGEN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/23/2025",
    "drugName": "OXYCODONE HYDROCHLORIDEANDA  #202116",
    "submission": "SUPPL-6",
    "activeIngredients": "OXYCODONE HYDROCHLORIDE",
    "company": "ALVOGEN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/23/2025",
    "drugName": "OXYCODONE HYDROCHLORIDEANDA  #202116",
    "submission": "SUPPL-8",
    "activeIngredients": "OXYCODONE HYDROCHLORIDE",
    "company": "ALVOGEN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/23/2025",
    "drugName": "OXYCODONE HYDROCHLORIDEANDA  #202116",
    "submission": "SUPPL-10",
    "activeIngredients": "OXYCODONE HYDROCHLORIDE",
    "company": "ALVOGEN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/23/2025",
    "drugName": "OXYCODONE HYDROCHLORIDEANDA  #202116",
    "submission": "SUPPL-12",
    "activeIngredients": "OXYCODONE HYDROCHLORIDE",
    "company": "ALVOGEN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/23/2025",
    "drugName": "OXYCODONE HYDROCHLORIDEANDA  #202116",
    "submission": "SUPPL-13",
    "activeIngredients": "OXYCODONE HYDROCHLORIDE",
    "company": "ALVOGEN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/23/2025",
    "drugName": "ARIPIPRAZOLEANDA  #204171",
    "submission": "SUPPL-9",
    "activeIngredients": "ARIPIPRAZOLE",
    "company": "LANNETT CO INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/23/2025",
    "drugName": "ARIPIPRAZOLEANDA  #204171",
    "submission": "SUPPL-10",
    "activeIngredients": "ARIPIPRAZOLE",
    "company": "LANNETT CO INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/23/2025",
    "drugName": "BOSENTANANDA  #207110",
    "submission": "SUPPL-6",
    "activeIngredients": "BOSENTAN",
    "company": "WATSON LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/23/2025",
    "drugName": "BOSENTANANDA  #207110",
    "submission": "SUPPL-7",
    "activeIngredients": "BOSENTAN",
    "company": "WATSON LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/23/2025",
    "drugName": "ARIPIPRAZOLEANDA  #207240",
    "submission": "SUPPL-11",
    "activeIngredients": "ARIPIPRAZOLE",
    "company": "SCIEGEN PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/23/2025",
    "drugName": "ARIPIPRAZOLEANDA  #207240",
    "submission": "SUPPL-14",
    "activeIngredients": "ARIPIPRAZOLE",
    "company": "SCIEGEN PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/23/2025",
    "drugName": "INVEGA HAFYERANDA   #207946",
    "submission": "SUPPL-17",
    "activeIngredients": "PALIPERIDONE PALMITATE",
    "company": "JANSSEN PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/23/2025",
    "drugName": "INVEGA TRINZANDA   #207946",
    "submission": "SUPPL-17",
    "activeIngredients": "PALIPERIDONE PALMITATE",
    "company": "JANSSEN PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/23/2025",
    "drugName": "ZULRESSONDA   #211371",
    "submission": "SUPPL-11",
    "activeIngredients": "BREXANOLONE",
    "company": "SAGE THERAP",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/23/2025",
    "drugName": "QELBREENDA   #211964",
    "submission": "SUPPL-13",
    "activeIngredients": "VILOXAZINE HYDROCHLORIDE",
    "company": "SUPERNUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/23/2025",
    "drugName": "ARIPIPRAZOLEANDA  #216351",
    "submission": "SUPPL-4",
    "activeIngredients": "ARIPIPRAZOLE",
    "company": "RUBICON RESEARCH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/23/2025",
    "drugName": "MESALAMINEANDA  #216941",
    "submission": "SUPPL-4",
    "activeIngredients": "MESALAMINE",
    "company": "ENCUBE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/23/2025",
    "drugName": "METHYLENE BLUEANDA  #217380",
    "submission": "ORIG-1",
    "activeIngredients": "METHYLENE BLUE",
    "company": "MEITHEAL",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/23/2025",
    "drugName": "LISDEXAMFETAMINE DIMESYLATEANDA  #217442",
    "submission": "SUPPL-3",
    "activeIngredients": "LISDEXAMFETAMINE DIMESYLATE",
    "company": "ASCENT PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/23/2025",
    "drugName": "EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDEANDA  #217781",
    "submission": "ORIG-1",
    "activeIngredients": "EMPAGLIFLOZIN;METFORMIN HYDROCHLORIDE",
    "company": "AJANTA PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "01/23/2025",
    "drugName": "TERIPARATIDENDA   #218771",
    "submission": "SUPPL-1",
    "activeIngredients": "TERIPARATIDE",
    "company": "ALMAJECT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/23/2025",
    "drugName": "SPIRONOLACTONEANDA  #219494",
    "submission": "ORIG-1",
    "activeIngredients": "SPIRONOLACTONE",
    "company": "GRAVITI PHARMS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/23/2025",
    "drugName": "DARZALEXBLA   #761036",
    "submission": "SUPPL-51",
    "activeIngredients": "DARATUMUMAB",
    "company": "JANSSEN BIOTECH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2025",
    "drugName": "RISPERIDONEANDA  #077328",
    "submission": "SUPPL-13",
    "activeIngredients": "RISPERIDONE",
    "company": "ANDA REPOSITORY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2025",
    "drugName": "ARIPIPRAZOLEANDA  #090165",
    "submission": "SUPPL-12",
    "activeIngredients": "ARIPIPRAZOLE",
    "company": "SQUARE PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2025",
    "drugName": "ARIPIPRAZOLEANDA  #202102",
    "submission": "SUPPL-26",
    "activeIngredients": "ARIPIPRAZOLE",
    "company": "ALEMBIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2025",
    "drugName": "ARIPIPRAZOLEANDA  #203906",
    "submission": "SUPPL-17",
    "activeIngredients": "ARIPIPRAZOLE",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2025",
    "drugName": "ARIPIPRAZOLEANDA  #204094",
    "submission": "SUPPL-14",
    "activeIngredients": "ARIPIPRAZOLE",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2025",
    "drugName": "MEKINISTNDA   #204114",
    "submission": "SUPPL-36",
    "activeIngredients": "TRAMETINIB DIMETHYL SULFOXIDE",
    "company": "NOVARTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2025",
    "drugName": "ARIPIPRAZOLEANDA  #204171",
    "submission": "SUPPL-13",
    "activeIngredients": "ARIPIPRAZOLE",
    "company": "LANNETT CO INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2025",
    "drugName": "ARIPIPRAZOLEANDA  #207240",
    "submission": "SUPPL-16",
    "activeIngredients": "ARIPIPRAZOLE",
    "company": "SCIEGEN PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2025",
    "drugName": "ROCKLATANNDA   #208259",
    "submission": "SUPPL-12",
    "activeIngredients": "LATANOPROST; NETARSUDIL DIMESYLATE",
    "company": "ALCON LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2025",
    "drugName": "SAPROPTERIN DIHYDROCHLORIDEANDA  #209452",
    "submission": "SUPPL-8",
    "activeIngredients": "SAPROPTERIN DIHYDROCHLORIDE",
    "company": "DR REDDYS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2025",
    "drugName": "ARIPIPRAZOLEANDA  #210479",
    "submission": "SUPPL-13",
    "activeIngredients": "ARIPIPRAZOLE",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2025",
    "drugName": "FLUOCINONIDE ACETONIDEANDA  #210539",
    "submission": "SUPPL-5",
    "activeIngredients": "FLUOCINOLONE ACETONIDE",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2025",
    "drugName": "PERSERIS KITNDA   #210655",
    "submission": "SUPPL-14",
    "activeIngredients": "RISPERIDONE",
    "company": "INDIVIOR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2025",
    "drugName": "AZACITIDINEANDA  #210748",
    "submission": "SUPPL-3",
    "activeIngredients": "AZACITIDINE",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2025",
    "drugName": "FRINDOVYXNDA   #210852",
    "submission": "SUPPL-5",
    "activeIngredients": "CYCLOPHOSPHAMIDE",
    "company": "AVYXA HOLDINGS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2025",
    "drugName": "FLUOCINONIDE ACETONIDEANDA  #211815",
    "submission": "SUPPL-4",
    "activeIngredients": "FLUOCINOLONE ACETONIDE",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2025",
    "drugName": "BONSITYNDA   #211939",
    "submission": "SUPPL-17",
    "activeIngredients": "TERIPARATIDE",
    "company": "ALVOGEN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2025",
    "drugName": "ARIPIPRAZOLEANDA  #212870",
    "submission": "SUPPL-9",
    "activeIngredients": "ARIPIPRAZOLE",
    "company": "VISTAPHARM LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2025",
    "drugName": "BRUKINSANDA   #213217",
    "submission": "SUPPL-15",
    "activeIngredients": "ZANUBRUTINIB",
    "company": "BEONE MEDICINES USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2025",
    "drugName": "FLUPHENAZINE HYDROCHLORIDEANDA  #214552",
    "submission": "SUPPL-2",
    "activeIngredients": "FLUPHENAZINE HYDROCHLORIDE",
    "company": "ZYDUS LIFESCIENCES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2025",
    "drugName": "SAPROPTERIN DIHYDROCHLORIDEANDA  #215420",
    "submission": "SUPPL-3",
    "activeIngredients": "SAPROPTERIN DIHYDROCHLORIDE",
    "company": "ANNORA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2025",
    "drugName": "ARIPIPRAZOLEANDA  #215595",
    "submission": "SUPPL-2",
    "activeIngredients": "ARIPIPRAZOLE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2025",
    "drugName": "METOPROLOL SUCCINATEANDA  #215637",
    "submission": "SUPPL-2",
    "activeIngredients": "METOPROLOL SUCCINATE",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2025",
    "drugName": "SAPROPTERIN DIHYDROCHLORIDEANDA  #215798",
    "submission": "SUPPL-3",
    "activeIngredients": "SAPROPTERIN DIHYDROCHLORIDE",
    "company": "DR REDDYS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2025",
    "drugName": "ARIPIPRAZOLEANDA  #216150",
    "submission": "SUPPL-2",
    "activeIngredients": "ARIPIPRAZOLE",
    "company": "HETERO LABS LTD III",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2025",
    "drugName": "ARIPIPRAZOLEANDA  #216351",
    "submission": "SUPPL-5",
    "activeIngredients": "ARIPIPRAZOLE",
    "company": "RUBICON RESEARCH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2025",
    "drugName": "MEKINISTNDA   #217513",
    "submission": "SUPPL-10",
    "activeIngredients": "TRAMETINIB",
    "company": "NOVARTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2025",
    "drugName": "MEKINISTNDA   #217513",
    "submission": "SUPPL-10",
    "activeIngredients": "TRAMETINIB DIMETHYL SULFOXIDE",
    "company": "NOVARTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2025",
    "drugName": "POTASSIUM PHOSPHATESANDA  #217892",
    "submission": "ORIG-1",
    "activeIngredients": "POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC",
    "company": "CIPLA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2025",
    "drugName": "OLAPARIBANDA  #219205",
    "submission": "ORIG-1",
    "activeIngredients": "OLAPARIB",
    "company": "QILU PHARM HAINAN",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "01/24/2025",
    "drugName": "LEQEMBIBLA   #761269",
    "submission": "SUPPL-5",
    "activeIngredients": "LECANEMAB-IRMB",
    "company": "EISAI INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/24/2025",
    "drugName": "AVTOZMABLA   #761420",
    "submission": "ORIG-1",
    "activeIngredients": "TOCILIZUMAB-ANOH",
    "company": "CELLTRION INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/26/2025",
    "drugName": "NIZORAL ANTI-DANDRUFFNDA   #020310",
    "submission": "SUPPL-34",
    "activeIngredients": "KETOCONAZOLE",
    "company": "KRAMER",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/27/2025",
    "drugName": "ISONIAZIDANDA  #040090",
    "submission": "SUPPL-5",
    "activeIngredients": "ISONIAZID",
    "company": "OMNIVIUM PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/27/2025",
    "drugName": "ISONIAZIDANDA  #040090",
    "submission": "SUPPL-6",
    "activeIngredients": "ISONIAZID",
    "company": "OMNIVIUM PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/27/2025",
    "drugName": "CARBAMAZEPINEANDA  #075712",
    "submission": "SUPPL-36",
    "activeIngredients": "CARBAMAZEPINE",
    "company": "TORRENT PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/27/2025",
    "drugName": "CARBAMAZEPINEANDA  #077272",
    "submission": "SUPPL-28",
    "activeIngredients": "CARBAMAZEPINE",
    "company": "TORRENT PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/27/2025",
    "drugName": "CARBAMAZEPINEANDA  #077272",
    "submission": "SUPPL-29",
    "activeIngredients": "CARBAMAZEPINE",
    "company": "TORRENT PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/27/2025",
    "drugName": "CYRAMZABLA   #125477",
    "submission": "SUPPL-48",
    "activeIngredients": "RAMUCIRUMAB",
    "company": "ELI LILLY AND CO",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/27/2025",
    "drugName": "ACETAZOLAMIDEANDA  #207659",
    "submission": "SUPPL-7",
    "activeIngredients": "ACETAZOLAMIDE",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/27/2025",
    "drugName": "EZETIMIBE AND SIMVASTATINANDA  #209461",
    "submission": "ORIG-1",
    "activeIngredients": "EZETIMIBE; SIMVASTATIN",
    "company": "TORRENT",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/27/2025",
    "drugName": "SORAFENIB TOSYLATEANDA  #212228",
    "submission": "ORIG-1",
    "activeIngredients": "SORAFENIB TOSYLATE",
    "company": "APOTEX",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/27/2025",
    "drugName": "PROCHLORPERAZINE MALEATEANDA  #216495",
    "submission": "SUPPL-1",
    "activeIngredients": "PROCHLORPERAZINE MALEATE",
    "company": "ZYDUS LIFESCIENCES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/27/2025",
    "drugName": "AZELASTINE HYDROCHLORIDE ALLERGYANDA  #216561",
    "submission": "ORIG-1",
    "activeIngredients": "AZELASTINE HYDROCHLORIDE",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/27/2025",
    "drugName": "AZELASTINE HYDROCHLORIDE ALLERGYANDA  #216561",
    "submission": "ORIG-2",
    "activeIngredients": "AZELASTINE HYDROCHLORIDE",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "01/27/2025",
    "drugName": "DOXYCYCLINEANDA  #217098",
    "submission": "ORIG-1",
    "activeIngredients": "DOXYCYCLINE",
    "company": "PRINSTON INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/27/2025",
    "drugName": "ACETAZOLAMIDEANDA  #217197",
    "submission": "SUPPL-1",
    "activeIngredients": "ACETAZOLAMIDE",
    "company": "NE RX PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/27/2025",
    "drugName": "IPRATROPIUM BROMIDEANDA  #217886",
    "submission": "ORIG-1",
    "activeIngredients": "IPRATROPIUM BROMIDE",
    "company": "LUPIN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/27/2025",
    "drugName": "OXALIPLATINANDA  #217925",
    "submission": "ORIG-1",
    "activeIngredients": "OXALIPLATIN",
    "company": "HETERO LABS LTD VI",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/27/2025",
    "drugName": "MOXIFLOXACIN HYDROCHLORIDEANDA  #217988",
    "submission": "ORIG-1",
    "activeIngredients": "MOXIFLOXACIN HYDROCHLORIDE",
    "company": "MANKIND PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/27/2025",
    "drugName": "ENHERTUBLA   #761139",
    "submission": "SUPPL-32",
    "activeIngredients": "FAM-TRASTUZUMAB DERUXTECAN-NXKI",
    "company": "DAIICHI SANKYO",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/27/2025",
    "drugName": "ENHERTUBLA   #761139",
    "submission": "SUPPL-35",
    "activeIngredients": "FAM-TRASTUZUMAB DERUXTECAN-NXKI",
    "company": "DAIICHI SANKYO",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/28/2025",
    "drugName": "YERVOYBLA   #125377",
    "submission": "SUPPL-132",
    "activeIngredients": "IPILIMUMAB",
    "company": "BRISTOL MYERS SQUIBB",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/28/2025",
    "drugName": "KEYTRUDABLA   #125514",
    "submission": "SUPPL-172",
    "activeIngredients": "PEMBROLIZUMAB",
    "company": "MERCK SHARP DOHME",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/28/2025",
    "drugName": "TENOFOVIR DISOPROXIL FUMARATEANDA  #206569",
    "submission": "SUPPL-1",
    "activeIngredients": "TENOFOVIR DISOPROXIL FUMARATE",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/28/2025",
    "drugName": "TENOFOVIR DISOPROXIL FUMARATEANDA  #206569",
    "submission": "SUPPL-2",
    "activeIngredients": "TENOFOVIR DISOPROXIL FUMARATE",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/28/2025",
    "drugName": "DABIGATRAN ETEXILATE MESYLATEANDA  #208048",
    "submission": "ORIG-1",
    "activeIngredients": "DABIGATRAN ETEXILATE MESYLATE",
    "company": "DR REDDYS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/28/2025",
    "drugName": "OZEMPICNDA   #209637",
    "submission": "SUPPL-25",
    "activeIngredients": "SEMAGLUTIDE",
    "company": "NOVO",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/28/2025",
    "drugName": "DIAZOXIDEANDA  #211050",
    "submission": "SUPPL-13",
    "activeIngredients": "DIAZOXIDE",
    "company": "E5 PHARMA INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/28/2025",
    "drugName": "LOTEPREDNOL ETABONATEANDA  #212080",
    "submission": "SUPPL-4",
    "activeIngredients": "LOTEPREDNOL ETABONATE",
    "company": "SENTISS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/28/2025",
    "drugName": "NEBIVOLOL HYDROCHLORIDEANDA  #212661",
    "submission": "ORIG-1",
    "activeIngredients": "NEBIVOLOL HYDROCHLORIDE",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/28/2025",
    "drugName": "OLOPATADINE HYDROCHLORIDEANDA  #213514",
    "submission": "ORIG-1",
    "activeIngredients": "OLOPATADINE HYDROCHLORIDE",
    "company": "GLAND PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "01/28/2025",
    "drugName": "TRIAMTERENE AND HYDROCHLOROTHIAZIDEANDA  #214611",
    "submission": "ORIG-1",
    "activeIngredients": "HYDROCHLOROTHIAZIDE; TRIAMTERENE",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/28/2025",
    "drugName": "TASCENSO ODTNDA   #214962",
    "submission": "SUPPL-3",
    "activeIngredients": "FINGOLIMOD LAURYL SULFATE",
    "company": "CYCLE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/28/2025",
    "drugName": "DARUNAVIR; COBICISTAT; EMTRICITABINE; TENOFOVIR ALAFENAMIDEANDA  #216511",
    "submission": "ORIG-1",
    "activeIngredients": "DARUNAVIR;COBICISTAT;EMTRICITABINE;TENOFOVIR ALAFENAMIDE",
    "company": "LUPIN LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "01/28/2025",
    "drugName": "EVEROLIMUSANDA  #217640",
    "submission": "ORIG-1",
    "activeIngredients": "EVEROLIMUS",
    "company": "NATCO",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/28/2025",
    "drugName": "PREGABALINANDA  #217857",
    "submission": "ORIG-1",
    "activeIngredients": "PREGABALIN",
    "company": "AIPING PHARM INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/28/2025",
    "drugName": "VENLAFAXINE HYDROCHLORIDEANDA  #218180",
    "submission": "ORIG-1",
    "activeIngredients": "VENLAFAXINE HYDROCHLORIDE",
    "company": "TORRENT",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/28/2025",
    "drugName": "INZIRQONDA   #219141",
    "submission": "ORIG-1",
    "activeIngredients": "HYDROCHLOROTHIAZIDE",
    "company": "NOVITIUM PHARMA",
    "submissionClassification": "Type 3 - New Dosage Form",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/28/2025",
    "drugName": "EPYSQLIBLA   #761340",
    "submission": "SUPPL-6",
    "activeIngredients": "ECULIZUMAB-AAGH",
    "company": "SAMSUNG BIOEPIS CO LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/29/2025",
    "drugName": "CIPROFLOXACIN HYDROCHLORIDEANDA  #075817",
    "submission": "SUPPL-43",
    "activeIngredients": "CIPROFLOXACIN HYDROCHLORIDE",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/29/2025",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #076711",
    "submission": "SUPPL-43",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "IMPAX LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/29/2025",
    "drugName": "ESTRADIOL AND NORGESTIMATEANDA  #076812",
    "submission": "SUPPL-22",
    "activeIngredients": "ESTRADIOL; NORGESTIMATE",
    "company": "BARR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/29/2025",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #076845",
    "submission": "SUPPL-10",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/29/2025",
    "drugName": "OLANZAPINE AND FLUOXETINE HYDROCHLORIDEANDA  #077528",
    "submission": "SUPPL-22",
    "activeIngredients": "FLUOXETINE HYDROCHLORIDE; OLANZAPINE",
    "company": "TEVA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/29/2025",
    "drugName": "SERTRALINE HYDROCHLORIDEANDA  #077670",
    "submission": "SUPPL-50",
    "activeIngredients": "SERTRALINE HYDROCHLORIDE",
    "company": "LUPIN",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/29/2025",
    "drugName": "FLUCONAZOLEANDA  #078423",
    "submission": "SUPPL-27",
    "activeIngredients": "FLUCONAZOLE",
    "company": "ANI PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/29/2025",
    "drugName": "FLUCONAZOLEANDA  #078423",
    "submission": "SUPPL-31",
    "activeIngredients": "FLUCONAZOLE",
    "company": "ANI PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/29/2025",
    "drugName": "LANIAZIDANDA  #080140",
    "submission": "SUPPL-12",
    "activeIngredients": "ISONIAZID",
    "company": "CHARTWELL MOLECULAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/29/2025",
    "drugName": "ISONIAZIDANDA  #088235",
    "submission": "SUPPL-8",
    "activeIngredients": "ISONIAZID",
    "company": "CMP PHARMA INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/29/2025",
    "drugName": "POLOCAINE-MPFANDA  #089406",
    "submission": "SUPPL-21",
    "activeIngredients": "MEPIVACAINE HYDROCHLORIDE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/29/2025",
    "drugName": "POLOCAINE-MPFANDA  #089406",
    "submission": "SUPPL-26",
    "activeIngredients": "MEPIVACAINE HYDROCHLORIDE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/29/2025",
    "drugName": "POLOCAINEANDA  #089407",
    "submission": "SUPPL-24",
    "activeIngredients": "MEPIVACAINE HYDROCHLORIDE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/29/2025",
    "drugName": "POLOCAINEANDA  #089407",
    "submission": "SUPPL-29",
    "activeIngredients": "MEPIVACAINE HYDROCHLORIDE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/29/2025",
    "drugName": "POLOCAINE-MPFANDA  #089408",
    "submission": "SUPPL-21",
    "activeIngredients": "MEPIVACAINE HYDROCHLORIDE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/29/2025",
    "drugName": "POLOCAINE-MPFANDA  #089408",
    "submission": "SUPPL-26",
    "activeIngredients": "MEPIVACAINE HYDROCHLORIDE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/29/2025",
    "drugName": "POLOCAINE-MPFANDA  #089409",
    "submission": "SUPPL-21",
    "activeIngredients": "MEPIVACAINE HYDROCHLORIDE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/29/2025",
    "drugName": "POLOCAINE-MPFANDA  #089409",
    "submission": "SUPPL-26",
    "activeIngredients": "MEPIVACAINE HYDROCHLORIDE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/29/2025",
    "drugName": "POLOCAINEANDA  #089410",
    "submission": "SUPPL-21",
    "activeIngredients": "MEPIVACAINE HYDROCHLORIDE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/29/2025",
    "drugName": "POLOCAINEANDA  #089410",
    "submission": "SUPPL-26",
    "activeIngredients": "MEPIVACAINE HYDROCHLORIDE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/29/2025",
    "drugName": "OLANZAPINE AND FLUOXETINE HYDROCHLORIDEANDA  #202074",
    "submission": "SUPPL-21",
    "activeIngredients": "FLUOXETINE HYDROCHLORIDE; OLANZAPINE",
    "company": "TEVA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/29/2025",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #202304",
    "submission": "SUPPL-17",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "PRINSTON INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/29/2025",
    "drugName": "EZETIMIBE AND SIMVASTATINANDA  #202968",
    "submission": "SUPPL-10",
    "activeIngredients": "EZETIMIBE; SIMVASTATIN",
    "company": "WATSON LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/29/2025",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #203013",
    "submission": "SUPPL-17",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "ALEMBIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/29/2025",
    "drugName": "OXYMORPHONE HYDROCHLORIDEANDA  #203601",
    "submission": "SUPPL-16",
    "activeIngredients": "OXYMORPHONE HYDROCHLORIDE",
    "company": "AVANTHI INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/29/2025",
    "drugName": "LENVIMANDA   #206947",
    "submission": "SUPPL-33",
    "activeIngredients": "LENVATINIB MESYLATE",
    "company": "EISAI INC",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/29/2025",
    "drugName": "TRETINOINANDA  #208279",
    "submission": "SUPPL-7",
    "activeIngredients": "TRETINOIN",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/29/2025",
    "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #209036",
    "submission": "SUPPL-17",
    "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
    "company": "ABHAI LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/29/2025",
    "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #209037",
    "submission": "SUPPL-17",
    "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
    "company": "ABHAI LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/29/2025",
    "drugName": "TERIFLUNOMIDEANDA  #209598",
    "submission": "SUPPL-3",
    "activeIngredients": "TERIFLUNOMIDE",
    "company": "HETERO LABS LTD V",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/29/2025",
    "drugName": "TERIFLUNOMIDEANDA  #209601",
    "submission": "SUPPL-7",
    "activeIngredients": "TERIFLUNOMIDE",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/29/2025",
    "drugName": "XOFLUZANDA   #210854",
    "submission": "SUPPL-24",
    "activeIngredients": "BALOXAVIR MARBOXIL",
    "company": "GENENTECH INC",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/29/2025",
    "drugName": "METHYLPHENIDATE HYDROCHLORIDEANDA  #211647",
    "submission": "SUPPL-2",
    "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/29/2025",
    "drugName": "ITRACONAZOLEANDA  #212239",
    "submission": "SUPPL-2",
    "activeIngredients": "ITRACONAZOLE",
    "company": "ANNORA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/29/2025",
    "drugName": "ITRACONAZOLEANDA  #212239",
    "submission": "SUPPL-4",
    "activeIngredients": "ITRACONAZOLE",
    "company": "ANNORA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/29/2025",
    "drugName": "BRIVARACETAMANDA  #214848",
    "submission": "SUPPL-2",
    "activeIngredients": "BRIVARACETAM",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/29/2025",
    "drugName": "LOTEPREDNOL ETABONATEANDA  #215204",
    "submission": "ORIG-1",
    "activeIngredients": "LOTEPREDNOL ETABONATE",
    "company": "PADAGIS US",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/29/2025",
    "drugName": "LISDEXAMFETAMINE DIMESYLATEANDA  #218987",
    "submission": "ORIG-1",
    "activeIngredients": "LISDEXAMFETAMINE DIMESYLATE",
    "company": "GRANULES",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/29/2025",
    "drugName": "PROPRANOLOL HYDROCHLORIDEANDA  #219574",
    "submission": "ORIG-1",
    "activeIngredients": "PROPRANOLOL HYDROCHLORIDE",
    "company": "RUBICON",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "01/30/2025",
    "drugName": "ASCLERANDA   #021201",
    "submission": "SUPPL-5",
    "activeIngredients": "POLIDOCANOL",
    "company": "CHEMISCH FBRK KRSSLR",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/30/2025",
    "drugName": "METHADONE HYDROCHLORIDEANDA  #040088",
    "submission": "SUPPL-29",
    "activeIngredients": "METHADONE HYDROCHLORIDE",
    "company": "VISTAPHARM LLC",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/30/2025",
    "drugName": "CLINDESSENDA   #050793",
    "submission": "SUPPL-33",
    "activeIngredients": "CLINDAMYCIN PHOSPHATE",
    "company": "PADAGIS US",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/30/2025",
    "drugName": "ROSUVASTATIN CALCIUMANDA  #079168",
    "submission": "SUPPL-3",
    "activeIngredients": "ROSUVASTATIN CALCIUM",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/30/2025",
    "drugName": "ROSUVASTATIN CALCIUMANDA  #079168",
    "submission": "SUPPL-4",
    "activeIngredients": "ROSUVASTATIN CALCIUM",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/30/2025",
    "drugName": "ROSUVASTATIN CALCIUMANDA  #079168",
    "submission": "SUPPL-5",
    "activeIngredients": "ROSUVASTATIN CALCIUM",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/30/2025",
    "drugName": "LANIAZIDANDA  #089776",
    "submission": "SUPPL-23",
    "activeIngredients": "ISONIAZID",
    "company": "CHARTWELL MOLECULAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/30/2025",
    "drugName": "TAFINLARNDA   #202806",
    "submission": "SUPPL-36",
    "activeIngredients": "DABRAFENIB MESYLATE",
    "company": "NOVARTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/30/2025",
    "drugName": "LINAGLIPTIN AND METFORMIN HYDROCHLORIDEANDA  #208427",
    "submission": "ORIG-1",
    "activeIngredients": "LINAGLIPTIN; METFORMIN HYDROCHLORIDE",
    "company": "DR REDDYS LABS LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "01/30/2025",
    "drugName": "PREVYMISNDA   #209939",
    "submission": "SUPPL-15",
    "activeIngredients": "LETERMOVIR",
    "company": "MERCK SHARP DOHME",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/30/2025",
    "drugName": "PREVYMISNDA   #209940",
    "submission": "SUPPL-15",
    "activeIngredients": "LETERMOVIR",
    "company": "MERCK SHARP DOHME",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/30/2025",
    "drugName": "FOTIVDANDA   #212904",
    "submission": "SUPPL-3",
    "activeIngredients": "TIVOZANIB HYDROCHLORIDE",
    "company": "AVEO PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/30/2025",
    "drugName": "SYMBRAVONDA   #215431",
    "submission": "ORIG-1",
    "activeIngredients": "MELOXICAM; RIZATRIPTAN BENZOATE",
    "company": "AXSOME",
    "submissionClassification": "Type 4 - New Combination",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/30/2025",
    "drugName": "FORMOTEROL FUMARATEANDA  #215907",
    "submission": "ORIG-1",
    "activeIngredients": "FORMOTEROL FUMARATE",
    "company": "DR REDDYS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/30/2025",
    "drugName": "POTASSIUM PHOSPHATESANDA  #216274",
    "submission": "SUPPL-2",
    "activeIngredients": "POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC",
    "company": "AM REGENT",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/30/2025",
    "drugName": "METHYLNALTREXONE BROMIDEANDA  #216836",
    "submission": "ORIG-1",
    "activeIngredients": "METHYLNALTREXONE BROMIDE",
    "company": "GLAND PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "01/30/2025",
    "drugName": "TAFINLARNDA   #217514",
    "submission": "SUPPL-10",
    "activeIngredients": "DABRAFENIB MESYLATE",
    "company": "NOVARTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/30/2025",
    "drugName": "PREVYMISNDA   #219104",
    "submission": "SUPPL-1",
    "activeIngredients": "LETERMOVIR",
    "company": "MSD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/30/2025",
    "drugName": "JOURNAVXNDA   #219209",
    "submission": "ORIG-1",
    "activeIngredients": "SUZETRIGINE",
    "company": "VERTEX PHARMS INC",
    "submissionClassification": "Type 1 - New Molecular Entity",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/30/2025",
    "drugName": "BUPRENORPHINE HYDROCHLORIDEANDA  #219302",
    "submission": "ORIG-1",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE",
    "company": "SOMERSET THERAPS LLC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/30/2025",
    "drugName": "BKEMVBLA   #761333",
    "submission": "SUPPL-3",
    "activeIngredients": "ECULIZUMAB-AEEB",
    "company": "AMGEN INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/31/2025",
    "drugName": "PEPCID COMPLETENDA   #020958",
    "submission": "SUPPL-41",
    "activeIngredients": "CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE",
    "company": "KENVUE BRANDS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/31/2025",
    "drugName": "NORDITROPINBLA   #021148",
    "submission": "SUPPL-56",
    "activeIngredients": "SOMATROPIN",
    "company": "NOVO NORDISK INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/31/2025",
    "drugName": "NORDITROPINBLA   #021148",
    "submission": "SUPPL-58",
    "activeIngredients": "SOMATROPIN",
    "company": "NOVO NORDISK INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/31/2025",
    "drugName": "NORDITROPIN FLEXPROBLA   #021148",
    "submission": "SUPPL-56",
    "activeIngredients": "SOMATROPIN",
    "company": "NOVO NORDISK INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/31/2025",
    "drugName": "NORDITROPIN FLEXPROBLA   #021148",
    "submission": "SUPPL-58",
    "activeIngredients": "SOMATROPIN",
    "company": "NOVO NORDISK INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/31/2025",
    "drugName": "NORDITROPIN NORDIFLEXBLA   #021148",
    "submission": "SUPPL-56",
    "activeIngredients": "SOMATROPIN",
    "company": "NOVO NORDISK INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/31/2025",
    "drugName": "NORDITROPIN NORDIFLEXBLA   #021148",
    "submission": "SUPPL-58",
    "activeIngredients": "SOMATROPIN",
    "company": "NOVO NORDISK INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/31/2025",
    "drugName": "UNASYNNDA   #050608",
    "submission": "SUPPL-56",
    "activeIngredients": "AMPICILLIN SODIUM; SULBACTAM SODIUM",
    "company": "PFIZER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/31/2025",
    "drugName": "ISONIAZIDANDA  #080212",
    "submission": "SUPPL-39",
    "activeIngredients": "ISONIAZID",
    "company": "HIKMA INTL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/31/2025",
    "drugName": "ISONIAZIDANDA  #080212",
    "submission": "SUPPL-41",
    "activeIngredients": "ISONIAZID",
    "company": "HIKMA INTL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/31/2025",
    "drugName": "ISONIAZIDANDA  #087425",
    "submission": "SUPPL-34",
    "activeIngredients": "ISONIAZID",
    "company": "HIKMA INTL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/31/2025",
    "drugName": "ISONIAZIDANDA  #087425",
    "submission": "SUPPL-36",
    "activeIngredients": "ISONIAZID",
    "company": "HIKMA INTL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/31/2025",
    "drugName": "METHOTREXATE SODIUM PRESERVATIVE FREEANDA  #090029",
    "submission": "SUPPL-14",
    "activeIngredients": "METHOTREXATE SODIUM",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/31/2025",
    "drugName": "METHOTREXATE SODIUM PRESERVATIVE FREEANDA  #090029",
    "submission": "SUPPL-15",
    "activeIngredients": "METHOTREXATE SODIUM",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/31/2025",
    "drugName": "METHOTREXATE SODIUM PRESERVATIVE FREEANDA  #090039",
    "submission": "SUPPL-15",
    "activeIngredients": "METHOTREXATE SODIUM",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/31/2025",
    "drugName": "METHOTREXATE SODIUM PRESERVATIVE FREEANDA  #090039",
    "submission": "SUPPL-16",
    "activeIngredients": "METHOTREXATE SODIUM",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/31/2025",
    "drugName": "AZTREONAMANDA  #206517",
    "submission": "SUPPL-5",
    "activeIngredients": "AZTREONAM",
    "company": "HOSPIRA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/31/2025",
    "drugName": "LANTHANUM CARBONATEANDA  #206868",
    "submission": "SUPPL-5",
    "activeIngredients": "LANTHANUM CARBONATE",
    "company": "INVAGEN PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/31/2025",
    "drugName": "TRAMADOL HYDROCHLORIDEANDA  #209404",
    "submission": "ORIG-1",
    "activeIngredients": "TRAMADOL HYDROCHLORIDE",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/31/2025",
    "drugName": "ROFLUMILASTANDA  #213298",
    "submission": "SUPPL-1",
    "activeIngredients": "ROFLUMILAST",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/31/2025",
    "drugName": "LENALIDOMIDEANDA  #216213",
    "submission": "ORIG-1",
    "activeIngredients": "LENALIDOMIDE",
    "company": "AMNEAL",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/31/2025",
    "drugName": "PAXLOVID (COPACKAGED)NDA   #217188",
    "submission": "SUPPL-8",
    "activeIngredients": "NIRMATRELVIR; RITONAVIR",
    "company": "PFIZER",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/31/2025",
    "drugName": "NOREPINEPHRINE BITARTRATEANDA  #219163",
    "submission": "ORIG-1",
    "activeIngredients": "NOREPINEPHRINE BITARTRATE",
    "company": "ASPIRO",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/31/2025",
    "drugName": "SOGROYABLA   #761156",
    "submission": "SUPPL-6",
    "activeIngredients": "SOMAPACITAN-BECO",
    "company": "NOVO NORDISK INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "01/31/2025",
    "drugName": "BIZENGRIBLA   #761352",
    "submission": "SUPPL-1",
    "activeIngredients": "ZENOCUTUZUMAB-ZBCO",
    "company": "MERUS N.V.",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  }
,
  {
    "approvalDate": "02/02/2025",
    "drugName": "Carbon Dioxide, USPNDA   #220266",
    "submission": "ORIG-1",
    "activeIngredients": "Carbon Dioxide",
    "company": "WELDERS SUPPLY COMPANY OF LOUISVILLE INC",
    "submissionClassification": "Medical Gas",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/03/2025",
    "drugName": "ULTANENDA   #020478",
    "submission": "SUPPL-35",
    "activeIngredients": "SEVOFLURANE",
    "company": "ABBVIE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/03/2025",
    "drugName": "APOKYNNDA   #021264",
    "submission": "SUPPL-25",
    "activeIngredients": "APOMORPHINE HYDROCHLORIDE",
    "company": "MDD US",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/03/2025",
    "drugName": "MIRALAXNDA   #022015",
    "submission": "SUPPL-50",
    "activeIngredients": "POLYETHYLENE GLYCOL 3350",
    "company": "BAYER HEALTHCARE LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/03/2025",
    "drugName": "HYDROCORTISONEANDA  #040761",
    "submission": "SUPPL-16",
    "activeIngredients": "HYDROCORTISONE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/03/2025",
    "drugName": "VALPROIC ACIDANDA  #075782",
    "submission": "SUPPL-12",
    "activeIngredients": "VALPROIC ACID",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/03/2025",
    "drugName": "RISPERIDONEANDA  #078269",
    "submission": "SUPPL-15",
    "activeIngredients": "RISPERIDONE",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/03/2025",
    "drugName": "RISPERIDONEANDA  #078269",
    "submission": "SUPPL-16",
    "activeIngredients": "RISPERIDONE",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/03/2025",
    "drugName": "MORPHINE SULFATEANDA  #203602",
    "submission": "SUPPL-2",
    "activeIngredients": "MORPHINE SULFATE",
    "company": "NOVEL LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/03/2025",
    "drugName": "MORPHINE SULFATEANDA  #203602",
    "submission": "SUPPL-5",
    "activeIngredients": "MORPHINE SULFATE",
    "company": "NOVEL LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/03/2025",
    "drugName": "MORPHINE SULFATEANDA  #203602",
    "submission": "SUPPL-8",
    "activeIngredients": "MORPHINE SULFATE",
    "company": "NOVEL LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/03/2025",
    "drugName": "MORPHINE SULFATEANDA  #203602",
    "submission": "SUPPL-9",
    "activeIngredients": "MORPHINE SULFATE",
    "company": "NOVEL LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/03/2025",
    "drugName": "MORPHINE SULFATEANDA  #203602",
    "submission": "SUPPL-11",
    "activeIngredients": "MORPHINE SULFATE",
    "company": "NOVEL LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/03/2025",
    "drugName": "ZOLEDRONIC ACIDANDA  #203841",
    "submission": "SUPPL-2",
    "activeIngredients": "ZOLEDRONIC ACID",
    "company": "MYLAN LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/03/2025",
    "drugName": "ZOLEDRONIC ACIDANDA  #203841",
    "submission": "SUPPL-5",
    "activeIngredients": "ZOLEDRONIC ACID",
    "company": "MYLAN LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/03/2025",
    "drugName": "LINEZOLIDANDA  #204764",
    "submission": "SUPPL-10",
    "activeIngredients": "LINEZOLID",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/03/2025",
    "drugName": "HYDROCORTISONEANDA  #207029",
    "submission": "SUPPL-19",
    "activeIngredients": "HYDROCORTISONE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/03/2025",
    "drugName": "LINEZOLIDANDA  #207354",
    "submission": "SUPPL-15",
    "activeIngredients": "LINEZOLID",
    "company": "NANG KUANG PHARM CO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/03/2025",
    "drugName": "DABIGATRAN ETEXILATE MESYLATEANDA  #208067",
    "submission": "ORIG-1",
    "activeIngredients": "DABIGATRAN ETEXILATE MESYLATE",
    "company": "MYLAN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/03/2025",
    "drugName": "ONAPGONDA   #214056",
    "submission": "ORIG-1",
    "activeIngredients": "APOMORPHINE HYDROCHLORIDE",
    "company": "MDD US",
    "submissionClassification": "Type 5 - New Formulation or New Manufacturer",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/03/2025",
    "drugName": "SULFAMETHOXAZOLE AND TRIMETHOPRIMANDA  #214330",
    "submission": "SUPPL-11",
    "activeIngredients": "SULFAMETHOXAZOLE; TRIMETHOPRIM",
    "company": "NOVITIUM PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/03/2025",
    "drugName": "NITAZOXANIDEANDA  #214844",
    "submission": "ORIG-1",
    "activeIngredients": "NITAZOXANIDE",
    "company": "ANI PHARMS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/03/2025",
    "drugName": "ARFORMOTEROL TARTRATEANDA  #218380",
    "submission": "ORIG-1",
    "activeIngredients": "ARFORMOTEROL TARTRATE",
    "company": "AUCTA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/03/2025",
    "drugName": "SEVELAMER HYDROCHLORIDEANDA  #218966",
    "submission": "ORIG-1",
    "activeIngredients": "SEVELAMER HYDROCHLORIDE",
    "company": "NAVINTA LLC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/03/2025",
    "drugName": "SUSVIMOBLA   #761197",
    "submission": "SUPPL-6",
    "activeIngredients": "RANIBIZUMAB",
    "company": "GENENTECH INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/04/2025",
    "drugName": "RITALINNDA   #010187",
    "submission": "SUPPL-94",
    "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/04/2025",
    "drugName": "ELIGARD KITNDA   #021343",
    "submission": "SUPPL-55",
    "activeIngredients": "LEUPROLIDE ACETATE",
    "company": "TOLMAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/04/2025",
    "drugName": "ELIGARD KITNDA   #021379",
    "submission": "SUPPL-58",
    "activeIngredients": "LEUPROLIDE ACETATE",
    "company": "TOLMAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/04/2025",
    "drugName": "ELIGARD KITNDA   #021488",
    "submission": "SUPPL-52",
    "activeIngredients": "LEUPROLIDE ACETATE",
    "company": "TOLMAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/04/2025",
    "drugName": "ELIGARD KITNDA   #021731",
    "submission": "SUPPL-55",
    "activeIngredients": "LEUPROLIDE ACETATE",
    "company": "TOLMAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/04/2025",
    "drugName": "MINOCYCLINE HYDROCHLORIDEANDA  #065470",
    "submission": "SUPPL-16",
    "activeIngredients": "MINOCYCLINE HYDROCHLORIDE",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/04/2025",
    "drugName": "FLUOXETINE HYDROCHLORIDEANDA  #202729",
    "submission": "SUPPL-2",
    "activeIngredients": "FLUOXETINE HYDROCHLORIDE",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/04/2025",
    "drugName": "LINAGLIPTINANDA  #208428",
    "submission": "ORIG-1",
    "activeIngredients": "LINAGLIPTIN",
    "company": "DR REDDYS LABS LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "02/04/2025",
    "drugName": "INGREZZANDA   #209241",
    "submission": "SUPPL-29",
    "activeIngredients": "VALBENAZINE TOSYLATE",
    "company": "NEUROCRINE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/04/2025",
    "drugName": "TAVALISSENDA   #209299",
    "submission": "SUPPL-3",
    "activeIngredients": "FOSTAMATINIB DISODIUM",
    "company": "RIGEL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/04/2025",
    "drugName": "RANOLAZINEANDA  #210407",
    "submission": "ORIG-1",
    "activeIngredients": "RANOLAZINE",
    "company": "TORRENT",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/04/2025",
    "drugName": "SOLIFENACIN SUCCINATEANDA  #210582",
    "submission": "SUPPL-2",
    "activeIngredients": "SOLIFENACIN SUCCINATE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/04/2025",
    "drugName": "GABAPENTINANDA  #211314",
    "submission": "SUPPL-3",
    "activeIngredients": "GABAPENTIN",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/04/2025",
    "drugName": "GABAPENTINANDA  #211314",
    "submission": "SUPPL-4",
    "activeIngredients": "GABAPENTIN",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/04/2025",
    "drugName": "PIRFENIDONEANDA  #212730",
    "submission": "SUPPL-3",
    "activeIngredients": "PIRFENIDONE",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/04/2025",
    "drugName": "PIRFENIDONEANDA  #212731",
    "submission": "SUPPL-3",
    "activeIngredients": "PIRFENIDONE",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/04/2025",
    "drugName": "HEPARIN SODIUMANDA  #214804",
    "submission": "SUPPL-8",
    "activeIngredients": "HEPARIN SODIUM",
    "company": "BE PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/04/2025",
    "drugName": "PROCAINAMIDE HYDROCHLORIDEANDA  #218674",
    "submission": "ORIG-1",
    "activeIngredients": "PROCAINAMIDE HYDROCHLORIDE",
    "company": "CAPLIN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2025",
    "drugName": "NYDRAZIDNDA   #008662",
    "submission": "SUPPL-20",
    "activeIngredients": "ISONIAZID",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2025",
    "drugName": "ISONIAZIDNDA   #008678",
    "submission": "SUPPL-30",
    "activeIngredients": "ISONIAZID",
    "company": "EPIC PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2025",
    "drugName": "WELLBUTRINNDA   #018644",
    "submission": "SUPPL-62",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "GLAXOSMITHKLINE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2025",
    "drugName": "ISONIAZIDANDA  #040090",
    "submission": "SUPPL-7",
    "activeIngredients": "ISONIAZID",
    "company": "OMNIVIUM PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2025",
    "drugName": "ISONIAZIDANDA  #040648",
    "submission": "SUPPL-24",
    "activeIngredients": "ISONIAZID",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2025",
    "drugName": "RIFATERNDA   #050705",
    "submission": "SUPPL-27",
    "activeIngredients": "ISONIAZID; PYRAZINAMIDE; RIFAMPIN",
    "company": "SANOFI AVENTIS US",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2025",
    "drugName": "RIFAMPIN AND ISONIAZIDANDA  #065221",
    "submission": "SUPPL-5",
    "activeIngredients": "ISONIAZID; RIFAMPIN",
    "company": "HIKMA INTL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2025",
    "drugName": "LEVETIRACETAMANDA  #078858",
    "submission": "SUPPL-37",
    "activeIngredients": "LEVETIRACETAM",
    "company": "TORRENT PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2025",
    "drugName": "LEVETIRACETAMANDA  #078993",
    "submission": "SUPPL-35",
    "activeIngredients": "LEVETIRACETAM",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2025",
    "drugName": "LANIAZIDANDA  #080140",
    "submission": "SUPPL-13",
    "activeIngredients": "ISONIAZID",
    "company": "CHARTWELL MOLECULAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2025",
    "drugName": "ISONIAZIDANDA  #080212",
    "submission": "SUPPL-43",
    "activeIngredients": "ISONIAZID",
    "company": "HIKMA INTL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2025",
    "drugName": "ISONIAZIDANDA  #080936",
    "submission": "SUPPL-61",
    "activeIngredients": "ISONIAZID",
    "company": "GENUS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2025",
    "drugName": "ISONIAZIDANDA  #080937",
    "submission": "SUPPL-68",
    "activeIngredients": "ISONIAZID",
    "company": "GENUS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2025",
    "drugName": "ISONIAZIDANDA  #081118",
    "submission": "SUPPL-4",
    "activeIngredients": "ISONIAZID",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2025",
    "drugName": "ISONIAZIDANDA  #087425",
    "submission": "SUPPL-38",
    "activeIngredients": "ISONIAZID",
    "company": "HIKMA INTL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2025",
    "drugName": "ISONIAZIDANDA  #088235",
    "submission": "SUPPL-11",
    "activeIngredients": "ISONIAZID",
    "company": "CMP PHARMA INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2025",
    "drugName": "LANIAZIDANDA  #089243",
    "submission": "SUPPL-12",
    "activeIngredients": "ISONIAZID",
    "company": "LANNETT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2025",
    "drugName": "LANIAZIDANDA  #089776",
    "submission": "SUPPL-29",
    "activeIngredients": "ISONIAZID",
    "company": "CHARTWELL MOLECULAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2025",
    "drugName": "ISONIAZIDANDA  #202610",
    "submission": "SUPPL-1",
    "activeIngredients": "ISONIAZID",
    "company": "THEPHARMANETWORK LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2025",
    "drugName": "IBRUTINIBANDA  #211344",
    "submission": "SUPPL-3",
    "activeIngredients": "IBRUTINIB",
    "company": "ZYDUS LIFESCIENCES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2025",
    "drugName": "BOSENTANANDA  #213154",
    "submission": "ORIG-1",
    "activeIngredients": "BOSENTAN",
    "company": "NATCO PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2025",
    "drugName": "GRAFAPEXNDA   #214759",
    "submission": "SUPPL-1",
    "activeIngredients": "TREOSULFAN",
    "company": "MEDEXUS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2025",
    "drugName": "METHYLNALTREXONE BROMIDEANDA  #216965",
    "submission": "ORIG-1",
    "activeIngredients": "METHYLNALTREXONE BROMIDE",
    "company": "GLAND PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "02/05/2025",
    "drugName": "DAPTOMYCINNDA   #217415",
    "submission": "SUPPL-3",
    "activeIngredients": "DAPTOMYCIN",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2025",
    "drugName": "METHIMAZOLEANDA  #218830",
    "submission": "ORIG-1",
    "activeIngredients": "METHIMAZOLE",
    "company": "SQUARE PHARMS PLC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/05/2025",
    "drugName": "HULIOBLA   #761154",
    "submission": "SUPPL-9",
    "activeIngredients": "ADALIMUMAB-FKJP",
    "company": "MYLAN PHARMS INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/06/2025",
    "drugName": "METHYLPHENIDATE HYDROCHLORIDEANDA  #209753",
    "submission": "SUPPL-4",
    "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "company": "BIONPHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/06/2025",
    "drugName": "METHYLPHENIDATE HYDROCHLORIDEANDA  #209753",
    "submission": "SUPPL-5",
    "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "company": "BIONPHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/06/2025",
    "drugName": "METHYLPHENIDATE HYDROCHLORIDEANDA  #209753",
    "submission": "SUPPL-7",
    "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "company": "BIONPHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/06/2025",
    "drugName": "METHYLPHENIDATE HYDROCHLORIDEANDA  #209753",
    "submission": "SUPPL-9",
    "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "company": "BIONPHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/06/2025",
    "drugName": "FLUOROURACILANDA  #215699",
    "submission": "ORIG-1",
    "activeIngredients": "FLUOROURACIL",
    "company": "KINDOS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/06/2025",
    "drugName": "AZILSARTANANDA  #216699",
    "submission": "ORIG-1",
    "activeIngredients": "MEDOXOMIL",
    "company": "SABA ILAC SANAYIVE",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "02/06/2025",
    "drugName": "EPINEPHRINEANDA  #219239",
    "submission": "ORIG-1",
    "activeIngredients": "EPINEPHRINE",
    "company": "GLAND",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/07/2025",
    "drugName": "LAMOTRIGINEANDA  #200220",
    "submission": "SUPPL-10",
    "activeIngredients": "LAMOTRIGINE",
    "company": "JUBILANT GENERICS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/07/2025",
    "drugName": "LAMOTRIGINEANDA  #200220",
    "submission": "SUPPL-11",
    "activeIngredients": "LAMOTRIGINE",
    "company": "JUBILANT GENERICS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/07/2025",
    "drugName": "OXCARBAZEPINEANDA  #202961",
    "submission": "SUPPL-20",
    "activeIngredients": "OXCARBAZEPINE",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/07/2025",
    "drugName": "PHOTREXANDA   #203324",
    "submission": "SUPPL-10",
    "activeIngredients": "RIBOFLAVIN 5'-PHOSPHATE",
    "company": "GLAUKOS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/07/2025",
    "drugName": "PHOTREXA VISCOUS IN DEXTRAN 20%NDA   #203324",
    "submission": "SUPPL-10",
    "activeIngredients": "RIBOFLAVIN 5'-PHOSPHATE",
    "company": "GLAUKOS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/07/2025",
    "drugName": "OSPHENANDA   #203505",
    "submission": "SUPPL-18",
    "activeIngredients": "OSPEMIFENE",
    "company": "DUCHESNAY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/07/2025",
    "drugName": "ATORVASTATIN CALCIUMANDA  #208478",
    "submission": "SUPPL-5",
    "activeIngredients": "ATORVASTATIN CALCIUM",
    "company": "PERRIGO R AND D",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/07/2025",
    "drugName": "MOXIDECTINNDA   #210867",
    "submission": "SUPPL-6",
    "activeIngredients": "MOXIDECTIN",
    "company": "MDGH",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/07/2025",
    "drugName": "ONGENTYSNDA   #212489",
    "submission": "SUPPL-7",
    "activeIngredients": "OPICAPONE",
    "company": "AMNEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/07/2025",
    "drugName": "OXCARBAZEPINEANDA  #216749",
    "submission": "SUPPL-2",
    "activeIngredients": "OXCARBAZEPINE",
    "company": "HETERO LABS LTD III",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/07/2025",
    "drugName": "ZEPBOUNDNDA   #217806",
    "submission": "SUPPL-20",
    "activeIngredients": "TIRZEPATIDE",
    "company": "ELI LILLY AND CO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/07/2025",
    "drugName": "ZEPBOUND (AUTOINJECTOR)NDA   #217806",
    "submission": "SUPPL-20",
    "activeIngredients": "TIRZEPATIDE",
    "company": "ELI LILLY AND CO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/07/2025",
    "drugName": "CYANOCOBALAMINANDA  #217839",
    "submission": "SUPPL-3",
    "activeIngredients": "CYANOCOBALAMIN",
    "company": "MANKIND PHARMA",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/07/2025",
    "drugName": "VENLAFAXINE HYDROCHLORIDEANDA  #217841",
    "submission": "ORIG-1",
    "activeIngredients": "VENLAFAXINE HYDROCHLORIDE",
    "company": "ABON PHARMS LLC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/07/2025",
    "drugName": "EMBLAVEONDA   #217906",
    "submission": "ORIG-1",
    "activeIngredients": "AVIBACTAM SODIUM; AZTREONAM",
    "company": "ABBVIE",
    "submissionClassification": "Type 4 - New Combination",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/07/2025",
    "drugName": "IPRATROPIUM BROMIDEANDA  #217912",
    "submission": "ORIG-1",
    "activeIngredients": "IPRATROPIUM BROMIDE",
    "company": "LUPIN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/10/2025",
    "drugName": "LEVETIRACETAMANDA  #076919",
    "submission": "SUPPL-15",
    "activeIngredients": "LEVETIRACETAM",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/10/2025",
    "drugName": "LEVETIRACETAMANDA  #076919",
    "submission": "SUPPL-17",
    "activeIngredients": "LEVETIRACETAM",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/10/2025",
    "drugName": "LEVETIRACETAMANDA  #076919",
    "submission": "SUPPL-19",
    "activeIngredients": "LEVETIRACETAM",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/10/2025",
    "drugName": "LEVETIRACETAMANDA  #076919",
    "submission": "SUPPL-21",
    "activeIngredients": "LEVETIRACETAM",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/10/2025",
    "drugName": "LEVETIRACETAMANDA  #076919",
    "submission": "SUPPL-22",
    "activeIngredients": "LEVETIRACETAM",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/10/2025",
    "drugName": "LEVETIRACETAMANDA  #076919",
    "submission": "SUPPL-24",
    "activeIngredients": "LEVETIRACETAM",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/10/2025",
    "drugName": "LEVETIRACETAMANDA  #076919",
    "submission": "SUPPL-25",
    "activeIngredients": "LEVETIRACETAM",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/10/2025",
    "drugName": "LEVETIRACETAMANDA  #076919",
    "submission": "SUPPL-30",
    "activeIngredients": "LEVETIRACETAM",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/10/2025",
    "drugName": "LEVETIRACETAMANDA  #076919",
    "submission": "SUPPL-31",
    "activeIngredients": "LEVETIRACETAM",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/10/2025",
    "drugName": "LEVETIRACETAMANDA  #090261",
    "submission": "SUPPL-14",
    "activeIngredients": "LEVETIRACETAM",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/10/2025",
    "drugName": "LEVETIRACETAMANDA  #090261",
    "submission": "SUPPL-16",
    "activeIngredients": "LEVETIRACETAM",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/10/2025",
    "drugName": "LEVETIRACETAMANDA  #090261",
    "submission": "SUPPL-18",
    "activeIngredients": "LEVETIRACETAM",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/10/2025",
    "drugName": "LEVETIRACETAMANDA  #090261",
    "submission": "SUPPL-20",
    "activeIngredients": "LEVETIRACETAM",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/10/2025",
    "drugName": "LEVETIRACETAMANDA  #090261",
    "submission": "SUPPL-21",
    "activeIngredients": "LEVETIRACETAM",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/10/2025",
    "drugName": "LEVETIRACETAMANDA  #090261",
    "submission": "SUPPL-23",
    "activeIngredients": "LEVETIRACETAM",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/10/2025",
    "drugName": "LEVETIRACETAMANDA  #090261",
    "submission": "SUPPL-24",
    "activeIngredients": "LEVETIRACETAM",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/10/2025",
    "drugName": "LEVETIRACETAMANDA  #090261",
    "submission": "SUPPL-29",
    "activeIngredients": "LEVETIRACETAM",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/10/2025",
    "drugName": "LEVETIRACETAMANDA  #090261",
    "submission": "SUPPL-30",
    "activeIngredients": "LEVETIRACETAM",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/10/2025",
    "drugName": "SILODOSINANDA  #210396",
    "submission": "ORIG-1",
    "activeIngredients": "SILODOSIN",
    "company": "TORRENT",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/10/2025",
    "drugName": "LEUCOVORIN CALCIUMANDA  #216590",
    "submission": "SUPPL-6",
    "activeIngredients": "LEUCOVORIN CALCIUM",
    "company": "MEITHEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/10/2025",
    "drugName": "SELENIOUS ACIDANDA  #218779",
    "submission": "ORIG-1",
    "activeIngredients": "SELENIOUS ACID",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/10/2025",
    "drugName": "ENZEEVUBLA   #761382",
    "submission": "SUPPL-3",
    "activeIngredients": "AFLIBERCEPT-ABZV",
    "company": "SANDOZ INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/11/2025",
    "drugName": "PEPCID COMPLETENDA   #020958",
    "submission": "SUPPL-43",
    "activeIngredients": "CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE",
    "company": "KENVUE BRANDS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/11/2025",
    "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #040400",
    "submission": "SUPPL-40",
    "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
    "company": "SPECGX LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/11/2025",
    "drugName": "ANEXSIA 7.5/325ANDA  #040405",
    "submission": "SUPPL-40",
    "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
    "company": "SPECGX LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/11/2025",
    "drugName": "ANEXSIA 5/325ANDA  #040409",
    "submission": "SUPPL-40",
    "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
    "company": "SPECGX LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/11/2025",
    "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #090415",
    "submission": "SUPPL-26",
    "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/11/2025",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #090693",
    "submission": "SUPPL-25",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/11/2025",
    "drugName": "ADCETRISBLA   #125388",
    "submission": "SUPPL-108",
    "activeIngredients": "BRENTUXIMAB VEDOTIN",
    "company": "SEATTLE GENETICS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/11/2025",
    "drugName": "CLOPIDOGREL BISULFATEANDA  #202925",
    "submission": "SUPPL-19",
    "activeIngredients": "CLOPIDOGREL BISULFATE",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/11/2025",
    "drugName": "ZOLMITRIPTANANDA  #202956",
    "submission": "SUPPL-10",
    "activeIngredients": "ZOLMITRIPTAN",
    "company": "JUBILANT GENERICS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/11/2025",
    "drugName": "DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATEANDA  #203058",
    "submission": "SUPPL-3",
    "activeIngredients": "DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE",
    "company": "EPIC PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/11/2025",
    "drugName": "TEMSIROLIMUSANDA  #203153",
    "submission": "SUPPL-4",
    "activeIngredients": "TEMSIROLIMUS",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/11/2025",
    "drugName": "ALLOPURINOLANDA  #203154",
    "submission": "SUPPL-9",
    "activeIngredients": "ALLOPURINOL",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/11/2025",
    "drugName": "BRISDELLENDA   #204516",
    "submission": "SUPPL-9",
    "activeIngredients": "PAROXETINE MESYLATE",
    "company": "LEGACY PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/11/2025",
    "drugName": "BRISDELLENDA   #204516",
    "submission": "SUPPL-14",
    "activeIngredients": "PAROXETINE MESYLATE",
    "company": "LEGACY PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/11/2025",
    "drugName": "ROPIVACAINE HYDROCHLORIDEANDA  #205612",
    "submission": "SUPPL-1",
    "activeIngredients": "ROPIVACAINE HYDROCHLORIDE",
    "company": "EUGIA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/11/2025",
    "drugName": "ROPIVACAINE HYDROCHLORIDEANDA  #205612",
    "submission": "SUPPL-8",
    "activeIngredients": "ROPIVACAINE HYDROCHLORIDE",
    "company": "EUGIA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/11/2025",
    "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #207808",
    "submission": "SUPPL-8",
    "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
    "company": "RHODES PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/11/2025",
    "drugName": "KISQALINDA   #209092",
    "submission": "SUPPL-23",
    "activeIngredients": "RIBOCICLIB SUCCINATE",
    "company": "NOVARTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/11/2025",
    "drugName": "TERIFLUNOMIDEANDA  #209710",
    "submission": "SUPPL-7",
    "activeIngredients": "TERIFLUNOMIDE",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/11/2025",
    "drugName": "KISQALI FEMARA CO-PACK (COPACKAGED)NDA   #209935",
    "submission": "SUPPL-29",
    "activeIngredients": "LETROZOLE; RIBOCICLIB SUCCINATE",
    "company": "NOVARTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/11/2025",
    "drugName": "CAMCEVI KITNDA   #211488",
    "submission": "SUPPL-6",
    "activeIngredients": "LEUPROLIDE MESYLATE",
    "company": "ACCORD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/11/2025",
    "drugName": "BENZTROPINE MESYLATEANDA  #212694",
    "submission": "ORIG-1",
    "activeIngredients": "BENZTROPINE MESYLATE",
    "company": "QUAGEN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/11/2025",
    "drugName": "SITAGLIPTINANDA  #212952",
    "submission": "ORIG-1",
    "activeIngredients": "SITAGLIPTIN",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "02/11/2025",
    "drugName": "EVRYSDINDA   #213535",
    "submission": "SUPPL-14",
    "activeIngredients": "RISDIPLAM",
    "company": "GENENTECH INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/11/2025",
    "drugName": "BREXPIPRAZOLEANDA  #213723",
    "submission": "ORIG-1",
    "activeIngredients": "BREXPIPRAZOLE",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "02/11/2025",
    "drugName": "DORZOLAMIDE HYDROCHLORIDEANDA  #215004",
    "submission": "ORIG-1",
    "activeIngredients": "DORZOLAMIDE HYDROCHLORIDE",
    "company": "SOMERSET THERAPS LLC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/11/2025",
    "drugName": "SUCCINYLCHOLINE CHLORIDEANDA  #217884",
    "submission": "ORIG-1",
    "activeIngredients": "SUCCINYLCHOLINE CHLORIDE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/11/2025",
    "drugName": "DIFLUPREDNATEANDA  #218191",
    "submission": "ORIG-1",
    "activeIngredients": "DIFLUPREDNATE",
    "company": "UPSHER SMITH LABS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/11/2025",
    "drugName": "FORMOTEROL FUMARATEANDA  #218308",
    "submission": "ORIG-1",
    "activeIngredients": "FORMOTEROL FUMARATE",
    "company": "DEVA HOLDING AS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/11/2025",
    "drugName": "GADOTERIDOLANDA  #218749",
    "submission": "ORIG-1",
    "activeIngredients": "GADOTERIDOL",
    "company": "HAINAN POLY",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/11/2025",
    "drugName": "EVRYSDINDA   #219285",
    "submission": "ORIG-1",
    "activeIngredients": "RISDIPLAM",
    "company": "GENENTECH INC",
    "submissionClassification": "Type 3 - New Dosage Form",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/11/2025",
    "drugName": "GOMEKLINDA   #219379",
    "submission": "ORIG-1",
    "activeIngredients": "MIRDAMETINIB",
    "company": "SPRINGWORKS",
    "submissionClassification": "Type 1 - New Molecular Entity",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/11/2025",
    "drugName": "GOMEKLINDA   #219389",
    "submission": "ORIG-1",
    "activeIngredients": "MIRDAMETINIB",
    "company": "SPRINGWORKS",
    "submissionClassification": "Type 3 - New Dosage Form",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/12/2025",
    "drugName": "VICTOZANDA   #022341",
    "submission": "SUPPL-42",
    "activeIngredients": "LIRAGLUTIDE",
    "company": "NOVO NORDISK INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/12/2025",
    "drugName": "METHYLPREDNISOLONE ACETATEANDA  #040719",
    "submission": "SUPPL-7",
    "activeIngredients": "METHYLPREDNISOLONE ACETATE",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/12/2025",
    "drugName": "METHYLPREDNISOLONE ACETATEANDA  #040719",
    "submission": "SUPPL-8",
    "activeIngredients": "METHYLPREDNISOLONE ACETATE",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/12/2025",
    "drugName": "MYCOPHENOLATE MOFETILANDA  #090055",
    "submission": "SUPPL-23",
    "activeIngredients": "MYCOPHENOLATE MOFETIL",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/12/2025",
    "drugName": "MYCOPHENOLATE MOFETILANDA  #090055",
    "submission": "SUPPL-24",
    "activeIngredients": "MYCOPHENOLATE MOFETIL",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/12/2025",
    "drugName": "MYCOPHENOLATE MOFETILANDA  #090055",
    "submission": "SUPPL-26",
    "activeIngredients": "MYCOPHENOLATE MOFETIL",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/12/2025",
    "drugName": "MYCOPHENOLATE MOFETILANDA  #090055",
    "submission": "SUPPL-27",
    "activeIngredients": "MYCOPHENOLATE MOFETIL",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/12/2025",
    "drugName": "MYCOPHENOLATE MOFETILANDA  #090456",
    "submission": "SUPPL-26",
    "activeIngredients": "MYCOPHENOLATE MOFETIL",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/12/2025",
    "drugName": "MYCOPHENOLATE MOFETILANDA  #090456",
    "submission": "SUPPL-27",
    "activeIngredients": "MYCOPHENOLATE MOFETIL",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/12/2025",
    "drugName": "MYCOPHENOLATE MOFETILANDA  #090456",
    "submission": "SUPPL-28",
    "activeIngredients": "MYCOPHENOLATE MOFETIL",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/12/2025",
    "drugName": "MYCOPHENOLATE MOFETILANDA  #090456",
    "submission": "SUPPL-30",
    "activeIngredients": "MYCOPHENOLATE MOFETIL",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/12/2025",
    "drugName": "LOSARTAN POTASSIUMANDA  #090544",
    "submission": "SUPPL-9",
    "activeIngredients": "LOSARTAN POTASSIUM",
    "company": "AIPING PHARM INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/12/2025",
    "drugName": "GUANFACINE HYDROCHLORIDEANDA  #201408",
    "submission": "SUPPL-12",
    "activeIngredients": "GUANFACINE HYDROCHLORIDE",
    "company": "TWI PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/12/2025",
    "drugName": "EZALLOR SPRINKLENDA   #208647",
    "submission": "SUPPL-15",
    "activeIngredients": "ROSUVASTATIN CALCIUM",
    "company": "SUN PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/12/2025",
    "drugName": "CABAZITAXELANDA  #216733",
    "submission": "ORIG-1",
    "activeIngredients": "CABAZITAXEL",
    "company": "EUGIA PHARMA SPECLTS",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "02/12/2025",
    "drugName": "FLUOROURACILANDA  #216942",
    "submission": "ORIG-1",
    "activeIngredients": "FLUOROURACIL",
    "company": "ENCUBE",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/12/2025",
    "drugName": "TACROLIMUSANDA  #217108",
    "submission": "ORIG-1",
    "activeIngredients": "TACROLIMUS",
    "company": "NEXUS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/12/2025",
    "drugName": "PAXLOVID (COPACKAGED)NDA   #217188",
    "submission": "SUPPL-10",
    "activeIngredients": "NIRMATRELVIR; RITONAVIR",
    "company": "PFIZER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/12/2025",
    "drugName": "IZERVAYNDA   #217225",
    "submission": "SUPPL-1",
    "activeIngredients": "AVACINCAPTAD PEGOL SODIUM",
    "company": "ASTELLAS",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/12/2025",
    "drugName": "ACETYLCYSTEINEANDA  #219194",
    "submission": "ORIG-1",
    "activeIngredients": "ACETYLCYSTEINE",
    "company": "SOMERSET THERAPS LLC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/12/2025",
    "drugName": "SELARSDIBLA   #761343",
    "submission": "SUPPL-5",
    "activeIngredients": "USTEKINUMAB-AEKN",
    "company": "ALVOTECH USA INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/13/2025",
    "drugName": "FML FORTENDA   #019216",
    "submission": "SUPPL-30",
    "activeIngredients": "FLUOROMETHOLONE",
    "company": "ABBVIE",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/13/2025",
    "drugName": "PREDNISOLONEANDA  #040571",
    "submission": "SUPPL-5",
    "activeIngredients": "PREDNISOLONE",
    "company": "PHARM ASSOC",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/13/2025",
    "drugName": "RISPERIDONEANDA  #090347",
    "submission": "SUPPL-4",
    "activeIngredients": "RISPERIDONE",
    "company": "TARO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/13/2025",
    "drugName": "RISPERIDONEANDA  #090347",
    "submission": "SUPPL-5",
    "activeIngredients": "RISPERIDONE",
    "company": "TARO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/13/2025",
    "drugName": "VERARINGANDA  #207577",
    "submission": "SUPPL-1",
    "activeIngredients": "ETHINYL ESTRADIOL; ETONOGESTREL",
    "company": "DR REDDYS LABS SA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/13/2025",
    "drugName": "TRUQAPNDA   #218197",
    "submission": "SUPPL-2",
    "activeIngredients": "CAPIVASERTIB",
    "company": "ASTRAZENECA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/13/2025",
    "drugName": "DENOSUMAB-DSSBBLA   #761392",
    "submission": "ORIG-1",
    "activeIngredients": "DENOSUMAB-DSSB",
    "company": "SAMSUNG BIOEPIS CO LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/13/2025",
    "drugName": "OSPOMYVBLA   #761392",
    "submission": "ORIG-1",
    "activeIngredients": "DENOSUMAB-DSSB",
    "company": "SAMSUNG BIOEPIS CO LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/13/2025",
    "drugName": "XBRYKBLA   #761392",
    "submission": "ORIG-1",
    "activeIngredients": "DENOSUMAB-DSSB",
    "company": "SAMSUNG BIOEPIS CO LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/14/2025",
    "drugName": "MERCAPTOPURINEANDA  #040594",
    "submission": "SUPPL-15",
    "activeIngredients": "MERCAPTOPURINE",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/14/2025",
    "drugName": "LEVETIRACETAMANDA  #078154",
    "submission": "SUPPL-44",
    "activeIngredients": "LEVETIRACETAM",
    "company": "LUPIN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/14/2025",
    "drugName": "LINEZOLIDANDA  #078845",
    "submission": "SUPPL-4",
    "activeIngredients": "LINEZOLID",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/14/2025",
    "drugName": "LINEZOLIDANDA  #078845",
    "submission": "SUPPL-5",
    "activeIngredients": "LINEZOLID",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/14/2025",
    "drugName": "LINEZOLIDANDA  #078845",
    "submission": "SUPPL-7",
    "activeIngredients": "LINEZOLID",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/14/2025",
    "drugName": "METRONIDAZOLEANDA  #079065",
    "submission": "SUPPL-22",
    "activeIngredients": "METRONIDAZOLE",
    "company": "ALEMBIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/14/2025",
    "drugName": "LEVETIRACETAMANDA  #090025",
    "submission": "SUPPL-45",
    "activeIngredients": "LEVETIRACETAM",
    "company": "LUPIN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/14/2025",
    "drugName": "ARIPIPRAZOLEANDA  #202547",
    "submission": "SUPPL-4",
    "activeIngredients": "ARIPIPRAZOLE",
    "company": "ORBION PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/14/2025",
    "drugName": "AMLODIPINE AND OLMESARTAN MEDOXOMILANDA  #209591",
    "submission": "ORIG-1",
    "activeIngredients": "AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL",
    "company": "HETERO LABS LTD V",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/14/2025",
    "drugName": "OXCARBAZEPINEANDA  #209652",
    "submission": "SUPPL-9",
    "activeIngredients": "OXCARBAZEPINE",
    "company": "BIONPHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/14/2025",
    "drugName": "APIXABANANDA  #209810",
    "submission": "ORIG-1",
    "activeIngredients": "APIXABAN",
    "company": "IMPAX",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/14/2025",
    "drugName": "SUNITINIB MALATEANDA  #214824",
    "submission": "ORIG-1",
    "activeIngredients": "SUNITINIB MALATE",
    "company": "MSN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/14/2025",
    "drugName": "PHENYLEPHRINE HYDROCHLORIDEANDA  #215617",
    "submission": "ORIG-1",
    "activeIngredients": "PHENYLEPHRINE HYDROCHLORIDE",
    "company": "SOMERSET THERAPS LLC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/14/2025",
    "drugName": "TOFACITINIB CITRATEANDA  #218462",
    "submission": "SUPPL-1",
    "activeIngredients": "TOFACITINIB CITRATE",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/14/2025",
    "drugName": "ROMVIMZANDA   #219304",
    "submission": "ORIG-1",
    "activeIngredients": "VIMSELTINIB",
    "company": "DECIPHERA PHARMS",
    "submissionClassification": "Type 1 - New Molecular Entity",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/14/2025",
    "drugName": "RYBREVANTBLA   #761210",
    "submission": "SUPPL-7",
    "activeIngredients": "AMIVANTAMAB-VMJW",
    "company": "JANSSEN BIOTECH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/14/2025",
    "drugName": "SIMLANDIBLA   #761299",
    "submission": "SUPPL-16",
    "activeIngredients": "ADALIMUMAB-RYVK",
    "company": "ALVOTECH USA INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/14/2025",
    "drugName": "MERILOGBLA   #761325",
    "submission": "ORIG-1",
    "activeIngredients": "INSULIN ASPART-SZJJ",
    "company": "SANOFI-AVENTIS U.S. LLC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/14/2025",
    "drugName": "MERILOG SOLOSTARBLA   #761325",
    "submission": "ORIG-1",
    "activeIngredients": "INSULIN ASPART-SZJJ",
    "company": "SANOFI-AVENTIS U.S. LLC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2025",
    "drugName": "NAPROXENANDA  #074190",
    "submission": "SUPPL-19",
    "activeIngredients": "NAPROXEN",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/15/2025",
    "drugName": "SERTRALINE HYDROCHLORIDEANDA  #214790",
    "submission": "SUPPL-5",
    "activeIngredients": "SERTRALINE HYDROCHLORIDE",
    "company": "ASCENT PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/18/2025",
    "drugName": "OXAPROZINANDA  #075855",
    "submission": "SUPPL-13",
    "activeIngredients": "OXAPROZIN",
    "company": "DR REDDYS LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/18/2025",
    "drugName": "PRAVASTATIN SODIUMANDA  #076341",
    "submission": "SUPPL-31",
    "activeIngredients": "PRAVASTATIN SODIUM",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/18/2025",
    "drugName": "PRAVASTATIN SODIUMANDA  #077013",
    "submission": "SUPPL-6",
    "activeIngredients": "PRAVASTATIN SODIUM",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/18/2025",
    "drugName": "PRAVASTATIN SODIUMANDA  #077751",
    "submission": "SUPPL-22",
    "activeIngredients": "PRAVASTATIN SODIUM",
    "company": "ZYDUS PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/18/2025",
    "drugName": "ANASTROZOLEANDA  #078921",
    "submission": "SUPPL-13",
    "activeIngredients": "ANASTROZOLE",
    "company": "ZYDUS PHARMS USA INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/18/2025",
    "drugName": "ANASTROZOLEANDA  #091164",
    "submission": "SUPPL-3",
    "activeIngredients": "ANASTROZOLE",
    "company": "CIPLA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/18/2025",
    "drugName": "ARIPIPRAZOLEANDA  #202547",
    "submission": "SUPPL-7",
    "activeIngredients": "ARIPIPRAZOLE",
    "company": "ORBION PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/18/2025",
    "drugName": "NORETHINDRONE ACETATE AND ETHINYL ESTRADIOLANDA  #202772",
    "submission": "SUPPL-7",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "XIROMED",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/18/2025",
    "drugName": "NORETHINDRONE ACETATE AND ETHINYL ESTRADIOLANDA  #202772",
    "submission": "SUPPL-9",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "XIROMED",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/18/2025",
    "drugName": "PROLENSANDA   #203168",
    "submission": "SUPPL-5",
    "activeIngredients": "BROMFENAC SODIUM",
    "company": "BAUSCH AND LOMB",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/18/2025",
    "drugName": "NITROFURANTOINANDA  #203233",
    "submission": "SUPPL-5",
    "activeIngredients": "NITROFURANTOIN, MACROCRYSTALLINE",
    "company": "NOVEL LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/18/2025",
    "drugName": "DULOXETINE HYDROCHLORIDEANDA  #204343",
    "submission": "SUPPL-12",
    "activeIngredients": "DULOXETINE HYDROCHLORIDE",
    "company": "HETERO LABS LTD III",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/18/2025",
    "drugName": "DULOXETINE HYDROCHLORIDEANDA  #204343",
    "submission": "SUPPL-19",
    "activeIngredients": "DULOXETINE HYDROCHLORIDE",
    "company": "HETERO LABS LTD III",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/18/2025",
    "drugName": "FLUCYTOSINEANDA  #206550",
    "submission": "SUPPL-1",
    "activeIngredients": "FLUCYTOSINE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/18/2025",
    "drugName": "FLUCYTOSINEANDA  #206550",
    "submission": "SUPPL-2",
    "activeIngredients": "FLUCYTOSINE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/18/2025",
    "drugName": "FLUCYTOSINEANDA  #206550",
    "submission": "SUPPL-3",
    "activeIngredients": "FLUCYTOSINE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/18/2025",
    "drugName": "BIVALIRUDINANDA  #206551",
    "submission": "SUPPL-2",
    "activeIngredients": "BIVALIRUDIN",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/18/2025",
    "drugName": "BIVALIRUDINANDA  #206551",
    "submission": "SUPPL-5",
    "activeIngredients": "BIVALIRUDIN",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/18/2025",
    "drugName": "BIVALIRUDINANDA  #206551",
    "submission": "SUPPL-7",
    "activeIngredients": "BIVALIRUDIN",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/18/2025",
    "drugName": "ACYCLOVIR SODIUMANDA  #206606",
    "submission": "SUPPL-1",
    "activeIngredients": "ACYCLOVIR SODIUM",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/18/2025",
    "drugName": "DOXYCYCLINEANDA  #209396",
    "submission": "SUPPL-3",
    "activeIngredients": "DOXYCYCLINE",
    "company": "DR REDDYS LABS SA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/18/2025",
    "drugName": "LORBRENANDA   #210868",
    "submission": "SUPPL-6",
    "activeIngredients": "LORLATINIB",
    "company": "PFIZER",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/18/2025",
    "drugName": "GABAPENTINANDA  #211330",
    "submission": "SUPPL-6",
    "activeIngredients": "GABAPENTIN",
    "company": "PAI HOLDINGS PHARM",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/18/2025",
    "drugName": "ATROPINE SULFATENDA   #214652",
    "submission": "SUPPL-4",
    "activeIngredients": "ATROPINE SULFATE",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/18/2025",
    "drugName": "MESALAMINEANDA  #215067",
    "submission": "ORIG-1",
    "activeIngredients": "MESALAMINE",
    "company": "AMNEAL",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/18/2025",
    "drugName": "DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATEANDA  #216308",
    "submission": "ORIG-1",
    "activeIngredients": "DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE",
    "company": "NEW HEIGHTSRX",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/18/2025",
    "drugName": "PITOLISANTANDA  #218796",
    "submission": "ORIG-1",
    "activeIngredients": "PITOLISANT",
    "company": "ZENARA PHARMA PRIVATE LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "02/18/2025",
    "drugName": "CARBIDOPA; LEVODOPAANDA  #219307",
    "submission": "ORIG-1",
    "activeIngredients": "CARBIDOPA; LEVODOPA",
    "company": "ASCENT PHARMS INC",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "02/19/2025",
    "drugName": "CLORAZEPATE DIPOTASSIUMANDA  #071852",
    "submission": "SUPPL-20",
    "activeIngredients": "CLORAZEPATE DIPOTASSIUM",
    "company": "WATSON LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/19/2025",
    "drugName": "CLORAZEPATE DIPOTASSIUMANDA  #071853",
    "submission": "SUPPL-20",
    "activeIngredients": "CLORAZEPATE DIPOTASSIUM",
    "company": "WATSON LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/19/2025",
    "drugName": "CLORAZEPATE DIPOTASSIUMANDA  #071854",
    "submission": "SUPPL-20",
    "activeIngredients": "CLORAZEPATE DIPOTASSIUM",
    "company": "WATSON LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/19/2025",
    "drugName": "FLUPHENAZINE DECANOATEANDA  #074531",
    "submission": "SUPPL-20",
    "activeIngredients": "FLUPHENAZINE DECANOATE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/19/2025",
    "drugName": "GALANTAMINE HYDROBROMIDEANDA  #077605",
    "submission": "SUPPL-11",
    "activeIngredients": "GALANTAMINE HYDROBROMIDE",
    "company": "BARR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/19/2025",
    "drugName": "TRANDOLAPRILANDA  #078508",
    "submission": "SUPPL-5",
    "activeIngredients": "TRANDOLAPRIL",
    "company": "EPIC PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/19/2025",
    "drugName": "TRANDOLAPRILANDA  #078508",
    "submission": "SUPPL-6",
    "activeIngredients": "TRANDOLAPRIL",
    "company": "EPIC PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/19/2025",
    "drugName": "PROCHLORPERAZINE EDISYLATEANDA  #089523",
    "submission": "SUPPL-4",
    "activeIngredients": "PROCHLORPERAZINE EDISYLATE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/19/2025",
    "drugName": "PROCHLORPERAZINE EDISYLATEANDA  #089903",
    "submission": "SUPPL-33",
    "activeIngredients": "PROCHLORPERAZINE EDISYLATE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/19/2025",
    "drugName": "METHYLPREDNISOLONE SODIUM SUCCINATEANDA  #203125",
    "submission": "SUPPL-2",
    "activeIngredients": "METHYLPREDNISOLONE SODIUM SUCCINATE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/19/2025",
    "drugName": "TADALAFILANDA  #204809",
    "submission": "SUPPL-13",
    "activeIngredients": "TADALAFIL",
    "company": "ALEMBIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/19/2025",
    "drugName": "PROCHLORPERAZINE EDISYLATEANDA  #204860",
    "submission": "SUPPL-1",
    "activeIngredients": "PROCHLORPERAZINE EDISYLATE",
    "company": "NEXUS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/19/2025",
    "drugName": "PALIPERIDONEANDA  #205559",
    "submission": "ORIG-1",
    "activeIngredients": "PALIPERIDONE",
    "company": "DR REDDYS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/19/2025",
    "drugName": "ITRACONAZOLEANDA  #206741",
    "submission": "SUPPL-18",
    "activeIngredients": "ITRACONAZOLE",
    "company": "ALEMBIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/19/2025",
    "drugName": "ITRACONAZOLEANDA  #206741",
    "submission": "SUPPL-19",
    "activeIngredients": "ITRACONAZOLE",
    "company": "ALEMBIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/19/2025",
    "drugName": "FINGOLIMOD HYDROCHLORIDEANDA  #208004",
    "submission": "SUPPL-7",
    "activeIngredients": "FINGOLIMOD HYDROCHLORIDE",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/19/2025",
    "drugName": "ODEFSEYNDA   #208351",
    "submission": "SUPPL-14",
    "activeIngredients": "EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR ALAFENAMIDE FUMARATE",
    "company": "GILEAD SCIENCES INC",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/19/2025",
    "drugName": "ODEFSEYNDA   #208351",
    "submission": "SUPPL-15",
    "activeIngredients": "EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR ALAFENAMIDE FUMARATE",
    "company": "GILEAD SCIENCES INC",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/19/2025",
    "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #211487",
    "submission": "SUPPL-11",
    "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
    "company": "ASCENT PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/19/2025",
    "drugName": "DAYVIGONDA   #212028",
    "submission": "SUPPL-11",
    "activeIngredients": "LEMBOREXANT",
    "company": "EISAI INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/19/2025",
    "drugName": "ACETAMINOPHEN AND CODEINE PHOSPHATEANDA  #212418",
    "submission": "SUPPL-5",
    "activeIngredients": "ACETAMINOPHEN; CODEINE PHOSPHATE",
    "company": "ELITE LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/19/2025",
    "drugName": "PRAMIPEXOLE DIHYDROCHLORIDEANDA  #212797",
    "submission": "SUPPL-2",
    "activeIngredients": "PRAMIPEXOLE DIHYDROCHLORIDE",
    "company": "XIAMEN LP PHARM CO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/19/2025",
    "drugName": "CLOBAZAMANDA  #213039",
    "submission": "SUPPL-5",
    "activeIngredients": "CLOBAZAM",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/19/2025",
    "drugName": "PROCHLORPERAZINE EDISYLATEANDA  #213630",
    "submission": "SUPPL-5",
    "activeIngredients": "PROCHLORPERAZINE EDISYLATE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/19/2025",
    "drugName": "POTASSIUM PHOSPHATESANDA  #216344",
    "submission": "SUPPL-3",
    "activeIngredients": "POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC",
    "company": "AMNEAL",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/19/2025",
    "drugName": "NILOTINIB D-TARTRATENDA   #218922",
    "submission": "ORIG-1",
    "activeIngredients": "NILOTINIB D-TARTRATE",
    "company": "CIPLA",
    "submissionClassification": "Type 3 - New Dosage Form",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/19/2025",
    "drugName": "OTULFIBLA   #761379",
    "submission": "SUPPL-3",
    "activeIngredients": "USTEKINUMAB-AAUZ",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/20/2025",
    "drugName": "TACROLIMUSANDA  #090596",
    "submission": "SUPPL-20",
    "activeIngredients": "TACROLIMUS",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/20/2025",
    "drugName": "TACROLIMUSANDA  #090596",
    "submission": "SUPPL-23",
    "activeIngredients": "TACROLIMUS",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/20/2025",
    "drugName": "TACROLIMUSANDA  #090596",
    "submission": "SUPPL-24",
    "activeIngredients": "TACROLIMUS",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/20/2025",
    "drugName": "TACROLIMUSANDA  #090596",
    "submission": "SUPPL-27",
    "activeIngredients": "TACROLIMUS",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/20/2025",
    "drugName": "IBRUTINIBANDA  #211182",
    "submission": "ORIG-1",
    "activeIngredients": "IBRUTINIB",
    "company": "HETERO LABS LTD V",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "02/20/2025",
    "drugName": "IBUPROFEN AND FAMOTIDINEANDA  #218684",
    "submission": "ORIG-1",
    "activeIngredients": "FAMOTIDINE; IBUPROFEN",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/20/2025",
    "drugName": "SELENIOUS ACIDANDA  #219547",
    "submission": "ORIG-1",
    "activeIngredients": "SELENIOUS ACID",
    "company": "SUN PHARM",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "SEPTRANDA   #017376",
    "submission": "SUPPL-68",
    "activeIngredients": "SULFAMETHOXAZOLE; TRIMETHOPRIM",
    "company": "MONARCH PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "SEPTRA DSNDA   #017376",
    "submission": "SUPPL-68",
    "activeIngredients": "SULFAMETHOXAZOLE; TRIMETHOPRIM",
    "company": "MONARCH PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "BACTRIMNDA   #017377",
    "submission": "SUPPL-85",
    "activeIngredients": "SULFAMETHOXAZOLE; TRIMETHOPRIM",
    "company": "SUN PHARM INDUSTRIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "BACTRIM DSNDA   #017377",
    "submission": "SUPPL-85",
    "activeIngredients": "SULFAMETHOXAZOLE; TRIMETHOPRIM",
    "company": "SUN PHARM INDUSTRIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "BACTRIMNDA   #017560",
    "submission": "SUPPL-47",
    "activeIngredients": "SULFAMETHOXAZOLE; TRIMETHOPRIM",
    "company": "SUN PHARM INDUSTRIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "BACTRIM PEDIATRICNDA   #017560",
    "submission": "SUPPL-47",
    "activeIngredients": "SULFAMETHOXAZOLE; TRIMETHOPRIM",
    "company": "SUN PHARM INDUSTRIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "BACTRIMNDA   #018374",
    "submission": "SUPPL-29",
    "activeIngredients": "SULFAMETHOXAZOLE; TRIMETHOPRIM",
    "company": "SUN PHARM INDS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "SULFAMETHOXAZOLE AND TRIMETHOPRIMNDA   #018598",
    "submission": "SUPPL-56",
    "activeIngredients": "SULFAMETHOXAZOLE; TRIMETHOPRIM",
    "company": "FOSUN PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTHNDA   #018598",
    "submission": "SUPPL-56",
    "activeIngredients": "SULFAMETHOXAZOLE; TRIMETHOPRIM",
    "company": "FOSUN PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "SULFATRIMNDA   #018615",
    "submission": "SUPPL-86",
    "activeIngredients": "SULFAMETHOXAZOLE; TRIMETHOPRIM",
    "company": "PHARM ASSOC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "SULFATRIM PEDIATRICNDA   #018615",
    "submission": "SUPPL-86",
    "activeIngredients": "SULFAMETHOXAZOLE; TRIMETHOPRIM",
    "company": "PHARM ASSOC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "CARDENENDA   #019734",
    "submission": "SUPPL-34",
    "activeIngredients": "NICARDIPINE HYDROCHLORIDE",
    "company": "CHIESI",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINERNDA   #019734",
    "submission": "SUPPL-34",
    "activeIngredients": "NICARDIPINE HYDROCHLORIDE",
    "company": "CHIESI",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "CARDENE IN 0.86% SODIUM CHLORIDE IN PLASTIC CONTAINERNDA   #019734",
    "submission": "SUPPL-34",
    "activeIngredients": "NICARDIPINE HYDROCHLORIDE",
    "company": "CHIESI",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "CARDENE IN 4.8% DEXTROSE IN PLASTIC CONTAINERNDA   #019734",
    "submission": "SUPPL-34",
    "activeIngredients": "NICARDIPINE HYDROCHLORIDE",
    "company": "CHIESI",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINERNDA   #019734",
    "submission": "SUPPL-34",
    "activeIngredients": "NICARDIPINE HYDROCHLORIDE",
    "company": "CHIESI",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "TRACLEERNDA   #021290",
    "submission": "SUPPL-46",
    "activeIngredients": "BOSENTAN",
    "company": "ACTELION",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "NEXTERONENDA   #022325",
    "submission": "SUPPL-19",
    "activeIngredients": "AMIODARONE HYDROCHLORIDE",
    "company": "BAXTER HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "SUBOXONENDA   #022410",
    "submission": "SUPPL-55",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE",
    "company": "INDIVIOR",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "SULFAMETHOXAZOLE AND TRIMETHOPRIMANDA  #070028",
    "submission": "SUPPL-35",
    "activeIngredients": "SULFAMETHOXAZOLE; TRIMETHOPRIM",
    "company": "ANI PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "SULFAMETHOXAZOLE AND TRIMETHOPRIMANDA  #073303",
    "submission": "SUPPL-38",
    "activeIngredients": "SULFAMETHOXAZOLE; TRIMETHOPRIM",
    "company": "TEVA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "SULFAMETHOXAZOLE AND TRIMETHOPRIMANDA  #073303",
    "submission": "SUPPL-43",
    "activeIngredients": "SULFAMETHOXAZOLE; TRIMETHOPRIM",
    "company": "TEVA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "SULFAMETHOXAZOLE AND TRIMETHOPRIMANDA  #074650",
    "submission": "SUPPL-24",
    "activeIngredients": "SULFAMETHOXAZOLE; TRIMETHOPRIM",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "SULFAMETHOXAZOLE AND TRIMETHOPRIMANDA  #077612",
    "submission": "SUPPL-19",
    "activeIngredients": "SULFAMETHOXAZOLE; TRIMETHOPRIM",
    "company": "PRASCO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "SULFAMETHOXAZOLE AND TRIMETHOPRIMANDA  #077785",
    "submission": "SUPPL-18",
    "activeIngredients": "SULFAMETHOXAZOLE; TRIMETHOPRIM",
    "company": "CHARTWELL MOLECULAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "LEVETIRACETAMANDA  #078106",
    "submission": "SUPPL-19",
    "activeIngredients": "LEVETIRACETAM",
    "company": "PRINSTON INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "ANASTROZOLEANDA  #078485",
    "submission": "SUPPL-8",
    "activeIngredients": "ANASTROZOLE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "BUPRENORPHINE HYDROCHLORIDEANDA  #078633",
    "submission": "SUPPL-36",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE",
    "company": "HIKMA",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "BUPRENORPHINE HYDROCHLORIDEANDA  #090279",
    "submission": "SUPPL-25",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE",
    "company": "RUBICON RESEARCH",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "BUPRENORPHINE HYDROCHLORIDEANDA  #090360",
    "submission": "SUPPL-29",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE",
    "company": "BARR",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "BUPRENORPHINE HYDROCHLORIDEANDA  #090622",
    "submission": "SUPPL-44",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE",
    "company": "ETHYPHARM",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "BUPRENORPHINE HYDROCHLORIDEANDA  #090819",
    "submission": "SUPPL-36",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE",
    "company": "ACTAVIS ELIZABETH",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #091149",
    "submission": "SUPPL-26",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE",
    "company": "TEVA PHARMS USA",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "PREGABALINANDA  #091222",
    "submission": "ORIG-1",
    "activeIngredients": "PREGABALIN",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "SULFAMETHOXAZOLE AND TRIMETHOPRIMANDA  #091348",
    "submission": "SUPPL-19",
    "activeIngredients": "SULFAMETHOXAZOLE; TRIMETHOPRIM",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #091422",
    "submission": "SUPPL-58",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE",
    "company": "ACTAVIS ELIZABETH",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "NPLATEBLA   #125268",
    "submission": "SUPPL-176",
    "activeIngredients": "ROMIPLOSTIM",
    "company": "AMGEN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE ANDA  #201633",
    "submission": "SUPPL-37",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE",
    "company": "SUN PHARM",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "BUPRENORPHINE HYDROCHLORIDEANDA  #201760",
    "submission": "SUPPL-38",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE",
    "company": "SUN PHARM",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE ANDA  #203136",
    "submission": "SUPPL-49",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "XELJANZNDA   #203214",
    "submission": "SUPPL-38",
    "activeIngredients": "TOFACITINIB CITRATE",
    "company": "PF PRISM CV",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #203326",
    "submission": "SUPPL-36",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE",
    "company": "HIKMA",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "ZUBSOLVNDA   #204242",
    "submission": "SUPPL-29",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE",
    "company": "OREXO US INC",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "LEVETIRACETAMANDA  #204312",
    "submission": "SUPPL-13",
    "activeIngredients": "LEVETIRACETAM",
    "company": "EUGIA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #204431",
    "submission": "SUPPL-36",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE",
    "company": "ETHYPHARM USA CORP",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #205022",
    "submission": "SUPPL-23",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE",
    "company": "LANNETT CO INC",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #205299",
    "submission": "SUPPL-20",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE",
    "company": "DR REDDYS LABS SA",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #205601",
    "submission": "SUPPL-20",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE",
    "company": "RHODES PHARMS",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "BOSENTANANDA  #205699",
    "submission": "SUPPL-5",
    "activeIngredients": "BOSENTAN",
    "company": "PH HEALTH",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #205806",
    "submission": "SUPPL-19",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE",
    "company": "DR REDDYS LABS SA",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #205954",
    "submission": "SUPPL-31",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE",
    "company": "ALVOGEN",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "SULFAMETHOXAZOLE AND TRIMETHOPRIMANDA  #206607",
    "submission": "SUPPL-11",
    "activeIngredients": "SULFAMETHOXAZOLE; TRIMETHOPRIM",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "PREGABALINANDA  #206942",
    "submission": "ORIG-1",
    "activeIngredients": "PREGABALIN",
    "company": "TORRENT",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "BOSENTANANDA  #206987",
    "submission": "SUPPL-6",
    "activeIngredients": "BOSENTAN",
    "company": "NATCO PHARMA LTD",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #207000",
    "submission": "SUPPL-38",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE",
    "company": "SPECGX LLC",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "BOSENTANANDA  #207110",
    "submission": "SUPPL-9",
    "activeIngredients": "BOSENTAN",
    "company": "WATSON LABS INC",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "BUPRENORPHINE HYDROCHLORIDEANDA  #207276",
    "submission": "SUPPL-20",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE",
    "company": "RHODES PHARMS",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #207607",
    "submission": "SUPPL-25",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE",
    "company": "MYLAN TECHNOLOGIES",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "BOSENTANANDA  #207760",
    "submission": "SUPPL-11",
    "activeIngredients": "BOSENTAN",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "XELJANZ XRNDA   #208246",
    "submission": "SUPPL-25",
    "activeIngredients": "TOFACITINIB CITRATE",
    "company": "PFIZER",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #209069",
    "submission": "SUPPL-15",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE",
    "company": "WES PHARMA INC",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "TRACLEERNDA   #209279",
    "submission": "SUPPL-12",
    "activeIngredients": "BOSENTAN",
    "company": "ACTELION",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "BOSENTANANDA  #209324",
    "submission": "SUPPL-14",
    "activeIngredients": "BOSENTAN",
    "company": "SUN PHARM",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "BOSENTANANDA  #209742",
    "submission": "SUPPL-10",
    "activeIngredients": "BOSENTAN",
    "company": "AMNEAL PHARMS CO",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "SUBLOCADENDA   #209819",
    "submission": "SUPPL-31",
    "activeIngredients": "BUPRENORPHINE",
    "company": "INDIVIOR",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #211785",
    "submission": "SUPPL-15",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE",
    "company": "MYLAN TECHNOLOGIES",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "SULFAMETHOXAZOLE AND TRIMETHOPRIMANDA  #212231",
    "submission": "SUPPL-12",
    "activeIngredients": "SULFAMETHOXAZOLE; TRIMETHOPRIM",
    "company": "SOMERSET",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "SULFAMETHOXAZOLE AND TRIMETHOPRIMANDA  #212699",
    "submission": "SUPPL-3",
    "activeIngredients": "SULFAMETHOXAZOLE; TRIMETHOPRIM",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #212756",
    "submission": "SUPPL-13",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE",
    "company": "DIFGEN PHARMS",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "XELJANZNDA   #213082",
    "submission": "SUPPL-10",
    "activeIngredients": "TOFACITINIB CITRATE",
    "company": "PFIZER",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "BOSENTANANDA  #213154",
    "submission": "SUPPL-2",
    "activeIngredients": "BOSENTAN",
    "company": "NATCO PHARMA LTD",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEANDA  #214930",
    "submission": "SUPPL-12",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "LEVETIRACETAMANDA  #216375",
    "submission": "SUPPL-2",
    "activeIngredients": "LEVETIRACETAM",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #217078",
    "submission": "ORIG-1",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "PRECISION DOSE INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "VASOPRESSIN IN SODIUM CHLORIDE 0.9%NDA   #217569",
    "submission": "SUPPL-3",
    "activeIngredients": "VASOPRESSIN",
    "company": "BAXTER HLTHCARE CORP",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "SUCCINYLCHOLINE CHLORIDEANDA  #217885",
    "submission": "ORIG-1",
    "activeIngredients": "SUCCINYLCHOLINE CHLORIDE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "DILTIAZEM HYDROCHLORIDE IN 0.72% SODIUM CHLORIDENDA   #218038",
    "submission": "ORIG-1",
    "activeIngredients": "DILTIAZEM HYDROCHLORIDE",
    "company": "HQ SPCLT PHARMA",
    "submissionClassification": "Type 5 - New Formulation or New Manufacturer",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "SPIRONOLACTONEANDA  #218085",
    "submission": "ORIG-1",
    "activeIngredients": "SPIRONOLACTONE",
    "company": "HETERO LABS LTD III",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/21/2025",
    "drugName": "CTEXLINDA   #219488",
    "submission": "ORIG-1",
    "activeIngredients": "CHENODIOL",
    "company": "MIRUM",
    "submissionClassification": "Type 5 - New Formulation or New Manufacturer",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/24/2025",
    "drugName": "ELIGARD KITNDA   #021343",
    "submission": "SUPPL-56",
    "activeIngredients": "LEUPROLIDE ACETATE",
    "company": "TOLMAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/24/2025",
    "drugName": "ELIGARD KITNDA   #021379",
    "submission": "SUPPL-59",
    "activeIngredients": "LEUPROLIDE ACETATE",
    "company": "TOLMAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/24/2025",
    "drugName": "ELIGARD KITNDA   #021488",
    "submission": "SUPPL-53",
    "activeIngredients": "LEUPROLIDE ACETATE",
    "company": "TOLMAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/24/2025",
    "drugName": "ELIGARD KITNDA   #021731",
    "submission": "SUPPL-56",
    "activeIngredients": "LEUPROLIDE ACETATE",
    "company": "TOLMAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/24/2025",
    "drugName": "SULFAMETHOXAZOLE AND TRIMETHOPRIMANDA  #073303",
    "submission": "SUPPL-45",
    "activeIngredients": "SULFAMETHOXAZOLE; TRIMETHOPRIM",
    "company": "TEVA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/24/2025",
    "drugName": "PRAVASTATIN SODIUMANDA  #076056",
    "submission": "SUPPL-25",
    "activeIngredients": "PRAVASTATIN SODIUM",
    "company": "AUROBINDO PHARMA USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/24/2025",
    "drugName": "PRAVASTATIN SODIUMANDA  #076939",
    "submission": "SUPPL-19",
    "activeIngredients": "PRAVASTATIN SODIUM",
    "company": "WATSON LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/24/2025",
    "drugName": "TRETINOINANDA  #077684",
    "submission": "SUPPL-14",
    "activeIngredients": "TRETINOIN",
    "company": "BARR LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/24/2025",
    "drugName": "TRETINOINANDA  #077684",
    "submission": "SUPPL-15",
    "activeIngredients": "TRETINOIN",
    "company": "BARR LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/24/2025",
    "drugName": "PRAVASTATIN SODIUMANDA  #077793",
    "submission": "SUPPL-18",
    "activeIngredients": "PRAVASTATIN SODIUM",
    "company": "AUROBINDO PHARMA USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/24/2025",
    "drugName": "METAXALONEANDA  #203399",
    "submission": "SUPPL-20",
    "activeIngredients": "METAXALONE",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/24/2025",
    "drugName": "DOFETILIDEANDA  #207058",
    "submission": "SUPPL-2",
    "activeIngredients": "DOFETILIDE",
    "company": "DR REDDYS LABS SA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/24/2025",
    "drugName": "CASPOFUNGIN ACETATEANDA  #207650",
    "submission": "SUPPL-2",
    "activeIngredients": "CASPOFUNGIN ACETATE",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/24/2025",
    "drugName": "CASPOFUNGIN ACETATEANDA  #207650",
    "submission": "SUPPL-3",
    "activeIngredients": "CASPOFUNGIN ACETATE",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/24/2025",
    "drugName": "ALBUTEROL SULFATE AND IPRATROPIUM BROMIDEANDA  #207875",
    "submission": "SUPPL-7",
    "activeIngredients": "ALBUTEROL SULFATE; IPRATROPIUM BROMIDE",
    "company": "SUN PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/24/2025",
    "drugName": "DABIGATRAN ETEXILATE MESYLATEANDA  #207961",
    "submission": "SUPPL-11",
    "activeIngredients": "DABIGATRAN ETEXILATE MESYLATE",
    "company": "HETERO LABS LTD III",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/24/2025",
    "drugName": "BREXPIPRAZOLEANDA  #213731",
    "submission": "ORIG-1",
    "activeIngredients": "BREXPIPRAZOLE",
    "company": "APOTEX",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/24/2025",
    "drugName": "INDOMETHACINANDA  #215399",
    "submission": "ORIG-1",
    "activeIngredients": "INDOMETHACIN",
    "company": "AMNEAL",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/24/2025",
    "drugName": "EMPAGLIFLOZIN; LINAGLIPTINANDA  #217353",
    "submission": "ORIG-1",
    "activeIngredients": "EMPAGLIFLOZIN;LINAGLIPTIN",
    "company": "AJANTA PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "02/24/2025",
    "drugName": "THIAMINE HYDROCHLORIDEANDA  #217800",
    "submission": "ORIG-1",
    "activeIngredients": "THIAMINE HYDROCHLORIDE",
    "company": "GLAND",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/24/2025",
    "drugName": "MIUDELLANDA   #218201",
    "submission": "ORIG-1",
    "activeIngredients": "COPPER",
    "company": "SEBELA WOMENS HLTH",
    "submissionClassification": "Type 5 - New Formulation or New Manufacturer",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/24/2025",
    "drugName": "POSACONAZOLEANDA  #218434",
    "submission": "ORIG-1",
    "activeIngredients": "POSACONAZOLE",
    "company": "MSN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/24/2025",
    "drugName": "LOFEXIDINE HYDROCHLORIDEANDA  #218699",
    "submission": "ORIG-1",
    "activeIngredients": "LOFEXIDINE HYDROCHLORIDE",
    "company": "MSN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/25/2025",
    "drugName": "LEVETIRACETAMANDA  #090767",
    "submission": "SUPPL-15",
    "activeIngredients": "LEVETIRACETAM",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/25/2025",
    "drugName": "LEVETIRACETAMANDA  #090767",
    "submission": "SUPPL-16",
    "activeIngredients": "LEVETIRACETAM",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/25/2025",
    "drugName": "CLOPIDOGREL BISULFATEANDA  #202928",
    "submission": "SUPPL-29",
    "activeIngredients": "CLOPIDOGREL BISULFATE",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/25/2025",
    "drugName": "CLOPIDOGREL BISULFATEANDA  #202928",
    "submission": "SUPPL-32",
    "activeIngredients": "CLOPIDOGREL BISULFATE",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/25/2025",
    "drugName": "LEVETIRACETAMANDA  #203052",
    "submission": "SUPPL-17",
    "activeIngredients": "LEVETIRACETAM",
    "company": "HETERO LABS LTD III",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/25/2025",
    "drugName": "LEVETIRACETAMANDA  #203052",
    "submission": "SUPPL-18",
    "activeIngredients": "LEVETIRACETAM",
    "company": "HETERO LABS LTD III",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/25/2025",
    "drugName": "STIVARGANDA   #203085",
    "submission": "SUPPL-16",
    "activeIngredients": "REGORAFENIB",
    "company": "BAYER HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/25/2025",
    "drugName": "PRAMIPEXOLE DIHYDROCHLORIDEANDA  #203354",
    "submission": "SUPPL-8",
    "activeIngredients": "PRAMIPEXOLE DIHYDROCHLORIDE",
    "company": "DR REDDYS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/25/2025",
    "drugName": "PRAMIPEXOLE DIHYDROCHLORIDEANDA  #203354",
    "submission": "SUPPL-12",
    "activeIngredients": "PRAMIPEXOLE DIHYDROCHLORIDE",
    "company": "DR REDDYS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/25/2025",
    "drugName": "BRIMONIDINE TARTRATE AND TIMOLOL MALEATEANDA  #219093",
    "submission": "ORIG-1",
    "activeIngredients": "BRIMONIDINE TARTRATE; TIMOLOL MALEATE",
    "company": "CAPLIN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/26/2025",
    "drugName": "SONAZINEANDA  #080983",
    "submission": "SUPPL-62",
    "activeIngredients": "CHLORPROMAZINE HYDROCHLORIDE",
    "company": "SAPTALIS PHARMS",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/26/2025",
    "drugName": "RIFABUTINANDA  #090033",
    "submission": "SUPPL-8",
    "activeIngredients": "RIFABUTIN",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/26/2025",
    "drugName": "POMALYSTNDA   #204026",
    "submission": "SUPPL-34",
    "activeIngredients": "POMALIDOMIDE",
    "company": "BRISTOL",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/26/2025",
    "drugName": "CELECOXIBANDA  #204197",
    "submission": "SUPPL-13",
    "activeIngredients": "CELECOXIB",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/26/2025",
    "drugName": "CELECOXIBANDA  #204197",
    "submission": "SUPPL-16",
    "activeIngredients": "CELECOXIB",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/26/2025",
    "drugName": "CELECOXIBANDA  #205129",
    "submission": "SUPPL-12",
    "activeIngredients": "CELECOXIB",
    "company": "SCIEGEN PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/26/2025",
    "drugName": "CELECOXIBANDA  #205129",
    "submission": "SUPPL-14",
    "activeIngredients": "CELECOXIB",
    "company": "SCIEGEN PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/26/2025",
    "drugName": "CELECOXIBANDA  #207677",
    "submission": "SUPPL-7",
    "activeIngredients": "CELECOXIB",
    "company": "TORRENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/26/2025",
    "drugName": "POMALIDOMIDEANDA  #210164",
    "submission": "SUPPL-2",
    "activeIngredients": "POMALIDOMIDE",
    "company": "APOTEX",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/26/2025",
    "drugName": "CRISABOROLEANDA  #212459",
    "submission": "ORIG-1",
    "activeIngredients": "CRISABOROLE",
    "company": "PADAGIS ISRAEL PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "02/26/2025",
    "drugName": "DIHYDROERGOTAMINE MESYLATEANDA  #215228",
    "submission": "ORIG-1",
    "activeIngredients": "DIHYDROERGOTAMINE MESYLATE",
    "company": "SOMERSET THERAPS LLC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/26/2025",
    "drugName": "FLUPHENAZINE DECANOATEANDA  #215365",
    "submission": "SUPPL-1",
    "activeIngredients": "FLUPHENAZINE DECANOATE",
    "company": "MSN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/26/2025",
    "drugName": "HALOPERIDOLANDA  #216004",
    "submission": "SUPPL-1",
    "activeIngredients": "HALOPERIDOL",
    "company": "MSN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/26/2025",
    "drugName": "FLUOCINONIDEANDA  #216389",
    "submission": "ORIG-1",
    "activeIngredients": "FLUOCINONIDE",
    "company": "QUAGEN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/26/2025",
    "drugName": "MERCAPTOPURINEANDA  #216418",
    "submission": "ORIG-1",
    "activeIngredients": "MERCAPTOPURINE",
    "company": "HIKMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/26/2025",
    "drugName": "TEPYLUTENDA   #216984",
    "submission": "SUPPL-1",
    "activeIngredients": "THIOTEPA",
    "company": "SHORLA",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/26/2025",
    "drugName": "FLUPHENAZINE HYDROCHLORIDEANDA  #217189",
    "submission": "SUPPL-1",
    "activeIngredients": "FLUPHENAZINE HYDROCHLORIDE",
    "company": "MSN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/26/2025",
    "drugName": "TOPIRAMATEANDA  #217795",
    "submission": "SUPPL-2",
    "activeIngredients": "TOPIRAMATE",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/26/2025",
    "drugName": "NILOTINIBANDA  #218350",
    "submission": "ORIG-1",
    "activeIngredients": "NILOTINIB HYDROCHLORIDE MONOHYDRATE",
    "company": "DR REDDYS LABS LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "02/27/2025",
    "drugName": "METHYLPREDNISOLONEANDA  #040183",
    "submission": "SUPPL-24",
    "activeIngredients": "METHYLPREDNISOLONE",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/27/2025",
    "drugName": "NEVIRAPINEANDA  #203411",
    "submission": "SUPPL-9",
    "activeIngredients": "NEVIRAPINE",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/27/2025",
    "drugName": "DICLOFENAC SODIUM AND MISOPROSTOLANDA  #204355",
    "submission": "SUPPL-4",
    "activeIngredients": "DICLOFENAC SODIUM; MISOPROSTOL",
    "company": "MICRO LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/27/2025",
    "drugName": "MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDEANDA  #208328",
    "submission": "SUPPL-1",
    "activeIngredients": "DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE",
    "company": "AMNEAL",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/27/2025",
    "drugName": "VERZENIONDA   #208716",
    "submission": "SUPPL-19",
    "activeIngredients": "ABEMACICLIB",
    "company": "ELI LILLY AND CO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/27/2025",
    "drugName": "LEVETIRACETAM IN SODIUM CHLORIDEANDA  #209705",
    "submission": "SUPPL-1",
    "activeIngredients": "LEVETIRACETAM",
    "company": "B BRAUN MEDICAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/27/2025",
    "drugName": "APIXABANANDA  #210067",
    "submission": "ORIG-1",
    "activeIngredients": "APIXABAN",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/27/2025",
    "drugName": "SEVELAMER CARBONATEANDA  #215909",
    "submission": "ORIG-1",
    "activeIngredients": "SEVELAMER CARBONATE",
    "company": "TORRENT",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/27/2025",
    "drugName": "TRETINOINANDA  #218245",
    "submission": "ORIG-1",
    "activeIngredients": "TRETINOIN",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/27/2025",
    "drugName": "BUMETANIDEANDA  #218746",
    "submission": "ORIG-1",
    "activeIngredients": "BUMETANIDE",
    "company": "ASPIRO",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/27/2025",
    "drugName": "PADCEVBLA   #761137",
    "submission": "SUPPL-29",
    "activeIngredients": "ENFORTUMAB VEDOTIN-EJFV",
    "company": "ASTELLAS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/28/2025",
    "drugName": "PURIFIED CORTROPHIN GELNDA   #008975",
    "submission": "SUPPL-16",
    "activeIngredients": "CORTICOTROPIN",
    "company": "ANI PHARMS",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/28/2025",
    "drugName": "AK-FLUOR 10%NDA   #022186",
    "submission": "SUPPL-13",
    "activeIngredients": "FLUORESCEIN SODIUM",
    "company": "LONG GROVE PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/28/2025",
    "drugName": "AK-FLUOR 25%NDA   #022186",
    "submission": "SUPPL-13",
    "activeIngredients": "FLUORESCEIN SODIUM",
    "company": "LONG GROVE PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/28/2025",
    "drugName": "OXAPROZINANDA  #075849",
    "submission": "SUPPL-16",
    "activeIngredients": "OXAPROZIN",
    "company": "TEVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/28/2025",
    "drugName": "PAROXETINE HYDROCHLORIDEANDA  #077584",
    "submission": "SUPPL-38",
    "activeIngredients": "PAROXETINE HYDROCHLORIDE",
    "company": "ZYDUS PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/28/2025",
    "drugName": "OXYCODONE AND ASPIRINANDA  #090084",
    "submission": "SUPPL-14",
    "activeIngredients": "ASPIRIN; OXYCODONE HYDROCHLORIDE",
    "company": "ACTAVIS LABS FL INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/28/2025",
    "drugName": "BUPIVACAINE HYDROCHLORIDEANDA  #091503",
    "submission": "SUPPL-2",
    "activeIngredients": "BUPIVACAINE HYDROCHLORIDE",
    "company": "ONESOURCE SPECIALTY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/28/2025",
    "drugName": "REMICADEBLA   #103772",
    "submission": "SUPPL-5412",
    "activeIngredients": "INFLIXIMAB",
    "company": "CENTOCOR INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/28/2025",
    "drugName": "TNKASEBLA   #103909",
    "submission": "SUPPL-5197",
    "activeIngredients": "TENECTEPLASE",
    "company": "GENENTECH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/28/2025",
    "drugName": "SOLIRISBLA   #125166",
    "submission": "SUPPL-448",
    "activeIngredients": "ECULIZUMAB",
    "company": "ALEXION PHARM",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/28/2025",
    "drugName": "PRAMIPEXOLE DIHYDROCHLORIDEANDA  #202353",
    "submission": "SUPPL-8",
    "activeIngredients": "PRAMIPEXOLE DIHYDROCHLORIDE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/28/2025",
    "drugName": "OPSUMITNDA   #204410",
    "submission": "SUPPL-29",
    "activeIngredients": "MACITENTAN",
    "company": "ACTELION",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/28/2025",
    "drugName": "LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOLANDA  #206053",
    "submission": "SUPPL-4",
    "activeIngredients": "ETHINYL ESTRADIOL; LEVONORGESTREL",
    "company": "XIROMED",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/28/2025",
    "drugName": "LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOLANDA  #206053",
    "submission": "SUPPL-7",
    "activeIngredients": "ETHINYL ESTRADIOL; LEVONORGESTREL",
    "company": "XIROMED",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/28/2025",
    "drugName": "AVYCAZNDA   #206494",
    "submission": "SUPPL-13",
    "activeIngredients": "AVIBACTAM SODIUM; CEFTAZIDIME",
    "company": "ABBVIE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/28/2025",
    "drugName": "FLUOCINOLONE ACETONIDEANDA  #207347",
    "submission": "SUPPL-1",
    "activeIngredients": "FLUOCINOLONE ACETONIDE",
    "company": "NOVEL LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/28/2025",
    "drugName": "DOCETAXELANDA  #207563",
    "submission": "SUPPL-11",
    "activeIngredients": "DOCETAXEL",
    "company": "NOVAST LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/28/2025",
    "drugName": "EPINEPHRINEANDA  #207568",
    "submission": "SUPPL-4",
    "activeIngredients": "EPINEPHRINE",
    "company": "AM REGENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/28/2025",
    "drugName": "SAPROPTERIN DIHYDROCHLORIDEANDA  #207685",
    "submission": "SUPPL-6",
    "activeIngredients": "SAPROPTERIN DIHYDROCHLORIDE",
    "company": "DR REDDYS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/28/2025",
    "drugName": "AUSTEDONDA   #208082",
    "submission": "SUPPL-18",
    "activeIngredients": "DEUTETRABENAZINE",
    "company": "TEVA BRANDED PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/28/2025",
    "drugName": "OXCARBAZEPINEANDA  #213183",
    "submission": "SUPPL-1",
    "activeIngredients": "OXCARBAZEPINE",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/28/2025",
    "drugName": "LYBALVINDA   #213378",
    "submission": "SUPPL-8",
    "activeIngredients": "OLANZAPINE; SAMIDORPHAN L-MALATE",
    "company": "ALKERMES INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/28/2025",
    "drugName": "LORATADINEANDA  #215127",
    "submission": "ORIG-1",
    "activeIngredients": "LORATADINE",
    "company": "CATALENT PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/28/2025",
    "drugName": "AUSTEDO XRNDA   #216354",
    "submission": "SUPPL-8",
    "activeIngredients": "DEUTETRABENAZINE",
    "company": "TEVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/28/2025",
    "drugName": "LIKMEZNDA   #216755",
    "submission": "SUPPL-4",
    "activeIngredients": "METRONIDAZOLE",
    "company": "SAPTALIS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/28/2025",
    "drugName": "ZILBRYSQNDA   #216834",
    "submission": "SUPPL-8",
    "activeIngredients": "ZILUCOPLAN SODIUM",
    "company": "UCB INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/28/2025",
    "drugName": "ZILBRYSQNDA   #216834",
    "submission": "SUPPL-9",
    "activeIngredients": "ZILUCOPLAN SODIUM",
    "company": "UCB INC",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/28/2025",
    "drugName": "FRUZAQLANDA   #217564",
    "submission": "SUPPL-2",
    "activeIngredients": "FRUQUINTINIB",
    "company": "TAKEDA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/28/2025",
    "drugName": "OXCARBAZEPINEANDA  #218278",
    "submission": "SUPPL-1",
    "activeIngredients": "OXCARBAZEPINE",
    "company": "BIOCON PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/28/2025",
    "drugName": "EPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDENDA   #218475",
    "submission": "ORIG-1",
    "activeIngredients": "EPINEPHRINE BITARTRATE",
    "company": "BAXTER HLTHCARE CORP",
    "submissionClassification": "Type 5 - New Formulation or New Manufacturer",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/28/2025",
    "drugName": "FEXOFENADINE HYDROCHLORIDEANDA  #219032",
    "submission": "ORIG-1",
    "activeIngredients": "FEXOFENADINE HYDROCHLORIDE",
    "company": "CONTRACT PHARMACAL",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/28/2025",
    "drugName": "OLOPATADINE HYDROCHLORIDEANDA  #219557",
    "submission": "ORIG-1",
    "activeIngredients": "OLOPATADINE HYDROCHLORIDE",
    "company": "GLENMARK PHARMS INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/28/2025",
    "drugName": "IMFINZIBLA   #761069",
    "submission": "SUPPL-51",
    "activeIngredients": "DURVALUMAB",
    "company": "ASTRAZENECA UK LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/28/2025",
    "drugName": "ONTRUZANTBLA   #761100",
    "submission": "SUPPL-25",
    "activeIngredients": "TRASTUZUMAB-DTTB",
    "company": "SAMSUNG BIOEPIS CO LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/28/2025",
    "drugName": "ULTOMIRISBLA   #761108",
    "submission": "SUPPL-38",
    "activeIngredients": "RAVULIZUMAB-CWVZ",
    "company": "ALEXION PHARM",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/28/2025",
    "drugName": "TYENNEBLA   #761275",
    "submission": "SUPPL-8",
    "activeIngredients": "TOCILIZUMAB-AAZG",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/28/2025",
    "drugName": "OSENVELTBLA   #761404",
    "submission": "ORIG-1",
    "activeIngredients": "DENOSUMAB-BMWO",
    "company": "CELLTRION INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "02/28/2025",
    "drugName": "STOBOCLOBLA   #761404",
    "submission": "ORIG-1",
    "activeIngredients": "DENOSUMAB-BMWO",
    "company": "CELLTRION INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  }
,
  {
    "approvalDate": "03/03/2025",
    "drugName": "CEFOBIDNDA   #050551",
    "submission": "SUPPL-48",
    "activeIngredients": "CEFOPERAZONE SODIUM",
    "company": "PFIZER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/03/2025",
    "drugName": "TIZANIDINE HYDROCHLORIDEANDA  #076533",
    "submission": "SUPPL-15",
    "activeIngredients": "TIZANIDINE HYDROCHLORIDE",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/03/2025",
    "drugName": "ESCITALOPRAM OXALATEANDA  #077512",
    "submission": "SUPPL-4",
    "activeIngredients": "ESCITALOPRAM OXALATE",
    "company": "AIPING PHARM INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/03/2025",
    "drugName": "ESCITALOPRAM OXALATEANDA  #077512",
    "submission": "SUPPL-5",
    "activeIngredients": "ESCITALOPRAM OXALATE",
    "company": "AIPING PHARM INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/03/2025",
    "drugName": "SIMVASTATINANDA  #078155",
    "submission": "SUPPL-41",
    "activeIngredients": "SIMVASTATIN",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/03/2025",
    "drugName": "DILTIAZEM HYDROCHLORIDEANDA  #090421",
    "submission": "SUPPL-5",
    "activeIngredients": "DILTIAZEM HYDROCHLORIDE",
    "company": "SUN PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/03/2025",
    "drugName": "DILTIAZEM HYDROCHLORIDEANDA  #090421",
    "submission": "SUPPL-21",
    "activeIngredients": "DILTIAZEM HYDROCHLORIDE",
    "company": "SUN PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/03/2025",
    "drugName": "DILTIAZEM HYDROCHLORIDEANDA  #090421",
    "submission": "SUPPL-23",
    "activeIngredients": "DILTIAZEM HYDROCHLORIDE",
    "company": "SUN PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/03/2025",
    "drugName": "BEKYREEANDA  #202226",
    "submission": "SUPPL-14",
    "activeIngredients": "DESOGESTREL; ETHINYL ESTRADIOL",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/03/2025",
    "drugName": "BEKYREEANDA  #202226",
    "submission": "SUPPL-15",
    "activeIngredients": "DESOGESTREL; ETHINYL ESTRADIOL",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/03/2025",
    "drugName": "PROGESTERONEANDA  #207724",
    "submission": "SUPPL-14",
    "activeIngredients": "PROGESTERONE",
    "company": "AMNEAL PHARMS NY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/03/2025",
    "drugName": "PROGESTERONEANDA  #207724",
    "submission": "SUPPL-15",
    "activeIngredients": "PROGESTERONE",
    "company": "AMNEAL PHARMS NY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/03/2025",
    "drugName": "RIVAROXABANANDA  #208555",
    "submission": "ORIG-1",
    "activeIngredients": "RIVAROXABAN",
    "company": "LUPIN LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/03/2025",
    "drugName": "RIVAROXABANANDA  #208557",
    "submission": "ORIG-1",
    "activeIngredients": "RIVAROXABAN",
    "company": "TARO",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/03/2025",
    "drugName": "OSELTAMIVIR PHOSPHATEANDA  #208578",
    "submission": "SUPPL-4",
    "activeIngredients": "OSELTAMIVIR PHOSPHATE",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/03/2025",
    "drugName": "OSELTAMIVIR PHOSPHATEANDA  #208578",
    "submission": "SUPPL-5",
    "activeIngredients": "OSELTAMIVIR PHOSPHATE",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/03/2025",
    "drugName": "OSELTAMIVIR PHOSPHATEANDA  #208578",
    "submission": "SUPPL-6",
    "activeIngredients": "OSELTAMIVIR PHOSPHATE",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/03/2025",
    "drugName": "OSELTAMIVIR PHOSPHATEANDA  #208578",
    "submission": "SUPPL-9",
    "activeIngredients": "OSELTAMIVIR PHOSPHATE",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/03/2025",
    "drugName": "OSELTAMIVIR PHOSPHATEANDA  #208578",
    "submission": "SUPPL-11",
    "activeIngredients": "OSELTAMIVIR PHOSPHATE",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/03/2025",
    "drugName": "BACLOFENANDA  #209594",
    "submission": "SUPPL-4",
    "activeIngredients": "BACLOFEN",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/03/2025",
    "drugName": "DASATINIBANDA  #213383",
    "submission": "ORIG-1",
    "activeIngredients": "DASATINIB",
    "company": "DR REDDYS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/03/2025",
    "drugName": "OSELTAMIVIR PHOSPHATEANDA  #213695",
    "submission": "ORIG-1",
    "activeIngredients": "OSELTAMIVIR PHOSPHATE",
    "company": "JUBILANT GENERICS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/03/2025",
    "drugName": "LENALIDOMIDEANDA  #215759",
    "submission": "ORIG-1",
    "activeIngredients": "LENALIDOMIDE",
    "company": "BIOCON PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/03/2025",
    "drugName": "DASATINIBANDA  #217217",
    "submission": "ORIG-1",
    "activeIngredients": "DASATINIB",
    "company": "BIOCON PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/03/2025",
    "drugName": "TRETINOINANDA  #217587",
    "submission": "ORIG-1",
    "activeIngredients": "TRETINOIN",
    "company": "ENCUBE",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/03/2025",
    "drugName": "TRETINOINANDA  #217588",
    "submission": "ORIG-1",
    "activeIngredients": "TRETINOIN",
    "company": "ENCUBE",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/03/2025",
    "drugName": "OXAZEPAMANDA  #218261",
    "submission": "ORIG-1",
    "activeIngredients": "OXAZEPAM",
    "company": "LEADING",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/03/2025",
    "drugName": "TELMISARTAN AND HYDROCHLOROTHIAZIDEANDA  #218406",
    "submission": "ORIG-1",
    "activeIngredients": "HYDROCHLOROTHIAZIDE; TELMISARTAN",
    "company": "MANKIND PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/03/2025",
    "drugName": "DASATINIBANDA  #218719",
    "submission": "ORIG-1",
    "activeIngredients": "DASATINIB",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/03/2025",
    "drugName": "TEVIMBRABLA   #761380",
    "submission": "ORIG-1",
    "activeIngredients": "islelizumab-jsgr",
    "company": "BEIGENE",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/04/2025",
    "drugName": "BENAZEPRIL HYDROCHLORIDEANDA  #076267",
    "submission": "SUPPL-8",
    "activeIngredients": "BENAZEPRIL HYDROCHLORIDE",
    "company": "HERITAGE PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/04/2025",
    "drugName": "BENAZEPRIL HYDROCHLORIDEANDA  #076267",
    "submission": "SUPPL-9",
    "activeIngredients": "BENAZEPRIL HYDROCHLORIDE",
    "company": "HERITAGE PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/04/2025",
    "drugName": "LEVETIRACETAMANDA  #078976",
    "submission": "SUPPL-22",
    "activeIngredients": "LEVETIRACETAM",
    "company": "ACTAVIS MID ATLANTIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/04/2025",
    "drugName": "SULFASALAZINEANDA  #085828",
    "submission": "SUPPL-44",
    "activeIngredients": "SULFASALAZINE",
    "company": "WATSON LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/04/2025",
    "drugName": "PREGABALINANDA  #091025",
    "submission": "SUPPL-6",
    "activeIngredients": "PREGABALIN",
    "company": "ACTAVIS ELIZABETH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/04/2025",
    "drugName": "SOLIFENACIN SUCCINATEANDA  #209424",
    "submission": "ORIG-1",
    "activeIngredients": "SOLIFENACIN SUCCINATE",
    "company": "TORRENT",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/04/2025",
    "drugName": "METHYLENE BLUEANDA  #215636",
    "submission": "SUPPL-5",
    "activeIngredients": "METHYLENE BLUE",
    "company": "ZYDUS LIFESCIENCES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/04/2025",
    "drugName": "ERIBULIN MESYLATEANDA  #218743",
    "submission": "ORIG-1",
    "activeIngredients": "ERIBULIN MESYLATE",
    "company": "CHIA TAI TIANQING",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/04/2025",
    "drugName": "RIMEGEPANTANDA  #219365",
    "submission": "ORIG-1",
    "activeIngredients": "RIMEGEPANT",
    "company": "TEVA PHARMACEUTICALS DEVELOPMENT INC",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "03/05/2025",
    "drugName": "OMNISCANNDA   #020123",
    "submission": "SUPPL-52",
    "activeIngredients": "GADODIAMIDE",
    "company": "GE HEALTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/05/2025",
    "drugName": "PROHANCENDA   #020131",
    "submission": "SUPPL-44",
    "activeIngredients": "GADOTERIDOL",
    "company": "BRACCO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/05/2025",
    "drugName": "MULTIHANCENDA   #021357",
    "submission": "SUPPL-28",
    "activeIngredients": "GADOBENATE DIMEGLUMINE",
    "company": "BRACCO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/05/2025",
    "drugName": "MULTIHANCE MULTIPACKNDA   #021358",
    "submission": "SUPPL-26",
    "activeIngredients": "GADOBENATE DIMEGLUMINE",
    "company": "BRACCO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/05/2025",
    "drugName": "PROHANCE MULTIPACKNDA   #021489",
    "submission": "SUPPL-25",
    "activeIngredients": "GADOTERIDOL",
    "company": "BRACCO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/05/2025",
    "drugName": "OMNISCANNDA   #022066",
    "submission": "SUPPL-15",
    "activeIngredients": "GADODIAMIDE",
    "company": "GE HEALTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/05/2025",
    "drugName": "EOVISTNDA   #022090",
    "submission": "SUPPL-27",
    "activeIngredients": "GADOXETATE DISODIUM",
    "company": "BAYER HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/05/2025",
    "drugName": "ACETAMINOPHEN AND CODEINE PHOSPHATEANDA  #040779",
    "submission": "SUPPL-38",
    "activeIngredients": "ACETAMINOPHEN; CODEINE PHOSPHATE",
    "company": "AMNEAL PHARMS NY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/05/2025",
    "drugName": "ESCITALOPRAM OXALATEANDA  #078032",
    "submission": "SUPPL-15",
    "activeIngredients": "ESCITALOPRAM OXALATE",
    "company": "PRINSTON INC",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/05/2025",
    "drugName": "GALANTAMINE HYDROBROMIDEANDA  #078189",
    "submission": "SUPPL-14",
    "activeIngredients": "GALANTAMINE HYDROBROMIDE",
    "company": "BARR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/05/2025",
    "drugName": "GALANTAMINE HYDROBROMIDEANDA  #078189",
    "submission": "SUPPL-15",
    "activeIngredients": "GALANTAMINE HYDROBROMIDE",
    "company": "BARR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/05/2025",
    "drugName": "GADAVISTNDA   #201277",
    "submission": "SUPPL-28",
    "activeIngredients": "GADOBUTROL",
    "company": "BAYER HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/05/2025",
    "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #202935",
    "submission": "SUPPL-15",
    "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/05/2025",
    "drugName": "DOTAREMNDA   #204781",
    "submission": "SUPPL-17",
    "activeIngredients": "GADOTERATE MEGLUMINE",
    "company": "GUERBET",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/05/2025",
    "drugName": "LEVETIRACETAM IN SODIUM CHLORIDEANDA  #211356",
    "submission": "SUPPL-2",
    "activeIngredients": "LEVETIRACETAM",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/05/2025",
    "drugName": "DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATEANDA  #211547",
    "submission": "SUPPL-9",
    "activeIngredients": "AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE",
    "company": "SPECGX LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/05/2025",
    "drugName": "ACETAMINOPHEN AND CODEINE PHOSPHATEANDA  #211610",
    "submission": "SUPPL-5",
    "activeIngredients": "ACETAMINOPHEN; CODEINE PHOSPHATE",
    "company": "HIBROW HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/05/2025",
    "drugName": "ESOMEPRAZOLE MAGNESIUMANDA  #212651",
    "submission": "ORIG-1",
    "activeIngredients": "ESOMEPRAZOLE MAGNESIUM",
    "company": "TORRENT",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/05/2025",
    "drugName": "ESOMEPRAZOLE MAGNESIUMANDA  #212652",
    "submission": "ORIG-1",
    "activeIngredients": "ESOMEPRAZOLE MAGNESIUM",
    "company": "TORRENT",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/05/2025",
    "drugName": "NEFFYNDA   #214697",
    "submission": "SUPPL-1",
    "activeIngredients": "EPINEPHRINE",
    "company": "ARS PHARMS OPERATION",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/05/2025",
    "drugName": "LEVOTHYROXINE SODIUMANDA  #216729",
    "submission": "ORIG-1",
    "activeIngredients": "LEVOTHYROXINE SODIUM",
    "company": "ONESOURCE SPECIALTY",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/05/2025",
    "drugName": "ELUCIREMNDA   #216986",
    "submission": "SUPPL-6",
    "activeIngredients": "GADOPICLENOL",
    "company": "GUERBET",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/05/2025",
    "drugName": "ESTRADIOLANDA  #218507",
    "submission": "ORIG-1",
    "activeIngredients": "ESTRADIOL",
    "company": "ENCUBE",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/05/2025",
    "drugName": "RIMEGEPANTANDA  #219376",
    "submission": "ORIG-1",
    "activeIngredients": "RIMEGEPANT",
    "company": "NATCO PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "03/06/2025",
    "drugName": "MINOCYCLINE HYDROCHLORIDEANDA  #065062",
    "submission": "SUPPL-22",
    "activeIngredients": "MINOCYCLINE HYDROCHLORIDE",
    "company": "TORRENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/06/2025",
    "drugName": "MINOCYCLINE HYDROCHLORIDEANDA  #065062",
    "submission": "SUPPL-24",
    "activeIngredients": "MINOCYCLINE HYDROCHLORIDE",
    "company": "TORRENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/06/2025",
    "drugName": "MINOCYCLINE HYDROCHLORIDEANDA  #065062",
    "submission": "SUPPL-30",
    "activeIngredients": "MINOCYCLINE HYDROCHLORIDE",
    "company": "TORRENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/06/2025",
    "drugName": "CICLOPIROXANDA  #077364",
    "submission": "SUPPL-7",
    "activeIngredients": "CICLOPIROX",
    "company": "PADAGIS ISRAEL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/06/2025",
    "drugName": "CICLOPIROXANDA  #077364",
    "submission": "SUPPL-9",
    "activeIngredients": "CICLOPIROX",
    "company": "PADAGIS ISRAEL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/06/2025",
    "drugName": "GABAPENTINANDA  #077894",
    "submission": "SUPPL-12",
    "activeIngredients": "GABAPENTIN",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/06/2025",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #201567",
    "submission": "SUPPL-16",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/06/2025",
    "drugName": "SILDENAFIL CITRATEANDA  #202954",
    "submission": "ORIG-1",
    "activeIngredients": "SILDENAFIL CITRATE",
    "company": "JUBILANT GENERICS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/06/2025",
    "drugName": "BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDEANDA  #205770",
    "submission": "SUPPL-2",
    "activeIngredients": "BISMUTH SUBCITRATE POTASSIUM; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/06/2025",
    "drugName": "IBRANCENDA   #207103",
    "submission": "SUPPL-21",
    "activeIngredients": "PALBOCICLIB",
    "company": "PFIZER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/06/2025",
    "drugName": "MESALAMINEANDA  #207873",
    "submission": "SUPPL-8",
    "activeIngredients": "MESALAMINE",
    "company": "TEVA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/06/2025",
    "drugName": "FUROSCIXNDA   #209988",
    "submission": "SUPPL-3",
    "activeIngredients": "FUROSEMIDE",
    "company": "SCPHARMACEUTICALS",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/06/2025",
    "drugName": "PREGABALINANDA  #211687",
    "submission": "SUPPL-3",
    "activeIngredients": "PREGABALIN",
    "company": "ALVOGEN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/06/2025",
    "drugName": "TACROLIMUSANDA  #211688",
    "submission": "SUPPL-4",
    "activeIngredients": "TACROLIMUS",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/06/2025",
    "drugName": "IBRANCENDA   #212436",
    "submission": "SUPPL-9",
    "activeIngredients": "PALBOCICLIB",
    "company": "PFIZER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/06/2025",
    "drugName": "SITAGLIPTINANDA  #216337",
    "submission": "ORIG-1",
    "activeIngredients": "SITAGLIPTIN",
    "company": "SCIEGEN PHARMACEUTICALS INC",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "03/06/2025",
    "drugName": "TOFIDENCEBLA   #761354",
    "submission": "SUPPL-5",
    "activeIngredients": "TOCILIZUMAB-BAVI",
    "company": "BIOGEN MA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/07/2025",
    "drugName": "OXYCODONE AND ASPIRINANDA  #040910",
    "submission": "SUPPL-5",
    "activeIngredients": "ASPIRIN; OXYCODONE HYDROCHLORIDE",
    "company": "EPIC PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/07/2025",
    "drugName": "BISOPROLOL FUMARATEANDA  #075643",
    "submission": "SUPPL-21",
    "activeIngredients": "BISOPROLOL FUMARATE",
    "company": "RUBICON RESEARCH",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/07/2025",
    "drugName": "CARBIDOPA AND LEVODOPAANDA  #078893",
    "submission": "SUPPL-9",
    "activeIngredients": "CARBIDOPA; LEVODOPA",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/07/2025",
    "drugName": "OXYCODONE AND ASPIRINANDA  #087794",
    "submission": "SUPPL-34",
    "activeIngredients": "ASPIRIN; OXYCODONE HYDROCHLORIDE; OXYCODONE TEREPHTHALATE",
    "company": "SUN PHARM INDUSTRIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/07/2025",
    "drugName": "GLATOPAANDA  #090218",
    "submission": "SUPPL-31",
    "activeIngredients": "GLATIRAMER ACETATE",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/07/2025",
    "drugName": "TAFINLARNDA   #202806",
    "submission": "SUPPL-33",
    "activeIngredients": "DABRAFENIB MESYLATE",
    "company": "NOVARTIS",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/07/2025",
    "drugName": "MEKINISTNDA   #204114",
    "submission": "SUPPL-34",
    "activeIngredients": "TRAMETINIB DIMETHYL SULFOXIDE",
    "company": "NOVARTIS",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/07/2025",
    "drugName": "MILIANDA  #205449",
    "submission": "SUPPL-4",
    "activeIngredients": "ETHINYL ESTRADIOL; NORGESTIMATE",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/07/2025",
    "drugName": "ALMOTRIPTAN MALATEANDA  #205523",
    "submission": "SUPPL-1",
    "activeIngredients": "ALMOTRIPTAN MALATE",
    "company": "AJANTA PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/07/2025",
    "drugName": "NORGESTIMATE AND ETHINYL ESTRADIOLANDA  #205630",
    "submission": "SUPPL-12",
    "activeIngredients": "ETHINYL ESTRADIOL; NORGESTIMATE",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/07/2025",
    "drugName": "SYNJARDYNDA   #206111",
    "submission": "SUPPL-45",
    "activeIngredients": "EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE",
    "company": "BOEHRINGER INGELHEIM",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/07/2025",
    "drugName": "GLATOPAANDA  #206921",
    "submission": "SUPPL-32",
    "activeIngredients": "GLATIRAMER ACETATE",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/07/2025",
    "drugName": "MYXREDLINBLA   #208157",
    "submission": "SUPPL-8",
    "activeIngredients": "INSULIN HUMAN",
    "company": "BAXTER HLTHCARE CORP",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/07/2025",
    "drugName": "SYNJARDY XRNDA   #208658",
    "submission": "SUPPL-32",
    "activeIngredients": "EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE",
    "company": "BOEHRINGER INGELHEIM",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/07/2025",
    "drugName": "TERIFLUNOMIDEANDA  #209677",
    "submission": "SUPPL-2",
    "activeIngredients": "TERIFLUNOMIDE",
    "company": "SOLA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/07/2025",
    "drugName": "TERIFLUNOMIDEANDA  #209677",
    "submission": "SUPPL-3",
    "activeIngredients": "TERIFLUNOMIDE",
    "company": "SOLA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/07/2025",
    "drugName": "DEFERASIROXANDA  #209878",
    "submission": "SUPPL-4",
    "activeIngredients": "DEFERASIROX",
    "company": "MSN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/07/2025",
    "drugName": "DEFERASIROXANDA  #209878",
    "submission": "SUPPL-6",
    "activeIngredients": "DEFERASIROX",
    "company": "MSN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/07/2025",
    "drugName": "MEKINISTNDA   #217513",
    "submission": "SUPPL-5",
    "activeIngredients": "TRAMETINIB",
    "company": "NOVARTIS",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/07/2025",
    "drugName": "MEKINISTNDA   #217513",
    "submission": "SUPPL-5",
    "activeIngredients": "TRAMETINIB DIMETHYL SULFOXIDE",
    "company": "NOVARTIS",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/07/2025",
    "drugName": "TAFINLARNDA   #217514",
    "submission": "SUPPL-6",
    "activeIngredients": "DABRAFENIB MESYLATE",
    "company": "NOVARTIS",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/07/2025",
    "drugName": "RALTEGRAVIRANDA  #218374",
    "submission": "ORIG-1",
    "activeIngredients": "RALTEGRAVIR",
    "company": "HETERO LABS UNIT III",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "03/07/2025",
    "drugName": "ARFORMOTEROL TARTRATEANDA  #218555",
    "submission": "ORIG-1",
    "activeIngredients": "ARFORMOTEROL TARTRATE",
    "company": "MICRO LABS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/07/2025",
    "drugName": "KETOCONAZOLEANDA  #218559",
    "submission": "ORIG-1",
    "activeIngredients": "KETOCONAZOLE",
    "company": "ZYDUS LIFESCIENCES",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/07/2025",
    "drugName": "OMLYCLOBLA   #761399",
    "submission": "ORIG-1",
    "activeIngredients": "OMALIZUMAB-IGEC",
    "company": "CELLTRION INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/10/2025",
    "drugName": "PRIMAQUINENDA   #008316",
    "submission": "SUPPL-25",
    "activeIngredients": "PRIMAQUINE PHOSPHATE",
    "company": "SANOFI AVENTIS US",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/10/2025",
    "drugName": "ACETAMINOPHEN AND CODEINE PHOSPHATEANDA  #040419",
    "submission": "SUPPL-37",
    "activeIngredients": "ACETAMINOPHEN; CODEINE PHOSPHATE",
    "company": "SPECGX LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/10/2025",
    "drugName": "ACETAMINOPHEN AND CODEINE PHOSPHATEANDA  #089990",
    "submission": "SUPPL-35",
    "activeIngredients": "ACETAMINOPHEN; CODEINE PHOSPHATE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/10/2025",
    "drugName": "DULOXETINE HYDROCHLORIDEANDA  #090694",
    "submission": "SUPPL-8",
    "activeIngredients": "DULOXETINE HYDROCHLORIDE",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/10/2025",
    "drugName": "DULOXETINE HYDROCHLORIDEANDA  #090694",
    "submission": "SUPPL-10",
    "activeIngredients": "DULOXETINE HYDROCHLORIDE",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/10/2025",
    "drugName": "DULOXETINE HYDROCHLORIDEANDA  #090694",
    "submission": "SUPPL-11",
    "activeIngredients": "DULOXETINE HYDROCHLORIDE",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/10/2025",
    "drugName": "DULOXETINE HYDROCHLORIDEANDA  #090694",
    "submission": "SUPPL-13",
    "activeIngredients": "DULOXETINE HYDROCHLORIDE",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/10/2025",
    "drugName": "DULOXETINE HYDROCHLORIDEANDA  #090694",
    "submission": "SUPPL-16",
    "activeIngredients": "DULOXETINE HYDROCHLORIDE",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/10/2025",
    "drugName": "DULOXETINE HYDROCHLORIDEANDA  #090694",
    "submission": "SUPPL-18",
    "activeIngredients": "DULOXETINE HYDROCHLORIDE",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/10/2025",
    "drugName": "DULOXETINE HYDROCHLORIDEANDA  #090694",
    "submission": "SUPPL-21",
    "activeIngredients": "DULOXETINE HYDROCHLORIDE",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/10/2025",
    "drugName": "DULOXETINE HYDROCHLORIDEANDA  #090694",
    "submission": "SUPPL-23",
    "activeIngredients": "DULOXETINE HYDROCHLORIDE",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/10/2025",
    "drugName": "DULOXETINE HYDROCHLORIDEANDA  #090694",
    "submission": "SUPPL-25",
    "activeIngredients": "DULOXETINE HYDROCHLORIDE",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/10/2025",
    "drugName": "TROKENDI XRNDA   #201635",
    "submission": "SUPPL-36",
    "activeIngredients": "TOPIRAMATE",
    "company": "SUPERNUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/10/2025",
    "drugName": "BELSOMRANDA   #204569",
    "submission": "SUPPL-10",
    "activeIngredients": "SUVOREXANT",
    "company": "MERCK SHARP DOHME",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/10/2025",
    "drugName": "ITRACONAZOLEANDA  #205080",
    "submission": "SUPPL-17",
    "activeIngredients": "ITRACONAZOLE",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/10/2025",
    "drugName": "ITRACONAZOLEANDA  #205080",
    "submission": "SUPPL-18",
    "activeIngredients": "ITRACONAZOLE",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/10/2025",
    "drugName": "SEVELAMER CARBONATEANDA  #206094",
    "submission": "SUPPL-9",
    "activeIngredients": "SEVELAMER CARBONATE",
    "company": "DR REDDYS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/10/2025",
    "drugName": "PRALATREXATEANDA  #206183",
    "submission": "ORIG-1",
    "activeIngredients": "PRALATREXATE",
    "company": "DR REDDYS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/10/2025",
    "drugName": "LEVETIRACETAM IN SODIUM CHLORIDEANDA  #207160",
    "submission": "SUPPL-9",
    "activeIngredients": "LEVETIRACETAM",
    "company": "EUGIA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/10/2025",
    "drugName": "TAZAROTENEANDA  #208662",
    "submission": "SUPPL-7",
    "activeIngredients": "TAZAROTENE",
    "company": "COSETTE",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/10/2025",
    "drugName": "XPOVIONDA   #212306",
    "submission": "SUPPL-13",
    "activeIngredients": "SELINEXOR",
    "company": "KARYOPHARM THERAPS",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/10/2025",
    "drugName": "LUMRYZNDA   #214755",
    "submission": "SUPPL-12",
    "activeIngredients": "SODIUM OXYBATE",
    "company": "AVADEL CNS",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/10/2025",
    "drugName": "EMPAGLIFLOZINANDA  #219206",
    "submission": "ORIG-1",
    "activeIngredients": "EMPAGLIFLOZIN",
    "company": "APOTEX INC",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "03/10/2025",
    "drugName": "METHENAMINE HIPPURATEANDA  #219661",
    "submission": "ORIG-1",
    "activeIngredients": "METHENAMINE HIPPURATE",
    "company": "ZYDUS LIFESCIENCES",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/11/2025",
    "drugName": "TRELSTARNDA   #020715",
    "submission": "SUPPL-50",
    "activeIngredients": "TRIPTORELIN PAMOATE",
    "company": "VERITY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/11/2025",
    "drugName": "TRELSTARNDA   #021288",
    "submission": "SUPPL-45",
    "activeIngredients": "TRIPTORELIN PAMOATE",
    "company": "VERITY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/11/2025",
    "drugName": "ARRANONNDA   #021877",
    "submission": "SUPPL-14",
    "activeIngredients": "NELARABINE",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/11/2025",
    "drugName": "TRELSTARNDA   #022437",
    "submission": "SUPPL-25",
    "activeIngredients": "TRIPTORELIN PAMOATE",
    "company": "VERITY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/11/2025",
    "drugName": "BICALUTAMIDEANDA  #079110",
    "submission": "SUPPL-11",
    "activeIngredients": "BICALUTAMIDE",
    "company": "SUN PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/11/2025",
    "drugName": "ATORVASTATIN CALCIUMANDA  #205300",
    "submission": "SUPPL-1",
    "activeIngredients": "ATORVASTATIN CALCIUM",
    "company": "TEVA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/11/2025",
    "drugName": "ATORVASTATIN CALCIUMANDA  #205300",
    "submission": "SUPPL-2",
    "activeIngredients": "ATORVASTATIN CALCIUM",
    "company": "TEVA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/11/2025",
    "drugName": "ATORVASTATIN CALCIUMANDA  #205300",
    "submission": "SUPPL-4",
    "activeIngredients": "ATORVASTATIN CALCIUM",
    "company": "TEVA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/11/2025",
    "drugName": "ATORVASTATIN CALCIUMANDA  #205300",
    "submission": "SUPPL-7",
    "activeIngredients": "ATORVASTATIN CALCIUM",
    "company": "TEVA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/11/2025",
    "drugName": "ATORVASTATIN CALCIUMANDA  #205300",
    "submission": "SUPPL-10",
    "activeIngredients": "ATORVASTATIN CALCIUM",
    "company": "TEVA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/11/2025",
    "drugName": "ATORVASTATIN CALCIUMANDA  #205300",
    "submission": "SUPPL-15",
    "activeIngredients": "ATORVASTATIN CALCIUM",
    "company": "TEVA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/11/2025",
    "drugName": "ATORVASTATIN CALCIUMANDA  #205300",
    "submission": "SUPPL-23",
    "activeIngredients": "ATORVASTATIN CALCIUM",
    "company": "TEVA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/11/2025",
    "drugName": "CYCLOPHOSPHAMIDENDA   #212501",
    "submission": "SUPPL-7",
    "activeIngredients": "CYCLOPHOSPHAMIDE",
    "company": "DR REDDYS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/11/2025",
    "drugName": "AMVUTTRANDA   #215515",
    "submission": "SUPPL-5",
    "activeIngredients": "VUTRISIRAN SODIUM",
    "company": "ALNYLAM PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/11/2025",
    "drugName": "FLUDEOXYGLUCOSE F18ANDA  #216125",
    "submission": "ORIG-1",
    "activeIngredients": "FLUDEOXYGLUCOSE F-18",
    "company": "BAMF",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/11/2025",
    "drugName": "EPHEDRINE SULFATEANDA  #218271",
    "submission": "ORIG-1",
    "activeIngredients": "EPHEDRINE SULFATE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2025",
    "drugName": "TOPAMAXNDA   #020505",
    "submission": "SUPPL-67",
    "activeIngredients": "TOPIRAMATE",
    "company": "JANSSEN PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2025",
    "drugName": "TOPAMAXNDA   #020844",
    "submission": "SUPPL-58",
    "activeIngredients": "TOPIRAMATE",
    "company": "JANSSEN PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2025",
    "drugName": "TOPAMAX SPRINKLENDA   #020844",
    "submission": "SUPPL-58",
    "activeIngredients": "TOPIRAMATE",
    "company": "JANSSEN PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2025",
    "drugName": "VFENDNDA   #021266",
    "submission": "SUPPL-57",
    "activeIngredients": "VORICONAZOLE",
    "company": "PF PRISM CV",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2025",
    "drugName": "VFENDNDA   #021267",
    "submission": "SUPPL-67",
    "activeIngredients": "VORICONAZOLE",
    "company": "PF PRISM CV",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2025",
    "drugName": "VFENDNDA   #021630",
    "submission": "SUPPL-47",
    "activeIngredients": "VORICONAZOLE",
    "company": "PF PRISM CV",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #065163",
    "submission": "SUPPL-12",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "HERITAGE PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #065163",
    "submission": "SUPPL-13",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "HERITAGE PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2025",
    "drugName": "TRIMETHOPRIMANDA  #091437",
    "submission": "SUPPL-2",
    "activeIngredients": "TRIMETHOPRIM",
    "company": "NOVEL LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2025",
    "drugName": "COSENTYXBLA   #125504",
    "submission": "SUPPL-84",
    "activeIngredients": "SECUKINUMAB",
    "company": "NOVARTIS PHARMS CORP",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2025",
    "drugName": "ILUVIENNDA   #201923",
    "submission": "SUPPL-6",
    "activeIngredients": "FLUOCINOLONE ACETONIDE",
    "company": "ALIMERA SCIENCES INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2025",
    "drugName": "ABILIFY MAINTENA KITNDA   #202971",
    "submission": "SUPPL-17",
    "activeIngredients": "ARIPIPRAZOLE",
    "company": "OTSUKA PHARM CO LTD",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2025",
    "drugName": "LANSOPRAZOLEANDA  #203957",
    "submission": "SUPPL-15",
    "activeIngredients": "LANSOPRAZOLE",
    "company": "AJANTA PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2025",
    "drugName": "METOPROLOL SUCCINATEANDA  #204161",
    "submission": "SUPPL-25",
    "activeIngredients": "METOPROLOL SUCCINATE",
    "company": "ACTAVIS ELIZABETH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2025",
    "drugName": "TELMISARTANANDA  #204164",
    "submission": "SUPPL-8",
    "activeIngredients": "TELMISARTAN",
    "company": "JUBILANT GENERICS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2025",
    "drugName": "QUDEXY XRNDA   #205122",
    "submission": "SUPPL-17",
    "activeIngredients": "TOPIRAMATE",
    "company": "UPSHER SMITH LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2025",
    "drugName": "ROSUVASTATIN CALCIUMANDA  #207616",
    "submission": "SUPPL-23",
    "activeIngredients": "ROSUVASTATIN CALCIUM",
    "company": "HETERO LABS LTD V",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2025",
    "drugName": "ITRACONAZOLEANDA  #208591",
    "submission": "SUPPL-13",
    "activeIngredients": "ITRACONAZOLE",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2025",
    "drugName": "ITRACONAZOLEANDA  #208591",
    "submission": "SUPPL-14",
    "activeIngredients": "ITRACONAZOLE",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2025",
    "drugName": "BRAFTOVINDA   #210496",
    "submission": "SUPPL-18",
    "activeIngredients": "ENCORAFENIB",
    "company": "ARRAY BIOPHARMA INC",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2025",
    "drugName": "MEKTOVINDA   #210498",
    "submission": "SUPPL-11",
    "activeIngredients": "BINIMETINIB",
    "company": "ARRAY BIOPHARMA INC",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2025",
    "drugName": "ACETAZOLAMIDEANDA  #211151",
    "submission": "SUPPL-4",
    "activeIngredients": "ACETAZOLAMIDE",
    "company": "AJANTA PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2025",
    "drugName": "EPRONTIANDA   #214679",
    "submission": "SUPPL-9",
    "activeIngredients": "TOPIRAMATE",
    "company": "AZURITY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2025",
    "drugName": "AMIFAMPRIDINEANDA  #217996",
    "submission": "ORIG-1",
    "activeIngredients": "AMIFAMPRIDINE",
    "company": "LUPIN LIMITED",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "03/12/2025",
    "drugName": "APIXABANANDA  #218119",
    "submission": "ORIG-1",
    "activeIngredients": "APIXABAN",
    "company": "SCIEGEN PHARMACEUTICALS INC",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "03/12/2025",
    "drugName": "ALBUTEROL SULFATEANDA  #218386",
    "submission": "ORIG-1",
    "activeIngredients": "ALBUTEROL SULFATE",
    "company": "RITEDOSE CORP",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2025",
    "drugName": "TRIAMCINOLONE ACETONIDEANDA  #218773",
    "submission": "ORIG-1",
    "activeIngredients": "TRIAMCINOLONE ACETONIDE",
    "company": "DR REDDYS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2025",
    "drugName": "EPYSQLIBLA   #761340",
    "submission": "SUPPL-7",
    "activeIngredients": "ECULIZUMAB-AAGH",
    "company": "SAMSUNG BIOEPIS CO LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/12/2025",
    "drugName": "COSENTYXBLA   #761349",
    "submission": "SUPPL-7",
    "activeIngredients": "SECUKINUMAB",
    "company": "NOVARTIS PHARMS CORP",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2025",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #075491",
    "submission": "SUPPL-42",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "AUROBINDO PHARMA USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2025",
    "drugName": "FLUVOXAMINE MALEATEANDA  #075900",
    "submission": "SUPPL-14",
    "activeIngredients": "FLUVOXAMINE MALEATE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2025",
    "drugName": "NAPROXENANDA  #075927",
    "submission": "SUPPL-35",
    "activeIngredients": "NAPROXEN",
    "company": "AMNEAL PHARMS NY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2025",
    "drugName": "NAPROXENANDA  #075927",
    "submission": "SUPPL-38",
    "activeIngredients": "NAPROXEN",
    "company": "AMNEAL PHARMS NY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2025",
    "drugName": "NAPROXENANDA  #075927",
    "submission": "SUPPL-42",
    "activeIngredients": "NAPROXEN",
    "company": "AMNEAL PHARMS NY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2025",
    "drugName": "NAPROXENANDA  #075927",
    "submission": "SUPPL-43",
    "activeIngredients": "NAPROXEN",
    "company": "AMNEAL PHARMS NY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2025",
    "drugName": "HYDROMORPHONE HYDROCHLORIDEANDA  #076855",
    "submission": "SUPPL-19",
    "activeIngredients": "HYDROMORPHONE HYDROCHLORIDE",
    "company": "SPECGX LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2025",
    "drugName": "HYDROMORPHONE HYDROCHLORIDEANDA  #076855",
    "submission": "SUPPL-23",
    "activeIngredients": "HYDROMORPHONE HYDROCHLORIDE",
    "company": "SPECGX LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2025",
    "drugName": "DONEPEZIL HYDROCHLORIDEANDA  #077344",
    "submission": "SUPPL-2",
    "activeIngredients": "DONEPEZIL HYDROCHLORIDE",
    "company": "HERITAGE PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2025",
    "drugName": "ALPRAZOLAMANDA  #077391",
    "submission": "SUPPL-10",
    "activeIngredients": "ALPRAZOLAM",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2025",
    "drugName": "ALPRAZOLAMANDA  #077391",
    "submission": "SUPPL-12",
    "activeIngredients": "ALPRAZOLAM",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2025",
    "drugName": "PAROXETINE HYDROCHLORIDEANDA  #077395",
    "submission": "SUPPL-16",
    "activeIngredients": "PAROXETINE HYDROCHLORIDE",
    "company": "APOTEX INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2025",
    "drugName": "CETIRIZINE HYDROCHLORIDE ALLERGYANDA  #077829",
    "submission": "SUPPL-19",
    "activeIngredients": "CETIRIZINE HYDROCHLORIDE",
    "company": "UNIQUE",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2025",
    "drugName": "CETIRIZINE HYDROCHLORIDE HIVESANDA  #077829",
    "submission": "SUPPL-19",
    "activeIngredients": "CETIRIZINE HYDROCHLORIDE",
    "company": "UNIQUE",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2025",
    "drugName": "PAROXETINE HYDROCHLORIDEANDA  #078406",
    "submission": "SUPPL-37",
    "activeIngredients": "PAROXETINE HYDROCHLORIDE",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2025",
    "drugName": "TIZANIDINE HYDROCHLORIDEANDA  #091283",
    "submission": "SUPPL-18",
    "activeIngredients": "TIZANIDINE HYDROCHLORIDE",
    "company": "UNICHEM LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2025",
    "drugName": "NAPROXENANDA  #200429",
    "submission": "SUPPL-14",
    "activeIngredients": "NAPROXEN",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2025",
    "drugName": "NAPROXENANDA  #200429",
    "submission": "SUPPL-19",
    "activeIngredients": "NAPROXEN",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2025",
    "drugName": "NAPROXENANDA  #200429",
    "submission": "SUPPL-20",
    "activeIngredients": "NAPROXEN",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2025",
    "drugName": "LANTHANUM CARBONATEANDA  #202329",
    "submission": "ORIG-1",
    "activeIngredients": "LANTHANUM CARBONATE",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2025",
    "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #202991",
    "submission": "SUPPL-11",
    "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
    "company": "RHODES PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2025",
    "drugName": "MILNACIPRAN HYDROCHLORIDEANDA  #205081",
    "submission": "SUPPL-7",
    "activeIngredients": "MILNACIPRAN HYDROCHLORIDE",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2025",
    "drugName": "MILNACIPRAN HYDROCHLORIDEANDA  #205081",
    "submission": "SUPPL-8",
    "activeIngredients": "MILNACIPRAN HYDROCHLORIDE",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2025",
    "drugName": "LINEZOLIDANDA  #206917",
    "submission": "SUPPL-9",
    "activeIngredients": "LINEZOLID",
    "company": "EUGIA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2025",
    "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #208540",
    "submission": "SUPPL-5",
    "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
    "company": "ALVOGEN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2025",
    "drugName": "ZOLEDRONIC ACIDANDA  #209125",
    "submission": "SUPPL-4",
    "activeIngredients": "ZOLEDRONIC ACID",
    "company": "EUGIA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2025",
    "drugName": "LACTATED RINGER'S IN PLASTIC CONTAINERANDA  #209338",
    "submission": "SUPPL-15",
    "activeIngredients": "CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2025",
    "drugName": "TERIFLUNOMIDEANDA  #209690",
    "submission": "SUPPL-3",
    "activeIngredients": "TERIFLUNOMIDE",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2025",
    "drugName": "TERIFLUNOMIDEANDA  #209700",
    "submission": "SUPPL-7",
    "activeIngredients": "TERIFLUNOMIDE",
    "company": "TEVA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2025",
    "drugName": "HYDROMORPHONE HYDROCHLORIDEANDA  #210176",
    "submission": "SUPPL-4",
    "activeIngredients": "HYDROMORPHONE HYDROCHLORIDE",
    "company": "ASCENT PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2025",
    "drugName": "ACETAZOLAMIDEANDA  #210588",
    "submission": "SUPPL-17",
    "activeIngredients": "ACETAZOLAMIDE",
    "company": "NOVITIUM PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2025",
    "drugName": "POSACONAZOLEANDA  #211500",
    "submission": "SUPPL-1",
    "activeIngredients": "POSACONAZOLE",
    "company": "MYLAN LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2025",
    "drugName": "ATORVASTATIN CALCIUMANDA  #211933",
    "submission": "SUPPL-20",
    "activeIngredients": "ATORVASTATIN CALCIUM",
    "company": "MSN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2025",
    "drugName": "DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATEANDA  #214959",
    "submission": "SUPPL-3",
    "activeIngredients": "AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE",
    "company": "ASCENT PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2025",
    "drugName": "METFORMIN HYDROCHLORIDEANDA  #215008",
    "submission": "ORIG-1",
    "activeIngredients": "METFORMIN HYDROCHLORIDE",
    "company": "ANNORA PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2025",
    "drugName": "MEDROXYPROGESTERONE ACETATEANDA  #215397",
    "submission": "SUPPL-5",
    "activeIngredients": "MEDROXYPROGESTERONE ACETATE",
    "company": "AMNEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2025",
    "drugName": "EPINEPHRINENDA   #215425",
    "submission": "ORIG-1",
    "activeIngredients": "EPINEPHRINE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Type 5 - New Formulation or New Manufacturer",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2025",
    "drugName": "SOHONOSNDA   #215559",
    "submission": "SUPPL-2",
    "activeIngredients": "PALOVAROTENE",
    "company": "IPSEN",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2025",
    "drugName": "MEROPENEMANDA  #216154",
    "submission": "SUPPL-1",
    "activeIngredients": "MEROPENEM",
    "company": "BROOKS STERISCIENCE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2025",
    "drugName": "SITAGLIPTIN PHOSPHATE AND METFORMIN HYDROCHLORIDEANDA  #216885",
    "submission": "ORIG-1",
    "activeIngredients": "METFORMIN HYDROCHLORIDE, SITAGLIPTIN PHOSPHATE",
    "company": "PRINSTON PHARMACEUTICAL INC",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "03/13/2025",
    "drugName": "GABAPENTINANDA  #217116",
    "submission": "SUPPL-4",
    "activeIngredients": "GABAPENTIN",
    "company": "GRANULES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2025",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #217805",
    "submission": "SUPPL-2",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "MICRO LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2025",
    "drugName": "BUSPIRONE HYDROCHLORIDEANDA  #218628",
    "submission": "ORIG-1",
    "activeIngredients": "BUSPIRONE HYDROCHLORIDE",
    "company": "PANGEA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2025",
    "drugName": "ARBLINDA   #218772",
    "submission": "ORIG-1",
    "activeIngredients": "LOSARTAN POTASSIUM",
    "company": "SCIENTURE",
    "submissionClassification": "Type 3 - New Dosage Form",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2025",
    "drugName": "TYENNEBLA   #761275",
    "submission": "SUPPL-15",
    "activeIngredients": "TOCILIZUMAB-AAZG",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2025",
    "drugName": "PYZCHIVABLA   #761373",
    "submission": "SUPPL-3",
    "activeIngredients": "USTEKINUMAB-TTWE",
    "company": "SAMSUNG BIOEPIS CO LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/13/2025",
    "drugName": "PYZCHIVABLA   #761425",
    "submission": "SUPPL-3",
    "activeIngredients": "USTEKINUMAB-TTWE",
    "company": "SAMSUNG BIOEPIS CO LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/14/2025",
    "drugName": "FLAGYL I.V. RTU IN PLASTIC CONTAINERNDA   #018657",
    "submission": "SUPPL-43",
    "activeIngredients": "METRONIDAZOLE",
    "company": "BAXTER HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/14/2025",
    "drugName": "METRONIDAZOLE IN PLASTIC CONTAINERNDA   #018890",
    "submission": "SUPPL-58",
    "activeIngredients": "METRONIDAZOLE",
    "company": "HOSPIRA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/14/2025",
    "drugName": "METRO I.V. IN PLASTIC CONTAINERNDA   #018900",
    "submission": "SUPPL-45",
    "activeIngredients": "METRONIDAZOLE",
    "company": "B BRAUN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/14/2025",
    "drugName": "OXYCODONE AND ASPIRINANDA  #040255",
    "submission": "SUPPL-34",
    "activeIngredients": "ASPIRIN; OXYCODONE HYDROCHLORIDE; OXYCODONE TEREPHTHALATE",
    "company": "ANI PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/14/2025",
    "drugName": "OXYCODONE AND ASPIRINANDA  #040260",
    "submission": "SUPPL-22",
    "activeIngredients": "ASPIRIN; OXYCODONE HYDROCHLORIDE; OXYCODONE TEREPHTHALATE",
    "company": "SUN PHARM INDUSTRIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/14/2025",
    "drugName": "TETRACYCLINE HYDROCHLORIDEANDA  #061837",
    "submission": "SUPPL-35",
    "activeIngredients": "TETRACYCLINE HYDROCHLORIDE",
    "company": "WATSON LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/14/2025",
    "drugName": "TETRACYCLINE HYDROCHLORIDEANDA  #061837",
    "submission": "SUPPL-39",
    "activeIngredients": "TETRACYCLINE HYDROCHLORIDE",
    "company": "WATSON LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/14/2025",
    "drugName": "GABAPENTINANDA  #075485",
    "submission": "SUPPL-1",
    "activeIngredients": "GABAPENTIN",
    "company": "WATSON LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/14/2025",
    "drugName": "VALACYCLOVIR HYDROCHLORIDEANDA  #079137",
    "submission": "SUPPL-1",
    "activeIngredients": "VALACYCLOVIR HYDROCHLORIDE",
    "company": "ZYDUS LIFESCIENCES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/14/2025",
    "drugName": "DOXERCALCIFEROLANDA  #203929",
    "submission": "SUPPL-8",
    "activeIngredients": "DOXERCALCIFEROL",
    "company": "EPIC PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/14/2025",
    "drugName": "COLCHICINEANDA  #203976",
    "submission": "SUPPL-4",
    "activeIngredients": "COLCHICINE",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/14/2025",
    "drugName": "IMPAVIDONDA   #204684",
    "submission": "SUPPL-7",
    "activeIngredients": "MILTEFOSINE",
    "company": "KNIGHT THERAPS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/14/2025",
    "drugName": "IMPAVIDONDA   #204684",
    "submission": "SUPPL-8",
    "activeIngredients": "MILTEFOSINE",
    "company": "KNIGHT THERAPS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/14/2025",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #207403",
    "submission": "SUPPL-5",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "MICRO LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/14/2025",
    "drugName": "BUPRENORPHINEANDA  #210162",
    "submission": "SUPPL-1",
    "activeIngredients": "BUPRENORPHINE",
    "company": "MYLAN TECH VIATRIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/14/2025",
    "drugName": "BUPRENORPHINEANDA  #210162",
    "submission": "SUPPL-3",
    "activeIngredients": "BUPRENORPHINE",
    "company": "MYLAN TECH VIATRIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/14/2025",
    "drugName": "GVOKE HYPOPENNDA   #212097",
    "submission": "SUPPL-12",
    "activeIngredients": "GLUCAGON",
    "company": "XERIS",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/14/2025",
    "drugName": "GVOKE KITNDA   #212097",
    "submission": "SUPPL-12",
    "activeIngredients": "GLUCAGON",
    "company": "XERIS",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/14/2025",
    "drugName": "GVOKE PFSNDA   #212097",
    "submission": "SUPPL-12",
    "activeIngredients": "GLUCAGON",
    "company": "XERIS",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/14/2025",
    "drugName": "GVOKE VIALDXNDA   #212097",
    "submission": "SUPPL-12",
    "activeIngredients": "GLUCAGON",
    "company": "XERIS",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/14/2025",
    "drugName": "ELUXADOLINEANDA  #213522",
    "submission": "ORIG-1",
    "activeIngredients": "ELUXADOLINE",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/14/2025",
    "drugName": "ACETYLCYSTEINEANDA  #214177",
    "submission": "ORIG-1",
    "activeIngredients": "ACETYLCYSTEINE",
    "company": "CONBA USA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/14/2025",
    "drugName": "LEVETIRACETAMANDA  #214757",
    "submission": "SUPPL-1",
    "activeIngredients": "LEVETIRACETAM",
    "company": "MSN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/14/2025",
    "drugName": "LEVETIRACETAMANDA  #214757",
    "submission": "SUPPL-3",
    "activeIngredients": "LEVETIRACETAM",
    "company": "MSN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/14/2025",
    "drugName": "LACTULOSEANDA  #217914",
    "submission": "ORIG-1",
    "activeIngredients": "LACTULOSE",
    "company": "PAI HOLDINGS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/14/2025",
    "drugName": "TRACE ELEMENTSANDA  #218537",
    "submission": "ORIG-1",
    "activeIngredients": "ZINC;COPPER;MANGANESE;SELENIUM",
    "company": "RK PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "03/14/2025",
    "drugName": "MIGLUSTATANDA  #219111",
    "submission": "ORIG-1",
    "activeIngredients": "MIGLUSTAT",
    "company": "NAVINTA LLC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/14/2025",
    "drugName": "TYENNEBLA   #761449",
    "submission": "ORIG-1",
    "activeIngredients": "TOCILIZUMAB-AAZG",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/17/2025",
    "drugName": "NICORETTENDA   #022360",
    "submission": "SUPPL-19",
    "activeIngredients": "NICOTINE POLACRILEX",
    "company": "HALEON US HOLDINGS",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/17/2025",
    "drugName": "ATENOLOLANDA  #074056",
    "submission": "SUPPL-51",
    "activeIngredients": "ATENOLOL",
    "company": "TEVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/17/2025",
    "drugName": "AMNESTEEMANDA  #075945",
    "submission": "SUPPL-48",
    "activeIngredients": "ISOTRETINOIN",
    "company": "MYLAN PHARMS INC",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/17/2025",
    "drugName": "PRAVASTATIN SODIUMANDA  #077917",
    "submission": "SUPPL-22",
    "activeIngredients": "PRAVASTATIN SODIUM",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/17/2025",
    "drugName": "PRAVASTATIN SODIUMANDA  #079187",
    "submission": "SUPPL-7",
    "activeIngredients": "PRAVASTATIN SODIUM",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/17/2025",
    "drugName": "LEVETIRACETAMANDA  #090981",
    "submission": "SUPPL-16",
    "activeIngredients": "LEVETIRACETAM",
    "company": "HIKMA FARMACEUTICA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/17/2025",
    "drugName": "LEVETIRACETAMANDA  #203308",
    "submission": "SUPPL-12",
    "activeIngredients": "LEVETIRACETAM",
    "company": "MYLAN LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/17/2025",
    "drugName": "LEVETIRACETAMANDA  #203308",
    "submission": "SUPPL-13",
    "activeIngredients": "LEVETIRACETAM",
    "company": "MYLAN LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/17/2025",
    "drugName": "PRAVASTATIN SODIUMANDA  #207068",
    "submission": "SUPPL-7",
    "activeIngredients": "PRAVASTATIN SODIUM",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/17/2025",
    "drugName": "PRAVASTATIN SODIUMANDA  #207068",
    "submission": "SUPPL-8",
    "activeIngredients": "PRAVASTATIN SODIUM",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/17/2025",
    "drugName": "BAQSIMINDA   #210134",
    "submission": "SUPPL-4",
    "activeIngredients": "GLUCAGON",
    "company": "AMPHASTAR PHARMS INC",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/17/2025",
    "drugName": "APALUTAMIDEANDA  #217113",
    "submission": "ORIG-1",
    "activeIngredients": "APALUTAMIDE",
    "company": "ZYDUS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/17/2025",
    "drugName": "BIMATOPROSTANDA  #218196",
    "submission": "ORIG-1",
    "activeIngredients": "BIMATOPROST",
    "company": "MANKIND PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/17/2025",
    "drugName": "HEMICLORNDA   #218647",
    "submission": "ORIG-1",
    "activeIngredients": "CHLORTHALIDONE",
    "company": "PRM PHARMA",
    "submissionClassification": "Type 3 - New Dosage Form",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/17/2025",
    "drugName": "SUMATRIPTAN SUCCINATEANDA  #219036",
    "submission": "SUPPL-1",
    "activeIngredients": "SUMATRIPTAN SUCCINATE",
    "company": "VKT PHARMA",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/17/2025",
    "drugName": "PRUCALOPRIDEANDA  #219071",
    "submission": "ORIG-1",
    "activeIngredients": "PRUCALOPRIDE",
    "company": "TEVA PHARMS INC",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "03/17/2025",
    "drugName": "GRANISETRON HYDROCHLORIDEANDA  #219282",
    "submission": "ORIG-1",
    "activeIngredients": "GRANISETRON HYDROCHLORIDE",
    "company": "INTRA SANA LABS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/17/2025",
    "drugName": "IMULDOSABLA   #761364",
    "submission": "SUPPL-1",
    "activeIngredients": "USTEKINUMAB-SRLF",
    "company": "ACCORD BIOPHARMA INC.",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/18/2025",
    "drugName": "SOLODYNNDA   #050808",
    "submission": "SUPPL-24",
    "activeIngredients": "MINOCYCLINE HYDROCHLORIDE",
    "company": "BAUSCH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/18/2025",
    "drugName": "SOLODYNNDA   #050808",
    "submission": "SUPPL-27",
    "activeIngredients": "MINOCYCLINE HYDROCHLORIDE",
    "company": "BAUSCH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/18/2025",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #075932",
    "submission": "SUPPL-51",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "EPIC PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/18/2025",
    "drugName": "PRAVASTATIN SODIUMANDA  #077987",
    "submission": "SUPPL-19",
    "activeIngredients": "PRAVASTATIN SODIUM",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/18/2025",
    "drugName": "PRAVASTATIN SODIUMANDA  #077987",
    "submission": "SUPPL-23",
    "activeIngredients": "PRAVASTATIN SODIUM",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/18/2025",
    "drugName": "TYSABRIBLA   #125104",
    "submission": "SUPPL-984",
    "activeIngredients": "NATALIZUMAB",
    "company": "BIOGEN IDEC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/18/2025",
    "drugName": "PRAVASTATIN SODIUMANDA  #203367",
    "submission": "SUPPL-9",
    "activeIngredients": "PRAVASTATIN SODIUM",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/18/2025",
    "drugName": "SILDENAFIL CITRATEANDA  #203963",
    "submission": "SUPPL-12",
    "activeIngredients": "SILDENAFIL CITRATE",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/18/2025",
    "drugName": "LAMIVUDINEANDA  #204002",
    "submission": "SUPPL-7",
    "activeIngredients": "LAMIVUDINE",
    "company": "AUROBINDO PHARMA USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/18/2025",
    "drugName": "ROPINIROLE HYDROCHLORIDEANDA  #204022",
    "submission": "SUPPL-5",
    "activeIngredients": "ROPINIROLE HYDROCHLORIDE",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/18/2025",
    "drugName": "METHYLPHENIDATE HYDROCHLORIDEANDA  #204115",
    "submission": "SUPPL-9",
    "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "company": "NOVEL LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/18/2025",
    "drugName": "ZIPRASIDONE HYDROCHLORIDEANDA  #204117",
    "submission": "SUPPL-17",
    "activeIngredients": "ZIPRASIDONE HYDROCHLORIDE",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/18/2025",
    "drugName": "ZIPRASIDONE HYDROCHLORIDEANDA  #204117",
    "submission": "SUPPL-18",
    "activeIngredients": "ZIPRASIDONE HYDROCHLORIDE",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/18/2025",
    "drugName": "PERPHENAZINEANDA  #213694",
    "submission": "ORIG-1",
    "activeIngredients": "PERPHENAZINE",
    "company": "JUBILANT GENERICS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/18/2025",
    "drugName": "DEFLAZACORTANDA  #217741",
    "submission": "ORIG-1",
    "activeIngredients": "DEFLAZACORT",
    "company": "SUN PHARM",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/18/2025",
    "drugName": "DRONEDARONEANDA  #219075",
    "submission": "ORIG-1",
    "activeIngredients": "DRONEDARONE",
    "company": "MSN LABORATORIES PRIVATE LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "03/19/2025",
    "drugName": "PROCHLORPERAZINE EDISYLATEANDA  #040540",
    "submission": "SUPPL-17",
    "activeIngredients": "PROCHLORPERAZINE EDISYLATE",
    "company": "SAGENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/19/2025",
    "drugName": "ALLOPURINOLANDA  #077353",
    "submission": "SUPPL-9",
    "activeIngredients": "ALLOPURINOL",
    "company": "CHARTWELL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/19/2025",
    "drugName": "CARVEDILOLANDA  #077614",
    "submission": "SUPPL-27",
    "activeIngredients": "CARVEDILOL",
    "company": "ZYDUS PHARMS USA INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/19/2025",
    "drugName": "KEYTRUDABLA   #125514",
    "submission": "SUPPL-170",
    "activeIngredients": "PEMBROLIZUMAB",
    "company": "MERCK SHARP DOHME",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/19/2025",
    "drugName": "TAFINLARNDA   #202806",
    "submission": "SUPPL-37",
    "activeIngredients": "DABRAFENIB MESYLATE",
    "company": "NOVARTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/19/2025",
    "drugName": "MEKINISTNDA   #204114",
    "submission": "SUPPL-37",
    "activeIngredients": "TRAMETINIB DIMETHYL SULFOXIDE",
    "company": "NOVARTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/19/2025",
    "drugName": "GALAFOLDNDA   #208623",
    "submission": "SUPPL-9",
    "activeIngredients": "MIGALASTAT HYDROCHLORIDE",
    "company": "AMICUS THERAP US",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/19/2025",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #211020",
    "submission": "SUPPL-25",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "GRAVITI PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/19/2025",
    "drugName": "GLYCOPYRROLATEANDA  #213655",
    "submission": "SUPPL-2",
    "activeIngredients": "GLYCOPYRROLATE",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/19/2025",
    "drugName": "MEKINISTNDA   #217513",
    "submission": "SUPPL-8",
    "activeIngredients": "TRAMETINIB",
    "company": "NOVARTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/19/2025",
    "drugName": "MEKINISTNDA   #217513",
    "submission": "SUPPL-8",
    "activeIngredients": "TRAMETINIB DIMETHYL SULFOXIDE",
    "company": "NOVARTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/19/2025",
    "drugName": "TAFINLARNDA   #217514",
    "submission": "SUPPL-8",
    "activeIngredients": "DABRAFENIB MESYLATE",
    "company": "NOVARTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/19/2025",
    "drugName": "FINASTERIDE AND TADALAFILANDA  #218499",
    "submission": "ORIG-1",
    "activeIngredients": "FINASTERIDE; TADALAFIL",
    "company": "NOVITIUM PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/19/2025",
    "drugName": "AZILSARTAN MEDOXOMILANDA  #219062",
    "submission": "ORIG-1",
    "activeIngredients": "AZILSARTAN MEDOXOMIL",
    "company": "HETERO LABS LIMITED",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "03/20/2025",
    "drugName": "TETRACYCLINE HYDROCHLORIDEANDA  #060768",
    "submission": "SUPPL-1",
    "activeIngredients": "TETRACYCLINE HYDROCHLORIDE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/20/2025",
    "drugName": "IBUPROFENANDA  #075139",
    "submission": "SUPPL-18",
    "activeIngredients": "IBUPROFEN",
    "company": "LNK",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/20/2025",
    "drugName": "IMATINIB MESYLATEANDA  #204285",
    "submission": "SUPPL-12",
    "activeIngredients": "IMATINIB MESYLATE",
    "company": "TEVA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/20/2025",
    "drugName": "IMATINIB MESYLATEANDA  #204285",
    "submission": "SUPPL-15",
    "activeIngredients": "IMATINIB MESYLATE",
    "company": "TEVA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/20/2025",
    "drugName": "IMATINIB MESYLATEANDA  #204285",
    "submission": "SUPPL-18",
    "activeIngredients": "IMATINIB MESYLATE",
    "company": "TEVA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/20/2025",
    "drugName": "GRISEOFULVIN, ULTRAMICROSIZEANDA  #204371",
    "submission": "SUPPL-1",
    "activeIngredients": "GRISEOFULVIN, ULTRAMICROSIZE",
    "company": "MOUNTAIN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/20/2025",
    "drugName": "ROPIVACAINE HYDROCHLORIDEANDA  #204636",
    "submission": "SUPPL-10",
    "activeIngredients": "ROPIVACAINE HYDROCHLORIDE",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/20/2025",
    "drugName": "DIFLUPREDNATEANDA  #212566",
    "submission": "ORIG-1",
    "activeIngredients": "DIFLUPREDNATE",
    "company": "MYLAN LABS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/20/2025",
    "drugName": "BYLVAYNDA   #215498",
    "submission": "SUPPL-6",
    "activeIngredients": "ODEVIXIBAT",
    "company": "IPSEN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/20/2025",
    "drugName": "AMVUTTRANDA   #215515",
    "submission": "SUPPL-6",
    "activeIngredients": "VUTRISIRAN SODIUM",
    "company": "ALNYLAM PHARMS INC",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/20/2025",
    "drugName": "OPIPZANDA   #216655",
    "submission": "SUPPL-1",
    "activeIngredients": "ARIPIPRAZOLE",
    "company": "XIAMEN LP PHARM CO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/20/2025",
    "drugName": "FABHALTANDA   #218276",
    "submission": "SUPPL-4",
    "activeIngredients": "IPTACOPAN HYDROCHLORIDE",
    "company": "NOVARTIS",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/20/2025",
    "drugName": "GOZELLIXNDA   #219592",
    "submission": "ORIG-1",
    "activeIngredients": "GALLIUM GA-68 GOZETOTIDE",
    "company": "TELIX INNOVATIONS",
    "submissionClassification": "Type 5 - New Formulation or New Manufacturer",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/20/2025",
    "drugName": "TREMFYABLA   #761061",
    "submission": "SUPPL-24",
    "activeIngredients": "GUSELKUMAB",
    "company": "JANSSEN BIOTECH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2025",
    "drugName": "ANASTROZOLEANDA  #090568",
    "submission": "SUPPL-12",
    "activeIngredients": "ANASTROZOLE",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2025",
    "drugName": "ANASTROZOLEANDA  #090568",
    "submission": "SUPPL-15",
    "activeIngredients": "ANASTROZOLE",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2025",
    "drugName": "MELAMISAANDA  #202016",
    "submission": "SUPPL-1",
    "activeIngredients": "DROSPIRENONE; ETHINYL ESTRADIOL",
    "company": "NOVAST LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2025",
    "drugName": "MELAMISAANDA  #202016",
    "submission": "SUPPL-7",
    "activeIngredients": "DROSPIRENONE; ETHINYL ESTRADIOL",
    "company": "NOVAST LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2025",
    "drugName": "MELAMISAANDA  #202016",
    "submission": "SUPPL-8",
    "activeIngredients": "DROSPIRENONE; ETHINYL ESTRADIOL",
    "company": "NOVAST LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2025",
    "drugName": "XTANDINDA   #203415",
    "submission": "SUPPL-24",
    "activeIngredients": "ENZALUTAMIDE",
    "company": "ASTELLAS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2025",
    "drugName": "TELMISARTAN AND HYDROCHLOROTHIAZIDEANDA  #204169",
    "submission": "SUPPL-25",
    "activeIngredients": "HYDROCHLOROTHIAZIDE; TELMISARTAN",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2025",
    "drugName": "NAPROXEN AND ESOMEPRAZOLE MAGNESIUMANDA  #204206",
    "submission": "SUPPL-10",
    "activeIngredients": "ESOMEPRAZOLE MAGNESIUM; NAPROXEN",
    "company": "DR REDDYS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2025",
    "drugName": "DESMOPRESSIN ACETATEANDA  #204751",
    "submission": "SUPPL-8",
    "activeIngredients": "DESMOPRESSIN ACETATE",
    "company": "SAGENT PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2025",
    "drugName": "PREZCOBIXNDA   #205395",
    "submission": "SUPPL-28",
    "activeIngredients": "COBICISTAT; DARUNAVIR ETHANOLATE",
    "company": "JANSSEN PRODS",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2025",
    "drugName": "METAXALONEANDA  #207466",
    "submission": "SUPPL-17",
    "activeIngredients": "METAXALONE",
    "company": "SCIEGEN PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2025",
    "drugName": "UBRELVYNDA   #211765",
    "submission": "SUPPL-13",
    "activeIngredients": "UBROGEPANT",
    "company": "ABBVIE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2025",
    "drugName": "NURTEC ODTNDA   #212728",
    "submission": "SUPPL-26",
    "activeIngredients": "RIMEGEPANT SULFATE",
    "company": "PFIZER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2025",
    "drugName": "XTANDINDA   #213674",
    "submission": "SUPPL-12",
    "activeIngredients": "ENZALUTAMIDE",
    "company": "ASTELLAS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2025",
    "drugName": "XPHOZAHNDA   #213931",
    "submission": "SUPPL-2",
    "activeIngredients": "TENAPANOR HYDROCHLORIDE",
    "company": "ARDELYX INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2025",
    "drugName": "QULIPTANDA   #215206",
    "submission": "SUPPL-11",
    "activeIngredients": "ATOGEPANT",
    "company": "ABBVIE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2025",
    "drugName": "ZAVZPRETNDA   #216386",
    "submission": "SUPPL-5",
    "activeIngredients": "ZAVEGEPANT HYDROCHLORIDE",
    "company": "PFIZER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2025",
    "drugName": "NITROFURANTOINANDA  #217272",
    "submission": "SUPPL-4",
    "activeIngredients": "NITROFURANTOIN, MACROCRYSTALLINE",
    "company": "MANKIND PHARMA",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2025",
    "drugName": "NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)ANDA  #217357",
    "submission": "SUPPL-5",
    "activeIngredients": "NITROFURANTOIN; NITROFURANTOIN, MACROCRYSTALLINE",
    "company": "MANKIND PHARMA",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2025",
    "drugName": "CABOZANTINIBANDA  #217870",
    "submission": "ORIG-1",
    "activeIngredients": "CABOZANTINIB",
    "company": "CIPLA LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "03/21/2025",
    "drugName": "VANCOMYCIN HYDROCHLORIDEANDA  #218140",
    "submission": "ORIG-1",
    "activeIngredients": "VANCOMYCIN HYDROCHLORIDE",
    "company": "GLAND",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2025",
    "drugName": "PRIMIDONEANDA  #218366",
    "submission": "SUPPL-1",
    "activeIngredients": "PRIMIDONE",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2025",
    "drugName": "NOREPINEPHRINE BITARTRATEANDA  #219443",
    "submission": "ORIG-1",
    "activeIngredients": "NOREPINEPHRINE BITARTRATE",
    "company": "BIOCON PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2025",
    "drugName": "NYSTATINANDA  #219527",
    "submission": "ORIG-1",
    "activeIngredients": "NYSTATIN",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2025",
    "drugName": "ROPIVACAINE HYDROCHLORIDEANDA  #219883",
    "submission": "ORIG-1",
    "activeIngredients": "ROPIVACAINE HYDROCHLORIDE",
    "company": "NEOCUBES PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2025",
    "drugName": "EMGALITYBLA   #761063",
    "submission": "SUPPL-10",
    "activeIngredients": "GALCANEZUMAB-GNLM",
    "company": "ELI LILLY AND CO",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2025",
    "drugName": "AIMOVIGBLA   #761077",
    "submission": "SUPPL-26",
    "activeIngredients": "ERENUMAB-AOOE",
    "company": "AMGEN INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2025",
    "drugName": "AJOVYBLA   #761089",
    "submission": "SUPPL-30",
    "activeIngredients": "FREMANEZUMAB-VFRM",
    "company": "TEVA PHARMS USA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2025",
    "drugName": "VYEPTIBLA   #761119",
    "submission": "SUPPL-9",
    "activeIngredients": "EPTINEZUMAB-JJMR",
    "company": "Lundbeck Seattle BioPharmaceuticals, Inc.",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2025",
    "drugName": "VYEPTIBLA   #761119",
    "submission": "SUPPL-12",
    "activeIngredients": "EPTINEZUMAB-JJMR",
    "company": "Lundbeck Seattle BioPharmaceuticals, Inc.",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/21/2025",
    "drugName": "OTULFIBLA   #761379",
    "submission": "SUPPL-2",
    "activeIngredients": "USTEKINUMAB-AAUZ",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/24/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #065103",
    "submission": "SUPPL-3",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "HIKMA INTL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/24/2025",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #077415",
    "submission": "SUPPL-41",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "IMPAX LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/24/2025",
    "drugName": "METOPROLOL TARTRATEANDA  #077761",
    "submission": "SUPPL-26",
    "activeIngredients": "METOPROLOL TARTRATE",
    "company": "HIKMA FARMACEUTICA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/24/2025",
    "drugName": "DIVALPROEX SODIUMANDA  #078182",
    "submission": "SUPPL-26",
    "activeIngredients": "DIVALPROEX SODIUM",
    "company": "UPSHER SMITH LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/24/2025",
    "drugName": "HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDEANDA  #088017",
    "submission": "SUPPL-53",
    "activeIngredients": "HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE",
    "company": "ACTAVIS MID ATLANTIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/24/2025",
    "drugName": "HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDEANDA  #088017",
    "submission": "SUPPL-55",
    "activeIngredients": "HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE",
    "company": "ACTAVIS MID ATLANTIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/24/2025",
    "drugName": "GRANISETRON HYDROCHLORIDEANDA  #204238",
    "submission": "SUPPL-1",
    "activeIngredients": "GRANISETRON HYDROCHLORIDE",
    "company": "EUGIA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/24/2025",
    "drugName": "PALONOSETRON HYDROCHLORIDEANDA  #204289",
    "submission": "SUPPL-4",
    "activeIngredients": "PALONOSETRON HYDROCHLORIDE",
    "company": "SAGENT PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/24/2025",
    "drugName": "MITIGOANDA  #204393",
    "submission": "SUPPL-3",
    "activeIngredients": "MORPHINE SULFATE",
    "company": "PIRAMAL CRITICAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/24/2025",
    "drugName": "PILOCARPINE HYDROCHLORIDEANDA  #204398",
    "submission": "SUPPL-9",
    "activeIngredients": "PILOCARPINE HYDROCHLORIDE",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/24/2025",
    "drugName": "EVEROLIMUSANDA  #205432",
    "submission": "SUPPL-10",
    "activeIngredients": "EVEROLIMUS",
    "company": "BRECKENRIDGE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/24/2025",
    "drugName": "EVEROLIMUSANDA  #205432",
    "submission": "SUPPL-11",
    "activeIngredients": "EVEROLIMUS",
    "company": "BRECKENRIDGE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/24/2025",
    "drugName": "CRESEMBANDA   #207500",
    "submission": "SUPPL-16",
    "activeIngredients": "ISAVUCONAZONIUM SULFATE",
    "company": "ASTELLAS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/24/2025",
    "drugName": "CRESEMBANDA   #207501",
    "submission": "SUPPL-16",
    "activeIngredients": "ISAVUCONAZONIUM SULFATE",
    "company": "ASTELLAS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/24/2025",
    "drugName": "SILDENAFIL CITRATEANDA  #210394",
    "submission": "SUPPL-23",
    "activeIngredients": "SILDENAFIL CITRATE",
    "company": "AJANTA PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/24/2025",
    "drugName": "SILDENAFIL CITRATEANDA  #210394",
    "submission": "SUPPL-25",
    "activeIngredients": "SILDENAFIL CITRATE",
    "company": "AJANTA PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/24/2025",
    "drugName": "SPRAVATONDA   #211243",
    "submission": "SUPPL-18",
    "activeIngredients": "ESKETAMINE HYDROCHLORIDE",
    "company": "JANSSEN PHARMS",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/24/2025",
    "drugName": "METFORMIN HYDROCHLORIDEANDA  #213344",
    "submission": "SUPPL-1",
    "activeIngredients": "METFORMIN HYDROCHLORIDE",
    "company": "GRANULES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/24/2025",
    "drugName": "ORLYNVAHNDA   #213972",
    "submission": "SUPPL-1",
    "activeIngredients": "PROBENECID; SULOPENEM ETZADROXIL",
    "company": "ITERUM THERAP",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/24/2025",
    "drugName": "DILTIAZEM HYDROCHLORIDEANDA  #219073",
    "submission": "ORIG-1",
    "activeIngredients": "DILTIAZEM HYDROCHLORIDE",
    "company": "UTOPIC PHARMS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/25/2025",
    "drugName": "ZYRTEC ALLERGYNDA   #019835",
    "submission": "SUPPL-52",
    "activeIngredients": "CETIRIZINE HYDROCHLORIDE",
    "company": "KENVUE BRANDS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/25/2025",
    "drugName": "ZYRTEC HIVESNDA   #019835",
    "submission": "SUPPL-52",
    "activeIngredients": "CETIRIZINE HYDROCHLORIDE",
    "company": "KENVUE BRANDS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/25/2025",
    "drugName": "HEPARIN SODIUM 1,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERNDA   #019953",
    "submission": "SUPPL-48",
    "activeIngredients": "HEPARIN SODIUM",
    "company": "B BRAUN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/25/2025",
    "drugName": "HEPARIN SODIUM 2,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERNDA   #019953",
    "submission": "SUPPL-48",
    "activeIngredients": "HEPARIN SODIUM",
    "company": "B BRAUN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/25/2025",
    "drugName": "HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINERNDA   #019953",
    "submission": "SUPPL-48",
    "activeIngredients": "HEPARIN SODIUM",
    "company": "B BRAUN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/25/2025",
    "drugName": "EGRIFTABLA   #022505",
    "submission": "SUPPL-20",
    "activeIngredients": "TESAMORELIN ACETATE",
    "company": "THERATECHNOLOGIES",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/25/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #062337",
    "submission": "SUPPL-27",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/25/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #062337",
    "submission": "SUPPL-30",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/25/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #062337",
    "submission": "SUPPL-31",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/25/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #062337",
    "submission": "SUPPL-33",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/25/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #062337",
    "submission": "SUPPL-35",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/25/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #062337",
    "submission": "SUPPL-38",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/25/2025",
    "drugName": "PANTOPRAZOLE SODIUMANDA  #204400",
    "submission": "SUPPL-6",
    "activeIngredients": "PANTOPRAZOLE SODIUM",
    "company": "GLAND",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/25/2025",
    "drugName": "EPTIFIBATIDEANDA  #204693",
    "submission": "SUPPL-1",
    "activeIngredients": "EPTIFIBATIDE",
    "company": "SAGENT PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/25/2025",
    "drugName": "PALONOSETRON HYDROCHLORIDEANDA  #204702",
    "submission": "SUPPL-2",
    "activeIngredients": "PALONOSETRON HYDROCHLORIDE",
    "company": "EUGIA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/25/2025",
    "drugName": "COLCHICINEANDA  #204711",
    "submission": "SUPPL-6",
    "activeIngredients": "COLCHICINE",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/25/2025",
    "drugName": "KORSUVANDA   #214916",
    "submission": "SUPPL-2",
    "activeIngredients": "DIFELIKEFALIN ACETATE",
    "company": "VIFOR INTL",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/25/2025",
    "drugName": "LIDOCAINEANDA  #217221",
    "submission": "ORIG-1",
    "activeIngredients": "LIDOCAINE",
    "company": "DIFGEN PHARMS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/25/2025",
    "drugName": "BLUJEPANDA   #218230",
    "submission": "ORIG-1",
    "activeIngredients": "GEPOTIDACIN MESYLATE",
    "company": "GLAXOSMITHKLINE",
    "submissionClassification": "Type 1 - New Molecular Entity",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/25/2025",
    "drugName": "FAMOTIDINEANDA  #218631",
    "submission": "ORIG-1",
    "activeIngredients": "FAMOTIDINE",
    "company": "BEXIMCO PHARMS USA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/25/2025",
    "drugName": "TREMFYABLA   #761061",
    "submission": "SUPPL-27",
    "activeIngredients": "GUSELKUMAB",
    "company": "JANSSEN BIOTECH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/25/2025",
    "drugName": "BOMYNTRABLA   #761398",
    "submission": "ORIG-1",
    "activeIngredients": "DENOSUMAB-BNHT",
    "company": "FRESENIUS KABI USA LLC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/25/2025",
    "drugName": "CONEXXENCEBLA   #761398",
    "submission": "ORIG-1",
    "activeIngredients": "DENOSUMAB-BNHT",
    "company": "FRESENIUS KABI USA LLC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/26/2025",
    "drugName": "FERRIPROXNDA   #021825",
    "submission": "SUPPL-12",
    "activeIngredients": "DEFERIPRONE",
    "company": "CHIESI",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/26/2025",
    "drugName": "LORAZEPAMANDA  #077657",
    "submission": "SUPPL-7",
    "activeIngredients": "LORAZEPAM",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/26/2025",
    "drugName": "LORAZEPAMANDA  #077657",
    "submission": "SUPPL-9",
    "activeIngredients": "LORAZEPAM",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/26/2025",
    "drugName": "LORAZEPAMANDA  #077657",
    "submission": "SUPPL-11",
    "activeIngredients": "LORAZEPAM",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/26/2025",
    "drugName": "DOXYCYCLINEANDA  #200065",
    "submission": "SUPPL-14",
    "activeIngredients": "DOXYCYCLINE",
    "company": "IMPAX LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/26/2025",
    "drugName": "DOXYCYCLINEANDA  #201678",
    "submission": "SUPPL-3",
    "activeIngredients": "DOXYCYCLINE",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/26/2025",
    "drugName": "DOXYCYCLINEANDA  #201678",
    "submission": "SUPPL-4",
    "activeIngredients": "DOXYCYCLINE",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/26/2025",
    "drugName": "DOXYCYCLINEANDA  #201678",
    "submission": "SUPPL-5",
    "activeIngredients": "DOXYCYCLINE",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/26/2025",
    "drugName": "DOXYCYCLINEANDA  #201678",
    "submission": "SUPPL-7",
    "activeIngredients": "DOXYCYCLINE",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/26/2025",
    "drugName": "DOXYCYCLINEANDA  #201678",
    "submission": "SUPPL-8",
    "activeIngredients": "DOXYCYCLINE",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/26/2025",
    "drugName": "RIZATRIPTAN BENZOATEANDA  #204722",
    "submission": "SUPPL-2",
    "activeIngredients": "RIZATRIPTAN BENZOATE",
    "company": "PANACEA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/26/2025",
    "drugName": "LEVETIRACETAM IN SODIUM CHLORIDEANDA  #206880",
    "submission": "SUPPL-8",
    "activeIngredients": "LEVETIRACETAM",
    "company": "GLAND",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/26/2025",
    "drugName": "FERRIPROXNDA   #208030",
    "submission": "SUPPL-9",
    "activeIngredients": "DEFERIPRONE",
    "company": "CHIESI",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/26/2025",
    "drugName": "CABOMETYXNDA   #208692",
    "submission": "SUPPL-17",
    "activeIngredients": "CABOZANTINIB S-MALATE",
    "company": "EXELIXIS INC",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/26/2025",
    "drugName": "LEVETIRACETAMANDA  #209474",
    "submission": "SUPPL-3",
    "activeIngredients": "LEVETIRACETAM",
    "company": "PRINSTON INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/26/2025",
    "drugName": "TERIFLUNOMIDEANDA  #209613",
    "submission": "SUPPL-9",
    "activeIngredients": "TERIFLUNOMIDE",
    "company": "AMNEAL PHARMS CO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/26/2025",
    "drugName": "TERIFLUNOMIDEANDA  #209613",
    "submission": "SUPPL-10",
    "activeIngredients": "TERIFLUNOMIDE",
    "company": "AMNEAL PHARMS CO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/26/2025",
    "drugName": "DEFERASIROXANDA  #210727",
    "submission": "SUPPL-2",
    "activeIngredients": "DEFERASIROX",
    "company": "STEVENS J",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/26/2025",
    "drugName": "RINVOQNDA   #211675",
    "submission": "SUPPL-27",
    "activeIngredients": "UPADACITINIB",
    "company": "ABBVIE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/26/2025",
    "drugName": "PLERIXAFORANDA  #211901",
    "submission": "SUPPL-1",
    "activeIngredients": "PLERIXAFOR",
    "company": "MSN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/26/2025",
    "drugName": "FERRIPROXNDA   #212269",
    "submission": "SUPPL-6",
    "activeIngredients": "DEFERIPRONE",
    "company": "CHIESI",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/26/2025",
    "drugName": "PLERIXAFORANDA  #213672",
    "submission": "SUPPL-1",
    "activeIngredients": "PLERIXAFOR",
    "company": "EUGIA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/26/2025",
    "drugName": "TECHNETIUM TC-99M PENTETATE KITANDA  #215146",
    "submission": "ORIG-1",
    "activeIngredients": "TECHNETIUM TC-99M PENTETATE KIT",
    "company": "CURIUM",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/26/2025",
    "drugName": "VYKAT XRNDA   #216665",
    "submission": "ORIG-1",
    "activeIngredients": "DIAZOXIDE CHOLINE",
    "company": "SOLENO THERAP",
    "submissionClassification": "Type 2 - New Active Ingredient",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/26/2025",
    "drugName": "DEXRAZOXANE HYDROCHLORIDEANDA  #216748",
    "submission": "ORIG-1",
    "activeIngredients": "DEXRAZOXANE HYDROCHLORIDE",
    "company": "MSN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/26/2025",
    "drugName": "RINVOQ LQNDA   #218347",
    "submission": "SUPPL-2",
    "activeIngredients": "UPADACITINIB",
    "company": "ABBVIE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/26/2025",
    "drugName": "THEOPHYLLINEANDA  #218401",
    "submission": "ORIG-2",
    "activeIngredients": "THEOPHYLLINE",
    "company": "AJANTA PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/26/2025",
    "drugName": "LUMATEPERONEANDA  #219085",
    "submission": "ORIG-1",
    "activeIngredients": "LUMATEPERONE",
    "company": "AUROBINDO PHARMA LIMITED",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "03/26/2025",
    "drugName": "TRODELVYBLA   #761115",
    "submission": "SUPPL-59",
    "activeIngredients": "SACITUZUMAB GOVITECAN-HZIY",
    "company": "IMMUNOMEDICS INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/26/2025",
    "drugName": "STIMUFENDBLA   #761173",
    "submission": "SUPPL-8",
    "activeIngredients": "PEGFILGRASTIM-FPGK",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/27/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #062538",
    "submission": "SUPPL-13",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/27/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #062538",
    "submission": "SUPPL-14",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/27/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #062538",
    "submission": "SUPPL-17",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/27/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #063187",
    "submission": "SUPPL-2",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "PLIVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/27/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #063187",
    "submission": "SUPPL-3",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "PLIVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/27/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #063187",
    "submission": "SUPPL-4",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "PLIVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/27/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #063187",
    "submission": "SUPPL-5",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "PLIVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/27/2025",
    "drugName": "GANCICLOVIR SODIUMANDA  #076222",
    "submission": "SUPPL-7",
    "activeIngredients": "GANCICLOVIR SODIUM",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/27/2025",
    "drugName": "CIPROFLOXACIN HYDROCHLORIDEANDA  #077859",
    "submission": "SUPPL-46",
    "activeIngredients": "CIPROFLOXACIN HYDROCHLORIDE",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/27/2025",
    "drugName": "DIVALPROEX SODIUMANDA  #202419",
    "submission": "SUPPL-31",
    "activeIngredients": "DIVALPROEX SODIUM",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/27/2025",
    "drugName": "METHADONE HYDROCHLORIDEANDA  #204166",
    "submission": "SUPPL-5",
    "activeIngredients": "METHADONE HYDROCHLORIDE",
    "company": "VISTAPHARM LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/27/2025",
    "drugName": "NEOMYCIN SULFATEANDA  #204435",
    "submission": "SUPPL-7",
    "activeIngredients": "NEOMYCIN SULFATE",
    "company": "CHARTWELL MOLECULAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/27/2025",
    "drugName": "DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATEANDA  #204777",
    "submission": "SUPPL-10",
    "activeIngredients": "DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE",
    "company": "MICRO LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/27/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #207773",
    "submission": "SUPPL-1",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "ZYDUS LIFESCIENCES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/27/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #207773",
    "submission": "SUPPL-5",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "ZYDUS LIFESCIENCES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/27/2025",
    "drugName": "DOXYCYCLINEANDA  #210381",
    "submission": "ORIG-1",
    "activeIngredients": "DOXYCYCLINE",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/27/2025",
    "drugName": "DEFERASIROXANDA  #213374",
    "submission": "SUPPL-3",
    "activeIngredients": "DEFERASIROX",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/27/2025",
    "drugName": "RIVFLOZANDA   #215842",
    "submission": "SUPPL-2",
    "activeIngredients": "NEDOSIRAN SODIUM",
    "company": "NOVO",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/27/2025",
    "drugName": "SYFOVRENDA   #217171",
    "submission": "SUPPL-3",
    "activeIngredients": "PEGCETACOPLAN",
    "company": "APELLIS PHARMS",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/27/2025",
    "drugName": "PALIPERIDONEANDA  #218514",
    "submission": "SUPPL-2",
    "activeIngredients": "PALIPERIDONE",
    "company": "AJANTA PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/27/2025",
    "drugName": "TIZANIDINE HYDROCHLORIDEANDA  #218920",
    "submission": "SUPPL-2",
    "activeIngredients": "TIZANIDINE HYDROCHLORIDE",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/28/2025",
    "drugName": "BETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATEANDA  #077838",
    "submission": "SUPPL-3",
    "activeIngredients": "BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/28/2025",
    "drugName": "ACETAMINOPHEN AND CODEINE PHOSPHATEANDA  #089805",
    "submission": "SUPPL-40",
    "activeIngredients": "ACETAMINOPHEN; CODEINE PHOSPHATE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/28/2025",
    "drugName": "ACETAMINOPHEN AND CODEINE PHOSPHATEANDA  #089828",
    "submission": "SUPPL-37",
    "activeIngredients": "ACETAMINOPHEN; CODEINE PHOSPHATE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/28/2025",
    "drugName": "ABILIFY MAINTENA KITNDA   #202971",
    "submission": "SUPPL-18",
    "activeIngredients": "ARIPIPRAZOLE",
    "company": "OTSUKA PHARM CO LTD",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/28/2025",
    "drugName": "DULOXETINE HYDROCHLORIDEANDA  #203088",
    "submission": "SUPPL-26",
    "activeIngredients": "DULOXETINE HYDROCHLORIDE",
    "company": "BRECKENRIDGE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/28/2025",
    "drugName": "DULOXETINE HYDROCHLORIDEANDA  #203088",
    "submission": "SUPPL-28",
    "activeIngredients": "DULOXETINE HYDROCHLORIDE",
    "company": "BRECKENRIDGE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/28/2025",
    "drugName": "METHAMPHETAMINE HYDROCHLORIDEANDA  #203846",
    "submission": "SUPPL-9",
    "activeIngredients": "METHAMPHETAMINE HYDROCHLORIDE",
    "company": "HIKMA",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/28/2025",
    "drugName": "DEXMEDETOMIDINE HYDROCHLORIDEANDA  #204023",
    "submission": "SUPPL-12",
    "activeIngredients": "DEXMEDETOMIDINE HYDROCHLORIDE",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/28/2025",
    "drugName": "DEXMEDETOMIDINE HYDROCHLORIDEANDA  #204023",
    "submission": "SUPPL-13",
    "activeIngredients": "DEXMEDETOMIDINE HYDROCHLORIDE",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/28/2025",
    "drugName": "DEXMEDETOMIDINE HYDROCHLORIDEANDA  #204023",
    "submission": "SUPPL-17",
    "activeIngredients": "DEXMEDETOMIDINE HYDROCHLORIDE",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/28/2025",
    "drugName": "ADZENYS XR-ODTNDA   #204326",
    "submission": "SUPPL-12",
    "activeIngredients": "AMPHETAMINE",
    "company": "NEOS THERAPS",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/28/2025",
    "drugName": "TYMLOSNDA   #208743",
    "submission": "SUPPL-17",
    "activeIngredients": "ABALOPARATIDE",
    "company": "RADIUS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/28/2025",
    "drugName": "DESOXIMETASONEANDA  #209973",
    "submission": "SUPPL-4",
    "activeIngredients": "DESOXIMETASONE",
    "company": "THE J MOLNER",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/28/2025",
    "drugName": "BRIXADINDA   #210136",
    "submission": "SUPPL-8",
    "activeIngredients": "BUPRENORPHINE",
    "company": "BRAEBURN",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/28/2025",
    "drugName": "ITRACONAZOLEANDA  #212239",
    "submission": "SUPPL-5",
    "activeIngredients": "ITRACONAZOLE",
    "company": "ANNORA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/28/2025",
    "drugName": "NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDEANDA  #215592",
    "submission": "SUPPL-2",
    "activeIngredients": "NICARDIPINE HYDROCHLORIDE",
    "company": "CIPLA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/28/2025",
    "drugName": "PLUVICTONDA   #215833",
    "submission": "SUPPL-21",
    "activeIngredients": "LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN",
    "company": "NOVARTIS",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/28/2025",
    "drugName": "PLUVICTONDA   #215833",
    "submission": "SUPPL-24",
    "activeIngredients": "LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN",
    "company": "NOVARTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/28/2025",
    "drugName": "LOCAMETZNDA   #215841",
    "submission": "SUPPL-6",
    "activeIngredients": "GALLIUM GA-68 GOZETOTIDE",
    "company": "NOVARTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/28/2025",
    "drugName": "ABILIFY ASIMTUFIINDA   #217006",
    "submission": "SUPPL-1",
    "activeIngredients": "ARIPIPRAZOLE",
    "company": "OTSUKA",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/28/2025",
    "drugName": "QFITLIANDA   #219019",
    "submission": "ORIG-1",
    "activeIngredients": "FITUSIRAN SODIUM",
    "company": "GENZYME CORP",
    "submissionClassification": "Type 1 - New Molecular Entity",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/28/2025",
    "drugName": "SUMATRIPTAN SUCCINATEANDA  #219036",
    "submission": "SUPPL-2",
    "activeIngredients": "SUMATRIPTAN SUCCINATE",
    "company": "VKT PHARMA",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/28/2025",
    "drugName": "IMFINZIBLA   #761069",
    "submission": "SUPPL-50",
    "activeIngredients": "DURVALUMAB",
    "company": "ASTRAZENECA UK LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "TYGACILNDA   #021821",
    "submission": "SUPPL-56",
    "activeIngredients": "TIGECYCLINE",
    "company": "PF PRISM CV",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "VIBRAMYCINNDA   #050006",
    "submission": "SUPPL-95",
    "activeIngredients": "DOXYCYCLINE",
    "company": "PFIZER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "VIBRAMYCINNDA   #050007",
    "submission": "SUPPL-39",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "PFIZER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "ACHROMYCIN VNDA   #050278",
    "submission": "SUPPL-49",
    "activeIngredients": "TETRACYCLINE HYDROCHLORIDE",
    "company": "AVET",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "MINOCINNDA   #050444",
    "submission": "SUPPL-53",
    "activeIngredients": "MINOCYCLINE HYDROCHLORIDE",
    "company": "REMPEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "MINOCINNDA   #050445",
    "submission": "SUPPL-32",
    "activeIngredients": "MINOCYCLINE HYDROCHLORIDE",
    "company": "BAUSCH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "VIBRAMYCINNDA   #050480",
    "submission": "SUPPL-63",
    "activeIngredients": "DOXYCYCLINE CALCIUM",
    "company": "PFIZER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "VIBRA-TABSNDA   #050533",
    "submission": "SUPPL-50",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "PFIZER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "DORYXNDA   #050582",
    "submission": "SUPPL-32",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "MAYNE PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "MONODOXNDA   #050641",
    "submission": "SUPPL-34",
    "activeIngredients": "DOXYCYCLINE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "MINOCINNDA   #050649",
    "submission": "SUPPL-29",
    "activeIngredients": "MINOCYCLINE HYDROCHLORIDE",
    "company": "BAUSCH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "HELIDACNDA   #050719",
    "submission": "SUPPL-26",
    "activeIngredients": "BISMUTH SUBSALICYLATE; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE",
    "company": "CASPER PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "PYLERANDA   #050786",
    "submission": "SUPPL-29",
    "activeIngredients": "BISMUTH SUBCITRATE POTASSIUM; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE",
    "company": "LABS JUVISE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "DORYXNDA   #050795",
    "submission": "SUPPL-37",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "MAYNE PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "DORYX MPCNDA   #050795",
    "submission": "SUPPL-37",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "MAYNE PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "SUMYCINANDA  #060400",
    "submission": "SUPPL-8",
    "activeIngredients": "TETRACYCLINE HYDROCHLORIDE",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "TETRACYCLINE HYDROCHLORIDEANDA  #060736",
    "submission": "SUPPL-26",
    "activeIngredients": "TETRACYCLINE HYDROCHLORIDE",
    "company": "SUN PHARM INDUSTRIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "TETRACYCLINE HYDROCHLORIDEANDA  #060768",
    "submission": "SUPPL-2",
    "activeIngredients": "TETRACYCLINE HYDROCHLORIDE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "OXYTETRACYCLINE HYDROCHLORIDEANDA  #060770",
    "submission": "SUPPL-4",
    "activeIngredients": "OXYTETRACYCLINE HYDROCHLORIDE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "TETRACYCLINE HYDROCHLORIDEANDA  #060783",
    "submission": "SUPPL-28",
    "activeIngredients": "TETRACYCLINE HYDROCHLORIDE",
    "company": "AUROBINDO PHARMA USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "SUMYCINANDA  #061147",
    "submission": "SUPPL-28",
    "activeIngredients": "TETRACYCLINE HYDROCHLORIDE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "TETRACYCLINE HYDROCHLORIDEANDA  #061837",
    "submission": "SUPPL-44",
    "activeIngredients": "TETRACYCLINE HYDROCHLORIDE",
    "company": "WATSON LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #062031",
    "submission": "SUPPL-85",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "ACTAVIS LABS FL INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #062269",
    "submission": "SUPPL-51",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "EPIC PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #062337",
    "submission": "SUPPL-39",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #062396",
    "submission": "SUPPL-89",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "HIKMA INTL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #062421",
    "submission": "SUPPL-75",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "ACTAVIS LABS FL INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #062432",
    "submission": "SUPPL-44",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "DOXY 100ANDA  #062475",
    "submission": "SUPPL-61",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "DOXY 200ANDA  #062475",
    "submission": "SUPPL-61",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #062500",
    "submission": "SUPPL-58",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "CHARTWELL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #062505",
    "submission": "SUPPL-84",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "CHARTWELL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #062538",
    "submission": "SUPPL-19",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #063187",
    "submission": "SUPPL-6",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "PLIVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #065095",
    "submission": "SUPPL-39",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "HIKMA INTL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #065103",
    "submission": "SUPPL-4",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "HIKMA INTL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #065163",
    "submission": "SUPPL-14",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "HERITAGE PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #065182",
    "submission": "SUPPL-13",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "EPIC PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #065277",
    "submission": "SUPPL-23",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "CHARTWELL MOLECULAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "DOXYCYCLINEANDA  #065454",
    "submission": "SUPPL-10",
    "activeIngredients": "DOXYCYCLINE",
    "company": "CHARTWELL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "MINOCYCLINE HYDROCHLORIDEANDA  #065485",
    "submission": "SUPPL-17",
    "activeIngredients": "MINOCYCLINE HYDROCHLORIDE",
    "company": "BARR LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "MINOCYCLINE HYDROCHLORIDEANDA  #090024",
    "submission": "SUPPL-10",
    "activeIngredients": "MINOCYCLINE HYDROCHLORIDE",
    "company": "IMPAX LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "MINOCYCLINE HYDROCHLORIDEANDA  #090422",
    "submission": "SUPPL-16",
    "activeIngredients": "MINOCYCLINE HYDROCHLORIDE",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "MINOCYCLINE HYDROCHLORIDEANDA  #091118",
    "submission": "SUPPL-2",
    "activeIngredients": "MINOCYCLINE HYDROCHLORIDE",
    "company": "SUN PHARM INDS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "LETROZOLEANDA  #091303",
    "submission": "SUPPL-5",
    "activeIngredients": "LETROZOLE",
    "company": "APOTEX INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "DOXYCYCLINEANDA  #091406",
    "submission": "SUPPL-22",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "MYLAN LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "MINOCYCLINE HYDROCHLORIDEANDA  #091424",
    "submission": "SUPPL-7",
    "activeIngredients": "MINOCYCLINE HYDROCHLORIDE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "DOXYCYCLINEANDA  #200065",
    "submission": "SUPPL-18",
    "activeIngredients": "DOXYCYCLINE",
    "company": "IMPAX LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "MINOCYCLINE HYDROCHLORIDEANDA  #201467",
    "submission": "SUPPL-1",
    "activeIngredients": "MINOCYCLINE HYDROCHLORIDE",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "DOXYCYCLINEANDA  #201678",
    "submission": "SUPPL-17",
    "activeIngredients": "DOXYCYCLINE",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "MINOCYCLINE HYDROCHLORIDEANDA  #202261",
    "submission": "SUPPL-9",
    "activeIngredients": "MINOCYCLINE HYDROCHLORIDE",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "BISMUTH SUBSALICYLATE, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDEANDA  #202584",
    "submission": "SUPPL-4",
    "activeIngredients": "BISMUTH SUBSALICYLATE; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE",
    "company": "AILEX PHARMS LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "MINOCYCLINE HYDROCHLORIDEANDA  #203443",
    "submission": "SUPPL-3",
    "activeIngredients": "MINOCYCLINE HYDROCHLORIDE",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "MINOCYCLINE HYDROCHLORIDEANDA  #203553",
    "submission": "SUPPL-1",
    "activeIngredients": "MINOCYCLINE HYDROCHLORIDE",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "DICLOFENAC SODIUM AND MISOPROSTOLANDA  #203995",
    "submission": "SUPPL-11",
    "activeIngredients": "DICLOFENAC SODIUM; MISOPROSTOL",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "DICLOFENAC SODIUM AND MISOPROSTOLANDA  #203995",
    "submission": "SUPPL-13",
    "activeIngredients": "DICLOFENAC SODIUM; MISOPROSTOL",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "DICLOFENAC SODIUM AND MISOPROSTOLANDA  #203995",
    "submission": "SUPPL-14",
    "activeIngredients": "DICLOFENAC SODIUM; MISOPROSTOL",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "DICLOFENAC SODIUM AND MISOPROSTOLANDA  #203995",
    "submission": "SUPPL-15",
    "activeIngredients": "DICLOFENAC SODIUM; MISOPROSTOL",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "DICLOFENAC SODIUM AND MISOPROSTOLANDA  #203995",
    "submission": "SUPPL-18",
    "activeIngredients": "DICLOFENAC SODIUM; MISOPROSTOL",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "DICLOFENAC SODIUM AND MISOPROSTOLANDA  #203995",
    "submission": "SUPPL-24",
    "activeIngredients": "DICLOFENAC SODIUM; MISOPROSTOL",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "CAPECITABINEANDA  #204345",
    "submission": "SUPPL-3",
    "activeIngredients": "CAPECITABINE",
    "company": "DR REDDYS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "MINOCYCLINE HYDROCHLORIDEANDA  #204394",
    "submission": "SUPPL-3",
    "activeIngredients": "MINOCYCLINE HYDROCHLORIDE",
    "company": "SUN PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "ROPINIROLE HYDROCHLORIDEANDA  #204413",
    "submission": "SUPPL-1",
    "activeIngredients": "ROPINIROLE HYDROCHLORIDE",
    "company": "PRINSTON INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "MINOCYCLINE HYDROCHLORIDEANDA  #204453",
    "submission": "SUPPL-8",
    "activeIngredients": "MINOCYCLINE HYDROCHLORIDE",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "HYDROCODONE BITARTRATE AND PSEUDOEPHEDRINE HYDROCHLORIDEANDA  #204658",
    "submission": "SUPPL-4",
    "activeIngredients": "HYDROCODONE BITARTRATE; PSEUDOEPHEDRINE HYDROCHLORIDE",
    "company": "PADAGIS US",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "TIGECYCLINENDA   #205645",
    "submission": "SUPPL-13",
    "activeIngredients": "TIGECYCLINE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "ACTICLATENDA   #205931",
    "submission": "SUPPL-6",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #207558",
    "submission": "SUPPL-5",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "NOVEL LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "DOXYCYCLINEANDA  #207757",
    "submission": "SUPPL-6",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #207773",
    "submission": "SUPPL-10",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "ZYDUS LIFESCIENCES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "ACTICLATE CAPNDA   #208253",
    "submission": "SUPPL-4",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "TIGECYCLINENDA   #208744",
    "submission": "SUPPL-6",
    "activeIngredients": "TIGECYCLINE",
    "company": "ACCORD HLTHCARE INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #209560",
    "submission": "SUPPL-1",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "NUZYRANDA   #209816",
    "submission": "SUPPL-17",
    "activeIngredients": "OMADACYCLINE TOSYLATE",
    "company": "PARATEK PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "NUZYRANDA   #209817",
    "submission": "SUPPL-17",
    "activeIngredients": "OMADACYCLINE TOSYLATE",
    "company": "PARATEK PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "LYMEPAKNDA   #209844",
    "submission": "SUPPL-2",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "CHARTWELL PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #209958",
    "submission": "SUPPL-5",
    "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
    "company": "ALVOGEN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #209969",
    "submission": "SUPPL-1",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "AVET LIFESCIENCES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #210536",
    "submission": "SUPPL-9",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "ALEMBIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #210537",
    "submission": "SUPPL-9",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "ALEMBIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "XERAVANDA   #211109",
    "submission": "SUPPL-14",
    "activeIngredients": "ERAVACYCLINE DIHYDROCHLORIDE",
    "company": "TETRAPHASE PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "TIGECYCLINENDA   #211158",
    "submission": "SUPPL-7",
    "activeIngredients": "TIGECYCLINE",
    "company": "AMNEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #211343",
    "submission": "SUPPL-9",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "CHANGZHOU PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #212487",
    "submission": "SUPPL-1",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "PRAXGEN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #213475",
    "submission": "SUPPL-1",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "MINOCYCLINE HYDROCHLORIDEANDA  #213662",
    "submission": "SUPPL-2",
    "activeIngredients": "MINOCYCLINE HYDROCHLORIDE",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "MINOCYCLINE HYDROCHLORIDEANDA  #215466",
    "submission": "SUPPL-3",
    "activeIngredients": "MINOCYCLINE HYDROCHLORIDE",
    "company": "REGCON HOLDINGS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #215583",
    "submission": "SUPPL-2",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "GLAND",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #216599",
    "submission": "SUPPL-2",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "AMNEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #216690",
    "submission": "SUPPL-3",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "PANTOPRAZOLE SODIUMANDA  #217458",
    "submission": "ORIG-1",
    "activeIngredients": "PANTOPRAZOLE SODIUM",
    "company": "CIPLA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #217685",
    "submission": "SUPPL-1",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "SLATE RUN PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #217794",
    "submission": "SUPPL-2",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #217854",
    "submission": "SUPPL-1",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "HERITAGE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "PANTOPRAZOLE SODIUMANDA  #217923",
    "submission": "ORIG-1",
    "activeIngredients": "PANTOPRAZOLE SODIUM",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #218053",
    "submission": "SUPPL-2",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "KINDOS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "03/31/2025",
    "drugName": "PANTOPRAZOLE SODIUMANDA  #219230",
    "submission": "ORIG-1",
    "activeIngredients": "PANTOPRAZOLE SODIUM",
    "company": "ALEMBIC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  }
,
  {
    "approvalDate": "04/01/2025",
    "drugName": "XYLOCAINENDA   #008816",
    "submission": "SUPPL-40",
    "activeIngredients": "LIDOCAINE HYDROCHLORIDE",
    "company": "EPIC PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/01/2025",
    "drugName": "PERIOSTATNDA   #050783",
    "submission": "SUPPL-5",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "GALDERMA LABS LP",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/01/2025",
    "drugName": "SOLODYNNDA   #050808",
    "submission": "SUPPL-28",
    "activeIngredients": "MINOCYCLINE HYDROCHLORIDE",
    "company": "BAUSCH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/01/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #062676",
    "submission": "SUPPL-57",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "SUN PHARM INDUSTRIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/01/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #062677",
    "submission": "SUPPL-59",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "SUN PHARM INDUSTRIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/01/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #065134",
    "submission": "SUPPL-22",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "SUN PHARM INDUSTRIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/01/2025",
    "drugName": "NICOTINE POLACRILEXANDA  #077007",
    "submission": "SUPPL-55",
    "activeIngredients": "NICOTINE POLACRILEX",
    "company": "PERRIGO R AND D",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/01/2025",
    "drugName": "STELARABLA   #125261",
    "submission": "SUPPL-168",
    "activeIngredients": "USTEKINUMAB",
    "company": "CENTOCOR ORTHO BIOTECH INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/01/2025",
    "drugName": "ADZENYS XR-ODTNDA   #204326",
    "submission": "SUPPL-18",
    "activeIngredients": "AMPHETAMINE",
    "company": "NEOS THERAPS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/01/2025",
    "drugName": "IBUPROFENANDA  #204469",
    "submission": "SUPPL-7",
    "activeIngredients": "IBUPROFEN",
    "company": "ONESOURCE SPECIALTY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/01/2025",
    "drugName": "IBUPROFENANDA  #204469",
    "submission": "SUPPL-8",
    "activeIngredients": "IBUPROFEN",
    "company": "ONESOURCE SPECIALTY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/01/2025",
    "drugName": "IBUPROFENANDA  #204469",
    "submission": "SUPPL-10",
    "activeIngredients": "IBUPROFEN",
    "company": "ONESOURCE SPECIALTY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/01/2025",
    "drugName": "STELARABLA   #761044",
    "submission": "SUPPL-16",
    "activeIngredients": "USTEKINUMAB",
    "company": "JANSSEN BIOTECH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/02/2025",
    "drugName": "ORACEANDA   #050805",
    "submission": "SUPPL-20",
    "activeIngredients": "DOXYCYCLINE",
    "company": "GALDERMA LABS LP",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/02/2025",
    "drugName": "PERJETABLA   #125409",
    "submission": "SUPPL-137",
    "activeIngredients": "PERTUZUMAB",
    "company": "GENENTECH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/02/2025",
    "drugName": "DONEPEZIL HYDROCHLORIDEANDA  #203034",
    "submission": "SUPPL-10",
    "activeIngredients": "DONEPEZIL HYDROCHLORIDE",
    "company": "HETERO LABS LTD V",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/02/2025",
    "drugName": "OPSUMITNDA   #204410",
    "submission": "SUPPL-31",
    "activeIngredients": "MACITENTAN",
    "company": "ACTELION",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/02/2025",
    "drugName": "LITHIUM CARBONATEANDA  #204779",
    "submission": "SUPPL-9",
    "activeIngredients": "LITHIUM CARBONATE",
    "company": "UNIQUE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/02/2025",
    "drugName": "FESOTERODINE FUMARATEANDA  #204792",
    "submission": "SUPPL-2",
    "activeIngredients": "FESOTERODINE FUMARATE",
    "company": "HETERO LABS LTD V",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/02/2025",
    "drugName": "NAPROXEN AND ESOMEPRAZOLE MAGNESIUMANDA  #204920",
    "submission": "SUPPL-7",
    "activeIngredients": "ESOMEPRAZOLE MAGNESIUM; NAPROXEN",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/02/2025",
    "drugName": "IMATINIB MESYLATEANDA  #206547",
    "submission": "SUPPL-11",
    "activeIngredients": "IMATINIB MESYLATE",
    "company": "DR REDDYS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/02/2025",
    "drugName": "DECITABINEANDA  #210756",
    "submission": "SUPPL-1",
    "activeIngredients": "DECITABINE",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/02/2025",
    "drugName": "DECITABINEANDA  #210756",
    "submission": "SUPPL-2",
    "activeIngredients": "DECITABINE",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/02/2025",
    "drugName": "DECITABINEANDA  #210756",
    "submission": "SUPPL-3",
    "activeIngredients": "DECITABINE",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/02/2025",
    "drugName": "SITAGLIPTIN PHOSPHATEANDA  #211073",
    "submission": "ORIG-1",
    "activeIngredients": "SITAGLIPTIN PHOSPHATE",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "04/02/2025",
    "drugName": "MACITENTANANDA  #211107",
    "submission": "SUPPL-2",
    "activeIngredients": "MACITENTAN",
    "company": "TORRENT",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/02/2025",
    "drugName": "MACITENTANANDA  #211195",
    "submission": "SUPPL-3",
    "activeIngredients": "MACITENTAN",
    "company": "APOTEX",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/02/2025",
    "drugName": "MACITENTANANDA  #211198",
    "submission": "SUPPL-4",
    "activeIngredients": "MACITENTAN",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/02/2025",
    "drugName": "MACITENTANANDA  #211224",
    "submission": "SUPPL-4",
    "activeIngredients": "MACITENTAN",
    "company": "ZYDUS LIFESCIENCES",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/02/2025",
    "drugName": "TRYVIONDA   #217686",
    "submission": "SUPPL-4",
    "activeIngredients": "APROCITENTAN",
    "company": "IDORSIA",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/02/2025",
    "drugName": "LIRAGLUTIDEANDA  #218115",
    "submission": "ORIG-1",
    "activeIngredients": "LIRAGLUTIDE",
    "company": "NANJING KING FRIEND",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/02/2025",
    "drugName": "OPSYNVINDA   #218490",
    "submission": "SUPPL-2",
    "activeIngredients": "MACITENTAN; TADALAFIL",
    "company": "ACTELION",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/02/2025",
    "drugName": "LIBERVANTNDA   #218623",
    "submission": "ORIG-1",
    "activeIngredients": "DIAZEPAM",
    "company": "AQUESTIVE",
    "submissionClassification": "Type 3 - New Dosage Form",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "04/02/2025",
    "drugName": "VANRAFIANDA   #219208",
    "submission": "ORIG-1",
    "activeIngredients": "ATRASENTAN HYDROCHLORIDE",
    "company": "NOVARTIS",
    "submissionClassification": "Type 1 - New Molecular Entity",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/02/2025",
    "drugName": "ACETAMINOPHENANDA  #219215",
    "submission": "ORIG-1",
    "activeIngredients": "ACETAMINOPHEN",
    "company": "GLAND",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/02/2025",
    "drugName": "LIDOCAINE HYDROCHLORIDEANDA  #219535",
    "submission": "ORIG-1",
    "activeIngredients": "LIDOCAINE HYDROCHLORIDE",
    "company": "NEOCUBES PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/03/2025",
    "drugName": "RIFAMPINANDA  #065421",
    "submission": "SUPPL-29",
    "activeIngredients": "RIFAMPIN",
    "company": "MYLAN LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/03/2025",
    "drugName": "CETIRIZINE HYDROCHLORIDE ALLERGYANDA  #078427",
    "submission": "SUPPL-6",
    "activeIngredients": "CETIRIZINE HYDROCHLORIDE",
    "company": "GLENMARK PHARMS INC",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/03/2025",
    "drugName": "MONTELUKAST SODIUMANDA  #090984",
    "submission": "SUPPL-17",
    "activeIngredients": "MONTELUKAST SODIUM",
    "company": "TORRENT PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/03/2025",
    "drugName": "OXCARBAZEPINEANDA  #201193",
    "submission": "SUPPL-9",
    "activeIngredients": "OXCARBAZEPINE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/03/2025",
    "drugName": "MONTELUKAST SODIUMANDA  #201515",
    "submission": "SUPPL-19",
    "activeIngredients": "MONTELUKAST SODIUM",
    "company": "TORRENT PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/03/2025",
    "drugName": "PIPERACILLIN AND TAZOBACTAM AND SODIUM CHLORIDE IN DUPLEX CONTAINERNDA   #206056",
    "submission": "ORIG-1",
    "activeIngredients": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
    "company": "B BRAUN MEDICAL",
    "submissionClassification": "Type 5 - New Formulation or New Manufacturer",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/03/2025",
    "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #206718",
    "submission": "SUPPL-16",
    "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
    "company": "SPECGX LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/03/2025",
    "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #210211",
    "submission": "SUPPL-11",
    "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
    "company": "WES PHARMA INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/03/2025",
    "drugName": "LEVOCETIRIZINE DIHYDROCHLORIDEANDA  #210375",
    "submission": "SUPPL-6",
    "activeIngredients": "LEVOCETIRIZINE DIHYDROCHLORIDE",
    "company": "DR REDDYS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/03/2025",
    "drugName": "LEVOCETIRIZINE DIHYDROCHLORIDEANDA  #210375",
    "submission": "SUPPL-11",
    "activeIngredients": "LEVOCETIRIZINE DIHYDROCHLORIDE",
    "company": "DR REDDYS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/03/2025",
    "drugName": "MONTELUKAST SODIUMANDA  #210431",
    "submission": "SUPPL-6",
    "activeIngredients": "MONTELUKAST SODIUM",
    "company": "TORRENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/03/2025",
    "drugName": "TRIAMCINOLONE ACETONIDEANDA  #212567",
    "submission": "SUPPL-4",
    "activeIngredients": "TRIAMCINOLONE ACETONIDE",
    "company": "MYLAN LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/03/2025",
    "drugName": "DOLUTEGRAVIR; LAMIVUDINEANDA  #213495",
    "submission": "ORIG-1",
    "activeIngredients": "DOLUTEGRAVIR;LAMIVUDINE",
    "company": "CIPLA LIMITED",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "04/03/2025",
    "drugName": "SAPROPTERIN DIHYDROCHLORIDEANDA  #215534",
    "submission": "SUPPL-3",
    "activeIngredients": "SAPROPTERIN DIHYDROCHLORIDE",
    "company": "ANNORA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/03/2025",
    "drugName": "DEXAMETHASONE SODIUM PHOSPHATEANDA  #215654",
    "submission": "SUPPL-4",
    "activeIngredients": "DEXAMETHASONE SODIUM PHOSPHATE",
    "company": "GLAND",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/03/2025",
    "drugName": "MICAFUNGIN SODIUMANDA  #219273",
    "submission": "ORIG-1",
    "activeIngredients": "MICAFUNGIN SODIUM",
    "company": "QILU PHARM HAINAN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/03/2025",
    "drugName": "BUMETANIDEANDA  #219291",
    "submission": "ORIG-1",
    "activeIngredients": "BUMETANIDE",
    "company": "MANKIND PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/03/2025",
    "drugName": "BALSALAZIDE DISODIUMANDA  #219422",
    "submission": "ORIG-1",
    "activeIngredients": "BALSALAZIDE DISODIUM",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/03/2025",
    "drugName": "UPLIZNABLA   #761142",
    "submission": "SUPPL-3",
    "activeIngredients": "INEBILIZUMAB-CDON",
    "company": "VIELA BIO",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/04/2025",
    "drugName": "RETISERTNDA   #021737",
    "submission": "SUPPL-26",
    "activeIngredients": "FLUOCINOLONE ACETONIDE",
    "company": "BAUSCH AND LOMB",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/04/2025",
    "drugName": "LETAIRISNDA   #022081",
    "submission": "SUPPL-45",
    "activeIngredients": "AMBRISENTAN",
    "company": "GILEAD",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/04/2025",
    "drugName": "GENGRAFANDA  #065003",
    "submission": "SUPPL-20",
    "activeIngredients": "CYCLOSPORINE",
    "company": "ABBVIE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/04/2025",
    "drugName": "CYCLOSPORINEANDA  #065025",
    "submission": "SUPPL-26",
    "activeIngredients": "CYCLOSPORINE",
    "company": "ABBVIE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/04/2025",
    "drugName": "CYCLOSPORINEANDA  #065025",
    "submission": "SUPPL-27",
    "activeIngredients": "CYCLOSPORINE",
    "company": "ABBVIE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/04/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #065287",
    "submission": "SUPPL-9",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/04/2025",
    "drugName": "LEVETIRACETAMANDA  #090876",
    "submission": "SUPPL-9",
    "activeIngredients": "LEVETIRACETAM",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/04/2025",
    "drugName": "TROSPIUM CHLORIDEANDA  #091575",
    "submission": "SUPPL-11",
    "activeIngredients": "TROSPIUM CHLORIDE",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/04/2025",
    "drugName": "SIVEXTRONDA   #205435",
    "submission": "SUPPL-16",
    "activeIngredients": "TEDIZOLID PHOSPHATE",
    "company": "CUBIST PHARMS LLC",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/04/2025",
    "drugName": "SIVEXTRONDA   #205436",
    "submission": "SUPPL-13",
    "activeIngredients": "TEDIZOLID PHOSPHATE",
    "company": "CUBIST PHARMS LLC",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/04/2025",
    "drugName": "AMBRISENTANANDA  #208252",
    "submission": "SUPPL-7",
    "activeIngredients": "AMBRISENTAN",
    "company": "WATSON LABS INC",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/04/2025",
    "drugName": "AMBRISENTANANDA  #208354",
    "submission": "SUPPL-6",
    "activeIngredients": "AMBRISENTAN",
    "company": "SIGMAPHARM LABS LLC",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/04/2025",
    "drugName": "AMBRISENTANANDA  #208441",
    "submission": "SUPPL-5",
    "activeIngredients": "AMBRISENTAN",
    "company": "MYLAN",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/04/2025",
    "drugName": "TICAGRELORANDA  #208597",
    "submission": "SUPPL-3",
    "activeIngredients": "TICAGRELOR",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/04/2025",
    "drugName": "TICAGRELORANDA  #208597",
    "submission": "SUPPL-5",
    "activeIngredients": "TICAGRELOR",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/04/2025",
    "drugName": "AMBRISENTANANDA  #209509",
    "submission": "SUPPL-6",
    "activeIngredients": "AMBRISENTAN",
    "company": "PH HEALTH",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/04/2025",
    "drugName": "TISSUEBLUENDA   #209569",
    "submission": "SUPPL-6",
    "activeIngredients": "BRILLIANT BLUE G",
    "company": "DUTCH OPHTHALMIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/04/2025",
    "drugName": "AMBRISENTANANDA  #210058",
    "submission": "SUPPL-9",
    "activeIngredients": "AMBRISENTAN",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/04/2025",
    "drugName": "FLUOCINOLONE ACETONIDEANDA  #210556",
    "submission": "SUPPL-4",
    "activeIngredients": "FLUOCINOLONE ACETONIDE",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/04/2025",
    "drugName": "AMBRISENTANANDA  #210701",
    "submission": "SUPPL-2",
    "activeIngredients": "AMBRISENTAN",
    "company": "APOTEX",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/04/2025",
    "drugName": "AMBRISENTANANDA  #210715",
    "submission": "SUPPL-10",
    "activeIngredients": "AMBRISENTAN",
    "company": "CIPLA",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/04/2025",
    "drugName": "AMBRISENTANANDA  #210784",
    "submission": "SUPPL-13",
    "activeIngredients": "AMBRISENTAN",
    "company": "SUN PHARM",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/04/2025",
    "drugName": "OXLUMONDA   #214103",
    "submission": "SUPPL-6",
    "activeIngredients": "LUMASIRAN SODIUM",
    "company": "ALNYLAM PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/04/2025",
    "drugName": "AMBRISENTANANDA  #216531",
    "submission": "SUPPL-2",
    "activeIngredients": "AMBRISENTAN",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/04/2025",
    "drugName": "DAPSONEANDA  #218457",
    "submission": "ORIG-1",
    "activeIngredients": "DAPSONE",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/07/2025",
    "drugName": "CYRAMZABLA   #125477",
    "submission": "SUPPL-49",
    "activeIngredients": "RAMUCIRUMAB",
    "company": "ELI LILLY AND CO",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/07/2025",
    "drugName": "TAFINLARNDA   #202806",
    "submission": "SUPPL-38",
    "activeIngredients": "DABRAFENIB MESYLATE",
    "company": "NOVARTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/07/2025",
    "drugName": "MEKINISTNDA   #204114",
    "submission": "SUPPL-38",
    "activeIngredients": "TRAMETINIB DIMETHYL SULFOXIDE",
    "company": "NOVARTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/07/2025",
    "drugName": "PALIPERIDONEANDA  #204452",
    "submission": "SUPPL-13",
    "activeIngredients": "PALIPERIDONE",
    "company": "INVENTIA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/07/2025",
    "drugName": "CELECOXIBANDA  #204590",
    "submission": "SUPPL-9",
    "activeIngredients": "CELECOXIB",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/07/2025",
    "drugName": "CELECOXIBANDA  #204590",
    "submission": "SUPPL-10",
    "activeIngredients": "CELECOXIB",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/07/2025",
    "drugName": "CELECOXIBANDA  #204590",
    "submission": "SUPPL-13",
    "activeIngredients": "CELECOXIB",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/07/2025",
    "drugName": "CELECOXIBANDA  #204590",
    "submission": "SUPPL-19",
    "activeIngredients": "CELECOXIB",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/07/2025",
    "drugName": "CELECOXIBANDA  #204590",
    "submission": "SUPPL-23",
    "activeIngredients": "CELECOXIB",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/07/2025",
    "drugName": "CELECOXIBANDA  #204590",
    "submission": "SUPPL-37",
    "activeIngredients": "CELECOXIB",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/07/2025",
    "drugName": "CLINDAMYCIN PHOSPHATEANDA  #204748",
    "submission": "SUPPL-1",
    "activeIngredients": "CLINDAMYCIN PHOSPHATE",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/07/2025",
    "drugName": "CLINDAMYCIN PHOSPHATEANDA  #204748",
    "submission": "SUPPL-3",
    "activeIngredients": "CLINDAMYCIN PHOSPHATE",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/07/2025",
    "drugName": "CLINDAMYCIN PHOSPHATEANDA  #204748",
    "submission": "SUPPL-5",
    "activeIngredients": "CLINDAMYCIN PHOSPHATE",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/07/2025",
    "drugName": "CLINDAMYCIN PHOSPHATEANDA  #204748",
    "submission": "SUPPL-8",
    "activeIngredients": "CLINDAMYCIN PHOSPHATE",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/07/2025",
    "drugName": "CLINDAMYCIN PHOSPHATEANDA  #204749",
    "submission": "SUPPL-1",
    "activeIngredients": "CLINDAMYCIN PHOSPHATE",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/07/2025",
    "drugName": "CLINDAMYCIN PHOSPHATEANDA  #204749",
    "submission": "SUPPL-2",
    "activeIngredients": "CLINDAMYCIN PHOSPHATE",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/07/2025",
    "drugName": "CLINDAMYCIN PHOSPHATEANDA  #204749",
    "submission": "SUPPL-4",
    "activeIngredients": "CLINDAMYCIN PHOSPHATE",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/07/2025",
    "drugName": "CLINDAMYCIN PHOSPHATEANDA  #204749",
    "submission": "SUPPL-5",
    "activeIngredients": "CLINDAMYCIN PHOSPHATE",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/07/2025",
    "drugName": "DEXTENZANDA   #208742",
    "submission": "SUPPL-13",
    "activeIngredients": "DEXAMETHASONE",
    "company": "OCULAR THERAPEUTIX",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/07/2025",
    "drugName": "MEKINISTNDA   #217513",
    "submission": "SUPPL-9",
    "activeIngredients": "TRAMETINIB",
    "company": "NOVARTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/07/2025",
    "drugName": "MEKINISTNDA   #217513",
    "submission": "SUPPL-9",
    "activeIngredients": "TRAMETINIB DIMETHYL SULFOXIDE",
    "company": "NOVARTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/07/2025",
    "drugName": "TAFINLARNDA   #217514",
    "submission": "SUPPL-9",
    "activeIngredients": "DABRAFENIB MESYLATE",
    "company": "NOVARTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/07/2025",
    "drugName": "BYQLOVINDA   #218158",
    "submission": "SUPPL-1",
    "activeIngredients": "CLOBETASOL PROPIONATE",
    "company": "HARROW EYE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/07/2025",
    "drugName": "TERIFLUNOMIDEANDA  #218663",
    "submission": "ORIG-1",
    "activeIngredients": "TERIFLUNOMIDE",
    "company": "CONCORD BIOTECH LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/07/2025",
    "drugName": "AMJEVITABLA   #761024",
    "submission": "SUPPL-23",
    "activeIngredients": "ADALIMUMAB-ATTO",
    "company": "AMGEN INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/07/2025",
    "drugName": "YUFLYMABLA   #761219",
    "submission": "SUPPL-17",
    "activeIngredients": "ADALIMUMAB-AATY",
    "company": "CELLTRION",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/07/2025",
    "drugName": "SIMLANDIBLA   #761299",
    "submission": "SUPPL-13",
    "activeIngredients": "ADALIMUMAB-RYVK",
    "company": "ALVOTECH USA INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/07/2025",
    "drugName": "SIMLANDIBLA   #761299",
    "submission": "SUPPL-20",
    "activeIngredients": "ADALIMUMAB-RYVK",
    "company": "ALVOTECH USA INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/08/2025",
    "drugName": "DOXYCYCLINEANDA  #062450",
    "submission": "SUPPL-23",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/08/2025",
    "drugName": "DOXYCYCLINEANDA  #062569",
    "submission": "SUPPL-15",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/08/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #062992",
    "submission": "SUPPL-9",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "WEST-WARD PHARMS INT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/08/2025",
    "drugName": "SULFAMETHOXAZOLE AND TRIMETHOPRIMANDA  #070627",
    "submission": "SUPPL-13",
    "activeIngredients": "SULFAMETHOXAZOLE; TRIMETHOPRIM",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/08/2025",
    "drugName": "SULFAMETHOXAZOLE AND TRIMETHOPRIMANDA  #070628",
    "submission": "SUPPL-16",
    "activeIngredients": "SULFAMETHOXAZOLE; TRIMETHOPRIM",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/08/2025",
    "drugName": "METHOCARBAMOLANDA  #086988",
    "submission": "SUPPL-15",
    "activeIngredients": "METHOCARBAMOL",
    "company": "PRINSTON INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/08/2025",
    "drugName": "YERVOYBLA   #125377",
    "submission": "SUPPL-135",
    "activeIngredients": "IPILIMUMAB",
    "company": "BRISTOL MYERS SQUIBB",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/08/2025",
    "drugName": "OPDIVOBLA   #125554",
    "submission": "SUPPL-132",
    "activeIngredients": "NIVOLUMAB",
    "company": "BRISTOL MYERS SQUIBB",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/08/2025",
    "drugName": "FOSAPREPITANT DIMEGLUMINEANDA  #204015",
    "submission": "SUPPL-5",
    "activeIngredients": "FOSAPREPITANT DIMEGLUMINE",
    "company": "MYLAN LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/08/2025",
    "drugName": "FOSAPREPITANT DIMEGLUMINEANDA  #204015",
    "submission": "SUPPL-6",
    "activeIngredients": "FOSAPREPITANT DIMEGLUMINE",
    "company": "MYLAN LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/08/2025",
    "drugName": "AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATEANDA  #208436",
    "submission": "ORIG-1",
    "activeIngredients": "AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE",
    "company": "TEVA PHARMS USA INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/08/2025",
    "drugName": "BUSPIRONE HYDROCHLORIDEANDA  #208829",
    "submission": "SUPPL-21",
    "activeIngredients": "BUSPIRONE HYDROCHLORIDE",
    "company": "AMNEAL PHARMS CO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/08/2025",
    "drugName": "FINTEPLANDA   #212102",
    "submission": "SUPPL-16",
    "activeIngredients": "FENFLURAMINE HYDROCHLORIDE",
    "company": "UCB INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/08/2025",
    "drugName": "GLYCOPYRROLATEANDA  #216084",
    "submission": "ORIG-1",
    "activeIngredients": "GLYCOPYRROLATE",
    "company": "MSN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/08/2025",
    "drugName": "VARENICLINE TARTRATEANDA  #216615",
    "submission": "ORIG-1",
    "activeIngredients": "VARENICLINE TARTRATE",
    "company": "SHILPA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/08/2025",
    "drugName": "VORANIGONDA   #218784",
    "submission": "SUPPL-2",
    "activeIngredients": "VORASIDENIB",
    "company": "SERVIER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/08/2025",
    "drugName": "JAYTHARIANDA  #219254",
    "submission": "ORIG-1",
    "activeIngredients": "DEFLAZACORT",
    "company": "ZYDUS LIFESCIENCES",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/08/2025",
    "drugName": "GLYCEROL PHENYLBUTYRATEANDA  #219540",
    "submission": "ORIG-1",
    "activeIngredients": "GLYCEROL PHENYLBUTYRATE",
    "company": "MSN LABS PVT LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "04/09/2025",
    "drugName": "VALSARTANANDA  #204038",
    "submission": "SUPPL-3",
    "activeIngredients": "VALSARTAN",
    "company": "SCIEGEN PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/09/2025",
    "drugName": "DESVENLAFAXINE SUCCINATEANDA  #204095",
    "submission": "SUPPL-8",
    "activeIngredients": "DESVENLAFAXINE SUCCINATE",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/09/2025",
    "drugName": "DEXMETHYLPHENIDATE HYDROCHLORIDEANDA  #204266",
    "submission": "SUPPL-6",
    "activeIngredients": "DEXMETHYLPHENIDATE HYDROCHLORIDE",
    "company": "AUROLIFE PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/09/2025",
    "drugName": "DEXMETHYLPHENIDATE HYDROCHLORIDEANDA  #204266",
    "submission": "SUPPL-8",
    "activeIngredients": "DEXMETHYLPHENIDATE HYDROCHLORIDE",
    "company": "AUROLIFE PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/09/2025",
    "drugName": "DEXMETHYLPHENIDATE HYDROCHLORIDEANDA  #204266",
    "submission": "SUPPL-9",
    "activeIngredients": "DEXMETHYLPHENIDATE HYDROCHLORIDE",
    "company": "AUROLIFE PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/09/2025",
    "drugName": "DAPSONEANDA  #204380",
    "submission": "SUPPL-1",
    "activeIngredients": "DAPSONE",
    "company": "ACTAVIS LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/09/2025",
    "drugName": "HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDEANDA  #204627",
    "submission": "SUPPL-5",
    "activeIngredients": "CHLORPHENIRAMINE MALEATE; HYDROCODONE BITARTRATE; PSEUDOEPHEDRINE HYDROCHLORIDE",
    "company": "PADAGIS US",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/09/2025",
    "drugName": "CAPECITABINEANDA  #204741",
    "submission": "SUPPL-2",
    "activeIngredients": "CAPECITABINE",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/09/2025",
    "drugName": "CAPECITABINEANDA  #204741",
    "submission": "SUPPL-9",
    "activeIngredients": "CAPECITABINE",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/09/2025",
    "drugName": "CAPECITABINEANDA  #204741",
    "submission": "SUPPL-11",
    "activeIngredients": "CAPECITABINE",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/09/2025",
    "drugName": "DAPTOMYCINANDA  #205037",
    "submission": "SUPPL-6",
    "activeIngredients": "DAPTOMYCIN",
    "company": "MYLAN LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/09/2025",
    "drugName": "DAPTOMYCINANDA  #205037",
    "submission": "SUPPL-7",
    "activeIngredients": "DAPTOMYCIN",
    "company": "MYLAN LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/09/2025",
    "drugName": "DAPTOMYCINANDA  #205037",
    "submission": "SUPPL-9",
    "activeIngredients": "DAPTOMYCIN",
    "company": "MYLAN LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/09/2025",
    "drugName": "DAPTOMYCINANDA  #205037",
    "submission": "SUPPL-11",
    "activeIngredients": "DAPTOMYCIN",
    "company": "MYLAN LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/09/2025",
    "drugName": "RISPERIDONEANDA  #205104",
    "submission": "SUPPL-1",
    "activeIngredients": "RISPERIDONE",
    "company": "IPCA LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/09/2025",
    "drugName": "LINEZOLIDANDA  #205154",
    "submission": "SUPPL-14",
    "activeIngredients": "LINEZOLID",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/09/2025",
    "drugName": "CARBIDOPAANDA  #205304",
    "submission": "SUPPL-5",
    "activeIngredients": "CARBIDOPA",
    "company": "EDENBRIDGE PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/09/2025",
    "drugName": "HEPARIN SODIUMANDA  #205323",
    "submission": "SUPPL-10",
    "activeIngredients": "HEPARIN SODIUM",
    "company": "GLAND",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/09/2025",
    "drugName": "VITRAKVINDA   #210861",
    "submission": "SUPPL-12",
    "activeIngredients": "LAROTRECTINIB SULFATE",
    "company": "BAYER HLTHCARE",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/09/2025",
    "drugName": "TRIENTINE HYDROCHLORIDEANDA  #211076",
    "submission": "SUPPL-6",
    "activeIngredients": "TRIENTINE HYDROCHLORIDE",
    "company": "DR REDDYS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/09/2025",
    "drugName": "VITRAKVINDA   #211710",
    "submission": "SUPPL-10",
    "activeIngredients": "LAROTRECTINIB SULFATE",
    "company": "BAYER HEALTHCARE",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/09/2025",
    "drugName": "POTASSIUM CHLORIDEANDA  #211992",
    "submission": "ORIG-1",
    "activeIngredients": "POTASSIUM CHLORIDE",
    "company": "ASCENT PHARMS INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/09/2025",
    "drugName": "EVEROLIMUSANDA  #216140",
    "submission": "ORIG-1",
    "activeIngredients": "EVEROLIMUS",
    "company": "BIOCON PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/09/2025",
    "drugName": "DICLOFENAC SODIUMANDA  #217646",
    "submission": "ORIG-1",
    "activeIngredients": "DICLOFENAC SODIUM",
    "company": "ENCUBE",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/09/2025",
    "drugName": "METYROSINEANDA  #218620",
    "submission": "ORIG-1",
    "activeIngredients": "METYROSINE",
    "company": "DR REDDYS LABS SA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/09/2025",
    "drugName": "TRABECTEDINNDA   #219617",
    "submission": "ORIG-1",
    "activeIngredients": "TRABECTEDIN",
    "company": "EVER VALINJECT",
    "submissionClassification": "Type 5 - New Formulation or New Manufacturer",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "04/09/2025",
    "drugName": "JOBEVNEBLA   #761175",
    "submission": "ORIG-1",
    "activeIngredients": "BEVACIZUMAB-NWGD",
    "company": "BIOCON BIOLOGICS INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/10/2025",
    "drugName": "BENICAR HCTNDA   #021532",
    "submission": "SUPPL-38",
    "activeIngredients": "HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL",
    "company": "COSETTE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/10/2025",
    "drugName": "CICLOPIROXANDA  #077676",
    "submission": "SUPPL-12",
    "activeIngredients": "CICLOPIROX",
    "company": "PADAGIS ISRAEL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/10/2025",
    "drugName": "NIACINANDA  #204934",
    "submission": "SUPPL-3",
    "activeIngredients": "NIACIN",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/10/2025",
    "drugName": "FLUOCINOLONE ACETONIDEANDA  #207345",
    "submission": "SUPPL-1",
    "activeIngredients": "FLUOCINOLONE ACETONIDE",
    "company": "NOVEL LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/10/2025",
    "drugName": "ROSUVASTATIN CALCIUMANDA  #207752",
    "submission": "SUPPL-26",
    "activeIngredients": "ROSUVASTATIN CALCIUM",
    "company": "BIOCON PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/10/2025",
    "drugName": "RIVAROXABANANDA  #208544",
    "submission": "ORIG-1",
    "activeIngredients": "RIVAROXABAN",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/10/2025",
    "drugName": "PACLITAXELANDA  #209657",
    "submission": "ORIG-1",
    "activeIngredients": "PACLITAXEL",
    "company": "CIPLA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/10/2025",
    "drugName": "AZACITIDINEANDA  #218751",
    "submission": "ORIG-1",
    "activeIngredients": "AZACITIDINE",
    "company": "TEVA PHARMACEUTICALS DEVELOPMENT INC",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "04/10/2025",
    "drugName": "LOPRESSORNDA   #219373",
    "submission": "ORIG-1",
    "activeIngredients": "METOPROLOL TARTRATE",
    "company": "RUBICON RESEARCH",
    "submissionClassification": "Type 3 - New Dosage Form",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/10/2025",
    "drugName": "LIVMARLINDA   #219485",
    "submission": "ORIG-1",
    "activeIngredients": "MARALIXIBAT CHLORIDE",
    "company": "MIRUM",
    "submissionClassification": "Type 3 - New Dosage Form",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/10/2025",
    "drugName": "DARZALEXBLA   #761036",
    "submission": "SUPPL-54",
    "activeIngredients": "DARATUMUMAB",
    "company": "JANSSEN BIOTECH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/10/2025",
    "drugName": "VYVGART HYTRULOBLA   #761304",
    "submission": "SUPPL-8",
    "activeIngredients": "EFGARTIGIMOD ALFA AND HYALURONIDASE-QVFC",
    "company": "ARGENX BV",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/11/2025",
    "drugName": "MORPHINE SULFATEANDA  #079040",
    "submission": "SUPPL-32",
    "activeIngredients": "MORPHINE SULFATE",
    "company": "ACTAVIS ELIZABETH",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/11/2025",
    "drugName": "YERVOYBLA   #125377",
    "submission": "SUPPL-133",
    "activeIngredients": "IPILIMUMAB",
    "company": "BRISTOL MYERS SQUIBB",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/11/2025",
    "drugName": "OPDIVOBLA   #125554",
    "submission": "SUPPL-129",
    "activeIngredients": "NIVOLUMAB",
    "company": "BRISTOL MYERS SQUIBB",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/11/2025",
    "drugName": "SUBLOCADENDA   #209819",
    "submission": "SUPPL-34",
    "activeIngredients": "BUPRENORPHINE",
    "company": "INDIVIOR",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/11/2025",
    "drugName": "DEFERASIROXANDA  #211660",
    "submission": "ORIG-1",
    "activeIngredients": "DEFERASIROX",
    "company": "JUBILANT GENERICS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/11/2025",
    "drugName": "VOCABRIANDA   #212887",
    "submission": "SUPPL-11",
    "activeIngredients": "CABOTEGRAVIR SODIUM",
    "company": "VIIV HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/11/2025",
    "drugName": "CABENUVA KITNDA   #212888",
    "submission": "SUPPL-16",
    "activeIngredients": "CABOTEGRAVIR; RILPIVIRINE",
    "company": "VIIV HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/11/2025",
    "drugName": "APRETUDENDA   #215499",
    "submission": "SUPPL-9",
    "activeIngredients": "CABOTEGRAVIR",
    "company": "VIIV HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/11/2025",
    "drugName": "EMPAGLIFLOZINANDA  #217055",
    "submission": "ORIG-1",
    "activeIngredients": "EMPAGLIFLOZIN",
    "company": "AJANTA PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "04/11/2025",
    "drugName": "TRIAMCINOLONE ACETONIDEANDA  #218421",
    "submission": "ORIG-1",
    "activeIngredients": "TRIAMCINOLONE ACETONIDE",
    "company": "DR REDDYS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/14/2025",
    "drugName": "DIGOXINNDA   #021648",
    "submission": "SUPPL-13",
    "activeIngredients": "DIGOXIN",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/14/2025",
    "drugName": "DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)ANDA  #203263",
    "submission": "SUPPL-38",
    "activeIngredients": "DOXORUBICIN HYDROCHLORIDE",
    "company": "SUN PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/14/2025",
    "drugName": "ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATEANDA  #204209",
    "submission": "SUPPL-14",
    "activeIngredients": "ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/14/2025",
    "drugName": "MOXIFLOXACIN HYDROCHLORIDEANDA  #205348",
    "submission": "SUPPL-6",
    "activeIngredients": "MOXIFLOXACIN HYDROCHLORIDE",
    "company": "CROSSMEDIKA SA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/14/2025",
    "drugName": "SUCRALFATEANDA  #211780",
    "submission": "ORIG-1",
    "activeIngredients": "SUCRALFATE",
    "company": "PADAGIS US",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/14/2025",
    "drugName": "IMATINIB MESYLATEANDA  #212975",
    "submission": "ORIG-1",
    "activeIngredients": "IMATINIB MESYLATE",
    "company": "HETERO LABS LTD V",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/14/2025",
    "drugName": "ALLOPURINOLANDA  #215091",
    "submission": "ORIG-1",
    "activeIngredients": "ALLOPURINOL",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/14/2025",
    "drugName": "ZINC CHLORIDEANDA  #217625",
    "submission": "ORIG-1",
    "activeIngredients": "ZINC CHLORIDE",
    "company": "RK PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/14/2025",
    "drugName": "MESALAMINEANDA  #219028",
    "submission": "ORIG-1",
    "activeIngredients": "MESALAMINE",
    "company": "RISING",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/14/2025",
    "drugName": "METFORMIN HYDROCHLORIDEANDA  #219151",
    "submission": "ORIG-1",
    "activeIngredients": "METFORMIN HYDROCHLORIDE",
    "company": "BIONPHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/14/2025",
    "drugName": "LATANOPROSTANDA  #219306",
    "submission": "ORIG-1",
    "activeIngredients": "LATANOPROST",
    "company": "MICRO LABS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/14/2025",
    "drugName": "OTULFIBLA   #761379",
    "submission": "SUPPL-1",
    "activeIngredients": "USTEKINUMAB-AAUZ",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/15/2025",
    "drugName": "PATADAY TWICE DAILY RELIEFNDA   #020688",
    "submission": "SUPPL-37",
    "activeIngredients": "OLOPATADINE HYDROCHLORIDE",
    "company": "ALCON LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/15/2025",
    "drugName": "PATADAY ONCE DAILY RELIEFNDA   #021545",
    "submission": "SUPPL-29",
    "activeIngredients": "OLOPATADINE HYDROCHLORIDE",
    "company": "ALCON LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/15/2025",
    "drugName": "GUAIFENESINANDA  #078912",
    "submission": "SUPPL-21",
    "activeIngredients": "GUAIFENESIN",
    "company": "PERRIGO R AND D",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/15/2025",
    "drugName": "ALMOTRIPTAN MALATEANDA  #205171",
    "submission": "SUPPL-2",
    "activeIngredients": "ALMOTRIPTAN MALATE",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/15/2025",
    "drugName": "PATADAY ONCE DAILY RELIEFNDA   #206276",
    "submission": "SUPPL-11",
    "activeIngredients": "OLOPATADINE HYDROCHLORIDE",
    "company": "ALCON LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/15/2025",
    "drugName": "LURASIDONE HYDROCHLORIDEANDA  #208031",
    "submission": "SUPPL-7",
    "activeIngredients": "LURASIDONE HYDROCHLORIDE",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/15/2025",
    "drugName": "TICAGRELORANDA  #208508",
    "submission": "SUPPL-6",
    "activeIngredients": "TICAGRELOR",
    "company": "SUNSHINE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/15/2025",
    "drugName": "RANOLAZINEANDA  #211361",
    "submission": "ORIG-1",
    "activeIngredients": "RANOLAZINE",
    "company": "JUBILANT GENERICS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/15/2025",
    "drugName": "MEZOFYNDA   #211448",
    "submission": "ORIG-1",
    "activeIngredients": "ARIPIPRAZOLE",
    "company": "CMG PHARM CO LTD",
    "submissionClassification": "Type 3 - New Dosage Form",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/15/2025",
    "drugName": "VALTOCONDA   #211635",
    "submission": "SUPPL-10",
    "activeIngredients": "DIAZEPAM",
    "company": "NEURELIS INC",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/15/2025",
    "drugName": "ISTURISANDA   #212801",
    "submission": "SUPPL-3",
    "activeIngredients": "OSILODROSTAT PHOSPHATE",
    "company": "RECORDATI RARE",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/15/2025",
    "drugName": "CARBIDOPA, LEVODOPA AND ENTACAPONEANDA  #214495",
    "submission": "ORIG-1",
    "activeIngredients": "CARBIDOPA; ENTACAPONE; LEVODOPA",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/15/2025",
    "drugName": "RUFINAMIDEANDA  #214817",
    "submission": "ORIG-1",
    "activeIngredients": "RUFINAMIDE",
    "company": "MSN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/15/2025",
    "drugName": "WELIREGNDA   #215383",
    "submission": "SUPPL-10",
    "activeIngredients": "BELZUTIFAN",
    "company": "MERCK SHARP DOHME",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/15/2025",
    "drugName": "WELIREGNDA   #215383",
    "submission": "SUPPL-11",
    "activeIngredients": "BELZUTIFAN",
    "company": "MERCK SHARP DOHME",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/15/2025",
    "drugName": "DIVALPROEX SODIUMANDA  #215527",
    "submission": "SUPPL-2",
    "activeIngredients": "DIVALPROEX SODIUM",
    "company": "ANNORA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/15/2025",
    "drugName": "NITROGLYCERINANDA  #218235",
    "submission": "ORIG-1",
    "activeIngredients": "NITROGLYCERIN",
    "company": "ENCUBE",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/15/2025",
    "drugName": "NITAZOXANIDEANDA  #218701",
    "submission": "ORIG-1",
    "activeIngredients": "NITAZOXANIDE",
    "company": "ANNORA PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/15/2025",
    "drugName": "ESOMEPRAZOLE MAGNESIUMANDA  #218948",
    "submission": "ORIG-1",
    "activeIngredients": "ESOMEPRAZOLE MAGNESIUM",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/15/2025",
    "drugName": "ESOMEPRAZOLE MAGNESIUMANDA  #219213",
    "submission": "ORIG-1",
    "activeIngredients": "ESOMEPRAZOLE MAGNESIUM",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/15/2025",
    "drugName": "GUANFACINE HYDROCHLORIDEANDA  #219689",
    "submission": "ORIG-1",
    "activeIngredients": "GUANFACINE HYDROCHLORIDE",
    "company": "RUBICON RESEARCH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/16/2025",
    "drugName": "CARDIZEMNDA   #018602",
    "submission": "SUPPL-72",
    "activeIngredients": "DILTIAZEM HYDROCHLORIDE",
    "company": "BAUSCH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/16/2025",
    "drugName": "CARDIZEM CDNDA   #020062",
    "submission": "SUPPL-48",
    "activeIngredients": "DILTIAZEM HYDROCHLORIDE",
    "company": "BAUSCH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/16/2025",
    "drugName": "TIAZACNDA   #020401",
    "submission": "SUPPL-44",
    "activeIngredients": "DILTIAZEM HYDROCHLORIDE",
    "company": "BAUSCH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/16/2025",
    "drugName": "CARDIZEM LANDA   #021392",
    "submission": "SUPPL-25",
    "activeIngredients": "DILTIAZEM HYDROCHLORIDE",
    "company": "BAUSCH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/16/2025",
    "drugName": "CARDIZEM LANDA   #021392",
    "submission": "SUPPL-28",
    "activeIngredients": "DILTIAZEM HYDROCHLORIDE",
    "company": "BAUSCH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/16/2025",
    "drugName": "POSFREANDA   #203050",
    "submission": "SUPPL-3",
    "activeIngredients": "PALONOSETRON HYDROCHLORIDE",
    "company": "AVYXA HOLDINGS",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/16/2025",
    "drugName": "MONTELUKAST SODIUMANDA  #205107",
    "submission": "SUPPL-1",
    "activeIngredients": "MONTELUKAST SODIUM",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/16/2025",
    "drugName": "ABACAVIR SULFATE AND LAMIVUDINEANDA  #205412",
    "submission": "ORIG-1",
    "activeIngredients": "ABACAVIR SULFATE; LAMIVUDINE",
    "company": "HETERO LABS LTD V",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/16/2025",
    "drugName": "DEXMEDETOMIDINE HYDROCHLORIDEANDA  #206407",
    "submission": "SUPPL-6",
    "activeIngredients": "DEXMEDETOMIDINE HYDROCHLORIDE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/16/2025",
    "drugName": "DEXMEDETOMIDINE HYDROCHLORIDEANDA  #206407",
    "submission": "SUPPL-7",
    "activeIngredients": "DEXMEDETOMIDINE HYDROCHLORIDE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/16/2025",
    "drugName": "MESALAMINEANDA  #215269",
    "submission": "ORIG-1",
    "activeIngredients": "MESALAMINE",
    "company": "NOVITIUM PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/16/2025",
    "drugName": "CARBAMAZEPINEANDA  #216623",
    "submission": "ORIG-1",
    "activeIngredients": "CARBAMAZEPINE",
    "company": "ALEMBIC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/16/2025",
    "drugName": "FROVATRIPTAN SUCCINATEANDA  #216998",
    "submission": "ORIG-1",
    "activeIngredients": "FROVATRIPTAN SUCCINATE",
    "company": "LEADING",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/16/2025",
    "drugName": "GADOBUTROLANDA  #217480",
    "submission": "SUPPL-4",
    "activeIngredients": "GADOBUTROL",
    "company": "HAINAN POLY PHARM",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/16/2025",
    "drugName": "VALGANCICLOVIR HYDROCHLORIDEANDA  #218027",
    "submission": "ORIG-1",
    "activeIngredients": "VALGANCICLOVIR HYDROCHLORIDE",
    "company": "SPH ZHONGXI PHARM",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/16/2025",
    "drugName": "BISOPROLOL FUMARATEANDA  #219044",
    "submission": "ORIG-1",
    "activeIngredients": "BISOPROLOL FUMARATE",
    "company": "UNIQUE PHARM",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/16/2025",
    "drugName": "METHYLPREDNISOLONE ACETATEANDA  #219145",
    "submission": "ORIG-1",
    "activeIngredients": "METHYLPREDNISOLONE ACETATE",
    "company": "HIKMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/16/2025",
    "drugName": "DUPIXENTBLA   #761055",
    "submission": "SUPPL-72",
    "activeIngredients": "DUPILUMAB",
    "company": "REGENERON PHARMACEUTICALS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/17/2025",
    "drugName": "CLARITINNDA   #019658",
    "submission": "SUPPL-62",
    "activeIngredients": "LORATADINE",
    "company": "BAYER HEALTHCARE LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/17/2025",
    "drugName": "CLARITIN HIVES RELIEFNDA   #019658",
    "submission": "SUPPL-62",
    "activeIngredients": "LORATADINE",
    "company": "BAYER HEALTHCARE LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/17/2025",
    "drugName": "CHILDREN'S CLARITINNDA   #021891",
    "submission": "SUPPL-46",
    "activeIngredients": "LORATADINE",
    "company": "BAYER HEALTHCARE LLC",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/17/2025",
    "drugName": "CLARITINNDA   #021891",
    "submission": "SUPPL-46",
    "activeIngredients": "LORATADINE",
    "company": "BAYER HEALTHCARE LLC",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/17/2025",
    "drugName": "NICARDIPINE HYDROCHLORIDEANDA  #074928",
    "submission": "SUPPL-8",
    "activeIngredients": "NICARDIPINE HYDROCHLORIDE",
    "company": "EPIC PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/17/2025",
    "drugName": "PANTOPRAZOLE SODIUMANDA  #077674",
    "submission": "SUPPL-12",
    "activeIngredients": "PANTOPRAZOLE SODIUM",
    "company": "SUN PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/17/2025",
    "drugName": "PANTOPRAZOLE SODIUMANDA  #077674",
    "submission": "SUPPL-15",
    "activeIngredients": "PANTOPRAZOLE SODIUM",
    "company": "SUN PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/17/2025",
    "drugName": "ELIQUISNDA   #202155",
    "submission": "SUPPL-39",
    "activeIngredients": "APIXABAN",
    "company": "BRISTOL MYERS SQUIBB",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/17/2025",
    "drugName": "ELIQUISNDA   #202155",
    "submission": "SUPPL-40",
    "activeIngredients": "APIXABAN",
    "company": "BRISTOL MYERS SQUIBB",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/17/2025",
    "drugName": "PHENTERMINE HYDROCHLORIDE AND TOPIRAMATEANDA  #204982",
    "submission": "SUPPL-11",
    "activeIngredients": "PHENTERMINE HYDROCHLORIDE; TOPIRAMATE",
    "company": "ACTAVIS LABS FL INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/17/2025",
    "drugName": "CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDEANDA  #205128",
    "submission": "SUPPL-2",
    "activeIngredients": "BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE",
    "company": "ACTAVIS LABS UT INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/17/2025",
    "drugName": "ESOMEPRAZOLE SODIUMANDA  #205379",
    "submission": "SUPPL-10",
    "activeIngredients": "ESOMEPRAZOLE SODIUM",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/17/2025",
    "drugName": "OLMESARTAN MEDOXOMILANDA  #205482",
    "submission": "SUPPL-8",
    "activeIngredients": "OLMESARTAN MEDOXOMIL",
    "company": "JUBILANT GENERICS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/17/2025",
    "drugName": "LINEZOLIDANDA  #206454",
    "submission": "SUPPL-3",
    "activeIngredients": "LINEZOLID",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/17/2025",
    "drugName": "CAMZYOSNDA   #214998",
    "submission": "SUPPL-10",
    "activeIngredients": "MAVACAMTEN",
    "company": "BRISTOL",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/17/2025",
    "drugName": "FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDEANDA  #215232",
    "submission": "ORIG-1",
    "activeIngredients": "FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/17/2025",
    "drugName": "PHYTONADIONEANDA  #219212",
    "submission": "ORIG-1",
    "activeIngredients": "PHYTONADIONE",
    "company": "CAPLIN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/17/2025",
    "drugName": "ELIQUISNDA   #220073",
    "submission": "ORIG-1",
    "activeIngredients": "APIXABAN",
    "company": "BRISTOL",
    "submissionClassification": "Type 3 - New Dosage Form",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/17/2025",
    "drugName": "ELIQUIS SPRINKLENDA   #220073",
    "submission": "ORIG-1",
    "activeIngredients": "APIXABAN",
    "company": "BRISTOL",
    "submissionClassification": "Type 3 - New Dosage Form",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/17/2025",
    "drugName": "DUPIXENTBLA   #761055",
    "submission": "SUPPL-51",
    "activeIngredients": "DUPILUMAB",
    "company": "REGENERON PHARMACEUTICALS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/17/2025",
    "drugName": "AHZANTIVEBLA   #761378",
    "submission": "SUPPL-1",
    "activeIngredients": "AFLIBERCEPT-MRBB",
    "company": "FORMYCON AG",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/18/2025",
    "drugName": "PREDNISOLONE SODIUM PHOSPHATEANDA  #076913",
    "submission": "SUPPL-16",
    "activeIngredients": "PREDNISOLONE SODIUM PHOSPHATE",
    "company": "PHARM ASSOC",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/18/2025",
    "drugName": "NEUPOGENBLA   #103353",
    "submission": "SUPPL-5201",
    "activeIngredients": "FILGRASTIM",
    "company": "AMGEN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/18/2025",
    "drugName": "SIMPONIBLA   #125289",
    "submission": "SUPPL-155",
    "activeIngredients": "GOLIMUMAB",
    "company": "CENTOCOR ORTHO BIOTECH INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/18/2025",
    "drugName": "SIMPONI ARIABLA   #125433",
    "submission": "SUPPL-36",
    "activeIngredients": "GOLIMUMAB",
    "company": "JANSSEN BIOTECH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/18/2025",
    "drugName": "DANTROLENE SODIUMANDA  #204762",
    "submission": "SUPPL-5",
    "activeIngredients": "DANTROLENE SODIUM",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/18/2025",
    "drugName": "COLESEVELAM HYDROCHLORIDEANDA  #204893",
    "submission": "ORIG-1",
    "activeIngredients": "COLESEVELAM HYDROCHLORIDE",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/18/2025",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #205794",
    "submission": "SUPPL-37",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "SCIEGEN PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/18/2025",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #205794",
    "submission": "SUPPL-40",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "SCIEGEN PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/18/2025",
    "drugName": "MEMANTINE HYDROCHLORIDEANDA  #206032",
    "submission": "SUPPL-6",
    "activeIngredients": "MEMANTINE HYDROCHLORIDE",
    "company": "RISING",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/18/2025",
    "drugName": "VORICONAZOLENDA   #208562",
    "submission": "SUPPL-11",
    "activeIngredients": "VORICONAZOLE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/18/2025",
    "drugName": "OJJAARANDA   #216873",
    "submission": "SUPPL-2",
    "activeIngredients": "MOMELOTINIB DIHYDROCHLORIDE",
    "company": "GLAXOSMITHKLINE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/18/2025",
    "drugName": "WAINUA (AUTOINJECTOR)NDA   #217388",
    "submission": "SUPPL-4",
    "activeIngredients": "EPLONTERSEN SODIUM",
    "company": "ASTRAZENECA AB",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/18/2025",
    "drugName": "BKEMVBLA   #761333",
    "submission": "SUPPL-4",
    "activeIngredients": "ECULIZUMAB-AEEB",
    "company": "AMGEN INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/21/2025",
    "drugName": "DOSTINEXNDA   #020664",
    "submission": "SUPPL-16",
    "activeIngredients": "CABERGOLINE",
    "company": "PFIZER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/21/2025",
    "drugName": "ZIDOVUDINEANDA  #078128",
    "submission": "SUPPL-18",
    "activeIngredients": "ZIDOVUDINE",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/21/2025",
    "drugName": "ZIDOVUDINEANDA  #078128",
    "submission": "SUPPL-22",
    "activeIngredients": "ZIDOVUDINE",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/21/2025",
    "drugName": "HYDRALAZINE HYDROCHLORIDEANDA  #086242",
    "submission": "SUPPL-44",
    "activeIngredients": "HYDRALAZINE HYDROCHLORIDE",
    "company": "HERITAGE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/21/2025",
    "drugName": "HYDRALAZINE HYDROCHLORIDEANDA  #086242",
    "submission": "SUPPL-51",
    "activeIngredients": "HYDRALAZINE HYDROCHLORIDE",
    "company": "HERITAGE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/21/2025",
    "drugName": "KEYTRUDABLA   #125514",
    "submission": "SUPPL-174",
    "activeIngredients": "PEMBROLIZUMAB",
    "company": "MERCK SHARP DOHME",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/21/2025",
    "drugName": "MEKINISTNDA   #204114",
    "submission": "SUPPL-39",
    "activeIngredients": "TRAMETINIB DIMETHYL SULFOXIDE",
    "company": "NOVARTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/21/2025",
    "drugName": "LITHIUM CARBONATEANDA  #205532",
    "submission": "SUPPL-9",
    "activeIngredients": "LITHIUM CARBONATE",
    "company": "HERITAGE PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/21/2025",
    "drugName": "LITHIUM CARBONATEANDA  #205532",
    "submission": "SUPPL-14",
    "activeIngredients": "LITHIUM CARBONATE",
    "company": "HERITAGE PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/21/2025",
    "drugName": "POTASSIUM CHLORIDEANDA  #205549",
    "submission": "SUPPL-1",
    "activeIngredients": "POTASSIUM CHLORIDE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/21/2025",
    "drugName": "PHEXXINDA   #208352",
    "submission": "SUPPL-5",
    "activeIngredients": "CITRIC ACID; LACTIC ACID; POTASSIUM BITARTRATE",
    "company": "EVOFEM INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/21/2025",
    "drugName": "IMATINIB MESYLATEANDA  #212193",
    "submission": "ORIG-1",
    "activeIngredients": "IMATINIB MESYLATE",
    "company": "CSPC OUYI",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/21/2025",
    "drugName": "TAFAMIDISANDA  #218905",
    "submission": "ORIG-1",
    "activeIngredients": "TAFAMIDIS",
    "company": "APOTEX INC",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "04/21/2025",
    "drugName": "CARBON DIOXIDE, USPNDA   #220461",
    "submission": "ORIG-1",
    "activeIngredients": "CARBON DIOXIDE",
    "company": "MITCHELL WEDLING SUPPLY",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/21/2025",
    "drugName": "NEMLUVIOBLA   #761390",
    "submission": "SUPPL-1",
    "activeIngredients": "NEMOLIZUMAB-ILTO",
    "company": "GALDERMA LABS LP",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/22/2025",
    "drugName": "PREMARINNDA   #004782",
    "submission": "SUPPL-179",
    "activeIngredients": "ESTROGENS, CONJUGATED",
    "company": "WYETH PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/22/2025",
    "drugName": "PREMARINNDA   #020216",
    "submission": "SUPPL-84",
    "activeIngredients": "ESTROGENS, CONJUGATED",
    "company": "WYETH PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/22/2025",
    "drugName": "PREMPHASE 14/14NDA   #020527",
    "submission": "SUPPL-67",
    "activeIngredients": "ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE",
    "company": "WYETH PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/22/2025",
    "drugName": "PREMPRONDA   #020527",
    "submission": "SUPPL-67",
    "activeIngredients": "ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE",
    "company": "WYETH PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/22/2025",
    "drugName": "LETROZOLEANDA  #090289",
    "submission": "SUPPL-11",
    "activeIngredients": "LETROZOLE",
    "company": "TEVA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/22/2025",
    "drugName": "LETROZOLEANDA  #090789",
    "submission": "SUPPL-4",
    "activeIngredients": "LETROZOLE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/22/2025",
    "drugName": "LETROZOLEANDA  #090789",
    "submission": "SUPPL-5",
    "activeIngredients": "LETROZOLE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/22/2025",
    "drugName": "FOSAMPRENAVIR CALCIUMANDA  #204024",
    "submission": "SUPPL-9",
    "activeIngredients": "FOSAMPRENAVIR CALCIUM",
    "company": "SUN PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/22/2025",
    "drugName": "VARDENAFIL HYDROCHLORIDEANDA  #204632",
    "submission": "SUPPL-6",
    "activeIngredients": "VARDENAFIL HYDROCHLORIDE",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/22/2025",
    "drugName": "COLESEVELAM HYDROCHLORIDEANDA  #208670",
    "submission": "SUPPL-1",
    "activeIngredients": "COLESEVELAM HYDROCHLORIDE",
    "company": "BIONPHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/22/2025",
    "drugName": "COLESEVELAM HYDROCHLORIDEANDA  #208670",
    "submission": "SUPPL-2",
    "activeIngredients": "COLESEVELAM HYDROCHLORIDE",
    "company": "BIONPHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/22/2025",
    "drugName": "DASATINIBANDA  #216547",
    "submission": "ORIG-1",
    "activeIngredients": "DASATINIB",
    "company": "EUGIA PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/22/2025",
    "drugName": "QAMZOVANDA   #217593",
    "submission": "ORIG-1",
    "activeIngredients": "MELOXICAM",
    "company": "NANJING DELOVA",
    "submissionClassification": "Type 5 - New Formulation or New Manufacturer",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/22/2025",
    "drugName": "HYDROXYZINE HYDROCHLORIDEANDA  #217652",
    "submission": "SUPPL-3",
    "activeIngredients": "HYDROXYZINE HYDROCHLORIDE",
    "company": "GRAVITI PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/22/2025",
    "drugName": "SIPONIMODANDA  #218444",
    "submission": "ORIG-1",
    "activeIngredients": "SIPONIMOD",
    "company": "RICONPHARMA LLC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/22/2025",
    "drugName": "BEIZRAYNDA   #218711",
    "submission": "SUPPL-1",
    "activeIngredients": "DOCETAXEL",
    "company": "ZHUHAI",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/22/2025",
    "drugName": "TEVIMBRABLA   #761232",
    "submission": "SUPPL-2",
    "activeIngredients": "TISLELIZUMAB-JSGR",
    "company": "BEIGENE",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/22/2025",
    "drugName": "TEVIMBRABLA   #761232",
    "submission": "SUPPL-3",
    "activeIngredients": "TISLELIZUMAB-JSGR",
    "company": "BEIGENE",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/22/2025",
    "drugName": "TEVIMBRABLA   #761232",
    "submission": "SUPPL-5",
    "activeIngredients": "TISLELIZUMAB-JSGR",
    "company": "BEIGENE",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/22/2025",
    "drugName": "TEVIMBRABLA   #761232",
    "submission": "SUPPL-6",
    "activeIngredients": "TISLELIZUMAB-JSGR",
    "company": "BEIGENE",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/22/2025",
    "drugName": "TEVIMBRABLA   #761232",
    "submission": "SUPPL-11",
    "activeIngredients": "TISLELIZUMAB-JSGR",
    "company": "BEIGENE",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/22/2025",
    "drugName": "TEVIMBRABLA   #761232",
    "submission": "SUPPL-12",
    "activeIngredients": "TISLELIZUMAB-JSGR",
    "company": "BEIGENE",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/23/2025",
    "drugName": "DAPSONEANDA  #086841",
    "submission": "SUPPL-22",
    "activeIngredients": "DAPSONE",
    "company": "EVEREST LIFE SCI",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/23/2025",
    "drugName": "DAPSONEANDA  #086842",
    "submission": "SUPPL-21",
    "activeIngredients": "DAPSONE",
    "company": "EVEREST LIFE SCI",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/23/2025",
    "drugName": "DAPSONEANDA  #203887",
    "submission": "SUPPL-3",
    "activeIngredients": "DAPSONE",
    "company": "SOLIS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/23/2025",
    "drugName": "DAPSONEANDA  #204074",
    "submission": "SUPPL-1",
    "activeIngredients": "DAPSONE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/23/2025",
    "drugName": "DAPSONEANDA  #204380",
    "submission": "SUPPL-2",
    "activeIngredients": "DAPSONE",
    "company": "ACTAVIS LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/23/2025",
    "drugName": "JYNARQUENDA   #204441",
    "submission": "SUPPL-14",
    "activeIngredients": "TOLVAPTAN",
    "company": "OTSUKA",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/23/2025",
    "drugName": "DICLOFENAC POTASSIUMANDA  #204648",
    "submission": "SUPPL-5",
    "activeIngredients": "DICLOFENAC POTASSIUM",
    "company": "BIONPHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/23/2025",
    "drugName": "DICLOFENAC POTASSIUMANDA  #204648",
    "submission": "SUPPL-10",
    "activeIngredients": "DICLOFENAC POTASSIUM",
    "company": "BIONPHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/23/2025",
    "drugName": "NAPROXEN SODIUMANDA  #204872",
    "submission": "SUPPL-10",
    "activeIngredients": "NAPROXEN SODIUM",
    "company": "LNK INTL INC",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/23/2025",
    "drugName": "VENLAFAXINE HYDROCHLORIDEANDA  #204889",
    "submission": "SUPPL-16",
    "activeIngredients": "VENLAFAXINE HYDROCHLORIDE",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/23/2025",
    "drugName": "VENLAFAXINE HYDROCHLORIDEANDA  #204889",
    "submission": "SUPPL-17",
    "activeIngredients": "VENLAFAXINE HYDROCHLORIDE",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/23/2025",
    "drugName": "VENLAFAXINE HYDROCHLORIDEANDA  #204889",
    "submission": "SUPPL-20",
    "activeIngredients": "VENLAFAXINE HYDROCHLORIDE",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/23/2025",
    "drugName": "VENLAFAXINE HYDROCHLORIDEANDA  #204889",
    "submission": "SUPPL-28",
    "activeIngredients": "VENLAFAXINE HYDROCHLORIDE",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/23/2025",
    "drugName": "DAPSONEANDA  #205429",
    "submission": "SUPPL-2",
    "activeIngredients": "DAPSONE",
    "company": "ALVOGEN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/23/2025",
    "drugName": "PALIPERIDONEANDA  #205618",
    "submission": "SUPPL-13",
    "activeIngredients": "PALIPERIDONE",
    "company": "SUN PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/23/2025",
    "drugName": "DAPSONEANDA  #206505",
    "submission": "SUPPL-24",
    "activeIngredients": "DAPSONE",
    "company": "NOVITIUM PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/23/2025",
    "drugName": "IBRANCENDA   #207103",
    "submission": "SUPPL-20",
    "activeIngredients": "PALBOCICLIB",
    "company": "PFIZER",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/23/2025",
    "drugName": "DAPSONEANDA  #207165",
    "submission": "SUPPL-5",
    "activeIngredients": "DAPSONE",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/23/2025",
    "drugName": "DAPSONEANDA  #209430",
    "submission": "SUPPL-1",
    "activeIngredients": "DAPSONE",
    "company": "TARO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/23/2025",
    "drugName": "IBRANCENDA   #212436",
    "submission": "SUPPL-8",
    "activeIngredients": "PALBOCICLIB",
    "company": "PFIZER",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/23/2025",
    "drugName": "TOLVAPTANANDA  #216063",
    "submission": "ORIG-1",
    "activeIngredients": "TOLVAPTAN",
    "company": "LUPIN LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/23/2025",
    "drugName": "POSACONAZOLEANDA  #217720",
    "submission": "ORIG-1",
    "activeIngredients": "POSACONAZOLE",
    "company": "QILU PHARM HAINAN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/23/2025",
    "drugName": "GANIRELIX ACETATEANDA  #218855",
    "submission": "ORIG-1",
    "activeIngredients": "GANIRELIX ACETATE",
    "company": "QILU",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/23/2025",
    "drugName": "FYLNETRABLA   #761084",
    "submission": "SUPPL-7",
    "activeIngredients": "PEGFILGRASTIM-PBBK",
    "company": "KASHIV BIOSCIENCES LLC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/23/2025",
    "drugName": "PENPULIMAB-KCQXBLA   #761258",
    "submission": "ORIG-1",
    "activeIngredients": "PENPULIMAB-KCQX",
    "company": "AKESO BIOPHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/24/2025",
    "drugName": "ZYRTEC ALLERGYNDA   #019835",
    "submission": "SUPPL-53",
    "activeIngredients": "CETIRIZINE HYDROCHLORIDE",
    "company": "KENVUE BRANDS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/24/2025",
    "drugName": "ZYRTEC HIVESNDA   #019835",
    "submission": "SUPPL-53",
    "activeIngredients": "CETIRIZINE HYDROCHLORIDE",
    "company": "KENVUE BRANDS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/24/2025",
    "drugName": "ALEVENDA   #020204",
    "submission": "SUPPL-89",
    "activeIngredients": "NAPROXEN SODIUM",
    "company": "BAYER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/24/2025",
    "drugName": "HYDROMORPHONE HYDROCHLORIDEANDA  #078228",
    "submission": "SUPPL-10",
    "activeIngredients": "HYDROMORPHONE HYDROCHLORIDE",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/24/2025",
    "drugName": "HYDROMORPHONE HYDROCHLORIDEANDA  #078261",
    "submission": "SUPPL-12",
    "activeIngredients": "HYDROMORPHONE HYDROCHLORIDE",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/24/2025",
    "drugName": "SEVELAMER CARBONATEANDA  #204451",
    "submission": "SUPPL-2",
    "activeIngredients": "SEVELAMER CARBONATE",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/24/2025",
    "drugName": "DESMOPRESSIN ACETATEANDA  #204695",
    "submission": "SUPPL-8",
    "activeIngredients": "DESMOPRESSIN ACETATE",
    "company": "SAGENT PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/24/2025",
    "drugName": "CAFFEINE CITRATEANDA  #205013",
    "submission": "SUPPL-3",
    "activeIngredients": "CAFFEINE CITRATE",
    "company": "EUGIA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/24/2025",
    "drugName": "HALOPERIDOL DECANOATEANDA  #205241",
    "submission": "SUPPL-7",
    "activeIngredients": "HALOPERIDOL DECANOATE",
    "company": "GLAND",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/24/2025",
    "drugName": "FENTANYL CITRATE PRESERVATIVE FREEANDA  #210762",
    "submission": "SUPPL-6",
    "activeIngredients": "FENTANYL CITRATE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/24/2025",
    "drugName": "FENTANYL CITRATE PRESERVATIVE FREEANDA  #210762",
    "submission": "SUPPL-7",
    "activeIngredients": "FENTANYL CITRATE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/24/2025",
    "drugName": "FENTANYL CITRATE PRESERVATIVE FREEANDA  #210762",
    "submission": "SUPPL-8",
    "activeIngredients": "FENTANYL CITRATE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/24/2025",
    "drugName": "KIMYRSANDA   #214155",
    "submission": "SUPPL-5",
    "activeIngredients": "ORITAVANCIN DIPHOSPHATE",
    "company": "MELINTA THERAP",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/24/2025",
    "drugName": "NALOXONE HYDROCHLORIDEANDA  #216719",
    "submission": "ORIG-1",
    "activeIngredients": "NALOXONE HYDROCHLORIDE",
    "company": "PADAGIS ISRAEL",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/24/2025",
    "drugName": "TAPENTADOL HYDROCHLORIDEANDA  #219119",
    "submission": "ORIG-1",
    "activeIngredients": "TAPENTADOL HYDROCHLORIDE",
    "company": "NOVITIUM PHARMA LLC",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "04/25/2025",
    "drugName": "TRANSDERM SCOPNDA   #017874",
    "submission": "SUPPL-53",
    "activeIngredients": "SCOPOLAMINE",
    "company": "BAXTER HLTHCARE CORP",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2025",
    "drugName": "NEURONTINNDA   #020235",
    "submission": "SUPPL-79",
    "activeIngredients": "GABAPENTIN",
    "company": "VIATRIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2025",
    "drugName": "LAMICTALNDA   #020241",
    "submission": "SUPPL-66",
    "activeIngredients": "LAMOTRIGINE",
    "company": "GLAXOSMITHKLINE LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2025",
    "drugName": "LAMICTALNDA   #020241",
    "submission": "SUPPL-67",
    "activeIngredients": "LAMOTRIGINE",
    "company": "GLAXOSMITHKLINE LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2025",
    "drugName": "LAMICTAL CDNDA   #020764",
    "submission": "SUPPL-59",
    "activeIngredients": "LAMOTRIGINE",
    "company": "GLAXOSMITHKLINE LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2025",
    "drugName": "LAMICTAL CDNDA   #020764",
    "submission": "SUPPL-60",
    "activeIngredients": "LAMOTRIGINE",
    "company": "GLAXOSMITHKLINE LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2025",
    "drugName": "NEURONTINNDA   #020882",
    "submission": "SUPPL-60",
    "activeIngredients": "GABAPENTIN",
    "company": "VIATRIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2025",
    "drugName": "NEURONTINNDA   #021129",
    "submission": "SUPPL-59",
    "activeIngredients": "GABAPENTIN",
    "company": "VIATRIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2025",
    "drugName": "LYRICANDA   #021446",
    "submission": "SUPPL-46",
    "activeIngredients": "PREGABALIN",
    "company": "UPJOHN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2025",
    "drugName": "LAMICTAL XRNDA   #022115",
    "submission": "SUPPL-31",
    "activeIngredients": "LAMOTRIGINE",
    "company": "GLAXOSMITHKLINE LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2025",
    "drugName": "LAMICTAL XRNDA   #022115",
    "submission": "SUPPL-32",
    "activeIngredients": "LAMOTRIGINE",
    "company": "GLAXOSMITHKLINE LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2025",
    "drugName": "LAMICTAL ODTNDA   #022251",
    "submission": "SUPPL-30",
    "activeIngredients": "LAMOTRIGINE",
    "company": "GLAXOSMITHKLINE LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2025",
    "drugName": "LAMICTAL ODTNDA   #022251",
    "submission": "SUPPL-31",
    "activeIngredients": "LAMOTRIGINE",
    "company": "GLAXOSMITHKLINE LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2025",
    "drugName": "HORIZANTNDA   #022399",
    "submission": "SUPPL-14",
    "activeIngredients": "GABAPENTIN ENACARBIL",
    "company": "AZURITY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2025",
    "drugName": "LYRICANDA   #022488",
    "submission": "SUPPL-22",
    "activeIngredients": "PREGABALIN",
    "company": "UPJOHN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2025",
    "drugName": "GRALISENDA   #022544",
    "submission": "SUPPL-31",
    "activeIngredients": "GABAPENTIN",
    "company": "ALMATICA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2025",
    "drugName": "FLUCONAZOLE IN SODIUM CHLORIDE 0.9%ANDA  #076736",
    "submission": "SUPPL-15",
    "activeIngredients": "FLUCONAZOLE",
    "company": "HIKMA FARMACEUTICA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2025",
    "drugName": "FLUCONAZOLE IN SODIUM CHLORIDE 0.9%ANDA  #076736",
    "submission": "SUPPL-16",
    "activeIngredients": "FLUCONAZOLE",
    "company": "HIKMA FARMACEUTICA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2025",
    "drugName": "FLUCONAZOLE IN SODIUM CHLORIDE 0.9%ANDA  #076736",
    "submission": "SUPPL-18",
    "activeIngredients": "FLUCONAZOLE",
    "company": "HIKMA FARMACEUTICA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2025",
    "drugName": "ZIDOVUDINEANDA  #078349",
    "submission": "SUPPL-24",
    "activeIngredients": "ZIDOVUDINE",
    "company": "CIPLA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2025",
    "drugName": "FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERANDA  #078698",
    "submission": "SUPPL-5",
    "activeIngredients": "FLUCONAZOLE",
    "company": "HIKMA FARMACEUTICA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2025",
    "drugName": "FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERANDA  #078698",
    "submission": "SUPPL-7",
    "activeIngredients": "FLUCONAZOLE",
    "company": "HIKMA FARMACEUTICA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2025",
    "drugName": "FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERANDA  #078698",
    "submission": "SUPPL-9",
    "activeIngredients": "FLUCONAZOLE",
    "company": "HIKMA FARMACEUTICA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2025",
    "drugName": "FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERANDA  #078698",
    "submission": "SUPPL-10",
    "activeIngredients": "FLUCONAZOLE",
    "company": "HIKMA FARMACEUTICA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2025",
    "drugName": "FLUCONAZOLE IN DEXTROSE 5% IN PLASTIC CONTAINERANDA  #078764",
    "submission": "SUPPL-6",
    "activeIngredients": "FLUCONAZOLE",
    "company": "HIKMA FARMACEUTICA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2025",
    "drugName": "FLUCONAZOLE IN DEXTROSE 5% IN PLASTIC CONTAINERANDA  #078764",
    "submission": "SUPPL-8",
    "activeIngredients": "FLUCONAZOLE",
    "company": "HIKMA FARMACEUTICA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2025",
    "drugName": "FLUCONAZOLE IN DEXTROSE 5% IN PLASTIC CONTAINERANDA  #078764",
    "submission": "SUPPL-10",
    "activeIngredients": "FLUCONAZOLE",
    "company": "HIKMA FARMACEUTICA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2025",
    "drugName": "FLUCONAZOLE IN DEXTROSE 5% IN PLASTIC CONTAINERANDA  #078764",
    "submission": "SUPPL-11",
    "activeIngredients": "FLUCONAZOLE",
    "company": "HIKMA FARMACEUTICA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2025",
    "drugName": "IMIQUIMODANDA  #078837",
    "submission": "SUPPL-14",
    "activeIngredients": "IMIQUIMOD",
    "company": "PADAGIS ISRAEL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2025",
    "drugName": "DOXYCYCLINEANDA  #204234",
    "submission": "SUPPL-6",
    "activeIngredients": "DOXYCYCLINE",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2025",
    "drugName": "DOXYCYCLINEANDA  #204234",
    "submission": "SUPPL-10",
    "activeIngredients": "DOXYCYCLINE",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2025",
    "drugName": "PANTOPRAZOLE SODIUMANDA  #205675",
    "submission": "SUPPL-25",
    "activeIngredients": "PANTOPRAZOLE SODIUM",
    "company": "EUGIA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2025",
    "drugName": "PANTOPRAZOLE SODIUMANDA  #205675",
    "submission": "SUPPL-26",
    "activeIngredients": "PANTOPRAZOLE SODIUM",
    "company": "EUGIA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2025",
    "drugName": "MEMANTINE HYDROCHLORIDEANDA  #205825",
    "submission": "SUPPL-21",
    "activeIngredients": "MEMANTINE HYDROCHLORIDE",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2025",
    "drugName": "CISATRACURIUM BESYLATE PRESERVATIVE FREEANDA  #205872",
    "submission": "SUPPL-5",
    "activeIngredients": "CISATRACURIUM BESYLATE",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2025",
    "drugName": "PRASUGRELANDA  #205897",
    "submission": "SUPPL-8",
    "activeIngredients": "PRASUGREL HYDROCHLORIDE",
    "company": "PANACEA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2025",
    "drugName": "AVYCAZNDA   #206494",
    "submission": "SUPPL-14",
    "activeIngredients": "AVIBACTAM SODIUM; CEFTAZIDIME",
    "company": "ABBVIE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2025",
    "drugName": "LYRICA CRNDA   #209501",
    "submission": "SUPPL-10",
    "activeIngredients": "PREGABALIN",
    "company": "UPJOHN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2025",
    "drugName": "LORATADINEANDA  #210088",
    "submission": "SUPPL-15",
    "activeIngredients": "LORATADINE",
    "company": "SUN PHARM",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2025",
    "drugName": "DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATEANDA  #215520",
    "submission": "SUPPL-2",
    "activeIngredients": "DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE",
    "company": "GLAND",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2025",
    "drugName": "CHLORPROMAZINE HYDROCHLORIDEANDA  #216788",
    "submission": "ORIG-1",
    "activeIngredients": "CHLORPROMAZINE HYDROCHLORIDE",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/25/2025",
    "drugName": "ARFORMOTEROL TARTRATEANDA  #218429",
    "submission": "ORIG-1",
    "activeIngredients": "ARFORMOTEROL TARTRATE",
    "company": "SABA ILAC SANAYI",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/28/2025",
    "drugName": "PROLIABLA   #125320",
    "submission": "SUPPL-221",
    "activeIngredients": "DENOSUMAB",
    "company": "AMGEN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/28/2025",
    "drugName": "XGEVABLA   #125320",
    "submission": "SUPPL-221",
    "activeIngredients": "DENOSUMAB",
    "company": "AMGEN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/28/2025",
    "drugName": "NIACINANDA  #203285",
    "submission": "ORIG-1",
    "activeIngredients": "NIACIN",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/28/2025",
    "drugName": "FINGOLIMOD HYDROCHLORIDEANDA  #207994",
    "submission": "SUPPL-3",
    "activeIngredients": "FINGOLIMOD HYDROCHLORIDE",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/28/2025",
    "drugName": "FINGOLIMOD HYDROCHLORIDEANDA  #207994",
    "submission": "SUPPL-4",
    "activeIngredients": "FINGOLIMOD HYDROCHLORIDE",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/28/2025",
    "drugName": "SPRAVATONDA   #211243",
    "submission": "SUPPL-19",
    "activeIngredients": "ESKETAMINE HYDROCHLORIDE",
    "company": "JANSSEN PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/28/2025",
    "drugName": "RINVOQNDA   #211675",
    "submission": "SUPPL-25",
    "activeIngredients": "UPADACITINIB",
    "company": "ABBVIE",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/28/2025",
    "drugName": "IVABRADINE HYDROCHLORIDEANDA  #213483",
    "submission": "ORIG-1",
    "activeIngredients": "IVABRADINE HYDROCHLORIDE",
    "company": "MSN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/28/2025",
    "drugName": "SUGAMMADEXANDA  #214230",
    "submission": "ORIG-1",
    "activeIngredients": "SUGAMMADEX",
    "company": "MANKIND PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "04/28/2025",
    "drugName": "DOLUTEGRAVIRANDA  #216731",
    "submission": "ORIG-1",
    "activeIngredients": "DOLUTEGRAVIR",
    "company": "STRIDES PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "04/28/2025",
    "drugName": "PILOCARPINE HYDROCHLORIDEANDA  #217733",
    "submission": "ORIG-1",
    "activeIngredients": "PILOCARPINE HYDROCHLORIDE",
    "company": "AMNEAL",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/28/2025",
    "drugName": "HYDROXYZINE HYDROCHLORIDEANDA  #219289",
    "submission": "ORIG-1",
    "activeIngredients": "HYDROXYZINE HYDROCHLORIDE",
    "company": "BIONPHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/28/2025",
    "drugName": "SELENIOUS ACIDANDA  #219492",
    "submission": "ORIG-1",
    "activeIngredients": "SELENIOUS ACID",
    "company": "STERISCIENCE PTE. LIMITED",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "04/28/2025",
    "drugName": "STEQEYMABLA   #761338",
    "submission": "SUPPL-1",
    "activeIngredients": "USTEKINUMAB-STBA",
    "company": "CELLTRION, INC.",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/29/2025",
    "drugName": "DIVIGELNDA   #022038",
    "submission": "SUPPL-14",
    "activeIngredients": "ESTRADIOL",
    "company": "VERTICAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/29/2025",
    "drugName": "TACROLIMUSANDA  #090687",
    "submission": "SUPPL-23",
    "activeIngredients": "TACROLIMUS",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/29/2025",
    "drugName": "BLINCYTOBLA   #125557",
    "submission": "SUPPL-31",
    "activeIngredients": "BLINATUMOMAB",
    "company": "AMGEN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/29/2025",
    "drugName": "IBUPROFENANDA  #210149",
    "submission": "SUPPL-7",
    "activeIngredients": "IBUPROFEN",
    "company": "GUARDIAN DRUG",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/29/2025",
    "drugName": "AZACITIDINEANDA  #212128",
    "submission": "SUPPL-6",
    "activeIngredients": "AZACITIDINE",
    "company": "MEITHEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/29/2025",
    "drugName": "AZACITIDINEANDA  #212128",
    "submission": "SUPPL-8",
    "activeIngredients": "AZACITIDINE",
    "company": "MEITHEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/29/2025",
    "drugName": "EFINACONAZOLEANDA  #212147",
    "submission": "ORIG-1",
    "activeIngredients": "EFINACONAZOLE",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "04/29/2025",
    "drugName": "CELECOXIBANDA  #213127",
    "submission": "ORIG-1",
    "activeIngredients": "CELECOXIB",
    "company": "STRIDES PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/29/2025",
    "drugName": "LATANOPROSTENE BUNODANDA  #217387",
    "submission": "ORIG-1",
    "activeIngredients": "LATANOPROSTENE BUNOD",
    "company": "GLAND",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/29/2025",
    "drugName": "ZELVYSIAANDA  #218645",
    "submission": "ORIG-1",
    "activeIngredients": "SAPROPTERIN DIHYDROCHLORIDE",
    "company": "AUCTA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/29/2025",
    "drugName": "RELEUKOBLA   #761082",
    "submission": "SUPPL-14",
    "activeIngredients": "FILGRASTIM-AYOW",
    "company": "KASHIV BIOSCIENCES LLC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/29/2025",
    "drugName": "IMAAVYBLA   #761430",
    "submission": "ORIG-1",
    "activeIngredients": "NIPOCALIMAB-AAHU",
    "company": "JANSSEN BIOTECH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2025",
    "drugName": "BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATEANDA  #075351",
    "submission": "SUPPL-9",
    "activeIngredients": "ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE",
    "company": "NOVITIUM PHARMA",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2025",
    "drugName": "AUVI-QNDA   #201739",
    "submission": "SUPPL-30",
    "activeIngredients": "EPINEPHRINE",
    "company": "KALEO INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2025",
    "drugName": "PREGABALINANDA  #206452",
    "submission": "SUPPL-1",
    "activeIngredients": "PREGABALIN",
    "company": "CADILA PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2025",
    "drugName": "DAPTOMYCINNDA   #208385",
    "submission": "SUPPL-11",
    "activeIngredients": "DAPTOMYCIN",
    "company": "SAGENT PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2025",
    "drugName": "DAPTOMYCINNDA   #209949",
    "submission": "SUPPL-14",
    "activeIngredients": "DAPTOMYCIN",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2025",
    "drugName": "DAPTOMYCINNDA   #210282",
    "submission": "SUPPL-4",
    "activeIngredients": "DAPTOMYCIN",
    "company": "HOSPIRA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2025",
    "drugName": "PREGABALINANDA  #211384",
    "submission": "SUPPL-15",
    "activeIngredients": "PREGABALIN",
    "company": "INVAGEN PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2025",
    "drugName": "MORPHINE SULFATEANDA  #211454",
    "submission": "SUPPL-3",
    "activeIngredients": "MORPHINE SULFATE",
    "company": "WINDER LABS LLC",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2025",
    "drugName": "DAPTOMYCIN IN 0.9% SODIUM CHLORIDENDA   #213645",
    "submission": "SUPPL-6",
    "activeIngredients": "DAPTOMYCIN",
    "company": "BAXTER HLTHCARE CORP",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2025",
    "drugName": "DAPZURA RTNDA   #213645",
    "submission": "SUPPL-6",
    "activeIngredients": "DAPTOMYCIN",
    "company": "BAXTER HLTHCARE CORP",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2025",
    "drugName": "ZEPZELCANDA   #213702",
    "submission": "SUPPL-10",
    "activeIngredients": "LURBINECTEDIN",
    "company": "JAZZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2025",
    "drugName": "DAPTOMYCINNDA   #217415",
    "submission": "SUPPL-4",
    "activeIngredients": "DAPTOMYCIN",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2025",
    "drugName": "ATZUMINDA   #217901",
    "submission": "ORIG-1",
    "activeIngredients": "DIHYDROERGOTAMINE MESYLATE",
    "company": "SATSUMA PHARMS",
    "submissionClassification": "Type 3 - New Dosage Form",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2025",
    "drugName": "OXCARBAZEPINEANDA  #219241",
    "submission": "ORIG-1",
    "activeIngredients": "OXCARBAZEPINE",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2025",
    "drugName": "STEQEYMABLA   #761338",
    "submission": "ORIG-2",
    "activeIngredients": "USTEKINUMAB-STBA",
    "company": "CELLTRION, INC.",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2025",
    "drugName": "EPYSQLIBLA   #761340",
    "submission": "SUPPL-5",
    "activeIngredients": "ECULIZUMAB-AAGH",
    "company": "SAMSUNG BIOEPIS CO LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2025",
    "drugName": "SELARSDIBLA   #761343",
    "submission": "SUPPL-4",
    "activeIngredients": "USTEKINUMAB-AEKN",
    "company": "ALVOTECH USA INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2025",
    "drugName": "PYZCHIVABLA   #761373",
    "submission": "ORIG-2",
    "activeIngredients": "USTEKINUMAB-TTWE",
    "company": "SAMSUNG BIOEPIS CO LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2025",
    "drugName": "PYZCHIVABLA   #761373",
    "submission": "SUPPL-4",
    "activeIngredients": "USTEKINUMAB-TTWE",
    "company": "SAMSUNG BIOEPIS CO LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2025",
    "drugName": "OTULFIBLA   #761379",
    "submission": "ORIG-2",
    "activeIngredients": "USTEKINUMAB-AAUZ",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2025",
    "drugName": "OTULFIBLA   #761379",
    "submission": "SUPPL-4",
    "activeIngredients": "USTEKINUMAB-AAUZ",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2025",
    "drugName": "YESINTEKBLA   #761406",
    "submission": "ORIG-2",
    "activeIngredients": "USTEKINUMAB-KFCE",
    "company": "BIOCON BIOLOGICS INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "04/30/2025",
    "drugName": "PYZCHIVABLA   #761425",
    "submission": "ORIG-2",
    "activeIngredients": "USTEKINUMAB-TTWE",
    "company": "SAMSUNG BIOEPIS CO LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  }
,
  {
    "approvalDate": "05/01/2025",
    "drugName": "DEPAKOTENDA   #018723",
    "submission": "SUPPL-70",
    "activeIngredients": "DIVALPROEX SODIUM",
    "company": "ABBVIE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2025",
    "drugName": "DEPAKOTENDA   #019680",
    "submission": "SUPPL-57",
    "activeIngredients": "DIVALPROEX SODIUM",
    "company": "ABBVIE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2025",
    "drugName": "DEPAKOTE ERNDA   #021168",
    "submission": "SUPPL-49",
    "activeIngredients": "DIVALPROEX SODIUM",
    "company": "ABBVIE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2025",
    "drugName": "LEVOTHYROXINE SODIUMANDA  #076187",
    "submission": "SUPPL-53",
    "activeIngredients": "LEVOTHYROXINE SODIUM",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2025",
    "drugName": "TICAGRELORANDA  #208584",
    "submission": "ORIG-1",
    "activeIngredients": "TICAGRELOR",
    "company": "APOTEX",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2025",
    "drugName": "MIDAZOLAM IN 0.8% SODIUM CHLORIDEANDA  #218454",
    "submission": "ORIG-1",
    "activeIngredients": "MIDAZOLAM",
    "company": "B BRAUN MEDICAL",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2025",
    "drugName": "LUMATEPERONE TOSYLATEANDA  #219248",
    "submission": "ORIG-1",
    "activeIngredients": "LUMATEPERONE TOSYLATE",
    "company": "MSN LABORATORIES PRIVATE LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "05/01/2025",
    "drugName": "ZINC SULFATEANDA  #219585",
    "submission": "ORIG-1",
    "activeIngredients": "ZINC SULFATE",
    "company": "ASPIRO",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2025",
    "drugName": "TAMSULOSIN HYDROCHLORIDEANDA  #219767",
    "submission": "ORIG-1",
    "activeIngredients": "TAMSULOSIN HYDROCHLORIDE",
    "company": "RISING",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/01/2025",
    "drugName": "TEVIMBRABLA   #761232",
    "submission": "SUPPL-4",
    "activeIngredients": "TISLELIZUMAB-JSGR",
    "company": "BEIGENE",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/02/2025",
    "drugName": "MERREM IVNDA   #050706",
    "submission": "SUPPL-45",
    "activeIngredients": "MEROPENEM",
    "company": "PFIZER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/02/2025",
    "drugName": "CYCLOMYDRILANDA  #084300",
    "submission": "SUPPL-44",
    "activeIngredients": "CYCLOPENTOLATE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE",
    "company": "ALCON LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/02/2025",
    "drugName": "IRINOTECAN HYDROCHLORIDEANDA  #203054",
    "submission": "SUPPL-4",
    "activeIngredients": "IRINOTECAN HYDROCHLORIDE",
    "company": "INTAS PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/02/2025",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #207874",
    "submission": "ORIG-1",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "IPCA LABS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/02/2025",
    "drugName": "TICAGRELORANDA  #208576",
    "submission": "ORIG-1",
    "activeIngredients": "TICAGRELOR",
    "company": "ALEMBIC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/02/2025",
    "drugName": "ACYCLOVIRANDA  #212981",
    "submission": "ORIG-1",
    "activeIngredients": "ACYCLOVIR",
    "company": "CIPLA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/02/2025",
    "drugName": "VARENICLINE TARTRATEANDA  #214595",
    "submission": "ORIG-1",
    "activeIngredients": "VARENICLINE TARTRATE",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/02/2025",
    "drugName": "HALOBETASOL PROPIONATE AND TAZAROTENEANDA  #217190",
    "submission": "ORIG-1",
    "activeIngredients": "HALOBETASOL PROPIONATE; TAZAROTENE",
    "company": "TARO",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/02/2025",
    "drugName": "RIVAROXABANANDA  #217810",
    "submission": "ORIG-1",
    "activeIngredients": "RIVAROXABAN",
    "company": "APOTEX",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/02/2025",
    "drugName": "HYDROCORTISONEANDA  #217881",
    "submission": "ORIG-1",
    "activeIngredients": "HYDROCORTISONE",
    "company": "NOVITIUM PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/02/2025",
    "drugName": "AVERIANDA  #218933",
    "submission": "ORIG-1",
    "activeIngredients": "DESOGESTREL; ETHINYL ESTRADIOL",
    "company": "AVION PHARMS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/02/2025",
    "drugName": "ALHEMOBLA   #761315",
    "submission": "SUPPL-1",
    "activeIngredients": "CONCIZUMAB-MTCI",
    "company": "NOVO NORDISK INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/05/2025",
    "drugName": "ALORANDA   #020655",
    "submission": "SUPPL-22",
    "activeIngredients": "ESTRADIOL",
    "company": "ABBVIE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/05/2025",
    "drugName": "FLUOXETINE HYDROCHLORIDEANDA  #075525",
    "submission": "SUPPL-7",
    "activeIngredients": "FLUOXETINE HYDROCHLORIDE",
    "company": "SCIEGEN PHARMS INC",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/05/2025",
    "drugName": "TICAGRELORANDA  #208537",
    "submission": "ORIG-1",
    "activeIngredients": "TICAGRELOR",
    "company": "INVAGEN PHARMS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/05/2025",
    "drugName": "RASAGILINE MESYLATEANDA  #210150",
    "submission": "ORIG-1",
    "activeIngredients": "RASAGILINE MESYLATE",
    "company": "TORRENT",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/05/2025",
    "drugName": "ADVIL DUAL ACTION WITH ACETAMINOPHENNDA   #211733",
    "submission": "SUPPL-7",
    "activeIngredients": "ACETAMINOPHEN; IBUPROFEN",
    "company": "HALEON US HOLDINGS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/05/2025",
    "drugName": "FENSOLVI KITNDA   #213150",
    "submission": "SUPPL-7",
    "activeIngredients": "LEUPROLIDE ACETATE",
    "company": "TOLMAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/05/2025",
    "drugName": "METHADONE HYDROCHLORIDEANDA  #218609",
    "submission": "ORIG-1",
    "activeIngredients": "METHADONE HYDROCHLORIDE",
    "company": "HIKMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/05/2025",
    "drugName": "EPOPROSTENOL SODIUMANDA  #219237",
    "submission": "ORIG-1",
    "activeIngredients": "EPOPROSTENOL SODIUM",
    "company": "GLAND PHARMA LIMITED",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "05/06/2025",
    "drugName": "RIFAMPINANDA  #064217",
    "submission": "SUPPL-17",
    "activeIngredients": "RIFAMPIN",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/06/2025",
    "drugName": "RIFAMPINANDA  #064217",
    "submission": "SUPPL-18",
    "activeIngredients": "RIFAMPIN",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/06/2025",
    "drugName": "DILTIAZEM HYDROCHLORIDEANDA  #074910",
    "submission": "SUPPL-28",
    "activeIngredients": "DILTIAZEM HYDROCHLORIDE",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/06/2025",
    "drugName": "GLIMEPIRIDEANDA  #077370",
    "submission": "SUPPL-13",
    "activeIngredients": "GLIMEPIRIDE",
    "company": "PRINSTON INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/06/2025",
    "drugName": "TRANDOLAPRILANDA  #077805",
    "submission": "SUPPL-10",
    "activeIngredients": "TRANDOLAPRIL",
    "company": "WATSON LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/06/2025",
    "drugName": "TRAMADOL HYDROCHLORIDEANDA  #205702",
    "submission": "SUPPL-28",
    "activeIngredients": "TRAMADOL HYDROCHLORIDE",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/06/2025",
    "drugName": "VARENICLINE TARTRATEANDA  #212879",
    "submission": "ORIG-1",
    "activeIngredients": "VARENICLINE TARTRATE",
    "company": "VIWIT PHARM",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/06/2025",
    "drugName": "QINLOCKNDA   #213973",
    "submission": "SUPPL-10",
    "activeIngredients": "RIPRETINIB",
    "company": "DECIPHERA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/06/2025",
    "drugName": "MIRABEGRONANDA  #217061",
    "submission": "ORIG-1",
    "activeIngredients": "MIRABEGRON",
    "company": "SAWAI USA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/06/2025",
    "drugName": "RALTEGRAVIR POTASSIUMANDA  #217990",
    "submission": "ORIG-1",
    "activeIngredients": "RALTEGRAVIR POTASSIUM",
    "company": "LUPIN LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/06/2025",
    "drugName": "PITOLISANTANDA  #218873",
    "submission": "ORIG-1",
    "activeIngredients": "PITOLISANT",
    "company": "MSN LABORATORIES PRIVATE LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "05/07/2025",
    "drugName": "HUMALOGBLA   #020563",
    "submission": "SUPPL-214",
    "activeIngredients": "INSULIN LISPRO RECOMBINANT",
    "company": "LILLY",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/07/2025",
    "drugName": "HUMALOG KWIKPENBLA   #020563",
    "submission": "SUPPL-214",
    "activeIngredients": "INSULIN LISPRO RECOMBINANT",
    "company": "LILLY",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/07/2025",
    "drugName": "HUMALOG PENBLA   #020563",
    "submission": "SUPPL-214",
    "activeIngredients": "INSULIN LISPRO RECOMBINANT",
    "company": "LILLY",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/07/2025",
    "drugName": "HUMALOG TEMPO PENBLA   #020563",
    "submission": "SUPPL-214",
    "activeIngredients": "INSULIN LISPRO RECOMBINANT",
    "company": "LILLY",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/07/2025",
    "drugName": "CEPHALEXINANDA  #063024",
    "submission": "SUPPL-30",
    "activeIngredients": "CEPHALEXIN",
    "company": "TEVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/07/2025",
    "drugName": "CEPHALEXINANDA  #063024",
    "submission": "SUPPL-31",
    "activeIngredients": "CEPHALEXIN",
    "company": "TEVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/07/2025",
    "drugName": "CEPHALEXINANDA  #063024",
    "submission": "SUPPL-32",
    "activeIngredients": "CEPHALEXIN",
    "company": "TEVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/07/2025",
    "drugName": "CEPHALEXINANDA  #063024",
    "submission": "SUPPL-33",
    "activeIngredients": "CEPHALEXIN",
    "company": "TEVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/07/2025",
    "drugName": "AZASANANDA  #075252",
    "submission": "SUPPL-26",
    "activeIngredients": "AZATHIOPRINE",
    "company": "AAIPHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/07/2025",
    "drugName": "AZASANANDA  #075252",
    "submission": "SUPPL-27",
    "activeIngredients": "AZATHIOPRINE",
    "company": "AAIPHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/07/2025",
    "drugName": "TACROLIMUSANDA  #090402",
    "submission": "SUPPL-4",
    "activeIngredients": "TACROLIMUS",
    "company": "HERITAGE PHARMA AVET",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/07/2025",
    "drugName": "HUMALOG KWIKPENBLA   #205747",
    "submission": "SUPPL-38",
    "activeIngredients": "INSULIN LISPRO RECOMBINANT",
    "company": "ELI LILLY AND CO",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/07/2025",
    "drugName": "GLATIRAMER ACETATEANDA  #208468",
    "submission": "ORIG-1",
    "activeIngredients": "GLATIRAMER ACETATE",
    "company": "CHEMI SPA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/07/2025",
    "drugName": "PANTOPRAZOLE SODIUMANDA  #209524",
    "submission": "SUPPL-4",
    "activeIngredients": "PANTOPRAZOLE SODIUM",
    "company": "HANGZHOU ZHONGMEI",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/07/2025",
    "drugName": "LABETALOL HYDROCHLORIDEANDA  #211953",
    "submission": "SUPPL-7",
    "activeIngredients": "LABETALOL HYDROCHLORIDE",
    "company": "RUBICON RESEARCH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/07/2025",
    "drugName": "ONYDA XRNDA   #217645",
    "submission": "SUPPL-4",
    "activeIngredients": "CLONIDINE HYDROCHLORIDE",
    "company": "TRIS PHARMA INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/07/2025",
    "drugName": "ELTROMBOPAGANDA  #219121",
    "submission": "ORIG-1",
    "activeIngredients": "ELTROMBOPAG",
    "company": "DR REDDYS LABS LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "05/07/2025",
    "drugName": "SKYRIZIBLA   #761105",
    "submission": "SUPPL-38",
    "activeIngredients": "RISANKIZUMAB-RZAA",
    "company": "ABBVIE INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/07/2025",
    "drugName": "SKYRIZIBLA   #761262",
    "submission": "SUPPL-10",
    "activeIngredients": "RISANKIZUMAB-RZAA",
    "company": "ABBVIE INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/08/2025",
    "drugName": "CUBICINNDA   #021572",
    "submission": "SUPPL-69",
    "activeIngredients": "DAPTOMYCIN",
    "company": "CUBIST PHARMS LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/08/2025",
    "drugName": "CUBICIN RFNDA   #021572",
    "submission": "SUPPL-69",
    "activeIngredients": "DAPTOMYCIN",
    "company": "CUBIST PHARMS LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/08/2025",
    "drugName": "METAXALONENDA   #022503",
    "submission": "SUPPL-4",
    "activeIngredients": "METAXALONE",
    "company": "PRIMUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/08/2025",
    "drugName": "DEFEROXAMINE MESYLATEANDA  #076019",
    "submission": "SUPPL-30",
    "activeIngredients": "DEFEROXAMINE MESYLATE",
    "company": "HOSPIRA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/08/2025",
    "drugName": "MIRTAZAPINEANDA  #077376",
    "submission": "SUPPL-28",
    "activeIngredients": "MIRTAZAPINE",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/08/2025",
    "drugName": "CAFFEINE CITRATEANDA  #077906",
    "submission": "SUPPL-3",
    "activeIngredients": "CAFFEINE CITRATE",
    "company": "AM REGENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/08/2025",
    "drugName": "CAFFEINE CITRATEANDA  #077906",
    "submission": "SUPPL-4",
    "activeIngredients": "CAFFEINE CITRATE",
    "company": "AM REGENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/08/2025",
    "drugName": "PROPRANOLOL HYDROCHLORIDEANDA  #078494",
    "submission": "SUPPL-27",
    "activeIngredients": "PROPRANOLOL HYDROCHLORIDE",
    "company": "ACTAVIS ELIZABETH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/08/2025",
    "drugName": "LAMIVUDINEANDA  #203260",
    "submission": "SUPPL-1",
    "activeIngredients": "LAMIVUDINE",
    "company": "HETERO LABS LTD V",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/08/2025",
    "drugName": "LAMIVUDINEANDA  #203260",
    "submission": "SUPPL-2",
    "activeIngredients": "LAMIVUDINE",
    "company": "HETERO LABS LTD V",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/08/2025",
    "drugName": "LAMIVUDINEANDA  #203260",
    "submission": "SUPPL-3",
    "activeIngredients": "LAMIVUDINE",
    "company": "HETERO LABS LTD V",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/08/2025",
    "drugName": "LINEZOLIDANDA  #204536",
    "submission": "SUPPL-10",
    "activeIngredients": "LINEZOLID",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/08/2025",
    "drugName": "VALSARTANANDA  #204821",
    "submission": "SUPPL-7",
    "activeIngredients": "VALSARTAN",
    "company": "PRINSTON INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/08/2025",
    "drugName": "VALSARTANANDA  #204821",
    "submission": "SUPPL-8",
    "activeIngredients": "VALSARTAN",
    "company": "PRINSTON INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/08/2025",
    "drugName": "LURASIDONE HYDROCHLORIDEANDA  #208031",
    "submission": "SUPPL-5",
    "activeIngredients": "LURASIDONE HYDROCHLORIDE",
    "company": "LUPIN LTD",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/08/2025",
    "drugName": "AMLODIPINE AND OLMESARTAN MEDOXOMILANDA  #209600",
    "submission": "SUPPL-2",
    "activeIngredients": "AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL",
    "company": "ACCORD HLTHCARE INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/08/2025",
    "drugName": "DAPAGLIFLOZINANDA  #211470",
    "submission": "ORIG-1",
    "activeIngredients": "DAPAGLIFLOZIN",
    "company": "BIOCON PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "05/08/2025",
    "drugName": "FUROSEMIDEANDA  #212174",
    "submission": "SUPPL-2",
    "activeIngredients": "FUROSEMIDE",
    "company": "EUGIA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/08/2025",
    "drugName": "ATAZANAVIR SULFATEANDA  #212278",
    "submission": "SUPPL-2",
    "activeIngredients": "ATAZANAVIR SULFATE",
    "company": "HETERO LABS LTD III",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/08/2025",
    "drugName": "VENETOCLAXANDA  #214733",
    "submission": "ORIG-1",
    "activeIngredients": "VENETOCLAX",
    "company": "DR REDDYS LABS LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "05/08/2025",
    "drugName": "DORZOLAMIDE HYDROCHLORIDEANDA  #215660",
    "submission": "SUPPL-1",
    "activeIngredients": "DORZOLAMIDE HYDROCHLORIDE",
    "company": "GLAND",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/08/2025",
    "drugName": "MIDODRINE HYDROCHLORIDEANDA  #217271",
    "submission": "SUPPL-4",
    "activeIngredients": "MIDODRINE HYDROCHLORIDE",
    "company": "MANKIND PHARMA",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/08/2025",
    "drugName": "DAPAGLIFLOZIN AND METFORMINANDA  #218091",
    "submission": "ORIG-1",
    "activeIngredients": "DAPAGLIFLOZIN || METFORMIN",
    "company": "SINOTHERAPEUTICS INC",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "05/08/2025",
    "drugName": "AVMAPKI FAKZYNJA CO-PACK (COPACKAGED)NDA   #219616",
    "submission": "ORIG-1",
    "activeIngredients": "AVUTOMETINIB POTASSIUM; DEFACTINIB HYDROCHLORIDE",
    "company": "VERASTEM INC",
    "submissionClassification": "Type 1 - New Molecular Entity",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/09/2025",
    "drugName": "NASACORT ALLERGY 24 HOURNDA   #020468",
    "submission": "SUPPL-49",
    "activeIngredients": "TRIAMCINOLONE ACETONIDE",
    "company": "CHATTEM SANOFI",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/09/2025",
    "drugName": "OPTISONNDA   #020899",
    "submission": "SUPPL-25",
    "activeIngredients": "ALBUMIN HUMAN",
    "company": "GE HEALTHCARE",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/09/2025",
    "drugName": "BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATEANDA  #075231",
    "submission": "SUPPL-13",
    "activeIngredients": "ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE",
    "company": "LGM PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/09/2025",
    "drugName": "IRINOTECAN HYDROCHLORIDEANDA  #079068",
    "submission": "SUPPL-6",
    "activeIngredients": "IRINOTECAN HYDROCHLORIDE",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/09/2025",
    "drugName": "NICARDIPINE HYDROCHLORIDEANDA  #090671",
    "submission": "SUPPL-3",
    "activeIngredients": "NICARDIPINE HYDROCHLORIDE",
    "company": "MANKIND PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/09/2025",
    "drugName": "REXULTINDA   #205422",
    "submission": "SUPPL-14",
    "activeIngredients": "BREXPIPRAZOLE",
    "company": "OTSUKA",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/09/2025",
    "drugName": "ICATIBANT ACETATEANDA  #208317",
    "submission": "SUPPL-3",
    "activeIngredients": "ICATIBANT ACETATE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/09/2025",
    "drugName": "DAPAGLIFLOZINANDA  #211312",
    "submission": "ORIG-1",
    "activeIngredients": "DAPAGLIFLOZIN",
    "company": "SANDOZ INC",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "05/09/2025",
    "drugName": "CLOZAPINEANDA  #212923",
    "submission": "SUPPL-1",
    "activeIngredients": "CLOZAPINE",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/09/2025",
    "drugName": "POSACONAZOLEANDA  #217709",
    "submission": "ORIG-1",
    "activeIngredients": "POSACONAZOLE",
    "company": "HAINAN POLY PHARM",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "05/12/2025",
    "drugName": "ZINECARDNDA   #020212",
    "submission": "SUPPL-21",
    "activeIngredients": "DEXRAZOXANE HYDROCHLORIDE",
    "company": "PFIZER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/12/2025",
    "drugName": "CUBICINNDA   #021572",
    "submission": "SUPPL-70",
    "activeIngredients": "DAPTOMYCIN",
    "company": "CUBIST PHARMS LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/12/2025",
    "drugName": "CUBICIN RFNDA   #021572",
    "submission": "SUPPL-70",
    "activeIngredients": "DAPTOMYCIN",
    "company": "CUBIST PHARMS LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/12/2025",
    "drugName": "EVOTAZNDA   #206353",
    "submission": "SUPPL-9",
    "activeIngredients": "ATAZANAVIR SULFATE; COBICISTAT",
    "company": "BRISTOL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/12/2025",
    "drugName": "INREBICNDA   #212327",
    "submission": "SUPPL-7",
    "activeIngredients": "FEDRATINIB HYDROCHLORIDE",
    "company": "BRISTOL-MYERS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/12/2025",
    "drugName": "SITAGLIPTIN PHOSPHATEANDA  #214700",
    "submission": "ORIG-1",
    "activeIngredients": "SITAGLIPTIN PHOSPHATE",
    "company": "DR REDDYS LABS LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "05/12/2025",
    "drugName": "ACALABRUTINIBANDA  #216833",
    "submission": "ORIG-1",
    "activeIngredients": "ACALABRUTINIB",
    "company": "MSN LABORATORIES PRIVATE LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "05/12/2025",
    "drugName": "TERAZOSIN HYDROCHLORIDEANDA  #219482",
    "submission": "ORIG-1",
    "activeIngredients": "TERAZOSIN HYDROCHLORIDE",
    "company": "AJANTA PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/12/2025",
    "drugName": "ZONISAMIDEANDA  #219507",
    "submission": "ORIG-1",
    "activeIngredients": "ZONISAMIDE",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/12/2025",
    "drugName": "TYENNEBLA   #761275",
    "submission": "SUPPL-4",
    "activeIngredients": "TOCILIZUMAB-AAZG",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/12/2025",
    "drugName": "TYENNEBLA   #761449",
    "submission": "SUPPL-1",
    "activeIngredients": "TOCILIZUMAB-AAZG",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/13/2025",
    "drugName": "PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDEANDA  #204802",
    "submission": "SUPPL-27",
    "activeIngredients": "METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/13/2025",
    "drugName": "PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDEANDA  #204802",
    "submission": "SUPPL-36",
    "activeIngredients": "METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/13/2025",
    "drugName": "EPINEPHRINENDA   #209359",
    "submission": "SUPPL-12",
    "activeIngredients": "EPINEPHRINE",
    "company": "HOSPIRA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/13/2025",
    "drugName": "DOCETAXELANDA  #213768",
    "submission": "ORIG-1",
    "activeIngredients": "DOCETAXEL",
    "company": "GUANGDONG SUNHO",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/13/2025",
    "drugName": "MARAVIROCANDA  #217880",
    "submission": "ORIG-1",
    "activeIngredients": "MARAVIROC",
    "company": "NAVINTA LLC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/13/2025",
    "drugName": "MUPIROCINANDA  #217943",
    "submission": "ORIG-1",
    "activeIngredients": "MUPIROCIN",
    "company": "ENCUBE",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/13/2025",
    "drugName": "HALOPERIDOL DECANOATEANDA  #219168",
    "submission": "ORIG-1",
    "activeIngredients": "HALOPERIDOL DECANOATE",
    "company": "CAPLIN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/14/2025",
    "drugName": "CHILDREN'S CLARITINNDA   #021891",
    "submission": "SUPPL-45",
    "activeIngredients": "LORATADINE",
    "company": "BAYER HEALTHCARE LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/14/2025",
    "drugName": "CLARITINNDA   #021891",
    "submission": "SUPPL-45",
    "activeIngredients": "LORATADINE",
    "company": "BAYER HEALTHCARE LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/14/2025",
    "drugName": "CAPRELSANDA   #022405",
    "submission": "SUPPL-23",
    "activeIngredients": "VANDETANIB",
    "company": "GENZYME CORP",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/14/2025",
    "drugName": "KADCYLABLA   #125427",
    "submission": "SUPPL-121",
    "activeIngredients": "ADO-TRASTUZUMAB EMTANSINE",
    "company": "GENENTECH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/14/2025",
    "drugName": "HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDEANDA  #205731",
    "submission": "SUPPL-3",
    "activeIngredients": "HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE",
    "company": "PADAGIS US",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/14/2025",
    "drugName": "HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDEANDA  #205731",
    "submission": "SUPPL-4",
    "activeIngredients": "HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE",
    "company": "PADAGIS US",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/14/2025",
    "drugName": "DABIGATRAN ETEXILATE MESYLATEANDA  #208039",
    "submission": "ORIG-1",
    "activeIngredients": "DABIGATRAN ETEXILATE MESYLATE",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/14/2025",
    "drugName": "RIVAROXABANANDA  #208534",
    "submission": "ORIG-1",
    "activeIngredients": "RIVAROXABAN",
    "company": "DR REDDYS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/14/2025",
    "drugName": "RIVAROXABANANDA  #208543",
    "submission": "ORIG-1",
    "activeIngredients": "RIVAROXABAN",
    "company": "INVAGEN PHARMS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/14/2025",
    "drugName": "RIVAROXABANANDA  #208555",
    "submission": "ORIG-2",
    "activeIngredients": "RIVAROXABAN",
    "company": "LUPIN LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/14/2025",
    "drugName": "RIVAROXABANANDA  #210301",
    "submission": "ORIG-1",
    "activeIngredients": "RIVAROXABAN",
    "company": "ALEMBIC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/14/2025",
    "drugName": "OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDEANDA  #210718",
    "submission": "ORIG-1",
    "activeIngredients": "AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL",
    "company": "PIRAMAL",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/14/2025",
    "drugName": "RIVAROXABANANDA  #213114",
    "submission": "ORIG-1",
    "activeIngredients": "RIVAROXABAN",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/14/2025",
    "drugName": "RIVAROXABANANDA  #213348",
    "submission": "ORIG-1",
    "activeIngredients": "RIVAROXABAN",
    "company": "SUNSHINE",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/14/2025",
    "drugName": "WELIREGNDA   #215383",
    "submission": "SUPPL-12",
    "activeIngredients": "BELZUTIFAN",
    "company": "MERCK SHARP DOHME",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/14/2025",
    "drugName": "BREKIYA (AUTOINJECTOR)NDA   #215400",
    "submission": "ORIG-1",
    "activeIngredients": "DIHYDROERGOTAMINE MESYLATE",
    "company": "AMNEAL",
    "submissionClassification": "Type 5 - New Formulation or New Manufacturer",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/14/2025",
    "drugName": "RIVAROXABANANDA  #216995",
    "submission": "ORIG-1",
    "activeIngredients": "RIVAROXABAN",
    "company": "AIPING PHARM INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/14/2025",
    "drugName": "RIVAROXABANANDA  #218107",
    "submission": "ORIG-1",
    "activeIngredients": "RIVAROXABAN",
    "company": "BIOCON PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/14/2025",
    "drugName": "NILOTINIBANDA  #218532",
    "submission": "ORIG-1",
    "activeIngredients": "NILOTINIB",
    "company": "TORRENT PHARMS LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "05/14/2025",
    "drugName": "RIVAROXABANANDA  #219332",
    "submission": "ORIG-1",
    "activeIngredients": "RIVAROXABAN",
    "company": "ASCENT PHARMS INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/14/2025",
    "drugName": "EMRELISBLA   #761384",
    "submission": "ORIG-1",
    "activeIngredients": "TELISOTUZUMAB VEDOTIN-TLLV",
    "company": "ABBVIE INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/14/2025",
    "drugName": "PIASKYBLA   #761388",
    "submission": "SUPPL-1",
    "activeIngredients": "CROVALIMAB-AKKZ",
    "company": "GENENTECH INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/15/2025",
    "drugName": "RIVAROXABANANDA  #208220",
    "submission": "ORIG-1",
    "activeIngredients": "RIVAROXABAN",
    "company": "BRECKENRIDGE",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/15/2025",
    "drugName": "RIVAROXABANANDA  #208544",
    "submission": "ORIG-2",
    "activeIngredients": "RIVAROXABAN",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/15/2025",
    "drugName": "SPRAVATONDA   #211243",
    "submission": "SUPPL-21",
    "activeIngredients": "ESKETAMINE HYDROCHLORIDE",
    "company": "JANSSEN PHARMS",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/15/2025",
    "drugName": "MOMETASONE FUROATEANDA  #211706",
    "submission": "ORIG-1",
    "activeIngredients": "MOMETASONE FUROATE",
    "company": "NASPRESS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/15/2025",
    "drugName": "PACLITAXELANDA  #216355",
    "submission": "ORIG-1",
    "activeIngredients": "PACLITAXEL",
    "company": "SHUANGCHENG",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/15/2025",
    "drugName": "ZYNYZBLA   #761334",
    "submission": "SUPPL-4",
    "activeIngredients": "RETIFANLIMAB-DLWR",
    "company": "INCYTE CORP",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/16/2025",
    "drugName": "RISPERIDONEANDA  #078707",
    "submission": "SUPPL-15",
    "activeIngredients": "RISPERIDONE",
    "company": "RENATA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/16/2025",
    "drugName": "RISPERIDONEANDA  #078707",
    "submission": "SUPPL-16",
    "activeIngredients": "RISPERIDONE",
    "company": "RENATA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/16/2025",
    "drugName": "RISPERIDONEANDA  #078707",
    "submission": "SUPPL-20",
    "activeIngredients": "RISPERIDONE",
    "company": "RENATA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/16/2025",
    "drugName": "RISPERIDONEANDA  #078707",
    "submission": "SUPPL-22",
    "activeIngredients": "RISPERIDONE",
    "company": "RENATA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/16/2025",
    "drugName": "TIMOLOL MALEATEANDA  #078771",
    "submission": "SUPPL-9",
    "activeIngredients": "TIMOLOL MALEATE",
    "company": "MANKIND PHARMA",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/16/2025",
    "drugName": "GLATIRAMER ACETATEANDA  #203857",
    "submission": "SUPPL-2",
    "activeIngredients": "GLATIRAMER ACETATE",
    "company": "SYNTHON PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/16/2025",
    "drugName": "ROSUVASTATIN CALCIUMANDA  #206603",
    "submission": "ORIG-1",
    "activeIngredients": "ROSUVASTATIN CALCIUM",
    "company": "MANKIND PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/16/2025",
    "drugName": "GLATIRAMER ACETATEANDA  #206873",
    "submission": "SUPPL-2",
    "activeIngredients": "GLATIRAMER ACETATE",
    "company": "SYNTHON PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/16/2025",
    "drugName": "METHYLNALTREXONE BROMIDEANDA  #208594",
    "submission": "ORIG-1",
    "activeIngredients": "METHYLNALTREXONE BROMIDE",
    "company": "MYLAN PHARMS INC",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "05/16/2025",
    "drugName": "GEFITINIBANDA  #211826",
    "submission": "ORIG-1",
    "activeIngredients": "GEFITINIB",
    "company": "CIPLA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/16/2025",
    "drugName": "PANTOPRAZOLE SODIUMANDA  #215074",
    "submission": "ORIG-1",
    "activeIngredients": "PANTOPRAZOLE SODIUM",
    "company": "DEVA HOLDING AS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/16/2025",
    "drugName": "PALIPERIDONE PALMITATEANDA  #216674",
    "submission": "ORIG-1",
    "activeIngredients": "PALIPERIDONE PALMITATE",
    "company": "ACCORD HLTHCARE INC",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "05/16/2025",
    "drugName": "OLANZAPINEANDA  #218116",
    "submission": "ORIG-1",
    "activeIngredients": "OLANZAPINE",
    "company": "QILU",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/18/2025",
    "drugName": "GANCICLOVIR SODIUMANDA  #204560",
    "submission": "SUPPL-1",
    "activeIngredients": "GANCICLOVIR SODIUM",
    "company": "ONESOURCE SPECIALTY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/18/2025",
    "drugName": "TETRABENAZINEANDA  #206129",
    "submission": "SUPPL-7",
    "activeIngredients": "TETRABENAZINE",
    "company": "SUN PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/19/2025",
    "drugName": "SUBOXONENDA   #022410",
    "submission": "SUPPL-56",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE",
    "company": "INDIVIOR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/19/2025",
    "drugName": "IMIQUIMODANDA  #078548",
    "submission": "SUPPL-13",
    "activeIngredients": "IMIQUIMOD",
    "company": "FOUGERA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/19/2025",
    "drugName": "TACROLIMUSANDA  #091195",
    "submission": "SUPPL-15",
    "activeIngredients": "TACROLIMUS",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/19/2025",
    "drugName": "TACROLIMUSANDA  #091195",
    "submission": "SUPPL-18",
    "activeIngredients": "TACROLIMUS",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/19/2025",
    "drugName": "TACROLIMUSANDA  #091195",
    "submission": "SUPPL-20",
    "activeIngredients": "TACROLIMUS",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/19/2025",
    "drugName": "TACROLIMUSANDA  #091195",
    "submission": "SUPPL-22",
    "activeIngredients": "TACROLIMUS",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/19/2025",
    "drugName": "FOSAPREPITANT DIMEGLUMINEANDA  #204025",
    "submission": "SUPPL-2",
    "activeIngredients": "FOSAPREPITANT DIMEGLUMINE",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/19/2025",
    "drugName": "ZUBSOLVNDA   #204242",
    "submission": "SUPPL-31",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE",
    "company": "OREXO US INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/19/2025",
    "drugName": "ABIRATERONE ACETATEANDA  #208446",
    "submission": "SUPPL-14",
    "activeIngredients": "ABIRATERONE ACETATE",
    "company": "MYLAN",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/19/2025",
    "drugName": "ESTRADIOLANDA  #212313",
    "submission": "SUPPL-3",
    "activeIngredients": "ESTRADIOL",
    "company": "PRASCO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/19/2025",
    "drugName": "AMINOCAPROIC ACIDANDA  #213216",
    "submission": "ORIG-1",
    "activeIngredients": "AMINOCAPROIC ACID",
    "company": "SCIEGEN PHARMS INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/19/2025",
    "drugName": "TIMOLOL MALEATEANDA  #216343",
    "submission": "SUPPL-1",
    "activeIngredients": "TIMOLOL MALEATE",
    "company": "AMNEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/19/2025",
    "drugName": "DIAZEPAMANDA  #216422",
    "submission": "ORIG-1",
    "activeIngredients": "DIAZEPAM",
    "company": "GALENICUM HLTH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/19/2025",
    "drugName": "PROCHLORPERAZINE MALEATEANDA  #217847",
    "submission": "ORIG-1",
    "activeIngredients": "PROCHLORPERAZINE MALEATE",
    "company": "DR REDDYS LABS SA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/19/2025",
    "drugName": "LUMATEPERONE TOSYLATEANDA  #219142",
    "submission": "ORIG-1",
    "activeIngredients": "LUMATEPERONE TOSYLATE",
    "company": "HETERO LABS LIMITED",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "05/20/2025",
    "drugName": "TIMOLOL MALEATEANDA  #077259",
    "submission": "SUPPL-14",
    "activeIngredients": "TIMOLOL MALEATE",
    "company": "FDC LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/20/2025",
    "drugName": "TIMOLOL MALEATEANDA  #077259",
    "submission": "SUPPL-23",
    "activeIngredients": "TIMOLOL MALEATE",
    "company": "FDC LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/20/2025",
    "drugName": "CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDEANDA  #090922",
    "submission": "SUPPL-16",
    "activeIngredients": "CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE",
    "company": "SUN PHARM INDS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/20/2025",
    "drugName": "CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDEANDA  #090922",
    "submission": "SUPPL-20",
    "activeIngredients": "CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE",
    "company": "SUN PHARM INDS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/20/2025",
    "drugName": "EMTRICITABINE, RILPIVIRINE AND TENOFOVIR DISOPROXIL FUMARATEANDA  #208452",
    "submission": "ORIG-1",
    "activeIngredients": "EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATE",
    "company": "MYLAN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/20/2025",
    "drugName": "PREGABALINANDA  #209530",
    "submission": "ORIG-1",
    "activeIngredients": "PREGABALIN",
    "company": "JUBILANT GENERICS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/20/2025",
    "drugName": "IBSRELANDA   #211801",
    "submission": "SUPPL-14",
    "activeIngredients": "TENAPANOR HYDROCHLORIDE",
    "company": "ARDELYX INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/20/2025",
    "drugName": "SUGAMMADEXANDA  #214311",
    "submission": "ORIG-1",
    "activeIngredients": "SUGAMMADEX",
    "company": "SANDOZ INC",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "05/20/2025",
    "drugName": "AUSUSVARNDA   #217062",
    "submission": "ORIG-1",
    "activeIngredients": "RIVAROXABAN",
    "company": "AUSON PHARM",
    "submissionClassification": "Type 3 - New Dosage Form",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "05/20/2025",
    "drugName": "AZACITIDINEANDA  #217453",
    "submission": "ORIG-1",
    "activeIngredients": "AZACITIDINE",
    "company": "RELIANCE LIFE",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/20/2025",
    "drugName": "LOTEPREDNOL ETABONATEANDA  #217484",
    "submission": "ORIG-1",
    "activeIngredients": "LOTEPREDNOL ETABONATE",
    "company": "AMNEAL",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/20/2025",
    "drugName": "BRIVARACETAMANDA  #219772",
    "submission": "ORIG-1",
    "activeIngredients": "BRIVARACETAM",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "05/20/2025",
    "drugName": "AMJEVITABLA   #761024",
    "submission": "SUPPL-21",
    "activeIngredients": "ADALIMUMAB-ATTO",
    "company": "AMGEN INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/20/2025",
    "drugName": "CYLTEZOBLA   #761058",
    "submission": "SUPPL-31",
    "activeIngredients": "ADALIMUMAB-ADBM",
    "company": "BOEHRINGER INGELHEIM",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/20/2025",
    "drugName": "HYRIMOZBLA   #761071",
    "submission": "SUPPL-22",
    "activeIngredients": "ADALIMUMAB-ADAZ",
    "company": "SANDOZ INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/21/2025",
    "drugName": "XYREMNDA   #021196",
    "submission": "SUPPL-47",
    "activeIngredients": "SODIUM OXYBATE",
    "company": "JAZZ PHARMS",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/21/2025",
    "drugName": "DARIFENACIN HYDROBROMIDEANDA  #205209",
    "submission": "SUPPL-7",
    "activeIngredients": "DARIFENACIN HYDROBROMIDE",
    "company": "TORRENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/21/2025",
    "drugName": "PALONOSETRON HYDROCHLORIDEANDA  #206396",
    "submission": "SUPPL-4",
    "activeIngredients": "PALONOSETRON HYDROCHLORIDE",
    "company": "CIPLA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/21/2025",
    "drugName": "DICLOFENAC SODIUMANDA  #206493",
    "submission": "SUPPL-9",
    "activeIngredients": "DICLOFENAC SODIUM",
    "company": "ACTAVIS MID ATLANTIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/21/2025",
    "drugName": "XYWAVNDA   #212690",
    "submission": "SUPPL-17",
    "activeIngredients": "CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE",
    "company": "JAZZ",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/21/2025",
    "drugName": "VARENICLINE TARTRATEANDA  #213268",
    "submission": "ORIG-1",
    "activeIngredients": "VARENICLINE TARTRATE",
    "company": "RHODES PHARMS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/21/2025",
    "drugName": "PROPARACAINE HYDROCHLORIDEANDA  #219136",
    "submission": "ORIG-1",
    "activeIngredients": "PROPARACAINE HYDROCHLORIDE",
    "company": "MANKIND PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/21/2025",
    "drugName": "HADLIMABLA   #761059",
    "submission": "SUPPL-25",
    "activeIngredients": "ADALIMUMAB-BWWD",
    "company": "SAMSUNG BIOEPIS CO LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/21/2025",
    "drugName": "HADLIMABLA   #761059",
    "submission": "SUPPL-26",
    "activeIngredients": "ADALIMUMAB-BWWD",
    "company": "SAMSUNG BIOEPIS CO LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/21/2025",
    "drugName": "SUSVIMOBLA   #761197",
    "submission": "SUPPL-7",
    "activeIngredients": "RANIBIZUMAB",
    "company": "GENENTECH INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/21/2025",
    "drugName": "YUFLYMABLA   #761219",
    "submission": "SUPPL-9",
    "activeIngredients": "ADALIMUMAB-AATY",
    "company": "CELLTRION",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/21/2025",
    "drugName": "YUFLYMABLA   #761219",
    "submission": "SUPPL-16",
    "activeIngredients": "ADALIMUMAB-AATY",
    "company": "CELLTRION",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/22/2025",
    "drugName": "TECHNESCAN PYP KITNDA   #017538",
    "submission": "SUPPL-23",
    "activeIngredients": "TECHNETIUM TC-99M PYROPHOSPHATE KIT",
    "company": "CURIUM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/22/2025",
    "drugName": "PHOSPHOTECNDA   #017680",
    "submission": "SUPPL-13",
    "activeIngredients": "TECHNETIUM TC-99M PYROPHOSPHATE KIT",
    "company": "BRACCO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/22/2025",
    "drugName": "OSTEOLITENDA   #017972",
    "submission": "SUPPL-17",
    "activeIngredients": "TECHNETIUM TC-99M MEDRONATE KIT",
    "company": "SUN PHARM INDS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/22/2025",
    "drugName": "DRAXIMAGE MDP-10NDA   #018035",
    "submission": "SUPPL-43",
    "activeIngredients": "TECHNETIUM TC-99M MEDRONATE",
    "company": "JUBILANT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/22/2025",
    "drugName": "DRAXIMAGE MDP-25NDA   #018035",
    "submission": "SUPPL-43",
    "activeIngredients": "TECHNETIUM TC-99M MEDRONATE",
    "company": "JUBILANT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/22/2025",
    "drugName": "TECHNETIUM TC-99M MEDRONATE KITNDA   #018107",
    "submission": "SUPPL-17",
    "activeIngredients": "TECHNETIUM TC-99M MEDRONATE KIT",
    "company": "CARDINAL HEALTH 414",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/22/2025",
    "drugName": "CIS-MDPNDA   #018124",
    "submission": "SUPPL-32",
    "activeIngredients": "TECHNETIUM TC-99M MEDRONATE KIT",
    "company": "SUN PHARM INDS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/22/2025",
    "drugName": "TECHNESCANNDA   #018321",
    "submission": "SUPPL-26",
    "activeIngredients": "TECHNETIUM TC-99M OXIDRONATE KIT",
    "company": "CURIUM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/22/2025",
    "drugName": "CIS-PYRONDA   #019039",
    "submission": "SUPPL-22",
    "activeIngredients": "TECHNETIUM TC-99M PYROPHOSPHATE KIT",
    "company": "SUN PHARM INDS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/22/2025",
    "drugName": "LUPRON DEPOT-PED KITNDA   #020263",
    "submission": "SUPPL-56",
    "activeIngredients": "LEUPROLIDE ACETATE",
    "company": "ABBVIE ENDOCRINE INC",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/22/2025",
    "drugName": "PAMIDRONATE DISODIUMNDA   #021113",
    "submission": "SUPPL-18",
    "activeIngredients": "PAMIDRONATE DISODIUM",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/22/2025",
    "drugName": "LEVONORGESTREL AND ETHINYL ESTRADIOLANDA  #076625",
    "submission": "SUPPL-18",
    "activeIngredients": "ETHINYL ESTRADIOL; LEVONORGESTREL",
    "company": "DR REDDYS LABS SA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/22/2025",
    "drugName": "GABAPENTINANDA  #090705",
    "submission": "SUPPL-37",
    "activeIngredients": "GABAPENTIN",
    "company": "INVAGEN PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/22/2025",
    "drugName": "PROLIABLA   #125320",
    "submission": "SUPPL-219",
    "activeIngredients": "DENOSUMAB",
    "company": "AMGEN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/22/2025",
    "drugName": "XGEVABLA   #125320",
    "submission": "SUPPL-219",
    "activeIngredients": "DENOSUMAB",
    "company": "AMGEN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/22/2025",
    "drugName": "KEYTRUDABLA   #125514",
    "submission": "SUPPL-182",
    "activeIngredients": "PEMBROLIZUMAB",
    "company": "MERCK SHARP DOHME",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/22/2025",
    "drugName": "NUCALABLA   #125526",
    "submission": "SUPPL-7",
    "activeIngredients": "MEPOLIZUMAB",
    "company": "GLAXOSMITHKLINE LLC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/22/2025",
    "drugName": "METOPROLOL TARTRATEANDA  #200981",
    "submission": "SUPPL-48",
    "activeIngredients": "METOPROLOL TARTRATE",
    "company": "RUBICON RESEARCH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/22/2025",
    "drugName": "FENOFIBRATEANDA  #201748",
    "submission": "SUPPL-7",
    "activeIngredients": "FENOFIBRATE",
    "company": "SUN PHARM INDS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/22/2025",
    "drugName": "FENOFIBRATEANDA  #201748",
    "submission": "SUPPL-10",
    "activeIngredients": "FENOFIBRATE",
    "company": "SUN PHARM INDS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/22/2025",
    "drugName": "KYPROLISNDA   #202714",
    "submission": "SUPPL-36",
    "activeIngredients": "CARFILZOMIB",
    "company": "ONYX PHARMS AMGEN",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/22/2025",
    "drugName": "KALYDECONDA   #203188",
    "submission": "SUPPL-41",
    "activeIngredients": "IVACAFTOR",
    "company": "VERTEX PHARMS",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/22/2025",
    "drugName": "SUPRAXNDA   #203195",
    "submission": "SUPPL-13",
    "activeIngredients": "CEFIXIME",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/22/2025",
    "drugName": "LINEZOLIDANDA  #204239",
    "submission": "SUPPL-9",
    "activeIngredients": "LINEZOLID",
    "company": "HETERO LABS LTD V",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/22/2025",
    "drugName": "LINEZOLIDANDA  #207001",
    "submission": "SUPPL-10",
    "activeIngredients": "LINEZOLID",
    "company": "HQ SPCLT PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/22/2025",
    "drugName": "KALYDECONDA   #207925",
    "submission": "SUPPL-19",
    "activeIngredients": "IVACAFTOR",
    "company": "VERTEX PHARMS INC",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/22/2025",
    "drugName": "LINEZOLIDANDA  #211813",
    "submission": "SUPPL-3",
    "activeIngredients": "LINEZOLID",
    "company": "HETERO LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/22/2025",
    "drugName": "XIPERENDA   #211950",
    "submission": "SUPPL-2",
    "activeIngredients": "TRIAMCINOLONE ACETONIDE",
    "company": "BAUSCH AND LOMB INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/22/2025",
    "drugName": "ISOTRETINOINANDA  #216633",
    "submission": "ORIG-1",
    "activeIngredients": "ISOTRETINOIN",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/22/2025",
    "drugName": "ZORYVENDA   #217242",
    "submission": "SUPPL-5",
    "activeIngredients": "ROFLUMILAST",
    "company": "ARCUTIS",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/22/2025",
    "drugName": "AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUMANDA  #217279",
    "submission": "ORIG-1",
    "activeIngredients": "AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM",
    "company": "ALEMBIC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/22/2025",
    "drugName": "LENALIDOMIDEANDA  #217554",
    "submission": "ORIG-1",
    "activeIngredients": "LENALIDOMIDE",
    "company": "DEVA HOLDING AS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/22/2025",
    "drugName": "OLAPARIBANDA  #217936",
    "submission": "ORIG-1",
    "activeIngredients": "OLAPARIB",
    "company": "SANDOZ INC",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "05/22/2025",
    "drugName": "HERZUMABLA   #761091",
    "submission": "SUPPL-35",
    "activeIngredients": "TRASTUZUMAB-PKRB",
    "company": "CELLTRION INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/22/2025",
    "drugName": "EBGLYSSBLA   #761306",
    "submission": "SUPPL-3",
    "activeIngredients": "LEBRIKIZUMAB-LBKZ",
    "company": "ELI LILLY AND CO",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/22/2025",
    "drugName": "STARJEMZABLA   #761419",
    "submission": "ORIG-1",
    "activeIngredients": "ustekinumab-hmny",
    "company": "BIO-THERA SOLUTIONS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/23/2025",
    "drugName": "METAXALONEANDA  #040486",
    "submission": "SUPPL-15",
    "activeIngredients": "METAXALONE",
    "company": "MOUNTAIN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/23/2025",
    "drugName": "ZIDOVUDINEANDA  #076844",
    "submission": "SUPPL-7",
    "activeIngredients": "ZIDOVUDINE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/23/2025",
    "drugName": "AZATHIOPRINEANDA  #077621",
    "submission": "SUPPL-21",
    "activeIngredients": "AZATHIOPRINE",
    "company": "ZYDUS PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/23/2025",
    "drugName": "CAFFEINE CITRATEANDA  #077997",
    "submission": "SUPPL-4",
    "activeIngredients": "CAFFEINE CITRATE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/23/2025",
    "drugName": "GUAIFENESINANDA  #078912",
    "submission": "SUPPL-23",
    "activeIngredients": "GUAIFENESIN",
    "company": "PERRIGO R AND D",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/23/2025",
    "drugName": "IRINOTECAN HYDROCHLORIDEANDA  #090675",
    "submission": "SUPPL-5",
    "activeIngredients": "IRINOTECAN HYDROCHLORIDE",
    "company": "HENGRUI PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/23/2025",
    "drugName": "IRINOTECAN HYDROCHLORIDEANDA  #090675",
    "submission": "SUPPL-10",
    "activeIngredients": "IRINOTECAN HYDROCHLORIDE",
    "company": "HENGRUI PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/23/2025",
    "drugName": "IRINOTECAN HYDROCHLORIDEANDA  #090675",
    "submission": "SUPPL-11",
    "activeIngredients": "IRINOTECAN HYDROCHLORIDE",
    "company": "HENGRUI PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/23/2025",
    "drugName": "IRINOTECAN HYDROCHLORIDEANDA  #090675",
    "submission": "SUPPL-13",
    "activeIngredients": "IRINOTECAN HYDROCHLORIDE",
    "company": "HENGRUI PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/23/2025",
    "drugName": "CLINDAMYCIN HYDROCHLORIDEANDA  #091225",
    "submission": "SUPPL-8",
    "activeIngredients": "CLINDAMYCIN HYDROCHLORIDE",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/23/2025",
    "drugName": "YERVOYBLA   #125377",
    "submission": "SUPPL-136",
    "activeIngredients": "IPILIMUMAB",
    "company": "BRISTOL MYERS SQUIBB",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/23/2025",
    "drugName": "OPDIVOBLA   #125554",
    "submission": "SUPPL-133",
    "activeIngredients": "NIVOLUMAB",
    "company": "BRISTOL MYERS SQUIBB",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/23/2025",
    "drugName": "AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUMANDA  #205199",
    "submission": "SUPPL-8",
    "activeIngredients": "AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/23/2025",
    "drugName": "AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUMANDA  #205199",
    "submission": "SUPPL-10",
    "activeIngredients": "AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/23/2025",
    "drugName": "CISATRACURIUM BESYLATEANDA  #205873",
    "submission": "SUPPL-5",
    "activeIngredients": "CISATRACURIUM BESYLATE",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/23/2025",
    "drugName": "PALONOSETRON HYDROCHLORIDEANDA  #206416",
    "submission": "SUPPL-1",
    "activeIngredients": "PALONOSETRON HYDROCHLORIDE",
    "company": "MYLAN INSTITUTIONAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/23/2025",
    "drugName": "LINEZOLIDANDA  #207526",
    "submission": "SUPPL-3",
    "activeIngredients": "LINEZOLID",
    "company": "NOVEL LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/23/2025",
    "drugName": "LINEZOLIDANDA  #207526",
    "submission": "SUPPL-4",
    "activeIngredients": "LINEZOLID",
    "company": "NOVEL LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/23/2025",
    "drugName": "LINEZOLIDANDA  #207526",
    "submission": "SUPPL-5",
    "activeIngredients": "LINEZOLID",
    "company": "NOVEL LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/23/2025",
    "drugName": "LINEZOLIDANDA  #207526",
    "submission": "SUPPL-6",
    "activeIngredients": "LINEZOLID",
    "company": "NOVEL LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/23/2025",
    "drugName": "BOSUTINIB MONOHYDRATEANDA  #209543",
    "submission": "ORIG-1",
    "activeIngredients": "BOSUTINIB MONOHYDRATE",
    "company": "ALEMBIC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/23/2025",
    "drugName": "PERAMPANELANDA  #209801",
    "submission": "ORIG-1",
    "activeIngredients": "PERAMPANEL",
    "company": "TEVA PHARMS USA INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/23/2025",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #210015",
    "submission": "SUPPL-21",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "YICHANG HUMANWELL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/23/2025",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #210015",
    "submission": "SUPPL-22",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "YICHANG HUMANWELL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/23/2025",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #210015",
    "submission": "SUPPL-25",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "YICHANG HUMANWELL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/23/2025",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #210015",
    "submission": "SUPPL-28",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "YICHANG HUMANWELL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/23/2025",
    "drugName": "WAKIXNDA   #211150",
    "submission": "SUPPL-7",
    "activeIngredients": "PITOLISANT HYDROCHLORIDE",
    "company": "HARMONY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/23/2025",
    "drugName": "YUTREPIANDA   #213005",
    "submission": "ORIG-1",
    "activeIngredients": "TREPROSTINIL SODIUM",
    "company": "LIQUIDIA TECH",
    "submissionClassification": "Type 5 - New Formulation or New Manufacturer",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/23/2025",
    "drugName": "LACOSAMIDEANDA  #218706",
    "submission": "ORIG-1",
    "activeIngredients": "LACOSAMIDE",
    "company": "WESTMINSTER PHARMS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/23/2025",
    "drugName": "OPDIVO QVANTIGBLA   #761381",
    "submission": "SUPPL-8",
    "activeIngredients": "NIVOLUMAB;HYALURONIDASE-NVHY",
    "company": "BRISTOL-MYERS SQUIBB",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/27/2025",
    "drugName": "EXIDINENDA   #019127",
    "submission": "SUPPL-27",
    "activeIngredients": "CHLORHEXIDINE GLUCONATE",
    "company": "XTTRIUM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/27/2025",
    "drugName": "DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATEANDA  #205295",
    "submission": "SUPPL-12",
    "activeIngredients": "DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE",
    "company": "FDC LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/27/2025",
    "drugName": "ASENAPINE MALEATEANDA  #206098",
    "submission": "SUPPL-12",
    "activeIngredients": "ASENAPINE MALEATE",
    "company": "ALEMBIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/27/2025",
    "drugName": "HEPARIN SODIUMANDA  #211007",
    "submission": "SUPPL-10",
    "activeIngredients": "HEPARIN SODIUM",
    "company": "EMERGE BIOSCIENCE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/27/2025",
    "drugName": "HEPARIN SODIUMANDA  #211007",
    "submission": "SUPPL-14",
    "activeIngredients": "HEPARIN SODIUM",
    "company": "EMERGE BIOSCIENCE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/27/2025",
    "drugName": "TOPIRAMATEANDA  #216683",
    "submission": "ORIG-1",
    "activeIngredients": "TOPIRAMATE",
    "company": "RUBICON RESEARCH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/27/2025",
    "drugName": "LUMATEPERONEANDA  #219200",
    "submission": "ORIG-1",
    "activeIngredients": "LUMATEPERONE",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "05/28/2025",
    "drugName": "METHOTREXATE LPFNDA   #011719",
    "submission": "SUPPL-142",
    "activeIngredients": "METHOTREXATE SODIUM",
    "company": "HOSPIRA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/28/2025",
    "drugName": "METHOTREXATE PRESERVATIVE FREENDA   #011719",
    "submission": "SUPPL-142",
    "activeIngredients": "METHOTREXATE SODIUM",
    "company": "HOSPIRA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/28/2025",
    "drugName": "METHOTREXATE SODIUMNDA   #011719",
    "submission": "SUPPL-142",
    "activeIngredients": "METHOTREXATE SODIUM",
    "company": "HOSPIRA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/28/2025",
    "drugName": "METHOTREXATE SODIUM PRESERVATIVE FREENDA   #011719",
    "submission": "SUPPL-142",
    "activeIngredients": "METHOTREXATE SODIUM",
    "company": "HOSPIRA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/28/2025",
    "drugName": "BYETTANDA   #021773",
    "submission": "SUPPL-50",
    "activeIngredients": "EXENATIDE SYNTHETIC",
    "company": "ASTRAZENECA AB",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/28/2025",
    "drugName": "BYDUREONNDA   #022200",
    "submission": "SUPPL-36",
    "activeIngredients": "EXENATIDE SYNTHETIC",
    "company": "ASTRAZENECA AB",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/28/2025",
    "drugName": "BYDUREON PENNDA   #022200",
    "submission": "SUPPL-36",
    "activeIngredients": "EXENATIDE SYNTHETIC",
    "company": "ASTRAZENECA AB",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/28/2025",
    "drugName": "VICTOZANDA   #022341",
    "submission": "SUPPL-44",
    "activeIngredients": "LIRAGLUTIDE",
    "company": "NOVO NORDISK INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/28/2025",
    "drugName": "RISPERIDONEANDA  #078909",
    "submission": "SUPPL-11",
    "activeIngredients": "RISPERIDONE",
    "company": "APOZEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/28/2025",
    "drugName": "RISPERIDONEANDA  #078909",
    "submission": "SUPPL-12",
    "activeIngredients": "RISPERIDONE",
    "company": "APOZEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/28/2025",
    "drugName": "RISPERIDONEANDA  #078909",
    "submission": "SUPPL-13",
    "activeIngredients": "RISPERIDONE",
    "company": "APOZEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/28/2025",
    "drugName": "RISPERIDONEANDA  #078909",
    "submission": "SUPPL-16",
    "activeIngredients": "RISPERIDONE",
    "company": "APOZEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/28/2025",
    "drugName": "RISPERIDONEANDA  #078909",
    "submission": "SUPPL-17",
    "activeIngredients": "RISPERIDONE",
    "company": "APOZEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/28/2025",
    "drugName": "TRULICITYBLA   #125469",
    "submission": "SUPPL-63",
    "activeIngredients": "DULAGLUTIDE",
    "company": "ELI LILLY AND CO",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/28/2025",
    "drugName": "SAXENDANDA   #206321",
    "submission": "SUPPL-20",
    "activeIngredients": "LIRAGLUTIDE",
    "company": "NOVO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/28/2025",
    "drugName": "ADLYXINBLA   #208471",
    "submission": "SUPPL-10",
    "activeIngredients": "LIXISENATIDE",
    "company": "SANOFI-AVENTIS US",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/28/2025",
    "drugName": "XULTOPHY 100/3.6BLA   #208583",
    "submission": "SUPPL-25",
    "activeIngredients": "INSULIN DEGLUDEC; LIRAGLUTIDE",
    "company": "NOVO",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/28/2025",
    "drugName": "METHYLNALTREXONE BROMIDEANDA  #208592",
    "submission": "ORIG-1",
    "activeIngredients": "METHYLNALTREXONE BROMIDE",
    "company": "MYLAN LABS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/28/2025",
    "drugName": "SOLIQUA 100/33BLA   #208673",
    "submission": "SUPPL-18",
    "activeIngredients": "INSULIN GLARGINE; LIXISENATIDE",
    "company": "SANOFI-AVENTIS US",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/28/2025",
    "drugName": "BYDUREON BCISENDA   #209210",
    "submission": "SUPPL-25",
    "activeIngredients": "EXENATIDE SYNTHETIC",
    "company": "ASTRAZENECA AB",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/28/2025",
    "drugName": "BOSUTINIBANDA  #209624",
    "submission": "ORIG-1",
    "activeIngredients": "BOSUTINIB MONOHYDRATE",
    "company": "MSN LABORATORIES PRIVATE LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "05/28/2025",
    "drugName": "MOUNJARONDA   #215866",
    "submission": "SUPPL-31",
    "activeIngredients": "TIRZEPATIDE",
    "company": "ELI LILLY AND CO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/28/2025",
    "drugName": "MOUNJARO (AUTOINJECTOR)NDA   #215866",
    "submission": "SUPPL-31",
    "activeIngredients": "TIRZEPATIDE",
    "company": "ELI LILLY AND CO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/28/2025",
    "drugName": "TRYPTYRNDA   #217370",
    "submission": "ORIG-1",
    "activeIngredients": "ACOLTREMON",
    "company": "ALCON LABS INC",
    "submissionClassification": "Type 1 - New Molecular Entity",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/28/2025",
    "drugName": "JOENJANDA   #217759",
    "submission": "SUPPL-5",
    "activeIngredients": "LENIOLISIB PHOSPHATE",
    "company": "PHARMING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/28/2025",
    "drugName": "SITAGLIPTIN AND METFORMIN HYDROCHLORIDEANDA  #218069",
    "submission": "ORIG-1",
    "activeIngredients": "METFORMIN HYDROCHLORIDE, SITAGLIPTIN",
    "company": "NOVAST LABS LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "05/28/2025",
    "drugName": "KHINDIVINDA   #218980",
    "submission": "ORIG-1",
    "activeIngredients": "HYDROCORTISONE",
    "company": "ETON",
    "submissionClassification": "Type 3 - New Dosage Form",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/28/2025",
    "drugName": "UBROGEPANTANDA  #219088",
    "submission": "ORIG-1",
    "activeIngredients": "UBROGEPANT",
    "company": "AUROBINDO PHARMA LIMITED",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "05/28/2025",
    "drugName": "MAGNESIUM SULFATEANDA  #219777",
    "submission": "ORIG-1",
    "activeIngredients": "MAGNESIUM SULFATE",
    "company": "ASPIRO",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/28/2025",
    "drugName": "SPEVIGOBLA   #761244",
    "submission": "SUPPL-4",
    "activeIngredients": "SPESOLIMAB-SBZO",
    "company": "BOEHRINGER INGELHEIM PHARMACEUTICALS INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/28/2025",
    "drugName": "SPEVIGOBLA   #761244",
    "submission": "SUPPL-6",
    "activeIngredients": "SPESOLIMAB-SBZO",
    "company": "BOEHRINGER INGELHEIM PHARMACEUTICALS INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/29/2025",
    "drugName": "METHERGINENDA   #006035",
    "submission": "SUPPL-80",
    "activeIngredients": "METHYLERGONOVINE MALEATE",
    "company": "EDISON THERAPS LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/29/2025",
    "drugName": "VANCOMYCIN HYDROCHLORIDE IN PLASTIC CONTAINERNDA   #050671",
    "submission": "SUPPL-36",
    "activeIngredients": "VANCOMYCIN HYDROCHLORIDE",
    "company": "BAXTER HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/29/2025",
    "drugName": "PHENTERMINE HYDROCHLORIDE AND TOPIRAMATEANDA  #204982",
    "submission": "SUPPL-12",
    "activeIngredients": "PHENTERMINE HYDROCHLORIDE; TOPIRAMATE",
    "company": "ACTAVIS LABS FL INC",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/29/2025",
    "drugName": "LACOSAMIDEANDA  #205011",
    "submission": "SUPPL-1",
    "activeIngredients": "LACOSAMIDE",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/29/2025",
    "drugName": "LACOSAMIDEANDA  #205011",
    "submission": "SUPPL-2",
    "activeIngredients": "LACOSAMIDE",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/29/2025",
    "drugName": "LINEZOLID IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERNDA   #206473",
    "submission": "SUPPL-11",
    "activeIngredients": "LINEZOLID",
    "company": "HOSPIRA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/29/2025",
    "drugName": "VANCOMYCIN HYDROCHLORIDENDA   #210274",
    "submission": "SUPPL-3",
    "activeIngredients": "VANCOMYCIN HYDROCHLORIDE",
    "company": "ZHEJIANG NOVUS PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/29/2025",
    "drugName": "RIFAXIMINANDA  #213713",
    "submission": "ORIG-1",
    "activeIngredients": "RIFAXIMIN",
    "company": "SANDOZ INC",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "05/29/2025",
    "drugName": "METHOTREXATENDA   #214121",
    "submission": "SUPPL-4",
    "activeIngredients": "METHOTREXATE",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/29/2025",
    "drugName": "FOCINVEZNDA   #216686",
    "submission": "SUPPL-2",
    "activeIngredients": "FOSAPREPITANT DIMEGLUMINE",
    "company": "STERISCIENCE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/29/2025",
    "drugName": "MESALAMINEANDA  #217337",
    "submission": "SUPPL-4",
    "activeIngredients": "MESALAMINE",
    "company": "SINOTHERAPEUTICS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/29/2025",
    "drugName": "ROCURONIUM BROMIDEANDA  #219674",
    "submission": "ORIG-1",
    "activeIngredients": "ROCURONIUM BROMIDE",
    "company": "MANKIND PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/30/2025",
    "drugName": "PROLIABLA   #125320",
    "submission": "SUPPL-222",
    "activeIngredients": "DENOSUMAB",
    "company": "AMGEN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/30/2025",
    "drugName": "XGEVABLA   #125320",
    "submission": "SUPPL-222",
    "activeIngredients": "DENOSUMAB",
    "company": "AMGEN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/30/2025",
    "drugName": "TOBRAMYCIN SULFATEANDA  #205685",
    "submission": "SUPPL-3",
    "activeIngredients": "TOBRAMYCIN SULFATE",
    "company": "XELLIA PHARMS APS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/30/2025",
    "drugName": "LINAGLIPTINANDA  #208457",
    "submission": "ORIG-1",
    "activeIngredients": "LINAGLIPTIN",
    "company": "MSN LABS PVT LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "05/30/2025",
    "drugName": "LINAGLIPTIN; METFORMIN HYDROCHLORIDEANDA  #208459",
    "submission": "ORIG-1",
    "activeIngredients": "LINAGLIPTIN; METFORMIN HYDROCHLORIDE",
    "company": "MSN LABS PVT LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "05/30/2025",
    "drugName": "XOFLUZANDA   #210854",
    "submission": "SUPPL-23",
    "activeIngredients": "BALOXAVIR MARBOXIL",
    "company": "GENENTECH INC",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/30/2025",
    "drugName": "ACETAZOLAMIDEANDA  #212089",
    "submission": "ORIG-1",
    "activeIngredients": "ACETAZOLAMIDE",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/30/2025",
    "drugName": "XENOVIEWNDA   #214375",
    "submission": "SUPPL-1",
    "activeIngredients": "XENON XE-129 HYPERPOLARIZED",
    "company": "POLAREAN",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/30/2025",
    "drugName": "XOFLUZANDA   #214410",
    "submission": "SUPPL-8",
    "activeIngredients": "BALOXAVIR MARBOXIL",
    "company": "GENENTECH INC",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/30/2025",
    "drugName": "SITAGLIPTIN; METFORMIN HYDROCHLORIDEANDA  #214685",
    "submission": "ORIG-1",
    "activeIngredients": "SITAGLIPTIN;METFORMIN HYDROCHLORIDE",
    "company": "DR REDDYS LABS LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "05/30/2025",
    "drugName": "PHENYLEPHRINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDENDA   #216830",
    "submission": "ORIG-1",
    "activeIngredients": "PHENYLEPHRINE HYDROCHLORIDE",
    "company": "DR REDDYS LABS SA",
    "submissionClassification": "Type 5 - New Formulation or New Manufacturer",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "05/30/2025",
    "drugName": "RIFAXIMINANDA  #218650",
    "submission": "ORIG-1",
    "activeIngredients": "RIFAXIMIN",
    "company": "ZYDUS PHARMS USA INC",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  }
,
  {
    "approvalDate": "06/02/2025",
    "drugName": "ZOFRANNDA   #020007",
    "submission": "SUPPL-50",
    "activeIngredients": "ONDANSETRON HYDROCHLORIDE",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/02/2025",
    "drugName": "ZOFRAN PRESERVATIVE FREENDA   #020007",
    "submission": "SUPPL-50",
    "activeIngredients": "ONDANSETRON HYDROCHLORIDE",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/02/2025",
    "drugName": "ZOFRANNDA   #020103",
    "submission": "SUPPL-39",
    "activeIngredients": "ONDANSETRON HYDROCHLORIDE",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/02/2025",
    "drugName": "ZOFRANNDA   #020605",
    "submission": "SUPPL-23",
    "activeIngredients": "ONDANSETRON HYDROCHLORIDE",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/02/2025",
    "drugName": "ZOFRAN ODTNDA   #020781",
    "submission": "SUPPL-23",
    "activeIngredients": "ONDANSETRON",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/02/2025",
    "drugName": "NAPROXEN SODIUMANDA  #078432",
    "submission": "SUPPL-11",
    "activeIngredients": "NAPROXEN SODIUM",
    "company": "AMNEAL PHARMS NY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/02/2025",
    "drugName": "NAPROXEN SODIUMANDA  #078432",
    "submission": "SUPPL-13",
    "activeIngredients": "NAPROXEN SODIUM",
    "company": "AMNEAL PHARMS NY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/02/2025",
    "drugName": "NAPROXEN SODIUMANDA  #078432",
    "submission": "SUPPL-17",
    "activeIngredients": "NAPROXEN SODIUM",
    "company": "AMNEAL PHARMS NY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/02/2025",
    "drugName": "NAPROXEN SODIUMANDA  #078432",
    "submission": "SUPPL-18",
    "activeIngredients": "NAPROXEN SODIUM",
    "company": "AMNEAL PHARMS NY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/02/2025",
    "drugName": "AMPHOTERICIN BANDA  #215354",
    "submission": "ORIG-1",
    "activeIngredients": "AMPHOTERICIN B",
    "company": "AVET LIFESCIENCES",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/02/2025",
    "drugName": "HYDRALAZINE HYDROCHLORIDEANDA  #217501",
    "submission": "ORIG-1",
    "activeIngredients": "HYDRALAZINE HYDROCHLORIDE",
    "company": "KINDOS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/02/2025",
    "drugName": "INDOMETHACINANDA  #217883",
    "submission": "SUPPL-5",
    "activeIngredients": "INDOMETHACIN",
    "company": "NOVITIUM PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/02/2025",
    "drugName": "FAMOTIDINEANDA  #217982",
    "submission": "ORIG-1",
    "activeIngredients": "FAMOTIDINE",
    "company": "LANNETT CO INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/02/2025",
    "drugName": "BORTEZOMIBANDA  #218688",
    "submission": "ORIG-1",
    "activeIngredients": "BORTEZOMIB",
    "company": "VILIN BIO MED",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/02/2025",
    "drugName": "TRANEXAMIC ACIDANDA  #218896",
    "submission": "ORIG-1",
    "activeIngredients": "TRANEXAMIC ACID",
    "company": "HERITAGE",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/02/2025",
    "drugName": "CENOBAMATEANDA  #219403",
    "submission": "ORIG-1",
    "activeIngredients": "CENOBAMATE",
    "company": "ZENARA PHARMA PRIVATE LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "06/02/2025",
    "drugName": "OLAPARIBANDA  #219410",
    "submission": "ORIG-1",
    "activeIngredients": "OLAPARIB",
    "company": "CIPLA LIMITED",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "06/03/2025",
    "drugName": "DOXORUBICIN HYDROCHLORIDEANDA  #063277",
    "submission": "SUPPL-24",
    "activeIngredients": "DOXORUBICIN HYDROCHLORIDE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/03/2025",
    "drugName": "DOXORUBICIN HYDROCHLORIDEANDA  #063277",
    "submission": "SUPPL-31",
    "activeIngredients": "DOXORUBICIN HYDROCHLORIDE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/03/2025",
    "drugName": "DOXORUBICIN HYDROCHLORIDEANDA  #063277",
    "submission": "SUPPL-32",
    "activeIngredients": "DOXORUBICIN HYDROCHLORIDE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/03/2025",
    "drugName": "MYORISANANDA  #076485",
    "submission": "SUPPL-40",
    "activeIngredients": "ISOTRETINOIN",
    "company": "UPSHER SMITH LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/03/2025",
    "drugName": "KEYTRUDABLA   #125514",
    "submission": "SUPPL-173",
    "activeIngredients": "PEMBROLIZUMAB",
    "company": "MERCK SHARP DOHME",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/03/2025",
    "drugName": "METHYLPHENIDATE HYDROCHLORIDEANDA  #204602",
    "submission": "SUPPL-3",
    "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "company": "NOVEL LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/03/2025",
    "drugName": "METHYLPHENIDATE HYDROCHLORIDEANDA  #204602",
    "submission": "SUPPL-5",
    "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "company": "NOVEL LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/03/2025",
    "drugName": "METHYLPHENIDATE HYDROCHLORIDEANDA  #204602",
    "submission": "SUPPL-6",
    "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "company": "NOVEL LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/03/2025",
    "drugName": "ISOTRETINOINANDA  #205063",
    "submission": "SUPPL-8",
    "activeIngredients": "ISOTRETINOIN",
    "company": "ACTAVIS LABS FL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/03/2025",
    "drugName": "EPOPROSTENOL SODIUMANDA  #210473",
    "submission": "SUPPL-5",
    "activeIngredients": "EPOPROSTENOL SODIUM",
    "company": "SUN PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/03/2025",
    "drugName": "NUBEQANDA   #212099",
    "submission": "SUPPL-8",
    "activeIngredients": "DAROLUTAMIDE",
    "company": "BAYER HEALTHCARE",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/03/2025",
    "drugName": "BACLOFENANDA  #212378",
    "submission": "SUPPL-7",
    "activeIngredients": "BACLOFEN",
    "company": "ANDAS 5 HOLDING",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/03/2025",
    "drugName": "BACLOFENANDA  #214445",
    "submission": "SUPPL-2",
    "activeIngredients": "BACLOFEN",
    "company": "RUBICON RESEARCH",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/03/2025",
    "drugName": "ANGIOTENSIN ll ACETATEANDA  #216966",
    "submission": "ORIG-1",
    "activeIngredients": "ANGIOTENSIN II ACETATE",
    "company": "GLAND",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/03/2025",
    "drugName": "FOSFOMYCIN TROMETHAMINEANDA  #217187",
    "submission": "ORIG-1",
    "activeIngredients": "FOSFOMYCIN TROMETHAMINE",
    "company": "PRECISION DOSE INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/03/2025",
    "drugName": "CETRORELIX ACETATEANDA  #218061",
    "submission": "ORIG-1",
    "activeIngredients": "CETRORELIX ACETATE",
    "company": "XIROMED",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/03/2025",
    "drugName": "EPINEPHRINEANDA  #218144",
    "submission": "ORIG-1",
    "activeIngredients": "EPINEPHRINE",
    "company": "GLAND",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/04/2025",
    "drugName": "DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINERNDA   #018826",
    "submission": "SUPPL-51",
    "activeIngredients": "DOPAMINE HYDROCHLORIDE",
    "company": "HOSPIRA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/04/2025",
    "drugName": "GABAPENTINANDA  #203244",
    "submission": "SUPPL-8",
    "activeIngredients": "GABAPENTIN",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/04/2025",
    "drugName": "GABAPENTINANDA  #203244",
    "submission": "SUPPL-9",
    "activeIngredients": "GABAPENTIN",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/04/2025",
    "drugName": "GABAPENTINANDA  #203244",
    "submission": "SUPPL-16",
    "activeIngredients": "GABAPENTIN",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/04/2025",
    "drugName": "GABAPENTINANDA  #203244",
    "submission": "SUPPL-17",
    "activeIngredients": "GABAPENTIN",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/04/2025",
    "drugName": "GABAPENTINANDA  #203244",
    "submission": "SUPPL-31",
    "activeIngredients": "GABAPENTIN",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/04/2025",
    "drugName": "GABAPENTINANDA  #203244",
    "submission": "SUPPL-32",
    "activeIngredients": "GABAPENTIN",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/04/2025",
    "drugName": "GABAPENTINANDA  #203244",
    "submission": "SUPPL-33",
    "activeIngredients": "GABAPENTIN",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/04/2025",
    "drugName": "SITAGLIPTIN AND METFORMIN HYDROCHLORIDEANDA  #204144",
    "submission": "ORIG-1",
    "activeIngredients": "METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE",
    "company": "PH HEALTH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/04/2025",
    "drugName": "PERAMPANELANDA  #209538",
    "submission": "ORIG-1",
    "activeIngredients": "PERAMPANEL",
    "company": "TARO PHARM INDS LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "06/04/2025",
    "drugName": "NALOXONE HYDROCHLORIDEANDA  #215964",
    "submission": "SUPPL-7",
    "activeIngredients": "NALOXONE HYDROCHLORIDE",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/04/2025",
    "drugName": "CRISABOROLEANDA  #216242",
    "submission": "ORIG-1",
    "activeIngredients": "CRISABOROLE",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "06/04/2025",
    "drugName": "OXCARBAZEPINEANDA  #218724",
    "submission": "ORIG-1",
    "activeIngredients": "OXCARBAZEPINE",
    "company": "NOVAST LABS LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "06/04/2025",
    "drugName": "BAVENCIOBLA   #761049",
    "submission": "SUPPL-21",
    "activeIngredients": "AVELUMAB",
    "company": "EMD SERONO INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2025",
    "drugName": "DULERANDA   #022518",
    "submission": "SUPPL-33",
    "activeIngredients": "FORMOTEROL FUMARATE; MOMETASONE FUROATE",
    "company": "ORGANON LLC",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2025",
    "drugName": "IMIPRAMINE PAMOATEANDA  #090444",
    "submission": "SUPPL-6",
    "activeIngredients": "IMIPRAMINE PAMOATE",
    "company": "LUPIN LTD",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2025",
    "drugName": "SILDENAFIL CITRATEANDA  #203623",
    "submission": "SUPPL-15",
    "activeIngredients": "SILDENAFIL CITRATE",
    "company": "HETERO LABS LTD V",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2025",
    "drugName": "SILDENAFIL CITRATEANDA  #203623",
    "submission": "SUPPL-16",
    "activeIngredients": "SILDENAFIL CITRATE",
    "company": "HETERO LABS LTD V",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2025",
    "drugName": "UBRELVYNDA   #211765",
    "submission": "SUPPL-12",
    "activeIngredients": "UBROGEPANT",
    "company": "ABBVIE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2025",
    "drugName": "OMEPRAZOLE MAGNESIUMANDA  #216096",
    "submission": "SUPPL-5",
    "activeIngredients": "OMEPRAZOLE MAGNESIUM",
    "company": "L PERRIGO CO",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2025",
    "drugName": "MILRINONE LACTATEANDA  #216373",
    "submission": "SUPPL-3",
    "activeIngredients": "MILRINONE LACTATE",
    "company": "SHANDONG",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2025",
    "drugName": "VALSARTANANDA  #216460",
    "submission": "ORIG-1",
    "activeIngredients": "VALSARTAN",
    "company": "RUBICON",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2025",
    "drugName": "FLUTICASONE PROPIONATEANDA  #218321",
    "submission": "ORIG-1",
    "activeIngredients": "FLUTICASONE PROPIONATE",
    "company": "RUBICON RESEARCH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2025",
    "drugName": "SIPONIMODANDA  #218393",
    "submission": "ORIG-1",
    "activeIngredients": "SIPONIMOD",
    "company": "DR REDDYS LABS LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "06/05/2025",
    "drugName": "XIFYRMNDA   #218395",
    "submission": "ORIG-1",
    "activeIngredients": "MELOXICAM",
    "company": "AZURITY",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/05/2025",
    "drugName": "WIDAPLIKNDA   #219423",
    "submission": "ORIG-1",
    "activeIngredients": "AMLODIPINE BESYLATE; INDAPAMIDE; TELMISARTAN",
    "company": "AZURITY",
    "submissionClassification": "Type 4 - New Combination",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/06/2025",
    "drugName": "DEXTROSE 5% IN PLASTIC CONTAINERNDA   #019466",
    "submission": "SUPPL-63",
    "activeIngredients": "DEXTROSE",
    "company": "HOSPIRA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/06/2025",
    "drugName": "DEXTROSE 5% IN PLASTIC CONTAINERNDA   #019479",
    "submission": "SUPPL-56",
    "activeIngredients": "DEXTROSE",
    "company": "HOSPIRA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/06/2025",
    "drugName": "LIPOFENNDA   #021612",
    "submission": "SUPPL-26",
    "activeIngredients": "FENOFIBRATE",
    "company": "CIPHER PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/06/2025",
    "drugName": "TRICORNDA   #021656",
    "submission": "SUPPL-32",
    "activeIngredients": "FENOFIBRATE",
    "company": "ABBVIE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/06/2025",
    "drugName": "FENOGLIDENDA   #022118",
    "submission": "SUPPL-14",
    "activeIngredients": "FENOFIBRATE",
    "company": "SALIX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/06/2025",
    "drugName": "TRILIPIXNDA   #022224",
    "submission": "SUPPL-18",
    "activeIngredients": "CHOLINE FENOFIBRATE",
    "company": "ABBVIE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/06/2025",
    "drugName": "PROMACTANDA   #022291",
    "submission": "SUPPL-41",
    "activeIngredients": "ELTROMBOPAG OLAMINE",
    "company": "NOVARTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/06/2025",
    "drugName": "FIBRICORNDA   #022418",
    "submission": "SUPPL-20",
    "activeIngredients": "FENOFIBRIC ACID",
    "company": "ATHENA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/06/2025",
    "drugName": "ESCITALOPRAM OXALATEANDA  #077734",
    "submission": "SUPPL-1",
    "activeIngredients": "ESCITALOPRAM OXALATE",
    "company": "ZYDUS LIFESCIENCES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/06/2025",
    "drugName": "ESCITALOPRAM OXALATEANDA  #077734",
    "submission": "SUPPL-2",
    "activeIngredients": "ESCITALOPRAM OXALATE",
    "company": "ZYDUS LIFESCIENCES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/06/2025",
    "drugName": "ESCITALOPRAM OXALATEANDA  #077734",
    "submission": "SUPPL-3",
    "activeIngredients": "ESCITALOPRAM OXALATE",
    "company": "ZYDUS LIFESCIENCES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/06/2025",
    "drugName": "KEYTRUDABLA   #125514",
    "submission": "SUPPL-183",
    "activeIngredients": "PEMBROLIZUMAB",
    "company": "MERCK SHARP DOHME",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/06/2025",
    "drugName": "PROMACTA KITNDA   #207027",
    "submission": "SUPPL-20",
    "activeIngredients": "ELTROMBOPAG OLAMINE",
    "company": "NOVARTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/06/2025",
    "drugName": "METHYLPHENIDATE HYDROCHLORIDEANDA  #207417",
    "submission": "SUPPL-1",
    "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "company": "ASCENT PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/06/2025",
    "drugName": "FETROJANDA   #209445",
    "submission": "SUPPL-9",
    "activeIngredients": "CEFIDEROCOL SULFATE TOSYLATE",
    "company": "SHIONOGI INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/06/2025",
    "drugName": "LABETALOL HYDROCHLORIDEANDA  #211953",
    "submission": "SUPPL-12",
    "activeIngredients": "LABETALOL HYDROCHLORIDE",
    "company": "RUBICON RESEARCH",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/06/2025",
    "drugName": "DICYCLOMINE HYDROCHLORIDEANDA  #218310",
    "submission": "ORIG-1",
    "activeIngredients": "DICYCLOMINE HYDROCHLORIDE",
    "company": "PRINSTON INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/06/2025",
    "drugName": "OXCARBAZEPINE EXTENDED RELEASE TABLETSANDA  #219404",
    "submission": "ORIG-1",
    "activeIngredients": "OXCARBAZEPINE",
    "company": "LUPIN LIMITED",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "06/06/2025",
    "drugName": "OPUVIZBLA   #761350",
    "submission": "SUPPL-6",
    "activeIngredients": "AFLIBERCEPT-YSZY",
    "company": "SAMSUNG BIOEPIS CO LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/06/2025",
    "drugName": "VYLOYBLA   #761365",
    "submission": "SUPPL-3",
    "activeIngredients": "ZOLBETUXIMAB-CLZB",
    "company": "ASTELLAS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/07/2025",
    "drugName": "EXXUANDA   #021164",
    "submission": "SUPPL-1",
    "activeIngredients": "GEPIRONE HYDROCHLORIDE",
    "company": "FABRE KRAMER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/09/2025",
    "drugName": "DEXTROSE 5% IN PLASTIC CONTAINERNDA   #016367",
    "submission": "SUPPL-231",
    "activeIngredients": "DEXTROSE",
    "company": "OTSUKA ICU MEDCL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/09/2025",
    "drugName": "DEXTROSE 10% IN PLASTIC CONTAINERNDA   #018080",
    "submission": "SUPPL-122",
    "activeIngredients": "DEXTROSE",
    "company": "OTSUKA ICU MEDCL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/09/2025",
    "drugName": "ITRACONAZOLEANDA  #076104",
    "submission": "SUPPL-28",
    "activeIngredients": "ITRACONAZOLE",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/09/2025",
    "drugName": "ERIBULIN MESYLATEANDA  #214310",
    "submission": "ORIG-1",
    "activeIngredients": "ERIBULIN MESYLATE",
    "company": "SANDOZ",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/09/2025",
    "drugName": "SAPROPTERIN DIHYDROCHLORIDEANDA  #216797",
    "submission": "ORIG-1",
    "activeIngredients": "SAPROPTERIN DIHYDROCHLORIDE",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/09/2025",
    "drugName": "TRANEXAMIC ACIDANDA  #217155",
    "submission": "SUPPL-3",
    "activeIngredients": "TRANEXAMIC ACID",
    "company": "AMNEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/09/2025",
    "drugName": "CALCIUM GLUCONATE IN SODIUM CHLORIDEANDA  #217174",
    "submission": "SUPPL-5",
    "activeIngredients": "CALCIUM GLUCONATE",
    "company": "AMNEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/09/2025",
    "drugName": "LEUPROLIDE ACETATEANDA  #217437",
    "submission": "ORIG-1",
    "activeIngredients": "LEUPROLIDE ACETATE",
    "company": "PH HEALTH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/09/2025",
    "drugName": "ROCURONIUM BROMIDENDA   #217472",
    "submission": "ORIG-1",
    "activeIngredients": "ROCURONIUM BROMIDE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Type 5 - New Formulation or New Manufacturer",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/09/2025",
    "drugName": "SCOPOLAMINEANDA  #218384",
    "submission": "ORIG-1",
    "activeIngredients": "SCOPOLAMINE",
    "company": "AMNEAL",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/09/2025",
    "drugName": "TRUXIMABLA   #761088",
    "submission": "SUPPL-32",
    "activeIngredients": "RITUXIMAB-ABBS",
    "company": "CELLTRION INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/09/2025",
    "drugName": "RUXIENCEBLA   #761103",
    "submission": "SUPPL-14",
    "activeIngredients": "RITUXIMAB-PVVR",
    "company": "PFIZER INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/09/2025",
    "drugName": "RIABNIBLA   #761140",
    "submission": "SUPPL-4",
    "activeIngredients": "RITUXIMAB-ARRX",
    "company": "AMGEN INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/09/2025",
    "drugName": "COLUMVIBLA   #761309",
    "submission": "SUPPL-3",
    "activeIngredients": "GLOFITAMAB-GXBM",
    "company": "GENENTECH INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/09/2025",
    "drugName": "ENFLONSIABLA   #761432",
    "submission": "ORIG-1",
    "activeIngredients": "CLESROVIMAB-CFOR",
    "company": "MERCK SHARP DOHME",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/10/2025",
    "drugName": "TRANSDERM SCOPNDA   #017874",
    "submission": "SUPPL-52",
    "activeIngredients": "SCOPOLAMINE",
    "company": "BAXTER HLTHCARE CORP",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/10/2025",
    "drugName": "NAPROXEN SODIUMANDA  #078486",
    "submission": "SUPPL-8",
    "activeIngredients": "NAPROXEN SODIUM",
    "company": "DR REDDYS LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/10/2025",
    "drugName": "NAPROXEN SODIUMANDA  #078486",
    "submission": "SUPPL-10",
    "activeIngredients": "NAPROXEN SODIUM",
    "company": "DR REDDYS LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/10/2025",
    "drugName": "NAPROXEN SODIUMANDA  #078486",
    "submission": "SUPPL-11",
    "activeIngredients": "NAPROXEN SODIUM",
    "company": "DR REDDYS LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/10/2025",
    "drugName": "EXEMESTANEANDA  #202602",
    "submission": "SUPPL-4",
    "activeIngredients": "EXEMESTANE",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/10/2025",
    "drugName": "VIZAMYLNDA   #203137",
    "submission": "SUPPL-32",
    "activeIngredients": "FLUTEMETAMOL F-18",
    "company": "GE HEALTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/10/2025",
    "drugName": "LEVOCETIRIZINE DIHYDROCHLORIDEANDA  #204599",
    "submission": "SUPPL-1",
    "activeIngredients": "LEVOCETIRIZINE DIHYDROCHLORIDE",
    "company": "CHARTWELL MOLECULAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/10/2025",
    "drugName": "LEVOCETIRIZINE DIHYDROCHLORIDEANDA  #204599",
    "submission": "SUPPL-2",
    "activeIngredients": "LEVOCETIRIZINE DIHYDROCHLORIDE",
    "company": "CHARTWELL MOLECULAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/10/2025",
    "drugName": "LEVOCETIRIZINE DIHYDROCHLORIDEANDA  #204599",
    "submission": "SUPPL-3",
    "activeIngredients": "LEVOCETIRIZINE DIHYDROCHLORIDE",
    "company": "CHARTWELL MOLECULAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/10/2025",
    "drugName": "LEVOCETIRIZINE DIHYDROCHLORIDEANDA  #204599",
    "submission": "SUPPL-4",
    "activeIngredients": "LEVOCETIRIZINE DIHYDROCHLORIDE",
    "company": "CHARTWELL MOLECULAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/10/2025",
    "drugName": "STERITALCNDA   #205555",
    "submission": "SUPPL-5",
    "activeIngredients": "TALC",
    "company": "NOVATECH SA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/10/2025",
    "drugName": "MAVYRETNDA   #209394",
    "submission": "SUPPL-19",
    "activeIngredients": "GLECAPREVIR; PIBRENTASVIR",
    "company": "ABBVIE",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/10/2025",
    "drugName": "HARLIKUNDA   #209449",
    "submission": "SUPPL-18",
    "activeIngredients": "NITISINONE",
    "company": "CYCLE",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/10/2025",
    "drugName": "NITYRNDA   #209449",
    "submission": "SUPPL-18",
    "activeIngredients": "NITISINONE",
    "company": "CYCLE",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/10/2025",
    "drugName": "BOSENTANANDA  #213981",
    "submission": "ORIG-1",
    "activeIngredients": "BOSENTAN",
    "company": "ZYDUS PHARMS USA INC",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "06/10/2025",
    "drugName": "SODIUM POLYSTYRENE SULFONATEANDA  #214912",
    "submission": "ORIG-1",
    "activeIngredients": "SODIUM POLYSTYRENE SULFONATE",
    "company": "LYNE",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/10/2025",
    "drugName": "EMPAVELINDA   #215014",
    "submission": "SUPPL-10",
    "activeIngredients": "PEGCETACOPLAN",
    "company": "APELLIS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/10/2025",
    "drugName": "MAVYRETNDA   #215110",
    "submission": "SUPPL-5",
    "activeIngredients": "GLECAPREVIR; PIBRENTASVIR",
    "company": "ABBVIE",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/10/2025",
    "drugName": "QULIPTANDA   #215206",
    "submission": "SUPPL-10",
    "activeIngredients": "ATOGEPANT",
    "company": "ABBVIE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/10/2025",
    "drugName": "QULIPTANDA   #215206",
    "submission": "SUPPL-12",
    "activeIngredients": "ATOGEPANT",
    "company": "ABBVIE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/10/2025",
    "drugName": "ZINC SULFATEANDA  #217624",
    "submission": "ORIG-1",
    "activeIngredients": "ZINC SULFATE",
    "company": "RK PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/10/2025",
    "drugName": "BRUKINSANDA   #218785",
    "submission": "ORIG-1",
    "activeIngredients": "ZANUBRUTINIB",
    "company": "BEONE MEDICINES USA",
    "submissionClassification": "Type 3 - New Dosage Form",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/10/2025",
    "drugName": "BRUKINSANDA   #218785",
    "submission": "ORIG-2",
    "activeIngredients": "ZANUBRUTINIB",
    "company": "BEONE MEDICINES USA",
    "submissionClassification": "Type 3 - New Dosage Form",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/11/2025",
    "drugName": "HECTOROLNDA   #020862",
    "submission": "SUPPL-33",
    "activeIngredients": "DOXERCALCIFEROL",
    "company": "SANOFI",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/11/2025",
    "drugName": "METOPROLOL TARTRATEANDA  #078085",
    "submission": "SUPPL-19",
    "activeIngredients": "METOPROLOL TARTRATE",
    "company": "HOSPIRA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/11/2025",
    "drugName": "OLANZAPINEANDA  #211072",
    "submission": "ORIG-1",
    "activeIngredients": "OLANZAPINE",
    "company": "UBI",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/11/2025",
    "drugName": "PREDNISOLONE ACETATEANDA  #218256",
    "submission": "ORIG-1",
    "activeIngredients": "PREDNISOLONE ACETATE",
    "company": "AMNEAL",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/11/2025",
    "drugName": "TRANEXAMIC ACIDANDA  #218729",
    "submission": "ORIG-1",
    "activeIngredients": "TRANEXAMIC ACID",
    "company": "APPCO",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/11/2025",
    "drugName": "SAPROPTERIN DIHYDROCHLORIDEANDA  #218797",
    "submission": "ORIG-1",
    "activeIngredients": "SAPROPTERIN DIHYDROCHLORIDE",
    "company": "ZENARA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/11/2025",
    "drugName": "SELENIOUS ACIDANDA  #219633",
    "submission": "ORIG-1",
    "activeIngredients": "SELENIOUS ACID",
    "company": "ASPIRO",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/11/2025",
    "drugName": "IBTROZINDA   #219713",
    "submission": "ORIG-1",
    "activeIngredients": "TALETRECTINIB ADIPATE",
    "company": "NUVATION",
    "submissionClassification": "Type 1 - New Molecular Entity",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2025",
    "drugName": "LEVOCETIRIZINE DIHYDROCHLORIDEANDA  #090362",
    "submission": "SUPPL-13",
    "activeIngredients": "LEVOCETIRIZINE DIHYDROCHLORIDE",
    "company": "SUN PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2025",
    "drugName": "EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATEANDA  #090958",
    "submission": "SUPPL-4",
    "activeIngredients": "EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE",
    "company": "CIPLA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2025",
    "drugName": "EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATEANDA  #090958",
    "submission": "SUPPL-9",
    "activeIngredients": "EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE",
    "company": "CIPLA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2025",
    "drugName": "EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATEANDA  #090958",
    "submission": "SUPPL-10",
    "activeIngredients": "EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE",
    "company": "CIPLA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2025",
    "drugName": "KEYTRUDABLA   #125514",
    "submission": "SUPPL-180",
    "activeIngredients": "PEMBROLIZUMAB",
    "company": "MERCK SHARP DOHME",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2025",
    "drugName": "LIOTHYRONINE SODIUMANDA  #200295",
    "submission": "SUPPL-9",
    "activeIngredients": "LIOTHYRONINE SODIUM",
    "company": "SIGMAPHARM LABS LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2025",
    "drugName": "ITRACONAZOLEANDA  #204672",
    "submission": "SUPPL-4",
    "activeIngredients": "ITRACONAZOLE",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2025",
    "drugName": "PHENTERMINE HYDROCHLORIDE AND TOPIRAMATEANDA  #208175",
    "submission": "ORIG-1",
    "activeIngredients": "PHENTERMINE HYDROCHLORIDE; TOPIRAMATE",
    "company": "DR REDDYS LABS SA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2025",
    "drugName": "DELSTRIGONDA   #210807",
    "submission": "SUPPL-16",
    "activeIngredients": "DORAVIRINE; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE",
    "company": "MSD MERCK CO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2025",
    "drugName": "DOLUTEGRAVIR SODIUM AND ABACAVIR SULFATE AND LAMIVUDINEANDA  #210811",
    "submission": "ORIG-1",
    "activeIngredients": "ABACAVIR || DOLUTEGRAVIR || LAMIVUDINE",
    "company": "CIPLA LIMITED",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "06/12/2025",
    "drugName": "TALZENNANDA   #211651",
    "submission": "SUPPL-13",
    "activeIngredients": "TALAZOPARIB TOSYLATE",
    "company": "PFIZER",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2025",
    "drugName": "SODIUM IODIDE I 131ANDA  #213615",
    "submission": "ORIG-1",
    "activeIngredients": "SODIUM IODIDE I-131",
    "company": "CARDINAL HLTH 414",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2025",
    "drugName": "MINOCYCLINE HYDROCHLORIDEANDA  #214934",
    "submission": "ORIG-1",
    "activeIngredients": "MINOCYCLINE HYDROCHLORIDE",
    "company": "NEXUS",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "06/12/2025",
    "drugName": "VOQUEZNA TRIPLE PAKNDA   #215152",
    "submission": "SUPPL-15",
    "activeIngredients": "AMOXICILLIN; CLARITHROMYCIN; VONOPRAZAN FUMARATE",
    "company": "PHATHOM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2025",
    "drugName": "VOQUEZNA DUAL PAKNDA   #215153",
    "submission": "SUPPL-14",
    "activeIngredients": "AMOXICILLIN; VONOPRAZAN FUMARATE",
    "company": "PHATHOM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2025",
    "drugName": "ZUSDURINDA   #215793",
    "submission": "ORIG-1",
    "activeIngredients": "MITOMYCIN",
    "company": "UROGEN PHARMA",
    "submissionClassification": "Type 3 - New Dosage Form",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2025",
    "drugName": "TALZENNANDA   #217439",
    "submission": "SUPPL-3",
    "activeIngredients": "TALAZOPARIB TOSYLATE",
    "company": "PFIZER",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/12/2025",
    "drugName": "SELENIOUS ACIDANDA  #219476",
    "submission": "ORIG-1",
    "activeIngredients": "SELENIOUS ACID",
    "company": "XIROMED",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "06/12/2025",
    "drugName": "DOLUTEGRAVIR AND LAMIVUDINEANDA  #219623",
    "submission": "ORIG-1",
    "activeIngredients": "DOLUTEGRAVIR AND LAMIVUDINE",
    "company": "EMCURE PHARMS LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "06/13/2025",
    "drugName": "CLOZARILNDA   #019758",
    "submission": "SUPPL-107",
    "activeIngredients": "CLOZAPINE",
    "company": "HERITAGE LIFE",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/13/2025",
    "drugName": "DIAZEPAMANDA  #070313",
    "submission": "SUPPL-30",
    "activeIngredients": "DIAZEPAM",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/13/2025",
    "drugName": "DIAZEPAMANDA  #070313",
    "submission": "SUPPL-31",
    "activeIngredients": "DIAZEPAM",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/13/2025",
    "drugName": "CLOZAPINEANDA  #074949",
    "submission": "SUPPL-90",
    "activeIngredients": "CLOZAPINE",
    "company": "IVAX SUB TEVA PHARMS",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/13/2025",
    "drugName": "CLOZAPINEANDA  #075417",
    "submission": "SUPPL-63",
    "activeIngredients": "CLOZAPINE",
    "company": "MYLAN",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/13/2025",
    "drugName": "CLOZAPINEANDA  #075713",
    "submission": "SUPPL-59",
    "activeIngredients": "CLOZAPINE",
    "company": "SUN PHARM INDS INC",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/13/2025",
    "drugName": "CLOZAPINEANDA  #076809",
    "submission": "SUPPL-53",
    "activeIngredients": "CLOZAPINE",
    "company": "IVAX SUB TEVA PHARMS",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/13/2025",
    "drugName": "RISPERIDONEANDA  #078040",
    "submission": "SUPPL-30",
    "activeIngredients": "RISPERIDONE",
    "company": "ZYDUS PHARMS USA INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/13/2025",
    "drugName": "NAPROXENANDA  #078620",
    "submission": "SUPPL-2",
    "activeIngredients": "NAPROXEN",
    "company": "ZYDUS PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/13/2025",
    "drugName": "NAPROXENANDA  #078620",
    "submission": "SUPPL-3",
    "activeIngredients": "NAPROXEN",
    "company": "ZYDUS PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/13/2025",
    "drugName": "NAPROXENANDA  #078620",
    "submission": "SUPPL-4",
    "activeIngredients": "NAPROXEN",
    "company": "ZYDUS PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/13/2025",
    "drugName": "NAPROXENANDA  #078620",
    "submission": "SUPPL-5",
    "activeIngredients": "NAPROXEN",
    "company": "ZYDUS PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/13/2025",
    "drugName": "THEOPHYLLINEANDA  #081236",
    "submission": "SUPPL-24",
    "activeIngredients": "THEOPHYLLINE",
    "company": "HERITAGE PHARMA AVET",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/13/2025",
    "drugName": "THEOPHYLLINEANDA  #089763",
    "submission": "SUPPL-32",
    "activeIngredients": "THEOPHYLLINE",
    "company": "HERITAGE PHARMA AVET",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/13/2025",
    "drugName": "CLOZAPINEANDA  #090308",
    "submission": "SUPPL-14",
    "activeIngredients": "CLOZAPINE",
    "company": "BARR LABS INC",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/13/2025",
    "drugName": "CLOZAPINEANDA  #090308",
    "submission": "SUPPL-15",
    "activeIngredients": "CLOZAPINE",
    "company": "BARR LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/13/2025",
    "drugName": "LEVOCETIRIZINE DIHYDROCHLORIDEANDA  #090486",
    "submission": "SUPPL-1",
    "activeIngredients": "LEVOCETIRIZINE DIHYDROCHLORIDE",
    "company": "GRANULES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/13/2025",
    "drugName": "MONTELUKAST SODIUMANDA  #091576",
    "submission": "SUPPL-21",
    "activeIngredients": "MONTELUKAST SODIUM",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/13/2025",
    "drugName": "MONTELUKAST SODIUMANDA  #091576",
    "submission": "SUPPL-22",
    "activeIngredients": "MONTELUKAST SODIUM",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/13/2025",
    "drugName": "MONTELUKAST SODIUMANDA  #091588",
    "submission": "SUPPL-20",
    "activeIngredients": "MONTELUKAST SODIUM",
    "company": "PHARMACO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/13/2025",
    "drugName": "MONTELUKAST SODIUMANDA  #091588",
    "submission": "SUPPL-21",
    "activeIngredients": "MONTELUKAST SODIUM",
    "company": "PHARMACO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/13/2025",
    "drugName": "SILDENAFIL CITRATEANDA  #201150",
    "submission": "SUPPL-11",
    "activeIngredients": "SILDENAFIL CITRATE",
    "company": "MYLAN PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/13/2025",
    "drugName": "CLOZAPINEANDA  #201824",
    "submission": "SUPPL-27",
    "activeIngredients": "CLOZAPINE",
    "company": "MYLAN",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/13/2025",
    "drugName": "CLOZAPINEANDA  #201824",
    "submission": "SUPPL-28",
    "activeIngredients": "CLOZAPINE",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/13/2025",
    "drugName": "LEVOCETIRIZINE DIHYDROCHLORIDEANDA  #202046",
    "submission": "SUPPL-9",
    "activeIngredients": "LEVOCETIRIZINE DIHYDROCHLORIDE",
    "company": "MICRO LABS LTD INDIA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/13/2025",
    "drugName": "LEVOCETIRIZINE DIHYDROCHLORIDEANDA  #202046",
    "submission": "SUPPL-12",
    "activeIngredients": "LEVOCETIRIZINE DIHYDROCHLORIDE",
    "company": "MICRO LABS LTD INDIA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/13/2025",
    "drugName": "LEVOCETIRIZINE DIHYDROCHLORIDEANDA  #202046",
    "submission": "SUPPL-13",
    "activeIngredients": "LEVOCETIRIZINE DIHYDROCHLORIDE",
    "company": "MICRO LABS LTD INDIA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/13/2025",
    "drugName": "CLOZAPINEANDA  #202873",
    "submission": "SUPPL-19",
    "activeIngredients": "CLOZAPINE",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/13/2025",
    "drugName": "VERSACLOZNDA   #203479",
    "submission": "SUPPL-26",
    "activeIngredients": "CLOZAPINE",
    "company": "DOUGLAS PHARMS",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/13/2025",
    "drugName": "CLOZAPINEANDA  #203807",
    "submission": "SUPPL-17",
    "activeIngredients": "CLOZAPINE",
    "company": "DR REDDYS LABS SA",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/13/2025",
    "drugName": "EPTIFIBATIDEANDA  #205557",
    "submission": "SUPPL-3",
    "activeIngredients": "EPTIFIBATIDE",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/13/2025",
    "drugName": "PITAVASTATIN CALCIUMANDA  #205932",
    "submission": "SUPPL-3",
    "activeIngredients": "PITAVASTATIN CALCIUM",
    "company": "ORIENT PHARMA CO LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/13/2025",
    "drugName": "CLOZAPINEANDA  #206433",
    "submission": "SUPPL-22",
    "activeIngredients": "CLOZAPINE",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/13/2025",
    "drugName": "AZATHIOPRINEANDA  #208687",
    "submission": "SUPPL-6",
    "activeIngredients": "AZATHIOPRINE",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/13/2025",
    "drugName": "ALLOPURINOLANDA  #210117",
    "submission": "SUPPL-6",
    "activeIngredients": "ALLOPURINOL",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/13/2025",
    "drugName": "HYDROXYCHLOROQUINE SULFATEANDA  #210543",
    "submission": "SUPPL-3",
    "activeIngredients": "HYDROXYCHLOROQUINE SULFATE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/13/2025",
    "drugName": "CLOZAPINEANDA  #212923",
    "submission": "SUPPL-2",
    "activeIngredients": "CLOZAPINE",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/13/2025",
    "drugName": "CLOZAPINEANDA  #212923",
    "submission": "SUPPL-3",
    "activeIngredients": "CLOZAPINE",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/13/2025",
    "drugName": "SAFINAMIDE MESYLATEANDA  #215913",
    "submission": "ORIG-1",
    "activeIngredients": "SAFINAMIDE MESYLATE",
    "company": "ZENARA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/13/2025",
    "drugName": "GLYCOPYRROLATEANDA  #216297",
    "submission": "SUPPL-1",
    "activeIngredients": "GLYCOPYRROLATE",
    "company": "SCIEGEN PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/13/2025",
    "drugName": "BUMETANIDEANDA  #219116",
    "submission": "SUPPL-1",
    "activeIngredients": "BUMETANIDE",
    "company": "QILU PHARM HAINAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/13/2025",
    "drugName": "CARBIDOPA AND LEVODOPAANDA  #219231",
    "submission": "ORIG-1",
    "activeIngredients": "CARBIDOPA, LEVODOPA",
    "company": "DR REDDYS LABS LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "06/13/2025",
    "drugName": "CLINDAMYCIN PHOSPHATEANDA  #219612",
    "submission": "ORIG-1",
    "activeIngredients": "CLINDAMYCIN PHOSPHATE",
    "company": "CARNEGIE",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/13/2025",
    "drugName": "STEQEYMABLA   #761338",
    "submission": "SUPPL-3",
    "activeIngredients": "USTEKINUMAB-STBA",
    "company": "CELLTRION, INC.",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/14/2025",
    "drugName": "VALTOCONDA   #211635",
    "submission": "SUPPL-12",
    "activeIngredients": "DIAZEPAM",
    "company": "NEURELIS INC",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/16/2025",
    "drugName": "INSPRANDA   #021437",
    "submission": "SUPPL-18",
    "activeIngredients": "EPLERENONE",
    "company": "UPJOHN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/16/2025",
    "drugName": "NEFAZODONE HYDROCHLORIDEANDA  #076037",
    "submission": "SUPPL-17",
    "activeIngredients": "NEFAZODONE HYDROCHLORIDE",
    "company": "TEVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/16/2025",
    "drugName": "AMITRIPTYLINE HYDROCHLORIDEANDA  #085031",
    "submission": "SUPPL-288",
    "activeIngredients": "AMITRIPTYLINE HYDROCHLORIDE",
    "company": "ANI PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/16/2025",
    "drugName": "EXEMESTANEANDA  #200898",
    "submission": "SUPPL-13",
    "activeIngredients": "EXEMESTANE",
    "company": "ALVOGEN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/16/2025",
    "drugName": "LARIN 24 FEANDA  #202994",
    "submission": "SUPPL-11",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "NOVAST LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/16/2025",
    "drugName": "RIVASTIGMINEANDA  #206318",
    "submission": "SUPPL-7",
    "activeIngredients": "RIVASTIGMINE",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/16/2025",
    "drugName": "TRAZODONE HYDROCHLORIDEANDA  #206923",
    "submission": "SUPPL-2",
    "activeIngredients": "TRAZODONE HYDROCHLORIDE",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/16/2025",
    "drugName": "TRAZODONE HYDROCHLORIDEANDA  #206923",
    "submission": "SUPPL-4",
    "activeIngredients": "TRAZODONE HYDROCHLORIDE",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/16/2025",
    "drugName": "ITRACONAZOLEANDA  #208481",
    "submission": "SUPPL-3",
    "activeIngredients": "ITRACONAZOLE",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/16/2025",
    "drugName": "ITRACONAZOLEANDA  #208481",
    "submission": "SUPPL-4",
    "activeIngredients": "ITRACONAZOLE",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/16/2025",
    "drugName": "EXEMESTANEANDA  #209208",
    "submission": "SUPPL-9",
    "activeIngredients": "EXEMESTANE",
    "company": "UPSHER SMITH LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/16/2025",
    "drugName": "XPHOZAHNDA   #213931",
    "submission": "SUPPL-5",
    "activeIngredients": "TENAPANOR HYDROCHLORIDE",
    "company": "ARDELYX INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/16/2025",
    "drugName": "ABACAVIR; DOLUTEGRAVIR; LAMIVUDINEANDA  #215348",
    "submission": "ORIG-1",
    "activeIngredients": "ABACAVIR;DOLUTEGRAVIR;LAMIVUDINE",
    "company": "HETERO LABS LTD V",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "06/16/2025",
    "drugName": "PLERIXAFORANDA  #217560",
    "submission": "ORIG-1",
    "activeIngredients": "PLERIXAFOR",
    "company": "HETERO LABS LTD VI",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/16/2025",
    "drugName": "ARYNTANDA   #219847",
    "submission": "ORIG-1",
    "activeIngredients": "LISDEXAMFETAMINE DIMESYLATE",
    "company": "AZURITY",
    "submissionClassification": "Type 3 - New Dosage Form",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/16/2025",
    "drugName": "CARBON DIOXIDE, USPNDA   #220634",
    "submission": "ORIG-1",
    "activeIngredients": "CARBON DIOXIDE",
    "company": "GENERAL DISTRIBUTING COMPANY",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/16/2025",
    "drugName": "ANDEMBRYBLA   #761367",
    "submission": "ORIG-1",
    "activeIngredients": "GARADACIMAB-GXII",
    "company": "CSL BEHRING LLC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/17/2025",
    "drugName": "XARELTONDA   #022406",
    "submission": "SUPPL-44",
    "activeIngredients": "RIVAROXABAN",
    "company": "JANSSEN PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/17/2025",
    "drugName": "PRADAXANDA   #022512",
    "submission": "SUPPL-49",
    "activeIngredients": "DABIGATRAN ETEXILATE MESYLATE",
    "company": "BOEHRINGER INGELHEIM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/17/2025",
    "drugName": "FINASTERIDEANDA  #076437",
    "submission": "SUPPL-10",
    "activeIngredients": "FINASTERIDE",
    "company": "DR REDDYS LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/17/2025",
    "drugName": "AMLODIPINE BESYLATEANDA  #078552",
    "submission": "SUPPL-15",
    "activeIngredients": "AMLODIPINE BESYLATE",
    "company": "EPIC PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/17/2025",
    "drugName": "DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATEANDA  #078704",
    "submission": "SUPPL-3",
    "activeIngredients": "DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE",
    "company": "TEVA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/17/2025",
    "drugName": "DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATEANDA  #078749",
    "submission": "SUPPL-2",
    "activeIngredients": "DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/17/2025",
    "drugName": "RISPERIDONEANDA  #079088",
    "submission": "SUPPL-25",
    "activeIngredients": "RISPERIDONE",
    "company": "TORRENT PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/17/2025",
    "drugName": "TOLTERODINE TARTRATEANDA  #079141",
    "submission": "SUPPL-14",
    "activeIngredients": "TOLTERODINE TARTRATE",
    "company": "TEVA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/17/2025",
    "drugName": "SPIRONOLACTONEANDA  #089424",
    "submission": "SUPPL-66",
    "activeIngredients": "SPIRONOLACTONE",
    "company": "SUN PHARM INDUSTRIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/17/2025",
    "drugName": "FINASTERIDEANDA  #090121",
    "submission": "SUPPL-16",
    "activeIngredients": "FINASTERIDE",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/17/2025",
    "drugName": "ZIDOVUDINEANDA  #090561",
    "submission": "SUPPL-14",
    "activeIngredients": "ZIDOVUDINE",
    "company": "CIPLA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/17/2025",
    "drugName": "MEFENAMIC ACIDANDA  #090562",
    "submission": "SUPPL-11",
    "activeIngredients": "MEFENAMIC ACID",
    "company": "MICRO LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/17/2025",
    "drugName": "SETLAKINANDA  #090716",
    "submission": "SUPPL-3",
    "activeIngredients": "ETHINYL ESTRADIOL; LEVONORGESTREL",
    "company": "NOVAST LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/17/2025",
    "drugName": "SETLAKINANDA  #090716",
    "submission": "SUPPL-8",
    "activeIngredients": "ETHINYL ESTRADIOL; LEVONORGESTREL",
    "company": "NOVAST LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/17/2025",
    "drugName": "SETLAKINANDA  #090716",
    "submission": "SUPPL-9",
    "activeIngredients": "ETHINYL ESTRADIOL; LEVONORGESTREL",
    "company": "NOVAST LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/17/2025",
    "drugName": "CLONIDINEANDA  #090873",
    "submission": "SUPPL-7",
    "activeIngredients": "CLONIDINE",
    "company": "ACTAVIS LABS UT INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/17/2025",
    "drugName": "CISATRACURIUM BESYLATE PRESERVATIVE FREEANDA  #203182",
    "submission": "SUPPL-11",
    "activeIngredients": "CISATRACURIUM BESYLATE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/17/2025",
    "drugName": "CISATRACURIUM BESYLATEANDA  #203183",
    "submission": "SUPPL-12",
    "activeIngredients": "CISATRACURIUM BESYLATE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/17/2025",
    "drugName": "COLCHICINEANDA  #204461",
    "submission": "SUPPL-1",
    "activeIngredients": "COLCHICINE",
    "company": "WATSON LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/17/2025",
    "drugName": "COLCHICINEANDA  #204461",
    "submission": "SUPPL-3",
    "activeIngredients": "COLCHICINE",
    "company": "WATSON LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/17/2025",
    "drugName": "CAPECITABINEANDA  #204668",
    "submission": "SUPPL-9",
    "activeIngredients": "CAPECITABINE",
    "company": "SUN PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/17/2025",
    "drugName": "CAPECITABINEANDA  #204668",
    "submission": "SUPPL-11",
    "activeIngredients": "CAPECITABINE",
    "company": "SUN PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/17/2025",
    "drugName": "MESALAMINEANDA  #205654",
    "submission": "SUPPL-6",
    "activeIngredients": "MESALAMINE",
    "company": "ACTAVIS MID ATLANTIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/17/2025",
    "drugName": "HAILEY FE 1/20ANDA  #206597",
    "submission": "SUPPL-4",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/17/2025",
    "drugName": "HAILEY FE 1/20ANDA  #206597",
    "submission": "SUPPL-5",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/17/2025",
    "drugName": "CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDEANDA  #211925",
    "submission": "SUPPL-2",
    "activeIngredients": "AMITRIPTYLINE HYDROCHLORIDE; CHLORDIAZEPOXIDE",
    "company": "MICRO LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/17/2025",
    "drugName": "ARGATROBANANDA  #214235",
    "submission": "SUPPL-3",
    "activeIngredients": "ARGATROBAN",
    "company": "CAPLIN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/17/2025",
    "drugName": "PRADAXANDA   #214358",
    "submission": "SUPPL-9",
    "activeIngredients": "DABIGATRAN ETEXILATE MESYLATE",
    "company": "BOEHRINGER INGELHEIM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/17/2025",
    "drugName": "DAPSONEANDA  #214722",
    "submission": "SUPPL-4",
    "activeIngredients": "DAPSONE",
    "company": "TORRENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/17/2025",
    "drugName": "XARELTONDA   #215859",
    "submission": "SUPPL-5",
    "activeIngredients": "RIVAROXABAN",
    "company": "JANSSEN PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/17/2025",
    "drugName": "ACETAZOLAMIDE SODIUMANDA  #219775",
    "submission": "ORIG-1",
    "activeIngredients": "ACETAZOLAMIDE SODIUM",
    "company": "GLAND",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/17/2025",
    "drugName": "TREMFYABLA   #761061",
    "submission": "SUPPL-30",
    "activeIngredients": "GUSELKUMAB",
    "company": "JANSSEN BIOTECH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/18/2025",
    "drugName": "TRI-LEGEST FEANDA  #076105",
    "submission": "SUPPL-20",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "BARR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/18/2025",
    "drugName": "DEPO-TESTOSTERONEANDA  #085635",
    "submission": "SUPPL-39",
    "activeIngredients": "TESTOSTERONE CYPIONATE",
    "company": "PFIZER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/18/2025",
    "drugName": "BLISOVI 24 FEANDA  #091398",
    "submission": "SUPPL-22",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/18/2025",
    "drugName": "BLISOVI 24 FEANDA  #091398",
    "submission": "SUPPL-23",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/18/2025",
    "drugName": "ENBRELBLA   #103795",
    "submission": "SUPPL-5603",
    "activeIngredients": "ETANERCEPT",
    "company": "IMMUNEX",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/18/2025",
    "drugName": "TRAZODONE HYDROCHLORIDEANDA  #202180",
    "submission": "SUPPL-6",
    "activeIngredients": "TRAZODONE HYDROCHLORIDE",
    "company": "TORRENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/18/2025",
    "drugName": "TRAZODONE HYDROCHLORIDEANDA  #202180",
    "submission": "SUPPL-11",
    "activeIngredients": "TRAZODONE HYDROCHLORIDE",
    "company": "TORRENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/18/2025",
    "drugName": "OXYCODONE HYDROCHLORIDEANDA  #204021",
    "submission": "SUPPL-3",
    "activeIngredients": "OXYCODONE HYDROCHLORIDE",
    "company": "NOVEL LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/18/2025",
    "drugName": "OXYCODONE HYDROCHLORIDEANDA  #204021",
    "submission": "SUPPL-5",
    "activeIngredients": "OXYCODONE HYDROCHLORIDE",
    "company": "NOVEL LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/18/2025",
    "drugName": "OXYCODONE HYDROCHLORIDEANDA  #204021",
    "submission": "SUPPL-8",
    "activeIngredients": "OXYCODONE HYDROCHLORIDE",
    "company": "NOVEL LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/18/2025",
    "drugName": "OXYCODONE HYDROCHLORIDEANDA  #204021",
    "submission": "SUPPL-9",
    "activeIngredients": "OXYCODONE HYDROCHLORIDE",
    "company": "NOVEL LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/18/2025",
    "drugName": "OXYCODONE HYDROCHLORIDEANDA  #204021",
    "submission": "SUPPL-11",
    "activeIngredients": "OXYCODONE HYDROCHLORIDE",
    "company": "NOVEL LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/18/2025",
    "drugName": "OXYCODONE HYDROCHLORIDEANDA  #204021",
    "submission": "SUPPL-12",
    "activeIngredients": "OXYCODONE HYDROCHLORIDE",
    "company": "NOVEL LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/18/2025",
    "drugName": "ISOTRETINOINANDA  #205063",
    "submission": "SUPPL-11",
    "activeIngredients": "ISOTRETINOIN",
    "company": "ACTAVIS LABS FL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/18/2025",
    "drugName": "SIMPESSEANDA  #206851",
    "submission": "SUPPL-4",
    "activeIngredients": "ETHINYL ESTRADIOL; LEVONORGESTREL",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/18/2025",
    "drugName": "ENDARINDA   #208587",
    "submission": "SUPPL-4",
    "activeIngredients": "L-GLUTAMINE",
    "company": "EMMAUS MEDCL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/18/2025",
    "drugName": "AXTLENDA   #210661",
    "submission": "SUPPL-3",
    "activeIngredients": "PEMETREXED DIPOTASSIUM",
    "company": "AVYXA HOLDINGS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/18/2025",
    "drugName": "CISATRACURIUM BESYLATEANDA  #211668",
    "submission": "SUPPL-10",
    "activeIngredients": "CISATRACURIUM BESYLATE",
    "company": "MEITHEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/18/2025",
    "drugName": "CISATRACURIUM BESYLATEANDA  #211669",
    "submission": "SUPPL-9",
    "activeIngredients": "CISATRACURIUM BESYLATE",
    "company": "MEITHEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/18/2025",
    "drugName": "ZEJULANDA   #214876",
    "submission": "SUPPL-3",
    "activeIngredients": "NIRAPARIB TOSYLATE",
    "company": "GLAXOSMITHKLINE",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/18/2025",
    "drugName": "ZEJULANDA   #214876",
    "submission": "SUPPL-4",
    "activeIngredients": "NIRAPARIB TOSYLATE",
    "company": "GLAXOSMITHKLINE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/18/2025",
    "drugName": "YEZTUGONDA   #220018",
    "submission": "ORIG-1",
    "activeIngredients": "LENACAPAVIR",
    "company": "GILEAD SCIENCES INC",
    "submissionClassification": "Type 10 - New Indication Submitted as Distinct NDA - Not Consolidated",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/18/2025",
    "drugName": "YEZTUGONDA   #220018",
    "submission": "ORIG-1",
    "activeIngredients": "LENACAPAVIR SODIUM",
    "company": "GILEAD SCIENCES INC",
    "submissionClassification": "Type 10 - New Indication Submitted as Distinct NDA - Not Consolidated",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/18/2025",
    "drugName": "YEZTUGONDA   #220020",
    "submission": "ORIG-1",
    "activeIngredients": "LENACAPAVIR SODIUM",
    "company": "GILEAD SCIENCES INC",
    "submissionClassification": "Type 10 - New Indication Submitted as Distinct NDA - Not Consolidated",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/18/2025",
    "drugName": "DUPIXENTBLA   #761055",
    "submission": "SUPPL-70",
    "activeIngredients": "DUPILUMAB",
    "company": "REGENERON PHARMACEUTICALS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/18/2025",
    "drugName": "MONJUVIBLA   #761163",
    "submission": "SUPPL-13",
    "activeIngredients": "TAFASITAMAB-CXIX",
    "company": "MORPHOSYS US INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/19/2025",
    "drugName": "AIMOVIGBLA   #761077",
    "submission": "SUPPL-25",
    "activeIngredients": "ERENUMAB-AOOE",
    "company": "AMGEN INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/20/2025",
    "drugName": "COZAARNDA   #020386",
    "submission": "SUPPL-69",
    "activeIngredients": "LOSARTAN POTASSIUM",
    "company": "ORGANON",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/20/2025",
    "drugName": "HYZAARNDA   #020387",
    "submission": "SUPPL-76",
    "activeIngredients": "HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM",
    "company": "ORGANON",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/20/2025",
    "drugName": "HALOPERIDOL DECANOATEANDA  #074893",
    "submission": "SUPPL-22",
    "activeIngredients": "HALOPERIDOL DECANOATE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/20/2025",
    "drugName": "HALOPERIDOL DECANOATEANDA  #074893",
    "submission": "SUPPL-23",
    "activeIngredients": "HALOPERIDOL DECANOATE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/20/2025",
    "drugName": "HALOPERIDOL DECANOATEANDA  #074893",
    "submission": "SUPPL-24",
    "activeIngredients": "HALOPERIDOL DECANOATE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/20/2025",
    "drugName": "GLYBURIDE AND METFORMIN HYDROCHLORIDEANDA  #079009",
    "submission": "SUPPL-5",
    "activeIngredients": "GLYBURIDE; METFORMIN HYDROCHLORIDE",
    "company": "HERITAGE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/20/2025",
    "drugName": "GLYBURIDE AND METFORMIN HYDROCHLORIDEANDA  #079009",
    "submission": "SUPPL-11",
    "activeIngredients": "GLYBURIDE; METFORMIN HYDROCHLORIDE",
    "company": "HERITAGE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/20/2025",
    "drugName": "METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDEANDA  #090654",
    "submission": "SUPPL-9",
    "activeIngredients": "HYDROCHLOROTHIAZIDE; METOPROLOL TARTRATE",
    "company": "SUN PHARM INDS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/20/2025",
    "drugName": "BENLYSTABLA   #125370",
    "submission": "SUPPL-85",
    "activeIngredients": "BELIMUMAB",
    "company": "HUMAN GENOME SCIENCES INC.",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/20/2025",
    "drugName": "AMITRIPTYLINE HYDROCHLORIDEANDA  #202446",
    "submission": "SUPPL-12",
    "activeIngredients": "AMITRIPTYLINE HYDROCHLORIDE",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/20/2025",
    "drugName": "TYBOSTNDA   #203094",
    "submission": "SUPPL-17",
    "activeIngredients": "COBICISTAT",
    "company": "GILEAD SCIENCES INC",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/20/2025",
    "drugName": "TYBOSTNDA   #203094",
    "submission": "SUPPL-18",
    "activeIngredients": "COBICISTAT",
    "company": "GILEAD SCIENCES INC",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/20/2025",
    "drugName": "PRAMIPEXOLE DIHYDROCHLORIDEANDA  #204518",
    "submission": "SUPPL-11",
    "activeIngredients": "PRAMIPEXOLE DIHYDROCHLORIDE",
    "company": "ALEMBIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/20/2025",
    "drugName": "OMTRYGNDA   #204977",
    "submission": "SUPPL-10",
    "activeIngredients": "OMEGA-3-ACID ETHYL ESTERS TYPE A",
    "company": "OSMOTICA PHARM US",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/20/2025",
    "drugName": "NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATEANDA  #206120",
    "submission": "SUPPL-4",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "XIROMED",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/20/2025",
    "drugName": "LO SIMPESSEANDA  #206852",
    "submission": "SUPPL-3",
    "activeIngredients": "ETHINYL ESTRADIOL; LEVONORGESTREL",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/20/2025",
    "drugName": "ESTRADIOL AND NORETHINDRONE ACETATEANDA  #207261",
    "submission": "SUPPL-1",
    "activeIngredients": "ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "XIROMED",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/20/2025",
    "drugName": "ESTRADIOL AND NORETHINDRONE ACETATEANDA  #207261",
    "submission": "SUPPL-2",
    "activeIngredients": "ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "XIROMED",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/20/2025",
    "drugName": "ESTRADIOL AND NORETHINDRONE ACETATEANDA  #207261",
    "submission": "SUPPL-3",
    "activeIngredients": "ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "XIROMED",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/20/2025",
    "drugName": "ESTRADIOL AND NORETHINDRONE ACETATEANDA  #207261",
    "submission": "SUPPL-6",
    "activeIngredients": "ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "XIROMED",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/20/2025",
    "drugName": "DESCOVYNDA   #208215",
    "submission": "SUPPL-23",
    "activeIngredients": "EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE",
    "company": "GILEAD SCIENCES INC",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/20/2025",
    "drugName": "DESCOVYNDA   #208215",
    "submission": "SUPPL-25",
    "activeIngredients": "EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE",
    "company": "GILEAD SCIENCES INC",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/20/2025",
    "drugName": "DECITABINEANDA  #208601",
    "submission": "SUPPL-2",
    "activeIngredients": "DECITABINE",
    "company": "CIPLA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/20/2025",
    "drugName": "DECITABINEANDA  #208601",
    "submission": "SUPPL-3",
    "activeIngredients": "DECITABINE",
    "company": "CIPLA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/20/2025",
    "drugName": "DECITABINEANDA  #208601",
    "submission": "SUPPL-4",
    "activeIngredients": "DECITABINE",
    "company": "CIPLA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/20/2025",
    "drugName": "APREMILASTANDA  #211834",
    "submission": "ORIG-1",
    "activeIngredients": "APREMILAST",
    "company": "TORRENT",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/20/2025",
    "drugName": "ETYQAANDA  #214729",
    "submission": "SUPPL-1",
    "activeIngredients": "ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/20/2025",
    "drugName": "BENLYSTABLA   #761043",
    "submission": "SUPPL-34",
    "activeIngredients": "BELIMUMAB",
    "company": "GLAXOSMITHKLINE LLC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/23/2025",
    "drugName": "BALSALAZIDE DISODIUMANDA  #077807",
    "submission": "SUPPL-6",
    "activeIngredients": "BALSALAZIDE DISODIUM",
    "company": "NOVITIUM PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/23/2025",
    "drugName": "BALSALAZIDE DISODIUMANDA  #077807",
    "submission": "SUPPL-8",
    "activeIngredients": "BALSALAZIDE DISODIUM",
    "company": "NOVITIUM PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/23/2025",
    "drugName": "AMYVIDNDA   #202008",
    "submission": "SUPPL-46",
    "activeIngredients": "FLORBETAPIR F-18",
    "company": "AVID RADIOPHARMS INC",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/23/2025",
    "drugName": "VIZAMYLNDA   #203137",
    "submission": "SUPPL-24",
    "activeIngredients": "FLUTEMETAMOL F-18",
    "company": "GE HEALTHCARE",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/23/2025",
    "drugName": "NEURACEQNDA   #204677",
    "submission": "SUPPL-24",
    "activeIngredients": "FLORBETABEN F-18",
    "company": "LIFE MOLECULAR",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/23/2025",
    "drugName": "NEURACEQNDA   #204677",
    "submission": "SUPPL-34",
    "activeIngredients": "FLORBETABEN F-18",
    "company": "LIFE MOLECULAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/23/2025",
    "drugName": "LACOSAMIDEANDA  #209301",
    "submission": "SUPPL-6",
    "activeIngredients": "LACOSAMIDE",
    "company": "HETERO LABS LTD III",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/23/2025",
    "drugName": "DEXAMETHASONE SODIUM PHOSPHATEANDA  #210967",
    "submission": "SUPPL-6",
    "activeIngredients": "DEXAMETHASONE SODIUM PHOSPHATE",
    "company": "EUGIA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/23/2025",
    "drugName": "MIDAZOLAM IN 0.9% SODIUM CHLORIDEANDA  #216159",
    "submission": "SUPPL-2",
    "activeIngredients": "MIDAZOLAM",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/23/2025",
    "drugName": "CARBAMAZEPINEANDA  #216193",
    "submission": "SUPPL-4",
    "activeIngredients": "CARBAMAZEPINE",
    "company": "AJANTA PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/23/2025",
    "drugName": "SITAGLIPTIN;METFORMIN HYDROCHLORIDEANDA  #216529",
    "submission": "ORIG-1",
    "activeIngredients": "SITAGLIPTIN;METFORMIN HYDROCHLORIDE",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "06/23/2025",
    "drugName": "DEHYDRATED ALCOHOLANDA  #217845",
    "submission": "ORIG-1",
    "activeIngredients": "ALCOHOL",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/23/2025",
    "drugName": "AMITRIPTYLINE HYDROCHLORIDEANDA  #218389",
    "submission": "ORIG-1",
    "activeIngredients": "AMITRIPTYLINE HYDROCHLORIDE",
    "company": "UNIQUE PHARM",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/23/2025",
    "drugName": "MEROPENEMANDA  #219084",
    "submission": "ORIG-1",
    "activeIngredients": "MEROPENEM",
    "company": "BROOKS STERISCIENCE",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/23/2025",
    "drugName": "FAMOTIDINEANDA  #219153",
    "submission": "ORIG-1",
    "activeIngredients": "FAMOTIDINE",
    "company": "BIONPHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/23/2025",
    "drugName": "DICYCLOMINE HYDROCHLORIDEANDA  #219242",
    "submission": "ORIG-1",
    "activeIngredients": "DICYCLOMINE HYDROCHLORIDE",
    "company": "RISING",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/23/2025",
    "drugName": "DEHYDRATED ALCOHOLANDA  #219400",
    "submission": "ORIG-1",
    "activeIngredients": "ALCOHOL",
    "company": "XGEN PHARMS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/23/2025",
    "drugName": "DEHYDRATED ALCOHOLANDA  #219444",
    "submission": "ORIG-1",
    "activeIngredients": "ALCOHOL",
    "company": "BRECKENRIDGE",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/23/2025",
    "drugName": "PREDNISOLONEANDA  #219509",
    "submission": "ORIG-1",
    "activeIngredients": "PREDNISOLONE",
    "company": "TP ANDA HOLDINGS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/23/2025",
    "drugName": "HADLIMABLA   #761059",
    "submission": "SUPPL-30",
    "activeIngredients": "ADALIMUMAB-BWWD",
    "company": "SAMSUNG BIOEPIS CO LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/23/2025",
    "drugName": "DATROWAYBLA   #761464",
    "submission": "ORIG-1",
    "activeIngredients": "DATOPOTAMAB DERUXTECAN-DLNK",
    "company": "DAIICHI SANKYO INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "NORPRAMINNDA   #014399",
    "submission": "SUPPL-72",
    "activeIngredients": "DESIPRAMINE HYDROCHLORIDE",
    "company": "VALIDUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "LIMBITROLNDA   #016949",
    "submission": "SUPPL-44",
    "activeIngredients": "AMITRIPTYLINE HYDROCHLORIDE; CHLORDIAZEPOXIDE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "LIMBITROL DSNDA   #016949",
    "submission": "SUPPL-44",
    "activeIngredients": "AMITRIPTYLINE HYDROCHLORIDE; CHLORDIAZEPOXIDE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "DESYRELNDA   #018207",
    "submission": "SUPPL-37",
    "activeIngredients": "TRAZODONE HYDROCHLORIDE",
    "company": "PRAGMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "FLAGYL I.V. RTU IN PLASTIC CONTAINERNDA   #018657",
    "submission": "SUPPL-45",
    "activeIngredients": "METRONIDAZOLE",
    "company": "BAXTER HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "CHANTIXNDA   #021928",
    "submission": "SUPPL-51",
    "activeIngredients": "VARENICLINE TARTRATE",
    "company": "PF PRISM CV",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "METHADOSEANDA  #040050",
    "submission": "SUPPL-32",
    "activeIngredients": "METHADONE HYDROCHLORIDE",
    "company": "SPECGX LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "AMITRIPTYLINE HYDROCHLORIDEANDA  #040218",
    "submission": "SUPPL-38",
    "activeIngredients": "AMITRIPTYLINE HYDROCHLORIDE",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "IMIPRAMINE HYDROCHLORIDEANDA  #040751",
    "submission": "SUPPL-7",
    "activeIngredients": "IMIPRAMINE HYDROCHLORIDE",
    "company": "OXFORD PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "AMITRIPTYLINE HYDROCHLORIDEANDA  #040816",
    "submission": "SUPPL-7",
    "activeIngredients": "AMITRIPTYLINE HYDROCHLORIDE",
    "company": "SUN PHARM INDS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "IMIPRAMINE HYDROCHLORIDEANDA  #040903",
    "submission": "SUPPL-11",
    "activeIngredients": "IMIPRAMINE HYDROCHLORIDE",
    "company": "LEADING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDEANDA  #070297",
    "submission": "SUPPL-31",
    "activeIngredients": "AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE",
    "company": "SUN PHARM INDUSTRIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDEANDA  #071062",
    "submission": "SUPPL-27",
    "activeIngredients": "AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE",
    "company": "FOSUN PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDEANDA  #071063",
    "submission": "SUPPL-27",
    "activeIngredients": "AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE",
    "company": "FOSUN PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDEANDA  #071064",
    "submission": "SUPPL-22",
    "activeIngredients": "AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE",
    "company": "FOSUN PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDEANDA  #071077",
    "submission": "SUPPL-32",
    "activeIngredients": "AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE",
    "company": "SUN PHARM INDUSTRIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDEANDA  #071078",
    "submission": "SUPPL-29",
    "activeIngredients": "AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE",
    "company": "SUN PHARM INDUSTRIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDEANDA  #071079",
    "submission": "SUPPL-31",
    "activeIngredients": "AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE",
    "company": "SUN PHARM INDUSTRIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "TRAZODONE HYDROCHLORIDEANDA  #071196",
    "submission": "SUPPL-82",
    "activeIngredients": "TRAZODONE HYDROCHLORIDE",
    "company": "APOTEX INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "TRAZODONE HYDROCHLORIDEANDA  #071258",
    "submission": "SUPPL-51",
    "activeIngredients": "TRAZODONE HYDROCHLORIDE",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDEANDA  #071297",
    "submission": "SUPPL-43",
    "activeIngredients": "AMITRIPTYLINE HYDROCHLORIDE; CHLORDIAZEPOXIDE",
    "company": "MYLAN PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDEANDA  #071297",
    "submission": "SUPPL-44",
    "activeIngredients": "AMITRIPTYLINE HYDROCHLORIDE; CHLORDIAZEPOXIDE",
    "company": "MYLAN PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "TRAZODONE HYDROCHLORIDEANDA  #071405",
    "submission": "SUPPL-8",
    "activeIngredients": "TRAZODONE HYDROCHLORIDE",
    "company": "NATCO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "TRAZODONE HYDROCHLORIDEANDA  #071406",
    "submission": "SUPPL-8",
    "activeIngredients": "TRAZODONE HYDROCHLORIDE",
    "company": "NATCO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDEANDA  #071443",
    "submission": "SUPPL-44",
    "activeIngredients": "AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "TRAZODONE HYDROCHLORIDEANDA  #071514",
    "submission": "SUPPL-23",
    "activeIngredients": "TRAZODONE HYDROCHLORIDE",
    "company": "ALVOGEN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "TRAZODONE HYDROCHLORIDEANDA  #071523",
    "submission": "SUPPL-74",
    "activeIngredients": "TRAZODONE HYDROCHLORIDE",
    "company": "TEVA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "TRAZODONE HYDROCHLORIDEANDA  #071524",
    "submission": "SUPPL-76",
    "activeIngredients": "TRAZODONE HYDROCHLORIDE",
    "company": "TEVA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "TRAZODONE HYDROCHLORIDEANDA  #071525",
    "submission": "SUPPL-79",
    "activeIngredients": "TRAZODONE HYDROCHLORIDE",
    "company": "PLIVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "TRAZODONE HYDROCHLORIDEANDA  #071636",
    "submission": "SUPPL-31",
    "activeIngredients": "TRAZODONE HYDROCHLORIDE",
    "company": "ALVOGEN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDEANDA  #071862",
    "submission": "SUPPL-21",
    "activeIngredients": "AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE",
    "company": "FOSUN PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDEANDA  #071863",
    "submission": "SUPPL-21",
    "activeIngredients": "AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDEANDA  #072052",
    "submission": "SUPPL-13",
    "activeIngredients": "AMITRIPTYLINE HYDROCHLORIDE; CHLORDIAZEPOXIDE",
    "company": "HERITAGE PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDEANDA  #072053",
    "submission": "SUPPL-13",
    "activeIngredients": "AMITRIPTYLINE HYDROCHLORIDE; CHLORDIAZEPOXIDE",
    "company": "HERITAGE PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "TRAZODONE HYDROCHLORIDEANDA  #072192",
    "submission": "SUPPL-58",
    "activeIngredients": "TRAZODONE HYDROCHLORIDE",
    "company": "OXFORD PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "TRAZODONE HYDROCHLORIDEANDA  #072193",
    "submission": "SUPPL-58",
    "activeIngredients": "TRAZODONE HYDROCHLORIDE",
    "company": "OXFORD PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDEANDA  #072277",
    "submission": "SUPPL-16",
    "activeIngredients": "AMITRIPTYLINE HYDROCHLORIDE; CHLORDIAZEPOXIDE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDEANDA  #072278",
    "submission": "SUPPL-16",
    "activeIngredients": "AMITRIPTYLINE HYDROCHLORIDE; CHLORDIAZEPOXIDE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "TRAZODONE HYDROCHLORIDEANDA  #072483",
    "submission": "SUPPL-14",
    "activeIngredients": "TRAZODONE HYDROCHLORIDE",
    "company": "AIPING PHARM INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDEANDA  #073007",
    "submission": "SUPPL-29",
    "activeIngredients": "AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDEANDA  #073008",
    "submission": "SUPPL-28",
    "activeIngredients": "AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDEANDA  #073009",
    "submission": "SUPPL-29",
    "activeIngredients": "AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDEANDA  #073010",
    "submission": "SUPPL-29",
    "activeIngredients": "AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "TRAZODONE HYDROCHLORIDEANDA  #073137",
    "submission": "SUPPL-47",
    "activeIngredients": "TRAZODONE HYDROCHLORIDE",
    "company": "SUN PHARM INDUSTRIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "NEFAZODONE HYDROCHLORIDEANDA  #076037",
    "submission": "SUPPL-18",
    "activeIngredients": "NEFAZODONE HYDROCHLORIDE",
    "company": "TEVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "NEFAZODONE HYDROCHLORIDEANDA  #076072",
    "submission": "SUPPL-5",
    "activeIngredients": "NEFAZODONE HYDROCHLORIDE",
    "company": "ANI PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "NEFAZODONE HYDROCHLORIDEANDA  #076073",
    "submission": "SUPPL-5",
    "activeIngredients": "NEFAZODONE HYDROCHLORIDE",
    "company": "WATSON LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "NEFAZODONE HYDROCHLORIDEANDA  #076129",
    "submission": "SUPPL-4",
    "activeIngredients": "NEFAZODONE HYDROCHLORIDE",
    "company": "AUROBINDO PHARMA USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "NEFAZODONE HYDROCHLORIDEANDA  #076302",
    "submission": "SUPPL-3",
    "activeIngredients": "NEFAZODONE HYDROCHLORIDE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "NEFAZODONE HYDROCHLORIDEANDA  #076309",
    "submission": "SUPPL-5",
    "activeIngredients": "NEFAZODONE HYDROCHLORIDE",
    "company": "DR REDDYS LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "METFORMIN HYDROCHLORIDEANDA  #077787",
    "submission": "SUPPL-4",
    "activeIngredients": "METFORMIN HYDROCHLORIDE",
    "company": "DR REDDYS LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "METFORMIN HYDROCHLORIDEANDA  #077787",
    "submission": "SUPPL-5",
    "activeIngredients": "METFORMIN HYDROCHLORIDE",
    "company": "DR REDDYS LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "IMIPRAMINE HYDROCHLORIDEANDA  #081048",
    "submission": "SUPPL-36",
    "activeIngredients": "IMIPRAMINE HYDROCHLORIDE",
    "company": "SUN PHARM INDUSTRIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "IMIPRAMINE HYDROCHLORIDEANDA  #081049",
    "submission": "SUPPL-39",
    "activeIngredients": "IMIPRAMINE HYDROCHLORIDE",
    "company": "SUN PHARM INDUSTRIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "IMIPRAMINE HYDROCHLORIDEANDA  #081050",
    "submission": "SUPPL-39",
    "activeIngredients": "IMIPRAMINE HYDROCHLORIDE",
    "company": "SUN PHARM INDUSTRIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "PROMETHAZINE HYDROCHLORIDEANDA  #083312",
    "submission": "SUPPL-64",
    "activeIngredients": "PROMETHAZINE HYDROCHLORIDE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "IMIPRAMINE HYDROCHLORIDEANDA  #083745",
    "submission": "SUPPL-130",
    "activeIngredients": "IMIPRAMINE HYDROCHLORIDE",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "IMIPRAMINE HYDROCHLORIDEANDA  #084936",
    "submission": "SUPPL-116",
    "activeIngredients": "IMIPRAMINE HYDROCHLORIDE",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "IMIPRAMINE HYDROCHLORIDEANDA  #084937",
    "submission": "SUPPL-136",
    "activeIngredients": "IMIPRAMINE HYDROCHLORIDE",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "AMITRIPTYLINE HYDROCHLORIDEANDA  #085031",
    "submission": "SUPPL-289",
    "activeIngredients": "AMITRIPTYLINE HYDROCHLORIDE",
    "company": "ANI PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "AMITRIPTYLINE HYDROCHLORIDEANDA  #085968",
    "submission": "SUPPL-112",
    "activeIngredients": "AMITRIPTYLINE HYDROCHLORIDE",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "AMITRIPTYLINE HYDROCHLORIDEANDA  #086009",
    "submission": "SUPPL-71",
    "activeIngredients": "AMITRIPTYLINE HYDROCHLORIDE",
    "company": "AUROBINDO PHARMA USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "IMIPRAMINE HYDROCHLORIDEANDA  #088262",
    "submission": "SUPPL-42",
    "activeIngredients": "IMIPRAMINE HYDROCHLORIDE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "IMIPRAMINE HYDROCHLORIDEANDA  #088276",
    "submission": "SUPPL-42",
    "activeIngredients": "IMIPRAMINE HYDROCHLORIDE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "IMIPRAMINE HYDROCHLORIDEANDA  #088292",
    "submission": "SUPPL-42",
    "activeIngredients": "IMIPRAMINE HYDROCHLORIDE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "AMITRIPTYLINE HYDROCHLORIDEANDA  #089399",
    "submission": "SUPPL-52",
    "activeIngredients": "AMITRIPTYLINE HYDROCHLORIDE",
    "company": "SUN PHARM INDS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "IMIPRAMINE HYDROCHLORIDEANDA  #090441",
    "submission": "SUPPL-9",
    "activeIngredients": "IMIPRAMINE HYDROCHLORIDE",
    "company": "CHARTWELL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "IMIPRAMINE PAMOATEANDA  #090444",
    "submission": "SUPPL-11",
    "activeIngredients": "IMIPRAMINE PAMOATE",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "TRAZODONE HYDROCHLORIDEANDA  #090514",
    "submission": "SUPPL-7",
    "activeIngredients": "TRAZODONE HYDROCHLORIDE",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #090693",
    "submission": "SUPPL-15",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #090693",
    "submission": "SUPPL-17",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "ESTRADIOL VALERATEANDA  #090920",
    "submission": "SUPPL-5",
    "activeIngredients": "ESTRADIOL VALERATE",
    "company": "AM REGENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "ESTRADIOL VALERATEANDA  #090920",
    "submission": "SUPPL-12",
    "activeIngredients": "ESTRADIOL VALERATE",
    "company": "AM REGENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "IMIPRAMINE PAMOATEANDA  #091099",
    "submission": "SUPPL-6",
    "activeIngredients": "IMIPRAMINE PAMOATE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "TRAZODONE HYDROCHLORIDEANDA  #202180",
    "submission": "SUPPL-14",
    "activeIngredients": "TRAZODONE HYDROCHLORIDE",
    "company": "TORRENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "IMIPRAMINE PAMOATEANDA  #202338",
    "submission": "SUPPL-4",
    "activeIngredients": "IMIPRAMINE PAMOATE",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "AMITRIPTYLINE HYDROCHLORIDEANDA  #202446",
    "submission": "SUPPL-14",
    "activeIngredients": "AMITRIPTYLINE HYDROCHLORIDE",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "ROCURONIUM BROMIDEANDA  #204679",
    "submission": "SUPPL-8",
    "activeIngredients": "ROCURONIUM BROMIDE",
    "company": "WEST WARD PHARM CORP",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "CARVEDILOL PHOSPHATEANDA  #204717",
    "submission": "SUPPL-6",
    "activeIngredients": "CARVEDILOL PHOSPHATE",
    "company": "IMPAX LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "TRAZODONE HYDROCHLORIDEANDA  #204852",
    "submission": "SUPPL-5",
    "activeIngredients": "TRAZODONE HYDROCHLORIDE",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "LACOSAMIDEANDA  #205006",
    "submission": "SUPPL-2",
    "activeIngredients": "LACOSAMIDE",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "LACOSAMIDEANDA  #205006",
    "submission": "SUPPL-3",
    "activeIngredients": "LACOSAMIDE",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "LACOSAMIDEANDA  #205006",
    "submission": "SUPPL-4",
    "activeIngredients": "LACOSAMIDE",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "TRAZODONE HYDROCHLORIDEANDA  #205253",
    "submission": "SUPPL-24",
    "activeIngredients": "TRAZODONE HYDROCHLORIDE",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "DIPHENHYDRAMINE HYDROCHLORIDEANDA  #205336",
    "submission": "ORIG-1",
    "activeIngredients": "DIPHENHYDRAMINE HYDROCHLORIDE",
    "company": "AVET LIFESCIENCES",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "TRAZODONE HYDROCHLORIDEANDA  #206923",
    "submission": "SUPPL-6",
    "activeIngredients": "TRAZODONE HYDROCHLORIDE",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #207289",
    "submission": "SUPPL-22",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "CLINDAMYCIN HYDROCHLORIDEANDA  #207402",
    "submission": "SUPPL-2",
    "activeIngredients": "CLINDAMYCIN HYDROCHLORIDE",
    "company": "MICRO LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "CLINDAMYCIN HYDROCHLORIDEANDA  #207402",
    "submission": "SUPPL-6",
    "activeIngredients": "CLINDAMYCIN HYDROCHLORIDE",
    "company": "MICRO LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "CLINDAMYCIN HYDROCHLORIDEANDA  #207402",
    "submission": "SUPPL-7",
    "activeIngredients": "CLINDAMYCIN HYDROCHLORIDE",
    "company": "MICRO LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "CLINDAMYCIN HYDROCHLORIDEANDA  #207402",
    "submission": "SUPPL-8",
    "activeIngredients": "CLINDAMYCIN HYDROCHLORIDE",
    "company": "MICRO LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "AMITRIPTYLINE HYDROCHLORIDEANDA  #210086",
    "submission": "SUPPL-14",
    "activeIngredients": "AMITRIPTYLINE HYDROCHLORIDE",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "TRAZODONE HYDROCHLORIDEANDA  #211116",
    "submission": "SUPPL-4",
    "activeIngredients": "TRAZODONE HYDROCHLORIDE",
    "company": "CROSSMEDIKA SA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDEANDA  #211925",
    "submission": "SUPPL-4",
    "activeIngredients": "AMITRIPTYLINE HYDROCHLORIDE; CHLORDIAZEPOXIDE",
    "company": "MICRO LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "AMITRIPTYLINE HYDROCHLORIDEANDA  #213999",
    "submission": "SUPPL-12",
    "activeIngredients": "AMITRIPTYLINE HYDROCHLORIDE",
    "company": "MANKIND PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "AMITRIPTYLINE HYDROCHLORIDEANDA  #214548",
    "submission": "SUPPL-2",
    "activeIngredients": "AMITRIPTYLINE HYDROCHLORIDE",
    "company": "UNICHEM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "AMITRIPTYLINE HYDROCHLORIDEANDA  #214548",
    "submission": "SUPPL-14",
    "activeIngredients": "AMITRIPTYLINE HYDROCHLORIDE",
    "company": "UNICHEM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "AMITRIPTYLINE HYDROCHLORIDEANDA  #215376",
    "submission": "SUPPL-3",
    "activeIngredients": "AMITRIPTYLINE HYDROCHLORIDE",
    "company": "RUBICON RESEARCH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "AMITRIPTYLINE HYDROCHLORIDEANDA  #216243",
    "submission": "SUPPL-1",
    "activeIngredients": "AMITRIPTYLINE HYDROCHLORIDE",
    "company": "BRECKENRIDGE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDEANDA  #216914",
    "submission": "ORIG-1",
    "activeIngredients": "BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE",
    "company": "CIPLA LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "AMITRIPTYLINE HYDROCHLORIDEANDA  #217411",
    "submission": "SUPPL-6",
    "activeIngredients": "AMITRIPTYLINE HYDROCHLORIDE",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "OCTREOTIDEANDA  #217507",
    "submission": "ORIG-1",
    "activeIngredients": "OCTREOTIDE",
    "company": "TEVA PHARMACEUTICALS USA, INC.",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "PRUCALOPRIDE SUCCINATEANDA  #217662",
    "submission": "ORIG-1",
    "activeIngredients": "PRUCALOPRIDE SUCCINATE",
    "company": "HIKMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "TRAZODONE HYDROCHLORIDEANDA  #217740",
    "submission": "SUPPL-3",
    "activeIngredients": "TRAZODONE HYDROCHLORIDE",
    "company": "GRAVITI PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "PRUCALOPRIDE SUCCINATEANDA  #218177",
    "submission": "ORIG-1",
    "activeIngredients": "PRUCALOPRIDE SUCCINATE",
    "company": "MSN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "PRUCALOPRIDE SUCCINATEANDA  #218295",
    "submission": "ORIG-1",
    "activeIngredients": "PRUCALOPRIDE SUCCINATE",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "RALDESYNDA   #218637",
    "submission": "SUPPL-3",
    "activeIngredients": "TRAZODONE HYDROCHLORIDE",
    "company": "KAMAT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "PRUCALOPRIDE SUCCINATEANDA  #218778",
    "submission": "ORIG-1",
    "activeIngredients": "PRUCALOPRIDE SUCCINATE",
    "company": "TORRENT",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "PRUCALOPRIDE SUCCINATEANDA  #218795",
    "submission": "ORIG-1",
    "activeIngredients": "PRUCALOPRIDE SUCCINATE",
    "company": "ZENARA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "PRUCALOPRIDE SUCCINATEANDA  #218812",
    "submission": "ORIG-1",
    "activeIngredients": "PRUCALOPRIDE SUCCINATE",
    "company": "AMNEAL",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "PRUCALOPRIDE SUCCINATEANDA  #218847",
    "submission": "ORIG-1",
    "activeIngredients": "PRUCALOPRIDE SUCCINATE",
    "company": "LUPIN LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "PRUCALOPRIDE SUCCINATEANDA  #218963",
    "submission": "ORIG-1",
    "activeIngredients": "PRUCALOPRIDE SUCCINATE",
    "company": "APPCO",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "PRUCALOPRIDE SUCCINATEANDA  #218977",
    "submission": "ORIG-1",
    "activeIngredients": "PRUCALOPRIDE SUCCINATE",
    "company": "APOTEX",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "TRAZODONE HYDROCHLORIDEANDA  #218988",
    "submission": "SUPPL-3",
    "activeIngredients": "TRAZODONE HYDROCHLORIDE",
    "company": "GRANULES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "PRUCALOPRIDE SUCCINATEANDA  #219078",
    "submission": "ORIG-1",
    "activeIngredients": "PRUCALOPRIDE SUCCINATE",
    "company": "SOMERSET THERAP",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "PRUCALOPRIDE SUCCINATEANDA  #219160",
    "submission": "ORIG-1",
    "activeIngredients": "PRUCALOPRIDE SUCCINATE",
    "company": "ANNORA PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "PRUCALOPRIDE SUCCINATEANDA  #219193",
    "submission": "ORIG-1",
    "activeIngredients": "PRUCALOPRIDE SUCCINATE",
    "company": "SPECGX LLC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "PRUCALOPRIDE SUCCINATEANDA  #219216",
    "submission": "ORIG-1",
    "activeIngredients": "PRUCALOPRIDE SUCCINATE",
    "company": "H2-PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/24/2025",
    "drugName": "ENZALUTAMIDEANDA  #219675",
    "submission": "ORIG-1",
    "activeIngredients": "ENZALUTAMIDE",
    "company": "HAIMEN PHARMA INC",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "06/25/2025",
    "drugName": "DOXORUBICIN HYDROCHLORIDEANDA  #065515",
    "submission": "SUPPL-1",
    "activeIngredients": "DOXORUBICIN HYDROCHLORIDE",
    "company": "ALMAJECT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/25/2025",
    "drugName": "DOXORUBICIN HYDROCHLORIDEANDA  #065515",
    "submission": "SUPPL-3",
    "activeIngredients": "DOXORUBICIN HYDROCHLORIDE",
    "company": "ALMAJECT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/25/2025",
    "drugName": "DOXORUBICIN HYDROCHLORIDEANDA  #065515",
    "submission": "SUPPL-4",
    "activeIngredients": "DOXORUBICIN HYDROCHLORIDE",
    "company": "ALMAJECT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/25/2025",
    "drugName": "METHADONE HYDROCHLORIDEANDA  #088109",
    "submission": "SUPPL-23",
    "activeIngredients": "METHADONE HYDROCHLORIDE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/25/2025",
    "drugName": "METOPROLOL SUCCINATEANDA  #206980",
    "submission": "ORIG-1",
    "activeIngredients": "METOPROLOL SUCCINATE",
    "company": "IPCA LABS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/25/2025",
    "drugName": "NICARDIPINE HYDROCHLORIDEANDA  #218638",
    "submission": "ORIG-1",
    "activeIngredients": "NICARDIPINE HYDROCHLORIDE",
    "company": "NAVINTA LLC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/25/2025",
    "drugName": "ZINC SULFATE HEPTAHYDRATE, CUPRIC SULFATE, MANGANESE SULFATE, SELENIOUS ACIDANDA  #219632",
    "submission": "ORIG-1",
    "activeIngredients": "ZINC SULFATE HEPTAHYDRATE, CUPRIC SULFATE, MANGANESE SULFATE, SELENIOUS ACID",
    "company": "GLAND PHARMA LIMITED",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "06/26/2025",
    "drugName": "PUR-WASHNDA   #022305",
    "submission": "SUPPL-7",
    "activeIngredients": "PURIFIED WATER",
    "company": "NIAGARA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/26/2025",
    "drugName": "CAPRELSANDA   #022405",
    "submission": "SUPPL-24",
    "activeIngredients": "VANDETANIB",
    "company": "GENZYME CORP",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/26/2025",
    "drugName": "MERCAPTOPURINEANDA  #040528",
    "submission": "SUPPL-13",
    "activeIngredients": "MERCAPTOPURINE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/26/2025",
    "drugName": "PRAVASTATIN SODIUMANDA  #076714",
    "submission": "SUPPL-14",
    "activeIngredients": "PRAVASTATIN SODIUM",
    "company": "DR REDDYS LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/26/2025",
    "drugName": "ATAZANAVIR SULFATEANDA  #204806",
    "submission": "SUPPL-13",
    "activeIngredients": "ATAZANAVIR SULFATE",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/26/2025",
    "drugName": "DILTIAZEM HYDROCHLORIDEANDA  #206641",
    "submission": "SUPPL-6",
    "activeIngredients": "DILTIAZEM HYDROCHLORIDE",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/26/2025",
    "drugName": "GLYCOPYRROLATEANDA  #207201",
    "submission": "SUPPL-6",
    "activeIngredients": "GLYCOPYRROLATE",
    "company": "APPCO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/26/2025",
    "drugName": "EPIDIOLEXNDA   #210365",
    "submission": "SUPPL-23",
    "activeIngredients": "CANNABIDIOL",
    "company": "JAZZ PHARMS RES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/26/2025",
    "drugName": "TYZAVANNDA   #211962",
    "submission": "SUPPL-14",
    "activeIngredients": "VANCOMYCIN HYDROCHLORIDE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/26/2025",
    "drugName": "NALOXONE HYDROCHLORIDEANDA  #216624",
    "submission": "SUPPL-4",
    "activeIngredients": "NALOXONE HYDROCHLORIDE",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/26/2025",
    "drugName": "RIVAROXABANANDA  #218502",
    "submission": "ORIG-1",
    "activeIngredients": "RIVAROXABAN",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/26/2025",
    "drugName": "LACOSAMIDEANDA  #219699",
    "submission": "ORIG-1",
    "activeIngredients": "LACOSAMIDE",
    "company": "AJENAT PHARMS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/26/2025",
    "drugName": "SODIUM BICARBONATEANDA  #219701",
    "submission": "ORIG-1",
    "activeIngredients": "SODIUM BICARBONATE",
    "company": "NEOCUBES PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/26/2025",
    "drugName": "NEMLUVIOBLA   #761390",
    "submission": "SUPPL-2",
    "activeIngredients": "NEMOLIZUMAB-ILTO",
    "company": "GALDERMA LABS LP",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/26/2025",
    "drugName": "NEMLUVIOBLA   #761391",
    "submission": "SUPPL-1",
    "activeIngredients": "NEMOLIZUMAB-ILTO",
    "company": "GALDERMA LABS LP",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/27/2025",
    "drugName": "NICARDIPINE HYDROCHLORIDENDA   #022276",
    "submission": "SUPPL-27",
    "activeIngredients": "NICARDIPINE HYDROCHLORIDE",
    "company": "HIKMA INTL PHARMS",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/27/2025",
    "drugName": "NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDENDA   #022276",
    "submission": "SUPPL-27",
    "activeIngredients": "NICARDIPINE HYDROCHLORIDE",
    "company": "HIKMA INTL PHARMS",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/27/2025",
    "drugName": "CELLCEPTNDA   #050722",
    "submission": "SUPPL-54",
    "activeIngredients": "MYCOPHENOLATE MOFETIL",
    "company": "ROCHE PALO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/27/2025",
    "drugName": "CELLCEPTNDA   #050723",
    "submission": "SUPPL-54",
    "activeIngredients": "MYCOPHENOLATE MOFETIL",
    "company": "ROCHE PALO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/27/2025",
    "drugName": "CELLCEPTNDA   #050758",
    "submission": "SUPPL-52",
    "activeIngredients": "MYCOPHENOLATE MOFETIL HYDROCHLORIDE",
    "company": "ROCHE PALO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/27/2025",
    "drugName": "CELLCEPTNDA   #050759",
    "submission": "SUPPL-61",
    "activeIngredients": "MYCOPHENOLATE MOFETIL",
    "company": "ROCHE PALO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/27/2025",
    "drugName": "MYFORTICNDA   #050791",
    "submission": "SUPPL-40",
    "activeIngredients": "MYCOPHENOLATE SODIUM",
    "company": "NOVARTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/27/2025",
    "drugName": "POLYMYXIN B SULFATEANDA  #065372",
    "submission": "SUPPL-4",
    "activeIngredients": "POLYMYXIN B SULFATE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/27/2025",
    "drugName": "LIGNOSPAN FORTEANDA  #088389",
    "submission": "SUPPL-52",
    "activeIngredients": "EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE",
    "company": "DEPROCO",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/27/2025",
    "drugName": "LIGNOSPAN STANDARDANDA  #088390",
    "submission": "SUPPL-62",
    "activeIngredients": "EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE",
    "company": "DEPROCO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/27/2025",
    "drugName": "SOLIRISBLA   #125166",
    "submission": "SUPPL-450",
    "activeIngredients": "ECULIZUMAB",
    "company": "ALEXION PHARM",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/27/2025",
    "drugName": "STELARABLA   #125261",
    "submission": "SUPPL-167",
    "activeIngredients": "USTEKINUMAB",
    "company": "CENTOCOR ORTHO BIOTECH INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/27/2025",
    "drugName": "PERJETABLA   #125409",
    "submission": "SUPPL-139",
    "activeIngredients": "PERTUZUMAB",
    "company": "GENENTECH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/27/2025",
    "drugName": "TESTOSTERONE CYPIONATEANDA  #201720",
    "submission": "SUPPL-11",
    "activeIngredients": "TESTOSTERONE CYPIONATE",
    "company": "SUN PHARM INDS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/27/2025",
    "drugName": "TESTOSTERONE CYPIONATEANDA  #201720",
    "submission": "SUPPL-23",
    "activeIngredients": "TESTOSTERONE CYPIONATE",
    "company": "SUN PHARM INDS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/27/2025",
    "drugName": "SPRITAMNDA   #207958",
    "submission": "SUPPL-27",
    "activeIngredients": "LEVETIRACETAM",
    "company": "APRECIA PHARMS",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/27/2025",
    "drugName": "TYZAVANNDA   #211962",
    "submission": "SUPPL-17",
    "activeIngredients": "VANCOMYCIN HYDROCHLORIDE",
    "company": "HIKMA",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/27/2025",
    "drugName": "AMITRIPTYLINE HYDROCHLORIDEANDA  #212654",
    "submission": "SUPPL-4",
    "activeIngredients": "AMITRIPTYLINE HYDROCHLORIDE",
    "company": "AIPING PHARM INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/27/2025",
    "drugName": "AMITRIPTYLINE HYDROCHLORIDEANDA  #212654",
    "submission": "SUPPL-5",
    "activeIngredients": "AMITRIPTYLINE HYDROCHLORIDE",
    "company": "AIPING PHARM INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/27/2025",
    "drugName": "IODIXANOLANDA  #214271",
    "submission": "SUPPL-15",
    "activeIngredients": "IODIXANOL",
    "company": "HENGRUI PHARMA",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/27/2025",
    "drugName": "MYHIBBINNDA   #216482",
    "submission": "SUPPL-2",
    "activeIngredients": "MYCOPHENOLATE MOFETIL",
    "company": "AZURITY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/27/2025",
    "drugName": "VOYDEYANDA   #218037",
    "submission": "SUPPL-4",
    "activeIngredients": "DANICOPAN",
    "company": "ALEXION PHARMS INC",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/27/2025",
    "drugName": "SUGAMMADEXANDA  #218727",
    "submission": "ORIG-1",
    "activeIngredients": "SUGAMMADEX",
    "company": "HIKMA PHARMACEUTICALS USA INC",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "06/27/2025",
    "drugName": "SUGAMMADEXANDA  #218728",
    "submission": "ORIG-1",
    "activeIngredients": "SUGAMMADEX",
    "company": "HIKMA PHARMACEUTICALS USA INC",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "06/27/2025",
    "drugName": "DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)ANDA  #219199",
    "submission": "ORIG-1",
    "activeIngredients": "DOXORUBICIN HYDROCHLORIDE",
    "company": "ALEMBIC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/27/2025",
    "drugName": "GANIRELIX ACETATEANDA  #219454",
    "submission": "ORIG-1",
    "activeIngredients": "GANIRELIX ACETATE",
    "company": "TRIS PHARMA INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/27/2025",
    "drugName": "AVGEMSINDA   #219920",
    "submission": "ORIG-1",
    "activeIngredients": "GEMCITABINE HYDROCHLORIDE",
    "company": "AVYXA HOLDINGS",
    "submissionClassification": "Type 5 - New Formulation or New Manufacturer",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/27/2025",
    "drugName": "AVGEMSINDA   #219920",
    "submission": "SUPPL-1",
    "activeIngredients": "GEMCITABINE HYDROCHLORIDE",
    "company": "AVYXA HOLDINGS",
    "submissionClassification": "Type 5 - New Formulation or New Manufacturer",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/27/2025",
    "drugName": "STELARABLA   #761044",
    "submission": "SUPPL-15",
    "activeIngredients": "USTEKINUMAB",
    "company": "JANSSEN BIOTECH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/27/2025",
    "drugName": "GAMIFANTBLA   #761107",
    "submission": "SUPPL-18",
    "activeIngredients": "EMAPALUMAB-LZSG",
    "company": "NOVIMMUNE S.A.",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/27/2025",
    "drugName": "ULTOMIRISBLA   #761108",
    "submission": "SUPPL-40",
    "activeIngredients": "RAVULIZUMAB-CWVZ",
    "company": "ALEXION PHARM",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/27/2025",
    "drugName": "PYZCHIVABLA   #761373",
    "submission": "SUPPL-1",
    "activeIngredients": "USTEKINUMAB-TTWE",
    "company": "SAMSUNG BIOEPIS CO LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/30/2025",
    "drugName": "DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATEANDA  #202424",
    "submission": "SUPPL-11",
    "activeIngredients": "AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE",
    "company": "AUROLIFE PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/30/2025",
    "drugName": "SILDENAFIL CITRATEANDA  #203814",
    "submission": "SUPPL-23",
    "activeIngredients": "SILDENAFIL CITRATE",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/30/2025",
    "drugName": "SILDENAFIL CITRATEANDA  #203814",
    "submission": "SUPPL-27",
    "activeIngredients": "SILDENAFIL CITRATE",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/30/2025",
    "drugName": "SILDENAFIL CITRATEANDA  #203814",
    "submission": "SUPPL-29",
    "activeIngredients": "SILDENAFIL CITRATE",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/30/2025",
    "drugName": "TESTOSTERONEANDA  #204571",
    "submission": "SUPPL-6",
    "activeIngredients": "TESTOSTERONE",
    "company": "ACTAVIS LABS UT INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/30/2025",
    "drugName": "EPINEPHRINENDA   #205029",
    "submission": "SUPPL-17",
    "activeIngredients": "EPINEPHRINE",
    "company": "BPI LABS",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/30/2025",
    "drugName": "ABACAVIR, DOLUTEGRAVIR, LAMIVUDINEANDA  #210391",
    "submission": "ORIG-1",
    "activeIngredients": "ABACAVIR, DOLUTEGRAVIR, LAMIVUDINE",
    "company": "CIPLA LIMITED",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "06/30/2025",
    "drugName": "AMPHOTERICIN BANDA  #212967",
    "submission": "ORIG-1",
    "activeIngredients": "AMPHOTERICIN B",
    "company": "MYLAN LABS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/30/2025",
    "drugName": "DICLOFENAC POTASSIUMANDA  #215750",
    "submission": "SUPPL-8",
    "activeIngredients": "DICLOFENAC POTASSIUM",
    "company": "UMEDICA",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/30/2025",
    "drugName": "LEVOCARNITINEANDA  #217430",
    "submission": "ORIG-1",
    "activeIngredients": "LEVOCARNITINE",
    "company": "DEVA HOLDING AS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/30/2025",
    "drugName": "MIRABEGRONANDA  #217989",
    "submission": "ORIG-1",
    "activeIngredients": "MIRABEGRON",
    "company": "QILU",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/30/2025",
    "drugName": "MINOXIDIL EXTRA STRENGTH (FOR MEN)ANDA  #217998",
    "submission": "ORIG-1",
    "activeIngredients": "MINOXIDIL",
    "company": "TARO",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/30/2025",
    "drugName": "LOTEPREDNOL ETABONATEANDA  #218087",
    "submission": "ORIG-1",
    "activeIngredients": "LOTEPREDNOL ETABONATE",
    "company": "LUPIN LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/30/2025",
    "drugName": "PYQUVIANDA  #219417",
    "submission": "ORIG-1",
    "activeIngredients": "DEFLAZACORT",
    "company": "AUCTA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "06/30/2025",
    "drugName": "IBUPROFEN AND FAMOTIDINEANDA  #219538",
    "submission": "ORIG-1",
    "activeIngredients": "FAMOTIDINE; IBUPROFEN",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  }
,
  {
    "approvalDate": "07/01/2025",
    "drugName": "OTICAIRANDA  #064065",
    "submission": "SUPPL-52",
    "activeIngredients": "HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE",
    "company": "BAUSCH AND LOMB",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/01/2025",
    "drugName": "OTICAIRANDA  #064065",
    "submission": "SUPPL-61",
    "activeIngredients": "HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE",
    "company": "BAUSCH AND LOMB",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/01/2025",
    "drugName": "CLINDAMYCIN HYDROCHLORIDEANDA  #065061",
    "submission": "SUPPL-56",
    "activeIngredients": "CLINDAMYCIN HYDROCHLORIDE",
    "company": "SUN PHARM INDS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/01/2025",
    "drugName": "HALOPERIDOL DECANOATEANDA  #074893",
    "submission": "SUPPL-29",
    "activeIngredients": "HALOPERIDOL DECANOATE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/01/2025",
    "drugName": "REPAGLINIDEANDA  #078555",
    "submission": "SUPPL-8",
    "activeIngredients": "REPAGLINIDE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/01/2025",
    "drugName": "REPAGLINIDEANDA  #078555",
    "submission": "SUPPL-9",
    "activeIngredients": "REPAGLINIDE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/01/2025",
    "drugName": "OPDIVOBLA   #125554",
    "submission": "SUPPL-131",
    "activeIngredients": "NIVOLUMAB",
    "company": "BRISTOL MYERS SQUIBB",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/01/2025",
    "drugName": "MONTELUKAST SODIUMANDA  #203328",
    "submission": "SUPPL-14",
    "activeIngredients": "MONTELUKAST SODIUM",
    "company": "AJANTA PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/01/2025",
    "drugName": "CINACALCET HYDROCHLORIDEANDA  #203422",
    "submission": "SUPPL-4",
    "activeIngredients": "CINACALCET HYDROCHLORIDE",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/01/2025",
    "drugName": "MONTELUKAST SODIUMANDA  #203432",
    "submission": "SUPPL-16",
    "activeIngredients": "MONTELUKAST SODIUM",
    "company": "AJANTA PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/01/2025",
    "drugName": "MONTELUKAST SODIUMANDA  #203438",
    "submission": "SUPPL-18",
    "activeIngredients": "MONTELUKAST SODIUM",
    "company": "AJANTA PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/01/2025",
    "drugName": "DECITABINEANDA  #203475",
    "submission": "SUPPL-7",
    "activeIngredients": "DECITABINE",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/01/2025",
    "drugName": "CALCIUM CHLORIDE 10%ANDA  #203477",
    "submission": "SUPPL-2",
    "activeIngredients": "CALCIUM CHLORIDE",
    "company": "INTL MEDICATION SYS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/01/2025",
    "drugName": "TEMOZOLOMIDEANDA  #203691",
    "submission": "SUPPL-14",
    "activeIngredients": "TEMOZOLOMIDE",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/01/2025",
    "drugName": "FLUDARABINE PHOSPHATEANDA  #203738",
    "submission": "SUPPL-3",
    "activeIngredients": "FLUDARABINE PHOSPHATE",
    "company": "ACTAVIS LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/01/2025",
    "drugName": "EXEMESTANEANDA  #206421",
    "submission": "SUPPL-8",
    "activeIngredients": "EXEMESTANE",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/01/2025",
    "drugName": "NEVIRAPINEANDA  #206448",
    "submission": "SUPPL-7",
    "activeIngredients": "NEVIRAPINE",
    "company": "CIPLA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/01/2025",
    "drugName": "AZACITIDINEANDA  #207234",
    "submission": "SUPPL-4",
    "activeIngredients": "AZACITIDINE",
    "company": "NATCO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/01/2025",
    "drugName": "AZACITIDINEANDA  #207234",
    "submission": "SUPPL-5",
    "activeIngredients": "AZACITIDINE",
    "company": "NATCO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/01/2025",
    "drugName": "LACOSAMIDEANDA  #208308",
    "submission": "SUPPL-3",
    "activeIngredients": "LACOSAMIDE",
    "company": "REGCON HOLDINGS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/01/2025",
    "drugName": "LACOSAMIDEANDA  #208308",
    "submission": "SUPPL-5",
    "activeIngredients": "LACOSAMIDE",
    "company": "REGCON HOLDINGS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/01/2025",
    "drugName": "LACOSAMIDEANDA  #208308",
    "submission": "SUPPL-9",
    "activeIngredients": "LACOSAMIDE",
    "company": "REGCON HOLDINGS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/01/2025",
    "drugName": "COLCHICINEANDA  #208678",
    "submission": "SUPPL-7",
    "activeIngredients": "COLCHICINE",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/01/2025",
    "drugName": "TRAMADOL HYDROCHLORIDEANDA  #208708",
    "submission": "SUPPL-17",
    "activeIngredients": "TRAMADOL HYDROCHLORIDE",
    "company": "RUBICON RESEARCH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/01/2025",
    "drugName": "EXEMESTANEANDA  #210323",
    "submission": "SUPPL-8",
    "activeIngredients": "EXEMESTANE",
    "company": "CIPLA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/01/2025",
    "drugName": "LURASIDONE HYDROCHLORIDEANDA  #212124",
    "submission": "SUPPL-1",
    "activeIngredients": "LURASIDONE HYDROCHLORIDE",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/01/2025",
    "drugName": "LURASIDONE HYDROCHLORIDEANDA  #212124",
    "submission": "SUPPL-7",
    "activeIngredients": "LURASIDONE HYDROCHLORIDE",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/01/2025",
    "drugName": "PREGABALINANDA  #212280",
    "submission": "SUPPL-10",
    "activeIngredients": "PREGABALIN",
    "company": "CIPLA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/01/2025",
    "drugName": "MESALAMINEANDA  #216967",
    "submission": "SUPPL-4",
    "activeIngredients": "MESALAMINE",
    "company": "ALEMBIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/01/2025",
    "drugName": "ELAGOLIXANDA  #217690",
    "submission": "ORIG-1",
    "activeIngredients": "ELAGOLIX",
    "company": "HETERO LABS LIMITED",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "07/01/2025",
    "drugName": "CARBAMAZEPINEANDA  #218221",
    "submission": "SUPPL-2",
    "activeIngredients": "CARBAMAZEPINE",
    "company": "BIONPHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/01/2025",
    "drugName": "TOPIRAMATEANDA  #218695",
    "submission": "SUPPL-1",
    "activeIngredients": "TOPIRAMATE",
    "company": "AMTA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/01/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #218753",
    "submission": "ORIG-1",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "DR REDDYS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/01/2025",
    "drugName": "KISUNLABLA   #761248",
    "submission": "SUPPL-4",
    "activeIngredients": "DONANEMAB-AZBT",
    "company": "ELI LILLY CO",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/02/2025",
    "drugName": "ORABLOCNDA   #022466",
    "submission": "SUPPL-9",
    "activeIngredients": "ARTICAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE",
    "company": "PIERREL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/02/2025",
    "drugName": "WARFARIN SODIUMANDA  #040616",
    "submission": "SUPPL-21",
    "activeIngredients": "WARFARIN SODIUM",
    "company": "PLIVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/02/2025",
    "drugName": "FLUCONAZOLEANDA  #074681",
    "submission": "SUPPL-13",
    "activeIngredients": "FLUCONAZOLE",
    "company": "TEVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/02/2025",
    "drugName": "PRAVASTATIN SODIUMANDA  #077904",
    "submission": "SUPPL-7",
    "activeIngredients": "PRAVASTATIN SODIUM",
    "company": "CIPLA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/02/2025",
    "drugName": "LETROZOLEANDA  #090838",
    "submission": "SUPPL-7",
    "activeIngredients": "LETROZOLE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/02/2025",
    "drugName": "ACITRETINANDA  #202552",
    "submission": "SUPPL-10",
    "activeIngredients": "ACITRETIN",
    "company": "IMPAX LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/02/2025",
    "drugName": "POSACONAZOLEANDA  #208768",
    "submission": "SUPPL-3",
    "activeIngredients": "POSACONAZOLE",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/02/2025",
    "drugName": "LETROZOLEANDA  #211717",
    "submission": "SUPPL-2",
    "activeIngredients": "LETROZOLE",
    "company": "EUGIA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/02/2025",
    "drugName": "NINTEDANIBANDA  #212609",
    "submission": "ORIG-1",
    "activeIngredients": "NINTEDANIB",
    "company": "CIPLA LIMITED",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "07/02/2025",
    "drugName": "DILTIAZEM HYDROCHLORIDEANDA  #218032",
    "submission": "ORIG-1",
    "activeIngredients": "DILTIAZEM HYDROCHLORIDE",
    "company": "NOVAST LABS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/02/2025",
    "drugName": "NITROFURANTOINANDA  #219495",
    "submission": "ORIG-1",
    "activeIngredients": "NITROFURANTOIN",
    "company": "ANNORA PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/02/2025",
    "drugName": "ZEGFROVYNDA   #219839",
    "submission": "ORIG-1",
    "activeIngredients": "SUNVOZERTINIB",
    "company": "DIZAL JIANGSU",
    "submissionClassification": "Type 1 - New Molecular Entity",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/02/2025",
    "drugName": "LYNOZYFICBLA   #761400",
    "submission": "ORIG-1",
    "activeIngredients": "LINVOSELTAMAB-GCPT",
    "company": "RENGENERON PHARMACEUTICALS, INC.",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/03/2025",
    "drugName": "SINEQUANNDA   #016798",
    "submission": "SUPPL-57",
    "activeIngredients": "DOXEPIN HYDROCHLORIDE",
    "company": "PFIZER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/03/2025",
    "drugName": "SINEQUANNDA   #017516",
    "submission": "SUPPL-26",
    "activeIngredients": "DOXEPIN HYDROCHLORIDE",
    "company": "PFIZER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/03/2025",
    "drugName": "METHYLPREDNISOLONE SODIUM SUCCINATEANDA  #040583",
    "submission": "SUPPL-15",
    "activeIngredients": "METHYLPREDNISOLONE SODIUM SUCCINATE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/03/2025",
    "drugName": "METHYLPREDNISOLONE SODIUM SUCCINATEANDA  #040583",
    "submission": "SUPPL-17",
    "activeIngredients": "METHYLPREDNISOLONE SODIUM SUCCINATE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/03/2025",
    "drugName": "METHYLPREDNISOLONE SODIUM SUCCINATEANDA  #040612",
    "submission": "SUPPL-15",
    "activeIngredients": "METHYLPREDNISOLONE SODIUM SUCCINATE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/03/2025",
    "drugName": "METHYLPREDNISOLONE SODIUM SUCCINATEANDA  #040612",
    "submission": "SUPPL-17",
    "activeIngredients": "METHYLPREDNISOLONE SODIUM SUCCINATE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/03/2025",
    "drugName": "COLY-MYCIN MNDA   #050108",
    "submission": "SUPPL-41",
    "activeIngredients": "COLISTIMETHATE SODIUM",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/03/2025",
    "drugName": "POLYMYXIN B SULFATEANDA  #060716",
    "submission": "SUPPL-27",
    "activeIngredients": "POLYMYXIN B SULFATE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/03/2025",
    "drugName": "POLYMYXIN B SULFATEANDA  #065372",
    "submission": "SUPPL-10",
    "activeIngredients": "POLYMYXIN B SULFATE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/03/2025",
    "drugName": "ALPRAZOLAMANDA  #074215",
    "submission": "SUPPL-27",
    "activeIngredients": "ALPRAZOLAM",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/03/2025",
    "drugName": "METHOTREXATE SODIUMANDA  #081099",
    "submission": "SUPPL-49",
    "activeIngredients": "METHOTREXATE SODIUM",
    "company": "BARR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/03/2025",
    "drugName": "POLYMYXIN B SULFATEANDA  #090110",
    "submission": "SUPPL-4",
    "activeIngredients": "POLYMYXIN B SULFATE",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/03/2025",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #090693",
    "submission": "SUPPL-23",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/03/2025",
    "drugName": "LINEZOLIDANDA  #200904",
    "submission": "SUPPL-16",
    "activeIngredients": "LINEZOLID",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/03/2025",
    "drugName": "IMIQUIMODANDA  #201994",
    "submission": "SUPPL-6",
    "activeIngredients": "IMIQUIMOD",
    "company": "GLENMARK PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/03/2025",
    "drugName": "BUSPIRONE HYDROCHLORIDEANDA  #202087",
    "submission": "SUPPL-5",
    "activeIngredients": "BUSPIRONE HYDROCHLORIDE",
    "company": "AIPING PHARM INC",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/03/2025",
    "drugName": "POLYMYXIN B SULFATEANDA  #202766",
    "submission": "SUPPL-11",
    "activeIngredients": "POLYMYXIN B SULFATE",
    "company": "XELLIA PHARMS APS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/03/2025",
    "drugName": "POLYMYXIN B SULFATEANDA  #206589",
    "submission": "SUPPL-8",
    "activeIngredients": "POLYMYXIN B SULFATE",
    "company": "EUGIA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/03/2025",
    "drugName": "POLYMYXIN B SULFATEANDA  #207322",
    "submission": "SUPPL-6",
    "activeIngredients": "POLYMYXIN B SULFATE",
    "company": "GLAND",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/03/2025",
    "drugName": "APREPITANTANDA  #207777",
    "submission": "SUPPL-2",
    "activeIngredients": "APREPITANT",
    "company": "GLENMARK SPECLT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/03/2025",
    "drugName": "ISTURISANDA   #212801",
    "submission": "SUPPL-4",
    "activeIngredients": "OSILODROSTAT PHOSPHATE",
    "company": "RECORDATI RARE",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/03/2025",
    "drugName": "INDOMETHACINANDA  #216905",
    "submission": "ORIG-1",
    "activeIngredients": "INDOMETHACIN",
    "company": "ANNORA PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/03/2025",
    "drugName": "ERIBULIN MESYLATEANDA  #217473",
    "submission": "ORIG-1",
    "activeIngredients": "ERIBULIN MESYLATE",
    "company": "DR REDDYS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/03/2025",
    "drugName": "POSACONAZOLEANDA  #217553",
    "submission": "SUPPL-2",
    "activeIngredients": "POSACONAZOLE",
    "company": "GLAND",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/03/2025",
    "drugName": "BENDAMUSTINE HYDROCHLORIDENDA   #219014",
    "submission": "ORIG-1",
    "activeIngredients": "BENDAMUSTINE HYDROCHLORIDE",
    "company": "DR REDDYS",
    "submissionClassification": "Type 5 - New Formulation or New Manufacturer",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/03/2025",
    "drugName": "KETOCONAZOLEANDA  #219129",
    "submission": "ORIG-1",
    "activeIngredients": "KETOCONAZOLE",
    "company": "NOVITIUM PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/03/2025",
    "drugName": "EKTERLYNDA   #219301",
    "submission": "ORIG-1",
    "activeIngredients": "SEBETRALSTAT",
    "company": "KALVISTA",
    "submissionClassification": "Type 1 - New Molecular Entity",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/07/2025",
    "drugName": "CABERGOLINEANDA  #077843",
    "submission": "SUPPL-5",
    "activeIngredients": "CABERGOLINE",
    "company": "IMPAX LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/07/2025",
    "drugName": "PREGABALINANDA  #206942",
    "submission": "SUPPL-1",
    "activeIngredients": "PREGABALIN",
    "company": "TORRENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/07/2025",
    "drugName": "PREGABALINANDA  #209743",
    "submission": "SUPPL-19",
    "activeIngredients": "PREGABALIN",
    "company": "AMNEAL PHARMS CO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/07/2025",
    "drugName": "MANGANESE CHLORIDEANDA  #217583",
    "submission": "ORIG-1",
    "activeIngredients": "MANGANESE CHLORIDE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/07/2025",
    "drugName": "ELETRIPTAN HYDROBROMIDEANDA  #219143",
    "submission": "ORIG-1",
    "activeIngredients": "ELETRIPTAN HYDROBROMIDE",
    "company": "ANNORA PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2025",
    "drugName": "GILDESS 24 FEANDA  #090293",
    "submission": "SUPPL-2",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2025",
    "drugName": "GILDESS 24 FEANDA  #090293",
    "submission": "SUPPL-3",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2025",
    "drugName": "GILDESS 24 FEANDA  #090293",
    "submission": "SUPPL-4",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2025",
    "drugName": "GILDESS 24 FEANDA  #090293",
    "submission": "SUPPL-5",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2025",
    "drugName": "GILDESS 24 FEANDA  #090293",
    "submission": "SUPPL-6",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2025",
    "drugName": "QUETIAPINE FUMARATEANDA  #091388",
    "submission": "SUPPL-26",
    "activeIngredients": "QUETIAPINE FUMARATE",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2025",
    "drugName": "ANASTROZOLEANDA  #200654",
    "submission": "SUPPL-4",
    "activeIngredients": "ANASTROZOLE",
    "company": "APOTEX INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2025",
    "drugName": "ANASTROZOLEANDA  #200654",
    "submission": "SUPPL-5",
    "activeIngredients": "ANASTROZOLE",
    "company": "APOTEX INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2025",
    "drugName": "SODIUM OXYBATEANDA  #202090",
    "submission": "SUPPL-10",
    "activeIngredients": "SODIUM OXYBATE",
    "company": "HIKMA",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2025",
    "drugName": "SELENIOUS ACIDANDA  #219629",
    "submission": "ORIG-1",
    "activeIngredients": "SELENIOUS ACID",
    "company": "GLAND",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2025",
    "drugName": "HEMLIBRABLA   #761083",
    "submission": "SUPPL-20",
    "activeIngredients": "EMICIZUMAB",
    "company": "GENENTECH INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/08/2025",
    "drugName": "ELREXFIOBLA   #761345",
    "submission": "SUPPL-4",
    "activeIngredients": "ELRANATAMAB",
    "company": "PFIZER INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/09/2025",
    "drugName": "CUPRIC CHLORIDE IN PLASTIC CONTAINERNDA   #018960",
    "submission": "SUPPL-29",
    "activeIngredients": "CUPRIC CHLORIDE",
    "company": "HOSPIRA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/09/2025",
    "drugName": "HUMATROPEBLA   #019640",
    "submission": "SUPPL-111",
    "activeIngredients": "SOMATROPIN",
    "company": "LILLY",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/09/2025",
    "drugName": "BIO-TROPINBLA   #019774",
    "submission": "SUPPL-65",
    "activeIngredients": "SOMATROPIN",
    "company": "FERRING",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/09/2025",
    "drugName": "ZOMACTONBLA   #019774",
    "submission": "SUPPL-65",
    "activeIngredients": "SOMATROPIN",
    "company": "FERRING",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/09/2025",
    "drugName": "GENOTROPINBLA   #020280",
    "submission": "SUPPL-108",
    "activeIngredients": "SOMATROPIN",
    "company": "PHARMACIA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/09/2025",
    "drugName": "GENOTROPIN PRESERVATIVE FREEBLA   #020280",
    "submission": "SUPPL-108",
    "activeIngredients": "SOMATROPIN",
    "company": "PHARMACIA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/09/2025",
    "drugName": "NUTROPIN AQBLA   #020522",
    "submission": "SUPPL-68",
    "activeIngredients": "SOMATROPIN",
    "company": "GENENTECH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/09/2025",
    "drugName": "NUTROPIN AQ NUSPINBLA   #020522",
    "submission": "SUPPL-68",
    "activeIngredients": "SOMATROPIN",
    "company": "GENENTECH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/09/2025",
    "drugName": "NUTROPIN AQ PENBLA   #020522",
    "submission": "SUPPL-68",
    "activeIngredients": "SOMATROPIN",
    "company": "GENENTECH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/09/2025",
    "drugName": "NORDITROPINBLA   #021148",
    "submission": "SUPPL-62",
    "activeIngredients": "SOMATROPIN",
    "company": "NOVO NORDISK INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/09/2025",
    "drugName": "NORDITROPIN FLEXPROBLA   #021148",
    "submission": "SUPPL-62",
    "activeIngredients": "SOMATROPIN",
    "company": "NOVO NORDISK INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/09/2025",
    "drugName": "NORDITROPIN NORDIFLEXBLA   #021148",
    "submission": "SUPPL-62",
    "activeIngredients": "SOMATROPIN",
    "company": "NOVO NORDISK INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/09/2025",
    "drugName": "OMNITROPEBLA   #021426",
    "submission": "SUPPL-62",
    "activeIngredients": "SOMATROPIN",
    "company": "SANDOZ",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/09/2025",
    "drugName": "INCRELEXBLA   #021839",
    "submission": "SUPPL-33",
    "activeIngredients": "MECASERMIN RECOMBINANT",
    "company": "IPSEN INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/09/2025",
    "drugName": "TESTOSTERONE CYPIONATEANDA  #091244",
    "submission": "SUPPL-12",
    "activeIngredients": "TESTOSTERONE CYPIONATE",
    "company": "HIKMA FARMACEUTICA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/09/2025",
    "drugName": "TESTOSTERONE CYPIONATEANDA  #091244",
    "submission": "SUPPL-13",
    "activeIngredients": "TESTOSTERONE CYPIONATE",
    "company": "HIKMA FARMACEUTICA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/09/2025",
    "drugName": "LEVETIRACETAMANDA  #091430",
    "submission": "SUPPL-7",
    "activeIngredients": "LEVETIRACETAM",
    "company": "TEVA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/09/2025",
    "drugName": "CIPROFLOXACIN AND DEXAMETHASONEANDA  #205548",
    "submission": "SUPPL-1",
    "activeIngredients": "CIPROFLOXACIN; DEXAMETHASONE",
    "company": "DR REDDYS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/09/2025",
    "drugName": "VORICONAZOLEANDA  #206398",
    "submission": "SUPPL-8",
    "activeIngredients": "VORICONAZOLE",
    "company": "ALMAJECT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/09/2025",
    "drugName": "PANTOPRAZOLE SODIUMANDA  #208580",
    "submission": "SUPPL-4",
    "activeIngredients": "PANTOPRAZOLE SODIUM",
    "company": "NORVIUM BIOSCIENCE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/09/2025",
    "drugName": "PANTOPRAZOLE SODIUMANDA  #208580",
    "submission": "SUPPL-5",
    "activeIngredients": "PANTOPRAZOLE SODIUM",
    "company": "NORVIUM BIOSCIENCE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/09/2025",
    "drugName": "PANTOPRAZOLE SODIUMANDA  #208580",
    "submission": "SUPPL-6",
    "activeIngredients": "PANTOPRAZOLE SODIUM",
    "company": "NORVIUM BIOSCIENCE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/09/2025",
    "drugName": "PANTOPRAZOLE SODIUMANDA  #208580",
    "submission": "SUPPL-7",
    "activeIngredients": "PANTOPRAZOLE SODIUM",
    "company": "NORVIUM BIOSCIENCE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/09/2025",
    "drugName": "GEMCITABINE HYDROCHLORIDEANDA  #210383",
    "submission": "SUPPL-5",
    "activeIngredients": "GEMCITABINE HYDROCHLORIDE",
    "company": "NOVAST LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/09/2025",
    "drugName": "OSELTAMIVIR PHOSPHATEANDA  #217274",
    "submission": "ORIG-1",
    "activeIngredients": "OSELTAMIVIR PHOSPHATE",
    "company": "SHANDONG",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/09/2025",
    "drugName": "FAMOTIDINEANDA  #219091",
    "submission": "ORIG-1",
    "activeIngredients": "FAMOTIDINE",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/09/2025",
    "drugName": "CALCITONIN-SALMONANDA  #219196",
    "submission": "ORIG-1",
    "activeIngredients": "CALCITONIN SALMON",
    "company": "SAGENT",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/09/2025",
    "drugName": "METRONIDAZOLEANDA  #219295",
    "submission": "ORIG-1",
    "activeIngredients": "METRONIDAZOLE",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/09/2025",
    "drugName": "DEHYDRATED ALCOHOLANDA  #219569",
    "submission": "ORIG-1",
    "activeIngredients": "ALCOHOL",
    "company": "INGENUS PHARMS LLC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/09/2025",
    "drugName": "SOGROYABLA   #761156",
    "submission": "SUPPL-13",
    "activeIngredients": "SOMAPACITAN-BECO",
    "company": "NOVO NORDISK INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/09/2025",
    "drugName": "SKYTROFABLA   #761177",
    "submission": "SUPPL-9",
    "activeIngredients": "LONAPEGSOMATROPIN-TCGD",
    "company": "ASCENDIS PHARMA ENCOCRINOLOGY DIV A/S",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/09/2025",
    "drugName": "NGENLABLA   #761184",
    "submission": "SUPPL-6",
    "activeIngredients": "SOMATROGON-GHLA",
    "company": "PFIZER IRELAND PHARMACEUTICALS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2025",
    "drugName": "CENTANYNDA   #050788",
    "submission": "SUPPL-9",
    "activeIngredients": "MUPIROCIN",
    "company": "PADAGIS US",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2025",
    "drugName": "AMANTADINE HYDROCHLORIDEANDA  #070589",
    "submission": "SUPPL-54",
    "activeIngredients": "AMANTADINE HYDROCHLORIDE",
    "company": "UPSHER SMITH LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2025",
    "drugName": "AMANTADINE HYDROCHLORIDEANDA  #071293",
    "submission": "SUPPL-44",
    "activeIngredients": "AMANTADINE HYDROCHLORIDE",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2025",
    "drugName": "AMANTADINE HYDROCHLORIDEANDA  #074028",
    "submission": "SUPPL-18",
    "activeIngredients": "AMANTADINE HYDROCHLORIDE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2025",
    "drugName": "AMANTADINE HYDROCHLORIDEANDA  #074170",
    "submission": "SUPPL-11",
    "activeIngredients": "AMANTADINE HYDROCHLORIDE",
    "company": "AUROBINDO PHARMA USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2025",
    "drugName": "AMANTADINE HYDROCHLORIDEANDA  #074509",
    "submission": "SUPPL-19",
    "activeIngredients": "AMANTADINE HYDROCHLORIDE",
    "company": "PHARM ASSOC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2025",
    "drugName": "AMANTADINE HYDROCHLORIDEANDA  #075060",
    "submission": "SUPPL-13",
    "activeIngredients": "AMANTADINE HYDROCHLORIDE",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2025",
    "drugName": "AMANTADINE HYDROCHLORIDEANDA  #075819",
    "submission": "SUPPL-3",
    "activeIngredients": "AMANTADINE HYDROCHLORIDE",
    "company": "ADAPTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2025",
    "drugName": "DILT-CDANDA  #076151",
    "submission": "SUPPL-16",
    "activeIngredients": "DILTIAZEM HYDROCHLORIDE",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2025",
    "drugName": "DILT-CDANDA  #076151",
    "submission": "SUPPL-17",
    "activeIngredients": "DILTIAZEM HYDROCHLORIDE",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2025",
    "drugName": "AMANTADINE HYDROCHLORIDEANDA  #076186",
    "submission": "SUPPL-31",
    "activeIngredients": "AMANTADINE HYDROCHLORIDE",
    "company": "UPSHER SMITH LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2025",
    "drugName": "AMANTADINE HYDROCHLORIDEANDA  #076352",
    "submission": "SUPPL-3",
    "activeIngredients": "AMANTADINE HYDROCHLORIDE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2025",
    "drugName": "DILTZACANDA  #076395",
    "submission": "SUPPL-9",
    "activeIngredients": "DILTIAZEM HYDROCHLORIDE",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2025",
    "drugName": "DILTZACANDA  #076395",
    "submission": "SUPPL-11",
    "activeIngredients": "DILTIAZEM HYDROCHLORIDE",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2025",
    "drugName": "AMANTADINE HYDROCHLORIDEANDA  #077659",
    "submission": "SUPPL-3",
    "activeIngredients": "AMANTADINE HYDROCHLORIDE",
    "company": "ACTAVIS ELIZABETH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2025",
    "drugName": "AMANTADINE HYDROCHLORIDEANDA  #077992",
    "submission": "SUPPL-11",
    "activeIngredients": "AMANTADINE HYDROCHLORIDE",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2025",
    "drugName": "AMANTADINE HYDROCHLORIDEANDA  #078720",
    "submission": "SUPPL-24",
    "activeIngredients": "AMANTADINE HYDROCHLORIDE",
    "company": "BIONPHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2025",
    "drugName": "DILTIAZEM HYDROCHLORIDEANDA  #203023",
    "submission": "SUPPL-12",
    "activeIngredients": "DILTIAZEM HYDROCHLORIDE",
    "company": "SUN PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2025",
    "drugName": "MOXIFLOXACIN HYDROCHLORIDEANDA  #206447",
    "submission": "SUPPL-4",
    "activeIngredients": "MOXIFLOXACIN HYDROCHLORIDE",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2025",
    "drugName": "AMANTADINE HYDROCHLORIDEANDA  #207570",
    "submission": "SUPPL-2",
    "activeIngredients": "AMANTADINE HYDROCHLORIDE",
    "company": "INVAGEN PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2025",
    "drugName": "AMANTADINE HYDROCHLORIDEANDA  #207571",
    "submission": "SUPPL-1",
    "activeIngredients": "AMANTADINE HYDROCHLORIDE",
    "company": "INVAGEN PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2025",
    "drugName": "AMANTADINE HYDROCHLORIDEANDA  #208096",
    "submission": "SUPPL-4",
    "activeIngredients": "AMANTADINE HYDROCHLORIDE",
    "company": "WATSON LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2025",
    "drugName": "AMANTADINE HYDROCHLORIDEANDA  #208107",
    "submission": "SUPPL-4",
    "activeIngredients": "AMANTADINE HYDROCHLORIDE",
    "company": "WATSON LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2025",
    "drugName": "AMANTADINE HYDROCHLORIDEANDA  #208278",
    "submission": "SUPPL-6",
    "activeIngredients": "AMANTADINE HYDROCHLORIDE",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2025",
    "drugName": "LYNPARZANDA   #208558",
    "submission": "SUPPL-31",
    "activeIngredients": "OLAPARIB",
    "company": "ASTRAZENECA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2025",
    "drugName": "GOCOVRINDA   #208944",
    "submission": "SUPPL-9",
    "activeIngredients": "AMANTADINE HYDROCHLORIDE",
    "company": "SUPERNUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2025",
    "drugName": "AMANTADINE HYDROCHLORIDEANDA  #208966",
    "submission": "SUPPL-20",
    "activeIngredients": "AMANTADINE HYDROCHLORIDE",
    "company": "ALEMBIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2025",
    "drugName": "AMANTADINE HYDROCHLORIDEANDA  #209035",
    "submission": "SUPPL-14",
    "activeIngredients": "AMANTADINE HYDROCHLORIDE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2025",
    "drugName": "AMANTADINE HYDROCHLORIDEANDA  #209047",
    "submission": "SUPPL-7",
    "activeIngredients": "AMANTADINE HYDROCHLORIDE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2025",
    "drugName": "AMANTADINE HYDROCHLORIDEANDA  #209171",
    "submission": "SUPPL-11",
    "activeIngredients": "AMANTADINE HYDROCHLORIDE",
    "company": "HERITAGE PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2025",
    "drugName": "AMANTADINE HYDROCHLORIDEANDA  #209221",
    "submission": "SUPPL-5",
    "activeIngredients": "AMANTADINE HYDROCHLORIDE",
    "company": "CHARTWELL MOLECULAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2025",
    "drugName": "OSMOLEX ERNDA   #209410",
    "submission": "SUPPL-9",
    "activeIngredients": "AMANTADINE HYDROCHLORIDE",
    "company": "SUPERNUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2025",
    "drugName": "DICLOFENAC POTASSIUMANDA  #210078",
    "submission": "SUPPL-1",
    "activeIngredients": "DICLOFENAC POTASSIUM",
    "company": "ONESOURCE SPECIALTY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2025",
    "drugName": "DICLOFENAC POTASSIUMANDA  #210078",
    "submission": "SUPPL-2",
    "activeIngredients": "DICLOFENAC POTASSIUM",
    "company": "ONESOURCE SPECIALTY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2025",
    "drugName": "DICLOFENAC POTASSIUMANDA  #210078",
    "submission": "SUPPL-4",
    "activeIngredients": "DICLOFENAC POTASSIUM",
    "company": "ONESOURCE SPECIALTY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2025",
    "drugName": "DICLOFENAC POTASSIUMANDA  #210078",
    "submission": "SUPPL-6",
    "activeIngredients": "DICLOFENAC POTASSIUM",
    "company": "ONESOURCE SPECIALTY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2025",
    "drugName": "DICLOFENAC POTASSIUMANDA  #210078",
    "submission": "SUPPL-8",
    "activeIngredients": "DICLOFENAC POTASSIUM",
    "company": "ONESOURCE SPECIALTY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2025",
    "drugName": "AMANTADINE HYDROCHLORIDEANDA  #210129",
    "submission": "SUPPL-1",
    "activeIngredients": "AMANTADINE HYDROCHLORIDE",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2025",
    "drugName": "MOTEGRITYNDA   #210166",
    "submission": "SUPPL-4",
    "activeIngredients": "PRUCALOPRIDE SUCCINATE",
    "company": "TAKEDA PHARMS USA",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2025",
    "drugName": "AMANTADINE HYDROCHLORIDEANDA  #210403",
    "submission": "SUPPL-11",
    "activeIngredients": "AMANTADINE HYDROCHLORIDE",
    "company": "JUBILANT GENERICS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2025",
    "drugName": "METOPROLOL SUCCINATEANDA  #210597",
    "submission": "SUPPL-2",
    "activeIngredients": "METOPROLOL SUCCINATE",
    "company": "PRINSTON INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2025",
    "drugName": "AMANTADINE HYDROCHLORIDEANDA  #211354",
    "submission": "SUPPL-2",
    "activeIngredients": "AMANTADINE HYDROCHLORIDE",
    "company": "ONESOURCE SPECIALTY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2025",
    "drugName": "AMANTADINE HYDROCHLORIDEANDA  #212044",
    "submission": "SUPPL-7",
    "activeIngredients": "AMANTADINE HYDROCHLORIDE",
    "company": "RUBICON RESEARCH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2025",
    "drugName": "AMANTADINE HYDROCHLORIDEANDA  #212407",
    "submission": "SUPPL-1",
    "activeIngredients": "AMANTADINE HYDROCHLORIDE",
    "company": "ADAPTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2025",
    "drugName": "PACLITAXELANDA  #212700",
    "submission": "SUPPL-4",
    "activeIngredients": "PACLITAXEL",
    "company": "HENGRUI PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2025",
    "drugName": "AMANTADINE HYDROCHLORIDEANDA  #214284",
    "submission": "SUPPL-6",
    "activeIngredients": "AMANTADINE HYDROCHLORIDE",
    "company": "ALEMBIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2025",
    "drugName": "AMANTADINE HYDROCHLORIDEANDA  #214580",
    "submission": "SUPPL-4",
    "activeIngredients": "AMANTADINE HYDROCHLORIDE",
    "company": "HUMANWELL PURACAP",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2025",
    "drugName": "RIFABUTINANDA  #215041",
    "submission": "SUPPL-15",
    "activeIngredients": "RIFABUTIN",
    "company": "NOVITIUM PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2025",
    "drugName": "POSACONAZOLEANDA  #217119",
    "submission": "SUPPL-1",
    "activeIngredients": "POSACONAZOLE",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2025",
    "drugName": "TRETINOINANDA  #217831",
    "submission": "ORIG-1",
    "activeIngredients": "TRETINOIN",
    "company": "ENCUBE",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2025",
    "drugName": "AMANTADINE HYDROCHLORIDEANDA  #218598",
    "submission": "SUPPL-1",
    "activeIngredients": "AMANTADINE HYDROCHLORIDE",
    "company": "ZHEJIANG JUTAI PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2025",
    "drugName": "NILOTINIB D-TARTRATENDA   #218922",
    "submission": "SUPPL-1",
    "activeIngredients": "NILOTINIB D-TARTRATE",
    "company": "CIPLA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/10/2025",
    "drugName": "ELREXFIOBLA   #761345",
    "submission": "SUPPL-3",
    "activeIngredients": "ELRANATAMAB",
    "company": "PFIZER INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "ANDROGELNDA   #021015",
    "submission": "SUPPL-47",
    "activeIngredients": "TESTOSTERONE",
    "company": "BESINS HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "AVELOXNDA   #021085",
    "submission": "SUPPL-69",
    "activeIngredients": "MOXIFLOXACIN HYDROCHLORIDE",
    "company": "BAYER HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINERNDA   #021277",
    "submission": "SUPPL-65",
    "activeIngredients": "MOXIFLOXACIN HYDROCHLORIDE",
    "company": "BAYER HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "TESTIMNDA   #021454",
    "submission": "SUPPL-36",
    "activeIngredients": "TESTOSTERONE",
    "company": "ENDO OPERATIONS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "FORTESTANDA   #021463",
    "submission": "SUPPL-29",
    "activeIngredients": "TESTOSTERONE",
    "company": "ENDO OPERATIONS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "XYZALNDA   #022064",
    "submission": "SUPPL-40",
    "activeIngredients": "LEVOCETIRIZINE DIHYDROCHLORIDE",
    "company": "CHATTEM SANOFI",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "XYZALNDA   #022157",
    "submission": "SUPPL-22",
    "activeIngredients": "LEVOCETIRIZINE DIHYDROCHLORIDE",
    "company": "CHATTEM SANOFI",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "AVEEDNDA   #022219",
    "submission": "SUPPL-21",
    "activeIngredients": "TESTOSTERONE UNDECANOATE",
    "company": "ENDO OPERATIONS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "ANDROGELNDA   #022309",
    "submission": "SUPPL-22",
    "activeIngredients": "TESTOSTERONE",
    "company": "BESINS HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "QSYMIANDA   #022580",
    "submission": "SUPPL-29",
    "activeIngredients": "PHENTERMINE HYDROCHLORIDE; TOPIRAMATE",
    "company": "VIVUS LLC",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "TESTOSTERONE CYPIONATEANDA  #040530",
    "submission": "SUPPL-28",
    "activeIngredients": "TESTOSTERONE CYPIONATE",
    "company": "PADAGIS US",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "TESTOSTERONE CYPIONATEANDA  #040530",
    "submission": "SUPPL-34",
    "activeIngredients": "TESTOSTERONE CYPIONATE",
    "company": "PADAGIS US",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "TESTOSTERONE ENANTHATEANDA  #040575",
    "submission": "SUPPL-11",
    "activeIngredients": "TESTOSTERONE ENANTHATE",
    "company": "NEXUS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "TESTOSTERONE CYPIONATEANDA  #040615",
    "submission": "SUPPL-7",
    "activeIngredients": "TESTOSTERONE CYPIONATE",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "TESTOSTERONE ENANTHATEANDA  #040647",
    "submission": "SUPPL-4",
    "activeIngredients": "TESTOSTERONE ENANTHATE",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "TESTOSTERONE CYPIONATEANDA  #040652",
    "submission": "SUPPL-10",
    "activeIngredients": "TESTOSTERONE CYPIONATE",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "CYCLOPHOSPHAMIDEANDA  #040745",
    "submission": "SUPPL-5",
    "activeIngredients": "CYCLOPHOSPHAMIDE",
    "company": "BAXTER HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "CETIRIZINE HYDROCHLORIDEANDA  #076601",
    "submission": "SUPPL-15",
    "activeIngredients": "CETIRIZINE HYDROCHLORIDE",
    "company": "TARO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "CETIRIZINE HYDROCHLORIDEANDA  #077279",
    "submission": "SUPPL-7",
    "activeIngredients": "CETIRIZINE HYDROCHLORIDE",
    "company": "TEVA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "CETIRIZINE HYDROCHLORIDEANDA  #078398",
    "submission": "SUPPL-9",
    "activeIngredients": "CETIRIZINE HYDROCHLORIDE",
    "company": "PADAGIS US",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "CETIRIZINE HYDROCHLORIDEANDA  #078412",
    "submission": "SUPPL-5",
    "activeIngredients": "CETIRIZINE HYDROCHLORIDE",
    "company": "PHARM ASSOC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "CETIRIZINE HYDROCHLORIDEANDA  #078488",
    "submission": "SUPPL-12",
    "activeIngredients": "CETIRIZINE HYDROCHLORIDE",
    "company": "BIONPHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "CETIRIZINE HYDROCHLORIDEANDA  #078496",
    "submission": "SUPPL-7",
    "activeIngredients": "CETIRIZINE HYDROCHLORIDE",
    "company": "LANNETT CO INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "CETIRIZINE HYDROCHLORIDEANDA  #078617",
    "submission": "SUPPL-2",
    "activeIngredients": "CETIRIZINE HYDROCHLORIDE",
    "company": "ACTAVIS MID ATLANTIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "FLUOXETINE HYDROCHLORIDEANDA  #078619",
    "submission": "SUPPL-29",
    "activeIngredients": "FLUOXETINE HYDROCHLORIDE",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "CETIRIZINE HYDROCHLORIDEANDA  #078757",
    "submission": "SUPPL-2",
    "activeIngredients": "CETIRIZINE HYDROCHLORIDE",
    "company": "WOCKHARDT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "CETIRIZINE HYDROCHLORIDEANDA  #078870",
    "submission": "SUPPL-12",
    "activeIngredients": "CETIRIZINE HYDROCHLORIDE",
    "company": "APOZEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "CETIRIZINE HYDROCHLORIDEANDA  #078876",
    "submission": "SUPPL-6",
    "activeIngredients": "CETIRIZINE HYDROCHLORIDE",
    "company": "CHARTWELL MOLECULAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "METHYLTESTOSTERONEANDA  #080767",
    "submission": "SUPPL-91",
    "activeIngredients": "METHYLTESTOSTERONE",
    "company": "IMPAX LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "TESTOPELANDA  #080911",
    "submission": "SUPPL-29",
    "activeIngredients": "TESTOSTERONE",
    "company": "ENDO OPERATIONS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "TESTREDANDA  #083976",
    "submission": "SUPPL-35",
    "activeIngredients": "METHYLTESTOSTERONE",
    "company": "BAUSCH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "TESTOSTERONE ENANTHATEANDA  #085598",
    "submission": "SUPPL-55",
    "activeIngredients": "TESTOSTERONE ENANTHATE",
    "company": "WATSON PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "DEPO-TESTOSTERONEANDA  #085635",
    "submission": "SUPPL-45",
    "activeIngredients": "TESTOSTERONE CYPIONATE",
    "company": "PFIZER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "TESTOSTERONE CYPIONATEANDA  #086030",
    "submission": "SUPPL-51",
    "activeIngredients": "TESTOSTERONE CYPIONATE",
    "company": "WATSON PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "TESTOSTERONEANDA  #086417",
    "submission": "SUPPL-28",
    "activeIngredients": "TESTOSTERONE",
    "company": "DR REDDYS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "ANDROID 10ANDA  #086450",
    "submission": "SUPPL-15",
    "activeIngredients": "METHYLTESTOSTERONE",
    "company": "VALEANT PHARMS NORTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "METHYLTESTOSTERONEANDA  #087092",
    "submission": "SUPPL-7",
    "activeIngredients": "METHYLTESTOSTERONE",
    "company": "LANNETT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "METHYLTESTOSTERONEANDA  #087111",
    "submission": "SUPPL-7",
    "activeIngredients": "METHYLTESTOSTERONE",
    "company": "LANNETT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "ANDROID 25ANDA  #087147",
    "submission": "SUPPL-15",
    "activeIngredients": "METHYLTESTOSTERONE",
    "company": "BAUSCH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "CETIRIZINE HYDROCHLORIDEANDA  #090191",
    "submission": "SUPPL-9",
    "activeIngredients": "CETIRIZINE HYDROCHLORIDE",
    "company": "BAJAJ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "LEVOCETIRIZINE DIHYDROCHLORIDEANDA  #090199",
    "submission": "SUPPL-22",
    "activeIngredients": "LEVOCETIRIZINE DIHYDROCHLORIDE",
    "company": "TEVA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "LEVOCETIRIZINE DIHYDROCHLORIDEANDA  #090229",
    "submission": "SUPPL-19",
    "activeIngredients": "LEVOCETIRIZINE DIHYDROCHLORIDE",
    "company": "SYNTHON BV",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "LEVOCETIRIZINE DIHYDROCHLORIDEANDA  #090362",
    "submission": "SUPPL-14",
    "activeIngredients": "LEVOCETIRIZINE DIHYDROCHLORIDE",
    "company": "SUN PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "LEVOCETIRIZINE DIHYDROCHLORIDEANDA  #090385",
    "submission": "SUPPL-18",
    "activeIngredients": "LEVOCETIRIZINE DIHYDROCHLORIDE",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "LEVOCETIRIZINE DIHYDROCHLORIDEANDA  #090392",
    "submission": "SUPPL-6",
    "activeIngredients": "LEVOCETIRIZINE DIHYDROCHLORIDE",
    "company": "DR REDDYS LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "LEVOCETIRIZINE DIHYDROCHLORIDEANDA  #090486",
    "submission": "SUPPL-3",
    "activeIngredients": "LEVOCETIRIZINE DIHYDROCHLORIDE",
    "company": "GRANULES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "CETIRIZINE HYDROCHLORIDEANDA  #090766",
    "submission": "SUPPL-5",
    "activeIngredients": "CETIRIZINE HYDROCHLORIDE",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "TESTOSTERONE ENANTHATEANDA  #091120",
    "submission": "SUPPL-10",
    "activeIngredients": "TESTOSTERONE ENANTHATE",
    "company": "HIKMA FARMACEUTICA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "TESTOSTERONE CYPIONATEANDA  #091244",
    "submission": "SUPPL-23",
    "activeIngredients": "TESTOSTERONE CYPIONATE",
    "company": "HIKMA FARMACEUTICA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "LEVOCETIRIZINE DIHYDROCHLORIDEANDA  #091263",
    "submission": "SUPPL-14",
    "activeIngredients": "LEVOCETIRIZINE DIHYDROCHLORIDE",
    "company": "PADAGIS US",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "LEVOCETIRIZINE DIHYDROCHLORIDEANDA  #091264",
    "submission": "SUPPL-13",
    "activeIngredients": "LEVOCETIRIZINE DIHYDROCHLORIDE",
    "company": "HETERO LABS LTD III",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "TESTOSTERONE CYPIONATEANDA  #201720",
    "submission": "SUPPL-33",
    "activeIngredients": "TESTOSTERONE CYPIONATE",
    "company": "SUN PHARM INDS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "LEVOCETIRIZINE DIHYDROCHLORIDEANDA  #202046",
    "submission": "SUPPL-17",
    "activeIngredients": "LEVOCETIRIZINE DIHYDROCHLORIDE",
    "company": "MICRO LABS LTD INDIA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "LEVOCETIRIZINE DIHYDROCHLORIDEANDA  #202673",
    "submission": "SUPPL-11",
    "activeIngredients": "LEVOCETIRIZINE DIHYDROCHLORIDE",
    "company": "TARO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "LEVOCETIRIZINE DIHYDROCHLORIDEANDA  #202915",
    "submission": "SUPPL-10",
    "activeIngredients": "LEVOCETIRIZINE DIHYDROCHLORIDE",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "LEVOCETIRIZINE DIHYDROCHLORIDEANDA  #203027",
    "submission": "SUPPL-12",
    "activeIngredients": "LEVOCETIRIZINE DIHYDROCHLORIDE",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "LEVOCETIRIZINE DIHYDROCHLORIDEANDA  #203646",
    "submission": "SUPPL-29",
    "activeIngredients": "LEVOCETIRIZINE DIHYDROCHLORIDE",
    "company": "SCIEGEN PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "TESTOSTERONEANDA  #204255",
    "submission": "SUPPL-13",
    "activeIngredients": "TESTOSTERONE",
    "company": "PADAGIS ISRAEL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "LEVOCETIRIZINE DIHYDROCHLORIDEANDA  #204323",
    "submission": "SUPPL-2",
    "activeIngredients": "LEVOCETIRIZINE DIHYDROCHLORIDE",
    "company": "US ANTIBIOTICS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "VOGELXONDA   #204399",
    "submission": "SUPPL-16",
    "activeIngredients": "TESTOSTERONE",
    "company": "UPSHER SMITH LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "LEVOCETIRIZINE DIHYDROCHLORIDEANDA  #204599",
    "submission": "SUPPL-5",
    "activeIngredients": "LEVOCETIRIZINE DIHYDROCHLORIDE",
    "company": "CHARTWELL MOLECULAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "LEVOCETIRIZINE DIHYDROCHLORIDEANDA  #204626",
    "submission": "SUPPL-1",
    "activeIngredients": "LEVOCETIRIZINE DIHYDROCHLORIDE",
    "company": "IPCA LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "METHYLTESTOSTERONEANDA  #204851",
    "submission": "SUPPL-10",
    "activeIngredients": "METHYLTESTOSTERONE",
    "company": "IMPAX LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "NATESTONDA   #205488",
    "submission": "SUPPL-5",
    "activeIngredients": "TESTOSTERONE",
    "company": "ACERUS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "LEVOCETIRIZINE DIHYDROCHLORIDEANDA  #205564",
    "submission": "SUPPL-39",
    "activeIngredients": "LEVOCETIRIZINE DIHYDROCHLORIDE",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "JATENZONDA   #206089",
    "submission": "SUPPL-9",
    "activeIngredients": "TESTOSTERONE UNDECANOATE",
    "company": "TOLMAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "TESTOSTERONE CYPIONATEANDA  #206368",
    "submission": "SUPPL-6",
    "activeIngredients": "TESTOSTERONE CYPIONATE",
    "company": "WILSHIRE PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "OXCARBAZEPINEANDA  #207300",
    "submission": "ORIG-1",
    "activeIngredients": "OXCARBAZEPINE",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "TESTOSTERONEANDA  #208061",
    "submission": "SUPPL-13",
    "activeIngredients": "TESTOSTERONE",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "TLANDONDA   #208088",
    "submission": "SUPPL-2",
    "activeIngredients": "TESTOSTERONE UNDECANOATE",
    "company": "VERITY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "TESTOSTERONEANDA  #209181",
    "submission": "SUPPL-1",
    "activeIngredients": "TESTOSTERONE",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "TESTOSTERONEANDA  #209533",
    "submission": "SUPPL-6",
    "activeIngredients": "TESTOSTERONE",
    "company": "CIPLA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "TESTOSTERONEANDA  #209836",
    "submission": "SUPPL-9",
    "activeIngredients": "TESTOSTERONE",
    "company": "TWI PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "XYOSTED (AUTOINJECTOR)NDA   #209863",
    "submission": "SUPPL-20",
    "activeIngredients": "TESTOSTERONE ENANTHATE",
    "company": "ANTARES PHARMA INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "TESTOSTERONE CYPIONATEANDA  #210362",
    "submission": "SUPPL-5",
    "activeIngredients": "TESTOSTERONE CYPIONATE",
    "company": "CIPLA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "LEVOCETIRIZINE HYDROCHLORIDEANDA  #210914",
    "submission": "SUPPL-4",
    "activeIngredients": "LEVOCETIRIZINE DIHYDROCHLORIDE",
    "company": "HETERO LABS LTD III",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "TESTOSTERONE CYPIONATEANDA  #211817",
    "submission": "SUPPL-4",
    "activeIngredients": "TESTOSTERONE CYPIONATE",
    "company": "EUGIA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "TESTOSTERONEANDA  #212301",
    "submission": "SUPPL-1",
    "activeIngredients": "TESTOSTERONE",
    "company": "ENCUBE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "TESTOSTERONE ENANTHATEANDA  #212659",
    "submission": "SUPPL-1",
    "activeIngredients": "TESTOSTERONE ENANTHATE",
    "company": "EUGIA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "TESTOSTERONEANDA  #212882",
    "submission": "SUPPL-1",
    "activeIngredients": "TESTOSTERONE",
    "company": "ALEMBIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "KYZATREXNDA   #213953",
    "submission": "SUPPL-5",
    "activeIngredients": "TESTOSTERONE UNDECANOATE",
    "company": "MARIUS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "METHYLTESTOSTERONEANDA  #215270",
    "submission": "SUPPL-10",
    "activeIngredients": "METHYLTESTOSTERONE",
    "company": "NOVITIUM PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "KERENDIANDA   #215341",
    "submission": "SUPPL-9",
    "activeIngredients": "FINERENONE",
    "company": "BAYER HLTHCARE",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "TESTOSTERONE CYPIONATEANDA  #215351",
    "submission": "SUPPL-7",
    "activeIngredients": "TESTOSTERONE CYPIONATE",
    "company": "XIROMED",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "AZMIRONDA   #216318",
    "submission": "SUPPL-5",
    "activeIngredients": "TESTOSTERONE CYPIONATE",
    "company": "AZURITY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "PERAMPANELANDA  #218152",
    "submission": "ORIG-1",
    "activeIngredients": "PERAMPANEL",
    "company": "MSN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/11/2025",
    "drugName": "POTASSIUM CHLORIDEANDA  #219009",
    "submission": "ORIG-1",
    "activeIngredients": "POTASSIUM CHLORIDE",
    "company": "ANDA REPOSITORY",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/14/2025",
    "drugName": "ISOSORBIDE MONONITRATEANDA  #075522",
    "submission": "SUPPL-31",
    "activeIngredients": "ISOSORBIDE MONONITRATE",
    "company": "DEXCEL LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/14/2025",
    "drugName": "TESTOSTERONE CYPIONATEANDA  #090387",
    "submission": "SUPPL-9",
    "activeIngredients": "TESTOSTERONE CYPIONATE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/14/2025",
    "drugName": "CELECOXIBANDA  #205938",
    "submission": "ORIG-1",
    "activeIngredients": "CELECOXIB",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/14/2025",
    "drugName": "ISOSORBIDE MONONITRATEANDA  #210822",
    "submission": "SUPPL-4",
    "activeIngredients": "ISOSORBIDE MONONITRATE",
    "company": "DEXCEL LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/14/2025",
    "drugName": "SITAGLIPTIN AND METFORMIN HYDROCHLORIDEANDA  #216288",
    "submission": "ORIG-1",
    "activeIngredients": "METFORMIN HYDROCHLORIDE, SITAGLIPTIN",
    "company": "MSN LABORATORIES PRIVATE LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "07/14/2025",
    "drugName": "OLOPATADINE HYDROCHLORIDEANDA  #217051",
    "submission": "ORIG-1",
    "activeIngredients": "OLOPATADINE HYDROCHLORIDE",
    "company": "FDC LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/14/2025",
    "drugName": "ELAHEREBLA   #761310",
    "submission": "SUPPL-10",
    "activeIngredients": "MIRVETUXIMAB SORAVTANSINE-GYNX",
    "company": "IMMUNOGEN INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/15/2025",
    "drugName": "DUREZOLNDA   #022212",
    "submission": "SUPPL-18",
    "activeIngredients": "DIFLUPREDNATE",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/15/2025",
    "drugName": "ANASTROZOLEANDA  #079220",
    "submission": "SUPPL-3",
    "activeIngredients": "ANASTROZOLE",
    "company": "NATCO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/15/2025",
    "drugName": "ANASTROZOLEANDA  #079220",
    "submission": "SUPPL-8",
    "activeIngredients": "ANASTROZOLE",
    "company": "NATCO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/15/2025",
    "drugName": "VIRILONANDA  #087750",
    "submission": "SUPPL-17",
    "activeIngredients": "METHYLTESTOSTERONE",
    "company": "CHARTWELL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/15/2025",
    "drugName": "TESTOSTERONEANDA  #204571",
    "submission": "SUPPL-11",
    "activeIngredients": "TESTOSTERONE",
    "company": "ACTAVIS LABS UT INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/15/2025",
    "drugName": "TESTOSTERONEANDA  #205328",
    "submission": "SUPPL-6",
    "activeIngredients": "TESTOSTERONE",
    "company": "ACTAVIS LABS UT INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/15/2025",
    "drugName": "SUMATRIPTAN SUCCINATEANDA  #206019",
    "submission": "ORIG-1",
    "activeIngredients": "SUMATRIPTAN SUCCINATE",
    "company": "IPCA LABS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/15/2025",
    "drugName": "MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDEANDA  #208672",
    "submission": "ORIG-1",
    "activeIngredients": "DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/15/2025",
    "drugName": "SYMPROICNDA   #208854",
    "submission": "SUPPL-7",
    "activeIngredients": "NALDEMEDINE TOSYLATE",
    "company": "BDSI",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/15/2025",
    "drugName": "SIROLIMUSANDA  #215116",
    "submission": "ORIG-1",
    "activeIngredients": "SIROLIMUS",
    "company": "RISING",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/15/2025",
    "drugName": "ESCITALOPRAM OXALATEANDA  #215177",
    "submission": "ORIG-1",
    "activeIngredients": "ESCITALOPRAM OXALATE",
    "company": "ASCENT PHARMS INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/15/2025",
    "drugName": "MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDEANDA  #216901",
    "submission": "ORIG-1",
    "activeIngredients": "DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE",
    "company": "XIAMEN LP PHARM CO",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/15/2025",
    "drugName": "KIRSTYBLA   #761188",
    "submission": "ORIG-1",
    "activeIngredients": "INSULIN ASPART-XJHZ",
    "company": "BIOCON BIOLOGICS INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/16/2025",
    "drugName": "ROBINULNDA   #017558",
    "submission": "SUPPL-68",
    "activeIngredients": "GLYCOPYRROLATE",
    "company": "HIKMA",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/16/2025",
    "drugName": "MIRTAZAPINEANDA  #076901",
    "submission": "SUPPL-14",
    "activeIngredients": "MIRTAZAPINE",
    "company": "IMPAX LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/16/2025",
    "drugName": "MIRTAZAPINEANDA  #076901",
    "submission": "SUPPL-16",
    "activeIngredients": "MIRTAZAPINE",
    "company": "IMPAX LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/16/2025",
    "drugName": "MIRTAZAPINEANDA  #076901",
    "submission": "SUPPL-17",
    "activeIngredients": "MIRTAZAPINE",
    "company": "IMPAX LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/16/2025",
    "drugName": "HUMIRABLA   #125057",
    "submission": "SUPPL-424",
    "activeIngredients": "ADALIMUMAB",
    "company": "ABBVIE INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/16/2025",
    "drugName": "GLYRX-PFNDA   #210997",
    "submission": "SUPPL-8",
    "activeIngredients": "GLYCOPYRROLATE",
    "company": "EXELA PHARMA",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/16/2025",
    "drugName": "AZELAIC ACIDANDA  #211077",
    "submission": "ORIG-1",
    "activeIngredients": "AZELAIC ACID",
    "company": "PERRIGO PHARMA INTL",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "07/16/2025",
    "drugName": "EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDEANDA  #212373",
    "submission": "ORIG-1",
    "activeIngredients": "EMPAGLIFLOZIN;METFORMIN HYDROCHLORIDE",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "07/16/2025",
    "drugName": "SACUBITRIL AND VALSARTANANDA  #213611",
    "submission": "ORIG-1",
    "activeIngredients": "SACUBITRIL; VALSARTAN",
    "company": "NOVUGEN PHARMA SDN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/16/2025",
    "drugName": "SACUBITRIL AND VALSARTANANDA  #213748",
    "submission": "ORIG-1",
    "activeIngredients": "SACUBITRIL; VALSARTAN",
    "company": "MSN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/16/2025",
    "drugName": "GLYCOPYRROLATENDA   #214919",
    "submission": "SUPPL-2",
    "activeIngredients": "GLYCOPYRROLATE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/16/2025",
    "drugName": "SERTRALINE HYDROCHLORIDEANDA  #218853",
    "submission": "ORIG-1",
    "activeIngredients": "SERTRALINE HYDROCHLORIDE",
    "company": "ZENARA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/16/2025",
    "drugName": "FAMOTIDINENDA   #219935",
    "submission": "ORIG-1",
    "activeIngredients": "FAMOTIDINE",
    "company": "SAGENT",
    "submissionClassification": "Type 5 - New Formulation or New Manufacturer",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/16/2025",
    "drugName": "STIMUFENDBLA   #761173",
    "submission": "SUPPL-13",
    "activeIngredients": "PEGFILGRASTIM-FPGK",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "07/17/2025",
    "drugName": "CETIRIZINE HYDROCHLORIDEANDA  #090191",
    "submission": "SUPPL-8",
    "activeIngredients": "CETIRIZINE HYDROCHLORIDE",
    "company": "BAJAJ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/17/2025",
    "drugName": "ATAZANAVIR SULFATEANDA  #200626",
    "submission": "SUPPL-6",
    "activeIngredients": "ATAZANAVIR SULFATE",
    "company": "CIPLA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/17/2025",
    "drugName": "FIRDAPSENDA   #208078",
    "submission": "SUPPL-15",
    "activeIngredients": "AMIFAMPRIDINE PHOSPHATE",
    "company": "CATALYST PHARMS",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/17/2025",
    "drugName": "SACUBITRIL AND VALSARTANANDA  #213668",
    "submission": "ORIG-1",
    "activeIngredients": "SACUBITRIL; VALSARTAN",
    "company": "HETERO LABS LTD III",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/17/2025",
    "drugName": "SUGAMMADEXANDA  #215260",
    "submission": "ORIG-1",
    "activeIngredients": "SUGAMMADEX",
    "company": "TAMARANG SA",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "07/17/2025",
    "drugName": "NICOTINE POLACRILEXANDA  #215276",
    "submission": "ORIG-1",
    "activeIngredients": "NICOTINE POLACRILEX",
    "company": "DR REDDYS LABS SA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/17/2025",
    "drugName": "FUROSEMIDEANDA  #218831",
    "submission": "ORIG-1",
    "activeIngredients": "FUROSEMIDE",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/17/2025",
    "drugName": "HYDRALAZINE HYDROCHLORIDEANDA  #219797",
    "submission": "ORIG-1",
    "activeIngredients": "HYDRALAZINE HYDROCHLORIDE",
    "company": "BAXTER HLTHCARE CORP",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/18/2025",
    "drugName": "QUETIAPINE FUMARATEANDA  #077745",
    "submission": "SUPPL-25",
    "activeIngredients": "QUETIAPINE FUMARATE",
    "company": "TEVA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/18/2025",
    "drugName": "FLUTICASONE PROPIONATEANDA  #078492",
    "submission": "SUPPL-13",
    "activeIngredients": "FLUTICASONE PROPIONATE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/18/2025",
    "drugName": "FLUOCINOLONE ACETONIDEANDA  #203378",
    "submission": "SUPPL-3",
    "activeIngredients": "FLUOCINOLONE ACETONIDE",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/18/2025",
    "drugName": "OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDEANDA  #207088",
    "submission": "ORIG-1",
    "activeIngredients": "AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/18/2025",
    "drugName": "REGORAFENIBANDA  #209728",
    "submission": "SUPPL-1",
    "activeIngredients": "REGORAFENIB",
    "company": "ACTAVIS LABS FL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/18/2025",
    "drugName": "EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATEANDA  #212114",
    "submission": "SUPPL-6",
    "activeIngredients": "EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE",
    "company": "LAURUS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/18/2025",
    "drugName": "EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATEANDA  #212114",
    "submission": "SUPPL-9",
    "activeIngredients": "EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE",
    "company": "LAURUS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/18/2025",
    "drugName": "EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATEANDA  #212114",
    "submission": "SUPPL-10",
    "activeIngredients": "EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE",
    "company": "LAURUS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/18/2025",
    "drugName": "EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATEANDA  #212114",
    "submission": "SUPPL-17",
    "activeIngredients": "EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE",
    "company": "LAURUS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/18/2025",
    "drugName": "EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATEANDA  #212114",
    "submission": "SUPPL-19",
    "activeIngredients": "EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE",
    "company": "LAURUS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/18/2025",
    "drugName": "ZEJULANDA   #214876",
    "submission": "SUPPL-5",
    "activeIngredients": "NIRAPARIB TOSYLATE",
    "company": "GLAXOSMITHKLINE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/18/2025",
    "drugName": "CASPOFUNGIN ACETATEANDA  #216506",
    "submission": "ORIG-1",
    "activeIngredients": "CASPOFUNGIN ACETATE",
    "company": "HANGZHOU ZHONGMEI",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/18/2025",
    "drugName": "AMBRISENTANANDA  #216531",
    "submission": "SUPPL-3",
    "activeIngredients": "AMBRISENTAN",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/18/2025",
    "drugName": "TOFACITINIB CITRATEANDA  #218462",
    "submission": "SUPPL-2",
    "activeIngredients": "TOFACITINIB CITRATE",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/18/2025",
    "drugName": "VORICONAZOLEANDA  #218533",
    "submission": "SUPPL-5",
    "activeIngredients": "VORICONAZOLE",
    "company": "ASPIRO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/21/2025",
    "drugName": "METHIMAZOLEANDA  #040411",
    "submission": "SUPPL-29",
    "activeIngredients": "METHIMAZOLE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/21/2025",
    "drugName": "CIPROFLOXACIN HYDROCHLORIDEANDA  #075685",
    "submission": "SUPPL-14",
    "activeIngredients": "CIPROFLOXACIN HYDROCHLORIDE",
    "company": "NATCO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/21/2025",
    "drugName": "CIPROFLOXACIN HYDROCHLORIDEANDA  #075685",
    "submission": "SUPPL-16",
    "activeIngredients": "CIPROFLOXACIN HYDROCHLORIDE",
    "company": "NATCO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/21/2025",
    "drugName": "CIPROFLOXACIN HYDROCHLORIDEANDA  #075685",
    "submission": "SUPPL-19",
    "activeIngredients": "CIPROFLOXACIN HYDROCHLORIDE",
    "company": "NATCO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/21/2025",
    "drugName": "CIPROFLOXACIN HYDROCHLORIDEANDA  #075685",
    "submission": "SUPPL-20",
    "activeIngredients": "CIPROFLOXACIN HYDROCHLORIDE",
    "company": "NATCO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/21/2025",
    "drugName": "PREGABALINANDA  #203459",
    "submission": "SUPPL-16",
    "activeIngredients": "PREGABALIN",
    "company": "ALEMBIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/21/2025",
    "drugName": "PREGABALINANDA  #205924",
    "submission": "SUPPL-1",
    "activeIngredients": "PREGABALIN",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/21/2025",
    "drugName": "ALPRAZOLAMANDA  #207507",
    "submission": "SUPPL-6",
    "activeIngredients": "ALPRAZOLAM",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/21/2025",
    "drugName": "ALPRAZOLAMANDA  #207507",
    "submission": "SUPPL-12",
    "activeIngredients": "ALPRAZOLAM",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/21/2025",
    "drugName": "TESTOSTERONE CYPIONATEANDA  #207742",
    "submission": "SUPPL-2",
    "activeIngredients": "TESTOSTERONE CYPIONATE",
    "company": "AM REGENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/21/2025",
    "drugName": "TESTOSTERONE CYPIONATEANDA  #207742",
    "submission": "SUPPL-16",
    "activeIngredients": "TESTOSTERONE CYPIONATE",
    "company": "AM REGENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/21/2025",
    "drugName": "LACOSAMIDEANDA  #209465",
    "submission": "SUPPL-2",
    "activeIngredients": "LACOSAMIDE",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/21/2025",
    "drugName": "LACOSAMIDEANDA  #209465",
    "submission": "SUPPL-4",
    "activeIngredients": "LACOSAMIDE",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/21/2025",
    "drugName": "LACOSAMIDEANDA  #209465",
    "submission": "SUPPL-5",
    "activeIngredients": "LACOSAMIDE",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/21/2025",
    "drugName": "TOFACITINIB CITRATEANDA  #209738",
    "submission": "SUPPL-1",
    "activeIngredients": "TOFACITINIB CITRATE",
    "company": "MICRO LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/21/2025",
    "drugName": "PREGABALINANDA  #209883",
    "submission": "SUPPL-1",
    "activeIngredients": "PREGABALIN",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/21/2025",
    "drugName": "EVEROLIMUSANDA  #210050",
    "submission": "SUPPL-1",
    "activeIngredients": "EVEROLIMUS",
    "company": "TEVA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/21/2025",
    "drugName": "EVEROLIMUSANDA  #210050",
    "submission": "SUPPL-4",
    "activeIngredients": "EVEROLIMUS",
    "company": "TEVA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/21/2025",
    "drugName": "EVEROLIMUSANDA  #210050",
    "submission": "SUPPL-5",
    "activeIngredients": "EVEROLIMUS",
    "company": "TEVA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/21/2025",
    "drugName": "NITISINONEANDA  #211041",
    "submission": "SUPPL-12",
    "activeIngredients": "NITISINONE",
    "company": "NOVITIUM PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/21/2025",
    "drugName": "FOSAPREPITANT DIMEGLUMINEANDA  #211160",
    "submission": "SUPPL-1",
    "activeIngredients": "FOSAPREPITANT DIMEGLUMINE",
    "company": "DR REDDYS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/21/2025",
    "drugName": "FOSAPREPITANT DIMEGLUMINEANDA  #211160",
    "submission": "SUPPL-6",
    "activeIngredients": "FOSAPREPITANT DIMEGLUMINE",
    "company": "DR REDDYS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/21/2025",
    "drugName": "GABAPENTINANDA  #211314",
    "submission": "SUPPL-9",
    "activeIngredients": "GABAPENTIN",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/21/2025",
    "drugName": "GABAPENTINANDA  #211314",
    "submission": "SUPPL-17",
    "activeIngredients": "GABAPENTIN",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/21/2025",
    "drugName": "NEXLETOLNDA   #211616",
    "submission": "SUPPL-22",
    "activeIngredients": "BEMPEDOIC ACID",
    "company": "ESPERION THERAPS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/21/2025",
    "drugName": "NEXLETOLNDA   #211616",
    "submission": "SUPPL-23",
    "activeIngredients": "BEMPEDOIC ACID",
    "company": "ESPERION THERAPS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/21/2025",
    "drugName": "NEXLIZETNDA   #211617",
    "submission": "SUPPL-27",
    "activeIngredients": "BEMPEDOIC ACID; EZETIMIBE",
    "company": "ESPERION THERAPS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/21/2025",
    "drugName": "NEXLIZETNDA   #211617",
    "submission": "SUPPL-28",
    "activeIngredients": "BEMPEDOIC ACID; EZETIMIBE",
    "company": "ESPERION THERAPS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/21/2025",
    "drugName": "AXITINIBANDA  #213235",
    "submission": "ORIG-1",
    "activeIngredients": "AXITINIB",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "07/21/2025",
    "drugName": "CABOZANTINIBANDA  #213878",
    "submission": "ORIG-1",
    "activeIngredients": "CABOZANTINIB",
    "company": "MSN LABORATORIES PRIVATE LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "07/21/2025",
    "drugName": "SELENIOUS ACIDANDA  #218661",
    "submission": "ORIG-1",
    "activeIngredients": "SELENIOUS ACID",
    "company": "CIPLA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/22/2025",
    "drugName": "DICLOXACILLIN SODIUMANDA  #061454",
    "submission": "SUPPL-18",
    "activeIngredients": "DICLOXACILLIN SODIUM",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/22/2025",
    "drugName": "DARUNAVIRANDA  #202136",
    "submission": "ORIG-1",
    "activeIngredients": "DARUNAVIR",
    "company": "MYLAN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/22/2025",
    "drugName": "XYZAL ALLERGY 24HRNDA   #209090",
    "submission": "SUPPL-6",
    "activeIngredients": "LEVOCETIRIZINE DIHYDROCHLORIDE",
    "company": "CHATTEM SANOFI",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/22/2025",
    "drugName": "IBRUTINIBANDA  #214296",
    "submission": "ORIG-1",
    "activeIngredients": "IBRUTINIB",
    "company": "ZYDUS WORLDWIDE DMCC",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "07/22/2025",
    "drugName": "GLUCAGONANDA  #214457",
    "submission": "ORIG-1",
    "activeIngredients": "GLUCAGON",
    "company": "LUPIN LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/22/2025",
    "drugName": "SUNITINIB MALATEANDA  #214824",
    "submission": "SUPPL-1",
    "activeIngredients": "SUNITINIB MALATE",
    "company": "MSN",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/22/2025",
    "drugName": "VIJOICENDA   #215039",
    "submission": "SUPPL-3",
    "activeIngredients": "ALPELISIB",
    "company": "NOVARTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/22/2025",
    "drugName": "LIRAGLUTIDEANDA  #215421",
    "submission": "ORIG-1",
    "activeIngredients": "LIRAGLUTIDE",
    "company": "LUPIN LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/22/2025",
    "drugName": "VIJOICENDA   #218466",
    "submission": "SUPPL-1",
    "activeIngredients": "ALPELISIB",
    "company": "NOVARTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/22/2025",
    "drugName": "POTASSIUM CHLORIDEANDA  #218960",
    "submission": "ORIG-1",
    "activeIngredients": "POTASSIUM CHLORIDE",
    "company": "TARO",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/22/2025",
    "drugName": "OZANIMODANDA  #219236",
    "submission": "ORIG-1",
    "activeIngredients": "OZANIMOD",
    "company": "SYNTHON BV",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "07/23/2025",
    "drugName": "ACETADOTENDA   #021539",
    "submission": "SUPPL-21",
    "activeIngredients": "ACETYLCYSTEINE",
    "company": "CUMBERLAND PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/23/2025",
    "drugName": "SOTALOL HYDROCHLORIDENDA   #022306",
    "submission": "SUPPL-8",
    "activeIngredients": "SOTALOL HYDROCHLORIDE",
    "company": "ALTATHERA PHARMS LLC",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/23/2025",
    "drugName": "AMPICILLIN AND SULBACTAMANDA  #065403",
    "submission": "SUPPL-20",
    "activeIngredients": "AMPICILLIN SODIUM; SULBACTAM SODIUM",
    "company": "ACS DOBFAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/23/2025",
    "drugName": "CARVEDILOLANDA  #077316",
    "submission": "SUPPL-23",
    "activeIngredients": "CARVEDILOL",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/23/2025",
    "drugName": "VORICONAZOLEANDA  #091658",
    "submission": "SUPPL-5",
    "activeIngredients": "VORICONAZOLE",
    "company": "TEVA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/23/2025",
    "drugName": "VORICONAZOLEANDA  #091658",
    "submission": "SUPPL-7",
    "activeIngredients": "VORICONAZOLE",
    "company": "TEVA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/23/2025",
    "drugName": "VORICONAZOLEANDA  #091658",
    "submission": "SUPPL-8",
    "activeIngredients": "VORICONAZOLE",
    "company": "TEVA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/23/2025",
    "drugName": "VORICONAZOLEANDA  #091658",
    "submission": "SUPPL-11",
    "activeIngredients": "VORICONAZOLE",
    "company": "TEVA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/23/2025",
    "drugName": "ATAZANAVIR SULFATEANDA  #091673",
    "submission": "SUPPL-14",
    "activeIngredients": "ATAZANAVIR SULFATE",
    "company": "TEVA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/23/2025",
    "drugName": "TRETINOINANDA  #201687",
    "submission": "SUPPL-12",
    "activeIngredients": "TRETINOIN",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/23/2025",
    "drugName": "OTEZLANDA   #205437",
    "submission": "SUPPL-14",
    "activeIngredients": "APREMILAST",
    "company": "AMGEN INC",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/23/2025",
    "drugName": "DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDEANDA  #205811",
    "submission": "SUPPL-10",
    "activeIngredients": "DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE",
    "company": "ACTAVIS LABS FL INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/23/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #209372",
    "submission": "SUPPL-8",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "AMNEAL PHARMS CO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/23/2025",
    "drugName": "LEVOMILNACIPRAN HYDROCHLORIDEANDA  #210790",
    "submission": "SUPPL-3",
    "activeIngredients": "LEVOMILNACIPRAN HYDROCHLORIDE",
    "company": "AMNEAL PHARMS CO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/23/2025",
    "drugName": "LEVOMILNACIPRAN HYDROCHLORIDEANDA  #210790",
    "submission": "SUPPL-4",
    "activeIngredients": "LEVOMILNACIPRAN HYDROCHLORIDE",
    "company": "AMNEAL PHARMS CO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/23/2025",
    "drugName": "LEVOMILNACIPRAN HYDROCHLORIDEANDA  #210790",
    "submission": "SUPPL-5",
    "activeIngredients": "LEVOMILNACIPRAN HYDROCHLORIDE",
    "company": "AMNEAL PHARMS CO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/23/2025",
    "drugName": "VORICONAZOLEANDA  #211099",
    "submission": "SUPPL-12",
    "activeIngredients": "VORICONAZOLE",
    "company": "GLAND",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/23/2025",
    "drugName": "QUETIAPINE FUMARATEANDA  #211144",
    "submission": "SUPPL-1",
    "activeIngredients": "QUETIAPINE FUMARATE",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/23/2025",
    "drugName": "MICAFUNGIN SODIUMANDA  #213261",
    "submission": "SUPPL-5",
    "activeIngredients": "MICAFUNGIN SODIUM",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/23/2025",
    "drugName": "TOPIRAMATEANDA  #215449",
    "submission": "SUPPL-1",
    "activeIngredients": "TOPIRAMATE",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/23/2025",
    "drugName": "TOPIRAMATEANDA  #215663",
    "submission": "SUPPL-4",
    "activeIngredients": "TOPIRAMATE",
    "company": "AJANTA PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/23/2025",
    "drugName": "SITAGLIPTINANDA  #216086",
    "submission": "ORIG-1",
    "activeIngredients": "SITAGLIPTIN PHOSPHATE",
    "company": "MSN LABORATORIES PRIVATE LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "07/23/2025",
    "drugName": "PREDNISOLONE SODIUM PHOSPHATEANDA  #216715",
    "submission": "SUPPL-3",
    "activeIngredients": "PREDNISOLONE SODIUM PHOSPHATE",
    "company": "AMNEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/23/2025",
    "drugName": "GABAPENTINANDA  #217116",
    "submission": "SUPPL-6",
    "activeIngredients": "GABAPENTIN",
    "company": "GRANULES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/23/2025",
    "drugName": "DEXAMETHASONE SODIUM PHOSPHATEANDA  #217797",
    "submission": "SUPPL-2",
    "activeIngredients": "DEXAMETHASONE SODIUM PHOSPHATE",
    "company": "MICRO LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/23/2025",
    "drugName": "FLUCYTOSINEANDA  #218005",
    "submission": "ORIG-1",
    "activeIngredients": "FLUCYTOSINE",
    "company": "LAURUS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/23/2025",
    "drugName": "GABAPENTINANDA  #218075",
    "submission": "SUPPL-2",
    "activeIngredients": "GABAPENTIN",
    "company": "ANNORA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/23/2025",
    "drugName": "LURASIDONE HYDROCHLORIDEANDA  #218174",
    "submission": "SUPPL-1",
    "activeIngredients": "LURASIDONE HYDROCHLORIDE",
    "company": "ANNORA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/23/2025",
    "drugName": "ANZUPGONDA   #219155",
    "submission": "ORIG-1",
    "activeIngredients": "DELGOCITINIB",
    "company": "LEO PHARMA AS",
    "submissionClassification": "Type 1 - New Molecular Entity",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/23/2025",
    "drugName": "VOSTALLYNDA   #219757",
    "submission": "ORIG-1",
    "activeIngredients": "RAMIPRIL",
    "company": "ROSEMONT PHARMS",
    "submissionClassification": "Type 3 - New Dosage Form",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/24/2025",
    "drugName": "INTRALIPID 10%NDA   #017643",
    "submission": "SUPPL-85",
    "activeIngredients": "SOYBEAN OIL",
    "company": "FRESENIUS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/24/2025",
    "drugName": "INTRALIPID 20%NDA   #018449",
    "submission": "SUPPL-54",
    "activeIngredients": "SOYBEAN OIL",
    "company": "FRESENIUS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/24/2025",
    "drugName": "NUTRILIPID 10%NDA   #019531",
    "submission": "SUPPL-17",
    "activeIngredients": "SOYBEAN OIL",
    "company": "B BRAUN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/24/2025",
    "drugName": "NUTRILIPID 10%NDA   #019531",
    "submission": "SUPPL-18",
    "activeIngredients": "SOYBEAN OIL",
    "company": "B BRAUN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/24/2025",
    "drugName": "NUTRILIPID 20%NDA   #019531",
    "submission": "SUPPL-17",
    "activeIngredients": "SOYBEAN OIL",
    "company": "B BRAUN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/24/2025",
    "drugName": "NUTRILIPID 20%NDA   #019531",
    "submission": "SUPPL-18",
    "activeIngredients": "SOYBEAN OIL",
    "company": "B BRAUN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/24/2025",
    "drugName": "INTRALIPID 30%NDA   #019942",
    "submission": "SUPPL-25",
    "activeIngredients": "SOYBEAN OIL",
    "company": "FRESENIUS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/24/2025",
    "drugName": "INTRALIPID 20%NDA   #020248",
    "submission": "SUPPL-31",
    "activeIngredients": "SOYBEAN OIL",
    "company": "FRESENIUS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/24/2025",
    "drugName": "PHENTERMINE HYDROCHLORIDEANDA  #083923",
    "submission": "SUPPL-48",
    "activeIngredients": "PHENTERMINE HYDROCHLORIDE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/24/2025",
    "drugName": "KEYTRUDABLA   #125514",
    "submission": "SUPPL-178",
    "activeIngredients": "PEMBROLIZUMAB",
    "company": "MERCK SHARP DOHME",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/24/2025",
    "drugName": "NAPROXEN SODIUMANDA  #200629",
    "submission": "SUPPL-18",
    "activeIngredients": "NAPROXEN SODIUM",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/24/2025",
    "drugName": "KABIVEN IN PLASTIC CONTAINERNDA   #200656",
    "submission": "SUPPL-24",
    "activeIngredients": "AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM GLYCEROPHOSPHATE; SOYBEAN OIL",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/24/2025",
    "drugName": "PERIKABIVEN IN PLASTIC CONTAINERNDA   #200656",
    "submission": "SUPPL-24",
    "activeIngredients": "AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM GLYCEROPHOSPHATE; SOYBEAN OIL",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/24/2025",
    "drugName": "EXEMESTANEANDA  #203315",
    "submission": "SUPPL-6",
    "activeIngredients": "EXEMESTANE",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/24/2025",
    "drugName": "CEVIMELINE HYDROCHLORIDEANDA  #203775",
    "submission": "SUPPL-4",
    "activeIngredients": "CEVIMELINE HYDROCHLORIDE",
    "company": "RISING",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/24/2025",
    "drugName": "CLINOLIPID 20%NDA   #204508",
    "submission": "SUPPL-26",
    "activeIngredients": "OLIVE OIL; SOYBEAN OIL",
    "company": "BAXTER HLTHCARE CORP",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/24/2025",
    "drugName": "SMOFLIPID 20%NDA   #207648",
    "submission": "SUPPL-13",
    "activeIngredients": "FISH OIL; MEDIUM CHAIN TRIGLYCERIDES; OLIVE OIL; SOYBEAN OIL",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/24/2025",
    "drugName": "DOPTELETNDA   #210238",
    "submission": "SUPPL-10",
    "activeIngredients": "AVATROMBOPAG MALEATE",
    "company": "AKARX INC",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/24/2025",
    "drugName": "OMEGAVENNDA   #210589",
    "submission": "SUPPL-5",
    "activeIngredients": "FISH OIL TRIGLYCERIDES",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/24/2025",
    "drugName": "GEMCITABINE HYDROCHLORIDEANDA  #212129",
    "submission": "SUPPL-2",
    "activeIngredients": "GEMCITABINE HYDROCHLORIDE",
    "company": "MEITHEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/24/2025",
    "drugName": "EXEMESTANEANDA  #213547",
    "submission": "SUPPL-6",
    "activeIngredients": "EXEMESTANE",
    "company": "QILU",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/24/2025",
    "drugName": "EXEMESTANEANDA  #216454",
    "submission": "SUPPL-4",
    "activeIngredients": "EXEMESTANE",
    "company": "EUGIA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/24/2025",
    "drugName": "SITAGLIPTIN AND METFORMIN HYDROCHLORIDEANDA  #216516",
    "submission": "ORIG-1",
    "activeIngredients": "METFORMIN HYDROCHLORIDE, SITAGLIPTIN",
    "company": "AJANTA PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "07/24/2025",
    "drugName": "HALOPERIDOL DECANOATEANDA  #216730",
    "submission": "SUPPL-4",
    "activeIngredients": "HALOPERIDOL DECANOATE",
    "company": "MANKIND PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/24/2025",
    "drugName": "LORAZEPAMANDA  #218597",
    "submission": "ORIG-1",
    "activeIngredients": "LORAZEPAM",
    "company": "GRAVITI PHARMS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/24/2025",
    "drugName": "SDAMLONDA   #219531",
    "submission": "ORIG-1",
    "activeIngredients": "AMLODIPINE BESYLATE",
    "company": "BRILLIAN PHARMA",
    "submissionClassification": "Type 3 - New Dosage Form",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/24/2025",
    "drugName": "DOPTELET SPRINKLENDA   #219696",
    "submission": "ORIG-1",
    "activeIngredients": "AVATROMBOPAG MALEATE",
    "company": "AKARX INC",
    "submissionClassification": "Type 3 - New Dosage Form",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/24/2025",
    "drugName": "FAMOTIDINEANDA  #219863",
    "submission": "ORIG-1",
    "activeIngredients": "FAMOTIDINE",
    "company": "MSN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/25/2025",
    "drugName": "DEXTROSE 25%NDA   #019445",
    "submission": "SUPPL-43",
    "activeIngredients": "DEXTROSE",
    "company": "HOSPIRA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/25/2025",
    "drugName": "DEXTROSE 25%NDA   #019445",
    "submission": "SUPPL-49",
    "activeIngredients": "DEXTROSE",
    "company": "HOSPIRA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/25/2025",
    "drugName": "DEXTROSE 50%NDA   #019445",
    "submission": "SUPPL-43",
    "activeIngredients": "DEXTROSE",
    "company": "HOSPIRA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/25/2025",
    "drugName": "DEXTROSE 50%NDA   #019445",
    "submission": "SUPPL-49",
    "activeIngredients": "DEXTROSE",
    "company": "HOSPIRA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/25/2025",
    "drugName": "AMOXICILLIN AND CLAVULANATE POTASSIUMANDA  #065065",
    "submission": "SUPPL-36",
    "activeIngredients": "AMOXICILLIN; CLAVULANATE POTASSIUM",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/25/2025",
    "drugName": "CEFPROZILANDA  #065236",
    "submission": "SUPPL-7",
    "activeIngredients": "CEFPROZIL",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/25/2025",
    "drugName": "ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDEANDA  #076116",
    "submission": "SUPPL-12",
    "activeIngredients": "ENALAPRIL MALEATE; HYDROCHLOROTHIAZIDE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/25/2025",
    "drugName": "RIFAMPINANDA  #091181",
    "submission": "SUPPL-13",
    "activeIngredients": "RIFAMPIN",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/25/2025",
    "drugName": "SUMATRIPTAN SUCCINATEANDA  #202758",
    "submission": "SUPPL-10",
    "activeIngredients": "SUMATRIPTAN SUCCINATE",
    "company": "EUGIA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/25/2025",
    "drugName": "MEROPENEMANDA  #205835",
    "submission": "SUPPL-13",
    "activeIngredients": "MEROPENEM",
    "company": "EUGIA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/25/2025",
    "drugName": "IBANDRONATE SODIUMANDA  #206058",
    "submission": "SUPPL-6",
    "activeIngredients": "IBANDRONATE SODIUM",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/25/2025",
    "drugName": "NIACINANDA  #207726",
    "submission": "ORIG-1",
    "activeIngredients": "NIACIN",
    "company": "MPP PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/25/2025",
    "drugName": "AMBRISENTANANDA  #208441",
    "submission": "SUPPL-6",
    "activeIngredients": "AMBRISENTAN",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/25/2025",
    "drugName": "OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDEANDA  #209199",
    "submission": "ORIG-1",
    "activeIngredients": "HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL",
    "company": "HETERO LABS LTD V",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/25/2025",
    "drugName": "PALONOSETRON HYDROCHLORIDEANDA  #209287",
    "submission": "SUPPL-1",
    "activeIngredients": "PALONOSETRON HYDROCHLORIDE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/25/2025",
    "drugName": "NELARABINEANDA  #215037",
    "submission": "SUPPL-5",
    "activeIngredients": "NELARABINE",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/25/2025",
    "drugName": "OSPEMIFENEANDA  #215574",
    "submission": "SUPPL-2",
    "activeIngredients": "OSPEMIFENE",
    "company": "HETERO LABS LTD V",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/25/2025",
    "drugName": "SPIRONOLACTONEANDA  #217761",
    "submission": "ORIG-1",
    "activeIngredients": "SPIRONOLACTONE",
    "company": "ANNORA PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/25/2025",
    "drugName": "CARBAMAZEPINEANDA  #219939",
    "submission": "ORIG-1",
    "activeIngredients": "CARBAMAZEPINE",
    "company": "ALEMBIC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/25/2025",
    "drugName": "SKYTROFABLA   #761177",
    "submission": "SUPPL-8",
    "activeIngredients": "LONAPEGSOMATROPIN-TCGD",
    "company": "ASCENDIS PHARMA ENCOCRINOLOGY DIV A/S",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/28/2025",
    "drugName": "XYREMNDA   #021196",
    "submission": "SUPPL-48",
    "activeIngredients": "SODIUM OXYBATE",
    "company": "JAZZ PHARMS",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/28/2025",
    "drugName": "DEPO-TESTOSTERONEANDA  #085635",
    "submission": "SUPPL-28",
    "activeIngredients": "TESTOSTERONE CYPIONATE",
    "company": "PFIZER",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/28/2025",
    "drugName": "SIRTURONDA   #204384",
    "submission": "SUPPL-20",
    "activeIngredients": "BEDAQUILINE FUMARATE",
    "company": "JANSSEN THERAP",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/28/2025",
    "drugName": "QUETIAPINE FUMARATEANDA  #205983",
    "submission": "SUPPL-1",
    "activeIngredients": "QUETIAPINE FUMARATE",
    "company": "IPCA LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/28/2025",
    "drugName": "KISQALINDA   #209092",
    "submission": "SUPPL-24",
    "activeIngredients": "RIBOCICLIB SUCCINATE",
    "company": "NOVARTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/28/2025",
    "drugName": "KISQALI FEMARA CO-PACK (COPACKAGED)NDA   #209935",
    "submission": "SUPPL-30",
    "activeIngredients": "LETROZOLE; RIBOCICLIB SUCCINATE",
    "company": "NOVARTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/28/2025",
    "drugName": "COPIKTRANDA   #211155",
    "submission": "SUPPL-8",
    "activeIngredients": "DUVELISIB",
    "company": "SECURA",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/28/2025",
    "drugName": "QUZYTTIRNDA   #211415",
    "submission": "SUPPL-8",
    "activeIngredients": "CETIRIZINE HYDROCHLORIDE",
    "company": "JDP",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/28/2025",
    "drugName": "XYWAVNDA   #212690",
    "submission": "SUPPL-19",
    "activeIngredients": "CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE",
    "company": "JAZZ",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/28/2025",
    "drugName": "EMPAVELINDA   #215014",
    "submission": "SUPPL-11",
    "activeIngredients": "PEGCETACOPLAN",
    "company": "APELLIS PHARMS",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/28/2025",
    "drugName": "SEPHIENCENDA   #219666",
    "submission": "ORIG-1",
    "activeIngredients": "SEPIAPTERIN",
    "company": "PTC THERAP",
    "submissionClassification": "Type 1 - New Molecular Entity",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/29/2025",
    "drugName": "CEFEPIME IN PLASTIC CONTAINERNDA   #050817",
    "submission": "SUPPL-12",
    "activeIngredients": "CEFEPIME HYDROCHLORIDE",
    "company": "BAXTER HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/29/2025",
    "drugName": "ATENOLOLANDA  #073542",
    "submission": "SUPPL-29",
    "activeIngredients": "ATENOLOL",
    "company": "NOVITIUM PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/29/2025",
    "drugName": "ATENOLOLANDA  #073542",
    "submission": "SUPPL-30",
    "activeIngredients": "ATENOLOL",
    "company": "NOVITIUM PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/29/2025",
    "drugName": "ATENOLOLANDA  #073543",
    "submission": "SUPPL-29",
    "activeIngredients": "ATENOLOL",
    "company": "NOVITIUM PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/29/2025",
    "drugName": "ATENOLOLANDA  #073543",
    "submission": "SUPPL-30",
    "activeIngredients": "ATENOLOL",
    "company": "NOVITIUM PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/29/2025",
    "drugName": "ATENOLOLANDA  #074099",
    "submission": "SUPPL-30",
    "activeIngredients": "ATENOLOL",
    "company": "NOVITIUM PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/29/2025",
    "drugName": "ATENOLOLANDA  #074099",
    "submission": "SUPPL-31",
    "activeIngredients": "ATENOLOL",
    "company": "NOVITIUM PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/29/2025",
    "drugName": "QUINIDINE SULFATEANDA  #089839",
    "submission": "SUPPL-7",
    "activeIngredients": "QUINIDINE SULFATE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/29/2025",
    "drugName": "ASPIRIN AND DIPYRIDAMOLEANDA  #206392",
    "submission": "SUPPL-12",
    "activeIngredients": "ASPIRIN; DIPYRIDAMOLE",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/29/2025",
    "drugName": "ASPIRIN AND DIPYRIDAMOLEANDA  #206392",
    "submission": "SUPPL-19",
    "activeIngredients": "ASPIRIN; DIPYRIDAMOLE",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/29/2025",
    "drugName": "ASPIRIN AND DIPYRIDAMOLEANDA  #206392",
    "submission": "SUPPL-24",
    "activeIngredients": "ASPIRIN; DIPYRIDAMOLE",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/29/2025",
    "drugName": "BUPRENORPHINE HYDROCHLORIDEANDA  #206586",
    "submission": "SUPPL-11",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/29/2025",
    "drugName": "BUPRENORPHINE HYDROCHLORIDEANDA  #206586",
    "submission": "SUPPL-14",
    "activeIngredients": "BUPRENORPHINE HYDROCHLORIDE",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/29/2025",
    "drugName": "VYSCOXANDA   #211759",
    "submission": "ORIG-1",
    "activeIngredients": "CELECOXIB",
    "company": "CARWIN PHARM ASSOC",
    "submissionClassification": "Type 3 - New Dosage Form",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/29/2025",
    "drugName": "TAZAROTENEANDA  #215393",
    "submission": "ORIG-1",
    "activeIngredients": "TAZAROTENE",
    "company": "PADAGIS ISRAEL",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/29/2025",
    "drugName": "FEMLYVNDA   #218718",
    "submission": "SUPPL-1",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "MILLICENT PR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/29/2025",
    "drugName": "LIDOCAINE HYDROCHLORIDEANDA  #219759",
    "submission": "ORIG-1",
    "activeIngredients": "LIDOCAINE HYDROCHLORIDE",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/29/2025",
    "drugName": "HYRIMOZBLA   #761071",
    "submission": "SUPPL-24",
    "activeIngredients": "ADALIMUMAB-ADAZ",
    "company": "SANDOZ INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/29/2025",
    "drugName": "AVTOZMABLA   #761420",
    "submission": "SUPPL-1",
    "activeIngredients": "TOCILIZUMAB-ANOH",
    "company": "CELLTRION INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/30/2025",
    "drugName": "ATROPINE SULFATENDA   #021146",
    "submission": "SUPPL-37",
    "activeIngredients": "ATROPINE SULFATE",
    "company": "HOSPIRA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/30/2025",
    "drugName": "TRACLEERNDA   #021290",
    "submission": "SUPPL-47",
    "activeIngredients": "BOSENTAN",
    "company": "ACTELION",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/30/2025",
    "drugName": "LOXAPINE SUCCINATEANDA  #072062",
    "submission": "SUPPL-44",
    "activeIngredients": "LOXAPINE SUCCINATE",
    "company": "WATSON LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/30/2025",
    "drugName": "LOXAPINE SUCCINATEANDA  #072204",
    "submission": "SUPPL-44",
    "activeIngredients": "LOXAPINE SUCCINATE",
    "company": "WATSON LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/30/2025",
    "drugName": "LOXAPINE SUCCINATEANDA  #072205",
    "submission": "SUPPL-46",
    "activeIngredients": "LOXAPINE SUCCINATE",
    "company": "WATSON LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/30/2025",
    "drugName": "LOXAPINE SUCCINATEANDA  #072206",
    "submission": "SUPPL-43",
    "activeIngredients": "LOXAPINE SUCCINATE",
    "company": "WATSON LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/30/2025",
    "drugName": "ATENOLOLANDA  #077443",
    "submission": "SUPPL-16",
    "activeIngredients": "ATENOLOL",
    "company": "UNIQUE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/30/2025",
    "drugName": "ACETAMINOPHEN AND CODEINE PHOSPHATEANDA  #089997",
    "submission": "SUPPL-27",
    "activeIngredients": "ACETAMINOPHEN; CODEINE PHOSPHATE",
    "company": "CHARTWELL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/30/2025",
    "drugName": "ACETAMINOPHEN AND CODEINE PHOSPHATEANDA  #089998",
    "submission": "SUPPL-27",
    "activeIngredients": "ACETAMINOPHEN; CODEINE PHOSPHATE",
    "company": "CHARTWELL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/30/2025",
    "drugName": "ACETAMINOPHEN AND CODEINE PHOSPHATEANDA  #089999",
    "submission": "SUPPL-27",
    "activeIngredients": "ACETAMINOPHEN; CODEINE PHOSPHATE",
    "company": "CHARTWELL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/30/2025",
    "drugName": "HEPZATONDA   #201848",
    "submission": "SUPPL-10",
    "activeIngredients": "MELPHALAN HYDROCHLORIDE",
    "company": "DELCATH SYSTEMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/30/2025",
    "drugName": "GLUCAGONNDA   #201849",
    "submission": "SUPPL-24",
    "activeIngredients": "GLUCAGON HYDROCHLORIDE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/30/2025",
    "drugName": "ZOLEDRONIC ACIDANDA  #205279",
    "submission": "SUPPL-9",
    "activeIngredients": "ZOLEDRONIC ACID",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/30/2025",
    "drugName": "TRACLEERNDA   #209279",
    "submission": "SUPPL-14",
    "activeIngredients": "BOSENTAN",
    "company": "ACTELION",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/30/2025",
    "drugName": "BIKTARVYNDA   #210251",
    "submission": "SUPPL-23",
    "activeIngredients": "BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE",
    "company": "GILEAD SCIENCES INC",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/30/2025",
    "drugName": "FLUVOXAMINE MALEATEANDA  #217024",
    "submission": "ORIG-1",
    "activeIngredients": "FLUVOXAMINE MALEATE",
    "company": "ANNORA PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/30/2025",
    "drugName": "BRIMONIDINE TARTRATEANDA  #217599",
    "submission": "ORIG-1",
    "activeIngredients": "BRIMONIDINE TARTRATE",
    "company": "UPSHER SMITH LABS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/30/2025",
    "drugName": "METHYLENE BLUEANDA  #219363",
    "submission": "ORIG-1",
    "activeIngredients": "METHYLENE BLUE",
    "company": "XIROMED",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/30/2025",
    "drugName": "ATMEKSINDA   #219843",
    "submission": "ORIG-1",
    "activeIngredients": "METHOCARBAMOL",
    "company": "ROSEMONT PHARMS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/31/2025",
    "drugName": "SPRAVATONDA   #211243",
    "submission": "SUPPL-24",
    "activeIngredients": "ESKETAMINE HYDROCHLORIDE",
    "company": "JANSSEN PHARMS",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/31/2025",
    "drugName": "LEQVIONDA   #214012",
    "submission": "SUPPL-16",
    "activeIngredients": "INCLISIRAN SODIUM",
    "company": "NOVARTIS",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/31/2025",
    "drugName": "RIVAROXABANANDA  #218117",
    "submission": "ORIG-1",
    "activeIngredients": "RIVAROXABAN",
    "company": "SCIEGEN PHARMS INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/31/2025",
    "drugName": "VIZZNDA   #218585",
    "submission": "ORIG-1",
    "activeIngredients": "ACECLIDINE HYDROCHLORIDE",
    "company": "LENZ THERAP",
    "submissionClassification": "Type 1 - New Molecular Entity",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/31/2025",
    "drugName": "ALHEMOBLA   #761315",
    "submission": "SUPPL-3",
    "activeIngredients": "CONCIZUMAB-MTCI",
    "company": "NOVO NORDISK INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "07/31/2025",
    "drugName": "ALHEMOBLA   #761428",
    "submission": "ORIG-1",
    "activeIngredients": "CONCIZUMAB",
    "company": "NOVO NORDISK INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  }
,
  {
    "approvalDate": "08/01/2025",
    "drugName": "AVAPRONDA   #020757",
    "submission": "SUPPL-80",
    "activeIngredients": "IRBESARTAN",
    "company": "SANOFI AVENTIS US",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/01/2025",
    "drugName": "AVALIDENDA   #020758",
    "submission": "SUPPL-87",
    "activeIngredients": "HYDROCHLOROTHIAZIDE; IRBESARTAN",
    "company": "SANOFI AVENTIS US",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/01/2025",
    "drugName": "METHYLPREDNISOLONEANDA  #040194",
    "submission": "SUPPL-21",
    "activeIngredients": "METHYLPREDNISOLONE",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/01/2025",
    "drugName": "METHYLPREDNISOLONEANDA  #040194",
    "submission": "SUPPL-26",
    "activeIngredients": "METHYLPREDNISOLONE",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/01/2025",
    "drugName": "METHYLPREDNISOLONEANDA  #040194",
    "submission": "SUPPL-28",
    "activeIngredients": "METHYLPREDNISOLONE",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/01/2025",
    "drugName": "ETHOSUXIMIDEANDA  #040253",
    "submission": "SUPPL-5",
    "activeIngredients": "ETHOSUXIMIDE",
    "company": "PHARM ASSOC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/01/2025",
    "drugName": "ETHOSUXIMIDEANDA  #040253",
    "submission": "SUPPL-10",
    "activeIngredients": "ETHOSUXIMIDE",
    "company": "PHARM ASSOC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/01/2025",
    "drugName": "CYCLOSPORINEANDA  #065040",
    "submission": "SUPPL-16",
    "activeIngredients": "CYCLOSPORINE",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/01/2025",
    "drugName": "CYCLOSPORINEANDA  #065040",
    "submission": "SUPPL-20",
    "activeIngredients": "CYCLOSPORINE",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/01/2025",
    "drugName": "CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGYANDA  #078692",
    "submission": "SUPPL-16",
    "activeIngredients": "CETIRIZINE HYDROCHLORIDE",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/01/2025",
    "drugName": "METOCLOPRAMIDE HYDROCHLORIDEANDA  #078807",
    "submission": "SUPPL-13",
    "activeIngredients": "METOCLOPRAMIDE HYDROCHLORIDE",
    "company": "IPCA LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/01/2025",
    "drugName": "METOCLOPRAMIDE HYDROCHLORIDEANDA  #078807",
    "submission": "SUPPL-14",
    "activeIngredients": "METOCLOPRAMIDE HYDROCHLORIDE",
    "company": "IPCA LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/01/2025",
    "drugName": "HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATEANDA  #091528",
    "submission": "SUPPL-6",
    "activeIngredients": "HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE",
    "company": "NOVEL LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/01/2025",
    "drugName": "HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATEANDA  #091528",
    "submission": "SUPPL-9",
    "activeIngredients": "HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE",
    "company": "NOVEL LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/01/2025",
    "drugName": "LIOTHYRONINE SODIUMANDA  #200295",
    "submission": "SUPPL-10",
    "activeIngredients": "LIOTHYRONINE SODIUM",
    "company": "SIGMAPHARM LABS LLC",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/01/2025",
    "drugName": "NEBIVOLOL HYDROCHLORIDEANDA  #203683",
    "submission": "SUPPL-1",
    "activeIngredients": "NEBIVOLOL HYDROCHLORIDE",
    "company": "WATSON LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/01/2025",
    "drugName": "NEBIVOLOL HYDROCHLORIDEANDA  #203683",
    "submission": "SUPPL-4",
    "activeIngredients": "NEBIVOLOL HYDROCHLORIDE",
    "company": "WATSON LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/01/2025",
    "drugName": "CLOPIDOGREL BISULFATEANDA  #203751",
    "submission": "SUPPL-9",
    "activeIngredients": "CLOPIDOGREL BISULFATE",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/01/2025",
    "drugName": "CLOPIDOGREL BISULFATEANDA  #203751",
    "submission": "SUPPL-10",
    "activeIngredients": "CLOPIDOGREL BISULFATE",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/01/2025",
    "drugName": "OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDEANDA  #204233",
    "submission": "SUPPL-25",
    "activeIngredients": "HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL",
    "company": "ALEMBIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/01/2025",
    "drugName": "MINOCYCLINE HYDROCHLORIDEANDA  #204394",
    "submission": "SUPPL-4",
    "activeIngredients": "MINOCYCLINE HYDROCHLORIDE",
    "company": "SUN PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/01/2025",
    "drugName": "PRAMIPEXOLE DIHYDROCHLORIDEANDA  #206156",
    "submission": "SUPPL-21",
    "activeIngredients": "PRAMIPEXOLE DIHYDROCHLORIDE",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/01/2025",
    "drugName": "PRAMIPEXOLE DIHYDROCHLORIDEANDA  #206156",
    "submission": "SUPPL-34",
    "activeIngredients": "PRAMIPEXOLE DIHYDROCHLORIDE",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/01/2025",
    "drugName": "NALOXONE HYDROCHLORIDEANDA  #207846",
    "submission": "SUPPL-1",
    "activeIngredients": "NALOXONE HYDROCHLORIDE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/01/2025",
    "drugName": "FRINDOVYXNDA   #210852",
    "submission": "SUPPL-6",
    "activeIngredients": "CYCLOPHOSPHAMIDE",
    "company": "AVYXA HOLDINGS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/01/2025",
    "drugName": "NURTEC ODTNDA   #212728",
    "submission": "SUPPL-28",
    "activeIngredients": "RIMEGEPANT SULFATE",
    "company": "PFIZER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/01/2025",
    "drugName": "PHYRAGONDA   #216099",
    "submission": "SUPPL-5",
    "activeIngredients": "DASATINIB",
    "company": "HANDA THERAP",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/01/2025",
    "drugName": "ZAVZPRETNDA   #216386",
    "submission": "SUPPL-7",
    "activeIngredients": "ZAVEGEPANT HYDROCHLORIDE",
    "company": "PFIZER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/01/2025",
    "drugName": "E-Z-DISKNDA   #219840",
    "submission": "ORIG-1",
    "activeIngredients": "BARIUM SULFATE",
    "company": "BRACCO",
    "submissionClassification": "Type 7 - Drug Already Marketed without Approved NDA",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/04/2025",
    "drugName": "POLYTRIMNDA   #050567",
    "submission": "SUPPL-28",
    "activeIngredients": "POLYMYXIN B SULFATE; TRIMETHOPRIM SULFATE",
    "company": "ALLERGAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/04/2025",
    "drugName": "OLANZAPINEANDA  #077301",
    "submission": "SUPPL-1",
    "activeIngredients": "OLANZAPINE",
    "company": "IVAX PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/04/2025",
    "drugName": "OLANZAPINEANDA  #077301",
    "submission": "SUPPL-2",
    "activeIngredients": "OLANZAPINE",
    "company": "IVAX PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/04/2025",
    "drugName": "OLANZAPINEANDA  #077301",
    "submission": "SUPPL-4",
    "activeIngredients": "OLANZAPINE",
    "company": "IVAX PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/04/2025",
    "drugName": "FLUOCINOLONE ACETONIDEANDA  #091306",
    "submission": "SUPPL-9",
    "activeIngredients": "FLUOCINOLONE ACETONIDE",
    "company": "AMNEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/04/2025",
    "drugName": "CELECOXIBANDA  #200562",
    "submission": "SUPPL-11",
    "activeIngredients": "CELECOXIB",
    "company": "WATSON LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/04/2025",
    "drugName": "FLUOCINOLONE ACETONIDEANDA  #201759",
    "submission": "SUPPL-9",
    "activeIngredients": "FLUOCINOLONE ACETONIDE",
    "company": "AMNEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/04/2025",
    "drugName": "OLANZAPINEANDA  #202287",
    "submission": "SUPPL-6",
    "activeIngredients": "OLANZAPINE",
    "company": "ORBION PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/04/2025",
    "drugName": "BUTALBITAL, ACETAMINOPHEN AND CAFFEINEANDA  #204733",
    "submission": "SUPPL-1",
    "activeIngredients": "ACETAMINOPHEN; BUTALBITAL; CAFFEINE",
    "company": "AUROLIFE PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/04/2025",
    "drugName": "GEMCITABINE HYDROCHLORIDEANDA  #205242",
    "submission": "SUPPL-9",
    "activeIngredients": "GEMCITABINE HYDROCHLORIDE",
    "company": "MYLAN LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/04/2025",
    "drugName": "ESTRADIOLANDA  #205256",
    "submission": "SUPPL-10",
    "activeIngredients": "ESTRADIOL",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/04/2025",
    "drugName": "ESTRADIOLANDA  #205256",
    "submission": "SUPPL-11",
    "activeIngredients": "ESTRADIOL",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/04/2025",
    "drugName": "ESTRADIOLANDA  #205256",
    "submission": "SUPPL-12",
    "activeIngredients": "ESTRADIOL",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/04/2025",
    "drugName": "ESTRADIOLANDA  #206388",
    "submission": "SUPPL-8",
    "activeIngredients": "ESTRADIOL",
    "company": "TEVA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/04/2025",
    "drugName": "ESTRADIOLANDA  #206388",
    "submission": "SUPPL-9",
    "activeIngredients": "ESTRADIOL",
    "company": "TEVA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/04/2025",
    "drugName": "OXYCODONE HYDROCHLORIDEANDA  #207418",
    "submission": "SUPPL-9",
    "activeIngredients": "OXYCODONE HYDROCHLORIDE",
    "company": "ASCENT PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/04/2025",
    "drugName": "GEMCITABINE HYDROCHLORIDEANDA  #210991",
    "submission": "SUPPL-1",
    "activeIngredients": "GEMCITABINE HYDROCHLORIDE",
    "company": "SHILPA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/04/2025",
    "drugName": "ESLICARBAZEPINE ACETATEANDA  #211219",
    "submission": "ORIG-1",
    "activeIngredients": "ESLICARBAZEPINE ACETATE",
    "company": "JUBILANT GENERICS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/04/2025",
    "drugName": "MOXIFLOXACIN HYDROCHLORIDEANDA  #219475",
    "submission": "ORIG-1",
    "activeIngredients": "MOXIFLOXACIN HYDROCHLORIDE",
    "company": "FDC LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/05/2025",
    "drugName": "VORICONAZOLEANDA  #090862",
    "submission": "SUPPL-22",
    "activeIngredients": "VORICONAZOLE",
    "company": "SANDOZ INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/05/2025",
    "drugName": "PRAVASTATIN SODIUMANDA  #209869",
    "submission": "SUPPL-13",
    "activeIngredients": "PRAVASTATIN SODIUM",
    "company": "BIOCON PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/05/2025",
    "drugName": "POMALIDOMIDEANDA  #209956",
    "submission": "SUPPL-1",
    "activeIngredients": "POMALIDOMIDE",
    "company": "TEVA PHARMS USA",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/05/2025",
    "drugName": "POMALIDOMIDEANDA  #210111",
    "submission": "SUPPL-2",
    "activeIngredients": "POMALIDOMIDE",
    "company": "BRECKENRIDGE",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/05/2025",
    "drugName": "POMALIDOMIDEANDA  #210249",
    "submission": "SUPPL-5",
    "activeIngredients": "POMALIDOMIDE",
    "company": "EUGIA PHARMA",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/05/2025",
    "drugName": "POMALIDOMIDEANDA  #210275",
    "submission": "SUPPL-2",
    "activeIngredients": "POMALIDOMIDE",
    "company": "MYLAN",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/05/2025",
    "drugName": "BUMETANIDEANDA  #212470",
    "submission": "ORIG-1",
    "activeIngredients": "BUMETANIDE",
    "company": "JUBILANT GENERICS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/05/2025",
    "drugName": "SUGAMMADEX SODIUMANDA  #214279",
    "submission": "ORIG-1",
    "activeIngredients": "SUGAMMADEX SODIUM",
    "company": "B BRAUN MEDICAL",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/05/2025",
    "drugName": "DAYBUENDA   #217026",
    "submission": "SUPPL-6",
    "activeIngredients": "TROFINETIDE",
    "company": "ACADIA PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/05/2025",
    "drugName": "DAYBUENDA   #217026",
    "submission": "SUPPL-7",
    "activeIngredients": "TROFINETIDE",
    "company": "ACADIA PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/05/2025",
    "drugName": "ERIBULIN MESYLATEANDA  #218142",
    "submission": "ORIG-1",
    "activeIngredients": "ERIBULIN MESYLATE",
    "company": "GLENMARK PHARMS INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/05/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #218888",
    "submission": "ORIG-1",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "ASPIRO",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/05/2025",
    "drugName": "ELTROMBOPAG OLAMINEANDA  #219638",
    "submission": "ORIG-1",
    "activeIngredients": "ELTROMBOPAG OLAMINE",
    "company": "SOMERSET THERAPEUTICS, LLC",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "08/05/2025",
    "drugName": "AJOVYBLA   #761089",
    "submission": "SUPPL-31",
    "activeIngredients": "FREMANEZUMAB-VFRM",
    "company": "TEVA PHARMS USA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/06/2025",
    "drugName": "LAMOTRIGINEANDA  #090169",
    "submission": "SUPPL-9",
    "activeIngredients": "LAMOTRIGINE",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/06/2025",
    "drugName": "LAMOTRIGINEANDA  #090170",
    "submission": "SUPPL-39",
    "activeIngredients": "LAMOTRIGINE",
    "company": "UNICHEM LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/06/2025",
    "drugName": "COSENTYXBLA   #125504",
    "submission": "SUPPL-88",
    "activeIngredients": "SECUKINUMAB",
    "company": "NOVARTIS PHARMS CORP",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/06/2025",
    "drugName": "IBANDRONATE SODIUMANDA  #202671",
    "submission": "SUPPL-7",
    "activeIngredients": "IBANDRONATE SODIUM",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/06/2025",
    "drugName": "PEMETREXED DISODIUMANDA  #203485",
    "submission": "SUPPL-4",
    "activeIngredients": "PEMETREXED DISODIUM",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/06/2025",
    "drugName": "ROPIVACAINE HYDROCHLORIDEANDA  #203955",
    "submission": "SUPPL-2",
    "activeIngredients": "ROPIVACAINE HYDROCHLORIDE",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/06/2025",
    "drugName": "ROPIVACAINE HYDROCHLORIDEANDA  #203955",
    "submission": "SUPPL-8",
    "activeIngredients": "ROPIVACAINE HYDROCHLORIDE",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/06/2025",
    "drugName": "TIGECYCLINEANDA  #204439",
    "submission": "SUPPL-7",
    "activeIngredients": "TIGECYCLINE",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/06/2025",
    "drugName": "LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDEANDA  #204832",
    "submission": "SUPPL-18",
    "activeIngredients": "HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM",
    "company": "UNICHEM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/06/2025",
    "drugName": "TERIFLUNOMIDEANDA  #209623",
    "submission": "SUPPL-7",
    "activeIngredients": "TERIFLUNOMIDE",
    "company": "MSN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/06/2025",
    "drugName": "LEVETIRACETAMANDA  #209781",
    "submission": "SUPPL-5",
    "activeIngredients": "LEVETIRACETAM",
    "company": "HAINAN POLY PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/06/2025",
    "drugName": "FUROSEMIDEANDA  #212803",
    "submission": "SUPPL-4",
    "activeIngredients": "FUROSEMIDE",
    "company": "MEITHEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/06/2025",
    "drugName": "ZTALMYNDA   #215904",
    "submission": "SUPPL-12",
    "activeIngredients": "GANAXOLONE",
    "company": "MARINUS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/06/2025",
    "drugName": "DOXEPIN HYDROCHLORIDEANDA  #219058",
    "submission": "ORIG-1",
    "activeIngredients": "DOXEPIN HYDROCHLORIDE",
    "company": "TARO",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/06/2025",
    "drugName": "ICOSAPENT ETHYLANDA  #219156",
    "submission": "ORIG-1",
    "activeIngredients": "ICOSAPENT ETHYL",
    "company": "XIAMEN LP PHARM CO",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/06/2025",
    "drugName": "LUMATEPERONEANDA  #219229",
    "submission": "ORIG-1",
    "activeIngredients": "LUMATEPERONE",
    "company": "DR. REDDY'S LABORATORIES LIMITED",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "08/06/2025",
    "drugName": "MODEYSONDA   #219876",
    "submission": "ORIG-1",
    "activeIngredients": "DORDAVIPRONE HYDROCHLORIDE",
    "company": "CHIMERIX",
    "submissionClassification": "Type 1 - New Molecular Entity",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/06/2025",
    "drugName": "NUCALABLA   #761122",
    "submission": "SUPPL-22",
    "activeIngredients": "MEPOLIZUMAB",
    "company": "GLAXOSMITHKLINE",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/06/2025",
    "drugName": "COSENTYXBLA   #761349",
    "submission": "SUPPL-8",
    "activeIngredients": "SECUKINUMAB",
    "company": "NOVARTIS PHARMS CORP",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/07/2025",
    "drugName": "FENOFIBRATEANDA  #208476",
    "submission": "SUPPL-9",
    "activeIngredients": "FENOFIBRATE",
    "company": "BOSTAL",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/07/2025",
    "drugName": "ASCORBIC ACIDANDA  #217131",
    "submission": "ORIG-1",
    "activeIngredients": "ASCORBIC ACID",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/07/2025",
    "drugName": "KETAMINE HYDROCHLORIDEANDA  #217858",
    "submission": "ORIG-1",
    "activeIngredients": "KETAMINE HYDROCHLORIDE",
    "company": "CAPLIN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/07/2025",
    "drugName": "PRUCALOPRIDE SUCCINATEANDA  #218056",
    "submission": "ORIG-1",
    "activeIngredients": "PRUCALOPRIDE SUCCINATE",
    "company": "ZYDUS LIFESCIENCES",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/07/2025",
    "drugName": "OMEPRAZOLE MAGNESIUMANDA  #218829",
    "submission": "ORIG-1",
    "activeIngredients": "OMEPRAZOLE MAGNESIUM",
    "company": "MARKSANS PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/07/2025",
    "drugName": "GABAPENTINANDA  #219319",
    "submission": "ORIG-1",
    "activeIngredients": "GABAPENTIN",
    "company": "ANDA REPOSITORY",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/08/2025",
    "drugName": "VIBRAMYCINNDA   #050006",
    "submission": "SUPPL-96",
    "activeIngredients": "DOXYCYCLINE",
    "company": "PFIZER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/08/2025",
    "drugName": "VIBRAMYCINNDA   #050007",
    "submission": "SUPPL-40",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "PFIZER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/08/2025",
    "drugName": "CORTISPORINNDA   #050168",
    "submission": "SUPPL-86",
    "activeIngredients": "BACITRACIN ZINC; HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE",
    "company": "MONARCH PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/08/2025",
    "drugName": "CORTISPORINNDA   #050218",
    "submission": "SUPPL-63",
    "activeIngredients": "HYDROCORTISONE ACETATE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE",
    "company": "MONARCH PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/08/2025",
    "drugName": "CORTISPORINNDA   #050479",
    "submission": "SUPPL-21",
    "activeIngredients": "HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE",
    "company": "MONARCH PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/08/2025",
    "drugName": "VIBRAMYCINNDA   #050480",
    "submission": "SUPPL-64",
    "activeIngredients": "DOXYCYCLINE CALCIUM",
    "company": "PFIZER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/08/2025",
    "drugName": "VIBRA-TABSNDA   #050533",
    "submission": "SUPPL-51",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "PFIZER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/08/2025",
    "drugName": "DIAZEPAMANDA  #070302",
    "submission": "SUPPL-14",
    "activeIngredients": "DIAZEPAM",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/08/2025",
    "drugName": "DIAZEPAMANDA  #070303",
    "submission": "SUPPL-14",
    "activeIngredients": "DIAZEPAM",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/08/2025",
    "drugName": "DIAZEPAMANDA  #070304",
    "submission": "SUPPL-13",
    "activeIngredients": "DIAZEPAM",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/08/2025",
    "drugName": "ACTEMRABLA   #125276",
    "submission": "SUPPL-149",
    "activeIngredients": "TOCILIZUMAB",
    "company": "GENENTECH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/08/2025",
    "drugName": "ACTEMRABLA   #125472",
    "submission": "SUPPL-61",
    "activeIngredients": "TOCILIZUMAB",
    "company": "GENENTECH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/08/2025",
    "drugName": "IRON SUCROSEANDA  #208977",
    "submission": "ORIG-1",
    "activeIngredients": "IRON SUCROSE",
    "company": "INTL MEDICATION SYS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/08/2025",
    "drugName": "AMPHETAMINEANDA  #209253",
    "submission": "SUPPL-3",
    "activeIngredients": "AMPHETAMINE",
    "company": "ACTAVIS LABS FL INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/08/2025",
    "drugName": "AMPHETAMINEANDA  #209253",
    "submission": "SUPPL-5",
    "activeIngredients": "AMPHETAMINE",
    "company": "ACTAVIS LABS FL INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/08/2025",
    "drugName": "CARBIDOPA; LEODOPAANDA  #210911",
    "submission": "ORIG-1",
    "activeIngredients": "CARBIDOPA;LEODOPA",
    "company": "ZYDUS PHARMS USA INC",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "08/08/2025",
    "drugName": "CARBIDOPA; LEODOPAANDA  #210911",
    "submission": "ORIG-2",
    "activeIngredients": "CARBIDOPA;LEODOPA",
    "company": "ZYDUS PHARMS USA INC",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "08/08/2025",
    "drugName": "VORICONAZOLEANDA  #211598",
    "submission": "ORIG-1",
    "activeIngredients": "VORICONAZOLE",
    "company": "HETERO LABS LTD V",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/08/2025",
    "drugName": "IRON SUCROSEANDA  #212340",
    "submission": "ORIG-1",
    "activeIngredients": "IRON SUCROSE",
    "company": "SANDOZ",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/08/2025",
    "drugName": "IRON SUCROSEANDA  #212559",
    "submission": "ORIG-1",
    "activeIngredients": "IRON SUCROSE",
    "company": "MYLAN LABS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/08/2025",
    "drugName": "DAPTOMYCINANDA  #216445",
    "submission": "SUPPL-6",
    "activeIngredients": "DAPTOMYCIN",
    "company": "ASPIRO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/08/2025",
    "drugName": "DILTIAZEM HYDROCHLORIDEANDA  #216968",
    "submission": "SUPPL-1",
    "activeIngredients": "DILTIAZEM HYDROCHLORIDE",
    "company": "ALEMBIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/08/2025",
    "drugName": "OLUMIANTANDA  #217585",
    "submission": "ORIG-1",
    "activeIngredients": "BARICITINIB",
    "company": "MSN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/08/2025",
    "drugName": "SODIUM ACETATEANDA  #218469",
    "submission": "ORIG-1",
    "activeIngredients": "SODIUM ACETATE",
    "company": "AMNEAL",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/08/2025",
    "drugName": "HERNEXEOSNDA   #219042",
    "submission": "ORIG-1",
    "activeIngredients": "ZONGERTINIB",
    "company": "BOEHRINGER INGELHEIM",
    "submissionClassification": "Type 1 - New Molecular Entity",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/08/2025",
    "drugName": "DILTIAZEM HYDROCHLORIDEANDA  #219253",
    "submission": "ORIG-1",
    "activeIngredients": "DILTIAZEM HYDROCHLORIDE",
    "company": "ZYDUS LIFESCIENCES",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/08/2025",
    "drugName": "KYXATANDA   #219921",
    "submission": "ORIG-1",
    "activeIngredients": "CARBOPLATIN",
    "company": "AVYXA HOLDINGS",
    "submissionClassification": "Type 5 - New Formulation or New Manufacturer",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/11/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #062421",
    "submission": "SUPPL-76",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "ACTAVIS LABS FL INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/11/2025",
    "drugName": "GLYCOPYRROLATEANDA  #203657",
    "submission": "SUPPL-1",
    "activeIngredients": "GLYCOPYRROLATE",
    "company": "ALEMBIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/11/2025",
    "drugName": "PIRFENIDONEANDA  #212596",
    "submission": "ORIG-1",
    "activeIngredients": "PIRFENIDONE",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/11/2025",
    "drugName": "CANGRELORANDA  #213551",
    "submission": "ORIG-1",
    "activeIngredients": "CANGRELOR",
    "company": "GLAND",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/11/2025",
    "drugName": "DEFLAZACORTANDA  #216992",
    "submission": "ORIG-1",
    "activeIngredients": "DEFLAZACORT",
    "company": "UPSHER SMITH LABS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/11/2025",
    "drugName": "RIVAROXABANANDA  #218445",
    "submission": "ORIG-1",
    "activeIngredients": "RIVAROXABAN",
    "company": "REGCON HOLDINGS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/11/2025",
    "drugName": "NOREPINEPHRINE BITARTRATE IN 5% DEXTROSEANDA  #219692",
    "submission": "ORIG-1",
    "activeIngredients": "NOREPINEPHRINE BITARTRATE",
    "company": "SAGENT",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/12/2025",
    "drugName": "PROPOFOLANDA  #075102",
    "submission": "SUPPL-46",
    "activeIngredients": "PROPOFOL",
    "company": "SAGENT PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/12/2025",
    "drugName": "LEVETIRACETAMANDA  #205102",
    "submission": "SUPPL-1",
    "activeIngredients": "LEVETIRACETAM",
    "company": "CHINA RESOURCES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/12/2025",
    "drugName": "LEVETIRACETAMANDA  #205102",
    "submission": "SUPPL-2",
    "activeIngredients": "LEVETIRACETAM",
    "company": "CHINA RESOURCES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/12/2025",
    "drugName": "LEVETIRACETAMANDA  #205102",
    "submission": "SUPPL-3",
    "activeIngredients": "LEVETIRACETAM",
    "company": "CHINA RESOURCES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/12/2025",
    "drugName": "LURASIDONE HYDROCHLORIDEANDA  #208066",
    "submission": "SUPPL-2",
    "activeIngredients": "LURASIDONE HYDROCHLORIDE",
    "company": "SUN PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/12/2025",
    "drugName": "LURASIDONE HYDROCHLORIDEANDA  #208066",
    "submission": "SUPPL-9",
    "activeIngredients": "LURASIDONE HYDROCHLORIDE",
    "company": "SUN PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/12/2025",
    "drugName": "TIZANIDINE HYDROCHLORIDEANDA  #208187",
    "submission": "SUPPL-4",
    "activeIngredients": "TIZANIDINE HYDROCHLORIDE",
    "company": "CADILA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/12/2025",
    "drugName": "TIZANIDINE HYDROCHLORIDEANDA  #208187",
    "submission": "SUPPL-5",
    "activeIngredients": "TIZANIDINE HYDROCHLORIDE",
    "company": "CADILA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/12/2025",
    "drugName": "ATAZANAVIR SULFATEANDA  #209717",
    "submission": "SUPPL-7",
    "activeIngredients": "ATAZANAVIR SULFATE",
    "company": "AMNEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/12/2025",
    "drugName": "ATAZANAVIR SULFATEANDA  #209717",
    "submission": "SUPPL-8",
    "activeIngredients": "ATAZANAVIR SULFATE",
    "company": "AMNEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/12/2025",
    "drugName": "ATAZANAVIR SULFATEANDA  #209717",
    "submission": "SUPPL-9",
    "activeIngredients": "ATAZANAVIR SULFATE",
    "company": "AMNEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/12/2025",
    "drugName": "RINVOQNDA   #211675",
    "submission": "SUPPL-29",
    "activeIngredients": "UPADACITINIB",
    "company": "ABBVIE",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/12/2025",
    "drugName": "VELSIPITYNDA   #216956",
    "submission": "SUPPL-2",
    "activeIngredients": "ETRASIMOD ARGININE",
    "company": "PFIZER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/12/2025",
    "drugName": "DIVALPROEX SODIUMANDA  #217358",
    "submission": "ORIG-1",
    "activeIngredients": "DIVALPROEX SODIUM",
    "company": "MANKIND PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/12/2025",
    "drugName": "BRINSUPRINDA   #217673",
    "submission": "ORIG-1",
    "activeIngredients": "BRENSOCATIB",
    "company": "INSMED INC",
    "submissionClassification": "Type 1 - New Molecular Entity",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/12/2025",
    "drugName": "SITAGLIPTIN AND METFORMIN HYDROCHLORIDEANDA  #219296",
    "submission": "ORIG-1",
    "activeIngredients": "METFORMIN HYDROCHLORIDE, SITAGLIPTIN",
    "company": "FOSUN WANBANG (JIANGSU) PHARMACEUTICAL GROUP CO.,",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "08/13/2025",
    "drugName": "FLUOXETINE HYDROCHLORIDEANDA  #076458",
    "submission": "SUPPL-12",
    "activeIngredients": "FLUOXETINE HYDROCHLORIDE",
    "company": "CHARTWELL MOLECULAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/13/2025",
    "drugName": "RISPERIDONEANDA  #078071",
    "submission": "SUPPL-4",
    "activeIngredients": "RISPERIDONE",
    "company": "AMNEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/13/2025",
    "drugName": "RISPERIDONEANDA  #078071",
    "submission": "SUPPL-9",
    "activeIngredients": "RISPERIDONE",
    "company": "AMNEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/13/2025",
    "drugName": "FOLIC ACIDANDA  #090035",
    "submission": "SUPPL-3",
    "activeIngredients": "FOLIC ACID",
    "company": "CHARTWELL MOLECULAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/13/2025",
    "drugName": "GATTEX KITNDA   #203441",
    "submission": "SUPPL-23",
    "activeIngredients": "TEDUGLUTIDE",
    "company": "TAKEDA PHARMS USA",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/13/2025",
    "drugName": "MESALAMINEANDA  #219864",
    "submission": "ORIG-1",
    "activeIngredients": "MESALAMINE",
    "company": "ANNORA PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/14/2025",
    "drugName": "DEXLANSOPRAZOLEANDA  #202294",
    "submission": "SUPPL-13",
    "activeIngredients": "DEXLANSOPRAZOLE",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/14/2025",
    "drugName": "DEXLANSOPRAZOLEANDA  #202294",
    "submission": "SUPPL-16",
    "activeIngredients": "DEXLANSOPRAZOLE",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/14/2025",
    "drugName": "DEXLANSOPRAZOLEANDA  #202666",
    "submission": "SUPPL-8",
    "activeIngredients": "DEXLANSOPRAZOLE",
    "company": "TWI PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/14/2025",
    "drugName": "DEXLANSOPRAZOLEANDA  #202666",
    "submission": "SUPPL-9",
    "activeIngredients": "DEXLANSOPRAZOLE",
    "company": "TWI PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/14/2025",
    "drugName": "TRETINOINANDA  #218399",
    "submission": "ORIG-1",
    "activeIngredients": "TRETINOIN",
    "company": "ALEMBIC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/14/2025",
    "drugName": "LAZCLUZENDA   #219008",
    "submission": "SUPPL-2",
    "activeIngredients": "LAZERTINIB MESYLATE",
    "company": "JANSSEN BIOTECH",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/14/2025",
    "drugName": "RYBREVANTBLA   #761210",
    "submission": "SUPPL-9",
    "activeIngredients": "AMIVANTAMAB-VMJW",
    "company": "JANSSEN BIOTECH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/14/2025",
    "drugName": "OTULFIBLA   #761379",
    "submission": "SUPPL-6",
    "activeIngredients": "USTEKINUMAB-AAUZ",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/14/2025",
    "drugName": "OTULFIBLA   #761379",
    "submission": "SUPPL-7",
    "activeIngredients": "USTEKINUMAB-AAUZ",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/15/2025",
    "drugName": "CEFPROZILANDA  #065381",
    "submission": "SUPPL-11",
    "activeIngredients": "CEFPROZIL",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/15/2025",
    "drugName": "MILOPHENEANDA  #072196",
    "submission": "SUPPL-8",
    "activeIngredients": "CLOMIPHENE CITRATE",
    "company": "GRANATA BIO CORP",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/15/2025",
    "drugName": "SIMVASTATINANDA  #076052",
    "submission": "SUPPL-49",
    "activeIngredients": "SIMVASTATIN",
    "company": "IVAX SUB TEVA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/15/2025",
    "drugName": "FLUCONAZOLEANDA  #076077",
    "submission": "SUPPL-22",
    "activeIngredients": "FLUCONAZOLE",
    "company": "IVAX SUB TEVA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/15/2025",
    "drugName": "OXCARBAZEPINEANDA  #078069",
    "submission": "SUPPL-23",
    "activeIngredients": "OXCARBAZEPINE",
    "company": "BRECKENRIDGE PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/15/2025",
    "drugName": "ZOLEDRONIC ACIDANDA  #202828",
    "submission": "SUPPL-17",
    "activeIngredients": "ZOLEDRONIC ACID",
    "company": "INFORLIFE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/15/2025",
    "drugName": "PRIMAQUINE PHOSPHATEANDA  #203924",
    "submission": "SUPPL-1",
    "activeIngredients": "PRIMAQUINE PHOSPHATE",
    "company": "ALVOGEN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/15/2025",
    "drugName": "LANSOPRAZOLEANDA  #203957",
    "submission": "SUPPL-17",
    "activeIngredients": "LANSOPRAZOLE",
    "company": "AJANTA PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/15/2025",
    "drugName": "DUTASTERIDEANDA  #204373",
    "submission": "SUPPL-2",
    "activeIngredients": "DUTASTERIDE",
    "company": "ZYDUS LIFESCIENCES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/15/2025",
    "drugName": "ITRACONAZOLEANDA  #205724",
    "submission": "SUPPL-6",
    "activeIngredients": "ITRACONAZOLE",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/15/2025",
    "drugName": "ITRACONAZOLEANDA  #205724",
    "submission": "SUPPL-7",
    "activeIngredients": "ITRACONAZOLE",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/15/2025",
    "drugName": "ITRACONAZOLEANDA  #205724",
    "submission": "SUPPL-8",
    "activeIngredients": "ITRACONAZOLE",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/15/2025",
    "drugName": "LETROZOLEANDA  #205869",
    "submission": "SUPPL-8",
    "activeIngredients": "LETROZOLE",
    "company": "BEIJING YILING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/15/2025",
    "drugName": "PREGABALINANDA  #208113",
    "submission": "SUPPL-2",
    "activeIngredients": "PREGABALIN",
    "company": "REGCON HOLDINGS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/15/2025",
    "drugName": "PREGABALINANDA  #209664",
    "submission": "SUPPL-8",
    "activeIngredients": "PREGABALIN",
    "company": "DR REDDYS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/15/2025",
    "drugName": "LEVETIRACETAMANDA  #209934",
    "submission": "SUPPL-3",
    "activeIngredients": "LEVETIRACETAM",
    "company": "EPIC PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/15/2025",
    "drugName": "LEVETIRACETAMANDA  #209934",
    "submission": "SUPPL-6",
    "activeIngredients": "LEVETIRACETAM",
    "company": "EPIC PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/15/2025",
    "drugName": "ALOSETRON HYDROCHLORIDEANDA  #211621",
    "submission": "SUPPL-2",
    "activeIngredients": "ALOSETRON HYDROCHLORIDE",
    "company": "HIBROW HLTHCARE",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/15/2025",
    "drugName": "DEFERIPRONEANDA  #213239",
    "submission": "SUPPL-7",
    "activeIngredients": "DEFERIPRONE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/15/2025",
    "drugName": "LAMOTRIGINEANDA  #213271",
    "submission": "SUPPL-17",
    "activeIngredients": "LAMOTRIGINE",
    "company": "AJANTA PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/15/2025",
    "drugName": "SUCCINYLCHOLINE CHLORIDEANDA  #213432",
    "submission": "SUPPL-1",
    "activeIngredients": "SUCCINYLCHOLINE CHLORIDE",
    "company": "AMPHASTAR PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/15/2025",
    "drugName": "SUCCINYLCHOLINE CHLORIDEANDA  #213432",
    "submission": "SUPPL-2",
    "activeIngredients": "SUCCINYLCHOLINE CHLORIDE",
    "company": "AMPHASTAR PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/15/2025",
    "drugName": "WEGOVYNDA   #215256",
    "submission": "SUPPL-24",
    "activeIngredients": "SEMAGLUTIDE",
    "company": "NOVO",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/15/2025",
    "drugName": "CARBAMAZEPINEANDA  #215591",
    "submission": "SUPPL-3",
    "activeIngredients": "CARBAMAZEPINE",
    "company": "ZHEJIANG JIUZHOU",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/15/2025",
    "drugName": "CYKLXNDA   #218643",
    "submission": "ORIG-1",
    "activeIngredients": "ARTICAINE HYDROCHLORIDE",
    "company": "AM GENOMICS",
    "submissionClassification": "Type 3 - New Dosage Form and Type 4 - New Combination",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/15/2025",
    "drugName": "FLUTICASONE PROPIONATEANDA  #219060",
    "submission": "ORIG-1",
    "activeIngredients": "FLUTICASONE PROPIONATE",
    "company": "RUBICON",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/15/2025",
    "drugName": "NINTEDANIBANDA  #219371",
    "submission": "ORIG-1",
    "activeIngredients": "NINTEDANIB",
    "company": "TEVA PHARMACEUTICALS DEVELOPMENT INC",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "08/15/2025",
    "drugName": "TONMYANDA   #219428",
    "submission": "ORIG-1",
    "activeIngredients": "CYCLOBENZAPRINE HYDROCHLORIDE",
    "company": "TONIX",
    "submissionClassification": "Type 3 - New Dosage Form",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/15/2025",
    "drugName": "BYOOVIZBLA   #761202",
    "submission": "SUPPL-16",
    "activeIngredients": "RANIBIZUMAB-NUNA",
    "company": "SAMSUNG BIOEPIS CO LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/18/2025",
    "drugName": "LUPRON DEPOTNDA   #019732",
    "submission": "SUPPL-50",
    "activeIngredients": "LEUPROLIDE ACETATE",
    "company": "ABBVIE ENDOCRINE INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/18/2025",
    "drugName": "LUPRON DEPOTNDA   #020517",
    "submission": "SUPPL-47",
    "activeIngredients": "LEUPROLIDE ACETATE",
    "company": "ABBVIE ENDOCRINE INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/18/2025",
    "drugName": "METHOTREXATE SODIUM PRESERVATIVE FREEANDA  #040632",
    "submission": "SUPPL-11",
    "activeIngredients": "METHOTREXATE SODIUM",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/18/2025",
    "drugName": "METHOTREXATE SODIUM PRESERVATIVE FREEANDA  #040632",
    "submission": "SUPPL-16",
    "activeIngredients": "METHOTREXATE SODIUM",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/18/2025",
    "drugName": "LORAZEPAMANDA  #071591",
    "submission": "SUPPL-11",
    "activeIngredients": "LORAZEPAM",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/18/2025",
    "drugName": "LORAZEPAMANDA  #071591",
    "submission": "SUPPL-13",
    "activeIngredients": "LORAZEPAM",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/18/2025",
    "drugName": "HALOPERIDOL DECANOATEANDA  #075440",
    "submission": "SUPPL-55",
    "activeIngredients": "HALOPERIDOL DECANOATE",
    "company": "MYLAN LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/18/2025",
    "drugName": "HALOPERIDOL DECANOATEANDA  #076463",
    "submission": "SUPPL-3",
    "activeIngredients": "HALOPERIDOL DECANOATE",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/18/2025",
    "drugName": "SERTRALINE HYDROCHLORIDEANDA  #077864",
    "submission": "SUPPL-3",
    "activeIngredients": "SERTRALINE HYDROCHLORIDE",
    "company": "HIKMA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/18/2025",
    "drugName": "SERTRALINE HYDROCHLORIDEANDA  #077864",
    "submission": "SUPPL-4",
    "activeIngredients": "SERTRALINE HYDROCHLORIDE",
    "company": "HIKMA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/18/2025",
    "drugName": "SERTRALINE HYDROCHLORIDEANDA  #077864",
    "submission": "SUPPL-5",
    "activeIngredients": "SERTRALINE HYDROCHLORIDE",
    "company": "HIKMA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/18/2025",
    "drugName": "GABAPENTINANDA  #090007",
    "submission": "SUPPL-13",
    "activeIngredients": "GABAPENTIN",
    "company": "MARKSANS PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/18/2025",
    "drugName": "GABAPENTINANDA  #090007",
    "submission": "SUPPL-14",
    "activeIngredients": "GABAPENTIN",
    "company": "MARKSANS PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/18/2025",
    "drugName": "PREGABALINANDA  #091025",
    "submission": "SUPPL-7",
    "activeIngredients": "PREGABALIN",
    "company": "ACTAVIS ELIZABETH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/18/2025",
    "drugName": "NEULASTABLA   #125031",
    "submission": "SUPPL-209",
    "activeIngredients": "PEGFILGRASTIM",
    "company": "AMGEN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/18/2025",
    "drugName": "ARZERRABLA   #125326",
    "submission": "SUPPL-83",
    "activeIngredients": "OFATUMUMAB",
    "company": "NOVARTIS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/18/2025",
    "drugName": "KESIMPTABLA   #125326",
    "submission": "SUPPL-83",
    "activeIngredients": "OFATUMUMAB",
    "company": "NOVARTIS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/18/2025",
    "drugName": "LOSARTAN POTASSIUMANDA  #200290",
    "submission": "SUPPL-7",
    "activeIngredients": "LOSARTAN POTASSIUM",
    "company": "IPCA LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/18/2025",
    "drugName": "LOSARTAN POTASSIUMANDA  #203030",
    "submission": "SUPPL-10",
    "activeIngredients": "LOSARTAN POTASSIUM",
    "company": "UNICHEM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/18/2025",
    "drugName": "PRIMAQUINE PHOSPHATEANDA  #204476",
    "submission": "SUPPL-6",
    "activeIngredients": "PRIMAQUINE PHOSPHATE",
    "company": "UNICHEM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/18/2025",
    "drugName": "PREGABALINANDA  #207799",
    "submission": "SUPPL-15",
    "activeIngredients": "PREGABALIN",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/18/2025",
    "drugName": "PREGABALINANDA  #210432",
    "submission": "SUPPL-11",
    "activeIngredients": "PREGABALIN",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/18/2025",
    "drugName": "MACITENTANANDA  #211128",
    "submission": "ORIG-1",
    "activeIngredients": "MACITENTAN",
    "company": "ALEMBIC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/18/2025",
    "drugName": "PREGABALINANDA  #211685",
    "submission": "SUPPL-2",
    "activeIngredients": "PREGABALIN",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/18/2025",
    "drugName": "XCOPRINDA   #212839",
    "submission": "SUPPL-13",
    "activeIngredients": "CENOBAMATE",
    "company": "SK LIFE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/18/2025",
    "drugName": "ADAPALENE AND BENZOYL PEROXIDEANDA  #214185",
    "submission": "SUPPL-3",
    "activeIngredients": "ADAPALENE; BENZOYL PEROXIDE",
    "company": "ALEMBIC",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/18/2025",
    "drugName": "DEGARELIX ACETATEANDA  #215791",
    "submission": "ORIG-1",
    "activeIngredients": "DEGARELIX ACETATE",
    "company": "CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "08/18/2025",
    "drugName": "TECENTRIQBLA   #761034",
    "submission": "SUPPL-57",
    "activeIngredients": "ATEZOLIZUMAB",
    "company": "GENENTECH INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/18/2025",
    "drugName": "OCREVUSBLA   #761053",
    "submission": "SUPPL-36",
    "activeIngredients": "OCRELIZUMAB",
    "company": "GENENTECH INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/18/2025",
    "drugName": "VYEPTIBLA   #761119",
    "submission": "SUPPL-10",
    "activeIngredients": "EPTINEZUMAB-JJMR",
    "company": "Lundbeck Seattle BioPharmaceuticals, Inc.",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/18/2025",
    "drugName": "BRIUMVIBLA   #761238",
    "submission": "SUPPL-22",
    "activeIngredients": "UBLITUXIMAB-XIIY",
    "company": "TG THERAPEUTICS, INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/18/2025",
    "drugName": "BRIUMVIBLA   #761238",
    "submission": "SUPPL-25",
    "activeIngredients": "UBLITUXIMAB-XIIY",
    "company": "TG THERAPEUTICS, INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/18/2025",
    "drugName": "TECENTRIQ HYBREZABLA   #761347",
    "submission": "SUPPL-2",
    "activeIngredients": "ATEZOLIZUMAB AND HYALURONIDASE-TQJS",
    "company": "GENENTECH INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/18/2025",
    "drugName": "OCREVUS ZUNOVOBLA   #761371",
    "submission": "SUPPL-1",
    "activeIngredients": "OCRELIZUMAB AND HYALURONIDASE-OCSQ",
    "company": "GENENTECH INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/19/2025",
    "drugName": "CYRAMZABLA   #125477",
    "submission": "SUPPL-51",
    "activeIngredients": "RAMUCIRUMAB",
    "company": "ELI LILLY AND CO",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/19/2025",
    "drugName": "DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDEANDA  #211559",
    "submission": "ORIG-1",
    "activeIngredients": "DAPAGLIFLOZIN, METFORMIN HYDROCHLORIDE",
    "company": "MACLEODS PHARMACEUTICALS LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "08/19/2025",
    "drugName": "PACLITAXELANDA  #217877",
    "submission": "ORIG-1",
    "activeIngredients": "PACLITAXEL",
    "company": "MYLAN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/19/2025",
    "drugName": "TRANEXAMIC ACIDANDA  #219123",
    "submission": "ORIG-1",
    "activeIngredients": "TRANEXAMIC ACID",
    "company": "BIONPHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/19/2025",
    "drugName": "TOFACITINIB CITRATEANDA  #219542",
    "submission": "ORIG-1",
    "activeIngredients": "TOFACITINIB CITRATE",
    "company": "AJANTA PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/19/2025",
    "drugName": "TOFACITINIB CITRATEANDA  #219542",
    "submission": "ORIG-2",
    "activeIngredients": "TOFACITINIB CITRATE",
    "company": "AJANTA PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "08/19/2025",
    "drugName": "TECVAYLIBLA   #761291",
    "submission": "SUPPL-13",
    "activeIngredients": "TECLISTAMAB-CQYV",
    "company": "JANSSEN BIOTECH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/19/2025",
    "drugName": "TALVEYBLA   #761342",
    "submission": "SUPPL-15",
    "activeIngredients": "TALQUETAMAB-TGVS",
    "company": "JANSSEN BIOTECH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/20/2025",
    "drugName": "IRINOTECAN HYDROCHLORIDEANDA  #077776",
    "submission": "SUPPL-4",
    "activeIngredients": "IRINOTECAN HYDROCHLORIDE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/20/2025",
    "drugName": "IRINOTECAN HYDROCHLORIDEANDA  #077776",
    "submission": "SUPPL-5",
    "activeIngredients": "IRINOTECAN HYDROCHLORIDE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/20/2025",
    "drugName": "IRINOTECAN HYDROCHLORIDEANDA  #077776",
    "submission": "SUPPL-6",
    "activeIngredients": "IRINOTECAN HYDROCHLORIDE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/20/2025",
    "drugName": "IRINOTECAN HYDROCHLORIDEANDA  #077776",
    "submission": "SUPPL-10",
    "activeIngredients": "IRINOTECAN HYDROCHLORIDE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/20/2025",
    "drugName": "IRINOTECAN HYDROCHLORIDEANDA  #077776",
    "submission": "SUPPL-12",
    "activeIngredients": "IRINOTECAN HYDROCHLORIDE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/20/2025",
    "drugName": "LAMIVUDINEANDA  #203564",
    "submission": "SUPPL-1",
    "activeIngredients": "LAMIVUDINE",
    "company": "CHARTWELL MOLECULAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/20/2025",
    "drugName": "LAMIVUDINEANDA  #203564",
    "submission": "SUPPL-2",
    "activeIngredients": "LAMIVUDINE",
    "company": "CHARTWELL MOLECULAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/20/2025",
    "drugName": "LAMIVUDINEANDA  #203564",
    "submission": "SUPPL-3",
    "activeIngredients": "LAMIVUDINE",
    "company": "CHARTWELL MOLECULAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/20/2025",
    "drugName": "LAMIVUDINEANDA  #203564",
    "submission": "SUPPL-4",
    "activeIngredients": "LAMIVUDINE",
    "company": "CHARTWELL MOLECULAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/20/2025",
    "drugName": "LAMIVUDINEANDA  #203564",
    "submission": "SUPPL-8",
    "activeIngredients": "LAMIVUDINE",
    "company": "CHARTWELL MOLECULAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/20/2025",
    "drugName": "TRANEXAMIC ACIDANDA  #205133",
    "submission": "SUPPL-3",
    "activeIngredients": "TRANEXAMIC ACID",
    "company": "AUROBINDO PHARMA USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/20/2025",
    "drugName": "AMBRISENTANANDA  #210058",
    "submission": "SUPPL-10",
    "activeIngredients": "AMBRISENTAN",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/20/2025",
    "drugName": "MACITENTANANDA  #211136",
    "submission": "ORIG-1",
    "activeIngredients": "MACITENTAN",
    "company": "MSN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/20/2025",
    "drugName": "AMPHETAMINE SULFATEANDA  #213720",
    "submission": "SUPPL-5",
    "activeIngredients": "AMPHETAMINE SULFATE",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/20/2025",
    "drugName": "AMPHETAMINE SULFATEANDA  #213763",
    "submission": "SUPPL-3",
    "activeIngredients": "AMPHETAMINE SULFATE",
    "company": "NOVAST LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/20/2025",
    "drugName": "OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDEANDA  #214427",
    "submission": "ORIG-1",
    "activeIngredients": "HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL",
    "company": "HANGZHOU BINJIANG",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/20/2025",
    "drugName": "NICARDIPINE HYDROCHLORIDEANDA  #216819",
    "submission": "ORIG-1",
    "activeIngredients": "NICARDIPINE HYDROCHLORIDE",
    "company": "NANJING KING FRIEND",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/20/2025",
    "drugName": "SCOPOLAMINEANDA  #217893",
    "submission": "SUPPL-1",
    "activeIngredients": "SCOPOLAMINE",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/20/2025",
    "drugName": "RILPIVIRINEANDA  #218798",
    "submission": "ORIG-1",
    "activeIngredients": "RILPIVIRINE",
    "company": "SOMERSET THERAPEUTICS, LLC",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "08/21/2025",
    "drugName": "RESTASISNDA   #050790",
    "submission": "SUPPL-31",
    "activeIngredients": "CYCLOSPORINE",
    "company": "ABBVIE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/21/2025",
    "drugName": "RESTASIS MULTIDOSENDA   #050790",
    "submission": "SUPPL-31",
    "activeIngredients": "CYCLOSPORINE",
    "company": "ABBVIE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/21/2025",
    "drugName": "CEFAZOLIN SODIUMANDA  #065047",
    "submission": "SUPPL-16",
    "activeIngredients": "CEFAZOLIN SODIUM",
    "company": "HIKMA FARMACEUTICA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/21/2025",
    "drugName": "CEFAZOLIN SODIUMANDA  #065047",
    "submission": "SUPPL-18",
    "activeIngredients": "CEFAZOLIN SODIUM",
    "company": "HIKMA FARMACEUTICA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/21/2025",
    "drugName": "CEFAZOLIN SODIUMANDA  #065047",
    "submission": "SUPPL-21",
    "activeIngredients": "CEFAZOLIN SODIUM",
    "company": "HIKMA FARMACEUTICA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/21/2025",
    "drugName": "CLORAZEPATE DIPOTASSIUMANDA  #071509",
    "submission": "SUPPL-3",
    "activeIngredients": "CLORAZEPATE DIPOTASSIUM",
    "company": "DASH PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/21/2025",
    "drugName": "CLORAZEPATE DIPOTASSIUMANDA  #071509",
    "submission": "SUPPL-5",
    "activeIngredients": "CLORAZEPATE DIPOTASSIUM",
    "company": "DASH PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/21/2025",
    "drugName": "CLORAZEPATE DIPOTASSIUMANDA  #071510",
    "submission": "SUPPL-3",
    "activeIngredients": "CLORAZEPATE DIPOTASSIUM",
    "company": "DASH PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/21/2025",
    "drugName": "CLORAZEPATE DIPOTASSIUMANDA  #071510",
    "submission": "SUPPL-5",
    "activeIngredients": "CLORAZEPATE DIPOTASSIUM",
    "company": "DASH PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/21/2025",
    "drugName": "CLORAZEPATE DIPOTASSIUMANDA  #071511",
    "submission": "SUPPL-3",
    "activeIngredients": "CLORAZEPATE DIPOTASSIUM",
    "company": "DASH PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/21/2025",
    "drugName": "CLORAZEPATE DIPOTASSIUMANDA  #071511",
    "submission": "SUPPL-5",
    "activeIngredients": "CLORAZEPATE DIPOTASSIUM",
    "company": "DASH PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/21/2025",
    "drugName": "TOPIRAMATEANDA  #078418",
    "submission": "SUPPL-4",
    "activeIngredients": "TOPIRAMATE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/21/2025",
    "drugName": "TOPIRAMATEANDA  #078418",
    "submission": "SUPPL-6",
    "activeIngredients": "TOPIRAMATE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/21/2025",
    "drugName": "TOPIRAMATEANDA  #078418",
    "submission": "SUPPL-8",
    "activeIngredients": "TOPIRAMATE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/21/2025",
    "drugName": "TOPIRAMATEANDA  #078418",
    "submission": "SUPPL-9",
    "activeIngredients": "TOPIRAMATE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/21/2025",
    "drugName": "TOPIRAMATEANDA  #078418",
    "submission": "SUPPL-11",
    "activeIngredients": "TOPIRAMATE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/21/2025",
    "drugName": "TOPIRAMATEANDA  #078418",
    "submission": "SUPPL-13",
    "activeIngredients": "TOPIRAMATE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/21/2025",
    "drugName": "QUINIDINE SULFATEANDA  #083743",
    "submission": "SUPPL-7",
    "activeIngredients": "QUINIDINE SULFATE",
    "company": "CHARTWELL MOLECULAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/21/2025",
    "drugName": "REPATHABLA   #125522",
    "submission": "SUPPL-45",
    "activeIngredients": "EVOLOCUMAB",
    "company": "AMGEN INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/21/2025",
    "drugName": "ZARXIOBLA   #125553",
    "submission": "SUPPL-44",
    "activeIngredients": "FILGRASTIM-SNDZ",
    "company": "SANDOZ INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/21/2025",
    "drugName": "TOLTERODINE TARTRATEANDA  #203016",
    "submission": "SUPPL-9",
    "activeIngredients": "TOLTERODINE TARTRATE",
    "company": "TORRENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/21/2025",
    "drugName": "MEROPENEMANDA  #205883",
    "submission": "SUPPL-13",
    "activeIngredients": "MEROPENEM",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/21/2025",
    "drugName": "MEROPENEMANDA  #205883",
    "submission": "SUPPL-14",
    "activeIngredients": "MEROPENEM",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/21/2025",
    "drugName": "MEROPENEMANDA  #206141",
    "submission": "SUPPL-13",
    "activeIngredients": "MEROPENEM",
    "company": "GLAND",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/21/2025",
    "drugName": "MEROPENEMANDA  #206141",
    "submission": "SUPPL-15",
    "activeIngredients": "MEROPENEM",
    "company": "GLAND",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/21/2025",
    "drugName": "PREGABALINANDA  #206912",
    "submission": "SUPPL-12",
    "activeIngredients": "PREGABALIN",
    "company": "HETERO LABS LTD III",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/21/2025",
    "drugName": "PREGABALINANDA  #208677",
    "submission": "SUPPL-20",
    "activeIngredients": "PREGABALIN",
    "company": "SCIEGEN PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/21/2025",
    "drugName": "FENOFIBRATEANDA  #208709",
    "submission": "SUPPL-11",
    "activeIngredients": "FENOFIBRATE",
    "company": "CIPLA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/21/2025",
    "drugName": "MAYZENTNDA   #209884",
    "submission": "SUPPL-20",
    "activeIngredients": "SIPONIMOD",
    "company": "NOVARTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/21/2025",
    "drugName": "FENOFIBRATEANDA  #209951",
    "submission": "SUPPL-8",
    "activeIngredients": "FENOFIBRATE",
    "company": "AMNEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/21/2025",
    "drugName": "IMCIVREENDA   #213793",
    "submission": "SUPPL-8",
    "activeIngredients": "SETMELANOTIDE ACETATE",
    "company": "RHYTHM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/21/2025",
    "drugName": "NALOXONE HYDROCHLORIDEANDA  #214211",
    "submission": "ORIG-1",
    "activeIngredients": "NALOXONE HYDROCHLORIDE",
    "company": "STERINOVA INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/21/2025",
    "drugName": "FENOFIBRATEANDA  #217732",
    "submission": "SUPPL-3",
    "activeIngredients": "FENOFIBRATE",
    "company": "CREEKWOOD PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/21/2025",
    "drugName": "DAWNZERA (AUTOINJECTOR)NDA   #219407",
    "submission": "ORIG-1",
    "activeIngredients": "DONIDALORSEN SODIUM",
    "company": "IONIS PHARMS INC",
    "submissionClassification": "Type 1 - New Molecular Entity",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/21/2025",
    "drugName": "TRAZIMERABLA   #761081",
    "submission": "SUPPL-17",
    "activeIngredients": "TRASTUZUMAB-QYYP",
    "company": "PFIZER INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/21/2025",
    "drugName": "LEQEMBIBLA   #761269",
    "submission": "SUPPL-13",
    "activeIngredients": "LECANEMAB-IRMB",
    "company": "EISAI INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/22/2025",
    "drugName": "TERCONAZOLENDA   #021735",
    "submission": "SUPPL-14",
    "activeIngredients": "TERCONAZOLE",
    "company": "FOUGERA PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/22/2025",
    "drugName": "GILENYANDA   #022527",
    "submission": "SUPPL-44",
    "activeIngredients": "FINGOLIMOD HYDROCHLORIDE",
    "company": "NOVARTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/22/2025",
    "drugName": "CLINDAMYCIN PHOSPHATEANDA  #064159",
    "submission": "SUPPL-13",
    "activeIngredients": "CLINDAMYCIN PHOSPHATE",
    "company": "FOUGERA PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/22/2025",
    "drugName": "CLINDAMYCIN PHOSPHATEANDA  #064159",
    "submission": "SUPPL-16",
    "activeIngredients": "CLINDAMYCIN PHOSPHATE",
    "company": "FOUGERA PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/22/2025",
    "drugName": "CLINDAMYCIN PHOSPHATEANDA  #064159",
    "submission": "SUPPL-17",
    "activeIngredients": "CLINDAMYCIN PHOSPHATE",
    "company": "FOUGERA PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/22/2025",
    "drugName": "CLINDAMYCIN PHOSPHATEANDA  #064159",
    "submission": "SUPPL-19",
    "activeIngredients": "CLINDAMYCIN PHOSPHATE",
    "company": "FOUGERA PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/22/2025",
    "drugName": "CLINDAMYCIN PHOSPHATEANDA  #064159",
    "submission": "SUPPL-20",
    "activeIngredients": "CLINDAMYCIN PHOSPHATE",
    "company": "FOUGERA PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/22/2025",
    "drugName": "CLINDAMYCIN PHOSPHATEANDA  #064160",
    "submission": "SUPPL-15",
    "activeIngredients": "CLINDAMYCIN PHOSPHATE",
    "company": "FOUGERA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/22/2025",
    "drugName": "CLINDAMYCIN PHOSPHATEANDA  #064160",
    "submission": "SUPPL-18",
    "activeIngredients": "CLINDAMYCIN PHOSPHATE",
    "company": "FOUGERA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/22/2025",
    "drugName": "CLINDAMYCIN PHOSPHATEANDA  #064160",
    "submission": "SUPPL-20",
    "activeIngredients": "CLINDAMYCIN PHOSPHATE",
    "company": "FOUGERA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/22/2025",
    "drugName": "CLINDAMYCIN PHOSPHATEANDA  #064160",
    "submission": "SUPPL-24",
    "activeIngredients": "CLINDAMYCIN PHOSPHATE",
    "company": "FOUGERA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/22/2025",
    "drugName": "CLINDAMYCIN PHOSPHATEANDA  #064160",
    "submission": "SUPPL-26",
    "activeIngredients": "CLINDAMYCIN PHOSPHATE",
    "company": "FOUGERA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/22/2025",
    "drugName": "CLINDAMYCIN PHOSPHATEANDA  #065067",
    "submission": "SUPPL-15",
    "activeIngredients": "CLINDAMYCIN PHOSPHATE",
    "company": "FOUGERA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/22/2025",
    "drugName": "CLINDAMYCIN PHOSPHATEANDA  #065067",
    "submission": "SUPPL-17",
    "activeIngredients": "CLINDAMYCIN PHOSPHATE",
    "company": "FOUGERA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/22/2025",
    "drugName": "CLINDAMYCIN PHOSPHATEANDA  #065067",
    "submission": "SUPPL-18",
    "activeIngredients": "CLINDAMYCIN PHOSPHATE",
    "company": "FOUGERA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/22/2025",
    "drugName": "CLINDAMYCIN PHOSPHATEANDA  #065067",
    "submission": "SUPPL-20",
    "activeIngredients": "CLINDAMYCIN PHOSPHATE",
    "company": "FOUGERA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/22/2025",
    "drugName": "CLINDAMYCIN PHOSPHATEANDA  #065067",
    "submission": "SUPPL-23",
    "activeIngredients": "CLINDAMYCIN PHOSPHATE",
    "company": "FOUGERA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/22/2025",
    "drugName": "CEFPROZILANDA  #065261",
    "submission": "SUPPL-21",
    "activeIngredients": "CEFPROZIL",
    "company": "LUPIN",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/22/2025",
    "drugName": "DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATEANDA  #077847",
    "submission": "SUPPL-15",
    "activeIngredients": "DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/22/2025",
    "drugName": "LIDOCAINE HYDROCHLORIDEANDA  #086283",
    "submission": "SUPPL-29",
    "activeIngredients": "LIDOCAINE HYDROCHLORIDE",
    "company": "INTL MEDICATION",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/22/2025",
    "drugName": "LIDOCAINE HYDROCHLORIDEANDA  #086283",
    "submission": "SUPPL-30",
    "activeIngredients": "LIDOCAINE HYDROCHLORIDE",
    "company": "INTL MEDICATION",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/22/2025",
    "drugName": "VONJONDA   #208712",
    "submission": "SUPPL-6",
    "activeIngredients": "PACRITINIB CITRATE",
    "company": "SOBI",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/22/2025",
    "drugName": "TENOFOVIR ALAFENAMIDE FUMARATEANDA  #214030",
    "submission": "ORIG-1",
    "activeIngredients": "TENOFOVIR ALAFENAMIDE FUMARATE",
    "company": "LAURUS LABS LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "08/22/2025",
    "drugName": "PENCICLOVIRANDA  #214100",
    "submission": "ORIG-1",
    "activeIngredients": "PENCICLOVIR",
    "company": "AMNEAL",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/22/2025",
    "drugName": "VEKLURYNDA   #214787",
    "submission": "SUPPL-31",
    "activeIngredients": "REMDESIVIR",
    "company": "GILEAD SCIENCES INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/22/2025",
    "drugName": "DIPHENHYDRAMINE HYDROCHLORIDEANDA  #219845",
    "submission": "ORIG-1",
    "activeIngredients": "DIPHENHYDRAMINE HYDROCHLORIDE",
    "company": "MICRO LABS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/25/2025",
    "drugName": "SODIUM BICARBONATEANDA  #206688",
    "submission": "ORIG-1",
    "activeIngredients": "SODIUM BICARBONATE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/25/2025",
    "drugName": "KLOXXADONDA   #212045",
    "submission": "SUPPL-5",
    "activeIngredients": "NALOXONE HYDROCHLORIDE",
    "company": "HIKMA",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/25/2025",
    "drugName": "MELPHALANANDA  #212810",
    "submission": "ORIG-1",
    "activeIngredients": "MELPHALAN",
    "company": "ALEMBIC GLOBAL",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "08/25/2025",
    "drugName": "COSELANDA   #214200",
    "submission": "SUPPL-7",
    "activeIngredients": "TRILACICLIB DIHYDROCHLORIDE",
    "company": "PHARMACOSMOS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/25/2025",
    "drugName": "DASATINIBANDA  #214350",
    "submission": "ORIG-1",
    "activeIngredients": "DASATINIB",
    "company": "LUPIN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/25/2025",
    "drugName": "VORICONAZOLEANDA  #216805",
    "submission": "SUPPL-1",
    "activeIngredients": "VORICONAZOLE",
    "company": "ZHEJIANG POLY PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/25/2025",
    "drugName": "SITAGLIPTINANDA  #218441",
    "submission": "ORIG-1",
    "activeIngredients": "SITAGLIPTIN",
    "company": "BIOCON PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "08/25/2025",
    "drugName": "CAMCEVI ETMNDA   #219745",
    "submission": "ORIG-1",
    "activeIngredients": "LEUPROLIDE MESYLATE",
    "company": "FORESEE PHARMS",
    "submissionClassification": "Type 5 - New Formulation or New Manufacturer",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/25/2025",
    "drugName": "AVSOLABLA   #761086",
    "submission": "SUPPL-13",
    "activeIngredients": "INFLIXIMAB-AXXQ",
    "company": "AMGEN INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/25/2025",
    "drugName": "OPUVIZBLA   #761350",
    "submission": "SUPPL-7",
    "activeIngredients": "AFLIBERCEPT-YSZY",
    "company": "SAMSUNG BIOEPIS CO LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/26/2025",
    "drugName": "METHIMAZOLEANDA  #040734",
    "submission": "SUPPL-9",
    "activeIngredients": "METHIMAZOLE",
    "company": "HERITAGE PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/26/2025",
    "drugName": "PENICILLIN G PROCAINEANDA  #060101",
    "submission": "SUPPL-46",
    "activeIngredients": "PENICILLIN G PROCAINE",
    "company": "KING PHARMS LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/26/2025",
    "drugName": "PENICILLIN G PROCAINEANDA  #060101",
    "submission": "SUPPL-47",
    "activeIngredients": "PENICILLIN G PROCAINE",
    "company": "KING PHARMS LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/26/2025",
    "drugName": "PENICILLIN G PROCAINEANDA  #060101",
    "submission": "SUPPL-49",
    "activeIngredients": "PENICILLIN G PROCAINE",
    "company": "KING PHARMS LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/26/2025",
    "drugName": "GABAPENTINANDA  #075360",
    "submission": "SUPPL-35",
    "activeIngredients": "GABAPENTIN",
    "company": "GRANULES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/26/2025",
    "drugName": "LAMOTRIGINEANDA  #077420",
    "submission": "SUPPL-20",
    "activeIngredients": "LAMOTRIGINE",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/26/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #209243",
    "submission": "SUPPL-2",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/26/2025",
    "drugName": "MACITENTANANDA  #211123",
    "submission": "ORIG-1",
    "activeIngredients": "MACITENTAN",
    "company": "SUN PHARM",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/26/2025",
    "drugName": "TEPEZZABLA   #761143",
    "submission": "SUPPL-31",
    "activeIngredients": "TEPROTUMUMAB-TRBW",
    "company": "HORIZON THERAPEUTICS IRELAND",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/27/2025",
    "drugName": "LIDOCAINE HYDROCHLORIDEANDA  #040433",
    "submission": "SUPPL-20",
    "activeIngredients": "LIDOCAINE HYDROCHLORIDE",
    "company": "SENTISS",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/27/2025",
    "drugName": "DESMOPRESSIN ACETATEANDA  #210223",
    "submission": "SUPPL-5",
    "activeIngredients": "DESMOPRESSIN ACETATE",
    "company": "UBI",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/27/2025",
    "drugName": "DASATINIBANDA  #211094",
    "submission": "ORIG-1",
    "activeIngredients": "DASATINIB",
    "company": "TEVA PHARMS USA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/27/2025",
    "drugName": "TURALIONDA   #211810",
    "submission": "SUPPL-14",
    "activeIngredients": "PEXIDARTINIB HYDROCHLORIDE",
    "company": "DAIICHI SANKYO INC",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/27/2025",
    "drugName": "SUGAMMADEXANDA  #214276",
    "submission": "ORIG-1",
    "activeIngredients": "SUGAMMADEX",
    "company": "USV PRIVATE LIMITED",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "08/27/2025",
    "drugName": "LIRAGLUTIDEANDA  #214568",
    "submission": "ORIG-1",
    "activeIngredients": "LIRAGLUTIDE",
    "company": "TEVA PHARMS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/27/2025",
    "drugName": "MYFEMBREENDA   #214846",
    "submission": "SUPPL-12",
    "activeIngredients": "ESTRADIOL; NORETHINDRONE ACETATE; RELUGOLIX",
    "company": "SUMITOMO PHARMA AM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/27/2025",
    "drugName": "FILSPARINDA   #216403",
    "submission": "SUPPL-5",
    "activeIngredients": "SPARSENTAN",
    "company": "TRAVERE",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/27/2025",
    "drugName": "OJEMDANDA   #217700",
    "submission": "SUPPL-2",
    "activeIngredients": "TOVORAFENIB",
    "company": "DAY ONE BIOPHARMS",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/27/2025",
    "drugName": "OJEMDANDA   #217700",
    "submission": "SUPPL-3",
    "activeIngredients": "TOVORAFENIB",
    "company": "DAY ONE BIOPHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/27/2025",
    "drugName": "OJEMDANDA   #217700",
    "submission": "SUPPL-4",
    "activeIngredients": "TOVORAFENIB",
    "company": "DAY ONE BIOPHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/27/2025",
    "drugName": "OJEMDANDA   #218033",
    "submission": "SUPPL-2",
    "activeIngredients": "TOVORAFENIB",
    "company": "DAY ONE BIOPHARMS",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/27/2025",
    "drugName": "OJEMDANDA   #218033",
    "submission": "SUPPL-3",
    "activeIngredients": "TOVORAFENIB",
    "company": "DAY ONE BIOPHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/27/2025",
    "drugName": "DANYELZABLA   #761171",
    "submission": "SUPPL-13",
    "activeIngredients": "NAXITAMAB-GQGK",
    "company": "Y-MABS THERAPEUTICS INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/28/2025",
    "drugName": "NAPROXEN SODIUMANDA  #074495",
    "submission": "SUPPL-11",
    "activeIngredients": "NAPROXEN SODIUM",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/28/2025",
    "drugName": "NAPROXEN SODIUMANDA  #074495",
    "submission": "SUPPL-13",
    "activeIngredients": "NAPROXEN SODIUM",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/28/2025",
    "drugName": "NAPROXEN SODIUMANDA  #074495",
    "submission": "SUPPL-15",
    "activeIngredients": "NAPROXEN SODIUM",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/28/2025",
    "drugName": "DASATINIBANDA  #202103",
    "submission": "SUPPL-10",
    "activeIngredients": "DASATINIB",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/28/2025",
    "drugName": "DASATINIBANDA  #202103",
    "submission": "SUPPL-11",
    "activeIngredients": "DASATINIB",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/28/2025",
    "drugName": "DASATINIBANDA  #203180",
    "submission": "SUPPL-3",
    "activeIngredients": "DASATINIB",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/28/2025",
    "drugName": "DASATINIBANDA  #203180",
    "submission": "SUPPL-4",
    "activeIngredients": "DASATINIB",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/28/2025",
    "drugName": "PARICALCITOLANDA  #203897",
    "submission": "SUPPL-5",
    "activeIngredients": "PARICALCITOL",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/28/2025",
    "drugName": "FENOFIBRATEANDA  #204598",
    "submission": "SUPPL-11",
    "activeIngredients": "FENOFIBRATE",
    "company": "HETERO LABS LTD III",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/28/2025",
    "drugName": "AMIKACIN SULFATEANDA  #205604",
    "submission": "SUPPL-6",
    "activeIngredients": "AMIKACIN SULFATE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/28/2025",
    "drugName": "BRIVIACTNDA   #205836",
    "submission": "SUPPL-17",
    "activeIngredients": "BRIVARACETAM",
    "company": "UCB INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/28/2025",
    "drugName": "BRIVIACTNDA   #205837",
    "submission": "SUPPL-14",
    "activeIngredients": "BRIVARACETAM",
    "company": "UCB INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/28/2025",
    "drugName": "BRIVIACTNDA   #205838",
    "submission": "SUPPL-15",
    "activeIngredients": "BRIVARACETAM",
    "company": "UCB INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/28/2025",
    "drugName": "MEMANTINE HYDROCHLORIDEANDA  #206310",
    "submission": "ORIG-1",
    "activeIngredients": "MEMANTINE HYDROCHLORIDE",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/28/2025",
    "drugName": "MOXIFLOXACIN HYDROCHLORIDEANDA  #207285",
    "submission": "SUPPL-1",
    "activeIngredients": "MOXIFLOXACIN HYDROCHLORIDE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/28/2025",
    "drugName": "MOXIFLOXACIN HYDROCHLORIDEANDA  #207285",
    "submission": "SUPPL-3",
    "activeIngredients": "MOXIFLOXACIN HYDROCHLORIDE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/28/2025",
    "drugName": "NAPROXENANDA  #212517",
    "submission": "SUPPL-15",
    "activeIngredients": "NAPROXEN",
    "company": "SCIEGEN PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/28/2025",
    "drugName": "AMINOCAPROIC ACIDANDA  #215374",
    "submission": "ORIG-1",
    "activeIngredients": "AMINOCAPROIC ACID",
    "company": "GEN ILAC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/28/2025",
    "drugName": "LOPRESSORNDA   #218698",
    "submission": "ORIG-1",
    "activeIngredients": "METOPROLOL TARTRATE",
    "company": "XTM CONSULTING",
    "submissionClassification": "Type 5 - New Formulation or New Manufacturer",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/28/2025",
    "drugName": "CRYSVITABLA   #761068",
    "submission": "SUPPL-9",
    "activeIngredients": "BUROSUMAB-TWZA",
    "company": "KYOWA KIRIN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/29/2025",
    "drugName": "CYKLOKAPRONNDA   #019281",
    "submission": "SUPPL-48",
    "activeIngredients": "TRANEXAMIC ACID",
    "company": "PFIZER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/29/2025",
    "drugName": "MICONAZOLE NITRATEANDA  #074444",
    "submission": "SUPPL-23",
    "activeIngredients": "MICONAZOLE NITRATE",
    "company": "TARO",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/29/2025",
    "drugName": "CETIRIZINE HYDROCHLORIDEANDA  #090191",
    "submission": "SUPPL-10",
    "activeIngredients": "CETIRIZINE HYDROCHLORIDE",
    "company": "BAJAJ",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/29/2025",
    "drugName": "QUININE SULFATEANDA  #203112",
    "submission": "SUPPL-3",
    "activeIngredients": "QUININE SULFATE",
    "company": "LUPIN LTD",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/29/2025",
    "drugName": "BRIXADINDA   #210136",
    "submission": "SUPPL-11",
    "activeIngredients": "BUPRENORPHINE",
    "company": "BRAEBURN",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/29/2025",
    "drugName": "OTEZLANDA   #210745",
    "submission": "ORIG-1",
    "activeIngredients": "APREMILAST",
    "company": "AMGEN INC",
    "submissionClassification": "Type 5 - New Formulation or New Manufacturer",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/29/2025",
    "drugName": "OTEZLANDA   #210745",
    "submission": "ORIG-2",
    "activeIngredients": "APREMILAST",
    "company": "AMGEN INC",
    "submissionClassification": "Type 5 - New Formulation or New Manufacturer",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/29/2025",
    "drugName": "OTEZLA XRNDA   #210745",
    "submission": "ORIG-1",
    "activeIngredients": "APREMILAST",
    "company": "AMGEN INC",
    "submissionClassification": "Type 5 - New Formulation or New Manufacturer",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/29/2025",
    "drugName": "OTEZLA XRNDA   #210745",
    "submission": "ORIG-2",
    "activeIngredients": "APREMILAST",
    "company": "AMGEN INC",
    "submissionClassification": "Type 5 - New Formulation or New Manufacturer",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/29/2025",
    "drugName": "TIOPRONINANDA  #216278",
    "submission": "SUPPL-2",
    "activeIngredients": "TIOPRONIN",
    "company": "AMNEAL",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/29/2025",
    "drugName": "DICLOFENAC POTASSIUMANDA  #217010",
    "submission": "ORIG-1",
    "activeIngredients": "DICLOFENAC POTASSIUM",
    "company": "UMEDICA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/29/2025",
    "drugName": "ESCITALOPRAMNDA   #219130",
    "submission": "ORIG-1",
    "activeIngredients": "ESCITALOPRAM OXALATE",
    "company": "ALMATICA",
    "submissionClassification": "Type 3 - New Dosage Form",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/29/2025",
    "drugName": "WAYRILZNDA   #219685",
    "submission": "ORIG-1",
    "activeIngredients": "RILZABRUTINIB",
    "company": "GENZYME CORP",
    "submissionClassification": "Type 1 - New Molecular Entity",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/29/2025",
    "drugName": "LEQEMBI IQLIKBLA   #761375",
    "submission": "ORIG-1",
    "activeIngredients": "LECANEMAB-IRMB",
    "company": "EISAI INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/29/2025",
    "drugName": "BILDYOSBLA   #761444",
    "submission": "ORIG-1",
    "activeIngredients": "DENOSUMAB-NXXP",
    "company": "SHANGHAI HENLIUS BIOTECH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "08/29/2025",
    "drugName": "BILPREVDABLA   #761444",
    "submission": "ORIG-1",
    "activeIngredients": "DENOSUMAB-NXXP",
    "company": "SHANGHAI HENLIUS BIOTECH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  }
,
  {
    "approvalDate": "09/02/2025",
    "drugName": "BYETTANDA   #021773",
    "submission": "SUPPL-51",
    "activeIngredients": "EXENATIDE SYNTHETIC",
    "company": "ASTRAZENECA AB",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/02/2025",
    "drugName": "AMPICILLIN TRIHYDRATEANDA  #064082",
    "submission": "SUPPL-23",
    "activeIngredients": "AMPICILLIN/AMPICILLIN TRIHYDRATE",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/02/2025",
    "drugName": "DIVALPROEX SODIUMANDA  #077567",
    "submission": "SUPPL-36",
    "activeIngredients": "DIVALPROEX SODIUM",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/02/2025",
    "drugName": "DIVALPROEX SODIUMANDA  #077567",
    "submission": "SUPPL-37",
    "activeIngredients": "DIVALPROEX SODIUM",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/02/2025",
    "drugName": "DIVALPROEX SODIUMANDA  #077567",
    "submission": "SUPPL-38",
    "activeIngredients": "DIVALPROEX SODIUM",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/02/2025",
    "drugName": "VENLAFAXINE HYDROCHLORIDEANDA  #091272",
    "submission": "SUPPL-28",
    "activeIngredients": "VENLAFAXINE HYDROCHLORIDE",
    "company": "SUN PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/02/2025",
    "drugName": "VENLAFAXINE HYDROCHLORIDEANDA  #091272",
    "submission": "SUPPL-33",
    "activeIngredients": "VENLAFAXINE HYDROCHLORIDE",
    "company": "SUN PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/02/2025",
    "drugName": "RISPERIDONEANDA  #211220",
    "submission": "ORIG-1",
    "activeIngredients": "RISPERIDONE",
    "company": "NANOMI",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/02/2025",
    "drugName": "RISPERIDONEANDA  #218586",
    "submission": "ORIG-1",
    "activeIngredients": "RISPERIDONE",
    "company": "AMNEAL",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/02/2025",
    "drugName": "PITOLISANTANDA  #218832",
    "submission": "ORIG-1",
    "activeIngredients": "PITOLISANT",
    "company": "ANNORA PHARMA PRIVATE LIMITED",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "09/02/2025",
    "drugName": "MILRINONE LACTATE IN DEXTROSE 5%ANDA  #219170",
    "submission": "ORIG-1",
    "activeIngredients": "MILRINONE LACTATE",
    "company": "CAPLIN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/02/2025",
    "drugName": "TASIMELTEONANDA  #219541",
    "submission": "ORIG-1",
    "activeIngredients": "TASIMELTEON",
    "company": "MSN LABORATORIES PRIVATE LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "09/02/2025",
    "drugName": "TOPIRAMATEANDA  #219564",
    "submission": "ORIG-1",
    "activeIngredients": "TOPIRAMATE",
    "company": "AJANTA PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/02/2025",
    "drugName": "EPYSQLIBLA   #761340",
    "submission": "SUPPL-15",
    "activeIngredients": "ECULIZUMAB-AAGH",
    "company": "SAMSUNG BIOEPIS CO LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/03/2025",
    "drugName": "METOPROLOL TARTRATEANDA  #074453",
    "submission": "SUPPL-2",
    "activeIngredients": "METOPROLOL TARTRATE",
    "company": "RENATA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/03/2025",
    "drugName": "METOPROLOL TARTRATEANDA  #074453",
    "submission": "SUPPL-4",
    "activeIngredients": "METOPROLOL TARTRATE",
    "company": "RENATA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/03/2025",
    "drugName": "METOPROLOL TARTRATEANDA  #074453",
    "submission": "SUPPL-6",
    "activeIngredients": "METOPROLOL TARTRATE",
    "company": "RENATA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/03/2025",
    "drugName": "INFLECTRABLA   #125544",
    "submission": "SUPPL-55",
    "activeIngredients": "INFLIXIMAB-DYYB",
    "company": "CELLTRION INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/03/2025",
    "drugName": "FLUOCINOLONE ACETONIDEANDA  #201764",
    "submission": "SUPPL-9",
    "activeIngredients": "FLUOCINOLONE ACETONIDE",
    "company": "AMNEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/03/2025",
    "drugName": "DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATEANDA  #201998",
    "submission": "SUPPL-1",
    "activeIngredients": "DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE",
    "company": "CHARTWELL MOLECULAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/03/2025",
    "drugName": "DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATEANDA  #201998",
    "submission": "SUPPL-2",
    "activeIngredients": "DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE",
    "company": "CHARTWELL MOLECULAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/03/2025",
    "drugName": "FLUOCINOLONE ACETONIDEANDA  #202847",
    "submission": "SUPPL-13",
    "activeIngredients": "FLUOCINOLONE ACETONIDE",
    "company": "PADAGIS ISRAEL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/03/2025",
    "drugName": "LAMOTRIGINEANDA  #204499",
    "submission": "SUPPL-2",
    "activeIngredients": "LAMOTRIGINE",
    "company": "IPCA LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/03/2025",
    "drugName": "PALIPERIDONEANDA  #204707",
    "submission": "SUPPL-20",
    "activeIngredients": "PALIPERIDONE",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/03/2025",
    "drugName": "LACOSAMIDEANDA  #205237",
    "submission": "SUPPL-4",
    "activeIngredients": "LACOSAMIDE",
    "company": "SCIEGEN PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/03/2025",
    "drugName": "LACOSAMIDEANDA  #205237",
    "submission": "SUPPL-9",
    "activeIngredients": "LACOSAMIDE",
    "company": "SCIEGEN PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/03/2025",
    "drugName": "IMIQUIMODANDA  #205971",
    "submission": "SUPPL-5",
    "activeIngredients": "IMIQUIMOD",
    "company": "TARO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/03/2025",
    "drugName": "TRAMADOL HYDROCHLORIDEANDA  #208708",
    "submission": "SUPPL-21",
    "activeIngredients": "TRAMADOL HYDROCHLORIDE",
    "company": "RUBICON RESEARCH",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/03/2025",
    "drugName": "OLANZAPINEANDA  #210968",
    "submission": "SUPPL-4",
    "activeIngredients": "OLANZAPINE",
    "company": "EUGIA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/03/2025",
    "drugName": "QUETIAPINE FUMARATEANDA  #211405",
    "submission": "SUPPL-8",
    "activeIngredients": "QUETIAPINE FUMARATE",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/03/2025",
    "drugName": "SAPROPTERIN DIHYDROCHLORIDEANDA  #216432",
    "submission": "ORIG-1",
    "activeIngredients": "SAPROPTERIN DIHYDROCHLORIDE",
    "company": "HOPEWELL PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/03/2025",
    "drugName": "ZIPRASIDONE MESYLATEANDA  #217595",
    "submission": "ORIG-1",
    "activeIngredients": "ZIPRASIDONE MESYLATE",
    "company": "STERISCIENCE",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/03/2025",
    "drugName": "VIGAFYDENDA   #217684",
    "submission": "SUPPL-2",
    "activeIngredients": "VIGABATRIN",
    "company": "PYROS PHARMS",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/03/2025",
    "drugName": "VIGAFYDENDA   #217684",
    "submission": "SUPPL-4",
    "activeIngredients": "VIGABATRIN",
    "company": "PYROS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/03/2025",
    "drugName": "SKYRIZIBLA   #761105",
    "submission": "SUPPL-39",
    "activeIngredients": "RISANKIZUMAB-RZAA",
    "company": "ABBVIE INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/03/2025",
    "drugName": "RYBREVANTBLA   #761210",
    "submission": "SUPPL-8",
    "activeIngredients": "AMIVANTAMAB-VMJW",
    "company": "JANSSEN BIOTECH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/03/2025",
    "drugName": "SKYRIZIBLA   #761262",
    "submission": "SUPPL-11",
    "activeIngredients": "RISANKIZUMAB-RZAA",
    "company": "ABBVIE INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/04/2025",
    "drugName": "SELEGILINE HYDROCHLORIDEANDA  #074565",
    "submission": "SUPPL-8",
    "activeIngredients": "SELEGILINE HYDROCHLORIDE",
    "company": "CHARTWELL MOLECULES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/04/2025",
    "drugName": "HEPZATONDA   #201848",
    "submission": "SUPPL-15",
    "activeIngredients": "MELPHALAN HYDROCHLORIDE",
    "company": "DELCATH SYSTEMS INC",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/04/2025",
    "drugName": "TACROLIMUSANDA  #215012",
    "submission": "SUPPL-1",
    "activeIngredients": "TACROLIMUS",
    "company": "CHENGDU",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/04/2025",
    "drugName": "PALIPERIDONEANDA  #218755",
    "submission": "ORIG-1",
    "activeIngredients": "PALIPERIDONE",
    "company": "ESKAYEF",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/04/2025",
    "drugName": "PAZOPANIB HYDROCHLORIDEANDA  #219922",
    "submission": "ORIG-1",
    "activeIngredients": "PAZOPANIB HYDROCHLORIDE",
    "company": "TORRENT",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/05/2025",
    "drugName": "GATTEX KITNDA   #203441",
    "submission": "SUPPL-24",
    "activeIngredients": "TEDUGLUTIDE",
    "company": "TAKEDA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/05/2025",
    "drugName": "DOXYCYCLINEANDA  #210381",
    "submission": "SUPPL-2",
    "activeIngredients": "DOXYCYCLINE",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/05/2025",
    "drugName": "MACITENTANANDA  #211198",
    "submission": "SUPPL-5",
    "activeIngredients": "MACITENTAN",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/05/2025",
    "drugName": "MACITENTANANDA  #211198",
    "submission": "SUPPL-6",
    "activeIngredients": "MACITENTAN",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/05/2025",
    "drugName": "GABAPENTINANDA  #211313",
    "submission": "SUPPL-2",
    "activeIngredients": "GABAPENTIN",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/05/2025",
    "drugName": "GABAPENTINANDA  #211313",
    "submission": "SUPPL-4",
    "activeIngredients": "GABAPENTIN",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/05/2025",
    "drugName": "DAPAGLIFLOZIN AND SAXAGLIPTINANDA  #211533",
    "submission": "ORIG-1",
    "activeIngredients": "DAPAGLIFLOZIN; SAXAGLIPTIN",
    "company": "MSN LABS PVT LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "09/05/2025",
    "drugName": "DOXYCYCLINEANDA  #216631",
    "submission": "SUPPL-1",
    "activeIngredients": "DOXYCYCLINE",
    "company": "LUPIN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/05/2025",
    "drugName": "SUSVIMOBLA   #761197",
    "submission": "SUPPL-8",
    "activeIngredients": "RANIBIZUMAB",
    "company": "GENENTECH INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/08/2025",
    "drugName": "FUROSEMIDEANDA  #203428",
    "submission": "SUPPL-31",
    "activeIngredients": "FUROSEMIDE",
    "company": "AVET LIFESCIENCES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/08/2025",
    "drugName": "OXCARBAZEPINEANDA  #212428",
    "submission": "SUPPL-4",
    "activeIngredients": "OXCARBAZEPINE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/08/2025",
    "drugName": "OXCARBAZEPINEANDA  #212428",
    "submission": "SUPPL-5",
    "activeIngredients": "OXCARBAZEPINE",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/08/2025",
    "drugName": "DEFERASIROXANDA  #215137",
    "submission": "ORIG-1",
    "activeIngredients": "DEFERASIROX",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/08/2025",
    "drugName": "PHYTONADIONEANDA  #216444",
    "submission": "ORIG-1",
    "activeIngredients": "PHYTONADIONE",
    "company": "ALEMBIC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/08/2025",
    "drugName": "PROCHLORPERAZINE MALEATEANDA  #218734",
    "submission": "ORIG-1",
    "activeIngredients": "PROCHLORPERAZINE MALEATE",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/09/2025",
    "drugName": "CLINDAMYCIN HYDROCHLORIDEANDA  #065243",
    "submission": "SUPPL-24",
    "activeIngredients": "CLINDAMYCIN HYDROCHLORIDE",
    "company": "CHARTWELL MOLECULAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/09/2025",
    "drugName": "CLINDAMYCIN HYDROCHLORIDEANDA  #065243",
    "submission": "SUPPL-28",
    "activeIngredients": "CLINDAMYCIN HYDROCHLORIDE",
    "company": "CHARTWELL MOLECULAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/09/2025",
    "drugName": "CLINDAMYCIN HYDROCHLORIDEANDA  #065243",
    "submission": "SUPPL-29",
    "activeIngredients": "CLINDAMYCIN HYDROCHLORIDE",
    "company": "CHARTWELL MOLECULAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/09/2025",
    "drugName": "ONDANSETRON HYDROCHLORIDEANDA  #077535",
    "submission": "SUPPL-21",
    "activeIngredients": "ONDANSETRON HYDROCHLORIDE",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/09/2025",
    "drugName": "ONDANSETRONANDA  #078152",
    "submission": "SUPPL-22",
    "activeIngredients": "ONDANSETRON",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/09/2025",
    "drugName": "SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSEANDA  #078215",
    "submission": "SUPPL-9",
    "activeIngredients": "SODIUM FERRIC GLUCONATE COMPLEX",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/09/2025",
    "drugName": "SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSEANDA  #078215",
    "submission": "SUPPL-11",
    "activeIngredients": "SODIUM FERRIC GLUCONATE COMPLEX",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/09/2025",
    "drugName": "SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSEANDA  #078215",
    "submission": "SUPPL-14",
    "activeIngredients": "SODIUM FERRIC GLUCONATE COMPLEX",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/09/2025",
    "drugName": "LOSARTAN POTASSIUMANDA  #078243",
    "submission": "SUPPL-45",
    "activeIngredients": "LOSARTAN POTASSIUM",
    "company": "ZYDUS PHARMS USA INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/09/2025",
    "drugName": "LOSARTAN POTASSIUMANDA  #090083",
    "submission": "SUPPL-36",
    "activeIngredients": "LOSARTAN POTASSIUM",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/09/2025",
    "drugName": "ZOLYMBUSNDA   #217307",
    "submission": "ORIG-1",
    "activeIngredients": "BIMATOPROST",
    "company": "THEA PHARMA",
    "submissionClassification": "Type 3 - New Dosage Form",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/09/2025",
    "drugName": "LOSARTAN POTASSIUMANDA  #217396",
    "submission": "SUPPL-5",
    "activeIngredients": "LOSARTAN POTASSIUM",
    "company": "MSN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/09/2025",
    "drugName": "LOSARTAN POTASSIUMANDA  #218551",
    "submission": "SUPPL-1",
    "activeIngredients": "LOSARTAN POTASSIUM",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/09/2025",
    "drugName": "IVERMECTINANDA  #218805",
    "submission": "ORIG-1",
    "activeIngredients": "IVERMECTIN",
    "company": "EPIC PHARMA LLC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/09/2025",
    "drugName": "INLEXZONDA   #219683",
    "submission": "ORIG-1",
    "activeIngredients": "GEMCITABINE HYDROCHLORIDE",
    "company": "JANSSEN BIOTECH",
    "submissionClassification": "Type 3 - New Dosage Form",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/09/2025",
    "drugName": "TOFACITINIBANDA  #219885",
    "submission": "ORIG-1",
    "activeIngredients": "TOFACITINIB",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "09/09/2025",
    "drugName": "TEPEZZABLA   #761143",
    "submission": "SUPPL-30",
    "activeIngredients": "TEPROTUMUMAB-TRBW",
    "company": "HORIZON THERAPEUTICS IRELAND",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/10/2025",
    "drugName": "LUPRON DEPOTNDA   #019943",
    "submission": "SUPPL-40",
    "activeIngredients": "LEUPROLIDE ACETATE",
    "company": "ABBVIE ENDOCRINE INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/10/2025",
    "drugName": "LUPRON DEPOTNDA   #019943",
    "submission": "SUPPL-41",
    "activeIngredients": "LEUPROLIDE ACETATE",
    "company": "ABBVIE ENDOCRINE INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/10/2025",
    "drugName": "LUPRON DEPOTNDA   #020011",
    "submission": "SUPPL-47",
    "activeIngredients": "LEUPROLIDE ACETATE",
    "company": "ABBVIE ENDOCRINE INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/10/2025",
    "drugName": "LUPRON DEPOTNDA   #020011",
    "submission": "SUPPL-48",
    "activeIngredients": "LEUPROLIDE ACETATE",
    "company": "ABBVIE ENDOCRINE INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/10/2025",
    "drugName": "RETIN-A MICRONDA   #020475",
    "submission": "SUPPL-29",
    "activeIngredients": "TRETINOIN",
    "company": "BAUSCH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/10/2025",
    "drugName": "RETIN-A-MICRONDA   #020475",
    "submission": "SUPPL-29",
    "activeIngredients": "TRETINOIN",
    "company": "BAUSCH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/10/2025",
    "drugName": "LUPRON DEPOTNDA   #020708",
    "submission": "SUPPL-40",
    "activeIngredients": "LEUPROLIDE ACETATE",
    "company": "ABBVIE ENDOCRINE INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/10/2025",
    "drugName": "LUPRON DEPOTNDA   #020708",
    "submission": "SUPPL-41",
    "activeIngredients": "LEUPROLIDE ACETATE",
    "company": "ABBVIE ENDOCRINE INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/10/2025",
    "drugName": "SAVELLANDA   #022256",
    "submission": "SUPPL-31",
    "activeIngredients": "MILNACIPRAN HYDROCHLORIDE",
    "company": "ABBVIE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/10/2025",
    "drugName": "MEFENAMIC ACIDANDA  #091322",
    "submission": "SUPPL-5",
    "activeIngredients": "MEFENAMIC ACID",
    "company": "LUPIN LTD",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/10/2025",
    "drugName": "SODIUM OXYBATEANDA  #203631",
    "submission": "ORIG-1",
    "activeIngredients": "SODIUM OXYBATE",
    "company": "AMNEAL",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/10/2025",
    "drugName": "CABOMETYXNDA   #208692",
    "submission": "SUPPL-18",
    "activeIngredients": "CABOZANTINIB S-MALATE",
    "company": "EXELIXIS INC",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/10/2025",
    "drugName": "KOSELUGONDA   #213756",
    "submission": "SUPPL-5",
    "activeIngredients": "SELUMETINIB SULFATE",
    "company": "ASTRAZENECA",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/10/2025",
    "drugName": "POTASSIUM CHLORIDEANDA  #218733",
    "submission": "ORIG-1",
    "activeIngredients": "POTASSIUM CHLORIDE",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/10/2025",
    "drugName": "KOSELUGONDA   #219943",
    "submission": "ORIG-1",
    "activeIngredients": "SELUMETINIB",
    "company": "ASTRAZENECA",
    "submissionClassification": "Type 3 - New Dosage Form",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/10/2025",
    "drugName": "KOSELUGONDA   #219943",
    "submission": "ORIG-1",
    "activeIngredients": "SELUMETINIB SULFATE",
    "company": "ASTRAZENECA",
    "submissionClassification": "Type 3 - New Dosage Form",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/10/2025",
    "drugName": "OSENVELTBLA   #761404",
    "submission": "SUPPL-3",
    "activeIngredients": "DENOSUMAB-BMWO",
    "company": "CELLTRION INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/10/2025",
    "drugName": "STOBOCLOBLA   #761404",
    "submission": "SUPPL-3",
    "activeIngredients": "DENOSUMAB-BMWO",
    "company": "CELLTRION INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/11/2025",
    "drugName": "RILUTEKNDA   #020599",
    "submission": "SUPPL-21",
    "activeIngredients": "RILUZOLE",
    "company": "COVIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/11/2025",
    "drugName": "TERBINAFINE HYDROCHLORIDEANDA  #077533",
    "submission": "SUPPL-14",
    "activeIngredients": "TERBINAFINE HYDROCHLORIDE",
    "company": "INVAGEN PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/11/2025",
    "drugName": "TERBINAFINE HYDROCHLORIDEANDA  #077533",
    "submission": "SUPPL-17",
    "activeIngredients": "TERBINAFINE HYDROCHLORIDE",
    "company": "INVAGEN PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/11/2025",
    "drugName": "CLOPIDOGREL BISULFATEANDA  #077665",
    "submission": "SUPPL-15",
    "activeIngredients": "CLOPIDOGREL BISULFATE",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/11/2025",
    "drugName": "RISPERIDONEANDA  #077953",
    "submission": "SUPPL-17",
    "activeIngredients": "RISPERIDONE",
    "company": "APOTEX INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/11/2025",
    "drugName": "DILTIAZEM HYDROCHLORIDEANDA  #202463",
    "submission": "SUPPL-10",
    "activeIngredients": "DILTIAZEM HYDROCHLORIDE",
    "company": "ACTAVIS ELIZABETH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/11/2025",
    "drugName": "DILTIAZEM HYDROCHLORIDEANDA  #202463",
    "submission": "SUPPL-14",
    "activeIngredients": "DILTIAZEM HYDROCHLORIDE",
    "company": "ACTAVIS ELIZABETH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/11/2025",
    "drugName": "DILTIAZEM HYDROCHLORIDEANDA  #202463",
    "submission": "SUPPL-18",
    "activeIngredients": "DILTIAZEM HYDROCHLORIDE",
    "company": "ACTAVIS ELIZABETH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/11/2025",
    "drugName": "TIGLUTIK KITNDA   #209080",
    "submission": "SUPPL-5",
    "activeIngredients": "RILUZOLE",
    "company": "ITALFARMACO SA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/11/2025",
    "drugName": "ILLUCCIXNDA   #214032",
    "submission": "SUPPL-14",
    "activeIngredients": "GALLIUM GA-68 GOZETOTIDE",
    "company": "TELIX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/11/2025",
    "drugName": "LIRAGLUTIDEANDA  #217234",
    "submission": "ORIG-1",
    "activeIngredients": "LIRAGLUTIDE",
    "company": "ORBICULAR PHARMACEUTICAL TECHNOLOGIES PVT LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "09/11/2025",
    "drugName": "POTASSIUM PHOSPHATESANDA  #217459",
    "submission": "ORIG-1",
    "activeIngredients": "POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC",
    "company": "HOSPIRA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/11/2025",
    "drugName": "EPKINLYBLA   #761324",
    "submission": "SUPPL-8",
    "activeIngredients": "EPCORITAMAB-BYSP",
    "company": "GENMAB US, INC.",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/12/2025",
    "drugName": "PIROXICAMANDA  #074131",
    "submission": "SUPPL-32",
    "activeIngredients": "PIROXICAM",
    "company": "TEVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/12/2025",
    "drugName": "FUROSEMIDEANDA  #075241",
    "submission": "SUPPL-23",
    "activeIngredients": "FUROSEMIDE",
    "company": "HOSPIRA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/12/2025",
    "drugName": "GABAPENTINANDA  #075694",
    "submission": "SUPPL-57",
    "activeIngredients": "GABAPENTIN",
    "company": "ACTAVIS ELIZABETH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/12/2025",
    "drugName": "TERBINAFINE HYDROCHLORIDEANDA  #078163",
    "submission": "SUPPL-9",
    "activeIngredients": "TERBINAFINE HYDROCHLORIDE",
    "company": "ORBION PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/12/2025",
    "drugName": "TERBINAFINE HYDROCHLORIDEANDA  #078163",
    "submission": "SUPPL-10",
    "activeIngredients": "TERBINAFINE HYDROCHLORIDE",
    "company": "ORBION PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/12/2025",
    "drugName": "TERBINAFINE HYDROCHLORIDEANDA  #078163",
    "submission": "SUPPL-12",
    "activeIngredients": "TERBINAFINE HYDROCHLORIDE",
    "company": "ORBION PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/12/2025",
    "drugName": "OLMESARTAN MEDOXOMILANDA  #078276",
    "submission": "SUPPL-1",
    "activeIngredients": "OLMESARTAN MEDOXOMIL",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/12/2025",
    "drugName": "OLMESARTAN MEDOXOMILANDA  #078276",
    "submission": "SUPPL-3",
    "activeIngredients": "OLMESARTAN MEDOXOMIL",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/12/2025",
    "drugName": "QUETIAPINE FUMARATEANDA  #090120",
    "submission": "SUPPL-18",
    "activeIngredients": "QUETIAPINE FUMARATE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/12/2025",
    "drugName": "QUETIAPINE FUMARATEANDA  #090749",
    "submission": "SUPPL-17",
    "activeIngredients": "QUETIAPINE FUMARATE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/12/2025",
    "drugName": "JATENZONDA   #206089",
    "submission": "SUPPL-7",
    "activeIngredients": "TESTOSTERONE UNDECANOATE",
    "company": "TOLMAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/12/2025",
    "drugName": "HALOPERIDOL DECANOATEANDA  #214507",
    "submission": "SUPPL-5",
    "activeIngredients": "HALOPERIDOL DECANOATE",
    "company": "MEITHEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/12/2025",
    "drugName": "DOXYCYCLINEANDA  #217170",
    "submission": "SUPPL-1",
    "activeIngredients": "DOXYCYCLINE",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/12/2025",
    "drugName": "DOXYCYCLINEANDA  #217674",
    "submission": "SUPPL-3",
    "activeIngredients": "DOXYCYCLINE",
    "company": "ALEMBIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/12/2025",
    "drugName": "ENBUMYSTNDA   #219500",
    "submission": "ORIG-1",
    "activeIngredients": "BUMETANIDE",
    "company": "CORSTASIS THERAP",
    "submissionClassification": "Type 3 - New Dosage Form",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/15/2025",
    "drugName": "FLONASE SENSIMIST ALLERGY RELIEFNDA   #022051",
    "submission": "SUPPL-25",
    "activeIngredients": "FLUTICASONE FUROATE",
    "company": "HALEON US HOLDINGS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/15/2025",
    "drugName": "METOPROLOL TARTRATEANDA  #074217",
    "submission": "SUPPL-29",
    "activeIngredients": "METOPROLOL TARTRATE",
    "company": "WATSON LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/15/2025",
    "drugName": "ONDANSETRON HYDROCHLORIDEANDA  #076960",
    "submission": "SUPPL-11",
    "activeIngredients": "ONDANSETRON HYDROCHLORIDE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/15/2025",
    "drugName": "OLANZAPINEANDA  #077243",
    "submission": "SUPPL-13",
    "activeIngredients": "OLANZAPINE",
    "company": "BARR LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/15/2025",
    "drugName": "ONDANSETRON HYDROCHLORIDEANDA  #091483",
    "submission": "SUPPL-17",
    "activeIngredients": "ONDANSETRON HYDROCHLORIDE",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/15/2025",
    "drugName": "OLANZAPINEANDA  #202937",
    "submission": "SUPPL-5",
    "activeIngredients": "OLANZAPINE",
    "company": "ORBION PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/15/2025",
    "drugName": "MACITENTANANDA  #211187",
    "submission": "ORIG-1",
    "activeIngredients": "MACITENTAN",
    "company": "TEVA PHARMS USA INC",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "09/15/2025",
    "drugName": "DAPAGLIFLOZINANDA  #211468",
    "submission": "ORIG-1",
    "activeIngredients": "DAPAGLIFLOZIN",
    "company": "AUROBINDO PHARMA LIMITED",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "09/15/2025",
    "drugName": "AIRSUPRANDA   #214070",
    "submission": "SUPPL-1",
    "activeIngredients": "ALBUTEROL SULFATE; BUDESONIDE",
    "company": "ASTRAZENECA",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/15/2025",
    "drugName": "DICYCLOMINE HYDROCHLORIDEANDA  #216736",
    "submission": "SUPPL-3",
    "activeIngredients": "DICYCLOMINE HYDROCHLORIDE",
    "company": "RUBICON RESEARCH",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/15/2025",
    "drugName": "GLUCAGONANDA  #218813",
    "submission": "ORIG-1",
    "activeIngredients": "GLUCAGON",
    "company": "CIPLA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/15/2025",
    "drugName": "CYCLOSPORINEANDA  #219049",
    "submission": "ORIG-1",
    "activeIngredients": "CYCLOSPORINE",
    "company": "QILU",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/15/2025",
    "drugName": "COLESTIPOL HYDROCHLORIDEANDA  #220012",
    "submission": "ORIG-1",
    "activeIngredients": "COLESTIPOL HYDROCHLORIDE",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/16/2025",
    "drugName": "GABAPENTINANDA  #077894",
    "submission": "SUPPL-13",
    "activeIngredients": "GABAPENTIN",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/16/2025",
    "drugName": "CAFFEINE CITRATEANDA  #077997",
    "submission": "SUPPL-3",
    "activeIngredients": "CAFFEINE CITRATE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/16/2025",
    "drugName": "ROPINIROLE HYDROCHLORIDEANDA  #078110",
    "submission": "SUPPL-18",
    "activeIngredients": "ROPINIROLE HYDROCHLORIDE",
    "company": "PRINSTON INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/16/2025",
    "drugName": "ROPINIROLE HYDROCHLORIDEANDA  #078110",
    "submission": "SUPPL-20",
    "activeIngredients": "ROPINIROLE HYDROCHLORIDE",
    "company": "PRINSTON INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/16/2025",
    "drugName": "ROPINIROLE HYDROCHLORIDEANDA  #078110",
    "submission": "SUPPL-21",
    "activeIngredients": "ROPINIROLE HYDROCHLORIDE",
    "company": "PRINSTON INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/16/2025",
    "drugName": "BETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATEANDA  #090747",
    "submission": "SUPPL-10",
    "activeIngredients": "BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE",
    "company": "AM REGENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/16/2025",
    "drugName": "BETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATEANDA  #090747",
    "submission": "SUPPL-26",
    "activeIngredients": "BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE",
    "company": "AM REGENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/16/2025",
    "drugName": "FLUOCINOLONE ACETONIDEANDA  #090982",
    "submission": "SUPPL-2",
    "activeIngredients": "FLUOCINOLONE ACETONIDE",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/16/2025",
    "drugName": "IRBESARTANANDA  #091236",
    "submission": "SUPPL-29",
    "activeIngredients": "IRBESARTAN",
    "company": "ALEMBIC PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/16/2025",
    "drugName": "IRBESARTANANDA  #201531",
    "submission": "SUPPL-14",
    "activeIngredients": "IRBESARTAN",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/16/2025",
    "drugName": "GABAPENTINANDA  #202024",
    "submission": "SUPPL-19",
    "activeIngredients": "GABAPENTIN",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/16/2025",
    "drugName": "GABAPENTINANDA  #202024",
    "submission": "SUPPL-21",
    "activeIngredients": "GABAPENTIN",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/16/2025",
    "drugName": "IRBESARTANANDA  #203020",
    "submission": "SUPPL-5",
    "activeIngredients": "IRBESARTAN",
    "company": "UNICHEM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/16/2025",
    "drugName": "VORICONAZOLEANDA  #203503",
    "submission": "SUPPL-13",
    "activeIngredients": "VORICONAZOLE",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/16/2025",
    "drugName": "ONDANSETRON HYDROCHLORIDEANDA  #203711",
    "submission": "SUPPL-17",
    "activeIngredients": "ONDANSETRON HYDROCHLORIDE",
    "company": "QILU PHARM HAINAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/16/2025",
    "drugName": "NAPROXEN SODIUMANDA  #204872",
    "submission": "SUPPL-1",
    "activeIngredients": "NAPROXEN SODIUM",
    "company": "LNK INTL INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/16/2025",
    "drugName": "NAPROXEN SODIUMANDA  #204872",
    "submission": "SUPPL-2",
    "activeIngredients": "NAPROXEN SODIUM",
    "company": "LNK INTL INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/16/2025",
    "drugName": "NAPROXEN SODIUMANDA  #204872",
    "submission": "SUPPL-6",
    "activeIngredients": "NAPROXEN SODIUM",
    "company": "LNK INTL INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/16/2025",
    "drugName": "NAPROXEN SODIUMANDA  #204872",
    "submission": "SUPPL-8",
    "activeIngredients": "NAPROXEN SODIUM",
    "company": "LNK INTL INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/16/2025",
    "drugName": "FESOTERODINE FUMARATEANDA  #205012",
    "submission": "SUPPL-1",
    "activeIngredients": "FESOTERODINE FUMARATE",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/16/2025",
    "drugName": "FESOTERODINE FUMARATEANDA  #205012",
    "submission": "SUPPL-2",
    "activeIngredients": "FESOTERODINE FUMARATE",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/16/2025",
    "drugName": "FEBUXOSTATANDA  #205385",
    "submission": "SUPPL-3",
    "activeIngredients": "FEBUXOSTAT",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/16/2025",
    "drugName": "BUDESONIDEANDA  #205457",
    "submission": "SUPPL-11",
    "activeIngredients": "BUDESONIDE",
    "company": "ACTAVIS LABS FL INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/16/2025",
    "drugName": "GEMCITABINE HYDROCHLORIDEANDA  #206776",
    "submission": "SUPPL-5",
    "activeIngredients": "GEMCITABINE HYDROCHLORIDE",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/16/2025",
    "drugName": "IBRANCENDA   #207103",
    "submission": "SUPPL-23",
    "activeIngredients": "PALBOCICLIB",
    "company": "PFIZER",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/16/2025",
    "drugName": "LANSOPRAZOLEANDA  #207156",
    "submission": "SUPPL-5",
    "activeIngredients": "LANSOPRAZOLE",
    "company": "CHARTWELL MOLECULAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/16/2025",
    "drugName": "LANSOPRAZOLEANDA  #207156",
    "submission": "SUPPL-7",
    "activeIngredients": "LANSOPRAZOLE",
    "company": "CHARTWELL MOLECULAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/16/2025",
    "drugName": "LANSOPRAZOLEANDA  #207156",
    "submission": "SUPPL-8",
    "activeIngredients": "LANSOPRAZOLE",
    "company": "CHARTWELL MOLECULAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/16/2025",
    "drugName": "LANSOPRAZOLEANDA  #207156",
    "submission": "SUPPL-10",
    "activeIngredients": "LANSOPRAZOLE",
    "company": "CHARTWELL MOLECULAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/16/2025",
    "drugName": "METHYLPHENIDATE HYDROCHLORIDEANDA  #207416",
    "submission": "SUPPL-13",
    "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "company": "ASCENT PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/16/2025",
    "drugName": "METHYLPHENIDATE HYDROCHLORIDEANDA  #207416",
    "submission": "SUPPL-15",
    "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "company": "ASCENT PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/16/2025",
    "drugName": "ACETAZOLAMIDEANDA  #209734",
    "submission": "SUPPL-16",
    "activeIngredients": "ACETAZOLAMIDE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/16/2025",
    "drugName": "IRBESARTANANDA  #211056",
    "submission": "SUPPL-1",
    "activeIngredients": "IRBESARTAN",
    "company": "IPCA LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/16/2025",
    "drugName": "IBRANCENDA   #212436",
    "submission": "SUPPL-11",
    "activeIngredients": "PALBOCICLIB",
    "company": "PFIZER",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/16/2025",
    "drugName": "ACETAZOLAMIDEANDA  #214282",
    "submission": "SUPPL-19",
    "activeIngredients": "ACETAZOLAMIDE",
    "company": "MANKIND PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/16/2025",
    "drugName": "LENALIDOMIDEANDA  #214398",
    "submission": "ORIG-1",
    "activeIngredients": "LENALIDOMIDE",
    "company": "LUPIN LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/16/2025",
    "drugName": "OXCARBAZEPINEANDA  #215332",
    "submission": "SUPPL-5",
    "activeIngredients": "OXCARBAZEPINE",
    "company": "AUCTA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/16/2025",
    "drugName": "SUBVENITENDA   #218879",
    "submission": "ORIG-1",
    "activeIngredients": "LAMOTRIGINE",
    "company": "OWP PHARMS",
    "submissionClassification": "Type 3 - New Dosage Form",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/16/2025",
    "drugName": "OXCARBAZEPINEANDA  #219673",
    "submission": "ORIG-1",
    "activeIngredients": "OXCARBAZEPINE",
    "company": "WUHAN HUMANWELL LIKANG PHARMACEUTICAL CO. LTD.",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "09/16/2025",
    "drugName": "HYMPAVZIBLA   #761369",
    "submission": "SUPPL-1",
    "activeIngredients": "MARSTACIMAB-HNCQ",
    "company": "PFIZER INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/16/2025",
    "drugName": "AUKELSOBLA   #761436",
    "submission": "ORIG-1",
    "activeIngredients": "DENOSUMAB-KYQQ",
    "company": "BIOCON BIOLOGICS INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/16/2025",
    "drugName": "BOSAYABLA   #761436",
    "submission": "ORIG-1",
    "activeIngredients": "DENOSUMAB-KYQQ",
    "company": "BIOCON BIOLOGICS INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/17/2025",
    "drugName": "AMOXICILLINANDA  #065334",
    "submission": "SUPPL-26",
    "activeIngredients": "AMOXICILLIN",
    "company": "AUROBINDO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/17/2025",
    "drugName": "ZIPRASIDONE HYDROCHLORIDEANDA  #077561",
    "submission": "SUPPL-21",
    "activeIngredients": "ZIPRASIDONE HYDROCHLORIDE",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/17/2025",
    "drugName": "ZIPRASIDONE HYDROCHLORIDEANDA  #077561",
    "submission": "SUPPL-22",
    "activeIngredients": "ZIPRASIDONE HYDROCHLORIDE",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/17/2025",
    "drugName": "ZIPRASIDONE HYDROCHLORIDEANDA  #077565",
    "submission": "SUPPL-26",
    "activeIngredients": "ZIPRASIDONE HYDROCHLORIDE",
    "company": "DR REDDYS LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/17/2025",
    "drugName": "OXCARBAZEPINEANDA  #077802",
    "submission": "SUPPL-24",
    "activeIngredients": "OXCARBAZEPINE",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/17/2025",
    "drugName": "ZIDOVUDINEANDA  #077981",
    "submission": "SUPPL-32",
    "activeIngredients": "ZIDOVUDINE",
    "company": "CIPLA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/17/2025",
    "drugName": "ONDANSETRON HYDROCHLORIDEANDA  #078127",
    "submission": "SUPPL-11",
    "activeIngredients": "ONDANSETRON HYDROCHLORIDE",
    "company": "PHARM ASSOC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/17/2025",
    "drugName": "ONDANSETRON HYDROCHLORIDEANDA  #078127",
    "submission": "SUPPL-12",
    "activeIngredients": "ONDANSETRON HYDROCHLORIDE",
    "company": "PHARM ASSOC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/17/2025",
    "drugName": "GLYCOPYRROLATEANDA  #091182",
    "submission": "SUPPL-8",
    "activeIngredients": "GLYCOPYRROLATE",
    "company": "REGCON HOLDINGS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/17/2025",
    "drugName": "MYALEPTBLA   #125390",
    "submission": "SUPPL-29",
    "activeIngredients": "METRELEPTIN",
    "company": "CHIESI FARMACEUTICI SPA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/17/2025",
    "drugName": "MEROPENEMANDA  #205835",
    "submission": "SUPPL-16",
    "activeIngredients": "MEROPENEM",
    "company": "EUGIA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/17/2025",
    "drugName": "MEROPENEMANDA  #210773",
    "submission": "SUPPL-6",
    "activeIngredients": "MEROPENEM",
    "company": "HQ SPCLT PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/17/2025",
    "drugName": "MEROPENEMANDA  #210773",
    "submission": "SUPPL-8",
    "activeIngredients": "MEROPENEM",
    "company": "HQ SPCLT PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/17/2025",
    "drugName": "VENLAFAXINE HYDROCHLORIDEANDA  #214654",
    "submission": "SUPPL-22",
    "activeIngredients": "VENLAFAXINE HYDROCHLORIDE",
    "company": "YICHANG HUMANWELL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/17/2025",
    "drugName": "FULVESTRANTANDA  #214682",
    "submission": "SUPPL-7",
    "activeIngredients": "FULVESTRANT",
    "company": "JIANGSU HANSOH PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/17/2025",
    "drugName": "TOFACITINIBANDA  #215356",
    "submission": "ORIG-1",
    "activeIngredients": "TOFACITINIB",
    "company": "AUROBINDO PHARMA LIMITED",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "09/17/2025",
    "drugName": "PREGABALINANDA  #216197",
    "submission": "SUPPL-3",
    "activeIngredients": "PREGABALIN",
    "company": "ADAPTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/17/2025",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #216766",
    "submission": "SUPPL-3",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "YICHANG HUMANWELL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/17/2025",
    "drugName": "ABACAVIR, DOLUTEGRAVIR AND LAMIVUDINEANDA  #217830",
    "submission": "ORIG-1",
    "activeIngredients": "ABACAVIR, DOLUTEGRAVIR, LAMIVUDINE",
    "company": "MACLEODS PHARMACEUTICALS LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "09/17/2025",
    "drugName": "PHENYLEPHRINE HYDROCHLORIDEANDA  #218129",
    "submission": "SUPPL-1",
    "activeIngredients": "PHENYLEPHRINE HYDROCHLORIDE",
    "company": "GLAND",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/17/2025",
    "drugName": "KETAMINE HYDROCHLORIDEANDA  #219684",
    "submission": "ORIG-1",
    "activeIngredients": "KETAMINE HYDROCHLORIDE",
    "company": "BAXTER HLTHCARE CORP",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/17/2025",
    "drugName": "AMJEVITABLA   #761024",
    "submission": "SUPPL-22",
    "activeIngredients": "ADALIMUMAB-ATTO",
    "company": "AMGEN INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/17/2025",
    "drugName": "BKEMVBLA   #761333",
    "submission": "SUPPL-6",
    "activeIngredients": "ECULIZUMAB-AEEB",
    "company": "AMGEN INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/18/2025",
    "drugName": "ACULARNDA   #019700",
    "submission": "SUPPL-33",
    "activeIngredients": "KETOROLAC TROMETHAMINE",
    "company": "ABBVIE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/18/2025",
    "drugName": "ALPHAGANNDA   #020490",
    "submission": "SUPPL-10",
    "activeIngredients": "BRIMONIDINE TARTRATE",
    "company": "ALLERGAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/18/2025",
    "drugName": "OPTIVARNDA   #021127",
    "submission": "SUPPL-18",
    "activeIngredients": "AZELASTINE HYDROCHLORIDE",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/18/2025",
    "drugName": "ALPHAGAN PNDA   #021262",
    "submission": "SUPPL-28",
    "activeIngredients": "BRIMONIDINE TARTRATE",
    "company": "ABBVIE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/18/2025",
    "drugName": "ALPHAGAN PNDA   #021770",
    "submission": "SUPPL-14",
    "activeIngredients": "BRIMONIDINE TARTRATE",
    "company": "ABBVIE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/18/2025",
    "drugName": "ATROPINE SULFATENDA   #206289",
    "submission": "SUPPL-14",
    "activeIngredients": "ATROPINE SULFATE",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/18/2025",
    "drugName": "SUGAMMADEXANDA  #214319",
    "submission": "ORIG-1",
    "activeIngredients": "SUGAMMADEX",
    "company": "SUN PHARM INDS",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "09/18/2025",
    "drugName": "OPZELURANDA   #215309",
    "submission": "SUPPL-7",
    "activeIngredients": "RUXOLITINIB PHOSPHATE",
    "company": "INCYTE CORP",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/18/2025",
    "drugName": "VEVYENDA   #217469",
    "submission": "SUPPL-7",
    "activeIngredients": "CYCLOSPORINE",
    "company": "HARROW EYE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/18/2025",
    "drugName": "SODIUM ACETATEANDA  #219826",
    "submission": "ORIG-1",
    "activeIngredients": "SODIUM ACETATE",
    "company": "SOMERSET THERAPS LLC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/18/2025",
    "drugName": "ACAMPROSATE CALCIUMANDA  #219904",
    "submission": "ORIG-1",
    "activeIngredients": "ACAMPROSATE CALCIUM",
    "company": "BIONPHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/19/2025",
    "drugName": "LEUPROLIDE ACETATEANDA  #075471",
    "submission": "SUPPL-37",
    "activeIngredients": "LEUPROLIDE ACETATE",
    "company": "MEITHEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/19/2025",
    "drugName": "LEUPROLIDE ACETATEANDA  #075471",
    "submission": "SUPPL-38",
    "activeIngredients": "LEUPROLIDE ACETATE",
    "company": "MEITHEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/19/2025",
    "drugName": "PROPOFOLANDA  #077908",
    "submission": "SUPPL-36",
    "activeIngredients": "PROPOFOL",
    "company": "HOSPIRA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/19/2025",
    "drugName": "DIVALPROEX SODIUMANDA  #078597",
    "submission": "SUPPL-43",
    "activeIngredients": "DIVALPROEX SODIUM",
    "company": "SUN PHARM INDS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/19/2025",
    "drugName": "DIVALPROEX SODIUMANDA  #078597",
    "submission": "SUPPL-44",
    "activeIngredients": "DIVALPROEX SODIUM",
    "company": "SUN PHARM INDS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/19/2025",
    "drugName": "LEUPROLIDE ACETATEANDA  #078885",
    "submission": "SUPPL-32",
    "activeIngredients": "LEUPROLIDE ACETATE",
    "company": "SUN PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/19/2025",
    "drugName": "GABAPENTINANDA  #078926",
    "submission": "SUPPL-20",
    "activeIngredients": "GABAPENTIN",
    "company": "ZYDUS PHARMS USA INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/19/2025",
    "drugName": "DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATEANDA  #086727",
    "submission": "SUPPL-55",
    "activeIngredients": "ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE",
    "company": "ANI PHARMS",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/19/2025",
    "drugName": "METHADONE HYDROCHLORIDEANDA  #090707",
    "submission": "SUPPL-31",
    "activeIngredients": "METHADONE HYDROCHLORIDE",
    "company": "VISTAPHARM LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/19/2025",
    "drugName": "AMBRISENTANANDA  #210701",
    "submission": "SUPPL-3",
    "activeIngredients": "AMBRISENTAN",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/19/2025",
    "drugName": "VERAPAMIL HYDROCHLORIDEANDA  #210994",
    "submission": "SUPPL-6",
    "activeIngredients": "VERAPAMIL HYDROCHLORIDE",
    "company": "AMNEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/19/2025",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #211347",
    "submission": "SUPPL-11",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "YICHANG HUMANWELL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/19/2025",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #211347",
    "submission": "SUPPL-13",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "YICHANG HUMANWELL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/19/2025",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #211347",
    "submission": "SUPPL-15",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "YICHANG HUMANWELL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/19/2025",
    "drugName": "FORZINITYNDA   #215244",
    "submission": "ORIG-1",
    "activeIngredients": "ELAMIPRETIDE HYDROCHLORIDE",
    "company": "STEALTH BIOTHERAPS",
    "submissionClassification": "Type 1 - New Molecular Entity",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/19/2025",
    "drugName": "PROGESTERONEANDA  #218391",
    "submission": "ORIG-1",
    "activeIngredients": "PROGESTERONE",
    "company": "XIROMED",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/19/2025",
    "drugName": "GABAPENTINANDA  #218491",
    "submission": "ORIG-1",
    "activeIngredients": "GABAPENTIN",
    "company": "SCIEGEN PHARMS INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/19/2025",
    "drugName": "LOSARTAN POTASSIUMANDA  #219859",
    "submission": "ORIG-1",
    "activeIngredients": "LOSARTAN POTASSIUM",
    "company": "GRAVITI PHARMS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/19/2025",
    "drugName": "LOPERAMIDE HYDROCHLORIDEANDA  #220100",
    "submission": "ORIG-1",
    "activeIngredients": "LOPERAMIDE HYDROCHLORIDE",
    "company": "BIONPHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/19/2025",
    "drugName": "TREMFYABLA   #761061",
    "submission": "SUPPL-26",
    "activeIngredients": "GUSELKUMAB",
    "company": "JANSSEN BIOTECH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/19/2025",
    "drugName": "KEYTRUDA QLEXBLA   #761467",
    "submission": "ORIG-1",
    "activeIngredients": "PEMBROLIZUMAB;BERAHYALURONIDASE ALFA-PMPH",
    "company": "MERCK SHARP DOHME",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/19/2025",
    "drugName": "KEYTRUDA QLEXBLA   #761467",
    "submission": "ORIG-2",
    "activeIngredients": "PEMBROLIZUMAB;BERAHYALURONIDASE ALFA-PMPH",
    "company": "MERCK SHARP DOHME",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/22/2025",
    "drugName": "IRON SUCROSEANDA  #212340",
    "submission": "SUPPL-1",
    "activeIngredients": "IRON SUCROSE",
    "company": "SANDOZ",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/22/2025",
    "drugName": "BIMATOPROSTANDA  #217289",
    "submission": "ORIG-1",
    "activeIngredients": "BIMATOPROST",
    "company": "AMNEAL",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/22/2025",
    "drugName": "SHEURANDA  #217650",
    "submission": "ORIG-1",
    "activeIngredients": "ELAGOLIX, ESTRADIOL AND NORETHINDRONE ACETATE AND ELAGOLIX",
    "company": "TEVA PHARM",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "09/22/2025",
    "drugName": "DOXYCYCLINEANDA  #218034",
    "submission": "SUPPL-1",
    "activeIngredients": "DOXYCYCLINE",
    "company": "DR REDDYS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "DEXEDRINE SPANSULENDA   #017078",
    "submission": "SUPPL-59",
    "activeIngredients": "DEXTROAMPHETAMINE SULFATE",
    "company": "IMPAX LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "LUPRONNDA   #019010",
    "submission": "SUPPL-43",
    "activeIngredients": "LEUPROLIDE ACETATE",
    "company": "ABBVIE ENDOCRINE INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "FLAREXNDA   #019079",
    "submission": "SUPPL-41",
    "activeIngredients": "FLUOROMETHOLONE ACETATE",
    "company": "HARROW EYE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "ZOLADEXNDA   #019726",
    "submission": "SUPPL-74",
    "activeIngredients": "GOSERELIN ACETATE",
    "company": "TERSERA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "LUPRON DEPOT-PED KITNDA   #020263",
    "submission": "SUPPL-58",
    "activeIngredients": "LEUPROLIDE ACETATE",
    "company": "ABBVIE ENDOCRINE INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "ZOLADEXNDA   #020515",
    "submission": "SUPPL-11",
    "activeIngredients": "GOSERELIN",
    "company": "TERSERA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "ZOLADEXNDA   #020578",
    "submission": "SUPPL-51",
    "activeIngredients": "GOSERELIN ACETATE",
    "company": "TERSERA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "TRELSTARNDA   #020715",
    "submission": "SUPPL-51",
    "activeIngredients": "TRIPTORELIN PAMOATE",
    "company": "VERITY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "TRILEPTALNDA   #021014",
    "submission": "SUPPL-49",
    "activeIngredients": "OXCARBAZEPINE",
    "company": "NOVARTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "CONCERTANDA   #021121",
    "submission": "SUPPL-53",
    "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "company": "JANSSEN PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "METADATE CDNDA   #021259",
    "submission": "SUPPL-36",
    "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "company": "AYTU BIOPHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "RITALIN LANDA   #021284",
    "submission": "SUPPL-50",
    "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "TRILEPTALNDA   #021285",
    "submission": "SUPPL-41",
    "activeIngredients": "OXCARBAZEPINE",
    "company": "NOVARTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "TRELSTARNDA   #021288",
    "submission": "SUPPL-46",
    "activeIngredients": "TRIPTORELIN PAMOATE",
    "company": "VERITY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "ADDERALL XR 10NDA   #021303",
    "submission": "SUPPL-42",
    "activeIngredients": "AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE",
    "company": "TAKEDA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "ADDERALL XR 15NDA   #021303",
    "submission": "SUPPL-42",
    "activeIngredients": "AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE",
    "company": "TAKEDA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "ADDERALL XR 20NDA   #021303",
    "submission": "SUPPL-42",
    "activeIngredients": "AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE",
    "company": "TAKEDA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "ADDERALL XR 25NDA   #021303",
    "submission": "SUPPL-42",
    "activeIngredients": "AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE",
    "company": "TAKEDA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "ADDERALL XR 30NDA   #021303",
    "submission": "SUPPL-42",
    "activeIngredients": "AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE",
    "company": "TAKEDA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "ADDERALL XR 5NDA   #021303",
    "submission": "SUPPL-42",
    "activeIngredients": "AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE",
    "company": "TAKEDA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "DAYTRANANDA   #021514",
    "submission": "SUPPL-43",
    "activeIngredients": "METHYLPHENIDATE",
    "company": "NOVEN PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "VANTASNDA   #021732",
    "submission": "SUPPL-25",
    "activeIngredients": "HISTRELIN ACETATE",
    "company": "ENDO OPERATIONS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "FOCALIN XRNDA   #021802",
    "submission": "SUPPL-45",
    "activeIngredients": "DEXMETHYLPHENIDATE HYDROCHLORIDE",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "VYVANSENDA   #021977",
    "submission": "SUPPL-54",
    "activeIngredients": "LISDEXAMFETAMINE DIMESYLATE",
    "company": "TAKEDA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "SUPPRELIN LANDA   #022058",
    "submission": "SUPPL-20",
    "activeIngredients": "HISTRELIN ACETATE",
    "company": "ENDO OPERATIONS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "CAPRELSANDA   #022405",
    "submission": "SUPPL-25",
    "activeIngredients": "VANDETANIB",
    "company": "GENZYME CORP",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "TRELSTARNDA   #022437",
    "submission": "SUPPL-26",
    "activeIngredients": "TRIPTORELIN PAMOATE",
    "company": "VERITY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "AZITHROMYCINANDA  #065488",
    "submission": "SUPPL-8",
    "activeIngredients": "AZITHROMYCIN",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "LEUPROLIDE ACETATEANDA  #074728",
    "submission": "SUPPL-34",
    "activeIngredients": "LEUPROLIDE ACETATE",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "METHYLPHENIDATE HYDROCHLORIDEANDA  #075450",
    "submission": "SUPPL-9",
    "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "company": "HERITAGE PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "LEUPROLIDE ACETATEANDA  #075471",
    "submission": "SUPPL-45",
    "activeIngredients": "LEUPROLIDE ACETATE",
    "company": "MEITHEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "LEUPROLIDE ACETATEANDA  #078885",
    "submission": "SUPPL-39",
    "activeIngredients": "LEUPROLIDE ACETATE",
    "company": "SUN PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "PRIMIDONEANDA  #083551",
    "submission": "SUPPL-51",
    "activeIngredients": "PRIMIDONE",
    "company": "WATSON LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "CIMZIABLA   #125160",
    "submission": "SUPPL-315",
    "activeIngredients": "CERTOLIZUMAB PEGOL",
    "company": "UCB INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "QUILLIVANT XRNDA   #202100",
    "submission": "SUPPL-24",
    "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "company": "NEXTWAVE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "ADZENYS XR-ODTNDA   #204326",
    "submission": "SUPPL-20",
    "activeIngredients": "AMPHETAMINE",
    "company": "NEOS THERAPS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "METHYLPHENIDATE HYDROCHLORIDEANDA  #204772",
    "submission": "SUPPL-9",
    "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "company": "ALVOGEN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "COTEMPLA XR-ODTNDA   #205489",
    "submission": "SUPPL-21",
    "activeIngredients": "METHYLPHENIDATE",
    "company": "NEOS THERAPS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "APTENSIO XRNDA   #205831",
    "submission": "SUPPL-12",
    "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "company": "RHODES PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "METHYLPHENIDATE HYDROCHLORIDEANDA  #207488",
    "submission": "SUPPL-18",
    "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "company": "ABHAI LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "QUILLICHEW ERNDA   #207960",
    "submission": "SUPPL-18",
    "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "company": "NEXTWAVE PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "DYANAVEL XRNDA   #208147",
    "submission": "SUPPL-18",
    "activeIngredients": "AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE",
    "company": "TRIS PHARMA INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "ALVIMOPANANDA  #208295",
    "submission": "SUPPL-5",
    "activeIngredients": "ALVIMOPAN",
    "company": "WATSON LABS TEVA",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "VYVANSENDA   #208510",
    "submission": "SUPPL-11",
    "activeIngredients": "LISDEXAMFETAMINE DIMESYLATE",
    "company": "TAKEDA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "TRIPTODUR KITNDA   #208956",
    "submission": "SUPPL-14",
    "activeIngredients": "TRIPTORELIN PAMOATE",
    "company": "AZURITY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "JORNAY PMNDA   #209311",
    "submission": "SUPPL-13",
    "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "company": "IRONSHORE PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "DYANAVEL XR 10NDA   #210526",
    "submission": "SUPPL-10",
    "activeIngredients": "AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE",
    "company": "TRIS PHARMA INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "DYANAVEL XR 15NDA   #210526",
    "submission": "SUPPL-10",
    "activeIngredients": "AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE",
    "company": "TRIS PHARMA INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "DYANAVEL XR 20NDA   #210526",
    "submission": "SUPPL-10",
    "activeIngredients": "AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE",
    "company": "TRIS PHARMA INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "DYANAVEL XR 5NDA   #210526",
    "submission": "SUPPL-10",
    "activeIngredients": "AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE",
    "company": "TRIS PHARMA INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "CAMCEVI KITNDA   #211488",
    "submission": "SUPPL-10",
    "activeIngredients": "LEUPROLIDE MESYLATE",
    "company": "ACCORD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "METHYLPHENIDATE HYDROCHLORIDEANDA  #212288",
    "submission": "SUPPL-4",
    "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "LEUPROLIDE ACETATEANDA  #212963",
    "submission": "SUPPL-2",
    "activeIngredients": "LEUPROLIDE ACETATE",
    "company": "EUGIA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "AZSTARYSNDA   #212994",
    "submission": "SUPPL-12",
    "activeIngredients": "DEXMETHYLPHENIDATE HYDROCHLORIDE; SERDEXMETHYLPHENIDATE CHLORIDE",
    "company": "COMMAVE THERAP",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "FENSOLVI KITNDA   #213150",
    "submission": "SUPPL-11",
    "activeIngredients": "LEUPROLIDE ACETATE",
    "company": "TOLMAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "LEUPROLIDE ACETATEANDA  #213829",
    "submission": "SUPPL-4",
    "activeIngredients": "LEUPROLIDE ACETATE",
    "company": "RK PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "LEUPROLIDE ACETATEANDA  #215336",
    "submission": "SUPPL-9",
    "activeIngredients": "LEUPROLIDE ACETATE",
    "company": "AMNEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "XELSTRYMNDA   #215401",
    "submission": "SUPPL-15",
    "activeIngredients": "DEXTROAMPHETAMINE",
    "company": "NOVEN PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "RIVASTIGMINEANDA  #215445",
    "submission": "ORIG-1",
    "activeIngredients": "RIVASTIGMINE",
    "company": "YICHANG HUMANWELL",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "RELEXXIINDA   #216117",
    "submission": "SUPPL-3",
    "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "company": "OSMOTICA PHARM US",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "ALVIMOPANANDA  #216843",
    "submission": "SUPPL-3",
    "activeIngredients": "ALVIMOPAN",
    "company": "PH HEALTH",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "ALVIMOPANANDA  #217753",
    "submission": "SUPPL-1",
    "activeIngredients": "ALVIMOPAN",
    "company": "HIKMA",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "LABETALOL HYDROCHLORIDEANDA  #217949",
    "submission": "ORIG-1",
    "activeIngredients": "LABETALOL HYDROCHLORIDE",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "LEUPROLIDE ACETATEANDA  #217957",
    "submission": "SUPPL-2",
    "activeIngredients": "LEUPROLIDE ACETATE",
    "company": "UBI",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/23/2025",
    "drugName": "ERYTHROMYCINANDA  #219691",
    "submission": "ORIG-1",
    "activeIngredients": "ERYTHROMYCIN",
    "company": "ABON PHARMS LLC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/24/2025",
    "drugName": "OPILLNDA   #017031",
    "submission": "SUPPL-44",
    "activeIngredients": "NORGESTREL",
    "company": "LABORATOIRE HRA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/24/2025",
    "drugName": "HEPARIN SODIUMNDA   #201370",
    "submission": "SUPPL-22",
    "activeIngredients": "HEPARIN SODIUM",
    "company": "PFIZER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/24/2025",
    "drugName": "HEPARIN SODIUM PRESERVATIVE FREENDA   #201370",
    "submission": "SUPPL-22",
    "activeIngredients": "HEPARIN SODIUM",
    "company": "PFIZER",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/24/2025",
    "drugName": "TIZANIDINE HYDROCHLORIDEANDA  #213223",
    "submission": "SUPPL-11",
    "activeIngredients": "TIZANIDINE HYDROCHLORIDE",
    "company": "ALEMBIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/24/2025",
    "drugName": "BONDLIDONDA   #215029",
    "submission": "ORIG-1",
    "activeIngredients": "LIDOCAINE",
    "company": "MEDRX USA",
    "submissionClassification": "Type 5 - New Formulation or New Manufacturer",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/24/2025",
    "drugName": "PAROXETINE HYDROCHLORIDEANDA  #217280",
    "submission": "ORIG-1",
    "activeIngredients": "PAROXETINE HYDROCHLORIDE",
    "company": "ALEMBIC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/24/2025",
    "drugName": "VARENICLINE TARTRATEANDA  #217283",
    "submission": "SUPPL-3",
    "activeIngredients": "VARENICLINE TARTRATE",
    "company": "NE RX PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/24/2025",
    "drugName": "MIRABEGRONANDA  #218172",
    "submission": "ORIG-1",
    "activeIngredients": "MIRABEGRON",
    "company": "ASCENT PHARMS INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/25/2025",
    "drugName": "FENTANYL CITRATENDA   #019101",
    "submission": "SUPPL-72",
    "activeIngredients": "FENTANYL CITRATE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/25/2025",
    "drugName": "CEFUROXIME AXETILANDA  #065166",
    "submission": "SUPPL-3",
    "activeIngredients": "CEFUROXIME AXETIL",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/25/2025",
    "drugName": "CEFUROXIME AXETILANDA  #065166",
    "submission": "SUPPL-4",
    "activeIngredients": "CEFUROXIME AXETIL",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/25/2025",
    "drugName": "CEFUROXIME AXETILANDA  #065166",
    "submission": "SUPPL-6",
    "activeIngredients": "CEFUROXIME AXETIL",
    "company": "CHARTWELL RX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/25/2025",
    "drugName": "OXYCODONE HYDROCHLORIDEANDA  #202773",
    "submission": "SUPPL-1",
    "activeIngredients": "OXYCODONE HYDROCHLORIDE",
    "company": "AVANTHI INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/25/2025",
    "drugName": "OXYCODONE HYDROCHLORIDEANDA  #202773",
    "submission": "SUPPL-11",
    "activeIngredients": "OXYCODONE HYDROCHLORIDE",
    "company": "AVANTHI INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/25/2025",
    "drugName": "KALYDECONDA   #203188",
    "submission": "SUPPL-42",
    "activeIngredients": "IVACAFTOR",
    "company": "VERTEX PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/25/2025",
    "drugName": "ORKAMBINDA   #206038",
    "submission": "SUPPL-19",
    "activeIngredients": "IVACAFTOR; LUMACAFTOR",
    "company": "VERTEX PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/25/2025",
    "drugName": "KALYDECONDA   #207925",
    "submission": "SUPPL-20",
    "activeIngredients": "IVACAFTOR",
    "company": "VERTEX PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/25/2025",
    "drugName": "SYMDEKO (COPACKAGED)NDA   #210491",
    "submission": "SUPPL-13",
    "activeIngredients": "IVACAFTOR; IVACAFTOR, TEZACAFTOR",
    "company": "VERTEX PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/25/2025",
    "drugName": "ORKAMBINDA   #211358",
    "submission": "SUPPL-7",
    "activeIngredients": "IVACAFTOR; LUMACAFTOR",
    "company": "VERTEX PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/25/2025",
    "drugName": "TRIKAFTA (COPACKAGED)NDA   #212273",
    "submission": "SUPPL-15",
    "activeIngredients": "ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR",
    "company": "VERTEX PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/25/2025",
    "drugName": "MOUNJARONDA   #215866",
    "submission": "SUPPL-34",
    "activeIngredients": "TIRZEPATIDE",
    "company": "ELI LILLY AND CO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/25/2025",
    "drugName": "MOUNJARO (AUTOINJECTOR)NDA   #215866",
    "submission": "SUPPL-34",
    "activeIngredients": "TIRZEPATIDE",
    "company": "ELI LILLY AND CO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/25/2025",
    "drugName": "TRIKAFTA (COPACKAGED)NDA   #217660",
    "submission": "SUPPL-9",
    "activeIngredients": "ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR",
    "company": "VERTEX PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/25/2025",
    "drugName": "ZEPBOUNDNDA   #217806",
    "submission": "SUPPL-31",
    "activeIngredients": "TIRZEPATIDE",
    "company": "ELI LILLY AND CO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/25/2025",
    "drugName": "ZEPBOUND (AUTOINJECTOR)NDA   #217806",
    "submission": "SUPPL-31",
    "activeIngredients": "TIRZEPATIDE",
    "company": "ELI LILLY AND CO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/25/2025",
    "drugName": "RIVAROXABANANDA  #218195",
    "submission": "ORIG-1",
    "activeIngredients": "RIVAROXABAN",
    "company": "LUPIN LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/25/2025",
    "drugName": "ALYFTREKNDA   #218730",
    "submission": "SUPPL-2",
    "activeIngredients": "DEUTIVACAFTOR; TEZACAFTOR; VANZACAFTOR CALCIUM",
    "company": "VERTEX PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/25/2025",
    "drugName": "INLURIYONDA   #218881",
    "submission": "ORIG-1",
    "activeIngredients": "IMLUNESTRANT TOSYLATE",
    "company": "ELI LILLY AND CO",
    "submissionClassification": "Type 1 - New Molecular Entity",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/25/2025",
    "drugName": "PALSONIFYNDA   #219070",
    "submission": "ORIG-1",
    "activeIngredients": "PALTUSOTINE HYDROCHLORIDE",
    "company": "CRINETICS",
    "submissionClassification": "Type 1 - New Molecular Entity",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/25/2025",
    "drugName": "ITOVEBINDA   #219249",
    "submission": "SUPPL-2",
    "activeIngredients": "INAVOLISIB",
    "company": "GENENTECH INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/25/2025",
    "drugName": "EVKEEZABLA   #761181",
    "submission": "SUPPL-2",
    "activeIngredients": "EVINACUMAB-DGNB",
    "company": "REGENERON PHARMACEUTICALS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/25/2025",
    "drugName": "WEZLANABLA   #761285",
    "submission": "SUPPL-4",
    "activeIngredients": "USTEKINUMAB-AUUB",
    "company": "AMGEN INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/25/2025",
    "drugName": "WEZLANABLA   #761331",
    "submission": "SUPPL-4",
    "activeIngredients": "USTEKINUMAB-AUUB",
    "company": "AMGEN INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/26/2025",
    "drugName": "PYRIDOSTIGMINE BROMIDENDA   #020414",
    "submission": "SUPPL-12",
    "activeIngredients": "PYRIDOSTIGMINE BROMIDE",
    "company": "US ARMY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/26/2025",
    "drugName": "CAFFEINE CITRATEANDA  #078002",
    "submission": "SUPPL-3",
    "activeIngredients": "CAFFEINE CITRATE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/26/2025",
    "drugName": "LIDOCAINE HYDROCHLORIDEANDA  #081318",
    "submission": "SUPPL-24",
    "activeIngredients": "LIDOCAINE HYDROCHLORIDE",
    "company": "COSETTE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/26/2025",
    "drugName": "VORICONAZOLEANDA  #206181",
    "submission": "SUPPL-31",
    "activeIngredients": "VORICONAZOLE",
    "company": "AJANTA PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/26/2025",
    "drugName": "HYDROCODONE BITARTRATEANDA  #206986",
    "submission": "SUPPL-6",
    "activeIngredients": "HYDROCODONE BITARTRATE",
    "company": "ALVOGEN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/26/2025",
    "drugName": "QVAR REDIHALERNDA   #207921",
    "submission": "SUPPL-7",
    "activeIngredients": "BECLOMETHASONE DIPROPIONATE",
    "company": "NORTON WATERFORD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/26/2025",
    "drugName": "FLUOXETINE HYDROCHLORIDEANDA  #209695",
    "submission": "SUPPL-5",
    "activeIngredients": "FLUOXETINE HYDROCHLORIDE",
    "company": "INVENTIA HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/26/2025",
    "drugName": "FLUOXETINE HYDROCHLORIDEANDA  #209695",
    "submission": "SUPPL-8",
    "activeIngredients": "FLUOXETINE HYDROCHLORIDE",
    "company": "INVENTIA HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/26/2025",
    "drugName": "DICLOFENAC SODIUMANDA  #210986",
    "submission": "SUPPL-5",
    "activeIngredients": "DICLOFENAC SODIUM",
    "company": "ENCUBE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/26/2025",
    "drugName": "AMPHETAMINE SULFATEANDA  #211139",
    "submission": "SUPPL-9",
    "activeIngredients": "AMPHETAMINE SULFATE",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/26/2025",
    "drugName": "TIZANIDINE HYDROCHLORIDEANDA  #211798",
    "submission": "SUPPL-6",
    "activeIngredients": "TIZANIDINE HYDROCHLORIDE",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/26/2025",
    "drugName": "TACROLIMUSANDA  #212297",
    "submission": "SUPPL-2",
    "activeIngredients": "TACROLIMUS",
    "company": "BIOCON PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/26/2025",
    "drugName": "TACROLIMUSANDA  #212297",
    "submission": "SUPPL-11",
    "activeIngredients": "TACROLIMUS",
    "company": "BIOCON PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/26/2025",
    "drugName": "XPOVIONDA   #212306",
    "submission": "SUPPL-16",
    "activeIngredients": "SELINEXOR",
    "company": "KARYOPHARM THERAPS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/26/2025",
    "drugName": "AMPHETAMINE SULFATEANDA  #212619",
    "submission": "SUPPL-12",
    "activeIngredients": "AMPHETAMINE SULFATE",
    "company": "GRANULES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/26/2025",
    "drugName": "CELECOXIBANDA  #213598",
    "submission": "SUPPL-1",
    "activeIngredients": "CELECOXIB",
    "company": "NANJING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/26/2025",
    "drugName": "CELECOXIBANDA  #213598",
    "submission": "SUPPL-2",
    "activeIngredients": "CELECOXIB",
    "company": "NANJING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/26/2025",
    "drugName": "CELECOXIBANDA  #213598",
    "submission": "SUPPL-3",
    "activeIngredients": "CELECOXIB",
    "company": "NANJING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/26/2025",
    "drugName": "AMPHETAMINE SULFATEANDA  #213898",
    "submission": "SUPPL-3",
    "activeIngredients": "AMPHETAMINE SULFATE",
    "company": "DR REDDYS LABS SA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/26/2025",
    "drugName": "AMPHETAMINE SULFATEANDA  #213980",
    "submission": "SUPPL-3",
    "activeIngredients": "AMPHETAMINE SULFATE",
    "company": "EPIC PHARMA LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/26/2025",
    "drugName": "AMPHETAMINE SULFATEANDA  #214574",
    "submission": "SUPPL-5",
    "activeIngredients": "AMPHETAMINE SULFATE",
    "company": "SUN PHARM INDS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/26/2025",
    "drugName": "CALCITONIN-SALMONANDA  #216294",
    "submission": "ORIG-1",
    "activeIngredients": "CALCITONIN SALMON",
    "company": "AMNEAL",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/26/2025",
    "drugName": "OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDEANDA  #217398",
    "submission": "ORIG-1",
    "activeIngredients": "HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL",
    "company": "MSN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/26/2025",
    "drugName": "CLOTICNDA   #217628",
    "submission": "ORIG-1",
    "activeIngredients": "CLOTRIMAZOLE",
    "company": "LAB SALVAT",
    "submissionClassification": "Type 3 - New Dosage Form",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/26/2025",
    "drugName": "ACETYLCYSTEINEANDA  #219194",
    "submission": "SUPPL-1",
    "activeIngredients": "ACETYLCYSTEINE",
    "company": "SOMERSET THERAPS LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/26/2025",
    "drugName": "TREMFYABLA   #761061",
    "submission": "SUPPL-28",
    "activeIngredients": "GUSELKUMAB",
    "company": "JANSSEN BIOTECH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/26/2025",
    "drugName": "TREMFYABLA   #761061",
    "submission": "SUPPL-29",
    "activeIngredients": "GUSELKUMAB",
    "company": "JANSSEN BIOTECH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/26/2025",
    "drugName": "ULTOMIRISBLA   #761108",
    "submission": "SUPPL-41",
    "activeIngredients": "RAVULIZUMAB-CWVZ",
    "company": "ALEXION PHARM",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/26/2025",
    "drugName": "ENOBYBLA   #761439",
    "submission": "ORIG-1",
    "activeIngredients": "DENOSUMAB-QBDE",
    "company": "HIKMA PHARMACEUTICALS USA INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/26/2025",
    "drugName": "XTRENBOBLA   #761439",
    "submission": "ORIG-1",
    "activeIngredients": "DENOSUMAB-QBDE",
    "company": "HIKMA PHARMACEUTICALS USA INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/28/2025",
    "drugName": "SULFAMETHOPRIMANDA  #070022",
    "submission": "SUPPL-17",
    "activeIngredients": "SULFAMETHOXAZOLE; TRIMETHOPRIM",
    "company": "NOVEL LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/28/2025",
    "drugName": "SULFAMETHOPRIMANDA  #070022",
    "submission": "SUPPL-18",
    "activeIngredients": "SULFAMETHOXAZOLE; TRIMETHOPRIM",
    "company": "NOVEL LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/28/2025",
    "drugName": "ESTRADIOL AND PROGESTERONEANDA  #214293",
    "submission": "SUPPL-1",
    "activeIngredients": "ESTRADIOL; PROGESTERONE",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/29/2025",
    "drugName": "IFOSFAMIDEANDA  #076078",
    "submission": "SUPPL-19",
    "activeIngredients": "IFOSFAMIDE",
    "company": "FRESENIUS KABI USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/29/2025",
    "drugName": "LAMOTRIGINEANDA  #077633",
    "submission": "SUPPL-41",
    "activeIngredients": "LAMOTRIGINE",
    "company": "ZYDUS PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/29/2025",
    "drugName": "LAMOTRIGINEANDA  #078009",
    "submission": "SUPPL-30",
    "activeIngredients": "LAMOTRIGINE",
    "company": "ZYDUS PHARMS USA INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/29/2025",
    "drugName": "DESIPRAMINE HYDROCHLORIDEANDA  #209785",
    "submission": "SUPPL-8",
    "activeIngredients": "DESIPRAMINE HYDROCHLORIDE",
    "company": "ALEMBIC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/29/2025",
    "drugName": "TIZANIDINE HYDROCHLORIDEANDA  #210267",
    "submission": "SUPPL-4",
    "activeIngredients": "TIZANIDINE HYDROCHLORIDE",
    "company": "NOVAST LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/29/2025",
    "drugName": "CANAGLIFLOZINANDA  #210503",
    "submission": "ORIG-1",
    "activeIngredients": "CANAGLIFLOZIN",
    "company": "LAURUS LABS LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "09/29/2025",
    "drugName": "DAPAGLIFLOZIN; SAXAGLIPTINANDA  #211537",
    "submission": "ORIG-1",
    "activeIngredients": "DAPAGLIFLOZIN;SAXAGLIPTIN",
    "company": "TORRENT PHARMS LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "09/29/2025",
    "drugName": "CALCIUM CHLORIDE 10%ANDA  #217463",
    "submission": "ORIG-1",
    "activeIngredients": "CALCIUM CHLORIDE",
    "company": "SQUARE PHARMS PLC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/29/2025",
    "drugName": "EPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDENDA   #218475",
    "submission": "SUPPL-1",
    "activeIngredients": "EPINEPHRINE BITARTRATE",
    "company": "BAXTER HLTHCARE CORP",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "09/30/2025",
    "drugName": "TEGRETOLNDA   #016608",
    "submission": "SUPPL-122",
    "activeIngredients": "CARBAMAZEPINE",
    "company": "NOVARTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/30/2025",
    "drugName": "TEGRETOLNDA   #018927",
    "submission": "SUPPL-61",
    "activeIngredients": "CARBAMAZEPINE",
    "company": "NOVARTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/30/2025",
    "drugName": "LUPRONNDA   #019010",
    "submission": "SUPPL-42",
    "activeIngredients": "LEUPROLIDE ACETATE",
    "company": "ABBVIE ENDOCRINE INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/30/2025",
    "drugName": "TEGRETOL-XRNDA   #020234",
    "submission": "SUPPL-55",
    "activeIngredients": "CARBAMAZEPINE",
    "company": "NOVARTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/30/2025",
    "drugName": "MIFEPREXNDA   #020687",
    "submission": "SUPPL-27",
    "activeIngredients": "MIFEPRISTONE",
    "company": "DANCO LABS LLC",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/30/2025",
    "drugName": "PEPCID COMPLETENDA   #020958",
    "submission": "SUPPL-44",
    "activeIngredients": "CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE",
    "company": "KENVUE BRANDS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/30/2025",
    "drugName": "CIPROFLOXACIN HYDROCHLORIDEANDA  #076896",
    "submission": "SUPPL-18",
    "activeIngredients": "CIPROFLOXACIN HYDROCHLORIDE",
    "company": "CHARTWELL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/30/2025",
    "drugName": "CIPROFLOXACIN HYDROCHLORIDEANDA  #076896",
    "submission": "SUPPL-19",
    "activeIngredients": "CIPROFLOXACIN HYDROCHLORIDE",
    "company": "CHARTWELL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/30/2025",
    "drugName": "CIPROFLOXACIN HYDROCHLORIDEANDA  #076896",
    "submission": "SUPPL-20",
    "activeIngredients": "CIPROFLOXACIN HYDROCHLORIDE",
    "company": "CHARTWELL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/30/2025",
    "drugName": "CIPROFLOXACIN HYDROCHLORIDEANDA  #076896",
    "submission": "SUPPL-21",
    "activeIngredients": "CIPROFLOXACIN HYDROCHLORIDE",
    "company": "CHARTWELL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/30/2025",
    "drugName": "CIPROFLOXACIN HYDROCHLORIDEANDA  #076896",
    "submission": "SUPPL-22",
    "activeIngredients": "CIPROFLOXACIN HYDROCHLORIDE",
    "company": "CHARTWELL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/30/2025",
    "drugName": "CIPROFLOXACIN HYDROCHLORIDEANDA  #076896",
    "submission": "SUPPL-23",
    "activeIngredients": "CIPROFLOXACIN HYDROCHLORIDE",
    "company": "CHARTWELL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/30/2025",
    "drugName": "CIPROFLOXACIN HYDROCHLORIDEANDA  #076896",
    "submission": "SUPPL-27",
    "activeIngredients": "CIPROFLOXACIN HYDROCHLORIDE",
    "company": "CHARTWELL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/30/2025",
    "drugName": "CIPROFLOXACIN HYDROCHLORIDEANDA  #076896",
    "submission": "SUPPL-29",
    "activeIngredients": "CIPROFLOXACIN HYDROCHLORIDE",
    "company": "CHARTWELL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/30/2025",
    "drugName": "ZIPRASIDONE HYDROCHLORIDEANDA  #077560",
    "submission": "SUPPL-25",
    "activeIngredients": "ZIPRASIDONE HYDROCHLORIDE",
    "company": "LUPIN PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/30/2025",
    "drugName": "TAMSULOSIN HYDROCHLORIDEANDA  #090408",
    "submission": "SUPPL-14",
    "activeIngredients": "TAMSULOSIN HYDROCHLORIDE",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/30/2025",
    "drugName": "ROPINIROLE HYDROCHLORIDEANDA  #090411",
    "submission": "SUPPL-7",
    "activeIngredients": "ROPINIROLE HYDROCHLORIDE",
    "company": "ZYDUS LIFESCIENCES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/30/2025",
    "drugName": "MIFEPRISTONEANDA  #091178",
    "submission": "SUPPL-7",
    "activeIngredients": "MIFEPRISTONE",
    "company": "GENBIOPRO",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/30/2025",
    "drugName": "LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDEANDA  #091629",
    "submission": "SUPPL-41",
    "activeIngredients": "HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/30/2025",
    "drugName": "FENOFIBRIC ACIDANDA  #200920",
    "submission": "SUPPL-6",
    "activeIngredients": "CHOLINE FENOFIBRATE",
    "company": "ACTAVIS ELIZABETH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/30/2025",
    "drugName": "LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDEANDA  #201682",
    "submission": "SUPPL-12",
    "activeIngredients": "HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM",
    "company": "IPCA LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/30/2025",
    "drugName": "OLANZAPINEANDA  #202889",
    "submission": "SUPPL-1",
    "activeIngredients": "OLANZAPINE",
    "company": "ZYDUS PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/30/2025",
    "drugName": "IRBESARTANANDA  #202910",
    "submission": "SUPPL-20",
    "activeIngredients": "IRBESARTAN",
    "company": "HETERO LABS LTD V",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/30/2025",
    "drugName": "MONTELUKAST SODIUMANDA  #204604",
    "submission": "SUPPL-4",
    "activeIngredients": "MONTELUKAST SODIUM",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/30/2025",
    "drugName": "MONTELUKAST SODIUMANDA  #204604",
    "submission": "SUPPL-5",
    "activeIngredients": "MONTELUKAST SODIUM",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/30/2025",
    "drugName": "MONTELUKAST SODIUMANDA  #204604",
    "submission": "SUPPL-6",
    "activeIngredients": "MONTELUKAST SODIUM",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/30/2025",
    "drugName": "OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDEANDA  #204801",
    "submission": "SUPPL-9",
    "activeIngredients": "HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/30/2025",
    "drugName": "TRAMADOL HYDROCHLORIDEANDA  #205257",
    "submission": "SUPPL-12",
    "activeIngredients": "TRAMADOL HYDROCHLORIDE",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/30/2025",
    "drugName": "OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDEANDA  #205391",
    "submission": "SUPPL-11",
    "activeIngredients": "HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/30/2025",
    "drugName": "VORICONAZOLEANDA  #206799",
    "submission": "SUPPL-15",
    "activeIngredients": "VORICONAZOLE",
    "company": "NOVEL LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/30/2025",
    "drugName": "TIZANIDINE HYDROCHLORIDEANDA  #212196",
    "submission": "SUPPL-3",
    "activeIngredients": "TIZANIDINE HYDROCHLORIDE",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/30/2025",
    "drugName": "DASATINIBANDA  #213383",
    "submission": "SUPPL-2",
    "activeIngredients": "DASATINIB",
    "company": "DR REDDYS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/30/2025",
    "drugName": "VORICONAZOLEANDA  #214516",
    "submission": "SUPPL-4",
    "activeIngredients": "VORICONAZOLE",
    "company": "MEITHEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/30/2025",
    "drugName": "QULIPTANDA   #215206",
    "submission": "SUPPL-13",
    "activeIngredients": "ATOGEPANT",
    "company": "ABBVIE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/30/2025",
    "drugName": "PREGABALINANDA  #215755",
    "submission": "SUPPL-2",
    "activeIngredients": "PREGABALIN",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/30/2025",
    "drugName": "TOFACITINIBANDA  #216001",
    "submission": "ORIG-1",
    "activeIngredients": "TOFACITINIB",
    "company": "SINOTHERAPEUTICS INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/30/2025",
    "drugName": "TOFACITINIBANDA  #216001",
    "submission": "ORIG-2",
    "activeIngredients": "TOFACITINIB",
    "company": "SINOTHERAPEUTICS INC",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "09/30/2025",
    "drugName": "TOFACITINIB CITRATEANDA  #216001",
    "submission": "ORIG-1",
    "activeIngredients": "TOFACITINIB CITRATE",
    "company": "SINOTHERAPEUTICS INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/30/2025",
    "drugName": "TOFACITINIB CITRATEANDA  #216001",
    "submission": "ORIG-2",
    "activeIngredients": "TOFACITINIB CITRATE",
    "company": "SINOTHERAPEUTICS INC",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "09/30/2025",
    "drugName": "DOXYCYCLINE HYCLATEANDA  #216599",
    "submission": "SUPPL-3",
    "activeIngredients": "DOXYCYCLINE HYCLATE",
    "company": "AMNEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/30/2025",
    "drugName": "MIFEPRISTONEANDA  #216616",
    "submission": "ORIG-1",
    "activeIngredients": "MIFEPRISTONE",
    "company": "EVITA SOLUTIONS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/30/2025",
    "drugName": "NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONEANDA  #217735",
    "submission": "ORIG-1",
    "activeIngredients": "HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE",
    "company": "AMNEAL",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/30/2025",
    "drugName": "RHAPSIDONDA   #218436",
    "submission": "ORIG-1",
    "activeIngredients": "REMIBRUTINIB",
    "company": "NOVARTIS",
    "submissionClassification": "Type 1 - New Molecular Entity",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "09/30/2025",
    "drugName": "LEVONORGESTRELANDA  #219102",
    "submission": "ORIG-1",
    "activeIngredients": "LEVONORGESTREL",
    "company": "ANNORA PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },

  {
    "approvalDate": "10/01/2025",
    "drugName": "DIAMOXNDA   #008943",
    "submission": "SUPPL-54",
    "activeIngredients": "ACETAZOLAMIDE",
    "company": "TEVA BRANDED PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/01/2025",
    "drugName": "ANTARA (MICRONIZED)NDA   #021695",
    "submission": "SUPPL-29",
    "activeIngredients": "FENOFIBRATE",
    "company": "LUPIN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/01/2025",
    "drugName": "MORPHINE SULFATEANDA  #079040",
    "submission": "SUPPL-29",
    "activeIngredients": "MORPHINE SULFATE",
    "company": "ACTAVIS ELIZABETH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/01/2025",
    "drugName": "PANTOPRAZOLE SODIUMANDA  #090296",
    "submission": "SUPPL-11",
    "activeIngredients": "PANTOPRAZOLE SODIUM",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/01/2025",
    "drugName": "PANTOPRAZOLE SODIUMANDA  #090296",
    "submission": "SUPPL-12",
    "activeIngredients": "PANTOPRAZOLE SODIUM",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/01/2025",
    "drugName": "PANTOPRAZOLE SODIUMANDA  #090296",
    "submission": "SUPPL-13",
    "activeIngredients": "PANTOPRAZOLE SODIUM",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/01/2025",
    "drugName": "LETROZOLEANDA  #090934",
    "submission": "SUPPL-17",
    "activeIngredients": "LETROZOLE",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/01/2025",
    "drugName": "LETROZOLEANDA  #090934",
    "submission": "SUPPL-18",
    "activeIngredients": "LETROZOLE",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/01/2025",
    "drugName": "SIMPONIBLA   #125289",
    "submission": "SUPPL-156",
    "activeIngredients": "GOLIMUMAB",
    "company": "CENTOCOR ORTHO BIOTECH INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/01/2025",
    "drugName": "FLUOCINOLONE ACETONIDEANDA  #202848",
    "submission": "SUPPL-14",
    "activeIngredients": "FLUOCINOLONE ACETONIDE",
    "company": "PADAGIS ISRAEL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/01/2025",
    "drugName": "FLUOCINOLONE ACETONIDEANDA  #202849",
    "submission": "SUPPL-4",
    "activeIngredients": "FLUOCINOLONE ACETONIDE",
    "company": "PADAGIS ISRAEL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/01/2025",
    "drugName": "IRBESARTANANDA  #203534",
    "submission": "SUPPL-19",
    "activeIngredients": "IRBESARTAN",
    "company": "JUBILANT GENERICS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/01/2025",
    "drugName": "MEROPENEMANDA  #204139",
    "submission": "SUPPL-3",
    "activeIngredients": "MEROPENEM",
    "company": "ACS DOBFAR SPA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/01/2025",
    "drugName": "MEROPENEMANDA  #204139",
    "submission": "SUPPL-4",
    "activeIngredients": "MEROPENEM",
    "company": "ACS DOBFAR SPA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/01/2025",
    "drugName": "HYDROMORPHONE HYDROCHLORIDEANDA  #204278",
    "submission": "SUPPL-22",
    "activeIngredients": "HYDROMORPHONE HYDROCHLORIDE",
    "company": "PADAGIS US",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/01/2025",
    "drugName": "DORZOLAMIDE HYDROCHLORIDEANDA  #204778",
    "submission": "SUPPL-5",
    "activeIngredients": "DORZOLAMIDE HYDROCHLORIDE",
    "company": "MICRO LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/01/2025",
    "drugName": "DORZOLAMIDE HYDROCHLORIDEANDA  #204778",
    "submission": "SUPPL-10",
    "activeIngredients": "DORZOLAMIDE HYDROCHLORIDE",
    "company": "MICRO LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/01/2025",
    "drugName": "VONJONDA   #208712",
    "submission": "SUPPL-4",
    "activeIngredients": "PACRITINIB CITRATE",
    "company": "SOBI",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/01/2025",
    "drugName": "NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATEANDA  #210369",
    "submission": "SUPPL-4",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/01/2025",
    "drugName": "NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATEANDA  #210369",
    "submission": "SUPPL-6",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/01/2025",
    "drugName": "NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATEANDA  #210369",
    "submission": "SUPPL-7",
    "activeIngredients": "ETHINYL ESTRADIOL; NORETHINDRONE ACETATE",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/01/2025",
    "drugName": "PREGABALINANDA  #213423",
    "submission": "SUPPL-3",
    "activeIngredients": "PREGABALIN",
    "company": "CREEKWOOD PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/01/2025",
    "drugName": "PREGABALINANDA  #213423",
    "submission": "SUPPL-6",
    "activeIngredients": "PREGABALIN",
    "company": "CREEKWOOD PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/01/2025",
    "drugName": "PREGABALINANDA  #213423",
    "submission": "SUPPL-7",
    "activeIngredients": "PREGABALIN",
    "company": "CREEKWOOD PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/01/2025",
    "drugName": "CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDEANDA  #215255",
    "submission": "ORIG-1",
    "activeIngredients": "METFORMIN HYDROCHLORIDE; CANAGLIFLOZIN",
    "company": "MACLEODS PHARMACEUTICALS LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "10/01/2025",
    "drugName": "ACETAMINOPHEN AND IBUPROFENANDA  #216592",
    "submission": "SUPPL-6",
    "activeIngredients": "ACETAMINOPHEN; IBUPROFEN",
    "company": "GRANULES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/01/2025",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #217898",
    "submission": "ORIG-1",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "ANNORA PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/01/2025",
    "drugName": "MIUDELLANDA   #218201",
    "submission": "SUPPL-2",
    "activeIngredients": "COPPER",
    "company": "SEBELA WOMENS HLTH",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/01/2025",
    "drugName": "PREDNISONEANDA  #219477",
    "submission": "ORIG-1",
    "activeIngredients": "PREDNISONE",
    "company": "DR REDDYS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/01/2025",
    "drugName": "DOXYCYCLINEANDA  #219978",
    "submission": "ORIG-1",
    "activeIngredients": "DOXYCYCLINE",
    "company": "CHANGZHOU PHARM",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/02/2025",
    "drugName": "METADATE ERANDA  #040306",
    "submission": "SUPPL-22",
    "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "company": "LANNETT CO INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/02/2025",
    "drugName": "CROMOLYN SODIUMANDA  #075271",
    "submission": "SUPPL-14",
    "activeIngredients": "CROMOLYN SODIUM",
    "company": "TEVA PHARMS",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/02/2025",
    "drugName": "METHYLIN ERANDA  #075629",
    "submission": "SUPPL-26",
    "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "company": "SPECGX LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/02/2025",
    "drugName": "SEVOFLURANEANDA  #075895",
    "submission": "SUPPL-19",
    "activeIngredients": "SEVOFLURANE",
    "company": "BAXTER HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/02/2025",
    "drugName": "METADATE ERANDA  #089601",
    "submission": "SUPPL-38",
    "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "company": "LANNETT CO INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/02/2025",
    "drugName": "OLANZAPINEANDA  #203456",
    "submission": "SUPPL-2",
    "activeIngredients": "OLANZAPINE",
    "company": "CHARTWELL MOLECULAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/02/2025",
    "drugName": "OLANZAPINEANDA  #203456",
    "submission": "SUPPL-5",
    "activeIngredients": "OLANZAPINE",
    "company": "CHARTWELL MOLECULAR",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/02/2025",
    "drugName": "ZEPZELCANDA   #213702",
    "submission": "SUPPL-11",
    "activeIngredients": "LURBINECTEDIN",
    "company": "JAZZ",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/02/2025",
    "drugName": "VANCOMYCIN HYDROCHLORIDEANDA  #215324",
    "submission": "ORIG-1",
    "activeIngredients": "VANCOMYCIN HYDROCHLORIDE",
    "company": "STERISCIENCE",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/02/2025",
    "drugName": "SCEMBLIXNDA   #215358",
    "submission": "SUPPL-10",
    "activeIngredients": "ASCIMINIB HYDROCHLORIDE",
    "company": "NOVARTIS",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/02/2025",
    "drugName": "PILOCARPINE HYDROCHLORIDEANDA  #217052",
    "submission": "ORIG-1",
    "activeIngredients": "PILOCARPINE HYDROCHLORIDE",
    "company": "FDC LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/02/2025",
    "drugName": "OSELTAMIVIR PHOSPHATEANDA  #218009",
    "submission": "SUPPL-1",
    "activeIngredients": "OSELTAMIVIR PHOSPHATE",
    "company": "ZHEJIANG POLY PHARM",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/02/2025",
    "drugName": "LABETALOL HYDROCHLORIDEANDA  #218870",
    "submission": "ORIG-1",
    "activeIngredients": "LABETALOL HYDROCHLORIDE",
    "company": "AMNEAL",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/02/2025",
    "drugName": "ETRAVIRINEANDA  #219152",
    "submission": "ORIG-1",
    "activeIngredients": "ETRAVIRINE",
    "company": "BIONPHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/02/2025",
    "drugName": "LIDOCAINE HYDROCHLORIDEANDA  #219535",
    "submission": "SUPPL-7",
    "activeIngredients": "LIDOCAINE HYDROCHLORIDE",
    "company": "NEOCUBES PHARMA",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/02/2025",
    "drugName": "MIRTAZAPINEANDA  #219721",
    "submission": "ORIG-1",
    "activeIngredients": "MIRTAZAPINE",
    "company": "ANNORA PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/02/2025",
    "drugName": "TECENTRIQBLA   #761034",
    "submission": "SUPPL-58",
    "activeIngredients": "ATEZOLIZUMAB",
    "company": "GENENTECH INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/02/2025",
    "drugName": "TECVAYLIBLA   #761291",
    "submission": "SUPPL-15",
    "activeIngredients": "TECLISTAMAB-CQYV",
    "company": "JANSSEN BIOTECH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/02/2025",
    "drugName": "TALVEYBLA   #761342",
    "submission": "SUPPL-16",
    "activeIngredients": "TALQUETAMAB-TGVS",
    "company": "JANSSEN BIOTECH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/02/2025",
    "drugName": "TECENTRIQ HYBREZABLA   #761347",
    "submission": "SUPPL-3",
    "activeIngredients": "ATEZOLIZUMAB AND HYALURONIDASE-TQJS",
    "company": "GENENTECH INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/02/2025",
    "drugName": "EYDENZELTBLA   #761377",
    "submission": "ORIG-1",
    "activeIngredients": "AFLIBERCEPT-BOAV",
    "company": "CELLTRION INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/03/2025",
    "drugName": "DOVONEXNDA   #020273",
    "submission": "SUPPL-15",
    "activeIngredients": "CALCIPOTRIENE",
    "company": "LEO PHARMA AS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/03/2025",
    "drugName": "DOVONEXNDA   #020554",
    "submission": "SUPPL-13",
    "activeIngredients": "CALCIPOTRIENE",
    "company": "LEO PHARMA AS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/03/2025",
    "drugName": "XELODANDA   #020896",
    "submission": "SUPPL-52",
    "activeIngredients": "CAPECITABINE",
    "company": "CHEPLAPHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/03/2025",
    "drugName": "OMEPRAZOLENDA   #022032",
    "submission": "SUPPL-70",
    "activeIngredients": "OMEPRAZOLE",
    "company": "DEXCEL PHARMA",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/03/2025",
    "drugName": "AXTLENDA   #210661",
    "submission": "SUPPL-4",
    "activeIngredients": "PEMETREXED DIPOTASSIUM",
    "company": "AVYXA HOLDINGS",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/03/2025",
    "drugName": "DOCOSANOLANDA  #214613",
    "submission": "ORIG-1",
    "activeIngredients": "DOCOSANOL",
    "company": "DR REDDYS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/03/2025",
    "drugName": "NAPROXENANDA  #216504",
    "submission": "ORIG-1",
    "activeIngredients": "NAPROXEN",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/03/2025",
    "drugName": "CLOMIPHENE CITRATEANDA  #219406",
    "submission": "ORIG-1",
    "activeIngredients": "CLOMIPHENE CITRATE",
    "company": "ACCORD HLTHCARE",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/03/2025",
    "drugName": "DEFLAZACORTANDA  #220042",
    "submission": "ORIG-1",
    "activeIngredients": "DEFLAZACORT",
    "company": "ZYDUS LIFESCIENCES",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/04/2025",
    "drugName": "ZORYVENDA   #215985",
    "submission": "SUPPL-12",
    "activeIngredients": "ROFLUMILAST",
    "company": "ARCUTIS",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/06/2025",
    "drugName": "SALONPASNDA   #022029",
    "submission": "SUPPL-20",
    "activeIngredients": "MENTHOL; METHYL SALICYLATE",
    "company": "HISAMITSU PHARM CO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/06/2025",
    "drugName": "BUSPIRONE HYDROCHLORIDEANDA  #075413",
    "submission": "SUPPL-2",
    "activeIngredients": "BUSPIRONE HYDROCHLORIDE",
    "company": "RISING",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/06/2025",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #076143",
    "submission": "SUPPL-36",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "APOTEX",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/06/2025",
    "drugName": "LITHIUM CARBONATEANDA  #076243",
    "submission": "SUPPL-16",
    "activeIngredients": "LITHIUM CARBONATE",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/06/2025",
    "drugName": "LITHIUM CARBONATEANDA  #078763",
    "submission": "SUPPL-10",
    "activeIngredients": "LITHIUM CARBONATE",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/06/2025",
    "drugName": "BUPROPION HYDROCHLORIDEANDA  #207403",
    "submission": "SUPPL-6",
    "activeIngredients": "BUPROPION HYDROCHLORIDE",
    "company": "MICRO LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/06/2025",
    "drugName": "OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDEANDA  #209242",
    "submission": "ORIG-1",
    "activeIngredients": "AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL",
    "company": "HETERO LABS LTD V",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/06/2025",
    "drugName": "LIDOCAINEANDA  #216484",
    "submission": "ORIG-1",
    "activeIngredients": "LIDOCAINE",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/06/2025",
    "drugName": "NINTEDANIBANDA  #216915",
    "submission": "ORIG-1",
    "activeIngredients": "NINTEDANIB",
    "company": "LOTUS PHARM CO LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "10/07/2025",
    "drugName": "METHYLIN ERANDA  #075629",
    "submission": "SUPPL-27",
    "activeIngredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "company": "SPECGX LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/07/2025",
    "drugName": "EXEMESTANEANDA  #077431",
    "submission": "SUPPL-12",
    "activeIngredients": "EXEMESTANE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/07/2025",
    "drugName": "TOPIRAMATEANDA  #078462",
    "submission": "SUPPL-36",
    "activeIngredients": "TOPIRAMATE",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/07/2025",
    "drugName": "SIMPONIBLA   #125289",
    "submission": "SUPPL-157",
    "activeIngredients": "GOLIMUMAB",
    "company": "CENTOCOR ORTHO BIOTECH INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/07/2025",
    "drugName": "RIVAROXABANANDA  #208557",
    "submission": "ORIG-2",
    "activeIngredients": "RIVAROXABAN",
    "company": "TARO",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/07/2025",
    "drugName": "VEKLURYNDA   #214787",
    "submission": "SUPPL-32",
    "activeIngredients": "REMDESIVIR",
    "company": "GILEAD SCIENCES INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/07/2025",
    "drugName": "ISOTRETINOINANDA  #216097",
    "submission": "ORIG-1",
    "activeIngredients": "ISOTRETINOIN",
    "company": "AMNEAL PHARMS NY",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/07/2025",
    "drugName": "FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDEANDA  #216792",
    "submission": "ORIG-1",
    "activeIngredients": "FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE",
    "company": "L PERRIGO CO",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/07/2025",
    "drugName": "LASIX ONYUNDA   #217294",
    "submission": "ORIG-1",
    "activeIngredients": "FUROSEMIDE",
    "company": "SQ INNOVATION",
    "submissionClassification": "Type 3 - New Dosage Form",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/07/2025",
    "drugName": "JASCAYDNDA   #218764",
    "submission": "ORIG-1",
    "activeIngredients": "NERANDOMILAST",
    "company": "BOEHRINGER INGELHEIM",
    "submissionClassification": "Type 1 - New Molecular Entity",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/07/2025",
    "drugName": "LAMOTRIGINEANDA  #219677",
    "submission": "ORIG-1",
    "activeIngredients": "LAMOTRIGINE",
    "company": "TARO",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/07/2025",
    "drugName": "AXITINIBANDA  #219705",
    "submission": "ORIG-1",
    "activeIngredients": "AXITINIB",
    "company": "SANDOZ INC",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "10/08/2025",
    "drugName": "RIFADINNDA   #050420",
    "submission": "SUPPL-93",
    "activeIngredients": "RIFAMPIN",
    "company": "SANOFI AVENTIS US",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/08/2025",
    "drugName": "RIFADINNDA   #050627",
    "submission": "SUPPL-38",
    "activeIngredients": "RIFAMPIN",
    "company": "SANOFI AVENTIS US",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/08/2025",
    "drugName": "RIFATERNDA   #050705",
    "submission": "SUPPL-28",
    "activeIngredients": "ISONIAZID; PYRAZINAMIDE; RIFAMPIN",
    "company": "SANOFI AVENTIS US",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/08/2025",
    "drugName": "TRIAMCINOLONE ACETONIDEANDA  #090164",
    "submission": "SUPPL-10",
    "activeIngredients": "TRIAMCINOLONE ACETONIDE",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/08/2025",
    "drugName": "AFATINIBANDA  #213499",
    "submission": "ORIG-1",
    "activeIngredients": "AFATINIB",
    "company": "QILU PHARM CO LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "10/08/2025",
    "drugName": "LUPKYNISNDA   #213716",
    "submission": "SUPPL-8",
    "activeIngredients": "VOCLOSPORIN",
    "company": "AURINIA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/08/2025",
    "drugName": "ORGOVYXNDA   #214621",
    "submission": "SUPPL-12",
    "activeIngredients": "RELUGOLIX",
    "company": "SUMITOMO PHARMA AM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/08/2025",
    "drugName": "SODIUM ZIRCONIUM CYCLOSILICATEANDA  #217558",
    "submission": "ORIG-1",
    "activeIngredients": "SODIUM ZIRCONIUM CYCLOSILICATE",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "10/08/2025",
    "drugName": "XELJANZANDA  #218407",
    "submission": "ORIG-1",
    "activeIngredients": "TOFACITINIB",
    "company": "SUN PHARM INDS INC",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "10/08/2025",
    "drugName": "CLADRIBINEANDA  #218425",
    "submission": "ORIG-1",
    "activeIngredients": "CLADRIBINE",
    "company": "APOTEX INC",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "10/08/2025",
    "drugName": "LIBTAYOBLA   #761097",
    "submission": "SUPPL-30",
    "activeIngredients": "CEMIPLIMAB-RWLC",
    "company": "REGENERON PHARMACEUTICALS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/08/2025",
    "drugName": "RYBREVANTBLA   #761210",
    "submission": "SUPPL-10",
    "activeIngredients": "AMIVANTAMAB-VMJW",
    "company": "JANSSEN BIOTECH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/09/2025",
    "drugName": "LANOXINNDA   #009330",
    "submission": "SUPPL-40",
    "activeIngredients": "DIGOXIN",
    "company": "COVIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/09/2025",
    "drugName": "LANOXIN PEDIATRICNDA   #009330",
    "submission": "SUPPL-40",
    "activeIngredients": "DIGOXIN",
    "company": "COVIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/09/2025",
    "drugName": "TRAVATAN ZNDA   #021994",
    "submission": "SUPPL-20",
    "activeIngredients": "TRAVOPROST",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/09/2025",
    "drugName": "LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDEANDA  #077732",
    "submission": "SUPPL-13",
    "activeIngredients": "HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/09/2025",
    "drugName": "ESCITALOPRAM OXALATEANDA  #079121",
    "submission": "SUPPL-14",
    "activeIngredients": "ESCITALOPRAM OXALATE",
    "company": "TARO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/09/2025",
    "drugName": "PRALUENTBLA   #125559",
    "submission": "SUPPL-47",
    "activeIngredients": "ALIROCUMAB",
    "company": "REGENERON PHARMACEUTICALS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/09/2025",
    "drugName": "MORPHINE SULFATEANDA  #200411",
    "submission": "SUPPL-24",
    "activeIngredients": "MORPHINE SULFATE",
    "company": "IMPAX LABS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/09/2025",
    "drugName": "MORPHINE SULFATEANDA  #202104",
    "submission": "SUPPL-24",
    "activeIngredients": "MORPHINE SULFATE",
    "company": "UPSHER SMITH LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/09/2025",
    "drugName": "MORPHINE SULFATEANDA  #202718",
    "submission": "SUPPL-13",
    "activeIngredients": "MORPHINE SULFATE",
    "company": "TEVA PHARMS USA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/09/2025",
    "drugName": "MORPHINE SULFATEANDA  #203158",
    "submission": "SUPPL-3",
    "activeIngredients": "MORPHINE SULFATE",
    "company": "ANDA REPOSITORY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/09/2025",
    "drugName": "COMETRIQNDA   #203756",
    "submission": "SUPPL-13",
    "activeIngredients": "CABOZANTINIB S-MALATE",
    "company": "EXELIXIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/09/2025",
    "drugName": "CABOMETYXNDA   #208692",
    "submission": "SUPPL-19",
    "activeIngredients": "CABOZANTINIB S-MALATE",
    "company": "EXELIXIS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/09/2025",
    "drugName": "SPRAVATONDA   #211243",
    "submission": "SUPPL-25",
    "activeIngredients": "ESKETAMINE HYDROCHLORIDE",
    "company": "JANSSEN PHARMS",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/09/2025",
    "drugName": "PEMETREXED DISODIUMANDA  #211899",
    "submission": "SUPPL-2",
    "activeIngredients": "PEMETREXED DISODIUM",
    "company": "RELIANCE LIFE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/09/2025",
    "drugName": "ZIPRASIDONE MESYLATEANDA  #211908",
    "submission": "SUPPL-5",
    "activeIngredients": "ZIPRASIDONE MESYLATE",
    "company": "GLAND",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/09/2025",
    "drugName": "HYDROMORPHONE HYDROCHLORIDEANDA  #212133",
    "submission": "SUPPL-4",
    "activeIngredients": "HYDROMORPHONE HYDROCHLORIDE",
    "company": "ASCENT PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/09/2025",
    "drugName": "LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDEANDA  #218015",
    "submission": "SUPPL-2",
    "activeIngredients": "HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM",
    "company": "GRANULES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/09/2025",
    "drugName": "IXIFIBLA   #761072",
    "submission": "SUPPL-14",
    "activeIngredients": "INFLIXIMAB-QBTX",
    "company": "PFIZER INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/10/2025",
    "drugName": "ISOVUE-128NDA   #018735",
    "submission": "SUPPL-75",
    "activeIngredients": "IOPAMIDOL",
    "company": "BRACCO",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/10/2025",
    "drugName": "ISOVUE-128NDA   #018735",
    "submission": "SUPPL-76",
    "activeIngredients": "IOPAMIDOL",
    "company": "BRACCO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/10/2025",
    "drugName": "ISOVUE-200NDA   #018735",
    "submission": "SUPPL-75",
    "activeIngredients": "IOPAMIDOL",
    "company": "BRACCO",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/10/2025",
    "drugName": "ISOVUE-200NDA   #018735",
    "submission": "SUPPL-76",
    "activeIngredients": "IOPAMIDOL",
    "company": "BRACCO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/10/2025",
    "drugName": "ISOVUE-250NDA   #018735",
    "submission": "SUPPL-75",
    "activeIngredients": "IOPAMIDOL",
    "company": "BRACCO",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/10/2025",
    "drugName": "ISOVUE-250NDA   #018735",
    "submission": "SUPPL-76",
    "activeIngredients": "IOPAMIDOL",
    "company": "BRACCO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/10/2025",
    "drugName": "ISOVUE-300NDA   #018735",
    "submission": "SUPPL-75",
    "activeIngredients": "IOPAMIDOL",
    "company": "BRACCO",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/10/2025",
    "drugName": "ISOVUE-300NDA   #018735",
    "submission": "SUPPL-76",
    "activeIngredients": "IOPAMIDOL",
    "company": "BRACCO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/10/2025",
    "drugName": "ISOVUE-370NDA   #018735",
    "submission": "SUPPL-75",
    "activeIngredients": "IOPAMIDOL",
    "company": "BRACCO",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/10/2025",
    "drugName": "ISOVUE-370NDA   #018735",
    "submission": "SUPPL-76",
    "activeIngredients": "IOPAMIDOL",
    "company": "BRACCO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/10/2025",
    "drugName": "ISOVUE-M 200NDA   #018735",
    "submission": "SUPPL-75",
    "activeIngredients": "IOPAMIDOL",
    "company": "BRACCO",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/10/2025",
    "drugName": "ISOVUE-M 200NDA   #018735",
    "submission": "SUPPL-76",
    "activeIngredients": "IOPAMIDOL",
    "company": "BRACCO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/10/2025",
    "drugName": "ISOVUE-M 300NDA   #018735",
    "submission": "SUPPL-75",
    "activeIngredients": "IOPAMIDOL",
    "company": "BRACCO",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/10/2025",
    "drugName": "ISOVUE-M 300NDA   #018735",
    "submission": "SUPPL-76",
    "activeIngredients": "IOPAMIDOL",
    "company": "BRACCO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/10/2025",
    "drugName": "LAMICTALNDA   #020241",
    "submission": "SUPPL-68",
    "activeIngredients": "LAMOTRIGINE",
    "company": "GLAXOSMITHKLINE LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/10/2025",
    "drugName": "LAMICTALNDA   #020241",
    "submission": "SUPPL-69",
    "activeIngredients": "LAMOTRIGINE",
    "company": "GLAXOSMITHKLINE LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/10/2025",
    "drugName": "LAMICTAL CDNDA   #020764",
    "submission": "SUPPL-61",
    "activeIngredients": "LAMOTRIGINE",
    "company": "GLAXOSMITHKLINE LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/10/2025",
    "drugName": "LAMICTAL CDNDA   #020764",
    "submission": "SUPPL-62",
    "activeIngredients": "LAMOTRIGINE",
    "company": "GLAXOSMITHKLINE LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/10/2025",
    "drugName": "LAMICTAL XRNDA   #022115",
    "submission": "SUPPL-33",
    "activeIngredients": "LAMOTRIGINE",
    "company": "GLAXOSMITHKLINE LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/10/2025",
    "drugName": "LAMICTAL XRNDA   #022115",
    "submission": "SUPPL-34",
    "activeIngredients": "LAMOTRIGINE",
    "company": "GLAXOSMITHKLINE LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/10/2025",
    "drugName": "LAMICTAL ODTNDA   #022251",
    "submission": "SUPPL-32",
    "activeIngredients": "LAMOTRIGINE",
    "company": "GLAXOSMITHKLINE LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/10/2025",
    "drugName": "LAMICTAL ODTNDA   #022251",
    "submission": "SUPPL-33",
    "activeIngredients": "LAMOTRIGINE",
    "company": "GLAXOSMITHKLINE LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/10/2025",
    "drugName": "MINOCYCLINE HYDROCHLORIDEANDA  #065062",
    "submission": "SUPPL-31",
    "activeIngredients": "MINOCYCLINE HYDROCHLORIDE",
    "company": "TORRENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/10/2025",
    "drugName": "ERRINANDA  #076225",
    "submission": "SUPPL-14",
    "activeIngredients": "NORETHINDRONE",
    "company": "DR REDDYS LABS SA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/10/2025",
    "drugName": "OXYMORPHONE HYDROCHLORIDEANDA  #090964",
    "submission": "SUPPL-11",
    "activeIngredients": "OXYMORPHONE HYDROCHLORIDE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/10/2025",
    "drugName": "OXYMORPHONE HYDROCHLORIDEANDA  #091443",
    "submission": "SUPPL-16",
    "activeIngredients": "OXYMORPHONE HYDROCHLORIDE",
    "company": "TEVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/10/2025",
    "drugName": "UNITUXINBLA   #125516",
    "submission": "SUPPL-41",
    "activeIngredients": "DINUTUXIMAB",
    "company": "UNITED THERAP",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/10/2025",
    "drugName": "ICLUSIGNDA   #203469",
    "submission": "SUPPL-38",
    "activeIngredients": "PONATINIB HYDROCHLORIDE",
    "company": "TAKEDA PHARMS USA",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/10/2025",
    "drugName": "OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDEANDA  #208847",
    "submission": "SUPPL-19",
    "activeIngredients": "HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL",
    "company": "UMEDICA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/10/2025",
    "drugName": "RINVOQNDA   #211675",
    "submission": "SUPPL-28",
    "activeIngredients": "UPADACITINIB",
    "company": "ABBVIE",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/10/2025",
    "drugName": "EMTRICITABINE AND TENOFOVIR ALAFENAMIDEANDA  #211680",
    "submission": "ORIG-1",
    "activeIngredients": "EMTRICITABINE, TENOFOVIR ALAFENAMIDE",
    "company": "CIPLA LIMITED",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "10/10/2025",
    "drugName": "ONGENTYSNDA   #212489",
    "submission": "SUPPL-11",
    "activeIngredients": "OPICAPONE",
    "company": "AMNEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/10/2025",
    "drugName": "UZEDYNDA   #213586",
    "submission": "SUPPL-8",
    "activeIngredients": "RISPERIDONE",
    "company": "TEVA",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/10/2025",
    "drugName": "UZEDYNDA   #213586",
    "submission": "SUPPL-9",
    "activeIngredients": "RISPERIDONE",
    "company": "TEVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/10/2025",
    "drugName": "OLPRUVANDA   #214860",
    "submission": "SUPPL-7",
    "activeIngredients": "SODIUM PHENYLBUTYRATE",
    "company": "ACER",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/10/2025",
    "drugName": "CHLORPROMAZINE HYDROCHLORIDEANDA  #216678",
    "submission": "ORIG-1",
    "activeIngredients": "CHLORPROMAZINE HYDROCHLORIDE",
    "company": "RUBICON",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/10/2025",
    "drugName": "RINVOQ LQNDA   #218347",
    "submission": "SUPPL-5",
    "activeIngredients": "UPADACITINIB",
    "company": "ABBVIE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/10/2025",
    "drugName": "GALLIUM GA 68 EDOTREOTIDEANDA  #218845",
    "submission": "ORIG-1",
    "activeIngredients": "GALLIUM GA-68 EDOTREOTIDE",
    "company": "METHODIST",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/14/2025",
    "drugName": "VICTOZANDA   #022341",
    "submission": "SUPPL-46",
    "activeIngredients": "LIRAGLUTIDE",
    "company": "NOVO NORDISK INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/14/2025",
    "drugName": "SAXENDANDA   #206321",
    "submission": "SUPPL-22",
    "activeIngredients": "LIRAGLUTIDE",
    "company": "NOVO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/14/2025",
    "drugName": "XULTOPHY 100/3.6BLA   #208583",
    "submission": "SUPPL-26",
    "activeIngredients": "INSULIN DEGLUDEC; LIRAGLUTIDE",
    "company": "NOVO",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/14/2025",
    "drugName": "OZEMPICNDA   #209637",
    "submission": "SUPPL-35",
    "activeIngredients": "SEMAGLUTIDE",
    "company": "NOVO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/14/2025",
    "drugName": "OZEMPICNDA   #209637",
    "submission": "SUPPL-37",
    "activeIngredients": "SEMAGLUTIDE",
    "company": "NOVO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/14/2025",
    "drugName": "DAPAGLIFLOZINANDA  #211482",
    "submission": "ORIG-1",
    "activeIngredients": "DAPAGLIFLOZIN",
    "company": "AJANTA PHARMA LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "10/14/2025",
    "drugName": "WEGOVYNDA   #215256",
    "submission": "SUPPL-26",
    "activeIngredients": "SEMAGLUTIDE",
    "company": "NOVO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/14/2025",
    "drugName": "EPINEPHRINEANDA  #217485",
    "submission": "ORIG-1",
    "activeIngredients": "EPINEPHRINE",
    "company": "AMNEAL",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/14/2025",
    "drugName": "BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDEANDA  #218766",
    "submission": "ORIG-1",
    "activeIngredients": "BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE",
    "company": "CIPLA LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "10/15/2025",
    "drugName": "AMLODIPINE BESYLATE AND VALSARTANANDA  #202377",
    "submission": "SUPPL-5",
    "activeIngredients": "AMLODIPINE BESYLATE; VALSARTAN",
    "company": "TORRENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/15/2025",
    "drugName": "AMLODIPINE BESYLATE AND VALSARTANANDA  #202377",
    "submission": "SUPPL-6",
    "activeIngredients": "AMLODIPINE BESYLATE; VALSARTAN",
    "company": "TORRENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/15/2025",
    "drugName": "LACOSAMIDEANDA  #204787",
    "submission": "SUPPL-1",
    "activeIngredients": "LACOSAMIDE",
    "company": "HETERO LABS LTD V",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/15/2025",
    "drugName": "LACOSAMIDEANDA  #204787",
    "submission": "SUPPL-2",
    "activeIngredients": "LACOSAMIDE",
    "company": "HETERO LABS LTD V",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/15/2025",
    "drugName": "LACOSAMIDEANDA  #204787",
    "submission": "SUPPL-4",
    "activeIngredients": "LACOSAMIDE",
    "company": "HETERO LABS LTD V",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/15/2025",
    "drugName": "LACOSAMIDEANDA  #204787",
    "submission": "SUPPL-5",
    "activeIngredients": "LACOSAMIDE",
    "company": "HETERO LABS LTD V",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/15/2025",
    "drugName": "LACOSAMIDEANDA  #204787",
    "submission": "SUPPL-8",
    "activeIngredients": "LACOSAMIDE",
    "company": "HETERO LABS LTD V",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/15/2025",
    "drugName": "CELECOXIBANDA  #211412",
    "submission": "SUPPL-1",
    "activeIngredients": "CELECOXIB",
    "company": "YILING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/15/2025",
    "drugName": "CELECOXIBANDA  #211412",
    "submission": "SUPPL-8",
    "activeIngredients": "CELECOXIB",
    "company": "YILING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/15/2025",
    "drugName": "DAPAGLIFLOZINANDA  #211506",
    "submission": "ORIG-1",
    "activeIngredients": "DAPAGLIFLOZIN",
    "company": "MACLEODS PHARMACEUTICALS LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "10/15/2025",
    "drugName": "FINTEPLANDA   #212102",
    "submission": "SUPPL-17",
    "activeIngredients": "FENFLURAMINE HYDROCHLORIDE",
    "company": "UCB INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/15/2025",
    "drugName": "SITAGLIPTIN AND METFORMIN HYDROCHLORIDEANDA  #212869",
    "submission": "ORIG-1",
    "activeIngredients": "SITAGLIPTIN, METFORMIN HYDROCHLORIDE",
    "company": "SINOTHERAPEUTICS INC",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "10/15/2025",
    "drugName": "PANTOPRAZOLE SODIUMANDA  #213778",
    "submission": "SUPPL-12",
    "activeIngredients": "PANTOPRAZOLE SODIUM",
    "company": "ASPIRO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/15/2025",
    "drugName": "PANTOPRAZOLE SODIUMANDA  #213778",
    "submission": "SUPPL-13",
    "activeIngredients": "PANTOPRAZOLE SODIUM",
    "company": "ASPIRO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/15/2025",
    "drugName": "CONJUGATED ESTROGENSANDA  #214023",
    "submission": "ORIG-1",
    "activeIngredients": "ESTROGENS, CONJUGATED",
    "company": "NOVAST LABS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/15/2025",
    "drugName": "CONJUGATED ESTROGENSANDA  #214025",
    "submission": "ORIG-1",
    "activeIngredients": "ESTROGENS, CONJUGATED",
    "company": "NOVAST LABS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/15/2025",
    "drugName": "LYTGOBINDA   #214801",
    "submission": "SUPPL-5",
    "activeIngredients": "FUTIBATINIB",
    "company": "TAIHO ONCOLOGY",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/15/2025",
    "drugName": "LIRAGLUTIDEANDA  #218115",
    "submission": "SUPPL-3",
    "activeIngredients": "LIRAGLUTIDE",
    "company": "NANJING KING FRIEND",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/16/2025",
    "drugName": "SOJOURNANDA  #077867",
    "submission": "SUPPL-30",
    "activeIngredients": "SEVOFLURANE",
    "company": "PIRAMAL CRITICAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/16/2025",
    "drugName": "XELJANZNDA   #203214",
    "submission": "SUPPL-39",
    "activeIngredients": "TOFACITINIB CITRATE",
    "company": "PF PRISM CV",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/16/2025",
    "drugName": "ALLOPURINOLANDA  #204467",
    "submission": "SUPPL-18",
    "activeIngredients": "ALLOPURINOL",
    "company": "REGCON HOLDINGS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/16/2025",
    "drugName": "XELJANZNDA   #213082",
    "submission": "SUPPL-11",
    "activeIngredients": "TOFACITINIB CITRATE",
    "company": "PFIZER",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/16/2025",
    "drugName": "ZTALMYNDA   #215904",
    "submission": "SUPPL-11",
    "activeIngredients": "GANAXOLONE",
    "company": "MARINUS",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/16/2025",
    "drugName": "ZTALMYNDA   #215904",
    "submission": "SUPPL-13",
    "activeIngredients": "GANAXOLONE",
    "company": "MARINUS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/16/2025",
    "drugName": "YORVIPATHNDA   #216490",
    "submission": "SUPPL-5",
    "activeIngredients": "PALOPEGTERIPARATIDE",
    "company": "ASCENDIS PHARMA BONE",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/16/2025",
    "drugName": "TRIMETHOBENZAMIDE HYDROCHLORIDEANDA  #219606",
    "submission": "ORIG-1",
    "activeIngredients": "TRIMETHOBENZAMIDE HYDROCHLORIDE",
    "company": "BPI LABS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/16/2025",
    "drugName": "FERABRIGHTNDA   #219868",
    "submission": "ORIG-1",
    "activeIngredients": "FERUMOXYTOL",
    "company": "COVIS",
    "submissionClassification": "Type 10 - New Indication Submitted as Distinct NDA - Not Consolidated",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/16/2025",
    "drugName": "AMJEVITABLA   #761024",
    "submission": "SUPPL-26",
    "activeIngredients": "ADALIMUMAB-ATTO",
    "company": "AMGEN INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/16/2025",
    "drugName": "CYLTEZOBLA   #761058",
    "submission": "SUPPL-35",
    "activeIngredients": "ADALIMUMAB-ADBM",
    "company": "BOEHRINGER INGELHEIM",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/16/2025",
    "drugName": "HYRIMOZBLA   #761071",
    "submission": "SUPPL-31",
    "activeIngredients": "ADALIMUMAB-ADAZ",
    "company": "SANDOZ INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/16/2025",
    "drugName": "YUFLYMABLA   #761219",
    "submission": "SUPPL-18",
    "activeIngredients": "ADALIMUMAB-AATY",
    "company": "CELLTRION",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/16/2025",
    "drugName": "SIMLANDIBLA   #761299",
    "submission": "SUPPL-25",
    "activeIngredients": "ADALIMUMAB-RYVK",
    "company": "ALVOTECH USA INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/17/2025",
    "drugName": "OXYMORPHONE HYDROCHLORIDEANDA  #079087",
    "submission": "SUPPL-47",
    "activeIngredients": "OXYMORPHONE HYDROCHLORIDE",
    "company": "IMPAX LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/17/2025",
    "drugName": "GAZYVABLA   #125486",
    "submission": "SUPPL-37",
    "activeIngredients": "OBINUTUZUMAB",
    "company": "GENENTECH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/17/2025",
    "drugName": "GAZYVABLA   #125486",
    "submission": "SUPPL-38",
    "activeIngredients": "OBINUTUZUMAB",
    "company": "GENENTECH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/17/2025",
    "drugName": "TACROLIMUSANDA  #206662",
    "submission": "SUPPL-1",
    "activeIngredients": "TACROLIMUS",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/17/2025",
    "drugName": "TACROLIMUSANDA  #206662",
    "submission": "SUPPL-3",
    "activeIngredients": "TACROLIMUS",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/17/2025",
    "drugName": "TACROLIMUSANDA  #206662",
    "submission": "SUPPL-7",
    "activeIngredients": "TACROLIMUS",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/17/2025",
    "drugName": "TACROLIMUSANDA  #206662",
    "submission": "SUPPL-11",
    "activeIngredients": "TACROLIMUS",
    "company": "GLENMARK PHARMS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/17/2025",
    "drugName": "POMALIDOMIDEANDA  #210275",
    "submission": "SUPPL-3",
    "activeIngredients": "POMALIDOMIDE",
    "company": "MYLAN",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/17/2025",
    "drugName": "BALVERSANDA   #212018",
    "submission": "SUPPL-11",
    "activeIngredients": "ERDAFITINIB",
    "company": "JANSSEN BIOTECH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/17/2025",
    "drugName": "RYBELSUSNDA   #213051",
    "submission": "SUPPL-24",
    "activeIngredients": "SEMAGLUTIDE",
    "company": "NOVO",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/17/2025",
    "drugName": "RYBELSUSNDA   #213051",
    "submission": "SUPPL-28",
    "activeIngredients": "SEMAGLUTIDE",
    "company": "NOVO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/17/2025",
    "drugName": "RYBELSUSNDA   #213051",
    "submission": "SUPPL-29",
    "activeIngredients": "SEMAGLUTIDE",
    "company": "NOVO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/17/2025",
    "drugName": "TRIAMCINOLONE ACETONIDEANDA  #218601",
    "submission": "ORIG-1",
    "activeIngredients": "TRIAMCINOLONE ACETONIDE",
    "company": "ALEMBIC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/17/2025",
    "drugName": "BUSPIRONE HYDROCHLORIDEANDA  #218628",
    "submission": "SUPPL-1",
    "activeIngredients": "BUSPIRONE HYDROCHLORIDE",
    "company": "PANGEA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/17/2025",
    "drugName": "CLOMIPHENE CITRATEANDA  #219781",
    "submission": "ORIG-1",
    "activeIngredients": "CLOMIPHENE CITRATE",
    "company": "NOVITIUM PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/17/2025",
    "drugName": "EPIOXA HD/EPIOXA KITNDA   #219910",
    "submission": "ORIG-1",
    "activeIngredients": "RIBOFLAVIN 5'-PHOSPHATE",
    "company": "GLAUKOS",
    "submissionClassification": "Type 5 - New Formulation or New Manufacturer",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/17/2025",
    "drugName": "TOLVAPTANANDA  #220147",
    "submission": "ORIG-1",
    "activeIngredients": "TOLVAPTAN",
    "company": "ALKEM LABORATORIES LIMITED",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "10/17/2025",
    "drugName": "HADLIMABLA   #761059",
    "submission": "SUPPL-32",
    "activeIngredients": "ADALIMUMAB-BWWD",
    "company": "SAMSUNG BIOEPIS CO LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/17/2025",
    "drugName": "VYVGARTBLA   #761195",
    "submission": "SUPPL-12",
    "activeIngredients": "EFGARTIGIMOD ALFA",
    "company": "ARGENX BV",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/17/2025",
    "drugName": "TEZSPIREBLA   #761224",
    "submission": "SUPPL-6",
    "activeIngredients": "TEZEPELUMAB-EKKO",
    "company": "ASTRAZENECA AB",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/17/2025",
    "drugName": "VYVGART HYTRULOBLA   #761304",
    "submission": "SUPPL-10",
    "activeIngredients": "EFGARTIGIMOD ALFA AND HYALURONIDASE-QVFC",
    "company": "ARGENX BV",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/20/2025",
    "drugName": "VANRAFIANDA   #219208",
    "submission": "SUPPL-1",
    "activeIngredients": "ATRASENTAN HYDROCHLORIDE",
    "company": "NOVARTIS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/20/2025",
    "drugName": "PROPARACAINE HYDROCHLORIDEANDA  #219294",
    "submission": "ORIG-1",
    "activeIngredients": "PROPARACAINE HYDROCHLORIDE",
    "company": "MICRO LABS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/20/2025",
    "drugName": "BEYFORTUSBLA   #761328",
    "submission": "SUPPL-12",
    "activeIngredients": "NIRSEVIMAB-ALIP",
    "company": "ASTRAZENECA AB",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/21/2025",
    "drugName": "TRIAMTERENE AND HYDROCHLOROTHIAZIDEANDA  #074701",
    "submission": "SUPPL-21",
    "activeIngredients": "HYDROCHLOROTHIAZIDE; TRIAMTERENE",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/21/2025",
    "drugName": "TRIAMTERENE AND HYDROCHLOROTHIAZIDEANDA  #074701",
    "submission": "SUPPL-28",
    "activeIngredients": "HYDROCHLOROTHIAZIDE; TRIAMTERENE",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/21/2025",
    "drugName": "SUMATRIPTAN SUCCINATEANDA  #077871",
    "submission": "SUPPL-2",
    "activeIngredients": "SUMATRIPTAN SUCCINATE",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/21/2025",
    "drugName": "TRAMADOL HYDROCHLORIDEANDA  #078783",
    "submission": "SUPPL-15",
    "activeIngredients": "TRAMADOL HYDROCHLORIDE",
    "company": "STRIDES PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/21/2025",
    "drugName": "TRAMADOL HYDROCHLORIDEANDA  #091498",
    "submission": "SUPPL-14",
    "activeIngredients": "TRAMADOL HYDROCHLORIDE",
    "company": "CSPC OUYI PHARM CO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/21/2025",
    "drugName": "BLINCYTOBLA   #125557",
    "submission": "SUPPL-32",
    "activeIngredients": "BLINATUMOMAB",
    "company": "AMGEN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/21/2025",
    "drugName": "TRAMADOL HYDROCHLORIDEANDA  #200503",
    "submission": "SUPPL-17",
    "activeIngredients": "TRAMADOL HYDROCHLORIDE",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/21/2025",
    "drugName": "OXYMORPHONE HYDROCHLORIDEANDA  #200822",
    "submission": "SUPPL-19",
    "activeIngredients": "OXYMORPHONE HYDROCHLORIDE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/21/2025",
    "drugName": "TRAMADOL HYDROCHLORIDEANDA  #201384",
    "submission": "SUPPL-30",
    "activeIngredients": "TRAMADOL HYDROCHLORIDE",
    "company": "SUN PHARM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/21/2025",
    "drugName": "CELECOXIBANDA  #202240",
    "submission": "SUPPL-16",
    "activeIngredients": "CELECOXIB",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/21/2025",
    "drugName": "DEFERASIROXANDA  #203560",
    "submission": "SUPPL-4",
    "activeIngredients": "DEFERASIROX",
    "company": "ACTAVIS ELIZABETH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/21/2025",
    "drugName": "DEFERASIROXANDA  #203560",
    "submission": "SUPPL-5",
    "activeIngredients": "DEFERASIROX",
    "company": "ACTAVIS ELIZABETH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/21/2025",
    "drugName": "DEFERASIROXANDA  #203560",
    "submission": "SUPPL-6",
    "activeIngredients": "DEFERASIROX",
    "company": "ACTAVIS ELIZABETH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/21/2025",
    "drugName": "DEFERASIROXANDA  #203560",
    "submission": "SUPPL-8",
    "activeIngredients": "DEFERASIROX",
    "company": "ACTAVIS ELIZABETH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/21/2025",
    "drugName": "DEFERASIROXANDA  #203560",
    "submission": "SUPPL-12",
    "activeIngredients": "DEFERASIROX",
    "company": "ACTAVIS ELIZABETH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/21/2025",
    "drugName": "DEFERASIROXANDA  #203560",
    "submission": "SUPPL-14",
    "activeIngredients": "DEFERASIROX",
    "company": "ACTAVIS ELIZABETH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/21/2025",
    "drugName": "IMBRUVICANDA   #205552",
    "submission": "SUPPL-44",
    "activeIngredients": "IBRUTINIB",
    "company": "PHARMACYCLICS LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/21/2025",
    "drugName": "IMBRUVICANDA   #210563",
    "submission": "SUPPL-20",
    "activeIngredients": "IBRUTINIB",
    "company": "PHARMACYCLICS LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/21/2025",
    "drugName": "MIEBONDA   #216675",
    "submission": "SUPPL-9",
    "activeIngredients": "PERFLUOROHEXYLOCTANE",
    "company": "BAUSCH AND LOMB INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/21/2025",
    "drugName": "IMBRUVICANDA   #217003",
    "submission": "SUPPL-5",
    "activeIngredients": "IBRUTINIB",
    "company": "PHARMACYCLICS LLC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/21/2025",
    "drugName": "CALCIUM CHLORIDE 10%ANDA  #217524",
    "submission": "SUPPL-1",
    "activeIngredients": "CALCIUM CHLORIDE",
    "company": "AMNEAL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/21/2025",
    "drugName": "TRIFAROTENEANDA  #218978",
    "submission": "ORIG-1",
    "activeIngredients": "TRIFAROTENE",
    "company": "TARO PHARMACEUTICALS INC",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "10/21/2025",
    "drugName": "SPEVIGOBLA   #761244",
    "submission": "SUPPL-7",
    "activeIngredients": "SPESOLIMAB-SBZO",
    "company": "BOEHRINGER INGELHEIM PHARMACEUTICALS INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/22/2025",
    "drugName": "VISINENDA   #020485",
    "submission": "SUPPL-21",
    "activeIngredients": "NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE",
    "company": "KENVUE BRANDS",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/22/2025",
    "drugName": "SIMPONIBLA   #125289",
    "submission": "SUPPL-158",
    "activeIngredients": "GOLIMUMAB",
    "company": "CENTOCOR ORTHO BIOTECH INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/22/2025",
    "drugName": "ESMOLOL HYDROCHLORIDEANDA  #207107",
    "submission": "SUPPL-4",
    "activeIngredients": "ESMOLOL HYDROCHLORIDE",
    "company": "SAGENT PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/22/2025",
    "drugName": "OXALIPLATINANDA  #207562",
    "submission": "SUPPL-10",
    "activeIngredients": "OXALIPLATIN",
    "company": "NOVAST LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/22/2025",
    "drugName": "CONTEPONDA   #212271",
    "submission": "ORIG-1",
    "activeIngredients": "FOSFOMYCIN",
    "company": "MEITHEAL",
    "submissionClassification": "Type 2 - New Active Ingredient",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/22/2025",
    "drugName": "ACETAMINOPHEN AND IBUPROFENANDA  #214836",
    "submission": "SUPPL-2",
    "activeIngredients": "ACETAMINOPHEN; IBUPROFEN",
    "company": "L PERRIGO CO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/22/2025",
    "drugName": "ACETAMINOPHEN AND IBUPROFENANDA  #214836",
    "submission": "SUPPL-3",
    "activeIngredients": "ACETAMINOPHEN; IBUPROFEN",
    "company": "L PERRIGO CO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/22/2025",
    "drugName": "ACETAMINOPHEN AND IBUPROFENANDA  #214836",
    "submission": "SUPPL-5",
    "activeIngredients": "ACETAMINOPHEN; IBUPROFEN",
    "company": "L PERRIGO CO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/22/2025",
    "drugName": "ARIPIPRAZOLEANDA  #215582",
    "submission": "ORIG-1",
    "activeIngredients": "ARIPIPRAZOLE",
    "company": "QUAGEN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/22/2025",
    "drugName": "LOFEXIDINE HYDROCHLORIDEANDA  #219917",
    "submission": "ORIG-1",
    "activeIngredients": "LOFEXIDINE HYDROCHLORIDE",
    "company": "NOVITIUM PHARMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/22/2025",
    "drugName": "NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDEANDA  #220243",
    "submission": "ORIG-1",
    "activeIngredients": "NICARDIPINE HYDROCHLORIDE",
    "company": "CAPLIN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/22/2025",
    "drugName": "VYEPTIBLA   #761119",
    "submission": "SUPPL-11",
    "activeIngredients": "EPTINEZUMAB-JJMR",
    "company": "Lundbeck Seattle BioPharmaceuticals, Inc.",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/23/2025",
    "drugName": "OLANZAPINEANDA  #076534",
    "submission": "SUPPL-17",
    "activeIngredients": "OLANZAPINE",
    "company": "DR REDDYS LABS LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/23/2025",
    "drugName": "QUINAPRIL HYDROCHLORIDEANDA  #076694",
    "submission": "SUPPL-13",
    "activeIngredients": "QUINAPRIL HYDROCHLORIDE",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/23/2025",
    "drugName": "QUINAPRIL HYDROCHLORIDEANDA  #076694",
    "submission": "SUPPL-14",
    "activeIngredients": "QUINAPRIL HYDROCHLORIDE",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/23/2025",
    "drugName": "ONDANSETRON HYDROCHLORIDEANDA  #078776",
    "submission": "SUPPL-19",
    "activeIngredients": "ONDANSETRON HYDROCHLORIDE",
    "company": "AUROBINDO PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/23/2025",
    "drugName": "VORICONAZOLEANDA  #090547",
    "submission": "SUPPL-19",
    "activeIngredients": "VORICONAZOLE",
    "company": "MYLAN PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/23/2025",
    "drugName": "OLANZAPINEANDA  #202050",
    "submission": "SUPPL-25",
    "activeIngredients": "OLANZAPINE",
    "company": "AUROBINDO PHARMA LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/23/2025",
    "drugName": "ONDANSETRON HYDROCHLORIDEANDA  #204906",
    "submission": "SUPPL-2",
    "activeIngredients": "ONDANSETRON HYDROCHLORIDE",
    "company": "RISING",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/23/2025",
    "drugName": "DESIPRAMINE HYDROCHLORIDEANDA  #204963",
    "submission": "SUPPL-6",
    "activeIngredients": "DESIPRAMINE HYDROCHLORIDE",
    "company": "NOVAST LABS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/23/2025",
    "drugName": "TOPIRAMATEANDA  #206210",
    "submission": "SUPPL-2",
    "activeIngredients": "TOPIRAMATE",
    "company": "ACTAVIS LABS FL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/23/2025",
    "drugName": "TOPIRAMATEANDA  #206210",
    "submission": "SUPPL-5",
    "activeIngredients": "TOPIRAMATE",
    "company": "ACTAVIS LABS FL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/23/2025",
    "drugName": "VORICONAZOLEANDA  #206747",
    "submission": "SUPPL-17",
    "activeIngredients": "VORICONAZOLE",
    "company": "CADILA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/23/2025",
    "drugName": "DEHYDRATED ALCOHOLNDA   #214988",
    "submission": "ORIG-1",
    "activeIngredients": "DEHYDRATED ALCOHOL",
    "company": "ROYAL PHARMA LLC",
    "submissionClassification": "Type 5 - New Formulation or New Manufacturer",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/23/2025",
    "drugName": "DOCOSANOLANDA  #215505",
    "submission": "ORIG-1",
    "activeIngredients": "DOCOSANOL",
    "company": "DR REDDYS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/23/2025",
    "drugName": "BEMPEDOIC ACID AND EZETIMIBEANDA  #219421",
    "submission": "ORIG-1",
    "activeIngredients": "BEMPEDOIC ACID, EZETIMIBE",
    "company": "ALKEM LABORATORIES LIMITED",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "10/23/2025",
    "drugName": "DALBAVANCIN HYDROCHLORIDEANDA  #219465",
    "submission": "ORIG-1",
    "activeIngredients": "DALBAVANCIN HYDROCHLORIDE",
    "company": "TEVA PHARMS INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/23/2025",
    "drugName": "JAVADINNDA   #220256",
    "submission": "ORIG-1",
    "activeIngredients": "CLONIDINE HYDROCHLORIDE",
    "company": "AZURITY",
    "submissionClassification": "Type 3 - New Dosage Form",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/23/2025",
    "drugName": "OMVOHBLA   #761279",
    "submission": "SUPPL-5",
    "activeIngredients": "MIRIKIZUMAB-MRKZ",
    "company": "ELI LILLY AND CO",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/23/2025",
    "drugName": "BLENREPBLA   #761440",
    "submission": "ORIG-1",
    "activeIngredients": "BELANTAMAB MAFODOTIN-BLMF",
    "company": "GLAXOSMITHKLINE LLC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/24/2025",
    "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #040248",
    "submission": "SUPPL-11",
    "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
    "company": "CHARTWELL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/24/2025",
    "drugName": "HYDROCODONE BITARTRATE AND ACETAMINOPHENANDA  #040432",
    "submission": "SUPPL-17",
    "activeIngredients": "ACETAMINOPHEN; HYDROCODONE BITARTRATE",
    "company": "CHARTWELL",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/24/2025",
    "drugName": "TRAMADOL HYDROCHLORIDEANDA  #076003",
    "submission": "SUPPL-57",
    "activeIngredients": "TRAMADOL HYDROCHLORIDE",
    "company": "AMNEAL PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/24/2025",
    "drugName": "TRAMADOL HYDROCHLORIDEANDA  #076100",
    "submission": "SUPPL-25",
    "activeIngredients": "TRAMADOL HYDROCHLORIDE",
    "company": "SUN PHARM INDUSTRIES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/24/2025",
    "drugName": "LEFLUNOMIDEANDA  #077086",
    "submission": "SUPPL-35",
    "activeIngredients": "LEFLUNOMIDE",
    "company": "HERITAGE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/24/2025",
    "drugName": "LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDEANDA  #078245",
    "submission": "SUPPL-46",
    "activeIngredients": "HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM",
    "company": "LUPIN LTD",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/24/2025",
    "drugName": "ANASTROZOLEANDA  #078485",
    "submission": "SUPPL-9",
    "activeIngredients": "ANASTROZOLE",
    "company": "HIKMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/24/2025",
    "drugName": "ANASTROZOLEANDA  #079007",
    "submission": "SUPPL-5",
    "activeIngredients": "ANASTROZOLE",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/24/2025",
    "drugName": "LETROZOLEANDA  #203796",
    "submission": "SUPPL-2",
    "activeIngredients": "LETROZOLE",
    "company": "HIKMA PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/24/2025",
    "drugName": "JARDIANCENDA   #204629",
    "submission": "SUPPL-63",
    "activeIngredients": "EMPAGLIFLOZIN",
    "company": "BOEHRINGER INGELHEIM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/24/2025",
    "drugName": "GLYXAMBINDA   #206073",
    "submission": "SUPPL-44",
    "activeIngredients": "EMPAGLIFLOZIN; LINAGLIPTIN",
    "company": "BOEHRINGER INGELHEIM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/24/2025",
    "drugName": "SYNJARDYNDA   #206111",
    "submission": "SUPPL-46",
    "activeIngredients": "EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE",
    "company": "BOEHRINGER INGELHEIM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/24/2025",
    "drugName": "RIVAROXABANANDA  #208546",
    "submission": "ORIG-1",
    "activeIngredients": "RIVAROXABAN",
    "company": "MSN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/24/2025",
    "drugName": "SYNJARDY XRNDA   #208658",
    "submission": "SUPPL-34",
    "activeIngredients": "EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE",
    "company": "BOEHRINGER INGELHEIM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/24/2025",
    "drugName": "NEOSTIGMINE METHYLSULFATEANDA  #209933",
    "submission": "SUPPL-2",
    "activeIngredients": "NEOSTIGMINE METHYLSULFATE",
    "company": "AMPHASTAR PHARMS INC",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/24/2025",
    "drugName": "COPIKTRANDA   #211155",
    "submission": "SUPPL-9",
    "activeIngredients": "DUVELISIB",
    "company": "SECURA",
    "submissionClassification": "REMS",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/24/2025",
    "drugName": "ANASTROZOLEANDA  #212434",
    "submission": "SUPPL-5",
    "activeIngredients": "ANASTROZOLE",
    "company": "EUGIA PHARMA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/24/2025",
    "drugName": "TRIJARDY XRNDA   #212614",
    "submission": "SUPPL-29",
    "activeIngredients": "EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE",
    "company": "BOEHRINGER INGELHEIM",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/24/2025",
    "drugName": "NEFFYNDA   #214697",
    "submission": "SUPPL-3",
    "activeIngredients": "EPINEPHRINE",
    "company": "ARS PHARMS OPERATION",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/24/2025",
    "drugName": "ATROPINE SULFATEANDA  #217345",
    "submission": "ORIG-1",
    "activeIngredients": "ATROPINE SULFATE",
    "company": "HIKMA",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/24/2025",
    "drugName": "REVUFORJNDA   #218944",
    "submission": "SUPPL-3",
    "activeIngredients": "REVUMENIB CITRATE",
    "company": "SYNDAX",
    "submissionClassification": "Efficacy",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/24/2025",
    "drugName": "ROCURONIUM BROMIDENDA   #219108",
    "submission": "ORIG-1",
    "activeIngredients": "ROCURONIUM BROMIDE",
    "company": "STERINOVA INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/24/2025",
    "drugName": "LYNKUETNDA   #219469",
    "submission": "ORIG-1",
    "activeIngredients": "ELINZANETANT",
    "company": "BAYER HEALTHCARE PHARMS",
    "submissionClassification": "Type 1 - New Molecular Entity",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/24/2025",
    "drugName": "RESNIBENNDA   #220258",
    "submission": "ORIG-1",
    "activeIngredients": "CABOZANTINIB",
    "company": "AZURITY",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "10/24/2025",
    "drugName": "WINREVAIRBLA   #761363",
    "submission": "SUPPL-7",
    "activeIngredients": "SOTATERCEPT-CSRK",
    "company": "MERCK SHARP DOHME",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/27/2025",
    "drugName": "DUREZOLNDA   #022212",
    "submission": "SUPPL-25",
    "activeIngredients": "DIFLUPREDNATE",
    "company": "SANDOZ",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/27/2025",
    "drugName": "TRAMADOL HYDROCHLORIDEANDA  #075982",
    "submission": "SUPPL-16",
    "activeIngredients": "TRAMADOL HYDROCHLORIDE",
    "company": "PLIVA",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/27/2025",
    "drugName": "KINERETBLA   #103950",
    "submission": "SUPPL-5197",
    "activeIngredients": "ANAKINRA",
    "company": "BIOVITRUM AB",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/27/2025",
    "drugName": "ASTEPRO ALLERGYNDA   #213872",
    "submission": "SUPPL-5",
    "activeIngredients": "AZELASTINE HYDROCHLORIDE",
    "company": "BAYER HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/27/2025",
    "drugName": "CHILDREN'S ASTEPRO ALLERGYNDA   #213872",
    "submission": "SUPPL-5",
    "activeIngredients": "AZELASTINE HYDROCHLORIDE",
    "company": "BAYER HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/27/2025",
    "drugName": "TAFAMIDISANDA  #218205",
    "submission": "ORIG-1",
    "activeIngredients": "TAFAMIDIS",
    "company": "ZENARA PHARMA PRIVATE LTD",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "10/27/2025",
    "drugName": "POTASSIUM CHLORIDEANDA  #218979",
    "submission": "SUPPL-3",
    "activeIngredients": "POTASSIUM CHLORIDE",
    "company": "TWI PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/27/2025",
    "drugName": "LOMUSTINEANDA  #219265",
    "submission": "ORIG-1",
    "activeIngredients": "LOMUSTINE",
    "company": "CARNEGIE",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/27/2025",
    "drugName": "GLYCOPYRROLATEANDA  #219267",
    "submission": "ORIG-1",
    "activeIngredients": "GLYCOPYRROLATE",
    "company": "AJENAT PHARMS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/27/2025",
    "drugName": "SEVELAMER CARBONATEANDA  #219931",
    "submission": "ORIG-1",
    "activeIngredients": "SEVELAMER CARBONATE",
    "company": "NAVINTA LLC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/27/2025",
    "drugName": "COLUMVIBLA   #761309",
    "submission": "SUPPL-4",
    "activeIngredients": "GLOFITAMAB-GXBM",
    "company": "GENENTECH INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/27/2025",
    "drugName": "OPDIVO QVANTIGBLA   #761381",
    "submission": "SUPPL-1",
    "activeIngredients": "NIVOLUMAB;HYALURONIDASE-NVHY",
    "company": "BRISTOL-MYERS SQUIBB",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/27/2025",
    "drugName": "OPDIVO QVANTIGBLA   #761381",
    "submission": "SUPPL-2",
    "activeIngredients": "NIVOLUMAB;HYALURONIDASE-NVHY",
    "company": "BRISTOL-MYERS SQUIBB",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/28/2025",
    "drugName": "ENLON-PLUSNDA   #019677",
    "submission": "SUPPL-11",
    "activeIngredients": "ATROPINE SULFATE; EDROPHONIUM CHLORIDE",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/28/2025",
    "drugName": "ENLON-PLUSNDA   #019678",
    "submission": "SUPPL-10",
    "activeIngredients": "ATROPINE SULFATE; EDROPHONIUM CHLORIDE",
    "company": "PHARMOBEDIENT",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/28/2025",
    "drugName": "TIVICAYNDA   #204790",
    "submission": "SUPPL-33",
    "activeIngredients": "DOLUTEGRAVIR SODIUM",
    "company": "VIIV HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/28/2025",
    "drugName": "TRIUMEQNDA   #205551",
    "submission": "SUPPL-34",
    "activeIngredients": "ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE",
    "company": "VIIV HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/28/2025",
    "drugName": "TICAGRELORANDA  #208508",
    "submission": "ORIG-2",
    "activeIngredients": "TICAGRELOR",
    "company": "SUNSHINE",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/28/2025",
    "drugName": "TICAGRELORANDA  #208537",
    "submission": "ORIG-2",
    "activeIngredients": "TICAGRELOR",
    "company": "INVAGEN PHARMS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/28/2025",
    "drugName": "TICAGRELORANDA  #208541",
    "submission": "ORIG-2",
    "activeIngredients": "TICAGRELOR",
    "company": "DR REDDYS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/28/2025",
    "drugName": "TICAGRELORANDA  #208576",
    "submission": "ORIG-2",
    "activeIngredients": "TICAGRELOR",
    "company": "ALEMBIC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/28/2025",
    "drugName": "TICAGRELORANDA  #208584",
    "submission": "ORIG-2",
    "activeIngredients": "TICAGRELOR",
    "company": "APOTEX",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/28/2025",
    "drugName": "TICAGRELORANDA  #208596",
    "submission": "ORIG-2",
    "activeIngredients": "TICAGRELOR",
    "company": "MSN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/28/2025",
    "drugName": "JULUCANDA   #210192",
    "submission": "SUPPL-17",
    "activeIngredients": "DOLUTEGRAVIR SODIUM; RILPIVIRINE HYDROCHLORIDE",
    "company": "VIIV HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/28/2025",
    "drugName": "TICAGRELORANDA  #210219",
    "submission": "ORIG-1",
    "activeIngredients": "TICAGRELOR",
    "company": "ALKEM LABS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/28/2025",
    "drugName": "TICAGRELORANDA  #211498",
    "submission": "ORIG-1",
    "activeIngredients": "TICAGRELOR",
    "company": "TARO",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/28/2025",
    "drugName": "DOVATONDA   #211994",
    "submission": "SUPPL-23",
    "activeIngredients": "DOLUTEGRAVIR SODIUM; LAMIVUDINE",
    "company": "VIIV HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/28/2025",
    "drugName": "TICAGRELORANDA  #212258",
    "submission": "ORIG-1",
    "activeIngredients": "TICAGRELOR",
    "company": "MACLEODS PHARMS LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/28/2025",
    "drugName": "BECLOMETHASONE DIPROPIONATEANDA  #213811",
    "submission": "ORIG-1",
    "activeIngredients": "BECLOMETHASONE DIPROPIONATE",
    "company": "AMNEAL IRELAND LIMITED",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "10/28/2025",
    "drugName": "TIVICAY PDNDA   #213983",
    "submission": "SUPPL-6",
    "activeIngredients": "DOLUTEGRAVIR SODIUM",
    "company": "VIIV HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/28/2025",
    "drugName": "TRIUMEQ PDNDA   #215413",
    "submission": "SUPPL-5",
    "activeIngredients": "ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE",
    "company": "VIIV HLTHCARE",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/28/2025",
    "drugName": "TICAGRELORANDA  #216187",
    "submission": "ORIG-1",
    "activeIngredients": "TICAGRELOR",
    "company": "CHANGZHOU PHARM",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/28/2025",
    "drugName": "DROSPIRENONE AND ESTRADIOLANDA  #218031",
    "submission": "ORIG-1",
    "activeIngredients": "DROSPIRENONE; ESTRADIOL",
    "company": "NOVAST LABS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/28/2025",
    "drugName": "DROSPIRENONE AND ESTRADIOLANDA  #218031",
    "submission": "ORIG-2",
    "activeIngredients": "DROSPIRENONE; ESTRADIOL",
    "company": "NOVAST LABS",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  },
  {
    "approvalDate": "10/28/2025",
    "drugName": "TICAGRELORANDA  #218962",
    "submission": "ORIG-1",
    "activeIngredients": "TICAGRELOR",
    "company": "SCIEGEN PHARMS INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/28/2025",
    "drugName": "NICARDIPINE HYDROCHLORIDEANDA  #219608",
    "submission": "ORIG-1",
    "activeIngredients": "NICARDIPINE HYDROCHLORIDE",
    "company": "QILU PHARM HAINAN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/28/2025",
    "drugName": "RENFLEXISBLA   #761054",
    "submission": "SUPPL-41",
    "activeIngredients": "INFLIXIMAB-ABDA",
    "company": "SAMSUNG BIOEPIS CO LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/28/2025",
    "drugName": "EBGLYSSBLA   #761306",
    "submission": "SUPPL-5",
    "activeIngredients": "LEBRIKIZUMAB-LBKZ",
    "company": "ELI LILLY AND CO",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/29/2025",
    "drugName": "KETALARNDA   #016812",
    "submission": "SUPPL-56",
    "activeIngredients": "KETAMINE HYDROCHLORIDE",
    "company": "PH HEALTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/29/2025",
    "drugName": "HIBICLENSNDA   #017768",
    "submission": "SUPPL-63",
    "activeIngredients": "CHLORHEXIDINE GLUCONATE",
    "company": "MOLNLYCKE HLTH",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/29/2025",
    "drugName": "PIFELTRONDA   #210806",
    "submission": "SUPPL-13",
    "activeIngredients": "DORAVIRINE",
    "company": "MSD MERCK CO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/29/2025",
    "drugName": "DELSTRIGONDA   #210807",
    "submission": "SUPPL-17",
    "activeIngredients": "DORAVIRINE; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE",
    "company": "MSD MERCK CO",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/29/2025",
    "drugName": "LOSARTAN POTASSIUMANDA  #215959",
    "submission": "SUPPL-7",
    "activeIngredients": "LOSARTAN POTASSIUM",
    "company": "GRANULES",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/29/2025",
    "drugName": "NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONEANDA  #217803",
    "submission": "ORIG-1",
    "activeIngredients": "HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE",
    "company": "AMNEAL",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/29/2025",
    "drugName": "VARENICLINE TARTRATEANDA  #218302",
    "submission": "ORIG-1",
    "activeIngredients": "VARENICLINE TARTRATE",
    "company": "MICRO LABS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/29/2025",
    "drugName": "POSACONAZOLEANDA  #218434",
    "submission": "SUPPL-1",
    "activeIngredients": "POSACONAZOLE",
    "company": "MSN",
    "submissionClassification": "Manufacturing (CMC)",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/29/2025",
    "drugName": "LIBTAYOBLA   #761097",
    "submission": "SUPPL-32",
    "activeIngredients": "CEMIPLIMAB-RWLC",
    "company": "REGENERON PHARMACEUTICALS",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/29/2025",
    "drugName": "JUBBONTIBLA   #761362",
    "submission": "SUPPL-5",
    "activeIngredients": "DENOSUMAB-BBDZ",
    "company": "SANDOZ INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/29/2025",
    "drugName": "WYOSTBLA   #761362",
    "submission": "SUPPL-5",
    "activeIngredients": "DENOSUMAB-BBDZ",
    "company": "SANDOZ INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/29/2025",
    "drugName": "DENOSUMAB-DSSBBLA   #761392",
    "submission": "ORIG-2",
    "activeIngredients": "DENOSUMAB-DSSB",
    "company": "SAMSUNG BIOEPIS CO LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/29/2025",
    "drugName": "OSPOMYVBLA   #761392",
    "submission": "ORIG-2",
    "activeIngredients": "DENOSUMAB-DSSB",
    "company": "SAMSUNG BIOEPIS CO LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/29/2025",
    "drugName": "XBRYKBLA   #761392",
    "submission": "ORIG-2",
    "activeIngredients": "DENOSUMAB-DSSB",
    "company": "SAMSUNG BIOEPIS CO LTD",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/29/2025",
    "drugName": "BOMYNTRABLA   #761398",
    "submission": "ORIG-2",
    "activeIngredients": "DENOSUMAB-BNHT",
    "company": "FRESENIUS KABI USA LLC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/29/2025",
    "drugName": "CONEXXENCEBLA   #761398",
    "submission": "ORIG-2",
    "activeIngredients": "DENOSUMAB-BNHT",
    "company": "FRESENIUS KABI USA LLC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/29/2025",
    "drugName": "OSENVELTBLA   #761404",
    "submission": "ORIG-2",
    "activeIngredients": "DENOSUMAB-BMWO",
    "company": "CELLTRION INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/29/2025",
    "drugName": "STOBOCLOBLA   #761404",
    "submission": "ORIG-2",
    "activeIngredients": "DENOSUMAB-BMWO",
    "company": "CELLTRION INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/29/2025",
    "drugName": "AUKELSOBLA   #761436",
    "submission": "ORIG-2",
    "activeIngredients": "DENOSUMAB-KYQQ",
    "company": "BIOCON BIOLOGICS INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/29/2025",
    "drugName": "BOSAYABLA   #761436",
    "submission": "ORIG-2",
    "activeIngredients": "DENOSUMAB-KYQQ",
    "company": "BIOCON BIOLOGICS INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/29/2025",
    "drugName": "ENOBYBLA   #761439",
    "submission": "ORIG-2",
    "activeIngredients": "DENOSUMAB-QBDE",
    "company": "HIKMA PHARMACEUTICALS USA INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/29/2025",
    "drugName": "XTRENBOBLA   #761439",
    "submission": "ORIG-2",
    "activeIngredients": "DENOSUMAB-QBDE",
    "company": "HIKMA PHARMACEUTICALS USA INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/29/2025",
    "drugName": "BILDYOSBLA   #761444",
    "submission": "ORIG-2",
    "activeIngredients": "DENOSUMAB-NXXP",
    "company": "SHANGHAI HENLIUS BIOTECH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/29/2025",
    "drugName": "BILPREVDABLA   #761444",
    "submission": "ORIG-2",
    "activeIngredients": "DENOSUMAB-NXXP",
    "company": "SHANGHAI HENLIUS BIOTECH",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/30/2025",
    "drugName": "HALDOLNDA   #018701",
    "submission": "SUPPL-77",
    "activeIngredients": "HALOPERIDOL DECANOATE",
    "company": "JANSSEN PHARMS",
    "submissionClassification": "Labeling",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/30/2025",
    "drugName": "VIMIZIMBLA   #125460",
    "submission": "SUPPL-25",
    "activeIngredients": "ELOSULFASE ALFA",
    "company": "BIOMARIN PHARM",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/30/2025",
    "drugName": "AXITINIBANDA  #211650",
    "submission": "ORIG-1",
    "activeIngredients": "AXITINIB",
    "company": "APOTEX",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/30/2025",
    "drugName": "EVEROLIMUSANDA  #219955",
    "submission": "ORIG-1",
    "activeIngredients": "EVEROLIMUS",
    "company": "NOVUGEN",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/30/2025",
    "drugName": "TYRUKOBLA   #761322",
    "submission": "SUPPL-2",
    "activeIngredients": "NATALIZUMAB-SZTN",
    "company": "SANDOZ INC",
    "submissionClassification": "",
    "submissionStatus": "Approval"
  },
  {
    "approvalDate": "10/31/2025",
    "drugName": "CANAGLIFLOZINANDA  #210312",
    "submission": "ORIG-1",
    "activeIngredients": "CANAGLIFLOZIN",
    "company": "INDOCO REMEDIES",
    "submissionClassification": "",
    "submissionStatus": "Tentative Approval"
  }
]

// Normalized helper: convert legacy keys to camelCase keys
type NormalizedRawItem = {
  approvalDate: string;
  drugName: string;
  submission: string;
  activeIngredients: string;
  company: string;
  submissionClassification: string;
  submissionStatus: string;
};

const normalizeRawItem = (item: any): NormalizedRawItem => ({
  approvalDate: item["approvalDate"] ?? "",
  drugName: item["drugName"] ?? "",
  submission: item["submission"] ?? "",
  activeIngredients: item["activeIngredients"] ?? "",
  company: item["company"] ?? "",
  submissionClassification: item["submissionClassification"] ?? "",
  submissionStatus: item["submissionStatus"] ?? "",
});

// Use this export wherever you need the new keys
export const sampleRawDataNormalized: NormalizedRawItem[] = (sampleRawData as any[]).map(normalizeRawItem);
